data_2m5d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m5d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.719 0.295 . . . . 73.33 111.137 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mm -89.85 153.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 74.45 111.112 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -145.7 153.09 40.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 75.1 110.934 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -92.2 165.51 13.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.292 -0.413 . . . . 75.25 110.882 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.96 -35.13 45.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.42 110.844 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -88.06 -31.61 19.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.52 111.131 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.02 -12.9 67.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 73.11 112.523 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -51.05 -32.26 21.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 72.14 111.156 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 mt -121.72 147.73 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 74.42 111.125 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -167.57 169.34 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 63.55 110.856 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.52 -176.04 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 71.15 111.117 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.3 t -166.97 133.79 2.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 71.32 110.859 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -70.17 118.12 12.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 75.41 110.875 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.92 -42.36 5.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.924 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.62 -169.95 3.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 71.44 110.859 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -47.61 63.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 73.3 110.919 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -134.59 28.69 3.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 75.04 110.905 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.43 120.57 60.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 75.45 111.089 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -125.66 159.28 32.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.938 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.5 t -121.74 108.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 65.21 111.122 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -101.17 138.26 38.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.33 110.832 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.1 m -137.01 124.39 21.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 73.4 111.156 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.68 177.46 4.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 65.15 110.888 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.78 135.76 45.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 75.11 110.929 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 70.32 112.499 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.417 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 98.1 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.646 0.736 . . . . 64.33 111.189 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.7 Cg_endo -69.67 142.7 49.03 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.641 2.227 . . . . 75.44 112.451 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -124.15 105.52 9.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 54.22 110.848 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -59.42 159.48 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 65.4 110.845 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.644 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -160.56 -160.22 10.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.74 . . . . 61.14 112.545 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -164.91 144.93 7.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 75.35 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -128.62 134.76 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 73.32 111.078 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.2 mt -103.47 136.13 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.952 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -106.34 74.82 1.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.818 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.6 p -83.1 177.84 8.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 73.51 111.127 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.44 30.51 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 73.11 110.845 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -155.6 24.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 65.31 110.893 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.61 130.81 4.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 65.42 112.457 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.98 166.76 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.845 0.355 . . . . 72.4 110.855 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.1 t -141.17 144.59 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.11 111.168 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.77 128.23 55.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.932 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.1 t -77.95 -3.04 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 71.14 111.136 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.644 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 2.9 p-10 179.23 132.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 72.53 110.87 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -71.34 -167.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 73.23 110.818 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.56 -173.28 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 71.32 110.825 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -67.55 -42.01 83.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 75.52 110.891 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.85 161.48 37.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 62.34 110.857 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.99 -38.07 69.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.86 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -71.45 -23.93 61.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 75.42 110.879 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -45.1 15.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 71.44 110.93 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.0 t -67.02 -25.37 66.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 75.55 111.149 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -53.09 -39.2 63.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 71.23 110.901 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -85.54 -14.56 45.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 71.32 110.827 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.76 -45.57 24.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.964 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.9 mt -71.73 -33.28 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.12 111.12 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.88 -17.15 62.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 72.51 110.846 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.2 mmm -85.43 -55.55 3.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.825 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.3 m -57.22 -37.2 55.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 72.22 111.068 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -86.71 49.95 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 74.31 110.851 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tpmp? -145.43 -42.13 0.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.908 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.82 -23.43 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 74.22 110.843 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.514 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 34.6 m-85 -90.04 11.24 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 75.02 110.923 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.92 46.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 74.41 110.892 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -154.29 -178.59 7.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 62.35 110.863 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 149.49 49.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.825 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 68.5 t -84.1 126.63 40.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 71.22 111.099 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.5 p -135.8 26.55 3.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 74.14 111.175 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -158.33 135.27 9.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.865 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 t -140.55 99.87 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.24 111.079 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.9 mt -77.21 126.0 37.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 74.0 111.06 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.6 mm -112.99 123.27 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 71.22 111.165 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.1 p -81.0 -52.81 7.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 75.44 111.125 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -135.33 167.63 20.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.853 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' H ' ' HD2' ' A' ' 152' ' ' ASP . . . -86.89 98.7 11.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 70.55 111.145 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -153.0 160.38 43.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 74.42 110.863 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.31 -28.09 62.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 75.51 111.027 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.443 ' HD2' HH21 ' A' ' 91' ' ' ARG . 1.0 OUTLIER -90.09 11.13 21.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.833 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.443 HH21 ' HD2' ' A' ' 90' ' ' ASP . 4.9 mmt180 -123.83 -52.62 1.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 72.11 110.924 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.79 16.92 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.11 111.165 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.42 -27.74 26.24 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.729 -0.748 . . . . 72.35 112.47 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.79 19.26 30.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.652 -0.785 . . . . 71.33 112.414 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 tt -48.73 -30.64 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 72.41 111.214 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -68.45 -43.97 75.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.855 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -69.38 -33.48 73.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 74.53 111.163 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.8 mt -63.75 -27.3 69.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 75.34 110.973 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.71 19.07 16.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 75.11 110.933 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.75 -23.87 7.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.911 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -110.87 10.02 22.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 73.03 110.865 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.17 18.76 66.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 70.14 112.471 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.0 mt -83.18 157.59 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 74.14 111.105 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.3 119.78 33.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 72.03 110.895 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.05 79.56 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 74.43 111.151 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -54.36 146.98 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 74.21 110.909 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.5 163.86 0.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.923 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.1 p -80.37 154.9 27.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.11 111.122 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.59 -29.88 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 71.54 111.104 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 tp -74.87 -43.25 55.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.935 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.0 m -53.19 -27.44 21.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 64.21 111.17 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.3 -28.02 21.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.056 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -60.12 -25.17 65.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.413 . . . . 75.32 110.887 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.6 mt -99.07 -24.67 14.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 75.31 110.88 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.65 -63.14 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.35 111.106 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -55.62 -25.74 40.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 74.33 110.855 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -24.67 65.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 72.44 110.875 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -95.32 -28.33 15.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 75.23 110.863 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.07 -5.44 7.82 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 71.4 112.442 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -59.6 -173.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 75.34 110.926 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -99.65 1.09 43.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.489 . . . . 72.13 110.911 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 65.69 122.84 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.719 0.771 . . . . 74.25 110.916 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.73 -170.52 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.647 2.231 . . . . 74.12 112.37 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.1 mt -52.16 -40.49 61.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.44 110.877 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.03 59.59 8.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 64.41 112.547 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -152.75 51.23 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 73.21 110.889 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 mp -130.1 -175.74 3.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.913 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.44 -167.93 2.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.952 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.3 m -49.15 -43.41 41.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 75.14 111.176 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.47 141.7 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 74.34 111.093 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.7 m -148.88 112.14 4.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.173 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.34 96.06 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 75.23 110.831 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 71.13 110.889 179.981 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.0 tpp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.876 0.37 . . . . 63.55 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 118.45 25.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.55 110.872 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.98 159.18 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 73.41 111.169 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -158.98 124.45 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 61.42 110.98 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.16 178.5 5.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 71.54 111.096 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -171.98 136.76 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.842 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -116.19 92.95 37.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.751 0.786 . . . . 74.34 110.896 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -48.72 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.615 2.21 . . . . 75.3 112.29 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.56 -170.38 42.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 72.11 112.479 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -84.26 123.61 30.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 75.42 110.938 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.476 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.18 -89.72 0.24 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.769 -0.729 . . . . 71.44 112.534 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -74.18 -28.27 61.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.367 . . . . 73.21 110.896 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.96 157.81 43.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 64.52 111.204 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -62.45 -25.14 67.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 75.1 110.891 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.533 ' HD2' ' H ' ' A' ' 87' ' ' ALA . 16.0 p30 -123.28 52.06 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.901 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.476 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 2.0 p30 -99.94 142.71 31.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.968 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.8 pt -144.28 158.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 75.12 111.173 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 18.4 m -105.11 150.5 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.44 111.113 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 96.0 t -102.56 139.05 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 72.05 111.116 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -126.99 150.71 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 74.42 110.904 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 20.7 mt -128.84 95.72 31.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.594 0.711 . . . . 75.41 110.853 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 72.18 1.51 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.699 2.266 . . . . 61.2 112.307 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.47 -34.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 74.1 110.908 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -117.95 -13.21 10.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.976 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.8 m120 69.0 26.19 5.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 75.44 110.918 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.83 117.61 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 72.33 111.107 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.13 138.04 41.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 73.2 110.946 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.52 68.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.1 111.143 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.37 -51.81 35.33 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.552 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.22 -135.44 12.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 62.14 112.501 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 31.4 m -62.22 -26.09 68.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 73.25 110.889 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -49.5 67.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 71.45 110.907 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.24 96.18 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 71.34 111.099 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -69.06 153.13 44.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.35 110.955 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.7 p -74.87 167.06 22.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.857 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 75.32 111.152 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.808 0.337 . . . . 72.21 111.124 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.7 -46.85 83.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 74.44 111.111 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.56 40.99 2.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 55.51 110.792 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -134.02 165.64 24.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.11 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -116.9 92.25 3.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.889 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 90.3 t -69.59 -23.81 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 72.55 111.19 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -25.81 39.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 74.52 110.904 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -97.75 -23.55 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 74.34 110.937 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -51.29 -54.42 26.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.974 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.3 t -51.88 -33.77 38.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 71.34 110.893 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 82.3 m -76.33 -34.01 59.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 73.21 111.182 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.9 m -66.36 -53.22 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 70.25 110.87 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.6 mm -56.3 -43.15 76.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 73.33 111.163 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.76 -19.77 59.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 70.54 110.884 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.63 -31.09 15.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 64.44 110.858 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.5 -50.74 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.13 111.101 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.08 -24.34 67.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 71.31 110.91 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.43 -43.78 15.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.92 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -52.95 -28.97 26.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.41 110.907 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -144.47 119.94 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.91 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.92 41.05 2.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 75.24 110.817 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.4 21.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.35 110.795 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -52.47 146.83 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 73.45 111.147 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.66 -28.87 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 75.41 110.902 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -159.61 139.28 11.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 74.11 111.069 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.18 126.04 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 74.22 111.146 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 55.8 t -107.66 113.12 61.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 71.14 111.077 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -170.27 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.687 2.258 . . . . 74.31 112.33 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.57 -31.25 7.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.67 -0.776 . . . . 74.45 112.489 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -143.5 94.61 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.827 0.346 . . . . 75.03 110.883 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 160.38 -114.94 0.63 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 74.34 112.454 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -150.27 162.77 39.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.957 0.408 . . . . 71.53 110.864 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.95 150.23 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.095 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.45 -108.81 0.56 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.772 -0.728 . . . . 64.23 112.551 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -159.81 -169.83 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 75.44 110.834 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -58.25 -20.19 40.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 73.54 110.899 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.67 -32.27 65.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.778 -0.725 . . . . 72.13 112.485 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 32.1 mt -51.03 -42.99 60.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.352 . . . . 73.31 110.892 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.43 -45.25 94.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.829 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.4 mt -64.27 -42.24 96.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.922 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -63.86 -39.67 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.963 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.5 m -51.75 -42.49 62.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 64.4 111.122 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.95 -39.91 87.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.92 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -28.03 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.43 110.849 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.27 -25.81 61.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 74.15 110.925 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.6 mt -87.42 -43.06 12.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 75.35 110.921 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.55 110.888 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 74.01 111.071 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.88 155.78 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 71.15 111.156 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -145.58 146.62 31.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.913 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 173.72 9.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 73.35 110.94 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.82 -36.01 77.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 61.21 110.893 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.3 p -95.17 -24.9 16.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 72.12 111.086 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.94 -11.3 57.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.728 . . . . 51.22 112.425 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.7 t -51.09 -33.28 25.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 62.21 111.119 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.64 148.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.04 111.13 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 p -169.2 165.56 10.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 75.23 110.87 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.15 -172.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 71.31 111.134 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.45 134.64 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 75.14 110.876 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.96 119.93 14.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 54.33 110.872 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -100.96 -55.02 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.882 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -138.47 53.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 73.41 110.894 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mttt 68.0 -76.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 72.44 110.88 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -84.11 -19.52 34.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 63.3 110.916 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.21 121.28 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 71.21 111.164 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -125.45 160.23 29.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.947 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -122.4 112.44 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 72.31 111.081 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -105.47 137.6 43.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 71.53 110.93 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 m -133.34 127.72 34.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 62.11 111.137 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.11 164.98 14.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.914 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.3 tp -118.84 143.3 47.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.91 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 72.3 112.508 179.843 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 121.587 0.708 . . . . 71.53 111.172 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 143.43 50.57 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.64 2.227 . . . . 73.22 112.349 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -130.92 95.87 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 74.52 110.857 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -51.94 155.21 1.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 71.22 110.843 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.558 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -155.97 -158.45 8.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.657 -0.782 . . . . 65.44 112.441 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.06 143.91 5.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 74.32 110.942 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.95 142.7 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 71.25 111.152 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.1 mt -111.92 127.5 55.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.908 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -93.33 48.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.871 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.6 p -56.52 166.18 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.11 111.127 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.5 t -95.99 34.17 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 72.4 110.843 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -157.65 28.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.9 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.6 124.1 4.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 75.32 112.516 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.1 mt -51.72 161.31 0.54 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.801 0.334 . . . . 74.15 110.88 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -139.74 144.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.114 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.63 129.93 56.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.003 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.36 -0.36 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 73.34 111.111 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.558 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 2.7 p-10 -179.72 132.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.54 110.845 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 m -71.24 -169.04 0.35 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.216 -0.447 . . . . 75.54 110.851 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.79 -170.75 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 74.2 110.843 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -72.86 -40.46 65.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.891 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.77 162.31 35.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 72.4 110.933 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.43 -33.51 67.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 71.23 110.91 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -75.63 -25.46 56.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 71.53 110.958 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -41.82 20.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.487 . . . . 73.44 110.939 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -68.03 -26.43 65.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.19 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.1 -43.69 70.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.936 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.05 -13.91 54.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.934 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.8 tp -77.35 -45.38 26.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.506 . . . . 75.42 110.926 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.22 -26.72 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 61.22 111.12 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.21 -10.15 59.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 74.34 110.891 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.0 mmm -90.82 -53.0 4.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 52.52 110.834 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 m -58.4 -39.85 76.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 72.33 111.155 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -84.29 51.09 2.0 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 65.42 110.877 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.14 -41.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 74.55 110.953 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.5 -19.18 13.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 75.25 110.848 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.519 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 24.2 m-85 -88.15 9.52 22.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 75.43 110.924 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.519 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.96 46.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 74.21 110.862 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -154.32 -179.15 7.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 73.53 110.902 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.21 149.39 51.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 75.43 110.884 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.9 t -82.22 128.43 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 75.15 111.13 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.5 p -138.94 23.04 2.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 75.4 111.15 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -154.93 132.6 11.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.226 -0.443 . . . . 72.42 110.846 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.6 99.89 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 72.51 111.091 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.0 mt -79.3 124.84 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 73.41 111.129 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.2 mm -111.51 132.88 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 75.35 111.171 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.5 p -89.05 -55.89 3.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 75.5 111.2 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -133.55 162.37 32.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.32 110.807 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.34 97.21 7.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 72.43 111.084 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -150.91 158.54 44.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 74.53 110.859 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.44 -25.59 59.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.33 111.086 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.37 13.17 18.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 72.32 110.894 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -128.12 -52.36 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 75.21 110.85 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.76 16.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 73.33 111.051 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.85 -27.52 21.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 44.43 112.512 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.11 20.83 23.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.723 . . . . 53.03 112.491 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 tt -48.48 -30.92 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 74.52 111.166 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -69.16 -43.76 73.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 71.13 110.878 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.5 m -67.84 -34.98 77.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 74.25 111.169 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.4 mt -60.63 -34.73 74.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.874 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.05 22.34 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 74.04 110.954 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -117.42 -20.27 9.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 72.24 110.933 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -115.78 5.9 14.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 74.15 110.872 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.4 60.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 53.51 112.489 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.4 mt -80.98 155.72 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.909 0.385 . . . . 75.23 111.106 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.48 122.94 41.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 73.51 110.914 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.98 81.61 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 71.12 111.055 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -57.87 146.88 30.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 75.42 110.798 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.21 159.32 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 72.3 110.846 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.0 p -72.81 152.67 41.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 73.41 111.185 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.58 -29.72 18.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.289 -0.414 . . . . 74.04 111.073 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.7 tp -74.6 -44.49 50.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.859 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.7 m -53.17 -27.63 22.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 72.21 111.168 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.66 -26.45 21.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 60.32 111.09 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -61.05 -26.88 67.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.202 -0.454 . . . . 73.33 110.979 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.6 -25.08 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 74.43 110.878 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.3 -64.4 0.88 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 71.51 111.081 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -55.41 -26.04 39.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 75.43 110.884 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -24.37 66.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.52 110.945 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -95.71 -32.2 12.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 73.44 110.87 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.47 -6.64 5.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 72.41 112.475 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -59.53 -173.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 75.42 110.923 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -99.46 -0.64 40.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 73.43 110.892 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 66.07 125.15 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.606 0.717 . . . . 74.51 110.892 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -170.6 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.69 2.26 . . . . 65.24 112.334 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 61.5 mt -53.66 -35.25 60.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.985 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.35 43.74 65.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 71.33 112.497 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -138.72 57.7 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 71.05 110.814 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.75 -169.74 2.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.926 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.2 -169.15 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 74.43 110.961 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 98.2 m -50.97 -70.13 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.145 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.45 109.27 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.094 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.1 m -112.72 103.69 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 74.23 111.146 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -66.14 96.18 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 70.33 110.861 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 72.45 110.818 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 tpt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.889 0.376 . . . . 72.23 110.862 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -130.42 127.62 39.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.917 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.9 t -139.76 157.5 26.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 75.42 111.084 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -155.35 119.79 4.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.9 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -178.17 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 75.03 111.169 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -175.49 137.93 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.5 110.943 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -121.89 96.16 47.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.684 0.754 . . . . 74.1 110.923 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.59 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.634 2.223 . . . . 71.41 112.297 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.09 -157.64 28.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 65.03 112.532 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.33 124.84 36.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.351 . . . . 74.21 110.88 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.46 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.17 -98.64 0.51 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.794 -0.717 . . . . 73.31 112.489 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -66.59 -26.95 67.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 71.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.98 161.5 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 73.31 111.167 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -64.37 -26.27 68.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 75.22 110.86 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -120.83 50.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.843 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.46 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.18 136.99 38.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 71.43 110.879 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.59 172.22 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 75.31 111.138 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.4 m -123.11 149.17 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 75.32 111.166 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -103.39 144.28 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 74.34 111.125 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -130.29 145.94 51.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 74.03 110.91 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.4 mt -123.91 96.71 42.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.545 0.688 . . . . 73.1 110.944 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 72.89 1.42 Allowed 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.669 2.246 . . . . 72.35 112.345 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.31 -34.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 72.51 110.823 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -117.44 -13.55 10.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 74.31 110.947 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m120 69.07 24.91 6.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 73.54 110.849 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.73 116.64 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.42 111.101 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.81 136.51 39.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 75.53 110.919 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.53 62.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 72.44 111.158 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.36 -55.7 18.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.676 -0.774 . . . . 75.43 112.529 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.15 -137.11 14.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 73.22 112.503 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.06 -20.18 56.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 71.33 110.9 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.86 -50.89 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 73.12 110.907 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.59 132.55 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.156 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.21 130.45 55.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 72.35 110.902 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.7 p -60.08 159.77 9.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 62.31 110.845 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 72.44 111.124 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.23 0.034 0 CA-C-O 120.81 0.338 . . . . 75.13 111.097 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.46 -34.94 67.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 75.32 111.058 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -122.74 35.86 4.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.835 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.41 165.84 23.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 74.04 111.139 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -113.76 92.75 4.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 74.3 110.927 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 91.6 t -68.54 -23.12 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 73.44 111.158 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.1 -25.65 36.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 74.51 110.85 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.49 -23.44 16.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 64.12 110.862 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.54 -52.49 46.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 74.22 110.953 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.7 p -52.0 -36.19 49.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 73.21 110.921 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.4 m -73.8 -36.51 65.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 72.23 111.14 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 74.3 m -63.38 -54.32 38.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.846 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.1 mm -56.35 -37.13 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.24 111.15 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.76 -22.59 66.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.827 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.13 -33.39 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 72.11 110.904 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 92.6 t -74.53 -49.36 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.31 111.135 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.7 -25.07 67.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 75.33 110.914 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -78.95 -45.55 20.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 74.35 110.947 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -60.09 -33.29 71.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.1 110.841 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -136.29 121.7 19.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.909 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -122.58 27.27 7.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 74.33 110.874 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.93 22.38 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.894 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.82 146.29 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.238 -0.437 . . . . 73.45 111.119 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -106.43 -25.69 11.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 74.32 110.878 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -163.59 128.6 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 71.34 111.128 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.15 118.88 55.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 74.01 111.17 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.8 98.05 16.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.699 . . . . 73.01 111.153 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -172.25 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.704 2.269 . . . . 72.51 112.383 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.74 -30.22 8.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.731 . . . . 73.51 112.475 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -142.56 106.23 4.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.872 0.368 . . . . 75.32 110.935 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 151.26 -96.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.81 -0.71 . . . . 72.04 112.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -178.96 153.99 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 73.02 110.838 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.4 t -63.79 147.83 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 75.15 111.114 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -152.38 -107.79 0.35 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.691 -0.766 . . . . 73.33 112.502 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -155.75 -173.57 4.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.926 0.393 . . . . 75.43 110.858 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -55.42 -22.83 21.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 62.52 110.843 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.03 -31.95 48.83 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 73.4 112.526 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 37.5 mt -50.99 -46.93 61.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 75.32 110.964 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.29 -43.3 70.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 75.44 110.92 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.33 -41.54 89.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.994 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -61.82 -38.1 86.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 73.43 110.911 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -55.76 -46.11 77.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 73.34 111.116 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.5 mt -54.22 -39.99 67.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.917 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -46.13 91.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 72.41 110.85 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.73 -26.39 56.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 72.41 110.889 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.5 mt -85.53 -45.6 11.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.93 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 64.01 110.896 179.826 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.801 0.334 . . . . 74.31 111.111 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mm -89.34 157.54 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 74.11 111.144 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -146.53 179.18 7.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 75.31 110.901 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.05 168.47 9.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 70.11 110.918 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -53.13 -29.52 31.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.894 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.6 p -104.74 -35.5 7.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 75.14 111.111 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.69 -4.58 29.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.798 -0.715 . . . . 70.01 112.501 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -51.18 -33.78 28.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.825 0.345 . . . . 75.52 111.154 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.4 mt -126.3 149.74 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 64.23 111.197 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.8 p -169.11 165.77 11.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 64.14 110.92 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.4 -171.79 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.081 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -174.49 133.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.881 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.57 120.66 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 72.13 110.93 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -101.61 -54.5 2.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.943 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -136.29 48.41 2.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 73.32 110.875 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt 70.68 -70.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 75.23 110.921 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -87.16 -22.18 25.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.924 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.45 123.78 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.12 111.121 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -125.43 159.94 30.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.904 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.8 t -120.23 110.1 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 75.13 111.097 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -104.59 139.25 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.833 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.3 m -137.07 132.27 33.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 75.15 111.17 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.516 ' HE2' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -123.42 166.75 14.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.844 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.3 tp -117.81 143.59 46.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 72.25 110.891 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 70.34 112.492 179.862 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.605 0.717 . . . . 73.34 111.123 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 141.57 45.64 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.724 2.283 . . . . 74.05 112.34 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -129.75 93.96 3.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.04 110.847 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -53.69 164.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 75.01 110.878 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.702 ' HA3' ' HD2' ' A' ' 56' ' ' ASP . . . -166.33 -165.58 23.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 64.21 112.531 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 tp -157.32 142.04 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 74.24 110.919 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.75 132.27 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 75.33 111.144 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.05 131.87 45.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.876 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -100.49 66.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 75.33 110.855 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.5 p -72.77 170.92 13.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 74.32 111.103 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.6 t -96.0 27.18 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.853 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -150.76 27.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 74.51 110.92 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.05 127.79 4.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.664 -0.779 . . . . 74.34 112.445 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.0 mt -55.51 161.04 2.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 63.11 110.962 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.6 t -140.13 142.17 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 72.01 111.118 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.87 129.58 56.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.946 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.73 0.36 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.148 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.702 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -179.12 129.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 72.32 110.804 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.53 -168.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.14 110.823 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.4 m -92.98 -174.54 3.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 71.34 110.833 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -67.41 -39.48 85.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 75.33 110.873 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.46 166.68 24.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 73.12 110.903 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -62.66 -28.29 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.44 110.828 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -75.94 -22.4 56.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 73.25 110.883 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.98 -46.45 9.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 70.44 110.943 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -58.36 -28.88 65.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 73.4 111.158 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -55.58 -43.29 75.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.44 . . . . 72.1 110.792 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -85.8 0.58 52.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.251 -0.431 . . . . 72.35 110.852 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.516 HD21 ' HE2' ' A' ' 30' ' ' GLU . 27.1 tp -95.3 -47.19 6.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 74.03 110.907 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.5 mt -69.53 -32.7 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.05 -17.81 58.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.11 110.903 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 42.8 mtp -82.15 -58.73 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 72.21 110.905 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.12 -35.8 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 71.52 111.14 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -86.85 49.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.05 110.943 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.85 -40.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.888 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -24.02 12.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 73.44 110.872 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 27.9 m-85 -88.89 10.23 21.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.41 . . . . 62.24 110.877 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.66 46.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.914 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -152.48 -179.23 7.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 75.03 110.906 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.63 143.82 51.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 74.21 110.895 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.8 t -75.09 130.07 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 74.52 111.12 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.2 p -142.05 31.0 1.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 75.14 111.16 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -164.35 126.67 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 64.42 110.89 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.3 t -133.69 101.85 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.03 111.096 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.7 mt -80.18 120.73 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 72.2 111.146 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.2 mm -108.71 129.81 62.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 72.51 111.103 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.9 p -85.37 -53.73 5.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 72.14 111.124 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -134.71 166.54 22.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 74.33 110.855 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.35 96.18 8.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 75.51 111.118 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.33 159.22 44.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.837 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.31 62.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 62.42 111.09 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.84 11.51 20.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 64.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -125.42 -54.67 1.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.882 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.3 16.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 71.52 111.106 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.21 -28.85 27.83 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.684 -0.77 . . . . 75.12 112.495 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.68 19.04 31.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 60.53 112.487 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 tt -48.89 -30.18 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 74.12 111.14 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -72.22 -43.26 64.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 75.43 110.925 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.5 m -64.22 -40.75 96.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 74.52 111.161 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.5 mt -60.96 -35.46 76.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.12 110.913 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -81.61 -23.26 37.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 74.13 110.884 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -82.34 -35.03 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 75.45 110.947 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -87.29 -45.77 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 61.41 110.873 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.12 -14.98 3.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.782 -0.723 . . . . 73.33 112.452 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.72 150.39 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.918 0.39 . . . . 73.23 111.151 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -111.46 126.65 55.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 75.32 110.932 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.29 83.02 6.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 64.23 111.043 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -57.95 143.55 42.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 75.12 110.916 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.68 150.76 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 71.34 110.823 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.8 p -63.88 179.28 0.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 75.3 111.146 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.9 -33.22 63.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.05 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 tp -72.88 -47.04 49.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 71.33 110.951 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.3 m -52.19 -28.9 20.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.54 111.153 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.92 -31.09 25.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.047 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -55.1 -48.38 73.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.892 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 39.9 mt -72.36 -25.0 61.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 72.31 110.901 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.73 -66.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 65.33 111.066 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -54.76 -26.57 35.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.42 110.91 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -23.83 67.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.02 110.89 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -93.74 -38.9 11.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 74.12 110.889 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 138.55 -7.76 3.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 72.31 112.508 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -59.55 -172.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.733 0.301 . . . . 70.15 110.987 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -99.87 0.11 40.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 64.41 110.909 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 66.31 130.7 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.639 0.733 . . . . 73.22 110.867 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.85 -170.3 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.636 2.224 . . . . 74.44 112.292 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 76.9 mt -53.81 -45.28 70.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 64.43 110.884 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.56 52.68 40.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.825 -0.703 . . . . 62.23 112.473 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -148.83 51.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 74.02 110.88 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.6 mt -133.0 178.79 6.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.304 -0.407 . . . . 74.41 110.931 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -140.61 -168.63 2.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 75.03 110.995 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.3 m -50.29 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 73.24 111.146 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.6 t -114.58 106.68 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.44 111.128 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.3 m -110.76 104.13 12.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 74.14 111.146 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -66.19 95.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 73.11 110.908 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 74.4 110.886 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.9 tpp . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.899 0.381 . . . . 73.23 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.86 128.75 39.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.922 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.9 t -141.06 157.39 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 74.23 111.142 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -154.72 120.73 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 65.13 110.883 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -179.1 3.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 71.43 111.184 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -175.61 139.89 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 71.11 110.897 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -122.15 96.28 46.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.71 0.767 . . . . 73.24 110.882 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 -48.9 0.64 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.755 2.303 . . . . 73.33 112.327 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.39 -155.74 24.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 62.45 112.516 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.63 126.02 41.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 71.24 110.896 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.472 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.72 -94.0 0.33 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.721 -0.752 . . . . 73.23 112.472 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -71.97 -29.3 64.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.359 . . . . 75.41 110.859 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.31 151.88 34.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.153 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -54.71 -38.44 67.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 60.41 110.849 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -109.15 52.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 72.22 110.906 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.472 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.5 p30 -100.73 136.24 40.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.861 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.5 pt -137.2 172.25 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 62.03 111.153 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.3 m -122.46 150.65 26.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 73.21 111.164 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.9 t -106.66 143.77 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.24 111.192 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -129.98 145.28 51.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 74.52 110.968 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.9 mt -122.91 96.83 44.6 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.643 0.735 . . . . 73.4 110.893 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 72.55 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.746 2.297 . . . . 70.54 112.315 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.54 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 75.42 110.848 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -117.05 -13.33 10.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 75.14 110.901 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m120 68.84 24.84 6.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 74.54 110.827 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 mp -98.19 116.62 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 74.1 111.154 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.1 136.92 38.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 73.24 110.904 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.47 62.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 71.53 111.089 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.4 -51.75 35.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 72.41 112.49 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.06 -139.23 15.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 53.35 112.535 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 81.4 m -62.94 -16.75 60.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 71.35 110.869 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.25 -52.45 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.916 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.47 119.68 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 74.42 111.085 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.05 127.17 38.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 75.21 110.838 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.9 t -62.72 166.66 5.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 73.02 110.831 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 73.02 111.149 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.817 0.341 . . . . 74.2 111.1 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.31 75.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.093 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.19 38.96 3.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.791 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -140.92 165.91 26.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 75.23 111.123 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -113.89 92.73 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.962 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.5 -23.05 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.102 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -81.41 -24.6 36.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 61.33 110.908 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -98.63 -23.88 15.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 74.54 110.882 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -51.49 -54.23 29.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.927 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.5 t -51.91 -32.58 33.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 55.1 110.8 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.7 m -77.44 -34.78 54.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 74.41 111.15 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 m -65.94 -54.33 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.5 110.817 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.8 mm -56.29 -37.52 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 72.32 111.107 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -65.29 -23.52 67.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 75.01 110.91 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -87.16 -31.94 20.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.902 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 95.5 t -74.45 -51.57 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 73.45 111.142 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.59 -24.86 67.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.926 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -47.62 12.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.804 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -51.92 -34.1 40.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 72.52 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -137.76 118.36 13.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 72.01 110.948 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -116.64 32.87 5.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.98 21.28 2.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 74.3 110.882 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.16 146.42 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 74.42 111.135 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -107.24 -30.95 8.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 63.24 110.878 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -160.69 127.43 4.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 64.35 111.122 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 92.0 t -101.35 125.48 55.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 71.13 111.125 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.31 89.76 6.22 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.569 0.699 . . . . 73.24 111.197 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 171.76 13.89 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.691 2.26 . . . . 74.33 112.336 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.58 -26.2 47.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 64.01 112.475 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -143.35 119.37 10.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 73.32 110.813 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 135.76 -95.21 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.799 -0.715 . . . . 74.24 112.49 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -179.67 168.83 1.37 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 72.42 110.853 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 31.5 t -79.14 142.3 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 62.15 111.131 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.74 -107.13 0.4 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.729 . . . . 64.3 112.55 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -154.46 -172.95 4.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 74.41 110.918 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -23.12 14.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.893 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.57 -32.57 46.47 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.698 -0.763 . . . . 73.22 112.511 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.5 mt -50.92 -44.45 60.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.866 0.365 . . . . 74.15 110.895 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.43 -44.75 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 74.04 110.871 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.6 mt -64.85 -41.97 95.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.44 110.895 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -62.37 -39.15 92.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 74.44 110.858 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.9 m -54.43 -41.58 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 74.55 111.137 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.13 -41.41 88.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 75.35 110.965 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -32.28 69.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 71.35 110.826 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.94 -25.79 63.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 72.31 110.938 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.5 mt -87.35 -44.97 10.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 75.52 110.885 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 72.42 110.892 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.4 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.794 0.33 . . . . 74.12 111.103 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -90.31 155.19 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 71.25 111.178 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -145.07 165.46 28.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.853 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.06 174.37 6.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 64.15 110.896 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -59.57 -28.57 67.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.855 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.7 p -101.92 -33.06 9.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 71.51 111.126 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.73 -8.66 47.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.63 -0.795 . . . . 72.2 112.484 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 t -50.99 -32.91 22.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.313 . . . . 73.23 111.167 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.0 mt -124.23 147.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 73.43 111.093 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.6 p -166.75 171.42 11.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.954 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.78 -176.39 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.183 -0.462 . . . . 71.34 111.159 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.7 t -166.44 133.67 2.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 72.15 110.878 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.46 118.33 12.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.511 . . . . 74.42 110.888 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.03 -41.64 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 74.02 110.973 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.56 -169.52 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 75.14 110.891 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -51.64 51.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 71.3 110.827 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -131.39 30.89 4.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 74.13 110.887 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.9 t -126.55 119.8 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 75.31 111.162 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -125.33 162.61 24.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 72.32 110.938 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.9 t -122.49 108.13 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 72.43 111.147 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -102.02 139.45 37.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 72.22 110.885 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.2 m -137.77 125.24 22.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 72.24 111.138 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.17 -177.72 3.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 73.01 110.906 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tp -134.38 134.8 42.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 73.3 110.952 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 61.55 112.485 179.881 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.621 0.724 . . . . 75.54 111.117 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 140.03 41.51 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.631 2.22 . . . . 73.53 112.368 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.6 ' HG ' ' HD2' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -128.62 122.22 30.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 62.02 110.841 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 212' ' ' GLU . 30.6 m-20 -67.46 168.6 10.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 72.31 110.915 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.627 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -173.41 170.12 43.25 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.672 -0.775 . . . . 71.23 112.45 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 tp -143.05 138.8 30.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.388 . . . . 74.01 110.897 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.05 130.23 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 73.22 111.138 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.5 mt -96.9 125.54 41.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.837 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.02 45.37 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.1 110.874 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.5 p -52.57 165.11 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 73.43 111.143 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.61 35.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 71.23 110.837 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -157.11 25.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.485 . . . . 71.33 110.924 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.68 124.6 3.77 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.66 -0.781 . . . . 52.44 112.442 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.2 mt -53.18 158.02 1.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 71.13 110.915 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.25 142.64 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 73.05 111.102 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.43 128.42 56.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 75.33 110.924 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.1 t -80.4 -0.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 75.45 111.1 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.627 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 1.1 p30 -174.81 132.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 75.23 110.911 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -74.59 -166.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.05 110.844 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.42 -170.24 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 71.54 110.848 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -74.8 -34.9 62.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 74.53 110.884 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.16 174.5 11.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.427 . . . . 75.43 110.857 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.44 -30.43 68.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 65.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -76.04 -25.53 55.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.885 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.32 -48.34 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.85 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.1 t -60.54 -27.82 67.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 65.33 111.173 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -43.08 75.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.864 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.55 1.29 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.11 110.92 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 tp -95.46 -45.33 7.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 74.13 110.912 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -68.79 -40.03 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 72.25 111.157 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -60.39 -22.23 63.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.12 -0.491 . . . . 64.21 110.942 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.5 mmm -72.64 -60.81 2.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 74.42 110.914 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 m -59.39 -30.16 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 72.12 111.122 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -88.51 48.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 73.44 110.914 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 -41.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.02 110.958 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.05 -25.23 14.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.9 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 35.9 m-85 -89.31 9.84 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.882 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.68 47.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 73.3 110.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -147.92 -177.54 5.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 75.54 110.851 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.6 130.9 37.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.932 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.4 t -67.86 130.12 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 72.32 111.112 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.4 p -136.82 18.62 3.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.481 . . . . 74.43 111.13 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -153.99 130.59 10.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 75.14 110.878 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.8 t -133.5 98.46 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.095 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.7 mt -73.71 125.73 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 75.21 111.128 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.4 mm -113.08 142.47 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 75.03 111.131 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.0 p -97.51 -59.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 64.31 111.147 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -129.47 164.19 24.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 74.35 110.859 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.49 98.03 9.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.44 111.078 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.03 159.03 43.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 74.54 110.88 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -26.73 61.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 64.41 111.088 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.6 ' HD2' ' HG ' ' A' ' 41' ' ' SER . 29.2 t0 -91.73 13.28 18.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 70.4 110.874 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -126.68 -50.86 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.867 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.75 16.24 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.54 111.15 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.73 -33.26 34.34 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.714 -0.755 . . . . 63.45 112.525 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.27 15.92 53.74 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.749 -0.738 . . . . 73.15 112.487 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.3 tt -46.16 -31.93 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 72.42 111.162 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -54.31 31.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.943 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.8 m -58.1 -41.07 82.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 72.2 111.16 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.3 mt -59.61 -31.21 69.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 75.13 110.934 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -97.82 25.08 6.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.3 110.911 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -115.75 -24.79 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.902 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -107.83 -21.4 12.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.88 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.68 13.34 5.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 62.33 112.44 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.0 mt -80.32 155.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 74.21 111.06 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.97 123.93 44.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 73.22 110.862 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.51 85.31 6.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 74.22 111.074 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -55.87 148.07 17.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 71.15 110.873 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.93 164.88 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 70.11 110.813 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.8 p -81.98 155.77 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 74.11 111.199 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.72 -29.91 20.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 75.53 111.143 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.1 tp -75.08 -47.58 28.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.904 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.7 m -53.93 -26.97 28.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 75.2 111.152 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.26 -27.1 24.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.24 111.05 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -64.13 -27.51 69.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 65.23 110.855 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.8 mp -92.96 -23.89 18.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 73.01 110.895 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.44 -62.98 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.51 111.137 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -25.42 42.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 75.03 110.873 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.0 -23.79 65.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.895 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -97.32 -26.36 14.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 72.33 110.876 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.89 -3.21 10.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.788 -0.72 . . . . 53.04 112.503 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -59.52 -173.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.887 0.375 . . . . 74.42 110.889 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -97.75 -1.34 43.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.89 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 66.36 124.96 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.623 0.725 . . . . 74.41 110.865 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -170.46 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.629 2.219 . . . . 74.13 112.387 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -53.44 -39.76 64.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.884 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.12 59.03 9.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.768 -0.73 . . . . 73.02 112.461 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -155.33 47.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 64.22 110.854 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.2 mt -127.07 -175.26 3.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 72.22 110.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -140.02 -168.66 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 75.02 110.858 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 78.7 m -50.21 -54.87 17.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 65.22 111.092 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.9 t -131.33 111.84 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 75.12 111.114 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.5 m -117.04 119.55 35.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 74.54 111.199 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -78.77 99.13 6.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 74.05 110.901 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.6 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 74.21 110.918 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.7 tpp . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.851 0.357 . . . . 74.53 110.836 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.96 112.73 14.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 75.23 110.894 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.08 152.55 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 71.32 111.127 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -151.07 120.78 7.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 54.23 110.888 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -179.08 2.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.45 111.149 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -175.29 136.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.879 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -116.79 93.63 41.77 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.712 0.768 . . . . 73.23 110.838 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 -48.92 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 73.21 112.33 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.62 -170.35 42.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.664 -0.779 . . . . 44.4 112.454 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -84.52 126.55 33.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.884 0.373 . . . . 72.44 110.87 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.468 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -136.64 -88.3 0.23 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 71.32 112.498 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -78.27 -23.67 47.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 73.4 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.95 163.99 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.22 111.218 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -70.09 -24.48 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.916 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -123.59 52.63 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 62.42 110.87 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.468 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 2.1 p30 -100.77 146.35 27.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 75.32 110.925 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 8.8 pt -145.14 173.28 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 74.25 111.161 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.1 m -123.03 138.8 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 74.53 111.156 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.0 t -95.1 125.69 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 72.43 111.126 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -111.0 148.88 31.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.15 110.936 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 47.5 mt -123.53 94.61 46.17 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.608 0.718 . . . . 71.44 110.888 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 70.98 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.716 2.278 . . . . 74.42 112.278 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.14 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.904 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -118.74 -9.98 10.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 73.1 110.897 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 68.2 21.03 8.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 70.33 110.868 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.1 115.67 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 73.31 111.129 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -101.37 122.93 44.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 74.23 110.923 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 41.5 t -114.9 73.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 75.13 111.217 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.12 -56.58 17.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 73.24 112.532 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 111.95 -139.0 15.36 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.749 -0.738 . . . . 72.25 112.412 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 46.6 m -58.03 -22.24 48.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 71.44 110.858 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.88 -48.32 79.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.43 110.938 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.57 127.57 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 62.41 111.124 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -95.49 134.94 37.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.925 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.2 p -70.23 157.03 38.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 74.12 110.829 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 75.2 111.164 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.869 0.366 . . . . 75.44 111.097 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.48 -46.06 77.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 62.14 111.084 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -112.38 44.09 1.51 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 73.35 110.921 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -134.87 173.92 11.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 71.32 111.114 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.61 88.48 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 75.23 110.918 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 23.5 t -68.11 -20.73 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 70.04 111.182 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -80.36 -28.41 38.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.868 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -22.59 16.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.04 110.918 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.07 -54.37 25.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.88 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -36.83 49.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 71.53 110.813 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 71.4 m -75.34 -39.01 59.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 74.24 111.139 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 44.6 m -58.81 -55.67 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.833 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.1 mm -54.27 -37.5 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 74.2 111.145 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -23.08 65.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.881 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -90.6 -27.43 19.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 62.44 110.879 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 39.8 t -78.42 -31.98 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 75.34 111.156 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.7 -29.87 23.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 63.23 110.968 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -78.98 -50.06 11.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.1 110.865 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -51.92 -30.17 23.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 71.41 110.9 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -138.14 116.86 12.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 74.34 110.894 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -116.5 37.62 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 71.44 110.883 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.24 22.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 65.52 110.921 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.63 142.74 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 64.13 111.093 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -103.53 -42.91 5.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 74.15 110.867 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.57 113.44 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 35.45 111.141 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.39 124.08 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.34 111.129 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 57.5 t -107.41 92.27 8.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.586 0.708 . . . . 75.24 111.129 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.3 Cg_endo -69.68 -174.7 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.269 . . . . 73.12 112.373 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.41 -17.44 33.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.804 -0.712 . . . . 60.02 112.515 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -147.19 125.97 12.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 75.31 110.906 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 123.0 -93.09 0.48 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.746 -0.74 . . . . 74.13 112.496 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.544 ' N ' HD22 ' A' ' 42' ' ' ASN . 0.6 OUTLIER -179.65 167.92 1.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 74.21 110.922 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.85 135.53 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 72.14 111.145 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -137.36 -102.8 0.62 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.773 . . . . 60.12 112.46 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -158.96 -171.34 3.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.923 0.392 . . . . 72.42 110.827 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 -23.92 13.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 74.51 110.83 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -52.52 -35.52 45.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.769 -0.729 . . . . 43.01 112.488 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 23.9 mt -51.0 -46.35 61.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 75.52 110.86 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.1 mp -56.32 -42.95 78.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 54.32 110.882 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.78 -41.46 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 73.24 110.893 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -61.31 -39.35 90.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 63.34 110.848 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.66 -46.22 63.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 75.25 111.103 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 51.5 mt -56.64 -44.22 81.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 74.42 110.939 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -31.51 60.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 60.42 110.872 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.7 -27.92 61.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 73.13 110.887 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.85 -30.87 24.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 73.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 75.25 110.894 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.792 0.33 . . . . 74.24 111.072 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mm -87.1 156.17 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 74.35 111.1 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -146.74 151.91 37.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 70.54 110.896 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.58 168.51 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 73.01 110.924 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.46 -32.55 62.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 71.13 110.92 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 p -93.04 -31.97 14.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 74.45 111.084 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.47 -12.51 58.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 53.04 112.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 t -51.73 -33.0 32.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 74.23 111.132 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.2 mt -119.58 150.87 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.12 111.089 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -170.2 170.84 7.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.782 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.47 -174.7 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 74.41 111.215 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -170.8 129.95 0.81 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 71.24 110.882 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 122.12 15.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 74.32 110.944 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -104.45 -46.84 4.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 74.31 110.949 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -149.41 52.43 0.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 74.42 110.83 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.58 -76.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.931 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -83.63 -20.37 33.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.898 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.26 120.6 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 72.42 111.171 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -125.41 159.81 30.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 74.35 110.957 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -122.23 112.7 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 75.53 111.147 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -103.48 137.04 42.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 73.52 110.9 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.6 m -131.17 130.93 43.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 71.14 111.091 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.19 163.17 23.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 73.43 110.868 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tp -110.14 145.7 36.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 74.1 110.924 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.736 -0.745 . . . . 72.22 112.465 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.572 0.701 . . . . 75.42 111.142 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.93 49.31 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.65 2.234 . . . . 75.12 112.349 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -126.33 108.12 10.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.87 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -61.87 151.52 34.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 74.43 110.888 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.698 ' CA ' ' HD2' ' A' ' 56' ' ' ASP . . . -154.3 -163.37 11.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.7 -0.762 . . . . 72.54 112.478 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.36 145.3 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.903 0.382 . . . . 75.14 110.903 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.8 t -129.49 130.12 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 71.54 111.097 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.7 mt -98.57 122.01 41.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.902 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -91.53 47.3 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 72.4 110.908 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.9 p -56.77 172.68 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 72.01 111.103 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.4 m -99.17 24.97 7.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 65.44 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.4 19.01 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.838 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.78 128.53 4.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 60.44 112.524 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.3 mt -52.63 157.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.817 0.341 . . . . 73.02 110.916 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.08 143.36 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 75.13 111.098 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -112.24 129.58 56.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.831 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 t -80.07 -1.26 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.044 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.698 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -179.32 130.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.24 -0.436 . . . . 75.42 110.89 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -67.82 -169.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.4 110.795 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.41 -175.94 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 70.2 110.826 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -67.35 -37.4 83.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 74.23 110.899 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -144.99 174.15 11.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 75.2 110.878 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.03 -28.46 65.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.84 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -77.63 -25.45 49.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.33 110.893 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.79 -40.98 15.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 75.33 110.863 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -66.18 -29.74 70.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 74.11 111.197 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -51.62 -45.04 63.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 53.12 110.91 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -81.64 -14.9 56.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.881 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.0 tp -78.08 -48.45 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.888 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.9 mt -71.85 -18.63 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 72.52 111.097 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.06 2.35 39.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 71.24 110.894 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.2 mmm -101.62 -53.04 3.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 75.4 110.908 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.7 m -59.4 -39.53 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 73.35 111.125 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.86 50.98 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 75.2 110.889 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.74 -39.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.881 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 -20.19 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.931 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.524 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 25.1 m-85 -89.14 12.28 16.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.859 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.524 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.86 47.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 71.52 110.93 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -155.93 -178.72 7.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 75.11 110.891 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.41 157.45 39.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.02 110.848 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.65 117.98 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 72.45 111.181 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.9 p -128.34 22.4 6.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.23 111.155 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.45 133.9 13.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.831 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.1 t -138.64 99.47 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.34 111.128 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.0 mt -77.49 126.07 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.03 111.071 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.9 mm -112.46 130.26 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 75.44 111.091 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.0 p -87.76 -54.85 4.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 72.21 111.077 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -133.93 170.0 16.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 75.23 110.868 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.96 97.77 11.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.465 . . . . 71.32 111.075 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.33 158.65 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 73.1 110.826 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.03 63.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 64.54 111.104 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.9 9.26 25.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.23 110.831 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -121.43 -52.81 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 74.44 110.865 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.5 18.24 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 74.52 111.198 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.05 -26.72 20.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.636 -0.792 . . . . 54.11 112.534 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.64 22.01 20.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.737 -0.744 . . . . 71.3 112.523 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.3 tt -48.55 -31.05 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.392 . . . . 74.02 111.137 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -70.65 -43.75 68.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.908 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.4 m -66.27 -35.49 80.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 74.42 111.119 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.4 mt -62.37 -32.51 73.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 72.44 110.933 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.29 20.92 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 64.45 110.88 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -117.35 -22.46 8.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 75.2 110.906 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.74 7.66 18.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 72.24 110.894 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.8 15.92 64.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.723 -0.751 . . . . 65.15 112.453 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.9 mt -80.33 155.03 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 74.1 111.113 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.98 117.58 29.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 74.05 110.911 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.52 79.32 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 63.43 111.064 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -55.16 147.66 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 70.05 110.896 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.86 166.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 73.44 110.916 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.1 p -87.99 158.13 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 64.34 111.078 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.82 -43.09 62.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 75.22 111.129 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -46.31 90.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.847 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.2 m -52.05 -42.58 63.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 71.15 111.08 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.3 -23.55 60.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 75.41 111.104 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -57.08 -40.49 77.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.856 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.21 -28.43 27.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 74.24 110.927 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.71 -68.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 72.42 111.077 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.34 -24.94 47.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 73.21 110.879 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -24.17 66.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.885 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -95.71 -37.33 10.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 52.25 110.871 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.68 -5.3 4.07 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.718 . . . . 65.22 112.502 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -59.63 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.816 0.341 . . . . 74.52 110.935 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -97.86 -1.0 44.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 72.4 110.891 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 66.15 125.38 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.674 0.749 . . . . 71.23 110.886 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -170.37 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.238 . . . . 62.55 112.343 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.8 mt -53.59 -41.2 66.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 71.23 110.942 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.28 59.72 8.6 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 74.32 112.482 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.75 54.63 0.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 75.4 110.896 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 mt -137.01 -173.21 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 61.51 110.902 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.0 -168.18 2.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.851 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.6 m -50.02 -41.66 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 61.3 111.197 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 m -140.51 141.82 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 72.42 111.141 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.0 m -149.04 110.88 4.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 74.35 111.154 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.89 98.01 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 72.1 110.865 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 73.24 110.883 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.876 0.37 . . . . 72.23 110.823 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.44 118.14 21.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 73.24 110.958 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.6 t -135.14 159.19 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 73.52 111.15 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -160.52 126.7 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.24 110.907 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.9 178.32 6.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 62.33 111.133 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -172.84 138.23 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.906 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -118.92 95.32 49.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.705 0.764 . . . . 73.21 110.864 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -48.75 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 65.5 112.365 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.42 -165.54 38.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 71.44 112.447 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -85.4 121.2 27.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.24 110.847 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.477 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.09 -94.28 0.46 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.738 -0.744 . . . . 75.14 112.443 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -70.58 -29.3 65.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.368 . . . . 74.33 110.814 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.32 154.71 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 65.24 111.129 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -58.35 -24.27 59.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 52.32 110.912 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -124.19 51.37 1.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 65.23 110.94 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.0 OUTLIER -100.79 136.36 40.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.976 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.3 pt -137.47 160.61 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.52 111.121 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.4 m -106.34 157.73 6.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 64.22 111.065 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.29 141.1 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 74.12 111.16 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -128.24 150.2 50.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.888 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.1 mt -129.0 95.9 30.34 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.62 0.724 . . . . 74.45 110.917 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 72.49 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.687 2.258 . . . . 64.11 112.286 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.52 -34.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 73.42 110.924 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -117.45 -13.56 10.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.975 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m120 69.38 25.82 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 71.41 110.835 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.09 119.12 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 70.44 111.099 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.71 138.46 40.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 73.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.09 66.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 75.02 111.111 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.47 -45.11 53.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.744 -0.741 . . . . 71.25 112.46 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.74 -141.48 15.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.76 -0.733 . . . . 65.23 112.509 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 43.7 m -57.35 -23.91 51.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 72.14 110.92 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -49.35 69.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.927 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.3 t -90.41 105.37 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.14 111.166 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.92 151.31 37.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 64.11 110.903 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.3 p -75.26 169.47 17.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 71.55 110.841 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 74.24 111.114 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.881 0.372 . . . . 74.01 111.132 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.01 84.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.493 . . . . 73.21 111.125 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.0 39.94 2.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.23 110.817 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.72 170.84 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 72.11 111.056 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -119.9 90.16 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 73.34 110.917 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.55 -20.94 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 75.54 111.097 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.97 -26.32 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 73.4 110.938 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.23 -23.15 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 64.25 110.886 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -51.27 -55.81 16.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.878 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -36.16 49.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 73.14 110.83 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.6 m -75.48 -34.24 60.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 74.32 111.081 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 67.4 m -64.38 -51.55 62.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.25 110.89 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.9 mm -56.72 -38.91 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 74.53 111.09 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -62.68 -22.07 66.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 72.43 110.857 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -90.72 -30.3 17.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 53.33 110.885 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 99.5 t -77.49 -37.05 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 73.13 111.176 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.4 pp -78.93 -25.21 43.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.878 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -83.13 -42.48 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.14 110.939 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -55.24 -26.45 39.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 74.41 110.895 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -143.81 118.54 9.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 74.24 110.918 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.37 37.52 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 73.12 110.909 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.43 21.27 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 72.02 110.902 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.25 146.85 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 73.14 111.142 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.56 -31.51 8.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.892 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -156.48 140.17 16.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 55.23 111.09 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 92.7 t -120.72 125.64 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 70.22 111.144 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.406 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 97.1 t -107.71 105.74 56.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.604 0.716 . . . . 73.23 111.1 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.4 Cg_endo -69.76 -179.85 3.19 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.705 2.27 . . . . 74.4 112.314 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.79 -33.83 26.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.729 -0.748 . . . . 62.03 112.518 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -143.61 111.13 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.344 . . . . 74.23 110.847 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.46 -114.2 0.72 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.761 . . . . 53.34 112.422 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -151.84 166.86 30.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.85 0.357 . . . . 73.33 110.939 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.8 t -74.34 149.94 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 74.13 111.127 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -147.31 -108.54 0.53 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.76 -0.734 . . . . 74.42 112.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -157.73 -171.77 3.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 74.12 110.816 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 35.7 tttt -56.65 -21.51 27.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.889 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.29 -31.98 57.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 74.23 112.467 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 37.1 mt -51.06 -45.41 61.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 74.22 110.873 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.6 -44.58 89.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 72.0 110.92 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.15 -42.01 94.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 73.03 110.95 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -66.24 -37.79 86.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.12 110.853 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.6 m -52.12 -43.01 63.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 73.45 111.08 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 61.5 mt -58.35 -42.29 86.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 75.11 110.863 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -26.86 66.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.841 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.4 mt -73.49 -25.88 60.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.45 110.925 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.1 mt -87.25 -42.2 13.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 65.25 110.88 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.922 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 80.8 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.863 0.363 . . . . 55.52 111.08 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mm -87.9 156.92 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.184 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -145.77 147.14 31.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 63.02 110.964 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.79 164.24 26.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 74.23 110.85 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -51.88 -38.2 55.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 73.4 110.958 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.5 p -92.43 -26.57 17.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 73.13 111.193 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.71 -11.69 56.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 71.34 112.501 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 t -51.48 -32.63 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 64.54 111.15 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.3 mt -120.92 149.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 75.34 111.103 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 p -169.98 167.53 8.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 71.45 110.862 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.57 -173.22 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 73.25 111.175 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -172.83 132.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.86 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.03 120.38 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 74.13 110.816 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.11 -47.86 4.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 63.4 110.889 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -146.99 53.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 74.35 110.887 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.28 -76.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 74.03 110.937 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.76 -20.97 30.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 75.34 110.871 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 t -97.1 119.73 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 63.12 111.143 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -124.67 162.01 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.936 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.4 t -124.26 111.26 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 74.14 111.098 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -103.21 137.62 41.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.468 . . . . 72.55 110.829 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.2 m -133.05 120.51 21.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 71.43 111.185 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.33 170.44 8.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 73.42 110.878 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.84 133.49 51.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 75.44 110.879 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.779 -0.724 . . . . 72.41 112.484 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.406 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 60.5 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.601 0.715 . . . . 73.1 111.185 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.3 Cg_endo -69.78 141.01 44.0 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.707 2.271 . . . . 74.1 112.306 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -124.69 117.66 24.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 73.14 110.838 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -71.22 147.52 48.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 75.13 110.857 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.618 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -148.74 -160.41 9.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.758 -0.734 . . . . 73.25 112.404 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.74 143.7 11.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.384 . . . . 74.32 110.913 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.1 t -127.44 141.24 46.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.42 111.142 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.3 mt -107.04 138.11 43.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 75.41 110.898 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -110.47 59.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.919 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.3 p -67.3 -172.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 71.41 111.16 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.26 26.38 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.992 0.425 . . . . 72.2 110.876 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -156.03 35.58 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 72.2 110.893 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.01 133.39 6.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.841 -0.695 . . . . 73.33 112.527 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.19 172.84 2.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.874 0.369 . . . . 71.31 110.925 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -148.18 143.42 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 75.53 111.103 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.84 130.01 56.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.119 -0.491 . . . . 74.1 110.876 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.36 -1.06 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 71.45 111.102 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.618 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 2.4 p-10 -179.55 133.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 65.5 110.877 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -71.17 -168.64 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 62.42 110.864 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -173.18 3.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 74.33 110.906 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -69.54 -41.24 76.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 74.21 110.907 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.0 165.92 25.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.291 -0.413 . . . . 61.3 110.88 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -60.82 -34.69 74.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.916 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -73.94 -22.77 59.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 71.43 110.944 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -43.44 15.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 75.15 110.893 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -66.99 -27.5 67.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.095 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.25 -43.52 71.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 73.13 110.89 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -82.91 -14.28 54.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 73.43 110.856 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 tp -76.63 -47.27 22.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 70.2 110.904 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.39 -33.4 53.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.43 111.12 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.8 -25.55 67.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 74.35 110.956 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 mmm -75.77 -59.83 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.499 . . . . 71.12 110.881 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.0 m -55.66 -31.91 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 72.41 111.102 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -89.69 48.29 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.875 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -143.65 -42.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.816 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.58 -25.9 14.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 75.4 110.869 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.505 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 35.5 m-85 -89.26 9.32 26.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 70.3 110.877 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.505 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.76 46.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.911 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -147.62 -177.76 5.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.2 110.896 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.95 130.04 39.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 75.32 110.824 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.72 127.5 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.132 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.4 p -133.95 18.73 3.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 73.5 111.084 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -153.63 136.13 15.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 55.1 110.846 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.2 t -139.75 97.82 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 74.04 111.086 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.1 mt -75.75 125.68 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 74.51 111.17 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.1 mm -111.33 121.65 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 72.33 111.116 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.9 p -77.37 -53.7 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.074 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -135.8 171.12 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 75.04 110.886 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.02 101.09 13.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 70.44 111.025 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 159.85 40.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.46 . . . . 72.01 110.881 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.32 -25.31 48.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.052 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -94.0 20.15 8.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 73.22 110.879 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -135.17 -50.45 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 75.24 110.893 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.57 14.47 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.43 111.143 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.61 -35.55 30.11 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.735 -0.745 . . . . 73.4 112.449 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.18 19.04 41.26 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.705 -0.76 . . . . 64.43 112.421 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.7 tt -45.97 -31.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 74.41 111.141 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -54.25 32.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 75.04 110.914 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.1 m -58.7 -41.15 85.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.416 . . . . 75.14 111.09 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.4 mt -57.49 -28.7 63.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 75.22 110.849 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -100.93 23.55 10.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 73.31 110.894 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -115.9 -26.57 7.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 73.01 110.861 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -103.34 -22.02 13.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 75.24 110.817 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.74 19.2 4.15 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.717 -0.754 . . . . 64.4 112.416 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.7 mt -87.23 154.67 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 74.31 111.117 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -117.16 121.98 42.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.918 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.33 80.47 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 62.54 111.116 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -54.32 144.11 21.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.869 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.8 153.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.45 110.88 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.4 p -74.75 158.4 33.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 71.23 111.159 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.83 -37.45 63.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 74.43 111.093 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.33 -46.0 82.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 73.4 110.892 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 m -52.89 -41.14 64.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 72.13 111.154 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.68 -22.33 60.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 55.31 111.114 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -38.78 82.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 72.44 110.839 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.594 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 12.2 mt -89.33 -26.27 21.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.906 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.4 -64.78 0.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 63.13 111.059 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -57.28 -23.96 51.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 71.31 110.912 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -23.77 66.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.914 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -94.47 -33.43 13.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.925 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 129.16 -5.15 6.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 65.04 112.464 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -59.81 -172.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 75.04 110.937 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -96.11 -3.6 44.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 75.35 110.836 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 66.38 125.52 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 75.12 110.886 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -172.52 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.646 2.231 . . . . 64.43 112.308 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.7 mt -51.93 -39.36 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.898 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.0 53.99 27.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.79 -0.719 . . . . 72.32 112.447 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -146.62 54.81 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.819 0.343 . . . . 70.42 110.876 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.31 -176.46 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 74.54 110.903 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -141.68 -168.4 2.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 51.02 110.883 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.3 m -49.93 -43.3 49.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 72.22 111.079 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.42 143.08 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 74.44 111.108 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.0 m -150.21 110.19 4.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 70.21 111.129 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -71.87 94.77 1.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 74.12 110.875 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 73.32 110.937 179.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 15.7 tpp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.904 0.383 . . . . 73.22 110.867 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.28 120.29 26.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 75.01 110.899 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.3 t -137.42 158.68 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 75.34 111.167 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -155.82 123.76 5.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 72.2 110.894 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.54 178.4 6.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 74.13 111.17 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -172.39 137.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 71.12 110.927 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -118.09 92.52 42.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 75.51 110.862 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -48.72 0.67 Allowed 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.698 2.265 . . . . 73.31 112.371 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.62 -152.82 16.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.798 -0.715 . . . . 65.13 112.494 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.99 123.18 44.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 73.25 110.909 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.499 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -130.99 -89.43 0.5 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.741 -0.742 . . . . 65.33 112.481 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -77.32 -29.67 53.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.831 0.348 . . . . 74.02 110.85 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.68 155.4 40.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 73.45 111.145 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -60.25 -24.19 64.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 72.03 110.843 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.594 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 1.9 p30 -119.17 49.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.42 110.915 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.499 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.0 OUTLIER -100.11 137.78 38.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 73.24 110.897 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.0 pt -139.16 158.81 29.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 72.31 111.153 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.2 m -106.97 145.08 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 65.44 111.026 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.7 t -100.16 144.22 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 75.21 111.118 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -131.53 149.3 52.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.23 -0.441 . . . . 72.44 110.898 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.1 mt -127.52 95.71 34.89 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 72.05 110.91 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 72.47 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 74.44 112.336 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.35 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 72.11 110.839 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.94 -13.05 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 75.53 110.954 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m120 69.51 23.15 6.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 61.3 110.923 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.84 114.56 30.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 74.22 111.161 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.95 136.83 39.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.887 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.48 68.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.02 111.164 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.76 -41.42 43.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 60.53 112.541 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.39 -129.1 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 73.33 112.496 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 69.5 m -74.82 -6.9 51.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 63.43 110.864 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.1 tp -73.24 -53.5 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 72.14 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.03 128.37 43.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.091 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -91.21 163.9 14.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 71.14 110.896 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 p -89.61 159.25 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.01 110.88 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.02 111.159 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.6 m . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.87 0.367 . . . . 74.4 111.062 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -51.6 -58.62 5.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 73.33 111.077 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -117.34 28.16 8.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 71.33 110.869 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -104.66 174.88 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 75.31 111.063 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -137.28 85.18 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.918 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.83 -21.49 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 74.54 111.093 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -75.51 -21.72 57.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 71.3 110.947 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -107.83 -26.58 10.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.892 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -51.28 -57.12 9.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.893 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 90.0 p -52.03 -30.42 25.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 73.35 110.817 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.3 m -80.98 -32.44 34.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 75.4 111.204 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.8 m -68.75 -56.66 7.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.912 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.8 mm -53.13 -42.03 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 65.15 111.157 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -63.43 -26.38 68.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 65.12 110.864 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -86.23 -31.23 21.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 75.24 110.858 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 99.1 t -73.22 -38.03 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 75.13 111.143 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.3 pp -79.9 -25.62 40.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.879 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -42.6 33.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 73.04 110.913 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 33.4 tpt85 -60.73 -29.82 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 75.35 110.901 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -139.54 117.19 11.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 71.14 110.885 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 32.3 6.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 73.05 110.828 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.1 21.41 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 73.53 110.925 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -52.23 146.19 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 74.42 111.137 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -105.15 -34.82 7.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 64.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -156.88 133.56 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 74.34 111.087 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.72 128.3 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 72.32 111.09 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.41 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 89.5 t -111.29 102.46 53.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.612 0.72 . . . . 74.05 111.116 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.6 Cg_endo -69.69 -170.13 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 70.52 112.416 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.11 -29.29 7.26 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.853 -0.689 . . . . 75.43 112.559 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -143.46 101.01 3.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.824 0.345 . . . . 72.14 110.899 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.83 -101.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 72.55 112.527 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -168.42 165.18 12.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 70.31 110.856 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.4 t -74.74 149.63 7.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 73.01 111.159 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -151.35 -108.42 0.4 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.7 -0.762 . . . . 74.14 112.441 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -155.37 -172.77 4.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 73.32 110.884 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -55.56 -22.39 21.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 73.54 110.88 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.19 -31.57 49.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 63.32 112.503 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 35.7 mt -50.95 -46.89 61.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 73.24 110.92 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -42.22 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 72.42 110.898 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.0 mt -68.08 -41.21 82.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 74.52 110.95 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -66.26 -36.48 83.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 72.04 110.872 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.0 m -51.66 -43.44 62.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 75.11 111.103 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 71.9 mt -56.85 -38.57 72.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 74.43 110.902 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -28.65 62.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.807 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.7 mt -76.13 -24.77 54.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.927 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.0 mt -89.06 -32.8 17.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.908 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.871 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.1 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.864 0.364 . . . . 74.1 111.108 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mm -90.48 154.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 74.42 111.08 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -146.01 146.06 30.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 75.22 110.868 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.34 163.34 21.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.871 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -51.67 -33.21 32.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 73.32 110.884 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -31.45 17.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 75.21 111.109 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.04 -12.45 65.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 61.03 112.425 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -51.21 -33.42 27.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.867 0.365 . . . . 74.13 111.144 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.0 mt -121.92 148.54 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 73.23 111.108 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.8 p -166.17 170.18 13.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 61.24 110.859 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.51 -175.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 73.41 111.156 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 t -167.02 133.87 2.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 73.11 110.858 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.76 118.07 15.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.88 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 mp -103.16 -39.31 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 74.24 110.899 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -149.44 -170.98 3.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 75.53 110.84 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -49.86 -51.25 41.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 71.15 110.893 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -132.23 41.11 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 54.21 110.838 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.02 120.45 25.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 71.43 111.142 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -129.77 154.32 47.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 75.05 110.94 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.1 t -117.48 105.01 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 71.21 111.067 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -99.07 137.91 36.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.907 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.3 m -134.91 136.39 42.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 74.05 111.163 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -125.47 170.52 11.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 75.51 110.907 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 tp -120.76 137.04 54.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.895 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.793 -0.718 . . . . 65.3 112.548 179.868 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.2 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.598 0.713 . . . . 60.45 111.105 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 141.74 46.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.683 2.255 . . . . 72.33 112.332 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.445 ' HG ' ' HD2' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -127.08 114.61 17.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 75.01 110.907 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.38 145.11 56.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 74.1 110.918 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.479 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -148.41 -175.62 21.15 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 73.25 112.517 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.98 141.75 19.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 74.12 110.915 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.15 137.53 57.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 75.23 111.086 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.2 mt -105.12 134.74 47.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 74.23 110.919 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -103.89 71.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 73.34 110.927 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 p -80.83 -172.03 3.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 70.43 111.19 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.59 -9.07 21.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 51.4 110.886 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.5 42.68 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 72.05 110.917 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.79 138.58 9.51 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 73.0 112.485 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -58.52 172.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 70.24 110.904 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.1 t -150.22 144.18 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 73.44 111.102 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mt -116.26 132.14 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.994 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 t -82.17 0.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 64.12 111.164 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.479 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -179.86 132.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 74.01 110.892 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -73.14 -168.42 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.21 110.827 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.3 m -94.62 -172.59 2.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.05 110.829 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -68.3 -35.08 77.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 75.03 110.923 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.72 168.27 24.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 72.23 110.885 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -25.82 68.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 63.12 110.886 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -76.28 -25.47 54.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 73.04 110.941 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.87 -48.07 9.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 71.31 110.866 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.7 t -59.86 -29.73 68.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.33 111.144 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -53.56 -41.62 66.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.882 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -84.81 -11.89 54.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 60.34 110.897 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 tp -80.44 -47.52 14.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.947 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.2 mt -64.94 -21.99 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 75.52 111.152 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -71.91 -21.69 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.863 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.4 mtp -81.24 -58.32 3.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 74.33 110.893 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.2 m -58.07 -35.66 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 75.31 111.2 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -88.75 48.79 1.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 64.53 110.88 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.47 -41.71 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 70.31 110.902 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.09 -26.34 13.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 70.14 110.881 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.505 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 37.8 m-85 -88.35 9.61 22.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.52 110.829 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.505 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.4 pp0? 32.38 48.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.15 110.867 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -151.22 180.0 7.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.4 110.919 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.25 133.16 46.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 75.31 110.833 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.79 130.52 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 74.45 111.102 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.7 p -137.47 17.79 2.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 63.24 111.121 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.87 133.59 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.51 110.865 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.0 t -137.36 101.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 71.52 111.069 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.9 mt -78.8 119.54 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 65.34 111.087 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.6 mm -106.3 133.52 50.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 70.12 111.121 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.4 p -89.3 -56.08 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.12 111.156 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -133.14 163.87 28.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 73.22 110.829 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.8 98.41 9.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 61.11 111.164 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 158.13 42.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 75.42 110.832 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.51 -25.32 51.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 75.13 111.069 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.445 ' HD2' ' HG ' ' A' ' 41' ' ' SER . 32.5 t0 -93.31 19.07 8.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 64.51 110.924 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -134.0 -51.35 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 75.31 110.827 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.03 15.79 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 73.31 111.092 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.96 -29.25 27.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.674 -0.774 . . . . 62.51 112.516 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.49 18.78 32.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 44.21 112.483 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.4 tt -49.24 -29.99 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 74.44 111.135 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -69.95 -43.03 72.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.811 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.3 m -69.32 -34.29 74.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 73.43 111.144 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.7 mt -64.36 -32.32 73.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.55 110.883 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -94.27 21.29 7.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 71.23 110.882 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.27 -19.89 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.868 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.73 1.82 14.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 75.2 110.895 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.31 14.68 53.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.685 -0.769 . . . . 73.54 112.478 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.9 mt -82.27 154.9 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.342 . . . . 75.11 111.101 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -118.89 122.79 43.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.869 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.28 79.2 5.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 63.44 111.075 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -51.82 145.95 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 64.24 110.887 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.23 154.77 0.87 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 53.41 110.851 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.4 p -72.57 160.09 32.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 54.45 111.109 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.22 -22.18 50.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 64.35 111.099 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.9 tp -76.83 -48.15 19.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.866 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 44.5 m -55.34 -27.27 46.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.34 111.094 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.45 -23.71 32.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.101 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.29 -33.71 75.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 73.33 110.877 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.1 -25.46 17.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 73.4 110.932 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.78 -65.1 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 52.34 111.135 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -56.58 -24.94 50.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 72.24 110.914 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -24.45 65.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 72.41 110.896 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -93.3 -33.48 13.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 71.52 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.03 -7.06 5.44 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 63.23 112.463 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -59.72 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.38 . . . . 53.31 110.918 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -98.01 -1.53 42.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 75.31 110.926 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 66.15 125.22 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.624 0.726 . . . . 64.1 110.924 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -170.65 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.651 2.234 . . . . 75.44 112.379 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.9 mt -54.18 -40.41 67.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 75.14 110.866 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.16 57.65 12.66 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.728 -0.748 . . . . 72.11 112.453 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -148.37 54.98 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 63.25 110.903 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -136.0 -169.63 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.927 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.61 -168.06 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.41 110.906 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 97.8 m -49.25 -44.05 43.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 72.42 111.132 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.01 141.04 29.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 75.11 111.118 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.7 m -148.56 101.53 3.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 71.04 111.147 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -65.86 96.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 74.23 110.942 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 tpp . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.862 0.363 . . . . 72.45 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.59 128.13 48.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 75.52 110.904 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.92 160.02 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 73.33 111.112 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -161.17 122.58 2.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.87 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.44 178.73 5.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 72.02 111.169 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -174.0 139.21 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 74.4 110.908 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -118.89 94.82 48.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.634 0.73 . . . . 75.04 110.928 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.74 0.66 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.749 2.299 . . . . 71.54 112.287 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.83 -156.39 25.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.682 -0.77 . . . . 61.23 112.451 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.36 121.94 39.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.736 0.303 . . . . 74.4 110.9 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.489 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -130.89 -93.65 0.64 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.67 -0.776 . . . . 71.24 112.451 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -73.04 -27.83 61.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 74.41 110.846 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.36 164.75 34.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 72.14 111.154 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -70.15 -23.88 63.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.41 110.865 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -119.41 49.0 1.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.871 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.5 p30 -99.62 137.58 37.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 70.24 110.911 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.8 pt -139.88 160.07 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.14 111.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.4 m -108.5 149.42 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 75.3 111.157 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -105.57 141.82 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 72.42 111.078 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -130.17 146.77 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.928 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.6 mt -124.39 97.13 40.31 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.636 0.731 . . . . 75.32 110.908 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 73.33 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.252 . . . . 74.23 112.353 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.79 -34.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 72.43 110.862 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -118.04 -12.38 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.897 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.6 m120 68.9 23.27 6.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.106 -0.497 . . . . 72.52 110.884 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.18 115.8 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 74.25 111.111 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.11 139.97 33.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 73.42 110.914 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.7 67.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.154 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.36 -54.13 25.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 73.15 112.478 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.38 -134.8 12.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.622 -0.799 . . . . 52.43 112.494 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 91.8 m -64.48 -15.6 61.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.401 . . . . 55.11 110.93 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.3 tp -69.92 -51.54 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 74.52 110.913 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.2 t -80.95 133.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 72.51 111.07 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -109.26 138.22 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 74.43 110.925 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.3 p -57.06 154.68 9.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.32 110.872 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 63.43 111.15 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.791 0.329 . . . . 75.41 111.114 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.85 78.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.52 111.131 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -119.21 40.99 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 72.25 110.935 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.85 172.78 12.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 73.11 111.055 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -119.79 89.78 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 71.51 110.868 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.5 -20.9 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 72.42 111.076 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -81.34 -27.24 35.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.83 -22.94 16.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 72.1 110.837 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.36 -55.05 20.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 73.42 110.865 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.3 p -51.88 -41.11 61.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 70.23 110.87 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 89.4 m -69.84 -40.21 75.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 73.32 111.175 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 70.6 m -58.31 -55.06 39.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 74.21 110.825 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.0 mm -54.36 -36.82 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 75.33 111.174 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -62.45 -23.39 66.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 71.33 110.914 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -90.41 -25.94 20.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 70.14 110.914 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 43.6 t -80.96 -32.7 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 73.31 111.08 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.8 -25.04 28.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 73.33 110.895 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -82.3 -46.07 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 75.22 110.942 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -52.14 -38.41 57.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.781 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -131.88 117.57 18.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 75.14 110.937 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -115.34 41.65 2.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 73.24 110.861 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.01 21.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 73.44 110.89 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -53.22 144.58 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.144 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.02 -33.2 8.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 70.43 110.916 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -157.54 127.26 6.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 75.51 111.085 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 86.9 t -106.76 118.09 53.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 75.04 111.15 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 57.4 t -100.84 104.11 29.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.571 0.701 . . . . 75.31 111.235 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.72 -172.14 0.54 Allowed 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.705 2.27 . . . . 72.33 112.301 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -100.64 -25.11 8.81 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 75.24 112.541 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -146.34 104.94 3.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 72.23 110.875 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.97 -91.43 0.15 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.71 -0.757 . . . . 72.03 112.453 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -178.9 153.28 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.373 . . . . 73.32 110.902 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.48 143.88 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.12 111.18 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -143.22 -105.56 0.54 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.696 -0.764 . . . . 61.54 112.487 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -155.49 -170.14 3.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.802 0.334 . . . . 71.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -57.74 -20.49 35.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.888 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.28 62.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.707 -0.758 . . . . 75.43 112.504 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 31.9 mt -50.78 -47.69 59.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 75.12 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 mp -56.93 -43.87 81.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.457 . . . . 74.41 110.836 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.3 mt -66.08 -41.66 90.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 75.44 110.951 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -60.34 -44.46 95.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.792 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -46.73 64.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 72.13 111.071 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 61.0 mt -51.78 -39.75 59.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.22 111.0 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -65.64 -44.62 85.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.886 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 20.7 mt -57.0 -25.84 59.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.908 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.56 -40.21 12.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 72.15 110.875 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.0 mttt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 65.45 110.88 179.852 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.786 0.327 . . . . 74.32 111.155 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mm -87.95 149.59 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 64.22 111.143 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -146.43 156.38 43.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 72.45 110.903 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.32 -177.52 4.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.878 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -67.14 -28.86 68.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 p -93.06 -35.95 12.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.12 111.057 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.96 -15.16 58.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.664 -0.779 . . . . 65.14 112.425 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.0 t -51.72 -33.06 32.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.725 0.298 . . . . 72.44 111.151 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.6 mt -117.11 150.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 74.21 111.027 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.9 p -170.66 173.24 5.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 71.15 110.827 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.78 -177.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 73.45 111.13 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -167.72 135.77 2.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.473 . . . . 63.52 110.833 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -69.8 118.97 13.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 75.12 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.44 -56.8 2.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 71.54 110.946 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -152.69 -172.57 4.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.88 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -52.57 109.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 74.4 110.856 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 58.77 26.16 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.891 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.5 t -128.44 110.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 75.42 111.124 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -123.39 163.75 20.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 75.44 110.94 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.9 t -124.42 109.81 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 72.52 111.181 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -99.32 136.92 38.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 71.44 110.888 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.4 m -130.99 125.9 34.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 71.41 111.13 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.88 168.09 10.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.829 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.68 132.92 52.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.41 110.91 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.231 0 C-N-CA 120.687 -0.768 . . . . 74.52 112.437 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 69.9 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.668 0.747 . . . . 72.23 111.141 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.0 Cg_endo -69.67 139.51 40.73 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.782 2.321 . . . . 61.12 112.285 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.62 127.02 51.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 44.23 110.857 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -78.17 137.84 38.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 75.34 110.906 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.711 ' CA ' ' HD2' ' A' ' 56' ' ' ASP . . . -138.18 -160.47 8.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 63.51 112.529 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.15 143.63 6.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.84 0.352 . . . . 73.44 110.886 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 63.5 t -126.25 131.92 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 74.43 111.145 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.5 mt -101.85 119.1 38.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.438 . . . . 73.25 110.92 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -90.07 48.28 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 61.31 110.84 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 p -58.48 176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 74.42 111.106 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.2 21.88 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 72.13 110.889 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.52 30.02 1.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.13 110.856 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.61 129.4 6.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 70.34 112.49 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.3 mt -51.62 165.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 63.42 110.97 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.3 t -147.31 144.9 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 75.22 111.181 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.7 126.66 54.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.11 110.921 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.06 -3.85 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 75.11 111.181 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.711 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 0.9 OUTLIER -178.8 129.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 74.31 110.846 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -166.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 70.23 110.857 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 t -94.66 -170.36 2.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 64.12 110.819 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -73.06 -38.8 66.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 72.25 110.878 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -140.0 161.73 36.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 71.13 110.87 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.22 -33.9 69.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 65.35 110.896 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -75.2 -25.75 58.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.903 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 -42.67 20.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 74.42 110.882 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -67.1 -27.05 67.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 65.4 111.168 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -53.42 -39.49 64.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.892 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -86.03 -13.96 45.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 65.54 110.912 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.7 tp -77.65 -43.14 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 72.34 110.911 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.24 -29.04 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 73.04 111.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.11 -11.7 61.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 73.15 110.889 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 mmm -89.38 -54.47 4.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 75.51 110.877 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.5 m -57.12 -39.87 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 72.43 111.051 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -84.41 51.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 73.35 110.899 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -142.54 -41.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 75.13 110.878 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -19.92 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 73.2 110.909 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.524 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 26.1 m-85 -89.22 10.81 20.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.14 110.883 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.524 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.64 47.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 61.43 110.902 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -155.3 -179.23 7.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.915 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 151.38 49.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.815 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.11 128.66 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 71.3 111.116 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.4 p -137.25 20.76 2.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 74.31 111.173 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -154.01 134.9 13.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 71.43 110.884 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.0 t -138.32 97.92 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 71.33 111.101 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.6 mt -75.02 129.69 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 74.02 111.131 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.5 mm -115.96 131.3 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 75.53 111.115 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.7 p -88.01 -57.93 2.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 71.21 111.157 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -132.86 157.6 44.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 62.33 110.865 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.482 ' H ' ' HD2' ' A' ' 152' ' ' ASP . . . -76.25 96.98 4.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 63.11 111.151 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.65 157.94 43.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.871 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.83 -27.17 62.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 44.32 111.15 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.25 8.15 28.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 61.03 110.875 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -122.89 -53.6 1.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 72.15 110.903 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.4 18.36 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.128 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.61 -27.97 20.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.656 -0.783 . . . . 74.35 112.548 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.98 23.0 20.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.707 -0.759 . . . . 64.41 112.492 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 tt -48.98 -30.36 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 72.43 111.111 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -71.06 -43.26 68.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.916 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 93.9 m -67.04 -36.03 81.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 72.14 111.118 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.6 mt -60.94 -33.48 73.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.33 110.926 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -94.3 21.84 6.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.911 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -117.24 -20.29 9.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.824 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -115.32 5.97 14.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.9 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.76 15.17 60.06 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 75.31 112.429 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 mt -81.62 155.71 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 74.01 111.175 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.95 122.1 40.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 75.35 110.893 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.51 81.45 7.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 72.14 111.046 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -56.58 147.71 21.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 70.41 110.889 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.64 166.43 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 71.14 110.799 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.1 p -86.08 157.05 20.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 62.42 111.145 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.41 -43.32 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 75.23 111.054 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.1 -46.04 90.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 70.44 110.986 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.2 m -52.04 -42.58 63.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 72.21 111.166 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.25 -24.79 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 70.43 111.117 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.87 -51.31 69.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 64.04 110.885 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.26 -25.03 54.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.919 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.92 -69.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 74.42 111.155 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -54.72 -26.64 35.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 73.5 110.951 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -24.48 67.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 74.32 110.853 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -92.81 -38.97 11.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 74.53 110.873 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.86 -6.47 3.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 44.42 112.554 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -59.77 -172.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.832 0.348 . . . . 63.33 110.95 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -98.63 -0.68 42.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 63.32 110.885 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 66.28 126.26 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.654 0.74 . . . . 72.21 110.85 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.677 2.251 . . . . 75.52 112.377 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.9 mt -52.21 -40.55 61.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.903 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.1 55.97 18.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.531 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -148.98 52.93 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 71.31 110.912 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.8 mt -135.74 -177.67 4.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.883 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.83 -168.59 2.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.883 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -50.1 -54.26 21.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.4 111.158 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.8 t -131.34 130.98 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 72.0 111.106 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.1 m -135.6 123.67 22.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 75.11 111.167 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -81.41 103.97 11.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 75.1 110.85 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 73.3 110.902 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 58.5 tpp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.866 0.365 . . . . 75.41 110.838 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -117.17 115.24 24.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.926 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.6 t -123.01 153.55 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 61.31 111.144 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -153.15 122.38 6.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 72.5 110.938 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.24 -178.18 2.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 75.31 111.148 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -175.35 134.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.84 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -121.09 96.06 48.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.702 0.763 . . . . 74.24 110.91 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.71 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.619 2.213 . . . . 71.24 112.336 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.61 -153.78 20.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.738 . . . . 63.15 112.451 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.7 124.62 39.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 71.33 110.905 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.466 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.42 -94.19 0.34 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 74.33 112.47 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -70.11 -26.86 64.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 75.44 110.895 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.41 159.62 42.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.468 . . . . 74.32 111.119 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.28 -23.09 66.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.873 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.482 ' HD2' ' H ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -124.02 50.07 1.69 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 75.52 110.868 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.19 139.87 34.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 73.12 110.904 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.6 pt -140.12 172.85 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 71.2 111.149 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.9 m -123.58 139.23 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 63.53 111.183 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.6 t -94.04 128.68 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.12 111.139 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -114.84 150.32 35.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.905 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.7 mt -124.77 94.87 43.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.595 0.712 . . . . 73.21 110.926 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 69.65 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.687 2.258 . . . . 74.42 112.317 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.37 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 74.23 110.874 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -117.49 -10.76 10.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 75.52 110.905 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.4 m120 68.18 21.01 8.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 73.35 110.88 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.41 116.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 70.44 111.097 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.98 123.46 45.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 75.43 110.984 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.0 t -117.37 72.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 73.42 111.078 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.17 -51.71 47.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 71.43 112.482 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.94 -138.02 14.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 72.33 112.483 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.91 -25.72 31.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 62.24 110.854 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.08 -49.63 75.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 65.53 110.95 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.56 131.37 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 62.34 111.111 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -101.6 148.64 24.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 75.34 110.887 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.2 t -73.56 158.86 34.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.827 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 72.03 111.197 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.783 0.325 . . . . 62.32 111.069 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.3 80.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 75.41 111.039 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -114.03 42.23 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 74.3 110.927 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.24 164.65 28.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.43 111.072 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -115.61 92.61 3.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 72.45 110.931 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.07 -23.68 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.1 111.201 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -79.39 -31.52 42.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 73.02 110.886 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.51 -22.7 20.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 71.5 110.911 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -51.49 -53.21 39.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 73.24 110.884 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.6 p -51.88 -37.93 54.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 71.04 110.86 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 91.8 m -70.64 -37.77 73.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 71.24 111.128 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.2 m -63.38 -55.27 25.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 70.51 110.876 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.8 mm -56.54 -37.63 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 73.22 111.112 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.06 -17.49 62.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 75.12 110.842 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -96.55 -28.96 14.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 61.14 110.901 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 96.0 t -82.69 -26.02 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 71.42 111.099 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.51 -23.27 20.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 64.45 110.909 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -88.51 -47.38 8.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 72.4 110.88 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 32.9 tpt85 -55.31 -32.59 62.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 74.31 110.834 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -130.89 116.91 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 72.3 110.888 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -119.3 34.94 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 75.34 110.897 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.02 22.33 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 70.3 110.859 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -51.51 143.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 75.24 111.146 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -103.0 -39.27 6.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 74.03 110.936 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.71 118.96 5.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 72.42 111.092 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 92.8 t -96.96 123.21 49.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 74.41 111.152 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.403 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 87.5 t -106.49 102.13 39.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 73.44 111.154 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.0 Cg_endo -69.69 -170.05 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.75 2.3 . . . . 50.23 112.347 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.87 -31.27 7.45 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.733 -0.746 . . . . 62.43 112.445 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -144.27 111.9 6.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 65.45 110.873 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 144.91 -94.17 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 74.44 112.447 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -176.06 164.09 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 72.55 110.917 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.59 150.57 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.41 111.07 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.77 -108.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.767 -0.73 . . . . 74.01 112.457 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -160.27 -169.85 2.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.876 0.369 . . . . 73.2 110.887 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -54.25 -24.76 19.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.43 110.87 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -52.16 -35.6 42.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 71.51 112.5 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 32.7 mt -50.96 -45.68 60.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.339 . . . . 73.43 110.918 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.14 -41.3 68.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 75.14 111.01 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.8 mt -69.36 -40.87 77.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.32 110.853 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -60.78 -42.14 96.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.762 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.25 -48.43 65.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 72.24 111.167 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.8 mt -56.28 -41.4 75.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 75.14 110.93 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.91 -42.07 79.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 73.24 110.904 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.5 mt -60.88 -37.4 82.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 75.03 110.894 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.7 mt -72.7 -40.53 66.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 70.31 110.944 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 71.32 110.909 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.804 0.335 . . . . 74.5 111.154 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mm -88.14 152.86 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 74.44 111.191 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -146.12 153.75 41.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 72.05 110.87 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.16 170.82 11.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 64.11 110.903 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -58.7 -27.17 64.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 73.42 110.885 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -100.13 -33.4 10.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 75.12 111.225 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.85 -9.76 51.8 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.737 -0.745 . . . . 50.42 112.446 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -50.94 -33.21 23.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.716 0.293 . . . . 72.51 111.123 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.6 mt -124.81 149.18 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.15 111.084 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -168.34 169.75 10.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 72.31 110.845 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.05 -172.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.503 . . . . 75.02 111.143 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.76 132.86 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 64.32 110.908 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.21 120.72 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.104 -0.498 . . . . 74.5 110.923 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -103.8 -49.28 3.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.932 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.33 51.87 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 69.03 -75.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.936 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -86.88 -19.91 28.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 71.45 110.897 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.6 t -97.45 118.52 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 71.43 111.123 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -122.35 161.56 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.939 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 70.4 t -122.35 106.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 75.14 111.108 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -95.83 137.37 34.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 74.24 110.876 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.3 m -132.46 128.76 38.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 75.25 111.156 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.29 -177.27 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.438 . . . . 73.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.79 133.16 35.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 73.23 110.865 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 75.53 112.484 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.409 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 59.4 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 121.643 0.735 . . . . 73.24 111.068 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.5 Cg_endo -69.69 141.04 44.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.649 2.233 . . . . 73.23 112.358 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -121.26 132.85 55.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 75.13 110.821 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -90.95 141.93 28.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 73.24 110.804 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.573 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -140.95 -155.87 6.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 53.44 112.53 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -164.93 144.13 6.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 73.53 110.903 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 t -128.08 133.28 67.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 75.33 111.115 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.6 mt -100.64 123.32 44.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.941 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -92.15 46.79 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 74.32 110.886 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.5 p -55.35 171.26 0.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 72.22 111.125 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.3 t -99.24 28.45 4.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.83 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 22.8 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 70.33 110.941 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.8 129.98 4.4 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 65.13 112.503 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.0 mt -57.26 157.81 5.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 74.51 110.957 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.2 t -140.76 143.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 74.13 111.123 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.47 130.07 56.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 72.01 110.934 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -79.77 -1.78 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.096 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.573 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 0.8 OUTLIER 179.78 134.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.88 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -166.7 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 75.32 110.821 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.17 -170.09 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 75.43 110.799 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -72.05 -40.22 68.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.094 -0.503 . . . . 75.23 110.931 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.79 175.54 9.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 62.45 110.958 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -68.9 -30.61 69.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 75.12 110.823 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -74.54 -22.39 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 74.31 110.918 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.27 -52.41 5.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 64.44 110.89 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -57.4 -28.35 63.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 72.44 111.138 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -55.93 -40.82 73.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 73.33 110.874 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.96 -1.36 57.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.414 . . . . 74.53 110.866 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 tp -92.88 -45.15 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.902 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.8 mt -72.18 -14.65 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 74.44 111.072 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -87.11 5.9 35.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 71.22 110.848 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.1 mtp -106.54 -53.69 2.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 73.32 110.859 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -58.42 -37.77 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 71.32 111.083 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -85.99 50.03 1.9 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.898 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.23 -42.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 73.51 110.837 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.9 -21.65 13.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.955 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.521 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 35.9 m-85 -91.23 12.94 18.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.883 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.521 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.72 46.91 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 71.13 110.923 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -155.57 -177.81 6.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 72.32 110.87 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.85 159.13 33.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 72.14 110.875 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.9 t -91.46 119.44 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 72.45 111.123 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.0 p -132.18 36.83 3.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.118 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.419 ' HD2' ' HD2' ' A' ' 104' ' ' LYS . 4.6 m-20 -169.76 134.29 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 75.5 110.794 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 t -140.66 100.27 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 74.53 111.09 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.7 mt -77.66 124.04 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 74.1 111.164 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.3 mm -109.24 142.43 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 75.24 111.132 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.8 p -98.69 -60.85 1.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 71.52 111.164 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -130.79 165.07 23.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 75.44 110.865 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.21 97.66 8.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.22 111.059 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.65 157.93 42.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.912 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.93 -29.57 63.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 73.33 111.087 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -89.66 10.7 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.873 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -121.94 -52.09 2.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 72.23 110.915 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.13 26.77 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.157 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.24 -28.19 18.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.707 -0.758 . . . . 62.42 112.479 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.02 30.61 6.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 65.32 112.543 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 tt -48.56 -34.21 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 75.1 111.098 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -34.51 33.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 75.53 110.853 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.9 m -62.44 -34.18 76.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 74.22 111.063 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.6 mt -65.4 -43.24 91.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 71.01 110.878 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -26.26 59.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.866 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.25 -29.82 70.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 72.23 110.896 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -105.58 -48.29 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.35 110.858 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.62 -15.75 1.08 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.72 -0.753 . . . . 72.02 112.499 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.56 151.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.13 111.123 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HD2' ' HD2' ' A' ' 81' ' ' ASP . 1.6 ptpm? -113.66 127.84 56.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.923 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.12 82.03 6.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 72.41 111.043 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -57.72 147.11 28.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.45 110.871 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.63 160.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 73.03 110.89 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.2 p -74.03 -175.61 2.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 72.24 111.111 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.12 -30.92 43.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 64.31 111.143 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.73 -44.68 40.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.958 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.7 m -55.41 -25.38 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 74.23 111.168 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.31 -34.34 14.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 74.43 111.159 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -53.69 -32.8 53.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 63.3 110.89 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.79 -25.84 18.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 71.13 110.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.65 -62.72 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.32 111.096 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -60.12 -26.09 65.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 72.11 110.898 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -25.18 68.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.893 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -92.16 -33.38 14.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.868 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.1 -10.78 4.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 74.33 112.494 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -59.59 -173.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.83 0.347 . . . . 72.41 110.871 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -98.71 0.32 44.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 54.44 110.886 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 66.42 132.59 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.656 0.741 . . . . 74.21 110.928 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.63 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.653 2.235 . . . . 70.1 112.4 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.2 mt -54.83 -51.11 66.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 73.11 110.959 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.4 51.72 8.2 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.75 -0.738 . . . . 62.12 112.471 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.46 55.42 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 64.32 110.833 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.61 -174.66 3.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.89 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.84 -168.16 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 98.1 m -49.66 -43.01 46.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 75.25 111.221 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.38 142.15 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 75.5 111.061 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.6 m -149.83 108.87 3.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.095 -0.502 . . . . 73.33 111.084 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -69.75 96.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 73.12 110.858 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 75.44 110.94 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.88 0.372 . . . . 75.11 110.832 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -120.51 127.72 52.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.848 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 t -141.51 158.96 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 73.31 111.145 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -159.01 124.58 4.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.23 110.891 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -178.27 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 72.33 111.13 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -175.36 140.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 71.5 110.895 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -123.24 97.66 42.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.598 0.713 . . . . 74.02 110.927 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.98 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.699 2.266 . . . . 64.25 112.371 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.59 -153.95 22.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.786 -0.721 . . . . 55.22 112.467 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.51 122.44 39.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 74.23 110.934 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.489 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.04 -97.76 0.56 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 52.21 112.481 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -67.65 -28.41 67.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.818 0.342 . . . . 64.24 110.862 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.69 156.44 41.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 73.12 111.114 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -59.91 -29.26 68.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 72.01 110.844 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.9 52.12 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.89 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.4 p30 -100.72 135.0 42.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 75.43 110.884 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.45 166.98 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 75.21 111.114 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.83 157.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 75.21 111.107 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.3 t -110.36 143.29 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.136 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -130.87 148.15 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 75.31 110.902 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 24.1 mt -125.53 95.37 40.8 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.57 0.7 . . . . 74.22 110.888 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 72.21 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.729 2.286 . . . . 64.34 112.317 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.08 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 70.33 110.934 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.89 -11.74 10.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.891 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 68.36 24.12 7.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 63.13 110.976 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.24 117.24 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 70.44 111.172 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.23 142.65 33.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 75.53 110.952 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.9 67.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 75.0 111.127 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.62 -55.19 21.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.67 -0.776 . . . . 71.25 112.544 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.14 -137.12 13.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.668 -0.777 . . . . 34.01 112.468 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 59.3 m -64.24 -15.8 60.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 73.03 110.934 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.5 tp -70.11 -47.59 61.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.914 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.91 115.92 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 75.53 111.148 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 155.76 23.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 75.31 110.892 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.5 t -84.0 162.29 20.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 73.14 110.843 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 73.3 111.161 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.856 0.36 . . . . 63.14 111.115 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.27 -47.05 82.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 70.25 111.155 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -117.42 42.99 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.844 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -133.62 162.17 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 73.23 111.138 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -115.72 93.49 4.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.022 0.439 . . . . 75.45 110.902 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.36 -20.91 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 75.24 111.06 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -81.98 -26.84 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 70.34 110.943 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.54 -21.37 16.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.53 110.841 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.41 -56.18 14.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.9 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.3 p -51.96 -37.77 54.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.837 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.1 m -72.56 -37.84 68.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 72.15 111.127 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 75.7 m -61.92 -54.92 35.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.04 110.83 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.7 mm -55.83 -36.75 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 75.35 111.087 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.88 -17.31 64.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.3 110.828 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -93.93 -31.03 14.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 70.5 110.871 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 87.3 t -77.26 -45.9 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 73.32 111.137 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.6 pp -69.77 -23.2 63.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.467 . . . . 72.24 110.878 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -86.23 -44.33 12.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.866 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -53.29 -28.5 28.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 74.14 110.874 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -142.52 121.24 12.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 72.01 110.96 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.42 35.69 4.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 75.23 110.879 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.25 21.8 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.914 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.6 mp -53.24 145.08 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.42 111.164 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -105.88 -33.76 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.91 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -155.92 128.37 7.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 70.11 111.111 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.85 117.42 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 74.25 111.126 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.414 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 75.3 t -100.04 104.3 28.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.594 0.711 . . . . 72.02 111.097 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.75 -173.7 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.707 2.271 . . . . 72.4 112.32 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.42 -28.85 10.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.737 . . . . 71.12 112.503 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -144.09 110.52 5.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 74.45 110.824 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 144.92 -98.41 0.2 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 73.53 112.508 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -174.62 154.75 2.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 72.12 110.928 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.9 t -57.32 149.59 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 70.13 111.157 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -148.72 -108.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.697 -0.763 . . . . 73.03 112.515 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -161.34 -169.85 2.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.893 0.378 . . . . 72.12 110.92 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -58.18 -20.56 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 65.34 110.949 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.63 -33.98 63.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.76 -0.734 . . . . 72.01 112.461 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 28.0 mt -50.59 -42.66 56.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.834 0.35 . . . . 74.42 110.896 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.43 -43.36 75.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.919 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.54 -40.41 80.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 72.11 110.9 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -60.72 -38.91 86.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.52 110.879 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.78 -45.07 63.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 73.4 111.081 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.4 -42.57 92.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 74.31 110.888 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -29.21 56.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.852 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.9 mt -75.21 -26.89 59.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 73.24 110.88 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.4 mt -86.09 -30.21 22.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.958 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 74.23 110.907 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.808 0.337 . . . . 74.43 111.154 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mm -93.76 156.88 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.05 111.155 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.42 170.08 19.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 75.12 110.933 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -99.89 -169.29 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 75.11 110.983 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.28 -20.96 58.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.44 110.877 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.3 p -107.66 -39.53 5.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 74.45 111.148 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.02 -2.65 30.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 54.11 112.473 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -50.57 -33.28 21.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 75.21 111.181 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.1 mt -129.25 158.96 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.12 111.093 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.9 p -175.8 164.23 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 64.02 110.823 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.88 -175.41 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.515 . . . . 74.45 111.163 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 t -167.54 131.07 1.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 54.12 110.845 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.12 118.48 11.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 73.12 110.922 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.57 -45.88 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.861 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -141.58 -169.63 2.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.3 110.916 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -51.07 -49.66 60.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.875 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -133.38 39.14 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 74.13 110.871 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.39 121.63 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 73.21 111.159 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -126.38 159.61 32.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 64.25 110.965 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.2 t -122.43 106.69 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 73.43 111.124 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.648 ' CE1' ' HE2' ' A' ' 30' ' ' GLU . 8.4 p80 -98.37 138.13 36.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 72.52 110.851 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 m -136.59 134.21 37.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 73.51 111.127 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.648 ' HE2' ' CE1' ' A' ' 28' ' ' HIS . 2.5 pm0 -125.93 175.74 7.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 64.21 110.907 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 tp -119.76 150.05 41.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.13 110.975 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.775 -0.726 . . . . 75.52 112.526 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.622 0.725 . . . . 74.41 111.151 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 151.97 69.34 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.693 2.262 . . . . 73.21 112.328 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 t -138.21 92.29 2.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 55.43 110.87 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -52.77 171.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 75.32 110.941 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.475 ' HA3' ' HD2' ' A' ' 56' ' ' ASP . . . -169.93 -156.43 11.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.729 -0.748 . . . . 74.11 112.5 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.68 144.39 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 75.13 110.934 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.94 138.51 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 73.32 111.144 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.8 mt -106.03 130.69 53.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.86 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.99 56.94 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 75.0 110.921 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 p -67.23 177.38 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 75.44 111.217 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.51 20.23 15.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 72.13 110.818 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.91 24.37 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.34 110.858 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.11 134.92 6.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 73.0 112.487 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 mt -60.93 157.54 15.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 73.1 110.908 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.5 t -136.94 142.8 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.11 111.121 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.86 128.85 56.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.14 110.92 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.95 -1.76 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 72.44 111.154 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 2.6 p-10 179.93 127.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.41 110.872 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -66.57 -166.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.827 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -95.06 -171.38 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 70.32 110.842 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -72.61 -37.34 68.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.01 110.927 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -145.77 157.61 43.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 73.44 110.829 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -54.25 -34.61 61.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 64.25 110.869 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -74.91 -25.55 59.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 73.3 110.957 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.49 -44.76 16.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.908 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 t -60.26 -26.16 66.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 72.43 111.175 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -54.36 -42.4 70.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 64.42 110.82 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.33 -10.51 59.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 75.42 110.883 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.2 tp -89.69 -52.38 5.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 74.22 110.909 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.1 mt -65.83 -15.3 18.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 73.44 111.117 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -87.3 7.09 30.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 63.32 110.866 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.1 mtp -103.26 -57.35 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 71.21 110.865 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.1 m -58.0 -39.22 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 71.5 111.117 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -84.07 50.79 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 72.35 110.846 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 -39.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 54.52 110.867 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 -21.62 12.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.897 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.525 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 29.0 m-85 -90.15 12.08 18.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.863 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.525 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.79 46.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 74.23 110.924 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.6 mttp -151.6 -177.04 5.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.252 -0.431 . . . . 74.24 110.977 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.41 158.4 38.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 70.45 110.863 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.53 117.13 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.42 111.096 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.9 p -133.03 38.19 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.4 111.247 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -168.83 134.97 1.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 63.11 110.838 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.1 t -143.01 102.19 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.43 111.162 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.8 mt -81.41 115.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.4 111.07 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.1 mm -101.33 129.86 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.11 111.097 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -87.68 -56.03 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.14 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -133.06 166.4 22.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 73.04 110.862 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.05 98.38 10.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.411 . . . . 54.13 111.149 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.23 159.65 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.9 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.09 -28.73 62.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 73.12 111.097 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.35 12.01 19.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 73.32 110.792 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -124.0 -52.26 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 74.1 110.866 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.32 17.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.45 111.157 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.9 -28.12 23.27 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.753 -0.736 . . . . 74.23 112.499 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.0 20.75 26.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 74.51 112.543 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -48.35 -31.03 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 74.24 111.134 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -69.49 -44.53 70.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 74.22 110.925 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 m -66.67 -34.36 77.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 74.4 111.14 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.1 mt -64.37 -26.87 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 75.12 110.912 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -99.77 21.01 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.914 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.07 -30.41 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 75.15 110.872 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -104.38 12.42 33.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 75.32 110.881 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.38 25.07 61.93 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.822 -0.704 . . . . 63.23 112.509 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.4 mt -88.11 157.07 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 75.52 111.163 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.32 118.79 31.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.918 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.17 78.31 6.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 75.21 111.009 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -54.77 147.92 13.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.41 110.898 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.93 163.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 65.22 110.891 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.7 p -85.13 158.17 20.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 55.51 111.182 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.7 61.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 72.54 111.103 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -46.89 86.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 75.05 110.873 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 100.0 m -52.43 -41.98 63.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 73.34 111.168 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.49 -23.38 61.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 73.4 111.137 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.87 -43.08 85.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 7.3 mp -81.1 -28.03 35.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.936 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.67 -70.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 75.44 111.03 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -26.0 36.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 74.14 110.962 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -23.65 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 75.23 110.869 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -96.07 -38.71 10.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 74.45 110.898 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.87 -6.39 3.76 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.698 -0.763 . . . . 71.22 112.483 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.62 -172.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 72.53 110.931 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -97.8 -1.57 42.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 74.24 110.842 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 66.31 129.13 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.657 0.741 . . . . 74.54 110.84 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.648 2.232 . . . . 73.23 112.341 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.6 mt -54.08 -35.96 62.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 74.52 110.955 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.12 49.04 51.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 70.21 112.457 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -142.8 56.28 1.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 71.5 110.857 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.79 -169.8 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 75.11 110.91 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -148.84 -168.79 3.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 73.4 110.879 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 99.3 m -50.27 -56.99 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 72.32 111.156 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 88.4 t -130.29 128.5 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 75.41 111.114 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.6 m -135.81 124.31 23.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 65.22 111.154 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -80.33 103.0 9.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.912 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 73.43 110.926 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 32.0 tpp . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.882 0.372 . . . . 74.33 110.88 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.14 120.99 28.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 62.41 110.868 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.3 t -131.57 155.67 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.22 111.145 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -153.09 125.06 7.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.872 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -177.95 3.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 64.32 111.18 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -175.18 137.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 75.43 110.887 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -122.61 94.86 47.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.692 0.758 . . . . 74.22 110.974 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -48.74 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 73.03 112.292 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.45 -152.24 15.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 54.41 112.437 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.62 125.81 45.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.346 . . . . 75.35 110.903 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.483 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -136.5 -87.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.71 . . . . 64.41 112.495 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -76.33 -29.18 57.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 70.24 110.91 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.68 156.11 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.24 111.19 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.81 -24.88 62.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 74.12 110.789 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.501 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 14.4 p30 -119.98 47.36 1.76 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 73.35 110.827 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -97.27 134.55 40.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 62.41 110.848 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.6 pt -136.07 169.87 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 72.32 111.089 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.9 m -120.98 145.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 74.43 111.077 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.1 t -98.29 143.58 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 73.21 111.12 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -129.85 149.74 51.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 74.44 110.914 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.5 mt -126.96 95.71 36.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.604 0.716 . . . . 64.51 110.936 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 71.91 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.679 2.253 . . . . 74.14 112.35 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 75.22 110.928 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -118.03 -13.18 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 75.13 110.908 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.6 m120 69.4 23.26 6.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 75.35 110.922 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.51 114.38 30.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 70.41 111.113 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.14 136.61 39.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 75.35 110.898 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 31.7 t -122.11 67.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 73.01 111.16 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.34 -55.62 18.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.74 -0.743 . . . . 72.55 112.559 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.18 -122.83 6.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.746 -0.74 . . . . 72.4 112.467 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.7 m -80.82 -0.8 40.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 70.31 110.909 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.31 -49.1 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 74.44 110.981 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.32 105.77 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 74.43 111.125 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.02 164.45 26.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.918 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 p -88.65 158.65 18.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.798 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 74.53 111.14 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.0 m . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.827 0.346 . . . . 64.22 111.082 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.63 91.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 75.32 111.07 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.88 44.66 1.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.14 110.937 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -134.93 174.16 10.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 72.15 111.067 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -127.24 87.46 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 64.03 110.985 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.39 -22.22 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 71.14 111.181 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.7 -32.96 58.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 74.21 110.922 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -93.53 -22.8 18.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 73.35 110.877 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.48 -55.88 16.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 72.01 110.83 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.3 p -51.94 -37.05 51.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 75.35 110.88 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m -74.18 -35.62 63.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 72.01 111.111 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 32.9 m -63.19 -52.38 62.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 74.53 110.838 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 27.7 mm -58.02 -39.15 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 74.22 111.092 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.22 -17.07 57.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 75.15 110.929 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -99.76 -23.83 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 73.52 110.843 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.34 -18.43 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 71.33 111.119 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.4 pp -105.52 1.27 27.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 75.54 110.939 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -117.81 -24.01 7.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 74.3 110.901 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -82.67 1.15 39.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 72.43 110.829 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -136.28 -72.3 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.215 -0.448 . . . . 75.23 110.972 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.78 21.97 9.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.14 110.866 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -144.51 21.95 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.4 110.889 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.27 145.86 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.52 111.184 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -102.56 -28.2 12.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 72.14 110.876 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -163.95 128.98 2.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 64.54 111.106 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 95.2 t -107.1 126.3 63.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 75.33 111.131 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 50.4 t -109.91 106.12 57.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.646 0.736 . . . . 75.0 111.102 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.75 -169.27 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.735 2.29 . . . . 64.41 112.304 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -111.14 -21.7 6.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 71.13 112.406 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -145.69 74.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 75.54 110.905 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.1 -101.75 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 73.52 112.5 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -171.66 140.26 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 74.43 110.83 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.45 143.78 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 74.13 111.142 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.6 -106.19 0.49 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.75 . . . . 71.03 112.489 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -156.22 -169.92 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.349 . . . . 63.13 110.9 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -56.36 -22.37 30.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.866 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.24 -32.8 51.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 75.33 112.484 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 31.3 mt -50.79 -41.55 57.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 71.11 110.98 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.02 -44.77 79.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 75.11 110.962 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.1 mt -67.82 -40.48 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 72.23 110.956 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -58.66 -43.76 89.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.831 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -48.36 63.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.22 111.16 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.1 mt -54.77 -41.28 70.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.925 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -32.73 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 64.11 110.863 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.21 -25.77 61.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 72.54 110.953 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.8 mt -87.37 -38.07 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.936 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 75.1 110.909 179.795 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.789 0.328 . . . . 74.25 111.147 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mm -94.64 153.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 71.41 111.167 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -148.84 156.29 42.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 74.0 110.846 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.45 -169.58 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.87 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 -23.49 52.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.874 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.9 p -101.79 -35.13 9.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.042 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.62 -5.13 51.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 64.43 112.478 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -50.49 -33.28 20.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 74.34 111.214 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -128.55 159.92 39.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 75.3 111.052 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -175.52 169.33 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.24 110.929 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.63 -174.13 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.41 111.137 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.38 131.7 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 65.04 110.894 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.52 119.09 14.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 70.02 110.916 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mp -107.94 -33.9 7.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 72.41 110.918 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.22 -178.1 6.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 72.3 110.813 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -51.06 -41.01 59.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 70.14 110.861 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -139.93 38.6 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 73.11 110.882 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.0 t -137.88 116.05 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 75.43 111.135 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -123.98 155.59 37.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.13 110.89 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.6 t -117.29 108.6 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 74.23 111.115 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -101.57 138.39 38.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 73.32 110.861 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.3 m -135.2 140.66 45.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 74.23 111.217 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.27 174.17 10.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 74.5 110.897 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 tp -119.48 148.53 43.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.34 110.896 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 73.14 112.477 179.917 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.584 0.707 . . . . 74.51 111.153 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 146.97 61.51 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.712 2.275 . . . . 74.14 112.317 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -134.55 98.19 4.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 53.25 110.904 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -51.99 168.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 61.54 110.887 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.59 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -167.68 -163.36 21.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 70.11 112.483 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -164.22 145.98 8.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.857 0.36 . . . . 74.34 110.917 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.05 140.77 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 74.02 111.14 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.2 mt -108.0 128.17 54.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 73.33 110.909 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -97.26 55.25 1.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.908 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 p -60.36 -170.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 73.35 111.1 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.6 6.49 16.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 72.11 110.848 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -118.32 -18.75 9.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 70.44 110.925 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.76 130.54 1.31 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.823 -0.703 . . . . 41.14 112.543 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.1 mt -49.37 153.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.923 0.392 . . . . 73.35 110.877 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.96 143.23 35.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.158 -0.474 . . . . 73.15 111.11 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.88 128.44 56.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.2 110.816 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.6 t -78.45 -2.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 71.33 111.147 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.59 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 3.7 p-10 -179.47 131.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 54.25 110.89 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.55 -167.31 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.906 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -173.14 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 63.41 110.889 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -71.0 -38.51 72.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 75.41 110.93 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -141.72 161.64 37.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.802 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.606 ' HD2' ' HZ2' ' A' ' 62' ' ' LYS . 7.6 p-10 -58.51 -33.02 69.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.34 110.92 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.606 ' HZ2' ' HD2' ' A' ' 61' ' ' ASP . 1.1 mttp -75.3 -25.58 58.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.869 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.7 -43.65 18.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 73.31 110.879 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.8 t -65.48 -23.35 66.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.174 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -53.81 -43.26 69.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 75.42 110.887 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.72 -15.73 55.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 74.41 110.941 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.6 tp -77.8 -50.17 12.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.491 . . . . 73.44 110.894 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.0 mt -71.93 -15.39 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 55.24 111.111 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -88.71 10.35 21.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.895 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.8 mmm -109.88 -55.56 2.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 74.24 110.913 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 m -57.55 -37.19 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 74.31 111.141 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.44 50.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.913 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.57 -39.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 74.52 110.865 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -21.25 12.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.863 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.53 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 29.0 m-85 -90.62 12.67 18.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 74.41 110.89 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.53 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 2.1 pp0? 31.5 49.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.52 110.949 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.0 -176.54 5.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 75.03 110.962 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.98 152.26 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 73.44 110.863 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 82.7 t -85.29 125.56 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 74.21 111.192 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.3 p -136.0 16.62 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 71.21 111.127 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -150.02 134.92 17.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 74.51 110.898 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.3 99.01 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 74.35 111.034 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.8 mt -76.29 126.54 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 74.24 111.203 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.8 mm -113.55 133.34 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 74.12 111.131 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -90.11 -54.89 3.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 73.21 111.134 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -134.38 165.78 24.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.45 110.848 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.561 ' H ' ' HD2' ' A' ' 152' ' ' ASP . . . -84.79 98.32 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 71.31 111.133 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.75 159.44 43.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 71.12 110.848 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.23 -28.71 63.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 74.33 111.058 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.98 10.72 22.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 70.31 110.855 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -122.67 -52.03 1.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 74.31 110.908 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.39 17.45 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 63.11 111.11 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.96 -26.53 27.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.701 -0.761 . . . . 63.23 112.442 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.93 18.46 31.42 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.77 -0.729 . . . . 63.52 112.5 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.2 tt -48.93 -30.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.834 0.35 . . . . 72.2 111.077 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -67.96 -43.65 78.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 72.42 110.931 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.4 m -69.78 -34.09 73.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 74.52 111.072 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.8 mt -63.47 -28.2 69.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.895 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.95 19.49 14.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.922 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -117.33 -21.9 8.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 71.2 110.896 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -113.08 8.8 18.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.33 110.88 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.2 16.92 65.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 74.34 112.481 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.9 mt -82.43 156.96 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 75.35 111.159 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -120.65 122.86 41.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.891 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.58 78.42 6.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 71.11 111.061 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -51.71 146.21 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 52.21 110.866 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.49 163.71 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 72.43 110.814 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -80.19 156.32 26.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 72.21 111.122 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.83 -27.03 27.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 73.42 111.091 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 tp -74.95 -45.89 39.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 74.01 110.954 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.8 m -52.96 -28.1 22.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 60.13 111.142 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.08 -29.76 26.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 73.34 111.015 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -58.89 -31.12 68.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.409 . . . . 75.32 110.913 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.55 -25.47 17.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.129 -0.487 . . . . 73.21 110.837 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.71 -65.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.42 111.135 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -56.59 -25.02 51.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 73.53 110.877 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -24.52 65.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 74.33 110.882 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -96.03 -28.22 14.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.881 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.23 -5.53 7.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 71.23 112.507 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -59.58 -173.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.826 0.346 . . . . 74.2 110.969 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -99.75 1.17 43.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 71.31 110.888 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 65.87 122.65 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 75.35 110.857 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -170.65 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.707 2.271 . . . . 62.45 112.39 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 mt -51.76 -39.25 58.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.922 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.0 37.3 44.79 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 64.45 112.45 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -132.89 48.44 2.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 64.51 110.836 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.52 -169.64 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.299 -0.409 . . . . 74.32 110.884 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -149.99 -169.05 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 73.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.6 m -50.63 -63.95 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 74.31 111.143 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.1 t -124.26 112.03 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 75.33 111.108 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.0 m -121.35 111.34 17.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.05 111.111 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -67.25 90.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 74.02 110.884 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 64.25 110.884 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 6.2 tpp . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.811 0.339 . . . . 71.53 110.977 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.72 116.25 18.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.302 -0.408 . . . . 74.43 110.946 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.63 151.55 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 70.35 111.204 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -148.81 117.45 6.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 63.43 110.839 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -178.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 72.22 111.132 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -175.29 136.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.2 110.857 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -118.24 92.66 43.39 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.715 0.769 . . . . 75.33 110.905 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -48.56 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.717 2.278 . . . . 73.2 112.407 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.04 -177.67 43.27 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 73.52 112.452 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -76.78 125.57 29.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.799 0.333 . . . . 74.52 110.926 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.47 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -136.28 -91.06 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 74.21 112.502 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -73.64 -30.73 63.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.367 . . . . 72.21 110.862 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.79 158.6 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 73.42 111.144 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -61.06 -27.66 68.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 72.14 110.893 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.561 ' HD2' ' H ' ' A' ' 87' ' ' ALA . 11.7 p30 -119.6 50.07 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 75.41 110.851 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.47 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.8 OUTLIER -98.07 137.62 36.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 73.41 110.88 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.01 168.82 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 65.24 111.096 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 m -119.3 144.71 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 72.15 111.156 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.17 144.08 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 70.03 111.138 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -130.09 147.66 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.951 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.9 mt -124.78 96.62 40.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.616 0.722 . . . . 74.32 110.946 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 72.5 1.43 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.78 2.32 . . . . 73.42 112.273 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.12 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 74.13 110.943 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -117.75 -13.91 10.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.952 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.5 m120 68.99 26.13 5.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.094 -0.503 . . . . 64.13 110.904 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.87 114.14 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 75.2 111.138 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.93 136.96 37.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.854 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.5 t -119.42 64.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 73.34 111.182 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.94 -54.5 25.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 73.31 112.477 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.26 -135.51 12.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.748 . . . . 74.22 112.467 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.5 m -60.89 -19.29 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 52.12 110.876 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -50.57 61.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.901 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.05 130.02 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 74.13 111.193 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.64 149.5 24.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 74.2 110.939 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 12.6 p -75.03 162.5 28.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 74.5 110.879 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 71.54 111.15 -179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.794 0.331 . . . . 74.53 111.087 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.61 -36.24 82.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 75.33 111.125 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -116.18 37.73 3.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.877 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.64 166.78 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 74.02 111.071 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -113.54 92.66 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 72.03 110.888 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.63 -23.21 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 72.25 111.155 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -25.3 38.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 62.23 110.886 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.34 -24.21 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.841 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -51.5 -53.9 32.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.463 . . . . 74.2 110.877 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 99.2 p -52.32 -35.44 50.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 72.54 110.856 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.2 m -73.58 -36.68 65.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 63.12 111.169 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.1 m -64.5 -54.12 37.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.812 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.6 mm -57.2 -41.26 77.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 75.02 111.126 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -60.85 -19.54 60.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 75.01 110.912 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -93.03 -29.61 15.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 61.42 110.914 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 59.4 t -81.42 -23.73 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 71.52 111.115 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.6 pp -97.25 -1.16 45.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 75.24 110.97 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -121.2 -6.67 9.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 74.41 110.879 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -89.77 -24.25 21.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 74.11 110.897 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -118.3 -67.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 71.21 110.925 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 63.41 27.46 15.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 72.44 110.873 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -151.47 23.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.836 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.4 mp -62.95 145.42 13.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 74.32 111.168 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -104.0 -26.45 12.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.31 110.902 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -161.24 128.73 4.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 71.21 111.1 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 71.9 t -108.86 124.51 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 71.31 111.058 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 48.6 t -108.99 104.38 54.77 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 121.558 0.694 . . . . 71.41 111.114 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.4 Cg_endo -69.76 -170.6 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.705 2.27 . . . . 65.43 112.369 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -103.27 -26.07 7.12 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.721 -0.752 . . . . 61.23 112.474 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -144.0 86.37 1.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 74.22 110.846 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 167.88 -102.76 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 72.11 112.457 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -169.62 158.94 7.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.885 0.374 . . . . 70.14 110.921 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 41.4 t -66.82 147.85 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 63.53 111.04 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -152.34 -107.12 0.32 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.774 -0.727 . . . . 71.32 112.526 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -159.13 -169.93 2.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 75.42 110.835 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -56.67 -21.79 30.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 73.44 110.892 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.98 -33.8 57.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.776 -0.726 . . . . 65.14 112.44 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 32.1 mt -50.79 -46.84 59.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.858 0.361 . . . . 73.15 110.912 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.12 -42.76 69.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 64.42 110.927 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.6 mt -67.07 -41.31 86.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 75.14 110.907 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.18 -36.54 82.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 75.3 110.849 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -45.64 83.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 64.03 111.07 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.5 mt -56.6 -40.21 74.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 73.03 110.994 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -41.05 77.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.55 110.825 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.09 -25.99 68.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 73.34 110.935 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.1 mt -85.52 -43.08 13.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 73.4 110.913 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.85 179.867 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.762 0.315 . . . . 72.14 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mm -91.23 153.97 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 64.21 111.105 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -145.81 146.09 31.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.893 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.4 164.33 21.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 71.45 110.894 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -51.94 -36.98 51.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.87 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.48 -27.87 22.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 55.52 111.091 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.05 -12.84 68.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.784 -0.722 . . . . 72.44 112.575 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.0 t -51.09 -32.6 22.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 75.24 111.191 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.7 mt -121.42 147.86 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 75.42 111.094 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.7 p -166.19 169.61 14.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 73.12 110.873 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.52 -176.49 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 71.21 111.114 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 t -166.09 135.33 3.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 70.2 110.867 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.48 117.79 13.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 73.03 110.858 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.02 -45.59 5.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 72.22 110.942 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -142.27 -169.43 2.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.833 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -50.65 -51.08 52.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.855 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -132.34 37.99 3.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 75.14 110.816 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 t -133.91 122.06 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.31 111.19 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.76 159.06 35.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.866 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.5 t -119.42 107.9 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 64.34 111.173 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.512 ' HE1' ' HE2' ' A' ' 30' ' ' GLU . 4.0 p80 -102.32 142.02 34.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 75.23 110.828 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 m -140.06 130.73 25.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 74.14 111.159 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.512 ' HE2' ' HE1' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -121.93 171.36 8.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.862 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 tp -117.17 147.27 42.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.894 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.688 -0.768 . . . . 71.31 112.432 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.595 0.712 . . . . 72.44 111.113 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 148.41 64.89 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.691 2.261 . . . . 44.54 112.381 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -134.44 100.0 4.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 75.13 110.855 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 212' ' ' GLU . 24.0 m-20 -51.86 169.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 75.43 110.899 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.689 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -172.8 -173.19 39.12 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.705 -0.76 . . . . 74.25 112.449 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 tp -156.92 140.81 16.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.905 0.383 . . . . 74.25 110.907 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.51 132.01 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 74.33 111.178 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 41.5 mt -97.15 128.89 44.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 75.04 110.964 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.73 57.65 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 73.45 110.95 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 p -67.19 165.62 15.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 71.25 111.097 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.89 25.81 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.864 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -147.25 28.61 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 74.42 110.881 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.33 123.25 4.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 73.14 112.472 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.1 mt -51.28 159.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 74.33 110.903 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -140.18 140.03 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.132 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.07 129.86 56.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 74.01 110.964 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 t -81.18 0.13 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.13 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.689 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 1.4 p30 -177.68 129.69 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.837 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -166.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.905 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.71 -169.9 2.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.247 -0.433 . . . . 73.03 110.884 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -74.81 -36.48 62.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 73.42 110.955 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -144.62 164.3 31.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 53.43 110.873 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.13 -34.57 72.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 71.11 110.888 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -74.88 -24.25 58.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 63.35 110.889 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.41 -41.14 18.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 75.05 110.927 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.3 t -70.13 -26.45 63.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 70.04 111.103 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -54.13 -42.64 69.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 74.55 110.891 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -83.49 -14.2 52.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 72.54 110.86 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.8 tp -77.03 -46.13 24.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 73.45 110.924 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.3 -31.93 40.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 74.04 111.135 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.78 -25.55 68.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 70.21 110.965 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.4 mmm -76.37 -58.84 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 75.02 110.873 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.9 m -56.23 -33.35 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 73.11 111.074 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -88.56 48.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 74.45 110.885 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -144.36 -41.82 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 72.2 110.895 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.64 -25.65 13.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 72.03 110.875 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.509 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 36.5 m-85 -88.94 9.22 25.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 74.53 110.851 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.509 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.86 46.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 75.0 110.896 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -147.15 -176.71 5.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 70.23 110.937 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.64 130.88 37.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 70.33 110.896 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.46 129.33 30.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 64.04 111.093 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.5 p -138.07 19.74 2.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 75.24 111.141 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -154.18 129.35 9.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 64.14 110.829 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.9 t -133.84 98.15 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 64.53 111.169 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -74.64 124.9 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 71.03 111.198 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.7 mm -111.07 127.14 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 65.33 111.126 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.5 p -83.86 -53.47 5.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 74.0 111.075 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -135.6 168.39 19.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 75.02 110.895 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.82 100.41 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 65.44 111.087 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -154.71 161.03 41.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 73.2 110.881 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.06 -27.72 61.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 72.24 111.04 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.23 13.8 16.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 42.13 110.876 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -127.11 -51.24 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 73.01 110.831 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.52 15.28 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 71.22 111.138 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.19 -33.84 31.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.736 -0.745 . . . . 50.34 112.439 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.93 17.68 44.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.757 -0.735 . . . . 74.51 112.461 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.9 tt -46.03 -31.33 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 71.31 111.172 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -55.19 23.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.95 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.7 m -59.38 -41.73 90.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 74.52 111.14 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.7 mt -55.9 -30.0 60.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.912 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.49 24.27 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 75.52 110.856 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -116.93 -26.18 6.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 75.11 110.869 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -104.59 -22.2 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 75.14 110.832 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.67 14.28 4.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 52.01 112.501 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.7 mt -82.07 155.84 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.89 0.376 . . . . 61.32 111.159 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.57 120.1 34.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 72.42 110.905 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.89 81.14 8.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 74.45 111.061 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -55.04 147.28 16.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 73.42 110.853 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.44 161.78 0.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 62.24 110.851 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.9 p -85.64 161.07 19.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 75.23 111.135 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.35 -47.25 62.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 63.1 111.074 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -44.45 92.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.984 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.4 m -53.03 -46.17 68.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 64.14 111.111 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.98 -21.99 61.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 74.34 111.103 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.12 -38.38 76.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 71.05 110.903 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.705 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 8.0 mt -87.52 -27.66 22.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 71.42 110.954 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.61 -65.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 72.53 111.141 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -26.09 38.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 75.03 110.875 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -23.07 66.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 73.1 110.927 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -96.88 -38.36 9.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 61.42 110.896 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.98 -1.64 5.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 62.31 112.501 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -59.75 -172.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 73.3 110.915 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -94.8 -2.28 51.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 54.33 110.864 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 65.96 126.19 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.634 0.73 . . . . 74.21 110.897 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -170.91 0.42 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.71 2.273 . . . . 72.43 112.332 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -52.59 -38.43 60.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 72.4 110.915 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.98 43.81 55.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 75.44 112.584 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -139.17 57.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.768 0.318 . . . . 74.51 110.837 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.36 -171.63 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 75.52 110.93 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.43 -168.56 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 71.35 110.891 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 75.1 m -50.0 -64.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.23 111.11 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.49 111.1 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 72.43 111.124 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.5 m -111.61 114.15 27.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.13 111.176 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -75.14 101.02 4.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 53.42 110.881 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 70.2 110.926 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.83 0.348 . . . . 73.14 110.872 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 121.61 28.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.423 . . . . 73.2 110.976 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 t -130.14 158.71 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 74.03 111.177 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -154.38 117.4 4.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 63.53 110.895 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -177.86 1.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.15 111.139 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -175.65 136.53 0.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 73.14 110.857 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 27.2 t80 -117.13 94.49 45.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 74.12 110.89 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.8 Cg_endo -69.73 -48.92 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.719 2.279 . . . . 74.02 112.384 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.69 -166.33 39.55 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.697 -0.763 . . . . 64.11 112.439 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -88.03 123.94 33.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.827 0.346 . . . . 65.33 110.879 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.476 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -134.06 -86.4 0.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 72.24 112.485 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -81.29 -26.02 36.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 75.15 110.897 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.52 157.02 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 73.1 111.14 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -64.17 -23.72 67.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.14 110.899 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.705 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -125.78 55.09 1.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 74.12 110.848 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.476 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.9 p30 -102.97 143.15 32.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 73.31 110.876 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.2 pt -142.53 171.22 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 74.13 111.164 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.7 m -120.47 143.58 31.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.109 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 68.6 t -100.11 129.07 51.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 73.23 111.144 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -115.76 145.41 42.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.261 -0.427 . . . . 71.23 110.926 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.6 mt -120.76 96.84 48.69 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.585 0.707 . . . . 74.25 110.967 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 70.16 1.54 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.689 2.259 . . . . 73.03 112.396 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.24 -33.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.992 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -116.93 -12.41 10.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 73.53 110.876 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.05 19.74 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 61.24 110.896 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.54 114.4 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 74.34 111.141 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -99.19 122.82 42.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 71.42 110.922 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.29 74.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 72.35 111.155 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.29 -50.28 51.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 65.34 112.553 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.08 -140.94 15.48 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 64.43 112.565 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 39.4 m -58.02 -21.99 47.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 70.24 110.863 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.1 -48.63 77.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.912 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 t -90.77 126.58 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 73.11 111.149 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.51 144.7 25.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 71.33 110.887 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.8 p -72.4 163.99 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 64.21 110.825 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.194 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.86 0.362 . . . . 73.52 111.181 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.04 -40.44 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 72.33 111.097 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.65 40.65 3.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 75.02 110.92 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.9 173.45 10.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 73.4 111.098 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -121.11 89.01 3.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 74.41 110.971 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.28 -21.14 24.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.073 -0.512 . . . . 73.14 111.116 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.44 -26.81 46.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.52 110.895 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -100.39 -24.42 14.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 71.52 110.911 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.31 -53.79 32.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 65.53 110.902 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 34.3 p -52.0 -34.83 44.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 54.23 110.83 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 54.6 m -77.99 -37.98 46.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 74.42 111.134 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.1 m -59.96 -54.89 40.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.819 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.0 mm -56.98 -36.87 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 74.21 111.132 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.49 -21.97 66.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 73.44 110.878 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -90.92 -30.36 16.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 65.0 110.817 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 92.4 t -77.18 -40.09 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 74.45 111.034 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.69 -25.78 57.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 73.54 110.913 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -84.46 -46.84 11.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 70.41 110.861 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -51.99 -30.16 23.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.857 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -138.52 116.9 11.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 70.41 110.868 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -115.26 39.11 3.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 75.2 110.884 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.75 22.03 0.79 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 63.34 110.811 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -51.63 144.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 74.3 111.133 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -103.61 -44.56 5.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 72.22 110.884 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -151.23 113.4 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 74.1 111.097 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 82.8 t -85.51 125.93 40.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 75.52 111.148 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 63.0 t -106.9 93.78 9.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.663 0.744 . . . . 74.1 111.085 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -171.88 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.667 2.244 . . . . 73.54 112.387 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.66 -25.62 9.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 54.02 112.5 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -145.63 109.68 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.352 . . . . 65.25 110.879 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 145.18 -93.18 0.16 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.668 -0.777 . . . . 70.1 112.482 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.435 ' N ' HD22 ' A' ' 42' ' ' ASN . 14.4 pt-20 -179.69 169.55 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.878 0.371 . . . . 74.35 110.879 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.3 t -80.1 139.94 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 72.41 111.15 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -144.92 -105.94 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 74.31 112.443 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -157.69 -171.5 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.848 0.356 . . . . 74.04 110.848 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -53.37 -24.18 11.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 75.34 110.903 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -52.47 -34.37 42.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 73.44 112.402 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.9 mt -50.85 -46.21 60.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 63.12 110.923 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.78 -43.62 85.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.926 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.36 -41.74 89.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 72.41 110.903 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -63.4 -35.98 82.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 74.31 110.811 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.0 m -58.76 -42.64 89.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 72.22 111.098 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.14 -38.9 84.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 74.21 110.864 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -27.87 65.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 75.42 110.795 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 8.4 mt -77.53 -25.95 50.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 72.32 110.922 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.2 -27.43 21.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 75.02 110.904 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 64.42 110.883 179.815 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.0 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.774 0.321 . . . . 70.33 111.11 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -93.1 157.79 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 72.3 111.152 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.54 149.26 34.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 75.43 110.908 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.16 167.4 21.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 73.3 110.942 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.87 -32.47 63.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.921 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.0 p -97.13 -29.93 13.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 65.13 111.171 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.2 -11.23 47.93 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 54.21 112.447 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 t -51.19 -32.6 24.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.701 0.286 . . . . 74.14 111.156 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.3 mt -123.24 151.1 27.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.443 . . . . 73.43 111.105 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.6 p -169.48 163.44 10.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 75.54 110.894 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.24 -177.18 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 73.03 111.134 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.4 t -166.36 135.37 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 61.11 110.805 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.59 116.99 13.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.117 -0.492 . . . . 74.11 110.904 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.42 -42.21 6.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.914 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.85 -169.91 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.43 110.856 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -49.25 62.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 74.21 110.877 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -133.68 30.37 3.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 71.44 110.859 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.15 118.55 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 71.11 111.123 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -124.09 160.56 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 65.23 110.967 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.14 108.56 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 53.33 111.13 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -102.38 138.54 39.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 75.25 110.795 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.4 m -136.5 131.74 34.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 74.15 111.069 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.97 -175.68 2.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.847 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.7 131.56 39.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 75.01 110.978 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.768 -0.729 . . . . 71.51 112.525 179.868 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.593 0.711 . . . . 72.11 111.163 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 149.02 66.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.259 . . . . 70.23 112.321 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.46 113.1 10.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 74.2 110.838 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.39 168.45 7.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 74.1 110.865 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.742 ' CA ' ' HD2' ' A' ' 56' ' ' ASP . . . -171.16 -169.55 34.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 71.54 112.462 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.94 146.62 17.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 72.54 110.919 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.5 142.69 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 71.3 111.106 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -110.7 128.76 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 65.32 110.914 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -97.03 51.25 1.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 72.2 110.904 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 p -60.06 173.06 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.32 111.127 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 30.3 3.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 63.34 110.847 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -156.59 36.08 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 71.35 110.882 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.65 128.57 6.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 61.35 112.491 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.4 mt -58.4 160.62 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 75.41 110.959 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.8 t -137.51 143.27 34.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.05 111.157 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.69 128.48 55.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 74.42 110.959 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 t -78.85 -2.08 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 64.22 111.093 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.742 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 0.9 OUTLIER -179.45 128.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 75.51 110.851 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -166.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 62.53 110.798 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 m -96.73 -171.43 2.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 73.52 110.843 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -71.18 -34.82 71.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.959 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -148.64 165.32 31.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 71.41 110.883 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -63.03 -30.12 71.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 64.24 110.868 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -75.34 -22.86 57.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.916 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -49.98 7.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 63.14 110.858 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 t -61.27 -25.2 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 72.42 111.178 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -52.86 -39.67 62.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 72.33 110.914 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -85.55 -14.34 46.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 64.1 110.903 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.5 tp -82.49 -45.62 14.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 70.2 110.937 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.8 mt -70.58 -19.36 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 75.14 111.106 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -83.01 -3.39 57.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 73.33 110.921 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.2 mmm -98.9 -51.58 3.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 75.1 110.824 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.2 m -58.58 -38.06 68.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.22 111.099 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.19 48.06 1.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 75.35 110.848 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 -39.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.872 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.01 -21.86 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.929 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.522 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 25.5 m-85 -89.23 11.08 19.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 73.14 110.887 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.522 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.5 pp0? 32.51 47.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 65.35 110.944 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -153.28 -179.83 8.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 71.13 110.904 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 150.92 49.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.11 110.827 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.0 t -83.18 129.74 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.21 111.1 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.3 p -144.25 31.67 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 72.31 111.085 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.413 ' HD2' ' HD2' ' A' ' 104' ' ' LYS . 15.5 m-20 -163.62 125.88 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.835 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.3 t -133.89 98.91 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.5 111.125 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.5 mt -76.87 118.06 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 73.21 111.035 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mm -104.96 133.18 49.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 72.5 111.108 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.8 p -88.79 -55.93 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.33 111.197 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -133.4 161.74 33.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.894 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.71 97.52 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 63.2 111.079 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.73 157.64 43.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 70.1 110.859 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.17 -26.59 60.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 74.22 111.07 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -90.91 13.43 16.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 64.11 110.899 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -127.56 -52.43 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.813 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.56 16.97 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 75.22 111.129 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.39 -29.39 30.57 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.691 -0.766 . . . . 60.15 112.484 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -107.4 17.34 37.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 55.13 112.451 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.3 tt -47.0 -31.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 64.5 111.115 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.7 -54.76 23.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 71.3 110.906 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.1 m -56.95 -41.18 77.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 72.42 111.171 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 24.8 mt -60.84 -37.79 83.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 62.04 110.928 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -81.52 -19.23 42.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.22 -0.446 . . . . 73.02 110.943 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -84.73 -39.53 18.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 75.33 110.857 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -81.4 -40.1 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 73.41 110.829 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.4 -16.28 4.11 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.699 -0.762 . . . . 63.44 112.435 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.83 149.17 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.873 0.368 . . . . 74.45 111.111 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HD2' ' HD2' ' A' ' 81' ' ' ASP . 1.2 ptpt -109.19 124.56 51.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.45 . . . . 74.55 110.918 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.45 83.23 6.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 74.1 111.127 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -56.95 147.63 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.92 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.85 160.11 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.014 0.435 . . . . 74.13 110.852 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.9 p -78.72 159.56 27.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 65.34 111.174 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.58 -36.78 46.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 71.45 111.038 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tp -71.57 -48.75 46.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 74.51 110.912 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 77.8 m -51.79 -29.09 17.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 74.02 111.128 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.82 -31.8 19.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 74.1 111.085 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -56.17 -44.43 79.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.932 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.424 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 44.6 mt -76.82 -23.03 52.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.41 110.934 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.27 -65.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 64.53 111.101 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -27.62 33.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.856 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -24.38 66.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 72.11 110.946 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -95.69 -37.48 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 72.33 110.877 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.68 -3.28 4.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 65.41 112.477 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -59.45 -173.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.312 . . . . 72.4 110.945 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -97.03 -0.82 46.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 75.31 110.947 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 65.95 126.0 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.677 0.751 . . . . 72.05 110.887 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -170.05 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.657 2.238 . . . . 73.05 112.379 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.6 mt -55.33 -35.58 65.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 73.41 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.96 54.26 29.61 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 63.24 112.434 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -147.39 54.32 1.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.886 0.374 . . . . 72.43 110.931 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.28 -172.19 2.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 72.1 110.86 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.2 -167.9 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.917 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 97.8 m -49.3 -41.77 39.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 75.53 111.126 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 m -144.31 137.43 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.092 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.2 m -142.66 107.39 4.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 70.42 111.132 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -71.56 99.41 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 74.12 110.91 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.963 179.92 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.6 tpp . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.809 0.338 . . . . 71.04 110.875 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.1 mmpm? -121.91 126.72 49.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 74.33 110.86 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 t -141.75 159.67 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 75.31 111.195 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -161.09 123.72 3.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.049 0.452 . . . . 71.52 110.839 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.92 179.92 4.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.507 . . . . 73.51 111.095 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -173.71 137.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.895 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 65.3 t80 -116.24 94.94 43.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.687 0.756 . . . . 74.23 110.898 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.5 Cg_endo -69.84 -48.66 0.66 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.741 2.294 . . . . 60.13 112.239 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.73 -164.67 38.25 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.742 -0.742 . . . . 75.53 112.514 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -86.52 118.71 26.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.785 0.326 . . . . 74.15 110.899 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.491 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -129.97 -98.4 0.84 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.679 -0.772 . . . . 73.51 112.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -69.86 -26.74 64.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 73.4 110.867 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.61 159.42 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 64.23 111.163 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -66.09 -23.97 66.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.949 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.424 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 9.3 p30 -123.17 53.09 1.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.904 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.491 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.7 p30 -102.41 149.32 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 71.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.4 pt -150.03 161.88 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 71.22 111.172 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.1 m -108.46 150.5 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 75.33 111.131 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 67.1 t -104.23 125.44 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 74.11 111.201 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -111.7 150.63 29.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.12 110.92 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 35.2 mt -126.53 96.15 36.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.718 . . . . 75.3 110.878 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.9 Cg_endo -69.77 71.23 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 75.25 112.329 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.12 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 75.12 110.885 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -118.85 -11.73 9.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 63.21 110.928 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 m120 67.88 22.79 8.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 63.41 110.843 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 mp -88.41 115.06 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 74.34 111.187 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -98.12 126.24 43.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 71.3 110.978 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.5 t -120.71 75.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 72.25 111.138 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.27 -54.79 27.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.762 -0.732 . . . . 72.55 112.503 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 109.39 -134.93 12.53 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.721 -0.752 . . . . 74.5 112.392 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 67.0 m -60.62 -19.07 56.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 72.35 110.861 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.41 -49.19 57.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 74.4 110.907 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 28.8 t -92.63 127.47 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 74.42 111.201 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.49 152.82 19.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.916 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.4 t -73.04 164.59 26.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 72.24 110.896 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.31 111.136 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.777 0.322 . . . . 73.12 111.084 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -52.34 -46.9 66.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 62.35 111.134 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -118.66 41.63 2.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.32 110.871 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.23 166.13 17.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.115 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -117.86 91.71 3.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 75.05 110.946 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.5 t -67.65 -21.8 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 73.43 111.174 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -82.36 -26.38 32.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 74.22 110.933 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -96.95 -21.76 17.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 71.14 110.861 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -51.1 -51.86 49.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 64.23 110.975 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.5 p -51.95 -35.67 46.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 70.01 110.878 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.7 m -74.1 -38.3 63.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 75.23 111.139 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 34.0 m -61.86 -56.24 21.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 75.25 110.809 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 28.8 mm -55.22 -38.67 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.457 . . . . 71.11 111.109 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -63.82 -25.15 68.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 71.4 110.873 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -85.79 -31.88 22.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 62.13 110.973 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 99.7 t -73.28 -40.29 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.04 111.138 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.68 -25.33 53.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 71.2 110.931 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.95 -44.23 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 73.15 110.967 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.83 -26.24 67.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 73.34 110.861 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -141.03 117.08 10.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 74.4 110.97 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.96 37.35 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 74.23 110.897 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.15 22.03 1.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 71.53 110.891 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.4 mp -51.57 145.67 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 72.22 111.113 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -107.67 -29.32 9.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 73.52 110.881 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -162.71 121.33 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 75.44 111.13 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.6 t -101.88 118.91 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 64.1 111.099 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.41 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 69.8 t -102.9 106.88 52.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.661 0.743 . . . . 72.21 111.07 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.4 Cg_endo -69.78 -170.36 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.657 2.238 . . . . 75.44 112.372 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.85 -26.95 6.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 70.14 112.441 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -143.84 98.14 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 73.24 110.878 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.54 -95.07 0.15 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 61.31 112.491 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -174.34 152.41 1.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.828 0.347 . . . . 53.24 110.922 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 p -67.38 144.12 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 63.14 111.143 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.67 -105.51 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.716 -0.754 . . . . 72.51 112.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -156.84 -169.61 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.891 0.377 . . . . 65.01 110.861 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -20.43 35.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.212 -0.449 . . . . 71.22 110.88 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.66 -33.1 62.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.715 -0.755 . . . . 63.25 112.5 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.2 mt -50.63 -48.91 57.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 75.54 110.984 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -54.16 -42.41 69.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 73.42 110.954 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.0 mt -68.12 -41.26 82.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.32 110.862 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -66.11 -36.91 84.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 64.33 110.839 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.2 m -54.1 -45.25 71.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.164 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 70.5 mt -57.24 -38.91 74.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.893 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -33.74 74.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 75.5 110.871 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.73 -25.81 65.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 74.24 110.89 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 mt -84.92 -48.99 8.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 75.1 110.92 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.7 mttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.885 179.852 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.807 0.337 . . . . 75.31 111.081 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -89.96 154.23 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 64.55 111.103 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -150.96 163.71 38.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.885 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -91.43 -169.14 2.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 63.42 110.888 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.75 -18.46 58.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 72.53 110.846 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.3 p -108.73 -39.83 5.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.149 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.52 -2.94 29.3 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.692 -0.766 . . . . 71.21 112.432 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 t -50.62 -33.53 22.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 63.31 111.127 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mt -130.04 159.71 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.14 111.096 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.8 p -175.52 167.55 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 71.32 110.836 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.7 -174.77 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 73.31 111.154 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -169.46 129.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 75.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 121.47 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 75.05 110.919 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.06 -42.42 5.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.4 110.916 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -146.1 -168.34 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 75.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -51.55 48.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 74.54 110.886 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -132.21 34.24 3.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.917 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.66 122.48 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 73.52 111.145 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -126.91 160.08 32.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.906 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.0 t -122.56 111.81 31.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 75.15 111.134 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -100.88 135.97 41.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 64.21 110.855 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 m -130.56 137.65 49.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.51 111.165 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -133.85 170.09 16.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 65.24 110.925 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 tp -116.98 148.17 41.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 70.5 110.924 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.764 -0.731 . . . . 75.44 112.494 179.885 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.23 0.049 0 CA-C-O 121.655 0.741 . . . . 74.54 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.87 157.35 60.46 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.62 2.213 . . . . 75.3 112.34 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.425 ' CB ' ' HD2' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -141.26 112.79 7.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 70.23 110.857 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -76.39 147.49 37.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 72.12 110.909 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.579 ' HA3' ' HD2' ' A' ' 56' ' ' ASP . . . -146.29 -153.81 6.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 73.24 112.526 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.22 142.61 4.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 75.21 110.912 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.47 138.85 53.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 65.33 111.124 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.7 mt -102.12 135.11 44.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.957 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -111.75 61.48 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.917 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 p -77.95 176.15 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 71.53 111.137 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.14 26.87 3.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 71.44 110.855 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -145.74 24.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 74.3 110.889 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.52 142.08 8.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 72.51 112.455 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 mt -70.96 162.3 29.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 75.45 110.852 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.1 t -141.81 144.49 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.33 111.088 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -115.45 128.27 55.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 74.2 110.877 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 t -78.62 -2.47 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.104 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.579 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 1.1 p30 179.98 130.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 74.34 110.859 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.06 -167.41 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.895 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.85 -169.69 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 75.12 110.869 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.36 -37.47 63.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 73.34 110.923 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -142.19 165.68 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 65.24 110.831 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.48 -33.89 74.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 74.45 110.889 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -74.17 -24.76 59.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.957 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.88 -48.36 12.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 64.1 110.939 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -57.57 -26.71 61.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 70.23 111.161 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -42.72 75.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.25 110.933 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -86.92 1.7 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 73.24 110.892 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 tp -96.9 -47.7 5.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 74.14 110.899 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.4 mt -70.81 -24.76 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.22 111.104 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -72.74 -12.83 61.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 60.4 110.834 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 30.5 mtp -82.28 -50.41 8.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.31 110.855 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.94 -40.57 87.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.53 111.142 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -83.95 51.63 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.913 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 -38.14 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.902 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 -22.93 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.926 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.521 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 24.9 m-85 -87.85 10.86 17.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 70.55 110.888 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.521 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.97 46.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.12 110.941 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -151.9 -178.46 6.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 73.15 110.916 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.87 50.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 54.42 110.838 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.0 t -86.84 127.57 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 71.34 111.099 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 p -138.22 25.84 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.116 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -156.89 133.06 9.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.926 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.98 99.89 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 63.14 111.128 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.4 mt -76.93 123.23 33.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 73.53 111.141 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.9 mm -111.65 131.74 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 74.4 111.106 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.5 p -86.96 -58.12 2.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 75.3 111.185 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -129.92 175.32 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.897 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.58 98.09 10.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 74.41 111.103 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.55 158.54 43.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.885 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.39 -26.72 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 73.44 111.102 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.425 ' HD2' ' CB ' ' A' ' 41' ' ' SER . 29.3 t0 -90.88 11.48 22.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 72.02 110.827 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -124.88 -52.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 75.1 110.917 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.61 17.35 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.51 111.117 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.36 -27.33 24.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.779 -0.725 . . . . 71.53 112.477 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.8 19.43 28.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 71.03 112.42 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 tt -48.92 -30.38 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 73.25 111.147 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -69.52 -43.96 71.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 72.44 110.878 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.1 m -68.04 -34.1 75.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 71.24 111.207 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.01 -29.33 70.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 75.21 110.935 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.78 19.67 13.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.03 110.885 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -117.92 -22.73 7.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 65.02 110.825 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -111.69 8.5 20.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 75.32 110.835 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.11 15.56 66.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 64.11 112.455 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.1 mt -81.58 156.59 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.399 . . . . 75.4 111.143 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -121.86 121.0 36.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.31 110.91 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.93 79.98 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 74.11 111.097 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -54.67 145.63 18.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 74.24 110.824 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.69 160.71 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 72.1 110.812 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -73.86 -176.64 2.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.511 . . . . 73.22 111.069 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.65 -27.24 45.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 75.31 111.115 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -76.31 -47.88 22.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 73.45 110.933 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.5 m -54.38 -26.27 29.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 72.34 111.081 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.62 -29.29 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 64.51 111.11 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -61.54 -31.29 71.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 72.44 110.855 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.38 -25.4 21.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.34 110.974 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.46 -67.48 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 72.01 111.116 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -26.4 37.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 64.33 110.842 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -24.59 67.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 71.33 110.884 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -94.75 -37.53 11.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.443 . . . . 73.54 110.871 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 138.95 -7.96 3.26 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.753 -0.737 . . . . 72.01 112.476 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.76 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 64.12 110.852 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -99.73 -1.14 38.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 65.21 110.894 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 66.41 129.33 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.719 . . . . 71.32 110.859 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -169.66 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.721 2.281 . . . . 65.41 112.3 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 76.2 mt -53.45 -43.89 68.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 75.31 110.876 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.44 57.13 19.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.716 . . . . 74.34 112.479 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -152.13 36.51 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 74.23 110.825 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.82 -169.67 1.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 75.24 110.906 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -153.82 -169.06 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 74.22 110.943 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 99.5 m -50.81 -57.8 7.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.146 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.54 123.09 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 73.12 111.214 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.6 m -131.54 124.97 31.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.083 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -80.82 103.04 10.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 65.03 110.948 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.3 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 73.32 110.934 180.0 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.5 tpp . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.854 0.359 . . . . 70.43 110.873 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -128.52 121.27 28.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 75.42 110.844 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.1 t -131.66 154.55 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.179 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -152.19 125.85 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.849 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -178.19 4.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.482 . . . . 65.23 111.15 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -175.28 140.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 73.53 110.854 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -125.22 96.21 39.89 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.639 0.733 . . . . 72.44 110.897 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -49.02 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.225 . . . . 60.41 112.426 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.73 -155.64 21.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 74.45 112.491 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.48 127.5 42.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 74.45 110.934 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.479 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -138.94 -93.51 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 72.03 112.496 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -69.67 -30.12 67.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.929 0.395 . . . . 62.45 110.879 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.57 160.33 43.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 72.53 111.147 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.82 -23.99 67.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 71.42 110.888 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -120.63 45.2 2.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 73.22 110.908 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -94.11 134.34 36.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.893 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.0 pt -136.19 171.3 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.51 111.116 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.9 m -121.85 150.11 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 74.51 111.131 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -103.07 143.48 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 73.1 111.082 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -129.52 150.09 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.928 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.6 mt -127.12 95.04 37.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.67 0.747 . . . . 72.44 110.934 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 71.96 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.685 2.257 . . . . 40.15 112.367 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.4 110.96 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -118.15 -13.08 9.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 65.24 110.898 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.8 m120 69.26 25.33 5.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.908 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.16 116.52 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.13 111.185 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.94 138.48 38.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 73.41 110.885 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.22 66.55 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 74.24 111.152 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.6 -54.28 25.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 73.21 112.5 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.48 -135.1 12.41 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.727 -0.749 . . . . 64.41 112.469 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 33.7 m -62.58 -17.04 59.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.85 0.357 . . . . 72.33 110.874 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.87 -51.36 33.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.895 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.48 129.18 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 72.45 111.108 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.02 145.27 29.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 75.45 110.905 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.6 p -70.3 157.78 37.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 64.33 110.851 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 74.05 111.119 -179.917 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.853 0.358 . . . . 72.21 111.075 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.27 84.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 65.33 111.148 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.42 39.65 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.856 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -135.53 168.62 18.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 73.02 111.109 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -115.35 91.89 3.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 64.44 110.916 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.3 t -68.71 -23.65 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.04 -0.527 . . . . 75.53 111.098 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -80.38 -25.63 39.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 74.41 110.875 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -97.57 -23.82 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 75.04 110.936 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.43 -56.88 10.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 75.54 110.949 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.7 t -51.89 -35.18 44.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 73.15 110.852 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.2 m -72.94 -33.8 66.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 60.33 111.055 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 57.1 m -68.01 -52.41 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 72.1 110.848 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.4 mm -58.56 -38.26 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 54.22 111.118 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.21 -16.53 60.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.33 110.919 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -99.29 -20.5 16.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 74.45 110.905 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.85 -25.42 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.13 111.166 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.6 pp -99.24 2.38 45.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 74.41 110.919 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -117.68 -14.59 10.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 70.52 110.89 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -93.28 2.11 56.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.21 110.911 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -137.89 -72.39 0.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 74.3 110.914 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 60.56 25.94 15.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 75.24 110.901 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -149.14 23.44 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 64.45 110.853 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -63.53 145.64 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 73.21 111.2 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -102.47 -28.1 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 73.1 110.915 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -161.3 131.26 4.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 74.33 111.075 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 89.5 t -110.84 123.67 66.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 74.13 111.149 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 49.1 t -110.3 103.84 54.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.672 0.749 . . . . 75.44 111.129 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.0 Cg_endo -69.81 -170.78 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.762 2.308 . . . . 71.34 112.314 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -105.48 -22.26 8.26 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 72.44 112.503 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -146.03 86.79 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 71.35 110.892 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 165.25 -99.33 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.705 -0.759 . . . . 74.5 112.47 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -171.75 161.38 5.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 62.53 110.872 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.5 150.5 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 73.31 111.133 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.12 -107.63 0.28 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 61.22 112.45 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -159.16 -170.04 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 75.4 110.897 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -23.23 26.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 71.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.59 -33.44 48.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.684 -0.77 . . . . 71.3 112.553 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 37.8 mt -51.16 -46.56 62.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 74.33 110.913 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.79 -43.7 85.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.949 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.46 -41.77 88.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 72.35 110.924 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -66.13 -38.79 89.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.847 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.9 m -52.57 -46.46 66.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 71.32 111.178 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 63.8 mt -53.59 -40.49 65.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 73.01 110.911 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -35.25 80.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 61.42 110.858 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 31.5 mt -62.68 -25.91 68.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 74.4 110.882 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 mt -90.12 -42.56 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 52.04 110.899 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 70.42 110.902 179.785 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.756 0.312 . . . . 74.44 111.132 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.89 155.92 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 71.33 111.096 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -146.78 156.76 43.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 71.43 110.854 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.35 171.69 10.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.12 110.941 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -58.71 -30.29 67.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 75.53 110.928 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.6 p -99.46 -32.13 11.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.159 -0.473 . . . . 74.42 111.136 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.06 -8.42 42.08 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 71.21 112.481 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 t -51.27 -33.14 27.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 71.12 111.146 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mt -124.15 152.6 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 74.41 111.165 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 p -171.93 165.32 6.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 72.23 110.834 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.68 -172.49 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 75.35 111.153 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.96 132.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 45.33 110.874 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.446 ' NE2' ' H ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -67.81 120.71 14.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 64.22 110.9 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.65 -45.47 5.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 75.23 110.967 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -146.09 48.75 1.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 75.2 110.879 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' H ' ' NE2' ' A' ' 20' ' ' GLN . 7.3 ttmm 70.59 -70.89 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.832 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -88.31 -23.25 23.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.929 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.82 120.21 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 54.24 111.139 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -123.89 161.01 26.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 70.04 110.852 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -123.15 107.98 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.13 111.127 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -101.59 137.68 39.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.44 110.861 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 m -133.12 136.27 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.108 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.15 165.16 20.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.411 . . . . 74.1 110.899 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.64 136.49 53.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 72.52 110.931 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.728 -0.749 . . . . 75.43 112.478 179.913 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 60.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.673 0.749 . . . . 74.03 111.178 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.3 Cg_endo -69.7 140.17 42.23 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.706 2.27 . . . . 74.54 112.438 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -122.76 108.58 13.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 71.12 110.848 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -67.88 143.02 55.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 75.43 110.858 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.507 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -141.49 -153.58 5.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 42.52 112.458 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.85 145.18 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 71.15 110.904 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.6 137.08 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.24 111.098 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.7 mt -105.11 130.3 53.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.109 -0.496 . . . . 75.1 110.949 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -99.66 56.43 0.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.862 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.2 p -65.69 169.74 5.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 71.53 111.061 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.99 27.26 3.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 33.33 110.869 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -150.04 28.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 74.31 110.876 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.42 127.34 5.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 65.13 112.508 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mt -54.78 168.03 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 65.25 110.97 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -146.68 143.49 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.22 111.138 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.52 127.92 56.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.993 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.7 t -78.06 -2.91 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.33 111.122 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.507 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 0.4 OUTLIER -179.21 132.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 61.5 110.848 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.57 -166.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.866 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.6 m -94.06 -175.04 3.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.841 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -68.38 -41.21 80.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 75.51 110.892 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.39 166.72 23.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.419 . . . . 44.25 110.859 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.44 -35.94 80.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 74.42 110.865 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -70.39 -23.48 62.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 64.13 110.927 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.81 -50.6 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 75.23 110.985 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -57.7 -31.07 66.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.32 111.129 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -54.58 -38.55 66.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 75.03 110.856 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.55 -11.31 54.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 74.24 110.828 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.8 tp -85.03 -47.36 10.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 74.02 110.923 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.3 mt -68.65 -11.98 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.106 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -92.17 16.45 11.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 74.54 110.889 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.5 mtp -115.83 -51.55 2.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 63.12 110.892 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.21 -36.08 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 73.3 111.128 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -85.72 50.56 1.99 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 75.34 110.885 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -142.84 -40.15 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 75.42 110.915 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 -23.81 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 75.52 110.889 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.529 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 30.4 m-85 -89.52 11.23 20.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 74.34 110.864 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.529 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.81 46.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 74.5 110.956 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -150.42 -176.57 5.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 72.21 110.857 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.01 152.09 51.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.817 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 85.0 t -87.19 118.18 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.15 111.178 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.1 p -127.37 21.3 6.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 73.02 111.142 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -154.0 134.1 13.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 73.11 110.912 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.65 99.6 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 75.44 111.126 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.9 mt -74.89 126.11 35.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 74.43 111.094 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.4 mm -113.88 129.5 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 73.13 111.116 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.0 p -88.34 -54.11 4.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.163 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -133.68 162.81 30.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 73.43 110.884 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.24 98.5 10.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 62.3 111.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -151.74 158.76 43.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.897 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.36 -24.38 54.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 71.01 111.098 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.87 16.36 12.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 74.44 110.94 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.3 mmt-85 -132.19 -52.53 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 73.43 110.889 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.15 15.24 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 75.42 111.109 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.91 -34.45 30.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 64.2 112.503 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.09 18.15 43.21 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.72 -0.752 . . . . 72.35 112.451 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 tt -46.16 -31.69 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 73.23 111.118 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -54.67 26.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 70.14 110.878 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.8 m -58.54 -39.82 81.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.19 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.9 mt -60.4 -29.52 69.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 72.04 110.888 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -99.31 24.11 8.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.898 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -114.1 -34.69 5.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 75.21 110.878 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -96.17 -21.94 17.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 63.23 110.856 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.59 16.82 4.48 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.772 -0.727 . . . . 71.11 112.503 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 mt -83.06 156.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 71.21 111.167 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 125.01 48.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.44 . . . . 73.4 110.853 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.04 82.4 5.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 75.44 111.092 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -51.91 142.59 15.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 73.42 110.855 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.67 151.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.03 110.899 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.1 p -70.63 157.45 37.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 74.2 111.137 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.62 -24.07 45.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 62.25 111.134 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.8 tp -77.0 -46.96 22.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 73.24 110.915 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.5 m -55.62 -27.93 52.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.224 -0.444 . . . . 64.22 111.184 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.49 -23.46 40.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.24 111.127 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.88 -38.25 90.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 71.14 110.839 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.4 mt -85.24 -24.52 27.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 73.14 110.878 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.8 -65.78 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 74.13 111.066 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -55.24 -26.2 38.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 65.11 110.949 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -24.17 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 73.44 110.877 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -95.09 -31.46 13.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.924 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.82 -4.84 6.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.731 . . . . 64.24 112.49 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -59.72 -172.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.883 0.373 . . . . 73.12 110.907 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -98.19 -1.32 42.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 74.41 110.9 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 66.16 126.97 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.71 0.767 . . . . 73.15 110.86 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -170.64 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.612 2.208 . . . . 65.31 112.39 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.7 mt -51.89 -36.38 48.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 63.13 110.907 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.98 53.93 28.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 75.1 112.48 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -152.02 48.46 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 72.11 110.833 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.65 -169.64 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.904 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -151.96 -168.74 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 74.2 110.936 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 98.3 m -50.24 -64.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 75.35 111.134 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 68.6 t -124.63 110.62 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 74.2 111.133 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.7 m -113.33 105.32 13.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.151 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.57 100.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 64.45 110.872 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.9 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.908 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.3 tpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.8 0.333 . . . . 74.25 110.913 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -124.24 125.34 44.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 65.13 110.897 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 t -138.0 157.69 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 74.03 111.147 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -155.66 125.22 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 61.1 110.842 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -177.06 3.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.138 -0.483 . . . . 75.11 111.124 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -175.33 136.19 0.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 74.01 110.897 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -119.47 93.77 47.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.624 0.726 . . . . 75.11 110.978 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 -48.55 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 72.31 112.355 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.88 -155.29 22.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 71.32 112.462 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.15 123.97 41.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.371 . . . . 74.54 110.826 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.484 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -134.66 -94.3 0.48 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.483 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -71.46 -29.58 65.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 73.32 110.899 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.8 153.13 34.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.117 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.52 -37.9 65.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 74.41 110.916 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -108.74 51.13 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.887 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.484 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -100.49 136.35 40.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 70.05 110.889 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 18.5 pt -137.48 169.01 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.32 111.122 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.6 m -119.37 140.93 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 72.23 111.177 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 84.4 t -95.85 144.24 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.11 111.145 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -131.16 146.94 52.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 75.31 110.896 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.43 97.47 42.39 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.599 0.714 . . . . 74.03 110.887 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 72.22 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 72.21 112.388 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.17 -34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.888 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -117.42 -13.28 10.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 64.05 110.904 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 m120 68.62 23.28 7.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.909 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.58 116.26 36.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 55.5 111.16 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.7 137.0 37.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 75.33 110.97 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.27 66.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 73.31 111.109 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.77 -55.33 21.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 73.13 112.452 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.21 -119.76 5.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 63.35 112.492 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 90.3 m -87.2 7.23 29.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 75.0 110.951 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.72 -50.17 6.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.922 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.1 120.86 40.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 74.31 111.098 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.03 154.78 19.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 73.25 110.963 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.8 p -77.65 161.43 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 72.15 110.861 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 73.02 111.115 -179.948 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.768 0.318 . . . . 71.54 111.118 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.67 85.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 64.4 111.116 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.06 44.82 2.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 73.32 110.867 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.52 171.34 14.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.064 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -117.37 90.57 3.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 70.25 110.952 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.91 -22.05 24.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 73.31 111.15 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -78.35 -24.88 46.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 73.53 110.957 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -101.76 -24.9 14.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 73.14 110.91 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -51.46 -56.72 11.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 74.41 110.945 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.2 p -52.17 -32.03 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 75.42 110.848 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.4 m -78.22 -31.47 49.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.01 111.164 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 40.2 m -69.45 -52.14 29.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 62.22 110.892 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.6 mm -56.08 -42.26 71.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 72.53 111.145 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.72 -19.81 59.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 72.23 110.864 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -95.84 -25.59 15.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 70.32 110.944 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.36 -20.79 8.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 63.24 111.159 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.5 pp -101.17 -2.33 31.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 71.25 110.933 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -116.4 -22.92 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.885 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -71.1 -23.73 62.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 75.15 110.841 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -118.09 -66.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 74.41 110.922 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.64 25.81 14.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 74.23 110.918 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -149.35 22.59 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 64.41 110.839 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.5 mp -60.19 144.62 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 65.31 111.175 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -103.07 -26.05 13.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.878 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -166.07 130.82 2.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 73.14 111.097 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.53 128.09 62.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 72.12 111.106 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.411 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 39.7 t -110.82 103.28 54.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.588 0.709 . . . . 72.2 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.7 -169.76 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.707 2.271 . . . . 63.44 112.336 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -108.86 -22.33 7.01 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 70.15 112.44 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -144.6 88.73 1.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 75.51 110.896 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 161.25 -93.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.783 -0.722 . . . . 73.03 112.523 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -178.91 156.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.925 0.393 . . . . 70.4 110.886 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.2 147.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 72.33 111.135 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -150.04 -107.97 0.42 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.684 -0.77 . . . . 54.24 112.405 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -154.52 -170.47 3.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 64.53 110.87 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -58.01 -20.2 36.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 75.45 110.878 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.93 -32.43 62.36 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.685 -0.769 . . . . 62.31 112.452 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 29.8 mt -50.74 -43.2 58.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 74.3 110.908 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.97 -45.05 93.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 75.13 110.965 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.58 -42.04 95.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.42 110.866 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -65.5 -36.6 84.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 73.34 110.869 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 33.0 m -51.7 -44.29 63.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 53.43 111.162 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 76.4 mt -56.32 -38.96 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.86 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -27.77 65.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 73.41 110.856 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.9 -25.47 56.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.866 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.22 -38.63 14.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 63.23 110.923 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.6 mttp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 75.22 110.914 179.836 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.4 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.846 0.355 . . . . 72.34 111.09 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.52 154.52 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 64.23 111.19 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -145.37 146.58 31.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.892 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.32 165.49 21.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 64.32 110.815 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -52.03 -43.35 63.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 63.14 110.878 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.52 -24.01 31.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 72.2 111.157 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.68 -14.0 66.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 70.52 112.484 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 t -50.81 -32.77 21.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 64.51 111.165 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 mt -118.79 148.08 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 74.13 111.072 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 p -170.59 166.97 8.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 73.54 110.851 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -172.91 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 72.32 111.109 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.74 133.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.89 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.98 119.12 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 75.12 110.879 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -101.5 -57.8 2.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.887 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -148.3 -170.08 3.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 72.15 110.861 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -52.34 108.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.922 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 57.96 23.21 9.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.426 . . . . 73.24 110.831 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.44 110.76 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 64.31 111.18 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -121.91 163.83 18.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.887 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.5 t -126.02 109.95 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 64.51 111.151 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -101.61 137.0 40.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.852 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 m -132.39 113.06 12.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 74.21 111.19 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.27 162.49 12.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 74.3 110.874 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.33 126.14 55.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 74.03 110.907 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 64.31 112.46 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.608 0.718 . . . . 70.21 111.109 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 166.22 28.34 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.667 2.245 . . . . 74.13 112.352 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -149.06 99.41 2.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 73.13 110.938 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -51.76 168.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 72.52 110.852 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.655 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -170.24 -160.3 18.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 73.43 112.478 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.81 141.49 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 74.42 110.932 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.84 135.58 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 74.23 111.141 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.5 mt -103.16 133.4 48.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 73.4 110.916 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -99.65 57.95 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 75.24 110.939 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 p -60.38 -169.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 74.51 111.182 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.5 m -114.43 2.89 14.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 73.41 110.83 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -118.53 -17.4 9.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.878 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.19 131.17 1.3 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.658 -0.782 . . . . 74.24 112.432 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.5 mt -48.98 159.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 70.5 110.932 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.5 t -140.12 144.07 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 74.13 111.153 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.72 128.83 56.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 63.13 110.901 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.4 t -78.84 -2.34 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 63.41 111.061 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.655 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 2.8 p-10 179.57 125.36 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.28 -0.418 . . . . 72.12 110.897 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -167.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 54.2 110.892 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 p -94.61 -169.75 2.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 72.05 110.842 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -73.45 -38.45 65.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.953 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -143.66 154.98 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.52 110.87 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -55.88 -28.35 56.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 73.13 110.862 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -78.1 -23.77 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 71.35 110.945 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.24 -40.19 14.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.03 110.929 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.1 t -66.53 -23.61 66.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.52 111.167 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -43.04 72.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 61.34 110.884 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -82.76 -14.6 54.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 73.12 110.886 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.3 tp -76.51 -44.49 34.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.949 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.9 mt -74.6 -30.06 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.04 111.185 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.52 -13.2 61.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 63.12 110.888 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 mmm -88.7 -54.76 4.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 73.2 110.87 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -57.5 -39.61 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 72.33 111.124 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -83.97 50.86 1.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.871 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.19 -41.02 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 73.22 110.897 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.83 -19.51 12.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 75.03 110.887 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 26.3 m-85 -88.64 9.73 23.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.52 110.822 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.533 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 2.1 pp0? 31.69 49.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.908 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.46 -177.21 6.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 74.33 110.97 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 144.87 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 75.25 110.831 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.8 t -76.57 123.63 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 73.34 111.089 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.2 p -134.48 20.78 3.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 74.22 111.149 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.56 135.5 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 72.35 110.868 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.4 t -140.53 100.77 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 74.55 111.071 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.8 mt -79.42 121.02 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.42 111.171 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.4 mm -105.72 130.47 57.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 73.14 111.079 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.0 p -90.91 -52.95 4.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 72.24 111.193 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -134.72 162.5 32.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 71.2 110.888 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.45 97.64 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.1 111.112 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.53 158.84 44.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 73.04 110.848 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.76 -30.32 63.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 74.35 111.118 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.29 9.99 21.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.899 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -121.86 -51.64 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 73.54 110.807 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.29 18.12 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 71.34 111.128 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.77 -28.45 23.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 72.43 112.495 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.05 21.31 27.38 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.698 -0.763 . . . . 60.44 112.552 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 tt -48.7 -30.77 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 65.21 111.084 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -69.9 -44.05 70.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 70.41 110.842 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.0 m -67.02 -35.01 78.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 74.15 111.201 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.4 mt -62.61 -30.74 71.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.896 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.58 22.61 7.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.945 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -120.71 -31.29 4.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 73.14 110.86 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -103.48 12.08 35.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 72.12 110.861 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.14 18.62 68.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 65.25 112.539 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.5 mt -83.64 157.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.819 0.343 . . . . 74.52 111.17 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.02 121.28 36.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.881 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.61 77.96 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.047 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -53.83 146.34 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.848 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.15 168.25 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.31 110.858 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.0 p -83.7 176.4 9.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 74.33 111.173 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.07 -23.93 60.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 74.24 111.052 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 tp -75.47 -51.2 13.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 70.32 110.923 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.7 m -52.65 -29.13 24.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 75.12 111.134 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.51 -30.41 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 72.02 111.074 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -58.93 -40.48 84.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 74.4 110.904 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 61.0 mt -85.09 -25.25 27.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 72.05 110.932 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.51 -68.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.42 111.099 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -56.35 -25.57 49.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 71.44 110.881 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -24.75 67.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 74.3 110.952 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -94.1 -37.25 11.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 75.23 110.896 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.14 -8.57 3.25 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.765 -0.731 . . . . 71.33 112.487 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -59.82 -172.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 74.21 110.967 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -101.21 0.24 37.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.148 -0.478 . . . . 70.24 110.903 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 66.14 127.18 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 63.54 110.911 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -170.3 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.738 2.292 . . . . 71.25 112.294 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.8 mt -52.85 -41.42 64.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 71.54 110.958 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 55.16 58.56 13.18 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.771 -0.728 . . . . 72.04 112.502 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -148.97 54.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 73.12 110.916 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.37 -169.7 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 73.2 110.909 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -150.75 -168.66 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.897 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 97.6 m -50.21 -41.1 49.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 73.32 111.149 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.76 140.78 25.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 64.41 111.146 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.6 m -149.55 102.47 3.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.106 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.33 95.44 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 70.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 71.43 110.924 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.1 tpp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.838 0.352 . . . . 71.43 110.935 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.62 130.05 45.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.889 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.3 t -142.92 159.54 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.54 111.203 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -160.44 118.12 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 74.12 110.925 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.94 179.67 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 75.41 111.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -175.19 143.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 74.43 110.851 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 66.2 t80 -120.78 94.98 49.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.673 0.749 . . . . 72.43 110.874 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.2 Cg_endo -69.87 -48.59 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.649 2.233 . . . . 75.12 112.344 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.15 -161.55 34.71 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 75.42 112.426 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.47 125.46 38.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.891 0.377 . . . . 65.23 110.856 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.483 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -136.37 -97.38 0.49 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 52.12 112.498 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -69.72 -35.77 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 75.0 110.867 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.43 147.29 39.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 75.13 111.176 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.99 -40.72 61.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 74.55 110.927 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -106.46 53.01 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 64.15 110.912 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 2.1 p30 -99.97 134.8 42.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.886 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.62 160.73 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 72.42 111.091 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.0 m -109.46 155.43 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 72.41 111.115 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.0 t -111.31 142.28 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 54.15 111.118 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -127.7 151.48 48.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.3 mt -130.24 96.93 23.61 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.594 0.711 . . . . 61.21 110.935 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 72.64 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.668 2.245 . . . . 73.42 112.353 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.62 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 73.21 110.954 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -118.04 -13.27 10.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 72.33 110.881 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.46 23.38 6.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 71.14 110.888 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.97 118.92 40.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 72.41 111.11 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.19 138.03 40.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 74.14 110.907 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.74 81.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 64.12 111.146 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.57 -67.94 1.68 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.8 -0.714 . . . . 73.04 112.528 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.87 89.35 2.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.707 -0.758 . . . . 74.12 112.457 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 63.6 m 61.48 16.85 7.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 73.31 110.873 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.7 tp -110.31 -45.48 3.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 55.44 110.901 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.2 t -96.44 116.93 39.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.106 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.35 146.59 31.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.24 110.911 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.8 p -78.92 161.54 26.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 71.24 110.878 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 64.43 111.088 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.723 0.297 . . . . 71.31 111.048 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.48 91.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 62.22 111.124 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.77 43.3 2.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 65.34 110.834 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.2 164.53 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 71.15 111.064 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -112.87 90.08 3.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.893 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.56 -17.2 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 74.44 111.173 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -88.06 -20.08 26.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 70.1 110.938 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -104.63 -20.87 13.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 62.31 110.907 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.09 -55.77 16.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 75.03 110.912 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 60.4 p -51.88 -38.62 56.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 54.03 110.897 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -68.77 -36.09 77.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 71.31 111.141 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.0 m -65.31 -52.09 56.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.908 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.5 mm -57.56 -36.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 73.51 111.127 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.75 -15.45 61.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 73.1 110.887 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -97.84 -27.3 14.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 72.54 110.93 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.34 -30.36 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 73.01 111.108 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.8 pp -85.64 -24.26 27.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 73.42 110.916 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.26 -39.7 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.933 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -56.39 -49.03 75.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 75.35 110.844 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -119.34 127.72 53.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 74.23 110.927 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.75 26.03 8.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.093 -0.503 . . . . 72.22 110.848 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.49 22.13 2.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 71.31 110.844 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.6 mp -52.11 147.42 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 64.12 111.198 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -106.85 -39.76 5.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 74.4 110.957 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.93 127.59 8.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.153 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.59 125.44 60.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 75.04 111.116 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.54 110.09 63.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.707 . . . . 72.53 111.142 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 72.24 112.341 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.89 -27.01 7.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 71.12 112.543 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -145.05 88.93 1.92 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.364 . . . . 75.15 110.871 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.17 -108.29 0.34 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.698 -0.763 . . . . 74.51 112.437 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -158.02 153.65 26.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.926 0.394 . . . . 72.32 110.894 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.3 p -68.69 144.0 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 74.12 111.102 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.07 -104.51 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 61.31 112.498 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -157.3 -169.65 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.885 0.374 . . . . 63.4 110.873 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -56.96 -21.02 26.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.911 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.94 -33.85 60.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.772 -0.728 . . . . 71.4 112.446 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.2 mt -50.63 -47.01 58.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.882 0.372 . . . . 73.41 110.913 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.1 mp -53.84 -42.7 68.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 74.01 110.98 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.4 mt -67.37 -41.28 85.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.946 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -64.09 -39.31 93.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 72.45 110.794 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.3 m -51.59 -45.23 63.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 75.03 111.136 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 46.6 mt -61.26 -39.83 91.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 74.24 110.91 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.31 -26.76 61.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.843 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.3 mt -76.82 -24.05 52.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 71.05 110.865 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.5 mt -90.97 -39.38 12.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 63.21 110.899 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 71.52 110.878 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.827 0.346 . . . . 64.34 111.16 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mm -94.56 152.62 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.33 111.104 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -150.83 155.34 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 74.33 110.905 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.23 -168.95 2.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.923 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -76.89 -25.25 52.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 72.22 110.834 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 p -95.04 -35.21 12.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 73.43 111.138 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.66 -9.16 64.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.759 . . . . 64.01 112.446 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 t -50.12 -33.36 18.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.688 0.28 . . . . 74.31 111.128 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.9 mt -124.21 160.32 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.433 . . . . 73.1 111.147 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -178.42 166.75 1.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 71.24 110.858 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.24 -175.71 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 72.22 111.113 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 t -169.14 129.97 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.51 110.894 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.3 120.19 12.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 55.34 110.942 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -103.56 -74.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.906 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.98 -170.43 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 61.51 110.843 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -52.62 109.48 0.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 70.22 110.876 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 58.6 23.86 11.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 75.53 110.832 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.3 t -122.96 116.42 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 75.32 111.114 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -124.36 163.13 22.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 75.54 110.954 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.59 107.72 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 75.12 111.114 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.765 ' CE1' ' HE2' ' A' ' 30' ' ' GLU . 6.8 p80 -100.49 138.49 37.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 75.43 110.856 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.8 m -136.2 133.44 37.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.115 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.765 ' HE2' ' CE1' ' A' ' 28' ' ' HIS . 2.9 pm0 -124.59 173.98 8.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.02 110.91 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tp -124.15 136.23 54.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 72.22 110.914 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.733 -0.746 . . . . 73.43 112.447 179.926 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.619 0.723 . . . . 75.45 111.096 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 142.87 48.99 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.74 2.293 . . . . 74.34 112.344 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.92 102.06 5.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 74.51 110.927 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -67.48 153.44 43.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 75.1 110.861 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.569 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -153.71 -155.99 7.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 70.34 112.528 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.7 tp -161.36 142.01 11.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 74.41 110.903 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.06 132.17 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 75.32 111.13 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 mt -98.5 122.59 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 74.03 110.952 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -94.8 60.26 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 74.35 110.9 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.4 p -66.0 179.83 0.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 75.12 111.173 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.6 m -104.95 26.04 9.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 74.32 110.836 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.08 23.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 72.01 110.912 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.81 130.25 4.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.769 -0.729 . . . . 72.02 112.431 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mt -60.33 158.96 10.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.825 0.345 . . . . 70.43 110.934 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.2 139.35 36.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 74.24 111.129 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -109.83 127.43 54.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 70.42 110.942 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.8 -0.5 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 73.44 111.152 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.569 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 0.9 OUTLIER -179.45 126.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 55.5 110.904 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -166.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 75.1 110.84 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -96.28 -174.46 3.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 70.32 110.874 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -67.68 -42.1 82.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 73.42 110.924 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.01 166.29 24.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 54.42 110.84 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.96 -36.18 80.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.861 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -71.21 -25.13 62.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.93 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -49.68 12.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 74.41 110.819 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 t -58.84 -29.54 67.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.33 111.125 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -52.76 -44.3 66.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 71.35 110.893 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -80.94 -12.89 59.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 63.44 110.889 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.9 tp -83.87 -50.29 8.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.904 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.4 mt -64.55 -18.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 74.0 111.193 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -80.91 -1.18 42.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 73.12 110.881 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.8 mtp -96.33 -57.56 2.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.843 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 m -58.29 -39.1 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 72.1 111.167 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.53 50.82 1.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 75.44 110.912 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -146.25 -40.95 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.879 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.19 -23.21 12.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.12 110.866 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.524 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 41.1 m-85 -90.03 11.57 20.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 75.01 110.851 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.524 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.78 46.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.43 110.927 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -152.05 -176.71 5.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.44 110.892 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.67 153.66 47.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 73.41 110.889 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.2 t -89.25 117.19 32.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 71.45 111.123 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.8 p -130.76 36.53 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 75.12 111.155 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -166.71 130.44 1.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 72.25 110.918 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.0 t -135.96 101.91 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 74.54 111.11 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.0 mt -80.22 119.79 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.14 111.074 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.6 mm -107.33 134.59 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.117 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.1 p -91.9 -55.36 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 54.34 111.204 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -133.17 163.95 28.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 74.35 110.795 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.8 97.22 8.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 71.44 111.086 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -151.05 158.8 44.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 64.54 110.851 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.27 -26.2 60.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.35 111.083 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.68 15.27 13.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 62.23 110.835 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -129.66 -53.12 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 75.44 110.829 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.88 16.54 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 71.32 111.189 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.56 25.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.797 -0.716 . . . . 74.23 112.494 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.88 20.04 29.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.743 . . . . 73.2 112.496 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 tt -48.23 -30.65 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.37 . . . . 73.32 111.127 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -70.13 -44.51 68.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 75.33 110.932 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.9 m -67.38 -32.59 73.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.142 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 mt -65.01 -30.53 71.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 72.4 110.944 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -96.69 21.6 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 73.14 110.925 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.44 -27.36 5.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.3 110.903 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.68 11.52 28.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 71.25 110.892 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.18 17.12 70.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 74.4 112.512 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.9 mt -83.19 157.52 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.888 0.375 . . . . 75.32 111.126 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -123.49 123.38 40.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.848 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.24 80.85 5.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.33 111.066 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -56.1 146.85 21.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.79 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.93 159.85 0.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 72.42 110.86 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.4 p -75.74 154.58 36.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 73.55 111.123 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.45 -32.41 26.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 73.42 111.043 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tp -73.64 -48.28 33.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.426 . . . . 74.31 110.878 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 99.8 m -52.02 -28.61 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 60.53 111.18 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.61 -31.6 21.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 63.13 111.127 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.03 -43.55 70.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 74.44 110.829 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.3 mt -79.87 -23.73 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 74.2 110.891 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.14 -69.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.42 111.061 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.42 -28.24 28.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 72.43 110.937 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -23.64 62.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 73.32 110.841 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -94.58 -38.78 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 74.33 110.827 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.72 -8.51 3.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 70.02 112.459 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.43 -172.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 71.43 110.936 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -98.47 -1.23 41.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 74.53 110.849 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 66.34 129.92 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.656 0.741 . . . . 73.13 110.893 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -169.65 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.608 2.205 . . . . 74.44 112.403 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -54.45 -37.75 65.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 73.45 110.872 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.06 57.71 12.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 72.04 112.527 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -153.29 49.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 72.12 110.829 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.19 -169.97 2.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 73.21 110.919 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -146.22 -169.08 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.925 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.1 m -50.72 -62.74 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 70.42 111.169 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.07 116.15 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.51 111.092 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.1 m -115.66 103.35 10.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 73.24 111.132 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -67.02 102.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 74.21 110.879 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 74.3 110.944 179.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 43.7 tpp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.9 0.381 . . . . 64.0 110.825 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.51 124.65 36.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 72.13 110.91 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.5 t -143.32 157.45 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.426 . . . . 75.45 111.107 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -158.53 125.31 4.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 64.52 110.886 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.63 -178.74 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 72.15 111.175 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -175.18 137.66 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 71.44 110.895 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -120.05 92.99 47.55 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.681 0.753 . . . . 63.41 110.881 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -48.81 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.744 2.296 . . . . 72.44 112.322 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.73 -166.34 39.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 63.32 112.458 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -85.35 126.94 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 74.3 110.875 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.463 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.75 -87.74 0.24 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 73.53 112.55 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -80.32 -23.67 40.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 63.24 110.842 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.52 158.3 43.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 74.15 111.215 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -63.1 -26.83 69.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 74.52 110.853 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -122.0 53.52 1.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 71.5 110.809 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.1 p30 -102.32 145.65 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 75.42 110.857 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 6.4 pt -142.05 172.45 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 74.3 111.13 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 m -122.5 142.64 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.118 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.19 144.46 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 71.05 111.139 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -131.1 149.35 52.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.947 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.0 mt -126.52 95.93 37.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.568 0.699 . . . . 72.2 110.877 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 72.08 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.705 2.27 . . . . 63.34 112.326 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.5 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.912 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -118.16 -13.21 9.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 75.21 110.833 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 m120 69.81 22.05 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 75.54 110.891 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.79 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 73.02 111.072 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.41 136.57 39.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.968 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 23.2 t -123.24 65.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 73.33 111.158 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.87 -48.24 45.38 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.758 -0.734 . . . . 64.4 112.454 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.64 -130.9 10.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 74.3 112.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 96.5 m -69.58 -19.13 63.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 64.44 110.923 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -47.11 70.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 72.33 110.822 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.49 116.0 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 71.04 111.113 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.95 147.74 23.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.864 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.6 t -87.19 157.24 19.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 74.13 110.84 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.1 p . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 73.25 111.117 -179.914 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.805 0.336 . . . . 74.03 111.088 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -51.71 -58.03 7.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 73.52 111.077 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.7 27.12 9.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.847 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -104.86 168.94 8.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 72.31 111.122 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -130.87 88.59 2.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 75.11 110.939 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.46 -18.02 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.098 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -78.87 -22.13 46.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 72.34 110.896 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -108.91 -25.42 10.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 75.42 110.936 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -51.04 -57.97 7.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.95 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.3 p -51.85 -30.56 24.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 64.03 110.87 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.0 m -80.06 -34.3 38.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 75.51 111.142 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 44.5 m -66.99 -55.55 13.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 73.11 110.819 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.6 mm -56.17 -40.17 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 73.15 111.114 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.22 -16.46 60.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 65.22 110.831 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -97.93 -21.88 16.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.883 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 94.5 t -88.42 -24.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.094 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.6 pp -98.84 1.53 45.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.94 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -117.25 -17.03 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 65.33 110.851 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -90.55 1.84 56.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.34 110.901 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -137.61 -72.46 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.32 110.9 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 61.16 25.3 15.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 70.31 110.87 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -147.29 21.06 1.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 75.4 110.856 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.45 144.93 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 65.32 111.174 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -103.87 -28.65 11.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 75.52 110.837 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -165.68 126.47 1.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 73.41 111.106 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 87.9 t -98.45 127.48 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 74.21 111.112 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 98.0 t -108.71 89.57 6.45 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.618 0.723 . . . . 74.2 111.133 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 167.96 22.92 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.632 2.221 . . . . 71.51 112.376 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.09 -15.94 63.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 73.14 112.46 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -146.83 111.09 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 74.44 110.904 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 137.69 -96.41 0.24 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.826 -0.702 . . . . 73.52 112.524 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -178.85 166.77 1.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 75.55 110.867 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.1 133.49 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 65.23 111.141 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.57 -106.62 0.73 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 54.23 112.497 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -155.64 -172.62 4.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.883 0.373 . . . . 74.21 110.856 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -22.04 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 74.41 110.901 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.4 -33.06 52.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.8 -0.714 . . . . 71.25 112.521 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 29.6 mt -50.38 -45.69 55.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 75.33 110.923 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -44.54 77.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 72.2 110.912 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.5 mt -64.9 -41.36 95.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 74.45 110.921 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -61.67 -38.85 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 75.23 110.901 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.6 -46.09 63.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 70.01 111.091 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 79.2 mt -52.5 -38.95 60.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 75.14 110.928 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -46.4 90.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 72.03 110.823 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.6 mt -56.54 -24.82 49.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.93 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.7 mt -87.32 -54.53 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 74.42 110.935 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.4 pttt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 75.41 110.955 179.802 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.1 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 74.31 111.092 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mm -89.03 154.86 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 71.22 111.082 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -150.84 172.96 14.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 64.35 110.854 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -104.61 -169.42 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.35 110.889 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -74.14 -26.18 60.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.882 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p -102.43 -35.48 8.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 75.31 111.135 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.16 -2.5 43.95 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 52.33 112.459 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 t -50.55 -33.26 21.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 53.14 111.195 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 mt -127.89 158.77 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 74.52 111.095 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 p -176.21 166.61 2.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 74.15 110.838 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.14 -172.7 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 75.22 111.12 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 t -171.75 130.67 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 74.15 110.796 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 121.72 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.053 -0.521 . . . . 73.41 110.869 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.26 -49.02 3.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.912 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -148.41 59.39 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 71.34 110.887 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.42 -81.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.52 110.929 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -82.93 -17.2 44.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.862 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.1 t -96.85 118.52 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.15 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -126.14 160.11 31.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 73.04 110.918 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.3 t -120.95 110.89 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 74.01 111.111 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -99.78 136.88 39.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 74.3 110.794 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.9 m -133.7 127.96 33.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.51 111.198 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.9 pm0 -120.91 -176.15 3.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 74.54 110.891 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 tp -135.75 138.36 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 71.22 110.889 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 65.5 112.438 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.601 0.715 . . . . 71.44 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 142.96 49.37 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.66 2.24 . . . . 65.35 112.342 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 t -142.15 110.99 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.51 110.822 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -100.29 146.37 27.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 71.42 110.883 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.677 ' HA3' ' HD2' ' A' ' 56' ' ' ASP . . . -133.37 -114.34 1.51 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.708 -0.758 . . . . 54.2 112.468 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -178.86 144.58 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.839 0.352 . . . . 72.41 110.989 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.88 131.91 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.52 111.124 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.2 mt -101.24 124.85 47.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.924 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.56 55.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 73.43 110.893 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 p -63.21 176.74 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 63.4 111.16 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 t -99.22 16.74 21.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 64.33 110.895 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.54 33.24 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.917 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.94 134.65 7.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 54.13 112.493 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mt -62.72 161.15 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.35 . . . . 73.54 110.918 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.6 t -139.91 143.38 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.33 111.168 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.2 129.73 56.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 73.52 110.857 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.1 t -79.12 -1.87 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 74.33 111.222 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.677 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 3.0 p-10 179.44 130.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 73.23 110.844 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 p -67.79 -166.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 73.04 110.805 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.6 t -94.61 -174.07 3.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 70.03 110.894 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -70.21 -36.11 74.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 71.25 110.935 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.74 164.31 31.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 60.44 110.854 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -63.18 -28.46 70.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 53.12 110.865 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -78.43 -25.48 46.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.914 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.47 -46.43 12.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.994 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 t -55.41 -28.49 54.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 72.4 111.18 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -55.9 -43.09 76.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 64.2 110.877 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.21 0.28 41.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 71.44 110.898 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.6 tp -99.42 -50.68 4.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 74.11 110.9 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.1 mt -64.93 -35.29 74.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 73.24 111.164 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.99 -16.75 60.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 73.01 110.916 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 32.1 mtp -76.57 -59.19 2.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 75.11 110.923 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.0 m -60.11 -33.3 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 74.13 111.158 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -87.76 49.72 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 74.11 110.896 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -147.65 -40.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 75.21 110.884 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.8 -26.63 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 63.42 110.838 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.507 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 38.8 m-85 -89.52 10.89 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 74.51 110.885 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.507 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.71 46.93 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 72.32 110.896 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -146.97 -178.8 6.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 75.31 110.905 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.28 142.71 50.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.888 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.48 130.81 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 74.14 111.09 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.5 p -142.86 24.74 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 70.13 111.11 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -157.85 133.95 9.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 75.02 110.928 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -140.24 101.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.14 111.134 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.8 mt -78.45 114.17 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 75.12 111.117 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.5 mm -100.84 124.76 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 75.51 111.101 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.9 p -81.93 -59.02 2.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 61.51 111.141 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -128.18 -175.11 3.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 75.45 110.895 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.97 100.2 10.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 71.24 111.127 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -153.84 160.6 42.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 74.21 110.84 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.78 -28.9 62.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 75.41 111.071 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.8 12.45 19.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.4 110.875 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -124.36 -50.43 1.77 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.971 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.85 15.69 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 73.44 111.106 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.7 -37.07 33.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 74.24 112.53 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.0 19.39 43.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 72.03 112.473 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 tt -45.83 -31.13 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 74.15 111.124 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.46 -55.46 17.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 71.43 110.962 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.9 m -57.57 -41.43 81.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 60.5 111.104 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.6 mt -58.44 -28.52 65.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.34 110.881 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -100.94 23.4 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 73.4 110.864 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -116.7 -39.7 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 74.21 110.877 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -88.4 -22.9 23.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 71.43 110.862 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.48 18.51 4.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.751 . . . . 74.44 112.482 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.84 155.71 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.915 0.388 . . . . 70.31 111.09 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -119.03 119.76 35.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 74.22 110.891 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.73 78.98 9.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 72.03 111.037 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -53.8 144.94 17.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 75.53 110.886 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.33 160.97 0.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 60.23 110.914 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.4 p -76.66 -177.66 4.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 73.3 111.177 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.3 -31.62 60.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 72.4 111.116 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.3 tp -74.68 -46.98 34.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.951 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -53.6 -27.7 28.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 54.54 111.098 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.89 -33.52 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 73.31 111.135 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.53 -39.58 67.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.855 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.543 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 38.3 mt -84.0 -23.65 30.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 74.25 110.958 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.62 -68.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.079 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -53.14 -28.57 26.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 74.2 110.933 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -23.63 51.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 73.41 110.828 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -95.1 -32.41 13.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 70.13 110.889 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.31 -7.25 5.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 62.03 112.557 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -59.5 -172.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 72.42 110.94 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.93 -3.09 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 75.55 110.914 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 66.29 132.34 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.656 0.741 . . . . 75.32 110.914 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -170.23 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.658 2.239 . . . . 62.33 112.342 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -53.53 -43.21 68.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.913 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 63.0 54.59 32.14 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 74.43 112.478 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -152.4 48.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.335 . . . . 74.52 110.844 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tp -131.7 167.54 19.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.253 -0.431 . . . . 73.43 110.924 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -126.18 -168.68 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 74.23 110.904 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 98.5 m -50.02 -56.44 10.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.427 . . . . 71.32 111.143 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.8 m -131.65 145.62 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 71.31 111.156 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.2 m -152.97 113.23 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.13 111.122 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.28 87.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.426 . . . . 72.33 110.882 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.962 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 59.7 tpp . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.916 0.389 . . . . 74.1 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -114.26 122.25 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.05 110.846 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.3 t -130.75 159.28 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.105 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -159.27 122.06 3.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 71.2 110.841 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -178.28 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.08 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -174.86 135.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.891 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -120.53 95.03 49.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.663 0.744 . . . . 74.31 110.919 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -48.71 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.686 2.257 . . . . 62.34 112.287 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.22 -155.44 24.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 73.44 112.451 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.03 123.59 37.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 72.11 110.858 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.47 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.69 -98.03 0.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.708 -0.758 . . . . 73.53 112.438 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -68.84 -27.64 66.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 74.13 110.878 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.62 154.02 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 75.41 111.131 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.57 -32.55 65.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.865 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.543 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 3.0 p30 -116.31 51.73 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 71.34 110.925 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.47 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.75 138.8 36.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 74.45 110.865 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.37 167.22 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 75.13 111.121 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 m -117.75 147.73 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 63.43 111.131 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -100.67 142.66 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 75.42 111.115 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -128.9 147.35 50.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.915 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.8 mt -125.11 95.91 40.8 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.62 0.724 . . . . 74.24 110.894 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 72.4 1.43 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.674 2.25 . . . . 73.11 112.343 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.5 -34.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 73.24 110.942 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -116.97 -13.51 10.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.54 110.985 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.17 25.37 5.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 64.11 110.926 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -98.13 118.0 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 75.34 111.151 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.39 137.14 41.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 72.21 110.875 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.4 t -118.94 65.15 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 75.34 111.08 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.25 -52.77 34.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 53.42 112.444 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 103.5 -132.07 10.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.796 -0.716 . . . . 60.42 112.463 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 34.0 m -65.14 -23.66 67.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 61.24 110.886 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 24.5 tp -64.02 -52.1 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.51 110.871 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.44 109.06 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 74.22 111.107 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.37 149.87 28.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.923 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.3 t -72.42 164.32 26.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 65.34 110.889 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 74.22 111.115 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.881 0.372 . . . . 74.12 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.29 -42.54 77.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 75.44 111.168 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.98 34.89 5.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 74.03 110.8 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.54 162.7 23.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 70.52 111.118 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -115.3 93.53 4.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 73.5 110.885 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 66.1 t -69.11 -21.29 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 73.04 111.154 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.39 -26.02 30.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 71.01 110.878 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -97.9 -21.08 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.43 110.87 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.15 -56.89 10.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 71.31 110.909 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 25.8 p -52.01 -36.91 51.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.856 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -70.82 -35.24 72.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 75.4 111.172 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.7 m -66.47 -52.18 48.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 63.02 110.841 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 mm -56.47 -37.95 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.171 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -62.08 -24.15 66.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 72.04 110.879 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -89.35 -25.54 21.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 70.15 110.909 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 43.2 t -81.89 -33.59 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 75.21 111.194 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.72 -25.53 35.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 73.53 110.904 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -83.08 -44.4 15.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.928 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -56.21 -29.05 60.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 74.14 110.891 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -142.58 119.15 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 74.41 110.866 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.31 34.41 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 74.13 110.906 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.85 22.19 1.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 72.02 110.834 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.5 mp -52.29 147.53 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.141 -0.481 . . . . 72.42 111.106 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -109.86 -25.77 10.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.109 -0.496 . . . . 72.4 110.909 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -163.58 132.54 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 72.51 111.124 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 89.0 t -115.12 122.15 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 75.21 111.097 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.28 109.7 63.52 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.609 0.719 . . . . 64.41 111.141 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.83 -167.99 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.711 2.274 . . . . 63.43 112.286 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.37 -32.23 6.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 62.51 112.522 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -138.49 101.16 4.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 74.55 110.887 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 150.99 -113.86 0.61 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 72.51 112.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.77 167.96 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 70.12 110.878 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.31 150.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 74.45 111.123 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.75 -107.05 0.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 73.1 112.492 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -162.92 -170.15 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 73.44 110.836 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -20.33 37.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 75.21 110.942 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.13 63.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.787 -0.72 . . . . 74.34 112.477 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 31.5 mt -51.07 -45.35 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.874 0.369 . . . . 73.14 110.905 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.5 mp -55.93 -42.96 76.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.891 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.4 mt -66.73 -41.41 87.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 72.43 110.963 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -61.58 -39.27 90.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 75.45 110.885 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -42.85 62.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 75.24 111.15 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 26.4 mt -61.19 -40.43 93.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 75.5 110.962 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -39.62 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 63.12 110.858 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.71 -26.28 68.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 74.4 110.93 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 5.3 mt -85.6 -42.09 14.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 72.21 110.921 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.2 mttt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.891 179.786 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.878 0.37 . . . . 74.52 111.123 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mm -90.3 153.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 75.5 111.132 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.23 172.29 13.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 71.01 110.884 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -107.22 179.0 4.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.875 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -63.65 -28.05 69.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.869 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -102.27 -33.82 9.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.14 -0.482 . . . . 64.32 111.132 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.58 -5.92 48.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 73.13 112.452 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -50.78 -33.09 21.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.762 0.315 . . . . 71.53 111.125 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 mt -126.36 150.86 32.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 75.14 111.106 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 p -171.16 163.76 7.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 73.15 110.851 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.25 -175.8 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 72.25 111.112 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 t -167.15 135.54 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.03 110.792 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -71.5 117.87 13.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.112 -0.495 . . . . 73.05 110.919 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -99.75 -73.11 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 73.45 110.93 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -132.31 -170.37 2.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.939 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -52.67 109.97 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 75.3 110.913 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 58.47 24.26 11.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.842 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.28 114.94 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 64.3 111.128 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -124.76 160.64 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.31 110.875 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.98 108.69 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.071 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -102.3 138.24 39.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 74.42 110.873 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.0 m -138.77 117.5 12.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 71.11 111.135 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -101.39 -172.89 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 64.14 110.919 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.28 130.45 23.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 54.21 110.905 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.747 -0.74 . . . . 70.53 112.479 179.914 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.424 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 61.1 t . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.567 0.699 . . . . 74.13 111.07 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.9 Cg_endo -69.72 142.67 48.76 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 75.04 112.322 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.63 114.53 20.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 64.23 110.84 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -60.81 169.94 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 72.3 110.863 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.53 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -172.28 -166.68 31.25 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.701 -0.762 . . . . 75.24 112.466 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.2 145.52 10.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 74.11 110.832 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.8 t -129.67 134.13 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 71.21 111.136 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.7 mt -102.71 126.72 49.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.901 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -97.32 59.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 63.34 110.878 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.1 p -68.04 171.6 6.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 74.33 111.091 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -97.13 30.2 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 74.1 110.875 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -156.54 35.52 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 74.33 110.935 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.74 126.03 5.54 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.787 -0.721 . . . . 60.51 112.506 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.9 mt -56.81 172.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 62.51 110.956 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.0 t -150.08 143.42 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.233 -0.439 . . . . 74.12 111.094 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.9 128.37 56.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.43 . . . . 73.22 110.944 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.0 t -77.67 -3.77 5.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.446 . . . . 74.31 111.181 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 0.8 OUTLIER 179.44 134.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.861 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -167.02 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 73.4 110.873 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.4 m -97.33 -175.84 3.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 61.42 110.928 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -64.45 -38.38 90.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 74.21 110.97 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -142.94 167.16 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 74.11 110.829 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.73 -35.77 80.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 75.24 110.789 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -69.39 -23.47 63.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 74.15 110.92 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.8 -50.78 7.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 74.03 110.945 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -60.33 -29.49 68.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 75.4 111.121 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -55.5 -40.65 72.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 73.21 110.872 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -88.15 3.17 50.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 73.42 110.888 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 tp -98.45 -41.75 7.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 73.11 110.942 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.2 mt -65.54 -34.44 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 75.25 111.074 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -69.29 -11.13 60.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.11 110.958 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.4 mtp -81.82 -50.85 8.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 64.24 110.87 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.1 m -67.42 -37.0 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 74.41 111.16 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -79.11 51.85 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 63.44 110.956 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -137.16 -42.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 73.04 110.901 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.15 -19.71 13.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.919 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 24.7 m-85 -91.83 6.2 47.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.893 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.3 pp0? 32.19 48.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.849 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -150.87 -178.14 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.942 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.53 138.91 50.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 73.23 110.859 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.1 t -70.54 132.89 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 74.31 111.103 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.425 ' HG1' ' HD2' ' A' ' 81' ' ' ASP . 37.4 p -139.95 15.06 2.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 73.4 111.158 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.425 ' HD2' ' HG1' ' A' ' 80' ' ' THR . 0.6 OUTLIER -148.65 131.14 15.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 63.01 110.827 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.04 99.34 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 73.01 111.077 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.4 mt -74.24 120.5 23.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 74.41 111.171 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.1 mm -108.12 128.5 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 74.24 111.116 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.0 p -85.47 -58.01 2.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 74.23 111.127 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -128.97 -175.22 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.842 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.16 100.63 10.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 73.54 111.137 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -154.4 160.96 41.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.908 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.84 -28.76 62.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 71.1 111.042 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.0 13.19 17.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 74.22 110.866 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -125.29 -50.78 1.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 71.1 110.877 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.54 15.44 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 73.24 111.133 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.88 -36.95 34.56 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.639 -0.791 . . . . 74.12 112.561 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.97 18.13 50.54 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.785 -0.721 . . . . 73.12 112.502 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 tt -45.92 -31.13 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 73.52 111.127 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -55.09 18.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 74.01 110.948 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -57.54 -40.98 80.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 62.32 111.143 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.5 mt -58.31 -30.05 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.959 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -100.29 23.86 9.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 70.51 110.925 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -114.83 -30.39 6.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 70.23 110.87 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.0 mtp85 -100.26 -21.99 15.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.51 110.892 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.69 13.69 5.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 64.24 112.511 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.8 mt -81.85 155.8 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.94 0.4 . . . . 73.32 111.112 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 124.01 44.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 74.34 110.919 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.52 82.55 6.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 72.52 111.126 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -51.73 143.45 12.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 75.13 110.849 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.73 151.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 73.14 110.832 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.9 p -74.87 175.02 8.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 75.22 111.148 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.26 83.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 70.45 111.03 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -45.89 80.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 74.4 110.95 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.5 m -53.3 -40.68 64.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 60.33 111.179 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.41 -20.99 60.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 62.42 111.035 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -40.45 92.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.861 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.669 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 10.8 mt -87.97 -25.2 23.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 63.45 110.969 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.22 -65.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 71.43 111.118 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -23.83 63.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 61.4 110.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -23.03 67.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 73.54 110.89 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -95.67 -38.49 10.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 73.34 110.955 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.15 -5.64 3.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 75.14 112.543 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -59.5 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 70.22 110.91 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -96.36 -2.88 44.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 71.35 110.908 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 66.21 130.7 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.718 . . . . 73.43 110.884 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.71 2.273 . . . . 72.14 112.348 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.3 mt -53.51 -34.31 57.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.45 110.896 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.08 39.07 49.0 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 75.21 112.466 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -136.34 58.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 74.42 110.876 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.71 -169.86 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 71.31 110.894 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.36 -168.69 3.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.896 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -50.23 -65.32 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 71.23 111.05 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.77 112.14 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 71.12 111.181 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 82.1 m -113.41 111.73 22.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 73.21 111.167 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -73.34 99.52 2.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 73.01 110.85 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.9 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 73.54 110.885 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.1 tpt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.877 0.37 . . . . 74.51 110.862 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -134.49 117.39 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.9 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.9 t -130.5 156.13 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 75.11 111.108 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -153.21 123.78 7.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 74.42 110.852 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -178.03 3.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 74.41 111.151 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -175.45 137.49 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.24 110.819 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -120.63 95.89 48.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.725 0.774 . . . . 74.42 110.884 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 -48.74 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.653 2.235 . . . . 74.55 112.306 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.78 -155.94 24.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.771 -0.728 . . . . 70.22 112.512 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.0 124.68 39.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.741 0.305 . . . . 73.25 110.902 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.466 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.46 -94.51 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 74.35 112.453 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -69.83 -28.58 65.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 74.34 110.879 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.24 158.18 43.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 70.24 111.165 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -61.33 -25.42 67.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 70.32 110.949 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.669 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 1.3 p30 -121.42 49.57 1.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 75.24 110.901 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.0 OUTLIER -98.59 138.12 36.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 72.42 110.923 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 7.4 pt -138.41 171.01 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 75.13 111.142 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.6 m -121.24 144.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 74.13 111.131 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.79 142.65 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 73.41 111.162 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -129.05 148.84 51.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 73.42 110.917 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.65 94.74 41.83 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.618 0.723 . . . . 75.21 110.899 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 71.92 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.702 2.268 . . . . 63.32 112.347 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.59 -34.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 74.43 110.886 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -117.7 -12.8 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.12 110.957 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.0 m120 69.18 25.29 5.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 71.21 110.898 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.31 117.66 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.102 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.42 137.65 40.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 75.12 110.875 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.7 t -121.35 63.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 64.13 111.103 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.93 -57.06 13.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 71.22 112.467 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.56 -135.57 12.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 73.21 112.485 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 34.7 m -61.49 -25.11 67.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 63.03 110.878 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -51.85 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.941 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 39.8 t -89.91 103.55 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 72.4 111.15 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -74.47 151.41 39.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 72.33 110.908 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.1 p -74.72 169.51 17.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.009 0.433 . . . . 73.15 110.804 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.097 -0.501 . . . . 74.23 111.116 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.7 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.87 0.367 . . . . 74.32 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.38 -42.19 73.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 71.34 111.107 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -116.23 37.07 3.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.875 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.31 164.39 23.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 72.22 111.052 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -116.44 92.75 3.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 63.23 110.901 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 46.1 t -69.57 -22.62 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.32 111.091 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -80.65 -26.57 37.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 73.05 110.882 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -97.84 -22.76 16.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 75.51 110.964 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.5 -57.51 8.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 74.5 110.884 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.84 -35.93 46.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 62.02 110.801 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 94.0 m -72.74 -32.35 65.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 73.14 111.177 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.8 m -69.14 -52.67 25.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 71.42 110.88 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.0 mm -54.32 -41.8 54.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 75.22 111.086 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.71 -19.72 59.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.886 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -93.19 -23.87 18.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 65.33 110.919 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 33.3 t -85.65 -26.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.501 . . . . 73.04 111.159 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.6 pp -89.29 -25.29 21.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 75.3 110.912 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -81.54 -31.37 32.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 70.43 110.922 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -72.67 -28.68 62.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 71.21 110.89 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -141.77 117.18 10.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 74.55 110.984 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -119.5 26.0 9.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.93 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.54 22.58 3.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 64.53 110.893 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.6 146.88 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 71.11 111.121 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -107.23 -25.7 11.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 72.15 110.871 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -164.07 133.39 3.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 55.25 111.163 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.9 t -114.16 124.0 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 74.52 111.133 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.414 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 52.1 t -107.35 104.87 54.18 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.629 0.728 . . . . 75.4 111.125 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.77 178.43 4.59 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.651 2.234 . . . . 50.31 112.307 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.05 -29.38 34.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 65.24 112.512 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -143.14 113.38 7.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 71.43 110.821 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 140.25 -112.61 0.82 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 75.55 112.478 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -155.05 166.55 33.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 74.1 110.888 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.41 150.03 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 74.14 111.168 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.35 -108.34 0.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.832 -0.699 . . . . 73.53 112.541 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -157.98 -173.33 4.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.931 0.396 . . . . 62.22 110.866 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -56.28 -21.53 24.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 72.41 110.869 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.41 -31.76 57.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 74.11 112.478 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 37.4 mt -50.91 -46.93 60.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.338 . . . . 75.44 110.869 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.0 mp -55.06 -43.54 73.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 71.45 110.886 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.4 mt -66.65 -41.55 88.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 73.42 110.875 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -61.46 -37.65 84.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 72.23 110.882 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.76 -45.09 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 74.41 111.13 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 49.8 mt -58.16 -39.8 79.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.428 . . . . 74.2 110.872 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.47 -37.58 78.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 73.32 110.906 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.2 mt -68.67 -26.04 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 74.15 110.879 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.1 mt -86.68 -41.66 14.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 64.35 110.917 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 74.33 110.878 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.8 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.773 0.32 . . . . 62.01 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mm -93.26 154.3 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 74.33 111.127 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -149.12 164.02 35.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 72.11 110.938 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -94.7 -169.32 2.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.913 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -23.08 55.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.23 110.902 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.5 p -103.54 -35.99 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 70.34 111.137 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.07 -4.28 45.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 63.03 112.478 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -50.7 -33.36 22.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.687 0.28 . . . . 74.2 111.184 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.7 mt -127.83 159.46 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 74.02 111.126 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -175.82 167.18 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 65.53 110.807 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.25 -175.78 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 71.53 111.198 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 t -168.98 129.73 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 75.44 110.797 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.51 120.48 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 71.1 110.895 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -103.53 -47.24 4.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.967 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -148.51 54.57 1.01 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 62.43 110.93 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.43 -77.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.25 110.852 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -83.63 -19.46 35.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 74.15 110.893 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.57 118.86 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 55.44 111.1 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -125.25 158.91 32.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.158 -0.473 . . . . 64.25 110.894 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.0 t -121.86 109.52 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 73.04 111.113 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -103.23 138.51 39.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.805 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.7 m -135.39 133.55 38.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 61.4 111.171 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.39 174.61 7.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 73.53 110.881 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.7 tp -121.0 148.24 44.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 75.22 110.852 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 74.4 112.493 179.933 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.681 0.753 . . . . 71.31 111.05 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 143.03 49.76 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.625 2.217 . . . . 72.44 112.352 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.0 t -129.96 95.23 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.32 110.825 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.96 162.47 0.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 70.42 110.846 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.66 ' CA ' ' HD2' ' A' ' 56' ' ' ASP . . . -164.09 -162.85 15.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 64.41 112.459 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.43 148.23 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 74.22 110.859 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.43 138.1 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 75.52 111.043 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.8 mt -105.39 136.89 44.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.48 . . . . 74.23 110.903 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -110.24 72.12 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 63.13 110.863 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.7 p -79.47 -173.22 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 65.52 111.162 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 t -107.61 28.05 8.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 74.41 110.87 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -154.32 25.01 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 72.43 110.916 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.45 137.35 5.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 73.13 112.494 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.2 mt -68.65 164.36 21.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 74.22 110.9 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.4 t -140.0 144.51 27.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 72.04 111.088 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.28 130.35 56.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.915 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.7 t -79.57 -1.72 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 71.14 111.179 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.66 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER 179.5 130.58 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 75.13 110.895 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.7 m -67.19 -168.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.836 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.47 -172.31 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 74.11 110.848 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -72.9 -44.92 60.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.495 . . . . 75.14 110.888 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -132.68 151.12 52.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.913 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -54.55 -30.81 55.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.448 . . . . 73.13 110.853 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -76.75 -26.84 55.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 74.01 110.862 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 -46.23 17.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 74.44 110.933 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 t -56.12 -25.38 45.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 74.23 111.111 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -55.28 -43.63 74.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.894 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -81.54 -4.5 56.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 65.5 110.877 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.4 tp -93.84 -45.62 7.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.219 -0.446 . . . . 74.54 110.927 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.0 mt -69.91 -33.42 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 64.02 111.096 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -67.61 -12.64 60.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 70.32 110.956 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.9 mmm -84.74 -59.47 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 62.4 110.944 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.0 m -55.04 -36.26 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 71.23 111.2 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -88.13 48.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 74.11 110.869 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -142.92 -41.87 0.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 72.44 110.939 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -24.54 13.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 72.22 110.878 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.516 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 37.4 m-85 -90.34 11.32 21.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 65.4 110.873 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.516 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.5 pp0? 32.69 47.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 71.42 110.874 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -150.85 -178.43 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.881 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 149.16 50.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.87 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.26 127.21 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 75.21 111.156 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 p -139.03 24.41 2.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 74.11 111.205 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.74 133.51 13.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.889 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 t -139.88 102.39 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 73.31 111.137 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.1 mt -79.11 115.68 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 74.14 111.134 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.35 122.3 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 73.13 111.094 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.1 p -79.16 -58.25 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 74.13 111.148 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -127.36 -175.09 3.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 70.24 110.865 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.82 99.39 9.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 61.52 111.111 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -152.88 159.66 43.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.834 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.69 -22.96 58.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 74.25 111.155 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.86 3.59 54.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 72.4 110.881 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.5 mmt-85 -118.1 -52.17 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 75.53 110.867 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.78 19.31 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.12 111.133 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.84 -29.29 26.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 52.44 112.484 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.36 22.05 20.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 74.11 112.483 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 tt -45.38 -32.05 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 64.44 111.129 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -54.89 18.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 65.42 110.906 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 m -56.05 -40.02 72.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 63.0 111.207 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.5 mt -59.22 -35.52 73.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 75.22 110.921 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.95 19.38 9.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.939 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.13 -25.95 6.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 74.51 110.92 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -106.48 7.52 30.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 73.23 110.801 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.99 14.69 66.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 61.42 112.49 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.0 mt -80.79 154.19 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.877 0.37 . . . . 74.54 111.147 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -117.41 119.56 35.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 74.11 110.863 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.05 81.3 6.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.42 111.052 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -54.55 147.54 14.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 63.43 110.825 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.73 157.99 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 60.3 110.834 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.3 p -82.35 157.68 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.42 111.146 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.34 -39.42 56.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.41 111.091 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -40.98 91.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 70.35 110.926 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.8 m -56.29 -41.68 76.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 74.31 111.175 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.44 -22.58 60.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.4 111.064 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.66 -41.22 81.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 71.13 110.943 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.726 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 7.7 mt -84.05 -27.71 28.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 72.03 110.956 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.43 -69.49 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 70.44 111.144 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -55.19 -26.3 38.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 71.22 110.912 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -24.5 67.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 74.15 110.873 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -93.56 -39.08 11.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.91 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 137.24 -6.7 3.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 73.2 112.494 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -59.75 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.931 0.396 . . . . 71.15 110.906 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -97.55 -1.76 43.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.041 -0.527 . . . . 75.33 110.925 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 66.38 129.93 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.601 0.715 . . . . 75.03 110.938 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.42 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.708 2.272 . . . . 73.35 112.338 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.4 mt -51.96 -46.53 64.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.888 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.86 57.75 14.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.798 -0.715 . . . . 74.23 112.509 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -152.09 51.07 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 72.35 110.869 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 mp -129.91 -177.47 4.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.88 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.58 -168.38 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.22 110.906 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 98.0 m -49.73 -45.21 49.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.14 111.119 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.31 142.6 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 74.44 111.157 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.6 m -149.56 110.89 4.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 72.43 111.139 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.02 98.93 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.834 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 74.41 110.887 179.911 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.1 tpp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.775 0.321 . . . . 73.11 110.899 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.66 119.42 27.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.864 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.9 t -136.44 159.89 37.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 73.41 111.115 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -163.12 123.67 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 74.34 110.915 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.0 178.3 4.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.12 111.156 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -172.72 135.03 0.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 72.24 110.836 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -117.21 92.13 38.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.763 0.792 . . . . 71.54 110.964 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.6 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.642 2.228 . . . . 55.23 112.345 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.02 -170.46 43.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.806 -0.712 . . . . 72.14 112.537 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -83.78 125.14 31.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 75.41 110.924 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.474 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.73 -87.23 0.23 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 71.12 112.468 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -77.89 -28.57 49.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 73.43 110.761 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.16 159.39 43.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.41 111.136 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.05 -23.66 67.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.828 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.726 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -125.29 52.89 1.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 71.31 110.921 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.7 p30 -100.35 148.3 24.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.851 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.7 pt -147.04 162.5 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.4 111.128 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.0 m -109.73 139.01 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.13 111.202 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.5 t -93.35 129.18 44.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.42 111.07 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -117.06 150.6 38.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 71.53 110.946 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 26.3 mt -127.05 97.64 31.84 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.619 0.723 . . . . 73.32 110.992 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.4 Cg_endo -69.7 70.86 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.684 2.256 . . . . 74.45 112.339 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.35 -34.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 74.05 110.884 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -118.34 -11.64 10.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 64.32 110.886 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.0 m120 67.34 21.97 9.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 75.2 110.892 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.15 115.26 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 73.14 111.155 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -98.98 123.14 43.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 71.42 110.912 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 18.3 t -117.58 73.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 63.25 111.086 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.06 -45.63 93.36 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.732 . . . . 54.22 112.521 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.42 -131.21 10.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 54.32 112.557 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.9 m -63.33 -22.45 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.818 0.342 . . . . 75.2 110.857 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -50.01 68.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.919 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.02 112.92 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 70.14 111.148 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -83.0 154.45 24.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 74.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 15.8 p -78.13 162.11 26.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 74.01 110.889 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 73.45 111.198 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.1 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.785 0.326 . . . . 72.21 111.155 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.73 83.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 70.22 111.092 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -119.2 34.83 5.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.01 110.858 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.13 164.85 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.11 111.106 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -117.61 92.17 3.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.93 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.64 -23.88 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 75.35 111.108 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.28 -26.48 42.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 75.41 110.79 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.69 -24.07 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 72.51 110.879 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.55 -54.49 26.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 75.44 110.928 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -34.55 44.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 65.52 110.813 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 61.4 m -74.29 -35.71 63.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 74.23 111.15 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 45.6 m -66.07 -55.55 16.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 71.42 110.905 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.3 mm -54.21 -46.99 68.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 73.41 111.122 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.38 -22.31 53.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.948 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -91.29 -25.03 19.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 72.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 91.8 t -84.05 -24.27 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 75.1 111.12 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 pp -95.85 -8.13 34.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 73.3 110.979 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -113.15 -5.87 13.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 63.51 110.873 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -88.5 -23.83 23.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 72.14 110.838 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -118.41 -60.87 1.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.948 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.75 25.75 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 75.24 110.855 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.95 21.75 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.858 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 4.0 mp -55.33 145.0 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 72.31 111.134 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -106.86 -31.36 8.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.33 110.922 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -160.07 117.46 2.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 75.43 111.155 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.9 t -95.86 125.62 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 72.13 111.15 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.46 109.07 62.47 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.581 0.705 . . . . 70.4 111.159 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -169.95 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.658 2.239 . . . . 73.11 112.35 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -106.49 -24.53 6.72 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.753 -0.736 . . . . 73.23 112.479 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -146.07 84.0 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 73.53 110.813 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 168.13 -102.0 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.759 . . . . 71.24 112.513 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.34 147.33 4.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.867 0.365 . . . . 72.01 110.876 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.62 143.89 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.132 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.56 -102.96 0.46 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 54.32 112.509 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -161.41 -169.83 2.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.801 0.334 . . . . 75.5 110.874 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -56.49 -21.77 28.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.865 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.82 -33.57 56.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.78 -0.724 . . . . 73.51 112.523 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 31.3 mt -50.86 -49.37 59.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 72.34 110.923 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.64 -42.25 67.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.89 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.7 mt -67.6 -41.39 84.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.93 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.4 -35.59 79.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.856 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -45.17 88.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 75.45 111.191 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.8 -37.86 71.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.963 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -42.81 97.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 72.55 110.946 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.25 -35.19 78.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.933 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.57 -29.49 46.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.41 110.862 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.4 mttp . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 73.04 110.834 179.925 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.3 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.863 0.364 . . . . 72.24 110.838 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -172.63 162.65 5.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 71.04 110.933 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.6 mptt 55.96 84.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 73.21 110.909 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -145.17 147.85 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.34 111.216 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -106.1 57.91 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 72.33 110.878 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -121.25 150.69 40.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 72.21 110.962 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.89 -179.81 7.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 64.45 111.162 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t 61.08 97.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 73.33 111.137 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mm -89.85 153.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 74.45 111.112 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -145.7 153.09 40.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 75.1 110.934 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -92.2 165.51 13.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.292 -0.413 . . . . 75.25 110.882 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.96 -35.13 45.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.42 110.844 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -88.06 -31.61 19.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.52 111.131 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.02 -12.9 67.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 73.11 112.523 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -51.05 -32.26 21.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 72.14 111.156 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 mt -121.72 147.73 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 74.42 111.125 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -167.57 169.34 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 63.55 110.856 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.52 -176.04 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 71.15 111.117 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.3 t -166.97 133.79 2.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 71.32 110.859 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -70.17 118.12 12.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 75.41 110.875 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.92 -42.36 5.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.924 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.62 -169.95 3.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 71.44 110.859 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -47.61 63.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 73.3 110.919 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -134.59 28.69 3.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 75.04 110.905 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.43 120.57 60.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 75.45 111.089 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -125.66 159.28 32.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.938 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.5 t -121.74 108.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 65.21 111.122 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -101.17 138.26 38.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.33 110.832 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.1 m -137.01 124.39 21.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 73.4 111.156 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.68 177.46 4.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 65.15 110.888 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.78 135.76 45.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 75.11 110.929 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -138.53 127.49 3.8 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 70.32 112.499 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.22 146.63 6.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.391 . . . . 62.55 110.834 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -172.19 122.41 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 74.33 110.889 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 62.07 35.01 16.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 73.45 110.855 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.33 29.32 74.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.754 -0.736 . . . . 62.21 112.49 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -151.14 179.79 7.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 70.03 110.875 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.08 138.99 39.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 74.55 111.059 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.417 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 98.1 t -137.01 104.11 8.89 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.646 0.736 . . . . 64.33 111.189 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.7 Cg_endo -69.67 142.7 49.03 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.641 2.227 . . . . 75.44 112.451 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -124.15 105.52 9.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 54.22 110.848 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -59.42 159.48 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 65.4 110.845 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.644 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -160.56 -160.22 10.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.74 . . . . 61.14 112.545 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -164.91 144.93 7.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 75.35 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -128.62 134.76 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 73.32 111.078 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.2 mt -103.47 136.13 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.952 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -106.34 74.82 1.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.818 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.6 p -83.1 177.84 8.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 73.51 111.127 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.44 30.51 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 73.11 110.845 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -155.6 24.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 65.31 110.893 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.61 130.81 4.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 65.42 112.457 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.98 166.76 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.845 0.355 . . . . 72.4 110.855 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.1 t -141.17 144.59 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.11 111.168 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.77 128.23 55.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.932 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.1 t -77.95 -3.04 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 71.14 111.136 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.644 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 2.9 p-10 179.23 132.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 72.53 110.87 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -71.34 -167.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 73.23 110.818 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.56 -173.28 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 71.32 110.825 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -67.55 -42.01 83.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 75.52 110.891 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.85 161.48 37.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 62.34 110.857 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.99 -38.07 69.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.86 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -71.45 -23.93 61.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 75.42 110.879 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -45.1 15.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 71.44 110.93 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.0 t -67.02 -25.37 66.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 75.55 111.149 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -53.09 -39.2 63.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 71.23 110.901 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -85.54 -14.56 45.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 71.32 110.827 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.76 -45.57 24.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.964 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.9 mt -71.73 -33.28 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.12 111.12 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.88 -17.15 62.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 72.51 110.846 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.2 mmm -85.43 -55.55 3.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.825 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.3 m -57.22 -37.2 55.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 72.22 111.068 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -86.71 49.95 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 74.31 110.851 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tpmp? -145.43 -42.13 0.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.908 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.82 -23.43 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 74.22 110.843 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.514 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 34.6 m-85 -90.04 11.24 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 75.02 110.923 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.92 46.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 74.41 110.892 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -154.29 -178.59 7.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 62.35 110.863 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 149.49 49.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.825 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 68.5 t -84.1 126.63 40.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 71.22 111.099 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.5 p -135.8 26.55 3.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 74.14 111.175 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -158.33 135.27 9.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.865 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 t -140.55 99.87 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.24 111.079 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.9 mt -77.21 126.0 37.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 74.0 111.06 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.6 mm -112.99 123.27 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 71.22 111.165 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.1 p -81.0 -52.81 7.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 75.44 111.125 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -135.33 167.63 20.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.853 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' H ' ' HD2' ' A' ' 152' ' ' ASP . . . -86.89 98.7 11.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 70.55 111.145 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -153.0 160.38 43.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 74.42 110.863 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.31 -28.09 62.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 75.51 111.027 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.443 ' HD2' HH21 ' A' ' 91' ' ' ARG . 1.0 OUTLIER -90.09 11.13 21.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.833 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.443 HH21 ' HD2' ' A' ' 90' ' ' ASP . 4.9 mmt180 -123.83 -52.62 1.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 72.11 110.924 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.79 16.92 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.11 111.165 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.42 -27.74 26.24 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.729 -0.748 . . . . 72.35 112.47 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.79 19.26 30.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.652 -0.785 . . . . 71.33 112.414 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 tt -48.73 -30.64 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 72.41 111.214 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -68.45 -43.97 75.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.855 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -69.38 -33.48 73.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 74.53 111.163 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.8 mt -63.75 -27.3 69.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 75.34 110.973 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.71 19.07 16.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 75.11 110.933 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.75 -23.87 7.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.911 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -110.87 10.02 22.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 73.03 110.865 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.17 18.76 66.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 70.14 112.471 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.0 mt -83.18 157.59 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 74.14 111.105 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.3 119.78 33.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 72.03 110.895 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.05 79.56 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 74.43 111.151 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -54.36 146.98 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 74.21 110.909 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.5 163.86 0.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.923 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.1 p -80.37 154.9 27.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.11 111.122 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.59 -29.88 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 71.54 111.104 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 tp -74.87 -43.25 55.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.935 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.0 m -53.19 -27.44 21.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 64.21 111.17 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.3 -28.02 21.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.056 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -60.12 -25.17 65.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.413 . . . . 75.32 110.887 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.6 mt -99.07 -24.67 14.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 75.31 110.88 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.65 -63.14 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.35 111.106 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -55.62 -25.74 40.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 74.33 110.855 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -24.67 65.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 72.44 110.875 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -95.32 -28.33 15.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 75.23 110.863 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.07 -5.44 7.82 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 71.4 112.442 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -59.6 -173.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 75.34 110.926 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -99.65 1.09 43.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.489 . . . . 72.13 110.911 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 65.69 122.84 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.719 0.771 . . . . 74.25 110.916 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.73 -170.52 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.647 2.231 . . . . 74.12 112.37 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.1 mt -52.16 -40.49 61.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.44 110.877 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.03 59.59 8.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 64.41 112.547 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -152.75 51.23 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 73.21 110.889 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 mp -130.1 -175.74 3.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.913 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.44 -167.93 2.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.952 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.3 m -49.15 -43.41 41.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 75.14 111.176 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.47 141.7 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 74.34 111.093 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.7 m -148.88 112.14 4.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.173 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.34 96.06 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 75.23 110.831 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mt -85.17 149.51 25.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 71.13 110.889 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.77 107.09 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 75.13 110.904 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -110.61 111.14 22.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 70.12 110.888 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 55.79 -100.55 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 63.53 112.47 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -120.02 59.55 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 74.31 110.86 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.0 tpp -147.99 155.01 41.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 63.55 110.88 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 118.45 25.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.55 110.872 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.98 159.18 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 73.41 111.169 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -158.98 124.45 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 61.42 110.98 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.16 178.5 5.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 71.54 111.096 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -171.98 136.76 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.842 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -116.19 92.95 37.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.751 0.786 . . . . 74.34 110.896 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -48.72 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.615 2.21 . . . . 75.3 112.29 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.56 -170.38 42.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 72.11 112.479 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -84.26 123.61 30.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 75.42 110.938 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.476 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.18 -89.72 0.24 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.769 -0.729 . . . . 71.44 112.534 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -74.18 -28.27 61.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.367 . . . . 73.21 110.896 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.96 157.81 43.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 64.52 111.204 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -62.45 -25.14 67.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 75.1 110.891 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.533 ' HD2' ' H ' ' A' ' 87' ' ' ALA . 16.0 p30 -123.28 52.06 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.901 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.476 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 2.0 p30 -99.94 142.71 31.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.968 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.8 pt -144.28 158.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 75.12 111.173 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 18.4 m -105.11 150.5 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.44 111.113 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 96.0 t -102.56 139.05 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 72.05 111.116 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -126.99 150.71 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 74.42 110.904 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 20.7 mt -128.84 95.72 31.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.594 0.711 . . . . 75.41 110.853 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 72.18 1.51 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.699 2.266 . . . . 61.2 112.307 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.47 -34.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 74.1 110.908 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -117.95 -13.21 10.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.976 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.8 m120 69.0 26.19 5.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 75.44 110.918 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.83 117.61 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 72.33 111.107 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.13 138.04 41.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 73.2 110.946 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.52 68.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.1 111.143 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.37 -51.81 35.33 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.552 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.22 -135.44 12.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 62.14 112.501 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 31.4 m -62.22 -26.09 68.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 73.25 110.889 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -49.5 67.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 71.45 110.907 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.24 96.18 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 71.34 111.099 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -69.06 153.13 44.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.35 110.955 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.7 p -74.87 167.06 22.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.857 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.85 -42.11 77.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 75.32 111.152 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.41 -29.27 65.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 74.43 110.833 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.36 160.28 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 73.32 111.079 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -117.88 -32.4 4.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.907 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.27 -177.08 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.828 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.23 -36.93 17.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.948 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.46 -154.29 21.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.672 -0.775 . . . . 74.4 112.5 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -52.08 126.75 19.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 72.11 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.56 29.96 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 72.21 111.124 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.7 -46.85 83.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 74.44 111.111 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.56 40.99 2.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 55.51 110.792 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -134.02 165.64 24.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.11 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -116.9 92.25 3.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.889 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 90.3 t -69.59 -23.81 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 72.55 111.19 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -25.81 39.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 74.52 110.904 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -97.75 -23.55 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 74.34 110.937 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -51.29 -54.42 26.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.974 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.3 t -51.88 -33.77 38.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 71.34 110.893 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 82.3 m -76.33 -34.01 59.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 73.21 111.182 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.9 m -66.36 -53.22 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 70.25 110.87 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.6 mm -56.3 -43.15 76.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 73.33 111.163 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.76 -19.77 59.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 70.54 110.884 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.63 -31.09 15.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 64.44 110.858 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.5 -50.74 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.13 111.101 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.08 -24.34 67.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 71.31 110.91 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.43 -43.78 15.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.92 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -52.95 -28.97 26.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.41 110.907 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -144.47 119.94 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.91 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.92 41.05 2.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 75.24 110.817 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.4 21.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.35 110.795 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -52.47 146.83 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 73.45 111.147 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.66 -28.87 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 75.41 110.902 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -159.61 139.28 11.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 74.11 111.069 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.18 126.04 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 74.22 111.146 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 55.8 t -107.66 113.12 61.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 71.14 111.077 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -170.27 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.687 2.258 . . . . 74.31 112.33 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.57 -31.25 7.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.67 -0.776 . . . . 74.45 112.489 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -143.5 94.61 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.827 0.346 . . . . 75.03 110.883 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 160.38 -114.94 0.63 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 74.34 112.454 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -150.27 162.77 39.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.957 0.408 . . . . 71.53 110.864 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.95 150.23 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.095 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.45 -108.81 0.56 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.772 -0.728 . . . . 64.23 112.551 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -159.81 -169.83 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 75.44 110.834 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -58.25 -20.19 40.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 73.54 110.899 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.67 -32.27 65.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.778 -0.725 . . . . 72.13 112.485 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 32.1 mt -51.03 -42.99 60.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.352 . . . . 73.31 110.892 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.43 -45.25 94.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.829 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.4 mt -64.27 -42.24 96.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.922 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -63.86 -39.67 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.963 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.5 m -51.75 -42.49 62.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 64.4 111.122 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.95 -39.91 87.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.92 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -28.03 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.43 110.849 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.27 -25.81 61.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 74.15 110.925 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.6 mt -87.42 -43.06 12.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 75.35 110.921 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.55 110.888 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.8 m . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.866 0.365 . . . . 64.31 110.895 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -124.36 132.94 53.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 65.44 110.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.14 136.95 3.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 74.11 110.912 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.1 p -176.22 145.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 75.34 111.109 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -137.79 66.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 70.12 110.892 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -148.83 155.02 40.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 75.34 110.929 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.56 178.38 8.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 71.4 111.089 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t 60.54 94.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.01 111.071 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.88 155.78 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 71.15 111.156 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -145.58 146.62 31.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.913 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 173.72 9.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 73.35 110.94 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.82 -36.01 77.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 61.21 110.893 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.3 p -95.17 -24.9 16.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 72.12 111.086 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.94 -11.3 57.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.728 . . . . 51.22 112.425 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.7 t -51.09 -33.28 25.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 62.21 111.119 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.64 148.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.04 111.13 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 p -169.2 165.56 10.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 75.23 110.87 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.15 -172.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 71.31 111.134 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.45 134.64 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 75.14 110.876 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.96 119.93 14.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 54.33 110.872 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -100.96 -55.02 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.882 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -138.47 53.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 73.41 110.894 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mttt 68.0 -76.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 72.44 110.88 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -84.11 -19.52 34.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 63.3 110.916 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.21 121.28 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 71.21 111.164 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -125.45 160.23 29.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.947 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -122.4 112.44 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 72.31 111.081 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -105.47 137.6 43.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 71.53 110.93 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 m -133.34 127.72 34.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 62.11 111.137 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.11 164.98 14.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.914 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.3 tp -118.84 143.3 47.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.91 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -158.42 137.01 5.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 72.3 112.508 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.3 137.41 50.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.953 0.406 . . . . 54.44 110.888 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -103.45 -32.55 9.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 75.04 110.914 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -171.31 34.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 63.41 110.916 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.05 6.89 8.83 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.707 -0.759 . . . . 44.45 112.495 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -152.83 127.28 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 70.41 110.937 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.2 133.88 50.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 61.22 111.08 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -126.11 126.72 24.77 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.587 0.708 . . . . 71.53 111.172 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 143.43 50.57 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.64 2.227 . . . . 73.22 112.349 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -130.92 95.87 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 74.52 110.857 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -51.94 155.21 1.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 71.22 110.843 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.558 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -155.97 -158.45 8.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.657 -0.782 . . . . 65.44 112.441 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.06 143.91 5.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 74.32 110.942 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.95 142.7 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 71.25 111.152 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.1 mt -111.92 127.5 55.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.908 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -93.33 48.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.871 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.6 p -56.52 166.18 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.11 111.127 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.5 t -95.99 34.17 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 72.4 110.843 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -157.65 28.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.9 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.6 124.1 4.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 75.32 112.516 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.1 mt -51.72 161.31 0.54 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.801 0.334 . . . . 74.15 110.88 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -139.74 144.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.114 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.63 129.93 56.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.003 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.36 -0.36 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 73.34 111.111 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.558 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 2.7 p-10 -179.72 132.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.54 110.845 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 m -71.24 -169.04 0.35 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.216 -0.447 . . . . 75.54 110.851 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.79 -170.75 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 74.2 110.843 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -72.86 -40.46 65.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.891 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.77 162.31 35.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 72.4 110.933 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.43 -33.51 67.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 71.23 110.91 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -75.63 -25.46 56.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 71.53 110.958 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -41.82 20.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.487 . . . . 73.44 110.939 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -68.03 -26.43 65.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.19 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.1 -43.69 70.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.936 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.05 -13.91 54.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.934 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.8 tp -77.35 -45.38 26.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.506 . . . . 75.42 110.926 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.22 -26.72 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 61.22 111.12 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.21 -10.15 59.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 74.34 110.891 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.0 mmm -90.82 -53.0 4.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 52.52 110.834 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 m -58.4 -39.85 76.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 72.33 111.155 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -84.29 51.09 2.0 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 65.42 110.877 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.14 -41.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 74.55 110.953 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.5 -19.18 13.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 75.25 110.848 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.519 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 24.2 m-85 -88.15 9.52 22.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 75.43 110.924 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.519 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.96 46.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 74.21 110.862 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -154.32 -179.15 7.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 73.53 110.902 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.21 149.39 51.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 75.43 110.884 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.9 t -82.22 128.43 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 75.15 111.13 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.5 p -138.94 23.04 2.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 75.4 111.15 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -154.93 132.6 11.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.226 -0.443 . . . . 72.42 110.846 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.6 99.89 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 72.51 111.091 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.0 mt -79.3 124.84 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 73.41 111.129 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.2 mm -111.51 132.88 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 75.35 111.171 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.5 p -89.05 -55.89 3.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 75.5 111.2 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -133.55 162.37 32.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.32 110.807 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.34 97.21 7.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 72.43 111.084 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -150.91 158.54 44.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 74.53 110.859 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.44 -25.59 59.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.33 111.086 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.37 13.17 18.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 72.32 110.894 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -128.12 -52.36 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 75.21 110.85 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.76 16.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 73.33 111.051 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.85 -27.52 21.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 44.43 112.512 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.11 20.83 23.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.723 . . . . 53.03 112.491 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 tt -48.48 -30.92 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 74.52 111.166 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -69.16 -43.76 73.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 71.13 110.878 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.5 m -67.84 -34.98 77.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 74.25 111.169 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.4 mt -60.63 -34.73 74.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.874 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.05 22.34 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 74.04 110.954 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -117.42 -20.27 9.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 72.24 110.933 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -115.78 5.9 14.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 74.15 110.872 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.4 60.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 53.51 112.489 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.4 mt -80.98 155.72 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.909 0.385 . . . . 75.23 111.106 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.48 122.94 41.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 73.51 110.914 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.98 81.61 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 71.12 111.055 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -57.87 146.88 30.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 75.42 110.798 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.21 159.32 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 72.3 110.846 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.0 p -72.81 152.67 41.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 73.41 111.185 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.58 -29.72 18.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.289 -0.414 . . . . 74.04 111.073 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.7 tp -74.6 -44.49 50.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.859 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.7 m -53.17 -27.63 22.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 72.21 111.168 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.66 -26.45 21.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 60.32 111.09 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -61.05 -26.88 67.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.202 -0.454 . . . . 73.33 110.979 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.6 -25.08 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 74.43 110.878 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.3 -64.4 0.88 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 71.51 111.081 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -55.41 -26.04 39.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 75.43 110.884 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -24.37 66.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.52 110.945 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -95.71 -32.2 12.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 73.44 110.87 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.47 -6.64 5.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 72.41 112.475 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -59.53 -173.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 75.42 110.923 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -99.46 -0.64 40.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 73.43 110.892 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 66.07 125.15 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.606 0.717 . . . . 74.51 110.892 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -170.6 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.69 2.26 . . . . 65.24 112.334 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 61.5 mt -53.66 -35.25 60.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.985 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.35 43.74 65.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 71.33 112.497 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -138.72 57.7 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 71.05 110.814 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.75 -169.74 2.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.926 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.2 -169.15 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 74.43 110.961 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 98.2 m -50.97 -70.13 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.145 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.45 109.27 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.094 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.1 m -112.72 103.69 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 74.23 111.146 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -66.14 96.18 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 70.33 110.861 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.59 159.71 17.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 72.45 110.818 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -156.7 106.51 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 75.3 110.954 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.08 -169.32 1.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 72.5 110.837 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -55.58 99.92 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 65.21 112.543 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 m120 58.22 49.77 10.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 72.44 110.9 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 tpt -151.77 153.13 33.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.862 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -130.42 127.62 39.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.917 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.9 t -139.76 157.5 26.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 75.42 111.084 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -155.35 119.79 4.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.9 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -178.17 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 75.03 111.169 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -175.49 137.93 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.5 110.943 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -121.89 96.16 47.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.684 0.754 . . . . 74.1 110.923 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.59 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.634 2.223 . . . . 71.41 112.297 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.09 -157.64 28.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 65.03 112.532 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.33 124.84 36.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.351 . . . . 74.21 110.88 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.46 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.17 -98.64 0.51 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.794 -0.717 . . . . 73.31 112.489 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -66.59 -26.95 67.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 71.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.98 161.5 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 73.31 111.167 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -64.37 -26.27 68.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 75.22 110.86 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -120.83 50.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.843 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.46 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.18 136.99 38.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 71.43 110.879 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.59 172.22 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 75.31 111.138 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.4 m -123.11 149.17 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 75.32 111.166 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -103.39 144.28 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 74.34 111.125 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -130.29 145.94 51.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 74.03 110.91 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.4 mt -123.91 96.71 42.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.545 0.688 . . . . 73.1 110.944 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 72.89 1.42 Allowed 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.669 2.246 . . . . 72.35 112.345 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.31 -34.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 72.51 110.823 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -117.44 -13.55 10.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 74.31 110.947 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m120 69.07 24.91 6.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 73.54 110.849 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.73 116.64 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.42 111.101 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.81 136.51 39.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 75.53 110.919 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.53 62.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 72.44 111.158 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.36 -55.7 18.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.676 -0.774 . . . . 75.43 112.529 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.15 -137.11 14.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 73.22 112.503 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.06 -20.18 56.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 71.33 110.9 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.86 -50.89 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 73.12 110.907 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.59 132.55 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.156 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.21 130.45 55.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 72.35 110.902 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.7 p -60.08 159.77 9.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 62.31 110.845 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.3 -48.03 83.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 72.44 111.124 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.9 t -53.48 -28.71 32.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 65.12 110.843 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.66 158.23 1.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 73.01 111.086 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.28 -30.58 5.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.852 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.78 175.7 12.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.301 -0.409 . . . . 71.34 110.788 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.08 -37.02 34.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 63.31 110.89 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 103.45 -167.19 16.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.681 -0.771 . . . . 64.01 112.472 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -51.94 118.62 3.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.916 0.389 . . . . 72.5 110.877 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 16.5 m -112.82 30.26 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 75.13 111.097 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.46 -34.94 67.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 75.32 111.058 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -122.74 35.86 4.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.835 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.41 165.84 23.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 74.04 111.139 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -113.76 92.75 4.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 74.3 110.927 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 91.6 t -68.54 -23.12 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 73.44 111.158 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.1 -25.65 36.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 74.51 110.85 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.49 -23.44 16.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 64.12 110.862 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.54 -52.49 46.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 74.22 110.953 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.7 p -52.0 -36.19 49.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 73.21 110.921 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.4 m -73.8 -36.51 65.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 72.23 111.14 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 74.3 m -63.38 -54.32 38.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.846 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.1 mm -56.35 -37.13 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.24 111.15 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.76 -22.59 66.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.827 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.13 -33.39 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 72.11 110.904 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 92.6 t -74.53 -49.36 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.31 111.135 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.7 -25.07 67.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 75.33 110.914 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -78.95 -45.55 20.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 74.35 110.947 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -60.09 -33.29 71.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.1 110.841 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -136.29 121.7 19.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.909 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -122.58 27.27 7.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 74.33 110.874 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.93 22.38 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.894 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.82 146.29 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.238 -0.437 . . . . 73.45 111.119 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -106.43 -25.69 11.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 74.32 110.878 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -163.59 128.6 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 71.34 111.128 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.15 118.88 55.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 74.01 111.17 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.8 98.05 16.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.699 . . . . 73.01 111.153 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -172.25 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.704 2.269 . . . . 72.51 112.383 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.74 -30.22 8.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.731 . . . . 73.51 112.475 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -142.56 106.23 4.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.872 0.368 . . . . 75.32 110.935 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 151.26 -96.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.81 -0.71 . . . . 72.04 112.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -178.96 153.99 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 73.02 110.838 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.4 t -63.79 147.83 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 75.15 111.114 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -152.38 -107.79 0.35 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.691 -0.766 . . . . 73.33 112.502 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -155.75 -173.57 4.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.926 0.393 . . . . 75.43 110.858 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -55.42 -22.83 21.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 62.52 110.843 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.03 -31.95 48.83 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 73.4 112.526 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 37.5 mt -50.99 -46.93 61.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 75.32 110.964 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.29 -43.3 70.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 75.44 110.92 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.33 -41.54 89.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.994 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -61.82 -38.1 86.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 73.43 110.911 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -55.76 -46.11 77.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 73.34 111.116 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.5 mt -54.22 -39.99 67.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.917 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -46.13 91.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 72.41 110.85 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.73 -26.39 56.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 72.41 110.889 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.5 mt -85.53 -45.6 11.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.93 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 64.01 110.896 179.826 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.816 0.341 . . . . 74.4 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.44 -32.33 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 72.5 110.95 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -162.15 149.87 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.928 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.7 p -175.26 143.02 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 61.4 111.139 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.42 60.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 71.43 110.936 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -142.56 154.07 44.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.53 110.941 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.86 179.92 7.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 73.4 111.132 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.8 t 60.79 94.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.111 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mm -89.34 157.54 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 74.11 111.144 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -146.53 179.18 7.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 75.31 110.901 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.05 168.47 9.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 70.11 110.918 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -53.13 -29.52 31.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.894 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.6 p -104.74 -35.5 7.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 75.14 111.111 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.69 -4.58 29.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.798 -0.715 . . . . 70.01 112.501 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -51.18 -33.78 28.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.825 0.345 . . . . 75.52 111.154 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.4 mt -126.3 149.74 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 64.23 111.197 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.8 p -169.11 165.77 11.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 64.14 110.92 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.4 -171.79 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.081 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -174.49 133.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.881 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.57 120.66 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 72.13 110.93 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -101.61 -54.5 2.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.943 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -136.29 48.41 2.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 73.32 110.875 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt 70.68 -70.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 75.23 110.921 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -87.16 -22.18 25.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.924 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.45 123.78 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.12 111.121 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -125.43 159.94 30.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.904 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.8 t -120.23 110.1 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 75.13 111.097 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -104.59 139.25 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.833 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.3 m -137.07 132.27 33.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 75.15 111.17 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.516 ' HE2' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -123.42 166.75 14.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.844 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.3 tp -117.81 143.59 46.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 72.25 110.891 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -158.39 137.18 5.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 70.34 112.492 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.78 135.74 48.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.344 . . . . 63.01 110.967 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -102.6 -32.33 9.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 72.5 110.811 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -172.3 38.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.892 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.64 7.13 16.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.729 -0.748 . . . . 72.24 112.529 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -152.77 127.68 9.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 71.32 110.869 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.25 134.14 49.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 75.42 111.121 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -126.75 126.82 24.52 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.605 0.717 . . . . 73.34 111.123 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 141.57 45.64 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.724 2.283 . . . . 74.05 112.34 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -129.75 93.96 3.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.04 110.847 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -53.69 164.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 75.01 110.878 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.702 ' HA3' ' HD2' ' A' ' 56' ' ' ASP . . . -166.33 -165.58 23.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 64.21 112.531 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 tp -157.32 142.04 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 74.24 110.919 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.75 132.27 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 75.33 111.144 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.05 131.87 45.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.876 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -100.49 66.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 75.33 110.855 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.5 p -72.77 170.92 13.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 74.32 111.103 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.6 t -96.0 27.18 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.853 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -150.76 27.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 74.51 110.92 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.05 127.79 4.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.664 -0.779 . . . . 74.34 112.445 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.0 mt -55.51 161.04 2.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 63.11 110.962 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.6 t -140.13 142.17 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 72.01 111.118 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.87 129.58 56.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.946 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.73 0.36 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.148 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.702 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -179.12 129.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 72.32 110.804 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.53 -168.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.14 110.823 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.4 m -92.98 -174.54 3.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 71.34 110.833 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -67.41 -39.48 85.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 75.33 110.873 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.46 166.68 24.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 73.12 110.903 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -62.66 -28.29 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.44 110.828 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -75.94 -22.4 56.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 73.25 110.883 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.98 -46.45 9.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 70.44 110.943 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -58.36 -28.88 65.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 73.4 111.158 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -55.58 -43.29 75.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.44 . . . . 72.1 110.792 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -85.8 0.58 52.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.251 -0.431 . . . . 72.35 110.852 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.516 HD21 ' HE2' ' A' ' 30' ' ' GLU . 27.1 tp -95.3 -47.19 6.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 74.03 110.907 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.5 mt -69.53 -32.7 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.05 -17.81 58.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.11 110.903 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 42.8 mtp -82.15 -58.73 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 72.21 110.905 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.12 -35.8 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 71.52 111.14 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -86.85 49.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.05 110.943 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.85 -40.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.888 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -24.02 12.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 73.44 110.872 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 27.9 m-85 -88.89 10.23 21.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.41 . . . . 62.24 110.877 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.66 46.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.914 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -152.48 -179.23 7.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 75.03 110.906 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.63 143.82 51.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 74.21 110.895 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.8 t -75.09 130.07 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 74.52 111.12 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.2 p -142.05 31.0 1.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 75.14 111.16 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -164.35 126.67 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 64.42 110.89 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.3 t -133.69 101.85 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.03 111.096 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.7 mt -80.18 120.73 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 72.2 111.146 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.2 mm -108.71 129.81 62.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 72.51 111.103 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.9 p -85.37 -53.73 5.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 72.14 111.124 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -134.71 166.54 22.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 74.33 110.855 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.35 96.18 8.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 75.51 111.118 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.33 159.22 44.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.837 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.31 62.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 62.42 111.09 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.84 11.51 20.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 64.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -125.42 -54.67 1.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.882 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.3 16.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 71.52 111.106 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.21 -28.85 27.83 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.684 -0.77 . . . . 75.12 112.495 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.68 19.04 31.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 60.53 112.487 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 tt -48.89 -30.18 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 74.12 111.14 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -72.22 -43.26 64.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 75.43 110.925 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.5 m -64.22 -40.75 96.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 74.52 111.161 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.5 mt -60.96 -35.46 76.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.12 110.913 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -81.61 -23.26 37.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 74.13 110.884 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -82.34 -35.03 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 75.45 110.947 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -87.29 -45.77 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 61.41 110.873 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.12 -14.98 3.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.782 -0.723 . . . . 73.33 112.452 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.72 150.39 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.918 0.39 . . . . 73.23 111.151 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -111.46 126.65 55.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 75.32 110.932 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.29 83.02 6.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 64.23 111.043 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -57.95 143.55 42.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 75.12 110.916 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.68 150.76 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 71.34 110.823 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.8 p -63.88 179.28 0.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 75.3 111.146 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.9 -33.22 63.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.05 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 tp -72.88 -47.04 49.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 71.33 110.951 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.3 m -52.19 -28.9 20.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.54 111.153 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.92 -31.09 25.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.047 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -55.1 -48.38 73.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.892 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 39.9 mt -72.36 -25.0 61.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 72.31 110.901 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.73 -66.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 65.33 111.066 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -54.76 -26.57 35.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.42 110.91 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -23.83 67.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.02 110.89 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -93.74 -38.9 11.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 74.12 110.889 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 138.55 -7.76 3.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 72.31 112.508 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -59.55 -172.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.733 0.301 . . . . 70.15 110.987 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -99.87 0.11 40.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 64.41 110.909 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 66.31 130.7 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.639 0.733 . . . . 73.22 110.867 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.85 -170.3 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.636 2.224 . . . . 74.44 112.292 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 76.9 mt -53.81 -45.28 70.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 64.43 110.884 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.56 52.68 40.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.825 -0.703 . . . . 62.23 112.473 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -148.83 51.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 74.02 110.88 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.6 mt -133.0 178.79 6.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.304 -0.407 . . . . 74.41 110.931 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -140.61 -168.63 2.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 75.03 110.995 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.3 m -50.29 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 73.24 111.146 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.6 t -114.58 106.68 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.44 111.128 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.3 m -110.76 104.13 12.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 74.14 111.146 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -66.19 95.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 73.11 110.908 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.72 159.74 18.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 74.4 110.886 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.31 106.87 2.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.465 . . . . 74.42 110.918 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -98.46 -169.15 1.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 74.15 110.887 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.39 100.96 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 64.3 112.458 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.0 46.72 21.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 72.41 110.901 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.9 tpp -147.01 154.83 41.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 73.23 110.899 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.86 128.75 39.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.922 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.9 t -141.06 157.39 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 74.23 111.142 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -154.72 120.73 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 65.13 110.883 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -179.1 3.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 71.43 111.184 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -175.61 139.89 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 71.11 110.897 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -122.15 96.28 46.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.71 0.767 . . . . 73.24 110.882 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 -48.9 0.64 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.755 2.303 . . . . 73.33 112.327 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.39 -155.74 24.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 62.45 112.516 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.63 126.02 41.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 71.24 110.896 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.472 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.72 -94.0 0.33 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.721 -0.752 . . . . 73.23 112.472 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -71.97 -29.3 64.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.359 . . . . 75.41 110.859 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.31 151.88 34.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.153 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -54.71 -38.44 67.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 60.41 110.849 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -109.15 52.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 72.22 110.906 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.472 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.5 p30 -100.73 136.24 40.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.861 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.5 pt -137.2 172.25 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 62.03 111.153 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.3 m -122.46 150.65 26.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 73.21 111.164 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.9 t -106.66 143.77 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.24 111.192 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -129.98 145.28 51.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 74.52 110.968 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.9 mt -122.91 96.83 44.6 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.643 0.735 . . . . 73.4 110.893 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 72.55 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.746 2.297 . . . . 70.54 112.315 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.54 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 75.42 110.848 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -117.05 -13.33 10.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 75.14 110.901 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m120 68.84 24.84 6.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 74.54 110.827 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 mp -98.19 116.62 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 74.1 111.154 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.1 136.92 38.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 73.24 110.904 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.5 t -121.47 62.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 71.53 111.089 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.4 -51.75 35.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 72.41 112.49 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.06 -139.23 15.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 53.35 112.535 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 81.4 m -62.94 -16.75 60.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 71.35 110.869 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.25 -52.45 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.916 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.47 119.68 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 74.42 111.085 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.05 127.17 38.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 75.21 110.838 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.9 t -62.72 166.66 5.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 73.02 110.831 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 3.1 p -63.96 -43.48 95.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 73.02 111.149 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.11 -30.78 27.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 70.4 110.846 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.83 163.92 24.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.11 111.095 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -154.03 24.23 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 73.45 110.842 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.85 154.01 1.82 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 61.12 110.811 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.8 mt -85.79 -33.89 21.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.902 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.96 -164.85 27.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 72.45 112.513 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.01 105.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 70.44 110.971 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 18.6 m -97.14 26.13 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 74.2 111.1 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.31 75.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.093 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.19 38.96 3.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.791 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -140.92 165.91 26.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 75.23 111.123 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -113.89 92.73 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.962 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 62.1 t -69.5 -23.05 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.102 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -81.41 -24.6 36.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 61.33 110.908 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -98.63 -23.88 15.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 74.54 110.882 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -51.49 -54.23 29.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.927 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.5 t -51.91 -32.58 33.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 55.1 110.8 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.7 m -77.44 -34.78 54.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 74.41 111.15 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 m -65.94 -54.33 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.5 110.817 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.8 mm -56.29 -37.52 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 72.32 111.107 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -65.29 -23.52 67.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 75.01 110.91 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -87.16 -31.94 20.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.902 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 95.5 t -74.45 -51.57 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 73.45 111.142 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.59 -24.86 67.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.926 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -47.62 12.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.804 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -51.92 -34.1 40.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 72.52 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -137.76 118.36 13.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 72.01 110.948 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -116.64 32.87 5.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.98 21.28 2.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 74.3 110.882 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.16 146.42 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 74.42 111.135 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -107.24 -30.95 8.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 63.24 110.878 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -160.69 127.43 4.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 64.35 111.122 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 92.0 t -101.35 125.48 55.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 71.13 111.125 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.31 89.76 6.22 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.569 0.699 . . . . 73.24 111.197 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 171.76 13.89 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.691 2.26 . . . . 74.33 112.336 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.58 -26.2 47.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 64.01 112.475 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -143.35 119.37 10.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 73.32 110.813 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 135.76 -95.21 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.799 -0.715 . . . . 74.24 112.49 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -179.67 168.83 1.37 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 72.42 110.853 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 31.5 t -79.14 142.3 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 62.15 111.131 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.74 -107.13 0.4 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.729 . . . . 64.3 112.55 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -154.46 -172.95 4.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 74.41 110.918 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -23.12 14.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.893 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.57 -32.57 46.47 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.698 -0.763 . . . . 73.22 112.511 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.5 mt -50.92 -44.45 60.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.866 0.365 . . . . 74.15 110.895 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.43 -44.75 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 74.04 110.871 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.6 mt -64.85 -41.97 95.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.44 110.895 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -62.37 -39.15 92.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 74.44 110.858 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.9 m -54.43 -41.58 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 74.55 111.137 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.13 -41.41 88.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 75.35 110.965 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -32.28 69.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 71.35 110.826 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.94 -25.79 63.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 72.31 110.938 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.5 mt -87.35 -44.97 10.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 75.52 110.885 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 72.42 110.892 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.828 0.347 . . . . 63.12 110.834 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.28 172.84 13.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.889 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 105.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 73.03 110.847 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.22 176.18 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 74.41 111.165 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -108.48 80.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 73.1 110.918 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -127.3 149.42 50.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 73.15 110.964 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.88 179.66 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.04 111.13 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.4 t 60.71 97.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.434 . . . . 74.12 111.103 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -90.31 155.19 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 71.25 111.178 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -145.07 165.46 28.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.853 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.06 174.37 6.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 64.15 110.896 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -59.57 -28.57 67.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.855 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.7 p -101.92 -33.06 9.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 71.51 111.126 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.73 -8.66 47.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.63 -0.795 . . . . 72.2 112.484 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 t -50.99 -32.91 22.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.313 . . . . 73.23 111.167 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.0 mt -124.23 147.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 73.43 111.093 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.6 p -166.75 171.42 11.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.954 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.78 -176.39 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.183 -0.462 . . . . 71.34 111.159 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.7 t -166.44 133.67 2.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 72.15 110.878 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.46 118.33 12.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.511 . . . . 74.42 110.888 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.03 -41.64 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 74.02 110.973 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.56 -169.52 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 75.14 110.891 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -51.64 51.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 71.3 110.827 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -131.39 30.89 4.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 74.13 110.887 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.9 t -126.55 119.8 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 75.31 111.162 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -125.33 162.61 24.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 72.32 110.938 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.9 t -122.49 108.13 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 72.43 111.147 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -102.02 139.45 37.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 72.22 110.885 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.2 m -137.77 125.24 22.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 72.24 111.138 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.17 -177.72 3.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 73.01 110.906 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tp -134.38 134.8 42.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 73.3 110.952 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.77 144.35 11.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 61.55 112.485 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.23 142.16 36.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.893 0.378 . . . . 72.02 110.89 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -103.14 -32.45 9.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 71.2 110.858 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -164.82 32.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 70.44 110.958 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.13 13.88 8.81 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.791 -0.719 . . . . 60.5 112.513 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -149.66 119.27 6.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.835 0.35 . . . . 75.1 110.907 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.87 137.76 57.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 62.31 111.096 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.7 t -136.71 124.91 14.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.621 0.724 . . . . 75.54 111.117 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 140.03 41.51 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.631 2.22 . . . . 73.53 112.368 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.6 ' HG ' ' HD2' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -128.62 122.22 30.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 62.02 110.841 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 212' ' ' GLU . 30.6 m-20 -67.46 168.6 10.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 72.31 110.915 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.627 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -173.41 170.12 43.25 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.672 -0.775 . . . . 71.23 112.45 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 tp -143.05 138.8 30.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.388 . . . . 74.01 110.897 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.05 130.23 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 73.22 111.138 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.5 mt -96.9 125.54 41.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.837 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.02 45.37 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.1 110.874 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.5 p -52.57 165.11 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 73.43 111.143 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.61 35.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 71.23 110.837 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -157.11 25.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.485 . . . . 71.33 110.924 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.68 124.6 3.77 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.66 -0.781 . . . . 52.44 112.442 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.2 mt -53.18 158.02 1.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 71.13 110.915 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.25 142.64 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 73.05 111.102 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.43 128.42 56.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 75.33 110.924 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.1 t -80.4 -0.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 75.45 111.1 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.627 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 1.1 p30 -174.81 132.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 75.23 110.911 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -74.59 -166.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.05 110.844 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.42 -170.24 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 71.54 110.848 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -74.8 -34.9 62.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 74.53 110.884 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.16 174.5 11.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.427 . . . . 75.43 110.857 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.44 -30.43 68.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 65.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -76.04 -25.53 55.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.885 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.32 -48.34 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.85 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.1 t -60.54 -27.82 67.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 65.33 111.173 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -43.08 75.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.864 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.55 1.29 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.11 110.92 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 tp -95.46 -45.33 7.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 74.13 110.912 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -68.79 -40.03 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 72.25 111.157 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -60.39 -22.23 63.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.12 -0.491 . . . . 64.21 110.942 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.5 mmm -72.64 -60.81 2.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 74.42 110.914 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 m -59.39 -30.16 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 72.12 111.122 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -88.51 48.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 73.44 110.914 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 -41.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.02 110.958 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.05 -25.23 14.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.9 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 35.9 m-85 -89.31 9.84 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.882 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.68 47.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 73.3 110.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -147.92 -177.54 5.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 75.54 110.851 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.6 130.9 37.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.932 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.4 t -67.86 130.12 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 72.32 111.112 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.4 p -136.82 18.62 3.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.481 . . . . 74.43 111.13 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -153.99 130.59 10.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 75.14 110.878 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.8 t -133.5 98.46 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.095 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.7 mt -73.71 125.73 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 75.21 111.128 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.4 mm -113.08 142.47 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 75.03 111.131 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.0 p -97.51 -59.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 64.31 111.147 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -129.47 164.19 24.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 74.35 110.859 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.49 98.03 9.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.44 111.078 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.03 159.03 43.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 74.54 110.88 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -26.73 61.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 64.41 111.088 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.6 ' HD2' ' HG ' ' A' ' 41' ' ' SER . 29.2 t0 -91.73 13.28 18.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 70.4 110.874 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -126.68 -50.86 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.867 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.75 16.24 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.54 111.15 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.73 -33.26 34.34 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.714 -0.755 . . . . 63.45 112.525 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.27 15.92 53.74 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.749 -0.738 . . . . 73.15 112.487 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.3 tt -46.16 -31.93 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 72.42 111.162 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -54.31 31.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.943 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.8 m -58.1 -41.07 82.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 72.2 111.16 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.3 mt -59.61 -31.21 69.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 75.13 110.934 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -97.82 25.08 6.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.3 110.911 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -115.75 -24.79 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.902 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -107.83 -21.4 12.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.88 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.68 13.34 5.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 62.33 112.44 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.0 mt -80.32 155.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 74.21 111.06 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.97 123.93 44.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 73.22 110.862 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.51 85.31 6.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 74.22 111.074 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -55.87 148.07 17.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 71.15 110.873 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.93 164.88 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 70.11 110.813 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.8 p -81.98 155.77 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 74.11 111.199 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.72 -29.91 20.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 75.53 111.143 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.1 tp -75.08 -47.58 28.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.904 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.7 m -53.93 -26.97 28.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 75.2 111.152 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.26 -27.1 24.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.24 111.05 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -64.13 -27.51 69.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 65.23 110.855 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.8 mp -92.96 -23.89 18.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 73.01 110.895 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.44 -62.98 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.51 111.137 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -25.42 42.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 75.03 110.873 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.0 -23.79 65.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.895 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -97.32 -26.36 14.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 72.33 110.876 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.89 -3.21 10.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.788 -0.72 . . . . 53.04 112.503 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -59.52 -173.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.887 0.375 . . . . 74.42 110.889 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -97.75 -1.34 43.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.89 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 66.36 124.96 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.623 0.725 . . . . 74.41 110.865 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -170.46 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.629 2.219 . . . . 74.13 112.387 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -53.44 -39.76 64.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.884 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.12 59.03 9.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.768 -0.73 . . . . 73.02 112.461 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -155.33 47.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 64.22 110.854 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.2 mt -127.07 -175.26 3.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 72.22 110.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -140.02 -168.66 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 75.02 110.858 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 78.7 m -50.21 -54.87 17.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 65.22 111.092 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.9 t -131.33 111.84 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 75.12 111.114 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 91.5 m -117.04 119.55 35.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 74.54 111.199 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -78.77 99.13 6.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 74.05 110.901 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.6 mt -85.76 149.44 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 74.21 110.918 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 106.96 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 74.43 110.905 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -106.06 57.9 0.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.893 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.11 -117.02 5.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.641 -0.79 . . . . 62.43 112.413 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -91.14 48.62 1.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.735 0.302 . . . . 71.0 110.825 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.7 tpp -143.17 151.6 40.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 74.53 110.836 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.96 112.73 14.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 75.23 110.894 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.08 152.55 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 71.32 111.127 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -151.07 120.78 7.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 54.23 110.888 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -179.08 2.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.45 111.149 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -175.29 136.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.879 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -116.79 93.63 41.77 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.712 0.768 . . . . 73.23 110.838 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 -48.92 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 73.21 112.33 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.62 -170.35 42.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.664 -0.779 . . . . 44.4 112.454 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -84.52 126.55 33.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.884 0.373 . . . . 72.44 110.87 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.468 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -136.64 -88.3 0.23 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 71.32 112.498 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -78.27 -23.67 47.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 73.4 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.95 163.99 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.22 111.218 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -70.09 -24.48 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.916 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -123.59 52.63 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 62.42 110.87 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.468 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 2.1 p30 -100.77 146.35 27.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 75.32 110.925 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 8.8 pt -145.14 173.28 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 74.25 111.161 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.1 m -123.03 138.8 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 74.53 111.156 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.0 t -95.1 125.69 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 72.43 111.126 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -111.0 148.88 31.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 74.15 110.936 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 47.5 mt -123.53 94.61 46.17 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.608 0.718 . . . . 71.44 110.888 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 70.98 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.716 2.278 . . . . 74.42 112.278 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.14 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.904 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -118.74 -9.98 10.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 73.1 110.897 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 68.2 21.03 8.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 70.33 110.868 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.1 115.67 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 73.31 111.129 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -101.37 122.93 44.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 74.23 110.923 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 41.5 t -114.9 73.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 75.13 111.217 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.12 -56.58 17.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 73.24 112.532 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 111.95 -139.0 15.36 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.749 -0.738 . . . . 72.25 112.412 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 46.6 m -58.03 -22.24 48.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 71.44 110.858 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.88 -48.32 79.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.43 110.938 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.57 127.57 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 62.41 111.124 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -95.49 134.94 37.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.925 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.2 p -70.23 157.03 38.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 74.12 110.829 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 p -59.52 -30.57 68.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 75.2 111.164 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.68 -31.16 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 71.31 110.86 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.5 -171.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.068 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -145.77 -42.38 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 75.55 110.948 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -143.63 178.22 7.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 55.44 110.846 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.8 mt -78.61 -49.18 13.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 74.31 110.915 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 98.74 -140.13 14.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 50.33 112.476 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -67.85 133.14 48.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.859 0.362 . . . . 73.52 110.906 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.83 44.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 75.44 111.097 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.48 -46.06 77.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 62.14 111.084 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -112.38 44.09 1.51 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 73.35 110.921 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -134.87 173.92 11.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 71.32 111.114 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.61 88.48 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 75.23 110.918 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 23.5 t -68.11 -20.73 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 70.04 111.182 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -80.36 -28.41 38.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.868 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -22.59 16.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.04 110.918 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.07 -54.37 25.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.88 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -36.83 49.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 71.53 110.813 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 71.4 m -75.34 -39.01 59.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 74.24 111.139 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 44.6 m -58.81 -55.67 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.833 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.1 mm -54.27 -37.5 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 74.2 111.145 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -23.08 65.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.881 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -90.6 -27.43 19.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 62.44 110.879 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 39.8 t -78.42 -31.98 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 75.34 111.156 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.7 -29.87 23.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 63.23 110.968 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -78.98 -50.06 11.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.1 110.865 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -51.92 -30.17 23.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 71.41 110.9 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -138.14 116.86 12.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 74.34 110.894 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -116.5 37.62 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 71.44 110.883 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.24 22.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 65.52 110.921 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.63 142.74 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 64.13 111.093 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -103.53 -42.91 5.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 74.15 110.867 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.57 113.44 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 35.45 111.141 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.39 124.08 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.34 111.129 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 57.5 t -107.41 92.27 8.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.586 0.708 . . . . 75.24 111.129 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.3 Cg_endo -69.68 -174.7 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.269 . . . . 73.12 112.373 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.41 -17.44 33.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.804 -0.712 . . . . 60.02 112.515 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -147.19 125.97 12.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 75.31 110.906 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 123.0 -93.09 0.48 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.746 -0.74 . . . . 74.13 112.496 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.544 ' N ' HD22 ' A' ' 42' ' ' ASN . 0.6 OUTLIER -179.65 167.92 1.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 74.21 110.922 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.85 135.53 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 72.14 111.145 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -137.36 -102.8 0.62 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.773 . . . . 60.12 112.46 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -158.96 -171.34 3.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.923 0.392 . . . . 72.42 110.827 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 -23.92 13.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 74.51 110.83 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -52.52 -35.52 45.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.769 -0.729 . . . . 43.01 112.488 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 23.9 mt -51.0 -46.35 61.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 75.52 110.86 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.1 mp -56.32 -42.95 78.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 54.32 110.882 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.78 -41.46 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 73.24 110.893 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -61.31 -39.35 90.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 63.34 110.848 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.66 -46.22 63.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 75.25 111.103 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 51.5 mt -56.64 -44.22 81.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 74.42 110.939 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -31.51 60.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 60.42 110.872 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.7 -27.92 61.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 73.13 110.887 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.85 -30.87 24.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 73.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 75.25 110.894 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.9 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.853 0.358 . . . . 71.34 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -159.26 -177.37 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.859 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.19 142.1 37.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 74.2 110.905 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.72 172.37 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 74.13 111.086 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -137.97 55.79 1.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 71.04 110.885 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -146.46 151.91 38.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 74.25 110.893 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.53 179.78 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 71.42 111.164 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.3 t 60.92 94.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 74.24 111.072 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mm -87.1 156.17 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 74.35 111.1 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -146.74 151.91 37.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 70.54 110.896 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.58 168.51 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 73.01 110.924 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.46 -32.55 62.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 71.13 110.92 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 p -93.04 -31.97 14.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 74.45 111.084 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.47 -12.51 58.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 53.04 112.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.4 t -51.73 -33.0 32.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 74.23 111.132 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.2 mt -119.58 150.87 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.12 111.089 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -170.2 170.84 7.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.782 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.47 -174.7 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 74.41 111.215 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -170.8 129.95 0.81 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 71.24 110.882 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 122.12 15.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 74.32 110.944 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -104.45 -46.84 4.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 74.31 110.949 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -149.41 52.43 0.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 74.42 110.83 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.58 -76.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.931 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -83.63 -20.37 33.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.898 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.26 120.6 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 72.42 111.171 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -125.41 159.81 30.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 74.35 110.957 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -122.23 112.7 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 75.53 111.147 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -103.48 137.04 42.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 73.52 110.9 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.6 m -131.17 130.93 43.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 71.14 111.091 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.19 163.17 23.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 73.43 110.868 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tp -110.14 145.7 36.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 74.1 110.924 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.09 -122.58 2.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.736 -0.745 . . . . 72.22 112.465 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.2 155.26 46.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.93 0.395 . . . . 74.31 110.832 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -173.44 102.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 73.32 110.848 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 51.45 56.23 8.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 75.3 110.921 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.91 26.37 67.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.802 -0.713 . . . . 54.12 112.49 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -151.57 119.46 6.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 73.45 110.873 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.45 144.19 21.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 71.33 111.098 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -132.07 126.68 20.71 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 75.42 111.142 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.93 49.31 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.65 2.234 . . . . 75.12 112.349 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -126.33 108.12 10.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.87 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -61.87 151.52 34.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 74.43 110.888 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.698 ' CA ' ' HD2' ' A' ' 56' ' ' ASP . . . -154.3 -163.37 11.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.7 -0.762 . . . . 72.54 112.478 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.36 145.3 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.903 0.382 . . . . 75.14 110.903 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.8 t -129.49 130.12 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 71.54 111.097 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.7 mt -98.57 122.01 41.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.902 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -91.53 47.3 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 72.4 110.908 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.9 p -56.77 172.68 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 72.01 111.103 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.4 m -99.17 24.97 7.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 65.44 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.4 19.01 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.838 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.78 128.53 4.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 60.44 112.524 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.3 mt -52.63 157.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.817 0.341 . . . . 73.02 110.916 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.08 143.36 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 75.13 111.098 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -112.24 129.58 56.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.831 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 t -80.07 -1.26 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.044 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.698 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -179.32 130.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.24 -0.436 . . . . 75.42 110.89 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -67.82 -169.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.4 110.795 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.41 -175.94 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 70.2 110.826 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -67.35 -37.4 83.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 74.23 110.899 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -144.99 174.15 11.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 75.2 110.878 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.03 -28.46 65.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.84 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -77.63 -25.45 49.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.33 110.893 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.79 -40.98 15.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 75.33 110.863 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -66.18 -29.74 70.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 74.11 111.197 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -51.62 -45.04 63.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 53.12 110.91 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -81.64 -14.9 56.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.881 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.0 tp -78.08 -48.45 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.888 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.9 mt -71.85 -18.63 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 72.52 111.097 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.06 2.35 39.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 71.24 110.894 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.2 mmm -101.62 -53.04 3.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 75.4 110.908 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.7 m -59.4 -39.53 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 73.35 111.125 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.86 50.98 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 75.2 110.889 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.74 -39.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.881 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 -20.19 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.931 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.524 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 25.1 m-85 -89.14 12.28 16.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.859 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.524 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.86 47.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 71.52 110.93 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -155.93 -178.72 7.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 75.11 110.891 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.41 157.45 39.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.02 110.848 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.5 t -92.65 117.98 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 72.45 111.181 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.9 p -128.34 22.4 6.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.23 111.155 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.45 133.9 13.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.831 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.1 t -138.64 99.47 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.34 111.128 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.0 mt -77.49 126.07 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.03 111.071 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.9 mm -112.46 130.26 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 75.44 111.091 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.0 p -87.76 -54.85 4.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 72.21 111.077 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -133.93 170.0 16.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 75.23 110.868 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.96 97.77 11.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.465 . . . . 71.32 111.075 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.33 158.65 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 73.1 110.826 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.03 63.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 64.54 111.104 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.9 9.26 25.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.23 110.831 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -121.43 -52.81 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 74.44 110.865 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.5 18.24 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 74.52 111.198 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.05 -26.72 20.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.636 -0.792 . . . . 54.11 112.534 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.64 22.01 20.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.737 -0.744 . . . . 71.3 112.523 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.3 tt -48.55 -31.05 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.392 . . . . 74.02 111.137 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -70.65 -43.75 68.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.908 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.4 m -66.27 -35.49 80.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 74.42 111.119 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.4 mt -62.37 -32.51 73.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 72.44 110.933 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.29 20.92 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 64.45 110.88 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -117.35 -22.46 8.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 75.2 110.906 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.74 7.66 18.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 72.24 110.894 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.8 15.92 64.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.723 -0.751 . . . . 65.15 112.453 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.9 mt -80.33 155.03 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 74.1 111.113 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.98 117.58 29.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 74.05 110.911 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.52 79.32 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 63.43 111.064 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -55.16 147.66 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 70.05 110.896 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.86 166.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 73.44 110.916 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.1 p -87.99 158.13 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 64.34 111.078 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.82 -43.09 62.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 75.22 111.129 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -46.31 90.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.847 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.2 m -52.05 -42.58 63.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 71.15 111.08 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.3 -23.55 60.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 75.41 111.104 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -57.08 -40.49 77.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.856 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.21 -28.43 27.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 74.24 110.927 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.71 -68.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 72.42 111.077 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.34 -24.94 47.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 73.21 110.879 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -24.17 66.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.885 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -95.71 -37.33 10.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 52.25 110.871 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.68 -5.3 4.07 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.718 . . . . 65.22 112.502 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -59.63 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.816 0.341 . . . . 74.52 110.935 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -97.86 -1.0 44.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 72.4 110.891 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 66.15 125.38 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.674 0.749 . . . . 71.23 110.886 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -170.37 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.238 . . . . 62.55 112.343 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.8 mt -53.59 -41.2 66.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 71.23 110.942 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.28 59.72 8.6 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 74.32 112.482 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.75 54.63 0.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 75.4 110.896 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 mt -137.01 -173.21 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 61.51 110.902 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.0 -168.18 2.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.851 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.6 m -50.02 -41.66 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 61.3 111.197 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 m -140.51 141.82 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 72.42 111.141 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.0 m -149.04 110.88 4.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 74.35 111.154 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.89 98.01 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 72.1 110.865 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.3 mt -87.62 149.77 24.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 73.24 110.883 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.31 131.29 17.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.889 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -134.35 99.17 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 73.32 110.863 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 61.51 -96.76 0.12 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.713 -0.756 . . . . 75.13 112.479 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -118.86 49.6 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 74.22 110.869 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.2 tpt -138.1 152.97 49.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 72.23 110.823 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.44 118.14 21.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 73.24 110.958 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.6 t -135.14 159.19 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 73.52 111.15 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -160.52 126.7 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.24 110.907 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.9 178.32 6.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 62.33 111.133 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -172.84 138.23 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.906 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -118.92 95.32 49.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.705 0.764 . . . . 73.21 110.864 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -48.75 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 65.5 112.365 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.42 -165.54 38.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 71.44 112.447 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -85.4 121.2 27.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.24 110.847 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.477 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.09 -94.28 0.46 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.738 -0.744 . . . . 75.14 112.443 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -70.58 -29.3 65.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.368 . . . . 74.33 110.814 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.32 154.71 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 65.24 111.129 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -58.35 -24.27 59.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 52.32 110.912 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -124.19 51.37 1.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 65.23 110.94 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.0 OUTLIER -100.79 136.36 40.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.976 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.3 pt -137.47 160.61 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.52 111.121 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.4 m -106.34 157.73 6.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 64.22 111.065 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.29 141.1 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 74.12 111.16 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -128.24 150.2 50.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.888 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.1 mt -129.0 95.9 30.34 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.62 0.724 . . . . 74.45 110.917 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 72.49 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.687 2.258 . . . . 64.11 112.286 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.52 -34.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 73.42 110.924 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -117.45 -13.56 10.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.975 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m120 69.38 25.82 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 71.41 110.835 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.09 119.12 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 70.44 111.099 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.71 138.46 40.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 73.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.09 66.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 75.02 111.111 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.47 -45.11 53.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.744 -0.741 . . . . 71.25 112.46 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.74 -141.48 15.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.76 -0.733 . . . . 65.23 112.509 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 43.7 m -57.35 -23.91 51.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 72.14 110.92 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.64 -49.35 69.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.927 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.3 t -90.41 105.37 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.14 111.166 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.92 151.31 37.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 64.11 110.903 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.3 p -75.26 169.47 17.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 71.55 110.841 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -38.61 86.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 74.24 111.114 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.57 -26.89 68.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.281 -0.418 . . . . 74.33 110.844 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.96 151.69 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 62.31 111.032 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.34 -30.79 5.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 73.14 110.859 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.19 173.55 15.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 64.52 110.809 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.45 -37.07 20.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 73.32 110.943 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 97.18 -163.47 22.09 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.755 -0.736 . . . . 75.44 112.409 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -52.07 112.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 70.32 110.895 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.3 m -105.95 34.82 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.144 -0.48 . . . . 74.01 111.132 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.01 84.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.493 . . . . 73.21 111.125 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.0 39.94 2.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.23 110.817 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.72 170.84 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 72.11 111.056 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -119.9 90.16 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 73.34 110.917 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.55 -20.94 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 75.54 111.097 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.97 -26.32 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 73.4 110.938 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.23 -23.15 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 64.25 110.886 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -51.27 -55.81 16.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.878 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -36.16 49.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 73.14 110.83 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.6 m -75.48 -34.24 60.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 74.32 111.081 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 67.4 m -64.38 -51.55 62.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.25 110.89 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.9 mm -56.72 -38.91 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 74.53 111.09 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -62.68 -22.07 66.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 72.43 110.857 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -90.72 -30.3 17.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 53.33 110.885 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 99.5 t -77.49 -37.05 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 73.13 111.176 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.4 pp -78.93 -25.21 43.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.878 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -83.13 -42.48 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.14 110.939 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -55.24 -26.45 39.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 74.41 110.895 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -143.81 118.54 9.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 74.24 110.918 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.37 37.52 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 73.12 110.909 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.43 21.27 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 72.02 110.902 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.25 146.85 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 73.14 111.142 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.56 -31.51 8.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.892 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -156.48 140.17 16.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 55.23 111.09 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 92.7 t -120.72 125.64 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 70.22 111.144 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.406 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 97.1 t -107.71 105.74 56.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.604 0.716 . . . . 73.23 111.1 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.4 Cg_endo -69.76 -179.85 3.19 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.705 2.27 . . . . 74.4 112.314 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.79 -33.83 26.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.729 -0.748 . . . . 62.03 112.518 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -143.61 111.13 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.344 . . . . 74.23 110.847 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.46 -114.2 0.72 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.761 . . . . 53.34 112.422 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -151.84 166.86 30.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.85 0.357 . . . . 73.33 110.939 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.8 t -74.34 149.94 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 74.13 111.127 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -147.31 -108.54 0.53 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.76 -0.734 . . . . 74.42 112.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -157.73 -171.77 3.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 74.12 110.816 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 35.7 tttt -56.65 -21.51 27.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.889 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.29 -31.98 57.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 74.23 112.467 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 37.1 mt -51.06 -45.41 61.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 74.22 110.873 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.6 -44.58 89.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 72.0 110.92 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.15 -42.01 94.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 73.03 110.95 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -66.24 -37.79 86.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.12 110.853 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.6 m -52.12 -43.01 63.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 73.45 111.08 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 61.5 mt -58.35 -42.29 86.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 75.11 110.863 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -26.86 66.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.841 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.4 mt -73.49 -25.88 60.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.45 110.925 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.1 mt -87.25 -42.2 13.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 65.25 110.88 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.922 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.77 0.319 . . . . 64.12 110.835 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -127.82 153.64 46.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.957 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -147.91 128.29 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 75.35 110.92 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 m -134.29 -176.32 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 75.53 111.142 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.35 115.64 30.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.874 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -155.96 154.7 31.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 70.42 110.875 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.5 178.46 8.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 74.34 111.072 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 80.8 t 60.37 94.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 55.52 111.08 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mm -87.9 156.92 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.184 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -145.77 147.14 31.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 63.02 110.964 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.79 164.24 26.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 74.23 110.85 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -51.88 -38.2 55.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 73.4 110.958 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.5 p -92.43 -26.57 17.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 73.13 111.193 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.71 -11.69 56.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 71.34 112.501 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 t -51.48 -32.63 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 64.54 111.15 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.3 mt -120.92 149.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 75.34 111.103 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 p -169.98 167.53 8.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 71.45 110.862 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.57 -173.22 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 73.25 111.175 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -172.83 132.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.86 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.03 120.38 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 74.13 110.816 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.11 -47.86 4.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 63.4 110.889 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -146.99 53.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 74.35 110.887 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.28 -76.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 74.03 110.937 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.76 -20.97 30.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 75.34 110.871 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 t -97.1 119.73 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 63.12 111.143 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -124.67 162.01 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.936 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.4 t -124.26 111.26 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 74.14 111.098 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -103.21 137.62 41.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.468 . . . . 72.55 110.829 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.2 m -133.05 120.51 21.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 71.43 111.185 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.33 170.44 8.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 73.42 110.878 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.84 133.49 51.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 75.44 110.879 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -127.52 113.72 1.76 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.779 -0.724 . . . . 72.41 112.484 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.67 111.36 0.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.962 0.411 . . . . 74.41 110.777 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.69 105.54 15.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 73.45 110.885 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.8 t30 53.07 29.24 7.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 74.2 110.897 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.25 18.89 44.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.711 -0.756 . . . . 73.11 112.525 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -131.57 119.57 21.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.819 0.343 . . . . 74.53 110.88 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.84 132.68 49.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 71.11 111.096 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.406 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 60.5 t -139.84 102.65 6.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.601 0.715 . . . . 73.1 111.185 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.3 Cg_endo -69.78 141.01 44.0 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.707 2.271 . . . . 74.1 112.306 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -124.69 117.66 24.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 73.14 110.838 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -71.22 147.52 48.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 75.13 110.857 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.618 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -148.74 -160.41 9.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.758 -0.734 . . . . 73.25 112.404 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.74 143.7 11.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.384 . . . . 74.32 110.913 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.1 t -127.44 141.24 46.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.42 111.142 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.3 mt -107.04 138.11 43.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 75.41 110.898 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -110.47 59.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.919 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.3 p -67.3 -172.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 71.41 111.16 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.26 26.38 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.992 0.425 . . . . 72.2 110.876 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -156.03 35.58 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 72.2 110.893 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.01 133.39 6.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.841 -0.695 . . . . 73.33 112.527 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.19 172.84 2.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.874 0.369 . . . . 71.31 110.925 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.0 t -148.18 143.42 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 75.53 111.103 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.84 130.01 56.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.119 -0.491 . . . . 74.1 110.876 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.36 -1.06 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 71.45 111.102 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.618 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 2.4 p-10 -179.55 133.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 65.5 110.877 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -71.17 -168.64 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 62.42 110.864 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -173.18 3.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 74.33 110.906 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -69.54 -41.24 76.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 74.21 110.907 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.0 165.92 25.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.291 -0.413 . . . . 61.3 110.88 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -60.82 -34.69 74.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.916 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -73.94 -22.77 59.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 71.43 110.944 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -43.44 15.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 75.15 110.893 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -66.99 -27.5 67.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.41 111.095 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.25 -43.52 71.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 73.13 110.89 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -82.91 -14.28 54.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 73.43 110.856 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 tp -76.63 -47.27 22.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 70.2 110.904 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.39 -33.4 53.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.43 111.12 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.8 -25.55 67.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 74.35 110.956 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 mmm -75.77 -59.83 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.499 . . . . 71.12 110.881 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.0 m -55.66 -31.91 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 72.41 111.102 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -89.69 48.29 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.875 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -143.65 -42.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.816 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.58 -25.9 14.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 75.4 110.869 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.505 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 35.5 m-85 -89.26 9.32 26.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 70.3 110.877 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.505 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.76 46.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.911 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -147.62 -177.76 5.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.2 110.896 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.95 130.04 39.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 75.32 110.824 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.72 127.5 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.132 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.4 p -133.95 18.73 3.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 73.5 111.084 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -153.63 136.13 15.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 55.1 110.846 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.2 t -139.75 97.82 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 74.04 111.086 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.1 mt -75.75 125.68 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 74.51 111.17 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.1 mm -111.33 121.65 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 72.33 111.116 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.9 p -77.37 -53.7 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.074 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -135.8 171.12 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 75.04 110.886 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.02 101.09 13.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 70.44 111.025 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 159.85 40.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.46 . . . . 72.01 110.881 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.32 -25.31 48.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.052 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -94.0 20.15 8.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 73.22 110.879 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -135.17 -50.45 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 75.24 110.893 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.57 14.47 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.43 111.143 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.61 -35.55 30.11 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.735 -0.745 . . . . 73.4 112.449 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.18 19.04 41.26 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.705 -0.76 . . . . 64.43 112.421 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.7 tt -45.97 -31.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 74.41 111.141 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -54.25 32.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 75.04 110.914 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.1 m -58.7 -41.15 85.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.416 . . . . 75.14 111.09 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.4 mt -57.49 -28.7 63.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 75.22 110.849 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -100.93 23.55 10.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 73.31 110.894 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -115.9 -26.57 7.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 73.01 110.861 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -103.34 -22.02 13.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 75.24 110.817 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.74 19.2 4.15 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.717 -0.754 . . . . 64.4 112.416 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.7 mt -87.23 154.67 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 74.31 111.117 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -117.16 121.98 42.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.918 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.33 80.47 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 62.54 111.116 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -54.32 144.11 21.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.869 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.8 153.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.45 110.88 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.4 p -74.75 158.4 33.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 71.23 111.159 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.83 -37.45 63.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 74.43 111.093 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.33 -46.0 82.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 73.4 110.892 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 m -52.89 -41.14 64.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 72.13 111.154 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.68 -22.33 60.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 55.31 111.114 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -38.78 82.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 72.44 110.839 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.594 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 12.2 mt -89.33 -26.27 21.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.906 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.4 -64.78 0.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 63.13 111.059 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -57.28 -23.96 51.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 71.31 110.912 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -23.77 66.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.914 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -94.47 -33.43 13.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.925 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 129.16 -5.15 6.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 65.04 112.464 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -59.81 -172.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 75.04 110.937 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -96.11 -3.6 44.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 75.35 110.836 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 66.38 125.52 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 75.12 110.886 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -172.52 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.646 2.231 . . . . 64.43 112.308 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.7 mt -51.93 -39.36 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.898 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.0 53.99 27.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.79 -0.719 . . . . 72.32 112.447 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -146.62 54.81 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.819 0.343 . . . . 70.42 110.876 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.31 -176.46 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 74.54 110.903 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -141.68 -168.4 2.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 51.02 110.883 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.3 m -49.93 -43.3 49.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 72.22 111.079 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.3 m -140.42 143.08 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 74.44 111.108 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.0 m -150.21 110.19 4.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 70.21 111.129 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -71.87 94.77 1.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 74.12 110.875 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mt -82.7 149.18 27.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 73.32 110.937 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.28 109.56 4.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 64.32 110.895 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -109.94 98.13 7.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 73.02 110.889 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 58.09 -98.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.714 -0.755 . . . . 75.14 112.477 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -112.57 58.5 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 64.11 110.887 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 15.7 tpp -151.2 151.66 32.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 73.22 110.867 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.28 120.29 26.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 75.01 110.899 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.3 t -137.42 158.68 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 75.34 111.167 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -155.82 123.76 5.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 72.2 110.894 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.54 178.4 6.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 74.13 111.17 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -172.39 137.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 71.12 110.927 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -118.09 92.52 42.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 75.51 110.862 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -48.72 0.67 Allowed 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.698 2.265 . . . . 73.31 112.371 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.62 -152.82 16.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.798 -0.715 . . . . 65.13 112.494 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.99 123.18 44.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 73.25 110.909 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.499 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -130.99 -89.43 0.5 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.741 -0.742 . . . . 65.33 112.481 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -77.32 -29.67 53.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.831 0.348 . . . . 74.02 110.85 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.68 155.4 40.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 73.45 111.145 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -60.25 -24.19 64.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 72.03 110.843 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.594 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 1.9 p30 -119.17 49.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.42 110.915 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.499 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.0 OUTLIER -100.11 137.78 38.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 73.24 110.897 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.0 pt -139.16 158.81 29.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 72.31 111.153 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.2 m -106.97 145.08 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 65.44 111.026 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.7 t -100.16 144.22 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 75.21 111.118 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -131.53 149.3 52.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.23 -0.441 . . . . 72.44 110.898 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 21.1 mt -127.52 95.71 34.89 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 72.05 110.91 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 72.47 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 74.44 112.336 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.35 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 72.11 110.839 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -117.94 -13.05 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 75.53 110.954 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m120 69.51 23.15 6.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 61.3 110.923 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.84 114.56 30.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 74.22 111.161 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.95 136.83 39.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.887 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.48 68.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.02 111.164 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.76 -41.42 43.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 60.53 112.541 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.39 -129.1 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 73.33 112.496 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 69.5 m -74.82 -6.9 51.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 63.43 110.864 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 2.1 tp -73.24 -53.5 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 72.14 110.876 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.03 128.37 43.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.091 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -91.21 163.9 14.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 71.14 110.896 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 p -89.61 159.25 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.01 110.88 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 20.9 p -55.29 -28.49 53.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.02 111.159 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.46 -25.77 57.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 73.43 110.815 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.8 170.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.155 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.06 -41.67 0.58 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 64.15 110.779 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -148.98 179.6 7.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 74.25 110.801 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.0 mt -100.03 -27.2 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 74.31 110.9 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 120.56 -142.31 15.73 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 75.44 112.52 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 181' ' ' VAL . 37.1 t30 -99.03 16.45 22.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 74.34 110.927 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 180' ' ' ASN . 11.6 m 34.86 48.67 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 74.4 111.062 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -51.6 -58.62 5.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 73.33 111.077 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -117.34 28.16 8.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 71.33 110.869 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -104.66 174.88 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 75.31 111.063 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -137.28 85.18 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.918 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.83 -21.49 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 74.54 111.093 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -75.51 -21.72 57.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 71.3 110.947 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -107.83 -26.58 10.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.892 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -51.28 -57.12 9.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.893 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 90.0 p -52.03 -30.42 25.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 73.35 110.817 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.3 m -80.98 -32.44 34.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 75.4 111.204 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.8 m -68.75 -56.66 7.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.912 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.8 mm -53.13 -42.03 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 65.15 111.157 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -63.43 -26.38 68.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 65.12 110.864 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -86.23 -31.23 21.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 75.24 110.858 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 99.1 t -73.22 -38.03 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 75.13 111.143 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.3 pp -79.9 -25.62 40.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.879 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -42.6 33.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 73.04 110.913 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 33.4 tpt85 -60.73 -29.82 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 75.35 110.901 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -139.54 117.19 11.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 71.14 110.885 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 32.3 6.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 73.05 110.828 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.1 21.41 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 73.53 110.925 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -52.23 146.19 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 74.42 111.137 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -105.15 -34.82 7.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 64.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -156.88 133.56 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 74.34 111.087 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.72 128.3 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 72.32 111.09 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.41 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 89.5 t -111.29 102.46 53.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.612 0.72 . . . . 74.05 111.116 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.6 Cg_endo -69.69 -170.13 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 70.52 112.416 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.11 -29.29 7.26 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.853 -0.689 . . . . 75.43 112.559 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -143.46 101.01 3.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.824 0.345 . . . . 72.14 110.899 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.83 -101.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 72.55 112.527 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -168.42 165.18 12.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 70.31 110.856 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.4 t -74.74 149.63 7.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 73.01 111.159 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -151.35 -108.42 0.4 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.7 -0.762 . . . . 74.14 112.441 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -155.37 -172.77 4.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 73.32 110.884 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -55.56 -22.39 21.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 73.54 110.88 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.19 -31.57 49.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 63.32 112.503 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 35.7 mt -50.95 -46.89 61.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 73.24 110.92 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -42.22 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 72.42 110.898 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.0 mt -68.08 -41.21 82.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 74.52 110.95 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -66.26 -36.48 83.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 72.04 110.872 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.0 m -51.66 -43.44 62.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 75.11 111.103 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 71.9 mt -56.85 -38.57 72.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 74.43 110.902 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -28.65 62.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.807 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.7 mt -76.13 -24.77 54.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.927 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.0 mt -89.06 -32.8 17.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.908 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.871 179.883 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.848 0.356 . . . . 74.3 110.839 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.52 177.9 3.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 72.3 110.867 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.71 128.29 10.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 75.34 110.922 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 m -142.71 176.79 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 54.35 111.134 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.88 41.01 3.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.465 . . . . 74.22 110.888 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -134.76 151.25 50.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.902 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.14 -179.65 6.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.21 111.16 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.1 t 60.8 98.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 74.1 111.108 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mm -90.48 154.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 74.42 111.08 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -146.01 146.06 30.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 75.22 110.868 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.34 163.34 21.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.871 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -51.67 -33.21 32.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 73.32 110.884 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -31.45 17.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 75.21 111.109 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.04 -12.45 65.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 61.03 112.425 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -51.21 -33.42 27.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.867 0.365 . . . . 74.13 111.144 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.0 mt -121.92 148.54 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 73.23 111.108 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.8 p -166.17 170.18 13.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 61.24 110.859 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.51 -175.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 73.41 111.156 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 t -167.02 133.87 2.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 73.11 110.858 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.76 118.07 15.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.88 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 mp -103.16 -39.31 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 74.24 110.899 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -149.44 -170.98 3.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 75.53 110.84 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -49.86 -51.25 41.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 71.15 110.893 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -132.23 41.11 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 54.21 110.838 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.02 120.45 25.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 71.43 111.142 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -129.77 154.32 47.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 75.05 110.94 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.1 t -117.48 105.01 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 71.21 111.067 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -99.07 137.91 36.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.907 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.3 m -134.91 136.39 42.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 74.05 111.163 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -125.47 170.52 11.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 75.51 110.907 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 tp -120.76 137.04 54.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.895 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.83 138.74 6.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.793 -0.718 . . . . 65.3 112.548 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.93 141.32 44.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 73.01 110.816 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -101.74 -32.55 10.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 74.14 110.869 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -166.36 34.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.918 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.6 13.63 9.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 64.21 112.522 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -151.41 119.74 6.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.829 0.347 . . . . 72.14 110.877 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.27 146.32 34.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 70.05 111.083 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.2 t -146.89 125.25 6.17 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.598 0.713 . . . . 60.45 111.105 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 141.74 46.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.683 2.255 . . . . 72.33 112.332 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.445 ' HG ' ' HD2' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -127.08 114.61 17.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 75.01 110.907 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.38 145.11 56.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 74.1 110.918 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.479 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -148.41 -175.62 21.15 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 73.25 112.517 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.98 141.75 19.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 74.12 110.915 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.15 137.53 57.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 75.23 111.086 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.2 mt -105.12 134.74 47.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 74.23 110.919 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -103.89 71.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 73.34 110.927 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 p -80.83 -172.03 3.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 70.43 111.19 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.59 -9.07 21.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 51.4 110.886 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.5 42.68 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 72.05 110.917 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.79 138.58 9.51 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 73.0 112.485 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -58.52 172.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 70.24 110.904 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.1 t -150.22 144.18 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 73.44 111.102 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 mt -116.26 132.14 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.994 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 t -82.17 0.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 64.12 111.164 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.479 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -179.86 132.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 74.01 110.892 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -73.14 -168.42 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.21 110.827 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.3 m -94.62 -172.59 2.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.05 110.829 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -68.3 -35.08 77.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 75.03 110.923 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.72 168.27 24.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 72.23 110.885 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -25.82 68.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 63.12 110.886 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -76.28 -25.47 54.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 73.04 110.941 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.87 -48.07 9.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 71.31 110.866 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.7 t -59.86 -29.73 68.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.33 111.144 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -53.56 -41.62 66.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.882 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -84.81 -11.89 54.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 60.34 110.897 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 tp -80.44 -47.52 14.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.947 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.2 mt -64.94 -21.99 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 75.52 111.152 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -71.91 -21.69 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.863 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.4 mtp -81.24 -58.32 3.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 74.33 110.893 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.2 m -58.07 -35.66 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 75.31 111.2 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -88.75 48.79 1.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 64.53 110.88 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.47 -41.71 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 70.31 110.902 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.09 -26.34 13.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 70.14 110.881 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.505 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 37.8 m-85 -88.35 9.61 22.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.52 110.829 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.505 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.4 pp0? 32.38 48.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.15 110.867 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -151.22 180.0 7.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.4 110.919 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.25 133.16 46.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 75.31 110.833 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.79 130.52 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 74.45 111.102 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.7 p -137.47 17.79 2.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 63.24 111.121 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.87 133.59 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.51 110.865 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.0 t -137.36 101.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 71.52 111.069 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.9 mt -78.8 119.54 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 65.34 111.087 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.6 mm -106.3 133.52 50.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 70.12 111.121 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.4 p -89.3 -56.08 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.12 111.156 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -133.14 163.87 28.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 73.22 110.829 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.8 98.41 9.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 61.11 111.164 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 158.13 42.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 75.42 110.832 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.51 -25.32 51.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 75.13 111.069 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.445 ' HD2' ' HG ' ' A' ' 41' ' ' SER . 32.5 t0 -93.31 19.07 8.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 64.51 110.924 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -134.0 -51.35 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 75.31 110.827 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.03 15.79 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 73.31 111.092 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.96 -29.25 27.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.674 -0.774 . . . . 62.51 112.516 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.49 18.78 32.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 44.21 112.483 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.4 tt -49.24 -29.99 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 74.44 111.135 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -69.95 -43.03 72.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.811 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.3 m -69.32 -34.29 74.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 73.43 111.144 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.7 mt -64.36 -32.32 73.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.55 110.883 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -94.27 21.29 7.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 71.23 110.882 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.27 -19.89 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.868 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.73 1.82 14.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 75.2 110.895 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.31 14.68 53.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.685 -0.769 . . . . 73.54 112.478 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.9 mt -82.27 154.9 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.342 . . . . 75.11 111.101 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -118.89 122.79 43.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.869 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.28 79.2 5.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 63.44 111.075 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -51.82 145.95 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 64.24 110.887 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.23 154.77 0.87 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 53.41 110.851 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.4 p -72.57 160.09 32.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 54.45 111.109 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.22 -22.18 50.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 64.35 111.099 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.9 tp -76.83 -48.15 19.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.866 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 44.5 m -55.34 -27.27 46.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.34 111.094 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.45 -23.71 32.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.101 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.29 -33.71 75.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 73.33 110.877 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.1 -25.46 17.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 73.4 110.932 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.78 -65.1 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 52.34 111.135 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -56.58 -24.94 50.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 72.24 110.914 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -24.45 65.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 72.41 110.896 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -93.3 -33.48 13.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 71.52 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.03 -7.06 5.44 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 63.23 112.463 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -59.72 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.38 . . . . 53.31 110.918 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -98.01 -1.53 42.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 75.31 110.926 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 66.15 125.22 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.624 0.726 . . . . 64.1 110.924 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -170.65 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.651 2.234 . . . . 75.44 112.379 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.9 mt -54.18 -40.41 67.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 75.14 110.866 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.16 57.65 12.66 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.728 -0.748 . . . . 72.11 112.453 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -148.37 54.98 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 63.25 110.903 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -136.0 -169.63 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.927 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.61 -168.06 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.41 110.906 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 97.8 m -49.25 -44.05 43.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 72.42 111.132 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.01 141.04 29.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 75.11 111.118 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.7 m -148.56 101.53 3.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 71.04 111.147 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -65.86 96.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.94 159.21 17.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 74.23 110.942 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.33 107.1 3.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.3 110.914 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -98.89 -167.63 1.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 75.11 110.91 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -51.57 100.77 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.727 . . . . 62.34 112.513 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 50.77 42.25 27.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.376 . . . . 75.33 110.86 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 tpp -139.42 151.71 46.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 72.45 110.867 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.59 128.13 48.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 75.52 110.904 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.92 160.02 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 73.33 111.112 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -161.17 122.58 2.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.87 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.44 178.73 5.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 72.02 111.169 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -174.0 139.21 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 74.4 110.908 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -118.89 94.82 48.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.634 0.73 . . . . 75.04 110.928 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.74 0.66 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.749 2.299 . . . . 71.54 112.287 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.83 -156.39 25.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.682 -0.77 . . . . 61.23 112.451 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.36 121.94 39.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.736 0.303 . . . . 74.4 110.9 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.489 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -130.89 -93.65 0.64 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.67 -0.776 . . . . 71.24 112.451 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -73.04 -27.83 61.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 74.41 110.846 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.36 164.75 34.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 72.14 111.154 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -70.15 -23.88 63.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.41 110.865 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -119.41 49.0 1.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.871 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.5 p30 -99.62 137.58 37.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 70.24 110.911 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.8 pt -139.88 160.07 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.14 111.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.4 m -108.5 149.42 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 75.3 111.157 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -105.57 141.82 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 72.42 111.078 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -130.17 146.77 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.928 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.6 mt -124.39 97.13 40.31 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.636 0.731 . . . . 75.32 110.908 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 73.33 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.252 . . . . 74.23 112.353 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.79 -34.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 72.43 110.862 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -118.04 -12.38 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.897 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.6 m120 68.9 23.27 6.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.106 -0.497 . . . . 72.52 110.884 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.18 115.8 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 74.25 111.111 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.11 139.97 33.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 73.42 110.914 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.7 67.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.154 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.36 -54.13 25.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 73.15 112.478 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.38 -134.8 12.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.622 -0.799 . . . . 52.43 112.494 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 91.8 m -64.48 -15.6 61.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.401 . . . . 55.11 110.93 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.3 tp -69.92 -51.54 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 74.52 110.913 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.2 t -80.95 133.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 72.51 111.07 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -109.26 138.22 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 74.43 110.925 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.3 p -57.06 154.68 9.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.32 110.872 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -49.95 75.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 63.43 111.15 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.22 -28.85 29.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 70.25 110.829 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.72 158.34 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 72.15 111.08 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -144.72 22.44 1.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 75.3 110.908 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.59 150.26 1.35 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 72.12 110.89 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.2 mt -80.64 -34.77 34.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.871 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.45 -169.21 20.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.763 -0.732 . . . . 65.22 112.456 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -54.62 115.48 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 74.55 110.933 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 17.6 m -110.29 32.16 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 75.41 111.114 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.85 78.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.52 111.131 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -119.21 40.99 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 72.25 110.935 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.85 172.78 12.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 73.11 111.055 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -119.79 89.78 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 71.51 110.868 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.5 -20.9 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 72.42 111.076 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -81.34 -27.24 35.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.83 -22.94 16.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 72.1 110.837 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.36 -55.05 20.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 73.42 110.865 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.3 p -51.88 -41.11 61.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 70.23 110.87 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 89.4 m -69.84 -40.21 75.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 73.32 111.175 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 70.6 m -58.31 -55.06 39.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 74.21 110.825 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.0 mm -54.36 -36.82 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 75.33 111.174 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -62.45 -23.39 66.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 71.33 110.914 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -90.41 -25.94 20.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 70.14 110.914 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 43.6 t -80.96 -32.7 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 73.31 111.08 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.8 -25.04 28.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 73.33 110.895 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -82.3 -46.07 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 75.22 110.942 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -52.14 -38.41 57.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.781 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -131.88 117.57 18.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 75.14 110.937 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -115.34 41.65 2.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 73.24 110.861 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.01 21.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 73.44 110.89 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -53.22 144.58 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.144 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.02 -33.2 8.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 70.43 110.916 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -157.54 127.26 6.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 75.51 111.085 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 86.9 t -106.76 118.09 53.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 75.04 111.15 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 57.4 t -100.84 104.11 29.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.571 0.701 . . . . 75.31 111.235 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.72 -172.14 0.54 Allowed 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.705 2.27 . . . . 72.33 112.301 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -100.64 -25.11 8.81 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 75.24 112.541 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -146.34 104.94 3.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 72.23 110.875 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.97 -91.43 0.15 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.71 -0.757 . . . . 72.03 112.453 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -178.9 153.28 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.373 . . . . 73.32 110.902 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.48 143.88 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 74.12 111.18 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -143.22 -105.56 0.54 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.696 -0.764 . . . . 61.54 112.487 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -155.49 -170.14 3.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.802 0.334 . . . . 71.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -57.74 -20.49 35.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.888 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.28 62.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.707 -0.758 . . . . 75.43 112.504 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 31.9 mt -50.78 -47.69 59.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 75.12 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 mp -56.93 -43.87 81.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.457 . . . . 74.41 110.836 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.3 mt -66.08 -41.66 90.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 75.44 110.951 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -60.34 -44.46 95.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.792 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -46.73 64.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 72.13 111.071 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 61.0 mt -51.78 -39.75 59.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.22 111.0 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -65.64 -44.62 85.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.886 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 20.7 mt -57.0 -25.84 59.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.908 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.56 -40.21 12.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 72.15 110.875 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.0 mttt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 65.45 110.88 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.791 0.329 . . . . 54.42 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.36 111.28 5.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.491 . . . . 73.34 110.928 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -138.46 169.64 17.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.931 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t 63.56 98.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 73.14 111.12 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -125.13 122.34 36.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 72.55 110.91 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mttp 60.37 170.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 72.42 110.909 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.4 90.49 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 75.33 111.171 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 t -157.85 114.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 74.32 111.155 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mm -87.95 149.59 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 64.22 111.143 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -146.43 156.38 43.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 72.45 110.903 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.32 -177.52 4.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.878 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -67.14 -28.86 68.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 p -93.06 -35.95 12.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.12 111.057 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.96 -15.16 58.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.664 -0.779 . . . . 65.14 112.425 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.0 t -51.72 -33.06 32.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.725 0.298 . . . . 72.44 111.151 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.6 mt -117.11 150.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 74.21 111.027 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.9 p -170.66 173.24 5.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 71.15 110.827 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.78 -177.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 73.45 111.13 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -167.72 135.77 2.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.473 . . . . 63.52 110.833 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -69.8 118.97 13.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 75.12 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.44 -56.8 2.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 71.54 110.946 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -152.69 -172.57 4.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.88 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -52.57 109.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 74.4 110.856 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 58.77 26.16 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.891 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.5 t -128.44 110.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 75.42 111.124 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -123.39 163.75 20.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 75.44 110.94 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.9 t -124.42 109.81 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 72.52 111.181 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -99.32 136.92 38.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 71.44 110.888 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.4 m -130.99 125.9 34.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 71.41 111.13 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.88 168.09 10.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.829 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.68 132.92 52.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.41 110.91 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.29 114.94 1.54 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.687 -0.768 . . . . 74.52 112.437 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.91 129.81 27.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 73.3 110.838 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.77 102.18 7.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 74.44 110.916 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 55.44 26.08 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 72.33 110.899 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.05 23.88 18.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 72.55 112.448 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -141.39 119.71 12.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 73.44 110.919 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.5 141.68 58.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 72.55 111.087 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 69.9 t -146.55 103.08 3.97 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.668 0.747 . . . . 72.23 111.141 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.0 Cg_endo -69.67 139.51 40.73 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.782 2.321 . . . . 61.12 112.285 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.62 127.02 51.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 44.23 110.857 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -78.17 137.84 38.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 75.34 110.906 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.711 ' CA ' ' HD2' ' A' ' 56' ' ' ASP . . . -138.18 -160.47 8.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 63.51 112.529 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.15 143.63 6.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.84 0.352 . . . . 73.44 110.886 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 63.5 t -126.25 131.92 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 74.43 111.145 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.5 mt -101.85 119.1 38.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.438 . . . . 73.25 110.92 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -90.07 48.28 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 61.31 110.84 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 p -58.48 176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 74.42 111.106 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.2 21.88 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 72.13 110.889 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.52 30.02 1.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.13 110.856 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.61 129.4 6.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 70.34 112.49 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.3 mt -51.62 165.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 63.42 110.97 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 50.3 t -147.31 144.9 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 75.22 111.181 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.7 126.66 54.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.11 110.921 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -77.06 -3.85 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 75.11 111.181 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.711 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 0.9 OUTLIER -178.8 129.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 74.31 110.846 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -166.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 70.23 110.857 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 t -94.66 -170.36 2.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 64.12 110.819 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -73.06 -38.8 66.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 72.25 110.878 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -140.0 161.73 36.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 71.13 110.87 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.22 -33.9 69.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 65.35 110.896 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -75.2 -25.75 58.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.903 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 -42.67 20.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 74.42 110.882 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -67.1 -27.05 67.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 65.4 111.168 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -53.42 -39.49 64.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.892 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -86.03 -13.96 45.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 65.54 110.912 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.7 tp -77.65 -43.14 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 72.34 110.911 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.24 -29.04 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 73.04 111.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.11 -11.7 61.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 73.15 110.889 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 mmm -89.38 -54.47 4.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 75.51 110.877 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.5 m -57.12 -39.87 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 72.43 111.051 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -84.41 51.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 73.35 110.899 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -142.54 -41.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 75.13 110.878 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -19.92 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 73.2 110.909 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.524 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 26.1 m-85 -89.22 10.81 20.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.14 110.883 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.524 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.64 47.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 61.43 110.902 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -155.3 -179.23 7.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.915 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 151.38 49.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.815 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.11 128.66 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 71.3 111.116 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.4 p -137.25 20.76 2.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 74.31 111.173 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -154.01 134.9 13.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 71.43 110.884 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.0 t -138.32 97.92 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 71.33 111.101 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.6 mt -75.02 129.69 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 74.02 111.131 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.5 mm -115.96 131.3 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 75.53 111.115 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.7 p -88.01 -57.93 2.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 71.21 111.157 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -132.86 157.6 44.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 62.33 110.865 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.482 ' H ' ' HD2' ' A' ' 152' ' ' ASP . . . -76.25 96.98 4.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 63.11 111.151 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.65 157.94 43.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.871 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.83 -27.17 62.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 44.32 111.15 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.25 8.15 28.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 61.03 110.875 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -122.89 -53.6 1.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 72.15 110.903 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.4 18.36 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.128 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.61 -27.97 20.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.656 -0.783 . . . . 74.35 112.548 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.98 23.0 20.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.707 -0.759 . . . . 64.41 112.492 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 tt -48.98 -30.36 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 72.43 111.111 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -71.06 -43.26 68.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.916 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 93.9 m -67.04 -36.03 81.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 72.14 111.118 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.6 mt -60.94 -33.48 73.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.33 110.926 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -94.3 21.84 6.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.911 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -117.24 -20.29 9.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.824 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -115.32 5.97 14.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.9 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.76 15.17 60.06 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 75.31 112.429 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 mt -81.62 155.71 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 74.01 111.175 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.95 122.1 40.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 75.35 110.893 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.51 81.45 7.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 72.14 111.046 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -56.58 147.71 21.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 70.41 110.889 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.64 166.43 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 71.14 110.799 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.1 p -86.08 157.05 20.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 62.42 111.145 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.41 -43.32 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 75.23 111.054 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.1 -46.04 90.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 70.44 110.986 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.2 m -52.04 -42.58 63.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 72.21 111.166 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.25 -24.79 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 70.43 111.117 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.87 -51.31 69.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 64.04 110.885 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.26 -25.03 54.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.919 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.92 -69.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 74.42 111.155 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -54.72 -26.64 35.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 73.5 110.951 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -24.48 67.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 74.32 110.853 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -92.81 -38.97 11.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 74.53 110.873 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.86 -6.47 3.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 44.42 112.554 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -59.77 -172.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.832 0.348 . . . . 63.33 110.95 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -98.63 -0.68 42.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 63.32 110.885 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 66.28 126.26 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.654 0.74 . . . . 72.21 110.85 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.677 2.251 . . . . 75.52 112.377 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.9 mt -52.21 -40.55 61.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.903 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.1 55.97 18.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.531 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -148.98 52.93 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 71.31 110.912 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.8 mt -135.74 -177.67 4.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.883 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.83 -168.59 2.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.883 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.7 m -50.1 -54.26 21.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.4 111.158 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.8 t -131.34 130.98 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 72.0 111.106 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.1 m -135.6 123.67 22.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 75.11 111.167 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -81.41 103.97 11.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 75.1 110.85 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 mt -91.97 150.43 21.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 73.3 110.902 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 130.42 16.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 74.22 110.898 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -133.42 37.6 3.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 64.1 110.873 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.76 111.67 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 72.33 112.496 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.73 28.29 14.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 74.44 110.858 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 58.5 tpp -152.73 126.02 8.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 75.41 110.838 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -117.17 115.24 24.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.926 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.6 t -123.01 153.55 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 61.31 111.144 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -153.15 122.38 6.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 72.5 110.938 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.24 -178.18 2.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 75.31 111.148 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -175.35 134.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.84 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -121.09 96.06 48.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.702 0.763 . . . . 74.24 110.91 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -48.71 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.619 2.213 . . . . 71.24 112.336 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.61 -153.78 20.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.738 . . . . 63.15 112.451 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.7 124.62 39.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 71.33 110.905 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.466 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.42 -94.19 0.34 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 74.33 112.47 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -70.11 -26.86 64.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 75.44 110.895 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.41 159.62 42.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.468 . . . . 74.32 111.119 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.28 -23.09 66.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.873 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.482 ' HD2' ' H ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -124.02 50.07 1.69 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 75.52 110.868 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.19 139.87 34.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 73.12 110.904 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.6 pt -140.12 172.85 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 71.2 111.149 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.9 m -123.58 139.23 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 63.53 111.183 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.6 t -94.04 128.68 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 73.12 111.139 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -114.84 150.32 35.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.905 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.7 mt -124.77 94.87 43.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.595 0.712 . . . . 73.21 110.926 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 69.65 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.687 2.258 . . . . 74.42 112.317 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.37 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 74.23 110.874 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -117.49 -10.76 10.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 75.52 110.905 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.4 m120 68.18 21.01 8.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 73.35 110.88 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.41 116.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 70.44 111.097 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.98 123.46 45.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 75.43 110.984 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.0 t -117.37 72.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 73.42 111.078 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.17 -51.71 47.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 71.43 112.482 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.94 -138.02 14.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 72.33 112.483 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.91 -25.72 31.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 62.24 110.854 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.08 -49.63 75.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 65.53 110.95 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.56 131.37 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 62.34 111.111 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -101.6 148.64 24.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 75.34 110.887 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.2 t -73.56 158.86 34.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.827 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.74 -24.95 66.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 72.03 111.197 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.8 p -77.9 -26.28 49.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.53 110.872 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.79 173.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 74.25 111.071 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 -39.69 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 72.24 110.901 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.04 178.39 10.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 53.15 110.865 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.07 -41.42 42.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.902 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.31 -158.35 22.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 73.14 112.484 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -52.09 137.13 28.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 75.13 110.93 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.41 38.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 62.32 111.069 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.3 80.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 75.41 111.039 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -114.03 42.23 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 74.3 110.927 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.24 164.65 28.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.43 111.072 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -115.61 92.61 3.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 72.45 110.931 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.07 -23.68 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.1 111.201 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -79.39 -31.52 42.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 73.02 110.886 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.51 -22.7 20.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 71.5 110.911 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -51.49 -53.21 39.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 73.24 110.884 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.6 p -51.88 -37.93 54.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 71.04 110.86 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 91.8 m -70.64 -37.77 73.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 71.24 111.128 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.2 m -63.38 -55.27 25.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 70.51 110.876 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.8 mm -56.54 -37.63 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 73.22 111.112 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.06 -17.49 62.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 75.12 110.842 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -96.55 -28.96 14.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 61.14 110.901 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 96.0 t -82.69 -26.02 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 71.42 111.099 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.3 pp -90.51 -23.27 20.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 64.45 110.909 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -88.51 -47.38 8.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 72.4 110.88 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 32.9 tpt85 -55.31 -32.59 62.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 74.31 110.834 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -130.89 116.91 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 72.3 110.888 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -119.3 34.94 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 75.34 110.897 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.02 22.33 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 70.3 110.859 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -51.51 143.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 75.24 111.146 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -103.0 -39.27 6.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 74.03 110.936 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.71 118.96 5.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 72.42 111.092 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 92.8 t -96.96 123.21 49.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 74.41 111.152 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.403 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 87.5 t -106.49 102.13 39.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 73.44 111.154 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.0 Cg_endo -69.69 -170.05 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.75 2.3 . . . . 50.23 112.347 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.87 -31.27 7.45 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.733 -0.746 . . . . 62.43 112.445 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -144.27 111.9 6.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 65.45 110.873 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 144.91 -94.17 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 74.44 112.447 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -176.06 164.09 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 72.55 110.917 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.59 150.57 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.41 111.07 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.77 -108.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.767 -0.73 . . . . 74.01 112.457 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -160.27 -169.85 2.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.876 0.369 . . . . 73.2 110.887 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -54.25 -24.76 19.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.43 110.87 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -52.16 -35.6 42.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 71.51 112.5 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 32.7 mt -50.96 -45.68 60.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.339 . . . . 73.43 110.918 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.14 -41.3 68.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 75.14 111.01 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.8 mt -69.36 -40.87 77.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.32 110.853 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -60.78 -42.14 96.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.762 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.25 -48.43 65.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 72.24 111.167 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.8 mt -56.28 -41.4 75.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 75.14 110.93 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.91 -42.07 79.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 73.24 110.904 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.5 mt -60.88 -37.4 82.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 75.03 110.894 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.7 mt -72.7 -40.53 66.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 70.31 110.944 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 71.32 110.909 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.773 0.32 . . . . 75.3 110.886 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.29 159.31 42.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 72.23 110.91 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -135.86 155.45 50.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 70.34 110.908 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -172.14 133.94 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.23 111.048 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 59.57 78.57 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 74.15 110.826 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.46 152.92 10.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.447 . . . . 74.33 110.929 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.09 -179.34 6.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 73.24 111.11 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.4 t 60.96 95.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 74.5 111.154 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mm -88.14 152.86 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 74.44 111.191 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -146.12 153.75 41.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 72.05 110.87 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.16 170.82 11.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 64.11 110.903 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -58.7 -27.17 64.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 73.42 110.885 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -100.13 -33.4 10.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 75.12 111.225 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.85 -9.76 51.8 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.737 -0.745 . . . . 50.42 112.446 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -50.94 -33.21 23.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.716 0.293 . . . . 72.51 111.123 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.6 mt -124.81 149.18 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.15 111.084 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -168.34 169.75 10.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 72.31 110.845 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.05 -172.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.503 . . . . 75.02 111.143 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.76 132.86 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 64.32 110.908 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.21 120.72 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.104 -0.498 . . . . 74.5 110.923 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -103.8 -49.28 3.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.932 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.33 51.87 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 69.03 -75.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.936 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -86.88 -19.91 28.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 71.45 110.897 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.6 t -97.45 118.52 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 71.43 111.123 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -122.35 161.56 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.939 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 70.4 t -122.35 106.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 75.14 111.108 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -95.83 137.37 34.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 74.24 110.876 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.3 m -132.46 128.76 38.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 75.25 111.156 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.29 -177.27 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.438 . . . . 73.0 110.865 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.79 133.16 35.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 73.23 110.865 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.83 111.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 75.53 112.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.94 137.93 44.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 71.23 110.868 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -99.81 -22.3 15.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.918 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -172.63 31.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 75.31 110.863 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.91 17.17 10.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.683 -0.77 . . . . 62.32 112.447 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -125.07 -169.5 2.0 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.924 0.392 . . . . 75.44 110.868 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.31 101.77 6.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 62.53 111.108 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.409 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 59.4 t -113.07 103.4 55.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.643 0.735 . . . . 73.24 111.068 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.5 Cg_endo -69.69 141.04 44.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.649 2.233 . . . . 73.23 112.358 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -121.26 132.85 55.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 75.13 110.821 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -90.95 141.93 28.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 73.24 110.804 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.573 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -140.95 -155.87 6.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 53.44 112.53 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -164.93 144.13 6.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 73.53 110.903 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 t -128.08 133.28 67.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 75.33 111.115 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.6 mt -100.64 123.32 44.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.941 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -92.15 46.79 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 74.32 110.886 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.5 p -55.35 171.26 0.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 72.22 111.125 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.3 t -99.24 28.45 4.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.83 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 22.8 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 70.33 110.941 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.8 129.98 4.4 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 65.13 112.503 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.0 mt -57.26 157.81 5.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 74.51 110.957 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.2 t -140.76 143.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 74.13 111.123 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.47 130.07 56.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 72.01 110.934 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -79.77 -1.78 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.096 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.573 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 0.8 OUTLIER 179.78 134.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.88 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -166.7 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 75.32 110.821 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.17 -170.09 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 75.43 110.799 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -72.05 -40.22 68.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.094 -0.503 . . . . 75.23 110.931 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.79 175.54 9.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 62.45 110.958 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -68.9 -30.61 69.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 75.12 110.823 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -74.54 -22.39 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 74.31 110.918 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.27 -52.41 5.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 64.44 110.89 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -57.4 -28.35 63.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 72.44 111.138 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -55.93 -40.82 73.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 73.33 110.874 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.96 -1.36 57.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.414 . . . . 74.53 110.866 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.5 tp -92.88 -45.15 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.902 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.8 mt -72.18 -14.65 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 74.44 111.072 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -87.11 5.9 35.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 71.22 110.848 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.1 mtp -106.54 -53.69 2.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 73.32 110.859 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -58.42 -37.77 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 71.32 111.083 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -85.99 50.03 1.9 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.898 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.23 -42.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 73.51 110.837 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.9 -21.65 13.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.955 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.521 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 35.9 m-85 -91.23 12.94 18.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.883 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.521 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.72 46.91 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 71.13 110.923 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -155.57 -177.81 6.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 72.32 110.87 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.85 159.13 33.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 72.14 110.875 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.9 t -91.46 119.44 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 72.45 111.123 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.0 p -132.18 36.83 3.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.118 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.419 ' HD2' ' HD2' ' A' ' 104' ' ' LYS . 4.6 m-20 -169.76 134.29 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 75.5 110.794 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 t -140.66 100.27 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 74.53 111.09 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.7 mt -77.66 124.04 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 74.1 111.164 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.3 mm -109.24 142.43 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 75.24 111.132 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.8 p -98.69 -60.85 1.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 71.52 111.164 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -130.79 165.07 23.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 75.44 110.865 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.21 97.66 8.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.22 111.059 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.65 157.93 42.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.912 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.93 -29.57 63.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 73.33 111.087 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -89.66 10.7 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.873 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -121.94 -52.09 2.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 72.23 110.915 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.13 26.77 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.157 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.24 -28.19 18.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.707 -0.758 . . . . 62.42 112.479 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.02 30.61 6.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 65.32 112.543 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 tt -48.56 -34.21 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 75.1 111.098 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -34.51 33.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 75.53 110.853 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.9 m -62.44 -34.18 76.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 74.22 111.063 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.6 mt -65.4 -43.24 91.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 71.01 110.878 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -26.26 59.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.866 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.25 -29.82 70.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 72.23 110.896 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -105.58 -48.29 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.35 110.858 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.62 -15.75 1.08 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.72 -0.753 . . . . 72.02 112.499 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.56 151.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.13 111.123 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HD2' ' HD2' ' A' ' 81' ' ' ASP . 1.6 ptpm? -113.66 127.84 56.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.923 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.12 82.03 6.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 72.41 111.043 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -57.72 147.11 28.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.45 110.871 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.63 160.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 73.03 110.89 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.2 p -74.03 -175.61 2.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 72.24 111.111 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.12 -30.92 43.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 64.31 111.143 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.73 -44.68 40.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.958 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.7 m -55.41 -25.38 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 74.23 111.168 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.31 -34.34 14.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 74.43 111.159 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -53.69 -32.8 53.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 63.3 110.89 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.79 -25.84 18.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 71.13 110.838 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.65 -62.72 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.32 111.096 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -60.12 -26.09 65.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 72.11 110.898 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -25.18 68.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.893 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -92.16 -33.38 14.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.868 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.1 -10.78 4.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 74.33 112.494 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -59.59 -173.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.83 0.347 . . . . 72.41 110.871 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -98.71 0.32 44.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 54.44 110.886 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 66.42 132.59 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.656 0.741 . . . . 74.21 110.928 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.63 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.653 2.235 . . . . 70.1 112.4 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.2 mt -54.83 -51.11 66.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 73.11 110.959 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.4 51.72 8.2 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.75 -0.738 . . . . 62.12 112.471 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.46 55.42 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 64.32 110.833 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.61 -174.66 3.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.89 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.84 -168.16 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 98.1 m -49.66 -43.01 46.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 75.25 111.221 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.38 142.15 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 75.5 111.061 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.6 m -149.83 108.87 3.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.095 -0.502 . . . . 73.33 111.084 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -69.75 96.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 73.12 110.858 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.3 mt -86.82 150.64 23.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 75.44 110.94 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 130.21 12.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 63.13 110.928 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -132.54 99.42 4.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 74.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 58.69 -97.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 74.44 112.514 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -115.12 57.81 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 52.41 110.877 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.2 tpt -153.72 142.68 21.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.832 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -120.51 127.72 52.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.848 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 t -141.51 158.96 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 73.31 111.145 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -159.01 124.58 4.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.23 110.891 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -178.27 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 72.33 111.13 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -175.36 140.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 71.5 110.895 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -123.24 97.66 42.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.598 0.713 . . . . 74.02 110.927 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -48.98 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.699 2.266 . . . . 64.25 112.371 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.59 -153.95 22.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.786 -0.721 . . . . 55.22 112.467 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.51 122.44 39.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 74.23 110.934 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.489 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.04 -97.76 0.56 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 52.21 112.481 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -67.65 -28.41 67.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.818 0.342 . . . . 64.24 110.862 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.69 156.44 41.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 73.12 111.114 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -59.91 -29.26 68.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 72.01 110.844 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.9 52.12 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.89 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.4 p30 -100.72 135.0 42.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 75.43 110.884 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.1 pt -136.45 166.98 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 75.21 111.114 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.83 157.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 75.21 111.107 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.3 t -110.36 143.29 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.136 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -130.87 148.15 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 75.31 110.902 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 24.1 mt -125.53 95.37 40.8 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.57 0.7 . . . . 74.22 110.888 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 72.21 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.729 2.286 . . . . 64.34 112.317 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.08 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 70.33 110.934 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.89 -11.74 10.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.891 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 68.36 24.12 7.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 63.13 110.976 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.24 117.24 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 70.44 111.172 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.23 142.65 33.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 75.53 110.952 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.9 67.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 75.0 111.127 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.62 -55.19 21.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.67 -0.776 . . . . 71.25 112.544 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.14 -137.12 13.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.668 -0.777 . . . . 34.01 112.468 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 59.3 m -64.24 -15.8 60.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 73.03 110.934 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.5 tp -70.11 -47.59 61.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.914 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.91 115.92 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 75.53 111.148 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 155.76 23.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 75.31 110.892 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.5 t -84.0 162.29 20.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 73.14 110.843 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.1 p -59.15 -31.41 68.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 73.3 111.161 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.38 -28.57 64.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.143 -0.481 . . . . 71.12 110.832 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.4 162.4 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 53.01 111.084 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -122.32 -37.02 2.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.884 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -154.91 171.92 18.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 74.21 110.918 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.66 -43.38 63.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.958 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 99.29 -154.47 19.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.686 -0.769 . . . . 73.42 112.523 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -52.03 126.85 19.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 72.15 110.906 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 6.7 m -117.7 31.68 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 63.14 111.115 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.27 -47.05 82.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 70.25 111.155 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -117.42 42.99 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.844 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -133.62 162.17 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 73.23 111.138 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -115.72 93.49 4.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.022 0.439 . . . . 75.45 110.902 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.36 -20.91 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 75.24 111.06 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -81.98 -26.84 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 70.34 110.943 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.54 -21.37 16.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.53 110.841 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.41 -56.18 14.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.9 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.3 p -51.96 -37.77 54.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.837 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.1 m -72.56 -37.84 68.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 72.15 111.127 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 75.7 m -61.92 -54.92 35.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.04 110.83 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.7 mm -55.83 -36.75 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 75.35 111.087 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.88 -17.31 64.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.3 110.828 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -93.93 -31.03 14.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 70.5 110.871 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 87.3 t -77.26 -45.9 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 73.32 111.137 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.6 pp -69.77 -23.2 63.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.467 . . . . 72.24 110.878 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -86.23 -44.33 12.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.866 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -53.29 -28.5 28.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 74.14 110.874 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -142.52 121.24 12.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 72.01 110.96 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.42 35.69 4.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 75.23 110.879 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.25 21.8 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.914 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.6 mp -53.24 145.08 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.42 111.164 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -105.88 -33.76 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.91 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -155.92 128.37 7.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 70.11 111.111 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.85 117.42 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 74.25 111.126 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.414 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 75.3 t -100.04 104.3 28.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.594 0.711 . . . . 72.02 111.097 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.75 -173.7 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.707 2.271 . . . . 72.4 112.32 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.42 -28.85 10.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.737 . . . . 71.12 112.503 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -144.09 110.52 5.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 74.45 110.824 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 144.92 -98.41 0.2 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 73.53 112.508 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -174.62 154.75 2.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 72.12 110.928 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.9 t -57.32 149.59 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 70.13 111.157 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -148.72 -108.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.697 -0.763 . . . . 73.03 112.515 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -161.34 -169.85 2.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.893 0.378 . . . . 72.12 110.92 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -58.18 -20.56 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 65.34 110.949 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.63 -33.98 63.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.76 -0.734 . . . . 72.01 112.461 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 28.0 mt -50.59 -42.66 56.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.834 0.35 . . . . 74.42 110.896 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.43 -43.36 75.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.919 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.9 mt -68.54 -40.41 80.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 72.11 110.9 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -60.72 -38.91 86.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.52 110.879 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.78 -45.07 63.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 73.4 111.081 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.4 -42.57 92.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 74.31 110.888 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -29.21 56.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.852 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.9 mt -75.21 -26.89 59.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 73.24 110.88 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.4 mt -86.09 -30.21 22.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.958 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 74.23 110.907 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.894 0.378 . . . . 73.51 110.899 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -134.96 133.85 39.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.057 -0.52 . . . . 73.34 110.859 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -133.44 162.45 31.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 74.43 110.924 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.5 m -149.81 164.38 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 72.5 111.207 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -99.89 43.78 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 74.42 110.865 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -108.05 150.85 26.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 71.34 110.941 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.74 -179.99 7.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 74.41 111.15 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.4 t 61.29 100.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 74.43 111.154 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mm -93.76 156.88 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.05 111.155 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.42 170.08 19.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 75.12 110.933 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -99.89 -169.29 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 75.11 110.983 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.28 -20.96 58.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.44 110.877 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.3 p -107.66 -39.53 5.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 74.45 111.148 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.02 -2.65 30.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 54.11 112.473 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -50.57 -33.28 21.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 75.21 111.181 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.1 mt -129.25 158.96 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.12 111.093 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.9 p -175.8 164.23 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 64.02 110.823 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.88 -175.41 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.515 . . . . 74.45 111.163 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 t -167.54 131.07 1.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 54.12 110.845 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.12 118.48 11.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 73.12 110.922 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.57 -45.88 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.861 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -141.58 -169.63 2.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.3 110.916 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -51.07 -49.66 60.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.875 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -133.38 39.14 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 74.13 110.871 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.39 121.63 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 73.21 111.159 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -126.38 159.61 32.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 64.25 110.965 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.2 t -122.43 106.69 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 73.43 111.124 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.648 ' CE1' ' HE2' ' A' ' 30' ' ' GLU . 8.4 p80 -98.37 138.13 36.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 72.52 110.851 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 m -136.59 134.21 37.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 73.51 111.127 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.648 ' HE2' ' CE1' ' A' ' 28' ' ' HIS . 2.5 pm0 -125.93 175.74 7.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 64.21 110.907 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 tp -119.76 150.05 41.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.13 110.975 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.72 -135.78 3.44 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.775 -0.726 . . . . 75.52 112.526 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.01 159.46 34.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.89 0.376 . . . . 64.0 110.825 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -177.91 91.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.93 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.94 61.7 2.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 63.11 110.822 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.03 30.71 60.8 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.744 -0.741 . . . . 61.13 112.437 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -149.28 128.68 12.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.865 0.364 . . . . 71.24 110.889 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.06 129.79 40.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 74.42 111.054 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -119.51 124.33 28.13 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.622 0.725 . . . . 74.41 111.151 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 151.97 69.34 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.693 2.262 . . . . 73.21 112.328 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 t -138.21 92.29 2.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 55.43 110.87 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -52.77 171.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 75.32 110.941 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.475 ' HA3' ' HD2' ' A' ' 56' ' ' ASP . . . -169.93 -156.43 11.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.729 -0.748 . . . . 74.11 112.5 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.68 144.39 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 75.13 110.934 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.94 138.51 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 73.32 111.144 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.8 mt -106.03 130.69 53.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.86 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.99 56.94 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 75.0 110.921 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 p -67.23 177.38 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 75.44 111.217 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.51 20.23 15.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 72.13 110.818 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.91 24.37 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 75.34 110.858 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.11 134.92 6.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 73.0 112.487 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 mt -60.93 157.54 15.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 73.1 110.908 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.5 t -136.94 142.8 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.11 111.121 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.86 128.85 56.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.14 110.92 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.95 -1.76 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 72.44 111.154 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 2.6 p-10 179.93 127.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.41 110.872 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -66.57 -166.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.827 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -95.06 -171.38 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 70.32 110.842 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -72.61 -37.34 68.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.01 110.927 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -145.77 157.61 43.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 73.44 110.829 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -54.25 -34.61 61.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 64.25 110.869 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -74.91 -25.55 59.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 73.3 110.957 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.49 -44.76 16.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.908 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 t -60.26 -26.16 66.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 72.43 111.175 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -54.36 -42.4 70.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 64.42 110.82 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.33 -10.51 59.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 75.42 110.883 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.2 tp -89.69 -52.38 5.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 74.22 110.909 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.1 mt -65.83 -15.3 18.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 73.44 111.117 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -87.3 7.09 30.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 63.32 110.866 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.1 mtp -103.26 -57.35 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 71.21 110.865 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.1 m -58.0 -39.22 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 71.5 111.117 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -84.07 50.79 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 72.35 110.846 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 -39.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 54.52 110.867 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 -21.62 12.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.897 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.525 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 29.0 m-85 -90.15 12.08 18.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.863 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.525 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.79 46.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 74.23 110.924 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.6 mttp -151.6 -177.04 5.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.252 -0.431 . . . . 74.24 110.977 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.41 158.4 38.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 70.45 110.863 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.1 t -89.53 117.13 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.42 111.096 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.9 p -133.03 38.19 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.4 111.247 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -168.83 134.97 1.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 63.11 110.838 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.1 t -143.01 102.19 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.43 111.162 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.8 mt -81.41 115.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.4 111.07 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.1 mm -101.33 129.86 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.11 111.097 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -87.68 -56.03 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.14 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -133.06 166.4 22.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 73.04 110.862 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.05 98.38 10.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.411 . . . . 54.13 111.149 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.23 159.65 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.9 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.09 -28.73 62.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 73.12 111.097 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.35 12.01 19.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 73.32 110.792 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -124.0 -52.26 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 74.1 110.866 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.32 17.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.45 111.157 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.9 -28.12 23.27 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.753 -0.736 . . . . 74.23 112.499 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.0 20.75 26.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 74.51 112.543 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -48.35 -31.03 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 74.24 111.134 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -69.49 -44.53 70.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 74.22 110.925 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 m -66.67 -34.36 77.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 74.4 111.14 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.1 mt -64.37 -26.87 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 75.12 110.912 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -99.77 21.01 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.914 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.07 -30.41 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 75.15 110.872 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -104.38 12.42 33.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 75.32 110.881 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.38 25.07 61.93 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.822 -0.704 . . . . 63.23 112.509 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.4 mt -88.11 157.07 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 75.52 111.163 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.32 118.79 31.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.918 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.17 78.31 6.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 75.21 111.009 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -54.77 147.92 13.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.41 110.898 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.93 163.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 65.22 110.891 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.7 p -85.13 158.17 20.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 55.51 111.182 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.7 61.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 72.54 111.103 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -46.89 86.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 75.05 110.873 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 100.0 m -52.43 -41.98 63.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 73.34 111.168 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.49 -23.38 61.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 73.4 111.137 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.87 -43.08 85.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 7.3 mp -81.1 -28.03 35.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.936 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.67 -70.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 75.44 111.03 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -26.0 36.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 74.14 110.962 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -23.65 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 75.23 110.869 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -96.07 -38.71 10.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 74.45 110.898 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.87 -6.39 3.76 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.698 -0.763 . . . . 71.22 112.483 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.62 -172.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 72.53 110.931 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -97.8 -1.57 42.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 74.24 110.842 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 66.31 129.13 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.657 0.741 . . . . 74.54 110.84 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.648 2.232 . . . . 73.23 112.341 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.6 mt -54.08 -35.96 62.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 74.52 110.955 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.12 49.04 51.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 70.21 112.457 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -142.8 56.28 1.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 71.5 110.857 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.79 -169.8 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 75.11 110.91 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -148.84 -168.79 3.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 73.4 110.879 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 99.3 m -50.27 -56.99 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 72.32 111.156 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 88.4 t -130.29 128.5 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 75.41 111.114 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.6 m -135.81 124.31 23.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 65.22 111.154 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -80.33 103.0 9.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.912 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.01 150.38 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 73.43 110.926 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.48 122.64 9.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.893 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -123.37 42.82 3.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 70.35 110.955 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.53 113.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 72.33 112.503 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.0 m120 62.45 27.17 16.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 74.31 110.85 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 32.0 tpp -149.76 139.66 21.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.88 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.14 120.99 28.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 62.41 110.868 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.3 t -131.57 155.67 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.22 111.145 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -153.09 125.06 7.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.872 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -177.95 3.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 64.32 111.18 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -175.18 137.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 75.43 110.887 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -122.61 94.86 47.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.692 0.758 . . . . 74.22 110.974 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -48.74 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 73.03 112.292 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.45 -152.24 15.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 54.41 112.437 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.62 125.81 45.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.346 . . . . 75.35 110.903 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.483 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -136.5 -87.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.71 . . . . 64.41 112.495 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -76.33 -29.18 57.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 70.24 110.91 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.68 156.11 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.24 111.19 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.81 -24.88 62.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 74.12 110.789 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.501 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 14.4 p30 -119.98 47.36 1.76 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 73.35 110.827 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -97.27 134.55 40.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 62.41 110.848 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.6 pt -136.07 169.87 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 72.32 111.089 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.9 m -120.98 145.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 74.43 111.077 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.1 t -98.29 143.58 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 73.21 111.12 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -129.85 149.74 51.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 74.44 110.914 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.5 mt -126.96 95.71 36.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.604 0.716 . . . . 64.51 110.936 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 71.91 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.679 2.253 . . . . 74.14 112.35 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 75.22 110.928 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -118.03 -13.18 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 75.13 110.908 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.6 m120 69.4 23.26 6.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 75.35 110.922 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.51 114.38 30.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 70.41 111.113 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.14 136.61 39.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 75.35 110.898 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 31.7 t -122.11 67.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 73.01 111.16 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.34 -55.62 18.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.74 -0.743 . . . . 72.55 112.559 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.18 -122.83 6.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.746 -0.74 . . . . 72.4 112.467 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.7 m -80.82 -0.8 40.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 70.31 110.909 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.31 -49.1 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 74.44 110.981 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.32 105.77 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 74.43 111.125 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.02 164.45 26.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.918 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 p -88.65 158.65 18.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.798 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.7 p -58.88 -27.21 64.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 74.53 111.14 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.9 t -74.09 -29.0 61.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.421 . . . . 72.23 110.873 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.62 158.49 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 54.24 111.09 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.65 -27.39 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 70.51 110.918 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -164.57 -180.0 6.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.822 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.61 -37.51 24.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 73.51 110.877 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.49 -157.53 22.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.793 -0.718 . . . . 72.21 112.453 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -52.24 129.67 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 74.53 110.898 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.0 m -122.59 39.7 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 64.22 111.082 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.63 91.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 75.32 111.07 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.88 44.66 1.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.14 110.937 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -134.93 174.16 10.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 72.15 111.067 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -127.24 87.46 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 64.03 110.985 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.39 -22.22 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 71.14 111.181 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.7 -32.96 58.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 74.21 110.922 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -93.53 -22.8 18.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 73.35 110.877 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.48 -55.88 16.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 72.01 110.83 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.3 p -51.94 -37.05 51.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 75.35 110.88 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m -74.18 -35.62 63.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 72.01 111.111 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 32.9 m -63.19 -52.38 62.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 74.53 110.838 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 27.7 mm -58.02 -39.15 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 74.22 111.092 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.22 -17.07 57.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 75.15 110.929 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -99.76 -23.83 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 73.52 110.843 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.34 -18.43 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 71.33 111.119 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.4 pp -105.52 1.27 27.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 75.54 110.939 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -117.81 -24.01 7.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 74.3 110.901 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -82.67 1.15 39.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 72.43 110.829 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -136.28 -72.3 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.215 -0.448 . . . . 75.23 110.972 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.78 21.97 9.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.14 110.866 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -144.51 21.95 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.4 110.889 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.27 145.86 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.52 111.184 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -102.56 -28.2 12.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 72.14 110.876 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -163.95 128.98 2.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 64.54 111.106 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 95.2 t -107.1 126.3 63.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 75.33 111.131 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 50.4 t -109.91 106.12 57.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.646 0.736 . . . . 75.0 111.102 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.75 -169.27 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.735 2.29 . . . . 64.41 112.304 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -111.14 -21.7 6.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 71.13 112.406 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -145.69 74.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 75.54 110.905 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.1 -101.75 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 73.52 112.5 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -171.66 140.26 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 74.43 110.83 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.45 143.78 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 74.13 111.142 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.6 -106.19 0.49 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.75 . . . . 71.03 112.489 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -156.22 -169.92 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.349 . . . . 63.13 110.9 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -56.36 -22.37 30.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.866 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.24 -32.8 51.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 75.33 112.484 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 31.3 mt -50.79 -41.55 57.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 71.11 110.98 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.02 -44.77 79.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 75.11 110.962 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.1 mt -67.82 -40.48 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 72.23 110.956 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -58.66 -43.76 89.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.831 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -48.36 63.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.22 111.16 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.1 mt -54.77 -41.28 70.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.925 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -32.73 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 64.11 110.863 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.21 -25.77 61.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 72.54 110.953 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.8 mt -87.37 -38.07 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.936 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 75.1 110.909 179.795 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.894 0.378 . . . . 55.44 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.94 178.76 4.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 74.41 110.837 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.77 137.74 51.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 75.21 110.89 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 p -173.21 142.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 64.33 111.14 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.24 91.14 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.888 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -132.25 151.83 51.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 74.22 110.878 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -144.24 -179.06 6.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 74.35 111.144 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.0 t 61.29 101.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 74.25 111.147 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mm -94.64 153.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 71.41 111.167 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -148.84 156.29 42.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 74.0 110.846 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.45 -169.58 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.87 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 -23.49 52.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.874 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.9 p -101.79 -35.13 9.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.042 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.62 -5.13 51.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 64.43 112.478 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -50.49 -33.28 20.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 74.34 111.214 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 mt -128.55 159.92 39.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 75.3 111.052 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -175.52 169.33 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.24 110.929 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.63 -174.13 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.41 111.137 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.38 131.7 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 65.04 110.894 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.52 119.09 14.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 70.02 110.916 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mp -107.94 -33.9 7.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 72.41 110.918 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.22 -178.1 6.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 72.3 110.813 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -51.06 -41.01 59.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 70.14 110.861 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -139.93 38.6 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 73.11 110.882 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.0 t -137.88 116.05 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 75.43 111.135 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -123.98 155.59 37.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 74.13 110.89 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.6 t -117.29 108.6 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 74.23 111.115 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -101.57 138.39 38.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 73.32 110.861 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.3 m -135.2 140.66 45.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 74.23 111.217 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.27 174.17 10.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 74.5 110.897 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 tp -119.48 148.53 43.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.34 110.896 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.2 -120.01 1.98 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 73.14 112.477 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.53 148.97 35.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 64.13 110.876 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -170.26 109.05 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.881 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 51.48 53.16 13.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 75.04 110.876 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.23 25.83 67.01 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.776 -0.726 . . . . 74.14 112.477 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -151.73 120.69 6.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 70.41 110.886 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.49 138.54 21.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 62.33 111.142 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -123.6 129.95 24.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.584 0.707 . . . . 74.51 111.153 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 146.97 61.51 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.712 2.275 . . . . 74.14 112.317 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -134.55 98.19 4.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 53.25 110.904 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -51.99 168.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 61.54 110.887 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.59 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -167.68 -163.36 21.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 70.11 112.483 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -164.22 145.98 8.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.857 0.36 . . . . 74.34 110.917 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.05 140.77 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 74.02 111.14 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 39.2 mt -108.0 128.17 54.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 73.33 110.909 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -97.26 55.25 1.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.908 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 p -60.36 -170.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 73.35 111.1 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.6 6.49 16.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 72.11 110.848 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -118.32 -18.75 9.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 70.44 110.925 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.76 130.54 1.31 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.823 -0.703 . . . . 41.14 112.543 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.1 mt -49.37 153.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.923 0.392 . . . . 73.35 110.877 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.96 143.23 35.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.158 -0.474 . . . . 73.15 111.11 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.88 128.44 56.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.2 110.816 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.6 t -78.45 -2.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 71.33 111.147 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.59 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 3.7 p-10 -179.47 131.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 54.25 110.89 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.55 -167.31 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.906 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -173.14 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 63.41 110.889 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -71.0 -38.51 72.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 75.41 110.93 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -141.72 161.64 37.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.802 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.606 ' HD2' ' HZ2' ' A' ' 62' ' ' LYS . 7.6 p-10 -58.51 -33.02 69.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.34 110.92 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.606 ' HZ2' ' HD2' ' A' ' 61' ' ' ASP . 1.1 mttp -75.3 -25.58 58.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.869 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.7 -43.65 18.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 73.31 110.879 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.8 t -65.48 -23.35 66.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.174 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -53.81 -43.26 69.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 75.42 110.887 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.72 -15.73 55.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 74.41 110.941 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.6 tp -77.8 -50.17 12.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.491 . . . . 73.44 110.894 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.0 mt -71.93 -15.39 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 55.24 111.111 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -88.71 10.35 21.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.895 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.8 mmm -109.88 -55.56 2.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 74.24 110.913 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 m -57.55 -37.19 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 74.31 111.141 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.44 50.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.913 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.57 -39.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 74.52 110.865 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -21.25 12.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.863 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.53 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 29.0 m-85 -90.62 12.67 18.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 74.41 110.89 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.53 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 2.1 pp0? 31.5 49.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.52 110.949 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.0 -176.54 5.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 75.03 110.962 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.98 152.26 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 73.44 110.863 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 82.7 t -85.29 125.56 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 74.21 111.192 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.3 p -136.0 16.62 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 71.21 111.127 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -150.02 134.92 17.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 74.51 110.898 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.6 t -139.3 99.01 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 74.35 111.034 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.8 mt -76.29 126.54 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 74.24 111.203 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.8 mm -113.55 133.34 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 74.12 111.131 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -90.11 -54.89 3.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 73.21 111.134 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -134.38 165.78 24.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.45 110.848 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.561 ' H ' ' HD2' ' A' ' 152' ' ' ASP . . . -84.79 98.32 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 71.31 111.133 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.75 159.44 43.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 71.12 110.848 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.23 -28.71 63.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 74.33 111.058 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.98 10.72 22.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 70.31 110.855 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -122.67 -52.03 1.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 74.31 110.908 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.39 17.45 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 63.11 111.11 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.96 -26.53 27.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.701 -0.761 . . . . 63.23 112.442 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.93 18.46 31.42 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.77 -0.729 . . . . 63.52 112.5 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.2 tt -48.93 -30.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.834 0.35 . . . . 72.2 111.077 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -67.96 -43.65 78.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 72.42 110.931 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.4 m -69.78 -34.09 73.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 74.52 111.072 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.8 mt -63.47 -28.2 69.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.895 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.95 19.49 14.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.922 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -117.33 -21.9 8.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 71.2 110.896 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -113.08 8.8 18.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.33 110.88 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.2 16.92 65.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 74.34 112.481 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.9 mt -82.43 156.96 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 75.35 111.159 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -120.65 122.86 41.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.891 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.58 78.42 6.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 71.11 111.061 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -51.71 146.21 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 52.21 110.866 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.49 163.71 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 72.43 110.814 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -80.19 156.32 26.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 72.21 111.122 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.83 -27.03 27.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 73.42 111.091 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 tp -74.95 -45.89 39.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 74.01 110.954 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.8 m -52.96 -28.1 22.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 60.13 111.142 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.08 -29.76 26.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 73.34 111.015 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -58.89 -31.12 68.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.409 . . . . 75.32 110.913 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.55 -25.47 17.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.129 -0.487 . . . . 73.21 110.837 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.71 -65.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.42 111.135 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -56.59 -25.02 51.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 73.53 110.877 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -24.52 65.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 74.33 110.882 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -96.03 -28.22 14.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.881 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.23 -5.53 7.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 71.23 112.507 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -59.58 -173.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.826 0.346 . . . . 74.2 110.969 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -99.75 1.17 43.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 71.31 110.888 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 65.87 122.65 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 75.35 110.857 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -170.65 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.707 2.271 . . . . 62.45 112.39 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 mt -51.76 -39.25 58.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.922 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.0 37.3 44.79 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 64.45 112.45 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -132.89 48.44 2.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 64.51 110.836 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.52 -169.64 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.299 -0.409 . . . . 74.32 110.884 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -149.99 -169.05 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 73.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.6 m -50.63 -63.95 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 74.31 111.143 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.1 t -124.26 112.03 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 75.33 111.108 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.0 m -121.35 111.34 17.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.05 111.111 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -67.25 90.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 74.02 110.884 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.78 159.39 23.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 64.25 110.884 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 117.46 4.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.84 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -109.17 49.57 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 75.2 110.889 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.64 -108.08 3.54 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 61.24 112.466 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -93.69 47.22 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 64.23 110.907 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 6.2 tpp -149.19 154.09 38.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 71.53 110.977 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.72 116.25 18.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.302 -0.408 . . . . 74.43 110.946 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.63 151.55 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 70.35 111.204 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -148.81 117.45 6.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 63.43 110.839 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -178.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 72.22 111.132 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -175.29 136.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.2 110.857 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -118.24 92.66 43.39 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.715 0.769 . . . . 75.33 110.905 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -48.56 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.717 2.278 . . . . 73.2 112.407 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.04 -177.67 43.27 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 73.52 112.452 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -76.78 125.57 29.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.799 0.333 . . . . 74.52 110.926 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.47 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -136.28 -91.06 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 74.21 112.502 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -73.64 -30.73 63.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.367 . . . . 72.21 110.862 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.79 158.6 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 73.42 111.144 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -61.06 -27.66 68.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 72.14 110.893 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.561 ' HD2' ' H ' ' A' ' 87' ' ' ALA . 11.7 p30 -119.6 50.07 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 75.41 110.851 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.47 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.8 OUTLIER -98.07 137.62 36.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 73.41 110.88 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.01 168.82 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 65.24 111.096 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 m -119.3 144.71 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 72.15 111.156 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.17 144.08 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 70.03 111.138 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -130.09 147.66 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.951 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 16.9 mt -124.78 96.62 40.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.616 0.722 . . . . 74.32 110.946 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 72.5 1.43 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.78 2.32 . . . . 73.42 112.273 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.12 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 74.13 110.943 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -117.75 -13.91 10.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.952 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.5 m120 68.99 26.13 5.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.094 -0.503 . . . . 64.13 110.904 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.87 114.14 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 75.2 111.138 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.93 136.96 37.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.854 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.5 t -119.42 64.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 73.34 111.182 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.94 -54.5 25.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 73.31 112.477 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.26 -135.51 12.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.748 . . . . 74.22 112.467 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.5 m -60.89 -19.29 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 52.12 110.876 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -50.57 61.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.901 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.05 130.02 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 74.13 111.193 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.64 149.5 24.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 74.2 110.939 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 12.6 p -75.03 162.5 28.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 74.5 110.879 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.3 p -69.05 -25.66 64.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 71.54 111.15 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.15 -26.25 60.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 63.52 110.835 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.84 177.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 73.21 111.066 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 -39.93 1.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 71.2 110.916 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -153.64 -177.41 6.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.453 . . . . 62.13 110.862 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.05 -39.15 23.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 72.41 110.901 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.42 -155.39 21.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.716 -0.754 . . . . 73.2 112.455 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.77 118.22 3.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 74.22 110.874 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.15 30.76 2.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 74.53 111.087 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.61 -36.24 82.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 75.33 111.125 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -116.18 37.73 3.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.877 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.64 166.78 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 74.02 111.071 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -113.54 92.66 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 72.03 110.888 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.63 -23.21 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 72.25 111.155 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -25.3 38.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 62.23 110.886 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.34 -24.21 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.841 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -51.5 -53.9 32.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.463 . . . . 74.2 110.877 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 99.2 p -52.32 -35.44 50.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 72.54 110.856 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.2 m -73.58 -36.68 65.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 63.12 111.169 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.1 m -64.5 -54.12 37.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.812 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.6 mm -57.2 -41.26 77.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 75.02 111.126 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -60.85 -19.54 60.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 75.01 110.912 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -93.03 -29.61 15.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 61.42 110.914 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 59.4 t -81.42 -23.73 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 71.52 111.115 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.6 pp -97.25 -1.16 45.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 75.24 110.97 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -121.2 -6.67 9.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 74.41 110.879 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -89.77 -24.25 21.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 74.11 110.897 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -118.3 -67.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 71.21 110.925 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 63.41 27.46 15.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 72.44 110.873 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -151.47 23.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.836 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.4 mp -62.95 145.42 13.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 74.32 111.168 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -104.0 -26.45 12.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.31 110.902 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -161.24 128.73 4.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 71.21 111.1 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 71.9 t -108.86 124.51 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 71.31 111.058 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 48.6 t -108.99 104.38 54.77 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 121.558 0.694 . . . . 71.41 111.114 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.4 Cg_endo -69.76 -170.6 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.705 2.27 . . . . 65.43 112.369 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -103.27 -26.07 7.12 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.721 -0.752 . . . . 61.23 112.474 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -144.0 86.37 1.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 74.22 110.846 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 167.88 -102.76 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 72.11 112.457 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -169.62 158.94 7.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.885 0.374 . . . . 70.14 110.921 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 41.4 t -66.82 147.85 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 63.53 111.04 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -152.34 -107.12 0.32 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.774 -0.727 . . . . 71.32 112.526 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -159.13 -169.93 2.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 75.42 110.835 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -56.67 -21.79 30.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 73.44 110.892 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.98 -33.8 57.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.776 -0.726 . . . . 65.14 112.44 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 32.1 mt -50.79 -46.84 59.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.858 0.361 . . . . 73.15 110.912 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.12 -42.76 69.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 64.42 110.927 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.6 mt -67.07 -41.31 86.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 75.14 110.907 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.18 -36.54 82.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 75.3 110.849 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -45.64 83.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 64.03 111.07 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.5 mt -56.6 -40.21 74.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 73.03 110.994 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -41.05 77.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.55 110.825 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.09 -25.99 68.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 73.34 110.935 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.1 mt -85.52 -43.08 13.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 73.4 110.913 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.85 179.867 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.831 0.348 . . . . 70.1 110.847 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -130.94 178.61 6.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.94 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -117.95 161.3 20.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.862 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.8 139.31 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 75.25 111.18 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -98.39 79.4 2.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 64.52 110.908 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -137.83 151.96 48.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 75.12 110.875 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.17 -179.17 6.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 72.43 111.135 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.6 t 61.21 98.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 72.14 111.132 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mm -91.23 153.97 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 64.21 111.105 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -145.81 146.09 31.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.893 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.4 164.33 21.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 71.45 110.894 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -51.94 -36.98 51.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.87 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.48 -27.87 22.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 55.52 111.091 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.05 -12.84 68.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.784 -0.722 . . . . 72.44 112.575 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.0 t -51.09 -32.6 22.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 75.24 111.191 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.7 mt -121.42 147.86 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 75.42 111.094 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.7 p -166.19 169.61 14.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 73.12 110.873 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -136.52 -176.49 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 71.21 111.114 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 t -166.09 135.33 3.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 70.2 110.867 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.48 117.79 13.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 73.03 110.858 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.02 -45.59 5.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 72.22 110.942 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -142.27 -169.43 2.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.833 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -50.65 -51.08 52.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.855 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -132.34 37.99 3.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 75.14 110.816 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 t -133.91 122.06 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.31 111.19 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.76 159.06 35.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.866 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.5 t -119.42 107.9 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 64.34 111.173 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.512 ' HE1' ' HE2' ' A' ' 30' ' ' GLU . 4.0 p80 -102.32 142.02 34.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 75.23 110.828 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 m -140.06 130.73 25.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 74.14 111.159 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.512 ' HE2' ' HE1' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -121.93 171.36 8.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.862 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.2 tp -117.17 147.27 42.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.894 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -133.02 -123.18 2.39 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.688 -0.768 . . . . 71.31 112.432 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.02 152.4 43.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.9 0.381 . . . . 53.13 110.853 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -172.06 104.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 73.12 110.91 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 t30 51.35 57.05 7.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 74.13 110.929 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.06 27.0 64.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.692 -0.766 . . . . 73.24 112.462 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -151.63 119.77 6.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 61.13 110.88 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.31 138.07 40.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 72.24 111.062 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -123.52 126.55 25.79 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.595 0.712 . . . . 72.44 111.113 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 148.41 64.89 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.691 2.261 . . . . 44.54 112.381 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -134.44 100.0 4.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 75.13 110.855 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 212' ' ' GLU . 24.0 m-20 -51.86 169.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 75.43 110.899 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.689 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -172.8 -173.19 39.12 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.705 -0.76 . . . . 74.25 112.449 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 tp -156.92 140.81 16.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.905 0.383 . . . . 74.25 110.907 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.51 132.01 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 74.33 111.178 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 41.5 mt -97.15 128.89 44.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 75.04 110.964 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.73 57.65 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 73.45 110.95 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 p -67.19 165.62 15.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 71.25 111.097 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.89 25.81 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.864 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -147.25 28.61 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 74.42 110.881 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.33 123.25 4.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 73.14 112.472 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.1 mt -51.28 159.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 74.33 110.903 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -140.18 140.03 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.132 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.07 129.86 56.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 74.01 110.964 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 t -81.18 0.13 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.13 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.689 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 1.4 p30 -177.68 129.69 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.837 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -166.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.905 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.71 -169.9 2.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.247 -0.433 . . . . 73.03 110.884 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -74.81 -36.48 62.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 73.42 110.955 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -144.62 164.3 31.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 53.43 110.873 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.13 -34.57 72.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 71.11 110.888 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -74.88 -24.25 58.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 63.35 110.889 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.41 -41.14 18.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 75.05 110.927 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.3 t -70.13 -26.45 63.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 70.04 111.103 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -54.13 -42.64 69.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 74.55 110.891 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -83.49 -14.2 52.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 72.54 110.86 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.8 tp -77.03 -46.13 24.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 73.45 110.924 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.3 -31.93 40.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 74.04 111.135 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.78 -25.55 68.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 70.21 110.965 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.4 mmm -76.37 -58.84 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 75.02 110.873 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.9 m -56.23 -33.35 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 73.11 111.074 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -88.56 48.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 74.45 110.885 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -144.36 -41.82 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 72.2 110.895 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.64 -25.65 13.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 72.03 110.875 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.509 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 36.5 m-85 -88.94 9.22 25.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 74.53 110.851 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.509 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.86 46.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 75.0 110.896 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -147.15 -176.71 5.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 70.23 110.937 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.64 130.88 37.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 70.33 110.896 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.4 t -66.46 129.33 30.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 64.04 111.093 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.5 p -138.07 19.74 2.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 75.24 111.141 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -154.18 129.35 9.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 64.14 110.829 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.9 t -133.84 98.15 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 64.53 111.169 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -74.64 124.9 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 71.03 111.198 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.7 mm -111.07 127.14 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 65.33 111.126 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.5 p -83.86 -53.47 5.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 74.0 111.075 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -135.6 168.39 19.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 75.02 110.895 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.82 100.41 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 65.44 111.087 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -154.71 161.03 41.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 73.2 110.881 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.06 -27.72 61.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 72.24 111.04 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.23 13.8 16.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 42.13 110.876 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -127.11 -51.24 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 73.01 110.831 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.52 15.28 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 71.22 111.138 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.19 -33.84 31.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.736 -0.745 . . . . 50.34 112.439 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.93 17.68 44.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.757 -0.735 . . . . 74.51 112.461 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.9 tt -46.03 -31.33 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 71.31 111.172 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -55.19 23.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.95 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.7 m -59.38 -41.73 90.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 74.52 111.14 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.7 mt -55.9 -30.0 60.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.912 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.49 24.27 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 75.52 110.856 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -116.93 -26.18 6.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 75.11 110.869 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -104.59 -22.2 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 75.14 110.832 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.67 14.28 4.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 52.01 112.501 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.7 mt -82.07 155.84 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.89 0.376 . . . . 61.32 111.159 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.57 120.1 34.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 72.42 110.905 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.89 81.14 8.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 74.45 111.061 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -55.04 147.28 16.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 73.42 110.853 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.44 161.78 0.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 62.24 110.851 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.9 p -85.64 161.07 19.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 75.23 111.135 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.35 -47.25 62.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 63.1 111.074 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -44.45 92.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.984 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.4 m -53.03 -46.17 68.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 64.14 111.111 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.98 -21.99 61.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 74.34 111.103 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.12 -38.38 76.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 71.05 110.903 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.705 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 8.0 mt -87.52 -27.66 22.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 71.42 110.954 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.61 -65.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 72.53 111.141 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -26.09 38.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 75.03 110.875 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -23.07 66.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 73.1 110.927 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -96.88 -38.36 9.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 61.42 110.896 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.98 -1.64 5.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 62.31 112.501 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -59.75 -172.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 73.3 110.915 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -94.8 -2.28 51.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 54.33 110.864 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 65.96 126.19 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.634 0.73 . . . . 74.21 110.897 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -170.91 0.42 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.71 2.273 . . . . 72.43 112.332 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -52.59 -38.43 60.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 72.4 110.915 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.98 43.81 55.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 75.44 112.584 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -139.17 57.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.768 0.318 . . . . 74.51 110.837 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.36 -171.63 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 75.52 110.93 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.43 -168.56 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 71.35 110.891 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 75.1 m -50.0 -64.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.23 111.11 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.49 111.1 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 72.43 111.124 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.5 m -111.61 114.15 27.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.13 111.176 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -75.14 101.02 4.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 53.42 110.881 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mt -91.95 152.07 20.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 70.2 110.926 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.42 108.48 3.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 65.4 110.881 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -106.84 -167.77 1.32 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 74.32 110.86 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -50.9 101.73 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 72.34 112.489 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 51.03 56.94 7.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.826 0.346 . . . . 52.14 110.922 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.2 tpt -158.27 147.54 19.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.872 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 121.61 28.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.423 . . . . 73.2 110.976 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 t -130.14 158.71 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 74.03 111.177 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -154.38 117.4 4.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 63.53 110.895 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -177.86 1.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.15 111.139 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -175.65 136.53 0.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 73.14 110.857 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 27.2 t80 -117.13 94.49 45.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 74.12 110.89 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.8 Cg_endo -69.73 -48.92 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.719 2.279 . . . . 74.02 112.384 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.69 -166.33 39.55 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.697 -0.763 . . . . 64.11 112.439 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -88.03 123.94 33.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.827 0.346 . . . . 65.33 110.879 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.476 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -134.06 -86.4 0.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 72.24 112.485 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -81.29 -26.02 36.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 75.15 110.897 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.52 157.02 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 73.1 111.14 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -64.17 -23.72 67.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.14 110.899 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.705 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -125.78 55.09 1.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 74.12 110.848 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.476 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.9 p30 -102.97 143.15 32.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 73.31 110.876 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.2 pt -142.53 171.22 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 74.13 111.164 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.7 m -120.47 143.58 31.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.109 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 68.6 t -100.11 129.07 51.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 73.23 111.144 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -115.76 145.41 42.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.261 -0.427 . . . . 71.23 110.926 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.6 mt -120.76 96.84 48.69 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.585 0.707 . . . . 74.25 110.967 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 70.16 1.54 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.689 2.259 . . . . 73.03 112.396 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.24 -33.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.992 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -116.93 -12.41 10.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 73.53 110.876 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.05 19.74 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 61.24 110.896 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.54 114.4 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 74.34 111.141 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -99.19 122.82 42.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 71.42 110.922 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.29 74.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 72.35 111.155 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.29 -50.28 51.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 65.34 112.553 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.08 -140.94 15.48 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 64.43 112.565 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 39.4 m -58.02 -21.99 47.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 70.24 110.863 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.1 -48.63 77.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.912 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 t -90.77 126.58 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 73.11 111.149 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.51 144.7 25.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 71.33 110.887 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.8 p -72.4 163.99 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 64.21 110.825 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.71 -35.32 79.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.194 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -26.95 63.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 73.51 110.842 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.77 167.8 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 71.11 111.099 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.64 -41.42 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 73.45 110.904 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -136.72 166.52 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.895 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.3 mt -72.85 -26.31 61.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 74.2 110.922 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.86 65.24 1.5 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.75 . . . . 54.4 112.401 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 63.3 160.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.324 . . . . 74.43 110.919 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 33.4 m -150.35 40.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 73.52 111.181 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.04 -40.44 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 72.33 111.097 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.65 40.65 3.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 75.02 110.92 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.9 173.45 10.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 73.4 111.098 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -121.11 89.01 3.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 74.41 110.971 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.28 -21.14 24.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.073 -0.512 . . . . 73.14 111.116 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.44 -26.81 46.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.52 110.895 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -100.39 -24.42 14.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 71.52 110.911 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.31 -53.79 32.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 65.53 110.902 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 34.3 p -52.0 -34.83 44.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 54.23 110.83 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 54.6 m -77.99 -37.98 46.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 74.42 111.134 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.1 m -59.96 -54.89 40.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.819 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.0 mm -56.98 -36.87 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 74.21 111.132 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.49 -21.97 66.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 73.44 110.878 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -90.92 -30.36 16.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 65.0 110.817 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 92.4 t -77.18 -40.09 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 74.45 111.034 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.69 -25.78 57.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 73.54 110.913 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -84.46 -46.84 11.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 70.41 110.861 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -51.99 -30.16 23.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.857 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -138.52 116.9 11.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 70.41 110.868 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -115.26 39.11 3.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 75.2 110.884 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.75 22.03 0.79 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 63.34 110.811 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -51.63 144.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 74.3 111.133 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -103.61 -44.56 5.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 72.22 110.884 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -151.23 113.4 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 74.1 111.097 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 82.8 t -85.51 125.93 40.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 75.52 111.148 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 63.0 t -106.9 93.78 9.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.663 0.744 . . . . 74.1 111.085 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -171.88 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.667 2.244 . . . . 73.54 112.387 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.66 -25.62 9.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 54.02 112.5 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -145.63 109.68 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.352 . . . . 65.25 110.879 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 145.18 -93.18 0.16 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.668 -0.777 . . . . 70.1 112.482 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.435 ' N ' HD22 ' A' ' 42' ' ' ASN . 14.4 pt-20 -179.69 169.55 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.878 0.371 . . . . 74.35 110.879 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.3 t -80.1 139.94 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 72.41 111.15 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -144.92 -105.94 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 74.31 112.443 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -157.69 -171.5 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.848 0.356 . . . . 74.04 110.848 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -53.37 -24.18 11.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 75.34 110.903 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -52.47 -34.37 42.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 73.44 112.402 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.9 mt -50.85 -46.21 60.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 63.12 110.923 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.78 -43.62 85.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.926 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.36 -41.74 89.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 72.41 110.903 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -63.4 -35.98 82.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 74.31 110.811 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.0 m -58.76 -42.64 89.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 72.22 111.098 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.14 -38.9 84.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 74.21 110.864 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -27.87 65.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 75.42 110.795 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 8.4 mt -77.53 -25.95 50.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 72.32 110.922 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.2 -27.43 21.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 75.02 110.904 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 64.42 110.883 179.815 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.9 p . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.847 0.356 . . . . 75.02 110.822 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.57 153.97 51.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 73.34 110.88 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -111.29 170.88 7.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.13 110.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.2 p -172.52 148.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 74.51 111.11 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 56.13 82.59 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 71.43 110.889 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.34 153.19 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 74.13 110.905 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.82 178.25 8.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.088 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.0 t 60.64 99.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 70.33 111.11 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -93.1 157.79 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 72.3 111.152 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.54 149.26 34.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 75.43 110.908 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.16 167.4 21.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 73.3 110.942 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.87 -32.47 63.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.921 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.0 p -97.13 -29.93 13.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 65.13 111.171 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.2 -11.23 47.93 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 54.21 112.447 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 t -51.19 -32.6 24.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.701 0.286 . . . . 74.14 111.156 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.3 mt -123.24 151.1 27.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.443 . . . . 73.43 111.105 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.6 p -169.48 163.44 10.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 75.54 110.894 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.24 -177.18 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 73.03 111.134 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.4 t -166.36 135.37 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 61.11 110.805 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.59 116.99 13.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.117 -0.492 . . . . 74.11 110.904 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.42 -42.21 6.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.914 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.85 -169.91 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.43 110.856 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -49.25 62.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 74.21 110.877 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -133.68 30.37 3.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 71.44 110.859 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.15 118.55 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 71.11 111.123 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -124.09 160.56 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 65.23 110.967 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.14 108.56 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 53.33 111.13 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -102.38 138.54 39.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 75.25 110.795 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.4 m -136.5 131.74 34.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 74.15 111.069 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.97 -175.68 2.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.847 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.7 131.56 39.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 75.01 110.978 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.51 -174.65 13.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.768 -0.729 . . . . 71.51 112.525 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.36 133.51 54.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 73.41 110.849 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -104.54 -18.35 14.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 75.14 110.877 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -176.53 45.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 71.2 110.919 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.81 14.84 57.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 70.14 112.464 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -124.58 -168.98 1.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 60.31 110.874 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.37 124.1 42.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 61.14 111.111 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.93 118.64 16.56 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.593 0.711 . . . . 72.11 111.163 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 149.02 66.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.259 . . . . 70.23 112.321 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.46 113.1 10.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 74.2 110.838 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.39 168.45 7.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 74.1 110.865 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.742 ' CA ' ' HD2' ' A' ' 56' ' ' ASP . . . -171.16 -169.55 34.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 71.54 112.462 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.94 146.62 17.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 72.54 110.919 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.5 142.69 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 71.3 111.106 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -110.7 128.76 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 65.32 110.914 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -97.03 51.25 1.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 72.2 110.904 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.8 p -60.06 173.06 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.32 111.127 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 30.3 3.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 63.34 110.847 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -156.59 36.08 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 71.35 110.882 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.65 128.57 6.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 61.35 112.491 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.4 mt -58.4 160.62 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 75.41 110.959 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.8 t -137.51 143.27 34.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.05 111.157 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.69 128.48 55.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 74.42 110.959 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 t -78.85 -2.08 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 64.22 111.093 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.742 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 0.9 OUTLIER -179.45 128.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 75.51 110.851 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -166.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 62.53 110.798 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 m -96.73 -171.43 2.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 73.52 110.843 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -71.18 -34.82 71.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.959 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -148.64 165.32 31.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 71.41 110.883 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -63.03 -30.12 71.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 64.24 110.868 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -75.34 -22.86 57.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.916 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -49.98 7.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 63.14 110.858 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 t -61.27 -25.2 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 72.42 111.178 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -52.86 -39.67 62.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 72.33 110.914 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -85.55 -14.34 46.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 64.1 110.903 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.5 tp -82.49 -45.62 14.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 70.2 110.937 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.8 mt -70.58 -19.36 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 75.14 111.106 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -83.01 -3.39 57.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 73.33 110.921 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.2 mmm -98.9 -51.58 3.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 75.1 110.824 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.2 m -58.58 -38.06 68.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.22 111.099 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.19 48.06 1.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 75.35 110.848 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 -39.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.872 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.01 -21.86 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.929 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 25.5 m-85 -89.23 11.08 19.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 73.14 110.887 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.522 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.5 pp0? 32.51 47.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 65.35 110.944 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -153.28 -179.83 8.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 71.13 110.904 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 150.92 49.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.11 110.827 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.0 t -83.18 129.74 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.21 111.1 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.3 p -144.25 31.67 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 72.31 111.085 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.413 ' HD2' ' HD2' ' A' ' 104' ' ' LYS . 15.5 m-20 -163.62 125.88 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.835 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.3 t -133.89 98.91 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.5 111.125 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.5 mt -76.87 118.06 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 73.21 111.035 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mm -104.96 133.18 49.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 72.5 111.108 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.8 p -88.79 -55.93 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.33 111.197 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -133.4 161.74 33.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.894 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.71 97.52 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 63.2 111.079 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.73 157.64 43.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 70.1 110.859 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.17 -26.59 60.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 74.22 111.07 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -90.91 13.43 16.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 64.11 110.899 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -127.56 -52.43 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.813 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.56 16.97 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 75.22 111.129 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.39 -29.39 30.57 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.691 -0.766 . . . . 60.15 112.484 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -107.4 17.34 37.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 55.13 112.451 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.3 tt -47.0 -31.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 64.5 111.115 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.7 -54.76 23.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 71.3 110.906 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.1 m -56.95 -41.18 77.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 72.42 111.171 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 24.8 mt -60.84 -37.79 83.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 62.04 110.928 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -81.52 -19.23 42.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.22 -0.446 . . . . 73.02 110.943 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -84.73 -39.53 18.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 75.33 110.857 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -81.4 -40.1 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 73.41 110.829 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.4 -16.28 4.11 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.699 -0.762 . . . . 63.44 112.435 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.1 mp -57.83 149.17 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.873 0.368 . . . . 74.45 111.111 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HD2' ' HD2' ' A' ' 81' ' ' ASP . 1.2 ptpt -109.19 124.56 51.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.45 . . . . 74.55 110.918 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.45 83.23 6.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 74.1 111.127 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -56.95 147.63 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.92 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.85 160.11 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.014 0.435 . . . . 74.13 110.852 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.9 p -78.72 159.56 27.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 65.34 111.174 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.58 -36.78 46.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 71.45 111.038 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tp -71.57 -48.75 46.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 74.51 110.912 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 77.8 m -51.79 -29.09 17.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 74.02 111.128 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.82 -31.8 19.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 74.1 111.085 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -56.17 -44.43 79.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.932 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.424 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 44.6 mt -76.82 -23.03 52.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.41 110.934 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.27 -65.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 64.53 111.101 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -27.62 33.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.856 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -24.38 66.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 72.11 110.946 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -95.69 -37.48 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 72.33 110.877 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.68 -3.28 4.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 65.41 112.477 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -59.45 -173.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.312 . . . . 72.4 110.945 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -97.03 -0.82 46.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 75.31 110.947 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 65.95 126.0 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.677 0.751 . . . . 72.05 110.887 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -170.05 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.657 2.238 . . . . 73.05 112.379 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.6 mt -55.33 -35.58 65.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 73.41 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.96 54.26 29.61 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 63.24 112.434 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -147.39 54.32 1.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.886 0.374 . . . . 72.43 110.931 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.28 -172.19 2.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 72.1 110.86 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.2 -167.9 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.917 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 97.8 m -49.3 -41.77 39.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 75.53 111.126 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 m -144.31 137.43 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.092 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.2 m -142.66 107.39 4.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 70.42 111.132 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -71.56 99.41 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 74.12 110.91 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 mt -90.19 151.07 21.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.963 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.14 127.99 11.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.896 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -129.31 -166.25 1.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 72.04 110.873 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -51.9 98.28 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 74.2 112.465 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 51.91 52.26 14.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 71.11 110.933 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.6 tpp -150.53 140.64 22.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 71.04 110.875 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.1 mmpm? -121.91 126.72 49.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 74.33 110.86 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 t -141.75 159.67 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 75.31 111.195 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -161.09 123.72 3.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.049 0.452 . . . . 71.52 110.839 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.92 179.92 4.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.507 . . . . 73.51 111.095 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -173.71 137.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.895 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 65.3 t80 -116.24 94.94 43.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.687 0.756 . . . . 74.23 110.898 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.5 Cg_endo -69.84 -48.66 0.66 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.741 2.294 . . . . 60.13 112.239 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.73 -164.67 38.25 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.742 -0.742 . . . . 75.53 112.514 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -86.52 118.71 26.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.785 0.326 . . . . 74.15 110.899 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.491 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -129.97 -98.4 0.84 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.679 -0.772 . . . . 73.51 112.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -69.86 -26.74 64.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 73.4 110.867 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.61 159.42 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 64.23 111.163 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -66.09 -23.97 66.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.949 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.424 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 9.3 p30 -123.17 53.09 1.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.904 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.491 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.7 p30 -102.41 149.32 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 71.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.4 pt -150.03 161.88 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 71.22 111.172 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.1 m -108.46 150.5 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 75.33 111.131 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 67.1 t -104.23 125.44 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 74.11 111.201 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -111.7 150.63 29.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.12 110.92 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 35.2 mt -126.53 96.15 36.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.718 . . . . 75.3 110.878 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.9 Cg_endo -69.77 71.23 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 75.25 112.329 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.12 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 75.12 110.885 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -118.85 -11.73 9.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 63.21 110.928 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 m120 67.88 22.79 8.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 63.41 110.843 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 mp -88.41 115.06 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 74.34 111.187 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -98.12 126.24 43.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 71.3 110.978 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.5 t -120.71 75.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 72.25 111.138 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.27 -54.79 27.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.762 -0.732 . . . . 72.55 112.503 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 109.39 -134.93 12.53 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.721 -0.752 . . . . 74.5 112.392 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 67.0 m -60.62 -19.07 56.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 72.35 110.861 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.41 -49.19 57.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 74.4 110.907 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 28.8 t -92.63 127.47 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 74.42 111.201 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.49 152.82 19.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.916 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.4 t -73.04 164.59 26.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 72.24 110.896 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.56 -38.91 84.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.31 111.136 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.84 -27.4 68.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 71.01 110.866 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.28 158.87 3.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 73.12 111.071 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.08 -30.94 6.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.45 110.973 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -151.25 -179.85 7.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.878 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.93 -42.97 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.3 110.923 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 103.64 -161.79 15.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.728 . . . . 73.41 112.504 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -52.01 137.32 27.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 75.44 110.88 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.22 41.64 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 73.12 111.084 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -52.34 -46.9 66.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 62.35 111.134 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -118.66 41.63 2.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.32 110.871 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.23 166.13 17.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.115 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -117.86 91.71 3.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 75.05 110.946 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.5 t -67.65 -21.8 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 73.43 111.174 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -82.36 -26.38 32.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 74.22 110.933 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -96.95 -21.76 17.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 71.14 110.861 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -51.1 -51.86 49.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 64.23 110.975 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.5 p -51.95 -35.67 46.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 70.01 110.878 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.7 m -74.1 -38.3 63.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 75.23 111.139 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 34.0 m -61.86 -56.24 21.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 75.25 110.809 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 28.8 mm -55.22 -38.67 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.457 . . . . 71.11 111.109 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -63.82 -25.15 68.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 71.4 110.873 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -85.79 -31.88 22.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 62.13 110.973 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 99.7 t -73.28 -40.29 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.04 111.138 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.68 -25.33 53.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 71.2 110.931 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.95 -44.23 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 73.15 110.967 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.83 -26.24 67.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 73.34 110.861 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -141.03 117.08 10.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 74.4 110.97 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.96 37.35 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 74.23 110.897 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.15 22.03 1.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 71.53 110.891 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.4 mp -51.57 145.67 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 72.22 111.113 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -107.67 -29.32 9.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 73.52 110.881 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -162.71 121.33 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 75.44 111.13 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.6 t -101.88 118.91 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 64.1 111.099 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.41 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 69.8 t -102.9 106.88 52.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.661 0.743 . . . . 72.21 111.07 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.4 Cg_endo -69.78 -170.36 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.657 2.238 . . . . 75.44 112.372 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.85 -26.95 6.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 70.14 112.441 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -143.84 98.14 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 73.24 110.878 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.54 -95.07 0.15 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 61.31 112.491 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -174.34 152.41 1.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.828 0.347 . . . . 53.24 110.922 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 p -67.38 144.12 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 63.14 111.143 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.67 -105.51 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.716 -0.754 . . . . 72.51 112.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -156.84 -169.61 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.891 0.377 . . . . 65.01 110.861 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -20.43 35.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.212 -0.449 . . . . 71.22 110.88 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.66 -33.1 62.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.715 -0.755 . . . . 63.25 112.5 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.2 mt -50.63 -48.91 57.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 75.54 110.984 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -54.16 -42.41 69.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 73.42 110.954 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.0 mt -68.12 -41.26 82.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 71.32 110.862 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -66.11 -36.91 84.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 64.33 110.839 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.2 m -54.1 -45.25 71.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.164 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 70.5 mt -57.24 -38.91 74.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.893 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -33.74 74.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 75.5 110.871 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.73 -25.81 65.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 74.24 110.89 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 mt -84.92 -48.99 8.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 75.1 110.92 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.7 mttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.885 179.852 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.851 0.358 . . . . 74.5 110.841 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -149.84 108.16 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 73.12 110.878 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -151.05 -175.27 5.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.858 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.1 t 62.55 99.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 75.32 111.116 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -106.33 144.32 33.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 73.3 110.92 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -156.25 151.93 27.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 73.52 110.891 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -143.42 -179.2 6.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 72.12 111.134 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t 61.0 96.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 75.31 111.081 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -89.96 154.23 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 64.55 111.103 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -150.96 163.71 38.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.885 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -91.43 -169.14 2.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 63.42 110.888 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.75 -18.46 58.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 72.53 110.846 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.3 p -108.73 -39.83 5.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.149 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.52 -2.94 29.3 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.692 -0.766 . . . . 71.21 112.432 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 t -50.62 -33.53 22.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 63.31 111.127 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mt -130.04 159.71 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.14 111.096 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.8 p -175.52 167.55 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 71.32 110.836 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.7 -174.77 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 73.31 111.154 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -169.46 129.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 75.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 121.47 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 75.05 110.919 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.06 -42.42 5.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.4 110.916 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -146.1 -168.34 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 75.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -51.55 48.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 74.54 110.886 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -132.21 34.24 3.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.917 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.66 122.48 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 73.52 111.145 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -126.91 160.08 32.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.906 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.0 t -122.56 111.81 31.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 75.15 111.134 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -100.88 135.97 41.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 64.21 110.855 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 m -130.56 137.65 49.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.51 111.165 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -133.85 170.09 16.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 65.24 110.925 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 tp -116.98 148.17 41.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 70.5 110.924 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.03 -141.27 4.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.764 -0.731 . . . . 75.44 112.494 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.68 161.66 22.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.382 . . . . 72.24 110.827 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -178.57 88.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 74.23 110.877 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 m120 55.08 58.51 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 72.51 110.914 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.54 28.26 67.33 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.764 -0.731 . . . . 73.23 112.496 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -144.52 133.62 22.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 72.51 110.899 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.16 127.4 32.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 73.2 111.17 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.36 119.97 30.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.655 0.741 . . . . 74.54 111.091 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.87 157.35 60.46 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.62 2.213 . . . . 75.3 112.34 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.425 ' CB ' ' HD2' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -141.26 112.79 7.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 70.23 110.857 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -76.39 147.49 37.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 72.12 110.909 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.579 ' HA3' ' HD2' ' A' ' 56' ' ' ASP . . . -146.29 -153.81 6.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 73.24 112.526 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.22 142.61 4.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 75.21 110.912 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.47 138.85 53.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 65.33 111.124 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.7 mt -102.12 135.11 44.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.957 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -111.75 61.48 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.917 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 p -77.95 176.15 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 71.53 111.137 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.14 26.87 3.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 71.44 110.855 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -145.74 24.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 74.3 110.889 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.52 142.08 8.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 72.51 112.455 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 mt -70.96 162.3 29.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 75.45 110.852 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.1 t -141.81 144.49 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.33 111.088 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -115.45 128.27 55.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 74.2 110.877 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 t -78.62 -2.47 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.104 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.579 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 1.1 p30 179.98 130.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 74.34 110.859 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.06 -167.41 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.895 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.85 -169.69 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 75.12 110.869 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -74.36 -37.47 63.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 73.34 110.923 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -142.19 165.68 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 65.24 110.831 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.48 -33.89 74.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 74.45 110.889 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -74.17 -24.76 59.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.957 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.88 -48.36 12.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 64.1 110.939 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -57.57 -26.71 61.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 70.23 111.161 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -42.72 75.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.25 110.933 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -86.92 1.7 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 73.24 110.892 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 tp -96.9 -47.7 5.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 74.14 110.899 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.4 mt -70.81 -24.76 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.22 111.104 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -72.74 -12.83 61.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 60.4 110.834 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 30.5 mtp -82.28 -50.41 8.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.31 110.855 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.94 -40.57 87.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.53 111.142 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -83.95 51.63 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.913 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 -38.14 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.902 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 -22.93 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.926 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.521 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 24.9 m-85 -87.85 10.86 17.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 70.55 110.888 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.521 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.97 46.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.12 110.941 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -151.9 -178.46 6.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 73.15 110.916 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.87 50.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 54.42 110.838 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 98.0 t -86.84 127.57 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 71.34 111.099 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.4 p -138.22 25.84 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.116 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -156.89 133.06 9.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.926 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.98 99.89 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 63.14 111.128 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.4 mt -76.93 123.23 33.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 73.53 111.141 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.9 mm -111.65 131.74 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 74.4 111.106 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.5 p -86.96 -58.12 2.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 75.3 111.185 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -129.92 175.32 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.897 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.58 98.09 10.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 74.41 111.103 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.55 158.54 43.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.885 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.39 -26.72 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 73.44 111.102 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.425 ' HD2' ' CB ' ' A' ' 41' ' ' SER . 29.3 t0 -90.88 11.48 22.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 72.02 110.827 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -124.88 -52.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 75.1 110.917 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.61 17.35 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.51 111.117 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.36 -27.33 24.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.779 -0.725 . . . . 71.53 112.477 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.8 19.43 28.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 71.03 112.42 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 tt -48.92 -30.38 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 73.25 111.147 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -69.52 -43.96 71.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 72.44 110.878 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.1 m -68.04 -34.1 75.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 71.24 111.207 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.01 -29.33 70.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 75.21 110.935 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.78 19.67 13.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.03 110.885 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -117.92 -22.73 7.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 65.02 110.825 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -111.69 8.5 20.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 75.32 110.835 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.11 15.56 66.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 64.11 112.455 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.1 mt -81.58 156.59 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.399 . . . . 75.4 111.143 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -121.86 121.0 36.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 74.31 110.91 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.93 79.98 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 74.11 111.097 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -54.67 145.63 18.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 74.24 110.824 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.69 160.71 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 72.1 110.812 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -73.86 -176.64 2.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.511 . . . . 73.22 111.069 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.65 -27.24 45.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 75.31 111.115 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -76.31 -47.88 22.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 73.45 110.933 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.5 m -54.38 -26.27 29.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 72.34 111.081 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.62 -29.29 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 64.51 111.11 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -61.54 -31.29 71.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 72.44 110.855 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.38 -25.4 21.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.34 110.974 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.46 -67.48 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 72.01 111.116 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -26.4 37.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 64.33 110.842 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -24.59 67.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 71.33 110.884 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -94.75 -37.53 11.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.443 . . . . 73.54 110.871 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 138.95 -7.96 3.26 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.753 -0.737 . . . . 72.01 112.476 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.76 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 64.12 110.852 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -99.73 -1.14 38.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 65.21 110.894 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 66.41 129.33 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.719 . . . . 71.32 110.859 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 -169.66 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.721 2.281 . . . . 65.41 112.3 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 76.2 mt -53.45 -43.89 68.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 75.31 110.876 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.44 57.13 19.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.716 . . . . 74.34 112.479 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -152.13 36.51 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 74.23 110.825 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.82 -169.67 1.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 75.24 110.906 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -153.82 -169.06 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 74.22 110.943 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 99.5 m -50.81 -57.8 7.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.146 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -129.54 123.09 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 73.12 111.214 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.6 m -131.54 124.97 31.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.083 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -80.82 103.04 10.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 65.03 110.948 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.3 mt -91.16 150.75 21.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 73.32 110.934 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 124.34 12.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 71.24 110.917 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -126.32 47.76 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.926 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.97 117.76 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.678 -0.772 . . . . 74.25 112.531 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.0 t30 52.46 29.53 7.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 70.44 110.864 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.5 tpp -145.81 140.57 27.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 70.43 110.873 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -128.52 121.27 28.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 75.42 110.844 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.1 t -131.66 154.55 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.179 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -152.19 125.85 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.849 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -178.19 4.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.482 . . . . 65.23 111.15 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -175.28 140.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 73.53 110.854 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -125.22 96.21 39.89 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.639 0.733 . . . . 72.44 110.897 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -49.02 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.225 . . . . 60.41 112.426 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.73 -155.64 21.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 74.45 112.491 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.48 127.5 42.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 74.45 110.934 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.479 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -138.94 -93.51 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 72.03 112.496 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -69.67 -30.12 67.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.929 0.395 . . . . 62.45 110.879 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.57 160.33 43.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 72.53 111.147 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.82 -23.99 67.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 71.42 110.888 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -120.63 45.2 2.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 73.22 110.908 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -94.11 134.34 36.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.893 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.0 pt -136.19 171.3 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.51 111.116 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.9 m -121.85 150.11 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 74.51 111.131 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -103.07 143.48 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 73.1 111.082 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -129.52 150.09 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.928 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.6 mt -127.12 95.04 37.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.67 0.747 . . . . 72.44 110.934 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 71.96 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.685 2.257 . . . . 40.15 112.367 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.4 110.96 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -118.15 -13.08 9.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 65.24 110.898 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.8 m120 69.26 25.33 5.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.908 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.16 116.52 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.13 111.185 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.94 138.48 38.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 73.41 110.885 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 24.9 t -123.22 66.55 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 74.24 111.152 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.6 -54.28 25.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 73.21 112.5 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.48 -135.1 12.41 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.727 -0.749 . . . . 64.41 112.469 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 33.7 m -62.58 -17.04 59.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.85 0.357 . . . . 72.33 110.874 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.87 -51.36 33.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.895 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.48 129.18 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 72.45 111.108 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.02 145.27 29.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 75.45 110.905 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.6 p -70.3 157.78 37.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 64.33 110.851 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.9 p -56.73 -47.86 79.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 74.05 111.119 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.39 -28.71 30.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 74.11 110.865 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.1 150.68 20.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 73.23 111.068 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -116.39 -26.49 7.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 73.13 110.851 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -148.77 179.35 7.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 74.42 110.887 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.07 -36.83 13.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 61.24 110.916 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 104.08 -156.44 17.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 73.15 112.539 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -57.15 117.47 4.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 71.32 110.902 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 15.4 m -116.35 38.03 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.075 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.27 84.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 65.33 111.148 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.42 39.65 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.856 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -135.53 168.62 18.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 73.02 111.109 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -115.35 91.89 3.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 64.44 110.916 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.3 t -68.71 -23.65 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.04 -0.527 . . . . 75.53 111.098 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -80.38 -25.63 39.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 74.41 110.875 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -97.57 -23.82 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 75.04 110.936 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.43 -56.88 10.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 75.54 110.949 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.7 t -51.89 -35.18 44.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 73.15 110.852 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.2 m -72.94 -33.8 66.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 60.33 111.055 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 57.1 m -68.01 -52.41 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 72.1 110.848 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.4 mm -58.56 -38.26 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 54.22 111.118 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.21 -16.53 60.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.33 110.919 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -99.29 -20.5 16.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 74.45 110.905 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 79.1 t -88.85 -25.42 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.13 111.166 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.6 pp -99.24 2.38 45.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 74.41 110.919 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -117.68 -14.59 10.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 70.52 110.89 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -93.28 2.11 56.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.21 110.911 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -137.89 -72.39 0.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 74.3 110.914 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 60.56 25.94 15.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 75.24 110.901 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -149.14 23.44 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 64.45 110.853 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -63.53 145.64 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 73.21 111.2 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -102.47 -28.1 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 73.1 110.915 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -161.3 131.26 4.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 74.33 111.075 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 89.5 t -110.84 123.67 66.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 74.13 111.149 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 49.1 t -110.3 103.84 54.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.672 0.749 . . . . 75.44 111.129 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.0 Cg_endo -69.81 -170.78 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.762 2.308 . . . . 71.34 112.314 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -105.48 -22.26 8.26 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 72.44 112.503 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -146.03 86.79 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 71.35 110.892 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 165.25 -99.33 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.705 -0.759 . . . . 74.5 112.47 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -171.75 161.38 5.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 62.53 110.872 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.5 150.5 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 73.31 111.133 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.12 -107.63 0.28 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 61.22 112.45 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -159.16 -170.04 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 75.4 110.897 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -23.23 26.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 71.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.59 -33.44 48.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.684 -0.77 . . . . 71.3 112.553 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 37.8 mt -51.16 -46.56 62.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 74.33 110.913 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.79 -43.7 85.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.949 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.46 -41.77 88.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 72.35 110.924 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -66.13 -38.79 89.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.847 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.9 m -52.57 -46.46 66.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 71.32 111.178 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 63.8 mt -53.59 -40.49 65.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 73.01 110.911 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -35.25 80.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 61.42 110.858 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 31.5 mt -62.68 -25.91 68.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 74.4 110.882 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 mt -90.12 -42.56 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 52.04 110.899 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 70.42 110.902 179.785 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.905 0.383 . . . . 73.31 110.855 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -150.19 126.7 10.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.883 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.33 148.56 41.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.24 110.937 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.68 141.4 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 74.33 111.16 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.85 147.75 2.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 63.34 110.936 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 mttp 62.5 163.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.807 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.08 179.72 7.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 71.14 111.119 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.9 t 60.83 94.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 74.44 111.132 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.89 155.92 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 71.33 111.096 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -146.78 156.76 43.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 71.43 110.854 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.35 171.69 10.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.12 110.941 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -58.71 -30.29 67.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 75.53 110.928 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.6 p -99.46 -32.13 11.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.159 -0.473 . . . . 74.42 111.136 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.06 -8.42 42.08 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 71.21 112.481 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 t -51.27 -33.14 27.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 71.12 111.146 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mt -124.15 152.6 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 74.41 111.165 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 p -171.93 165.32 6.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 72.23 110.834 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.68 -172.49 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 75.35 111.153 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.96 132.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 45.33 110.874 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.446 ' NE2' ' H ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -67.81 120.71 14.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 64.22 110.9 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.65 -45.47 5.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 75.23 110.967 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -146.09 48.75 1.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 75.2 110.879 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' H ' ' NE2' ' A' ' 20' ' ' GLN . 7.3 ttmm 70.59 -70.89 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.832 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -88.31 -23.25 23.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.929 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.82 120.21 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 54.24 111.139 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -123.89 161.01 26.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 70.04 110.852 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -123.15 107.98 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.13 111.127 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -101.59 137.68 39.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.44 110.861 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 m -133.12 136.27 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.108 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.15 165.16 20.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.411 . . . . 74.1 110.899 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.64 136.49 53.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 72.52 110.931 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.51 109.48 0.85 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.728 -0.749 . . . . 75.43 112.478 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.95 120.1 4.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 53.02 110.887 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.92 96.26 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 72.11 110.914 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.1 t30 57.07 26.15 11.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 74.1 110.934 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.39 30.48 7.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.705 -0.76 . . . . 51.04 112.449 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -144.54 120.06 10.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 73.32 110.841 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.31 132.65 47.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 71.41 111.076 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 60.4 t -142.31 103.12 5.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.673 0.749 . . . . 74.03 111.178 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.3 Cg_endo -69.7 140.17 42.23 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.706 2.27 . . . . 74.54 112.438 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -122.76 108.58 13.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 71.12 110.848 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -67.88 143.02 55.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 75.43 110.858 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.507 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -141.49 -153.58 5.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 42.52 112.458 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.85 145.18 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 71.15 110.904 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.6 137.08 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.24 111.098 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.7 mt -105.11 130.3 53.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.109 -0.496 . . . . 75.1 110.949 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -99.66 56.43 0.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.862 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.2 p -65.69 169.74 5.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 71.53 111.061 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.99 27.26 3.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 33.33 110.869 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -150.04 28.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 74.31 110.876 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.42 127.34 5.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 65.13 112.508 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 mt -54.78 168.03 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 65.25 110.97 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -146.68 143.49 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.22 111.138 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.52 127.92 56.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.993 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.7 t -78.06 -2.91 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.33 111.122 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.507 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 0.4 OUTLIER -179.21 132.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 61.5 110.848 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.57 -166.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.866 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.6 m -94.06 -175.04 3.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.841 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -68.38 -41.21 80.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 75.51 110.892 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.39 166.72 23.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.419 . . . . 44.25 110.859 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.44 -35.94 80.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 74.42 110.865 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -70.39 -23.48 62.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 64.13 110.927 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.81 -50.6 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 75.23 110.985 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -57.7 -31.07 66.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.32 111.129 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -54.58 -38.55 66.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 75.03 110.856 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.55 -11.31 54.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 74.24 110.828 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.8 tp -85.03 -47.36 10.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 74.02 110.923 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.3 mt -68.65 -11.98 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.106 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -92.17 16.45 11.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 74.54 110.889 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.5 mtp -115.83 -51.55 2.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 63.12 110.892 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.21 -36.08 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 73.3 111.128 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -85.72 50.56 1.99 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 75.34 110.885 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -142.84 -40.15 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 75.42 110.915 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 -23.81 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 75.52 110.889 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.529 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 30.4 m-85 -89.52 11.23 20.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 74.34 110.864 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.529 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.81 46.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 74.5 110.956 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -150.42 -176.57 5.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 72.21 110.857 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.01 152.09 51.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.817 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 85.0 t -87.19 118.18 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.15 111.178 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.1 p -127.37 21.3 6.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 73.02 111.142 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -154.0 134.1 13.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 73.11 110.912 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.65 99.6 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 75.44 111.126 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.9 mt -74.89 126.11 35.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 74.43 111.094 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.4 mm -113.88 129.5 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 73.13 111.116 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.0 p -88.34 -54.11 4.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.163 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -133.68 162.81 30.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 73.43 110.884 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.24 98.5 10.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 62.3 111.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -151.74 158.76 43.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.897 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.36 -24.38 54.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 71.01 111.098 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.87 16.36 12.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 74.44 110.94 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.3 mmt-85 -132.19 -52.53 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 73.43 110.889 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.15 15.24 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 75.42 111.109 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.91 -34.45 30.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 64.2 112.503 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.09 18.15 43.21 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.72 -0.752 . . . . 72.35 112.451 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 tt -46.16 -31.69 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 73.23 111.118 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -54.67 26.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 70.14 110.878 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.8 m -58.54 -39.82 81.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.19 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.9 mt -60.4 -29.52 69.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 72.04 110.888 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -99.31 24.11 8.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.898 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -114.1 -34.69 5.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 75.21 110.878 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -96.17 -21.94 17.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 63.23 110.856 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.59 16.82 4.48 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.772 -0.727 . . . . 71.11 112.503 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.2 mt -83.06 156.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 71.21 111.167 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 125.01 48.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.44 . . . . 73.4 110.853 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.04 82.4 5.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 75.44 111.092 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -51.91 142.59 15.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 73.42 110.855 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.67 151.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.03 110.899 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.1 p -70.63 157.45 37.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 74.2 111.137 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.62 -24.07 45.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 62.25 111.134 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.8 tp -77.0 -46.96 22.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 73.24 110.915 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.5 m -55.62 -27.93 52.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.224 -0.444 . . . . 64.22 111.184 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.49 -23.46 40.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.24 111.127 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.88 -38.25 90.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 71.14 110.839 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.4 mt -85.24 -24.52 27.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 73.14 110.878 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.8 -65.78 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 74.13 111.066 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -55.24 -26.2 38.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 65.11 110.949 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -24.17 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 73.44 110.877 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -95.09 -31.46 13.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.924 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.82 -4.84 6.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.731 . . . . 64.24 112.49 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -59.72 -172.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.883 0.373 . . . . 73.12 110.907 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -98.19 -1.32 42.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 74.41 110.9 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 66.16 126.97 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.71 0.767 . . . . 73.15 110.86 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -170.64 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.612 2.208 . . . . 65.31 112.39 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.7 mt -51.89 -36.38 48.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 63.13 110.907 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.98 53.93 28.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 75.1 112.48 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -152.02 48.46 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 72.11 110.833 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.65 -169.64 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.904 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -151.96 -168.74 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 74.2 110.936 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 98.3 m -50.24 -64.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 75.35 111.134 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 68.6 t -124.63 110.62 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 74.2 111.133 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.7 m -113.33 105.32 13.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.151 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.57 100.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 64.45 110.872 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.9 mt -89.92 153.69 20.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.908 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -151.94 128.14 10.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 74.41 110.873 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -129.51 -165.97 1.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 70.45 110.857 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -51.63 98.95 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.753 . . . . 71.22 112.517 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 51.37 52.42 14.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.331 . . . . 73.12 110.906 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.3 tpt -150.85 142.2 23.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 74.25 110.913 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -124.24 125.34 44.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 65.13 110.897 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 t -138.0 157.69 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 74.03 111.147 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -155.66 125.22 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 61.1 110.842 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -177.06 3.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.138 -0.483 . . . . 75.11 111.124 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -175.33 136.19 0.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 74.01 110.897 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -119.47 93.77 47.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.624 0.726 . . . . 75.11 110.978 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 -48.55 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 72.31 112.355 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.88 -155.29 22.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 71.32 112.462 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.15 123.97 41.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.371 . . . . 74.54 110.826 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.484 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -134.66 -94.3 0.48 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.483 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -71.46 -29.58 65.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 73.32 110.899 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.8 153.13 34.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.117 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.52 -37.9 65.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 74.41 110.916 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -108.74 51.13 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.887 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.484 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -100.49 136.35 40.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 70.05 110.889 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 18.5 pt -137.48 169.01 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 75.32 111.122 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.6 m -119.37 140.93 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 72.23 111.177 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 84.4 t -95.85 144.24 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.11 111.145 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -131.16 146.94 52.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 75.31 110.896 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.43 97.47 42.39 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.599 0.714 . . . . 74.03 110.887 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 72.22 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 72.21 112.388 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.17 -34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.888 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -117.42 -13.28 10.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 64.05 110.904 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 m120 68.62 23.28 7.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.909 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.58 116.26 36.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 55.5 111.16 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.7 137.0 37.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 75.33 110.97 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.27 66.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 73.31 111.109 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.77 -55.33 21.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 73.13 112.452 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.21 -119.76 5.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 63.35 112.492 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 90.3 m -87.2 7.23 29.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 75.0 110.951 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.72 -50.17 6.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.922 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.1 120.86 40.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 74.31 111.098 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.03 154.78 19.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 73.25 110.963 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.8 p -77.65 161.43 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 72.15 110.861 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.4 p -61.79 -34.61 76.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 73.02 111.115 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -26.68 65.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 53.15 110.864 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.53 154.39 11.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 71.54 111.111 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.95 -32.63 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 73.4 110.851 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.41 -179.83 5.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 74.21 110.854 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mt -78.18 -48.29 16.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.871 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 112.3 68.22 0.53 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.764 -0.731 . . . . 73.43 112.468 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.1 t30 62.73 104.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 74.22 110.823 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.8 m -100.11 35.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 71.54 111.118 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.67 85.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 64.4 111.116 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.06 44.82 2.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 73.32 110.867 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.52 171.34 14.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.064 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -117.37 90.57 3.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 70.25 110.952 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.91 -22.05 24.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 73.31 111.15 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -78.35 -24.88 46.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 73.53 110.957 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -101.76 -24.9 14.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 73.14 110.91 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -51.46 -56.72 11.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 74.41 110.945 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.2 p -52.17 -32.03 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 75.42 110.848 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.4 m -78.22 -31.47 49.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.01 111.164 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 40.2 m -69.45 -52.14 29.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 62.22 110.892 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.6 mm -56.08 -42.26 71.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 72.53 111.145 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.72 -19.81 59.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 72.23 110.864 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -95.84 -25.59 15.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 70.32 110.944 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.36 -20.79 8.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 63.24 111.159 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.5 pp -101.17 -2.33 31.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 71.25 110.933 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -116.4 -22.92 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.885 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -71.1 -23.73 62.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 75.15 110.841 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -118.09 -66.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 74.41 110.922 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.64 25.81 14.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 74.23 110.918 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -149.35 22.59 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 64.41 110.839 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.5 mp -60.19 144.62 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 65.31 111.175 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -103.07 -26.05 13.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.878 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -166.07 130.82 2.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 73.14 111.097 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.53 128.09 62.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 72.12 111.106 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.411 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 39.7 t -110.82 103.28 54.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.588 0.709 . . . . 72.2 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.7 -169.76 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.707 2.271 . . . . 63.44 112.336 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -108.86 -22.33 7.01 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 70.15 112.44 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -144.6 88.73 1.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 75.51 110.896 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 161.25 -93.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.783 -0.722 . . . . 73.03 112.523 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -178.91 156.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.925 0.393 . . . . 70.4 110.886 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.2 147.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 72.33 111.135 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -150.04 -107.97 0.42 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.684 -0.77 . . . . 54.24 112.405 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -154.52 -170.47 3.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 64.53 110.87 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -58.01 -20.2 36.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 75.45 110.878 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.93 -32.43 62.36 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.685 -0.769 . . . . 62.31 112.452 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 29.8 mt -50.74 -43.2 58.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 74.3 110.908 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.97 -45.05 93.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 75.13 110.965 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.58 -42.04 95.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.42 110.866 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -65.5 -36.6 84.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 73.34 110.869 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 33.0 m -51.7 -44.29 63.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 53.43 111.162 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 76.4 mt -56.32 -38.96 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.86 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -27.77 65.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 73.41 110.856 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.9 -25.47 56.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.866 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.22 -38.63 14.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 63.23 110.923 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.6 mttp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 75.22 110.914 179.836 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.853 0.358 . . . . 75.41 110.926 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -159.06 150.86 20.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 73.24 110.887 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.52 97.84 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.896 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 p -166.89 146.63 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 74.51 111.164 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.31 107.29 18.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 63.33 110.938 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -148.4 153.12 38.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 74.42 110.947 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.54 179.0 7.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 72.42 111.102 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.4 t 60.56 93.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.462 . . . . 72.34 111.09 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.52 154.52 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 64.23 111.19 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -145.37 146.58 31.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.892 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.32 165.49 21.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 64.32 110.815 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -52.03 -43.35 63.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 63.14 110.878 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.52 -24.01 31.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 72.2 111.157 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.68 -14.0 66.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 70.52 112.484 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 t -50.81 -32.77 21.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 64.51 111.165 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 mt -118.79 148.08 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 74.13 111.072 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 p -170.59 166.97 8.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 73.54 110.851 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -172.91 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 72.32 111.109 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.74 133.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.89 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.98 119.12 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 75.12 110.879 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -101.5 -57.8 2.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.887 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -148.3 -170.08 3.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 72.15 110.861 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -52.34 108.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.922 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 57.96 23.21 9.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.426 . . . . 73.24 110.831 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.44 110.76 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 64.31 111.18 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -121.91 163.83 18.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.887 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.5 t -126.02 109.95 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 64.51 111.151 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -101.61 137.0 40.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.852 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 m -132.39 113.06 12.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 74.21 111.19 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.27 162.49 12.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 74.3 110.874 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.33 126.14 55.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 74.03 110.907 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.0 -173.0 17.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 64.31 112.46 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.3 163.8 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 72.34 110.835 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -178.37 112.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.917 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 51.9 40.71 28.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.839 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.59 27.67 72.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 75.43 112.492 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -134.43 -171.17 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 71.04 110.853 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.13 127.77 55.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 65.13 111.067 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.26 116.61 16.59 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 121.608 0.718 . . . . 70.21 111.109 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 166.22 28.34 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.667 2.245 . . . . 74.13 112.352 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -149.06 99.41 2.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 73.13 110.938 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -51.76 168.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 72.52 110.852 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.655 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -170.24 -160.3 18.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 73.43 112.478 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.81 141.49 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 74.42 110.932 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.84 135.58 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 74.23 111.141 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.5 mt -103.16 133.4 48.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 73.4 110.916 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -99.65 57.95 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 75.24 110.939 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 p -60.38 -169.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 74.51 111.182 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.5 m -114.43 2.89 14.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 73.41 110.83 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -118.53 -17.4 9.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.878 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.19 131.17 1.3 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.658 -0.782 . . . . 74.24 112.432 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.5 mt -48.98 159.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 70.5 110.932 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.5 t -140.12 144.07 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 74.13 111.153 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.72 128.83 56.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 63.13 110.901 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.4 t -78.84 -2.34 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 63.41 111.061 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.655 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 2.8 p-10 179.57 125.36 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.28 -0.418 . . . . 72.12 110.897 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -167.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 54.2 110.892 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 p -94.61 -169.75 2.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 72.05 110.842 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -73.45 -38.45 65.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.953 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -143.66 154.98 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.52 110.87 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -55.88 -28.35 56.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 73.13 110.862 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -78.1 -23.77 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 71.35 110.945 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.24 -40.19 14.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.03 110.929 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.1 t -66.53 -23.61 66.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.52 111.167 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -43.04 72.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 61.34 110.884 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -82.76 -14.6 54.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 73.12 110.886 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.3 tp -76.51 -44.49 34.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.949 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.9 mt -74.6 -30.06 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.04 111.185 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.52 -13.2 61.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 63.12 110.888 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 mmm -88.7 -54.76 4.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 73.2 110.87 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -57.5 -39.61 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 72.33 111.124 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -83.97 50.86 1.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.871 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.19 -41.02 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 73.22 110.897 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.83 -19.51 12.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 75.03 110.887 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 26.3 m-85 -88.64 9.73 23.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.52 110.822 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.533 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 2.1 pp0? 31.69 49.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.908 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.46 -177.21 6.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 74.33 110.97 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 144.87 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 75.25 110.831 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.8 t -76.57 123.63 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 73.34 111.089 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.2 p -134.48 20.78 3.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 74.22 111.149 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.56 135.5 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 72.35 110.868 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.4 t -140.53 100.77 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 74.55 111.071 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.8 mt -79.42 121.02 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 74.42 111.171 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.4 mm -105.72 130.47 57.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 73.14 111.079 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.0 p -90.91 -52.95 4.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 72.24 111.193 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -134.72 162.5 32.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 71.2 110.888 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.45 97.64 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.1 111.112 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.53 158.84 44.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 73.04 110.848 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.76 -30.32 63.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 74.35 111.118 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.29 9.99 21.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.899 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -121.86 -51.64 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 73.54 110.807 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.29 18.12 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 71.34 111.128 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.77 -28.45 23.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 72.43 112.495 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.05 21.31 27.38 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.698 -0.763 . . . . 60.44 112.552 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 tt -48.7 -30.77 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 65.21 111.084 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -69.9 -44.05 70.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 70.41 110.842 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.0 m -67.02 -35.01 78.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 74.15 111.201 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.4 mt -62.61 -30.74 71.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.896 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.58 22.61 7.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.945 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -120.71 -31.29 4.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 73.14 110.86 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -103.48 12.08 35.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 72.12 110.861 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.14 18.62 68.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 65.25 112.539 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.5 mt -83.64 157.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.819 0.343 . . . . 74.52 111.17 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.02 121.28 36.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.881 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.61 77.96 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.047 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -53.83 146.34 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.848 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.15 168.25 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.31 110.858 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.0 p -83.7 176.4 9.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 74.33 111.173 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.07 -23.93 60.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 74.24 111.052 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 tp -75.47 -51.2 13.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 70.32 110.923 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.7 m -52.65 -29.13 24.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 75.12 111.134 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -82.51 -30.41 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 72.02 111.074 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -58.93 -40.48 84.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 74.4 110.904 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 61.0 mt -85.09 -25.25 27.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 72.05 110.932 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.51 -68.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.42 111.099 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -56.35 -25.57 49.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 71.44 110.881 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -24.75 67.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 74.3 110.952 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -94.1 -37.25 11.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 75.23 110.896 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.14 -8.57 3.25 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.765 -0.731 . . . . 71.33 112.487 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -59.82 -172.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 74.21 110.967 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -101.21 0.24 37.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.148 -0.478 . . . . 70.24 110.903 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 66.14 127.18 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 63.54 110.911 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -170.3 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.738 2.292 . . . . 71.25 112.294 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.8 mt -52.85 -41.42 64.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 71.54 110.958 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 55.16 58.56 13.18 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.771 -0.728 . . . . 72.04 112.502 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -148.97 54.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 73.12 110.916 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.37 -169.7 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 73.2 110.909 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -150.75 -168.66 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.897 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 97.6 m -50.21 -41.1 49.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 73.32 111.149 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.76 140.78 25.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 64.41 111.146 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.6 m -149.55 102.47 3.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.106 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.33 95.44 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 70.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.48 159.18 19.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 71.43 110.924 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.46 107.23 2.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 75.21 110.902 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -99.59 -168.99 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 73.33 110.858 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -52.25 101.97 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.688 -0.767 . . . . 63.31 112.525 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.2 m120 51.76 49.4 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 72.4 110.876 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.1 tpp -148.68 155.13 40.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 71.43 110.935 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.62 130.05 45.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.889 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.3 t -142.92 159.54 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.54 111.203 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -160.44 118.12 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 74.12 110.925 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.94 179.67 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 75.41 111.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -175.19 143.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 74.43 110.851 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 145' ' ' PRO . 66.2 t80 -120.78 94.98 49.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.673 0.749 . . . . 72.43 110.874 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.2 Cg_endo -69.87 -48.59 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.649 2.233 . . . . 75.12 112.344 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.15 -161.55 34.71 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 75.42 112.426 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.47 125.46 38.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.891 0.377 . . . . 65.23 110.856 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.483 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -136.37 -97.38 0.49 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 52.12 112.498 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -69.72 -35.77 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 75.0 110.867 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.43 147.29 39.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 75.13 111.176 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.99 -40.72 61.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 74.55 110.927 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -106.46 53.01 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 64.15 110.912 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 2.1 p30 -99.97 134.8 42.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.886 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.62 160.73 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 72.42 111.091 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.0 m -109.46 155.43 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 72.41 111.115 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.0 t -111.31 142.28 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 54.15 111.118 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -127.7 151.48 48.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.3 mt -130.24 96.93 23.61 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.594 0.711 . . . . 61.21 110.935 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 72.64 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.668 2.245 . . . . 73.42 112.353 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.62 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 73.21 110.954 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -118.04 -13.27 10.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 72.33 110.881 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.46 23.38 6.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 71.14 110.888 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.97 118.92 40.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 72.41 111.11 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.19 138.03 40.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 74.14 110.907 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.74 81.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 64.12 111.146 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.57 -67.94 1.68 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.8 -0.714 . . . . 73.04 112.528 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.87 89.35 2.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.707 -0.758 . . . . 74.12 112.457 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 63.6 m 61.48 16.85 7.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 73.31 110.873 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.7 tp -110.31 -45.48 3.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 55.44 110.901 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.2 t -96.44 116.93 39.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.106 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.35 146.59 31.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.24 110.911 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.8 p -78.92 161.54 26.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 71.24 110.878 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.6 p -56.5 -48.47 77.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 64.43 111.088 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 53.7 p -56.36 -27.89 57.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 70.45 110.807 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.03 157.68 18.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 74.22 111.101 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -143.34 22.44 1.86 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 70.12 110.904 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.82 163.82 3.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.878 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 9.0 mt -81.19 -26.2 36.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 74.15 110.889 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.19 81.36 0.91 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.761 -0.733 . . . . 73.1 112.51 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.2 t30 64.15 155.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 73.44 110.906 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.3 m -150.44 24.81 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 71.31 111.048 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.48 91.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 62.22 111.124 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.77 43.3 2.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 65.34 110.834 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.2 164.53 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 71.15 111.064 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -112.87 90.08 3.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.893 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.56 -17.2 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 74.44 111.173 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -88.06 -20.08 26.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 70.1 110.938 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -104.63 -20.87 13.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 62.31 110.907 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.09 -55.77 16.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 75.03 110.912 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 60.4 p -51.88 -38.62 56.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 54.03 110.897 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -68.77 -36.09 77.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 71.31 111.141 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.0 m -65.31 -52.09 56.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.908 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.5 mm -57.56 -36.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 73.51 111.127 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.75 -15.45 61.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 73.1 110.887 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -97.84 -27.3 14.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 72.54 110.93 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.34 -30.36 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 73.01 111.108 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.8 pp -85.64 -24.26 27.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 73.42 110.916 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.26 -39.7 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.933 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -56.39 -49.03 75.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 75.35 110.844 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -119.34 127.72 53.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 74.23 110.927 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.75 26.03 8.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.093 -0.503 . . . . 72.22 110.848 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.49 22.13 2.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 71.31 110.844 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.6 mp -52.11 147.42 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 64.12 111.198 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -106.85 -39.76 5.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 74.4 110.957 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.93 127.59 8.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.153 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.59 125.44 60.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 75.04 111.116 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.54 110.09 63.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.707 . . . . 72.53 111.142 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 72.24 112.341 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.89 -27.01 7.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 71.12 112.543 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -145.05 88.93 1.92 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.364 . . . . 75.15 110.871 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.17 -108.29 0.34 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.698 -0.763 . . . . 74.51 112.437 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -158.02 153.65 26.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.926 0.394 . . . . 72.32 110.894 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.3 p -68.69 144.0 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 74.12 111.102 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.07 -104.51 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 61.31 112.498 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -157.3 -169.65 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.885 0.374 . . . . 63.4 110.873 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -56.96 -21.02 26.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.911 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.94 -33.85 60.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.772 -0.728 . . . . 71.4 112.446 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.2 mt -50.63 -47.01 58.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.882 0.372 . . . . 73.41 110.913 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.1 mp -53.84 -42.7 68.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 74.01 110.98 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.4 mt -67.37 -41.28 85.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.946 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -64.09 -39.31 93.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 72.45 110.794 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.3 m -51.59 -45.23 63.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 75.03 111.136 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 46.6 mt -61.26 -39.83 91.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 74.24 110.91 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.31 -26.76 61.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.843 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.3 mt -76.82 -24.05 52.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 71.05 110.865 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.5 mt -90.97 -39.38 12.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 63.21 110.899 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 71.52 110.878 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.792 0.329 . . . . 74.51 110.868 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -156.08 156.57 34.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 74.11 110.893 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.85 105.04 15.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.89 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -144.99 69.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 75.54 111.13 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -148.01 154.29 40.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.482 . . . . 74.01 110.817 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.25 160.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 72.34 110.943 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.4 -179.35 6.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 73.13 111.193 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.1 t 61.26 100.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 64.34 111.16 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mm -94.56 152.62 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.33 111.104 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -150.83 155.34 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 74.33 110.905 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.23 -168.95 2.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.923 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -76.89 -25.25 52.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 72.22 110.834 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 p -95.04 -35.21 12.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 73.43 111.138 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.66 -9.16 64.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.759 . . . . 64.01 112.446 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 t -50.12 -33.36 18.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.688 0.28 . . . . 74.31 111.128 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.9 mt -124.21 160.32 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.433 . . . . 73.1 111.147 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -178.42 166.75 1.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 71.24 110.858 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.24 -175.71 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 72.22 111.113 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 t -169.14 129.97 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.51 110.894 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.3 120.19 12.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 55.34 110.942 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -103.56 -74.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.906 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.98 -170.43 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 61.51 110.843 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -52.62 109.48 0.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 70.22 110.876 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 58.6 23.86 11.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 75.53 110.832 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.3 t -122.96 116.42 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 75.32 111.114 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -124.36 163.13 22.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 75.54 110.954 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.59 107.72 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 75.12 111.114 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.765 ' CE1' ' HE2' ' A' ' 30' ' ' GLU . 6.8 p80 -100.49 138.49 37.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 75.43 110.856 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.8 m -136.2 133.44 37.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.115 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.765 ' HE2' ' CE1' ' A' ' 28' ' ' HIS . 2.9 pm0 -124.59 173.98 8.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 73.02 110.91 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tp -124.15 136.23 54.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 72.22 110.914 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.37 141.69 8.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.733 -0.746 . . . . 73.43 112.447 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.04 139.91 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.961 0.41 . . . . 61.14 110.849 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -102.46 -31.98 10.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 75.13 110.945 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -169.78 30.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 64.33 110.907 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.56 7.5 6.82 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.741 . . . . 71.2 112.505 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -149.06 122.48 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.909 0.385 . . . . 73.2 110.851 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.3 128.5 36.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 74.41 111.074 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 t -124.95 132.17 24.26 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.619 0.723 . . . . 75.45 111.096 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 142.87 48.99 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.74 2.293 . . . . 74.34 112.344 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.92 102.06 5.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 74.51 110.927 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -67.48 153.44 43.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 75.1 110.861 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.569 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -153.71 -155.99 7.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 70.34 112.528 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.7 tp -161.36 142.01 11.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 74.41 110.903 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.06 132.17 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 75.32 111.13 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 mt -98.5 122.59 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 74.03 110.952 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -94.8 60.26 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 74.35 110.9 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.4 p -66.0 179.83 0.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 75.12 111.173 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.6 m -104.95 26.04 9.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 74.32 110.836 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.08 23.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 72.01 110.912 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.81 130.25 4.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.769 -0.729 . . . . 72.02 112.431 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mt -60.33 158.96 10.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.825 0.345 . . . . 70.43 110.934 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.2 139.35 36.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 74.24 111.129 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -109.83 127.43 54.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 70.42 110.942 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.8 -0.5 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 73.44 111.152 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.569 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 0.9 OUTLIER -179.45 126.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 55.5 110.904 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -166.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 75.1 110.84 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -96.28 -174.46 3.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 70.32 110.874 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -67.68 -42.1 82.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 73.42 110.924 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.01 166.29 24.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 54.42 110.84 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.96 -36.18 80.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.861 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -71.21 -25.13 62.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.93 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -49.68 12.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 74.41 110.819 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 t -58.84 -29.54 67.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.33 111.125 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -52.76 -44.3 66.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 71.35 110.893 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -80.94 -12.89 59.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 63.44 110.889 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.9 tp -83.87 -50.29 8.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.904 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.4 mt -64.55 -18.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 74.0 111.193 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -80.91 -1.18 42.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 73.12 110.881 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.8 mtp -96.33 -57.56 2.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.843 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 m -58.29 -39.1 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 72.1 111.167 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.53 50.82 1.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 75.44 110.912 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -146.25 -40.95 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.879 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.19 -23.21 12.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.12 110.866 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.524 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 41.1 m-85 -90.03 11.57 20.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 75.01 110.851 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.524 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.78 46.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.43 110.927 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -152.05 -176.71 5.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.44 110.892 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.67 153.66 47.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 73.41 110.889 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.2 t -89.25 117.19 32.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 71.45 111.123 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.8 p -130.76 36.53 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 75.12 111.155 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -166.71 130.44 1.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 72.25 110.918 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.0 t -135.96 101.91 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 74.54 111.11 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.0 mt -80.22 119.79 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.14 111.074 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.6 mm -107.33 134.59 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.117 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.1 p -91.9 -55.36 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 54.34 111.204 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -133.17 163.95 28.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 74.35 110.795 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.8 97.22 8.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 71.44 111.086 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -151.05 158.8 44.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 64.54 110.851 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.27 -26.2 60.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.35 111.083 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.68 15.27 13.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 62.23 110.835 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -129.66 -53.12 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 75.44 110.829 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.88 16.54 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 71.32 111.189 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.56 25.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.797 -0.716 . . . . 74.23 112.494 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.88 20.04 29.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.743 . . . . 73.2 112.496 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 tt -48.23 -30.65 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.37 . . . . 73.32 111.127 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -70.13 -44.51 68.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 75.33 110.932 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.9 m -67.38 -32.59 73.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.142 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 mt -65.01 -30.53 71.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 72.4 110.944 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -96.69 21.6 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 73.14 110.925 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.44 -27.36 5.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.3 110.903 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.68 11.52 28.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 71.25 110.892 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.18 17.12 70.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 74.4 112.512 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.9 mt -83.19 157.52 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.888 0.375 . . . . 75.32 111.126 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -123.49 123.38 40.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.848 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.24 80.85 5.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.33 111.066 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -56.1 146.85 21.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.79 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.93 159.85 0.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 72.42 110.86 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.4 p -75.74 154.58 36.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 73.55 111.123 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.45 -32.41 26.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 73.42 111.043 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tp -73.64 -48.28 33.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.426 . . . . 74.31 110.878 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 99.8 m -52.02 -28.61 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 60.53 111.18 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.61 -31.6 21.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 63.13 111.127 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.03 -43.55 70.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 74.44 110.829 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.3 mt -79.87 -23.73 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 74.2 110.891 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.14 -69.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.42 111.061 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.42 -28.24 28.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 72.43 110.937 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -23.64 62.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 73.32 110.841 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -94.58 -38.78 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 74.33 110.827 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.72 -8.51 3.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 70.02 112.459 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.43 -172.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 71.43 110.936 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -98.47 -1.23 41.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 74.53 110.849 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 66.34 129.92 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.656 0.741 . . . . 73.13 110.893 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -169.65 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.608 2.205 . . . . 74.44 112.403 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -54.45 -37.75 65.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 73.45 110.872 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.06 57.71 12.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 72.04 112.527 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -153.29 49.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 72.12 110.829 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.19 -169.97 2.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 73.21 110.919 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -146.22 -169.08 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.925 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.1 m -50.72 -62.74 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 70.42 111.169 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.07 116.15 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.51 111.092 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.1 m -115.66 103.35 10.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 73.24 111.132 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -67.02 102.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 74.21 110.879 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.8 mt -94.15 151.4 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 74.3 110.944 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.7 108.22 2.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 64.25 110.919 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -105.92 -167.87 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.909 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -51.06 102.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.726 -0.749 . . . . 75.02 112.499 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 51.59 56.47 7.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 75.5 110.862 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 43.7 tpp -153.36 149.11 27.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 64.0 110.825 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.51 124.65 36.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 72.13 110.91 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.5 t -143.32 157.45 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.426 . . . . 75.45 111.107 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -158.53 125.31 4.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 64.52 110.886 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.63 -178.74 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 72.15 111.175 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -175.18 137.66 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 71.44 110.895 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -120.05 92.99 47.55 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.681 0.753 . . . . 63.41 110.881 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -48.81 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.744 2.296 . . . . 72.44 112.322 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.73 -166.34 39.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 63.32 112.458 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -85.35 126.94 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 74.3 110.875 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.463 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.75 -87.74 0.24 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 73.53 112.55 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -80.32 -23.67 40.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 63.24 110.842 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.52 158.3 43.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 74.15 111.215 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -63.1 -26.83 69.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 74.52 110.853 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -122.0 53.52 1.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 71.5 110.809 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.1 p30 -102.32 145.65 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 75.42 110.857 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 6.4 pt -142.05 172.45 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 74.3 111.13 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 m -122.5 142.64 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.118 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.19 144.46 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 71.05 111.139 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -131.1 149.35 52.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.947 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 23.0 mt -126.52 95.93 37.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.568 0.699 . . . . 72.2 110.877 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 72.08 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.705 2.27 . . . . 63.34 112.326 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.5 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.912 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -118.16 -13.21 9.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 75.21 110.833 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 m120 69.81 22.05 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 75.54 110.891 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.79 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 73.02 111.072 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.41 136.57 39.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.968 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 23.2 t -123.24 65.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 73.33 111.158 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.87 -48.24 45.38 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.758 -0.734 . . . . 64.4 112.454 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.64 -130.9 10.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 74.3 112.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 96.5 m -69.58 -19.13 63.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 64.44 110.923 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -47.11 70.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 72.33 110.822 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.49 116.0 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 71.04 111.113 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.95 147.74 23.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.864 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.6 t -87.19 157.24 19.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 74.13 110.84 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.1 p -54.53 -29.18 50.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 73.25 111.117 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.4 p -66.04 -27.05 67.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 72.14 110.83 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.64 -169.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.4 111.043 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -152.39 -42.7 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 70.22 110.9 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -147.21 171.38 15.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 74.34 110.85 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.2 mt -91.35 -23.43 20.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 73.15 110.925 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 114.56 -142.91 17.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.798 -0.715 . . . . 60.54 112.507 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 181' ' ' VAL . 28.0 p30 -99.48 16.87 21.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 70.4 110.922 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 180' ' ' ASN . 11.9 m 34.98 47.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.03 111.088 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -51.71 -58.03 7.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 73.52 111.077 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.7 27.12 9.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.847 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -104.86 168.94 8.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 72.31 111.122 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -130.87 88.59 2.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 75.11 110.939 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.46 -18.02 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.098 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -78.87 -22.13 46.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 72.34 110.896 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -108.91 -25.42 10.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 75.42 110.936 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -51.04 -57.97 7.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.95 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.3 p -51.85 -30.56 24.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 64.03 110.87 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.0 m -80.06 -34.3 38.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 75.51 111.142 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 44.5 m -66.99 -55.55 13.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 73.11 110.819 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.6 mm -56.17 -40.17 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 73.15 111.114 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.22 -16.46 60.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 65.22 110.831 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -97.93 -21.88 16.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.883 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 94.5 t -88.42 -24.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.094 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.6 pp -98.84 1.53 45.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.94 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -117.25 -17.03 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 65.33 110.851 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -90.55 1.84 56.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.34 110.901 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -137.61 -72.46 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.32 110.9 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 61.16 25.3 15.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 70.31 110.87 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -147.29 21.06 1.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 75.4 110.856 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.45 144.93 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 65.32 111.174 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -103.87 -28.65 11.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 75.52 110.837 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -165.68 126.47 1.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 73.41 111.106 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 87.9 t -98.45 127.48 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 74.21 111.112 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 98.0 t -108.71 89.57 6.45 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.618 0.723 . . . . 74.2 111.133 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 167.96 22.92 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.632 2.221 . . . . 71.51 112.376 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.09 -15.94 63.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 73.14 112.46 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -146.83 111.09 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 74.44 110.904 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 137.69 -96.41 0.24 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.826 -0.702 . . . . 73.52 112.524 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -178.85 166.77 1.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 75.55 110.867 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.1 133.49 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 65.23 111.141 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.57 -106.62 0.73 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 54.23 112.497 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -155.64 -172.62 4.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.883 0.373 . . . . 74.21 110.856 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -22.04 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 74.41 110.901 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.4 -33.06 52.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.8 -0.714 . . . . 71.25 112.521 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 29.6 mt -50.38 -45.69 55.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 75.33 110.923 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -44.54 77.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 72.2 110.912 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.5 mt -64.9 -41.36 95.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 74.45 110.921 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 64.7 t60 -61.67 -38.85 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 75.23 110.901 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.6 -46.09 63.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 70.01 111.091 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 79.2 mt -52.5 -38.95 60.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 75.14 110.928 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -46.4 90.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 72.03 110.823 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.6 mt -56.54 -24.82 49.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.93 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.7 mt -87.32 -54.53 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 74.42 110.935 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.4 pttt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 75.41 110.955 179.802 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.857 0.36 . . . . 62.34 110.837 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.58 45.05 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.908 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.72 173.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 71.33 110.839 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.4 t -142.42 124.16 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 74.5 111.18 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -168.68 35.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 65.02 110.925 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -139.19 150.1 45.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.883 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.44 179.74 7.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 75.43 111.16 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.1 t 60.72 96.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.092 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mm -89.03 154.86 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 71.22 111.082 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -150.84 172.96 14.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 64.35 110.854 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -104.61 -169.42 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.35 110.889 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -74.14 -26.18 60.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.882 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p -102.43 -35.48 8.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 75.31 111.135 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.16 -2.5 43.95 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 52.33 112.459 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 t -50.55 -33.26 21.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 53.14 111.195 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.0 mt -127.89 158.77 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 74.52 111.095 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 p -176.21 166.61 2.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 74.15 110.838 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.14 -172.7 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 75.22 111.12 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 t -171.75 130.67 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 74.15 110.796 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 121.72 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.053 -0.521 . . . . 73.41 110.869 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.26 -49.02 3.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.912 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -148.41 59.39 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 71.34 110.887 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.42 -81.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.52 110.929 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -82.93 -17.2 44.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.862 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.1 t -96.85 118.52 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.15 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -126.14 160.11 31.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 73.04 110.918 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.3 t -120.95 110.89 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 74.01 111.111 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -99.78 136.88 39.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 74.3 110.794 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.9 m -133.7 127.96 33.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.51 111.198 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.9 pm0 -120.91 -176.15 3.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 74.54 110.891 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 tp -135.75 138.36 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 71.22 110.889 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.82 135.67 4.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 65.5 112.438 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.25 140.59 43.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.409 . . . . 70.42 110.797 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -105.74 -31.94 8.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 75.03 110.865 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -170.57 42.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 74.4 110.889 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.31 7.03 31.0 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.797 -0.715 . . . . 71.32 112.52 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -146.25 122.86 11.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.362 . . . . 73.44 110.908 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.55 129.36 39.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 74.05 111.107 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -120.44 125.07 27.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.601 0.715 . . . . 71.44 111.118 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 142.96 49.37 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.66 2.24 . . . . 65.35 112.342 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 t -142.15 110.99 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.51 110.822 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -100.29 146.37 27.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 71.42 110.883 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.677 ' HA3' ' HD2' ' A' ' 56' ' ' ASP . . . -133.37 -114.34 1.51 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.708 -0.758 . . . . 54.2 112.468 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -178.86 144.58 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.839 0.352 . . . . 72.41 110.989 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.88 131.91 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.52 111.124 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.2 mt -101.24 124.85 47.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.924 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.56 55.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 73.43 110.893 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 p -63.21 176.74 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 63.4 111.16 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 t -99.22 16.74 21.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 64.33 110.895 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.54 33.24 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.917 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.94 134.65 7.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 54.13 112.493 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mt -62.72 161.15 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.35 . . . . 73.54 110.918 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.6 t -139.91 143.38 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.33 111.168 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.2 129.73 56.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 73.52 110.857 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.1 t -79.12 -1.87 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 74.33 111.222 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.677 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 3.0 p-10 179.44 130.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 73.23 110.844 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 p -67.79 -166.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 73.04 110.805 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.6 t -94.61 -174.07 3.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 70.03 110.894 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -70.21 -36.11 74.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 71.25 110.935 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.74 164.31 31.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 60.44 110.854 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -63.18 -28.46 70.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 53.12 110.865 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -78.43 -25.48 46.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.914 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.47 -46.43 12.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.994 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 t -55.41 -28.49 54.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 72.4 111.18 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -55.9 -43.09 76.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 64.2 110.877 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.21 0.28 41.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 71.44 110.898 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.6 tp -99.42 -50.68 4.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 74.11 110.9 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.1 mt -64.93 -35.29 74.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 73.24 111.164 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.99 -16.75 60.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 73.01 110.916 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 32.1 mtp -76.57 -59.19 2.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 75.11 110.923 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.0 m -60.11 -33.3 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 74.13 111.158 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -87.76 49.72 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 74.11 110.896 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -147.65 -40.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 75.21 110.884 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.8 -26.63 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 63.42 110.838 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.507 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 38.8 m-85 -89.52 10.89 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 74.51 110.885 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.507 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.71 46.93 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 72.32 110.896 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -146.97 -178.8 6.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 75.31 110.905 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.28 142.71 50.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.888 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.48 130.81 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 74.14 111.09 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.5 p -142.86 24.74 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 70.13 111.11 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -157.85 133.95 9.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 75.02 110.928 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -140.24 101.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.14 111.134 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.8 mt -78.45 114.17 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 75.12 111.117 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.5 mm -100.84 124.76 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 75.51 111.101 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.9 p -81.93 -59.02 2.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 61.51 111.141 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -128.18 -175.11 3.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 75.45 110.895 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.97 100.2 10.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 71.24 111.127 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -153.84 160.6 42.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 74.21 110.84 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.78 -28.9 62.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 75.41 111.071 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.8 12.45 19.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.4 110.875 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -124.36 -50.43 1.77 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.971 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.85 15.69 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 73.44 111.106 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.7 -37.07 33.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 74.24 112.53 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.0 19.39 43.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 72.03 112.473 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 tt -45.83 -31.13 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 74.15 111.124 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.46 -55.46 17.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 71.43 110.962 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.9 m -57.57 -41.43 81.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 60.5 111.104 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.6 mt -58.44 -28.52 65.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.34 110.881 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -100.94 23.4 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 73.4 110.864 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -116.7 -39.7 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 74.21 110.877 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -88.4 -22.9 23.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 71.43 110.862 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.48 18.51 4.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.751 . . . . 74.44 112.482 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.84 155.71 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.915 0.388 . . . . 70.31 111.09 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -119.03 119.76 35.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 74.22 110.891 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.73 78.98 9.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 72.03 111.037 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -53.8 144.94 17.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 75.53 110.886 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.33 160.97 0.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 60.23 110.914 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.4 p -76.66 -177.66 4.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 73.3 111.177 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.3 -31.62 60.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 72.4 111.116 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.3 tp -74.68 -46.98 34.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.951 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -53.6 -27.7 28.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 54.54 111.098 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.89 -33.52 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 73.31 111.135 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.53 -39.58 67.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.855 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.543 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 38.3 mt -84.0 -23.65 30.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 74.25 110.958 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.62 -68.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.079 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -53.14 -28.57 26.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 74.2 110.933 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -23.63 51.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 73.41 110.828 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -95.1 -32.41 13.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 70.13 110.889 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.31 -7.25 5.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 62.03 112.557 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -59.5 -172.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 72.42 110.94 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.93 -3.09 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 75.55 110.914 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 66.29 132.34 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.656 0.741 . . . . 75.32 110.914 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -170.23 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.658 2.239 . . . . 62.33 112.342 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -53.53 -43.21 68.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.913 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 63.0 54.59 32.14 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 74.43 112.478 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -152.4 48.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.335 . . . . 74.52 110.844 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tp -131.7 167.54 19.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.253 -0.431 . . . . 73.43 110.924 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -126.18 -168.68 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 74.23 110.904 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 98.5 m -50.02 -56.44 10.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.427 . . . . 71.32 111.143 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.8 m -131.65 145.62 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 71.31 111.156 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.2 m -152.97 113.23 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.13 111.122 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.28 87.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.426 . . . . 72.33 110.882 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.04 159.69 27.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.962 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.24 130.9 8.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 75.44 110.911 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -128.29 45.1 2.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 72.12 110.908 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.62 111.56 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 64.44 112.538 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 63.65 28.8 15.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 74.22 110.868 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 59.7 tpp -155.36 125.38 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 74.1 110.873 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -114.26 122.25 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.05 110.846 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.3 t -130.75 159.28 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.105 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -159.27 122.06 3.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 71.2 110.841 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -178.28 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.08 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -174.86 135.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.891 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -120.53 95.03 49.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.663 0.744 . . . . 74.31 110.919 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -48.71 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.686 2.257 . . . . 62.34 112.287 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.22 -155.44 24.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 73.44 112.451 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.03 123.59 37.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 72.11 110.858 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.47 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.69 -98.03 0.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.708 -0.758 . . . . 73.53 112.438 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -68.84 -27.64 66.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 74.13 110.878 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.62 154.02 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 75.41 111.131 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.57 -32.55 65.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.865 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.543 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 3.0 p30 -116.31 51.73 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 71.34 110.925 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.47 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.75 138.8 36.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 74.45 110.865 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 6.8 pt -139.37 167.22 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 75.13 111.121 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 m -117.75 147.73 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 63.43 111.131 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -100.67 142.66 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 75.42 111.115 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -128.9 147.35 50.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.915 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.8 mt -125.11 95.91 40.8 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.62 0.724 . . . . 74.24 110.894 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 72.4 1.43 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.674 2.25 . . . . 73.11 112.343 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.5 -34.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 73.24 110.942 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -116.97 -13.51 10.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.54 110.985 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.17 25.37 5.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 64.11 110.926 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -98.13 118.0 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 75.34 111.151 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.39 137.14 41.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 72.21 110.875 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.4 t -118.94 65.15 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 75.34 111.08 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.25 -52.77 34.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 53.42 112.444 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 103.5 -132.07 10.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.796 -0.716 . . . . 60.42 112.463 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 34.0 m -65.14 -23.66 67.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 61.24 110.886 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 24.5 tp -64.02 -52.1 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.51 110.871 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.44 109.06 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 74.22 111.107 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.37 149.87 28.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.923 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.3 t -72.42 164.32 26.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 65.34 110.889 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.84 -29.1 68.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 74.22 111.115 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.73 -26.57 62.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 63.14 110.845 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.69 159.48 5.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 61.4 111.076 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.88 -30.78 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 75.34 110.791 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -152.68 177.15 10.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 63.31 110.862 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.8 -40.27 28.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 72.1 110.937 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 99.4 -152.9 19.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 35.44 112.523 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -53.02 133.94 38.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 75.41 110.9 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.63 31.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 74.12 111.162 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.29 -42.54 77.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 75.44 111.168 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.98 34.89 5.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 74.03 110.8 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.54 162.7 23.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 70.52 111.118 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -115.3 93.53 4.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 73.5 110.885 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 66.1 t -69.11 -21.29 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 73.04 111.154 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.39 -26.02 30.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 71.01 110.878 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -97.9 -21.08 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.43 110.87 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.15 -56.89 10.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 71.31 110.909 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 25.8 p -52.01 -36.91 51.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.856 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -70.82 -35.24 72.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 75.4 111.172 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.7 m -66.47 -52.18 48.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 63.02 110.841 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 mm -56.47 -37.95 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.171 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -62.08 -24.15 66.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 72.04 110.879 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -89.35 -25.54 21.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 70.15 110.909 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 43.2 t -81.89 -33.59 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 75.21 111.194 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.72 -25.53 35.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 73.53 110.904 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -83.08 -44.4 15.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.928 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -56.21 -29.05 60.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 74.14 110.891 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -142.58 119.15 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 74.41 110.866 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.31 34.41 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 74.13 110.906 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.85 22.19 1.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 72.02 110.834 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.5 mp -52.29 147.53 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.141 -0.481 . . . . 72.42 111.106 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -109.86 -25.77 10.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.109 -0.496 . . . . 72.4 110.909 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -163.58 132.54 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 72.51 111.124 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 89.0 t -115.12 122.15 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 75.21 111.097 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.28 109.7 63.52 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.609 0.719 . . . . 64.41 111.141 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.83 -167.99 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.711 2.274 . . . . 63.43 112.286 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.37 -32.23 6.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 62.51 112.522 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -138.49 101.16 4.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 74.55 110.887 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 150.99 -113.86 0.61 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 72.51 112.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.77 167.96 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 70.12 110.878 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.31 150.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 74.45 111.123 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.75 -107.05 0.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 73.1 112.492 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -162.92 -170.15 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 73.44 110.836 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -20.33 37.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 75.21 110.942 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.13 63.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.787 -0.72 . . . . 74.34 112.477 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 31.5 mt -51.07 -45.35 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.874 0.369 . . . . 73.14 110.905 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.5 mp -55.93 -42.96 76.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.891 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.4 mt -66.73 -41.41 87.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 72.43 110.963 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -61.58 -39.27 90.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 75.45 110.885 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.68 -42.85 62.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 75.24 111.15 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 26.4 mt -61.19 -40.43 93.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 75.5 110.962 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -39.62 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 63.12 110.858 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.71 -26.28 68.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 74.4 110.93 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 5.3 mt -85.6 -42.09 14.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 72.21 110.921 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.2 mttt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.891 179.786 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.806 0.336 . . . . 73.24 110.868 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.46 118.52 4.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 74.31 110.852 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.36 167.06 6.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 62.11 110.934 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.01 134.68 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 73.25 111.133 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.44 26.44 0.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 74.01 110.878 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 148.73 44.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 74.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.65 -179.99 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 62.42 111.167 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.9 t 60.42 95.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 74.52 111.123 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mm -90.3 153.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 75.5 111.132 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.23 172.29 13.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 71.01 110.884 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -107.22 179.0 4.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.875 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -63.65 -28.05 69.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.869 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -102.27 -33.82 9.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.14 -0.482 . . . . 64.32 111.132 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.58 -5.92 48.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 73.13 112.452 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -50.78 -33.09 21.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.762 0.315 . . . . 71.53 111.125 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 mt -126.36 150.86 32.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 75.14 111.106 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 p -171.16 163.76 7.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 73.15 110.851 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.25 -175.8 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 72.25 111.112 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 t -167.15 135.54 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.03 110.792 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -71.5 117.87 13.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.112 -0.495 . . . . 73.05 110.919 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -99.75 -73.11 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 73.45 110.93 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -132.31 -170.37 2.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.939 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -52.67 109.97 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 75.3 110.913 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 58.47 24.26 11.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.842 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.28 114.94 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 64.3 111.128 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -124.76 160.64 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.31 110.875 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.98 108.69 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.071 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -102.3 138.24 39.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 74.42 110.873 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.0 m -138.77 117.5 12.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 71.11 111.135 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -101.39 -172.89 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 64.14 110.919 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.28 130.45 23.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 54.21 110.905 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.19 132.46 6.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.747 -0.74 . . . . 70.53 112.479 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.4 147.8 5.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 71.33 110.871 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -173.22 118.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 75.43 110.879 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.12 38.08 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 71.44 110.895 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.69 34.78 89.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.683 -0.77 . . . . 72.11 112.524 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -151.7 -172.79 4.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.8 0.333 . . . . 72.12 110.941 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.7 132.65 54.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 72.35 111.165 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.424 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 61.1 t -134.08 104.05 11.62 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.699 . . . . 74.13 111.07 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.9 Cg_endo -69.72 142.67 48.76 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 75.04 112.322 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.63 114.53 20.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 64.23 110.84 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -60.81 169.94 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 72.3 110.863 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.53 ' HA2' ' HD2' ' A' ' 56' ' ' ASP . . . -172.28 -166.68 31.25 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.701 -0.762 . . . . 75.24 112.466 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.2 145.52 10.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 74.11 110.832 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.8 t -129.67 134.13 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 71.21 111.136 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.7 mt -102.71 126.72 49.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.901 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -97.32 59.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 63.34 110.878 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.1 p -68.04 171.6 6.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 74.33 111.091 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -97.13 30.2 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 74.1 110.875 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -156.54 35.52 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 74.33 110.935 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.74 126.03 5.54 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.787 -0.721 . . . . 60.51 112.506 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.9 mt -56.81 172.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 62.51 110.956 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.0 t -150.08 143.42 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.233 -0.439 . . . . 74.12 111.094 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.9 128.37 56.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.43 . . . . 73.22 110.944 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.0 t -77.67 -3.77 5.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.446 . . . . 74.31 111.181 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' HD2' ' HA2' ' A' ' 43' ' ' GLY . 0.8 OUTLIER 179.44 134.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.861 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -167.02 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 73.4 110.873 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.4 m -97.33 -175.84 3.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 61.42 110.928 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -64.45 -38.38 90.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 74.21 110.97 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -142.94 167.16 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 74.11 110.829 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.73 -35.77 80.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 75.24 110.789 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -69.39 -23.47 63.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 74.15 110.92 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.8 -50.78 7.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 74.03 110.945 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -60.33 -29.49 68.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 75.4 111.121 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -55.5 -40.65 72.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 73.21 110.872 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -88.15 3.17 50.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 73.42 110.888 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 tp -98.45 -41.75 7.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 73.11 110.942 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.2 mt -65.54 -34.44 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 75.25 111.074 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -69.29 -11.13 60.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.11 110.958 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.4 mtp -81.82 -50.85 8.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 64.24 110.87 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.1 m -67.42 -37.0 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 74.41 111.16 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -79.11 51.85 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 63.44 110.956 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -137.16 -42.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 73.04 110.901 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.15 -19.71 13.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.919 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 24.7 m-85 -91.83 6.2 47.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.893 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.3 pp0? 32.19 48.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.849 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -150.87 -178.14 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.942 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.53 138.91 50.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 73.23 110.859 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.1 t -70.54 132.89 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 74.31 111.103 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.425 ' HG1' ' HD2' ' A' ' 81' ' ' ASP . 37.4 p -139.95 15.06 2.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 73.4 111.158 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.425 ' HD2' ' HG1' ' A' ' 80' ' ' THR . 0.6 OUTLIER -148.65 131.14 15.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 63.01 110.827 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.04 99.34 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 73.01 111.077 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.4 mt -74.24 120.5 23.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 74.41 111.171 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.1 mm -108.12 128.5 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 74.24 111.116 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.0 p -85.47 -58.01 2.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 74.23 111.127 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -128.97 -175.22 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.842 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.16 100.63 10.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 73.54 111.137 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -154.4 160.96 41.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.908 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.84 -28.76 62.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 71.1 111.042 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.0 13.19 17.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 74.22 110.866 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -125.29 -50.78 1.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 71.1 110.877 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.54 15.44 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 73.24 111.133 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.88 -36.95 34.56 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.639 -0.791 . . . . 74.12 112.561 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.97 18.13 50.54 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.785 -0.721 . . . . 73.12 112.502 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 tt -45.92 -31.13 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 73.52 111.127 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -55.09 18.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 74.01 110.948 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -57.54 -40.98 80.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 62.32 111.143 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.5 mt -58.31 -30.05 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.959 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -100.29 23.86 9.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 70.51 110.925 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -114.83 -30.39 6.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 70.23 110.87 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.0 mtp85 -100.26 -21.99 15.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.51 110.892 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.69 13.69 5.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 64.24 112.511 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.8 mt -81.85 155.8 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.94 0.4 . . . . 73.32 111.112 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 124.01 44.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 74.34 110.919 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.52 82.55 6.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 72.52 111.126 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -51.73 143.45 12.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 75.13 110.849 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.73 151.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 73.14 110.832 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.9 p -74.87 175.02 8.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 75.22 111.148 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.26 83.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 70.45 111.03 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -45.89 80.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 74.4 110.95 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.5 m -53.3 -40.68 64.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 60.33 111.179 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.41 -20.99 60.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 62.42 111.035 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -40.45 92.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.861 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.669 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 10.8 mt -87.97 -25.2 23.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 63.45 110.969 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.22 -65.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 71.43 111.118 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -23.83 63.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 61.4 110.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -23.03 67.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 73.54 110.89 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -95.67 -38.49 10.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 73.34 110.955 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.15 -5.64 3.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 75.14 112.543 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -59.5 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 70.22 110.91 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -96.36 -2.88 44.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 71.35 110.908 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 66.21 130.7 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.718 . . . . 73.43 110.884 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.71 2.273 . . . . 72.14 112.348 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.3 mt -53.51 -34.31 57.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.45 110.896 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.08 39.07 49.0 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 75.21 112.466 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -136.34 58.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 74.42 110.876 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.71 -169.86 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 71.31 110.894 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.36 -168.69 3.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.896 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -50.23 -65.32 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 71.23 111.05 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.77 112.14 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 71.12 111.181 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 82.1 m -113.41 111.73 22.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 73.21 111.167 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -73.34 99.52 2.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 73.01 110.85 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.9 mt -88.44 151.1 22.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 73.54 110.885 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.38 128.43 13.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 74.43 110.841 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -130.58 -166.24 1.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 72.14 110.82 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -52.11 98.23 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.683 -0.77 . . . . 75.01 112.501 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 52.72 55.6 8.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 75.43 110.922 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.1 tpt -151.75 151.29 31.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.862 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -134.49 117.39 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.9 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.9 t -130.5 156.13 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 75.11 111.108 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -153.21 123.78 7.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 74.42 110.852 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -178.03 3.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 74.41 111.151 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -175.45 137.49 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.24 110.819 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -120.63 95.89 48.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.725 0.774 . . . . 74.42 110.884 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 -48.74 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.653 2.235 . . . . 74.55 112.306 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.78 -155.94 24.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.771 -0.728 . . . . 70.22 112.512 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.0 124.68 39.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.741 0.305 . . . . 73.25 110.902 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.466 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.46 -94.51 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 74.35 112.453 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -69.83 -28.58 65.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 74.34 110.879 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.24 158.18 43.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 70.24 111.165 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -61.33 -25.42 67.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 70.32 110.949 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.669 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 1.3 p30 -121.42 49.57 1.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 75.24 110.901 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.0 OUTLIER -98.59 138.12 36.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 72.42 110.923 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 7.4 pt -138.41 171.01 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 75.13 111.142 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.6 m -121.24 144.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 74.13 111.131 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.79 142.65 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 73.41 111.162 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -129.05 148.84 51.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 73.42 110.917 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.65 94.74 41.83 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.618 0.723 . . . . 75.21 110.899 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 71.92 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.702 2.268 . . . . 63.32 112.347 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.59 -34.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 74.43 110.886 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -117.7 -12.8 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.12 110.957 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.0 m120 69.18 25.29 5.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 71.21 110.898 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.31 117.66 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.102 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.42 137.65 40.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 75.12 110.875 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.7 t -121.35 63.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 64.13 111.103 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.93 -57.06 13.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 71.22 112.467 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.56 -135.57 12.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 73.21 112.485 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 34.7 m -61.49 -25.11 67.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 63.03 110.878 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.3 -51.85 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.941 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 39.8 t -89.91 103.55 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 72.4 111.15 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -74.47 151.41 39.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 72.33 110.908 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.1 p -74.72 169.51 17.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.009 0.433 . . . . 73.15 110.804 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.92 -36.87 72.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.097 -0.501 . . . . 74.23 111.116 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -37.48 85.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 70.15 110.86 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.26 170.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 72.01 111.043 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -158.4 24.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.889 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -173.35 157.22 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 55.14 110.85 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.4 mt -87.13 -33.37 19.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 73.51 110.906 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 90.3 -166.94 32.35 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 75.54 112.529 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -52.16 112.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 75.21 110.892 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.7 m -108.4 33.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 74.32 111.165 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.38 -42.19 73.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 71.34 111.107 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -116.23 37.07 3.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.875 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.31 164.39 23.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 72.22 111.052 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -116.44 92.75 3.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 63.23 110.901 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 46.1 t -69.57 -22.62 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.32 111.091 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -80.65 -26.57 37.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 73.05 110.882 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -97.84 -22.76 16.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 75.51 110.964 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.5 -57.51 8.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 74.5 110.884 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.84 -35.93 46.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 62.02 110.801 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 94.0 m -72.74 -32.35 65.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 73.14 111.177 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.8 m -69.14 -52.67 25.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 71.42 110.88 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.0 mm -54.32 -41.8 54.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 75.22 111.086 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.71 -19.72 59.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.886 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -93.19 -23.87 18.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 65.33 110.919 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 33.3 t -85.65 -26.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.501 . . . . 73.04 111.159 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.6 pp -89.29 -25.29 21.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 75.3 110.912 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -81.54 -31.37 32.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 70.43 110.922 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -72.67 -28.68 62.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 71.21 110.89 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -141.77 117.18 10.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 74.55 110.984 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -119.5 26.0 9.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.93 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.54 22.58 3.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 64.53 110.893 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.6 146.88 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 71.11 111.121 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -107.23 -25.7 11.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 72.15 110.871 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -164.07 133.39 3.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 55.25 111.163 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.9 t -114.16 124.0 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 74.52 111.133 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.414 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 52.1 t -107.35 104.87 54.18 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.629 0.728 . . . . 75.4 111.125 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.77 178.43 4.59 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.651 2.234 . . . . 50.31 112.307 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.05 -29.38 34.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 65.24 112.512 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -143.14 113.38 7.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 71.43 110.821 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 140.25 -112.61 0.82 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 75.55 112.478 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -155.05 166.55 33.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 74.1 110.888 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.41 150.03 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 74.14 111.168 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.35 -108.34 0.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.832 -0.699 . . . . 73.53 112.541 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -157.98 -173.33 4.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.931 0.396 . . . . 62.22 110.866 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -56.28 -21.53 24.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 72.41 110.869 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -55.41 -31.76 57.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 74.11 112.478 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 37.4 mt -50.91 -46.93 60.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.338 . . . . 75.44 110.869 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.0 mp -55.06 -43.54 73.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 71.45 110.886 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.4 mt -66.65 -41.55 88.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 73.42 110.875 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -61.46 -37.65 84.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 72.23 110.882 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.76 -45.09 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 74.41 111.13 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 49.8 mt -58.16 -39.8 79.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.428 . . . . 74.2 110.872 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.47 -37.58 78.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 73.32 110.906 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.2 mt -68.67 -26.04 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 74.15 110.879 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.1 mt -86.68 -41.66 14.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 64.35 110.917 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 74.33 110.878 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.864 0.364 . . . . 75.44 110.84 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.82 129.99 19.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 65.12 110.894 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.15 175.15 10.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 74.32 110.906 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.6 p -169.91 146.06 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 72.52 111.171 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.21 167.28 4.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 74.41 110.838 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.42 160.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 71.14 110.874 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.8 -179.58 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 74.33 111.206 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.8 t 60.85 99.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 62.01 111.153 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mm -93.26 154.3 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 74.33 111.127 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -149.12 164.02 35.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 72.11 110.938 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -94.7 -169.32 2.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.913 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -23.08 55.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.23 110.902 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.5 p -103.54 -35.99 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 70.34 111.137 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.07 -4.28 45.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 63.03 112.478 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.8 t -50.7 -33.36 22.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.687 0.28 . . . . 74.2 111.184 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.7 mt -127.83 159.46 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 74.02 111.126 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -175.82 167.18 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 65.53 110.807 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.25 -175.78 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 71.53 111.198 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 t -168.98 129.73 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 75.44 110.797 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.51 120.48 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 71.1 110.895 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -103.53 -47.24 4.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.967 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -148.51 54.57 1.01 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 62.43 110.93 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.43 -77.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.25 110.852 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -83.63 -19.46 35.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 74.15 110.893 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.57 118.86 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 55.44 111.1 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -125.25 158.91 32.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.158 -0.473 . . . . 64.25 110.894 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.0 t -121.86 109.52 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 73.04 111.113 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -103.23 138.51 39.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.805 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.7 m -135.39 133.55 38.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 61.4 111.171 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.39 174.61 7.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 73.53 110.881 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.7 tp -121.0 148.24 44.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 75.22 110.852 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.39 -121.86 2.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 74.4 112.493 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.34 150.37 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.877 0.37 . . . . 74.04 110.844 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -171.87 108.27 0.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 72.42 110.889 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.66 53.24 13.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 54.22 110.866 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.06 26.09 67.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.663 -0.779 . . . . 71.4 112.507 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -151.63 121.75 7.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 71.03 110.874 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -52.99 139.52 27.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.1 111.026 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.12 126.68 25.54 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.681 0.753 . . . . 71.31 111.05 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 143.03 49.76 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.625 2.217 . . . . 72.44 112.352 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.0 t -129.96 95.23 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.32 110.825 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.96 162.47 0.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 70.42 110.846 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.66 ' CA ' ' HD2' ' A' ' 56' ' ' ASP . . . -164.09 -162.85 15.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 64.41 112.459 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.43 148.23 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 74.22 110.859 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.43 138.1 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 75.52 111.043 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.8 mt -105.39 136.89 44.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.48 . . . . 74.23 110.903 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -110.24 72.12 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 63.13 110.863 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.7 p -79.47 -173.22 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 65.52 111.162 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 t -107.61 28.05 8.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 74.41 110.87 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -154.32 25.01 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 72.43 110.916 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.45 137.35 5.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 73.13 112.494 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.2 mt -68.65 164.36 21.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 74.22 110.9 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.4 t -140.0 144.51 27.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 72.04 111.088 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.28 130.35 56.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.915 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.7 t -79.57 -1.72 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 71.14 111.179 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.66 ' HD2' ' CA ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER 179.5 130.58 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 75.13 110.895 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.7 m -67.19 -168.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.836 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.47 -172.31 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 74.11 110.848 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -72.9 -44.92 60.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.495 . . . . 75.14 110.888 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -132.68 151.12 52.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.913 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -54.55 -30.81 55.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.448 . . . . 73.13 110.853 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -76.75 -26.84 55.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 74.01 110.862 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 -46.23 17.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 74.44 110.933 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 t -56.12 -25.38 45.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 74.23 111.111 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -55.28 -43.63 74.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.894 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -81.54 -4.5 56.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 65.5 110.877 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.4 tp -93.84 -45.62 7.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.219 -0.446 . . . . 74.54 110.927 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.0 mt -69.91 -33.42 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 64.02 111.096 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -67.61 -12.64 60.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 70.32 110.956 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.9 mmm -84.74 -59.47 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 62.4 110.944 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.0 m -55.04 -36.26 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 71.23 111.2 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -88.13 48.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 74.11 110.869 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -142.92 -41.87 0.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 72.44 110.939 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -24.54 13.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 72.22 110.878 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.516 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 37.4 m-85 -90.34 11.32 21.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 65.4 110.873 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.516 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.5 pp0? 32.69 47.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 71.42 110.874 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -150.85 -178.43 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.881 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 149.16 50.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.87 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.26 127.21 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 75.21 111.156 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 p -139.03 24.41 2.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 74.11 111.205 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.74 133.51 13.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.889 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 t -139.88 102.39 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 73.31 111.137 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.1 mt -79.11 115.68 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 74.14 111.134 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.4 mm -104.35 122.3 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 73.13 111.094 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.1 p -79.16 -58.25 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 74.13 111.148 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -127.36 -175.09 3.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 70.24 110.865 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.82 99.39 9.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 61.52 111.111 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -152.88 159.66 43.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.834 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.69 -22.96 58.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 74.25 111.155 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.86 3.59 54.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 72.4 110.881 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.5 mmt-85 -118.1 -52.17 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 75.53 110.867 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.78 19.31 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.12 111.133 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.84 -29.29 26.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 52.44 112.484 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.36 22.05 20.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 74.11 112.483 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 tt -45.38 -32.05 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 64.44 111.129 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -54.89 18.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 65.42 110.906 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 m -56.05 -40.02 72.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 63.0 111.207 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.5 mt -59.22 -35.52 73.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 75.22 110.921 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.95 19.38 9.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.939 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.13 -25.95 6.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 74.51 110.92 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -106.48 7.52 30.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 73.23 110.801 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.99 14.69 66.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 61.42 112.49 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.0 mt -80.79 154.19 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.877 0.37 . . . . 74.54 111.147 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -117.41 119.56 35.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 74.11 110.863 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.05 81.3 6.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.42 111.052 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -54.55 147.54 14.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 63.43 110.825 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.73 157.99 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 60.3 110.834 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.3 p -82.35 157.68 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.42 111.146 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.34 -39.42 56.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.41 111.091 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -40.98 91.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 70.35 110.926 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.8 m -56.29 -41.68 76.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 74.31 111.175 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.44 -22.58 60.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.4 111.064 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.66 -41.22 81.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 71.13 110.943 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.726 ' HB2' ' HD2' ' A' ' 152' ' ' ASP . 7.7 mt -84.05 -27.71 28.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 72.03 110.956 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.43 -69.49 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 70.44 111.144 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -55.19 -26.3 38.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 71.22 110.912 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -24.5 67.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 74.15 110.873 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -93.56 -39.08 11.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.91 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 137.24 -6.7 3.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 73.2 112.494 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -59.75 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.931 0.396 . . . . 71.15 110.906 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -97.55 -1.76 43.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.041 -0.527 . . . . 75.33 110.925 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 66.38 129.93 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.601 0.715 . . . . 75.03 110.938 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.42 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.708 2.272 . . . . 73.35 112.338 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.4 mt -51.96 -46.53 64.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.888 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.86 57.75 14.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.798 -0.715 . . . . 74.23 112.509 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -152.09 51.07 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 72.35 110.869 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 mp -129.91 -177.47 4.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.88 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.58 -168.38 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.22 110.906 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 98.0 m -49.73 -45.21 49.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.14 111.119 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.31 142.6 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 74.44 111.157 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.6 m -149.56 110.89 4.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 72.43 111.139 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.02 98.93 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.834 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.8 mt -89.19 150.22 22.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 74.41 110.887 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.18 109.6 4.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 73.31 110.933 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -112.5 113.03 24.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 70.33 110.782 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 54.78 -101.06 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.756 -0.735 . . . . 65.21 112.446 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -120.08 54.78 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.346 . . . . 65.43 110.899 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.1 tpp -142.05 155.29 45.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 73.11 110.899 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.66 119.42 27.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.864 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.9 t -136.44 159.89 37.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 73.41 111.115 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -163.12 123.67 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 74.34 110.915 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.0 178.3 4.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.12 111.156 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -172.72 135.03 0.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 72.24 110.836 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -117.21 92.13 38.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.763 0.792 . . . . 71.54 110.964 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.6 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.642 2.228 . . . . 55.23 112.345 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.02 -170.46 43.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.806 -0.712 . . . . 72.14 112.537 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -83.78 125.14 31.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 75.41 110.924 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.474 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.73 -87.23 0.23 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 71.12 112.468 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -77.89 -28.57 49.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 73.43 110.761 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.16 159.39 43.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.41 111.136 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.05 -23.66 67.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.828 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.726 ' HD2' ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -125.29 52.89 1.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 71.31 110.921 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.7 p30 -100.35 148.3 24.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.851 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.7 pt -147.04 162.5 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.4 111.128 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.0 m -109.73 139.01 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.13 111.202 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.5 t -93.35 129.18 44.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.42 111.07 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -117.06 150.6 38.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 71.53 110.946 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 26.3 mt -127.05 97.64 31.84 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.619 0.723 . . . . 73.32 110.992 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.4 Cg_endo -69.7 70.86 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.684 2.256 . . . . 74.45 112.339 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.35 -34.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 74.05 110.884 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -118.34 -11.64 10.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 64.32 110.886 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.0 m120 67.34 21.97 9.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 75.2 110.892 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.15 115.26 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 73.14 111.155 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -98.98 123.14 43.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 71.42 110.912 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 18.3 t -117.58 73.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 63.25 111.086 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.06 -45.63 93.36 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.732 . . . . 54.22 112.521 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.42 -131.21 10.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 54.32 112.557 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.9 m -63.33 -22.45 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.818 0.342 . . . . 75.2 110.857 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -50.01 68.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.919 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.02 112.92 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 70.14 111.148 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -83.0 154.45 24.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 74.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 15.8 p -78.13 162.11 26.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 74.01 110.889 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.5 p -66.06 -25.65 67.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 73.45 111.198 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 64.4 p -71.51 -31.44 67.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 52.11 110.912 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.08 170.86 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 74.45 111.114 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -152.18 22.59 0.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.931 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.37 168.74 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.873 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mt -93.91 -35.75 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 74.4 110.887 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.67 -167.08 24.21 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.743 . . . . 72.41 112.453 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -52.04 121.04 6.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 74.31 110.877 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.1 m -111.57 31.67 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 72.21 111.155 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.73 83.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 70.22 111.092 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -119.2 34.83 5.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.01 110.858 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.13 164.85 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.11 111.106 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -117.61 92.17 3.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.93 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.64 -23.88 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 75.35 111.108 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.28 -26.48 42.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 75.41 110.79 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.69 -24.07 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 72.51 110.879 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.55 -54.49 26.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 75.44 110.928 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -34.55 44.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 65.52 110.813 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 61.4 m -74.29 -35.71 63.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 74.23 111.15 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 45.6 m -66.07 -55.55 16.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 71.42 110.905 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.3 mm -54.21 -46.99 68.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 73.41 111.122 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.38 -22.31 53.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.948 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -91.29 -25.03 19.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 72.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 91.8 t -84.05 -24.27 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 75.1 111.12 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 pp -95.85 -8.13 34.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 73.3 110.979 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -113.15 -5.87 13.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 63.51 110.873 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -88.5 -23.83 23.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 72.14 110.838 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -118.41 -60.87 1.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.948 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.75 25.75 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 75.24 110.855 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.95 21.75 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.858 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 4.0 mp -55.33 145.0 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 72.31 111.134 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -106.86 -31.36 8.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.33 110.922 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -160.07 117.46 2.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 75.43 111.155 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.9 t -95.86 125.62 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 72.13 111.15 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.46 109.07 62.47 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.581 0.705 . . . . 70.4 111.159 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -169.95 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.658 2.239 . . . . 73.11 112.35 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -106.49 -24.53 6.72 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.753 -0.736 . . . . 73.23 112.479 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -146.07 84.0 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 73.53 110.813 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 168.13 -102.0 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.759 . . . . 71.24 112.513 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.34 147.33 4.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.867 0.365 . . . . 72.01 110.876 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.62 143.89 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.132 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.56 -102.96 0.46 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 54.32 112.509 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -161.41 -169.83 2.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.801 0.334 . . . . 75.5 110.874 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -56.49 -21.77 28.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.865 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.82 -33.57 56.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.78 -0.724 . . . . 73.51 112.523 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 31.3 mt -50.86 -49.37 59.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 72.34 110.923 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.64 -42.25 67.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.89 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 6.7 mt -67.6 -41.39 84.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.93 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.4 -35.59 79.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.856 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -45.17 88.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 75.45 111.191 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.8 -37.86 71.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.963 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -42.81 97.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 72.55 110.946 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.25 -35.19 78.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.933 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.57 -29.49 46.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.41 110.862 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.4 mttp . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 73.04 110.834 179.925 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 18' ' ' ILE . 91.5 t . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.719 0.295 . . . . 72.4 111.137 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.73 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.1 mm -89.85 153.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 74.45 111.112 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -145.7 153.09 40.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 74.11 110.934 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -92.2 165.51 13.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.292 -0.413 . . . . 75.25 110.882 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.96 -35.13 45.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 60.45 110.844 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -88.06 -31.61 19.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.52 111.131 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.02 -12.9 67.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 73.11 112.523 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.727 HG23 HG13 ' A' ' 16' ' ' ILE . 2.2 t -51.05 -32.26 21.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 72.14 111.156 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.727 HG13 HG23 ' A' ' 15' ' ' THR . 16.5 mt -121.72 147.73 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 60.24 111.125 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -167.57 169.34 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 53.21 110.856 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.531 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -134.52 -176.04 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 64.33 111.117 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.3 t -166.97 133.79 2.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 65.43 110.859 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -70.17 118.12 12.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 75.41 110.875 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HG ' HG23 ' A' ' 27' ' ' VAL . 2.7 mm? -102.92 -42.36 5.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.924 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.62 -169.95 3.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 71.44 110.859 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -47.61 63.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 73.3 110.919 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -134.59 28.69 3.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.905 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.43 120.57 60.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.089 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -125.66 159.28 32.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.938 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 213' ' ' VAL . 73.5 t -121.74 108.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 65.21 111.122 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.531 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.0 p80 -101.17 138.26 38.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.33 110.832 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.1 m -137.01 124.39 21.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 60.12 111.156 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.589 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -110.68 177.46 4.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 51.4 110.888 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.431 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -132.78 135.76 45.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 74.21 110.929 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 70.32 112.499 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 98.1 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.646 0.736 . . . . 43.33 111.189 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.7 Cg_endo -69.67 142.7 49.03 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.641 2.227 . . . . 70.33 112.451 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -124.15 105.52 9.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 54.22 110.848 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -59.42 159.48 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 54.25 110.845 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.639 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -160.56 -160.22 10.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.74 . . . . 41.05 112.545 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.953 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -164.91 144.93 7.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 74.3 110.872 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 54' ' ' LEU . 54.1 t -128.62 134.76 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 73.32 111.078 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.49 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 19.2 mt -103.47 136.13 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 63.42 110.952 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -106.34 74.82 1.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.818 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.6 p -83.1 177.84 8.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 73.51 111.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.44 30.51 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 70.43 110.845 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -155.6 24.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 50.22 110.893 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.61 130.81 4.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 65.42 112.457 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.775 HD21 ' HB3' ' A' ' 75' ' ' PHE . 16.7 mt -59.98 166.76 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.845 0.355 . . . . 72.11 110.855 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 81' ' ' ASP . 60.1 t -141.17 144.59 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.11 111.168 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -116.77 128.23 55.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.932 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 55' ' ' VAL . 15.1 t -77.95 -3.04 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 70.11 111.136 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 179.23 132.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 72.53 110.87 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -71.34 -167.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 73.23 110.818 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.56 -173.28 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 71.32 110.825 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.798 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.4 m95 -67.55 -42.01 83.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 75.52 110.891 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.85 161.48 37.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 62.34 110.857 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.99 -38.07 69.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 64.42 110.86 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -71.45 -23.93 61.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 75.42 110.879 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -82.3 -45.1 15.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 71.44 110.93 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.0 t -67.02 -25.37 66.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 53.3 111.149 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -53.09 -39.2 63.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 64.23 110.901 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -85.54 -14.56 45.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 71.32 110.827 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.589 HD22 ' OE2' ' A' ' 30' ' ' GLU . 15.2 tp -77.76 -45.57 24.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.964 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.9 mt -71.73 -33.28 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.12 111.12 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.88 -17.15 62.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 72.51 110.846 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.2 mmm -85.43 -55.55 3.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.825 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.748 ' HB ' HD13 ' A' ' 52' ' ' LEU . 27.3 m -57.22 -37.2 55.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 71.23 111.068 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HG3' HG23 ' A' ' 71' ' ' VAL . 57.3 mt-10 -86.71 49.95 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 62.4 110.851 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tpmp? -145.43 -42.13 0.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.908 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.73 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.82 -23.43 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 73.43 110.843 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.775 ' HB3' HD21 ' A' ' 52' ' ' LEU . 34.6 m-85 -90.04 11.24 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 75.02 110.923 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.51 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.92 46.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 74.41 110.892 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -154.29 -178.59 7.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 62.35 110.863 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.42 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -127.09 149.49 49.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.2 110.825 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 52' ' ' LEU . 68.5 t -84.1 126.63 40.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 71.22 111.099 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.42 HG23 ' HD3' ' A' ' 78' ' ' ARG . 22.5 p -135.8 26.55 3.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 50.01 111.175 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.754 ' HB2' HG22 ' A' ' 53' ' ' VAL . 8.7 m-20 -158.33 135.27 9.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.865 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.643 HG21 ' CD2' ' A' ' 98' ' ' LEU . 20.5 t -140.55 99.87 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 71.41 111.079 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.9 mt -77.21 126.0 37.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 73.54 111.06 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.646 HG23 ' HB3' ' A' ' 91' ' ' ARG . 34.6 mm -112.99 123.27 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 71.22 111.165 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.1 p -81.0 -52.81 7.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 75.44 111.125 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -135.33 167.63 20.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.853 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -86.89 98.7 11.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 70.55 111.145 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.651 ' O ' HD13 ' A' ' 92' ' ' ILE . 1.4 m170 -153.0 160.38 43.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 74.42 110.863 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.31 -28.09 62.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 75.51 111.027 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.09 11.13 21.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.833 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.646 ' HB3' HG23 ' A' ' 84' ' ' ILE . 4.9 mmt180 -123.83 -52.62 1.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 72.11 110.924 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.79 16.92 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 70.55 111.165 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.42 -27.74 26.24 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.729 -0.748 . . . . 72.35 112.47 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.79 19.26 30.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.652 -0.785 . . . . 33.24 112.414 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.439 HG21 ' H ' ' A' ' 121' ' ' GLU . 4.2 tt -48.73 -30.64 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 63.25 111.214 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -68.45 -43.97 75.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 63.24 110.855 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -69.38 -33.48 73.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 64.14 111.163 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.643 ' CD2' HG21 ' A' ' 82' ' ' VAL . 58.8 mt -63.75 -27.3 69.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 72.41 110.973 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.71 19.07 16.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 74.02 110.933 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.75 -23.87 7.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.911 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -110.87 10.02 22.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 72.03 110.865 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.17 18.76 66.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 70.14 112.471 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.0 mt -83.18 157.59 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 70.25 111.105 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.67 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -121.3 119.78 33.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 64.3 110.895 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.527 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . . . -89.05 79.56 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 74.43 111.151 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.581 ' HA ' HD12 ' A' ' 124' ' ' LEU . 96.9 m-70 -54.36 146.98 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 74.21 110.909 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.5 163.86 0.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.923 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 127' ' ' LEU . 81.1 p -80.37 154.9 27.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 61.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.59 -29.88 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 44.13 111.104 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 152' ' ' ASP . 6.6 tp -74.87 -43.25 55.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.935 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.0 m -53.19 -27.44 21.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 63.25 111.17 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.3 -28.02 21.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.056 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -60.12 -25.17 65.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.413 . . . . 75.32 110.887 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.653 HD12 ' OD1' ' A' ' 152' ' ' ASP . 47.6 mt -99.07 -24.67 14.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 65.23 110.88 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.65 -63.14 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.11 111.106 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -55.62 -25.74 40.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 74.33 110.855 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -24.67 65.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 71.14 110.875 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -95.32 -28.33 15.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.1 110.863 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.07 -5.44 7.82 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 71.4 112.442 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -59.6 -173.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 73.15 110.926 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.439 ' H ' HG21 ' A' ' 95' ' ' ILE . 25.4 mm-40 -99.65 1.09 43.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.489 . . . . 53.14 110.911 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 65.69 122.84 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.719 0.771 . . . . 74.25 110.916 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.73 -170.52 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.647 2.231 . . . . 74.12 112.37 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 104' ' ' LYS . 60.1 mt -52.16 -40.49 61.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.44 110.877 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.03 59.59 8.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 62.01 112.547 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -152.75 51.23 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 73.21 110.889 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB3' HG22 ' A' ' 108' ' ' THR . 1.2 mp -130.1 -175.74 3.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 63.42 110.913 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.44 -167.93 2.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 60.1 110.952 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.794 HG23 ' HB3' ' A' ' 144' ' ' TYR . 96.3 m -49.15 -43.41 41.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 73.51 111.176 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 142' ' ' THR . 3.6 m -141.47 141.7 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 74.23 111.093 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 HD23 ' A' ' 133' ' ' LEU . 60.7 m -148.88 112.14 4.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.173 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.34 96.06 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 74.25 110.831 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.642 HD23 HG22 ' A' ' 131' ' ' THR . 3.7 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 51.31 110.889 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.73 ' HB2' HG22 ' A' ' 48' ' ' THR . 3.0 tpp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.876 0.37 . . . . 63.55 110.88 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 118.45 25.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.55 110.872 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.665 HG13 HD23 ' A' ' 158' ' ' LEU . 4.5 t -134.98 159.18 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 73.41 111.169 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.412 ' N ' HG12 ' A' ' 140' ' ' VAL . 32.3 tt0 -158.98 124.45 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 61.42 110.98 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.41 ' O ' HG12 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -75.16 178.5 5.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 55.4 111.096 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -171.98 136.76 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.842 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.794 ' HB3' HG23 ' A' ' 129' ' ' THR . 33.0 t80 -116.19 92.95 37.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.751 0.786 . . . . 74.34 110.896 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -48.72 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.615 2.21 . . . . 73.13 112.29 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.56 -170.38 42.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 72.11 112.479 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -84.26 123.61 30.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 75.13 110.938 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.492 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.18 -89.72 0.24 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.769 -0.729 . . . . 64.35 112.534 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -74.18 -28.27 61.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.367 . . . . 73.21 110.896 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.96 157.81 43.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 62.15 111.204 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -62.45 -25.14 67.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 43.5 110.891 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.653 ' OD1' HD12 ' A' ' 114' ' ' LEU . 16.0 p30 -123.28 52.06 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.901 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.523 ' OD1' HD13 ' A' ' 169' ' ' LEU . 2.0 p30 -99.94 142.71 31.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.968 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.8 pt -144.28 158.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 75.12 111.173 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 196' ' ' VAL . 18.4 m -105.11 150.5 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.44 111.113 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 96.0 t -102.56 139.05 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 72.05 111.116 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -126.99 150.71 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 74.42 110.904 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.665 HD23 HG13 ' A' ' 140' ' ' VAL . 20.7 mt -128.84 95.72 31.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.594 0.711 . . . . 75.41 110.853 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 72.18 1.51 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.699 2.266 . . . . 61.2 112.307 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 179.47 -34.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 65.14 110.908 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.535 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.6 m-85 -117.95 -13.21 10.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.976 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.8 m120 69.0 26.19 5.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 64.2 110.918 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.549 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.6 mp -96.83 117.61 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 51.41 111.107 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.13 138.04 41.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 71.24 110.946 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.499 HG21 HD22 ' A' ' 44' ' ' LEU . 21.7 t -121.52 68.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.31 111.143 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.37 -51.81 35.33 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.552 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.22 -135.44 12.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 52.43 112.501 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 31.4 m -62.22 -26.09 68.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 73.25 110.889 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.523 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.4 OUTLIER -66.14 -49.5 67.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 54.04 110.907 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 206' ' ' VAL . 57.7 t -92.24 96.18 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 71.34 111.099 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -69.06 153.13 44.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.35 110.955 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.698 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.7 p -74.87 167.06 22.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.857 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.447 HG23 HD23 ' A' ' 218' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 75.32 111.152 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 186' ' ' VAL . 17.1 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.808 0.337 . . . . 63.01 111.124 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.7 -46.85 83.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 74.44 111.111 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.56 40.99 2.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 55.51 110.792 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -134.02 165.64 24.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.11 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -116.9 92.25 3.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.889 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.469 ' CG2' HG11 ' A' ' 181' ' ' VAL . 90.3 t -69.59 -23.81 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 52.1 111.19 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -25.81 39.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 74.52 110.904 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -97.75 -23.55 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 70.4 110.937 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -51.29 -54.42 26.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.974 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.3 t -51.88 -33.77 38.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 71.34 110.893 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 82.3 m -76.33 -34.01 59.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 42.24 111.182 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.9 m -66.36 -53.22 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 70.25 110.87 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.784 HG22 HD23 ' A' ' 197' ' ' LEU . 34.6 mm -56.3 -43.15 76.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 73.33 111.163 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.76 -19.77 59.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 70.54 110.884 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.63 -31.09 15.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 50.1 110.858 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.503 ' CG1' HD21 ' A' ' 219' ' ' LEU . 94.2 t -75.5 -50.74 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.11 111.101 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.784 HD23 HG22 ' A' ' 193' ' ' ILE . 3.9 pp -65.08 -24.34 67.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 54.3 110.91 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.43 -43.78 15.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.92 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -52.95 -28.97 26.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.41 110.907 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -144.47 119.94 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.91 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.92 41.05 2.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 71.44 110.817 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.4 21.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.35 110.795 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -52.47 146.83 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 73.45 111.147 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.66 -28.87 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 74.43 110.902 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.447 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -159.61 139.28 11.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 74.11 111.069 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 170' ' ' VAL . 84.6 t -123.18 126.04 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 60.34 111.146 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.953 HG21 HD11 ' A' ' 44' ' ' LEU . 55.8 t -107.66 113.12 61.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 70.51 111.077 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -170.27 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.687 2.258 . . . . 73.34 112.33 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.57 -31.25 7.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.67 -0.776 . . . . 74.45 112.489 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -143.5 94.61 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.827 0.346 . . . . 75.03 110.883 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 160.38 -114.94 0.63 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 74.34 112.454 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -150.27 162.77 39.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.957 0.408 . . . . 71.53 110.864 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.793 HG22 HG22 ' A' ' 207' ' ' VAL . 22.0 t -67.95 150.23 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 72.32 111.095 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.45 -108.81 0.56 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.772 -0.728 . . . . 64.23 112.551 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -159.81 -169.83 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 75.44 110.834 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -58.25 -20.19 40.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 73.52 110.899 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -57.67 -32.27 65.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.778 -0.725 . . . . 51.22 112.485 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.698 HD22 ' HA ' ' A' ' 172' ' ' SER . 32.1 mt -51.03 -42.99 60.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.352 . . . . 65.33 110.892 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.503 HD21 ' CG1' ' A' ' 196' ' ' VAL . 1.0 OUTLIER -60.43 -45.25 94.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 54.22 110.829 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.752 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -64.27 -42.24 96.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 52.2 110.922 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.682 ' NE2' HD21 ' A' ' 225' ' ' LEU . 78.7 t60 -63.86 -39.67 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.963 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.5 m -51.75 -42.49 62.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 64.4 111.122 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' A' ' 226' ' ' LEU . 78.6 mt -59.95 -39.91 87.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.92 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -28.03 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.43 110.849 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.682 HD21 ' NE2' ' A' ' 221' ' ' HIS . 20.6 mt -72.27 -25.81 61.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 73.43 110.925 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.6 mt -87.42 -43.06 12.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 74.13 110.921 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 54.43 110.888 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.582 HG22 ' OG ' ' A' ' 19' ' ' SER . 88.4 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 55.13 111.071 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.88 155.78 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 71.15 111.156 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -145.58 146.62 31.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.913 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 173.72 9.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 73.35 110.94 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.82 -36.01 77.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 61.21 110.893 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.459 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.3 p -95.17 -24.9 16.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 71.41 111.086 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.94 -11.3 57.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.728 . . . . 41.45 112.425 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.808 HG23 HG13 ' A' ' 16' ' ' ILE . 3.7 t -51.09 -33.28 25.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 54.42 111.119 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.808 HG13 HG23 ' A' ' 15' ' ' THR . 18.8 mt -121.64 148.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.04 111.13 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 p -169.2 165.56 10.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 75.23 110.87 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.577 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -132.15 -172.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 70.12 111.134 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.582 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -173.45 134.64 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 75.14 110.876 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.96 119.93 14.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 54.14 110.872 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.406 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.4 mm? -100.96 -55.02 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.882 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -138.47 53.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 73.41 110.894 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mttt 68.0 -76.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 71.53 110.88 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -84.11 -19.52 34.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 63.3 110.916 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.21 121.28 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 64.34 111.164 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -125.45 160.23 29.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.947 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.406 HG23 ' HG ' ' A' ' 21' ' ' LEU . 72.8 t -122.4 112.44 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 62.34 111.081 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.577 ' HB3' HG23 ' A' ' 18' ' ' ILE . 8.7 p80 -105.47 137.6 43.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 65.14 110.93 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 m -133.34 127.72 34.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 51.14 111.137 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.646 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -118.11 164.98 14.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.914 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.493 HD12 ' CA ' ' A' ' 40' ' ' PRO . 5.3 tp -118.84 143.3 47.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.91 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 39' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 72.3 112.508 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.66 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.3 p . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 121.587 0.708 . . . . 63.2 111.172 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.493 ' CA ' HD12 ' A' ' 31' ' ' LEU . 53.8 Cg_endo -69.81 143.43 50.57 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.64 2.227 . . . . 50.21 112.349 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -130.92 95.87 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 74.44 110.857 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -51.94 155.21 1.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 62.21 110.843 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.621 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -155.97 -158.45 8.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.657 -0.782 . . . . 65.44 112.441 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.865 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -166.06 143.91 5.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 74.32 110.942 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.58 HG22 HD13 ' A' ' 54' ' ' LEU . 50.6 t -126.95 142.7 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 63.12 111.152 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.1 mt -111.92 127.5 55.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 53.3 110.908 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -93.33 48.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.871 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.6 p -56.52 166.18 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 60.34 111.127 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.5 t -95.99 34.17 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 72.4 110.843 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -157.65 28.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.43 110.9 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.6 124.1 4.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 75.32 112.516 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.772 HD13 ' HB ' ' A' ' 71' ' ' VAL . 20.1 mt -51.72 161.31 0.54 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.801 0.334 . . . . 74.12 110.88 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.774 HG22 ' HB2' ' A' ' 81' ' ' ASP . 59.8 t -139.74 144.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.114 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.58 HD13 HG22 ' A' ' 45' ' ' VAL . 3.5 mm? -116.63 129.93 56.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.003 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.5 t -80.36 -0.36 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 64.24 111.111 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -179.72 132.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.54 110.845 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 m -71.24 -169.04 0.35 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.216 -0.447 . . . . 75.54 110.851 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.79 -170.75 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 74.2 110.843 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.776 ' HB2' HD13 ' A' ' 63' ' ' LEU . 93.1 m95 -72.86 -40.46 65.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.891 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.77 162.31 35.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 63.21 110.933 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.43 -33.51 67.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 71.23 110.91 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -75.63 -25.46 56.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 71.1 110.958 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -81.75 -41.82 20.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.487 . . . . 72.4 110.939 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -68.03 -26.43 65.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.19 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.1 -43.69 70.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.936 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.05 -13.91 54.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.934 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.646 HD22 ' OE2' ' A' ' 30' ' ' GLU . 17.8 tp -77.35 -45.38 26.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.506 . . . . 75.42 110.926 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.22 -26.72 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 61.02 111.12 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.21 -10.15 59.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 74.34 110.891 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.0 mmm -90.82 -53.0 4.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 52.43 110.834 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.772 ' HB ' HD13 ' A' ' 52' ' ' LEU . 21.5 m -58.4 -39.85 76.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 72.33 111.155 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 71' ' ' VAL . 53.4 mt-10 -84.29 51.09 2.0 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 65.42 110.877 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.14 -41.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 71.13 110.953 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.5 -19.18 13.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 71.22 110.848 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.671 ' HB3' HD21 ' A' ' 52' ' ' LEU . 24.2 m-85 -88.15 9.52 22.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 75.43 110.924 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.96 46.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 71.03 110.862 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -154.32 -179.15 7.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 73.53 110.902 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.21 149.39 51.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 75.43 110.884 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 52' ' ' LEU . 69.9 t -82.22 128.43 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 75.15 111.13 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.5 p -138.94 23.04 2.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 75.4 111.15 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.774 ' HB2' HG22 ' A' ' 53' ' ' VAL . 3.7 m-20 -154.93 132.6 11.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.226 -0.443 . . . . 72.42 110.846 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.637 HG21 HD22 ' A' ' 98' ' ' LEU . 23.4 t -138.6 99.89 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 62.42 111.091 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.0 mt -79.3 124.84 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 73.41 111.129 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 91' ' ' ARG . 38.2 mm -111.51 132.88 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 75.35 111.171 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.5 p -89.05 -55.89 3.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 75.5 111.2 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -133.55 162.37 32.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.32 110.807 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -81.34 97.21 7.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 72.43 111.084 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.635 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.5 OUTLIER -150.91 158.54 44.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 74.53 110.859 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.44 -25.59 59.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.33 111.086 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.37 13.17 18.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 72.32 110.894 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.442 ' O ' HD12 ' A' ' 84' ' ' ILE . 3.3 mpt_? -128.12 -52.36 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 64.02 110.85 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.76 16.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 61.22 111.051 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.85 -27.52 21.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 44.43 112.512 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.11 20.83 23.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.723 . . . . 52.12 112.491 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' H ' ' A' ' 121' ' ' GLU . 4.5 tt -48.48 -30.92 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 63.02 111.166 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -69.16 -43.76 73.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 71.13 110.878 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.5 m -67.84 -34.98 77.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 74.25 111.169 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.637 HD22 HG21 ' A' ' 82' ' ' VAL . 51.4 mt -60.63 -34.73 74.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 74.1 110.874 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.05 22.34 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 74.04 110.954 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -117.42 -20.27 9.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 72.24 110.933 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -115.78 5.9 14.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 74.15 110.872 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.4 60.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 53.51 112.489 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 98' ' ' LEU . 15.4 mt -80.98 155.72 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.909 0.385 . . . . 75.23 111.106 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.785 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -120.48 122.94 41.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 73.51 110.914 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.537 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -90.98 81.61 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 61.42 111.055 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.438 ' ND1' HD12 ' A' ' 124' ' ' LEU . 96.9 m-70 -57.87 146.88 30.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 71.23 110.798 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.21 159.32 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 72.3 110.846 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.0 p -72.81 152.67 41.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 73.41 111.185 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.58 -29.72 18.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.289 -0.414 . . . . 74.04 111.073 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 152' ' ' ASP . 6.7 tp -74.6 -44.49 50.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.859 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 96.7 m -53.17 -27.63 22.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 53.13 111.168 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.422 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -88.66 -26.45 21.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 60.32 111.09 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -61.05 -26.88 67.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.202 -0.454 . . . . 73.33 110.979 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.538 HD13 ' OD2' ' A' ' 152' ' ' ASP . 8.9 mp -96.6 -25.08 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 74.43 110.878 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.3 -64.4 0.88 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 55.3 111.081 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -55.41 -26.04 39.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 75.43 110.884 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -24.37 66.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.11 110.945 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -95.71 -32.2 12.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 73.44 110.87 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.47 -6.64 5.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 72.41 112.475 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -59.53 -173.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 75.42 110.923 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.476 ' H ' HG21 ' A' ' 95' ' ' ILE . 40.2 mm-40 -99.46 -0.64 40.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 72.21 110.892 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.422 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.0 OUTLIER 66.07 125.15 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.606 0.717 . . . . 74.45 110.892 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -170.6 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.69 2.26 . . . . 52.34 112.334 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.785 HD11 ' HB2' ' A' ' 104' ' ' LYS . 61.5 mt -53.66 -35.25 60.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.985 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.35 43.74 65.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 71.33 112.497 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -138.72 57.7 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 71.05 110.814 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.75 -169.74 2.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.926 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.2 -169.15 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 74.43 110.961 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.825 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.2 m -50.97 -70.13 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.145 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.79 HG23 HG22 ' A' ' 129' ' ' THR . 62.4 t -120.45 109.27 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.094 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.1 m -112.72 103.69 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 71.03 111.146 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -66.14 96.18 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 62.02 110.861 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 72.45 110.818 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 tpt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.889 0.376 . . . . 72.23 110.862 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -130.42 127.62 39.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 72.44 110.917 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.563 HG13 HD23 ' A' ' 158' ' ' LEU . 5.9 t -139.76 157.5 26.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 75.42 111.084 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.423 ' HG2' HG13 ' A' ' 130' ' ' VAL . 74.6 tt0 -155.35 119.79 4.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 64.33 110.9 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.654 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.86 -178.17 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 75.03 111.169 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.712 ' HA ' HG22 ' A' ' 130' ' ' VAL . 74.0 t80 -175.49 137.93 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.5 110.943 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.825 ' HB3' HG23 ' A' ' 129' ' ' THR . 35.5 t80 -121.89 96.16 47.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.684 0.754 . . . . 74.1 110.923 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.59 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.634 2.223 . . . . 71.41 112.297 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.09 -157.64 28.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 60.34 112.532 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.33 124.84 36.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.351 . . . . 74.21 110.88 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.482 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.17 -98.64 0.51 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.794 -0.717 . . . . 73.31 112.489 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -66.59 -26.95 67.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 71.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.98 161.5 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 63.12 111.167 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -64.37 -26.27 68.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 75.22 110.86 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.538 ' OD2' HD13 ' A' ' 114' ' ' LEU . 11.6 p30 -120.83 50.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.843 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.18 136.99 38.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 64.2 110.879 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.654 HD12 HG22 ' A' ' 142' ' ' THR . 5.8 pt -137.59 172.22 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 72.2 111.138 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.442 ' CG1' HD22 ' A' ' 169' ' ' LEU . 9.4 m -123.11 149.17 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 75.32 111.166 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -103.39 144.28 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 74.34 111.125 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -130.29 145.94 51.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 73.13 110.91 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.563 HD23 HG13 ' A' ' 140' ' ' VAL . 13.4 mt -123.91 96.71 42.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.545 0.688 . . . . 63.23 110.944 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 72.89 1.42 Allowed 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.669 2.246 . . . . 72.35 112.345 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.31 -34.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 72.51 110.823 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.441 ' O ' HD12 ' A' ' 163' ' ' ILE . 7.1 m-85 -117.44 -13.55 10.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 74.31 110.947 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m120 69.07 24.91 6.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 73.54 110.849 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -97.73 116.64 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.12 111.101 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.81 136.51 39.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 75.53 110.919 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.526 HG21 HD22 ' A' ' 44' ' ' LEU . 19.4 t -120.53 62.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 72.44 111.158 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.36 -55.7 18.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.676 -0.774 . . . . 33.34 112.529 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.15 -137.11 14.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 73.22 112.503 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.06 -20.18 56.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 71.33 110.9 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.463 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.7 OUTLIER -65.86 -50.89 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.907 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.723 HG11 HG11 ' A' ' 206' ' ' VAL . 21.8 t -81.59 132.55 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.156 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.418 ' HB2' HG23 ' A' ' 222' ' ' THR . 0.6 OUTLIER -109.21 130.45 55.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 55.04 110.902 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.587 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.7 p -60.08 159.77 9.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 62.31 110.845 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 72.4 111.124 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.57 HG11 ' CG2' ' A' ' 186' ' ' VAL . 16.5 m . . . . . 0 C--O 1.23 0.034 0 CA-C-O 120.81 0.338 . . . . 53.14 111.097 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.46 -34.94 67.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 75.32 111.058 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -122.74 35.86 4.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 74.03 110.835 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -132.41 165.84 23.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 54.12 111.139 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -113.76 92.75 4.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 74.3 110.927 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.57 ' CG2' HG11 ' A' ' 181' ' ' VAL . 91.6 t -68.54 -23.12 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 73.44 111.158 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.1 -25.65 36.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 74.51 110.85 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.49 -23.44 16.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 64.12 110.862 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.54 -52.49 46.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 71.41 110.953 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.7 p -52.0 -36.19 49.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 64.21 110.921 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.4 m -73.8 -36.51 65.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 44.53 111.14 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 74.3 m -63.38 -54.32 38.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.846 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.605 HG22 HD23 ' A' ' 197' ' ' LEU . 30.1 mm -56.35 -37.13 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 72.34 111.15 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.76 -22.59 66.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.827 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.13 -33.39 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 72.11 110.904 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.404 HG21 HG11 ' A' ' 155' ' ' VAL . 92.6 t -74.53 -49.36 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.31 111.135 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.605 HD23 HG22 ' A' ' 193' ' ' ILE . 4.6 pp -64.7 -25.07 67.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 75.33 110.914 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -78.95 -45.55 20.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 61.52 110.947 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -60.09 -33.29 71.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 62.43 110.841 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -136.29 121.7 19.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.42 110.909 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -122.58 27.27 7.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 74.33 110.874 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.93 22.38 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 53.35 110.894 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.82 146.29 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.238 -0.437 . . . . 72.31 111.119 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -106.43 -25.69 11.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 74.32 110.878 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.507 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -163.59 128.6 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 71.34 111.128 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.732 ' CG1' HD12 ' A' ' 218' ' ' LEU . 75.9 t -107.15 118.88 55.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 61.41 111.17 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.865 HG21 HD11 ' A' ' 44' ' ' LEU . 47.1 t -105.8 98.05 16.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.699 . . . . 65.34 111.153 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.6 Cg_endo -69.77 -172.25 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.704 2.269 . . . . 72.51 112.383 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.74 -30.22 8.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.731 . . . . 64.21 112.475 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -142.56 106.23 4.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.872 0.368 . . . . 75.32 110.935 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 151.26 -96.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.81 -0.71 . . . . 70.35 112.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -178.96 153.99 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 62.23 110.838 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.534 HG22 HG22 ' A' ' 207' ' ' VAL . 22.4 t -63.79 147.83 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 72.34 111.114 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -152.38 -107.79 0.35 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.691 -0.766 . . . . 73.33 112.502 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -155.75 -173.57 4.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.926 0.393 . . . . 74.13 110.858 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -55.42 -22.83 21.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 61.31 110.843 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.751 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.03 -31.95 48.83 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 43.44 112.526 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.732 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.5 mt -50.99 -46.93 61.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 71.34 110.964 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.601 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -54.29 -43.3 70.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 75.44 110.92 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.751 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.6 mt -66.33 -41.54 89.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.994 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.489 ' NE2' HD21 ' A' ' 225' ' ' LEU . 78.9 t60 -61.82 -38.1 86.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 72.34 110.911 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -55.76 -46.11 77.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 73.34 111.116 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.789 ' HA ' HD12 ' A' ' 226' ' ' LEU . 2.5 mt -54.22 -39.99 67.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.14 110.917 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -46.13 91.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 52.32 110.85 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.489 HD21 ' NE2' ' A' ' 221' ' ' HIS . 17.5 mt -56.73 -26.39 56.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 72.41 110.889 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 223' ' ' LEU . 4.5 mt -85.53 -45.6 11.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 62.13 110.93 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 64.01 110.896 179.826 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.556 HG22 ' OG ' ' A' ' 19' ' ' SER . 94.8 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.801 0.334 . . . . 74.31 111.111 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.752 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.9 mm -89.34 157.54 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 74.11 111.144 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -146.53 179.18 7.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 74.14 110.901 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.05 168.47 9.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 70.11 110.918 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HG3' HG23 ' A' ' 13' ' ' THR . 8.4 pt-20 -53.13 -29.52 31.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.894 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.434 HG23 ' HG3' ' A' ' 12' ' ' GLU . 23.6 p -104.74 -35.5 7.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 74.52 111.111 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.69 -4.58 29.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.798 -0.715 . . . . 70.01 112.501 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.695 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -51.18 -33.78 28.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.825 0.345 . . . . 75.52 111.154 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.695 HG13 HG23 ' A' ' 15' ' ' THR . 11.4 mt -126.3 149.74 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 61.24 111.197 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.8 p -169.11 165.77 11.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 44.25 110.92 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.511 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -132.4 -171.79 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.081 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.556 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -174.49 133.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.881 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.57 120.66 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 72.13 110.93 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.4 mm? -101.61 -54.5 2.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 65.14 110.943 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -136.29 48.41 2.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 73.32 110.875 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt 70.68 -70.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 65.03 110.921 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -87.16 -22.18 25.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 71.51 110.924 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.45 123.78 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.12 111.121 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -125.43 159.94 30.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.904 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.824 HG21 HG21 ' A' ' 213' ' ' VAL . 75.8 t -120.23 110.1 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 72.23 111.097 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.511 ' HB3' HG23 ' A' ' 18' ' ' ILE . 3.4 p80 -104.59 139.25 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.833 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.3 m -137.07 132.27 33.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 75.15 111.17 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.42 166.75 14.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.844 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.496 HD12 ' CA ' ' A' ' 40' ' ' PRO . 5.3 tp -117.81 143.59 46.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 62.14 110.891 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 39' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 70.34 112.492 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.663 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.3 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.605 0.717 . . . . 63.15 111.123 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.496 ' CA ' HD12 ' A' ' 31' ' ' LEU . 54.1 Cg_endo -69.75 141.57 45.64 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.724 2.283 . . . . 65.11 112.34 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -129.75 93.96 3.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.04 110.847 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -53.69 164.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 75.01 110.878 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.33 -165.58 23.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 52.04 112.531 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.021 HD13 HG21 ' A' ' 207' ' ' VAL . 4.1 tp -157.32 142.04 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 61.52 110.919 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 54' ' ' LEU . 21.8 t -125.75 132.27 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 71.45 111.144 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.05 131.87 45.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.876 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -100.49 66.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 74.02 110.855 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.5 p -72.77 170.92 13.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 74.32 111.103 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.6 t -96.0 27.18 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 70.24 110.853 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -150.76 27.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 54.44 110.92 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.05 127.79 4.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.664 -0.779 . . . . 74.34 112.445 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.763 HD13 ' HB ' ' A' ' 71' ' ' VAL . 19.0 mt -55.51 161.04 2.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 63.11 110.962 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 81' ' ' ASP . 49.6 t -140.13 142.17 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 71.1 111.118 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.705 HD13 HG22 ' A' ' 45' ' ' VAL . 2.9 mm? -115.87 129.58 56.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.946 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 165' ' ' VAL . 14.2 t -80.73 0.36 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 72.5 111.148 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.12 129.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 72.32 110.804 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.53 -168.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.14 110.823 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.4 m -92.98 -174.54 3.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 63.21 110.833 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.697 ' HB2' HD13 ' A' ' 63' ' ' LEU . 95.9 m95 -67.41 -39.48 85.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 70.32 110.873 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.46 166.68 24.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 73.12 110.903 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -62.66 -28.29 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 71.11 110.828 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -75.94 -22.4 56.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 73.04 110.883 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.697 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -86.98 -46.45 9.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 52.45 110.943 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -58.36 -28.88 65.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.24 111.158 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -55.58 -43.29 75.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.44 . . . . 63.42 110.792 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -85.8 0.58 52.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.251 -0.431 . . . . 72.35 110.852 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.3 -47.19 6.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.31 110.907 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.5 mt -69.53 -32.7 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 64.13 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.05 -17.81 58.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.11 110.903 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 42.8 mtp -82.15 -58.73 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 72.21 110.905 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.763 ' HB ' HD13 ' A' ' 52' ' ' LEU . 33.4 m -57.12 -35.8 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 62.34 111.14 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -86.85 49.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 64.2 110.943 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.85 -40.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.888 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.752 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -105.56 -24.02 12.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 62.13 110.872 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.588 ' HB3' HD21 ' A' ' 52' ' ' LEU . 27.9 m-85 -88.89 10.23 21.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.41 . . . . 61.5 110.877 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.509 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.66 46.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.914 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -152.48 -179.23 7.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 75.03 110.906 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.63 143.82 51.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 64.04 110.895 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 52' ' ' LEU . 94.8 t -75.09 130.07 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 74.52 111.12 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.2 p -142.05 31.0 1.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 63.31 111.16 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.763 ' HB2' HG22 ' A' ' 53' ' ' VAL . 15.4 m-20 -164.35 126.67 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 64.42 110.89 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.705 HG23 HG21 ' A' ' 103' ' ' ILE . 17.3 t -133.69 101.85 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 73.05 111.096 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.7 mt -80.18 120.73 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 70.1 111.146 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 91' ' ' ARG . 36.2 mm -108.71 129.81 62.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 71.15 111.103 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.9 p -85.37 -53.73 5.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 72.14 111.124 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -134.71 166.54 22.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 74.33 110.855 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -84.35 96.18 8.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 53.14 111.118 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.617 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -149.33 159.22 44.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.837 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.31 62.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 62.42 111.09 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.84 11.51 20.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 64.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 84' ' ' ILE . 3.5 mpt_? -125.42 -54.67 1.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.882 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.617 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -111.3 16.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 65.31 111.106 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.21 -28.85 27.83 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.684 -0.77 . . . . 75.12 112.495 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.68 19.04 31.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 60.53 112.487 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.489 HD11 ' C ' ' A' ' 122' ' ' GLU . 3.9 tt -48.89 -30.18 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 74.12 111.14 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -72.22 -43.26 64.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 75.43 110.925 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.5 m -64.22 -40.75 96.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 74.52 111.161 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.617 HD12 ' HB2' ' A' ' 105' ' ' ALA . 32.5 mt -60.96 -35.46 76.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 52.51 110.913 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -81.61 -23.26 37.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 74.13 110.884 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -82.34 -35.03 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 75.45 110.947 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.539 ' HB2' HD12 ' A' ' 103' ' ' ILE . 3.1 mtt-85 -87.29 -45.77 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 61.31 110.873 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.12 -14.98 3.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.782 -0.723 . . . . 73.33 112.452 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.705 HG21 HG23 ' A' ' 82' ' ' VAL . 1.9 mp -60.72 150.39 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.918 0.39 . . . . 73.23 111.151 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.751 ' HB2' HD11 ' A' ' 124' ' ' LEU . 3.4 ptpt -111.46 126.65 55.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 75.32 110.932 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.617 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -89.29 83.02 6.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 61.25 111.043 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.435 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.3 m-70 -57.95 143.55 42.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 75.12 110.916 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.68 150.76 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 71.12 110.823 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.8 p -63.88 179.28 0.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 62.12 111.146 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.9 -33.22 63.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 43.23 111.05 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 152' ' ' ASP . 9.9 tp -72.88 -47.04 49.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 42.11 110.951 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.734 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 98.3 m -52.19 -28.9 20.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.54 111.153 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.92 -31.09 25.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.047 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -55.1 -48.38 73.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.892 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.678 HD12 ' OD2' ' A' ' 152' ' ' ASP . 39.9 mt -72.36 -25.0 61.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 71.21 110.901 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.73 -66.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 53.43 111.066 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -54.76 -26.57 35.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.42 110.91 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -23.83 67.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.02 110.89 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -93.74 -38.9 11.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 73.51 110.889 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 138.55 -7.76 3.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 54.22 112.508 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -59.55 -172.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.733 0.301 . . . . 70.15 110.987 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.46 ' H ' HG21 ' A' ' 95' ' ' ILE . 61.6 mm-40 -99.87 0.11 40.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 62.34 110.909 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.489 ' C ' HD11 ' A' ' 95' ' ' ILE . 0.9 OUTLIER 66.31 130.7 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.639 0.733 . . . . 73.22 110.867 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.85 -170.3 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.636 2.224 . . . . 74.44 112.292 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 104' ' ' LYS . 76.9 mt -53.81 -45.28 70.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 64.04 110.884 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.56 52.68 40.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.825 -0.703 . . . . 62.23 112.473 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -148.83 51.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 74.02 110.88 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 127' ' ' LEU . 17.6 mt -133.0 178.79 6.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.304 -0.407 . . . . 64.35 110.931 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -140.61 -168.63 2.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 75.03 110.995 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.844 HG23 ' HB3' ' A' ' 144' ' ' TYR . 92.3 m -50.29 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 73.24 111.146 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.769 HG23 HG22 ' A' ' 129' ' ' THR . 58.6 t -114.58 106.68 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.44 111.128 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.3 m -110.76 104.13 12.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 74.14 111.146 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -66.19 95.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 63.21 110.908 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.486 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 62.51 110.886 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.9 tpp . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.899 0.381 . . . . 72.14 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.86 128.75 39.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 62.45 110.922 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.644 HG13 HD23 ' A' ' 158' ' ' LEU . 5.9 t -141.06 157.39 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 74.23 111.142 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.441 ' HG2' HG13 ' A' ' 130' ' ' VAL . 41.8 tt0 -154.72 120.73 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 53.34 110.883 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.646 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -73.53 -179.1 3.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 71.43 111.184 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.711 ' HA ' HG22 ' A' ' 130' ' ' VAL . 76.8 t80 -175.61 139.89 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 65.21 110.897 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.844 ' HB3' HG23 ' A' ' 129' ' ' THR . 39.3 t80 -122.15 96.28 46.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.71 0.767 . . . . 71.03 110.882 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 -48.9 0.64 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.755 2.303 . . . . 73.33 112.327 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.39 -155.74 24.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 53.34 112.516 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.63 126.02 41.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 71.24 110.896 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.496 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -137.72 -94.0 0.33 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.721 -0.752 . . . . 34.35 112.472 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -71.97 -29.3 64.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.359 . . . . 65.52 110.859 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.31 151.88 34.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.153 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -54.71 -38.44 67.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 60.41 110.849 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.678 ' OD2' HD12 ' A' ' 114' ' ' LEU . 2.5 p30 -109.15 52.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 61.04 110.906 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.543 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.5 p30 -100.73 136.24 40.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.31 110.861 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.646 HD12 HG22 ' A' ' 142' ' ' THR . 4.5 pt -137.2 172.25 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 62.03 111.153 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.3 m -122.46 150.65 26.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.35 111.164 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.9 t -106.66 143.77 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.24 111.192 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -129.98 145.28 51.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 71.14 110.968 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.644 HD23 HG13 ' A' ' 140' ' ' VAL . 12.9 mt -122.91 96.83 44.6 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.643 0.735 . . . . 63.41 110.893 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 72.55 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.746 2.297 . . . . 70.54 112.315 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.54 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 75.42 110.848 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.449 ' O ' HD12 ' A' ' 163' ' ' ILE . 7.2 m-85 -117.05 -13.33 10.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 71.43 110.901 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m120 68.84 24.84 6.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 74.54 110.827 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.49 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.5 mp -98.19 116.62 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 55.22 111.154 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.1 136.92 38.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 73.24 110.904 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.633 ' CG2' HD22 ' A' ' 44' ' ' LEU . 19.5 t -121.47 62.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 71.53 111.089 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.4 -51.75 35.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 64.02 112.49 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.06 -139.23 15.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 53.35 112.535 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 81.4 m -62.94 -16.75 60.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 71.35 110.869 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.543 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.5 OUTLIER -66.25 -52.45 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 33.13 110.916 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.569 HG11 HG11 ' A' ' 206' ' ' VAL . 21.8 t -83.47 119.68 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 74.42 111.085 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.425 ' HB2' HG23 ' A' ' 222' ' ' THR . 0.3 OUTLIER -93.05 127.17 38.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 75.21 110.838 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.696 ' HA ' HD22 ' A' ' 218' ' ' LEU . 3.9 t -62.72 166.66 5.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 70.44 110.831 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.503 HG23 HD23 ' A' ' 218' ' ' LEU . 3.1 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 52.13 111.149 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.477 HG11 ' CG2' ' A' ' 186' ' ' VAL . 18.6 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.817 0.341 . . . . 74.2 111.1 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.31 75.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.093 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.19 38.96 3.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.791 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -140.92 165.91 26.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.23 111.123 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -113.89 92.73 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.962 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.477 ' CG2' HG11 ' A' ' 181' ' ' VAL . 62.1 t -69.5 -23.05 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.102 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -81.41 -24.6 36.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 61.33 110.908 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -98.63 -23.88 15.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 71.25 110.882 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -51.49 -54.23 29.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 72.43 110.927 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.5 t -51.91 -32.58 33.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 55.1 110.8 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.7 m -77.44 -34.78 54.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 74.41 111.15 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 m -65.94 -54.33 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.5 110.817 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.659 HG22 HD23 ' A' ' 197' ' ' LEU . 32.8 mm -56.29 -37.52 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 72.32 111.107 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -65.29 -23.52 67.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 63.22 110.91 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -87.16 -31.94 20.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.902 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.421 ' CG1' HD21 ' A' ' 219' ' ' LEU . 95.5 t -74.45 -51.57 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 73.45 111.142 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.659 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -63.59 -24.86 67.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 71.44 110.926 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -47.62 12.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.804 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -51.92 -34.1 40.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 72.13 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -137.76 118.36 13.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 72.01 110.948 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -116.64 32.87 5.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.98 21.28 2.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 74.3 110.882 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.16 146.42 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 72.22 111.135 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -107.24 -30.95 8.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 61.05 110.878 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -160.69 127.43 4.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 53.5 111.122 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.626 ' CG1' HD12 ' A' ' 218' ' ' LEU . 92.0 t -101.35 125.48 55.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 71.13 111.125 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.021 HG21 HD13 ' A' ' 44' ' ' LEU . 40.2 t -108.31 89.76 6.22 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.569 0.699 . . . . 73.24 111.197 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.78 171.76 13.89 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.691 2.26 . . . . 74.33 112.336 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.58 -26.2 47.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 63.42 112.475 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -143.35 119.37 10.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 73.32 110.813 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 135.76 -95.21 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.799 -0.715 . . . . 55.32 112.49 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -179.67 168.83 1.37 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 72.42 110.853 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.824 HG21 HG21 ' A' ' 27' ' ' VAL . 31.5 t -79.14 142.3 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 62.15 111.131 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.74 -107.13 0.4 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.729 . . . . 64.3 112.55 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -154.46 -172.95 4.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 73.44 110.918 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -23.12 14.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 61.41 110.893 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -53.57 -32.57 46.47 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.698 -0.763 . . . . 73.22 112.511 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.696 HD22 ' HA ' ' A' ' 172' ' ' SER . 30.5 mt -50.92 -44.45 60.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.866 0.365 . . . . 74.15 110.895 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.513 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -58.43 -44.75 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 53.14 110.871 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.752 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.6 mt -64.85 -41.97 95.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.44 110.895 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.489 ' NE2' HD21 ' A' ' 225' ' ' LEU . 77.2 t60 -62.37 -39.15 92.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 74.44 110.858 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.425 HG23 ' HB2' ' A' ' 171' ' ' LYS . 3.9 m -54.43 -41.58 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 73.43 111.137 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.806 ' HA ' HD12 ' A' ' 226' ' ' LEU . 95.9 mt -59.13 -41.41 88.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 75.35 110.965 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -32.28 69.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 71.35 110.826 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.489 HD21 ' NE2' ' A' ' 221' ' ' HIS . 16.0 mt -69.94 -25.79 63.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 72.31 110.938 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.806 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.5 mt -87.35 -44.97 10.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 71.54 110.885 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 72.42 110.892 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 18' ' ' ILE . 84.4 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.794 0.33 . . . . 70.33 111.103 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.69 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.0 mm -90.31 155.19 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 71.25 111.178 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -145.07 165.46 28.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.853 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.06 174.37 6.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 52.45 110.896 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -59.57 -28.57 67.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.855 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.485 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.7 p -101.92 -33.06 9.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 43.32 111.126 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.73 -8.66 47.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.63 -0.795 . . . . 72.2 112.484 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.777 HG23 HG13 ' A' ' 16' ' ' ILE . 3.2 t -50.99 -32.91 22.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.313 . . . . 73.23 111.167 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.777 HG13 HG23 ' A' ' 15' ' ' THR . 16.0 mt -124.23 147.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 73.43 111.093 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.6 p -166.75 171.42 11.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.954 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -137.78 -176.39 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.183 -0.462 . . . . 62.15 111.159 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 18' ' ' ILE . 6.7 t -166.44 133.67 2.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 61.34 110.878 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.46 118.33 12.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.511 . . . . 72.41 110.888 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.03 -41.64 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 74.02 110.973 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.56 -169.52 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 75.14 110.891 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -51.64 51.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 70.04 110.827 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -131.39 30.89 4.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 74.13 110.887 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.9 t -126.55 119.8 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 61.14 111.162 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -125.33 162.61 24.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 71.03 110.938 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 213' ' ' VAL . 75.9 t -122.49 108.13 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 71.43 111.147 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.475 ' HB3' HG23 ' A' ' 18' ' ' ILE . 5.3 p80 -102.02 139.45 37.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.885 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 41' ' ' SER . 25.2 m -137.77 125.24 22.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 71.51 111.138 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.521 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -114.17 -177.72 3.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 64.34 110.906 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.42 HD12 ' CA ' ' A' ' 40' ' ' PRO . 2.3 tp -134.38 134.8 42.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 73.3 110.952 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 61.55 112.485 179.881 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.621 0.724 . . . . 72.01 111.117 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' CA ' HD12 ' A' ' 31' ' ' LEU . 53.6 Cg_endo -69.8 140.03 41.51 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.631 2.22 . . . . 73.53 112.368 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 29' ' ' THR . 1.0 OUTLIER -128.62 122.22 30.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 54.32 110.841 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -67.46 168.6 10.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 70.44 110.915 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.41 170.12 43.25 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.672 -0.775 . . . . 71.23 112.45 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.011 HD13 HG21 ' A' ' 207' ' ' VAL . 3.9 tp -143.05 138.8 30.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.388 . . . . 74.01 110.897 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.71 HG22 HD13 ' A' ' 54' ' ' LEU . 38.3 t -122.05 130.23 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 70.12 111.138 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.574 HD22 ' HE3' ' A' ' 138' ' ' MET . 45.5 mt -96.9 125.54 41.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.837 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.02 45.37 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.1 110.874 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.632 HG22 ' HB2' ' A' ' 138' ' ' MET . 27.5 p -52.57 165.11 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 72.53 111.143 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.61 35.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 62.45 110.837 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -157.11 25.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.485 . . . . 64.33 110.924 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.68 124.6 3.77 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.66 -0.781 . . . . 52.44 112.442 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.721 HD21 ' HB3' ' A' ' 75' ' ' PHE . 35.2 mt -53.18 158.02 1.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 71.13 110.915 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.605 HG22 ' HB2' ' A' ' 81' ' ' ASP . 90.5 t -141.25 142.64 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 73.05 111.102 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.71 HD13 HG22 ' A' ' 45' ' ' VAL . 3.2 mm? -114.43 128.42 56.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 74.44 110.924 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 55' ' ' VAL . 13.1 t -80.4 -0.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 75.45 111.1 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -174.81 132.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 74.14 110.911 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -74.59 -166.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.05 110.844 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.42 -170.24 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 55.11 110.848 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.666 ' HB2' HD13 ' A' ' 63' ' ' LEU . 88.5 m95 -74.8 -34.9 62.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 74.53 110.884 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.16 174.5 11.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.427 . . . . 71.22 110.857 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.44 -30.43 68.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 65.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -76.04 -25.53 55.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 73.5 110.885 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -83.32 -48.34 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.85 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.1 t -60.54 -27.82 67.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 63.0 111.173 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -43.08 75.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.864 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.55 1.29 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.11 110.92 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.521 HD22 ' OE2' ' A' ' 30' ' ' GLU . 23.8 tp -95.46 -45.33 7.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 74.13 110.912 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -68.79 -40.03 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 62.12 111.157 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -60.39 -22.23 63.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.12 -0.491 . . . . 61.25 110.942 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.5 mmm -72.64 -60.81 2.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.914 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.514 ' HB ' HD13 ' A' ' 52' ' ' LEU . 19.7 m -59.39 -30.16 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 63.54 111.122 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -88.51 48.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 73.44 110.914 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 -41.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.02 110.958 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.69 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.05 -25.23 14.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.9 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.721 ' HB3' HD21 ' A' ' 52' ' ' LEU . 35.9 m-85 -89.31 9.84 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.882 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.499 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.68 47.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 73.3 110.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -147.92 -177.54 5.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.851 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.6 130.9 37.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.932 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 52' ' ' LEU . 61.4 t -67.86 130.12 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 72.32 111.112 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.4 p -136.82 18.62 3.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.481 . . . . 61.21 111.13 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.605 ' HB2' HG22 ' A' ' 53' ' ' VAL . 8.4 m-20 -153.99 130.59 10.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 75.14 110.878 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 98' ' ' LEU . 24.8 t -133.5 98.46 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.095 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.7 mt -73.71 125.73 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 73.43 111.128 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 91' ' ' ARG . 42.4 mm -113.08 142.47 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 65.44 111.131 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.0 p -97.51 -59.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 64.31 111.147 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -129.47 164.19 24.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 61.12 110.859 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.49 98.03 9.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.44 111.078 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.661 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -152.03 159.03 43.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 74.54 110.88 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -26.73 61.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 64.41 111.088 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -91.73 13.28 18.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 70.4 110.874 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HB3' HG23 ' A' ' 84' ' ' ILE . 2.0 mmp_? -126.68 -50.86 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.867 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -118.75 16.24 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 55.13 111.15 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.73 -33.26 34.34 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.714 -0.755 . . . . 63.45 112.525 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.27 15.92 53.74 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.749 -0.738 . . . . 61.4 112.487 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.517 HG21 ' H ' ' A' ' 121' ' ' GLU . 11.3 tt -46.16 -31.93 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 72.42 111.162 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -54.31 31.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.943 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.8 m -58.1 -41.07 82.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 72.2 111.16 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 82' ' ' VAL . 27.3 mt -59.61 -31.21 69.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 75.13 110.934 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -97.82 25.08 6.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.3 110.911 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -115.75 -24.79 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.902 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -107.83 -21.4 12.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 70.41 110.88 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.68 13.34 5.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 62.33 112.44 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 98' ' ' LEU . 16.0 mt -80.32 155.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 74.21 111.06 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.648 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -119.97 123.93 44.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 73.22 110.862 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.51 85.31 6.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 74.22 111.074 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.424 ' HB3' HD11 ' A' ' 127' ' ' LEU . 54.3 m-70 -55.87 148.07 17.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 71.15 110.873 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.93 164.88 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 64.04 110.813 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.8 p -81.98 155.77 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 44.15 111.199 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.72 -29.91 20.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 75.53 111.143 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 152' ' ' ASP . 7.1 tp -75.08 -47.58 28.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 73.02 110.904 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.706 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.7 m -53.93 -26.97 28.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 61.43 111.152 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.456 ' HB1' ' OE2' ' A' ' 122' ' ' GLU . . . -86.26 -27.1 24.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.24 111.05 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -64.13 -27.51 69.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 65.23 110.855 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.611 HD13 ' OD2' ' A' ' 152' ' ' ASP . 9.8 mp -92.96 -23.89 18.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 73.01 110.895 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.44 -62.98 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.51 111.137 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -25.42 42.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 51.42 110.873 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.0 -23.79 65.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.895 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -97.32 -26.36 14.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 72.33 110.876 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.89 -3.21 10.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.788 -0.72 . . . . 32.33 112.503 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -59.52 -173.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.887 0.375 . . . . 74.42 110.889 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.517 ' H ' HG21 ' A' ' 95' ' ' ILE . 8.6 mm-40 -97.75 -1.34 43.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.89 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.456 ' OE2' ' HB1' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 66.36 124.96 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.623 0.725 . . . . 74.41 110.865 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -170.46 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.629 2.219 . . . . 71.25 112.387 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 104' ' ' LYS . 65.7 mt -53.44 -39.76 64.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.884 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.12 59.03 9.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.768 -0.73 . . . . 73.02 112.461 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -155.33 47.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 64.22 110.854 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 106' ' ' HIS . 76.2 mt -127.07 -175.26 3.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 64.3 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -140.02 -168.66 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.858 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.831 HG23 ' HB3' ' A' ' 144' ' ' TYR . 78.7 m -50.21 -54.87 17.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 65.22 111.092 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.744 HG22 ' HA ' ' A' ' 143' ' ' PHE . 91.9 t -131.33 111.84 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 75.12 111.114 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.591 HG22 HD23 ' A' ' 133' ' ' LEU . 91.5 m -117.04 119.55 35.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 73.44 111.199 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -78.77 99.13 6.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 74.05 110.901 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.591 HD23 HG22 ' A' ' 131' ' ' THR . 3.6 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 64.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.632 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.7 tpp . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.851 0.357 . . . . 73.44 110.836 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.96 112.73 14.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 72.21 110.894 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.48 HG13 HD23 ' A' ' 158' ' ' LEU . 16.5 t -126.08 152.55 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 54.31 111.127 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -151.07 120.78 7.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 54.23 110.888 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.687 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.22 -179.08 2.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.45 111.149 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.744 ' HA ' HG22 ' A' ' 130' ' ' VAL . 78.4 t80 -175.29 136.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.879 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.831 ' HB3' HG23 ' A' ' 129' ' ' THR . 59.2 t80 -116.79 93.63 41.77 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.712 0.768 . . . . 73.23 110.838 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 -48.92 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 61.3 112.33 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.62 -170.35 42.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.664 -0.779 . . . . 34.53 112.454 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -84.52 126.55 33.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.884 0.373 . . . . 64.54 110.87 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.665 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -136.64 -88.3 0.23 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 71.32 112.498 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -78.27 -23.67 47.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 73.4 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.95 163.99 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.22 111.218 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -70.09 -24.48 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.916 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.611 ' OD2' HD13 ' A' ' 114' ' ' LEU . 10.6 p30 -123.59 52.63 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 62.42 110.87 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 2.1 p30 -100.77 146.35 27.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.925 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.687 HD12 HG22 ' A' ' 142' ' ' THR . 8.8 pt -145.14 173.28 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 74.25 111.161 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.1 m -123.03 138.8 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 64.32 111.156 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.454 ' O ' HD22 ' A' ' 164' ' ' LEU . 79.0 t -95.1 125.69 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 62.31 111.126 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -111.0 148.88 31.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 72.33 110.936 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 163' ' ' ILE . 47.5 mt -123.53 94.61 46.17 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.608 0.718 . . . . 71.44 110.888 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 70.98 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.716 2.278 . . . . 74.42 112.278 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.14 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.904 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.594 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.2 m-85 -118.74 -9.98 10.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 73.1 110.897 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 68.2 21.03 8.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 53.43 110.868 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.609 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.7 mp -87.1 115.67 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 71.14 111.129 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.478 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.5 tm? -101.37 122.93 44.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 70.11 110.923 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 44' ' ' LEU . 41.5 t -114.9 73.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 44.44 111.217 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.408 ' H ' HD13 ' A' ' 164' ' ' LEU . . . -64.12 -56.58 17.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 73.24 112.532 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 111.95 -139.0 15.36 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.749 -0.738 . . . . 72.25 112.412 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 46.6 m -58.03 -22.24 48.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 24.13 110.858 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.471 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.0 OUTLIER -62.88 -48.32 79.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.43 110.938 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.544 HG11 HG11 ' A' ' 206' ' ' VAL . 21.5 t -92.57 127.57 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 62.41 111.124 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.535 ' H ' HG23 ' A' ' 222' ' ' THR . 1.6 tppt? -95.49 134.94 37.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.925 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.641 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.2 p -70.23 157.03 38.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 74.12 110.829 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 75.2 111.164 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.869 0.366 . . . . 75.44 111.097 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.48 -46.06 77.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 62.14 111.084 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -112.38 44.09 1.51 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 73.35 110.921 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -134.87 173.92 11.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 31.34 111.114 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.61 88.48 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 75.23 110.918 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.419 HG13 HD23 ' A' ' 226' ' ' LEU . 23.5 t -68.11 -20.73 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 70.04 111.182 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -80.36 -28.41 38.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.868 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -22.59 16.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.04 110.918 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.07 -54.37 25.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.88 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -36.83 49.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 43.51 110.813 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 71.4 m -75.34 -39.01 59.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.53 111.139 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 44.6 m -58.81 -55.67 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.833 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.514 HG21 ' O ' ' A' ' 219' ' ' LEU . 33.1 mm -54.27 -37.5 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 73.2 111.145 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -23.08 65.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.881 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -90.6 -27.43 19.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 62.23 110.879 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.589 HG12 HD21 ' A' ' 219' ' ' LEU . 39.8 t -78.42 -31.98 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 72.22 111.156 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.7 -29.87 23.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 61.05 110.968 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -78.98 -50.06 11.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.1 110.865 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -51.92 -30.17 23.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 65.21 110.9 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -138.14 116.86 12.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 74.34 110.894 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -116.5 37.62 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 71.44 110.883 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.24 22.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 65.52 110.921 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.47 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.1 mp -51.63 142.74 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 64.13 111.093 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -103.53 -42.91 5.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 74.15 110.867 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.57 113.44 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 35.45 111.141 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.544 HG11 HG11 ' A' ' 170' ' ' VAL . 89.3 t -85.39 124.08 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.34 111.129 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.011 HG21 HD13 ' A' ' 44' ' ' LEU . 57.5 t -107.41 92.27 8.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.586 0.708 . . . . 72.41 111.129 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.3 Cg_endo -69.68 -174.7 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.269 . . . . 73.12 112.373 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.41 -17.44 33.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.804 -0.712 . . . . 60.02 112.515 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -147.19 125.97 12.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 75.31 110.906 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 123.0 -93.09 0.48 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.746 -0.74 . . . . 74.13 112.496 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -179.65 167.92 1.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 70.03 110.922 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 27' ' ' VAL . 42.6 t -79.85 135.53 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 72.14 111.145 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -137.36 -102.8 0.62 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.773 . . . . 54.34 112.46 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -158.96 -171.34 3.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.923 0.392 . . . . 61.4 110.827 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 -23.92 13.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 62.24 110.83 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -52.52 -35.52 45.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.769 -0.729 . . . . 34.11 112.488 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 172' ' ' SER . 23.9 mt -51.0 -46.35 61.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 75.52 110.86 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.589 HD21 HG12 ' A' ' 196' ' ' VAL . 7.1 mp -56.32 -42.95 78.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 54.32 110.882 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.755 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.1 mt -66.78 -41.46 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 73.24 110.893 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.45 ' NE2' HD21 ' A' ' 225' ' ' LEU . 85.2 t60 -61.31 -39.35 90.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 63.34 110.848 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.535 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.66 -46.22 63.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 75.25 111.103 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.81 ' HA ' HD12 ' A' ' 226' ' ' LEU . 51.5 mt -56.64 -44.22 81.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 74.42 110.939 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -31.51 60.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 60.42 110.872 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.45 HD21 ' NE2' ' A' ' 221' ' ' HIS . 6.8 mt -73.7 -27.92 61.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 73.13 110.887 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.5 mt -84.85 -30.87 24.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 73.0 110.899 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 75.25 110.894 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 18' ' ' ILE . 97.3 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.792 0.33 . . . . 73.24 111.072 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.467 HD11 ' HE3' ' A' ' 74' ' ' LYS . 3.4 mm -87.1 156.17 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 74.35 111.1 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -146.74 151.91 37.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 63.12 110.896 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.58 168.51 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 65.13 110.924 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.46 -32.55 62.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 71.13 110.92 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 p -93.04 -31.97 14.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 74.45 111.084 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.47 -12.51 58.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 53.04 112.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.714 HG23 HG13 ' A' ' 16' ' ' ILE . 2.4 t -51.73 -33.0 32.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 60.45 111.132 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.714 HG13 HG23 ' A' ' 15' ' ' THR . 28.2 mt -119.58 150.87 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 72.05 111.089 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -170.2 170.84 7.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.782 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -136.47 -174.7 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 74.41 111.215 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.442 ' OG ' HG22 ' A' ' 8' ' ' VAL . 1.2 t -170.8 129.95 0.81 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 63.35 110.882 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 122.12 15.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 53.31 110.944 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.436 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.5 mm? -104.45 -46.84 4.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 61.1 110.949 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -149.41 52.43 0.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.83 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.58 -76.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.931 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -83.63 -20.37 33.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.898 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.26 120.6 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 64.33 111.171 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -125.41 159.81 30.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 60.31 110.957 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.436 HG23 ' HG ' ' A' ' 21' ' ' LEU . 53.3 t -122.23 112.7 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 75.53 111.147 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.446 ' HB3' HG23 ' A' ' 18' ' ' ILE . 11.1 p80 -103.48 137.04 42.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 73.52 110.9 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.6 m -131.17 130.93 43.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 55.3 111.091 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.628 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -126.19 163.17 23.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 73.43 110.868 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.483 HD12 ' CA ' ' A' ' 40' ' ' PRO . 4.9 tp -110.14 145.7 36.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.924 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.736 -0.745 . . . . 72.22 112.465 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.533 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.2 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.572 0.701 . . . . 73.32 111.142 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.483 ' CA ' HD12 ' A' ' 31' ' ' LEU . 54.1 Cg_endo -69.75 142.93 49.31 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.65 2.234 . . . . 75.12 112.349 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -126.33 108.12 10.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.87 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -61.87 151.52 34.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 74.43 110.888 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.582 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -154.3 -163.37 11.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.7 -0.762 . . . . 54.24 112.478 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.998 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -162.36 145.3 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.903 0.382 . . . . 72.32 110.903 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 54' ' ' LEU . 43.8 t -129.49 130.12 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 62.22 111.097 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.471 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 46.7 mt -98.57 122.01 41.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.902 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -91.53 47.3 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 72.4 110.908 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 138' ' ' MET . 22.9 p -56.77 172.68 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 70.52 111.103 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.4 m -99.17 24.97 7.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 62.01 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.4 19.01 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.838 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.78 128.53 4.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 52.22 112.524 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.815 HD21 ' HB3' ' A' ' 75' ' ' PHE . 35.3 mt -52.63 157.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.817 0.341 . . . . 73.02 110.916 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.785 HG22 ' HB2' ' A' ' 81' ' ' ASP . 93.6 t -142.08 143.36 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 60.55 111.098 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 45' ' ' VAL . 3.5 mm? -112.24 129.58 56.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.831 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 55' ' ' VAL . 12.4 t -80.07 -1.26 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.044 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.32 130.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.24 -0.436 . . . . 75.42 110.89 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -67.82 -169.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.4 110.795 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.41 -175.94 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 70.2 110.826 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.699 ' HB2' HD13 ' A' ' 63' ' ' LEU . 92.1 m95 -67.35 -37.4 83.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 74.23 110.899 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -144.99 174.15 11.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 75.2 110.878 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.436 ' HA ' HG22 ' A' ' 64' ' ' THR . 1.0 OUTLIER -70.03 -28.46 65.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 71.13 110.84 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -77.63 -25.45 49.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.33 110.893 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 59' ' ' TRP . 1.3 mt -85.79 -40.98 15.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 75.33 110.863 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 61' ' ' ASP . 14.6 t -66.18 -29.74 70.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 42.45 111.197 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -51.62 -45.04 63.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 50.21 110.91 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -81.64 -14.9 56.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.881 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.628 HD22 ' OE2' ' A' ' 30' ' ' GLU . 40.0 tp -78.08 -48.45 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.888 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.9 mt -71.85 -18.63 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 45.21 111.097 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.06 2.35 39.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 71.24 110.894 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.2 mmm -101.62 -53.04 3.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 75.4 110.908 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.779 ' HB ' HD13 ' A' ' 52' ' ' LEU . 22.7 m -59.4 -39.53 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 64.5 111.125 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.483 ' HG3' HG23 ' A' ' 71' ' ' VAL . 33.5 mt-10 -84.86 50.98 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 75.2 110.889 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.74 -39.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.881 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.467 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -110.17 -20.19 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.931 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.815 ' HB3' HD21 ' A' ' 52' ' ' LEU . 25.1 m-85 -89.14 12.28 16.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.859 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.518 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.86 47.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 71.52 110.93 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -155.93 -178.72 7.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 70.43 110.891 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.41 157.45 39.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.02 110.848 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 52' ' ' LEU . 98.5 t -92.65 117.98 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 72.45 111.181 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.9 p -128.34 22.4 6.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.23 111.155 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.785 ' HB2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -153.45 133.9 13.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.831 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.567 HG11 HD11 ' A' ' 98' ' ' LEU . 24.1 t -138.64 99.47 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 54.12 111.128 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.0 mt -77.49 126.07 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.03 111.071 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.9 mm -112.46 130.26 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 75.33 111.091 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.0 p -87.76 -54.85 4.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 71.54 111.077 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -133.93 170.0 16.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.868 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -88.96 97.77 11.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.465 . . . . 54.44 111.075 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.65 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -150.33 158.65 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 73.1 110.826 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.03 63.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 51.34 111.104 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.9 9.26 25.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 72.15 110.831 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -121.43 -52.81 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 74.44 110.865 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.65 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.5 18.24 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 61.51 111.198 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.05 -26.72 20.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.636 -0.792 . . . . 54.11 112.534 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.64 22.01 20.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.737 -0.744 . . . . 71.3 112.523 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.427 HG21 ' H ' ' A' ' 121' ' ' GLU . 2.3 tt -48.55 -31.05 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.392 . . . . 74.02 111.137 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -70.65 -43.75 68.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.908 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.4 m -66.27 -35.49 80.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 61.3 111.119 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.567 HD11 HG11 ' A' ' 82' ' ' VAL . 48.4 mt -62.37 -32.51 73.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.933 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.29 20.92 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 64.45 110.88 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -117.35 -22.46 8.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 75.2 110.906 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.74 7.66 18.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 72.24 110.894 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.8 15.92 64.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.723 -0.751 . . . . 65.15 112.453 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 98' ' ' LEU . 16.9 mt -80.33 155.03 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 63.4 111.113 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.82 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -118.98 117.58 29.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 55.24 110.911 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.513 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -86.52 79.32 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 63.43 111.064 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.511 ' HA ' HD12 ' A' ' 124' ' ' LEU . 96.5 m-70 -55.16 147.66 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 70.05 110.896 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.463 ' C ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -179.86 166.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 73.44 110.916 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 127' ' ' LEU . 76.1 p -87.99 158.13 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 52.35 111.078 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.82 -43.09 62.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 72.04 111.129 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.625 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -61.81 -46.31 90.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 71.04 110.847 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.702 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.2 m -52.05 -42.58 63.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 63.04 111.08 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.464 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -73.3 -23.55 60.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 71.43 111.104 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -57.08 -40.49 77.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.856 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.63 HD12 ' OD1' ' A' ' 152' ' ' ASP . 8.4 mt -84.21 -28.43 27.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.927 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.71 -68.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 64.11 111.077 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.34 -24.94 47.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 73.21 110.879 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -24.17 66.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.885 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -95.71 -37.33 10.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 51.4 110.871 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.68 -5.3 4.07 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.718 . . . . 65.22 112.502 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -59.63 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.816 0.341 . . . . 63.4 110.935 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.427 ' H ' HG21 ' A' ' 95' ' ' ILE . 19.8 mm-40 -97.86 -1.0 44.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 72.4 110.891 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.464 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.0 OUTLIER 66.15 125.38 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.674 0.749 . . . . 65.44 110.886 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -170.37 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.238 . . . . 62.51 112.343 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 104' ' ' LYS . 70.8 mt -53.59 -41.2 66.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 71.23 110.942 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.28 59.72 8.6 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 74.32 112.482 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.75 54.63 0.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 75.4 110.896 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 107' ' ' SER . 67.1 mt -137.01 -173.21 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 61.51 110.902 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.0 -168.18 2.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.851 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.799 HG23 ' HB3' ' A' ' 144' ' ' TYR . 96.6 m -50.02 -41.66 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 61.3 111.197 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 m -140.51 141.82 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 72.42 111.141 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.647 HG22 HD23 ' A' ' 133' ' ' LEU . 60.0 m -149.04 110.88 4.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 63.34 111.154 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.89 98.01 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 64.53 110.865 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.647 HD23 HG22 ' A' ' 131' ' ' THR . 3.3 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 61.44 110.883 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.601 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.2 tpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.876 0.37 . . . . 72.23 110.823 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.44 118.14 21.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 63.23 110.958 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.645 HG13 HD23 ' A' ' 158' ' ' LEU . 4.6 t -135.14 159.19 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 63.31 111.15 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 140' ' ' VAL . 30.6 tt0 -160.52 126.7 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.24 110.907 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.9 178.32 6.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 62.33 111.133 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -172.84 138.23 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.906 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.799 ' HB3' HG23 ' A' ' 129' ' ' THR . 22.4 t80 -118.92 95.32 49.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.705 0.764 . . . . 73.21 110.864 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -48.75 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 45.31 112.365 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.42 -165.54 38.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 71.44 112.447 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -85.4 121.2 27.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.24 110.847 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.618 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -135.09 -94.28 0.46 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.738 -0.744 . . . . 75.14 112.443 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -70.58 -29.3 65.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.368 . . . . 74.33 110.814 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.32 154.71 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 65.24 111.129 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -58.35 -24.27 59.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 52.32 110.912 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.63 ' OD1' HD12 ' A' ' 114' ' ' LEU . 1.1 p30 -124.19 51.37 1.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 65.23 110.94 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.53 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.0 OUTLIER -100.79 136.36 40.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.976 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.467 HG22 ' CD1' ' A' ' 144' ' ' TYR . 10.3 pt -137.47 160.61 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.52 111.121 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 196' ' ' VAL . 15.4 m -106.34 157.73 6.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 45.35 111.065 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.29 141.1 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 74.12 111.16 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -128.24 150.2 50.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.888 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.645 HD23 HG13 ' A' ' 140' ' ' VAL . 15.1 mt -129.0 95.9 30.34 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.62 0.724 . . . . 74.45 110.917 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 72.49 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.687 2.258 . . . . 64.11 112.286 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 179.52 -34.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 64.13 110.924 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.523 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.8 m-85 -117.45 -13.56 10.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 71.41 110.975 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m120 69.38 25.82 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 55.43 110.835 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.545 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -97.09 119.12 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 63.44 111.099 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.479 HD11 HG13 ' A' ' 196' ' ' VAL . 0.5 OUTLIER -104.71 138.46 40.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 71.15 110.877 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.543 HG21 HD22 ' A' ' 44' ' ' LEU . 21.6 t -124.09 66.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 54.14 111.111 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.47 -45.11 53.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.744 -0.741 . . . . 53.42 112.46 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.74 -141.48 15.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.76 -0.733 . . . . 61.34 112.509 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 43.7 m -57.35 -23.91 51.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 62.42 110.92 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.53 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.5 OUTLIER -65.64 -49.35 69.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.927 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.562 HG11 HG11 ' A' ' 206' ' ' VAL . 46.3 t -90.41 105.37 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.14 111.166 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.92 151.31 37.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 64.11 110.903 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.671 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.3 p -75.26 169.47 17.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 71.55 110.841 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 63.15 111.114 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.486 HG11 ' CG2' ' A' ' 186' ' ' VAL . 35.3 m . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.881 0.372 . . . . 71.52 111.132 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.01 84.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.493 . . . . 73.21 111.125 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.0 39.94 2.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.23 110.817 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -139.72 170.84 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 72.11 111.056 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -119.9 90.16 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 73.34 110.917 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.486 ' CG2' HG11 ' A' ' 181' ' ' VAL . 61.5 t -69.55 -20.94 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 75.54 111.097 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.97 -26.32 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 60.44 110.938 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.23 -23.15 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 62.42 110.886 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -51.27 -55.81 16.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.878 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -36.16 49.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 62.42 110.83 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.6 m -75.48 -34.24 60.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 74.32 111.081 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 67.4 m -64.38 -51.55 62.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.51 110.89 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.739 HG22 HD23 ' A' ' 197' ' ' LEU . 32.9 mm -56.72 -38.91 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 74.53 111.09 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -62.68 -22.07 66.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 72.43 110.857 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -90.72 -30.3 17.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 53.33 110.885 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.485 ' CG1' HD21 ' A' ' 219' ' ' LEU . 99.5 t -77.49 -37.05 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 63.12 111.176 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.739 HD23 HG22 ' A' ' 193' ' ' ILE . 4.4 pp -78.93 -25.21 43.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.878 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -83.13 -42.48 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.14 110.939 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -55.24 -26.45 39.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.21 110.895 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -143.81 118.54 9.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 71.53 110.918 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.37 37.52 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 73.12 110.909 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.43 21.27 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 55.43 110.902 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.25 146.85 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 72.51 111.142 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.56 -31.51 8.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.892 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.545 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -156.48 140.17 16.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 54.14 111.09 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.742 ' CG1' HD12 ' A' ' 218' ' ' LEU . 92.7 t -120.72 125.64 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 61.33 111.144 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.998 HG21 HD11 ' A' ' 44' ' ' LEU . 97.1 t -107.71 105.74 56.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.604 0.716 . . . . 73.23 111.1 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.4 Cg_endo -69.76 -179.85 3.19 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.705 2.27 . . . . 74.4 112.314 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.79 -33.83 26.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.729 -0.748 . . . . 62.03 112.518 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -143.61 111.13 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.344 . . . . 74.23 110.847 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.46 -114.2 0.72 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.761 . . . . 53.34 112.422 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -151.84 166.86 30.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.85 0.357 . . . . 73.33 110.939 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.781 HG22 HG22 ' A' ' 207' ' ' VAL . 21.8 t -74.34 149.94 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 74.13 111.127 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -147.31 -108.54 0.53 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.76 -0.734 . . . . 74.42 112.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -157.73 -171.77 3.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 62.31 110.816 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 35.7 tttt -56.65 -21.51 27.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.889 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.759 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -55.29 -31.98 57.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 61.01 112.467 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.742 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.1 mt -51.06 -45.41 61.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 74.22 110.873 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.526 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -58.6 -44.58 89.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 72.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.759 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.7 mt -65.15 -42.01 94.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 73.03 110.95 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.657 ' NE2' HD21 ' A' ' 225' ' ' LEU . 77.5 t60 -66.24 -37.79 86.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.853 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.6 m -52.12 -43.01 63.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 73.45 111.08 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.753 ' HA ' HD12 ' A' ' 226' ' ' LEU . 61.5 mt -58.35 -42.29 86.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 75.11 110.863 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -26.86 66.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.841 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.657 HD21 ' NE2' ' A' ' 221' ' ' HIS . 22.4 mt -73.49 -25.88 60.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.45 110.925 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.753 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.1 mt -87.25 -42.2 13.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 35.15 110.88 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.31 110.922 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.562 HG22 ' OG ' ' A' ' 19' ' ' SER . 80.8 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.863 0.363 . . . . 54.24 111.08 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.697 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.3 mm -87.9 156.92 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.184 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -145.77 147.14 31.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 60.02 110.964 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.79 164.24 26.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 62.11 110.85 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -51.88 -38.2 55.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 73.4 110.958 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.473 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.5 p -92.43 -26.57 17.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 42.35 111.193 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.71 -11.69 56.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 53.45 112.501 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.796 HG23 HG13 ' A' ' 16' ' ' ILE . 4.2 t -51.48 -32.63 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 64.54 111.15 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.796 HG13 HG23 ' A' ' 15' ' ' THR . 29.3 mt -120.92 149.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 74.13 111.103 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 p -169.98 167.53 8.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 71.45 110.862 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -135.57 -173.22 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 73.25 111.175 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -172.83 132.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.86 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.03 120.38 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 74.13 110.816 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.11 -47.86 4.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 55.51 110.889 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -146.99 53.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 63.31 110.887 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.28 -76.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 74.03 110.937 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.76 -20.97 30.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.871 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 t -97.1 119.73 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 63.12 111.143 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -124.67 162.01 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.936 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.484 HG21 HG21 ' A' ' 213' ' ' VAL . 79.4 t -124.26 111.26 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 52.44 111.098 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.526 ' HB3' HG23 ' A' ' 18' ' ' ILE . 10.1 p80 -103.21 137.62 41.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.468 . . . . 72.44 110.829 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.2 m -133.05 120.51 21.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 71.03 111.185 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.618 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -111.33 170.44 8.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 62.43 110.878 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.84 133.49 51.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 63.4 110.879 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.779 -0.724 . . . . 72.41 112.484 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 60.5 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.601 0.715 . . . . 73.1 111.185 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.3 Cg_endo -69.78 141.01 44.0 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.707 2.271 . . . . 53.35 112.306 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -124.69 117.66 24.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 73.14 110.838 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -71.22 147.52 48.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 75.13 110.857 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.528 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -148.74 -160.41 9.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.758 -0.734 . . . . 73.25 112.404 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.974 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -161.74 143.7 11.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.384 . . . . 74.1 110.913 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 HD13 ' A' ' 54' ' ' LEU . 58.1 t -127.44 141.24 46.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 64.32 111.142 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.537 HD22 ' HE3' ' A' ' 138' ' ' MET . 13.3 mt -107.04 138.11 43.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 70.05 110.898 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -110.47 59.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.919 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.773 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.3 p -67.3 -172.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 71.41 111.16 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.26 26.38 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.992 0.425 . . . . 72.2 110.876 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -156.03 35.58 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 72.2 110.893 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.01 133.39 6.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.841 -0.695 . . . . 73.33 112.527 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.806 HD21 ' HB3' ' A' ' 75' ' ' PHE . 17.1 mt -64.19 172.84 2.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.874 0.369 . . . . 61.2 110.925 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 81' ' ' ASP . 61.0 t -148.18 143.42 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 75.53 111.103 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.563 HD13 HG22 ' A' ' 45' ' ' VAL . 3.3 mm? -115.84 130.01 56.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.119 -0.491 . . . . 74.1 110.876 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.5 t -80.36 -1.06 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 71.45 111.102 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -179.55 133.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 65.5 110.877 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -71.17 -168.64 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 55.32 110.864 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -173.18 3.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 74.33 110.906 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.718 ' HB2' HD13 ' A' ' 63' ' ' LEU . 89.9 m95 -69.54 -41.24 76.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 74.21 110.907 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.0 165.92 25.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.291 -0.413 . . . . 61.3 110.88 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -60.82 -34.69 74.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.916 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -73.94 -22.77 59.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 71.43 110.944 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.718 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -84.01 -43.44 15.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 75.15 110.893 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -66.99 -27.5 67.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 70.43 111.095 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.25 -43.52 71.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 73.12 110.89 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -82.91 -14.28 54.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 73.43 110.856 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.618 HD22 ' OE2' ' A' ' 30' ' ' GLU . 27.3 tp -76.63 -47.27 22.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 64.45 110.904 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.39 -33.4 53.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.43 111.12 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.8 -25.55 67.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 74.35 110.956 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 mmm -75.77 -59.83 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.499 . . . . 71.12 110.881 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.679 ' HB ' HD13 ' A' ' 52' ' ' LEU . 33.0 m -55.66 -31.91 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 72.41 111.102 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -89.69 48.29 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.875 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -143.65 -42.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.816 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.697 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -100.58 -25.9 14.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 75.4 110.869 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.806 ' HB3' HD21 ' A' ' 52' ' ' LEU . 35.5 m-85 -89.26 9.32 26.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 70.3 110.877 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.76 46.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.911 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -147.62 -177.76 5.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.05 110.896 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.95 130.04 39.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.824 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 52' ' ' LEU . 88.1 t -64.72 127.5 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.132 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.4 p -133.95 18.73 3.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 73.5 111.084 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.581 ' HB2' HG13 ' A' ' 53' ' ' VAL . 7.1 m-20 -153.63 136.13 15.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 53.24 110.846 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.453 HG11 ' CD1' ' A' ' 98' ' ' LEU . 25.2 t -139.75 97.82 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 63.24 111.086 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.1 mt -75.75 125.68 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 74.51 111.17 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 91' ' ' ARG . 41.1 mm -111.33 121.65 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 62.23 111.116 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.9 p -77.37 -53.7 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 72.55 111.074 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.499 ' HA ' HG23 ' A' ' 111' ' ' THR . 16.0 p-80 -135.8 171.12 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 75.04 110.886 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -91.02 101.09 13.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 70.44 111.025 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.643 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -155.23 159.85 40.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.46 . . . . 65.05 110.881 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.32 -25.31 48.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.052 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -94.0 20.15 8.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 73.22 110.879 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.5 mpt_? -135.17 -50.45 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 74.03 110.893 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -117.57 14.47 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.43 111.143 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.61 -35.55 30.11 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.735 -0.745 . . . . 73.4 112.449 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.18 19.04 41.26 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.705 -0.76 . . . . 64.43 112.421 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.593 HG21 ' H ' ' A' ' 121' ' ' GLU . 11.7 tt -45.97 -31.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 71.44 111.141 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -54.25 32.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 73.1 110.914 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.1 m -58.7 -41.15 85.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.416 . . . . 75.14 111.09 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.453 ' CD1' HG11 ' A' ' 82' ' ' VAL . 30.4 mt -57.49 -28.7 63.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 60.14 110.849 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -100.93 23.55 10.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 51.33 110.894 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -115.9 -26.57 7.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 44.4 110.861 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -103.34 -22.02 13.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 75.24 110.817 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.74 19.2 4.15 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.717 -0.754 . . . . 64.4 112.416 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.7 mt -87.23 154.67 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 74.24 111.117 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.499 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.5 ptpt -117.16 121.98 42.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.918 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.33 80.47 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 62.54 111.116 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.507 ' HA ' HD12 ' A' ' 124' ' ' LEU . 92.1 m-70 -54.32 144.11 21.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 64.44 110.869 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.8 153.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.15 110.88 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.618 HG22 ' HB3' ' A' ' 127' ' ' LEU . 19.4 p -74.75 158.4 33.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 51.42 111.159 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.83 -37.45 63.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 73.31 111.093 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -65.33 -46.0 82.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 65.32 110.892 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 2.0 m -52.89 -41.14 64.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 72.13 111.154 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.521 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -72.68 -22.33 60.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 55.31 111.114 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -38.78 82.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 72.44 110.839 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.679 HD12 ' OD2' ' A' ' 152' ' ' ASP . 12.2 mt -89.33 -26.27 21.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 74.04 110.906 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.4 -64.78 0.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 63.13 111.059 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -57.28 -23.96 51.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 71.11 110.912 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -23.77 66.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 72.12 110.914 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -94.47 -33.43 13.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 65.52 110.925 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 129.16 -5.15 6.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 65.04 112.464 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -59.81 -172.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 75.04 110.937 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.593 ' H ' HG21 ' A' ' 95' ' ' ILE . 29.4 mm-40 -96.11 -3.6 44.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 62.14 110.836 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.521 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.4 mt-10 66.38 125.52 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 75.12 110.886 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -172.52 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.646 2.231 . . . . 64.43 112.308 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 106' ' ' HIS . 37.7 mt -51.93 -39.36 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.898 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.0 53.99 27.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.79 -0.719 . . . . 72.32 112.447 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -146.62 54.81 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.819 0.343 . . . . 70.42 110.876 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.618 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.9 OUTLIER -132.31 -176.46 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 74.54 110.903 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -141.68 -168.4 2.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 51.02 110.883 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.741 HG23 ' HB3' ' A' ' 144' ' ' TYR . 87.3 m -49.93 -43.3 49.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 72.22 111.079 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 142' ' ' THR . 3.3 m -140.42 143.08 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 71.21 111.108 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 HD23 ' A' ' 133' ' ' LEU . 63.0 m -150.21 110.19 4.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 70.21 111.129 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -71.87 94.77 1.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 74.12 110.875 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 131' ' ' THR . 4.5 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 73.23 110.937 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.773 ' HB2' HG22 ' A' ' 48' ' ' THR . 15.7 tpp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.904 0.383 . . . . 73.22 110.867 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.28 120.29 26.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.32 110.899 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.699 HG13 HD23 ' A' ' 158' ' ' LEU . 5.3 t -137.42 158.68 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 75.34 111.167 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 30.7 tt0 -155.82 123.76 5.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 64.43 110.894 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -76.54 178.4 6.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 74.13 111.17 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -172.39 137.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 71.12 110.927 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.741 ' HB3' HG23 ' A' ' 129' ' ' THR . 27.7 t80 -118.09 92.52 42.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 73.45 110.862 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -48.72 0.67 Allowed 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.698 2.265 . . . . 73.31 112.371 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.62 -152.82 16.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.798 -0.715 . . . . 45.35 112.494 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.99 123.18 44.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 71.21 110.909 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.52 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -130.99 -89.43 0.5 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.741 -0.742 . . . . 65.33 112.481 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -77.32 -29.67 53.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.831 0.348 . . . . 74.02 110.85 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.68 155.4 40.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 73.45 111.145 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -60.25 -24.19 64.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 70.53 110.843 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.679 ' OD2' HD12 ' A' ' 114' ' ' LEU . 1.9 p30 -119.17 49.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.42 110.915 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.562 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.0 OUTLIER -100.11 137.78 38.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 61.21 110.897 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.453 HG22 ' HD1' ' A' ' 144' ' ' TYR . 5.0 pt -139.16 158.81 29.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 55.5 111.153 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.572 ' CG1' HD22 ' A' ' 169' ' ' LEU . 10.2 m -106.97 145.08 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 65.44 111.026 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.7 t -100.16 144.22 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 74.45 111.118 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -131.53 149.3 52.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.23 -0.441 . . . . 71.44 110.898 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.699 HD23 HG13 ' A' ' 140' ' ' VAL . 21.1 mt -127.52 95.71 34.89 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 61.43 110.91 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 72.47 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 62.25 112.336 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 179.35 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 72.11 110.839 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.54 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.1 m-85 -117.94 -13.05 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 72.34 110.954 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m120 69.51 23.15 6.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 61.3 110.923 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.54 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.7 mp -93.84 114.56 30.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 72.03 111.161 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.95 136.83 39.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.887 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.511 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.6 t -125.48 68.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.02 111.164 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.76 -41.42 43.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 42.2 112.541 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.39 -129.1 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 71.43 112.496 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 69.5 m -74.82 -6.9 51.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 63.43 110.864 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.572 HD22 ' CG1' ' A' ' 155' ' ' VAL . 2.1 tp -73.24 -53.5 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 72.14 110.876 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.03 128.37 43.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.091 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -91.21 163.9 14.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 71.14 110.896 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 p -89.61 159.25 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.01 110.88 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.435 HG23 ' CD2' ' A' ' 218' ' ' LEU . 20.9 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.02 111.159 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.716 HG11 ' CG2' ' A' ' 186' ' ' VAL . 11.6 m . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.87 0.367 . . . . 63.24 111.062 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -51.6 -58.62 5.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 73.03 111.077 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -117.34 28.16 8.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 71.1 110.869 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -104.66 174.88 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 75.31 111.063 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -137.28 85.18 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.918 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.716 ' CG2' HG11 ' A' ' 181' ' ' VAL . 86.2 t -58.83 -21.49 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 74.54 111.093 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -75.51 -21.72 57.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 71.3 110.947 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -107.83 -26.58 10.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 71.42 110.892 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -51.28 -57.12 9.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.893 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 90.0 p -52.03 -30.42 25.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 72.23 110.817 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.3 m -80.98 -32.44 34.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 75.4 111.204 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 196' ' ' VAL . 71.8 m -68.75 -56.66 7.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 70.13 110.912 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.8 mm -53.13 -42.03 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 64.14 111.157 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -63.43 -26.38 68.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 60.32 110.864 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -86.23 -31.23 21.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.53 110.858 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.531 HG21 HG11 ' A' ' 155' ' ' VAL . 99.1 t -73.22 -38.03 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 75.13 111.143 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.476 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -79.9 -25.62 40.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.879 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -42.6 33.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 73.04 110.913 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 33.4 tpt85 -60.73 -29.82 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 75.35 110.901 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -139.54 117.19 11.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 64.02 110.885 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 32.3 6.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 73.05 110.828 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.1 21.41 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 73.53 110.925 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -52.23 146.19 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 74.42 111.137 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -105.15 -34.82 7.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 64.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.404 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -156.88 133.56 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 74.34 111.087 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.735 ' CG1' HD12 ' A' ' 218' ' ' LEU . 88.5 t -109.72 128.3 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 71.13 111.09 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.974 HG21 HD11 ' A' ' 44' ' ' LEU . 89.5 t -111.29 102.46 53.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.612 0.72 . . . . 52.14 111.116 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.6 Cg_endo -69.69 -170.13 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 70.52 112.416 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.11 -29.29 7.26 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.853 -0.689 . . . . 75.43 112.559 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -143.46 101.01 3.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.824 0.345 . . . . 72.14 110.899 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.83 -101.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 72.55 112.527 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -168.42 165.18 12.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 70.31 110.856 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.66 HG22 HG22 ' A' ' 207' ' ' VAL . 22.4 t -74.74 149.63 7.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 73.01 111.159 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -151.35 -108.42 0.4 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.7 -0.762 . . . . 74.14 112.441 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -155.37 -172.77 4.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 73.32 110.884 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -55.56 -22.39 21.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 64.14 110.88 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.735 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.19 -31.57 49.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 63.32 112.503 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.735 HD12 ' CG1' ' A' ' 206' ' ' VAL . 35.7 mt -50.95 -46.89 61.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 73.24 110.92 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.498 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -53.55 -42.22 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 72.42 110.898 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.735 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.0 mt -68.08 -41.21 82.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 74.5 110.95 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -66.26 -36.48 83.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 72.04 110.872 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.0 m -51.66 -43.44 62.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 75.11 111.103 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.782 ' HA ' HD12 ' A' ' 226' ' ' LEU . 71.9 mt -56.85 -38.57 72.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 74.43 110.902 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -28.65 62.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.807 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.7 mt -76.13 -24.77 54.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.927 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.0 mt -89.06 -32.8 17.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.908 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.871 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 18' ' ' ILE . 81.1 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.864 0.364 . . . . 72.33 111.108 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.722 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.2 mm -90.48 154.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 74.42 111.08 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -146.01 146.06 30.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 75.22 110.868 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.34 163.34 21.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.871 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -51.67 -33.21 32.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 72.12 110.884 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -31.45 17.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 42.22 111.109 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.04 -12.45 65.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 61.03 112.425 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.698 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -51.21 -33.42 27.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.867 0.365 . . . . 73.04 111.144 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.698 HG13 HG23 ' A' ' 15' ' ' THR . 15.0 mt -121.92 148.54 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 73.23 111.108 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.8 p -166.17 170.18 13.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 43.43 110.859 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.56 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -135.51 -175.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 72.43 111.156 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.482 ' HA ' HG22 ' A' ' 8' ' ' VAL . 1.1 t -167.02 133.87 2.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 72.21 110.858 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.76 118.07 15.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.88 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.471 HD13 HG23 ' A' ' 27' ' ' VAL . 4.8 mp -103.16 -39.31 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 74.24 110.899 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -149.44 -170.98 3.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 75.53 110.84 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -49.86 -51.25 41.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 51.31 110.893 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -132.23 41.11 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 42.02 110.838 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.02 120.45 25.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 71.43 111.142 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -129.77 154.32 47.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.94 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.471 HG23 HD13 ' A' ' 21' ' ' LEU . 19.1 t -117.48 105.01 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 71.21 111.067 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HB3' HG23 ' A' ' 18' ' ' ILE . 11.5 p-80 -99.07 137.91 36.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.907 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.3 m -134.91 136.39 42.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 63.43 111.163 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -125.47 170.52 11.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 75.51 110.907 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 tp -120.76 137.04 54.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.895 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.793 -0.718 . . . . 62.21 112.548 179.868 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.2 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.598 0.713 . . . . 60.45 111.105 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 141.74 46.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.683 2.255 . . . . 72.33 112.332 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.08 114.61 17.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 50.34 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.38 145.11 56.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 74.1 110.918 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.41 -175.62 21.15 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 72.44 112.517 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.784 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -154.98 141.75 19.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 74.12 110.915 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.51 HG22 HD23 ' A' ' 54' ' ' LEU . 21.2 t -126.15 137.53 57.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 75.23 111.086 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.2 mt -105.12 134.74 47.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 53.54 110.919 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -103.89 71.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 71.22 110.927 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 p -80.83 -172.03 3.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 70.43 111.19 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.59 -9.07 21.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 51.4 110.886 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.5 42.68 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 72.05 110.917 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.79 138.58 9.51 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 73.0 112.485 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.728 HD21 ' HB3' ' A' ' 75' ' ' PHE . 25.1 mt -58.52 172.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 70.24 110.904 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 81' ' ' ASP . 85.1 t -150.22 144.18 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 73.44 111.102 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.758 HD12 HG11 ' A' ' 79' ' ' VAL . 1.9 mt -116.26 132.14 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.994 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 55' ' ' VAL . 12.3 t -82.17 0.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 63.23 111.164 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.86 132.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 63.21 110.892 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -73.14 -168.42 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.21 110.827 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.3 m -94.62 -172.59 2.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.05 110.829 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.485 ' HB2' HD13 ' A' ' 63' ' ' LEU . 95.1 m95 -68.3 -35.08 77.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 75.03 110.923 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.72 168.27 24.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 61.14 110.885 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.436 ' HA ' HG22 ' A' ' 64' ' ' THR . 1.0 OUTLIER -64.53 -25.82 68.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 63.12 110.886 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -76.28 -25.47 54.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 73.04 110.941 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -85.87 -48.07 9.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 71.13 110.866 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 61' ' ' ASP . 13.7 t -59.86 -29.73 68.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 55.24 111.144 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -53.56 -41.62 66.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 64.12 110.882 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -84.81 -11.89 54.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 60.34 110.897 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 16' ' ' ILE . 35.1 tp -80.44 -47.52 14.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.947 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.2 mt -64.94 -21.99 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 75.31 111.152 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -71.91 -21.69 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.863 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.4 mtp -81.24 -58.32 3.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 74.33 110.893 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.615 ' HB ' HD13 ' A' ' 52' ' ' LEU . 35.2 m -58.07 -35.66 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 63.22 111.2 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -88.75 48.79 1.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 64.53 110.88 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.47 -41.71 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 61.24 110.902 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.722 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -102.09 -26.34 13.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 70.14 110.881 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.728 ' HB3' HD21 ' A' ' 52' ' ' LEU . 37.8 m-85 -88.35 9.61 22.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.01 110.829 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.5 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.4 pp0? 32.38 48.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.15 110.867 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -151.22 180.0 7.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.4 110.919 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.25 133.16 46.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 75.31 110.833 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.758 HG11 HD12 ' A' ' 54' ' ' LEU . 61.7 t -69.79 130.52 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 74.45 111.102 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.7 p -137.47 17.79 2.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 63.24 111.121 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.567 ' HB2' HG13 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -149.87 133.59 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.51 110.865 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG11 HD11 ' A' ' 98' ' ' LEU . 17.0 t -137.36 101.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 64.22 111.069 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.9 mt -78.8 119.54 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 65.34 111.087 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 91' ' ' ARG . 44.6 mm -106.3 133.52 50.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 55.45 111.121 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.4 p -89.3 -56.08 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.12 111.156 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.445 ' C ' HG23 ' A' ' 111' ' ' THR . 19.6 p-80 -133.14 163.87 28.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 73.22 110.829 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.8 98.41 9.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 61.11 111.164 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.626 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -152.54 158.13 42.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 75.42 110.832 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.51 -25.32 51.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 41.43 111.069 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -93.31 19.07 8.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 64.51 110.924 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.427 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.5 mpt_? -134.0 -51.35 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 64.34 110.827 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.626 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.03 15.79 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 73.31 111.092 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.96 -29.25 27.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.674 -0.774 . . . . 50.41 112.516 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.49 18.78 32.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 42.24 112.483 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.519 HG21 ' H ' ' A' ' 121' ' ' GLU . 8.4 tt -49.24 -29.99 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 73.11 111.135 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -69.95 -43.03 72.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 62.23 110.811 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.3 m -69.32 -34.29 74.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 73.43 111.144 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.458 HD11 HG11 ' A' ' 82' ' ' VAL . 52.7 mt -64.36 -32.32 73.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 54.03 110.883 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -94.27 21.29 7.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 71.23 110.882 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.27 -19.89 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.868 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.73 1.82 14.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 75.2 110.895 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.31 14.68 53.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.685 -0.769 . . . . 73.54 112.478 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.9 mt -82.27 154.9 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.342 . . . . 75.11 111.101 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.638 ' HB2' HD11 ' A' ' 124' ' ' LEU . 10.1 ptpt -118.89 122.79 43.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.869 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.415 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -91.28 79.2 5.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 62.2 111.075 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.525 ' HA ' HD12 ' A' ' 124' ' ' LEU . 72.2 m-70 -51.82 145.95 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 64.24 110.887 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.23 154.77 0.87 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 53.41 110.851 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 127' ' ' LEU . 73.4 p -72.57 160.09 32.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 53.35 111.109 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.22 -22.18 50.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 64.35 111.099 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 152' ' ' ASP . 8.9 tp -76.83 -48.15 19.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.866 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 44.5 m -55.34 -27.27 46.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.34 111.094 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.59 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -83.45 -23.71 32.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.101 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.29 -33.71 75.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 55.44 110.877 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.695 HD13 ' OD2' ' A' ' 152' ' ' ASP . 6.8 mp -93.1 -25.46 17.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 73.4 110.932 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.78 -65.1 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 52.34 111.135 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -56.58 -24.94 50.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 70.44 110.914 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -24.45 65.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 72.41 110.896 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -93.3 -33.48 13.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 64.01 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.03 -7.06 5.44 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 42.34 112.463 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -59.72 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.38 . . . . 53.31 110.918 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.519 ' H ' HG21 ' A' ' 95' ' ' ILE . 23.8 mm-40 -98.01 -1.53 42.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 73.21 110.926 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.59 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 2.1 mt-10 66.15 125.22 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.624 0.726 . . . . 64.1 110.924 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -170.65 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.651 2.234 . . . . 73.42 112.379 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' A' ' 104' ' ' LYS . 56.9 mt -54.18 -40.41 67.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 75.14 110.866 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.16 57.65 12.66 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.728 -0.748 . . . . 63.45 112.453 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.685 ' O ' HD23 ' A' ' 127' ' ' LEU . 13.7 m-20 -148.37 54.98 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 63.25 110.903 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 126' ' ' ASP . 41.2 mt -136.0 -169.63 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.927 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.61 -168.06 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.41 110.906 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.782 HG23 ' HB3' ' A' ' 144' ' ' TYR . 97.8 m -49.25 -44.05 43.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 61.34 111.132 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.01 141.04 29.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 75.11 111.118 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.7 m -148.56 101.53 3.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 55.44 111.147 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -65.86 96.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 73.51 110.942 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 tpp . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.862 0.363 . . . . 72.42 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.59 128.13 48.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 75.52 110.904 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.557 HG13 HD23 ' A' ' 158' ' ' LEU . 3.9 t -140.92 160.02 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 73.23 111.112 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 33.3 tt0 -161.17 122.58 2.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.87 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.44 178.73 5.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 44.5 111.169 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -174.0 139.21 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 64.35 110.908 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.782 ' HB3' HG23 ' A' ' 129' ' ' THR . 69.3 t80 -118.89 94.82 48.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.634 0.73 . . . . 75.04 110.928 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.74 0.66 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.749 2.299 . . . . 33.33 112.287 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.83 -156.39 25.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.682 -0.77 . . . . 61.23 112.451 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.36 121.94 39.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.736 0.303 . . . . 63.04 110.9 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.621 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -130.89 -93.65 0.64 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.67 -0.776 . . . . 52.21 112.451 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -73.04 -27.83 61.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 74.41 110.846 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.36 164.75 34.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 72.14 111.154 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -70.15 -23.88 63.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.41 110.865 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.695 ' OD2' HD13 ' A' ' 114' ' ' LEU . 8.8 p30 -119.41 49.0 1.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.871 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.5 p30 -99.62 137.58 37.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 70.24 110.911 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.8 pt -139.88 160.07 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.04 111.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 196' ' ' VAL . 9.4 m -108.5 149.42 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 75.3 111.157 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -105.57 141.82 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 72.42 111.078 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -130.17 146.77 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.928 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.557 HD23 HG13 ' A' ' 140' ' ' VAL . 9.6 mt -124.39 97.13 40.31 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.636 0.731 . . . . 75.32 110.908 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 73.33 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.252 . . . . 73.23 112.353 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.79 -34.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 72.24 110.862 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.436 ' O ' HD12 ' A' ' 163' ' ' ILE . 6.5 m-85 -118.04 -12.38 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.897 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.6 m120 68.9 23.27 6.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.106 -0.497 . . . . 72.52 110.884 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.445 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.5 mp -96.18 115.8 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 72.22 111.111 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.406 HD11 HG13 ' A' ' 196' ' ' VAL . 0.7 OUTLIER -99.11 139.97 33.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 73.42 110.914 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.612 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.5 t -126.7 67.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 74.23 111.154 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.36 -54.13 25.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 52.24 112.478 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.38 -134.8 12.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.622 -0.799 . . . . 44.4 112.494 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 91.8 m -64.48 -15.6 61.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.401 . . . . 55.11 110.93 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.408 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.3 tp -69.92 -51.54 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 74.52 110.913 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 206' ' ' VAL . 22.2 t -80.95 133.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 62.33 111.07 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -109.26 138.22 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 74.43 110.925 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.3 p -57.06 154.68 9.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.2 110.872 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.786 HG23 HD23 ' A' ' 218' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 55.11 111.15 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.439 HG11 ' CG2' ' A' ' 186' ' ' VAL . 17.6 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.791 0.329 . . . . 75.31 111.114 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.85 78.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.52 111.131 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -119.21 40.99 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 62.22 110.935 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -132.85 172.78 12.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 73.11 111.055 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -119.79 89.78 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 71.51 110.868 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.439 ' CG2' HG11 ' A' ' 181' ' ' VAL . 58.0 t -68.5 -20.9 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 62.14 111.076 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -81.34 -27.24 35.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 53.31 110.91 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.83 -22.94 16.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 61.23 110.837 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.36 -55.05 20.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 73.42 110.865 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.3 p -51.88 -41.11 61.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 70.23 110.87 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 89.4 m -69.84 -40.21 75.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 70.12 111.175 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 70.6 m -58.31 -55.06 39.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 74.21 110.825 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.63 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.0 mm -54.36 -36.82 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 54.34 111.174 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -62.45 -23.39 66.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 71.33 110.914 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -90.41 -25.94 20.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 70.1 110.914 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.543 HG12 HD21 ' A' ' 219' ' ' LEU . 43.6 t -80.96 -32.7 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 73.31 111.08 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.452 HD23 HG22 ' A' ' 193' ' ' ILE . 2.9 pp -84.8 -25.04 28.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 71.54 110.895 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -82.3 -46.07 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 75.22 110.942 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -52.14 -38.41 57.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 70.12 110.781 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -131.88 117.57 18.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 75.14 110.937 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -115.34 41.65 2.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 73.24 110.861 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.01 21.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.89 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.431 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.3 mp -53.22 144.58 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.144 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.02 -33.2 8.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 70.43 110.916 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.445 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -157.54 127.26 6.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 75.51 111.085 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 170' ' ' VAL . 86.9 t -106.76 118.09 53.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 72.25 111.15 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.784 HG21 HD11 ' A' ' 44' ' ' LEU . 57.4 t -100.84 104.11 29.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.571 0.701 . . . . 75.31 111.235 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.72 -172.14 0.54 Allowed 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.705 2.27 . . . . 63.33 112.301 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -100.64 -25.11 8.81 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 71.44 112.541 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -146.34 104.94 3.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 72.23 110.875 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.97 -91.43 0.15 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.71 -0.757 . . . . 72.03 112.453 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -178.9 153.28 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.373 . . . . 73.32 110.902 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.48 143.88 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 41.33 111.18 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -143.22 -105.56 0.54 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.696 -0.764 . . . . 44.13 112.487 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -155.49 -170.14 3.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.802 0.334 . . . . 70.32 110.911 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -57.74 -20.49 35.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.888 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.766 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.6 -33.28 62.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.707 -0.758 . . . . 75.43 112.504 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.786 HD23 HG23 ' A' ' 173' ' ' THR . 31.9 mt -50.78 -47.69 59.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 75.12 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.63 ' O ' HG21 ' A' ' 193' ' ' ILE . 7.0 mp -56.93 -43.87 81.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.457 . . . . 44.35 110.836 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.766 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.3 mt -66.08 -41.66 90.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 75.44 110.951 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.679 ' NE2' HD21 ' A' ' 225' ' ' LEU . 84.4 t60 -60.34 -44.46 95.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.792 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -46.73 64.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 65.25 111.071 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.62 ' HA ' HD12 ' A' ' 226' ' ' LEU . 61.0 mt -51.78 -39.75 59.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.22 111.0 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -65.64 -44.62 85.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.886 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.679 HD21 ' NE2' ' A' ' 221' ' ' HIS . 20.7 mt -57.0 -25.84 59.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.908 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.0 mt -90.56 -40.21 12.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 72.15 110.875 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.0 mttt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 61.41 110.88 179.852 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.786 0.327 . . . . 74.32 111.155 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.694 HD11 ' HE3' ' A' ' 74' ' ' LYS . 2.8 mm -87.95 149.59 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 51.41 111.143 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -146.43 156.38 43.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 71.11 110.903 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.32 -177.52 4.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.878 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -67.14 -28.86 68.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.494 ' OG1' HG22 ' A' ' 15' ' ' THR . 5.6 p -93.06 -35.95 12.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.12 111.057 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.96 -15.16 58.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.664 -0.779 . . . . 65.14 112.425 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.707 HG23 HG13 ' A' ' 16' ' ' ILE . 2.0 t -51.72 -33.06 32.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.725 0.298 . . . . 53.02 111.151 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.707 HG13 HG23 ' A' ' 15' ' ' THR . 28.6 mt -117.11 150.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 45.51 111.027 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.9 p -170.66 173.24 5.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 71.15 110.827 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 19' ' ' SER . 0.3 OUTLIER -139.78 -177.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 62.24 111.13 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.444 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.2 t -167.72 135.77 2.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.473 . . . . 63.33 110.833 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -69.8 118.97 13.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 63.25 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.5 mm? -102.44 -56.8 2.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 65.03 110.946 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -152.69 -172.57 4.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.88 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.3 mttt -52.57 109.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 62.14 110.856 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 58.77 26.16 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 71.52 110.891 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 23' ' ' LYS . 69.5 t -128.44 110.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 75.42 111.124 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -123.39 163.75 20.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 75.44 110.94 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 213' ' ' VAL . 71.9 t -124.42 109.81 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 62.54 111.181 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -99.32 136.92 38.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 71.44 110.888 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.4 m -130.99 125.9 34.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 54.52 111.13 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.635 ' OE1' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -117.88 168.09 10.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.829 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.68 132.92 52.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 63.13 110.91 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.231 0 C-N-CA 120.687 -0.768 . . . . 74.52 112.437 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 69.9 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.668 0.747 . . . . 71.33 111.141 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.0 Cg_endo -69.67 139.51 40.73 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.782 2.321 . . . . 45.0 112.285 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.62 127.02 51.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 44.23 110.857 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -78.17 137.84 38.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 74.31 110.906 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.628 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -138.18 -160.47 8.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 62.21 112.529 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.049 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -165.15 143.63 6.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.84 0.352 . . . . 62.4 110.886 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.402 HG22 HD13 ' A' ' 54' ' ' LEU . 63.5 t -126.25 131.92 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 74.43 111.145 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.5 mt -101.85 119.1 38.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.438 . . . . 73.25 110.92 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -90.07 48.28 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 61.31 110.84 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.41 HG22 ' CB ' ' A' ' 138' ' ' MET . 19.5 p -58.48 176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 73.41 111.106 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.2 21.88 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 72.13 110.889 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.52 30.02 1.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.13 110.856 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.61 129.4 6.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 33.45 112.49 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.764 HD21 ' HB3' ' A' ' 75' ' ' PHE . 46.3 mt -51.62 165.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 52.43 110.97 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 81' ' ' ASP . 50.3 t -147.31 144.9 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 75.22 111.181 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 53' ' ' VAL . 3.5 mm? -115.7 126.66 54.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.11 110.921 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 55' ' ' VAL . 15.5 t -77.06 -3.85 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 75.11 111.181 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.8 129.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 74.31 110.846 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -166.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 70.23 110.857 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 t -94.66 -170.36 2.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 53.34 110.819 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.752 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.7 m95 -73.06 -38.8 66.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 72.25 110.878 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -140.0 161.73 36.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 71.13 110.87 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.22 -33.9 69.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 65.35 110.896 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -75.2 -25.75 58.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 70.21 110.903 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.752 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -81.16 -42.67 20.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 62.02 110.882 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -67.1 -27.05 67.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 65.4 111.168 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -53.42 -39.49 64.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.892 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -86.03 -13.96 45.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 65.54 110.912 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.635 HD22 ' OE1' ' A' ' 30' ' ' GLU . 11.7 tp -77.65 -43.14 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 72.34 110.911 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.24 -29.04 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 73.04 111.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.11 -11.7 61.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 73.15 110.889 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 mmm -89.38 -54.47 4.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.877 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.762 ' HB ' HD13 ' A' ' 52' ' ' LEU . 18.5 m -57.12 -39.87 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 60.3 111.051 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HG3' HG23 ' A' ' 71' ' ' VAL . 51.2 mt-10 -84.41 51.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 73.35 110.899 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -142.54 -41.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 75.13 110.878 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.694 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.62 -19.92 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 72.23 110.909 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.764 ' HB3' HD21 ' A' ' 52' ' ' LEU . 26.1 m-85 -89.22 10.81 20.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 65.31 110.883 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.518 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.64 47.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 61.43 110.902 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -155.3 -179.23 7.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 55.35 110.915 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.565 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -127.99 151.38 49.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 62.43 110.815 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 52' ' ' LEU . 57.7 t -86.11 128.66 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 70.15 111.116 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.565 HG23 ' HD3' ' A' ' 78' ' ' ARG . 65.4 p -137.25 20.76 2.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 72.11 111.173 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.582 ' HB2' HG13 ' A' ' 53' ' ' VAL . 5.8 m-20 -154.01 134.9 13.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 42.23 110.884 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.633 HG21 HD22 ' A' ' 98' ' ' LEU . 25.0 t -138.32 97.92 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 71.12 111.101 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.6 mt -75.02 129.69 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 71.21 111.131 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.5 mm -115.96 131.3 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 72.4 111.115 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.7 p -88.01 -57.93 2.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 64.34 111.157 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -132.86 157.6 44.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 53.24 110.865 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -76.25 96.98 4.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 63.11 111.151 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.639 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -150.65 157.94 43.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.871 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.83 -27.17 62.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 24.44 111.15 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.25 8.15 28.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 61.03 110.875 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -122.89 -53.6 1.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.903 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.639 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -113.4 18.36 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.128 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.61 -27.97 20.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.656 -0.783 . . . . 53.34 112.548 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.98 23.0 20.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.707 -0.759 . . . . 64.41 112.492 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.404 HG21 ' H ' ' A' ' 121' ' ' GLU . 3.9 tt -48.98 -30.36 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 62.22 111.111 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -71.06 -43.26 68.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.916 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 93.9 m -67.04 -36.03 81.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 70.44 111.118 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.633 HD22 HG21 ' A' ' 82' ' ' VAL . 48.6 mt -60.94 -33.48 73.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.33 110.926 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -94.3 21.84 6.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.911 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -117.24 -20.29 9.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.824 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -115.32 5.97 14.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.21 110.9 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.76 15.17 60.06 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 44.13 112.429 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 98' ' ' LEU . 14.3 mt -81.62 155.71 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 73.43 111.175 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.774 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -119.95 122.1 40.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 75.35 110.893 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -88.51 81.45 7.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 72.14 111.046 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.422 ' ND1' HD12 ' A' ' 124' ' ' LEU . 96.7 m-70 -56.58 147.71 21.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 70.41 110.889 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.64 166.43 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 71.14 110.799 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.1 p -86.08 157.05 20.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 61.01 111.145 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.41 -43.32 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.52 111.054 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.668 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -62.1 -46.04 90.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 52.12 110.986 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.679 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 98.2 m -52.04 -42.58 63.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 72.21 111.166 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.25 -24.79 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 63.32 111.117 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.87 -51.31 69.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 64.04 110.885 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.647 HD13 ' OD1' ' A' ' 152' ' ' ASP . 6.5 mp -76.26 -25.03 54.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.919 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.92 -69.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 74.42 111.155 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -54.72 -26.64 35.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 73.5 110.951 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -24.48 67.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 53.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -92.81 -38.97 11.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 74.53 110.873 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.86 -6.47 3.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 44.41 112.554 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -59.77 -172.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.832 0.348 . . . . 61.03 110.95 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.404 ' H ' HG21 ' A' ' 95' ' ' ILE . 56.0 mm-40 -98.63 -0.68 42.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 63.32 110.885 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 66.28 126.26 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.654 0.74 . . . . 72.21 110.85 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.677 2.251 . . . . 55.41 112.377 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 104' ' ' LYS . 62.9 mt -52.21 -40.55 61.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.903 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.1 55.97 18.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.531 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -148.98 52.93 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 71.31 110.912 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.8 mt -135.74 -177.67 4.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.883 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.83 -168.59 2.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.883 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.847 HG23 ' HB3' ' A' ' 144' ' ' TYR . 92.7 m -50.1 -54.26 21.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 70.23 111.158 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.699 HG22 ' HA ' ' A' ' 143' ' ' PHE . 90.8 t -131.34 130.98 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 64.02 111.106 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.565 HG22 HD23 ' A' ' 133' ' ' LEU . 99.1 m -135.6 123.67 22.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 75.11 111.167 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -81.41 103.97 11.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 75.1 110.85 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.565 HD23 HG22 ' A' ' 131' ' ' THR . 1.6 mt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 73.13 110.902 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.41 ' CB ' HG22 ' A' ' 48' ' ' THR . 58.5 tpp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.866 0.365 . . . . 75.41 110.838 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -117.17 115.24 24.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.926 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.6 t -123.01 153.55 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 61.31 111.144 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -153.15 122.38 6.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 70.21 110.938 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.538 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -73.24 -178.18 2.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 42.13 111.148 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.699 ' HA ' HG22 ' A' ' 130' ' ' VAL . 71.2 t80 -175.35 134.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.84 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.847 ' HB3' HG23 ' A' ' 129' ' ' THR . 29.1 t80 -121.09 96.06 48.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.702 0.763 . . . . 74.24 110.91 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.7 Cg_endo -69.79 -48.71 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.619 2.213 . . . . 64.25 112.336 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.61 -153.78 20.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.738 . . . . 63.15 112.451 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.7 124.62 39.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 71.33 110.905 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.48 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.42 -94.19 0.34 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 53.32 112.47 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -70.11 -26.86 64.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 62.4 110.895 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.41 159.62 42.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.468 . . . . 74.32 111.119 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.28 -23.09 66.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.873 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.668 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -124.02 50.07 1.69 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 75.52 110.868 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.19 139.87 34.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 73.12 110.904 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.538 HD12 HG22 ' A' ' 142' ' ' THR . 5.6 pt -140.12 172.85 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 61.44 111.149 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 196' ' ' VAL . 7.9 m -123.58 139.23 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 45.21 111.183 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.447 ' O ' HD22 ' A' ' 164' ' ' LEU . 77.6 t -94.04 128.68 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 70.34 111.139 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -114.84 150.32 35.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.905 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.674 HD12 ' HB ' ' A' ' 163' ' ' ILE . 53.7 mt -124.77 94.87 43.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.595 0.712 . . . . 73.15 110.926 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 69.65 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.687 2.258 . . . . 65.14 112.317 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.37 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 74.23 110.874 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.617 ' CB ' HD13 ' A' ' 163' ' ' ILE . 7.3 m-85 -117.49 -10.76 10.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 75.52 110.905 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.4 m120 68.18 21.01 8.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 73.35 110.88 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.674 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.5 mp -86.41 116.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 65.44 111.097 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.6 tm? -101.98 123.46 45.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 52.42 110.984 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.489 ' N ' HD22 ' A' ' 164' ' ' LEU . 26.0 t -117.37 72.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 65.12 111.078 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.416 ' H ' HD13 ' A' ' 164' ' ' LEU . . . -65.17 -51.71 47.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 71.43 112.482 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.94 -138.02 14.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 72.33 112.483 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.91 -25.72 31.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 52.23 110.854 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.483 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.6 OUTLIER -62.08 -49.63 75.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 63.43 110.95 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.741 HG11 HG11 ' A' ' 206' ' ' VAL . 21.4 t -89.56 131.37 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 61.53 111.111 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -101.6 148.64 24.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 73.01 110.887 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.632 ' HA ' HD22 ' A' ' 218' ' ' LEU . 2.2 t -73.56 158.86 34.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.827 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 72.03 111.197 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 186' ' ' VAL . 35.4 m . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.783 0.325 . . . . 61.4 111.069 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.3 80.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 71.55 111.039 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -114.03 42.23 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 74.3 110.927 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.24 164.65 28.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.43 111.072 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -115.61 92.61 3.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 72.45 110.931 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.53 ' CG2' HG11 ' A' ' 181' ' ' VAL . 61.7 t -67.07 -23.68 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.1 111.201 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -79.39 -31.52 42.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 25.31 110.886 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.51 -22.7 20.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 62.41 110.911 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -51.49 -53.21 39.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 64.15 110.884 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.6 p -51.88 -37.93 54.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 71.04 110.86 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 91.8 m -70.64 -37.77 73.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 60.22 111.128 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.2 m -63.38 -55.27 25.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 70.51 110.876 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.939 HG22 HD23 ' A' ' 197' ' ' LEU . 25.8 mm -56.54 -37.63 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 64.12 111.112 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.06 -17.49 62.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 75.12 110.842 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -96.55 -28.96 14.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 61.14 110.901 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.518 HG21 HG11 ' A' ' 155' ' ' VAL . 96.0 t -82.69 -26.02 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 71.42 111.099 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.939 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -90.51 -23.27 20.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 64.45 110.909 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -88.51 -47.38 8.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 72.4 110.88 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 32.9 tpt85 -55.31 -32.59 62.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.834 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -130.89 116.91 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 72.3 110.888 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -119.3 34.94 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 75.34 110.897 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.02 22.33 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 70.3 110.859 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.541 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.2 mp -51.51 143.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 74.44 111.146 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.0 -39.27 6.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 74.03 110.936 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.432 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -153.71 118.96 5.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 72.42 111.092 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.741 HG11 HG11 ' A' ' 170' ' ' VAL . 92.8 t -96.96 123.21 49.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 74.41 111.152 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.049 HG21 HD11 ' A' ' 44' ' ' LEU . 87.5 t -106.49 102.13 39.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 73.44 111.154 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.0 Cg_endo -69.69 -170.05 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.75 2.3 . . . . 50.23 112.347 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.87 -31.27 7.45 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.733 -0.746 . . . . 61.54 112.445 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -144.27 111.9 6.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 65.45 110.873 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 144.91 -94.17 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 74.44 112.447 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -176.06 164.09 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 72.55 110.917 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.694 HG22 HG22 ' A' ' 207' ' ' VAL . 21.3 t -72.59 150.57 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.41 111.07 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.77 -108.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.767 -0.73 . . . . 74.01 112.457 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -160.27 -169.85 2.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.876 0.369 . . . . 63.14 110.887 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -54.25 -24.76 19.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 72.41 110.87 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.73 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -52.16 -35.6 42.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 71.51 112.5 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.711 HD12 ' CG1' ' A' ' 206' ' ' VAL . 32.7 mt -50.96 -45.68 60.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.339 . . . . 64.31 110.918 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.716 HD12 HG23 ' A' ' 193' ' ' ILE . 4.3 mm? -54.14 -41.3 68.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 74.41 111.01 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.73 HD12 ' HA2' ' A' ' 217' ' ' GLY . 4.8 mt -69.36 -40.87 77.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.32 110.853 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -60.78 -42.14 96.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.762 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.25 -48.43 65.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 62.31 111.167 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.799 ' HA ' HD12 ' A' ' 226' ' ' LEU . 3.8 mt -56.28 -41.4 75.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 62.12 110.93 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.91 -42.07 79.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 73.22 110.904 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.5 mt -60.88 -37.4 82.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 75.03 110.894 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' A' ' 223' ' ' LEU . 4.7 mt -72.7 -40.53 66.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 65.22 110.944 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 71.32 110.909 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.575 HG22 ' OG ' ' A' ' 19' ' ' SER . 92.4 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.804 0.335 . . . . 60.2 111.154 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.6 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.1 mm -88.14 152.86 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 73.23 111.191 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -146.12 153.75 41.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 71.42 110.87 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.16 170.82 11.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 55.24 110.903 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -58.7 -27.17 64.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 73.42 110.885 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -100.13 -33.4 10.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 71.55 111.225 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.85 -9.76 51.8 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.737 -0.745 . . . . 50.42 112.446 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.704 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.94 -33.21 23.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.716 0.293 . . . . 72.51 111.123 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.704 HG13 HG23 ' A' ' 15' ' ' THR . 14.6 mt -124.81 149.18 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.15 111.084 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -168.34 169.75 10.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 72.31 110.845 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -135.05 -172.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.503 . . . . 75.02 111.143 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.575 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -173.76 132.86 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 60.51 110.908 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.21 120.72 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.104 -0.498 . . . . 74.5 110.923 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -103.8 -49.28 3.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.45 . . . . 54.22 110.932 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.33 51.87 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 69.03 -75.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.936 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.621 ' OD1' HG23 ' A' ' 25' ' ' VAL . 14.5 p30 -86.88 -19.91 28.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 71.45 110.897 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.621 HG23 ' OD1' ' A' ' 24' ' ' ASN . 99.6 t -97.45 118.52 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 65.34 111.123 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -122.35 161.56 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.939 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.5 HG21 HG21 ' A' ' 213' ' ' VAL . 70.4 t -122.35 106.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 64.55 111.108 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.456 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.1 p80 -95.83 137.37 34.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 74.24 110.876 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 41' ' ' SER . 37.3 m -132.46 128.76 38.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 62.14 111.156 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.651 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -120.29 -177.27 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.438 . . . . 73.0 110.865 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.507 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -136.79 133.16 35.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 73.23 110.865 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 75.53 112.484 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.421 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 59.4 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 121.643 0.735 . . . . 72.24 111.068 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.5 Cg_endo -69.69 141.04 44.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.649 2.233 . . . . 73.23 112.358 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.625 ' O ' HG23 ' A' ' 29' ' ' THR . 1.1 t -121.26 132.85 55.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 62.4 110.821 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -90.95 141.93 28.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 73.24 110.804 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.627 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -140.95 -155.87 6.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 52.04 112.53 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.919 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -164.93 144.13 6.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 71.44 110.903 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 54' ' ' LEU . 31.6 t -128.08 133.28 67.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 53.23 111.115 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.554 HD22 ' HE3' ' A' ' 138' ' ' MET . 39.6 mt -100.64 123.32 44.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.941 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -92.15 46.79 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 74.32 110.886 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.538 HG22 ' CB ' ' A' ' 138' ' ' MET . 24.5 p -55.35 171.26 0.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 63.44 111.125 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.3 t -99.24 28.45 4.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.83 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 22.8 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 70.33 110.941 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.8 129.98 4.4 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 65.13 112.503 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.799 HD13 ' HB ' ' A' ' 71' ' ' VAL . 26.0 mt -57.26 157.81 5.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 74.51 110.957 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' A' ' 81' ' ' ASP . 95.2 t -140.76 143.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 64.14 111.123 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.557 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -113.47 130.07 56.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 72.01 110.934 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.8 t -79.77 -1.78 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.096 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.78 134.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.88 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -166.7 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 71.41 110.821 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.17 -170.09 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 53.23 110.799 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.677 ' HB2' HD13 ' A' ' 63' ' ' LEU . 85.7 m95 -72.05 -40.22 68.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.094 -0.503 . . . . 71.21 110.931 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.79 175.54 9.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 32.31 110.958 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HA ' HG22 ' A' ' 64' ' ' THR . 4.1 p-10 -68.9 -30.61 69.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 75.12 110.823 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -74.54 -22.39 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 70.23 110.918 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.27 -52.41 5.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 64.44 110.89 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.495 HG21 ' HA3' ' A' ' 94' ' ' GLY . 10.2 t -57.4 -28.35 63.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 72.44 111.138 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -55.93 -40.82 73.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 53.24 110.874 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.96 -1.36 57.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.414 . . . . 74.53 110.866 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.651 HD22 ' OE2' ' A' ' 30' ' ' GLU . 15.5 tp -92.88 -45.15 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.902 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.8 mt -72.18 -14.65 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 73.42 111.072 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -87.11 5.9 35.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 63.15 110.848 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.1 mtp -106.54 -53.69 2.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 73.32 110.859 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.799 ' HB ' HD13 ' A' ' 52' ' ' LEU . 21.3 m -58.42 -37.77 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 71.32 111.083 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HG3' HG23 ' A' ' 71' ' ' VAL . 32.7 mt-10 -85.99 50.03 1.9 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.898 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.23 -42.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 72.02 110.837 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.6 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -103.9 -21.65 13.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.955 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.757 ' HB3' HD21 ' A' ' 52' ' ' LEU . 35.9 m-85 -91.23 12.94 18.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.883 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.511 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.72 46.91 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 71.13 110.923 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -155.57 -177.81 6.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 72.32 110.87 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.1 OUTLIER -125.85 159.13 33.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 71.13 110.875 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 52' ' ' LEU . 89.9 t -91.46 119.44 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 52.14 111.123 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.414 HG23 ' HG2' ' A' ' 78' ' ' ARG . 30.0 p -132.18 36.83 3.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.118 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.819 ' HB2' HG22 ' A' ' 53' ' ' VAL . 4.6 m-20 -169.76 134.29 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 73.12 110.794 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.677 HG23 HG21 ' A' ' 103' ' ' ILE . 22.4 t -140.66 100.27 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 71.22 111.09 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.7 mt -77.66 124.04 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 55.54 111.164 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.3 mm -109.24 142.43 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 74.24 111.132 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.8 p -98.69 -60.85 1.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 71.52 111.164 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -130.79 165.07 23.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 75.44 110.865 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.21 97.66 8.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.22 111.059 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.667 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.65 157.93 42.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 73.25 110.912 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.93 -29.57 63.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 73.33 111.087 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -89.66 10.7 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.873 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -121.94 -52.09 2.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 65.31 110.915 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -117.13 26.77 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.157 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.24 -28.19 18.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.707 -0.758 . . . . 60.04 112.479 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 64' ' ' THR . . . -116.02 30.61 6.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 65.32 112.543 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.514 HD11 ' C ' ' A' ' 122' ' ' GLU . 1.1 tt -48.56 -34.21 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 75.1 111.098 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -34.51 33.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 75.33 110.853 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.9 m -62.44 -34.18 76.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 72.44 111.063 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.967 HD12 ' HB2' ' A' ' 105' ' ' ALA . 27.6 mt -65.4 -43.24 91.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 63.32 110.878 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -26.26 59.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.866 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.25 -29.82 70.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 72.23 110.896 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -105.58 -48.29 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.35 110.858 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.62 -15.75 1.08 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.72 -0.753 . . . . 72.02 112.499 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.677 HG21 HG23 ' A' ' 82' ' ' VAL . 1.9 mp -54.56 151.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.13 111.123 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.787 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.6 ptpm? -113.66 127.84 56.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.923 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.967 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -90.12 82.03 6.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 40.42 111.043 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.456 ' ND1' HD12 ' A' ' 124' ' ' LEU . 93.7 m-70 -57.72 147.11 28.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.45 110.871 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.63 160.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 73.03 110.89 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.637 HG22 ' HB3' ' A' ' 127' ' ' LEU . 72.2 p -74.03 -175.61 2.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 41.14 111.111 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.12 -30.92 43.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 51.33 111.143 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.73 -44.68 40.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.958 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.7 m -55.41 -25.38 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 73.13 111.168 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.518 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -91.31 -34.34 14.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 64.23 111.159 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -53.69 -32.8 53.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 60.31 110.89 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.558 HD13 ' OD1' ' A' ' 152' ' ' ASP . 9.8 mp -91.79 -25.84 18.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 70.35 110.838 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . . . -53.65 -62.72 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.32 111.096 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -60.12 -26.09 65.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 71.3 110.898 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -25.18 68.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.893 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -92.16 -33.38 14.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 64.3 110.868 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.1 -10.78 4.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 32.34 112.494 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -59.59 -173.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.83 0.347 . . . . 72.41 110.871 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -98.71 0.32 44.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 54.44 110.886 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.514 ' C ' HD11 ' A' ' 95' ' ' ILE . 1.2 mt-10 66.42 132.59 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.656 0.741 . . . . 74.21 110.928 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.8 -169.63 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.653 2.235 . . . . 61.33 112.4 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.787 HD11 ' HB2' ' A' ' 104' ' ' LYS . 54.2 mt -54.83 -51.11 66.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 73.11 110.959 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.4 51.72 8.2 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.75 -0.738 . . . . 62.12 112.471 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.46 55.42 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 64.32 110.833 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.637 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.5 OUTLIER -137.61 -174.66 3.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 61.1 110.89 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.84 -168.16 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.764 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.1 m -49.66 -43.01 46.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 65.42 111.221 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.38 142.15 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 75.5 111.061 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.654 HG22 HD23 ' A' ' 133' ' ' LEU . 60.6 m -149.83 108.87 3.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.095 -0.502 . . . . 72.03 111.084 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -69.75 96.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 72.53 110.858 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.654 HD23 HG22 ' A' ' 131' ' ' THR . 3.3 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 54.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.554 ' HE3' HD22 ' A' ' 46' ' ' LEU . 2.2 tpt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.88 0.372 . . . . 65.33 110.832 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -120.51 127.72 52.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 62.34 110.848 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.702 HG13 HD23 ' A' ' 158' ' ' LEU . 5.0 t -141.51 158.96 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 43.35 111.145 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.417 ' N ' HG12 ' A' ' 140' ' ' VAL . 30.7 tt0 -159.01 124.58 4.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 52.11 110.891 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.412 HG22 ' CD1' ' A' ' 154' ' ' ILE . 0.0 OUTLIER -74.97 -178.27 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 72.33 111.13 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -175.36 140.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 71.5 110.895 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.764 ' HB3' HG23 ' A' ' 129' ' ' THR . 49.7 t80 -123.24 97.66 42.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.598 0.713 . . . . 74.02 110.927 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.478 ' HB3' HG23 ' A' ' 196' ' ' VAL . 54.0 Cg_endo -69.7 -48.98 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.699 2.266 . . . . 54.12 112.371 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.59 -153.95 22.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.786 -0.721 . . . . 55.22 112.467 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.51 122.44 39.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 74.23 110.934 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.5 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -135.04 -97.76 0.56 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 52.21 112.481 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -67.65 -28.41 67.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.818 0.342 . . . . 64.24 110.862 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.69 156.44 41.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 73.12 111.114 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -59.91 -29.26 68.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 72.01 110.844 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.558 ' OD1' HD13 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -117.9 52.12 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.89 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.72 135.0 42.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 75.43 110.884 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.415 HG22 ' HD1' ' A' ' 144' ' ' TYR . 1.1 pt -136.45 166.98 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 74.23 111.114 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.442 ' CG1' HD23 ' A' ' 169' ' ' LEU . 10.5 m -116.83 157.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 70.13 111.107 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.3 t -110.36 143.29 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.136 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -130.87 148.15 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 71.14 110.902 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.702 HD23 HG13 ' A' ' 140' ' ' VAL . 24.1 mt -125.53 95.37 40.8 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.57 0.7 . . . . 74.22 110.888 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 72.21 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.729 2.286 . . . . 52.12 112.317 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.08 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 70.33 110.934 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.89 -11.74 10.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.891 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 68.36 24.12 7.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 63.13 110.976 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.562 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.7 mp -96.24 117.24 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 64.33 111.172 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.23 142.65 33.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.952 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.507 HG21 HD22 ' A' ' 44' ' ' LEU . 21.6 t -127.9 67.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 75.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.62 -55.19 21.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.67 -0.776 . . . . 71.25 112.544 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.14 -137.12 13.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.668 -0.777 . . . . 34.01 112.468 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 59.3 m -64.24 -15.8 60.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 61.43 110.934 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.651 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.5 tp -70.11 -47.59 61.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.914 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 218' ' ' LEU . 21.8 t -95.91 115.92 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 53.43 111.148 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.615 ' H ' HG23 ' A' ' 222' ' ' THR . 0.1 OUTLIER -82.85 155.76 23.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 73.42 110.892 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.619 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.5 t -84.0 162.29 20.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 73.14 110.843 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 73.3 111.161 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.488 HG11 ' CG2' ' A' ' 186' ' ' VAL . 6.7 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.856 0.36 . . . . 63.14 111.115 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.27 -47.05 82.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 70.25 111.155 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -117.42 42.99 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.35 110.844 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -133.62 162.17 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 73.23 111.138 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -115.72 93.49 4.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.022 0.439 . . . . 75.45 110.902 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.488 ' CG2' HG11 ' A' ' 181' ' ' VAL . 49.1 t -69.36 -20.91 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 74.25 111.06 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -81.98 -26.84 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 70.34 110.943 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.54 -21.37 16.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.53 110.841 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.651 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -51.41 -56.18 14.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.9 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.3 p -51.96 -37.77 54.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.837 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.1 m -72.56 -37.84 68.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 72.15 111.127 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 75.7 m -61.92 -54.92 35.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.04 110.83 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.772 HG23 HD12 ' A' ' 219' ' ' LEU . 26.7 mm -55.83 -36.75 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 74.15 111.087 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.88 -17.31 64.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.3 110.828 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -93.93 -31.03 14.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 70.5 110.871 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 145' ' ' PRO . 87.3 t -77.26 -45.9 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 54.13 111.137 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.713 HD23 HG22 ' A' ' 193' ' ' ILE . 3.6 pp -69.77 -23.2 63.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.467 . . . . 63.12 110.878 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -86.23 -44.33 12.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 63.51 110.866 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -53.29 -28.5 28.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 73.02 110.874 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -142.52 121.24 12.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 64.53 110.96 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.42 35.69 4.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 73.41 110.879 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.25 21.8 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.914 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.449 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.6 mp -53.24 145.08 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.42 111.164 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -105.88 -33.76 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.91 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.562 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -155.92 128.37 7.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 44.23 111.111 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.498 HG12 HD12 ' A' ' 218' ' ' LEU . 94.8 t -109.85 117.42 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 44.41 111.126 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.919 HG21 HD11 ' A' ' 44' ' ' LEU . 75.3 t -100.04 104.3 28.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.594 0.711 . . . . 70.41 111.097 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.75 -173.7 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.707 2.271 . . . . 72.4 112.32 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.42 -28.85 10.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.737 . . . . 65.13 112.503 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -144.09 110.52 5.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 74.11 110.824 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 144.92 -98.41 0.2 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 44.23 112.508 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -174.62 154.75 2.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 72.12 110.928 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.816 HG22 HG22 ' A' ' 207' ' ' VAL . 22.9 t -57.32 149.59 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 62.33 111.157 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -148.72 -108.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.697 -0.763 . . . . 73.03 112.515 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -161.34 -169.85 2.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.893 0.378 . . . . 72.12 110.92 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -58.18 -20.56 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 44.32 110.949 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.63 -33.98 63.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.76 -0.734 . . . . 55.45 112.461 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 172' ' ' SER . 28.0 mt -50.59 -42.66 56.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.834 0.35 . . . . 72.14 110.896 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.772 HD12 HG23 ' A' ' 193' ' ' ILE . 4.6 mm? -55.43 -43.36 75.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.919 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.571 HD12 ' HA2' ' A' ' 217' ' ' GLY . 4.9 mt -68.54 -40.41 80.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 72.11 110.9 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -60.72 -38.91 86.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.52 110.879 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.615 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.78 -45.07 63.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 70.42 111.081 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.791 ' HA ' HD12 ' A' ' 226' ' ' LEU . 9.5 mt -59.4 -42.57 92.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.888 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -29.21 56.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.852 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.9 mt -75.21 -26.89 59.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 73.24 110.88 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.791 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.4 mt -86.09 -30.21 22.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.958 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 63.25 110.907 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 18' ' ' ILE . 95.4 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.808 0.337 . . . . 74.43 111.154 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.696 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.9 mm -93.76 156.88 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 70.23 111.155 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.42 170.08 19.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 75.12 110.933 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -99.89 -169.29 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 75.11 110.983 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.578 ' HG3' HG23 ' A' ' 13' ' ' THR . 18.5 pt-20 -75.28 -20.96 58.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.877 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 12' ' ' GLU . 26.3 p -107.66 -39.53 5.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 71.41 111.148 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.02 -2.65 30.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 54.11 112.473 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.733 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.57 -33.28 21.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 75.21 111.181 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.733 HG13 HG23 ' A' ' 15' ' ' THR . 8.1 mt -129.25 158.96 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.12 111.093 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 16' ' ' ILE . 35.9 p -175.8 164.23 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 64.02 110.823 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.572 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.88 -175.41 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.515 . . . . 62.14 111.163 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.443 ' HA ' HG22 ' A' ' 8' ' ' VAL . 1.7 t -167.54 131.07 1.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 53.52 110.845 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.12 118.48 11.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 71.44 110.922 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.57 -45.88 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.861 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -141.58 -169.63 2.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.3 110.916 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -51.07 -49.66 60.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.875 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -133.38 39.14 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 74.13 110.871 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.39 121.63 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 71.54 111.159 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -126.38 159.61 32.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 64.25 110.965 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.2 t -122.43 106.69 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 73.43 111.124 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.528 ' HB3' HG23 ' A' ' 18' ' ' ILE . 8.4 p80 -98.37 138.13 36.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 72.43 110.851 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 m -136.59 134.21 37.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 73.43 111.127 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' HB3' HG23 ' A' ' 16' ' ' ILE . 2.5 pm0 -125.93 175.74 7.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 64.21 110.907 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 40' ' ' PRO . 4.2 tp -119.76 150.05 41.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.13 110.975 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.775 -0.726 . . . . 55.33 112.526 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.622 0.725 . . . . 74.41 111.151 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.624 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.4 Cg_endo -69.73 151.97 69.34 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.693 2.262 . . . . 54.15 112.328 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 t -138.21 92.29 2.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 55.43 110.87 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -52.77 171.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 75.32 110.941 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -169.93 -156.43 11.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.729 -0.748 . . . . 74.11 112.5 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.912 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -166.68 144.39 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 75.13 110.934 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.632 HG11 HG11 ' A' ' 71' ' ' VAL . 41.5 t -128.94 138.51 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 62.0 111.144 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.61 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 45.8 mt -106.03 130.69 53.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 72.1 110.86 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.99 56.94 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 75.0 110.921 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 p -67.23 177.38 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 64.42 111.217 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.51 20.23 15.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 72.13 110.818 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.91 24.37 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.858 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.11 134.92 6.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 72.22 112.487 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.764 HD13 ' HB ' ' A' ' 71' ' ' VAL . 6.8 mt -60.93 157.54 15.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 72.25 110.908 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.809 HG22 ' HB2' ' A' ' 81' ' ' ASP . 84.5 t -136.94 142.8 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.03 111.121 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.587 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -113.86 128.85 56.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.14 110.92 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 55' ' ' VAL . 13.8 t -78.95 -1.76 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 55.34 111.154 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 179.93 127.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 63.04 110.872 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -66.57 -166.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.827 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -95.06 -171.38 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 70.32 110.842 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.782 ' HB2' HD13 ' A' ' 63' ' ' LEU . 88.6 m95 -72.61 -37.34 68.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.01 110.927 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -145.77 157.61 43.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 73.44 110.829 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -54.25 -34.61 61.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 54.11 110.869 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -74.91 -25.55 59.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 73.3 110.957 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.782 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -81.49 -44.76 16.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 71.53 110.908 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 t -60.26 -26.16 66.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 72.1 111.175 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -54.36 -42.4 70.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 52.14 110.82 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.33 -10.51 59.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 75.42 110.883 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 16' ' ' ILE . 55.2 tp -89.69 -52.38 5.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 74.22 110.909 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.1 mt -65.83 -15.3 18.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 52.12 111.117 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -87.3 7.09 30.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 63.32 110.866 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.1 mtp -103.26 -57.35 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 71.21 110.865 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.764 ' HB ' HD13 ' A' ' 52' ' ' LEU . 19.1 m -58.0 -39.22 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 71.5 111.117 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -84.07 50.79 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 72.35 110.846 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 -39.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 54.14 110.867 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.696 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -110.66 -21.62 12.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.897 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.516 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 29.0 m-85 -90.15 12.08 18.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 65.45 110.863 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.516 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.79 46.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 74.23 110.924 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.6 mttp -151.6 -177.04 5.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.252 -0.431 . . . . 72.14 110.977 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.535 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.41 158.4 38.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 70.43 110.863 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.452 ' CG1' HD23 ' A' ' 54' ' ' LEU . 26.1 t -89.53 117.13 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.42 111.096 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.535 HG23 ' HG2' ' A' ' 78' ' ' ARG . 42.9 p -133.03 38.19 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.4 111.247 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.809 ' HB2' HG22 ' A' ' 53' ' ' VAL . 2.4 m-20 -168.83 134.97 1.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 44.11 110.838 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 98' ' ' LEU . 16.1 t -143.01 102.19 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.43 111.162 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.8 mt -81.41 115.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 62.44 111.07 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.528 HG23 ' HB3' ' A' ' 91' ' ' ARG . 42.1 mm -101.33 129.86 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.11 111.097 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -87.68 -56.03 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.14 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -133.06 166.4 22.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 64.44 110.862 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -85.05 98.38 10.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.411 . . . . 43.34 111.149 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.645 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -152.23 159.65 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.9 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.09 -28.73 62.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 73.12 111.097 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.35 12.01 19.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 53.05 110.792 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.528 ' HB3' HG23 ' A' ' 84' ' ' ILE . 1.9 mmp_? -124.0 -52.26 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 74.1 110.866 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.32 17.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 61.04 111.157 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.9 -28.12 23.27 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.753 -0.736 . . . . 62.52 112.499 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.0 20.75 26.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 74.51 112.543 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.459 HG21 ' H ' ' A' ' 121' ' ' GLU . 1.6 tt -48.35 -31.03 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 74.24 111.134 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -69.49 -44.53 70.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 74.22 110.925 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 m -66.67 -34.36 77.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 63.51 111.14 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.561 ' CD2' HG21 ' A' ' 82' ' ' VAL . 50.1 mt -64.37 -26.87 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 71.51 110.912 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -99.77 21.01 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 64.32 110.914 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.07 -30.41 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 70.21 110.872 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -104.38 12.42 33.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 64.31 110.881 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.38 25.07 61.93 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.822 -0.704 . . . . 63.23 112.509 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 98' ' ' LEU . 11.4 mt -88.11 157.07 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 75.52 111.163 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.819 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -120.32 118.79 31.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 72.43 110.918 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.509 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . . . -90.17 78.31 6.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 64.51 111.009 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.504 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.3 m-70 -54.77 147.92 13.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 62.2 110.898 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.93 163.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 65.22 110.891 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 127' ' ' LEU . 68.7 p -85.13 158.17 20.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 51.32 111.182 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.7 61.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 72.54 111.103 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.692 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -62.71 -46.89 86.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 71.32 110.873 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.729 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 100.0 m -52.43 -41.98 63.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 73.34 111.168 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.49 -23.38 61.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 65.24 111.137 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.87 -43.08 85.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.473 HD13 ' OD2' ' A' ' 152' ' ' ASP . 7.3 mp -81.1 -28.03 35.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 54.51 110.936 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.425 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . . . -51.67 -70.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 65.25 111.03 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -26.0 36.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 72.15 110.962 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -23.65 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 75.23 110.869 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -96.07 -38.71 10.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 74.45 110.898 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.87 -6.39 3.76 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.698 -0.763 . . . . 71.22 112.483 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.62 -172.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 70.23 110.931 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.459 ' H ' HG21 ' A' ' 95' ' ' ILE . 26.4 mm-40 -97.8 -1.57 42.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 74.24 110.842 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.458 ' C ' HD11 ' A' ' 95' ' ' ILE . 1.1 mt-10 66.31 129.13 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.657 0.741 . . . . 52.41 110.84 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.648 2.232 . . . . 53.55 112.341 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 104' ' ' LYS . 79.6 mt -54.08 -35.96 62.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 51.32 110.955 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.12 49.04 51.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 70.21 112.457 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -142.8 56.28 1.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 71.5 110.857 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.519 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.7 OUTLIER -136.79 -169.8 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 75.11 110.91 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -148.84 -168.79 3.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 63.42 110.879 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.829 HG23 ' HB3' ' A' ' 144' ' ' TYR . 99.3 m -50.27 -56.99 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 72.32 111.156 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.701 HG23 HG22 ' A' ' 129' ' ' THR . 88.4 t -130.29 128.5 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 75.41 111.114 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.538 HG22 HD23 ' A' ' 133' ' ' LEU . 90.6 m -135.81 124.31 23.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 62.35 111.154 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -80.33 103.0 9.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.912 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.538 HD23 HG22 ' A' ' 131' ' ' THR . 2.6 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 55.21 110.926 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.61 ' HE3' ' HB3' ' A' ' 46' ' ' LEU . 32.0 tpp . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.882 0.372 . . . . 74.33 110.88 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.14 120.99 28.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 62.41 110.868 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.588 HG13 HD23 ' A' ' 158' ' ' LEU . 10.3 t -131.57 155.67 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.22 111.145 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -153.09 125.06 7.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.872 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.544 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -75.47 -177.95 3.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 64.32 111.18 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.678 ' HA ' HG22 ' A' ' 130' ' ' VAL . 73.4 t80 -175.18 137.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.887 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.829 ' HB3' HG23 ' A' ' 129' ' ' THR . 29.5 t80 -122.61 94.86 47.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.692 0.758 . . . . 74.22 110.974 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.9 Cg_endo -69.76 -48.74 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 73.03 112.292 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.45 -152.24 15.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 54.34 112.437 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.62 125.81 45.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.346 . . . . 75.35 110.903 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.653 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -136.5 -87.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.71 . . . . 42.24 112.495 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -76.33 -29.18 57.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 64.21 110.91 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.68 156.11 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.24 111.19 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.81 -24.88 62.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 74.12 110.789 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.692 ' HB3' HD12 ' A' ' 110' ' ' LEU . 14.4 p30 -119.98 47.36 1.76 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 73.35 110.827 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.495 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -97.27 134.55 40.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 62.41 110.848 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.577 HG22 ' CD1' ' A' ' 144' ' ' TYR . 2.6 pt -136.07 169.87 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 71.45 111.089 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.421 ' CG1' HD22 ' A' ' 169' ' ' LEU . 6.9 m -120.98 145.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 74.43 111.077 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.1 t -98.29 143.58 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 65.41 111.12 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -129.85 149.74 51.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 71.43 110.914 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.588 HD23 HG13 ' A' ' 140' ' ' VAL . 28.5 mt -126.96 95.71 36.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.604 0.716 . . . . 64.51 110.936 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 71.91 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.679 2.253 . . . . 74.14 112.35 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.928 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.552 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.2 m-85 -118.03 -13.18 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 71.11 110.908 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.6 m120 69.4 23.26 6.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 75.35 110.922 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.552 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.6 mp -93.51 114.38 30.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 70.41 111.113 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.14 136.61 39.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 74.35 110.898 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.596 HG21 HD22 ' A' ' 44' ' ' LEU . 31.7 t -122.11 67.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 73.01 111.16 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.34 -55.62 18.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.74 -0.743 . . . . 72.55 112.559 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.18 -122.83 6.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.746 -0.74 . . . . 72.4 112.467 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.7 m -80.82 -0.8 40.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 70.31 110.909 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.478 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.6 OUTLIER -85.31 -49.1 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 74.44 110.981 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 206' ' ' VAL . 45.2 t -94.32 105.77 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 74.14 111.125 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.532 ' H ' HG23 ' A' ' 222' ' ' THR . 0.1 OUTLIER -75.02 164.45 26.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.918 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.65 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.4 p -88.65 158.65 18.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.798 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.513 HG23 HD23 ' A' ' 218' ' ' LEU . 1.7 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 71.12 111.14 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 186' ' ' VAL . 26.0 m . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.827 0.346 . . . . 61.44 111.082 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.63 91.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 65.44 111.07 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.88 44.66 1.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.14 110.937 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -134.93 174.16 10.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 60.11 111.067 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -127.24 87.46 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 54.51 110.985 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' A' ' 181' ' ' VAL . 21.9 t -66.39 -22.22 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 71.14 111.181 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.7 -32.96 58.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 40.35 110.922 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -93.53 -22.8 18.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 73.35 110.877 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.48 -55.88 16.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 64.43 110.83 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.3 p -51.94 -37.05 51.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.88 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m -74.18 -35.62 63.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 63.55 111.111 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 196' ' ' VAL . 32.9 m -63.19 -52.38 62.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 74.53 110.838 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.975 HG22 HD23 ' A' ' 197' ' ' LEU . 27.7 mm -58.02 -39.15 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 74.22 111.092 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.22 -17.07 57.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 74.43 110.929 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -99.76 -23.83 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 73.52 110.843 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 192' ' ' SER . 48.6 t -88.34 -18.43 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 65.01 111.119 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.975 HD23 HG22 ' A' ' 193' ' ' ILE . 2.4 pp -105.52 1.27 27.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.939 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -117.81 -24.01 7.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 43.43 110.901 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -82.67 1.15 39.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 64.43 110.829 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -136.28 -72.3 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.215 -0.448 . . . . 63.52 110.972 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.78 21.97 9.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 63.41 110.866 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -144.51 21.95 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.4 110.889 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.27 145.86 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.52 111.184 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -102.56 -28.2 12.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 61.43 110.876 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -163.95 128.98 2.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 64.54 111.106 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.747 ' CG1' HD12 ' A' ' 218' ' ' LEU . 95.2 t -107.1 126.3 63.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 75.33 111.131 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.912 HG21 HD11 ' A' ' 44' ' ' LEU . 50.4 t -109.91 106.12 57.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.646 0.736 . . . . 73.13 111.102 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.75 -169.27 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.735 2.29 . . . . 63.35 112.304 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -111.14 -21.7 6.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 61.55 112.406 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -145.69 74.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 75.54 110.905 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.1 -101.75 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 73.52 112.5 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -171.66 140.26 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 74.32 110.83 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.45 143.78 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 61.3 111.142 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.6 -106.19 0.49 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.75 . . . . 63.32 112.489 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -156.22 -169.92 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.349 . . . . 63.13 110.9 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -56.36 -22.37 30.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.866 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.483 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.24 -32.8 51.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 75.33 112.484 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.747 HD12 ' CG1' ' A' ' 206' ' ' VAL . 31.3 mt -50.79 -41.55 57.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 53.02 110.98 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 193' ' ' ILE . 4.3 mm? -56.02 -44.77 79.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 73.22 110.962 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.483 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.1 mt -67.82 -40.48 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 72.23 110.956 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -58.66 -43.76 89.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.831 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.68 -48.36 63.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.22 111.16 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.75 ' HA ' HD12 ' A' ' 226' ' ' LEU . 44.1 mt -54.77 -41.28 70.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.925 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -32.73 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 64.11 110.863 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.21 -25.77 61.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 72.54 110.953 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.75 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.8 mt -87.37 -38.07 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.31 110.936 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 63.42 110.909 179.795 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 18' ' ' ILE . 97.0 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.789 0.328 . . . . 74.25 111.147 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.643 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.6 mm -94.64 153.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 64.31 111.167 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -148.84 156.29 42.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 72.34 110.846 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.45 -169.58 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.87 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 -23.49 52.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.874 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.9 p -101.79 -35.13 9.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.042 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.62 -5.13 51.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 52.31 112.478 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.78 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.49 -33.28 20.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 74.34 111.214 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.78 HG13 HG23 ' A' ' 15' ' ' THR . 6.3 mt -128.55 159.92 39.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 63.13 111.052 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -175.52 169.33 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.24 110.929 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -131.63 -174.13 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 64.02 111.137 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.467 ' HA ' HG22 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -169.38 131.7 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 65.04 110.894 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.52 119.09 14.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 70.02 110.916 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.56 HD21 HG21 ' A' ' 213' ' ' VAL . 4.1 mp -107.94 -33.9 7.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 72.41 110.918 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -149.22 -178.1 6.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 72.02 110.813 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -51.06 -41.01 59.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 65.42 110.861 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -139.93 38.6 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 73.11 110.882 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 22' ' ' ASN . 15.0 t -137.88 116.05 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 72.23 111.135 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -123.98 155.59 37.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 73.12 110.89 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.53 HG23 HD13 ' A' ' 21' ' ' LEU . 29.6 t -117.29 108.6 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 71.31 111.115 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.559 ' HB3' HG23 ' A' ' 18' ' ' ILE . 8.2 p80 -101.57 138.39 38.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 72.41 110.861 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.3 m -135.2 140.66 45.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 74.23 111.217 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HB3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -131.27 174.17 10.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 74.5 110.897 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 40' ' ' PRO . 5.2 tp -119.48 148.53 43.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.34 110.896 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 73.14 112.477 179.917 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.628 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.4 p . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.584 0.707 . . . . 71.41 111.153 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.5 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.1 Cg_endo -69.81 146.97 61.51 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.712 2.275 . . . . 74.14 112.317 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -134.55 98.19 4.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 51.23 110.904 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -51.99 168.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 61.13 110.887 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.635 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -167.68 -163.36 21.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 70.11 112.483 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.902 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -164.22 145.98 8.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.857 0.36 . . . . 63.41 110.917 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.636 HG22 HD13 ' A' ' 54' ' ' LEU . 59.3 t -131.05 140.77 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 74.02 111.14 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.472 HD13 ' HG2' ' A' ' 138' ' ' MET . 39.2 mt -108.0 128.17 54.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 62.41 110.909 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -97.26 55.25 1.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.908 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.525 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.8 p -60.36 -170.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 64.51 111.1 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.6 6.49 16.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 71.24 110.848 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -118.32 -18.75 9.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 70.44 110.925 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.76 130.54 1.31 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.823 -0.703 . . . . 41.14 112.543 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.746 HD13 ' HB ' ' A' ' 71' ' ' VAL . 14.1 mt -49.37 153.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.923 0.392 . . . . 65.45 110.877 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.576 HG13 ' HB2' ' A' ' 81' ' ' ASP . 93.8 t -136.96 143.23 35.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.158 -0.474 . . . . 73.15 111.11 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.636 HD13 HG22 ' A' ' 45' ' ' VAL . 3.5 mm? -114.88 128.44 56.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.2 110.816 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 55' ' ' VAL . 13.6 t -78.45 -2.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 64.13 111.147 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -179.47 131.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 54.25 110.89 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.55 -167.31 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 60.1 110.906 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -173.14 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 63.11 110.889 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.648 ' HB2' HD13 ' A' ' 63' ' ' LEU . 85.6 m95 -71.0 -38.51 72.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 75.41 110.93 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -141.72 161.64 37.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.802 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.51 -33.02 69.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.34 110.92 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -75.3 -25.58 58.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.869 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -81.7 -43.65 18.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 72.11 110.879 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.8 t -65.48 -23.35 66.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.174 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -53.81 -43.26 69.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 70.11 110.887 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.72 -15.73 55.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 74.41 110.941 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.461 HD22 ' OE2' ' A' ' 30' ' ' GLU . 21.6 tp -77.8 -50.17 12.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.491 . . . . 73.44 110.894 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.0 mt -71.93 -15.39 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 55.24 111.111 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -88.71 10.35 21.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 70.33 110.895 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.8 mmm -109.88 -55.56 2.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.913 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.746 ' HB ' HD13 ' A' ' 52' ' ' LEU . 17.0 m -57.55 -37.19 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 74.31 111.141 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.44 50.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 71.32 110.913 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.57 -39.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 74.52 110.865 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.643 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -110.9 -21.25 12.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.863 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.555 ' CB ' HD21 ' A' ' 52' ' ' LEU . 29.0 m-85 -90.62 12.67 18.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 63.31 110.89 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.522 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 2.1 pp0? 31.5 49.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.52 110.949 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.0 -176.54 5.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 75.03 110.962 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.629 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -133.98 152.26 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 63.44 110.863 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 52' ' ' LEU . 82.7 t -85.29 125.56 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 64.23 111.192 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.629 HG23 ' HD3' ' A' ' 78' ' ' ARG . 74.3 p -136.0 16.62 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 61.21 111.127 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.576 ' HB2' HG13 ' A' ' 53' ' ' VAL . 1.4 m-20 -150.02 134.92 17.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 74.51 110.898 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.623 HG21 ' CD2' ' A' ' 98' ' ' LEU . 24.6 t -139.3 99.01 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 74.35 111.034 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.8 mt -76.29 126.54 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 55.22 111.203 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 91' ' ' ARG . 40.8 mm -113.55 133.34 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 64.01 111.131 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -90.11 -54.89 3.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 72.41 111.134 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -134.38 165.78 24.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.848 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.692 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -84.79 98.32 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 40.33 111.133 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.654 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.75 159.44 43.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 71.12 110.848 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.23 -28.71 63.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 65.53 111.058 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.98 10.72 22.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 70.31 110.855 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HB3' HG23 ' A' ' 84' ' ' ILE . 1.9 mmp_? -122.67 -52.03 1.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 65.45 110.908 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -116.39 17.45 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 63.11 111.11 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.96 -26.53 27.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.701 -0.761 . . . . 63.23 112.442 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.93 18.46 31.42 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.77 -0.729 . . . . 63.52 112.5 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.435 HG21 ' H ' ' A' ' 121' ' ' GLU . 5.2 tt -48.93 -30.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.834 0.35 . . . . 72.2 111.077 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -67.96 -43.65 78.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 55.13 110.931 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.4 m -69.78 -34.09 73.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 74.52 111.072 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.623 ' CD2' HG21 ' A' ' 82' ' ' VAL . 55.8 mt -63.47 -28.2 69.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 70.33 110.895 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.95 19.49 14.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.922 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -117.33 -21.9 8.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 71.2 110.896 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -113.08 8.8 18.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 71.41 110.88 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.2 16.92 65.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 61.44 112.481 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 98' ' ' LEU . 13.9 mt -82.43 156.96 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 71.52 111.159 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.762 ' HB2' HD11 ' A' ' 124' ' ' LEU . 13.3 ptpt -120.65 122.86 41.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 55.22 110.891 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.483 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -90.58 78.42 6.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 71.11 111.061 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.617 ' HA ' HD12 ' A' ' 124' ' ' LEU . 88.6 m-70 -51.71 146.21 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 33.33 110.866 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.49 163.71 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 72.42 110.814 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -80.19 156.32 26.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 72.21 111.122 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.83 -27.03 27.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 53.0 111.091 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 152' ' ' ASP . 6.9 tp -74.95 -45.89 39.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 73.44 110.954 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.692 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 91.8 m -52.96 -28.1 22.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 60.13 111.142 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -84.08 -29.76 26.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 62.31 111.015 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -58.89 -31.12 68.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.409 . . . . 75.32 110.913 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.674 HD13 ' OD1' ' A' ' 152' ' ' ASP . 7.4 mp -93.55 -25.47 17.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.129 -0.487 . . . . 63.45 110.837 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.71 -65.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 65.34 111.135 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -56.59 -25.02 51.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 52.24 110.877 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -24.52 65.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 74.33 110.882 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -96.03 -28.22 14.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.881 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.23 -5.53 7.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 71.23 112.507 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -59.58 -173.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.826 0.346 . . . . 73.11 110.969 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.435 ' H ' HG21 ' A' ' 95' ' ' ILE . 40.7 mm-40 -99.75 1.17 43.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 71.31 110.888 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.523 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 0.9 OUTLIER 65.87 122.65 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 75.35 110.857 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -170.65 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.707 2.271 . . . . 61.44 112.39 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.762 HD11 ' HB2' ' A' ' 104' ' ' LYS . 58.5 mt -51.76 -39.25 58.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 71.52 110.922 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.0 37.3 44.79 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 64.45 112.45 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -132.89 48.44 2.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 64.11 110.836 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.52 -169.64 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.299 -0.409 . . . . 72.33 110.884 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -149.99 -169.05 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 72.12 110.919 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.8 HG23 ' HB3' ' A' ' 144' ' ' TYR . 94.6 m -50.63 -63.95 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 74.31 111.143 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.734 HG23 HG22 ' A' ' 129' ' ' THR . 86.1 t -124.26 112.03 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 54.13 111.108 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.0 m -121.35 111.34 17.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.05 111.111 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -67.25 90.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 74.02 110.884 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.451 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 64.25 110.884 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.525 ' HB2' HG22 ' A' ' 48' ' ' THR . 6.2 tpp . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.811 0.339 . . . . 71.53 110.977 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.72 116.25 18.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.302 -0.408 . . . . 71.43 110.946 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.63 151.55 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 70.35 111.204 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -148.81 117.45 6.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 61.11 110.839 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.732 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -70.47 -178.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 35.31 111.132 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.629 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.5 t80 -175.29 136.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 64.41 110.857 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.8 ' HB3' HG23 ' A' ' 129' ' ' THR . 31.6 t80 -118.24 92.66 43.39 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.715 0.769 . . . . 75.33 110.905 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -48.56 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.717 2.278 . . . . 73.2 112.407 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.04 -177.67 43.27 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 64.21 112.452 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -76.78 125.57 29.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.799 0.333 . . . . 73.31 110.926 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.518 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -136.28 -91.06 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 74.21 112.502 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -73.64 -30.73 63.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.367 . . . . 72.21 110.862 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.79 158.6 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 72.14 111.144 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -61.06 -27.66 68.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 72.14 110.893 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.674 ' OD1' HD13 ' A' ' 114' ' ' LEU . 11.7 p30 -119.6 50.07 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 75.41 110.851 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.8 OUTLIER -98.07 137.62 36.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 73.41 110.88 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.732 HD12 HG22 ' A' ' 142' ' ' THR . 12.5 pt -139.01 168.82 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 63.11 111.096 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.498 ' CG1' HD22 ' A' ' 169' ' ' LEU . 7.8 m -119.3 144.71 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 72.15 111.156 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.17 144.08 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 70.03 111.138 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -130.09 147.66 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.951 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.487 HD12 ' HB ' ' A' ' 163' ' ' ILE . 16.9 mt -124.78 96.62 40.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.616 0.722 . . . . 61.53 110.946 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 72.5 1.43 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.78 2.32 . . . . 73.42 112.273 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.12 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 74.13 110.943 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.482 ' CB ' HD13 ' A' ' 163' ' ' ILE . 4.4 m-85 -117.75 -13.91 10.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.952 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.5 m120 68.99 26.13 5.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.094 -0.503 . . . . 53.44 110.904 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.498 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -97.87 114.14 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 71.33 111.138 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.93 136.96 37.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.854 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.55 HG21 HD22 ' A' ' 44' ' ' LEU . 16.5 t -119.42 64.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 62.15 111.182 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.94 -54.5 25.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 54.12 112.477 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.26 -135.51 12.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.748 . . . . 74.22 112.467 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.5 m -60.89 -19.29 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 42.5 110.876 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.498 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.9 OUTLIER -66.93 -50.57 61.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.901 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.707 HG11 HG11 ' A' ' 206' ' ' VAL . 24.7 t -89.05 130.02 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 71.11 111.193 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.64 149.5 24.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 54.0 110.939 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.624 ' HA ' HD22 ' A' ' 218' ' ' LEU . 12.6 p -75.03 162.5 28.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 61.2 110.879 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.612 HG23 HD23 ' A' ' 218' ' ' LEU . 7.3 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 53.15 111.15 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.516 HG11 ' CG2' ' A' ' 186' ' ' VAL . 16.8 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.794 0.331 . . . . 74.53 111.087 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.61 -36.24 82.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 75.33 111.125 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -116.18 37.73 3.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.877 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -139.64 166.78 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 74.02 111.071 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -113.54 92.66 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 72.03 110.888 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.516 ' CG2' HG11 ' A' ' 181' ' ' VAL . 92.5 t -69.63 -23.21 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 72.25 111.155 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -25.3 38.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 62.23 110.886 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.34 -24.21 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 55.34 110.841 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -51.5 -53.9 32.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.463 . . . . 74.2 110.877 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 99.2 p -52.32 -35.44 50.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 54.13 110.856 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.2 m -73.58 -36.68 65.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 51.34 111.169 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.1 m -64.5 -54.12 37.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.812 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.753 HG22 HD23 ' A' ' 197' ' ' LEU . 31.6 mm -57.2 -41.26 77.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 75.02 111.126 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -60.85 -19.54 60.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 75.01 110.912 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -93.03 -29.61 15.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 54.21 110.914 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.403 ' CG1' HD21 ' A' ' 219' ' ' LEU . 59.4 t -81.42 -23.73 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 71.52 111.115 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.753 HD23 HG22 ' A' ' 193' ' ' ILE . 2.6 pp -97.25 -1.16 45.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 75.24 110.97 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -121.2 -6.67 9.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 61.5 110.879 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -89.77 -24.25 21.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.897 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -118.3 -67.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 71.21 110.925 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 63.41 27.46 15.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 72.44 110.873 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -151.47 23.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.836 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.41 HG21 HG22 ' A' ' 206' ' ' VAL . 3.4 mp -62.95 145.42 13.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 73.0 111.168 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -104.0 -26.45 12.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.31 110.902 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.498 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -161.24 128.73 4.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 53.01 111.1 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.707 HG11 HG11 ' A' ' 170' ' ' VAL . 71.9 t -108.86 124.51 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 71.31 111.058 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.902 HG21 HD11 ' A' ' 44' ' ' LEU . 48.6 t -108.99 104.38 54.77 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 121.558 0.694 . . . . 54.5 111.114 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.4 Cg_endo -69.76 -170.6 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.705 2.27 . . . . 65.43 112.369 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -103.27 -26.07 7.12 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.721 -0.752 . . . . 61.23 112.474 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -144.0 86.37 1.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 63.44 110.846 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 167.88 -102.76 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 40.24 112.457 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -169.62 158.94 7.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.885 0.374 . . . . 70.14 110.921 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.643 HG22 HG22 ' A' ' 207' ' ' VAL . 41.4 t -66.82 147.85 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 62.12 111.04 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -152.34 -107.12 0.32 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.774 -0.727 . . . . 71.32 112.526 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -159.13 -169.93 2.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 74.2 110.835 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -56.67 -21.79 30.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 65.35 110.892 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.749 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.98 -33.8 57.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.776 -0.726 . . . . 65.14 112.44 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 172' ' ' SER . 32.1 mt -50.79 -46.84 59.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.858 0.361 . . . . 71.12 110.912 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.552 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mp -54.12 -42.76 69.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 64.42 110.927 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.749 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.6 mt -67.07 -41.31 86.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 75.14 110.907 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.18 -36.54 82.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 75.3 110.849 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -45.64 83.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 43.55 111.07 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.803 ' HA ' HD12 ' A' ' 226' ' ' LEU . 2.5 mt -56.6 -40.21 74.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 73.03 110.994 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -41.05 77.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.55 110.825 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.09 -25.99 68.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 62.34 110.935 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.803 HD12 ' HA ' ' A' ' 223' ' ' LEU . 6.1 mt -85.52 -43.08 13.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 70.2 110.913 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.85 179.867 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 18' ' ' ILE . 89.6 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.762 0.315 . . . . 45.31 111.132 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.722 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.9 mm -91.23 153.97 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 53.44 111.105 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -145.81 146.09 31.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.893 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.4 164.33 21.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 71.45 110.894 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -51.94 -36.98 51.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.87 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.48 -27.87 22.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 40.12 111.091 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.05 -12.84 68.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.784 -0.722 . . . . 72.44 112.575 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.724 HG23 HG13 ' A' ' 16' ' ' ILE . 2.0 t -51.09 -32.6 22.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 74.14 111.191 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.724 HG13 HG23 ' A' ' 15' ' ' THR . 14.7 mt -121.42 147.86 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 64.13 111.094 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.7 p -166.19 169.61 14.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 64.42 110.873 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.518 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -136.52 -176.49 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 54.41 111.114 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 18' ' ' ILE . 6.1 t -166.09 135.33 3.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 61.42 110.867 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.48 117.79 13.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 73.03 110.858 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HG ' HG23 ' A' ' 27' ' ' VAL . 2.2 mm? -102.02 -45.59 5.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 63.32 110.942 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -142.27 -169.43 2.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.833 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -50.65 -51.08 52.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.855 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -132.34 37.99 3.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 75.14 110.816 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 t -133.91 122.06 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.31 111.19 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.76 159.06 35.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.866 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.983 HG21 HG21 ' A' ' 213' ' ' VAL . 69.5 t -119.42 107.9 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 64.34 111.173 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.518 ' HB3' HG23 ' A' ' 18' ' ' ILE . 4.0 p80 -102.32 142.02 34.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 72.31 110.828 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 m -140.06 130.73 25.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 74.14 111.159 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.93 171.36 8.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.862 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 40' ' ' PRO . 5.2 tp -117.17 147.27 42.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.894 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.688 -0.768 . . . . 71.31 112.432 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.476 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.2 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.595 0.712 . . . . 72.44 111.113 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.524 ' HA ' HD12 ' A' ' 31' ' ' LEU . 54.0 Cg_endo -69.78 148.41 64.89 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.691 2.261 . . . . 44.54 112.381 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -134.44 100.0 4.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 54.45 110.855 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -51.86 169.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 75.43 110.899 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.8 -173.19 39.12 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.705 -0.76 . . . . 74.25 112.449 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.047 HD13 HG21 ' A' ' 207' ' ' VAL . 3.9 tp -156.92 140.81 16.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.905 0.383 . . . . 73.23 110.907 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.719 HG22 HD13 ' A' ' 54' ' ' LEU . 21.4 t -125.51 132.01 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 72.32 111.178 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 41.5 mt -97.15 128.89 44.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 75.04 110.964 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.73 57.65 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 65.31 110.95 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 p -67.19 165.62 15.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 71.25 111.097 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.89 25.81 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.864 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -147.25 28.61 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 74.42 110.881 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.33 123.25 4.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 42.32 112.472 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' A' ' 75' ' ' PHE . 33.1 mt -51.28 159.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 74.13 110.903 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 81' ' ' ASP . 59.6 t -140.18 140.03 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.132 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.719 HD13 HG22 ' A' ' 45' ' ' VAL . 3.0 mm? -114.07 129.86 56.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.964 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.8 t -81.18 0.13 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.13 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -177.68 129.69 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.837 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -166.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.905 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.71 -169.9 2.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.247 -0.433 . . . . 73.03 110.884 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.779 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.4 m95 -74.81 -36.48 62.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 73.42 110.955 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -144.62 164.3 31.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 53.43 110.873 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.13 -34.57 72.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 54.22 110.888 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -74.88 -24.25 58.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 54.15 110.889 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -83.41 -41.14 18.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 73.11 110.927 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.3 t -70.13 -26.45 63.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 70.04 111.103 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -54.13 -42.64 69.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 74.55 110.891 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -83.49 -14.2 52.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 72.54 110.86 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.417 ' HB2' HD13 ' A' ' 16' ' ' ILE . 32.8 tp -77.03 -46.13 24.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 52.34 110.924 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.3 -31.93 40.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 74.04 111.135 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.78 -25.55 68.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 70.21 110.965 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.4 mmm -76.37 -58.84 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 61.22 110.873 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.705 ' HB ' HD13 ' A' ' 52' ' ' LEU . 33.9 m -56.23 -33.35 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 73.11 111.074 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -88.56 48.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 74.45 110.885 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -144.36 -41.82 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 53.14 110.895 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.722 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.64 -25.65 13.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 72.01 110.875 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.716 ' HB3' HD21 ' A' ' 52' ' ' LEU . 36.5 m-85 -88.94 9.22 25.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 74.53 110.851 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.5 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.86 46.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 75.0 110.896 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -147.15 -176.71 5.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 62.44 110.937 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.64 130.88 37.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 70.33 110.896 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.626 HG22 ' HB2' ' A' ' 52' ' ' LEU . 66.4 t -66.46 129.33 30.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 64.04 111.093 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.5 p -138.07 19.74 2.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 44.04 111.141 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.593 ' HB2' HG22 ' A' ' 53' ' ' VAL . 7.4 m-20 -154.18 129.35 9.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 43.43 110.829 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.426 HG11 ' CD1' ' A' ' 98' ' ' LEU . 24.9 t -133.84 98.15 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 63.33 111.169 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -74.64 124.9 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 71.03 111.198 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.613 HG23 ' HB3' ' A' ' 91' ' ' ARG . 38.7 mm -111.07 127.14 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 65.33 111.126 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.5 p -83.86 -53.47 5.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 74.0 111.075 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -135.6 168.39 19.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 73.25 110.895 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -87.82 100.41 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 63.35 111.087 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.669 ' O ' HD13 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -154.71 161.03 41.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 72.11 110.881 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.06 -27.72 61.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 71.14 111.04 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.23 13.8 16.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 33.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.613 ' HB3' HG23 ' A' ' 84' ' ' ILE . 1.1 mmt180 -127.11 -51.24 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 70.21 110.831 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.669 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -118.52 15.28 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 63.52 111.138 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.19 -33.84 31.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.736 -0.745 . . . . 44.22 112.439 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.93 17.68 44.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.757 -0.735 . . . . 62.45 112.461 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.565 HG21 ' H ' ' A' ' 121' ' ' GLU . 9.9 tt -46.03 -31.33 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 71.31 111.172 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -55.19 23.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.95 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.7 m -59.38 -41.73 90.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 64.41 111.14 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.464 ' HA ' HD12 ' A' ' 103' ' ' ILE . 31.7 mt -55.9 -30.0 60.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.912 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.49 24.27 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 64.1 110.856 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -116.93 -26.18 6.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 75.11 110.869 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -104.59 -22.2 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 61.11 110.832 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.67 14.28 4.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 52.01 112.501 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.7 mt -82.07 155.84 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.89 0.376 . . . . 52.32 111.159 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.554 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.8 OUTLIER -120.57 120.1 34.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 51.14 110.905 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.89 81.14 8.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 74.45 111.061 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.521 ' HA ' HD12 ' A' ' 124' ' ' LEU . 92.1 m-70 -55.04 147.28 16.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 50.13 110.853 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.44 161.78 0.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 44.14 110.851 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.557 HG22 ' HB3' ' A' ' 127' ' ' LEU . 19.9 p -85.64 161.07 19.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 75.23 111.135 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.35 -47.25 62.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 63.1 111.074 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.617 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -59.22 -44.45 92.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 62.44 110.984 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.671 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 80.4 m -53.03 -46.17 68.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 64.14 111.111 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.98 -21.99 61.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 74.34 111.103 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.12 -38.38 76.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 71.05 110.903 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.616 HD12 ' OD2' ' A' ' 152' ' ' ASP . 8.0 mt -87.52 -27.66 22.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 71.42 110.954 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.61 -65.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 72.44 111.141 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -26.09 38.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 75.03 110.875 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -23.07 66.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 73.1 110.927 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -96.88 -38.36 9.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 60.21 110.896 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.98 -1.64 5.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 53.24 112.501 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -59.75 -172.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 73.3 110.915 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.565 ' H ' HG21 ' A' ' 95' ' ' ILE . 23.9 mm-40 -94.8 -2.28 51.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 54.33 110.864 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 65.96 126.19 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.634 0.73 . . . . 74.21 110.897 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -170.91 0.42 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.71 2.273 . . . . 72.43 112.332 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 104' ' ' LYS . 51.5 mt -52.59 -38.43 60.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 72.4 110.915 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.98 43.81 55.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 75.44 112.584 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -139.17 57.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.768 0.318 . . . . 74.51 110.837 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.557 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -137.36 -171.63 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 62.01 110.93 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.43 -168.56 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 71.35 110.891 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.829 HG23 ' HB3' ' A' ' 144' ' ' TYR . 75.1 m -50.0 -64.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.23 111.11 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.765 HG22 ' HA ' ' A' ' 143' ' ' PHE . 58.4 t -122.49 111.1 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 64.13 111.124 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.631 HG22 HD23 ' A' ' 133' ' ' LEU . 68.5 m -111.61 114.15 27.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 70.51 111.176 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -75.14 101.02 4.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 53.42 110.881 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.631 HD23 HG22 ' A' ' 131' ' ' THR . 1.9 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 70.2 110.926 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.83 0.348 . . . . 63.44 110.872 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 121.61 28.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.423 . . . . 72.43 110.976 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.73 HG13 HD23 ' A' ' 158' ' ' LEU . 5.0 t -130.14 158.71 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 61.42 111.177 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 75.7 tt0 -154.38 117.4 4.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 53.12 110.895 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.699 ' O ' HG13 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -69.38 -177.86 1.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.15 111.139 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.765 ' HA ' HG22 ' A' ' 130' ' ' VAL . 82.4 t80 -175.65 136.53 0.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 63.33 110.857 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.829 ' HB3' HG23 ' A' ' 129' ' ' THR . 27.2 t80 -117.13 94.49 45.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 74.12 110.89 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -48.92 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.719 2.279 . . . . 63.51 112.384 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.69 -166.33 39.55 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.697 -0.763 . . . . 54.22 112.439 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -88.03 123.94 33.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.827 0.346 . . . . 65.33 110.879 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.668 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -134.06 -86.4 0.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 72.24 112.485 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -81.29 -26.02 36.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 75.15 110.897 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.52 157.02 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 73.1 111.14 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -64.17 -23.72 67.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 53.24 110.899 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.617 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -125.78 55.09 1.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 74.12 110.848 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.564 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.9 p30 -102.97 143.15 32.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 54.12 110.876 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.643 HD12 HG22 ' A' ' 142' ' ' THR . 11.2 pt -142.53 171.22 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 52.23 111.164 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.7 m -120.47 143.58 31.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.109 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.455 ' O ' HD22 ' A' ' 164' ' ' LEU . 68.6 t -100.11 129.07 51.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 61.43 111.144 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -115.76 145.41 42.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.261 -0.427 . . . . 71.23 110.926 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.73 HD23 HG13 ' A' ' 140' ' ' VAL . 23.6 mt -120.76 96.84 48.69 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.585 0.707 . . . . 70.1 110.967 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 70.16 1.54 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.689 2.259 . . . . 70.34 112.396 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.24 -33.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.992 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.56 ' CB ' HD13 ' A' ' 163' ' ' ILE . 10.2 m-85 -116.93 -12.41 10.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 73.53 110.876 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.05 19.74 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 61.24 110.896 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.624 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.7 mp -86.54 114.4 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 74.21 111.141 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.5 tm? -99.19 122.82 42.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.922 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.827 HG21 HD22 ' A' ' 44' ' ' LEU . 40.4 t -115.29 74.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 72.35 111.155 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.29 -50.28 51.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 63.51 112.553 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.08 -140.94 15.48 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 64.43 112.565 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 39.4 m -58.02 -21.99 47.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 70.24 110.863 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.564 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.0 OUTLIER -63.1 -48.63 77.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 72.03 110.912 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.642 HG11 HG11 ' A' ' 206' ' ' VAL . 22.8 t -90.77 126.58 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 73.11 111.149 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.51 144.7 25.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 64.13 110.887 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.693 ' HA ' HD22 ' A' ' 218' ' ' LEU . 6.8 p -72.4 163.99 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 62.43 110.825 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.548 HG23 HD23 ' A' ' 218' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.194 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 184' ' ' ALA . 33.4 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.86 0.362 . . . . 73.52 111.181 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.04 -40.44 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 71.53 111.097 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.65 40.65 3.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 75.02 110.92 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -129.9 173.45 10.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 73.4 111.098 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -121.11 89.01 3.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 74.41 110.971 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.601 ' CG2' HG21 ' A' ' 181' ' ' VAL . 21.7 t -69.28 -21.14 24.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.073 -0.512 . . . . 62.33 111.116 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.44 -26.81 46.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.52 110.895 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -100.39 -24.42 14.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 71.52 110.911 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.31 -53.79 32.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 65.53 110.902 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 34.3 p -52.0 -34.83 44.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 54.23 110.83 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 54.6 m -77.99 -37.98 46.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 71.25 111.134 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.1 m -59.96 -54.89 40.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.14 110.819 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.642 HG22 HD23 ' A' ' 197' ' ' LEU . 33.0 mm -56.98 -36.87 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 74.21 111.132 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.49 -21.97 66.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 73.44 110.878 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -90.92 -30.36 16.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 63.43 110.817 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.512 ' CG1' HD21 ' A' ' 219' ' ' LEU . 92.4 t -77.18 -40.09 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 74.45 111.034 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.642 HD23 HG22 ' A' ' 193' ' ' ILE . 3.8 pp -75.69 -25.78 57.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 54.11 110.913 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -84.46 -46.84 11.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 62.11 110.861 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -51.99 -30.16 23.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.857 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -138.52 116.9 11.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 70.41 110.868 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -115.26 39.11 3.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 71.31 110.884 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.75 22.03 0.79 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 63.34 110.811 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.465 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.2 mp -51.63 144.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 61.15 111.133 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -103.61 -44.56 5.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 72.22 110.884 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.47 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -151.23 113.4 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 41.32 111.097 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.645 ' CG1' HD12 ' A' ' 218' ' ' LEU . 82.8 t -85.51 125.93 40.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 75.52 111.148 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.047 HG21 HD13 ' A' ' 44' ' ' LEU . 63.0 t -106.9 93.78 9.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.663 0.744 . . . . 74.1 111.085 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.1 Cg_endo -69.75 -171.88 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.667 2.244 . . . . 65.33 112.387 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.66 -25.62 9.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 54.02 112.5 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -145.63 109.68 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.352 . . . . 65.25 110.879 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 145.18 -93.18 0.16 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.668 -0.777 . . . . 70.1 112.482 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -179.69 169.55 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.878 0.371 . . . . 70.41 110.879 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.983 HG21 HG21 ' A' ' 27' ' ' VAL . 98.3 t -80.1 139.94 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 72.41 111.15 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -144.92 -105.94 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 54.33 112.443 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -157.69 -171.5 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.848 0.356 . . . . 74.04 110.848 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -53.37 -24.18 11.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 72.25 110.903 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -52.47 -34.37 42.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 73.22 112.402 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.693 HD22 ' HA ' ' A' ' 172' ' ' SER . 30.9 mt -50.85 -46.21 60.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 63.12 110.923 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.512 HD21 ' CG1' ' A' ' 196' ' ' VAL . 1.1 mt -57.78 -43.62 85.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 73.41 110.926 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.752 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.9 mt -66.36 -41.74 89.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 60.4 110.903 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -63.4 -35.98 82.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 62.54 110.811 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.0 m -58.76 -42.64 89.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 72.22 111.098 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.815 ' HA ' HD12 ' A' ' 226' ' ' LEU . 85.0 mt -60.14 -38.9 84.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 74.21 110.864 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -27.87 65.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 70.13 110.795 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 8.4 mt -77.53 -25.95 50.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 63.21 110.922 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 223' ' ' LEU . 1.9 mt -88.2 -27.43 21.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.904 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 64.42 110.883 179.815 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 18' ' ' ILE . 92.0 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.774 0.321 . . . . 64.04 111.11 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.727 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.0 mm -93.1 157.79 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 72.3 111.152 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.54 149.26 34.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 73.41 110.908 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.16 167.4 21.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 71.51 110.942 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 13' ' ' THR . 7.4 pt-20 -55.87 -32.47 63.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.921 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.464 ' OG1' HG22 ' A' ' 15' ' ' THR . 21.0 p -97.13 -29.93 13.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 50.04 111.171 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.2 -11.23 47.93 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 44.23 112.447 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.792 HG23 HG13 ' A' ' 16' ' ' ILE . 3.8 t -51.19 -32.6 24.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.701 0.286 . . . . 73.34 111.156 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.792 HG13 HG23 ' A' ' 15' ' ' THR . 23.3 mt -123.24 151.1 27.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.443 . . . . 73.43 111.105 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.6 p -169.48 163.44 10.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 75.54 110.894 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -130.24 -177.18 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 72.13 111.134 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.486 ' HA ' HG22 ' A' ' 8' ' ' VAL . 3.4 t -166.36 135.37 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 61.11 110.805 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.59 116.99 13.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.117 -0.492 . . . . 74.11 110.904 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.42 -42.21 6.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.914 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.85 -169.91 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.43 110.856 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -49.25 62.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 74.21 110.877 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -133.68 30.37 3.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.859 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.15 118.55 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 62.42 111.123 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -124.09 160.56 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 65.23 110.967 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.14 108.56 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 43.24 111.13 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.606 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.5 p80 -102.38 138.54 39.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 73.5 110.795 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 41' ' ' SER . 32.4 m -136.5 131.74 34.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 74.15 111.069 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.97 -175.68 2.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.2 110.847 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.7 131.56 39.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 75.01 110.978 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.768 -0.729 . . . . 71.51 112.525 179.868 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.593 0.711 . . . . 72.11 111.163 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 149.02 66.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.259 . . . . 70.23 112.321 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 29' ' ' THR . 0.8 OUTLIER -135.46 113.1 10.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 74.2 110.838 -179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.39 168.45 7.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 74.1 110.865 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.509 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -171.16 -169.55 34.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 71.54 112.462 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.996 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -158.94 146.62 17.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 72.54 110.919 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 54' ' ' LEU . 36.5 t -129.5 142.69 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 62.43 111.106 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -110.7 128.76 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 65.32 110.914 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -97.03 51.25 1.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 72.2 110.904 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.8 p -60.06 173.06 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.32 111.127 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 30.3 3.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 63.34 110.847 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -156.59 36.08 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 71.35 110.882 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.65 128.57 6.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 45.11 112.491 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.771 HD13 ' HB ' ' A' ' 71' ' ' VAL . 13.4 mt -58.4 160.62 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 50.32 110.959 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 81' ' ' ASP . 52.8 t -137.51 143.27 34.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.05 111.157 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.557 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -115.69 128.48 55.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 64.33 110.959 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.6 t -78.85 -2.08 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 62.25 111.093 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.45 128.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 75.51 110.851 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -166.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 62.53 110.798 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 m -96.73 -171.43 2.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 73.52 110.843 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.683 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.1 m95 -71.18 -34.82 71.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.959 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -148.64 165.32 31.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 71.41 110.883 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -63.03 -30.12 71.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 64.24 110.868 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -75.34 -22.86 57.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 72.44 110.916 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -84.78 -49.98 7.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 62.34 110.858 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 t -61.27 -25.2 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 63.22 111.178 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -52.86 -39.67 62.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 72.33 110.914 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -85.55 -14.34 46.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 63.34 110.903 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' A' ' 16' ' ' ILE . 13.5 tp -82.49 -45.62 14.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 63.24 110.937 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.8 mt -70.58 -19.36 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 75.14 111.106 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -83.01 -3.39 57.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 73.33 110.921 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.2 mmm -98.9 -51.58 3.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 73.24 110.824 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.771 ' HB ' HD13 ' A' ' 52' ' ' LEU . 29.2 m -58.58 -38.06 68.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.22 111.099 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' HG3' HG23 ' A' ' 71' ' ' VAL . 36.4 mt-10 -88.19 48.06 1.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 64.41 110.848 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 -39.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.872 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.727 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -109.01 -21.86 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 54.02 110.929 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.56 ' HB3' HD21 ' A' ' 52' ' ' LEU . 25.5 m-85 -89.23 11.08 19.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 72.14 110.887 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.515 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.51 47.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 65.35 110.944 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -153.28 -179.83 8.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 71.13 110.904 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 150.92 49.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.11 110.827 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 52' ' ' LEU . 98.0 t -83.18 129.74 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.21 111.1 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.3 p -144.25 31.67 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 65.23 111.085 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.755 ' HB2' HG22 ' A' ' 53' ' ' VAL . 15.5 m-20 -163.62 125.88 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 53.01 110.835 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 103' ' ' ILE . 24.3 t -133.89 98.91 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.5 111.125 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.5 mt -76.87 118.06 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 65.45 111.035 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 91' ' ' ARG . 44.3 mm -104.96 133.18 49.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 72.5 111.108 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.8 p -88.79 -55.93 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.33 111.197 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -133.4 161.74 33.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.894 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -80.71 97.52 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 62.24 111.079 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.631 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -150.73 157.64 43.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 70.1 110.859 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.17 -26.59 60.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 74.22 111.07 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -90.91 13.43 16.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 64.11 110.899 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.424 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.4 mpt_? -127.56 -52.43 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.813 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.631 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.56 16.97 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 71.21 111.129 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.39 -29.39 30.57 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.691 -0.766 . . . . 32.44 112.484 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -107.4 17.34 37.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 42.11 112.451 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.497 HG21 ' H ' ' A' ' 121' ' ' GLU . 8.3 tt -47.0 -31.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 64.5 111.115 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.7 -54.76 23.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 71.3 110.906 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.1 m -56.95 -41.18 77.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 63.45 111.171 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.435 ' CD1' HG21 ' A' ' 82' ' ' VAL . 24.8 mt -60.84 -37.79 83.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 62.04 110.928 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -81.52 -19.23 42.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.22 -0.446 . . . . 73.02 110.943 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -84.73 -39.53 18.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 75.33 110.857 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.53 ' HB2' HD12 ' A' ' 103' ' ' ILE . 2.3 mtp85 -81.4 -40.1 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 72.11 110.829 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.4 -16.28 4.11 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.699 -0.762 . . . . 63.44 112.435 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 82' ' ' VAL . 2.1 mp -57.83 149.17 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.873 0.368 . . . . 74.45 111.111 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.74 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.2 ptpt -109.19 124.56 51.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.45 . . . . 74.55 110.918 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.45 83.23 6.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 74.1 111.127 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.437 ' ND1' HD12 ' A' ' 124' ' ' LEU . 96.3 m-70 -56.95 147.63 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.92 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.85 160.11 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.014 0.435 . . . . 74.13 110.852 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.638 HG22 ' HB3' ' A' ' 127' ' ' LEU . 19.9 p -78.72 159.56 27.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 65.34 111.174 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.58 -36.78 46.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 55.21 111.038 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 152' ' ' ASP . 8.6 tp -71.57 -48.75 46.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 74.23 110.912 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.76 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 77.8 m -51.79 -29.09 17.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 74.02 111.128 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.586 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -87.82 -31.8 19.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 72.43 111.085 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -56.17 -44.43 79.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.932 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.641 HD12 ' OD2' ' A' ' 152' ' ' ASP . 44.6 mt -76.82 -23.03 52.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.41 110.934 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.27 -65.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 64.53 111.101 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -27.62 33.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.856 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -24.38 66.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 72.11 110.946 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -95.69 -37.48 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 52.52 110.877 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.68 -3.28 4.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 65.41 112.477 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -59.45 -173.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.312 . . . . 72.4 110.945 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.497 ' H ' HG21 ' A' ' 95' ' ' ILE . 16.4 mm-40 -97.03 -0.82 46.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 75.31 110.947 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 65.95 126.0 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.677 0.751 . . . . 72.05 110.887 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.586 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.1 Cg_endo -69.69 -170.05 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.657 2.238 . . . . 73.05 112.379 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' A' ' 104' ' ' LYS . 56.6 mt -55.33 -35.58 65.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 73.41 110.879 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.96 54.26 29.61 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 54.12 112.434 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -147.39 54.32 1.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.886 0.374 . . . . 72.43 110.931 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.638 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.2 OUTLIER -132.28 -172.19 2.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 72.05 110.86 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.2 -167.9 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.917 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.756 HG23 ' HB3' ' A' ' 144' ' ' TYR . 97.8 m -49.3 -41.77 39.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 75.53 111.126 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 m -144.31 137.43 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.092 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 HD23 ' A' ' 133' ' ' LEU . 39.2 m -142.66 107.39 4.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 70.42 111.132 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -71.56 99.41 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 64.24 110.91 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.637 HD23 HG22 ' A' ' 131' ' ' THR . 2.6 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.963 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.502 ' HB2' HG22 ' A' ' 48' ' ' THR . 54.6 tpp . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.809 0.338 . . . . 71.04 110.875 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.1 mmpm? -121.91 126.72 49.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 74.33 110.86 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.616 HG13 HD23 ' A' ' 158' ' ' LEU . 4.1 t -141.75 159.67 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 75.31 111.195 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.415 ' N ' HG12 ' A' ' 140' ' ' VAL . 25.6 tt0 -161.09 123.72 3.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.049 0.452 . . . . 71.52 110.839 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.92 179.92 4.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.507 . . . . 62.33 111.095 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -173.71 137.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.895 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.756 ' HB3' HG23 ' A' ' 129' ' ' THR . 65.3 t80 -116.24 94.94 43.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.687 0.756 . . . . 65.41 110.898 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -48.66 0.66 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.741 2.294 . . . . 60.13 112.239 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.73 -164.67 38.25 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.742 -0.742 . . . . 75.53 112.514 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -86.52 118.71 26.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.785 0.326 . . . . 72.33 110.899 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.517 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -129.97 -98.4 0.84 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.679 -0.772 . . . . 73.51 112.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -69.86 -26.74 64.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 52.14 110.867 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.61 159.42 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 60.31 111.163 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -66.09 -23.97 66.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.949 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.641 ' OD2' HD12 ' A' ' 114' ' ' LEU . 9.3 p30 -123.17 53.09 1.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.904 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.548 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.7 p30 -102.41 149.32 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 31.22 110.9 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.4 pt -150.03 161.88 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.23 111.172 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 196' ' ' VAL . 14.1 m -108.46 150.5 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 72.35 111.131 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.47 ' O ' HD22 ' A' ' 164' ' ' LEU . 67.1 t -104.23 125.44 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 54.13 111.201 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.461 ' O ' HD23 ' A' ' 158' ' ' LEU . 73.0 t-105 -111.7 150.63 29.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.12 110.92 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.616 HD23 HG13 ' A' ' 140' ' ' VAL . 35.2 mt -126.53 96.15 36.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.718 . . . . 64.32 110.878 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 71.23 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 75.25 112.329 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.12 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.885 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.609 ' CB ' HD13 ' A' ' 163' ' ' ILE . 5.9 m-85 -118.85 -11.73 9.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 63.21 110.928 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 m120 67.88 22.79 8.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 63.41 110.843 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.609 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.5 mp -88.41 115.06 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 71.2 111.187 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.8 tm? -98.12 126.24 43.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 52.12 110.978 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.598 HG21 HD22 ' A' ' 44' ' ' LEU . 16.5 t -120.71 75.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 61.4 111.138 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.27 -54.79 27.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.762 -0.732 . . . . 72.55 112.503 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 109.39 -134.93 12.53 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.721 -0.752 . . . . 74.5 112.392 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 67.0 m -60.62 -19.07 56.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 72.35 110.861 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.548 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.6 OUTLIER -69.41 -49.19 57.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 72.42 110.907 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.621 HG11 HG11 ' A' ' 206' ' ' VAL . 28.8 t -92.63 127.47 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 71.35 111.201 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.49 152.82 19.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.916 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.568 ' HA ' HD22 ' A' ' 218' ' ' LEU . 4.4 t -73.04 164.59 26.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 72.24 110.896 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.592 HG23 HD23 ' A' ' 218' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.31 111.136 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 184' ' ' ALA . 35.9 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.777 0.322 . . . . 42.2 111.084 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -52.34 -46.9 66.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 55.35 111.134 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -118.66 41.63 2.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.32 110.871 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . . . -126.23 166.13 17.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.115 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -117.86 91.71 3.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 75.05 110.946 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.5 t -67.65 -21.8 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 73.43 111.174 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -82.36 -26.38 32.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 71.24 110.933 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -96.95 -21.76 17.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 71.14 110.861 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -51.1 -51.86 49.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 64.23 110.975 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.5 p -51.95 -35.67 46.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 70.01 110.878 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.7 m -74.1 -38.3 63.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 75.23 111.139 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 34.0 m -61.86 -56.24 21.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.809 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.587 HG21 ' O ' ' A' ' 219' ' ' LEU . 28.8 mm -55.22 -38.67 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.457 . . . . 71.11 111.109 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.406 ' HA ' HD21 ' A' ' 197' ' ' LEU . 7.6 mt-10 -63.82 -25.15 68.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 62.11 110.873 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -85.79 -31.88 22.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 62.13 110.973 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.429 HG21 HG11 ' A' ' 155' ' ' VAL . 99.7 t -73.28 -40.29 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.04 111.138 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.586 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -76.68 -25.33 53.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 71.2 110.931 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.95 -44.23 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 73.15 110.967 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.83 -26.24 67.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 73.34 110.861 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -141.03 117.08 10.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 70.35 110.97 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.96 37.35 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 74.23 110.897 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.15 22.03 1.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 71.53 110.891 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.523 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.4 mp -51.57 145.67 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 71.4 111.113 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -107.67 -29.32 9.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 62.45 110.881 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.43 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -162.71 121.33 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 75.44 111.13 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.621 HG11 HG11 ' A' ' 170' ' ' VAL . 97.6 t -101.88 118.91 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 62.15 111.099 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.996 HG21 HD11 ' A' ' 44' ' ' LEU . 69.8 t -102.9 106.88 52.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.661 0.743 . . . . 72.21 111.07 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.4 Cg_endo -69.78 -170.36 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.657 2.238 . . . . 75.44 112.372 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.85 -26.95 6.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 51.53 112.441 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -143.84 98.14 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 70.45 110.878 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.54 -95.07 0.15 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 61.31 112.491 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -174.34 152.41 1.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.828 0.347 . . . . 33.32 110.922 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.466 ' HB ' HG22 ' A' ' 207' ' ' VAL . 5.9 p -67.38 144.12 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 63.14 111.143 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.67 -105.51 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.716 -0.754 . . . . 72.51 112.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -156.84 -169.61 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.891 0.377 . . . . 65.01 110.861 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -20.43 35.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.212 -0.449 . . . . 63.43 110.88 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.741 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.66 -33.1 62.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.715 -0.755 . . . . 63.25 112.5 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.592 HD23 HG23 ' A' ' 173' ' ' THR . 30.2 mt -50.63 -48.91 57.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 75.54 110.984 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.587 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -54.16 -42.41 69.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 53.1 110.954 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.741 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.0 mt -68.12 -41.26 82.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 62.51 110.862 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.55 ' NE2' HD21 ' A' ' 225' ' ' LEU . 86.0 t60 -66.11 -36.91 84.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 52.32 110.839 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.2 m -54.1 -45.25 71.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.164 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.772 ' HA ' HD12 ' A' ' 226' ' ' LEU . 70.5 mt -57.24 -38.91 74.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.893 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -33.74 74.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 75.5 110.871 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.55 HD21 ' NE2' ' A' ' 221' ' ' HIS . 16.9 mt -67.73 -25.81 65.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 61.51 110.89 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 223' ' ' LEU . 4.4 mt -84.92 -48.99 8.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 71.22 110.92 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.7 mttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 61.4 110.885 179.852 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 18' ' ' ILE . 95.9 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.807 0.337 . . . . 75.31 111.081 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.482 HD11 ' HE3' ' A' ' 74' ' ' LYS . 3.0 mm -89.96 154.23 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 52.51 111.103 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -150.96 163.71 38.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.885 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -91.43 -169.14 2.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 54.41 110.888 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.592 ' HG3' HG23 ' A' ' 13' ' ' THR . 7.0 pt-20 -76.75 -18.46 58.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 62.01 110.846 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 12' ' ' GLU . 22.3 p -108.73 -39.83 5.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 54.4 111.149 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.52 -2.94 29.3 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.692 -0.766 . . . . 34.03 112.432 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.716 HG23 HG13 ' A' ' 16' ' ' ILE . 1.7 t -50.62 -33.53 22.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 63.31 111.127 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.716 HG13 HG23 ' A' ' 15' ' ' THR . 7.6 mt -130.04 159.71 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 64.4 111.096 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.403 ' N ' HG22 ' A' ' 16' ' ' ILE . 74.8 p -175.52 167.55 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 65.1 110.836 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -130.7 -174.77 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 73.12 111.154 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -169.46 129.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 75.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 121.47 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.919 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.8 mm? -105.06 -42.42 5.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.4 110.916 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -146.1 -168.34 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 64.25 110.91 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -51.55 48.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 63.55 110.886 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -132.21 34.24 3.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.917 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.66 122.48 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 73.52 111.145 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -126.91 160.08 32.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.129 -0.487 . . . . 71.44 110.906 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.423 HG23 ' HG ' ' A' ' 21' ' ' LEU . 61.0 t -122.56 111.81 31.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 64.23 111.134 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -100.88 135.97 41.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 64.21 110.855 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 m -130.56 137.65 49.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.51 111.165 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HB3' HG23 ' A' ' 16' ' ' ILE . 2.5 pm0 -133.85 170.09 16.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 65.24 110.925 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.622 HD12 ' HA ' ' A' ' 40' ' ' PRO . 3.8 tp -116.98 148.17 41.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 62.42 110.924 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.764 -0.731 . . . . 75.44 112.494 179.885 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.23 0.049 0 CA-C-O 121.655 0.741 . . . . 64.11 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.622 ' HA ' HD12 ' A' ' 31' ' ' LEU . 52.9 Cg_endo -69.87 157.35 60.46 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.62 2.213 . . . . 75.3 112.34 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.26 112.79 7.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 70.23 110.857 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -76.39 147.49 37.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 70.51 110.909 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.593 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -146.29 -153.81 6.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 63.24 112.526 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.895 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -166.22 142.61 4.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 61.4 110.912 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG22 HD13 ' A' ' 54' ' ' LEU . 47.4 t -127.47 138.85 53.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 65.33 111.124 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.7 mt -102.12 135.11 44.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.957 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -111.75 61.48 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.917 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 138' ' ' MET . 18.1 p -77.95 176.15 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 71.53 111.137 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.14 26.87 3.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 61.34 110.855 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -145.74 24.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 71.04 110.889 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.52 142.08 8.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 72.51 112.455 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.809 HD13 ' HB ' ' A' ' 71' ' ' VAL . 8.8 mt -70.96 162.3 29.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 53.03 110.852 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 81' ' ' ASP . 61.1 t -141.81 144.49 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.33 111.088 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.568 HD13 HG22 ' A' ' 45' ' ' VAL . 3.1 mm? -115.45 128.27 55.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 64.42 110.877 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.6 t -78.62 -2.47 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 63.12 111.104 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p30 179.98 130.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 74.34 110.859 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.06 -167.41 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.895 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.85 -169.69 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 75.12 110.869 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.726 ' HB2' HD13 ' A' ' 63' ' ' LEU . 88.0 m95 -74.36 -37.47 63.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 65.23 110.923 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -142.19 165.68 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 64.42 110.831 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.48 -33.89 74.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 74.45 110.889 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -74.17 -24.76 59.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.957 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.726 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -80.88 -48.36 12.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 61.24 110.939 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -57.57 -26.71 61.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 70.23 111.161 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -42.72 75.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.25 110.933 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -86.92 1.7 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 73.24 110.892 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.516 HD13 HG21 ' A' ' 16' ' ' ILE . 16.7 tp -96.9 -47.7 5.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 64.24 110.899 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.4 mt -70.81 -24.76 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.22 111.104 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -72.74 -12.83 61.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 60.4 110.834 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 30.5 mtp -82.28 -50.41 8.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 61.55 110.855 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.809 ' HB ' HD13 ' A' ' 52' ' ' LEU . 29.1 m -65.94 -40.57 87.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.53 111.142 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG3' HG23 ' A' ' 71' ' ' VAL . 47.4 mt-10 -83.95 51.63 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.913 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 -38.14 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.902 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -111.81 -22.93 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.926 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.63 ' HB3' HD21 ' A' ' 52' ' ' LEU . 24.9 m-85 -87.85 10.86 17.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 65.4 110.888 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.511 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.97 46.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 73.23 110.941 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -151.9 -178.46 6.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 72.12 110.916 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.444 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -129.23 150.87 50.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 54.42 110.838 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 52' ' ' LEU . 98.0 t -86.84 127.57 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 64.44 111.099 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.444 HG23 ' HD3' ' A' ' 78' ' ' ARG . 22.4 p -138.22 25.84 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.116 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.734 ' HB2' HG22 ' A' ' 53' ' ' VAL . 24.3 m-20 -156.89 133.06 9.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.926 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.586 HG21 ' CD2' ' A' ' 98' ' ' LEU . 21.5 t -138.98 99.89 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 62.44 111.128 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.4 mt -76.93 123.23 33.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 64.41 111.141 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 91' ' ' ARG . 43.9 mm -111.65 131.74 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 54.15 111.106 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.487 HG22 HG13 ' A' ' 154' ' ' ILE . 19.5 p -86.96 -58.12 2.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 75.3 111.185 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.629 ' C ' HG23 ' A' ' 111' ' ' THR . 31.4 p-80 -129.92 175.32 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.897 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -93.58 98.09 10.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 74.41 111.103 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.637 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.55 158.54 43.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.885 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.39 -26.72 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 63.12 111.102 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.88 11.48 22.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 72.02 110.827 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.434 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.4 mpt_? -124.88 -52.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 75.1 110.917 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.61 17.35 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.51 111.117 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.36 -27.33 24.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.779 -0.725 . . . . 54.34 112.477 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.8 19.43 28.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 53.25 112.42 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' H ' ' A' ' 121' ' ' GLU . 3.3 tt -48.92 -30.38 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 71.44 111.147 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -69.52 -43.96 71.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 72.44 110.878 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.1 m -68.04 -34.1 75.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 34.34 111.207 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.586 ' CD2' HG21 ' A' ' 82' ' ' VAL . 52.5 mt -63.01 -29.33 70.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.935 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.78 19.67 13.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.02 110.885 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -117.92 -22.73 7.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 62.2 110.825 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -111.69 8.5 20.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 75.32 110.835 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.11 15.56 66.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 64.11 112.455 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 98' ' ' LEU . 14.1 mt -81.58 156.59 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.399 . . . . 65.44 111.143 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.781 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.3 ptpm? -121.86 121.0 36.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.52 110.91 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -87.93 79.98 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 63.13 111.097 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.488 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.8 m-70 -54.67 145.63 18.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 71.32 110.824 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.69 160.71 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 72.1 110.812 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -73.86 -176.64 2.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.511 . . . . 73.22 111.069 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.65 -27.24 45.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 75.31 111.115 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 152' ' ' ASP . 5.5 tp -76.31 -47.88 22.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 71.43 110.933 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.749 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.5 m -54.38 -26.27 29.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 72.34 111.081 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -88.62 -29.29 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 64.51 111.11 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -61.54 -31.29 71.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 72.44 110.855 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.43 HD22 ' OD2' ' A' ' 152' ' ' ASP . 10.2 mp -89.38 -25.4 21.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.34 110.974 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.46 -67.48 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 72.01 111.116 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -26.4 37.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 64.33 110.842 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -24.59 67.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 71.33 110.884 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -94.75 -37.53 11.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.443 . . . . 73.54 110.871 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 138.95 -7.96 3.26 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.753 -0.737 . . . . 72.01 112.476 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.76 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 64.12 110.852 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.476 ' H ' HG21 ' A' ' 95' ' ' ILE . 36.7 mm-40 -99.73 -1.14 38.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 65.21 110.894 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.469 ' C ' HD11 ' A' ' 95' ' ' ILE . 1.6 mt-10 66.41 129.33 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.719 . . . . 60.12 110.859 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.405 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.3 Cg_endo -69.83 -169.66 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.721 2.281 . . . . 63.41 112.3 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 104' ' ' LYS . 76.2 mt -53.45 -43.89 68.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 75.31 110.876 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.44 57.13 19.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.716 . . . . 64.22 112.479 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -152.13 36.51 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 51.41 110.825 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.82 -169.67 1.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 75.24 110.906 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -153.82 -169.06 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 53.32 110.943 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.84 HG23 ' HB3' ' A' ' 144' ' ' TYR . 99.5 m -50.81 -57.8 7.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.146 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.695 HG23 HG22 ' A' ' 129' ' ' THR . 93.7 t -129.54 123.09 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 73.12 111.214 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.556 HG22 HD23 ' A' ' 133' ' ' LEU . 93.6 m -131.54 124.97 31.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.083 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -80.82 103.04 10.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 65.03 110.948 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.556 HD23 HG22 ' A' ' 131' ' ' THR . 2.3 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 73.32 110.934 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.45 ' HB2' HG22 ' A' ' 48' ' ' THR . 30.5 tpp . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.854 0.359 . . . . 70.43 110.873 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -128.52 121.27 28.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 75.42 110.844 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.593 HG13 HD23 ' A' ' 158' ' ' LEU . 12.1 t -131.66 154.55 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.179 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -152.19 125.85 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.849 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.5 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -76.17 -178.19 4.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.482 . . . . 62.11 111.15 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.625 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.0 t80 -175.28 140.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 73.53 110.854 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.84 ' HB3' HG23 ' A' ' 129' ' ' THR . 39.6 t80 -125.22 96.21 39.89 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.639 0.733 . . . . 72.44 110.897 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 54.9 Cg_endo -69.7 -49.02 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.225 . . . . 53.05 112.426 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.73 -155.64 21.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 74.45 112.491 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.48 127.5 42.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 72.4 110.934 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.591 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -138.94 -93.51 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 72.03 112.496 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -69.67 -30.12 67.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.929 0.395 . . . . 61.42 110.879 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.57 160.33 43.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 53.55 111.147 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.82 -23.99 67.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 71.42 110.888 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.455 ' HB3' HD23 ' A' ' 110' ' ' LEU . 6.9 p30 -120.63 45.2 2.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 73.22 110.908 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -94.11 134.34 36.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 50.55 110.893 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.562 HG22 ' CD1' ' A' ' 144' ' ' TYR . 2.0 pt -136.19 171.3 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.116 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.466 ' CG1' HD22 ' A' ' 169' ' ' LEU . 5.9 m -121.85 150.11 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 74.51 111.131 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -103.07 143.48 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 73.1 111.082 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -129.52 150.09 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.928 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.593 HD23 HG13 ' A' ' 140' ' ' VAL . 36.6 mt -127.12 95.04 37.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.67 0.747 . . . . 72.44 110.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 71.96 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.685 2.257 . . . . 33.5 112.367 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.4 110.96 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.532 ' CB ' HD13 ' A' ' 163' ' ' ILE . 5.8 m-85 -118.15 -13.08 9.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 65.24 110.898 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.8 m120 69.26 25.33 5.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 72.22 110.908 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.541 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.6 mp -96.16 116.52 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 55.44 111.185 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.94 138.48 38.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 64.51 110.885 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.557 HG21 HD22 ' A' ' 44' ' ' LEU . 24.9 t -123.22 66.55 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 52.05 111.152 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.6 -54.28 25.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 30.03 112.5 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.48 -135.1 12.41 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.727 -0.749 . . . . 64.41 112.469 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 33.7 m -62.58 -17.04 59.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.85 0.357 . . . . 72.33 110.874 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.485 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.8 OUTLIER -69.87 -51.36 33.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.895 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.617 HG11 HG11 ' A' ' 206' ' ' VAL . 38.8 t -87.48 129.18 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 53.33 111.108 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.02 145.27 29.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 75.45 110.905 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.63 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.6 p -70.3 157.78 37.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 55.15 110.851 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.554 HG23 HD23 ' A' ' 218' ' ' LEU . 6.9 p . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 65.34 111.119 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.853 0.358 . . . . 72.21 111.075 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.27 84.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 65.33 111.148 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.42 39.65 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 62.21 110.856 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -135.53 168.62 18.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 63.13 111.109 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -115.35 91.89 3.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 63.22 110.916 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.413 HG13 HD23 ' A' ' 226' ' ' LEU . 94.3 t -68.71 -23.65 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.04 -0.527 . . . . 75.53 111.098 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -80.38 -25.63 39.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 64.44 110.875 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -97.57 -23.82 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 75.04 110.936 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.43 -56.88 10.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 75.54 110.949 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.7 t -51.89 -35.18 44.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 64.43 110.852 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.2 m -72.94 -33.8 66.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 54.42 111.055 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 57.1 m -68.01 -52.41 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 62.31 110.848 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.88 HG22 HD23 ' A' ' 197' ' ' LEU . 30.4 mm -58.56 -38.26 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 54.22 111.118 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.21 -16.53 60.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 73.1 110.919 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -99.29 -20.5 16.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 62.11 110.905 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.434 ' CG1' HD21 ' A' ' 219' ' ' LEU . 79.1 t -88.85 -25.42 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.13 111.166 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.88 HD23 HG22 ' A' ' 193' ' ' ILE . 2.6 pp -99.24 2.38 45.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 73.33 110.919 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -117.68 -14.59 10.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 70.44 110.89 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -93.28 2.11 56.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 73.03 110.911 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -137.89 -72.39 0.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 74.3 110.914 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 60.56 25.94 15.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 75.24 110.901 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -149.14 23.44 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 64.02 110.853 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -63.53 145.64 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 72.23 111.2 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -102.47 -28.1 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 65.43 110.915 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.408 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -161.3 131.26 4.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 63.23 111.075 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.743 ' CG1' HD12 ' A' ' 218' ' ' LEU . 89.5 t -110.84 123.67 66.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 74.13 111.149 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 44' ' ' LEU . 49.1 t -110.3 103.84 54.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.672 0.749 . . . . 75.44 111.129 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.0 Cg_endo -69.81 -170.78 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.762 2.308 . . . . 70.15 112.314 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -105.48 -22.26 8.26 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 72.44 112.503 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -146.03 86.79 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 71.35 110.892 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 165.25 -99.33 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.705 -0.759 . . . . 62.34 112.47 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -171.75 161.38 5.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 62.53 110.872 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 207' ' ' VAL . 21.4 t -70.5 150.5 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 60.31 111.133 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.12 -107.63 0.28 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 52.41 112.45 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -159.16 -170.04 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 75.4 110.897 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -23.23 26.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 64.05 110.878 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.769 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -53.59 -33.44 48.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.684 -0.77 . . . . 34.33 112.553 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.743 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.8 mt -51.16 -46.56 62.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 74.33 110.913 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.601 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -57.79 -43.7 85.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.949 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.769 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.9 mt -66.46 -41.77 88.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 72.35 110.924 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.682 ' NE2' HD21 ' A' ' 225' ' ' LEU . 84.5 t60 -66.13 -38.79 89.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 74.03 110.847 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.9 m -52.57 -46.46 66.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 71.32 111.178 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.69 ' HA ' HD12 ' A' ' 226' ' ' LEU . 63.8 mt -53.59 -40.49 65.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 73.01 110.911 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -35.25 80.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 61.42 110.858 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.682 HD21 ' NE2' ' A' ' 221' ' ' HIS . 31.5 mt -62.68 -25.91 68.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 74.4 110.882 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 223' ' ' LEU . 1.2 mt -90.12 -42.56 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 43.14 110.899 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 70.42 110.902 179.785 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.574 HG22 ' OG ' ' A' ' 19' ' ' SER . 91.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.756 0.312 . . . . 74.44 111.132 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.727 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.0 mm -88.89 155.92 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 62.43 111.096 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -146.78 156.76 43.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 71.43 110.854 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.35 171.69 10.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.12 110.941 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -58.71 -30.29 67.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 75.53 110.928 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.459 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.6 p -99.46 -32.13 11.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.159 -0.473 . . . . 62.31 111.136 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.06 -8.42 42.08 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 71.21 112.481 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.769 HG23 HG13 ' A' ' 16' ' ' ILE . 2.8 t -51.27 -33.14 27.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 71.12 111.146 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.769 HG13 HG23 ' A' ' 15' ' ' THR . 18.9 mt -124.15 152.6 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 64.31 111.165 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 p -171.93 165.32 6.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 72.23 110.834 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -130.68 -172.49 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 53.5 111.153 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.574 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -173.96 132.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 45.33 110.874 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.81 120.71 14.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 64.22 110.9 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.65 -45.47 5.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 75.23 110.967 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -146.09 48.75 1.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.0 110.879 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm 70.59 -70.89 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.832 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -88.31 -23.25 23.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.929 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.82 120.21 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 54.24 111.139 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -123.89 161.01 26.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 70.04 110.852 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.508 HG21 HG21 ' A' ' 213' ' ' VAL . 84.9 t -123.15 107.98 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.13 111.127 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.614 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.8 p80 -101.59 137.68 39.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.44 110.861 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 m -133.12 136.27 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.108 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' OE1' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -128.15 165.16 20.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.411 . . . . 74.1 110.899 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.64 136.49 53.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 63.44 110.931 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.728 -0.749 . . . . 75.43 112.478 179.913 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 60.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.673 0.749 . . . . 43.43 111.178 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.3 Cg_endo -69.7 140.17 42.23 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.706 2.27 . . . . 74.54 112.438 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -122.76 108.58 13.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 71.12 110.848 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -67.88 143.02 55.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 52.33 110.858 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.643 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -141.49 -153.58 5.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 42.52 112.458 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -165.85 145.18 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 62.11 110.904 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.602 HG22 HD13 ' A' ' 54' ' ' LEU . 78.8 t -128.6 137.08 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.24 111.098 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.7 mt -105.11 130.3 53.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.109 -0.496 . . . . 75.1 110.949 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.422 ' HA ' HD23 ' A' ' 52' ' ' LEU . 82.3 m-20 -99.66 56.43 0.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.862 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.2 p -65.69 169.74 5.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 71.53 111.061 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.99 27.26 3.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 20.33 110.869 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -150.04 28.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 74.31 110.876 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.42 127.34 5.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 41.13 112.508 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.695 HD13 ' HB ' ' A' ' 71' ' ' VAL . 9.1 mt -54.78 168.03 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 65.25 110.97 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 81' ' ' ASP . 60.2 t -146.68 143.49 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 61.43 111.138 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.602 HD13 HG22 ' A' ' 45' ' ' VAL . 3.6 mm? -114.52 127.92 56.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 71.14 110.993 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG11 HG11 ' A' ' 165' ' ' VAL . 14.7 t -78.06 -2.91 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 43.01 111.122 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.21 132.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 61.5 110.848 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.57 -166.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.866 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.6 m -94.06 -175.04 3.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.841 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.739 ' HB2' HD13 ' A' ' 63' ' ' LEU . 90.1 m95 -68.38 -41.21 80.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 75.51 110.892 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.39 166.72 23.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.419 . . . . 44.25 110.859 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.44 -35.94 80.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 74.42 110.865 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -70.39 -23.48 62.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 64.13 110.927 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -81.81 -50.6 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 75.23 110.985 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -57.7 -31.07 66.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 72.34 111.129 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -54.58 -38.55 66.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 54.34 110.856 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.55 -11.31 54.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 74.24 110.828 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.541 HD13 HG21 ' A' ' 16' ' ' ILE . 36.8 tp -85.03 -47.36 10.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 60.23 110.923 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 68' ' ' ILE . 37.3 mt -68.65 -11.98 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.21 111.106 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -92.17 16.45 11.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 70.31 110.889 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.5 mtp -115.83 -51.55 2.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 63.12 110.892 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.695 ' HB ' HD13 ' A' ' 52' ' ' LEU . 28.1 m -64.21 -36.08 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 73.3 111.128 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -85.72 50.56 1.99 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 70.41 110.885 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -142.84 -40.15 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 75.42 110.915 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.727 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.28 -23.81 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 75.52 110.889 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.548 ' CB ' HD21 ' A' ' 52' ' ' LEU . 30.4 m-85 -89.52 11.23 20.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 74.34 110.864 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.81 46.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 74.5 110.956 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -150.42 -176.57 5.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 72.21 110.857 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -134.01 152.09 51.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.817 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.559 HG22 ' HB2' ' A' ' 52' ' ' LEU . 85.0 t -87.19 118.18 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 55.35 111.178 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.487 HG23 ' HG2' ' A' ' 78' ' ' ARG . 74.1 p -127.37 21.3 6.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 73.02 111.142 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 53' ' ' VAL . 5.6 m-20 -154.0 134.1 13.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 73.11 110.912 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.564 HG21 HD13 ' A' ' 98' ' ' LEU . 21.2 t -136.65 99.6 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 75.44 111.126 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.9 mt -74.89 126.11 35.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 72.41 111.094 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.497 HG23 ' HB3' ' A' ' 91' ' ' ARG . 29.4 mm -113.88 129.5 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 63.44 111.116 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.0 p -88.34 -54.11 4.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.163 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -133.68 162.81 30.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 73.43 110.884 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -84.24 98.5 10.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 62.12 111.041 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.627 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.8 OUTLIER -151.74 158.76 43.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.0 110.897 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.36 -24.38 54.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 45.13 111.098 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.87 16.36 12.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 74.44 110.94 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HB3' HG23 ' A' ' 84' ' ' ILE . 53.3 mmt-85 -132.19 -52.53 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 73.43 110.889 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.15 15.24 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.44 111.109 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.91 -34.45 30.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 45.24 112.503 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.09 18.15 43.21 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.72 -0.752 . . . . 72.35 112.451 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.561 HG21 ' H ' ' A' ' 121' ' ' GLU . 8.0 tt -46.16 -31.69 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 40.2 111.118 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -54.67 26.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 70.14 110.878 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.8 m -58.54 -39.82 81.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.19 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.564 HD13 HG21 ' A' ' 82' ' ' VAL . 28.9 mt -60.4 -29.52 69.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 71.42 110.888 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -99.31 24.11 8.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.898 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -114.1 -34.69 5.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 54.13 110.878 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -96.17 -21.94 17.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 63.23 110.856 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.59 16.82 4.48 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.772 -0.727 . . . . 40.52 112.503 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.2 mt -83.06 156.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 64.22 111.167 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.616 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -119.26 125.01 48.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.44 . . . . 73.33 110.853 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.04 82.4 5.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 55.33 111.092 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.518 ' HA ' HD12 ' A' ' 124' ' ' LEU . 59.1 m-70 -51.91 142.59 15.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 73.42 110.855 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.67 151.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.03 110.899 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.64 HG22 ' HB3' ' A' ' 127' ' ' LEU . 71.1 p -70.63 157.45 37.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 74.2 111.137 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.62 -24.07 45.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 34.34 111.134 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' A' ' 152' ' ' ASP . 10.8 tp -77.0 -46.96 22.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 73.24 110.915 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 33.5 m -55.62 -27.93 52.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.224 -0.444 . . . . 61.1 111.184 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.645 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -80.49 -23.46 40.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.24 111.127 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.88 -38.25 90.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 71.14 110.839 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.4 mt -85.24 -24.52 27.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 73.14 110.878 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.8 -65.78 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 72.41 111.066 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -55.24 -26.2 38.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 63.33 110.949 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -24.17 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.877 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -95.09 -31.46 13.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.924 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.82 -4.84 6.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.731 . . . . 51.23 112.49 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -59.72 -172.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.883 0.373 . . . . 73.12 110.907 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.561 ' H ' HG21 ' A' ' 95' ' ' ILE . 9.5 mm-40 -98.19 -1.32 42.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 74.41 110.9 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.645 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 66.16 126.97 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.71 0.767 . . . . 73.15 110.86 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -170.64 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.612 2.208 . . . . 65.31 112.39 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' A' ' 104' ' ' LYS . 64.7 mt -51.89 -36.38 48.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 55.13 110.907 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.98 53.93 28.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 75.1 112.48 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -152.02 48.46 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 72.11 110.833 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.64 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.2 OUTLIER -123.65 -169.64 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.904 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -151.96 -168.74 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 74.2 110.936 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.817 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.3 m -50.24 -64.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 54.05 111.134 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.764 HG23 HG22 ' A' ' 129' ' ' THR . 68.6 t -124.63 110.62 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 43.3 111.133 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.632 HG22 HD23 ' A' ' 133' ' ' LEU . 90.7 m -113.33 105.32 13.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.151 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.57 100.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 64.45 110.872 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.632 HD23 HG22 ' A' ' 131' ' ' THR . 2.9 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.908 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.3 tpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.8 0.333 . . . . 45.3 110.913 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -124.24 125.34 44.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 65.13 110.897 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.749 HG13 HD23 ' A' ' 158' ' ' LEU . 6.5 t -138.0 157.69 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 62.42 111.147 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 140' ' ' VAL . 64.8 tt0 -155.66 125.22 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 61.1 110.842 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.693 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -74.99 -177.06 3.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.138 -0.483 . . . . 65.11 111.124 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.744 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.0 t80 -175.33 136.19 0.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.817 ' HB3' HG23 ' A' ' 129' ' ' THR . 28.4 t80 -119.47 93.77 47.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.624 0.726 . . . . 75.11 110.978 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 -48.55 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 72.31 112.355 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.88 -155.29 22.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 34.11 112.462 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.15 123.97 41.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.371 . . . . 73.15 110.826 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.638 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -134.66 -94.3 0.48 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.483 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -71.46 -29.58 65.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 73.14 110.899 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.8 153.13 34.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.117 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.52 -37.9 65.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 72.12 110.916 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.5 ' HB3' HD23 ' A' ' 110' ' ' LEU . 1.4 p30 -108.74 51.13 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.887 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.567 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.9 OUTLIER -100.49 136.35 40.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 70.05 110.889 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.693 HD12 HG22 ' A' ' 142' ' ' THR . 18.5 pt -137.48 169.01 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.22 111.122 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.43 ' CG1' HD22 ' A' ' 169' ' ' LEU . 10.6 m -119.37 140.93 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 61.01 111.177 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 84.4 t -95.85 144.24 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.11 111.145 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -131.16 146.94 52.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 75.31 110.896 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.749 HD23 HG13 ' A' ' 140' ' ' VAL . 15.7 mt -123.43 97.47 42.39 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.599 0.714 . . . . 50.12 110.887 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 72.22 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 53.11 112.388 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.17 -34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.888 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -117.42 -13.28 10.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 54.54 110.904 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 m120 68.62 23.28 7.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 73.23 110.909 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.437 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.7 mp -95.58 116.26 36.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 41.11 111.16 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.7 137.0 37.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 75.33 110.97 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.517 HG21 HD22 ' A' ' 44' ' ' LEU . 21.5 t -121.27 66.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 73.13 111.109 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.77 -55.33 21.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 73.13 112.452 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.21 -119.76 5.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 63.35 112.492 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 90.3 m -87.2 7.23 29.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 62.23 110.951 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.567 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.0 OUTLIER -88.72 -50.17 6.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.157 -0.474 . . . . 75.13 110.922 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.469 HG11 HG11 ' A' ' 206' ' ' VAL . 21.7 t -91.1 120.86 40.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 61.43 111.098 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.03 154.78 19.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 62.53 110.963 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.608 ' HA ' HD22 ' A' ' 218' ' ' LEU . 5.8 p -77.65 161.43 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 52.44 110.861 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.592 HG23 HD23 ' A' ' 218' ' ' LEU . 1.4 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 73.02 111.115 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 186' ' ' VAL . 21.8 m . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.768 0.318 . . . . 54.34 111.118 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.67 85.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 64.4 111.116 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.06 44.82 2.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 61.45 110.867 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -138.52 171.34 14.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.064 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -117.37 90.57 3.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 70.25 110.952 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.484 HG13 ' CD2' ' A' ' 226' ' ' LEU . 91.1 t -69.91 -22.05 24.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 73.13 111.15 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -78.35 -24.88 46.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 62.3 110.957 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -101.76 -24.9 14.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 73.14 110.91 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -51.46 -56.72 11.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 64.33 110.945 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.2 p -52.17 -32.03 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 71.4 110.848 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.4 m -78.22 -31.47 49.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.01 111.164 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 196' ' ' VAL . 40.2 m -69.45 -52.14 29.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 62.22 110.892 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.796 HG22 HD23 ' A' ' 197' ' ' LEU . 35.6 mm -56.08 -42.26 71.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 63.2 111.145 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.72 -19.81 59.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 72.23 110.864 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -95.84 -25.59 15.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 70.32 110.944 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.404 ' CG1' HD21 ' A' ' 219' ' ' LEU . 60.6 t -85.36 -20.79 8.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 63.24 111.159 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.796 HD23 HG22 ' A' ' 193' ' ' ILE . 2.5 pp -101.17 -2.33 31.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 71.25 110.933 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -116.4 -22.92 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.885 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -71.1 -23.73 62.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 75.15 110.841 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -118.09 -66.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 74.41 110.922 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.64 25.81 14.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 74.23 110.918 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -149.35 22.59 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 61.45 110.839 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.5 mp -60.19 144.62 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 55.25 111.175 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -103.07 -26.05 13.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.878 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -166.07 130.82 2.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 53.53 111.097 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.482 ' CG1' HD12 ' A' ' 218' ' ' LEU . 89.9 t -107.53 128.09 62.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 72.12 111.106 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.936 HG21 HD11 ' A' ' 44' ' ' LEU . 39.7 t -110.82 103.28 54.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.588 0.709 . . . . 70.21 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.7 -169.76 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.707 2.271 . . . . 60.44 112.336 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -108.86 -22.33 7.01 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 70.15 112.44 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -144.6 88.73 1.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 71.44 110.896 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 161.25 -93.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.783 -0.722 . . . . 50.41 112.523 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -178.91 156.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.925 0.393 . . . . 70.4 110.886 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 207' ' ' VAL . 39.1 t -67.2 147.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 72.33 111.135 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -150.04 -107.97 0.42 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.684 -0.77 . . . . 54.24 112.405 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -154.52 -170.47 3.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 42.32 110.87 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -58.01 -20.2 36.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 75.45 110.878 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.742 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.93 -32.43 62.36 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.685 -0.769 . . . . 62.31 112.452 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 172' ' ' SER . 29.8 mt -50.74 -43.2 58.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 53.11 110.908 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.529 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -59.97 -45.05 93.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.965 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.742 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.2 mt -64.58 -42.04 95.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 70.41 110.866 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -65.5 -36.6 84.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 73.21 110.869 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 33.0 m -51.7 -44.29 63.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 53.11 111.162 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.755 ' HA ' HD12 ' A' ' 226' ' ' LEU . 76.4 mt -56.32 -38.96 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.86 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -27.77 65.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 73.41 110.856 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.9 -25.47 56.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 62.33 110.866 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.755 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.6 mt -89.22 -38.63 14.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 63.23 110.923 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.6 mttp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 75.22 110.914 179.836 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.593 HG22 ' OG ' ' A' ' 19' ' ' SER . 91.4 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.846 0.355 . . . . 72.34 111.09 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.52 154.52 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 52.24 111.19 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.403 ' N ' ' HE3' ' A' ' 70' ' ' MET . 21.6 mtmt -145.37 146.58 31.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.892 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.32 165.49 21.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 64.32 110.815 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -52.03 -43.35 63.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 63.14 110.878 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.52 -24.01 31.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 70.23 111.157 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.68 -14.0 66.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 70.52 112.484 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.715 HG23 HG13 ' A' ' 16' ' ' ILE . 1.9 t -50.81 -32.77 21.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 64.51 111.165 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.715 HG13 HG23 ' A' ' 15' ' ' THR . 20.1 mt -118.79 148.08 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 55.34 111.072 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 p -170.59 166.97 8.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 73.54 110.851 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -133.27 -172.91 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 72.32 111.109 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.593 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -173.74 133.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.89 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.98 119.12 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.41 110.879 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.401 HD11 HG11 ' A' ' 213' ' ' VAL . 1.4 mm? -101.5 -57.8 2.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 64.0 110.887 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -148.3 -170.08 3.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 72.15 110.861 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.532 ' O ' HG23 ' A' ' 25' ' ' VAL . 16.3 mttt -52.34 108.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.922 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 57.96 23.21 9.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.426 . . . . 73.24 110.831 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 23' ' ' LYS . 99.1 t -122.44 110.76 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 64.31 111.18 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -121.91 163.83 18.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.887 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.5 t -126.02 109.95 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 43.03 111.151 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.552 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.2 p80 -101.61 137.0 40.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.852 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 m -132.39 113.06 12.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 73.12 111.19 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.569 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -100.27 162.49 12.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 74.3 110.874 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.419 HD22 ' CA ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -113.33 126.14 55.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 74.03 110.907 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 63.11 112.46 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.1 p . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.608 0.718 . . . . 63.4 111.109 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.419 ' CA ' HD22 ' A' ' 31' ' ' LEU . 53.5 Cg_endo -69.75 166.22 28.34 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.667 2.245 . . . . 74.13 112.352 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -149.06 99.41 2.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 73.13 110.938 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -51.76 168.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 72.52 110.852 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.583 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -170.24 -160.3 18.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 73.43 112.478 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.99 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -165.81 141.49 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 64.02 110.932 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 54' ' ' LEU . 21.8 t -125.84 135.58 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 74.23 111.141 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.45 HD22 ' HE3' ' A' ' 138' ' ' MET . 18.5 mt -103.16 133.4 48.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 65.12 110.916 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -99.65 57.95 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 71.23 110.939 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 p -60.38 -169.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 41.51 111.182 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.5 m -114.43 2.89 14.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 71.45 110.83 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -118.53 -17.4 9.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.878 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.19 131.17 1.3 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.658 -0.782 . . . . 74.24 112.432 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 75' ' ' PHE . 16.5 mt -48.98 159.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 70.13 110.932 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 81' ' ' ASP . 96.5 t -140.12 144.07 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 74.13 111.153 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.459 HD13 HG22 ' A' ' 45' ' ' VAL . 3.6 mm? -115.72 128.83 56.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 61.42 110.901 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.4 t -78.84 -2.34 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 63.41 111.061 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 179.57 125.36 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.28 -0.418 . . . . 72.12 110.897 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -167.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 54.2 110.892 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 p -94.61 -169.75 2.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 72.05 110.842 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.425 ' HB2' HD13 ' A' ' 63' ' ' LEU . 84.2 m95 -73.45 -38.45 65.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.953 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -143.66 154.98 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.52 110.87 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HA ' HG22 ' A' ' 64' ' ' THR . 5.4 p-10 -55.88 -28.35 56.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 73.13 110.862 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -78.1 -23.77 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 71.35 110.945 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -87.24 -40.19 14.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.03 110.929 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 61' ' ' ASP . 14.1 t -66.53 -23.61 66.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.52 111.167 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -43.04 72.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 52.32 110.884 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -82.76 -14.6 54.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 64.32 110.886 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.569 HD22 ' OE2' ' A' ' 30' ' ' GLU . 15.3 tp -76.51 -44.49 34.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 72.25 110.949 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.9 mt -74.6 -30.06 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.04 111.185 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.52 -13.2 61.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 63.12 110.888 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.403 ' HE3' ' N ' ' A' ' 10' ' ' LYS . 2.7 mmm -88.7 -54.76 4.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 73.2 110.87 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 52' ' ' LEU . 19.2 m -57.5 -39.61 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 72.33 111.124 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.449 ' HG3' HG23 ' A' ' 71' ' ' VAL . 63.5 mt-10 -83.97 50.86 1.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 52.34 110.871 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.19 -41.02 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 64.22 110.897 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.83 -19.51 12.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 75.03 110.887 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.719 ' HB3' HD21 ' A' ' 52' ' ' LEU . 26.3 m-85 -88.64 9.73 23.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.52 110.822 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.527 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 2.1 pp0? 31.69 49.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.908 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.418 ' NZ ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -155.46 -177.21 6.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 74.33 110.97 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 144.87 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 72.35 110.831 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 52' ' ' LEU . 93.8 t -76.57 123.63 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 73.34 111.089 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.2 p -134.48 20.78 3.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 74.22 111.149 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.805 ' HB2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -153.56 135.5 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 72.35 110.868 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.573 HG21 ' CD2' ' A' ' 98' ' ' LEU . 19.4 t -140.53 100.77 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 74.55 111.071 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.8 mt -79.42 121.02 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 65.44 111.171 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 91' ' ' ARG . 45.4 mm -105.72 130.47 57.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 70.11 111.079 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.0 p -90.91 -52.95 4.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 72.24 111.193 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -134.72 162.5 32.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 52.3 110.888 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.45 97.64 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.1 111.112 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.662 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.53 158.84 44.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 73.04 110.848 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.76 -30.32 63.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 71.5 111.118 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.29 9.99 21.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.899 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.401 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.9 mmp_? -121.86 -51.64 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 73.54 110.807 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.662 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -117.29 18.12 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 71.34 111.128 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.77 -28.45 23.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 72.43 112.495 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.05 21.31 27.38 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.698 -0.763 . . . . 60.44 112.552 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.421 HD11 ' C ' ' A' ' 122' ' ' GLU . 2.6 tt -48.7 -30.77 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 52.03 111.084 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -69.9 -44.05 70.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 70.41 110.842 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.0 m -67.02 -35.01 78.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 74.15 111.201 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.573 ' CD2' HG21 ' A' ' 82' ' ' VAL . 51.4 mt -62.61 -30.74 71.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 60.2 110.896 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.58 22.61 7.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.945 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -120.71 -31.29 4.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 73.14 110.86 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -103.48 12.08 35.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 64.42 110.861 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.14 18.62 68.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 65.25 112.539 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 98' ' ' LEU . 11.5 mt -83.64 157.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.819 0.343 . . . . 71.22 111.17 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.809 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -122.02 121.28 36.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 74.15 110.881 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.497 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -89.61 77.96 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.047 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.539 ' HA ' HD12 ' A' ' 124' ' ' LEU . 96.7 m-70 -53.83 146.34 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.848 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.15 168.25 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.31 110.858 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.657 HG22 ' HB3' ' A' ' 127' ' ' LEU . 81.0 p -83.7 176.4 9.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 70.21 111.173 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.07 -23.93 60.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 74.02 111.052 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 152' ' ' ASP . 10.2 tp -75.47 -51.2 13.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 64.45 110.923 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.665 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 91.7 m -52.65 -29.13 24.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 72.34 111.134 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.516 ' HB1' ' OE2' ' A' ' 122' ' ' GLU . . . -82.51 -30.41 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 70.32 111.074 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -58.93 -40.48 84.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 74.4 110.904 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.659 HD12 ' OD2' ' A' ' 152' ' ' ASP . 61.0 mt -85.09 -25.25 27.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 65.1 110.932 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.51 -68.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.34 111.099 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -56.35 -25.57 49.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 64.55 110.881 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -24.75 67.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 71.43 110.952 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -94.1 -37.25 11.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 75.23 110.896 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.14 -8.57 3.25 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.765 -0.731 . . . . 71.33 112.487 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -59.82 -172.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 74.21 110.967 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -101.21 0.24 37.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.148 -0.478 . . . . 62.34 110.903 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.516 ' OE2' ' HB1' ' A' ' 112' ' ' ALA . 1.5 mt-10 66.14 127.18 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 63.54 110.911 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -170.3 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.738 2.292 . . . . 71.25 112.294 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.809 HD11 ' HB2' ' A' ' 104' ' ' LYS . 69.8 mt -52.85 -41.42 64.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 71.54 110.958 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 55.16 58.56 13.18 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.771 -0.728 . . . . 72.04 112.502 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -148.97 54.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 61.41 110.916 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.657 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.3 OUTLIER -136.37 -169.7 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 73.2 110.909 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -150.75 -168.66 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 72.45 110.897 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.828 HG23 ' HB3' ' A' ' 144' ' ' TYR . 97.6 m -50.21 -41.1 49.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 70.42 111.149 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.76 140.78 25.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 64.41 111.146 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.6 m -149.55 102.47 3.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.106 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.33 95.44 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 70.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 63.13 110.924 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.45 ' HE3' HD22 ' A' ' 46' ' ' LEU . 3.1 tpp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.838 0.352 . . . . 71.43 110.935 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.62 130.05 45.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.889 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.577 HG13 HD23 ' A' ' 158' ' ' LEU . 4.3 t -142.92 159.54 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 72.51 111.203 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 140' ' ' VAL . 41.4 tt0 -160.44 118.12 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 74.12 110.925 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.46 HG22 ' CD1' ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.94 179.67 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 72.33 111.153 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -175.19 143.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 74.43 110.851 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.828 ' HB3' HG23 ' A' ' 129' ' ' THR . 66.2 t80 -120.78 94.98 49.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.673 0.749 . . . . 55.51 110.874 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 -48.59 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.649 2.233 . . . . 64.34 112.344 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.15 -161.55 34.71 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 75.42 112.426 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.47 125.46 38.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.891 0.377 . . . . 65.23 110.856 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -136.37 -97.38 0.49 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 42.32 112.498 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -69.72 -35.77 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 74.2 110.867 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.43 147.29 39.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 43.11 111.176 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.99 -40.72 61.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 74.55 110.927 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.659 ' OD2' HD12 ' A' ' 114' ' ' LEU . 11.1 p30 -106.46 53.01 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 64.15 110.912 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.97 134.8 42.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.886 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.46 ' CD1' HG22 ' A' ' 142' ' ' THR . 1.0 OUTLIER -136.62 160.73 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 60.41 111.091 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.0 m -109.46 155.43 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 65.21 111.115 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.0 t -111.31 142.28 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 54.15 111.118 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 158' ' ' LEU . 75.0 t-105 -127.7 151.48 48.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 73.2 110.904 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.577 HD23 HG13 ' A' ' 140' ' ' VAL . 13.3 mt -130.24 96.93 23.61 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.594 0.711 . . . . 53.4 110.935 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 72.64 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.668 2.245 . . . . 73.42 112.353 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 179.62 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 72.45 110.954 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.542 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.9 m-85 -118.04 -13.27 10.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 72.33 110.881 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.46 23.38 6.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 71.14 110.888 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.542 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.6 mp -93.97 118.92 40.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.11 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.453 HD11 HG13 ' A' ' 196' ' ' VAL . 0.4 OUTLIER -103.19 138.03 40.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 64.23 110.907 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.509 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.3 t -127.74 81.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 62.43 111.146 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.57 -67.94 1.68 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.8 -0.714 . . . . 73.04 112.528 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.87 89.35 2.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.707 -0.758 . . . . 63.33 112.457 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 63.6 m 61.48 16.85 7.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 73.31 110.873 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.643 HD12 ' NE1' ' A' ' 189' ' ' TRP . 21.7 tp -110.31 -45.48 3.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 51.24 110.901 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 218' ' ' LEU . 16.2 t -96.44 116.93 39.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.106 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.35 146.59 31.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.14 110.911 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.711 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.8 p -78.92 161.54 26.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 62.02 110.878 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 63.51 111.088 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.723 0.297 . . . . 71.31 111.048 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.48 91.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 62.22 111.124 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.77 43.3 2.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 64.14 110.834 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.2 164.53 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 71.15 111.064 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -112.87 90.08 3.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.893 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.414 HG13 HD23 ' A' ' 226' ' ' LEU . 21.6 t -67.56 -17.2 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 74.13 111.173 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -88.06 -20.08 26.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 65.21 110.938 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -104.63 -20.87 13.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 62.31 110.907 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.643 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -51.09 -55.77 16.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 75.03 110.912 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 60.4 p -51.88 -38.62 56.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 54.03 110.897 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -68.77 -36.09 77.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 71.15 111.141 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.0 m -65.31 -52.09 56.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.908 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.566 HG22 HD23 ' A' ' 197' ' ' LEU . 31.5 mm -57.56 -36.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 64.24 111.127 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.75 -15.45 61.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 65.11 110.887 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -97.84 -27.3 14.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 64.33 110.93 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.553 HG12 HD21 ' A' ' 219' ' ' LEU . 46.3 t -82.34 -30.36 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 62.23 111.108 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.566 HD23 HG22 ' A' ' 193' ' ' ILE . 2.8 pp -85.64 -24.26 27.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 65.54 110.916 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.26 -39.7 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 71.15 110.933 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -56.39 -49.03 75.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 71.11 110.844 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -119.34 127.72 53.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 74.23 110.927 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.75 26.03 8.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.093 -0.503 . . . . 72.22 110.848 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.49 22.13 2.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 71.31 110.844 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 203' ' ' ILE . 3.6 mp -52.11 147.42 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 64.12 111.198 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -106.85 -39.76 5.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 73.33 110.957 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.93 127.59 8.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.153 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.525 HG12 HD12 ' A' ' 218' ' ' LEU . 86.1 t -105.59 125.44 60.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 55.24 111.116 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.99 HG21 HD11 ' A' ' 44' ' ' LEU . 23.5 t -106.54 110.09 63.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.707 . . . . 53.43 111.142 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 54.43 112.341 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.89 -27.01 7.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 71.12 112.543 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -145.05 88.93 1.92 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.364 . . . . 75.15 110.871 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.17 -108.29 0.34 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.698 -0.763 . . . . 61.15 112.437 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -158.02 153.65 26.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.926 0.394 . . . . 52.23 110.894 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 21' ' ' LEU . 5.3 p -68.69 144.0 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 62.43 111.102 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.07 -104.51 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 61.31 112.498 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -157.3 -169.65 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.885 0.374 . . . . 63.4 110.873 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -56.96 -21.02 26.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.911 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.748 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -55.94 -33.85 60.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.772 -0.728 . . . . 71.4 112.446 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.711 HD22 ' HA ' ' A' ' 172' ' ' SER . 30.2 mt -50.63 -47.01 58.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.882 0.372 . . . . 73.41 110.913 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.553 HD21 HG12 ' A' ' 196' ' ' VAL . 7.1 mp -53.84 -42.7 68.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 74.01 110.98 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.748 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -67.37 -41.28 85.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.946 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -64.09 -39.31 93.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 72.45 110.794 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.3 m -51.59 -45.23 63.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 73.0 111.136 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.777 ' HA ' HD12 ' A' ' 226' ' ' LEU . 46.6 mt -61.26 -39.83 91.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 74.24 110.91 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.31 -26.76 61.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.843 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.3 mt -76.82 -24.05 52.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 71.05 110.865 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.5 mt -90.97 -39.38 12.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 63.21 110.899 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 71.44 110.878 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 18' ' ' ILE . 95.1 t . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.827 0.346 . . . . 54.54 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.581 HD11 ' HE3' ' A' ' 74' ' ' LYS . 2.6 mm -94.56 152.62 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.33 111.104 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -150.83 155.34 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 64.2 110.905 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.23 -168.95 2.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.923 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -76.89 -25.25 52.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 72.22 110.834 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 p -95.04 -35.21 12.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 73.21 111.138 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.66 -9.16 64.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.759 . . . . 64.01 112.446 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.77 HG23 HG13 ' A' ' 16' ' ' ILE . 1.7 t -50.12 -33.36 18.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.688 0.28 . . . . 71.02 111.128 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.77 HG13 HG23 ' A' ' 15' ' ' THR . 5.9 mt -124.21 160.32 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.433 . . . . 72.53 111.147 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 16' ' ' ILE . 1.8 p -178.42 166.75 1.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 63.31 110.858 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -129.24 -175.71 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 71.41 111.113 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.405 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.0 t -169.14 129.97 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.51 110.894 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.3 120.19 12.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 55.34 110.942 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.5 mm? -103.56 -74.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 63.23 110.906 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.98 -170.43 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 61.51 110.843 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' HG23 ' A' ' 25' ' ' VAL . 6.6 mmtt -52.62 109.48 0.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 70.22 110.876 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 58.6 23.86 11.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 75.53 110.832 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 23' ' ' LYS . 99.3 t -122.96 116.42 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 75.32 111.114 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -124.36 163.13 22.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 75.54 110.954 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.719 HG22 HD12 ' A' ' 44' ' ' LEU . 55.8 t -123.59 107.72 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 72.21 111.114 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.558 ' CE1' HD21 ' A' ' 67' ' ' LEU . 6.8 p80 -100.49 138.49 37.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 71.34 110.856 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.8 m -136.2 133.44 37.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.115 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.486 ' HB3' HG23 ' A' ' 16' ' ' ILE . 2.9 pm0 -124.59 173.98 8.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 44.13 110.91 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.496 ' O ' HD21 ' A' ' 63' ' ' LEU . 3.3 tp -124.15 136.23 54.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 52.32 110.914 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.733 -0.746 . . . . 73.43 112.447 179.926 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.619 0.723 . . . . 75.42 111.096 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 142.87 48.99 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.74 2.293 . . . . 71.44 112.344 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.92 102.06 5.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 74.51 110.927 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -67.48 153.44 43.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 75.1 110.861 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.71 -155.99 7.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 54.12 112.528 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.871 HD22 HG21 ' A' ' 165' ' ' VAL . 4.7 tp -161.36 142.01 11.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 74.41 110.903 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.631 HG22 HD13 ' A' ' 54' ' ' LEU . 46.4 t -125.06 132.17 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 53.32 111.13 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 mt -98.5 122.59 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 71.02 110.952 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -94.8 60.26 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 61.25 110.9 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.4 p -66.0 179.83 0.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 75.12 111.173 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.6 m -104.95 26.04 9.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 74.32 110.836 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.08 23.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 65.22 110.912 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.81 130.25 4.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.769 -0.729 . . . . 35.32 112.431 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.797 HD13 ' HB ' ' A' ' 71' ' ' VAL . 10.0 mt -60.33 158.96 10.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.825 0.345 . . . . 70.43 110.934 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.798 HG22 ' HB2' ' A' ' 81' ' ' ASP . 57.8 t -140.2 139.35 36.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 65.33 111.129 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.631 HD13 HG22 ' A' ' 45' ' ' VAL . 2.9 mm? -109.83 127.43 54.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.942 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 55' ' ' VAL . 18.0 t -79.8 -0.5 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 73.44 111.152 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.45 126.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 51.41 110.904 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -166.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 75.1 110.84 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -96.28 -174.46 3.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 70.32 110.874 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.771 ' HB2' HD13 ' A' ' 63' ' ' LEU . 92.9 m95 -67.68 -42.1 82.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 72.33 110.924 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.01 166.29 24.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 54.42 110.84 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.96 -36.18 80.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.861 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -71.21 -25.13 62.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.93 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -78.99 -49.68 12.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 64.21 110.819 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 t -58.84 -29.54 67.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.33 111.125 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -52.76 -44.3 66.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 70.55 110.893 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -80.94 -12.89 59.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 63.44 110.889 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 16' ' ' ILE . 38.9 tp -83.87 -50.29 8.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 72.3 110.904 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.4 mt -64.55 -18.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 52.33 111.193 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -80.91 -1.18 42.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 73.12 110.881 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.8 mtp -96.33 -57.56 2.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.843 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.797 ' HB ' HD13 ' A' ' 52' ' ' LEU . 20.5 m -58.29 -39.1 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 72.1 111.167 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.53 50.82 1.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 74.03 110.912 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -146.25 -40.95 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 72.4 110.879 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.581 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.19 -23.21 12.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 63.32 110.866 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.601 ' HB3' HD21 ' A' ' 52' ' ' LEU . 41.1 m-85 -90.03 11.57 20.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 73.43 110.851 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.515 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.78 46.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.43 110.927 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -152.05 -176.71 5.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.52 110.892 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.67 153.66 47.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 51.41 110.889 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 52' ' ' LEU . 87.2 t -89.25 117.19 32.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 64.2 111.123 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.54 HG23 ' HG2' ' A' ' 78' ' ' ARG . 42.8 p -130.76 36.53 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 75.12 111.155 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.798 ' HB2' HG22 ' A' ' 53' ' ' VAL . 6.1 m-20 -166.71 130.44 1.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 64.31 110.918 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.616 HG21 ' CD2' ' A' ' 98' ' ' LEU . 17.0 t -135.96 101.91 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 74.54 111.11 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.0 mt -80.22 119.79 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.14 111.074 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 91' ' ' ARG . 39.6 mm -107.33 134.59 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.117 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.1 p -91.9 -55.36 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 54.34 111.204 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -133.17 163.95 28.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 74.35 110.795 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -82.8 97.22 8.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 65.4 111.086 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.619 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.6 OUTLIER -151.05 158.8 44.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 64.54 110.851 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.27 -26.2 60.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.35 111.083 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.68 15.27 13.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 51.12 110.835 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.458 ' O ' HD12 ' A' ' 84' ' ' ILE . 3.1 mpt_? -129.66 -53.12 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 75.44 110.829 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -112.88 16.54 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 65.23 111.189 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.56 25.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.797 -0.716 . . . . 45.03 112.494 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.88 20.04 29.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.743 . . . . 73.2 112.496 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.483 HG21 ' H ' ' A' ' 121' ' ' GLU . 2.4 tt -48.23 -30.65 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.37 . . . . 73.32 111.127 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -70.13 -44.51 68.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 73.2 110.932 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.9 m -67.38 -32.59 73.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 53.43 111.142 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.616 ' CD2' HG21 ' A' ' 82' ' ' VAL . 58.3 mt -65.01 -30.53 71.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 71.3 110.944 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -96.69 21.6 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 63.2 110.925 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.44 -27.36 5.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.3 110.903 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.68 11.52 28.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 71.1 110.892 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.18 17.12 70.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 71.31 112.512 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 98' ' ' LEU . 11.9 mt -83.19 157.52 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.888 0.375 . . . . 75.32 111.126 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.774 ' HB2' HD11 ' A' ' 124' ' ' LEU . 10.9 ptpt -123.49 123.38 40.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.848 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . . . -91.24 80.85 5.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.33 111.066 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.504 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.4 m-70 -56.1 146.85 21.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.79 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.93 159.85 0.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 72.42 110.86 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.4 p -75.74 154.58 36.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 73.55 111.123 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.45 -32.41 26.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 73.42 111.043 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 152' ' ' ASP . 7.3 tp -73.64 -48.28 33.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.426 . . . . 74.31 110.878 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.73 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 99.8 m -52.02 -28.61 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 60.53 111.18 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -86.61 -31.6 21.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 63.13 111.127 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.03 -43.55 70.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 52.41 110.829 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.64 HD12 ' OD1' ' A' ' 152' ' ' ASP . 21.3 mt -79.87 -23.73 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 64.03 110.891 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.14 -69.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.42 111.061 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.42 -28.24 28.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 71.53 110.937 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -23.64 62.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 73.32 110.841 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -94.58 -38.78 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 74.33 110.827 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.72 -8.51 3.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 44.41 112.459 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.43 -172.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 71.43 110.936 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.483 ' H ' HG21 ' A' ' 95' ' ' ILE . 58.4 mm-40 -98.47 -1.23 41.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 74.42 110.849 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.478 ' C ' HD11 ' A' ' 95' ' ' ILE . 0.7 OUTLIER 66.34 129.92 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.656 0.741 . . . . 65.11 110.893 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.557 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.85 -169.65 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.608 2.205 . . . . 74.44 112.403 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 104' ' ' LYS . 86.4 mt -54.45 -37.75 65.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 73.41 110.872 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.06 57.71 12.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 72.04 112.527 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -153.29 49.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 72.12 110.829 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.19 -169.97 2.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 73.21 110.919 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -146.22 -169.08 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.925 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 144' ' ' TYR . 94.1 m -50.72 -62.74 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 64.24 111.169 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 143' ' ' PHE . 92.2 t -125.07 116.15 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.51 111.092 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.63 HG22 HD23 ' A' ' 133' ' ' LEU . 60.1 m -115.66 103.35 10.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 73.24 111.132 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -67.02 102.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 74.21 110.879 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.63 HD23 HG22 ' A' ' 131' ' ' THR . 1.8 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 64.43 110.944 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 43.7 tpp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.9 0.381 . . . . 61.14 110.825 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.51 124.65 36.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 62.22 110.91 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.693 HG13 HD23 ' A' ' 158' ' ' LEU . 8.5 t -143.32 157.45 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.426 . . . . 74.24 111.107 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.403 ' N ' HG12 ' A' ' 140' ' ' VAL . 83.8 tt0 -158.53 125.31 4.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 64.52 110.886 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.649 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -74.63 -178.74 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 62.13 111.175 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.759 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.5 t80 -175.18 137.66 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 63.12 110.895 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.816 ' HB3' HG23 ' A' ' 129' ' ' THR . 52.7 t80 -120.05 92.99 47.55 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.681 0.753 . . . . 63.41 110.881 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -48.81 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.744 2.296 . . . . 72.25 112.322 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.73 -166.34 39.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 63.32 112.458 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -85.35 126.94 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 74.3 110.875 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.49 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -135.75 -87.74 0.24 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 73.53 112.55 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -80.32 -23.67 40.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 55.45 110.842 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.52 158.3 43.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 74.15 111.215 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -63.1 -26.83 69.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 74.52 110.853 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.64 ' OD1' HD12 ' A' ' 114' ' ' LEU . 2.6 p30 -122.0 53.52 1.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 71.5 110.809 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.1 p30 -102.32 145.65 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 75.42 110.857 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.649 HD12 HG22 ' A' ' 142' ' ' THR . 6.4 pt -142.05 172.45 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 74.3 111.13 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.461 ' CG1' HD22 ' A' ' 169' ' ' LEU . 5.2 m -122.5 142.64 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.118 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.19 144.46 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 64.41 111.139 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -131.1 149.35 52.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 71.12 110.947 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.693 HD23 HG13 ' A' ' 140' ' ' VAL . 23.0 mt -126.52 95.93 37.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.568 0.699 . . . . 51.22 110.877 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 72.08 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.705 2.27 . . . . 63.34 112.326 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.5 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.912 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.544 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.3 m-85 -118.16 -13.21 9.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.833 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 m120 69.81 22.05 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 75.54 110.891 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.544 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.7 mp -92.79 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 72.44 111.072 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.41 136.57 39.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.968 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.871 HG21 HD22 ' A' ' 44' ' ' LEU . 23.2 t -123.24 65.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 45.11 111.158 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.87 -48.24 45.38 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.758 -0.734 . . . . 64.4 112.454 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.64 -130.9 10.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 74.3 112.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 96.5 m -69.58 -19.13 63.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 42.52 110.923 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.461 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.4 OUTLIER -67.65 -47.11 70.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 65.34 110.822 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.619 HG11 HG11 ' A' ' 206' ' ' VAL . 46.1 t -92.49 116.0 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 64.13 111.113 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.487 ' H ' HG23 ' A' ' 222' ' ' THR . 0.2 OUTLIER -89.95 147.74 23.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 53.43 110.864 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.741 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.6 t -87.19 157.24 19.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 71.04 110.84 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.1 p . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 63.22 111.117 -179.914 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.714 HG11 ' CG2' ' A' ' 186' ' ' VAL . 11.9 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.805 0.336 . . . . 74.03 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -51.71 -58.03 7.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 64.3 111.077 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.7 27.12 9.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.847 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -104.86 168.94 8.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.03 111.122 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -130.87 88.59 2.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 75.11 110.939 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.714 ' CG2' HG11 ' A' ' 181' ' ' VAL . 61.0 t -62.46 -18.02 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.098 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -78.87 -22.13 46.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 53.42 110.896 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -108.91 -25.42 10.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 75.42 110.936 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -51.04 -57.97 7.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.95 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.3 p -51.85 -30.56 24.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 51.33 110.87 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.0 m -80.06 -34.3 38.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 75.51 111.142 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 44.5 m -66.99 -55.55 13.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 73.11 110.819 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.766 HG22 HD23 ' A' ' 197' ' ' LEU . 33.6 mm -56.17 -40.17 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 73.15 111.114 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.22 -16.46 60.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 65.22 110.831 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -97.93 -21.88 16.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.883 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.466 ' CG1' HD21 ' A' ' 219' ' ' LEU . 94.5 t -88.42 -24.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.094 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 193' ' ' ILE . 2.6 pp -98.84 1.53 45.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 73.23 110.94 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -117.25 -17.03 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 54.34 110.851 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -90.55 1.84 56.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 71.11 110.901 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -137.61 -72.46 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.32 110.9 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 61.16 25.3 15.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 54.44 110.87 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -147.29 21.06 1.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 75.4 110.856 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.45 144.93 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 65.32 111.174 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -103.87 -28.65 11.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 61.14 110.837 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.465 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -165.68 126.47 1.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 73.41 111.106 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.636 ' CG1' HD12 ' A' ' 218' ' ' LEU . 87.9 t -98.45 127.48 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 51.44 111.112 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.855 HG21 HD13 ' A' ' 44' ' ' LEU . 98.0 t -108.71 89.57 6.45 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.618 0.723 . . . . 74.2 111.133 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 167.96 22.92 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.632 2.221 . . . . 71.11 112.376 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.09 -15.94 63.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 73.14 112.46 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -146.83 111.09 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 60.22 110.904 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 137.69 -96.41 0.24 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.826 -0.702 . . . . 73.52 112.524 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -178.85 166.77 1.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 75.55 110.867 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.695 HG21 HG21 ' A' ' 27' ' ' VAL . 21.6 t -75.1 133.49 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 63.24 111.141 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.57 -106.62 0.73 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 53.12 112.497 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -155.64 -172.62 4.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.883 0.373 . . . . 73.11 110.856 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -22.04 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.42 110.901 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.75 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.4 -33.06 52.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.8 -0.714 . . . . 71.25 112.521 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 172' ' ' SER . 29.6 mt -50.38 -45.69 55.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 74.21 110.923 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.522 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -55.66 -44.54 77.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.912 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.75 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.5 mt -64.9 -41.36 95.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 63.13 110.921 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.47 ' NE2' HD21 ' A' ' 225' ' ' LEU . 64.7 t60 -61.67 -38.85 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 64.12 110.901 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.487 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.2 OUTLIER -51.6 -46.09 63.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 70.01 111.091 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 226' ' ' LEU . 79.2 mt -52.5 -38.95 60.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.5 110.928 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -46.4 90.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 72.03 110.823 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.47 HD21 ' NE2' ' A' ' 221' ' ' HIS . 17.6 mt -56.54 -24.82 49.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.93 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.747 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.7 mt -87.32 -54.53 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 65.32 110.935 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.4 pttt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 72.42 110.955 179.802 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.1 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 74.31 111.092 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.705 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.3 mm -89.03 154.86 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 71.22 111.082 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -150.84 172.96 14.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 64.35 110.854 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -104.61 -169.42 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 71.45 110.889 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -74.14 -26.18 60.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 72.03 110.882 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p -102.43 -35.48 8.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 75.31 111.135 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.16 -2.5 43.95 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 52.33 112.459 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.758 HG23 HG13 ' A' ' 16' ' ' ILE . 1.7 t -50.55 -33.26 21.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 53.14 111.195 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.758 HG13 HG23 ' A' ' 15' ' ' THR . 7.0 mt -127.89 158.77 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 71.34 111.095 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 p -176.21 166.61 2.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 70.3 110.838 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 19' ' ' SER . 0.2 OUTLIER -130.14 -172.7 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 63.32 111.12 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.409 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.9 t -171.75 130.67 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 53.32 110.796 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.83 121.72 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.053 -0.521 . . . . 71.54 110.869 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.8 mm? -105.26 -49.02 3.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 74.14 110.912 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -148.41 59.39 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 53.43 110.887 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.42 -81.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.52 110.929 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.604 ' OD1' HG23 ' A' ' 25' ' ' VAL . 14.7 p30 -82.93 -17.2 44.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.862 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.604 HG23 ' OD1' ' A' ' 24' ' ' ASN . 21.1 t -96.85 118.52 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 71.24 111.15 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -126.14 160.11 31.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 72.24 110.918 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 213' ' ' VAL . 68.3 t -120.95 110.89 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 71.32 111.111 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.502 ' CE1' HD21 ' A' ' 67' ' ' LEU . 11.5 p80 -99.78 136.88 39.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 74.3 110.794 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.9 m -133.7 127.96 33.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.51 111.198 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.48 ' HB3' HG23 ' A' ' 16' ' ' ILE . 19.9 pm0 -120.91 -176.15 3.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 74.54 110.891 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 40' ' ' PRO . 3.6 tp -135.75 138.36 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 63.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 65.5 112.438 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.601 0.715 . . . . 53.32 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.513 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.9 Cg_endo -69.75 142.96 49.37 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.66 2.24 . . . . 40.22 112.342 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 t -142.15 110.99 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.23 110.822 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -100.29 146.37 27.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 71.42 110.883 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.601 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -133.37 -114.34 1.51 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.708 -0.758 . . . . 51.33 112.468 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.784 HD13 HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -178.86 144.58 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.839 0.352 . . . . 72.23 110.989 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 71' ' ' VAL . 40.4 t -127.88 131.91 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 72.44 111.124 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.2 mt -101.24 124.85 47.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 73.21 110.924 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.56 55.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 65.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 138' ' ' MET . 16.3 p -63.21 176.74 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 63.4 111.16 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 t -99.22 16.74 21.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 64.33 110.895 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.54 33.24 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.917 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.94 134.65 7.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 42.54 112.493 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.558 HD13 ' HB ' ' A' ' 71' ' ' VAL . 7.4 mt -62.72 161.15 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.35 . . . . 71.44 110.918 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.756 HG22 ' HB2' ' A' ' 81' ' ' ASP . 64.6 t -139.91 143.38 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.33 111.168 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.609 HD13 HG22 ' A' ' 45' ' ' VAL . 3.2 mm? -116.2 129.73 56.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 73.52 110.857 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 55' ' ' VAL . 16.1 t -79.12 -1.87 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 62.42 111.222 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 179.44 130.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 73.23 110.844 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 p -67.79 -166.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 71.25 110.805 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.6 t -94.61 -174.07 3.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 63.42 110.894 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.675 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.4 m95 -70.21 -36.11 74.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 71.25 110.935 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.74 164.31 31.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 53.05 110.854 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -63.18 -28.46 70.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 53.12 110.865 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -78.43 -25.48 46.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.914 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 59' ' ' TRP . 1.2 mt -83.47 -46.43 12.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 60.24 110.994 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 t -55.41 -28.49 54.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 64.01 111.18 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -55.9 -43.09 76.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 44.41 110.877 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.21 0.28 41.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 55.31 110.898 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.502 HD21 ' CE1' ' A' ' 28' ' ' HIS . 51.6 tp -99.42 -50.68 4.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 73.33 110.9 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.664 HG23 HG21 ' A' ' 79' ' ' VAL . 37.1 mt -64.93 -35.29 74.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 73.24 111.164 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.99 -16.75 60.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 73.01 110.916 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 32.1 mtp -76.57 -59.19 2.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 75.11 110.923 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 45' ' ' VAL . 33.0 m -60.11 -33.3 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 74.13 111.158 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -87.76 49.72 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 74.11 110.896 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -147.65 -40.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 75.21 110.884 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.705 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -103.8 -26.63 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 62.31 110.838 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' CB ' HD21 ' A' ' 52' ' ' LEU . 38.8 m-85 -89.52 10.89 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 74.51 110.885 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.5 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.71 46.93 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 72.32 110.896 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -146.97 -178.8 6.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 75.31 110.905 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.28 142.71 50.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.888 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.664 HG21 HG23 ' A' ' 68' ' ' ILE . 21.4 t -75.48 130.81 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 61.31 111.09 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.5 p -142.86 24.74 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 51.1 111.11 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.756 ' HB2' HG22 ' A' ' 53' ' ' VAL . 4.9 m-20 -157.85 133.95 9.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 75.02 110.928 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 98' ' ' LEU . 15.4 t -140.24 101.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 63.24 111.134 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.8 mt -78.45 114.17 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 75.12 111.117 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 91' ' ' ARG . 45.5 mm -100.84 124.76 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 75.51 111.101 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.9 p -81.93 -59.02 2.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 61.51 111.141 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.43 ' C ' HG23 ' A' ' 111' ' ' THR . 37.9 p-80 -128.18 -175.11 3.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 64.13 110.895 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -102.97 100.2 10.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 53.22 111.127 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.676 ' O ' HD13 ' A' ' 92' ' ' ILE . 2.8 m170 -153.84 160.6 42.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 74.21 110.84 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.78 -28.9 62.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 75.41 111.071 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.8 12.45 19.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.4 110.875 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.493 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.3 mpt_? -124.36 -50.43 1.77 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.971 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -119.85 15.69 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 73.44 111.106 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.7 -37.07 33.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 74.24 112.53 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.0 19.39 43.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 72.03 112.473 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.55 HG21 ' H ' ' A' ' 121' ' ' GLU . 4.5 tt -45.83 -31.13 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 74.15 111.124 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.46 -55.46 17.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 62.41 110.962 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.9 m -57.57 -41.43 81.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 60.5 111.104 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 103' ' ' ILE . 28.6 mt -58.44 -28.52 65.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.03 110.881 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -100.94 23.4 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 73.02 110.864 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -116.7 -39.7 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 74.05 110.877 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -88.4 -22.9 23.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 71.43 110.862 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.48 18.51 4.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.751 . . . . 42.34 112.482 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.3 mt -84.84 155.71 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.915 0.388 . . . . 64.25 111.09 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.771 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.4 ptpm? -119.03 119.76 35.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 73.54 110.891 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.73 78.98 9.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 61.21 111.037 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.619 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.6 m-70 -53.8 144.94 17.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.886 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.33 160.97 0.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 45.4 110.914 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.4 p -76.66 -177.66 4.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 73.3 111.177 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.3 -31.62 60.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 72.4 111.116 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 152' ' ' ASP . 8.3 tp -74.68 -46.98 34.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.951 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 98.5 m -53.6 -27.7 28.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 44.22 111.098 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -89.89 -33.52 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 61.13 111.135 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.53 -39.58 67.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.855 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.632 HD12 ' OD2' ' A' ' 152' ' ' ASP . 38.3 mt -84.0 -23.65 30.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 74.25 110.958 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.62 -68.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.079 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -53.14 -28.57 26.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.933 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -23.63 51.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 73.41 110.828 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -95.1 -32.41 13.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 70.13 110.889 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.31 -7.25 5.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 55.15 112.557 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -59.5 -172.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 72.42 110.94 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.55 ' H ' HG21 ' A' ' 95' ' ' ILE . 7.7 mm-40 -97.93 -3.09 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 70.21 110.914 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.437 ' C ' HD11 ' A' ' 95' ' ' ILE . 0.9 OUTLIER 66.29 132.34 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.656 0.741 . . . . 62.2 110.914 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.73 -170.23 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.658 2.239 . . . . 62.25 112.342 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 104' ' ' LYS . 97.8 mt -53.53 -43.21 68.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 73.15 110.913 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 63.0 54.59 32.14 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 74.43 112.478 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -152.4 48.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.335 . . . . 74.52 110.844 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tp -131.7 167.54 19.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.253 -0.431 . . . . 73.1 110.924 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -126.18 -168.68 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 74.23 110.904 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.828 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.5 m -50.02 -56.44 10.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.427 . . . . 71.32 111.143 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.68 HG13 HG22 ' A' ' 129' ' ' THR . 17.8 m -131.65 145.62 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 71.13 111.156 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.2 m -152.97 113.23 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.13 111.122 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.28 87.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.426 . . . . 72.33 110.882 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.962 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.466 ' HB2' HG22 ' A' ' 48' ' ' THR . 59.7 tpp . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.916 0.389 . . . . 74.1 110.873 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -114.26 122.25 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.05 110.846 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.631 HG13 HD23 ' A' ' 158' ' ' LEU . 4.3 t -130.75 159.28 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.105 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 35.6 tt0 -159.27 122.06 3.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 71.2 110.841 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.535 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.6 -178.28 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.08 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.665 ' HA ' HG12 ' A' ' 130' ' ' VAL . 72.5 t80 -174.86 135.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 65.41 110.891 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.828 ' HB3' HG23 ' A' ' 129' ' ' THR . 26.9 t80 -120.53 95.03 49.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.663 0.744 . . . . 50.14 110.919 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -48.71 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.686 2.257 . . . . 62.34 112.287 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.22 -155.44 24.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 73.44 112.451 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.03 123.59 37.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 72.11 110.858 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -135.69 -98.03 0.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.708 -0.758 . . . . 73.53 112.438 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -68.84 -27.64 66.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 72.25 110.878 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.62 154.02 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 75.41 111.131 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.57 -32.55 65.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.865 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.632 ' OD2' HD12 ' A' ' 114' ' ' LEU . 3.0 p30 -116.31 51.73 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 71.34 110.925 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.75 138.8 36.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 60.34 110.865 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.535 HD12 HG22 ' A' ' 142' ' ' THR . 6.8 pt -139.37 167.22 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 75.13 111.121 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 m -117.75 147.73 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 63.43 111.131 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.468 HG21 HG13 ' A' ' 55' ' ' VAL . 88.8 t -100.67 142.66 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 75.42 111.115 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -128.9 147.35 50.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 63.34 110.915 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.631 HD23 HG13 ' A' ' 140' ' ' VAL . 14.8 mt -125.11 95.91 40.8 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.62 0.724 . . . . 54.23 110.894 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 72.4 1.43 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.674 2.25 . . . . 73.11 112.343 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.5 -34.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 70.2 110.942 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.449 ' CB ' HD13 ' A' ' 163' ' ' ILE . 2.9 m-85 -116.97 -13.51 10.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 64.33 110.985 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.17 25.37 5.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 62.41 110.926 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.508 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -98.13 118.0 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 73.22 111.151 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.39 137.14 41.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 43.4 110.875 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.784 HG22 HD13 ' A' ' 44' ' ' LEU . 19.4 t -118.94 65.15 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 72.52 111.08 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.25 -52.77 34.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 53.42 112.444 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 103.5 -132.07 10.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.796 -0.716 . . . . 43.41 112.463 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 34.0 m -65.14 -23.66 67.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 61.24 110.886 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.664 HD12 ' NE1' ' A' ' 189' ' ' TRP . 24.5 tp -64.02 -52.1 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.51 110.871 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.751 HG11 HG11 ' A' ' 206' ' ' VAL . 21.3 t -88.44 109.06 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 74.22 111.107 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.527 ' H ' HG23 ' A' ' 222' ' ' THR . 0.4 OUTLIER -81.37 149.87 28.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 61.44 110.923 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.631 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.3 t -72.42 164.32 26.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 60.02 110.889 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.569 HG23 HD23 ' A' ' 218' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 72.52 111.115 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.497 HG11 ' CG2' ' A' ' 186' ' ' VAL . 15.9 m . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.881 0.372 . . . . 74.12 111.162 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.29 -42.54 77.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 75.44 111.168 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.98 34.89 5.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.8 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.54 162.7 23.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 64.13 111.118 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -115.3 93.53 4.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 73.5 110.885 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.497 ' CG2' HG11 ' A' ' 181' ' ' VAL . 66.1 t -69.11 -21.29 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 63.22 111.154 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.39 -26.02 30.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 54.3 110.878 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -97.9 -21.08 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 70.13 110.87 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.664 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.4 t90 -51.15 -56.89 10.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 71.31 110.909 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 25.8 p -52.01 -36.91 51.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.856 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -70.82 -35.24 72.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 75.4 111.172 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 196' ' ' VAL . 50.7 m -66.47 -52.18 48.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 63.02 110.841 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.665 HG22 HD23 ' A' ' 197' ' ' LEU . 35.5 mm -56.47 -37.95 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 73.11 111.171 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -62.08 -24.15 66.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 72.04 110.879 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -89.35 -25.54 21.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 62.33 110.909 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.517 HG12 HD21 ' A' ' 219' ' ' LEU . 43.2 t -81.89 -33.59 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 71.43 111.194 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.665 HD23 HG22 ' A' ' 193' ' ' ILE . 4.6 pp -81.72 -25.53 35.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 72.31 110.904 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.452 ' N ' HD12 ' A' ' 197' ' ' LEU . 1.4 mttt -83.08 -44.4 15.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 74.31 110.928 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -56.21 -29.05 60.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 74.14 110.891 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -142.58 119.15 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 74.41 110.866 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.31 34.41 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 74.13 110.906 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.85 22.19 1.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 72.02 110.834 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.458 ' H ' HD12 ' A' ' 203' ' ' ILE . 3.5 mp -52.29 147.53 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.141 -0.481 . . . . 72.1 111.106 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -109.86 -25.77 10.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.109 -0.496 . . . . 72.4 110.909 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.508 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -163.58 132.54 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 65.53 111.124 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.751 HG11 HG11 ' A' ' 170' ' ' VAL . 89.0 t -115.12 122.15 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 75.21 111.097 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 213' ' ' VAL . 96.4 t -105.28 109.7 63.52 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.609 0.719 . . . . 64.41 111.141 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 52.8 Cg_endo -69.83 -167.99 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.711 2.274 . . . . 63.35 112.286 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.37 -32.23 6.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 62.51 112.522 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -138.49 101.16 4.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 74.55 110.887 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 150.99 -113.86 0.61 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 72.51 112.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.77 167.96 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 70.12 110.878 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 207' ' ' VAL . 21.7 t -71.31 150.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 62.04 111.123 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.75 -107.05 0.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 54.03 112.492 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -162.92 -170.15 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 73.44 110.836 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -20.33 37.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 75.21 110.942 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.754 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.89 -33.13 63.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.787 -0.72 . . . . 74.34 112.477 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.631 HD22 ' HA ' ' A' ' 172' ' ' SER . 31.5 mt -51.07 -45.35 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.874 0.369 . . . . 73.14 110.905 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.517 HD21 HG12 ' A' ' 196' ' ' VAL . 6.5 mp -55.93 -42.96 76.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.891 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.754 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -66.73 -41.41 87.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 70.4 110.963 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.652 ' NE2' HD21 ' A' ' 225' ' ' LEU . 85.8 t60 -61.58 -39.27 90.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 72.03 110.885 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.68 -42.85 62.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 73.32 111.15 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.801 ' HA ' HD12 ' A' ' 226' ' ' LEU . 26.4 mt -61.19 -40.43 93.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 75.5 110.962 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -39.62 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 63.12 110.858 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.652 HD21 ' NE2' ' A' ' 221' ' ' HIS . 12.6 mt -64.71 -26.28 68.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.93 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 223' ' ' LEU . 5.3 mt -85.6 -42.09 14.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 65.42 110.921 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.2 mttt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.891 179.786 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.878 0.37 . . . . 64.44 111.123 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.548 HD11 ' HE3' ' A' ' 74' ' ' LYS . 4.1 mm -90.3 153.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 75.5 111.132 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.23 172.29 13.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 71.01 110.884 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -107.22 179.0 4.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.875 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -63.65 -28.05 69.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.869 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -102.27 -33.82 9.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.14 -0.482 . . . . 64.32 111.132 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.58 -5.92 48.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 73.13 112.452 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.735 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.78 -33.09 21.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.762 0.315 . . . . 71.53 111.125 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.735 HG13 HG23 ' A' ' 15' ' ' THR . 8.6 mt -126.36 150.86 32.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 75.14 111.106 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 p -171.16 163.76 7.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 54.35 110.851 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.654 HD12 ' NZ ' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -129.25 -175.8 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 63.22 111.112 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.414 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.1 t -167.15 135.54 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.44 110.792 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -71.5 117.87 13.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.112 -0.495 . . . . 62.43 110.919 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.403 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.8 mm? -99.75 -73.11 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 71.44 110.93 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -132.31 -170.37 2.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.939 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' O ' HG23 ' A' ' 25' ' ' VAL . 11.4 mtpt -52.67 109.97 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 72.12 110.913 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 58.47 24.26 11.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.842 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 23' ' ' LYS . 92.7 t -123.28 114.94 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 63.04 111.128 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -124.76 160.64 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 73.52 110.875 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 213' ' ' VAL . 69.8 t -122.98 108.69 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.071 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.585 ' HB3' HG23 ' A' ' 18' ' ' ILE . 7.3 p80 -102.3 138.24 39.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 74.42 110.873 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.477 HG23 ' C ' ' A' ' 41' ' ' SER . 41.0 m -138.77 117.5 12.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 63.23 111.135 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -101.39 -172.89 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 43.23 110.919 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.503 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -141.28 130.45 23.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 54.21 110.905 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.747 -0.74 . . . . 62.53 112.479 179.914 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 61.1 t . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.567 0.699 . . . . 63.13 111.07 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.9 Cg_endo -69.72 142.67 48.76 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 72.21 112.322 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.477 ' C ' HG23 ' A' ' 29' ' ' THR . 0.9 OUTLIER -122.63 114.53 20.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 64.23 110.84 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -60.81 169.94 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 72.3 110.863 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.629 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -172.28 -166.68 31.25 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.701 -0.762 . . . . 75.24 112.466 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.014 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -163.2 145.52 10.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 65.21 110.832 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 HD13 ' A' ' 54' ' ' LEU . 36.8 t -129.67 134.13 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 64.41 111.136 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.7 mt -102.71 126.72 49.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 72.4 110.901 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -97.32 59.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 63.34 110.878 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.1 p -68.04 171.6 6.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 74.33 111.091 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -97.13 30.2 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 72.21 110.875 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -156.54 35.52 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 74.33 110.935 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.74 126.03 5.54 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.787 -0.721 . . . . 50.44 112.506 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.735 HD21 ' HB3' ' A' ' 75' ' ' PHE . 30.9 mt -56.81 172.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 62.51 110.956 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 81' ' ' ASP . 98.0 t -150.08 143.42 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.233 -0.439 . . . . 63.44 111.094 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.563 HD13 HG22 ' A' ' 45' ' ' VAL . 3.3 mm? -114.9 128.37 56.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.43 . . . . 65.31 110.944 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.0 t -77.67 -3.77 5.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.446 . . . . 74.31 111.181 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.44 134.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.861 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -167.02 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 70.14 110.873 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.4 m -97.33 -175.84 3.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 61.42 110.928 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.699 ' HB2' HD13 ' A' ' 63' ' ' LEU . 93.6 m95 -64.45 -38.38 90.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 74.21 110.97 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -142.94 167.16 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 74.11 110.829 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.73 -35.77 80.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 75.24 110.789 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -69.39 -23.47 63.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.1 110.92 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -83.8 -50.78 7.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 73.51 110.945 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -60.33 -29.49 68.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 75.4 111.121 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -55.5 -40.65 72.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 73.21 110.872 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -88.15 3.17 50.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 71.11 110.888 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.562 HD21 ' CE1' ' A' ' 28' ' ' HIS . 12.7 tp -98.45 -41.75 7.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 73.11 110.942 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.2 mt -65.54 -34.44 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 73.12 111.074 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -69.29 -11.13 60.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.11 110.958 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.4 mtp -81.82 -50.85 8.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 64.24 110.87 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.544 ' HB ' HD13 ' A' ' 52' ' ' LEU . 29.1 m -67.42 -37.0 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 74.41 111.16 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -79.11 51.85 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 63.44 110.956 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -137.16 -42.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 71.01 110.901 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.654 ' NZ ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -106.15 -19.71 13.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.919 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.735 ' HB3' HD21 ' A' ' 52' ' ' LEU . 24.7 m-85 -91.83 6.2 47.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.04 110.893 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.501 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.19 48.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.849 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -150.87 -178.14 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.942 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.581 ' HD2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -130.53 138.91 50.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 72.42 110.859 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 52' ' ' LEU . 96.1 t -70.54 132.89 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 53.25 111.103 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.581 HG23 ' HD2' ' A' ' 78' ' ' ARG . 37.4 p -139.95 15.06 2.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 73.4 111.158 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.562 ' HB2' HG13 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -148.65 131.14 15.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 63.01 110.827 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 98' ' ' LEU . 20.5 t -134.04 99.34 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 65.14 111.077 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.4 mt -74.24 120.5 23.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 74.41 111.171 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 91' ' ' ARG . 45.1 mm -108.12 128.5 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.22 111.116 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.0 p -85.47 -58.01 2.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 71.14 111.127 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.582 ' HA ' HG23 ' A' ' 111' ' ' THR . 31.7 p-80 -128.97 -175.22 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.842 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -103.16 100.63 10.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 73.54 111.137 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.673 ' O ' HD13 ' A' ' 92' ' ' ILE . 3.6 m170 -154.4 160.96 41.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.02 110.908 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.84 -28.76 62.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 71.1 111.042 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.0 13.19 17.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 74.22 110.866 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.472 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.5 mpt_? -125.29 -50.78 1.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 70.2 110.877 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.673 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -119.54 15.44 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 72.24 111.133 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.88 -36.95 34.56 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.639 -0.791 . . . . 73.25 112.561 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.97 18.13 50.54 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.785 -0.721 . . . . 63.43 112.502 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.575 HG21 ' H ' ' A' ' 121' ' ' GLU . 5.0 tt -45.92 -31.13 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 73.52 111.127 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -55.09 18.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 73.34 110.948 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -57.54 -40.98 80.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 62.32 111.143 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.482 HD13 HG21 ' A' ' 82' ' ' VAL . 30.5 mt -58.31 -30.05 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 72.31 110.959 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -100.29 23.86 9.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 70.51 110.925 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -114.83 -30.39 6.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 70.23 110.87 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.0 mtp85 -100.26 -21.99 15.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 71.51 110.892 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.69 13.69 5.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 63.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.8 mt -81.85 155.8 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.94 0.4 . . . . 53.54 111.112 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.637 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -120.16 124.01 44.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 74.34 110.919 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.52 82.55 6.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 72.52 111.126 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.546 ' HA ' HD12 ' A' ' 124' ' ' LEU . 87.9 m-70 -51.73 143.45 12.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 75.13 110.849 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.73 151.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 73.14 110.832 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.646 HG22 ' HB3' ' A' ' 127' ' ' LEU . 60.9 p -74.87 175.02 8.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 75.22 111.148 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.26 83.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 51.43 111.03 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -65.93 -45.89 80.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 63.22 110.95 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.582 HG23 ' HA ' ' A' ' 86' ' ' HIS . 2.5 m -53.3 -40.68 64.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 44.04 111.179 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.561 ' HB1' ' OE2' ' A' ' 122' ' ' GLU . . . -73.41 -20.99 60.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 55.41 111.035 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -40.45 92.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.861 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.608 HD12 ' OD2' ' A' ' 152' ' ' ASP . 10.8 mt -87.97 -25.2 23.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 53.43 110.969 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.22 -65.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 63.11 111.118 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -23.83 63.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 61.4 110.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -23.03 67.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 73.54 110.89 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -95.67 -38.49 10.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 51.4 110.955 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.15 -5.64 3.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 75.14 112.543 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -59.5 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 70.22 110.91 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.575 ' H ' HG21 ' A' ' 95' ' ' ILE . 7.7 mm-40 -96.36 -2.88 44.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 71.35 110.908 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.561 ' OE2' ' HB1' ' A' ' 112' ' ' ALA . 1.6 mt-10 66.21 130.7 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.718 . . . . 71.32 110.884 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.71 2.273 . . . . 72.14 112.348 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' A' ' 104' ' ' LYS . 69.3 mt -53.51 -34.31 57.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.896 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.08 39.07 49.0 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 42.24 112.466 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -136.34 58.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 73.02 110.876 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.646 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -137.71 -169.86 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 53.54 110.894 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.36 -168.69 3.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.896 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.817 HG23 ' HB3' ' A' ' 144' ' ' TYR . 86.9 m -50.23 -65.32 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 70.31 111.05 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 143' ' ' PHE . 58.8 t -120.77 112.14 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 71.12 111.181 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.641 HG22 HD23 ' A' ' 133' ' ' LEU . 82.1 m -113.41 111.73 22.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 55.13 111.167 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -73.34 99.52 2.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 73.01 110.85 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.641 HD23 HG22 ' A' ' 131' ' ' THR . 2.9 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 62.22 110.885 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.1 tpt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.877 0.37 . . . . 72.51 110.862 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -134.49 117.39 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.9 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.695 HG13 HD23 ' A' ' 158' ' ' LEU . 10.9 t -130.5 156.13 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 75.11 111.108 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -153.21 123.78 7.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 61.23 110.852 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.691 ' O ' HG13 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -74.98 -178.03 3.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 74.41 111.151 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.754 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.4 t80 -175.45 137.49 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.24 110.819 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.817 ' HB3' HG23 ' A' ' 129' ' ' THR . 28.1 t80 -120.63 95.89 48.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.725 0.774 . . . . 74.42 110.884 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.2 Cg_endo -69.86 -48.74 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.653 2.235 . . . . 74.55 112.306 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.78 -155.94 24.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.771 -0.728 . . . . 53.22 112.512 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.0 124.68 39.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.741 0.305 . . . . 73.25 110.902 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.486 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.46 -94.51 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 71.42 112.453 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -69.83 -28.58 65.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 74.34 110.879 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.24 158.18 43.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 50.42 111.165 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -61.33 -25.42 67.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 70.32 110.949 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.673 ' HB3' HD12 ' A' ' 110' ' ' LEU . 1.3 p30 -121.42 49.57 1.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 74.12 110.901 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.0 OUTLIER -98.59 138.12 36.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 72.42 110.923 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.668 HD12 HG22 ' A' ' 142' ' ' THR . 7.4 pt -138.41 171.01 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 64.21 111.142 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.423 ' CG1' HD22 ' A' ' 169' ' ' LEU . 10.6 m -121.24 144.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 74.13 111.131 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.79 142.65 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 62.12 111.162 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -129.05 148.84 51.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 73.14 110.917 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.695 HD23 HG13 ' A' ' 140' ' ' VAL . 24.3 mt -125.65 94.74 41.83 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.618 0.723 . . . . 75.21 110.899 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 71.92 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.702 2.268 . . . . 63.32 112.347 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.59 -34.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 74.43 110.886 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.489 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.6 m-85 -117.7 -12.8 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 63.04 110.957 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.0 m120 69.18 25.29 5.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 45.11 110.898 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.518 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.6 mp -97.31 117.66 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.102 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.42 137.65 40.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 75.03 110.875 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 44' ' ' LEU . 20.7 t -121.35 63.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 63.35 111.103 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.93 -57.06 13.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 71.22 112.467 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.56 -135.57 12.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 72.3 112.485 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 34.7 m -61.49 -25.11 67.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 52.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.484 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.6 OUTLIER -63.3 -51.85 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 74.13 110.941 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 206' ' ' VAL . 39.8 t -89.91 103.55 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 72.4 111.15 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.517 ' H ' HG23 ' A' ' 222' ' ' THR . 1.1 tppt? -74.47 151.41 39.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 72.33 110.908 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.649 ' HA ' HD22 ' A' ' 218' ' ' LEU . 5.1 p -74.72 169.51 17.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.009 0.433 . . . . 50.41 110.804 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.507 HG23 HD23 ' A' ' 218' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.097 -0.501 . . . . 70.23 111.116 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.7 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.87 0.367 . . . . 74.32 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.38 -42.19 73.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 71.34 111.107 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -116.23 37.07 3.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 52.11 110.875 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.31 164.39 23.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 33.34 111.052 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -116.44 92.75 3.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 63.23 110.901 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.474 HG13 HD23 ' A' ' 226' ' ' LEU . 46.1 t -69.57 -22.62 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.32 111.091 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -80.65 -26.57 37.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 73.05 110.882 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -97.84 -22.76 16.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 75.51 110.964 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.5 -57.51 8.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 70.41 110.884 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.84 -35.93 46.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 62.02 110.801 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 94.0 m -72.74 -32.35 65.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 71.42 111.177 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.8 m -69.14 -52.67 25.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 63.23 110.88 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.681 HG22 HD23 ' A' ' 197' ' ' LEU . 34.0 mm -54.32 -41.8 54.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 75.22 111.086 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.71 -19.72 59.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.886 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -93.19 -23.87 18.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 65.33 110.919 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.432 HG12 HD21 ' A' ' 219' ' ' LEU . 33.3 t -85.65 -26.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.501 . . . . 73.04 111.159 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.681 HD23 HG22 ' A' ' 193' ' ' ILE . 4.6 pp -89.29 -25.29 21.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 65.3 110.912 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.477 ' N ' HD12 ' A' ' 197' ' ' LEU . 4.7 ptmm? -81.54 -31.37 32.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 70.43 110.922 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -72.67 -28.68 62.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 41.32 110.89 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -141.77 117.18 10.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 72.22 110.984 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -119.5 26.0 9.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 64.32 110.93 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.54 22.58 3.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 60.44 110.893 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.6 146.88 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 71.11 111.121 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -107.23 -25.7 11.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 72.15 110.871 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.482 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -164.07 133.39 3.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 43.55 111.163 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.747 ' CG1' HD12 ' A' ' 218' ' ' LEU . 97.9 t -114.16 124.0 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 50.43 111.133 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.014 HG21 HD11 ' A' ' 44' ' ' LEU . 52.1 t -107.35 104.87 54.18 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.629 0.728 . . . . 75.4 111.125 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.77 178.43 4.59 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.651 2.234 . . . . 50.31 112.307 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.05 -29.38 34.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 65.24 112.512 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -143.14 113.38 7.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 71.43 110.821 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 140.25 -112.61 0.82 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 75.55 112.478 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -155.05 166.55 33.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 74.1 110.888 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.763 HG22 HG22 ' A' ' 207' ' ' VAL . 21.8 t -72.41 150.03 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 51.15 111.168 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.35 -108.34 0.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.832 -0.699 . . . . 73.53 112.541 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -157.98 -173.33 4.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.931 0.396 . . . . 62.22 110.866 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -56.28 -21.53 24.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 72.32 110.869 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.749 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -55.41 -31.76 57.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 74.11 112.478 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.747 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.4 mt -50.91 -46.93 60.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.338 . . . . 75.44 110.869 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.446 ' O ' HG21 ' A' ' 193' ' ' ILE . 6.0 mp -55.06 -43.54 73.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 71.45 110.886 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.749 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -66.65 -41.55 88.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 64.21 110.875 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.696 ' NE2' HD21 ' A' ' 225' ' ' LEU . 85.1 t60 -61.46 -37.65 84.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 72.23 110.882 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.2 OUTLIER -51.76 -45.09 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 73.43 111.13 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.829 ' HA ' HD12 ' A' ' 226' ' ' LEU . 49.8 mt -58.16 -39.8 79.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.428 . . . . 74.2 110.872 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.47 -37.58 78.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.44 110.906 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.696 HD21 ' NE2' ' A' ' 221' ' ' HIS . 11.2 mt -68.67 -26.04 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 72.14 110.879 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.1 mt -86.68 -41.66 14.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 63.41 110.917 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 65.05 110.878 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 18' ' ' ILE . 92.8 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.773 0.32 . . . . 53.12 111.153 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.688 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.7 mm -93.26 154.3 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 74.33 111.127 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -149.12 164.02 35.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 65.31 110.938 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -94.7 -169.32 2.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.913 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -23.08 55.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.23 110.902 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.5 p -103.54 -35.99 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 65.21 111.137 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.07 -4.28 45.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 54.41 112.478 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.768 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.7 -33.36 22.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.687 0.28 . . . . 74.2 111.184 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.768 HG13 HG23 ' A' ' 15' ' ' THR . 6.7 mt -127.83 159.46 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 72.22 111.126 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -175.82 167.18 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 65.53 110.807 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.551 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -130.25 -175.78 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 71.53 111.198 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.405 ' H ' HG22 ' A' ' 18' ' ' ILE . 1.9 t -168.98 129.73 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 75.44 110.797 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.51 120.48 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 64.14 110.895 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.7 mm? -103.53 -47.24 4.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.967 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -148.51 54.57 1.01 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 62.43 110.93 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.43 -77.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 62.4 110.852 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -83.63 -19.46 35.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 62.25 110.893 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.57 118.86 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 55.44 111.1 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -125.25 158.91 32.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.158 -0.473 . . . . 64.25 110.894 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.404 HG23 ' HG ' ' A' ' 21' ' ' LEU . 73.0 t -121.86 109.52 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 72.12 111.113 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.551 ' HB3' HG23 ' A' ' 18' ' ' ILE . 7.2 p80 -103.23 138.51 39.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.805 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.7 m -135.39 133.55 38.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 61.33 111.171 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.562 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -124.39 174.61 7.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 73.53 110.881 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 40' ' ' PRO . 4.7 tp -121.0 148.24 44.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 75.14 110.852 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 74.4 112.493 179.933 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.567 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.2 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.681 0.753 . . . . 63.24 111.05 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.535 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.5 Cg_endo -69.71 143.03 49.76 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.625 2.217 . . . . 72.44 112.352 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.0 t -129.96 95.23 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 52.32 110.825 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.96 162.47 0.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 70.42 110.846 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.646 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -164.09 -162.85 15.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 64.41 112.459 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -162.43 148.23 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 74.22 110.859 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 54' ' ' LEU . 62.0 t -131.43 138.1 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 75.52 111.043 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.483 HD22 ' HE3' ' A' ' 138' ' ' MET . 24.8 mt -105.39 136.89 44.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.48 . . . . 70.05 110.903 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -110.24 72.12 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 63.13 110.863 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 138' ' ' MET . 20.7 p -79.47 -173.22 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 62.12 111.162 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 t -107.61 28.05 8.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 74.41 110.87 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -154.32 25.01 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 70.51 110.916 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.45 137.35 5.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 73.13 112.494 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.8 HD13 ' HB ' ' A' ' 71' ' ' VAL . 9.2 mt -68.65 164.36 21.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 72.34 110.9 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' ' 81' ' ' ASP . 84.4 t -140.0 144.51 27.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 64.44 111.088 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.639 HD13 HG22 ' A' ' 45' ' ' VAL . 3.3 mm? -115.28 130.35 56.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.915 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.514 HG13 HG21 ' A' ' 156' ' ' VAL . 12.7 t -79.57 -1.72 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 71.14 111.179 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.5 130.58 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 75.13 110.895 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.426 ' OG ' HD11 ' A' ' 98' ' ' LEU . 7.7 m -67.19 -168.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.836 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.47 -172.31 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 74.11 110.848 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.567 ' CZ2' HG13 ' A' ' 39' ' ' VAL . 86.5 m95 -72.9 -44.92 60.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.495 . . . . 73.32 110.888 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -132.68 151.12 52.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.913 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -54.55 -30.81 55.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.448 . . . . 73.13 110.853 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -76.75 -26.84 55.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.862 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 -46.23 17.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 74.44 110.933 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 t -56.12 -25.38 45.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 63.52 111.111 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -55.28 -43.63 74.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.894 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -81.54 -4.5 56.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 65.5 110.877 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.562 HD22 ' OE2' ' A' ' 30' ' ' GLU . 16.4 tp -93.84 -45.62 7.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.219 -0.446 . . . . 70.01 110.927 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.0 mt -69.91 -33.42 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 62.32 111.096 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -67.61 -12.64 60.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 70.32 110.956 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.9 mmm -84.74 -59.47 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 54.03 110.944 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.8 ' HB ' HD13 ' A' ' 52' ' ' LEU . 28.0 m -55.04 -36.26 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 71.23 111.2 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HG3' HG23 ' A' ' 71' ' ' VAL . 55.6 mt-10 -88.13 48.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 74.11 110.869 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -142.92 -41.87 0.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 70.45 110.939 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.688 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -102.58 -24.54 13.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 63.34 110.878 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.657 ' HB3' HD21 ' A' ' 52' ' ' LEU . 37.4 m-85 -90.34 11.32 21.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 65.4 110.873 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.506 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.69 47.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 62.35 110.874 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -150.85 -178.43 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.881 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 149.16 50.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 75.23 110.87 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 52' ' ' LEU . 60.2 t -86.26 127.21 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 75.21 111.156 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 p -139.03 24.41 2.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 71.25 111.205 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.803 ' HB2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -153.74 133.51 13.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.889 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 82' ' ' VAL . 13.5 t -139.88 102.39 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 73.31 111.137 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.1 mt -79.11 115.68 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 62.4 111.134 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.483 HG23 ' HB3' ' A' ' 91' ' ' ARG . 46.4 mm -104.35 122.3 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 70.24 111.094 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.1 p -79.16 -58.25 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 74.13 111.148 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -127.36 -175.09 3.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 70.24 110.865 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -103.82 99.39 9.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 54.04 111.111 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.632 ' O ' HD13 ' A' ' 92' ' ' ILE . 4.5 m170 -152.88 159.66 43.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.834 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.69 -22.96 58.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 74.25 111.155 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.86 3.59 54.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 72.24 110.881 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HB3' HG23 ' A' ' 84' ' ' ILE . 25.5 mmt-85 -118.1 -52.17 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 71.54 110.867 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.632 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.78 19.31 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 72.2 111.133 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.84 -29.29 26.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 52.44 112.484 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.36 22.05 20.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 74.11 112.483 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 tt -45.38 -32.05 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 64.44 111.129 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -54.89 18.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 64.22 110.906 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 m -56.05 -40.02 72.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 63.0 111.207 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 103' ' ' ILE . 31.5 mt -59.22 -35.52 73.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 75.03 110.921 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.95 19.38 9.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 70.34 110.939 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.13 -25.95 6.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 52.54 110.92 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -106.48 7.52 30.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 73.23 110.801 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.99 14.69 66.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 61.42 112.49 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 98' ' ' LEU . 16.0 mt -80.79 154.19 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.877 0.37 . . . . 74.54 111.147 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.762 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.6 ptmt -117.41 119.56 35.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 71.21 110.863 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.05 81.3 6.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 54.31 111.052 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.606 ' HA ' HD12 ' A' ' 124' ' ' LEU . 93.8 m-70 -54.55 147.54 14.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 63.43 110.825 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.73 157.99 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 51.13 110.834 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 127' ' ' LEU . 20.3 p -82.35 157.68 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.42 111.146 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.34 -39.42 56.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.14 111.091 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -66.07 -40.98 91.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 65.31 110.926 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 96.8 m -56.29 -41.68 76.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.21 111.175 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.469 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -73.44 -22.58 60.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.4 111.064 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.66 -41.22 81.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 71.13 110.943 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.591 HD12 ' OD2' ' A' ' 152' ' ' ASP . 7.7 mt -84.05 -27.71 28.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 64.32 110.956 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.43 -69.49 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 40.22 111.144 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -55.19 -26.3 38.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 71.22 110.912 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -24.5 67.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 74.15 110.873 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -93.56 -39.08 11.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 64.22 110.91 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 137.24 -6.7 3.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 73.2 112.494 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -59.75 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.931 0.396 . . . . 64.32 110.906 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -97.55 -1.76 43.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.041 -0.527 . . . . 75.33 110.925 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.469 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.3 mt-10 66.38 129.93 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.601 0.715 . . . . 54.53 110.938 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.42 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.708 2.272 . . . . 70.35 112.338 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.762 HD11 ' HB2' ' A' ' 104' ' ' LYS . 91.4 mt -51.96 -46.53 64.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.888 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.86 57.75 14.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.798 -0.715 . . . . 51.34 112.509 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -152.09 51.07 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 72.35 110.869 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.655 ' HB3' HG22 ' A' ' 108' ' ' THR . 1.3 mp -129.91 -177.47 4.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.88 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.58 -168.38 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.22 110.906 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.755 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.0 m -49.73 -45.21 49.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.14 111.119 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 143' ' ' PHE . 3.6 m -141.31 142.6 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 73.44 111.157 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 HD23 ' A' ' 133' ' ' LEU . 63.6 m -149.56 110.89 4.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 72.43 111.139 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.02 98.93 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.834 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.637 HD23 HG22 ' A' ' 131' ' ' THR . 2.8 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 72.45 110.887 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.782 ' HB2' HG22 ' A' ' 48' ' ' THR . 3.1 tpp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.775 0.321 . . . . 52.34 110.899 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.66 119.42 27.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 54.01 110.864 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.567 HG13 HD23 ' A' ' 158' ' ' LEU . 3.9 t -136.44 159.89 37.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 71.02 111.115 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 31.7 tt0 -163.12 123.67 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 74.34 110.915 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.0 178.3 4.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 74.44 111.156 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.428 ' HA ' HG12 ' A' ' 130' ' ' VAL . 75.2 t80 -172.72 135.03 0.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 72.24 110.836 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.755 ' HB3' HG23 ' A' ' 129' ' ' THR . 68.4 t80 -117.21 92.13 38.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.763 0.792 . . . . 70.11 110.964 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.6 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.642 2.228 . . . . 51.4 112.345 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.02 -170.46 43.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.806 -0.712 . . . . 72.14 112.537 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -83.78 125.14 31.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 61.11 110.924 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.48 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.73 -87.23 0.23 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 71.12 112.468 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -77.89 -28.57 49.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 72.21 110.761 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.16 159.39 43.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.2 111.136 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.05 -23.66 67.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.828 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.604 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -125.29 52.89 1.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 71.31 110.921 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.7 p30 -100.35 148.3 24.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.851 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.7 pt -147.04 162.5 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 63.35 111.128 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.502 HG11 HG21 ' A' ' 196' ' ' VAL . 8.0 m -109.73 139.01 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.13 111.202 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.514 HG21 HG13 ' A' ' 55' ' ' VAL . 74.5 t -93.35 129.18 44.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 65.12 111.07 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.437 ' O ' HD23 ' A' ' 158' ' ' LEU . 74.2 t-105 -117.06 150.6 38.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 71.24 110.946 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 163' ' ' ILE . 26.3 mt -127.05 97.64 31.84 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.619 0.723 . . . . 73.32 110.992 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 70.86 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.684 2.256 . . . . 74.45 112.339 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 179.35 -34.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 70.23 110.884 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.619 ' CB ' HD13 ' A' ' 163' ' ' ILE . 7.0 m-85 -118.34 -11.64 10.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 64.25 110.886 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.0 m120 67.34 21.97 9.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 74.11 110.892 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.619 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.5 mp -86.15 115.26 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 64.44 111.155 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.6 tm? -98.98 123.14 43.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 71.42 110.912 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.629 HG21 HD22 ' A' ' 44' ' ' LEU . 18.3 t -117.58 73.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 63.25 111.086 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.402 ' H ' HD13 ' A' ' 164' ' ' LEU . . . -64.06 -45.63 93.36 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.732 . . . . 52.41 112.521 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.42 -131.21 10.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 52.41 112.557 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.9 m -63.33 -22.45 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.818 0.342 . . . . 71.31 110.857 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.451 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.9 OUTLIER -64.9 -50.01 68.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.919 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.764 HG11 HG11 ' A' ' 206' ' ' VAL . 21.3 t -93.02 112.92 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 70.14 111.148 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.421 ' H ' HG23 ' A' ' 222' ' ' THR . 3.5 tppt? -83.0 154.45 24.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 62.12 110.882 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.617 ' HA ' HD22 ' A' ' 218' ' ' LEU . 15.8 p -78.13 162.11 26.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 74.01 110.889 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.591 HG23 HD23 ' A' ' 218' ' ' LEU . 1.5 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 72.3 111.198 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.557 HG11 ' CG2' ' A' ' 186' ' ' VAL . 11.1 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.785 0.326 . . . . 60.23 111.155 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.73 83.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 32.32 111.092 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -119.2 34.83 5.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.01 110.858 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -125.13 164.85 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.11 111.106 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -117.61 92.17 3.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.93 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.557 ' CG2' HG11 ' A' ' 181' ' ' VAL . 87.7 t -69.64 -23.88 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 73.25 111.108 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.28 -26.48 42.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.79 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.69 -24.07 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 72.51 110.879 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.55 -54.49 26.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 71.22 110.928 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -34.55 44.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 65.52 110.813 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 61.4 m -74.29 -35.71 63.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 62.13 111.15 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 196' ' ' VAL . 45.6 m -66.07 -55.55 16.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 54.35 110.905 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.792 HG22 HD23 ' A' ' 197' ' ' LEU . 34.3 mm -54.21 -46.99 68.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 64.35 111.122 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.38 -22.31 53.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.948 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -91.29 -25.03 19.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 42.32 110.917 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.502 HG21 HG11 ' A' ' 155' ' ' VAL . 91.8 t -84.05 -24.27 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 75.1 111.12 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.792 HD23 HG22 ' A' ' 193' ' ' ILE . 3.9 pp -95.85 -8.13 34.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 53.25 110.979 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.625 ' HG2' HD12 ' A' ' 197' ' ' LEU . 2.7 mmmt -113.15 -5.87 13.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 62.25 110.873 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -88.5 -23.83 23.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 72.14 110.838 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -118.41 -60.87 1.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.948 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.75 25.75 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 75.24 110.855 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.95 21.75 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.858 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.528 HG21 ' CG2' ' A' ' 206' ' ' VAL . 4.0 mp -55.33 145.0 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 63.34 111.134 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -106.86 -31.36 8.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.33 110.922 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.506 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -160.07 117.46 2.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 70.4 111.155 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.764 HG11 HG11 ' A' ' 170' ' ' VAL . 97.9 t -95.86 125.62 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 51.21 111.15 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 44' ' ' LEU . 58.4 t -107.46 109.07 62.47 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.581 0.705 . . . . 64.11 111.159 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -169.95 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.658 2.239 . . . . 73.11 112.35 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -106.49 -24.53 6.72 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.753 -0.736 . . . . 73.23 112.479 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -146.07 84.0 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 73.53 110.813 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 168.13 -102.0 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.759 . . . . 71.24 112.513 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.34 147.33 4.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.867 0.365 . . . . 72.01 110.876 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.62 143.89 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.132 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.56 -102.96 0.46 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 24.13 112.509 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -161.41 -169.83 2.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.801 0.334 . . . . 75.5 110.874 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -56.49 -21.77 28.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.865 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.753 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.82 -33.57 56.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.78 -0.724 . . . . 73.51 112.523 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.755 HD12 HG12 ' A' ' 206' ' ' VAL . 31.3 mt -50.86 -49.37 59.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 54.24 110.923 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.537 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -53.64 -42.25 67.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 71.22 110.89 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.753 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.7 mt -67.6 -41.39 84.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 52.31 110.93 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.4 -35.59 79.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.856 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -58.36 -45.17 88.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 75.45 111.191 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.713 ' HA ' HD12 ' A' ' 226' ' ' LEU . 82.4 mt -56.8 -37.86 71.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.963 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -42.81 97.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 72.55 110.946 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.25 -35.19 78.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 51.33 110.933 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.8 mt -78.57 -29.49 46.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 63.44 110.862 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.4 mttp . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 71.43 110.834 179.925 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.3 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.863 0.364 . . . . 72.24 110.838 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -172.63 162.65 5.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 71.04 110.933 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.6 mptt 55.96 84.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 63.21 110.909 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -145.17 147.85 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.34 111.216 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -106.1 57.91 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 72.33 110.878 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -121.25 150.69 40.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 72.21 110.962 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -147.89 -179.81 7.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 64.45 111.162 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 18' ' ' ILE . 91.5 t 61.08 97.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 72.4 111.137 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.73 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.1 mm -89.85 153.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 74.45 111.112 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -145.7 153.09 40.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 74.11 110.934 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -92.2 165.51 13.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.292 -0.413 . . . . 75.25 110.882 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.96 -35.13 45.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 60.45 110.844 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -88.06 -31.61 19.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.52 111.131 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.02 -12.9 67.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 73.11 112.523 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.727 HG23 HG13 ' A' ' 16' ' ' ILE . 2.2 t -51.05 -32.26 21.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 72.14 111.156 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.727 HG13 HG23 ' A' ' 15' ' ' THR . 16.5 mt -121.72 147.73 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 60.24 111.125 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -167.57 169.34 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 53.21 110.856 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.531 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -134.52 -176.04 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 64.33 111.117 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.3 t -166.97 133.79 2.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 65.43 110.859 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -70.17 118.12 12.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 75.41 110.875 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HG ' HG23 ' A' ' 27' ' ' VAL . 2.7 mm? -102.92 -42.36 5.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.924 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.62 -169.95 3.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 71.44 110.859 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -47.61 63.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 73.3 110.919 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -134.59 28.69 3.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.905 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.43 120.57 60.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.089 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.46 ' CH2' HG22 ' A' ' 7' ' ' THR . 16.0 m95 -125.66 159.28 32.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.938 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 213' ' ' VAL . 73.5 t -121.74 108.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 65.21 111.122 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.531 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.0 p80 -101.17 138.26 38.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.33 110.832 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.1 m -137.01 124.39 21.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 60.12 111.156 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.589 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -110.68 177.46 4.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 51.4 110.888 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.775 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.3 OUTLIER -132.78 135.76 45.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 74.21 110.929 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -138.53 127.49 3.8 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 70.32 112.499 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.22 146.63 6.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.391 . . . . 62.55 110.834 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -172.19 122.41 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 73.41 110.889 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 62.07 35.01 16.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 62.14 110.855 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.33 29.32 74.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.754 -0.736 . . . . 62.21 112.49 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -151.14 179.79 7.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 70.03 110.875 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.775 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -104.08 138.99 39.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 74.55 111.059 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.773 HG11 ' HD2' ' A' ' 303' ' ' RTD . 98.1 t -137.01 104.11 8.89 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.646 0.736 . . . . 43.33 111.189 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.7 Cg_endo -69.67 142.7 49.03 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.641 2.227 . . . . 70.33 112.451 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -124.15 105.52 9.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 54.22 110.848 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -59.42 159.48 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 54.25 110.845 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.639 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -160.56 -160.22 10.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.74 . . . . 41.05 112.545 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.953 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -164.91 144.93 7.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 74.3 110.872 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 54' ' ' LEU . 54.1 t -128.62 134.76 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 73.32 111.078 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.49 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 19.2 mt -103.47 136.13 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 63.42 110.952 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -106.34 74.82 1.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.818 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.6 p -83.1 177.84 8.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 73.51 111.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.44 30.51 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 70.43 110.845 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -155.6 24.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 50.22 110.893 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.61 130.81 4.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 65.42 112.457 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.775 HD21 ' HB3' ' A' ' 75' ' ' PHE . 16.7 mt -59.98 166.76 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.845 0.355 . . . . 72.11 110.855 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 81' ' ' ASP . 60.1 t -141.17 144.59 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.11 111.168 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -116.77 128.23 55.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.932 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 55' ' ' VAL . 15.1 t -77.95 -3.04 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 70.11 111.136 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 179.23 132.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 72.53 110.87 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -71.34 -167.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 73.23 110.818 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.56 -173.28 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 71.32 110.825 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.798 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.4 m95 -67.55 -42.01 83.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 75.52 110.891 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.85 161.48 37.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 62.34 110.857 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.99 -38.07 69.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 64.42 110.86 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -71.45 -23.93 61.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 75.42 110.879 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -82.3 -45.1 15.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 71.44 110.93 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.0 t -67.02 -25.37 66.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 53.3 111.149 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -53.09 -39.2 63.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 64.23 110.901 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -85.54 -14.56 45.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 71.32 110.827 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.589 HD22 ' OE2' ' A' ' 30' ' ' GLU . 15.2 tp -77.76 -45.57 24.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.964 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.9 mt -71.73 -33.28 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.12 111.12 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.88 -17.15 62.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 72.51 110.846 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.2 mmm -85.43 -55.55 3.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.825 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.748 ' HB ' HD13 ' A' ' 52' ' ' LEU . 27.3 m -57.22 -37.2 55.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 71.23 111.068 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HG3' HG23 ' A' ' 71' ' ' VAL . 57.3 mt-10 -86.71 49.95 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 62.4 110.851 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tpmp? -145.43 -42.13 0.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.908 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.73 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.82 -23.43 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 73.43 110.843 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.775 ' HB3' HD21 ' A' ' 52' ' ' LEU . 34.6 m-85 -90.04 11.24 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 75.02 110.923 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.51 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.92 46.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 74.41 110.892 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -154.29 -178.59 7.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 62.35 110.863 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.42 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -127.09 149.49 49.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.2 110.825 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 52' ' ' LEU . 68.5 t -84.1 126.63 40.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 71.22 111.099 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.42 HG23 ' HD3' ' A' ' 78' ' ' ARG . 22.5 p -135.8 26.55 3.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 50.01 111.175 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.754 ' HB2' HG22 ' A' ' 53' ' ' VAL . 8.7 m-20 -158.33 135.27 9.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.865 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.643 HG21 ' CD2' ' A' ' 98' ' ' LEU . 20.5 t -140.55 99.87 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 71.41 111.079 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.9 mt -77.21 126.0 37.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 73.54 111.06 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.646 HG23 ' HB3' ' A' ' 91' ' ' ARG . 34.6 mm -112.99 123.27 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 71.22 111.165 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.1 p -81.0 -52.81 7.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 75.44 111.125 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -135.33 167.63 20.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.853 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -86.89 98.7 11.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 70.55 111.145 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.651 ' O ' HD13 ' A' ' 92' ' ' ILE . 1.4 m170 -153.0 160.38 43.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 74.42 110.863 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.31 -28.09 62.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 75.51 111.027 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.09 11.13 21.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.833 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.646 ' HB3' HG23 ' A' ' 84' ' ' ILE . 4.9 mmt180 -123.83 -52.62 1.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 72.11 110.924 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.79 16.92 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 70.55 111.165 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.42 -27.74 26.24 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.729 -0.748 . . . . 72.35 112.47 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.79 19.26 30.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.652 -0.785 . . . . 33.24 112.414 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.439 HG21 ' H ' ' A' ' 121' ' ' GLU . 4.2 tt -48.73 -30.64 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 63.25 111.214 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -68.45 -43.97 75.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 63.24 110.855 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -69.38 -33.48 73.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 64.14 111.163 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.643 ' CD2' HG21 ' A' ' 82' ' ' VAL . 58.8 mt -63.75 -27.3 69.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 72.41 110.973 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.71 19.07 16.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 74.02 110.933 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.75 -23.87 7.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.911 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -110.87 10.02 22.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 72.03 110.865 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.17 18.76 66.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 70.14 112.471 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.0 mt -83.18 157.59 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 70.25 111.105 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.67 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -121.3 119.78 33.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 64.3 110.895 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.527 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . . . -89.05 79.56 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 74.43 111.151 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.581 ' HA ' HD12 ' A' ' 124' ' ' LEU . 96.9 m-70 -54.36 146.98 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 74.21 110.909 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.5 163.86 0.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.923 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 127' ' ' LEU . 81.1 p -80.37 154.9 27.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 61.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.59 -29.88 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 44.13 111.104 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 152' ' ' ASP . 6.6 tp -74.87 -43.25 55.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.935 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.0 m -53.19 -27.44 21.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 63.25 111.17 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.3 -28.02 21.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.056 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -60.12 -25.17 65.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.413 . . . . 75.32 110.887 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.653 HD12 ' OD1' ' A' ' 152' ' ' ASP . 47.6 mt -99.07 -24.67 14.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 65.23 110.88 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.65 -63.14 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.11 111.106 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -55.62 -25.74 40.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 74.33 110.855 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -24.67 65.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 71.14 110.875 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -95.32 -28.33 15.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.1 110.863 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.07 -5.44 7.82 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 71.4 112.442 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -59.6 -173.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 73.15 110.926 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.439 ' H ' HG21 ' A' ' 95' ' ' ILE . 25.4 mm-40 -99.65 1.09 43.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.489 . . . . 53.14 110.911 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 65.69 122.84 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.719 0.771 . . . . 74.25 110.916 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.73 -170.52 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.647 2.231 . . . . 74.12 112.37 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 104' ' ' LYS . 60.1 mt -52.16 -40.49 61.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.44 110.877 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.03 59.59 8.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 62.01 112.547 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -152.75 51.23 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 73.21 110.889 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB3' HG22 ' A' ' 108' ' ' THR . 1.2 mp -130.1 -175.74 3.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 63.42 110.913 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.44 -167.93 2.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 60.1 110.952 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.794 HG23 ' HB3' ' A' ' 144' ' ' TYR . 96.3 m -49.15 -43.41 41.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 73.51 111.176 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 142' ' ' THR . 3.6 m -141.47 141.7 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 74.23 111.093 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 HD23 ' A' ' 133' ' ' LEU . 60.7 m -148.88 112.14 4.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.173 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.34 96.06 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 74.25 110.831 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.642 HD23 HG22 ' A' ' 131' ' ' THR . 3.7 mt -85.17 149.51 25.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 51.31 110.889 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.77 107.09 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.11 110.904 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.55 ' HB2' HG21 ' A' ' 48' ' ' THR . 23.6 m-85 -110.61 111.14 22.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 65.4 110.888 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 55.79 -100.55 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 24.11 112.47 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -120.02 59.55 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 74.31 110.86 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.73 ' HB2' HG22 ' A' ' 48' ' ' THR . 3.0 tpp -147.99 155.01 41.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 63.55 110.88 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 118.45 25.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.55 110.872 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.665 HG13 HD23 ' A' ' 158' ' ' LEU . 4.5 t -134.98 159.18 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 73.41 111.169 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.412 ' N ' HG12 ' A' ' 140' ' ' VAL . 32.3 tt0 -158.98 124.45 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 61.42 110.98 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.41 ' O ' HG12 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -75.16 178.5 5.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 55.4 111.096 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -171.98 136.76 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.842 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.794 ' HB3' HG23 ' A' ' 129' ' ' THR . 33.0 t80 -116.19 92.95 37.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.751 0.786 . . . . 74.34 110.896 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -48.72 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.615 2.21 . . . . 73.13 112.29 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.56 -170.38 42.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 72.11 112.479 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -84.26 123.61 30.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 75.13 110.938 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.492 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.18 -89.72 0.24 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.769 -0.729 . . . . 64.35 112.534 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -74.18 -28.27 61.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.367 . . . . 73.21 110.896 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.96 157.81 43.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 62.15 111.204 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -62.45 -25.14 67.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 43.5 110.891 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.653 ' OD1' HD12 ' A' ' 114' ' ' LEU . 16.0 p30 -123.28 52.06 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.901 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.523 ' OD1' HD13 ' A' ' 169' ' ' LEU . 2.0 p30 -99.94 142.71 31.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.968 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.8 pt -144.28 158.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 75.12 111.173 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 196' ' ' VAL . 18.4 m -105.11 150.5 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.44 111.113 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 96.0 t -102.56 139.05 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 72.05 111.116 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -126.99 150.71 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 74.42 110.904 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.665 HD23 HG13 ' A' ' 140' ' ' VAL . 20.7 mt -128.84 95.72 31.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.594 0.711 . . . . 75.41 110.853 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 72.18 1.51 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.699 2.266 . . . . 61.2 112.307 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 179.47 -34.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 65.14 110.908 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.535 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.6 m-85 -117.95 -13.21 10.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.976 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.8 m120 69.0 26.19 5.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 64.2 110.918 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.549 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.6 mp -96.83 117.61 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 51.41 111.107 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.13 138.04 41.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 71.24 110.946 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.499 HG21 HD22 ' A' ' 44' ' ' LEU . 21.7 t -121.52 68.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.31 111.143 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.37 -51.81 35.33 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.552 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.22 -135.44 12.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 52.43 112.501 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 31.4 m -62.22 -26.09 68.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 73.25 110.889 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.523 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.4 OUTLIER -66.14 -49.5 67.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 54.04 110.907 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 206' ' ' VAL . 57.7 t -92.24 96.18 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 71.34 111.099 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -69.06 153.13 44.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.35 110.955 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.698 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.7 p -74.87 167.06 22.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.857 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.447 HG23 HD23 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -68.85 -42.11 77.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 75.32 111.152 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.41 -29.27 65.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 74.43 110.833 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.36 160.28 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 73.32 111.079 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -117.88 -32.4 4.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.907 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.27 -177.08 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.828 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.538 HD22 ' CE3' ' A' ' 189' ' ' TRP . 0.6 OUTLIER -87.23 -36.93 17.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.948 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.46 -154.29 21.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.672 -0.775 . . . . 64.41 112.5 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -52.08 126.75 19.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 72.11 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 186' ' ' VAL . 17.1 m -123.56 29.96 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 63.01 111.124 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.7 -46.85 83.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 74.44 111.111 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.56 40.99 2.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 55.51 110.792 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -134.02 165.64 24.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.11 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -116.9 92.25 3.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.889 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.469 ' CG2' HG11 ' A' ' 181' ' ' VAL . 90.3 t -69.59 -23.81 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 52.1 111.19 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -25.81 39.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 74.52 110.904 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -97.75 -23.55 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 70.4 110.937 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.538 ' CE3' HD22 ' A' ' 178' ' ' LEU . 1.2 t90 -51.29 -54.42 26.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.974 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.3 t -51.88 -33.77 38.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 71.34 110.893 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 82.3 m -76.33 -34.01 59.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 42.24 111.182 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.9 m -66.36 -53.22 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 70.25 110.87 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.784 HG22 HD23 ' A' ' 197' ' ' LEU . 34.6 mm -56.3 -43.15 76.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 73.33 111.163 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.76 -19.77 59.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 70.54 110.884 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.63 -31.09 15.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 50.1 110.858 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.503 ' CG1' HD21 ' A' ' 219' ' ' LEU . 94.2 t -75.5 -50.74 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.11 111.101 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.784 HD23 HG22 ' A' ' 193' ' ' ILE . 3.9 pp -65.08 -24.34 67.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 54.3 110.91 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.43 -43.78 15.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.92 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -52.95 -28.97 26.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.41 110.907 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -144.47 119.94 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.91 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.92 41.05 2.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 71.44 110.817 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.4 21.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.35 110.795 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -52.47 146.83 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 73.45 111.147 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.66 -28.87 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 74.43 110.902 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.447 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -159.61 139.28 11.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 74.11 111.069 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 170' ' ' VAL . 84.6 t -123.18 126.04 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 60.34 111.146 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.953 HG21 HD11 ' A' ' 44' ' ' LEU . 55.8 t -107.66 113.12 61.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 70.51 111.077 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -170.27 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.687 2.258 . . . . 73.34 112.33 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.57 -31.25 7.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.67 -0.776 . . . . 74.45 112.489 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -143.5 94.61 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.827 0.346 . . . . 75.03 110.883 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 160.38 -114.94 0.63 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 74.34 112.454 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -150.27 162.77 39.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.957 0.408 . . . . 71.53 110.864 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.793 HG22 HG22 ' A' ' 207' ' ' VAL . 22.0 t -67.95 150.23 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 72.32 111.095 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.45 -108.81 0.56 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.772 -0.728 . . . . 64.23 112.551 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -159.81 -169.83 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 75.44 110.834 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -58.25 -20.19 40.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 73.52 110.899 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -57.67 -32.27 65.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.778 -0.725 . . . . 51.22 112.485 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.698 HD22 ' HA ' ' A' ' 172' ' ' SER . 32.1 mt -51.03 -42.99 60.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.352 . . . . 65.33 110.892 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.503 HD21 ' CG1' ' A' ' 196' ' ' VAL . 1.0 OUTLIER -60.43 -45.25 94.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 54.22 110.829 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.752 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -64.27 -42.24 96.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 52.2 110.922 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.682 ' NE2' HD21 ' A' ' 225' ' ' LEU . 78.7 t60 -63.86 -39.67 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.963 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.5 m -51.75 -42.49 62.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 64.4 111.122 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' A' ' 226' ' ' LEU . 78.6 mt -59.95 -39.91 87.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.92 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -28.03 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.43 110.849 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.682 HD21 ' NE2' ' A' ' 221' ' ' HIS . 20.6 mt -72.27 -25.81 61.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 73.43 110.925 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.6 mt -87.42 -43.06 12.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 74.13 110.921 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 54.43 110.888 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.773 ' HD2' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.8 m . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.866 0.365 . . . . 64.31 110.895 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -124.36 132.94 53.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 60.55 110.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.14 136.95 3.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 74.11 110.912 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.1 p -176.22 145.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 75.34 111.109 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -137.79 66.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 61.02 110.892 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -148.83 155.02 40.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 71.2 110.929 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.586 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -146.56 178.38 8.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 71.4 111.089 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.582 HG22 ' OG ' ' A' ' 19' ' ' SER . 88.4 t 60.54 94.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 55.13 111.071 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.88 155.78 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 71.15 111.156 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -145.58 146.62 31.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.913 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 173.72 9.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 73.35 110.94 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.82 -36.01 77.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 61.21 110.893 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.459 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.3 p -95.17 -24.9 16.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 71.41 111.086 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.94 -11.3 57.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.728 . . . . 41.45 112.425 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.808 HG23 HG13 ' A' ' 16' ' ' ILE . 3.7 t -51.09 -33.28 25.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 54.42 111.119 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.808 HG13 HG23 ' A' ' 15' ' ' THR . 18.8 mt -121.64 148.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.04 111.13 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 p -169.2 165.56 10.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 75.23 110.87 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.577 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -132.15 -172.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 70.12 111.134 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.582 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -173.45 134.64 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 75.14 110.876 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.96 119.93 14.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 54.14 110.872 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.406 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.4 mm? -100.96 -55.02 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.882 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -138.47 53.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 73.41 110.894 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mttt 68.0 -76.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 71.53 110.88 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -84.11 -19.52 34.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 63.3 110.916 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.21 121.28 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 64.34 111.164 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.586 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.0 m95 -125.45 160.23 29.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.947 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.406 HG23 ' HG ' ' A' ' 21' ' ' LEU . 72.8 t -122.4 112.44 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 62.34 111.081 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.577 ' HB3' HG23 ' A' ' 18' ' ' ILE . 8.7 p80 -105.47 137.6 43.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 65.14 110.93 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 m -133.34 127.72 34.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 51.14 111.137 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.646 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -118.11 164.98 14.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.914 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.637 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 5.3 tp -118.84 143.3 47.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.91 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 39' ' ' VAL . . . -158.42 137.01 5.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 72.3 112.508 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.3 137.41 50.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.953 0.406 . . . . 33.45 110.888 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -103.45 -32.55 9.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 72.33 110.914 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -171.31 34.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 51.24 110.916 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.05 6.89 8.83 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.707 -0.759 . . . . 44.45 112.495 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -152.83 127.28 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 70.41 110.937 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.637 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -67.2 133.88 50.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 61.22 111.08 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.66 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.3 p -126.11 126.72 24.77 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.587 0.708 . . . . 63.2 111.172 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.493 ' CA ' HD12 ' A' ' 31' ' ' LEU . 53.8 Cg_endo -69.81 143.43 50.57 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.64 2.227 . . . . 50.21 112.349 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -130.92 95.87 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 74.44 110.857 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -51.94 155.21 1.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 62.21 110.843 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.621 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -155.97 -158.45 8.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.657 -0.782 . . . . 65.44 112.441 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.865 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -166.06 143.91 5.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 74.32 110.942 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.58 HG22 HD13 ' A' ' 54' ' ' LEU . 50.6 t -126.95 142.7 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 63.12 111.152 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.1 mt -111.92 127.5 55.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 53.3 110.908 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -93.33 48.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.871 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.6 p -56.52 166.18 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 60.34 111.127 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.5 t -95.99 34.17 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 72.4 110.843 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -157.65 28.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.43 110.9 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.6 124.1 4.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 75.32 112.516 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.772 HD13 ' HB ' ' A' ' 71' ' ' VAL . 20.1 mt -51.72 161.31 0.54 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.801 0.334 . . . . 74.12 110.88 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.774 HG22 ' HB2' ' A' ' 81' ' ' ASP . 59.8 t -139.74 144.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.114 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.58 HD13 HG22 ' A' ' 45' ' ' VAL . 3.5 mm? -116.63 129.93 56.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.003 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.5 t -80.36 -0.36 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 64.24 111.111 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -179.72 132.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.54 110.845 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 m -71.24 -169.04 0.35 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.216 -0.447 . . . . 75.54 110.851 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.79 -170.75 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 74.2 110.843 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.776 ' HB2' HD13 ' A' ' 63' ' ' LEU . 93.1 m95 -72.86 -40.46 65.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.891 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.77 162.31 35.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 63.21 110.933 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.43 -33.51 67.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 71.23 110.91 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -75.63 -25.46 56.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 71.1 110.958 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -81.75 -41.82 20.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.487 . . . . 72.4 110.939 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -68.03 -26.43 65.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.19 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.1 -43.69 70.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.936 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.05 -13.91 54.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.934 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.646 HD22 ' OE2' ' A' ' 30' ' ' GLU . 17.8 tp -77.35 -45.38 26.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.506 . . . . 75.42 110.926 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.22 -26.72 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 61.02 111.12 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.21 -10.15 59.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 74.34 110.891 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.0 mmm -90.82 -53.0 4.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 52.43 110.834 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.772 ' HB ' HD13 ' A' ' 52' ' ' LEU . 21.5 m -58.4 -39.85 76.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 72.33 111.155 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 71' ' ' VAL . 53.4 mt-10 -84.29 51.09 2.0 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 65.42 110.877 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.14 -41.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 71.13 110.953 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.5 -19.18 13.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 71.22 110.848 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.671 ' HB3' HD21 ' A' ' 52' ' ' LEU . 24.2 m-85 -88.15 9.52 22.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 75.43 110.924 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.96 46.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 71.03 110.862 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -154.32 -179.15 7.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 73.53 110.902 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.21 149.39 51.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 75.43 110.884 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 52' ' ' LEU . 69.9 t -82.22 128.43 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 75.15 111.13 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.5 p -138.94 23.04 2.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 75.4 111.15 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.774 ' HB2' HG22 ' A' ' 53' ' ' VAL . 3.7 m-20 -154.93 132.6 11.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.226 -0.443 . . . . 72.42 110.846 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.637 HG21 HD22 ' A' ' 98' ' ' LEU . 23.4 t -138.6 99.89 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 62.42 111.091 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.0 mt -79.3 124.84 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 73.41 111.129 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 91' ' ' ARG . 38.2 mm -111.51 132.88 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 75.35 111.171 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.5 p -89.05 -55.89 3.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 75.5 111.2 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -133.55 162.37 32.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.32 110.807 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -81.34 97.21 7.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 72.43 111.084 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.635 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.5 OUTLIER -150.91 158.54 44.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 74.53 110.859 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.44 -25.59 59.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.33 111.086 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.37 13.17 18.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 72.32 110.894 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.442 ' O ' HD12 ' A' ' 84' ' ' ILE . 3.3 mpt_? -128.12 -52.36 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 64.02 110.85 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.76 16.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 61.22 111.051 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.85 -27.52 21.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 44.43 112.512 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.11 20.83 23.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.723 . . . . 52.12 112.491 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' H ' ' A' ' 121' ' ' GLU . 4.5 tt -48.48 -30.92 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 63.02 111.166 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -69.16 -43.76 73.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 71.13 110.878 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.5 m -67.84 -34.98 77.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 74.25 111.169 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.637 HD22 HG21 ' A' ' 82' ' ' VAL . 51.4 mt -60.63 -34.73 74.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 74.1 110.874 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.05 22.34 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 74.04 110.954 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -117.42 -20.27 9.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 72.24 110.933 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -115.78 5.9 14.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 74.15 110.872 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.4 60.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 53.51 112.489 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 98' ' ' LEU . 15.4 mt -80.98 155.72 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.909 0.385 . . . . 75.23 111.106 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.785 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -120.48 122.94 41.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 73.51 110.914 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.537 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -90.98 81.61 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 61.42 111.055 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.438 ' ND1' HD12 ' A' ' 124' ' ' LEU . 96.9 m-70 -57.87 146.88 30.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 71.23 110.798 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.21 159.32 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 72.3 110.846 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.0 p -72.81 152.67 41.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 73.41 111.185 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.58 -29.72 18.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.289 -0.414 . . . . 74.04 111.073 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 152' ' ' ASP . 6.7 tp -74.6 -44.49 50.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.859 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 96.7 m -53.17 -27.63 22.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 53.13 111.168 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.422 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -88.66 -26.45 21.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 60.32 111.09 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -61.05 -26.88 67.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.202 -0.454 . . . . 73.33 110.979 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.538 HD13 ' OD2' ' A' ' 152' ' ' ASP . 8.9 mp -96.6 -25.08 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 74.43 110.878 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.3 -64.4 0.88 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 55.3 111.081 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -55.41 -26.04 39.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 75.43 110.884 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -24.37 66.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.11 110.945 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -95.71 -32.2 12.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 73.44 110.87 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.47 -6.64 5.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 72.41 112.475 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -59.53 -173.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 75.42 110.923 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.476 ' H ' HG21 ' A' ' 95' ' ' ILE . 40.2 mm-40 -99.46 -0.64 40.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 72.21 110.892 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.422 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.0 OUTLIER 66.07 125.15 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.606 0.717 . . . . 74.45 110.892 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -170.6 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.69 2.26 . . . . 52.34 112.334 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.785 HD11 ' HB2' ' A' ' 104' ' ' LYS . 61.5 mt -53.66 -35.25 60.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.985 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.35 43.74 65.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 71.33 112.497 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -138.72 57.7 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 71.05 110.814 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.75 -169.74 2.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.926 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.2 -169.15 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 74.43 110.961 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.825 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.2 m -50.97 -70.13 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.145 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.79 HG23 HG22 ' A' ' 129' ' ' THR . 62.4 t -120.45 109.27 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.094 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.1 m -112.72 103.69 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 71.03 111.146 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -66.14 96.18 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 62.02 110.861 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -88.59 159.71 17.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 72.45 110.818 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -156.7 106.51 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.954 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.08 -169.32 1.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 72.5 110.837 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -55.58 99.92 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 65.21 112.543 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 m120 58.22 49.77 10.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 52.23 110.9 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 tpt -151.77 153.13 33.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.862 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -130.42 127.62 39.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 72.44 110.917 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.563 HG13 HD23 ' A' ' 158' ' ' LEU . 5.9 t -139.76 157.5 26.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 75.42 111.084 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.423 ' HG2' HG13 ' A' ' 130' ' ' VAL . 74.6 tt0 -155.35 119.79 4.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 64.33 110.9 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.654 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.86 -178.17 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 75.03 111.169 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.712 ' HA ' HG22 ' A' ' 130' ' ' VAL . 74.0 t80 -175.49 137.93 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.5 110.943 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.825 ' HB3' HG23 ' A' ' 129' ' ' THR . 35.5 t80 -121.89 96.16 47.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.684 0.754 . . . . 74.1 110.923 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.59 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.634 2.223 . . . . 71.41 112.297 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.09 -157.64 28.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 60.34 112.532 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.33 124.84 36.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.351 . . . . 74.21 110.88 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.482 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.17 -98.64 0.51 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.794 -0.717 . . . . 73.31 112.489 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -66.59 -26.95 67.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 71.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.98 161.5 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 63.12 111.167 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -64.37 -26.27 68.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 75.22 110.86 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.538 ' OD2' HD13 ' A' ' 114' ' ' LEU . 11.6 p30 -120.83 50.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.843 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.18 136.99 38.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 64.2 110.879 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.654 HD12 HG22 ' A' ' 142' ' ' THR . 5.8 pt -137.59 172.22 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 72.2 111.138 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.442 ' CG1' HD22 ' A' ' 169' ' ' LEU . 9.4 m -123.11 149.17 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 75.32 111.166 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -103.39 144.28 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 74.34 111.125 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -130.29 145.94 51.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 73.13 110.91 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.563 HD23 HG13 ' A' ' 140' ' ' VAL . 13.4 mt -123.91 96.71 42.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.545 0.688 . . . . 63.23 110.944 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 72.89 1.42 Allowed 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.669 2.246 . . . . 72.35 112.345 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.31 -34.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 72.51 110.823 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.441 ' O ' HD12 ' A' ' 163' ' ' ILE . 7.1 m-85 -117.44 -13.55 10.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 74.31 110.947 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m120 69.07 24.91 6.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 73.54 110.849 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -97.73 116.64 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.12 111.101 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.81 136.51 39.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 75.53 110.919 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.526 HG21 HD22 ' A' ' 44' ' ' LEU . 19.4 t -120.53 62.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 72.44 111.158 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.36 -55.7 18.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.676 -0.774 . . . . 33.34 112.529 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.15 -137.11 14.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 73.22 112.503 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.06 -20.18 56.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 71.33 110.9 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.463 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.7 OUTLIER -65.86 -50.89 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.907 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.723 HG11 HG11 ' A' ' 206' ' ' VAL . 21.8 t -81.59 132.55 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.156 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.418 ' HB2' HG23 ' A' ' 222' ' ' THR . 0.6 OUTLIER -109.21 130.45 55.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 55.04 110.902 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.587 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.7 p -60.08 159.77 9.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 62.31 110.845 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.3 -48.03 83.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 72.4 111.124 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.9 t -53.48 -28.71 32.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 63.31 110.843 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 172' ' ' SER . . . -52.66 158.23 1.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 71.14 111.086 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.28 -30.58 5.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 71.34 110.852 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.78 175.7 12.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.301 -0.409 . . . . 71.34 110.788 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.565 HD11 HD23 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -80.08 -37.02 34.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 55.04 110.89 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 103.45 -167.19 16.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.681 -0.771 . . . . 54.5 112.472 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -51.94 118.62 3.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.916 0.389 . . . . 54.43 110.877 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.57 HG11 ' CG2' ' A' ' 186' ' ' VAL . 16.5 m -112.82 30.26 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 53.14 111.097 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.46 -34.94 67.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 75.32 111.058 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -122.74 35.86 4.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 74.03 110.835 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -132.41 165.84 23.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 54.12 111.139 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -113.76 92.75 4.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 74.3 110.927 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.57 ' CG2' HG11 ' A' ' 181' ' ' VAL . 91.6 t -68.54 -23.12 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 73.44 111.158 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.1 -25.65 36.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 74.51 110.85 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.49 -23.44 16.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 64.12 110.862 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.477 ' CE3' HD22 ' A' ' 178' ' ' LEU . 1.4 t90 -51.54 -52.49 46.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 71.41 110.953 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.7 p -52.0 -36.19 49.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 64.21 110.921 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.4 m -73.8 -36.51 65.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 44.53 111.14 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 74.3 m -63.38 -54.32 38.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.846 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.605 HG22 HD23 ' A' ' 197' ' ' LEU . 30.1 mm -56.35 -37.13 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 72.34 111.15 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.76 -22.59 66.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.827 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.13 -33.39 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 72.11 110.904 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.404 HG21 HG11 ' A' ' 155' ' ' VAL . 92.6 t -74.53 -49.36 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.31 111.135 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.605 HD23 HG22 ' A' ' 193' ' ' ILE . 4.6 pp -64.7 -25.07 67.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 75.33 110.914 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -78.95 -45.55 20.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 61.52 110.947 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -60.09 -33.29 71.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 62.43 110.841 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -136.29 121.7 19.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.42 110.909 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -122.58 27.27 7.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 74.33 110.874 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.93 22.38 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 53.35 110.894 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.82 146.29 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.238 -0.437 . . . . 72.31 111.119 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -106.43 -25.69 11.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 74.32 110.878 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.507 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -163.59 128.6 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 71.34 111.128 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.732 ' CG1' HD12 ' A' ' 218' ' ' LEU . 75.9 t -107.15 118.88 55.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 61.41 111.17 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.865 HG21 HD11 ' A' ' 44' ' ' LEU . 47.1 t -105.8 98.05 16.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.699 . . . . 65.34 111.153 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.6 Cg_endo -69.77 -172.25 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.704 2.269 . . . . 72.51 112.383 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.74 -30.22 8.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.731 . . . . 64.21 112.475 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -142.56 106.23 4.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.872 0.368 . . . . 75.32 110.935 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 151.26 -96.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.81 -0.71 . . . . 70.35 112.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -178.96 153.99 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 62.23 110.838 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.534 HG22 HG22 ' A' ' 207' ' ' VAL . 22.4 t -63.79 147.83 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 72.34 111.114 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -152.38 -107.79 0.35 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.691 -0.766 . . . . 73.33 112.502 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -155.75 -173.57 4.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.926 0.393 . . . . 74.13 110.858 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -55.42 -22.83 21.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 61.31 110.843 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.751 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.03 -31.95 48.83 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 43.44 112.526 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.732 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.5 mt -50.99 -46.93 61.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 71.34 110.964 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.601 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -54.29 -43.3 70.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 75.44 110.92 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.751 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.6 mt -66.33 -41.54 89.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.994 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.489 ' NE2' HD21 ' A' ' 225' ' ' LEU . 78.9 t60 -61.82 -38.1 86.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 72.34 110.911 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -55.76 -46.11 77.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 73.34 111.116 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.789 ' HA ' HD12 ' A' ' 226' ' ' LEU . 2.5 mt -54.22 -39.99 67.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.14 110.917 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -46.13 91.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 52.32 110.85 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.489 HD21 ' NE2' ' A' ' 221' ' ' HIS . 17.5 mt -56.73 -26.39 56.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 72.41 110.889 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 223' ' ' LEU . 4.5 mt -85.53 -45.6 11.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 62.13 110.93 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 64.01 110.896 179.826 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.622 ' HD1' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.816 0.341 . . . . 72.54 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.44 -32.33 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 72.5 110.95 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -162.15 149.87 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.928 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.7 p -175.26 143.02 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 61.4 111.139 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.42 60.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 71.43 110.936 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -142.56 154.07 44.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.53 110.941 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.58 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -145.86 179.92 7.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 60.33 111.132 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.556 HG22 ' OG ' ' A' ' 19' ' ' SER . 94.8 t 60.79 94.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.111 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.752 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.9 mm -89.34 157.54 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 74.11 111.144 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -146.53 179.18 7.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 74.14 110.901 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.05 168.47 9.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 70.11 110.918 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HG3' HG23 ' A' ' 13' ' ' THR . 8.4 pt-20 -53.13 -29.52 31.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.894 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.434 HG23 ' HG3' ' A' ' 12' ' ' GLU . 23.6 p -104.74 -35.5 7.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 74.52 111.111 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.69 -4.58 29.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.798 -0.715 . . . . 70.01 112.501 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.695 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -51.18 -33.78 28.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.825 0.345 . . . . 75.52 111.154 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.695 HG13 HG23 ' A' ' 15' ' ' THR . 11.4 mt -126.3 149.74 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 61.24 111.197 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.8 p -169.11 165.77 11.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 44.25 110.92 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.511 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -132.4 -171.79 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.081 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.556 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -174.49 133.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.881 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.57 120.66 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 72.13 110.93 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.4 mm? -101.61 -54.5 2.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 65.14 110.943 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -136.29 48.41 2.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 73.32 110.875 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt 70.68 -70.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 65.03 110.921 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -87.16 -22.18 25.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 71.51 110.924 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.45 123.78 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.12 111.121 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.58 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.3 m95 -125.43 159.94 30.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.904 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.824 HG21 HG21 ' A' ' 213' ' ' VAL . 75.8 t -120.23 110.1 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 72.23 111.097 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.511 ' HB3' HG23 ' A' ' 18' ' ' ILE . 3.4 p80 -104.59 139.25 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.833 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.3 m -137.07 132.27 33.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 75.15 111.17 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.42 166.75 14.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.844 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.618 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 5.3 tp -117.81 143.59 46.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 62.14 110.891 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 39' ' ' VAL . . . -158.39 137.18 5.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 70.34 112.492 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.78 135.74 48.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.344 . . . . 63.01 110.967 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -102.6 -32.33 9.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 72.5 110.811 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -172.3 38.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 73.15 110.892 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.64 7.13 16.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.729 -0.748 . . . . 71.33 112.529 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -152.77 127.68 9.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 71.32 110.869 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.618 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -68.25 134.14 49.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 54.52 111.121 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.663 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.3 p -126.75 126.82 24.52 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.605 0.717 . . . . 63.15 111.123 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.496 ' CA ' HD12 ' A' ' 31' ' ' LEU . 54.1 Cg_endo -69.75 141.57 45.64 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.724 2.283 . . . . 65.11 112.34 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -129.75 93.96 3.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.04 110.847 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -53.69 164.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 75.01 110.878 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.33 -165.58 23.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 52.04 112.531 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.021 HD13 HG21 ' A' ' 207' ' ' VAL . 4.1 tp -157.32 142.04 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 61.52 110.919 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 54' ' ' LEU . 21.8 t -125.75 132.27 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 71.45 111.144 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.05 131.87 45.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.876 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -100.49 66.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 74.02 110.855 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.418 HG21 ' HB2' ' A' ' 135' ' ' PHE . 18.5 p -72.77 170.92 13.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 74.32 111.103 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.6 t -96.0 27.18 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 70.24 110.853 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -150.76 27.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 54.44 110.92 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.05 127.79 4.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.664 -0.779 . . . . 74.34 112.445 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.763 HD13 ' HB ' ' A' ' 71' ' ' VAL . 19.0 mt -55.51 161.04 2.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 63.11 110.962 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 81' ' ' ASP . 49.6 t -140.13 142.17 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 71.1 111.118 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.705 HD13 HG22 ' A' ' 45' ' ' VAL . 2.9 mm? -115.87 129.58 56.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.946 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 165' ' ' VAL . 14.2 t -80.73 0.36 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 72.5 111.148 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.12 129.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 72.32 110.804 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.53 -168.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.14 110.823 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.4 m -92.98 -174.54 3.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 63.21 110.833 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.697 ' HB2' HD13 ' A' ' 63' ' ' LEU . 95.9 m95 -67.41 -39.48 85.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 70.32 110.873 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.46 166.68 24.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 73.12 110.903 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -62.66 -28.29 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 71.11 110.828 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -75.94 -22.4 56.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 73.04 110.883 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.697 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -86.98 -46.45 9.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 52.45 110.943 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -58.36 -28.88 65.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.24 111.158 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -55.58 -43.29 75.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.44 . . . . 63.42 110.792 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -85.8 0.58 52.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.251 -0.431 . . . . 72.35 110.852 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.3 -47.19 6.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.31 110.907 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.5 mt -69.53 -32.7 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 64.13 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.05 -17.81 58.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.11 110.903 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 42.8 mtp -82.15 -58.73 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 72.21 110.905 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.763 ' HB ' HD13 ' A' ' 52' ' ' LEU . 33.4 m -57.12 -35.8 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 62.34 111.14 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -86.85 49.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 64.2 110.943 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.85 -40.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.888 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.752 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -105.56 -24.02 12.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 62.13 110.872 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.588 ' HB3' HD21 ' A' ' 52' ' ' LEU . 27.9 m-85 -88.89 10.23 21.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.41 . . . . 61.5 110.877 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.509 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.66 46.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.914 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -152.48 -179.23 7.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 75.03 110.906 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.63 143.82 51.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 64.04 110.895 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 52' ' ' LEU . 94.8 t -75.09 130.07 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 74.52 111.12 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.2 p -142.05 31.0 1.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 63.31 111.16 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.763 ' HB2' HG22 ' A' ' 53' ' ' VAL . 15.4 m-20 -164.35 126.67 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 64.42 110.89 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.705 HG23 HG21 ' A' ' 103' ' ' ILE . 17.3 t -133.69 101.85 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 73.05 111.096 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.7 mt -80.18 120.73 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 70.1 111.146 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 91' ' ' ARG . 36.2 mm -108.71 129.81 62.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 71.15 111.103 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.9 p -85.37 -53.73 5.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 72.14 111.124 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -134.71 166.54 22.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 74.33 110.855 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -84.35 96.18 8.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 53.14 111.118 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.617 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -149.33 159.22 44.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.837 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.31 62.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 62.42 111.09 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.84 11.51 20.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 64.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 84' ' ' ILE . 3.5 mpt_? -125.42 -54.67 1.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.882 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.617 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -111.3 16.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 65.31 111.106 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.21 -28.85 27.83 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.684 -0.77 . . . . 75.12 112.495 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.68 19.04 31.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 60.53 112.487 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.489 HD11 ' C ' ' A' ' 122' ' ' GLU . 3.9 tt -48.89 -30.18 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 74.12 111.14 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -72.22 -43.26 64.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 75.43 110.925 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.5 m -64.22 -40.75 96.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 74.52 111.161 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.617 HD12 ' HB2' ' A' ' 105' ' ' ALA . 32.5 mt -60.96 -35.46 76.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 52.51 110.913 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -81.61 -23.26 37.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 74.13 110.884 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -82.34 -35.03 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 75.45 110.947 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.539 ' HB2' HD12 ' A' ' 103' ' ' ILE . 3.1 mtt-85 -87.29 -45.77 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 61.31 110.873 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.12 -14.98 3.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.782 -0.723 . . . . 73.33 112.452 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.705 HG21 HG23 ' A' ' 82' ' ' VAL . 1.9 mp -60.72 150.39 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.918 0.39 . . . . 73.23 111.151 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.751 ' HB2' HD11 ' A' ' 124' ' ' LEU . 3.4 ptpt -111.46 126.65 55.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 75.32 110.932 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.617 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -89.29 83.02 6.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 61.25 111.043 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.435 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.3 m-70 -57.95 143.55 42.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 75.12 110.916 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.68 150.76 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 71.12 110.823 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.8 p -63.88 179.28 0.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 62.12 111.146 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.9 -33.22 63.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 43.23 111.05 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 152' ' ' ASP . 9.9 tp -72.88 -47.04 49.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 42.11 110.951 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.734 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 98.3 m -52.19 -28.9 20.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.54 111.153 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.92 -31.09 25.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.047 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -55.1 -48.38 73.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.892 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.678 HD12 ' OD2' ' A' ' 152' ' ' ASP . 39.9 mt -72.36 -25.0 61.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 71.21 110.901 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.73 -66.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 53.43 111.066 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -54.76 -26.57 35.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.42 110.91 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -23.83 67.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.02 110.89 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -93.74 -38.9 11.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 73.51 110.889 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 138.55 -7.76 3.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 54.22 112.508 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -59.55 -172.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.733 0.301 . . . . 70.15 110.987 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.46 ' H ' HG21 ' A' ' 95' ' ' ILE . 61.6 mm-40 -99.87 0.11 40.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 62.34 110.909 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.489 ' C ' HD11 ' A' ' 95' ' ' ILE . 0.9 OUTLIER 66.31 130.7 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.639 0.733 . . . . 73.22 110.867 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.85 -170.3 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.636 2.224 . . . . 74.44 112.292 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 104' ' ' LYS . 76.9 mt -53.81 -45.28 70.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 64.04 110.884 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.56 52.68 40.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.825 -0.703 . . . . 62.23 112.473 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -148.83 51.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 74.02 110.88 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 127' ' ' LEU . 17.6 mt -133.0 178.79 6.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.304 -0.407 . . . . 64.35 110.931 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -140.61 -168.63 2.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 75.03 110.995 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.844 HG23 ' HB3' ' A' ' 144' ' ' TYR . 92.3 m -50.29 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 73.24 111.146 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.769 HG23 HG22 ' A' ' 129' ' ' THR . 58.6 t -114.58 106.68 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.44 111.128 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.3 m -110.76 104.13 12.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 74.14 111.146 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -66.19 95.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 63.21 110.908 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.486 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -87.72 159.74 18.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 62.51 110.886 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.31 106.87 2.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.465 . . . . 64.13 110.918 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.418 ' HB2' HG21 ' A' ' 48' ' ' THR . 20.6 m-85 -98.46 -169.15 1.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 74.15 110.887 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.39 100.96 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 43.21 112.458 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.0 46.72 21.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 72.41 110.901 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.9 tpp -147.01 154.83 41.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 72.14 110.899 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.86 128.75 39.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 62.45 110.922 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.644 HG13 HD23 ' A' ' 158' ' ' LEU . 5.9 t -141.06 157.39 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 74.23 111.142 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.441 ' HG2' HG13 ' A' ' 130' ' ' VAL . 41.8 tt0 -154.72 120.73 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 53.34 110.883 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.646 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -73.53 -179.1 3.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 71.43 111.184 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.711 ' HA ' HG22 ' A' ' 130' ' ' VAL . 76.8 t80 -175.61 139.89 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 65.21 110.897 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.844 ' HB3' HG23 ' A' ' 129' ' ' THR . 39.3 t80 -122.15 96.28 46.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.71 0.767 . . . . 71.03 110.882 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 -48.9 0.64 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.755 2.303 . . . . 73.33 112.327 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.39 -155.74 24.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 53.34 112.516 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.63 126.02 41.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 71.24 110.896 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.496 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -137.72 -94.0 0.33 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.721 -0.752 . . . . 34.35 112.472 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -71.97 -29.3 64.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.359 . . . . 65.52 110.859 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.31 151.88 34.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.153 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -54.71 -38.44 67.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 60.41 110.849 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.678 ' OD2' HD12 ' A' ' 114' ' ' LEU . 2.5 p30 -109.15 52.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 61.04 110.906 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.543 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.5 p30 -100.73 136.24 40.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.31 110.861 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.646 HD12 HG22 ' A' ' 142' ' ' THR . 4.5 pt -137.2 172.25 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 62.03 111.153 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.3 m -122.46 150.65 26.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.35 111.164 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.9 t -106.66 143.77 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.24 111.192 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -129.98 145.28 51.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 71.14 110.968 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.644 HD23 HG13 ' A' ' 140' ' ' VAL . 12.9 mt -122.91 96.83 44.6 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.643 0.735 . . . . 63.41 110.893 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 72.55 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.746 2.297 . . . . 70.54 112.315 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.54 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 75.42 110.848 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.449 ' O ' HD12 ' A' ' 163' ' ' ILE . 7.2 m-85 -117.05 -13.33 10.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 71.43 110.901 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m120 68.84 24.84 6.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 74.54 110.827 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.49 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.5 mp -98.19 116.62 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 55.22 111.154 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.1 136.92 38.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 73.24 110.904 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.633 ' CG2' HD22 ' A' ' 44' ' ' LEU . 19.5 t -121.47 62.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 71.53 111.089 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.4 -51.75 35.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 64.02 112.49 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.06 -139.23 15.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 53.35 112.535 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 81.4 m -62.94 -16.75 60.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 71.35 110.869 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.543 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.5 OUTLIER -66.25 -52.45 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 33.13 110.916 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.569 HG11 HG11 ' A' ' 206' ' ' VAL . 21.8 t -83.47 119.68 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 74.42 111.085 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.425 ' HB2' HG23 ' A' ' 222' ' ' THR . 0.3 OUTLIER -93.05 127.17 38.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 75.21 110.838 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.696 ' HA ' HD22 ' A' ' 218' ' ' LEU . 3.9 t -62.72 166.66 5.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 70.44 110.831 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.503 HG23 HD23 ' A' ' 218' ' ' LEU . 3.1 p -63.96 -43.48 95.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 52.13 111.149 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.11 -30.78 27.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 70.4 110.846 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.83 163.92 24.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 60.44 111.095 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -154.03 24.23 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 71.22 110.842 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.85 154.01 1.82 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 61.12 110.811 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.47 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 1.8 mt -85.79 -33.89 21.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 65.21 110.902 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.422 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 92.96 -164.85 27.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 72.45 112.513 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.01 105.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 64.45 110.971 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.477 HG11 ' CG2' ' A' ' 186' ' ' VAL . 18.6 m -97.14 26.13 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 74.2 111.1 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.31 75.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.093 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.19 38.96 3.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.791 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -140.92 165.91 26.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.23 111.123 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -113.89 92.73 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.962 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.477 ' CG2' HG11 ' A' ' 181' ' ' VAL . 62.1 t -69.5 -23.05 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.102 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -81.41 -24.6 36.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 61.33 110.908 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -98.63 -23.88 15.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 71.25 110.882 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.47 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.2 t90 -51.49 -54.23 29.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 72.43 110.927 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.5 t -51.91 -32.58 33.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 55.1 110.8 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.7 m -77.44 -34.78 54.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 74.41 111.15 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 m -65.94 -54.33 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.5 110.817 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.659 HG22 HD23 ' A' ' 197' ' ' LEU . 32.8 mm -56.29 -37.52 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 72.32 111.107 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -65.29 -23.52 67.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 63.22 110.91 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -87.16 -31.94 20.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.902 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.421 ' CG1' HD21 ' A' ' 219' ' ' LEU . 95.5 t -74.45 -51.57 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 73.45 111.142 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.659 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -63.59 -24.86 67.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 71.44 110.926 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -47.62 12.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.804 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -51.92 -34.1 40.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 72.13 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -137.76 118.36 13.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 72.01 110.948 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -116.64 32.87 5.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.98 21.28 2.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 74.3 110.882 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.16 146.42 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 72.22 111.135 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -107.24 -30.95 8.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 61.05 110.878 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -160.69 127.43 4.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 53.5 111.122 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.626 ' CG1' HD12 ' A' ' 218' ' ' LEU . 92.0 t -101.35 125.48 55.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 71.13 111.125 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.021 HG21 HD13 ' A' ' 44' ' ' LEU . 40.2 t -108.31 89.76 6.22 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.569 0.699 . . . . 73.24 111.197 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.78 171.76 13.89 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.691 2.26 . . . . 74.33 112.336 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.58 -26.2 47.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 63.42 112.475 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -143.35 119.37 10.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 73.32 110.813 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 135.76 -95.21 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.799 -0.715 . . . . 55.32 112.49 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -179.67 168.83 1.37 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 72.42 110.853 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.824 HG21 HG21 ' A' ' 27' ' ' VAL . 31.5 t -79.14 142.3 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 62.15 111.131 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.74 -107.13 0.4 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.729 . . . . 64.3 112.55 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -154.46 -172.95 4.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 73.44 110.918 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -23.12 14.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 61.41 110.893 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -53.57 -32.57 46.47 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.698 -0.763 . . . . 73.22 112.511 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.696 HD22 ' HA ' ' A' ' 172' ' ' SER . 30.5 mt -50.92 -44.45 60.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.866 0.365 . . . . 74.15 110.895 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.513 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -58.43 -44.75 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 53.14 110.871 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.752 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.6 mt -64.85 -41.97 95.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.44 110.895 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.489 ' NE2' HD21 ' A' ' 225' ' ' LEU . 77.2 t60 -62.37 -39.15 92.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 74.44 110.858 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.425 HG23 ' HB2' ' A' ' 171' ' ' LYS . 3.9 m -54.43 -41.58 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 73.43 111.137 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.806 ' HA ' HD12 ' A' ' 226' ' ' LEU . 95.9 mt -59.13 -41.41 88.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 75.35 110.965 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -32.28 69.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 71.35 110.826 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.489 HD21 ' NE2' ' A' ' 221' ' ' HIS . 16.0 mt -69.94 -25.79 63.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 72.31 110.938 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.806 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.5 mt -87.35 -44.97 10.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 71.54 110.885 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 72.42 110.892 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.643 ' HD1' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.828 0.347 . . . . 51.0 110.834 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.28 172.84 13.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 64.34 110.889 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 105.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 73.03 110.847 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.22 176.18 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 54.23 111.165 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -108.48 80.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 73.1 110.918 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -127.3 149.42 50.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 62.32 110.964 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.466 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -147.88 179.66 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 63.25 111.13 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 18' ' ' ILE . 84.4 t 60.71 97.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.434 . . . . 70.33 111.103 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.69 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.0 mm -90.31 155.19 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 71.25 111.178 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -145.07 165.46 28.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.853 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.06 174.37 6.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 52.45 110.896 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -59.57 -28.57 67.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.855 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.485 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.7 p -101.92 -33.06 9.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 43.32 111.126 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.73 -8.66 47.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.63 -0.795 . . . . 72.2 112.484 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.777 HG23 HG13 ' A' ' 16' ' ' ILE . 3.2 t -50.99 -32.91 22.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.313 . . . . 73.23 111.167 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.777 HG13 HG23 ' A' ' 15' ' ' THR . 16.0 mt -124.23 147.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 73.43 111.093 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.6 p -166.75 171.42 11.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.954 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -137.78 -176.39 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.183 -0.462 . . . . 62.15 111.159 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 18' ' ' ILE . 6.7 t -166.44 133.67 2.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 61.34 110.878 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.46 118.33 12.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.511 . . . . 72.41 110.888 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.03 -41.64 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 74.02 110.973 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.56 -169.52 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 75.14 110.891 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -51.64 51.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 70.04 110.827 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -131.39 30.89 4.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 74.13 110.887 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.9 t -126.55 119.8 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 61.14 111.162 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.466 ' CH2' HG22 ' A' ' 7' ' ' THR . 14.3 m95 -125.33 162.61 24.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 71.03 110.938 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 213' ' ' VAL . 75.9 t -122.49 108.13 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 71.43 111.147 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.475 ' HB3' HG23 ' A' ' 18' ' ' ILE . 5.3 p80 -102.02 139.45 37.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.885 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 41' ' ' SER . 25.2 m -137.77 125.24 22.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 71.51 111.138 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.521 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -114.17 -177.72 3.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 64.34 110.906 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.543 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 2.3 tp -134.38 134.8 42.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 73.3 110.952 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.77 144.35 11.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 61.55 112.485 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.23 142.16 36.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.893 0.378 . . . . 60.3 110.89 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -103.14 -32.45 9.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 53.14 110.858 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -164.82 32.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 70.44 110.958 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.13 13.88 8.81 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.791 -0.719 . . . . 55.34 112.513 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -149.66 119.27 6.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.835 0.35 . . . . 75.1 110.907 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -59.87 137.76 57.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 62.31 111.096 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.705 HG11 ' HD2' ' A' ' 303' ' ' RTD . 96.7 t -136.71 124.91 14.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.621 0.724 . . . . 72.01 111.117 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' CA ' HD12 ' A' ' 31' ' ' LEU . 53.6 Cg_endo -69.8 140.03 41.51 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.631 2.22 . . . . 73.53 112.368 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 29' ' ' THR . 1.0 OUTLIER -128.62 122.22 30.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 54.32 110.841 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -67.46 168.6 10.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 70.44 110.915 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.41 170.12 43.25 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.672 -0.775 . . . . 71.23 112.45 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.011 HD13 HG21 ' A' ' 207' ' ' VAL . 3.9 tp -143.05 138.8 30.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.388 . . . . 74.01 110.897 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.71 HG22 HD13 ' A' ' 54' ' ' LEU . 38.3 t -122.05 130.23 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 70.12 111.138 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.574 HD22 ' HE3' ' A' ' 138' ' ' MET . 45.5 mt -96.9 125.54 41.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.837 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.02 45.37 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.1 110.874 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.632 HG22 ' HB2' ' A' ' 138' ' ' MET . 27.5 p -52.57 165.11 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 72.53 111.143 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.61 35.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 62.45 110.837 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -157.11 25.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.485 . . . . 64.33 110.924 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.68 124.6 3.77 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.66 -0.781 . . . . 52.44 112.442 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.721 HD21 ' HB3' ' A' ' 75' ' ' PHE . 35.2 mt -53.18 158.02 1.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 71.13 110.915 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.605 HG22 ' HB2' ' A' ' 81' ' ' ASP . 90.5 t -141.25 142.64 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 73.05 111.102 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.71 HD13 HG22 ' A' ' 45' ' ' VAL . 3.2 mm? -114.43 128.42 56.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 74.44 110.924 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 55' ' ' VAL . 13.1 t -80.4 -0.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 75.45 111.1 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -174.81 132.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 74.14 110.911 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -74.59 -166.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.05 110.844 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.42 -170.24 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 55.11 110.848 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.666 ' HB2' HD13 ' A' ' 63' ' ' LEU . 88.5 m95 -74.8 -34.9 62.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 74.53 110.884 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.16 174.5 11.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.427 . . . . 71.22 110.857 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.44 -30.43 68.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 65.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -76.04 -25.53 55.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 73.5 110.885 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -83.32 -48.34 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.85 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.1 t -60.54 -27.82 67.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 63.0 111.173 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -43.08 75.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.864 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.55 1.29 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.11 110.92 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.521 HD22 ' OE2' ' A' ' 30' ' ' GLU . 23.8 tp -95.46 -45.33 7.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 74.13 110.912 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -68.79 -40.03 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 62.12 111.157 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -60.39 -22.23 63.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.12 -0.491 . . . . 61.25 110.942 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.5 mmm -72.64 -60.81 2.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.914 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.514 ' HB ' HD13 ' A' ' 52' ' ' LEU . 19.7 m -59.39 -30.16 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 63.54 111.122 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -88.51 48.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 73.44 110.914 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 -41.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.02 110.958 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.69 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.05 -25.23 14.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.9 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.721 ' HB3' HD21 ' A' ' 52' ' ' LEU . 35.9 m-85 -89.31 9.84 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.882 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.499 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.68 47.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 73.3 110.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -147.92 -177.54 5.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.851 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.6 130.9 37.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.932 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 52' ' ' LEU . 61.4 t -67.86 130.12 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 72.32 111.112 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.4 p -136.82 18.62 3.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.481 . . . . 61.21 111.13 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.605 ' HB2' HG22 ' A' ' 53' ' ' VAL . 8.4 m-20 -153.99 130.59 10.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 75.14 110.878 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 98' ' ' LEU . 24.8 t -133.5 98.46 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.095 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.7 mt -73.71 125.73 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 73.43 111.128 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 91' ' ' ARG . 42.4 mm -113.08 142.47 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 65.44 111.131 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.0 p -97.51 -59.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 64.31 111.147 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -129.47 164.19 24.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 61.12 110.859 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.49 98.03 9.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.44 111.078 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.661 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -152.03 159.03 43.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 74.54 110.88 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -26.73 61.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 64.41 111.088 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -91.73 13.28 18.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 70.4 110.874 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HB3' HG23 ' A' ' 84' ' ' ILE . 2.0 mmp_? -126.68 -50.86 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.867 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -118.75 16.24 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 55.13 111.15 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.73 -33.26 34.34 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.714 -0.755 . . . . 63.45 112.525 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.27 15.92 53.74 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.749 -0.738 . . . . 61.4 112.487 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.517 HG21 ' H ' ' A' ' 121' ' ' GLU . 11.3 tt -46.16 -31.93 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 72.42 111.162 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -54.31 31.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.943 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.8 m -58.1 -41.07 82.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 72.2 111.16 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 82' ' ' VAL . 27.3 mt -59.61 -31.21 69.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 75.13 110.934 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -97.82 25.08 6.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.3 110.911 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -115.75 -24.79 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.902 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -107.83 -21.4 12.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 70.41 110.88 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.68 13.34 5.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 62.33 112.44 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 98' ' ' LEU . 16.0 mt -80.32 155.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 74.21 111.06 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.648 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -119.97 123.93 44.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 73.22 110.862 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.51 85.31 6.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 74.22 111.074 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.424 ' HB3' HD11 ' A' ' 127' ' ' LEU . 54.3 m-70 -55.87 148.07 17.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 71.15 110.873 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.93 164.88 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 64.04 110.813 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.8 p -81.98 155.77 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 44.15 111.199 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.72 -29.91 20.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 75.53 111.143 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 152' ' ' ASP . 7.1 tp -75.08 -47.58 28.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 73.02 110.904 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.706 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.7 m -53.93 -26.97 28.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 61.43 111.152 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.456 ' HB1' ' OE2' ' A' ' 122' ' ' GLU . . . -86.26 -27.1 24.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.24 111.05 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -64.13 -27.51 69.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 65.23 110.855 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.611 HD13 ' OD2' ' A' ' 152' ' ' ASP . 9.8 mp -92.96 -23.89 18.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 73.01 110.895 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.44 -62.98 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.51 111.137 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -25.42 42.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 51.42 110.873 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.0 -23.79 65.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.895 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -97.32 -26.36 14.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 72.33 110.876 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.89 -3.21 10.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.788 -0.72 . . . . 32.33 112.503 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -59.52 -173.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.887 0.375 . . . . 74.42 110.889 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.517 ' H ' HG21 ' A' ' 95' ' ' ILE . 8.6 mm-40 -97.75 -1.34 43.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.89 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.456 ' OE2' ' HB1' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 66.36 124.96 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.623 0.725 . . . . 74.41 110.865 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -170.46 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.629 2.219 . . . . 71.25 112.387 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 104' ' ' LYS . 65.7 mt -53.44 -39.76 64.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.884 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.12 59.03 9.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.768 -0.73 . . . . 73.02 112.461 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -155.33 47.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 64.22 110.854 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 106' ' ' HIS . 76.2 mt -127.07 -175.26 3.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 64.3 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -140.02 -168.66 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.858 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.831 HG23 ' HB3' ' A' ' 144' ' ' TYR . 78.7 m -50.21 -54.87 17.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 65.22 111.092 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.744 HG22 ' HA ' ' A' ' 143' ' ' PHE . 91.9 t -131.33 111.84 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 75.12 111.114 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.591 HG22 HD23 ' A' ' 133' ' ' LEU . 91.5 m -117.04 119.55 35.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 73.44 111.199 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -78.77 99.13 6.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 74.05 110.901 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.591 HD23 HG22 ' A' ' 131' ' ' THR . 3.6 mt -85.76 149.44 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 64.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 106.96 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 74.43 110.905 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.434 ' HB2' HG21 ' A' ' 48' ' ' THR . 13.1 m-85 -106.06 57.9 0.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.893 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.11 -117.02 5.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.641 -0.79 . . . . 61.43 112.413 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -91.14 48.62 1.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.735 0.302 . . . . 65.41 110.825 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.632 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.7 tpp -143.17 151.6 40.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 73.44 110.836 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.96 112.73 14.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 72.21 110.894 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.48 HG13 HD23 ' A' ' 158' ' ' LEU . 16.5 t -126.08 152.55 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 54.31 111.127 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -151.07 120.78 7.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 54.23 110.888 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.687 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.22 -179.08 2.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.45 111.149 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.744 ' HA ' HG22 ' A' ' 130' ' ' VAL . 78.4 t80 -175.29 136.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.879 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.831 ' HB3' HG23 ' A' ' 129' ' ' THR . 59.2 t80 -116.79 93.63 41.77 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.712 0.768 . . . . 73.23 110.838 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 -48.92 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 61.3 112.33 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.62 -170.35 42.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.664 -0.779 . . . . 34.53 112.454 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -84.52 126.55 33.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.884 0.373 . . . . 64.54 110.87 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.665 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -136.64 -88.3 0.23 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 71.32 112.498 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -78.27 -23.67 47.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 73.4 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.95 163.99 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.22 111.218 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -70.09 -24.48 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.916 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.611 ' OD2' HD13 ' A' ' 114' ' ' LEU . 10.6 p30 -123.59 52.63 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 62.42 110.87 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 2.1 p30 -100.77 146.35 27.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.925 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.687 HD12 HG22 ' A' ' 142' ' ' THR . 8.8 pt -145.14 173.28 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 74.25 111.161 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.1 m -123.03 138.8 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 64.32 111.156 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.454 ' O ' HD22 ' A' ' 164' ' ' LEU . 79.0 t -95.1 125.69 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 62.31 111.126 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -111.0 148.88 31.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 72.33 110.936 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 163' ' ' ILE . 47.5 mt -123.53 94.61 46.17 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.608 0.718 . . . . 71.44 110.888 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 70.98 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.716 2.278 . . . . 74.42 112.278 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.14 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.904 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.594 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.2 m-85 -118.74 -9.98 10.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 73.1 110.897 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 68.2 21.03 8.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 53.43 110.868 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.609 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.7 mp -87.1 115.67 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 71.14 111.129 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.478 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.5 tm? -101.37 122.93 44.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 70.11 110.923 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 44' ' ' LEU . 41.5 t -114.9 73.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 44.44 111.217 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.408 ' H ' HD13 ' A' ' 164' ' ' LEU . . . -64.12 -56.58 17.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 73.24 112.532 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 111.95 -139.0 15.36 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.749 -0.738 . . . . 72.25 112.412 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 46.6 m -58.03 -22.24 48.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 24.13 110.858 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.471 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.0 OUTLIER -62.88 -48.32 79.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.43 110.938 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.544 HG11 HG11 ' A' ' 206' ' ' VAL . 21.5 t -92.57 127.57 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 62.41 111.124 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.535 ' H ' HG23 ' A' ' 222' ' ' THR . 1.6 tppt? -95.49 134.94 37.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.925 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.641 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.2 p -70.23 157.03 38.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 74.12 110.829 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 p -59.52 -30.57 68.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 75.2 111.164 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.68 -31.16 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 71.31 110.86 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.5 -171.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.068 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.615 ' O ' HD22 ' A' ' 225' ' ' LEU . 1.2 tptt -145.77 -42.38 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 75.55 110.948 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -143.63 178.22 7.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 55.44 110.846 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.664 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 1.8 mt -78.61 -49.18 13.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 74.31 110.915 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 98.74 -140.13 14.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 50.33 112.476 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -67.85 133.14 48.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.859 0.362 . . . . 73.52 110.906 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.83 44.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 75.44 111.097 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.48 -46.06 77.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 62.14 111.084 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -112.38 44.09 1.51 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 73.35 110.921 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -134.87 173.92 11.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 31.34 111.114 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.61 88.48 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 75.23 110.918 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.419 HG13 HD23 ' A' ' 226' ' ' LEU . 23.5 t -68.11 -20.73 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 70.04 111.182 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -80.36 -28.41 38.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.868 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -22.59 16.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.04 110.918 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.664 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.3 t90 -51.07 -54.37 25.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.88 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -36.83 49.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 43.51 110.813 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 71.4 m -75.34 -39.01 59.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.53 111.139 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 44.6 m -58.81 -55.67 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.833 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.514 HG21 ' O ' ' A' ' 219' ' ' LEU . 33.1 mm -54.27 -37.5 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 73.2 111.145 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -23.08 65.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.881 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -90.6 -27.43 19.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 62.23 110.879 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.589 HG12 HD21 ' A' ' 219' ' ' LEU . 39.8 t -78.42 -31.98 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 72.22 111.156 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.7 -29.87 23.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 61.05 110.968 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -78.98 -50.06 11.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.1 110.865 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -51.92 -30.17 23.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 65.21 110.9 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -138.14 116.86 12.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 74.34 110.894 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -116.5 37.62 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 71.44 110.883 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.24 22.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 65.52 110.921 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.47 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.1 mp -51.63 142.74 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 64.13 111.093 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -103.53 -42.91 5.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 74.15 110.867 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.57 113.44 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 35.45 111.141 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.544 HG11 HG11 ' A' ' 170' ' ' VAL . 89.3 t -85.39 124.08 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.34 111.129 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.011 HG21 HD13 ' A' ' 44' ' ' LEU . 57.5 t -107.41 92.27 8.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.586 0.708 . . . . 72.41 111.129 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.3 Cg_endo -69.68 -174.7 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.269 . . . . 73.12 112.373 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.41 -17.44 33.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.804 -0.712 . . . . 60.02 112.515 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -147.19 125.97 12.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 75.31 110.906 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 123.0 -93.09 0.48 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.746 -0.74 . . . . 74.13 112.496 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -179.65 167.92 1.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 70.03 110.922 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 27' ' ' VAL . 42.6 t -79.85 135.53 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 72.14 111.145 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -137.36 -102.8 0.62 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.773 . . . . 54.34 112.46 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -158.96 -171.34 3.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.923 0.392 . . . . 61.4 110.827 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 -23.92 13.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 62.24 110.83 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -52.52 -35.52 45.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.769 -0.729 . . . . 34.11 112.488 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 172' ' ' SER . 23.9 mt -51.0 -46.35 61.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 75.52 110.86 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.589 HD21 HG12 ' A' ' 196' ' ' VAL . 7.1 mp -56.32 -42.95 78.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 54.32 110.882 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.755 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.1 mt -66.78 -41.46 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 73.24 110.893 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.45 ' NE2' HD21 ' A' ' 225' ' ' LEU . 85.2 t60 -61.31 -39.35 90.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 63.34 110.848 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.535 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.66 -46.22 63.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 75.25 111.103 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.81 ' HA ' HD12 ' A' ' 226' ' ' LEU . 51.5 mt -56.64 -44.22 81.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 74.42 110.939 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -31.51 60.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 60.42 110.872 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.615 HD22 ' O ' ' A' ' 176' ' ' LYS . 6.8 mt -73.7 -27.92 61.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 73.13 110.887 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.5 mt -84.85 -30.87 24.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 73.0 110.899 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 75.25 110.894 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.705 ' HD2' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.9 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.853 0.358 . . . . 71.34 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -159.26 -177.37 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 62.41 110.859 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.19 142.1 37.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 74.2 110.905 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.72 172.37 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 64.12 111.086 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -137.97 55.79 1.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 71.04 110.885 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -146.46 151.91 38.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 63.44 110.893 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.461 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -145.53 179.78 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 71.42 111.164 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 18' ' ' ILE . 97.3 t 60.92 94.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 73.24 111.072 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.467 HD11 ' HE3' ' A' ' 74' ' ' LYS . 3.4 mm -87.1 156.17 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 74.35 111.1 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -146.74 151.91 37.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 63.12 110.896 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.58 168.51 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 65.13 110.924 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.46 -32.55 62.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 71.13 110.92 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 p -93.04 -31.97 14.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 74.45 111.084 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.47 -12.51 58.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 53.04 112.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.714 HG23 HG13 ' A' ' 16' ' ' ILE . 2.4 t -51.73 -33.0 32.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 60.45 111.132 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.714 HG13 HG23 ' A' ' 15' ' ' THR . 28.2 mt -119.58 150.87 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 72.05 111.089 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -170.2 170.84 7.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.782 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -136.47 -174.7 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 74.41 111.215 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.442 ' OG ' HG22 ' A' ' 8' ' ' VAL . 1.2 t -170.8 129.95 0.81 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 63.35 110.882 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 122.12 15.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 53.31 110.944 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.436 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.5 mm? -104.45 -46.84 4.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 61.1 110.949 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -149.41 52.43 0.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.83 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.58 -76.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.931 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -83.63 -20.37 33.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.898 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.26 120.6 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 64.33 111.171 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.461 ' CH2' HG22 ' A' ' 7' ' ' THR . 18.2 m95 -125.41 159.81 30.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 60.31 110.957 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.436 HG23 ' HG ' ' A' ' 21' ' ' LEU . 53.3 t -122.23 112.7 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 75.53 111.147 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.446 ' HB3' HG23 ' A' ' 18' ' ' ILE . 11.1 p80 -103.48 137.04 42.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 73.52 110.9 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.6 m -131.17 130.93 43.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 55.3 111.091 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.628 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -126.19 163.17 23.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 73.43 110.868 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.604 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 4.9 tp -110.14 145.7 36.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.924 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.09 -122.58 2.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.736 -0.745 . . . . 72.22 112.465 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.2 155.26 46.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.93 0.395 . . . . 74.31 110.832 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -173.44 102.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 73.32 110.848 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 51.45 56.23 8.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 75.3 110.921 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.91 26.37 67.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.802 -0.713 . . . . 54.12 112.49 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -151.57 119.46 6.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 62.43 110.873 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.604 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -54.45 144.19 21.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 63.41 111.098 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.694 HG21 ' HD1' ' A' ' 303' ' ' RTD . 2.2 p -132.07 126.68 20.71 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 73.32 111.142 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.483 ' CA ' HD12 ' A' ' 31' ' ' LEU . 54.1 Cg_endo -69.75 142.93 49.31 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.65 2.234 . . . . 75.12 112.349 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -126.33 108.12 10.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.87 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -61.87 151.52 34.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 74.43 110.888 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.582 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -154.3 -163.37 11.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.7 -0.762 . . . . 54.24 112.478 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.998 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -162.36 145.3 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.903 0.382 . . . . 72.32 110.903 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 54' ' ' LEU . 43.8 t -129.49 130.12 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 62.22 111.097 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.471 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 46.7 mt -98.57 122.01 41.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.902 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -91.53 47.3 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 72.4 110.908 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 138' ' ' MET . 22.9 p -56.77 172.68 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 70.52 111.103 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.4 m -99.17 24.97 7.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 62.01 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.4 19.01 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.838 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.78 128.53 4.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 52.22 112.524 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.815 HD21 ' HB3' ' A' ' 75' ' ' PHE . 35.3 mt -52.63 157.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.817 0.341 . . . . 73.02 110.916 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.785 HG22 ' HB2' ' A' ' 81' ' ' ASP . 93.6 t -142.08 143.36 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 60.55 111.098 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 45' ' ' VAL . 3.5 mm? -112.24 129.58 56.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.831 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 55' ' ' VAL . 12.4 t -80.07 -1.26 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.044 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.32 130.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.24 -0.436 . . . . 75.42 110.89 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -67.82 -169.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.4 110.795 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.41 -175.94 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 70.2 110.826 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.699 ' HB2' HD13 ' A' ' 63' ' ' LEU . 92.1 m95 -67.35 -37.4 83.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 74.23 110.899 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -144.99 174.15 11.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 75.2 110.878 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.436 ' HA ' HG22 ' A' ' 64' ' ' THR . 1.0 OUTLIER -70.03 -28.46 65.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 71.13 110.84 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -77.63 -25.45 49.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.33 110.893 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 59' ' ' TRP . 1.3 mt -85.79 -40.98 15.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 75.33 110.863 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 61' ' ' ASP . 14.6 t -66.18 -29.74 70.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 42.45 111.197 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -51.62 -45.04 63.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 50.21 110.91 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -81.64 -14.9 56.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.881 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.628 HD22 ' OE2' ' A' ' 30' ' ' GLU . 40.0 tp -78.08 -48.45 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.888 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.9 mt -71.85 -18.63 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 45.21 111.097 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.06 2.35 39.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 71.24 110.894 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.2 mmm -101.62 -53.04 3.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 75.4 110.908 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.779 ' HB ' HD13 ' A' ' 52' ' ' LEU . 22.7 m -59.4 -39.53 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 64.5 111.125 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.483 ' HG3' HG23 ' A' ' 71' ' ' VAL . 33.5 mt-10 -84.86 50.98 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 75.2 110.889 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.74 -39.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.881 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -110.17 -20.19 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.931 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.815 ' HB3' HD21 ' A' ' 52' ' ' LEU . 25.1 m-85 -89.14 12.28 16.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.859 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.518 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.86 47.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 71.52 110.93 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -155.93 -178.72 7.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 70.43 110.891 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.41 157.45 39.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.02 110.848 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 52' ' ' LEU . 98.5 t -92.65 117.98 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 72.45 111.181 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.9 p -128.34 22.4 6.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.23 111.155 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.785 ' HB2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -153.45 133.9 13.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.831 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.567 HG11 HD11 ' A' ' 98' ' ' LEU . 24.1 t -138.64 99.47 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 54.12 111.128 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.0 mt -77.49 126.07 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.03 111.071 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.9 mm -112.46 130.26 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 75.33 111.091 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.0 p -87.76 -54.85 4.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 71.54 111.077 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -133.93 170.0 16.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.868 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -88.96 97.77 11.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.465 . . . . 54.44 111.075 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.65 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -150.33 158.65 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 73.1 110.826 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.03 63.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 51.34 111.104 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.9 9.26 25.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 72.15 110.831 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -121.43 -52.81 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 74.44 110.865 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.65 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.5 18.24 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 61.51 111.198 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.05 -26.72 20.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.636 -0.792 . . . . 54.11 112.534 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.64 22.01 20.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.737 -0.744 . . . . 71.3 112.523 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.427 HG21 ' H ' ' A' ' 121' ' ' GLU . 2.3 tt -48.55 -31.05 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.392 . . . . 74.02 111.137 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -70.65 -43.75 68.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.908 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.4 m -66.27 -35.49 80.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 61.3 111.119 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.567 HD11 HG11 ' A' ' 82' ' ' VAL . 48.4 mt -62.37 -32.51 73.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.933 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.29 20.92 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 64.45 110.88 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -117.35 -22.46 8.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 75.2 110.906 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.74 7.66 18.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 72.24 110.894 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.8 15.92 64.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.723 -0.751 . . . . 65.15 112.453 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 98' ' ' LEU . 16.9 mt -80.33 155.03 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 63.4 111.113 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.82 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -118.98 117.58 29.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 55.24 110.911 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.513 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -86.52 79.32 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 63.43 111.064 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.511 ' HA ' HD12 ' A' ' 124' ' ' LEU . 96.5 m-70 -55.16 147.66 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 70.05 110.896 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.463 ' C ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -179.86 166.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 73.44 110.916 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 127' ' ' LEU . 76.1 p -87.99 158.13 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 52.35 111.078 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.82 -43.09 62.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 72.04 111.129 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.625 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -61.81 -46.31 90.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 71.04 110.847 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.702 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.2 m -52.05 -42.58 63.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 63.04 111.08 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.464 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -73.3 -23.55 60.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 71.43 111.104 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -57.08 -40.49 77.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.856 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.63 HD12 ' OD1' ' A' ' 152' ' ' ASP . 8.4 mt -84.21 -28.43 27.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.927 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.71 -68.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 64.11 111.077 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.34 -24.94 47.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 73.21 110.879 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -24.17 66.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.885 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -95.71 -37.33 10.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 51.4 110.871 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.68 -5.3 4.07 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.718 . . . . 65.22 112.502 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -59.63 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.816 0.341 . . . . 63.4 110.935 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.427 ' H ' HG21 ' A' ' 95' ' ' ILE . 19.8 mm-40 -97.86 -1.0 44.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 72.4 110.891 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.464 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.0 OUTLIER 66.15 125.38 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.674 0.749 . . . . 65.44 110.886 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -170.37 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.238 . . . . 62.51 112.343 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 104' ' ' LYS . 70.8 mt -53.59 -41.2 66.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 71.23 110.942 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.28 59.72 8.6 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 74.32 112.482 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.75 54.63 0.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 75.4 110.896 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 107' ' ' SER . 67.1 mt -137.01 -173.21 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 61.51 110.902 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.0 -168.18 2.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.851 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.799 HG23 ' HB3' ' A' ' 144' ' ' TYR . 96.6 m -50.02 -41.66 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 61.3 111.197 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 m -140.51 141.82 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 72.42 111.141 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.647 HG22 HD23 ' A' ' 133' ' ' LEU . 60.0 m -149.04 110.88 4.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 63.34 111.154 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.89 98.01 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 64.53 110.865 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.647 HD23 HG22 ' A' ' 131' ' ' THR . 3.3 mt -87.62 149.77 24.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 61.44 110.883 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.31 131.29 17.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.889 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.401 ' HB2' HG21 ' A' ' 48' ' ' THR . 16.6 m-85 -134.35 99.17 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 73.32 110.863 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 61.51 -96.76 0.12 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.713 -0.756 . . . . 63.21 112.479 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -118.86 49.6 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 64.14 110.869 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.601 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.2 tpt -138.1 152.97 49.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 72.23 110.823 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.44 118.14 21.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 63.23 110.958 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.645 HG13 HD23 ' A' ' 158' ' ' LEU . 4.6 t -135.14 159.19 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 63.31 111.15 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 140' ' ' VAL . 30.6 tt0 -160.52 126.7 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.24 110.907 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.9 178.32 6.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 62.33 111.133 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -172.84 138.23 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.906 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.799 ' HB3' HG23 ' A' ' 129' ' ' THR . 22.4 t80 -118.92 95.32 49.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.705 0.764 . . . . 73.21 110.864 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -48.75 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 45.31 112.365 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.42 -165.54 38.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 71.44 112.447 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -85.4 121.2 27.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.24 110.847 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.618 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -135.09 -94.28 0.46 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.738 -0.744 . . . . 75.14 112.443 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -70.58 -29.3 65.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.368 . . . . 74.33 110.814 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.32 154.71 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 65.24 111.129 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -58.35 -24.27 59.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 52.32 110.912 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.63 ' OD1' HD12 ' A' ' 114' ' ' LEU . 1.1 p30 -124.19 51.37 1.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 65.23 110.94 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.53 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.0 OUTLIER -100.79 136.36 40.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.976 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.467 HG22 ' CD1' ' A' ' 144' ' ' TYR . 10.3 pt -137.47 160.61 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.52 111.121 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 196' ' ' VAL . 15.4 m -106.34 157.73 6.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 45.35 111.065 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.29 141.1 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 74.12 111.16 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -128.24 150.2 50.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.888 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.645 HD23 HG13 ' A' ' 140' ' ' VAL . 15.1 mt -129.0 95.9 30.34 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.62 0.724 . . . . 74.45 110.917 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 72.49 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.687 2.258 . . . . 64.11 112.286 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 179.52 -34.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 64.13 110.924 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.523 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.8 m-85 -117.45 -13.56 10.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 71.41 110.975 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m120 69.38 25.82 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 55.43 110.835 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.545 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -97.09 119.12 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 63.44 111.099 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.479 HD11 HG13 ' A' ' 196' ' ' VAL . 0.5 OUTLIER -104.71 138.46 40.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 71.15 110.877 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.543 HG21 HD22 ' A' ' 44' ' ' LEU . 21.6 t -124.09 66.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 54.14 111.111 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.47 -45.11 53.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.744 -0.741 . . . . 53.42 112.46 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.74 -141.48 15.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.76 -0.733 . . . . 61.34 112.509 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 43.7 m -57.35 -23.91 51.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 62.42 110.92 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.53 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.5 OUTLIER -65.64 -49.35 69.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.927 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.562 HG11 HG11 ' A' ' 206' ' ' VAL . 46.3 t -90.41 105.37 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.14 111.166 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.92 151.31 37.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 64.11 110.903 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.671 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.3 p -75.26 169.47 17.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 71.55 110.841 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -38.61 86.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 63.15 111.114 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.57 -26.89 68.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.281 -0.418 . . . . 64.11 110.844 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.96 151.69 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 45.42 111.032 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.34 -30.79 5.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 64.53 110.859 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.19 173.55 15.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 64.52 110.809 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.554 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 0.5 OUTLIER -85.45 -37.07 20.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 73.32 110.943 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 97.18 -163.47 22.09 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.755 -0.736 . . . . 75.44 112.409 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -52.07 112.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 70.32 110.895 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 179' ' ' GLY . 35.3 m -105.95 34.82 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.144 -0.48 . . . . 71.52 111.132 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.01 84.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.493 . . . . 73.21 111.125 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.0 39.94 2.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.23 110.817 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -139.72 170.84 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 72.11 111.056 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -119.9 90.16 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 73.34 110.917 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.486 ' CG2' HG11 ' A' ' 181' ' ' VAL . 61.5 t -69.55 -20.94 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 75.54 111.097 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.97 -26.32 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 60.44 110.938 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.23 -23.15 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 62.42 110.886 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.554 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.6 t90 -51.27 -55.81 16.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.878 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -36.16 49.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 62.42 110.83 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.6 m -75.48 -34.24 60.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 74.32 111.081 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 67.4 m -64.38 -51.55 62.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.51 110.89 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.739 HG22 HD23 ' A' ' 197' ' ' LEU . 32.9 mm -56.72 -38.91 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 74.53 111.09 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -62.68 -22.07 66.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 72.43 110.857 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -90.72 -30.3 17.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 53.33 110.885 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.485 ' CG1' HD21 ' A' ' 219' ' ' LEU . 99.5 t -77.49 -37.05 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 63.12 111.176 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.739 HD23 HG22 ' A' ' 193' ' ' ILE . 4.4 pp -78.93 -25.21 43.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.878 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -83.13 -42.48 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.14 110.939 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -55.24 -26.45 39.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.21 110.895 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -143.81 118.54 9.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 71.53 110.918 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.37 37.52 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 73.12 110.909 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.43 21.27 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 55.43 110.902 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.25 146.85 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 72.51 111.142 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.56 -31.51 8.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.892 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.545 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -156.48 140.17 16.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 54.14 111.09 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.742 ' CG1' HD12 ' A' ' 218' ' ' LEU . 92.7 t -120.72 125.64 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 61.33 111.144 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.998 HG21 HD11 ' A' ' 44' ' ' LEU . 97.1 t -107.71 105.74 56.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.604 0.716 . . . . 73.23 111.1 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.4 Cg_endo -69.76 -179.85 3.19 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.705 2.27 . . . . 74.4 112.314 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.79 -33.83 26.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.729 -0.748 . . . . 62.03 112.518 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -143.61 111.13 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.344 . . . . 74.23 110.847 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.46 -114.2 0.72 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.761 . . . . 53.34 112.422 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -151.84 166.86 30.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.85 0.357 . . . . 73.33 110.939 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.781 HG22 HG22 ' A' ' 207' ' ' VAL . 21.8 t -74.34 149.94 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 74.13 111.127 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -147.31 -108.54 0.53 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.76 -0.734 . . . . 74.42 112.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -157.73 -171.77 3.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 62.31 110.816 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 35.7 tttt -56.65 -21.51 27.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.889 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.759 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -55.29 -31.98 57.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 61.01 112.467 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.742 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.1 mt -51.06 -45.41 61.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 74.22 110.873 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.526 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -58.6 -44.58 89.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 72.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.759 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.7 mt -65.15 -42.01 94.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 73.03 110.95 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.657 ' NE2' HD21 ' A' ' 225' ' ' LEU . 77.5 t60 -66.24 -37.79 86.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.853 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.6 m -52.12 -43.01 63.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 73.45 111.08 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.753 ' HA ' HD12 ' A' ' 226' ' ' LEU . 61.5 mt -58.35 -42.29 86.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 75.11 110.863 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -26.86 66.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.841 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.657 HD21 ' NE2' ' A' ' 221' ' ' HIS . 22.4 mt -73.49 -25.88 60.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.45 110.925 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.753 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.1 mt -87.25 -42.2 13.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 35.15 110.88 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.31 110.922 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.694 ' HD1' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.77 0.319 . . . . 54.33 110.835 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -127.82 153.64 46.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 74.23 110.957 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -147.91 128.29 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.92 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 m -134.29 -176.32 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 75.53 111.142 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.35 115.64 30.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.874 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -155.96 154.7 31.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 70.34 110.875 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.553 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -147.5 178.46 8.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 74.34 111.072 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.562 HG22 ' OG ' ' A' ' 19' ' ' SER . 80.8 t 60.37 94.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 54.24 111.08 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.697 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.3 mm -87.9 156.92 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.184 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -145.77 147.14 31.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 60.02 110.964 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.79 164.24 26.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 62.11 110.85 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -51.88 -38.2 55.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 73.4 110.958 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.473 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.5 p -92.43 -26.57 17.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 42.35 111.193 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.71 -11.69 56.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 53.45 112.501 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.796 HG23 HG13 ' A' ' 16' ' ' ILE . 4.2 t -51.48 -32.63 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 64.54 111.15 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.796 HG13 HG23 ' A' ' 15' ' ' THR . 29.3 mt -120.92 149.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 74.13 111.103 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 p -169.98 167.53 8.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 71.45 110.862 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -135.57 -173.22 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 73.25 111.175 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -172.83 132.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.86 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.03 120.38 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 74.13 110.816 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.11 -47.86 4.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 55.51 110.889 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -146.99 53.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 63.31 110.887 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.28 -76.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 74.03 110.937 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.76 -20.97 30.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.871 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 t -97.1 119.73 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 63.12 111.143 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.553 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.7 m95 -124.67 162.01 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.936 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.484 HG21 HG21 ' A' ' 213' ' ' VAL . 79.4 t -124.26 111.26 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 52.44 111.098 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.526 ' HB3' HG23 ' A' ' 18' ' ' ILE . 10.1 p80 -103.21 137.62 41.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.468 . . . . 72.44 110.829 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.2 m -133.05 120.51 21.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 71.03 111.185 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.618 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -111.33 170.44 8.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 62.43 110.878 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.955 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -125.84 133.49 51.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 63.4 110.879 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -127.52 113.72 1.76 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.779 -0.724 . . . . 72.41 112.484 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.67 111.36 0.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.962 0.411 . . . . 74.41 110.777 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.69 105.54 15.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 73.45 110.885 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.8 t30 53.07 29.24 7.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 74.2 110.897 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.25 18.89 44.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.711 -0.756 . . . . 60.02 112.525 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -131.57 119.57 21.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.819 0.343 . . . . 72.13 110.88 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.955 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -65.84 132.68 49.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 35.33 111.096 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.727 HG11 ' HD1' ' A' ' 303' ' ' RTD . 60.5 t -139.84 102.65 6.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.601 0.715 . . . . 73.1 111.185 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.3 Cg_endo -69.78 141.01 44.0 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.707 2.271 . . . . 53.35 112.306 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -124.69 117.66 24.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 73.14 110.838 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -71.22 147.52 48.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 75.13 110.857 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.528 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -148.74 -160.41 9.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.758 -0.734 . . . . 73.25 112.404 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.974 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -161.74 143.7 11.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.384 . . . . 74.1 110.913 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 HD13 ' A' ' 54' ' ' LEU . 58.1 t -127.44 141.24 46.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 64.32 111.142 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.537 HD22 ' HE3' ' A' ' 138' ' ' MET . 13.3 mt -107.04 138.11 43.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 70.05 110.898 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -110.47 59.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.919 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.773 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.3 p -67.3 -172.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 71.41 111.16 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.26 26.38 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.992 0.425 . . . . 72.2 110.876 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -156.03 35.58 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 72.2 110.893 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.01 133.39 6.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.841 -0.695 . . . . 73.33 112.527 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.806 HD21 ' HB3' ' A' ' 75' ' ' PHE . 17.1 mt -64.19 172.84 2.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.874 0.369 . . . . 61.2 110.925 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 81' ' ' ASP . 61.0 t -148.18 143.42 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 75.53 111.103 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.563 HD13 HG22 ' A' ' 45' ' ' VAL . 3.3 mm? -115.84 130.01 56.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.119 -0.491 . . . . 74.1 110.876 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.5 t -80.36 -1.06 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 71.45 111.102 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -179.55 133.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 65.5 110.877 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -71.17 -168.64 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 55.32 110.864 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -173.18 3.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 74.33 110.906 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.718 ' HB2' HD13 ' A' ' 63' ' ' LEU . 89.9 m95 -69.54 -41.24 76.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 74.21 110.907 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.0 165.92 25.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.291 -0.413 . . . . 61.3 110.88 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -60.82 -34.69 74.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.916 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -73.94 -22.77 59.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 71.43 110.944 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.718 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -84.01 -43.44 15.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 75.15 110.893 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -66.99 -27.5 67.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 70.43 111.095 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.25 -43.52 71.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 73.12 110.89 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -82.91 -14.28 54.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 73.43 110.856 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.618 HD22 ' OE2' ' A' ' 30' ' ' GLU . 27.3 tp -76.63 -47.27 22.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 64.45 110.904 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.39 -33.4 53.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.43 111.12 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.8 -25.55 67.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 74.35 110.956 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 mmm -75.77 -59.83 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.499 . . . . 71.12 110.881 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.679 ' HB ' HD13 ' A' ' 52' ' ' LEU . 33.0 m -55.66 -31.91 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 72.41 111.102 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -89.69 48.29 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.875 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -143.65 -42.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.816 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.697 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -100.58 -25.9 14.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 75.4 110.869 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.806 ' HB3' HD21 ' A' ' 52' ' ' LEU . 35.5 m-85 -89.26 9.32 26.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 70.3 110.877 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.76 46.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.911 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -147.62 -177.76 5.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.05 110.896 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.95 130.04 39.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.824 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 52' ' ' LEU . 88.1 t -64.72 127.5 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.132 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.4 p -133.95 18.73 3.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 73.5 111.084 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.581 ' HB2' HG13 ' A' ' 53' ' ' VAL . 7.1 m-20 -153.63 136.13 15.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 53.24 110.846 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.453 HG11 ' CD1' ' A' ' 98' ' ' LEU . 25.2 t -139.75 97.82 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 63.24 111.086 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.1 mt -75.75 125.68 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 74.51 111.17 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 91' ' ' ARG . 41.1 mm -111.33 121.65 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 62.23 111.116 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.9 p -77.37 -53.7 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 72.55 111.074 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.499 ' HA ' HG23 ' A' ' 111' ' ' THR . 16.0 p-80 -135.8 171.12 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 75.04 110.886 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -91.02 101.09 13.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 70.44 111.025 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.643 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -155.23 159.85 40.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.46 . . . . 65.05 110.881 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.32 -25.31 48.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.052 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -94.0 20.15 8.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 73.22 110.879 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.5 mpt_? -135.17 -50.45 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 74.03 110.893 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -117.57 14.47 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.43 111.143 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.61 -35.55 30.11 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.735 -0.745 . . . . 73.4 112.449 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.18 19.04 41.26 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.705 -0.76 . . . . 64.43 112.421 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.593 HG21 ' H ' ' A' ' 121' ' ' GLU . 11.7 tt -45.97 -31.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 71.44 111.141 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -54.25 32.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 73.1 110.914 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.1 m -58.7 -41.15 85.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.416 . . . . 75.14 111.09 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.453 ' CD1' HG11 ' A' ' 82' ' ' VAL . 30.4 mt -57.49 -28.7 63.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 60.14 110.849 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -100.93 23.55 10.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 51.33 110.894 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -115.9 -26.57 7.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 44.4 110.861 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -103.34 -22.02 13.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 75.24 110.817 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.74 19.2 4.15 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.717 -0.754 . . . . 64.4 112.416 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.7 mt -87.23 154.67 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 74.24 111.117 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.499 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.5 ptpt -117.16 121.98 42.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.918 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.33 80.47 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 62.54 111.116 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.507 ' HA ' HD12 ' A' ' 124' ' ' LEU . 92.1 m-70 -54.32 144.11 21.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 64.44 110.869 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.8 153.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.15 110.88 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.618 HG22 ' HB3' ' A' ' 127' ' ' LEU . 19.4 p -74.75 158.4 33.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 51.42 111.159 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.83 -37.45 63.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 73.31 111.093 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -65.33 -46.0 82.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 65.32 110.892 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 2.0 m -52.89 -41.14 64.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 72.13 111.154 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.521 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -72.68 -22.33 60.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 55.31 111.114 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -38.78 82.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 72.44 110.839 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.679 HD12 ' OD2' ' A' ' 152' ' ' ASP . 12.2 mt -89.33 -26.27 21.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 74.04 110.906 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.4 -64.78 0.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 63.13 111.059 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -57.28 -23.96 51.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 71.11 110.912 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -23.77 66.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 72.12 110.914 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -94.47 -33.43 13.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 65.52 110.925 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 129.16 -5.15 6.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 65.04 112.464 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -59.81 -172.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 75.04 110.937 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.593 ' H ' HG21 ' A' ' 95' ' ' ILE . 29.4 mm-40 -96.11 -3.6 44.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 62.14 110.836 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.521 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.4 mt-10 66.38 125.52 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 75.12 110.886 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -172.52 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.646 2.231 . . . . 64.43 112.308 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 106' ' ' HIS . 37.7 mt -51.93 -39.36 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.898 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.0 53.99 27.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.79 -0.719 . . . . 72.32 112.447 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -146.62 54.81 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.819 0.343 . . . . 70.42 110.876 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.618 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.9 OUTLIER -132.31 -176.46 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 74.54 110.903 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -141.68 -168.4 2.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 51.02 110.883 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.741 HG23 ' HB3' ' A' ' 144' ' ' TYR . 87.3 m -49.93 -43.3 49.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 72.22 111.079 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 142' ' ' THR . 3.3 m -140.42 143.08 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 71.21 111.108 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 HD23 ' A' ' 133' ' ' LEU . 63.0 m -150.21 110.19 4.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 70.21 111.129 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -71.87 94.77 1.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 74.12 110.875 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 131' ' ' THR . 4.5 mt -82.7 149.18 27.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 73.23 110.937 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.28 109.56 4.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 64.32 110.895 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.641 ' HB2' HG21 ' A' ' 48' ' ' THR . 18.6 m-85 -109.94 98.13 7.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 73.02 110.889 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 58.09 -98.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.714 -0.755 . . . . 75.14 112.477 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -112.57 58.5 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 61.23 110.887 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.773 ' HB2' HG22 ' A' ' 48' ' ' THR . 15.7 tpp -151.2 151.66 32.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 73.22 110.867 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.28 120.29 26.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.32 110.899 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.699 HG13 HD23 ' A' ' 158' ' ' LEU . 5.3 t -137.42 158.68 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 75.34 111.167 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 30.7 tt0 -155.82 123.76 5.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 64.43 110.894 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -76.54 178.4 6.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 74.13 111.17 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -172.39 137.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 71.12 110.927 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.741 ' HB3' HG23 ' A' ' 129' ' ' THR . 27.7 t80 -118.09 92.52 42.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 73.45 110.862 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -48.72 0.67 Allowed 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.698 2.265 . . . . 73.31 112.371 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.62 -152.82 16.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.798 -0.715 . . . . 45.35 112.494 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.99 123.18 44.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 71.21 110.909 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.52 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -130.99 -89.43 0.5 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.741 -0.742 . . . . 65.33 112.481 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -77.32 -29.67 53.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.831 0.348 . . . . 74.02 110.85 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.68 155.4 40.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 73.45 111.145 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -60.25 -24.19 64.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 70.53 110.843 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.679 ' OD2' HD12 ' A' ' 114' ' ' LEU . 1.9 p30 -119.17 49.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.42 110.915 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.562 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.0 OUTLIER -100.11 137.78 38.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 61.21 110.897 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.453 HG22 ' HD1' ' A' ' 144' ' ' TYR . 5.0 pt -139.16 158.81 29.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 55.5 111.153 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.572 ' CG1' HD22 ' A' ' 169' ' ' LEU . 10.2 m -106.97 145.08 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 65.44 111.026 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.7 t -100.16 144.22 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 74.45 111.118 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -131.53 149.3 52.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.23 -0.441 . . . . 71.44 110.898 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.699 HD23 HG13 ' A' ' 140' ' ' VAL . 21.1 mt -127.52 95.71 34.89 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 61.43 110.91 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 72.47 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 62.25 112.336 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 179.35 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 72.11 110.839 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.54 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.1 m-85 -117.94 -13.05 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 72.34 110.954 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m120 69.51 23.15 6.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 61.3 110.923 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.54 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.7 mp -93.84 114.56 30.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 72.03 111.161 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.95 136.83 39.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.887 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.511 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.6 t -125.48 68.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.02 111.164 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.76 -41.42 43.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 42.2 112.541 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.39 -129.1 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 71.43 112.496 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 69.5 m -74.82 -6.9 51.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 63.43 110.864 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.572 HD22 ' CG1' ' A' ' 155' ' ' VAL . 2.1 tp -73.24 -53.5 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 72.14 110.876 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.03 128.37 43.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.091 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.733 ' HE2' HD23 ' A' ' 178' ' ' LEU . 1.2 tppt? -91.21 163.9 14.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 71.14 110.896 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 p -89.61 159.25 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.01 110.88 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.435 HG23 ' CD2' ' A' ' 218' ' ' LEU . 20.9 p -55.29 -28.49 53.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.02 111.159 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.46 -25.77 57.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 62.22 110.815 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.8 170.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 72.31 111.155 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.06 -41.67 0.58 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 64.15 110.779 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -148.98 179.6 7.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 74.25 110.801 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.784 HD22 ' CH2' ' A' ' 189' ' ' TRP . 3.0 mt -100.03 -27.2 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 71.3 110.9 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 120.56 -142.31 15.73 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 75.44 112.52 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 181' ' ' VAL . 37.1 t30 -99.03 16.45 22.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 74.34 110.927 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.716 HG11 ' CG2' ' A' ' 186' ' ' VAL . 11.6 m 34.86 48.67 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 63.24 111.062 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -51.6 -58.62 5.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 73.03 111.077 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -117.34 28.16 8.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 71.1 110.869 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -104.66 174.88 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 75.31 111.063 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -137.28 85.18 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.918 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.716 ' CG2' HG11 ' A' ' 181' ' ' VAL . 86.2 t -58.83 -21.49 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 74.54 111.093 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -75.51 -21.72 57.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 71.3 110.947 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -107.83 -26.58 10.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 71.42 110.892 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.784 ' CH2' HD22 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -51.28 -57.12 9.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.893 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 90.0 p -52.03 -30.42 25.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 72.23 110.817 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.3 m -80.98 -32.44 34.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 75.4 111.204 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 196' ' ' VAL . 71.8 m -68.75 -56.66 7.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 70.13 110.912 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.8 mm -53.13 -42.03 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 64.14 111.157 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -63.43 -26.38 68.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 60.32 110.864 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -86.23 -31.23 21.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.53 110.858 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.531 HG21 HG11 ' A' ' 155' ' ' VAL . 99.1 t -73.22 -38.03 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 75.13 111.143 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.476 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -79.9 -25.62 40.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.879 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -42.6 33.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 73.04 110.913 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 33.4 tpt85 -60.73 -29.82 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 75.35 110.901 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -139.54 117.19 11.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 64.02 110.885 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 32.3 6.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 73.05 110.828 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.1 21.41 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 73.53 110.925 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -52.23 146.19 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 74.42 111.137 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -105.15 -34.82 7.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 64.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.404 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -156.88 133.56 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 74.34 111.087 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.735 ' CG1' HD12 ' A' ' 218' ' ' LEU . 88.5 t -109.72 128.3 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 71.13 111.09 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.974 HG21 HD11 ' A' ' 44' ' ' LEU . 89.5 t -111.29 102.46 53.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.612 0.72 . . . . 52.14 111.116 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.6 Cg_endo -69.69 -170.13 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 70.52 112.416 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.11 -29.29 7.26 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.853 -0.689 . . . . 75.43 112.559 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -143.46 101.01 3.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.824 0.345 . . . . 72.14 110.899 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.83 -101.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 72.55 112.527 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -168.42 165.18 12.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 70.31 110.856 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.66 HG22 HG22 ' A' ' 207' ' ' VAL . 22.4 t -74.74 149.63 7.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 73.01 111.159 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -151.35 -108.42 0.4 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.7 -0.762 . . . . 74.14 112.441 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -155.37 -172.77 4.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 73.32 110.884 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -55.56 -22.39 21.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 64.14 110.88 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.735 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.19 -31.57 49.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 63.32 112.503 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.735 HD12 ' CG1' ' A' ' 206' ' ' VAL . 35.7 mt -50.95 -46.89 61.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 73.24 110.92 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.498 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -53.55 -42.22 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 72.42 110.898 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.735 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.0 mt -68.08 -41.21 82.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 74.5 110.95 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -66.26 -36.48 83.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 72.04 110.872 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.0 m -51.66 -43.44 62.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 75.11 111.103 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.782 ' HA ' HD12 ' A' ' 226' ' ' LEU . 71.9 mt -56.85 -38.57 72.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 74.43 110.902 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -28.65 62.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.807 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.7 mt -76.13 -24.77 54.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.927 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.0 mt -89.06 -32.8 17.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.908 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.871 179.883 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.727 ' HD1' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.848 0.356 . . . . 74.3 110.839 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.52 177.9 3.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 63.43 110.867 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.71 128.29 10.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 75.34 110.922 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 m -142.71 176.79 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 44.52 111.134 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.88 41.01 3.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.465 . . . . 71.42 110.888 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -134.76 151.25 50.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 70.22 110.902 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.436 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -146.14 -179.65 6.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.21 111.16 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 18' ' ' ILE . 81.1 t 60.8 98.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 72.33 111.108 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.722 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.2 mm -90.48 154.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 74.42 111.08 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -146.01 146.06 30.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 75.22 110.868 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.34 163.34 21.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.871 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -51.67 -33.21 32.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 72.12 110.884 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -31.45 17.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 42.22 111.109 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.04 -12.45 65.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 61.03 112.425 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.698 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -51.21 -33.42 27.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.867 0.365 . . . . 73.04 111.144 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.698 HG13 HG23 ' A' ' 15' ' ' THR . 15.0 mt -121.92 148.54 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 73.23 111.108 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.8 p -166.17 170.18 13.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 43.43 110.859 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.56 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -135.51 -175.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 72.43 111.156 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.482 ' HA ' HG22 ' A' ' 8' ' ' VAL . 1.1 t -167.02 133.87 2.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 72.21 110.858 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.76 118.07 15.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.88 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.471 HD13 HG23 ' A' ' 27' ' ' VAL . 4.8 mp -103.16 -39.31 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 74.24 110.899 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -149.44 -170.98 3.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 75.53 110.84 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -49.86 -51.25 41.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 51.31 110.893 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -132.23 41.11 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 42.02 110.838 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.02 120.45 25.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 71.43 111.142 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.436 ' CH2' HG22 ' A' ' 7' ' ' THR . 16.8 m95 -129.77 154.32 47.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.94 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.471 HG23 HD13 ' A' ' 21' ' ' LEU . 19.1 t -117.48 105.01 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 71.21 111.067 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HB3' HG23 ' A' ' 18' ' ' ILE . 11.5 p-80 -99.07 137.91 36.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.907 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.3 m -134.91 136.39 42.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 63.43 111.163 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -125.47 170.52 11.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 75.51 110.907 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 2.2 tp -120.76 137.04 54.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.895 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.83 138.74 6.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.793 -0.718 . . . . 62.21 112.548 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.93 141.32 44.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 73.01 110.816 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -101.74 -32.55 10.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 74.14 110.869 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -166.36 34.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.918 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.6 13.63 9.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 64.21 112.522 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -151.41 119.74 6.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.829 0.347 . . . . 72.14 110.877 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -58.27 146.32 34.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 70.05 111.083 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.758 HG11 ' HD1' ' A' ' 303' ' ' RTD . 78.2 t -146.89 125.25 6.17 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.598 0.713 . . . . 60.45 111.105 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 141.74 46.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.683 2.255 . . . . 72.33 112.332 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.08 114.61 17.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 50.34 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.38 145.11 56.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 74.1 110.918 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.41 -175.62 21.15 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 72.44 112.517 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.784 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -154.98 141.75 19.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 74.12 110.915 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.51 HG22 HD23 ' A' ' 54' ' ' LEU . 21.2 t -126.15 137.53 57.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 75.23 111.086 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.2 mt -105.12 134.74 47.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 53.54 110.919 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -103.89 71.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 71.22 110.927 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 p -80.83 -172.03 3.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 70.43 111.19 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.59 -9.07 21.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 51.4 110.886 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.5 42.68 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 72.05 110.917 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.79 138.58 9.51 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 73.0 112.485 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.728 HD21 ' HB3' ' A' ' 75' ' ' PHE . 25.1 mt -58.52 172.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 70.24 110.904 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 81' ' ' ASP . 85.1 t -150.22 144.18 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 73.44 111.102 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.758 HD12 HG11 ' A' ' 79' ' ' VAL . 1.9 mt -116.26 132.14 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.994 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 55' ' ' VAL . 12.3 t -82.17 0.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 63.23 111.164 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.86 132.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 63.21 110.892 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -73.14 -168.42 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.21 110.827 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.3 m -94.62 -172.59 2.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.05 110.829 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.485 ' HB2' HD13 ' A' ' 63' ' ' LEU . 95.1 m95 -68.3 -35.08 77.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 75.03 110.923 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.72 168.27 24.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 61.14 110.885 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.436 ' HA ' HG22 ' A' ' 64' ' ' THR . 1.0 OUTLIER -64.53 -25.82 68.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 63.12 110.886 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -76.28 -25.47 54.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 73.04 110.941 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -85.87 -48.07 9.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 71.13 110.866 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 61' ' ' ASP . 13.7 t -59.86 -29.73 68.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 55.24 111.144 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -53.56 -41.62 66.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 64.12 110.882 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -84.81 -11.89 54.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 60.34 110.897 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 16' ' ' ILE . 35.1 tp -80.44 -47.52 14.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.947 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.2 mt -64.94 -21.99 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 75.31 111.152 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -71.91 -21.69 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.863 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.4 mtp -81.24 -58.32 3.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 74.33 110.893 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.615 ' HB ' HD13 ' A' ' 52' ' ' LEU . 35.2 m -58.07 -35.66 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 63.22 111.2 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -88.75 48.79 1.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 64.53 110.88 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.47 -41.71 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 61.24 110.902 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.722 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -102.09 -26.34 13.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 70.14 110.881 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.728 ' HB3' HD21 ' A' ' 52' ' ' LEU . 37.8 m-85 -88.35 9.61 22.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.01 110.829 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.5 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.4 pp0? 32.38 48.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.15 110.867 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -151.22 180.0 7.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.4 110.919 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.25 133.16 46.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 75.31 110.833 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.758 HG11 HD12 ' A' ' 54' ' ' LEU . 61.7 t -69.79 130.52 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 74.45 111.102 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.7 p -137.47 17.79 2.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 63.24 111.121 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.567 ' HB2' HG13 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -149.87 133.59 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.51 110.865 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG11 HD11 ' A' ' 98' ' ' LEU . 17.0 t -137.36 101.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 64.22 111.069 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.9 mt -78.8 119.54 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 65.34 111.087 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 91' ' ' ARG . 44.6 mm -106.3 133.52 50.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 55.45 111.121 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.4 p -89.3 -56.08 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.12 111.156 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.445 ' C ' HG23 ' A' ' 111' ' ' THR . 19.6 p-80 -133.14 163.87 28.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 73.22 110.829 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.8 98.41 9.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 61.11 111.164 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.626 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -152.54 158.13 42.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 75.42 110.832 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.51 -25.32 51.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 41.43 111.069 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -93.31 19.07 8.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 64.51 110.924 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.427 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.5 mpt_? -134.0 -51.35 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 64.34 110.827 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.626 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.03 15.79 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 73.31 111.092 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.96 -29.25 27.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.674 -0.774 . . . . 50.41 112.516 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.49 18.78 32.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 42.24 112.483 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.519 HG21 ' H ' ' A' ' 121' ' ' GLU . 8.4 tt -49.24 -29.99 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 73.11 111.135 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -69.95 -43.03 72.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 62.23 110.811 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.3 m -69.32 -34.29 74.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 73.43 111.144 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.458 HD11 HG11 ' A' ' 82' ' ' VAL . 52.7 mt -64.36 -32.32 73.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 54.03 110.883 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -94.27 21.29 7.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 71.23 110.882 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.27 -19.89 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.868 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.73 1.82 14.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 75.2 110.895 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.31 14.68 53.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.685 -0.769 . . . . 73.54 112.478 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.9 mt -82.27 154.9 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.342 . . . . 75.11 111.101 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.638 ' HB2' HD11 ' A' ' 124' ' ' LEU . 10.1 ptpt -118.89 122.79 43.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.869 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.415 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -91.28 79.2 5.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 62.2 111.075 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.525 ' HA ' HD12 ' A' ' 124' ' ' LEU . 72.2 m-70 -51.82 145.95 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 64.24 110.887 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.23 154.77 0.87 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 53.41 110.851 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 127' ' ' LEU . 73.4 p -72.57 160.09 32.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 53.35 111.109 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.22 -22.18 50.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 64.35 111.099 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 152' ' ' ASP . 8.9 tp -76.83 -48.15 19.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.866 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 44.5 m -55.34 -27.27 46.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.34 111.094 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.59 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -83.45 -23.71 32.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.101 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.29 -33.71 75.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 55.44 110.877 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.695 HD13 ' OD2' ' A' ' 152' ' ' ASP . 6.8 mp -93.1 -25.46 17.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 73.4 110.932 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.78 -65.1 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 52.34 111.135 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -56.58 -24.94 50.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 70.44 110.914 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -24.45 65.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 72.41 110.896 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -93.3 -33.48 13.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 64.01 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.03 -7.06 5.44 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 42.34 112.463 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -59.72 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.38 . . . . 53.31 110.918 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.519 ' H ' HG21 ' A' ' 95' ' ' ILE . 23.8 mm-40 -98.01 -1.53 42.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 73.21 110.926 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.59 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 2.1 mt-10 66.15 125.22 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.624 0.726 . . . . 64.1 110.924 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -170.65 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.651 2.234 . . . . 73.42 112.379 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' A' ' 104' ' ' LYS . 56.9 mt -54.18 -40.41 67.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 75.14 110.866 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.16 57.65 12.66 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.728 -0.748 . . . . 63.45 112.453 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.685 ' O ' HD23 ' A' ' 127' ' ' LEU . 13.7 m-20 -148.37 54.98 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 63.25 110.903 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 126' ' ' ASP . 41.2 mt -136.0 -169.63 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.927 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.61 -168.06 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.41 110.906 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.782 HG23 ' HB3' ' A' ' 144' ' ' TYR . 97.8 m -49.25 -44.05 43.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 61.34 111.132 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.01 141.04 29.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 75.11 111.118 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.7 m -148.56 101.53 3.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 55.44 111.147 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -65.86 96.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -88.94 159.21 17.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 73.51 110.942 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.33 107.1 3.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.3 110.914 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -98.89 -167.63 1.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 54.33 110.91 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -51.57 100.77 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.727 . . . . 62.34 112.513 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 50.77 42.25 27.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.376 . . . . 75.33 110.86 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 tpp -139.42 151.71 46.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 72.42 110.867 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.59 128.13 48.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 75.52 110.904 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.557 HG13 HD23 ' A' ' 158' ' ' LEU . 3.9 t -140.92 160.02 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 73.23 111.112 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 33.3 tt0 -161.17 122.58 2.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.87 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.44 178.73 5.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 44.5 111.169 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -174.0 139.21 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 64.35 110.908 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.782 ' HB3' HG23 ' A' ' 129' ' ' THR . 69.3 t80 -118.89 94.82 48.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.634 0.73 . . . . 75.04 110.928 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.74 0.66 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.749 2.299 . . . . 33.33 112.287 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.83 -156.39 25.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.682 -0.77 . . . . 61.23 112.451 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.36 121.94 39.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.736 0.303 . . . . 63.04 110.9 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.621 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -130.89 -93.65 0.64 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.67 -0.776 . . . . 52.21 112.451 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -73.04 -27.83 61.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 74.41 110.846 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.36 164.75 34.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 72.14 111.154 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -70.15 -23.88 63.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.41 110.865 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.695 ' OD2' HD13 ' A' ' 114' ' ' LEU . 8.8 p30 -119.41 49.0 1.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.871 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.5 p30 -99.62 137.58 37.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 70.24 110.911 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.8 pt -139.88 160.07 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.04 111.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 196' ' ' VAL . 9.4 m -108.5 149.42 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 75.3 111.157 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -105.57 141.82 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 72.42 111.078 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -130.17 146.77 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.928 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.557 HD23 HG13 ' A' ' 140' ' ' VAL . 9.6 mt -124.39 97.13 40.31 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.636 0.731 . . . . 75.32 110.908 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 73.33 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.252 . . . . 73.23 112.353 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.79 -34.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 72.24 110.862 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.436 ' O ' HD12 ' A' ' 163' ' ' ILE . 6.5 m-85 -118.04 -12.38 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.897 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.6 m120 68.9 23.27 6.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.106 -0.497 . . . . 72.52 110.884 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.445 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.5 mp -96.18 115.8 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 72.22 111.111 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.406 HD11 HG13 ' A' ' 196' ' ' VAL . 0.7 OUTLIER -99.11 139.97 33.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 73.42 110.914 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.612 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.5 t -126.7 67.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 74.23 111.154 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.36 -54.13 25.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 52.24 112.478 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.38 -134.8 12.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.622 -0.799 . . . . 44.4 112.494 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 91.8 m -64.48 -15.6 61.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.401 . . . . 55.11 110.93 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.408 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.3 tp -69.92 -51.54 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 74.52 110.913 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 206' ' ' VAL . 22.2 t -80.95 133.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 62.33 111.07 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -109.26 138.22 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 74.43 110.925 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 175' ' ' ALA . 3.3 p -57.06 154.68 9.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.2 110.872 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.786 HG23 HD23 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -60.23 -49.95 75.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 55.11 111.15 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.22 -28.85 29.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 54.45 110.829 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 172' ' ' SER . . . -54.72 158.34 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 72.15 111.08 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -144.72 22.44 1.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 75.14 110.908 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.59 150.26 1.35 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 72.12 110.89 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.413 HD11 HD23 ' A' ' 226' ' ' LEU . 1.2 mt -80.64 -34.77 34.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.871 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.45 -169.21 20.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.763 -0.732 . . . . 65.22 112.456 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -54.62 115.48 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 74.55 110.933 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.439 HG11 ' CG2' ' A' ' 186' ' ' VAL . 17.6 m -110.29 32.16 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 75.31 111.114 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.85 78.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.52 111.131 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -119.21 40.99 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 62.22 110.935 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -132.85 172.78 12.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 73.11 111.055 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -119.79 89.78 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 71.51 110.868 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.439 ' CG2' HG11 ' A' ' 181' ' ' VAL . 58.0 t -68.5 -20.9 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 62.14 111.076 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -81.34 -27.24 35.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 53.31 110.91 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.83 -22.94 16.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 61.23 110.837 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.36 -55.05 20.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 73.42 110.865 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.3 p -51.88 -41.11 61.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 70.23 110.87 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 89.4 m -69.84 -40.21 75.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 70.12 111.175 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 70.6 m -58.31 -55.06 39.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 74.21 110.825 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.63 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.0 mm -54.36 -36.82 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 54.34 111.174 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -62.45 -23.39 66.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 71.33 110.914 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -90.41 -25.94 20.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 70.1 110.914 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.543 HG12 HD21 ' A' ' 219' ' ' LEU . 43.6 t -80.96 -32.7 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 73.31 111.08 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.452 HD23 HG22 ' A' ' 193' ' ' ILE . 2.9 pp -84.8 -25.04 28.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 71.54 110.895 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -82.3 -46.07 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 75.22 110.942 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -52.14 -38.41 57.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 70.12 110.781 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -131.88 117.57 18.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 75.14 110.937 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -115.34 41.65 2.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 73.24 110.861 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.01 21.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.89 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.431 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.3 mp -53.22 144.58 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.144 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.02 -33.2 8.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 70.43 110.916 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.445 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -157.54 127.26 6.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 75.51 111.085 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 170' ' ' VAL . 86.9 t -106.76 118.09 53.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 72.25 111.15 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.784 HG21 HD11 ' A' ' 44' ' ' LEU . 57.4 t -100.84 104.11 29.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.571 0.701 . . . . 75.31 111.235 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.72 -172.14 0.54 Allowed 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.705 2.27 . . . . 63.33 112.301 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -100.64 -25.11 8.81 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 71.44 112.541 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -146.34 104.94 3.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 72.23 110.875 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.97 -91.43 0.15 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.71 -0.757 . . . . 72.03 112.453 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -178.9 153.28 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.373 . . . . 73.32 110.902 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.48 143.88 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 41.33 111.18 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -143.22 -105.56 0.54 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.696 -0.764 . . . . 44.13 112.487 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -155.49 -170.14 3.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.802 0.334 . . . . 70.32 110.911 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -57.74 -20.49 35.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.888 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.766 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.6 -33.28 62.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.707 -0.758 . . . . 75.43 112.504 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.786 HD23 HG23 ' A' ' 173' ' ' THR . 31.9 mt -50.78 -47.69 59.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 75.12 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.63 ' O ' HG21 ' A' ' 193' ' ' ILE . 7.0 mp -56.93 -43.87 81.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.457 . . . . 44.35 110.836 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.766 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.3 mt -66.08 -41.66 90.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 75.44 110.951 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.679 ' NE2' HD21 ' A' ' 225' ' ' LEU . 84.4 t60 -60.34 -44.46 95.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.792 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -46.73 64.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 65.25 111.071 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.62 ' HA ' HD12 ' A' ' 226' ' ' LEU . 61.0 mt -51.78 -39.75 59.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.22 111.0 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -65.64 -44.62 85.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.886 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.679 HD21 ' NE2' ' A' ' 221' ' ' HIS . 20.7 mt -57.0 -25.84 59.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.908 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.0 mt -90.56 -40.21 12.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 72.15 110.875 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.0 mttt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 61.41 110.88 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.758 ' HD1' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.791 0.329 . . . . 54.42 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.36 111.28 5.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.491 . . . . 63.11 110.928 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -138.46 169.64 17.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.931 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t 63.56 98.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 73.14 111.12 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -125.13 122.34 36.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 63.42 110.91 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mttp 60.37 170.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 64.42 110.909 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -113.4 90.49 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 73.4 111.171 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 7' ' ' THR . 3.0 t -157.85 114.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 74.32 111.155 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.694 HD11 ' HE3' ' A' ' 74' ' ' LYS . 2.8 mm -87.95 149.59 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 51.41 111.143 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -146.43 156.38 43.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 71.11 110.903 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.32 -177.52 4.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.878 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -67.14 -28.86 68.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.494 ' OG1' HG22 ' A' ' 15' ' ' THR . 5.6 p -93.06 -35.95 12.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.12 111.057 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.96 -15.16 58.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.664 -0.779 . . . . 65.14 112.425 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.707 HG23 HG13 ' A' ' 16' ' ' ILE . 2.0 t -51.72 -33.06 32.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.725 0.298 . . . . 53.02 111.151 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.707 HG13 HG23 ' A' ' 15' ' ' THR . 28.6 mt -117.11 150.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 45.51 111.027 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.9 p -170.66 173.24 5.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 71.15 110.827 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 19' ' ' SER . 0.3 OUTLIER -139.78 -177.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 62.24 111.13 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.444 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.2 t -167.72 135.77 2.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.473 . . . . 63.33 110.833 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -69.8 118.97 13.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 63.25 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.5 mm? -102.44 -56.8 2.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 65.03 110.946 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -152.69 -172.57 4.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.88 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.3 mttt -52.57 109.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 62.14 110.856 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 58.77 26.16 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 71.52 110.891 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 23' ' ' LYS . 69.5 t -128.44 110.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 75.42 111.124 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.494 ' HH2' HG22 ' A' ' 7' ' ' THR . 16.7 m95 -123.39 163.75 20.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 75.44 110.94 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 213' ' ' VAL . 71.9 t -124.42 109.81 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 62.54 111.181 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -99.32 136.92 38.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 71.44 110.888 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.4 m -130.99 125.9 34.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 54.52 111.13 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.635 ' OE1' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -117.88 168.09 10.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.829 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -125.68 132.92 52.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 63.13 110.91 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.29 114.94 1.54 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.687 -0.768 . . . . 74.52 112.437 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.91 129.81 27.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 63.22 110.838 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.77 102.18 7.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 74.44 110.916 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 55.44 26.08 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 72.33 110.899 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.05 23.88 18.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 42.34 112.448 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -141.39 119.71 12.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 73.44 110.919 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -65.5 141.68 58.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 72.55 111.087 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.734 HG11 ' HD2' ' A' ' 303' ' ' RTD . 69.9 t -146.55 103.08 3.97 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.668 0.747 . . . . 71.33 111.141 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.0 Cg_endo -69.67 139.51 40.73 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.782 2.321 . . . . 45.0 112.285 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.62 127.02 51.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 44.23 110.857 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -78.17 137.84 38.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 74.31 110.906 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.628 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -138.18 -160.47 8.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 62.21 112.529 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.049 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -165.15 143.63 6.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.84 0.352 . . . . 62.4 110.886 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.402 HG22 HD13 ' A' ' 54' ' ' LEU . 63.5 t -126.25 131.92 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 74.43 111.145 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.5 mt -101.85 119.1 38.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.438 . . . . 73.25 110.92 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -90.07 48.28 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 61.31 110.84 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 135' ' ' PHE . 19.5 p -58.48 176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 73.41 111.106 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.2 21.88 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 72.13 110.889 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.52 30.02 1.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.13 110.856 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.61 129.4 6.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 33.45 112.49 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.764 HD21 ' HB3' ' A' ' 75' ' ' PHE . 46.3 mt -51.62 165.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 52.43 110.97 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 81' ' ' ASP . 50.3 t -147.31 144.9 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 75.22 111.181 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 53' ' ' VAL . 3.5 mm? -115.7 126.66 54.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.11 110.921 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 55' ' ' VAL . 15.5 t -77.06 -3.85 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 75.11 111.181 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.8 129.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 74.31 110.846 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -166.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 70.23 110.857 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 t -94.66 -170.36 2.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 53.34 110.819 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.752 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.7 m95 -73.06 -38.8 66.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 72.25 110.878 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -140.0 161.73 36.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 71.13 110.87 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.22 -33.9 69.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 65.35 110.896 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -75.2 -25.75 58.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 70.21 110.903 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.752 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -81.16 -42.67 20.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 62.02 110.882 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -67.1 -27.05 67.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 65.4 111.168 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -53.42 -39.49 64.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.892 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -86.03 -13.96 45.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 65.54 110.912 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.635 HD22 ' OE1' ' A' ' 30' ' ' GLU . 11.7 tp -77.65 -43.14 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 72.34 110.911 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.24 -29.04 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 73.04 111.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.11 -11.7 61.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 73.15 110.889 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 mmm -89.38 -54.47 4.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.877 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.762 ' HB ' HD13 ' A' ' 52' ' ' LEU . 18.5 m -57.12 -39.87 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 60.3 111.051 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HG3' HG23 ' A' ' 71' ' ' VAL . 51.2 mt-10 -84.41 51.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 73.35 110.899 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -142.54 -41.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 75.13 110.878 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.694 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.62 -19.92 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 72.23 110.909 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.764 ' HB3' HD21 ' A' ' 52' ' ' LEU . 26.1 m-85 -89.22 10.81 20.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 65.31 110.883 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.518 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.64 47.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 61.43 110.902 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -155.3 -179.23 7.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 55.35 110.915 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.565 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -127.99 151.38 49.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 62.43 110.815 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 52' ' ' LEU . 57.7 t -86.11 128.66 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 70.15 111.116 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.565 HG23 ' HD3' ' A' ' 78' ' ' ARG . 65.4 p -137.25 20.76 2.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 72.11 111.173 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.582 ' HB2' HG13 ' A' ' 53' ' ' VAL . 5.8 m-20 -154.01 134.9 13.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 42.23 110.884 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.633 HG21 HD22 ' A' ' 98' ' ' LEU . 25.0 t -138.32 97.92 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 71.12 111.101 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.6 mt -75.02 129.69 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 71.21 111.131 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.5 mm -115.96 131.3 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 72.4 111.115 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.7 p -88.01 -57.93 2.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 64.34 111.157 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -132.86 157.6 44.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 53.24 110.865 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -76.25 96.98 4.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 63.11 111.151 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.639 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -150.65 157.94 43.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.871 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.83 -27.17 62.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 24.44 111.15 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.25 8.15 28.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 61.03 110.875 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -122.89 -53.6 1.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.903 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.639 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -113.4 18.36 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.128 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.61 -27.97 20.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.656 -0.783 . . . . 53.34 112.548 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.98 23.0 20.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.707 -0.759 . . . . 64.41 112.492 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.404 HG21 ' H ' ' A' ' 121' ' ' GLU . 3.9 tt -48.98 -30.36 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 62.22 111.111 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -71.06 -43.26 68.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.916 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 93.9 m -67.04 -36.03 81.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 70.44 111.118 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.633 HD22 HG21 ' A' ' 82' ' ' VAL . 48.6 mt -60.94 -33.48 73.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.33 110.926 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -94.3 21.84 6.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.911 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -117.24 -20.29 9.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.824 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -115.32 5.97 14.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.21 110.9 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.76 15.17 60.06 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 44.13 112.429 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 98' ' ' LEU . 14.3 mt -81.62 155.71 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 73.43 111.175 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.774 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -119.95 122.1 40.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 75.35 110.893 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -88.51 81.45 7.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 72.14 111.046 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.422 ' ND1' HD12 ' A' ' 124' ' ' LEU . 96.7 m-70 -56.58 147.71 21.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 70.41 110.889 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.64 166.43 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 71.14 110.799 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.1 p -86.08 157.05 20.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 61.01 111.145 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.41 -43.32 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.52 111.054 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.668 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -62.1 -46.04 90.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 52.12 110.986 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.679 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 98.2 m -52.04 -42.58 63.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 72.21 111.166 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.25 -24.79 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 63.32 111.117 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.87 -51.31 69.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 64.04 110.885 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.647 HD13 ' OD1' ' A' ' 152' ' ' ASP . 6.5 mp -76.26 -25.03 54.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.919 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.92 -69.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 74.42 111.155 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -54.72 -26.64 35.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 73.5 110.951 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -24.48 67.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 53.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -92.81 -38.97 11.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 74.53 110.873 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.86 -6.47 3.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 44.41 112.554 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -59.77 -172.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.832 0.348 . . . . 61.03 110.95 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.404 ' H ' HG21 ' A' ' 95' ' ' ILE . 56.0 mm-40 -98.63 -0.68 42.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 63.32 110.885 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 66.28 126.26 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.654 0.74 . . . . 72.21 110.85 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.677 2.251 . . . . 55.41 112.377 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 104' ' ' LYS . 62.9 mt -52.21 -40.55 61.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.903 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.1 55.97 18.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.531 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -148.98 52.93 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 71.31 110.912 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.8 mt -135.74 -177.67 4.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.883 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.83 -168.59 2.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.883 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.847 HG23 ' HB3' ' A' ' 144' ' ' TYR . 92.7 m -50.1 -54.26 21.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 70.23 111.158 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.699 HG22 ' HA ' ' A' ' 143' ' ' PHE . 90.8 t -131.34 130.98 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 64.02 111.106 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.565 HG22 HD23 ' A' ' 133' ' ' LEU . 99.1 m -135.6 123.67 22.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 75.11 111.167 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -81.41 103.97 11.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 75.1 110.85 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.565 HD23 HG22 ' A' ' 131' ' ' THR . 1.6 mt -91.97 150.43 21.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 73.13 110.902 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 130.42 16.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 74.22 110.898 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.489 ' HB2' HG21 ' A' ' 48' ' ' THR . 7.3 m-85 -133.42 37.6 3.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 54.14 110.873 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.76 111.67 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 72.33 112.496 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.73 28.29 14.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 74.44 110.858 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.41 ' CB ' HG22 ' A' ' 48' ' ' THR . 58.5 tpp -152.73 126.02 8.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 75.41 110.838 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -117.17 115.24 24.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.926 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.6 t -123.01 153.55 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 61.31 111.144 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -153.15 122.38 6.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 70.21 110.938 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.538 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -73.24 -178.18 2.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 42.13 111.148 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.699 ' HA ' HG22 ' A' ' 130' ' ' VAL . 71.2 t80 -175.35 134.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.84 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.847 ' HB3' HG23 ' A' ' 129' ' ' THR . 29.1 t80 -121.09 96.06 48.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.702 0.763 . . . . 74.24 110.91 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.7 Cg_endo -69.79 -48.71 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.619 2.213 . . . . 64.25 112.336 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.61 -153.78 20.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.738 . . . . 63.15 112.451 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.7 124.62 39.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 71.33 110.905 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.48 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.42 -94.19 0.34 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 53.32 112.47 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -70.11 -26.86 64.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 62.4 110.895 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.41 159.62 42.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.468 . . . . 74.32 111.119 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.28 -23.09 66.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.873 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.668 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -124.02 50.07 1.69 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 75.52 110.868 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.19 139.87 34.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 73.12 110.904 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.538 HD12 HG22 ' A' ' 142' ' ' THR . 5.6 pt -140.12 172.85 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 61.44 111.149 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 196' ' ' VAL . 7.9 m -123.58 139.23 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 45.21 111.183 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.447 ' O ' HD22 ' A' ' 164' ' ' LEU . 77.6 t -94.04 128.68 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 70.34 111.139 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -114.84 150.32 35.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.905 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.674 HD12 ' HB ' ' A' ' 163' ' ' ILE . 53.7 mt -124.77 94.87 43.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.595 0.712 . . . . 73.15 110.926 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 69.65 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.687 2.258 . . . . 65.14 112.317 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.37 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 74.23 110.874 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.617 ' CB ' HD13 ' A' ' 163' ' ' ILE . 7.3 m-85 -117.49 -10.76 10.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 75.52 110.905 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.4 m120 68.18 21.01 8.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 73.35 110.88 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.674 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.5 mp -86.41 116.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 65.44 111.097 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.6 tm? -101.98 123.46 45.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 52.42 110.984 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.489 ' N ' HD22 ' A' ' 164' ' ' LEU . 26.0 t -117.37 72.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 65.12 111.078 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.416 ' H ' HD13 ' A' ' 164' ' ' LEU . . . -65.17 -51.71 47.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 71.43 112.482 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.94 -138.02 14.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 72.33 112.483 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.91 -25.72 31.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 52.23 110.854 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.483 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.6 OUTLIER -62.08 -49.63 75.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 63.43 110.95 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.741 HG11 HG11 ' A' ' 206' ' ' VAL . 21.4 t -89.56 131.37 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 61.53 111.111 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -101.6 148.64 24.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 73.01 110.887 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.632 ' HA ' HD22 ' A' ' 218' ' ' LEU . 2.2 t -73.56 158.86 34.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.827 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.74 -24.95 66.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 72.03 111.197 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.8 p -77.9 -26.28 49.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 54.05 110.872 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.79 173.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 73.02 111.071 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.546 ' O ' HD22 ' A' ' 225' ' ' LEU . 0.1 OUTLIER -123.48 -39.69 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 72.24 110.901 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.549 ' HA ' HD22 ' A' ' 225' ' ' LEU . 0.3 OUTLIER -155.04 178.39 10.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 53.15 110.865 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.473 HD22 ' CE3' ' A' ' 189' ' ' TRP . 0.6 OUTLIER -77.07 -41.42 42.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.902 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 95.31 -158.35 22.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 73.14 112.484 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -52.09 137.13 28.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 72.41 110.93 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 186' ' ' VAL . 35.4 m -133.41 38.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 61.4 111.069 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.3 80.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 71.55 111.039 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -114.03 42.23 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 74.3 110.927 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.24 164.65 28.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.43 111.072 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -115.61 92.61 3.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 72.45 110.931 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.53 ' CG2' HG11 ' A' ' 181' ' ' VAL . 61.7 t -67.07 -23.68 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.1 111.201 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -79.39 -31.52 42.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 25.31 110.886 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.51 -22.7 20.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 62.41 110.911 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.473 ' CE3' HD22 ' A' ' 178' ' ' LEU . 1.5 t90 -51.49 -53.21 39.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 64.15 110.884 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.6 p -51.88 -37.93 54.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 71.04 110.86 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 91.8 m -70.64 -37.77 73.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 60.22 111.128 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.2 m -63.38 -55.27 25.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 70.51 110.876 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.939 HG22 HD23 ' A' ' 197' ' ' LEU . 25.8 mm -56.54 -37.63 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 64.12 111.112 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.06 -17.49 62.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 75.12 110.842 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -96.55 -28.96 14.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 61.14 110.901 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.518 HG21 HG11 ' A' ' 155' ' ' VAL . 96.0 t -82.69 -26.02 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 71.42 111.099 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.939 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -90.51 -23.27 20.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 64.45 110.909 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -88.51 -47.38 8.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 72.4 110.88 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 32.9 tpt85 -55.31 -32.59 62.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.834 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -130.89 116.91 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 72.3 110.888 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -119.3 34.94 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 75.34 110.897 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.02 22.33 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 70.3 110.859 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.541 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.2 mp -51.51 143.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 74.44 111.146 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -103.0 -39.27 6.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 74.03 110.936 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.432 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -153.71 118.96 5.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 72.42 111.092 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.741 HG11 HG11 ' A' ' 170' ' ' VAL . 92.8 t -96.96 123.21 49.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 74.41 111.152 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.049 HG21 HD11 ' A' ' 44' ' ' LEU . 87.5 t -106.49 102.13 39.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 73.44 111.154 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.0 Cg_endo -69.69 -170.05 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.75 2.3 . . . . 50.23 112.347 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.87 -31.27 7.45 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.733 -0.746 . . . . 61.54 112.445 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -144.27 111.9 6.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 65.45 110.873 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 144.91 -94.17 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 74.44 112.447 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -176.06 164.09 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 72.55 110.917 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.694 HG22 HG22 ' A' ' 207' ' ' VAL . 21.3 t -72.59 150.57 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.41 111.07 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.77 -108.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.767 -0.73 . . . . 74.01 112.457 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -160.27 -169.85 2.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.876 0.369 . . . . 63.14 110.887 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -54.25 -24.76 19.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 72.41 110.87 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.73 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -52.16 -35.6 42.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 71.51 112.5 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.711 HD12 ' CG1' ' A' ' 206' ' ' VAL . 32.7 mt -50.96 -45.68 60.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.339 . . . . 64.31 110.918 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.716 HD12 HG23 ' A' ' 193' ' ' ILE . 4.3 mm? -54.14 -41.3 68.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 74.41 111.01 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.73 HD12 ' HA2' ' A' ' 217' ' ' GLY . 4.8 mt -69.36 -40.87 77.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.32 110.853 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -60.78 -42.14 96.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.762 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.25 -48.43 65.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 62.31 111.167 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.799 ' HA ' HD12 ' A' ' 226' ' ' LEU . 3.8 mt -56.28 -41.4 75.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 62.12 110.93 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.91 -42.07 79.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 73.22 110.904 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 177' ' ' ASP . 17.5 mt -60.88 -37.4 82.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 75.03 110.894 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' A' ' 223' ' ' LEU . 4.7 mt -72.7 -40.53 66.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 65.22 110.944 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 71.32 110.909 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.734 ' HD2' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.773 0.32 . . . . 75.3 110.886 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.29 159.31 42.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 72.23 110.91 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -135.86 155.45 50.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 63.24 110.908 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -172.14 133.94 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 70.52 111.048 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 59.57 78.57 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 64.43 110.826 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.46 152.92 10.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.447 . . . . 53.15 110.929 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.529 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -146.09 -179.34 6.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 60.14 111.11 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.575 HG22 ' OG ' ' A' ' 19' ' ' SER . 92.4 t 60.96 95.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 60.2 111.154 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.6 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.1 mm -88.14 152.86 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 73.23 111.191 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -146.12 153.75 41.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 71.42 110.87 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.16 170.82 11.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 55.24 110.903 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -58.7 -27.17 64.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 73.42 110.885 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -100.13 -33.4 10.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 71.55 111.225 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.85 -9.76 51.8 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.737 -0.745 . . . . 50.42 112.446 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.704 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.94 -33.21 23.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.716 0.293 . . . . 72.51 111.123 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.704 HG13 HG23 ' A' ' 15' ' ' THR . 14.6 mt -124.81 149.18 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.15 111.084 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -168.34 169.75 10.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 72.31 110.845 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -135.05 -172.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.503 . . . . 75.02 111.143 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.575 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -173.76 132.86 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 60.51 110.908 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.21 120.72 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.104 -0.498 . . . . 74.5 110.923 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -103.8 -49.28 3.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.45 . . . . 54.22 110.932 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.33 51.87 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 69.03 -75.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.936 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.621 ' OD1' HG23 ' A' ' 25' ' ' VAL . 14.5 p30 -86.88 -19.91 28.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 71.45 110.897 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.621 HG23 ' OD1' ' A' ' 24' ' ' ASN . 99.6 t -97.45 118.52 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 65.34 111.123 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.529 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.4 m95 -122.35 161.56 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.939 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.5 HG21 HG21 ' A' ' 213' ' ' VAL . 70.4 t -122.35 106.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 64.55 111.108 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.456 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.1 p80 -95.83 137.37 34.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 74.24 110.876 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 41' ' ' SER . 37.3 m -132.46 128.76 38.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 62.14 111.156 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.651 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -120.29 -177.27 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.438 . . . . 73.0 110.865 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.09 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.3 OUTLIER -136.79 133.16 35.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 73.23 110.865 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.83 111.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 75.53 112.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.94 137.93 44.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 71.23 110.868 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -99.81 -22.3 15.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.918 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -172.63 31.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 75.31 110.863 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.91 17.17 10.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.683 -0.77 . . . . 35.21 112.447 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -125.07 -169.5 2.0 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.924 0.392 . . . . 72.23 110.868 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.09 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -128.31 101.77 6.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 60.21 111.108 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.743 HG11 ' HD1' ' A' ' 303' ' ' RTD . 59.4 t -113.07 103.4 55.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.643 0.735 . . . . 72.24 111.068 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.5 Cg_endo -69.69 141.04 44.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.649 2.233 . . . . 73.23 112.358 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.625 ' O ' HG23 ' A' ' 29' ' ' THR . 1.1 t -121.26 132.85 55.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 62.4 110.821 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -90.95 141.93 28.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 73.24 110.804 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.627 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -140.95 -155.87 6.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 52.04 112.53 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.919 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -164.93 144.13 6.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 71.44 110.903 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 54' ' ' LEU . 31.6 t -128.08 133.28 67.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 53.23 111.115 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.554 HD22 ' HE3' ' A' ' 138' ' ' MET . 39.6 mt -100.64 123.32 44.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.941 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -92.15 46.79 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 74.32 110.886 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.538 HG22 ' CB ' ' A' ' 138' ' ' MET . 24.5 p -55.35 171.26 0.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 63.44 111.125 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.3 t -99.24 28.45 4.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.83 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 22.8 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 70.33 110.941 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.8 129.98 4.4 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 65.13 112.503 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.799 HD13 ' HB ' ' A' ' 71' ' ' VAL . 26.0 mt -57.26 157.81 5.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 74.51 110.957 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' A' ' 81' ' ' ASP . 95.2 t -140.76 143.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 64.14 111.123 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.557 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -113.47 130.07 56.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 72.01 110.934 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.8 t -79.77 -1.78 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.096 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.78 134.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.88 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -166.7 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 71.41 110.821 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.17 -170.09 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 53.23 110.799 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.677 ' HB2' HD13 ' A' ' 63' ' ' LEU . 85.7 m95 -72.05 -40.22 68.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.094 -0.503 . . . . 71.21 110.931 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.79 175.54 9.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 32.31 110.958 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HA ' HG22 ' A' ' 64' ' ' THR . 4.1 p-10 -68.9 -30.61 69.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 75.12 110.823 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -74.54 -22.39 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 70.23 110.918 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.27 -52.41 5.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 64.44 110.89 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.495 HG21 ' HA3' ' A' ' 94' ' ' GLY . 10.2 t -57.4 -28.35 63.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 72.44 111.138 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -55.93 -40.82 73.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 53.24 110.874 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.96 -1.36 57.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.414 . . . . 74.53 110.866 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.651 HD22 ' OE2' ' A' ' 30' ' ' GLU . 15.5 tp -92.88 -45.15 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.902 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.8 mt -72.18 -14.65 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 73.42 111.072 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -87.11 5.9 35.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 63.15 110.848 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.1 mtp -106.54 -53.69 2.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 73.32 110.859 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.799 ' HB ' HD13 ' A' ' 52' ' ' LEU . 21.3 m -58.42 -37.77 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 71.32 111.083 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HG3' HG23 ' A' ' 71' ' ' VAL . 32.7 mt-10 -85.99 50.03 1.9 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.898 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.23 -42.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 72.02 110.837 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.6 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -103.9 -21.65 13.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.955 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.757 ' HB3' HD21 ' A' ' 52' ' ' LEU . 35.9 m-85 -91.23 12.94 18.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.883 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.511 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.72 46.91 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 71.13 110.923 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -155.57 -177.81 6.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 72.32 110.87 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.1 OUTLIER -125.85 159.13 33.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 71.13 110.875 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 52' ' ' LEU . 89.9 t -91.46 119.44 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 52.14 111.123 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.414 HG23 ' HG2' ' A' ' 78' ' ' ARG . 30.0 p -132.18 36.83 3.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.118 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.819 ' HB2' HG22 ' A' ' 53' ' ' VAL . 4.6 m-20 -169.76 134.29 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 73.12 110.794 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.677 HG23 HG21 ' A' ' 103' ' ' ILE . 22.4 t -140.66 100.27 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 71.22 111.09 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.7 mt -77.66 124.04 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 55.54 111.164 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.3 mm -109.24 142.43 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 74.24 111.132 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.8 p -98.69 -60.85 1.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 71.52 111.164 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -130.79 165.07 23.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 75.44 110.865 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.21 97.66 8.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.22 111.059 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.667 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.65 157.93 42.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 73.25 110.912 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.93 -29.57 63.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 73.33 111.087 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -89.66 10.7 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.873 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -121.94 -52.09 2.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 65.31 110.915 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -117.13 26.77 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.157 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.24 -28.19 18.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.707 -0.758 . . . . 60.04 112.479 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 64' ' ' THR . . . -116.02 30.61 6.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 65.32 112.543 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.514 HD11 ' C ' ' A' ' 122' ' ' GLU . 1.1 tt -48.56 -34.21 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 75.1 111.098 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -34.51 33.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 75.33 110.853 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.9 m -62.44 -34.18 76.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 72.44 111.063 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.967 HD12 ' HB2' ' A' ' 105' ' ' ALA . 27.6 mt -65.4 -43.24 91.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 63.32 110.878 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -26.26 59.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.866 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.25 -29.82 70.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 72.23 110.896 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -105.58 -48.29 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.35 110.858 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.62 -15.75 1.08 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.72 -0.753 . . . . 72.02 112.499 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.677 HG21 HG23 ' A' ' 82' ' ' VAL . 1.9 mp -54.56 151.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.13 111.123 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.787 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.6 ptpm? -113.66 127.84 56.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.923 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.967 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -90.12 82.03 6.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 40.42 111.043 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.456 ' ND1' HD12 ' A' ' 124' ' ' LEU . 93.7 m-70 -57.72 147.11 28.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.45 110.871 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.63 160.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 73.03 110.89 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.637 HG22 ' HB3' ' A' ' 127' ' ' LEU . 72.2 p -74.03 -175.61 2.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 41.14 111.111 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.12 -30.92 43.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 51.33 111.143 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.73 -44.68 40.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.958 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.7 m -55.41 -25.38 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 73.13 111.168 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.518 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -91.31 -34.34 14.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 64.23 111.159 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -53.69 -32.8 53.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 60.31 110.89 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.558 HD13 ' OD1' ' A' ' 152' ' ' ASP . 9.8 mp -91.79 -25.84 18.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 70.35 110.838 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . . . -53.65 -62.72 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.32 111.096 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -60.12 -26.09 65.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 71.3 110.898 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -25.18 68.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.893 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -92.16 -33.38 14.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 64.3 110.868 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.1 -10.78 4.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 32.34 112.494 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -59.59 -173.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.83 0.347 . . . . 72.41 110.871 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -98.71 0.32 44.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 54.44 110.886 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.514 ' C ' HD11 ' A' ' 95' ' ' ILE . 1.2 mt-10 66.42 132.59 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.656 0.741 . . . . 74.21 110.928 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.8 -169.63 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.653 2.235 . . . . 61.33 112.4 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.787 HD11 ' HB2' ' A' ' 104' ' ' LYS . 54.2 mt -54.83 -51.11 66.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 73.11 110.959 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.4 51.72 8.2 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.75 -0.738 . . . . 62.12 112.471 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.46 55.42 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 64.32 110.833 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.637 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.5 OUTLIER -137.61 -174.66 3.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 61.1 110.89 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.84 -168.16 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.764 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.1 m -49.66 -43.01 46.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 65.42 111.221 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.38 142.15 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 75.5 111.061 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.654 HG22 HD23 ' A' ' 133' ' ' LEU . 60.6 m -149.83 108.87 3.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.095 -0.502 . . . . 72.03 111.084 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -69.75 96.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 72.53 110.858 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.654 HD23 HG22 ' A' ' 131' ' ' THR . 3.3 mt -86.82 150.64 23.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 54.0 110.94 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 130.21 12.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 45.23 110.928 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.474 ' HB2' HG21 ' A' ' 48' ' ' THR . 6.7 m-85 -132.54 99.42 4.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 74.0 110.881 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 58.69 -97.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 72.12 112.514 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -115.12 57.81 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 52.41 110.877 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.554 ' HE3' HD22 ' A' ' 46' ' ' LEU . 2.2 tpt -153.72 142.68 21.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 65.33 110.832 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -120.51 127.72 52.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 62.34 110.848 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.702 HG13 HD23 ' A' ' 158' ' ' LEU . 5.0 t -141.51 158.96 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 43.35 111.145 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.417 ' N ' HG12 ' A' ' 140' ' ' VAL . 30.7 tt0 -159.01 124.58 4.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 52.11 110.891 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.412 HG22 ' CD1' ' A' ' 154' ' ' ILE . 0.0 OUTLIER -74.97 -178.27 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 72.33 111.13 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -175.36 140.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 71.5 110.895 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.764 ' HB3' HG23 ' A' ' 129' ' ' THR . 49.7 t80 -123.24 97.66 42.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.598 0.713 . . . . 74.02 110.927 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.478 ' HB3' HG23 ' A' ' 196' ' ' VAL . 54.0 Cg_endo -69.7 -48.98 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.699 2.266 . . . . 54.12 112.371 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.59 -153.95 22.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.786 -0.721 . . . . 55.22 112.467 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.51 122.44 39.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 74.23 110.934 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.5 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -135.04 -97.76 0.56 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 52.21 112.481 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -67.65 -28.41 67.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.818 0.342 . . . . 64.24 110.862 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.69 156.44 41.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 73.12 111.114 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -59.91 -29.26 68.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 72.01 110.844 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.558 ' OD1' HD13 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -117.9 52.12 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.89 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.72 135.0 42.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 75.43 110.884 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.415 HG22 ' HD1' ' A' ' 144' ' ' TYR . 1.1 pt -136.45 166.98 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 74.23 111.114 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.442 ' CG1' HD23 ' A' ' 169' ' ' LEU . 10.5 m -116.83 157.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 70.13 111.107 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.3 t -110.36 143.29 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.136 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -130.87 148.15 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 71.14 110.902 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.702 HD23 HG13 ' A' ' 140' ' ' VAL . 24.1 mt -125.53 95.37 40.8 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.57 0.7 . . . . 74.22 110.888 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 72.21 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.729 2.286 . . . . 52.12 112.317 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.08 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 70.33 110.934 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.89 -11.74 10.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.891 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 68.36 24.12 7.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 63.13 110.976 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.562 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.7 mp -96.24 117.24 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 64.33 111.172 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.23 142.65 33.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.952 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.507 HG21 HD22 ' A' ' 44' ' ' LEU . 21.6 t -127.9 67.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 75.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.62 -55.19 21.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.67 -0.776 . . . . 71.25 112.544 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.14 -137.12 13.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.668 -0.777 . . . . 34.01 112.468 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 59.3 m -64.24 -15.8 60.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 61.43 110.934 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.651 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.5 tp -70.11 -47.59 61.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.914 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 218' ' ' LEU . 21.8 t -95.91 115.92 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 53.43 111.148 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.615 ' H ' HG23 ' A' ' 222' ' ' THR . 0.1 OUTLIER -82.85 155.76 23.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 73.42 110.892 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.619 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.5 t -84.0 162.29 20.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 73.14 110.843 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.1 p -59.15 -31.41 68.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 73.3 111.161 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.38 -28.57 64.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.143 -0.481 . . . . 61.13 110.832 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.4 162.4 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 52.22 111.084 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -122.32 -37.02 2.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.884 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -154.91 171.92 18.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 41.11 110.918 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.601 HD11 HD23 ' A' ' 226' ' ' LEU . 2.1 mt -72.66 -43.38 63.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.958 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 99.29 -154.47 19.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.686 -0.769 . . . . 73.42 112.523 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -52.03 126.85 19.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 72.15 110.906 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.488 HG11 ' CG2' ' A' ' 186' ' ' VAL . 6.7 m -117.7 31.68 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 63.14 111.115 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.27 -47.05 82.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 70.25 111.155 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -117.42 42.99 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.35 110.844 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -133.62 162.17 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 73.23 111.138 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -115.72 93.49 4.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.022 0.439 . . . . 75.45 110.902 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.488 ' CG2' HG11 ' A' ' 181' ' ' VAL . 49.1 t -69.36 -20.91 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 74.25 111.06 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -81.98 -26.84 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 70.34 110.943 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.54 -21.37 16.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.53 110.841 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.651 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -51.41 -56.18 14.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.9 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.3 p -51.96 -37.77 54.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.837 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.1 m -72.56 -37.84 68.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 72.15 111.127 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 75.7 m -61.92 -54.92 35.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.04 110.83 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.772 HG23 HD12 ' A' ' 219' ' ' LEU . 26.7 mm -55.83 -36.75 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 74.15 111.087 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.88 -17.31 64.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.3 110.828 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -93.93 -31.03 14.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 70.5 110.871 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 145' ' ' PRO . 87.3 t -77.26 -45.9 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 54.13 111.137 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.713 HD23 HG22 ' A' ' 193' ' ' ILE . 3.6 pp -69.77 -23.2 63.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.467 . . . . 63.12 110.878 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -86.23 -44.33 12.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 63.51 110.866 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -53.29 -28.5 28.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 73.02 110.874 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -142.52 121.24 12.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 64.53 110.96 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.42 35.69 4.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 73.41 110.879 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.25 21.8 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.914 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.449 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.6 mp -53.24 145.08 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.42 111.164 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -105.88 -33.76 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.91 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.562 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -155.92 128.37 7.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 44.23 111.111 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.498 HG12 HD12 ' A' ' 218' ' ' LEU . 94.8 t -109.85 117.42 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 44.41 111.126 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.919 HG21 HD11 ' A' ' 44' ' ' LEU . 75.3 t -100.04 104.3 28.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.594 0.711 . . . . 70.41 111.097 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.75 -173.7 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.707 2.271 . . . . 72.4 112.32 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.42 -28.85 10.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.737 . . . . 65.13 112.503 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -144.09 110.52 5.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 74.11 110.824 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 144.92 -98.41 0.2 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 44.23 112.508 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -174.62 154.75 2.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 72.12 110.928 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.816 HG22 HG22 ' A' ' 207' ' ' VAL . 22.9 t -57.32 149.59 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 62.33 111.157 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -148.72 -108.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.697 -0.763 . . . . 73.03 112.515 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -161.34 -169.85 2.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.893 0.378 . . . . 72.12 110.92 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -58.18 -20.56 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 44.32 110.949 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.63 -33.98 63.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.76 -0.734 . . . . 55.45 112.461 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 172' ' ' SER . 28.0 mt -50.59 -42.66 56.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.834 0.35 . . . . 72.14 110.896 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.772 HD12 HG23 ' A' ' 193' ' ' ILE . 4.6 mm? -55.43 -43.36 75.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.919 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.571 HD12 ' HA2' ' A' ' 217' ' ' GLY . 4.9 mt -68.54 -40.41 80.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 72.11 110.9 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -60.72 -38.91 86.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.52 110.879 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.615 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.78 -45.07 63.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 70.42 111.081 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.791 ' HA ' HD12 ' A' ' 226' ' ' LEU . 9.5 mt -59.4 -42.57 92.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.888 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -29.21 56.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.852 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.9 mt -75.21 -26.89 59.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 73.24 110.88 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.791 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.4 mt -86.09 -30.21 22.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.958 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 63.25 110.907 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.743 ' HD1' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.894 0.378 . . . . 73.51 110.899 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -134.96 133.85 39.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.057 -0.52 . . . . 64.04 110.859 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -133.44 162.45 31.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 71.41 110.924 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.5 m -149.81 164.38 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 72.5 111.207 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -99.89 43.78 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 64.21 110.865 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -108.05 150.85 26.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 51.43 110.941 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -145.74 -179.99 7.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 74.41 111.15 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 18' ' ' ILE . 95.4 t 61.29 100.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 74.43 111.154 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.696 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.9 mm -93.76 156.88 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 70.23 111.155 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.42 170.08 19.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 75.12 110.933 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -99.89 -169.29 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 75.11 110.983 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.578 ' HG3' HG23 ' A' ' 13' ' ' THR . 18.5 pt-20 -75.28 -20.96 58.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.877 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 12' ' ' GLU . 26.3 p -107.66 -39.53 5.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 71.41 111.148 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.02 -2.65 30.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 54.11 112.473 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.733 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.57 -33.28 21.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 75.21 111.181 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.733 HG13 HG23 ' A' ' 15' ' ' THR . 8.1 mt -129.25 158.96 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.12 111.093 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 16' ' ' ILE . 35.9 p -175.8 164.23 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 64.02 110.823 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.572 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.88 -175.41 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.515 . . . . 62.14 111.163 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.443 ' HA ' HG22 ' A' ' 8' ' ' VAL . 1.7 t -167.54 131.07 1.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 53.52 110.845 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.12 118.48 11.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 71.44 110.922 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.57 -45.88 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.861 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -141.58 -169.63 2.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.3 110.916 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -51.07 -49.66 60.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.875 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -133.38 39.14 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 74.13 110.871 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.39 121.63 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 71.54 111.159 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.45 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.1 m95 -126.38 159.61 32.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 64.25 110.965 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.2 t -122.43 106.69 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 73.43 111.124 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.528 ' HB3' HG23 ' A' ' 18' ' ' ILE . 8.4 p80 -98.37 138.13 36.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 72.43 110.851 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 m -136.59 134.21 37.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 73.43 111.127 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' HB3' HG23 ' A' ' 16' ' ' ILE . 2.5 pm0 -125.93 175.74 7.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 64.21 110.907 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 40' ' ' PRO . 4.2 tp -119.76 150.05 41.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.13 110.975 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.72 -135.78 3.44 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.775 -0.726 . . . . 55.33 112.526 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.01 159.46 34.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.89 0.376 . . . . 64.0 110.825 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -177.91 91.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.93 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.94 61.7 2.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 63.11 110.822 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.03 30.71 60.8 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.744 -0.741 . . . . 34.53 112.437 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -149.28 128.68 12.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.865 0.364 . . . . 71.24 110.889 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.491 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -68.06 129.79 40.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 74.42 111.054 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.66 HG21 ' HD2' ' A' ' 303' ' ' RTD . 2.3 p -119.51 124.33 28.13 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.622 0.725 . . . . 74.41 111.151 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.624 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.4 Cg_endo -69.73 151.97 69.34 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.693 2.262 . . . . 54.15 112.328 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 t -138.21 92.29 2.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 55.43 110.87 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -52.77 171.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 75.32 110.941 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -169.93 -156.43 11.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.729 -0.748 . . . . 74.11 112.5 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.912 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -166.68 144.39 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 75.13 110.934 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.632 HG11 HG11 ' A' ' 71' ' ' VAL . 41.5 t -128.94 138.51 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 62.0 111.144 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.61 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 45.8 mt -106.03 130.69 53.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 72.1 110.86 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.99 56.94 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 75.0 110.921 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 135' ' ' PHE . 17.9 p -67.23 177.38 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 64.42 111.217 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.51 20.23 15.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 72.13 110.818 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.91 24.37 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.858 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.11 134.92 6.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 72.22 112.487 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.764 HD13 ' HB ' ' A' ' 71' ' ' VAL . 6.8 mt -60.93 157.54 15.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 72.25 110.908 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.809 HG22 ' HB2' ' A' ' 81' ' ' ASP . 84.5 t -136.94 142.8 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.03 111.121 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.587 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -113.86 128.85 56.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.14 110.92 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 55' ' ' VAL . 13.8 t -78.95 -1.76 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 55.34 111.154 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 179.93 127.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 63.04 110.872 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -66.57 -166.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.827 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -95.06 -171.38 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 70.32 110.842 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.782 ' HB2' HD13 ' A' ' 63' ' ' LEU . 88.6 m95 -72.61 -37.34 68.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.01 110.927 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -145.77 157.61 43.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 73.44 110.829 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -54.25 -34.61 61.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 54.11 110.869 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -74.91 -25.55 59.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 73.3 110.957 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.782 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -81.49 -44.76 16.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 71.53 110.908 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 t -60.26 -26.16 66.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 72.1 111.175 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -54.36 -42.4 70.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 52.14 110.82 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.33 -10.51 59.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 75.42 110.883 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 16' ' ' ILE . 55.2 tp -89.69 -52.38 5.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 74.22 110.909 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.1 mt -65.83 -15.3 18.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 52.12 111.117 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -87.3 7.09 30.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 63.32 110.866 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.1 mtp -103.26 -57.35 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 71.21 110.865 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.764 ' HB ' HD13 ' A' ' 52' ' ' LEU . 19.1 m -58.0 -39.22 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 71.5 111.117 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -84.07 50.79 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 72.35 110.846 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 -39.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 54.14 110.867 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.696 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -110.66 -21.62 12.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.897 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.516 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 29.0 m-85 -90.15 12.08 18.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 65.45 110.863 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.516 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.79 46.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 74.23 110.924 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.6 mttp -151.6 -177.04 5.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.252 -0.431 . . . . 72.14 110.977 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.535 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.41 158.4 38.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 70.43 110.863 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.452 ' CG1' HD23 ' A' ' 54' ' ' LEU . 26.1 t -89.53 117.13 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.42 111.096 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.535 HG23 ' HG2' ' A' ' 78' ' ' ARG . 42.9 p -133.03 38.19 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.4 111.247 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.809 ' HB2' HG22 ' A' ' 53' ' ' VAL . 2.4 m-20 -168.83 134.97 1.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 44.11 110.838 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 98' ' ' LEU . 16.1 t -143.01 102.19 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.43 111.162 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.8 mt -81.41 115.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 62.44 111.07 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.528 HG23 ' HB3' ' A' ' 91' ' ' ARG . 42.1 mm -101.33 129.86 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.11 111.097 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -87.68 -56.03 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.14 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -133.06 166.4 22.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 64.44 110.862 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -85.05 98.38 10.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.411 . . . . 43.34 111.149 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.645 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -152.23 159.65 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.9 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.09 -28.73 62.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 73.12 111.097 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.35 12.01 19.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 53.05 110.792 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.528 ' HB3' HG23 ' A' ' 84' ' ' ILE . 1.9 mmp_? -124.0 -52.26 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 74.1 110.866 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.32 17.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 61.04 111.157 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.9 -28.12 23.27 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.753 -0.736 . . . . 62.52 112.499 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.0 20.75 26.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 74.51 112.543 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.459 HG21 ' H ' ' A' ' 121' ' ' GLU . 1.6 tt -48.35 -31.03 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 74.24 111.134 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -69.49 -44.53 70.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 74.22 110.925 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 m -66.67 -34.36 77.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 63.51 111.14 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.561 ' CD2' HG21 ' A' ' 82' ' ' VAL . 50.1 mt -64.37 -26.87 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 71.51 110.912 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -99.77 21.01 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 64.32 110.914 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.07 -30.41 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 70.21 110.872 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -104.38 12.42 33.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 64.31 110.881 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.38 25.07 61.93 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.822 -0.704 . . . . 63.23 112.509 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 98' ' ' LEU . 11.4 mt -88.11 157.07 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 75.52 111.163 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.819 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -120.32 118.79 31.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 72.43 110.918 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.509 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . . . -90.17 78.31 6.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 64.51 111.009 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.504 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.3 m-70 -54.77 147.92 13.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 62.2 110.898 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.93 163.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 65.22 110.891 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 127' ' ' LEU . 68.7 p -85.13 158.17 20.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 51.32 111.182 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.7 61.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 72.54 111.103 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.692 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -62.71 -46.89 86.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 71.32 110.873 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.729 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 100.0 m -52.43 -41.98 63.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 73.34 111.168 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.49 -23.38 61.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 65.24 111.137 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.87 -43.08 85.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.473 HD13 ' OD2' ' A' ' 152' ' ' ASP . 7.3 mp -81.1 -28.03 35.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 54.51 110.936 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.425 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . . . -51.67 -70.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 65.25 111.03 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -26.0 36.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 72.15 110.962 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -23.65 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 75.23 110.869 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -96.07 -38.71 10.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 74.45 110.898 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.87 -6.39 3.76 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.698 -0.763 . . . . 71.22 112.483 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.62 -172.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 70.23 110.931 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.459 ' H ' HG21 ' A' ' 95' ' ' ILE . 26.4 mm-40 -97.8 -1.57 42.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 74.24 110.842 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.458 ' C ' HD11 ' A' ' 95' ' ' ILE . 1.1 mt-10 66.31 129.13 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.657 0.741 . . . . 52.41 110.84 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.648 2.232 . . . . 53.55 112.341 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 104' ' ' LYS . 79.6 mt -54.08 -35.96 62.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 51.32 110.955 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.12 49.04 51.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 70.21 112.457 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -142.8 56.28 1.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 71.5 110.857 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.519 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.7 OUTLIER -136.79 -169.8 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 75.11 110.91 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -148.84 -168.79 3.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 63.42 110.879 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.829 HG23 ' HB3' ' A' ' 144' ' ' TYR . 99.3 m -50.27 -56.99 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 72.32 111.156 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.701 HG23 HG22 ' A' ' 129' ' ' THR . 88.4 t -130.29 128.5 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 75.41 111.114 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.538 HG22 HD23 ' A' ' 133' ' ' LEU . 90.6 m -135.81 124.31 23.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 62.35 111.154 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -80.33 103.0 9.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.912 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.538 HD23 HG22 ' A' ' 131' ' ' THR . 2.6 mt -90.01 150.38 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 55.21 110.926 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.48 122.64 9.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 62.0 110.893 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.635 ' HB2' HG21 ' A' ' 48' ' ' THR . 11.0 m-85 -123.37 42.82 3.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 54.3 110.955 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.53 113.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 72.33 112.503 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.0 m120 62.45 27.17 16.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 74.31 110.85 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.61 ' HE3' ' HB3' ' A' ' 46' ' ' LEU . 32.0 tpp -149.76 139.66 21.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.88 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.14 120.99 28.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 62.41 110.868 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.588 HG13 HD23 ' A' ' 158' ' ' LEU . 10.3 t -131.57 155.67 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.22 111.145 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -153.09 125.06 7.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.872 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.544 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -75.47 -177.95 3.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 64.32 111.18 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.678 ' HA ' HG22 ' A' ' 130' ' ' VAL . 73.4 t80 -175.18 137.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.887 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.829 ' HB3' HG23 ' A' ' 129' ' ' THR . 29.5 t80 -122.61 94.86 47.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.692 0.758 . . . . 74.22 110.974 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.9 Cg_endo -69.76 -48.74 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 73.03 112.292 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.45 -152.24 15.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 54.34 112.437 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.62 125.81 45.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.346 . . . . 75.35 110.903 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.653 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -136.5 -87.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.71 . . . . 42.24 112.495 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -76.33 -29.18 57.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 64.21 110.91 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.68 156.11 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.24 111.19 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.81 -24.88 62.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 74.12 110.789 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.692 ' HB3' HD12 ' A' ' 110' ' ' LEU . 14.4 p30 -119.98 47.36 1.76 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 73.35 110.827 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.495 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -97.27 134.55 40.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 62.41 110.848 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.577 HG22 ' CD1' ' A' ' 144' ' ' TYR . 2.6 pt -136.07 169.87 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 71.45 111.089 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.421 ' CG1' HD22 ' A' ' 169' ' ' LEU . 6.9 m -120.98 145.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 74.43 111.077 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.1 t -98.29 143.58 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 65.41 111.12 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -129.85 149.74 51.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 71.43 110.914 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.588 HD23 HG13 ' A' ' 140' ' ' VAL . 28.5 mt -126.96 95.71 36.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.604 0.716 . . . . 64.51 110.936 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 71.91 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.679 2.253 . . . . 74.14 112.35 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.928 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.552 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.2 m-85 -118.03 -13.18 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 71.11 110.908 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.6 m120 69.4 23.26 6.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 75.35 110.922 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.552 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.6 mp -93.51 114.38 30.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 70.41 111.113 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.14 136.61 39.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 74.35 110.898 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.596 HG21 HD22 ' A' ' 44' ' ' LEU . 31.7 t -122.11 67.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 73.01 111.16 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.34 -55.62 18.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.74 -0.743 . . . . 72.55 112.559 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.18 -122.83 6.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.746 -0.74 . . . . 72.4 112.467 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.7 m -80.82 -0.8 40.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 70.31 110.909 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.478 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.6 OUTLIER -85.31 -49.1 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 74.44 110.981 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 206' ' ' VAL . 45.2 t -94.32 105.77 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 74.14 111.125 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.532 ' H ' HG23 ' A' ' 222' ' ' THR . 0.1 OUTLIER -75.02 164.45 26.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.918 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.65 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.4 p -88.65 158.65 18.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.798 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.513 HG23 HD23 ' A' ' 218' ' ' LEU . 1.7 p -58.88 -27.21 64.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 71.12 111.14 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.9 t -74.09 -29.0 61.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.421 . . . . 65.41 110.873 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.62 158.49 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 43.1 111.09 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.65 -27.39 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 70.51 110.918 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -164.57 -180.0 6.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 70.14 110.822 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.513 HD11 HD23 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -82.61 -37.51 24.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 54.41 110.877 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.49 -157.53 22.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.793 -0.718 . . . . 72.21 112.453 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -52.24 129.67 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 74.53 110.898 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 186' ' ' VAL . 26.0 m -122.59 39.7 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 61.44 111.082 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.63 91.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 65.44 111.07 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.88 44.66 1.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.14 110.937 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -134.93 174.16 10.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 60.11 111.067 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -127.24 87.46 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 54.51 110.985 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' A' ' 181' ' ' VAL . 21.9 t -66.39 -22.22 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 71.14 111.181 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.7 -32.96 58.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 40.35 110.922 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -93.53 -22.8 18.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 73.35 110.877 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.495 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.4 t90 -51.48 -55.88 16.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 64.43 110.83 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.3 p -51.94 -37.05 51.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.88 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m -74.18 -35.62 63.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 63.55 111.111 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 196' ' ' VAL . 32.9 m -63.19 -52.38 62.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 74.53 110.838 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.975 HG22 HD23 ' A' ' 197' ' ' LEU . 27.7 mm -58.02 -39.15 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 74.22 111.092 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.22 -17.07 57.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 74.43 110.929 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -99.76 -23.83 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 73.52 110.843 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 192' ' ' SER . 48.6 t -88.34 -18.43 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 65.01 111.119 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.975 HD23 HG22 ' A' ' 193' ' ' ILE . 2.4 pp -105.52 1.27 27.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.939 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -117.81 -24.01 7.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 43.43 110.901 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -82.67 1.15 39.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 64.43 110.829 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -136.28 -72.3 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.215 -0.448 . . . . 63.52 110.972 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.78 21.97 9.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 63.41 110.866 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -144.51 21.95 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.4 110.889 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.27 145.86 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.52 111.184 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -102.56 -28.2 12.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 61.43 110.876 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -163.95 128.98 2.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 64.54 111.106 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.747 ' CG1' HD12 ' A' ' 218' ' ' LEU . 95.2 t -107.1 126.3 63.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 75.33 111.131 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.912 HG21 HD11 ' A' ' 44' ' ' LEU . 50.4 t -109.91 106.12 57.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.646 0.736 . . . . 73.13 111.102 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.75 -169.27 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.735 2.29 . . . . 63.35 112.304 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -111.14 -21.7 6.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 61.55 112.406 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -145.69 74.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 75.54 110.905 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.1 -101.75 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 73.52 112.5 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -171.66 140.26 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 74.32 110.83 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.45 143.78 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 61.3 111.142 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.6 -106.19 0.49 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.75 . . . . 63.32 112.489 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -156.22 -169.92 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.349 . . . . 63.13 110.9 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -56.36 -22.37 30.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.866 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.483 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.24 -32.8 51.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 75.33 112.484 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.747 HD12 ' CG1' ' A' ' 206' ' ' VAL . 31.3 mt -50.79 -41.55 57.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 53.02 110.98 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 193' ' ' ILE . 4.3 mm? -56.02 -44.77 79.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 73.22 110.962 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.483 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.1 mt -67.82 -40.48 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 72.23 110.956 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -58.66 -43.76 89.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.831 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.68 -48.36 63.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.22 111.16 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.75 ' HA ' HD12 ' A' ' 226' ' ' LEU . 44.1 mt -54.77 -41.28 70.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.925 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -32.73 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 64.11 110.863 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.21 -25.77 61.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 72.54 110.953 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.75 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.8 mt -87.37 -38.07 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.31 110.936 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 63.42 110.909 179.795 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.66 ' HD2' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.894 0.378 . . . . 44.52 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.94 178.76 4.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 73.42 110.837 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.77 137.74 51.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 63.43 110.89 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 p -173.21 142.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 64.33 111.14 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.24 91.14 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.888 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -132.25 151.83 51.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 64.42 110.878 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.436 HG22 ' CH2' ' A' ' 26' ' ' TRP . 1.1 p -144.24 -179.06 6.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 72.04 111.144 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 18' ' ' ILE . 97.0 t 61.29 101.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 74.25 111.147 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.643 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.6 mm -94.64 153.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 64.31 111.167 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -148.84 156.29 42.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 72.34 110.846 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.45 -169.58 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.87 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 -23.49 52.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.874 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.9 p -101.79 -35.13 9.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.042 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.62 -5.13 51.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 52.31 112.478 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.78 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.49 -33.28 20.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 74.34 111.214 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.78 HG13 HG23 ' A' ' 15' ' ' THR . 6.3 mt -128.55 159.92 39.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 63.13 111.052 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -175.52 169.33 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.24 110.929 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -131.63 -174.13 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 64.02 111.137 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.467 ' HA ' HG22 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -169.38 131.7 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 65.04 110.894 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.52 119.09 14.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 70.02 110.916 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.56 HD21 HG21 ' A' ' 213' ' ' VAL . 4.1 mp -107.94 -33.9 7.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 72.41 110.918 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -149.22 -178.1 6.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 72.02 110.813 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -51.06 -41.01 59.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 65.42 110.861 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -139.93 38.6 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 73.11 110.882 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 22' ' ' ASN . 15.0 t -137.88 116.05 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 72.23 111.135 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.436 ' CH2' HG22 ' A' ' 7' ' ' THR . 14.0 m95 -123.98 155.59 37.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 73.12 110.89 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.53 HG23 HD13 ' A' ' 21' ' ' LEU . 29.6 t -117.29 108.6 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 71.31 111.115 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.559 ' HB3' HG23 ' A' ' 18' ' ' ILE . 8.2 p80 -101.57 138.39 38.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 72.41 110.861 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.3 m -135.2 140.66 45.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 74.23 111.217 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HB3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -131.27 174.17 10.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 74.5 110.897 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.66 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 5.2 tp -119.48 148.53 43.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.34 110.896 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.2 -120.01 1.98 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 73.14 112.477 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.53 148.97 35.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 61.32 110.876 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -170.26 109.05 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.881 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 51.48 53.16 13.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 52.01 110.876 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.23 25.83 67.01 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.776 -0.726 . . . . 55.41 112.477 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -151.73 120.69 6.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 70.41 110.886 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -51.49 138.54 21.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 55.11 111.142 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.628 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.4 p -123.6 129.95 24.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.584 0.707 . . . . 71.41 111.153 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.5 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.1 Cg_endo -69.81 146.97 61.51 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.712 2.275 . . . . 74.14 112.317 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -134.55 98.19 4.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 51.23 110.904 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -51.99 168.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 61.13 110.887 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.635 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -167.68 -163.36 21.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 70.11 112.483 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.902 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -164.22 145.98 8.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.857 0.36 . . . . 63.41 110.917 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.636 HG22 HD13 ' A' ' 54' ' ' LEU . 59.3 t -131.05 140.77 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 74.02 111.14 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.472 HD13 ' HG2' ' A' ' 138' ' ' MET . 39.2 mt -108.0 128.17 54.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 62.41 110.909 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -97.26 55.25 1.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.908 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.827 HG21 ' HB2' ' A' ' 135' ' ' PHE . 19.8 p -60.36 -170.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 64.51 111.1 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.6 6.49 16.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 71.24 110.848 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -118.32 -18.75 9.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 70.44 110.925 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.76 130.54 1.31 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.823 -0.703 . . . . 41.14 112.543 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.746 HD13 ' HB ' ' A' ' 71' ' ' VAL . 14.1 mt -49.37 153.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.923 0.392 . . . . 65.45 110.877 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.707 HG21 ' CG ' ' A' ' 135' ' ' PHE . 93.8 t -136.96 143.23 35.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.158 -0.474 . . . . 73.15 111.11 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.636 HD13 HG22 ' A' ' 45' ' ' VAL . 3.5 mm? -114.88 128.44 56.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.2 110.816 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 55' ' ' VAL . 13.6 t -78.45 -2.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 64.13 111.147 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -179.47 131.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 54.25 110.89 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.55 -167.31 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 60.1 110.906 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -173.14 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 63.11 110.889 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.648 ' HB2' HD13 ' A' ' 63' ' ' LEU . 85.6 m95 -71.0 -38.51 72.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 75.41 110.93 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -141.72 161.64 37.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.802 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.51 -33.02 69.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.34 110.92 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -75.3 -25.58 58.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.869 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -81.7 -43.65 18.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 72.11 110.879 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.8 t -65.48 -23.35 66.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.174 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -53.81 -43.26 69.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 70.11 110.887 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.72 -15.73 55.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 74.41 110.941 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.461 HD22 ' OE2' ' A' ' 30' ' ' GLU . 21.6 tp -77.8 -50.17 12.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.491 . . . . 73.44 110.894 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.0 mt -71.93 -15.39 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 55.24 111.111 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -88.71 10.35 21.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 70.33 110.895 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.8 mmm -109.88 -55.56 2.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.913 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.746 ' HB ' HD13 ' A' ' 52' ' ' LEU . 17.0 m -57.55 -37.19 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 74.31 111.141 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.44 50.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 71.32 110.913 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.57 -39.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 74.52 110.865 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.643 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -110.9 -21.25 12.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.863 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.555 ' CB ' HD21 ' A' ' 52' ' ' LEU . 29.0 m-85 -90.62 12.67 18.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 63.31 110.89 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.522 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 2.1 pp0? 31.5 49.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.52 110.949 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.0 -176.54 5.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 75.03 110.962 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.629 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -133.98 152.26 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 63.44 110.863 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 52' ' ' LEU . 82.7 t -85.29 125.56 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 64.23 111.192 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.629 HG23 ' HD3' ' A' ' 78' ' ' ARG . 74.3 p -136.0 16.62 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 61.21 111.127 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.576 ' HB2' HG13 ' A' ' 53' ' ' VAL . 1.4 m-20 -150.02 134.92 17.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 74.51 110.898 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.623 HG21 ' CD2' ' A' ' 98' ' ' LEU . 24.6 t -139.3 99.01 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 74.35 111.034 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.8 mt -76.29 126.54 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 55.22 111.203 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 91' ' ' ARG . 40.8 mm -113.55 133.34 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 64.01 111.131 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -90.11 -54.89 3.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 72.41 111.134 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -134.38 165.78 24.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.848 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.692 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -84.79 98.32 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 40.33 111.133 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.654 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.75 159.44 43.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 71.12 110.848 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.23 -28.71 63.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 65.53 111.058 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.98 10.72 22.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 70.31 110.855 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HB3' HG23 ' A' ' 84' ' ' ILE . 1.9 mmp_? -122.67 -52.03 1.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 65.45 110.908 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -116.39 17.45 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 63.11 111.11 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.96 -26.53 27.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.701 -0.761 . . . . 63.23 112.442 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.93 18.46 31.42 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.77 -0.729 . . . . 63.52 112.5 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.435 HG21 ' H ' ' A' ' 121' ' ' GLU . 5.2 tt -48.93 -30.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.834 0.35 . . . . 72.2 111.077 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -67.96 -43.65 78.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 55.13 110.931 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.4 m -69.78 -34.09 73.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 74.52 111.072 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.623 ' CD2' HG21 ' A' ' 82' ' ' VAL . 55.8 mt -63.47 -28.2 69.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 70.33 110.895 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.95 19.49 14.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.922 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -117.33 -21.9 8.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 71.2 110.896 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -113.08 8.8 18.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 71.41 110.88 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.2 16.92 65.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 61.44 112.481 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 98' ' ' LEU . 13.9 mt -82.43 156.96 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 71.52 111.159 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.762 ' HB2' HD11 ' A' ' 124' ' ' LEU . 13.3 ptpt -120.65 122.86 41.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 55.22 110.891 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.483 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -90.58 78.42 6.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 71.11 111.061 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.617 ' HA ' HD12 ' A' ' 124' ' ' LEU . 88.6 m-70 -51.71 146.21 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 33.33 110.866 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.49 163.71 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 72.42 110.814 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -80.19 156.32 26.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 72.21 111.122 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.83 -27.03 27.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 53.0 111.091 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 152' ' ' ASP . 6.9 tp -74.95 -45.89 39.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 73.44 110.954 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.692 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 91.8 m -52.96 -28.1 22.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 60.13 111.142 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -84.08 -29.76 26.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 62.31 111.015 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -58.89 -31.12 68.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.409 . . . . 75.32 110.913 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.674 HD13 ' OD1' ' A' ' 152' ' ' ASP . 7.4 mp -93.55 -25.47 17.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.129 -0.487 . . . . 63.45 110.837 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.71 -65.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 65.34 111.135 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -56.59 -25.02 51.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 52.24 110.877 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -24.52 65.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 74.33 110.882 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -96.03 -28.22 14.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.881 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.23 -5.53 7.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 71.23 112.507 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -59.58 -173.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.826 0.346 . . . . 73.11 110.969 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.435 ' H ' HG21 ' A' ' 95' ' ' ILE . 40.7 mm-40 -99.75 1.17 43.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 71.31 110.888 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.523 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 0.9 OUTLIER 65.87 122.65 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 75.35 110.857 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -170.65 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.707 2.271 . . . . 61.44 112.39 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.762 HD11 ' HB2' ' A' ' 104' ' ' LYS . 58.5 mt -51.76 -39.25 58.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 71.52 110.922 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.0 37.3 44.79 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 64.45 112.45 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -132.89 48.44 2.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 64.11 110.836 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.52 -169.64 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.299 -0.409 . . . . 72.33 110.884 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -149.99 -169.05 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 72.12 110.919 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.8 HG23 ' HB3' ' A' ' 144' ' ' TYR . 94.6 m -50.63 -63.95 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 74.31 111.143 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.734 HG23 HG22 ' A' ' 129' ' ' THR . 86.1 t -124.26 112.03 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 54.13 111.108 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.0 m -121.35 111.34 17.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.05 111.111 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -67.25 90.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 74.02 110.884 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.451 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -81.78 159.39 23.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 64.25 110.884 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 117.46 4.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.84 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.827 ' HB2' HG21 ' A' ' 48' ' ' THR . 19.0 m-85 -109.17 49.57 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 75.2 110.889 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.64 -108.08 3.54 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 61.2 112.466 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -93.69 47.22 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 63.3 110.907 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.525 ' HB2' HG22 ' A' ' 48' ' ' THR . 6.2 tpp -149.19 154.09 38.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 71.53 110.977 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.72 116.25 18.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.302 -0.408 . . . . 71.43 110.946 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.63 151.55 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 70.35 111.204 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -148.81 117.45 6.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 61.11 110.839 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.732 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -70.47 -178.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 35.31 111.132 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.629 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.5 t80 -175.29 136.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 64.41 110.857 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.8 ' HB3' HG23 ' A' ' 129' ' ' THR . 31.6 t80 -118.24 92.66 43.39 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.715 0.769 . . . . 75.33 110.905 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -48.56 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.717 2.278 . . . . 73.2 112.407 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.04 -177.67 43.27 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 64.21 112.452 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -76.78 125.57 29.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.799 0.333 . . . . 73.31 110.926 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.518 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -136.28 -91.06 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 74.21 112.502 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -73.64 -30.73 63.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.367 . . . . 72.21 110.862 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.79 158.6 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 72.14 111.144 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -61.06 -27.66 68.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 72.14 110.893 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.674 ' OD1' HD13 ' A' ' 114' ' ' LEU . 11.7 p30 -119.6 50.07 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 75.41 110.851 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.8 OUTLIER -98.07 137.62 36.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 73.41 110.88 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.732 HD12 HG22 ' A' ' 142' ' ' THR . 12.5 pt -139.01 168.82 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 63.11 111.096 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.498 ' CG1' HD22 ' A' ' 169' ' ' LEU . 7.8 m -119.3 144.71 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 72.15 111.156 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.17 144.08 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 70.03 111.138 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -130.09 147.66 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.951 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.487 HD12 ' HB ' ' A' ' 163' ' ' ILE . 16.9 mt -124.78 96.62 40.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.616 0.722 . . . . 61.53 110.946 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 72.5 1.43 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.78 2.32 . . . . 73.42 112.273 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.12 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 74.13 110.943 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.482 ' CB ' HD13 ' A' ' 163' ' ' ILE . 4.4 m-85 -117.75 -13.91 10.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.952 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.5 m120 68.99 26.13 5.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.094 -0.503 . . . . 53.44 110.904 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.498 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -97.87 114.14 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 71.33 111.138 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.93 136.96 37.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.854 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.55 HG21 HD22 ' A' ' 44' ' ' LEU . 16.5 t -119.42 64.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 62.15 111.182 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.94 -54.5 25.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 54.12 112.477 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.26 -135.51 12.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.748 . . . . 74.22 112.467 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.5 m -60.89 -19.29 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 42.5 110.876 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.498 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.9 OUTLIER -66.93 -50.57 61.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.901 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.707 HG11 HG11 ' A' ' 206' ' ' VAL . 24.7 t -89.05 130.02 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 71.11 111.193 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.64 149.5 24.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 54.0 110.939 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.624 ' HA ' HD22 ' A' ' 218' ' ' LEU . 12.6 p -75.03 162.5 28.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 61.2 110.879 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.612 HG23 HD23 ' A' ' 218' ' ' LEU . 7.3 p -69.05 -25.66 64.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 53.15 111.15 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.15 -26.25 60.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 63.52 110.835 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.84 177.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 54.12 111.066 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.6 ' O ' HD22 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -128.24 -39.93 1.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 71.2 110.916 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -153.64 -177.41 6.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.453 . . . . 62.13 110.862 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.531 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 0.7 OUTLIER -82.05 -39.15 23.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 72.41 110.901 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.42 -155.39 21.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.716 -0.754 . . . . 73.2 112.455 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.77 118.22 3.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 74.22 110.874 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.516 HG11 ' CG2' ' A' ' 186' ' ' VAL . 16.8 m -116.15 30.76 2.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 74.53 111.087 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.61 -36.24 82.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 75.33 111.125 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -116.18 37.73 3.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.877 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -139.64 166.78 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 74.02 111.071 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -113.54 92.66 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 72.03 110.888 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.516 ' CG2' HG11 ' A' ' 181' ' ' VAL . 92.5 t -69.63 -23.21 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 72.25 111.155 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -25.3 38.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 62.23 110.886 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.34 -24.21 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 55.34 110.841 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.531 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.5 t90 -51.5 -53.9 32.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.463 . . . . 74.2 110.877 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 99.2 p -52.32 -35.44 50.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 54.13 110.856 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.2 m -73.58 -36.68 65.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 51.34 111.169 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.1 m -64.5 -54.12 37.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.812 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.753 HG22 HD23 ' A' ' 197' ' ' LEU . 31.6 mm -57.2 -41.26 77.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 75.02 111.126 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -60.85 -19.54 60.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 75.01 110.912 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -93.03 -29.61 15.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 54.21 110.914 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.403 ' CG1' HD21 ' A' ' 219' ' ' LEU . 59.4 t -81.42 -23.73 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 71.52 111.115 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.753 HD23 HG22 ' A' ' 193' ' ' ILE . 2.6 pp -97.25 -1.16 45.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 75.24 110.97 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -121.2 -6.67 9.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 61.5 110.879 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -89.77 -24.25 21.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.897 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -118.3 -67.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 71.21 110.925 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 63.41 27.46 15.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 72.44 110.873 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -151.47 23.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.836 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.41 HG21 HG22 ' A' ' 206' ' ' VAL . 3.4 mp -62.95 145.42 13.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 73.0 111.168 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -104.0 -26.45 12.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.31 110.902 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.498 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -161.24 128.73 4.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 53.01 111.1 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.707 HG11 HG11 ' A' ' 170' ' ' VAL . 71.9 t -108.86 124.51 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 71.31 111.058 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.902 HG21 HD11 ' A' ' 44' ' ' LEU . 48.6 t -108.99 104.38 54.77 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 121.558 0.694 . . . . 54.5 111.114 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.4 Cg_endo -69.76 -170.6 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.705 2.27 . . . . 65.43 112.369 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -103.27 -26.07 7.12 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.721 -0.752 . . . . 61.23 112.474 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -144.0 86.37 1.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 63.44 110.846 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 167.88 -102.76 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 40.24 112.457 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -169.62 158.94 7.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.885 0.374 . . . . 70.14 110.921 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.643 HG22 HG22 ' A' ' 207' ' ' VAL . 41.4 t -66.82 147.85 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 62.12 111.04 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -152.34 -107.12 0.32 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.774 -0.727 . . . . 71.32 112.526 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -159.13 -169.93 2.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 74.2 110.835 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -56.67 -21.79 30.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 65.35 110.892 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.749 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.98 -33.8 57.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.776 -0.726 . . . . 65.14 112.44 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 172' ' ' SER . 32.1 mt -50.79 -46.84 59.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.858 0.361 . . . . 71.12 110.912 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.552 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mp -54.12 -42.76 69.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 64.42 110.927 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.749 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.6 mt -67.07 -41.31 86.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 75.14 110.907 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.18 -36.54 82.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 75.3 110.849 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -45.64 83.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 43.55 111.07 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.803 ' HA ' HD12 ' A' ' 226' ' ' LEU . 2.5 mt -56.6 -40.21 74.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 73.03 110.994 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -41.05 77.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.55 110.825 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.6 HD22 ' O ' ' A' ' 176' ' ' LYS . 12.2 mt -65.09 -25.99 68.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 62.34 110.935 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.803 HD12 ' HA ' ' A' ' 223' ' ' LEU . 6.1 mt -85.52 -43.08 13.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 70.2 110.913 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.85 179.867 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.831 0.348 . . . . 64.54 110.847 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.94 178.61 6.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.94 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -117.95 161.3 20.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 63.5 110.862 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.8 139.31 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 75.25 111.18 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -98.39 79.4 2.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 61.52 110.908 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -137.83 151.96 48.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 75.12 110.875 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.454 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -147.17 -179.17 6.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 61.34 111.135 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 18' ' ' ILE . 89.6 t 61.21 98.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 45.31 111.132 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.722 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.9 mm -91.23 153.97 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 53.44 111.105 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -145.81 146.09 31.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.893 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.4 164.33 21.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 71.45 110.894 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -51.94 -36.98 51.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.87 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.48 -27.87 22.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 40.12 111.091 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.05 -12.84 68.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.784 -0.722 . . . . 72.44 112.575 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.724 HG23 HG13 ' A' ' 16' ' ' ILE . 2.0 t -51.09 -32.6 22.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 74.14 111.191 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.724 HG13 HG23 ' A' ' 15' ' ' THR . 14.7 mt -121.42 147.86 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 64.13 111.094 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.7 p -166.19 169.61 14.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 64.42 110.873 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.518 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -136.52 -176.49 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 54.41 111.114 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 18' ' ' ILE . 6.1 t -166.09 135.33 3.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 61.42 110.867 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.48 117.79 13.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 73.03 110.858 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HG ' HG23 ' A' ' 27' ' ' VAL . 2.2 mm? -102.02 -45.59 5.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 63.32 110.942 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -142.27 -169.43 2.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.833 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -50.65 -51.08 52.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.855 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -132.34 37.99 3.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 75.14 110.816 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 t -133.91 122.06 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.31 111.19 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.454 ' CH2' HG22 ' A' ' 7' ' ' THR . 14.9 m95 -127.76 159.06 35.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.866 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.983 HG21 HG21 ' A' ' 213' ' ' VAL . 69.5 t -119.42 107.9 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 64.34 111.173 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.518 ' HB3' HG23 ' A' ' 18' ' ' ILE . 4.0 p80 -102.32 142.02 34.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 72.31 110.828 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 m -140.06 130.73 25.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 74.14 111.159 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.93 171.36 8.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.862 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.624 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 5.2 tp -117.17 147.27 42.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.894 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -133.02 -123.18 2.39 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.688 -0.768 . . . . 71.31 112.432 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.02 152.4 43.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.9 0.381 . . . . 52.44 110.853 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -172.06 104.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 63.44 110.91 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 t30 51.35 57.05 7.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 74.13 110.929 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.06 27.0 64.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.692 -0.766 . . . . 73.24 112.462 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -151.63 119.77 6.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 55.25 110.88 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.624 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -54.31 138.07 40.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 64.32 111.062 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.681 HG21 ' HD2' ' A' ' 303' ' ' RTD . 2.2 p -123.52 126.55 25.79 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.595 0.712 . . . . 72.44 111.113 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.524 ' HA ' HD12 ' A' ' 31' ' ' LEU . 54.0 Cg_endo -69.78 148.41 64.89 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.691 2.261 . . . . 44.54 112.381 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -134.44 100.0 4.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 54.45 110.855 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -51.86 169.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 75.43 110.899 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.8 -173.19 39.12 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.705 -0.76 . . . . 74.25 112.449 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.047 HD13 HG21 ' A' ' 207' ' ' VAL . 3.9 tp -156.92 140.81 16.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.905 0.383 . . . . 73.23 110.907 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.719 HG22 HD13 ' A' ' 54' ' ' LEU . 21.4 t -125.51 132.01 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 72.32 111.178 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 41.5 mt -97.15 128.89 44.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 75.04 110.964 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.73 57.65 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 65.31 110.95 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 p -67.19 165.62 15.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 71.25 111.097 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.89 25.81 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.864 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -147.25 28.61 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 74.42 110.881 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.33 123.25 4.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 42.32 112.472 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' A' ' 75' ' ' PHE . 33.1 mt -51.28 159.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 74.13 110.903 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 81' ' ' ASP . 59.6 t -140.18 140.03 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.132 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.719 HD13 HG22 ' A' ' 45' ' ' VAL . 3.0 mm? -114.07 129.86 56.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.964 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.8 t -81.18 0.13 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.13 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -177.68 129.69 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.837 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -166.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.905 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.71 -169.9 2.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.247 -0.433 . . . . 73.03 110.884 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.779 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.4 m95 -74.81 -36.48 62.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 73.42 110.955 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -144.62 164.3 31.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 53.43 110.873 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.13 -34.57 72.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 54.22 110.888 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -74.88 -24.25 58.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 54.15 110.889 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -83.41 -41.14 18.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 73.11 110.927 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.3 t -70.13 -26.45 63.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 70.04 111.103 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -54.13 -42.64 69.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 74.55 110.891 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -83.49 -14.2 52.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 72.54 110.86 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.417 ' HB2' HD13 ' A' ' 16' ' ' ILE . 32.8 tp -77.03 -46.13 24.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 52.34 110.924 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.3 -31.93 40.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 74.04 111.135 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.78 -25.55 68.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 70.21 110.965 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.4 mmm -76.37 -58.84 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 61.22 110.873 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.705 ' HB ' HD13 ' A' ' 52' ' ' LEU . 33.9 m -56.23 -33.35 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 73.11 111.074 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -88.56 48.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 74.45 110.885 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -144.36 -41.82 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 53.14 110.895 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.722 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.64 -25.65 13.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 72.01 110.875 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.716 ' HB3' HD21 ' A' ' 52' ' ' LEU . 36.5 m-85 -88.94 9.22 25.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 74.53 110.851 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.5 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.86 46.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 75.0 110.896 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -147.15 -176.71 5.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 62.44 110.937 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.64 130.88 37.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 70.33 110.896 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.626 HG22 ' HB2' ' A' ' 52' ' ' LEU . 66.4 t -66.46 129.33 30.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 64.04 111.093 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.5 p -138.07 19.74 2.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 44.04 111.141 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.593 ' HB2' HG22 ' A' ' 53' ' ' VAL . 7.4 m-20 -154.18 129.35 9.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 43.43 110.829 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.426 HG11 ' CD1' ' A' ' 98' ' ' LEU . 24.9 t -133.84 98.15 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 63.33 111.169 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -74.64 124.9 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 71.03 111.198 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.613 HG23 ' HB3' ' A' ' 91' ' ' ARG . 38.7 mm -111.07 127.14 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 65.33 111.126 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.5 p -83.86 -53.47 5.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 74.0 111.075 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -135.6 168.39 19.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 73.25 110.895 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -87.82 100.41 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 63.35 111.087 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.669 ' O ' HD13 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -154.71 161.03 41.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 72.11 110.881 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.06 -27.72 61.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 71.14 111.04 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.23 13.8 16.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 33.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.613 ' HB3' HG23 ' A' ' 84' ' ' ILE . 1.1 mmt180 -127.11 -51.24 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 70.21 110.831 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.669 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -118.52 15.28 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 63.52 111.138 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.19 -33.84 31.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.736 -0.745 . . . . 44.22 112.439 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.93 17.68 44.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.757 -0.735 . . . . 62.45 112.461 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.565 HG21 ' H ' ' A' ' 121' ' ' GLU . 9.9 tt -46.03 -31.33 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 71.31 111.172 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -55.19 23.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.95 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.7 m -59.38 -41.73 90.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 64.41 111.14 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.464 ' HA ' HD12 ' A' ' 103' ' ' ILE . 31.7 mt -55.9 -30.0 60.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.912 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.49 24.27 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 64.1 110.856 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -116.93 -26.18 6.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 75.11 110.869 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -104.59 -22.2 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 61.11 110.832 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.67 14.28 4.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 52.01 112.501 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.7 mt -82.07 155.84 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.89 0.376 . . . . 52.32 111.159 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.554 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.8 OUTLIER -120.57 120.1 34.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 51.14 110.905 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.89 81.14 8.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 74.45 111.061 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.521 ' HA ' HD12 ' A' ' 124' ' ' LEU . 92.1 m-70 -55.04 147.28 16.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 50.13 110.853 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.44 161.78 0.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 44.14 110.851 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.557 HG22 ' HB3' ' A' ' 127' ' ' LEU . 19.9 p -85.64 161.07 19.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 75.23 111.135 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.35 -47.25 62.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 63.1 111.074 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.617 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -59.22 -44.45 92.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 62.44 110.984 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.671 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 80.4 m -53.03 -46.17 68.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 64.14 111.111 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.98 -21.99 61.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 74.34 111.103 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.12 -38.38 76.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 71.05 110.903 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.616 HD12 ' OD2' ' A' ' 152' ' ' ASP . 8.0 mt -87.52 -27.66 22.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 71.42 110.954 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.61 -65.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 72.44 111.141 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -26.09 38.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 75.03 110.875 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -23.07 66.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 73.1 110.927 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -96.88 -38.36 9.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 60.21 110.896 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.98 -1.64 5.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 53.24 112.501 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -59.75 -172.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 73.3 110.915 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.565 ' H ' HG21 ' A' ' 95' ' ' ILE . 23.9 mm-40 -94.8 -2.28 51.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 54.33 110.864 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 65.96 126.19 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.634 0.73 . . . . 74.21 110.897 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -170.91 0.42 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.71 2.273 . . . . 72.43 112.332 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 104' ' ' LYS . 51.5 mt -52.59 -38.43 60.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 72.4 110.915 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.98 43.81 55.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 75.44 112.584 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -139.17 57.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.768 0.318 . . . . 74.51 110.837 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.557 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -137.36 -171.63 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 62.01 110.93 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.43 -168.56 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 71.35 110.891 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.829 HG23 ' HB3' ' A' ' 144' ' ' TYR . 75.1 m -50.0 -64.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.23 111.11 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.765 HG22 ' HA ' ' A' ' 143' ' ' PHE . 58.4 t -122.49 111.1 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 64.13 111.124 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.631 HG22 HD23 ' A' ' 133' ' ' LEU . 68.5 m -111.61 114.15 27.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 70.51 111.176 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -75.14 101.02 4.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 53.42 110.881 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.631 HD23 HG22 ' A' ' 131' ' ' THR . 1.9 mt -91.95 152.07 20.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 70.2 110.926 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.42 108.48 3.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 60.41 110.881 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -106.84 -167.77 1.32 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 74.32 110.86 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -50.9 101.73 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 72.34 112.489 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 51.03 56.94 7.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.826 0.346 . . . . 52.14 110.922 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.2 tpt -158.27 147.54 19.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 63.44 110.872 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 121.61 28.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.423 . . . . 72.43 110.976 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.73 HG13 HD23 ' A' ' 158' ' ' LEU . 5.0 t -130.14 158.71 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 61.42 111.177 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 75.7 tt0 -154.38 117.4 4.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 53.12 110.895 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.699 ' O ' HG13 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -69.38 -177.86 1.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.15 111.139 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.765 ' HA ' HG22 ' A' ' 130' ' ' VAL . 82.4 t80 -175.65 136.53 0.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 63.33 110.857 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.829 ' HB3' HG23 ' A' ' 129' ' ' THR . 27.2 t80 -117.13 94.49 45.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 74.12 110.89 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -48.92 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.719 2.279 . . . . 63.51 112.384 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.69 -166.33 39.55 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.697 -0.763 . . . . 54.22 112.439 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -88.03 123.94 33.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.827 0.346 . . . . 65.33 110.879 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.668 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -134.06 -86.4 0.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 72.24 112.485 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -81.29 -26.02 36.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 75.15 110.897 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.52 157.02 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 73.1 111.14 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -64.17 -23.72 67.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 53.24 110.899 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.617 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -125.78 55.09 1.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 74.12 110.848 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.564 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.9 p30 -102.97 143.15 32.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 54.12 110.876 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.643 HD12 HG22 ' A' ' 142' ' ' THR . 11.2 pt -142.53 171.22 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 52.23 111.164 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.7 m -120.47 143.58 31.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.109 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.455 ' O ' HD22 ' A' ' 164' ' ' LEU . 68.6 t -100.11 129.07 51.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 61.43 111.144 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -115.76 145.41 42.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.261 -0.427 . . . . 71.23 110.926 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.73 HD23 HG13 ' A' ' 140' ' ' VAL . 23.6 mt -120.76 96.84 48.69 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.585 0.707 . . . . 70.1 110.967 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 70.16 1.54 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.689 2.259 . . . . 70.34 112.396 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.24 -33.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.992 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.56 ' CB ' HD13 ' A' ' 163' ' ' ILE . 10.2 m-85 -116.93 -12.41 10.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 73.53 110.876 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.05 19.74 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 61.24 110.896 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.624 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.7 mp -86.54 114.4 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 74.21 111.141 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.5 tm? -99.19 122.82 42.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.922 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.827 HG21 HD22 ' A' ' 44' ' ' LEU . 40.4 t -115.29 74.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 72.35 111.155 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.29 -50.28 51.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 63.51 112.553 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.08 -140.94 15.48 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 64.43 112.565 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 39.4 m -58.02 -21.99 47.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 70.24 110.863 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.564 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.0 OUTLIER -63.1 -48.63 77.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 72.03 110.912 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.642 HG11 HG11 ' A' ' 206' ' ' VAL . 22.8 t -90.77 126.58 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 73.11 111.149 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.8 ' HE3' HD23 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -93.51 144.7 25.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 64.13 110.887 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.693 ' HA ' HD22 ' A' ' 218' ' ' LEU . 6.8 p -72.4 163.99 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 62.43 110.825 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.548 HG23 HD23 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -66.71 -35.32 79.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.194 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -26.95 63.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 73.51 110.842 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.77 167.8 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 71.11 111.099 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.631 ' O ' HD22 ' A' ' 225' ' ' LEU . 0.1 OUTLIER -130.64 -41.42 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 73.45 110.904 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -136.72 166.52 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.895 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.8 HD23 ' HE3' ' A' ' 171' ' ' LYS . 5.3 mt -72.85 -26.31 61.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 42.43 110.922 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.86 65.24 1.5 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.75 . . . . 52.34 112.401 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 63.3 160.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.324 . . . . 74.43 110.919 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 184' ' ' ALA . 33.4 m -150.35 40.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 73.52 111.181 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.04 -40.44 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 71.53 111.097 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.65 40.65 3.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 75.02 110.92 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -129.9 173.45 10.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 73.4 111.098 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -121.11 89.01 3.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 74.41 110.971 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.601 ' CG2' HG21 ' A' ' 181' ' ' VAL . 21.7 t -69.28 -21.14 24.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.073 -0.512 . . . . 62.33 111.116 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.44 -26.81 46.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.52 110.895 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -100.39 -24.42 14.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 71.52 110.911 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.31 -53.79 32.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 65.53 110.902 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 34.3 p -52.0 -34.83 44.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 54.23 110.83 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 54.6 m -77.99 -37.98 46.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 71.25 111.134 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.1 m -59.96 -54.89 40.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.14 110.819 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.642 HG22 HD23 ' A' ' 197' ' ' LEU . 33.0 mm -56.98 -36.87 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 74.21 111.132 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.49 -21.97 66.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 73.44 110.878 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -90.92 -30.36 16.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 63.43 110.817 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.512 ' CG1' HD21 ' A' ' 219' ' ' LEU . 92.4 t -77.18 -40.09 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 74.45 111.034 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.642 HD23 HG22 ' A' ' 193' ' ' ILE . 3.8 pp -75.69 -25.78 57.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 54.11 110.913 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -84.46 -46.84 11.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 62.11 110.861 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -51.99 -30.16 23.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.857 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -138.52 116.9 11.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 70.41 110.868 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -115.26 39.11 3.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 71.31 110.884 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.75 22.03 0.79 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 63.34 110.811 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.465 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.2 mp -51.63 144.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 61.15 111.133 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -103.61 -44.56 5.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 72.22 110.884 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.47 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -151.23 113.4 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 41.32 111.097 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.645 ' CG1' HD12 ' A' ' 218' ' ' LEU . 82.8 t -85.51 125.93 40.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 75.52 111.148 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.047 HG21 HD13 ' A' ' 44' ' ' LEU . 63.0 t -106.9 93.78 9.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.663 0.744 . . . . 74.1 111.085 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.1 Cg_endo -69.75 -171.88 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.667 2.244 . . . . 65.33 112.387 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.66 -25.62 9.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 54.02 112.5 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -145.63 109.68 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.352 . . . . 65.25 110.879 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 145.18 -93.18 0.16 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.668 -0.777 . . . . 70.1 112.482 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -179.69 169.55 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.878 0.371 . . . . 70.41 110.879 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.983 HG21 HG21 ' A' ' 27' ' ' VAL . 98.3 t -80.1 139.94 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 72.41 111.15 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -144.92 -105.94 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 54.33 112.443 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -157.69 -171.5 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.848 0.356 . . . . 74.04 110.848 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -53.37 -24.18 11.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 72.25 110.903 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -52.47 -34.37 42.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 73.22 112.402 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.693 HD22 ' HA ' ' A' ' 172' ' ' SER . 30.9 mt -50.85 -46.21 60.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 63.12 110.923 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.512 HD21 ' CG1' ' A' ' 196' ' ' VAL . 1.1 mt -57.78 -43.62 85.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 73.41 110.926 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.752 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.9 mt -66.36 -41.74 89.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 60.4 110.903 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -63.4 -35.98 82.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 62.54 110.811 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.0 m -58.76 -42.64 89.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 72.22 111.098 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.815 ' HA ' HD12 ' A' ' 226' ' ' LEU . 85.0 mt -60.14 -38.9 84.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 74.21 110.864 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -27.87 65.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 70.13 110.795 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.631 HD22 ' O ' ' A' ' 176' ' ' LYS . 8.4 mt -77.53 -25.95 50.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 63.21 110.922 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 223' ' ' LEU . 1.9 mt -88.2 -27.43 21.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.904 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 64.42 110.883 179.815 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.681 ' HD2' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.9 p . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.847 0.356 . . . . 75.02 110.822 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.57 153.97 51.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 73.34 110.88 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -111.29 170.88 7.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 60.12 110.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.2 p -172.52 148.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 74.51 111.11 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 56.13 82.59 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 71.43 110.889 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.34 153.19 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 43.54 110.905 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.487 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -146.82 178.25 8.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.088 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 18' ' ' ILE . 92.0 t 60.64 99.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.04 111.11 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.727 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.0 mm -93.1 157.79 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 72.3 111.152 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.54 149.26 34.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 73.41 110.908 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.16 167.4 21.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 71.51 110.942 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 13' ' ' THR . 7.4 pt-20 -55.87 -32.47 63.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.921 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.464 ' OG1' HG22 ' A' ' 15' ' ' THR . 21.0 p -97.13 -29.93 13.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 50.04 111.171 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.2 -11.23 47.93 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 44.23 112.447 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.792 HG23 HG13 ' A' ' 16' ' ' ILE . 3.8 t -51.19 -32.6 24.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.701 0.286 . . . . 73.34 111.156 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.792 HG13 HG23 ' A' ' 15' ' ' THR . 23.3 mt -123.24 151.1 27.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.443 . . . . 73.43 111.105 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.6 p -169.48 163.44 10.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 75.54 110.894 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -130.24 -177.18 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 72.13 111.134 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.486 ' HA ' HG22 ' A' ' 8' ' ' VAL . 3.4 t -166.36 135.37 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 61.11 110.805 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.59 116.99 13.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.117 -0.492 . . . . 74.11 110.904 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.42 -42.21 6.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.914 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.85 -169.91 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.43 110.856 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -49.25 62.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 74.21 110.877 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -133.68 30.37 3.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.859 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.15 118.55 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 62.42 111.123 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CH2' HG22 ' A' ' 7' ' ' THR . 13.8 m95 -124.09 160.56 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 65.23 110.967 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.14 108.56 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 43.24 111.13 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.606 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.5 p80 -102.38 138.54 39.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 73.5 110.795 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 41' ' ' SER . 32.4 m -136.5 131.74 34.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 74.15 111.069 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.97 -175.68 2.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.2 110.847 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.856 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -133.7 131.56 39.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 75.01 110.978 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.51 -174.65 13.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.768 -0.729 . . . . 71.51 112.525 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.36 133.51 54.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 73.41 110.849 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -104.54 -18.35 14.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 75.14 110.877 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -176.53 45.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 71.2 110.919 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.81 14.84 57.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 45.51 112.464 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -124.58 -168.98 1.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 60.31 110.874 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.856 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -122.37 124.1 42.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 61.14 111.111 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.545 HG21 ' HD2' ' A' ' 303' ' ' RTD . 2.5 p -131.93 118.64 16.56 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.593 0.711 . . . . 72.11 111.163 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 149.02 66.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.259 . . . . 70.23 112.321 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 29' ' ' THR . 0.8 OUTLIER -135.46 113.1 10.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 74.2 110.838 -179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.39 168.45 7.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 74.1 110.865 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.509 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -171.16 -169.55 34.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 71.54 112.462 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.996 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -158.94 146.62 17.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 72.54 110.919 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 54' ' ' LEU . 36.5 t -129.5 142.69 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 62.43 111.106 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -110.7 128.76 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 65.32 110.914 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -97.03 51.25 1.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 72.2 110.904 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.8 p -60.06 173.06 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.32 111.127 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 30.3 3.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 63.34 110.847 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -156.59 36.08 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 71.35 110.882 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.65 128.57 6.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 45.11 112.491 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.771 HD13 ' HB ' ' A' ' 71' ' ' VAL . 13.4 mt -58.4 160.62 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 50.32 110.959 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 81' ' ' ASP . 52.8 t -137.51 143.27 34.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.05 111.157 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.557 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -115.69 128.48 55.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 64.33 110.959 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.6 t -78.85 -2.08 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 62.25 111.093 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.45 128.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 75.51 110.851 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -166.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 62.53 110.798 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 m -96.73 -171.43 2.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 73.52 110.843 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.683 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.1 m95 -71.18 -34.82 71.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.959 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -148.64 165.32 31.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 71.41 110.883 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -63.03 -30.12 71.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 64.24 110.868 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -75.34 -22.86 57.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 72.44 110.916 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -84.78 -49.98 7.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 62.34 110.858 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 t -61.27 -25.2 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 63.22 111.178 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -52.86 -39.67 62.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 72.33 110.914 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -85.55 -14.34 46.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 63.34 110.903 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' A' ' 16' ' ' ILE . 13.5 tp -82.49 -45.62 14.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 63.24 110.937 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.8 mt -70.58 -19.36 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 75.14 111.106 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -83.01 -3.39 57.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 73.33 110.921 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.2 mmm -98.9 -51.58 3.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 73.24 110.824 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.771 ' HB ' HD13 ' A' ' 52' ' ' LEU . 29.2 m -58.58 -38.06 68.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.22 111.099 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' HG3' HG23 ' A' ' 71' ' ' VAL . 36.4 mt-10 -88.19 48.06 1.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 64.41 110.848 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 -39.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.872 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.727 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -109.01 -21.86 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 54.02 110.929 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.56 ' HB3' HD21 ' A' ' 52' ' ' LEU . 25.5 m-85 -89.23 11.08 19.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 72.14 110.887 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.515 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.51 47.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 65.35 110.944 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -153.28 -179.83 8.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 71.13 110.904 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 150.92 49.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.11 110.827 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 52' ' ' LEU . 98.0 t -83.18 129.74 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.21 111.1 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.3 p -144.25 31.67 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 65.23 111.085 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.755 ' HB2' HG22 ' A' ' 53' ' ' VAL . 15.5 m-20 -163.62 125.88 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 53.01 110.835 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 103' ' ' ILE . 24.3 t -133.89 98.91 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.5 111.125 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.5 mt -76.87 118.06 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 65.45 111.035 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 91' ' ' ARG . 44.3 mm -104.96 133.18 49.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 72.5 111.108 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.8 p -88.79 -55.93 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.33 111.197 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -133.4 161.74 33.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.894 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -80.71 97.52 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 62.24 111.079 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.631 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -150.73 157.64 43.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 70.1 110.859 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.17 -26.59 60.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 74.22 111.07 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -90.91 13.43 16.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 64.11 110.899 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.424 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.4 mpt_? -127.56 -52.43 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.813 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.631 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.56 16.97 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 71.21 111.129 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.39 -29.39 30.57 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.691 -0.766 . . . . 32.44 112.484 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -107.4 17.34 37.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 42.11 112.451 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.497 HG21 ' H ' ' A' ' 121' ' ' GLU . 8.3 tt -47.0 -31.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 64.5 111.115 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.7 -54.76 23.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 71.3 110.906 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.1 m -56.95 -41.18 77.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 63.45 111.171 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.435 ' CD1' HG21 ' A' ' 82' ' ' VAL . 24.8 mt -60.84 -37.79 83.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 62.04 110.928 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -81.52 -19.23 42.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.22 -0.446 . . . . 73.02 110.943 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -84.73 -39.53 18.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 75.33 110.857 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.53 ' HB2' HD12 ' A' ' 103' ' ' ILE . 2.3 mtp85 -81.4 -40.1 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 72.11 110.829 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.4 -16.28 4.11 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.699 -0.762 . . . . 63.44 112.435 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 82' ' ' VAL . 2.1 mp -57.83 149.17 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.873 0.368 . . . . 74.45 111.111 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.74 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.2 ptpt -109.19 124.56 51.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.45 . . . . 74.55 110.918 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.45 83.23 6.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 74.1 111.127 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.437 ' ND1' HD12 ' A' ' 124' ' ' LEU . 96.3 m-70 -56.95 147.63 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.92 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.85 160.11 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.014 0.435 . . . . 74.13 110.852 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.638 HG22 ' HB3' ' A' ' 127' ' ' LEU . 19.9 p -78.72 159.56 27.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 65.34 111.174 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.58 -36.78 46.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 55.21 111.038 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 152' ' ' ASP . 8.6 tp -71.57 -48.75 46.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 74.23 110.912 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.76 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 77.8 m -51.79 -29.09 17.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 74.02 111.128 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.586 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -87.82 -31.8 19.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 72.43 111.085 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -56.17 -44.43 79.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.932 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.641 HD12 ' OD2' ' A' ' 152' ' ' ASP . 44.6 mt -76.82 -23.03 52.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.41 110.934 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.27 -65.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 64.53 111.101 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -27.62 33.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.856 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -24.38 66.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 72.11 110.946 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -95.69 -37.48 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 52.52 110.877 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.68 -3.28 4.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 65.41 112.477 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -59.45 -173.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.312 . . . . 72.4 110.945 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.497 ' H ' HG21 ' A' ' 95' ' ' ILE . 16.4 mm-40 -97.03 -0.82 46.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 75.31 110.947 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 65.95 126.0 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.677 0.751 . . . . 72.05 110.887 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.586 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.1 Cg_endo -69.69 -170.05 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.657 2.238 . . . . 73.05 112.379 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' A' ' 104' ' ' LYS . 56.6 mt -55.33 -35.58 65.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 73.41 110.879 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.96 54.26 29.61 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 54.12 112.434 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -147.39 54.32 1.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.886 0.374 . . . . 72.43 110.931 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.638 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.2 OUTLIER -132.28 -172.19 2.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 72.05 110.86 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.2 -167.9 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.917 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.756 HG23 ' HB3' ' A' ' 144' ' ' TYR . 97.8 m -49.3 -41.77 39.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 75.53 111.126 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 m -144.31 137.43 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.092 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 HD23 ' A' ' 133' ' ' LEU . 39.2 m -142.66 107.39 4.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 70.42 111.132 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -71.56 99.41 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 64.24 110.91 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.637 HD23 HG22 ' A' ' 131' ' ' THR . 2.6 mt -90.19 151.07 21.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.963 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.14 127.99 11.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.896 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -129.31 -166.25 1.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 71.31 110.873 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -51.9 98.28 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 52.34 112.465 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 51.91 52.26 14.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 62.41 110.933 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.502 ' HB2' HG22 ' A' ' 48' ' ' THR . 54.6 tpp -150.53 140.64 22.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 71.04 110.875 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.1 mmpm? -121.91 126.72 49.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 74.33 110.86 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.616 HG13 HD23 ' A' ' 158' ' ' LEU . 4.1 t -141.75 159.67 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 75.31 111.195 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.415 ' N ' HG12 ' A' ' 140' ' ' VAL . 25.6 tt0 -161.09 123.72 3.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.049 0.452 . . . . 71.52 110.839 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.92 179.92 4.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.507 . . . . 62.33 111.095 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -173.71 137.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.895 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.756 ' HB3' HG23 ' A' ' 129' ' ' THR . 65.3 t80 -116.24 94.94 43.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.687 0.756 . . . . 65.41 110.898 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -48.66 0.66 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.741 2.294 . . . . 60.13 112.239 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.73 -164.67 38.25 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.742 -0.742 . . . . 75.53 112.514 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -86.52 118.71 26.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.785 0.326 . . . . 72.33 110.899 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.517 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -129.97 -98.4 0.84 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.679 -0.772 . . . . 73.51 112.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -69.86 -26.74 64.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 52.14 110.867 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.61 159.42 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 60.31 111.163 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -66.09 -23.97 66.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.949 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.641 ' OD2' HD12 ' A' ' 114' ' ' LEU . 9.3 p30 -123.17 53.09 1.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.904 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.548 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.7 p30 -102.41 149.32 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 31.22 110.9 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.4 pt -150.03 161.88 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.23 111.172 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 196' ' ' VAL . 14.1 m -108.46 150.5 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 72.35 111.131 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.47 ' O ' HD22 ' A' ' 164' ' ' LEU . 67.1 t -104.23 125.44 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 54.13 111.201 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.461 ' O ' HD23 ' A' ' 158' ' ' LEU . 73.0 t-105 -111.7 150.63 29.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.12 110.92 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.616 HD23 HG13 ' A' ' 140' ' ' VAL . 35.2 mt -126.53 96.15 36.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.718 . . . . 64.32 110.878 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 71.23 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 75.25 112.329 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.12 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.885 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.609 ' CB ' HD13 ' A' ' 163' ' ' ILE . 5.9 m-85 -118.85 -11.73 9.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 63.21 110.928 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 m120 67.88 22.79 8.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 63.41 110.843 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.609 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.5 mp -88.41 115.06 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 71.2 111.187 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.8 tm? -98.12 126.24 43.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 52.12 110.978 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.598 HG21 HD22 ' A' ' 44' ' ' LEU . 16.5 t -120.71 75.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 61.4 111.138 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.27 -54.79 27.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.762 -0.732 . . . . 72.55 112.503 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 109.39 -134.93 12.53 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.721 -0.752 . . . . 74.5 112.392 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 67.0 m -60.62 -19.07 56.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 72.35 110.861 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.548 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.6 OUTLIER -69.41 -49.19 57.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 72.42 110.907 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.621 HG11 HG11 ' A' ' 206' ' ' VAL . 28.8 t -92.63 127.47 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 71.35 111.201 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.49 152.82 19.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.916 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.568 ' HA ' HD22 ' A' ' 218' ' ' LEU . 4.4 t -73.04 164.59 26.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 72.24 110.896 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.592 HG23 HD23 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -67.56 -38.91 84.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.31 111.136 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.84 -27.4 68.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 71.01 110.866 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.28 158.87 3.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 62.32 111.071 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.43 ' O ' HD22 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -115.08 -30.94 6.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.45 110.973 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -151.25 -179.85 7.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 64.24 110.878 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.686 HD11 HD23 ' A' ' 226' ' ' LEU . 1.0 OUTLIER -81.93 -42.97 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.31 110.923 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.44 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 103.64 -161.79 15.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.728 . . . . 62.14 112.504 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -52.01 137.32 27.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 75.44 110.88 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 184' ' ' ALA . 35.9 m -136.22 41.64 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 42.2 111.084 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -52.34 -46.9 66.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 55.35 111.134 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -118.66 41.63 2.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.32 110.871 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . . . -126.23 166.13 17.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.115 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -117.86 91.71 3.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 75.05 110.946 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.5 t -67.65 -21.8 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 73.43 111.174 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -82.36 -26.38 32.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 71.24 110.933 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -96.95 -21.76 17.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 71.14 110.861 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.589 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.2 t90 -51.1 -51.86 49.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 64.23 110.975 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.5 p -51.95 -35.67 46.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 70.01 110.878 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.7 m -74.1 -38.3 63.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 75.23 111.139 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 34.0 m -61.86 -56.24 21.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.809 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.587 HG21 ' O ' ' A' ' 219' ' ' LEU . 28.8 mm -55.22 -38.67 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.457 . . . . 71.11 111.109 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.406 ' HA ' HD21 ' A' ' 197' ' ' LEU . 7.6 mt-10 -63.82 -25.15 68.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 62.11 110.873 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -85.79 -31.88 22.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 62.13 110.973 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.429 HG21 HG11 ' A' ' 155' ' ' VAL . 99.7 t -73.28 -40.29 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.04 111.138 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.586 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -76.68 -25.33 53.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 71.2 110.931 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.95 -44.23 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 73.15 110.967 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.83 -26.24 67.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 73.34 110.861 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -141.03 117.08 10.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 70.35 110.97 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.96 37.35 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 74.23 110.897 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.15 22.03 1.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 71.53 110.891 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.523 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.4 mp -51.57 145.67 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 71.4 111.113 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -107.67 -29.32 9.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 62.45 110.881 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.43 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -162.71 121.33 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 75.44 111.13 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.621 HG11 HG11 ' A' ' 170' ' ' VAL . 97.6 t -101.88 118.91 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 62.15 111.099 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.996 HG21 HD11 ' A' ' 44' ' ' LEU . 69.8 t -102.9 106.88 52.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.661 0.743 . . . . 72.21 111.07 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.4 Cg_endo -69.78 -170.36 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.657 2.238 . . . . 75.44 112.372 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.85 -26.95 6.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 51.53 112.441 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -143.84 98.14 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 70.45 110.878 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.54 -95.07 0.15 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 61.31 112.491 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -174.34 152.41 1.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.828 0.347 . . . . 33.32 110.922 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.466 ' HB ' HG22 ' A' ' 207' ' ' VAL . 5.9 p -67.38 144.12 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 63.14 111.143 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.67 -105.51 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.716 -0.754 . . . . 72.51 112.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -156.84 -169.61 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.891 0.377 . . . . 65.01 110.861 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -20.43 35.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.212 -0.449 . . . . 63.43 110.88 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.741 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.66 -33.1 62.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.715 -0.755 . . . . 63.25 112.5 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.592 HD23 HG23 ' A' ' 173' ' ' THR . 30.2 mt -50.63 -48.91 57.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 75.54 110.984 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.587 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -54.16 -42.41 69.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 53.1 110.954 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.741 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.0 mt -68.12 -41.26 82.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 62.51 110.862 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.55 ' NE2' HD21 ' A' ' 225' ' ' LEU . 86.0 t60 -66.11 -36.91 84.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 52.32 110.839 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.2 m -54.1 -45.25 71.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.164 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.772 ' HA ' HD12 ' A' ' 226' ' ' LEU . 70.5 mt -57.24 -38.91 74.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.893 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -33.74 74.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 75.5 110.871 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.55 HD21 ' NE2' ' A' ' 221' ' ' HIS . 16.9 mt -67.73 -25.81 65.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 61.51 110.89 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 223' ' ' LEU . 4.4 mt -84.92 -48.99 8.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 71.22 110.92 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.7 mttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 61.4 110.885 179.852 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.545 ' HD2' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.851 0.358 . . . . 53.0 110.841 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -149.84 108.16 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 73.12 110.878 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -151.05 -175.27 5.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 73.31 110.858 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.1 t 62.55 99.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 65.04 111.116 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -106.33 144.32 33.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 73.3 110.92 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -156.25 151.93 27.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 73.52 110.891 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -143.42 -179.2 6.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 72.12 111.134 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 18' ' ' ILE . 95.9 t 61.0 96.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 75.31 111.081 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.482 HD11 ' HE3' ' A' ' 74' ' ' LYS . 3.0 mm -89.96 154.23 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 52.51 111.103 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -150.96 163.71 38.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.885 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -91.43 -169.14 2.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 54.41 110.888 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.592 ' HG3' HG23 ' A' ' 13' ' ' THR . 7.0 pt-20 -76.75 -18.46 58.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 62.01 110.846 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 12' ' ' GLU . 22.3 p -108.73 -39.83 5.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 54.4 111.149 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.52 -2.94 29.3 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.692 -0.766 . . . . 34.03 112.432 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.716 HG23 HG13 ' A' ' 16' ' ' ILE . 1.7 t -50.62 -33.53 22.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 63.31 111.127 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.716 HG13 HG23 ' A' ' 15' ' ' THR . 7.6 mt -130.04 159.71 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 64.4 111.096 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.403 ' N ' HG22 ' A' ' 16' ' ' ILE . 74.8 p -175.52 167.55 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 65.1 110.836 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -130.7 -174.77 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 73.12 111.154 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -169.46 129.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 75.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 121.47 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.919 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.8 mm? -105.06 -42.42 5.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.4 110.916 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -146.1 -168.34 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 64.25 110.91 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -51.55 48.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 63.55 110.886 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -132.21 34.24 3.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.917 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.66 122.48 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 73.52 111.145 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -126.91 160.08 32.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.129 -0.487 . . . . 71.44 110.906 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.423 HG23 ' HG ' ' A' ' 21' ' ' LEU . 61.0 t -122.56 111.81 31.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 64.23 111.134 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -100.88 135.97 41.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 64.21 110.855 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 m -130.56 137.65 49.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.51 111.165 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HB3' HG23 ' A' ' 16' ' ' ILE . 2.5 pm0 -133.85 170.09 16.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 65.24 110.925 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.622 HD12 ' HA ' ' A' ' 40' ' ' PRO . 3.8 tp -116.98 148.17 41.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 62.42 110.924 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.03 -141.27 4.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.764 -0.731 . . . . 75.44 112.494 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.68 161.66 22.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.382 . . . . 64.42 110.827 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -178.57 88.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 74.23 110.877 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 m120 55.08 58.51 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 72.51 110.914 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.54 28.26 67.33 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.764 -0.731 . . . . 72.43 112.496 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -144.52 133.62 22.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 72.51 110.899 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.555 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -72.16 127.4 32.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 73.2 111.17 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.701 HG21 ' HD2' ' A' ' 303' ' ' RTD . 2.5 p -120.36 119.97 30.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.655 0.741 . . . . 64.11 111.091 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.622 ' HA ' HD12 ' A' ' 31' ' ' LEU . 52.9 Cg_endo -69.87 157.35 60.46 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.62 2.213 . . . . 75.3 112.34 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.26 112.79 7.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 70.23 110.857 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -76.39 147.49 37.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 70.51 110.909 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.593 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -146.29 -153.81 6.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 63.24 112.526 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.895 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -166.22 142.61 4.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 61.4 110.912 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG22 HD13 ' A' ' 54' ' ' LEU . 47.4 t -127.47 138.85 53.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 65.33 111.124 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.7 mt -102.12 135.11 44.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.957 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -111.75 61.48 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.917 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.501 HG21 ' HB2' ' A' ' 135' ' ' PHE . 18.1 p -77.95 176.15 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 71.53 111.137 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.14 26.87 3.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 61.34 110.855 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -145.74 24.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 71.04 110.889 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.52 142.08 8.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 72.51 112.455 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.809 HD13 ' HB ' ' A' ' 71' ' ' VAL . 8.8 mt -70.96 162.3 29.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 53.03 110.852 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 81' ' ' ASP . 61.1 t -141.81 144.49 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.33 111.088 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.568 HD13 HG22 ' A' ' 45' ' ' VAL . 3.1 mm? -115.45 128.27 55.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 64.42 110.877 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.6 t -78.62 -2.47 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 63.12 111.104 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p30 179.98 130.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 74.34 110.859 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.06 -167.41 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.895 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.85 -169.69 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 75.12 110.869 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.726 ' HB2' HD13 ' A' ' 63' ' ' LEU . 88.0 m95 -74.36 -37.47 63.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 65.23 110.923 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -142.19 165.68 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 64.42 110.831 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.48 -33.89 74.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 74.45 110.889 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -74.17 -24.76 59.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.957 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.726 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -80.88 -48.36 12.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 61.24 110.939 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -57.57 -26.71 61.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 70.23 111.161 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -42.72 75.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.25 110.933 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -86.92 1.7 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 73.24 110.892 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.516 HD13 HG21 ' A' ' 16' ' ' ILE . 16.7 tp -96.9 -47.7 5.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 64.24 110.899 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.4 mt -70.81 -24.76 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.22 111.104 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -72.74 -12.83 61.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 60.4 110.834 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 30.5 mtp -82.28 -50.41 8.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 61.55 110.855 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.809 ' HB ' HD13 ' A' ' 52' ' ' LEU . 29.1 m -65.94 -40.57 87.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.53 111.142 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG3' HG23 ' A' ' 71' ' ' VAL . 47.4 mt-10 -83.95 51.63 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.913 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 -38.14 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.902 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -111.81 -22.93 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.926 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.63 ' HB3' HD21 ' A' ' 52' ' ' LEU . 24.9 m-85 -87.85 10.86 17.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 65.4 110.888 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.511 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.97 46.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 73.23 110.941 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -151.9 -178.46 6.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 72.12 110.916 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.444 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -129.23 150.87 50.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 54.42 110.838 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 52' ' ' LEU . 98.0 t -86.84 127.57 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 64.44 111.099 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.444 HG23 ' HD3' ' A' ' 78' ' ' ARG . 22.4 p -138.22 25.84 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.116 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.734 ' HB2' HG22 ' A' ' 53' ' ' VAL . 24.3 m-20 -156.89 133.06 9.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.926 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.586 HG21 ' CD2' ' A' ' 98' ' ' LEU . 21.5 t -138.98 99.89 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 62.44 111.128 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.4 mt -76.93 123.23 33.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 64.41 111.141 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 91' ' ' ARG . 43.9 mm -111.65 131.74 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 54.15 111.106 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.487 HG22 HG13 ' A' ' 154' ' ' ILE . 19.5 p -86.96 -58.12 2.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 75.3 111.185 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.629 ' C ' HG23 ' A' ' 111' ' ' THR . 31.4 p-80 -129.92 175.32 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.897 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -93.58 98.09 10.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 74.41 111.103 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.637 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.55 158.54 43.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.885 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.39 -26.72 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 63.12 111.102 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.88 11.48 22.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 72.02 110.827 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.434 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.4 mpt_? -124.88 -52.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 75.1 110.917 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.61 17.35 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.51 111.117 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.36 -27.33 24.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.779 -0.725 . . . . 54.34 112.477 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.8 19.43 28.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 53.25 112.42 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' H ' ' A' ' 121' ' ' GLU . 3.3 tt -48.92 -30.38 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 71.44 111.147 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -69.52 -43.96 71.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 72.44 110.878 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.1 m -68.04 -34.1 75.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 34.34 111.207 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.586 ' CD2' HG21 ' A' ' 82' ' ' VAL . 52.5 mt -63.01 -29.33 70.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.935 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.78 19.67 13.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.02 110.885 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -117.92 -22.73 7.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 62.2 110.825 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -111.69 8.5 20.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 75.32 110.835 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.11 15.56 66.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 64.11 112.455 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 98' ' ' LEU . 14.1 mt -81.58 156.59 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.399 . . . . 65.44 111.143 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.781 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.3 ptpm? -121.86 121.0 36.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.52 110.91 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -87.93 79.98 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 63.13 111.097 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.488 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.8 m-70 -54.67 145.63 18.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 71.32 110.824 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.69 160.71 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 72.1 110.812 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -73.86 -176.64 2.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.511 . . . . 73.22 111.069 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.65 -27.24 45.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 75.31 111.115 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 152' ' ' ASP . 5.5 tp -76.31 -47.88 22.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 71.43 110.933 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.749 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.5 m -54.38 -26.27 29.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 72.34 111.081 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -88.62 -29.29 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 64.51 111.11 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -61.54 -31.29 71.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 72.44 110.855 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.43 HD22 ' OD2' ' A' ' 152' ' ' ASP . 10.2 mp -89.38 -25.4 21.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.34 110.974 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.46 -67.48 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 72.01 111.116 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -26.4 37.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 64.33 110.842 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -24.59 67.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 71.33 110.884 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -94.75 -37.53 11.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.443 . . . . 73.54 110.871 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 138.95 -7.96 3.26 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.753 -0.737 . . . . 72.01 112.476 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.76 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 64.12 110.852 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.476 ' H ' HG21 ' A' ' 95' ' ' ILE . 36.7 mm-40 -99.73 -1.14 38.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 65.21 110.894 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.469 ' C ' HD11 ' A' ' 95' ' ' ILE . 1.6 mt-10 66.41 129.33 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.719 . . . . 60.12 110.859 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.405 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.3 Cg_endo -69.83 -169.66 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.721 2.281 . . . . 63.41 112.3 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 104' ' ' LYS . 76.2 mt -53.45 -43.89 68.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 75.31 110.876 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.44 57.13 19.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.716 . . . . 64.22 112.479 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -152.13 36.51 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 51.41 110.825 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.82 -169.67 1.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 75.24 110.906 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -153.82 -169.06 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 53.32 110.943 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.84 HG23 ' HB3' ' A' ' 144' ' ' TYR . 99.5 m -50.81 -57.8 7.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.146 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.695 HG23 HG22 ' A' ' 129' ' ' THR . 93.7 t -129.54 123.09 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 73.12 111.214 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.556 HG22 HD23 ' A' ' 133' ' ' LEU . 93.6 m -131.54 124.97 31.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.083 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -80.82 103.04 10.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 65.03 110.948 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.556 HD23 HG22 ' A' ' 131' ' ' THR . 2.3 mt -91.16 150.75 21.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 73.32 110.934 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 124.34 12.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 70.22 110.917 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.501 ' HB2' HG21 ' A' ' 48' ' ' THR . 14.1 m-85 -126.32 47.76 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.926 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.97 117.76 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.678 -0.772 . . . . 41.12 112.531 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.0 t30 52.46 29.53 7.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 70.31 110.864 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.45 ' HB2' HG22 ' A' ' 48' ' ' THR . 30.5 tpp -145.81 140.57 27.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 70.43 110.873 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -128.52 121.27 28.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 75.42 110.844 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.593 HG13 HD23 ' A' ' 158' ' ' LEU . 12.1 t -131.66 154.55 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.179 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -152.19 125.85 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.849 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.5 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -76.17 -178.19 4.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.482 . . . . 62.11 111.15 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.625 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.0 t80 -175.28 140.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 73.53 110.854 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.84 ' HB3' HG23 ' A' ' 129' ' ' THR . 39.6 t80 -125.22 96.21 39.89 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.639 0.733 . . . . 72.44 110.897 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 54.9 Cg_endo -69.7 -49.02 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.225 . . . . 53.05 112.426 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.73 -155.64 21.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 74.45 112.491 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.48 127.5 42.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 72.4 110.934 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.591 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -138.94 -93.51 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 72.03 112.496 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -69.67 -30.12 67.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.929 0.395 . . . . 61.42 110.879 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.57 160.33 43.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 53.55 111.147 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.82 -23.99 67.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 71.42 110.888 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.455 ' HB3' HD23 ' A' ' 110' ' ' LEU . 6.9 p30 -120.63 45.2 2.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 73.22 110.908 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -94.11 134.34 36.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 50.55 110.893 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.562 HG22 ' CD1' ' A' ' 144' ' ' TYR . 2.0 pt -136.19 171.3 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.116 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.466 ' CG1' HD22 ' A' ' 169' ' ' LEU . 5.9 m -121.85 150.11 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 74.51 111.131 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -103.07 143.48 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 73.1 111.082 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -129.52 150.09 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.928 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.593 HD23 HG13 ' A' ' 140' ' ' VAL . 36.6 mt -127.12 95.04 37.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.67 0.747 . . . . 72.44 110.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 71.96 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.685 2.257 . . . . 33.5 112.367 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.4 110.96 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.532 ' CB ' HD13 ' A' ' 163' ' ' ILE . 5.8 m-85 -118.15 -13.08 9.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 65.24 110.898 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.8 m120 69.26 25.33 5.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 72.22 110.908 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.541 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.6 mp -96.16 116.52 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 55.44 111.185 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.94 138.48 38.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 64.51 110.885 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.557 HG21 HD22 ' A' ' 44' ' ' LEU . 24.9 t -123.22 66.55 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 52.05 111.152 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.6 -54.28 25.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 30.03 112.5 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.48 -135.1 12.41 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.727 -0.749 . . . . 64.41 112.469 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 33.7 m -62.58 -17.04 59.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.85 0.357 . . . . 72.33 110.874 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.485 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.8 OUTLIER -69.87 -51.36 33.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.895 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.617 HG11 HG11 ' A' ' 206' ' ' VAL . 38.8 t -87.48 129.18 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 53.33 111.108 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.02 145.27 29.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 75.45 110.905 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.63 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.6 p -70.3 157.78 37.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 55.15 110.851 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.554 HG23 HD23 ' A' ' 218' ' ' LEU . 6.9 p -56.73 -47.86 79.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 65.34 111.119 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.39 -28.71 30.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 74.11 110.865 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 172' ' ' SER . . . -58.1 150.68 20.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 70.33 111.068 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -116.39 -26.49 7.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 73.13 110.851 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -148.77 179.35 7.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 74.42 110.887 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.58 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 0.6 OUTLIER -91.07 -36.83 13.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 55.21 110.916 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 104.08 -156.44 17.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 73.15 112.539 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -57.15 117.47 4.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 64.45 110.902 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 15.4 m -116.35 38.03 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.075 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.27 84.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 65.33 111.148 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.42 39.65 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 62.21 110.856 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -135.53 168.62 18.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 63.13 111.109 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -115.35 91.89 3.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 63.22 110.916 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.413 HG13 HD23 ' A' ' 226' ' ' LEU . 94.3 t -68.71 -23.65 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.04 -0.527 . . . . 75.53 111.098 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -80.38 -25.63 39.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 64.44 110.875 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -97.57 -23.82 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 75.04 110.936 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.58 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.4 t90 -51.43 -56.88 10.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 75.54 110.949 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.7 t -51.89 -35.18 44.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 64.43 110.852 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.2 m -72.94 -33.8 66.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 54.42 111.055 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 57.1 m -68.01 -52.41 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 62.31 110.848 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.88 HG22 HD23 ' A' ' 197' ' ' LEU . 30.4 mm -58.56 -38.26 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 54.22 111.118 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.21 -16.53 60.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 73.1 110.919 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -99.29 -20.5 16.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 62.11 110.905 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.434 ' CG1' HD21 ' A' ' 219' ' ' LEU . 79.1 t -88.85 -25.42 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.13 111.166 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.88 HD23 HG22 ' A' ' 193' ' ' ILE . 2.6 pp -99.24 2.38 45.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 73.33 110.919 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -117.68 -14.59 10.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 70.44 110.89 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -93.28 2.11 56.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 73.03 110.911 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -137.89 -72.39 0.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 74.3 110.914 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 60.56 25.94 15.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 75.24 110.901 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -149.14 23.44 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 64.02 110.853 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -63.53 145.64 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 72.23 111.2 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -102.47 -28.1 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 65.43 110.915 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.408 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -161.3 131.26 4.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 63.23 111.075 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.743 ' CG1' HD12 ' A' ' 218' ' ' LEU . 89.5 t -110.84 123.67 66.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 74.13 111.149 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 44' ' ' LEU . 49.1 t -110.3 103.84 54.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.672 0.749 . . . . 75.44 111.129 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.0 Cg_endo -69.81 -170.78 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.762 2.308 . . . . 70.15 112.314 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -105.48 -22.26 8.26 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 72.44 112.503 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -146.03 86.79 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 71.35 110.892 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 165.25 -99.33 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.705 -0.759 . . . . 62.34 112.47 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -171.75 161.38 5.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 62.53 110.872 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 207' ' ' VAL . 21.4 t -70.5 150.5 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 60.31 111.133 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.12 -107.63 0.28 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 52.41 112.45 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -159.16 -170.04 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 75.4 110.897 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -23.23 26.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 64.05 110.878 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.769 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -53.59 -33.44 48.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.684 -0.77 . . . . 34.33 112.553 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.743 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.8 mt -51.16 -46.56 62.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 74.33 110.913 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.601 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -57.79 -43.7 85.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.949 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.769 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.9 mt -66.46 -41.77 88.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 72.35 110.924 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.682 ' NE2' HD21 ' A' ' 225' ' ' LEU . 84.5 t60 -66.13 -38.79 89.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 74.03 110.847 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.9 m -52.57 -46.46 66.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 71.32 111.178 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.69 ' HA ' HD12 ' A' ' 226' ' ' LEU . 63.8 mt -53.59 -40.49 65.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 73.01 110.911 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -35.25 80.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 61.42 110.858 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.682 HD21 ' NE2' ' A' ' 221' ' ' HIS . 31.5 mt -62.68 -25.91 68.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 74.4 110.882 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 223' ' ' LEU . 1.2 mt -90.12 -42.56 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 43.14 110.899 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 70.42 110.902 179.785 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.701 ' HD2' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.905 0.383 . . . . 60.24 110.855 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -150.19 126.7 10.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 73.23 110.883 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.33 148.56 41.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.24 110.937 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.68 141.4 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 74.33 111.16 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.85 147.75 2.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 45.24 110.936 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 mttp 62.5 163.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.807 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.539 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -147.08 179.72 7.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 71.14 111.119 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.574 HG22 ' OG ' ' A' ' 19' ' ' SER . 91.9 t 60.83 94.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 74.44 111.132 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.727 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.0 mm -88.89 155.92 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 62.43 111.096 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -146.78 156.76 43.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 71.43 110.854 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.35 171.69 10.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.12 110.941 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -58.71 -30.29 67.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 75.53 110.928 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.459 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.6 p -99.46 -32.13 11.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.159 -0.473 . . . . 62.31 111.136 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.06 -8.42 42.08 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 71.21 112.481 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.769 HG23 HG13 ' A' ' 16' ' ' ILE . 2.8 t -51.27 -33.14 27.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 71.12 111.146 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.769 HG13 HG23 ' A' ' 15' ' ' THR . 18.9 mt -124.15 152.6 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 64.31 111.165 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 p -171.93 165.32 6.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 72.23 110.834 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -130.68 -172.49 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 53.5 111.153 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.574 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -173.96 132.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 45.33 110.874 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.81 120.71 14.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 64.22 110.9 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.65 -45.47 5.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 75.23 110.967 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -146.09 48.75 1.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.0 110.879 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm 70.59 -70.89 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.832 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -88.31 -23.25 23.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.929 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.82 120.21 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 54.24 111.139 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.539 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.1 m95 -123.89 161.01 26.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 70.04 110.852 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.508 HG21 HG21 ' A' ' 213' ' ' VAL . 84.9 t -123.15 107.98 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.13 111.127 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.614 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.8 p80 -101.59 137.68 39.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.44 110.861 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 m -133.12 136.27 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.108 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' OE1' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -128.15 165.16 20.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.411 . . . . 74.1 110.899 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.897 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -117.64 136.49 53.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 63.44 110.931 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.51 109.48 0.85 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.728 -0.749 . . . . 75.43 112.478 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.95 120.1 4.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 51.32 110.887 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.92 96.26 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 72.11 110.914 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.1 t30 57.07 26.15 11.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 74.1 110.934 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.39 30.48 7.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.705 -0.76 . . . . 51.04 112.449 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -144.54 120.06 10.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 73.32 110.841 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.897 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -68.31 132.65 47.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 64.12 111.076 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.72 HG11 ' HD2' ' A' ' 303' ' ' RTD . 60.4 t -142.31 103.12 5.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.673 0.749 . . . . 43.43 111.178 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.3 Cg_endo -69.7 140.17 42.23 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.706 2.27 . . . . 74.54 112.438 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -122.76 108.58 13.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 71.12 110.848 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -67.88 143.02 55.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 52.33 110.858 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.643 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -141.49 -153.58 5.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 42.52 112.458 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -165.85 145.18 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 62.11 110.904 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.602 HG22 HD13 ' A' ' 54' ' ' LEU . 78.8 t -128.6 137.08 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.24 111.098 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.7 mt -105.11 130.3 53.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.109 -0.496 . . . . 75.1 110.949 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.422 ' HA ' HD23 ' A' ' 52' ' ' LEU . 82.3 m-20 -99.66 56.43 0.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.862 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.411 HG21 ' HB2' ' A' ' 135' ' ' PHE . 22.2 p -65.69 169.74 5.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 71.53 111.061 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.99 27.26 3.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 20.33 110.869 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -150.04 28.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 74.31 110.876 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.42 127.34 5.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 41.13 112.508 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.695 HD13 ' HB ' ' A' ' 71' ' ' VAL . 9.1 mt -54.78 168.03 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 65.25 110.97 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 81' ' ' ASP . 60.2 t -146.68 143.49 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 61.43 111.138 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.602 HD13 HG22 ' A' ' 45' ' ' VAL . 3.6 mm? -114.52 127.92 56.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 71.14 110.993 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG11 HG11 ' A' ' 165' ' ' VAL . 14.7 t -78.06 -2.91 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 43.01 111.122 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.21 132.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 61.5 110.848 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.57 -166.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.866 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.6 m -94.06 -175.04 3.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.841 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.739 ' HB2' HD13 ' A' ' 63' ' ' LEU . 90.1 m95 -68.38 -41.21 80.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 75.51 110.892 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.39 166.72 23.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.419 . . . . 44.25 110.859 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.44 -35.94 80.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 74.42 110.865 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -70.39 -23.48 62.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 64.13 110.927 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -81.81 -50.6 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 75.23 110.985 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -57.7 -31.07 66.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 72.34 111.129 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -54.58 -38.55 66.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 54.34 110.856 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.55 -11.31 54.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 74.24 110.828 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.541 HD13 HG21 ' A' ' 16' ' ' ILE . 36.8 tp -85.03 -47.36 10.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 60.23 110.923 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 68' ' ' ILE . 37.3 mt -68.65 -11.98 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.21 111.106 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -92.17 16.45 11.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 70.31 110.889 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.5 mtp -115.83 -51.55 2.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 63.12 110.892 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.695 ' HB ' HD13 ' A' ' 52' ' ' LEU . 28.1 m -64.21 -36.08 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 73.3 111.128 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -85.72 50.56 1.99 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 70.41 110.885 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -142.84 -40.15 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 75.42 110.915 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.727 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.28 -23.81 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 75.52 110.889 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.548 ' CB ' HD21 ' A' ' 52' ' ' LEU . 30.4 m-85 -89.52 11.23 20.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 74.34 110.864 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.81 46.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 74.5 110.956 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -150.42 -176.57 5.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 72.21 110.857 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -134.01 152.09 51.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.817 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.559 HG22 ' HB2' ' A' ' 52' ' ' LEU . 85.0 t -87.19 118.18 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 55.35 111.178 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.487 HG23 ' HG2' ' A' ' 78' ' ' ARG . 74.1 p -127.37 21.3 6.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 73.02 111.142 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 53' ' ' VAL . 5.6 m-20 -154.0 134.1 13.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 73.11 110.912 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.564 HG21 HD13 ' A' ' 98' ' ' LEU . 21.2 t -136.65 99.6 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 75.44 111.126 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.9 mt -74.89 126.11 35.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 72.41 111.094 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.497 HG23 ' HB3' ' A' ' 91' ' ' ARG . 29.4 mm -113.88 129.5 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 63.44 111.116 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.0 p -88.34 -54.11 4.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.163 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -133.68 162.81 30.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 73.43 110.884 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -84.24 98.5 10.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 62.12 111.041 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.627 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.8 OUTLIER -151.74 158.76 43.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.0 110.897 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.36 -24.38 54.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 45.13 111.098 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.87 16.36 12.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 74.44 110.94 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HB3' HG23 ' A' ' 84' ' ' ILE . 53.3 mmt-85 -132.19 -52.53 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 73.43 110.889 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.15 15.24 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.44 111.109 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.91 -34.45 30.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 45.24 112.503 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.09 18.15 43.21 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.72 -0.752 . . . . 72.35 112.451 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.561 HG21 ' H ' ' A' ' 121' ' ' GLU . 8.0 tt -46.16 -31.69 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 40.2 111.118 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -54.67 26.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 70.14 110.878 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.8 m -58.54 -39.82 81.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.19 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.564 HD13 HG21 ' A' ' 82' ' ' VAL . 28.9 mt -60.4 -29.52 69.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 71.42 110.888 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -99.31 24.11 8.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.898 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -114.1 -34.69 5.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 54.13 110.878 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -96.17 -21.94 17.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 63.23 110.856 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.59 16.82 4.48 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.772 -0.727 . . . . 40.52 112.503 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.2 mt -83.06 156.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 64.22 111.167 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.616 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -119.26 125.01 48.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.44 . . . . 73.33 110.853 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.04 82.4 5.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 55.33 111.092 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.518 ' HA ' HD12 ' A' ' 124' ' ' LEU . 59.1 m-70 -51.91 142.59 15.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 73.42 110.855 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.67 151.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.03 110.899 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.64 HG22 ' HB3' ' A' ' 127' ' ' LEU . 71.1 p -70.63 157.45 37.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 74.2 111.137 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.62 -24.07 45.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 34.34 111.134 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' A' ' 152' ' ' ASP . 10.8 tp -77.0 -46.96 22.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 73.24 110.915 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 33.5 m -55.62 -27.93 52.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.224 -0.444 . . . . 61.1 111.184 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.645 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -80.49 -23.46 40.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.24 111.127 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.88 -38.25 90.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 71.14 110.839 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.4 mt -85.24 -24.52 27.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 73.14 110.878 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.8 -65.78 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 72.41 111.066 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -55.24 -26.2 38.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 63.33 110.949 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -24.17 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.877 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -95.09 -31.46 13.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.924 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.82 -4.84 6.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.731 . . . . 51.23 112.49 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -59.72 -172.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.883 0.373 . . . . 73.12 110.907 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.561 ' H ' HG21 ' A' ' 95' ' ' ILE . 9.5 mm-40 -98.19 -1.32 42.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 74.41 110.9 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.645 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 66.16 126.97 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.71 0.767 . . . . 73.15 110.86 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -170.64 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.612 2.208 . . . . 65.31 112.39 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' A' ' 104' ' ' LYS . 64.7 mt -51.89 -36.38 48.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 55.13 110.907 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.98 53.93 28.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 75.1 112.48 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -152.02 48.46 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 72.11 110.833 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.64 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.2 OUTLIER -123.65 -169.64 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.904 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -151.96 -168.74 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 74.2 110.936 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.817 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.3 m -50.24 -64.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 54.05 111.134 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.764 HG23 HG22 ' A' ' 129' ' ' THR . 68.6 t -124.63 110.62 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 43.3 111.133 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.632 HG22 HD23 ' A' ' 133' ' ' LEU . 90.7 m -113.33 105.32 13.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.151 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.57 100.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 64.45 110.872 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.632 HD23 HG22 ' A' ' 131' ' ' THR . 2.9 mt -89.92 153.69 20.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.908 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -151.94 128.14 10.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 74.41 110.873 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.411 ' HB2' HG21 ' A' ' 48' ' ' THR . 10.3 m-85 -129.51 -165.97 1.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 70.32 110.857 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -51.63 98.95 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.753 . . . . 71.22 112.517 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 51.37 52.42 14.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.331 . . . . 71.54 110.906 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.3 tpt -150.85 142.2 23.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 45.3 110.913 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -124.24 125.34 44.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 65.13 110.897 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.749 HG13 HD23 ' A' ' 158' ' ' LEU . 6.5 t -138.0 157.69 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 62.42 111.147 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 140' ' ' VAL . 64.8 tt0 -155.66 125.22 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 61.1 110.842 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.693 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -74.99 -177.06 3.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.138 -0.483 . . . . 65.11 111.124 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.744 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.0 t80 -175.33 136.19 0.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.817 ' HB3' HG23 ' A' ' 129' ' ' THR . 28.4 t80 -119.47 93.77 47.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.624 0.726 . . . . 75.11 110.978 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 -48.55 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 72.31 112.355 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.88 -155.29 22.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 34.11 112.462 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.15 123.97 41.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.371 . . . . 73.15 110.826 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.638 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -134.66 -94.3 0.48 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.483 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -71.46 -29.58 65.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 73.14 110.899 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.8 153.13 34.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.117 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.52 -37.9 65.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 72.12 110.916 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.5 ' HB3' HD23 ' A' ' 110' ' ' LEU . 1.4 p30 -108.74 51.13 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.887 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.567 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.9 OUTLIER -100.49 136.35 40.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 70.05 110.889 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.693 HD12 HG22 ' A' ' 142' ' ' THR . 18.5 pt -137.48 169.01 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.22 111.122 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.43 ' CG1' HD22 ' A' ' 169' ' ' LEU . 10.6 m -119.37 140.93 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 61.01 111.177 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 84.4 t -95.85 144.24 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.11 111.145 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -131.16 146.94 52.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 75.31 110.896 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.749 HD23 HG13 ' A' ' 140' ' ' VAL . 15.7 mt -123.43 97.47 42.39 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.599 0.714 . . . . 50.12 110.887 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 72.22 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 53.11 112.388 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.17 -34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.888 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -117.42 -13.28 10.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 54.54 110.904 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 m120 68.62 23.28 7.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 73.23 110.909 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.437 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.7 mp -95.58 116.26 36.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 41.11 111.16 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.7 137.0 37.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 75.33 110.97 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.517 HG21 HD22 ' A' ' 44' ' ' LEU . 21.5 t -121.27 66.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 73.13 111.109 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.77 -55.33 21.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 73.13 112.452 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.21 -119.76 5.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 63.35 112.492 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 90.3 m -87.2 7.23 29.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 62.23 110.951 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.567 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.0 OUTLIER -88.72 -50.17 6.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.157 -0.474 . . . . 75.13 110.922 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.469 HG11 HG11 ' A' ' 206' ' ' VAL . 21.7 t -91.1 120.86 40.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 61.43 111.098 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.03 154.78 19.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 62.53 110.963 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.608 ' HA ' HD22 ' A' ' 218' ' ' LEU . 5.8 p -77.65 161.43 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 52.44 110.861 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.592 HG23 HD23 ' A' ' 218' ' ' LEU . 1.4 p -61.79 -34.61 76.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 73.02 111.115 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -26.68 65.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 53.15 110.864 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.53 154.39 11.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 32.21 111.111 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.95 -32.63 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 73.24 110.851 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.41 -179.83 5.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 73.43 110.854 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.624 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 3.8 mt -78.18 -48.29 16.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 62.02 110.871 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 112.3 68.22 0.53 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.764 -0.731 . . . . 73.43 112.468 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.1 t30 62.73 104.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 54.53 110.823 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 186' ' ' VAL . 21.8 m -100.11 35.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 54.34 111.118 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.67 85.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 64.4 111.116 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.06 44.82 2.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 61.45 110.867 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -138.52 171.34 14.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.064 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -117.37 90.57 3.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 70.25 110.952 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.484 HG13 ' CD2' ' A' ' 226' ' ' LEU . 91.1 t -69.91 -22.05 24.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 73.13 111.15 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -78.35 -24.88 46.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 62.3 110.957 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -101.76 -24.9 14.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 73.14 110.91 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.624 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.5 t90 -51.46 -56.72 11.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 64.33 110.945 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.2 p -52.17 -32.03 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 71.4 110.848 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.4 m -78.22 -31.47 49.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.01 111.164 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 196' ' ' VAL . 40.2 m -69.45 -52.14 29.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 62.22 110.892 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.796 HG22 HD23 ' A' ' 197' ' ' LEU . 35.6 mm -56.08 -42.26 71.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 63.2 111.145 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.72 -19.81 59.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 72.23 110.864 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -95.84 -25.59 15.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 70.32 110.944 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.404 ' CG1' HD21 ' A' ' 219' ' ' LEU . 60.6 t -85.36 -20.79 8.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 63.24 111.159 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.796 HD23 HG22 ' A' ' 193' ' ' ILE . 2.5 pp -101.17 -2.33 31.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 71.25 110.933 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -116.4 -22.92 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.885 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -71.1 -23.73 62.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 75.15 110.841 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -118.09 -66.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 74.41 110.922 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.64 25.81 14.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 74.23 110.918 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -149.35 22.59 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 61.45 110.839 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.5 mp -60.19 144.62 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 55.25 111.175 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -103.07 -26.05 13.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.878 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -166.07 130.82 2.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 53.53 111.097 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.482 ' CG1' HD12 ' A' ' 218' ' ' LEU . 89.9 t -107.53 128.09 62.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 72.12 111.106 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.936 HG21 HD11 ' A' ' 44' ' ' LEU . 39.7 t -110.82 103.28 54.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.588 0.709 . . . . 70.21 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.7 -169.76 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.707 2.271 . . . . 60.44 112.336 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -108.86 -22.33 7.01 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 70.15 112.44 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -144.6 88.73 1.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 71.44 110.896 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 161.25 -93.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.783 -0.722 . . . . 50.41 112.523 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -178.91 156.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.925 0.393 . . . . 70.4 110.886 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 207' ' ' VAL . 39.1 t -67.2 147.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 72.33 111.135 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -150.04 -107.97 0.42 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.684 -0.77 . . . . 54.24 112.405 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -154.52 -170.47 3.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 42.32 110.87 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -58.01 -20.2 36.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 75.45 110.878 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.742 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.93 -32.43 62.36 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.685 -0.769 . . . . 62.31 112.452 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 172' ' ' SER . 29.8 mt -50.74 -43.2 58.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 53.11 110.908 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.529 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -59.97 -45.05 93.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.965 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.742 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.2 mt -64.58 -42.04 95.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 70.41 110.866 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -65.5 -36.6 84.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 73.21 110.869 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 33.0 m -51.7 -44.29 63.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 53.11 111.162 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.755 ' HA ' HD12 ' A' ' 226' ' ' LEU . 76.4 mt -56.32 -38.96 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.86 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -27.77 65.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 73.41 110.856 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.9 -25.47 56.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 62.33 110.866 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.755 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.6 mt -89.22 -38.63 14.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 63.23 110.923 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.6 mttp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 75.22 110.914 179.836 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.72 ' HD2' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.853 0.358 . . . . 75.41 110.926 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -159.06 150.86 20.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 72.35 110.887 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.52 97.84 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 61.15 110.896 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 p -166.89 146.63 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 54.54 111.164 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.31 107.29 18.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 63.33 110.938 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -148.4 153.12 38.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 60.52 110.947 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.577 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -146.54 179.0 7.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 70.11 111.102 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.593 HG22 ' OG ' ' A' ' 19' ' ' SER . 91.4 t 60.56 93.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.462 . . . . 72.34 111.09 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.52 154.52 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 52.24 111.19 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' N ' ' HE3' ' A' ' 70' ' ' MET . 21.6 mtmt -145.37 146.58 31.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.892 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.32 165.49 21.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 64.32 110.815 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -52.03 -43.35 63.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 63.14 110.878 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.52 -24.01 31.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 70.23 111.157 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.68 -14.0 66.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 70.52 112.484 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.715 HG23 HG13 ' A' ' 16' ' ' ILE . 1.9 t -50.81 -32.77 21.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 64.51 111.165 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.715 HG13 HG23 ' A' ' 15' ' ' THR . 20.1 mt -118.79 148.08 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 55.34 111.072 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 p -170.59 166.97 8.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 73.54 110.851 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -133.27 -172.91 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 72.32 111.109 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.593 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -173.74 133.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.89 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.98 119.12 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.41 110.879 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.401 HD11 HG11 ' A' ' 213' ' ' VAL . 1.4 mm? -101.5 -57.8 2.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 64.0 110.887 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -148.3 -170.08 3.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 72.15 110.861 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.532 ' O ' HG23 ' A' ' 25' ' ' VAL . 16.3 mttt -52.34 108.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.922 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 57.96 23.21 9.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.426 . . . . 73.24 110.831 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 23' ' ' LYS . 99.1 t -122.44 110.76 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 64.31 111.18 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.577 ' CH2' HG22 ' A' ' 7' ' ' THR . 14.9 m95 -121.91 163.83 18.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.887 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.5 t -126.02 109.95 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 43.03 111.151 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.552 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.2 p80 -101.61 137.0 40.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.852 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 m -132.39 113.06 12.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 73.12 111.19 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.569 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -100.27 162.49 12.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 74.3 110.874 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.655 ' CD1' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -113.33 126.14 55.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 74.03 110.907 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.0 -173.0 17.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 63.11 112.46 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.3 163.8 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 72.34 110.835 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -178.37 112.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.917 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 51.9 40.71 28.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.839 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.59 27.67 72.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 75.43 112.492 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -134.43 -171.17 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 53.1 110.853 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.655 ' HB1' ' CD1' ' A' ' 31' ' ' LEU . . . -116.13 127.77 55.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 60.11 111.067 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.72 HG21 ' HD2' ' A' ' 303' ' ' RTD . 4.1 p -131.26 116.61 16.59 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 121.608 0.718 . . . . 63.4 111.109 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.419 ' CA ' HD22 ' A' ' 31' ' ' LEU . 53.5 Cg_endo -69.75 166.22 28.34 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.667 2.245 . . . . 74.13 112.352 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -149.06 99.41 2.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 73.13 110.938 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -51.76 168.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 72.52 110.852 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.583 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -170.24 -160.3 18.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 73.43 112.478 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.99 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -165.81 141.49 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 64.02 110.932 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 54' ' ' LEU . 21.8 t -125.84 135.58 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 74.23 111.141 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.45 HD22 ' HE3' ' A' ' 138' ' ' MET . 18.5 mt -103.16 133.4 48.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 65.12 110.916 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -99.65 57.95 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 71.23 110.939 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 p -60.38 -169.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 41.51 111.182 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.5 m -114.43 2.89 14.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 71.45 110.83 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -118.53 -17.4 9.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.878 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.19 131.17 1.3 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.658 -0.782 . . . . 74.24 112.432 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 75' ' ' PHE . 16.5 mt -48.98 159.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 70.13 110.932 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 81' ' ' ASP . 96.5 t -140.12 144.07 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 74.13 111.153 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.459 HD13 HG22 ' A' ' 45' ' ' VAL . 3.6 mm? -115.72 128.83 56.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 61.42 110.901 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.4 t -78.84 -2.34 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 63.41 111.061 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 179.57 125.36 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.28 -0.418 . . . . 72.12 110.897 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -167.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 54.2 110.892 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 p -94.61 -169.75 2.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 72.05 110.842 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.425 ' HB2' HD13 ' A' ' 63' ' ' LEU . 84.2 m95 -73.45 -38.45 65.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.953 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -143.66 154.98 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.52 110.87 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HA ' HG22 ' A' ' 64' ' ' THR . 5.4 p-10 -55.88 -28.35 56.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 73.13 110.862 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -78.1 -23.77 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 71.35 110.945 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -87.24 -40.19 14.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.03 110.929 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 61' ' ' ASP . 14.1 t -66.53 -23.61 66.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.52 111.167 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -43.04 72.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 52.32 110.884 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -82.76 -14.6 54.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 64.32 110.886 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.569 HD22 ' OE2' ' A' ' 30' ' ' GLU . 15.3 tp -76.51 -44.49 34.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 72.25 110.949 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.9 mt -74.6 -30.06 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.04 111.185 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.52 -13.2 61.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 63.12 110.888 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.403 ' HE3' ' N ' ' A' ' 10' ' ' LYS . 2.7 mmm -88.7 -54.76 4.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 73.2 110.87 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 52' ' ' LEU . 19.2 m -57.5 -39.61 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 72.33 111.124 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.449 ' HG3' HG23 ' A' ' 71' ' ' VAL . 63.5 mt-10 -83.97 50.86 1.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 52.34 110.871 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.19 -41.02 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 64.22 110.897 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.83 -19.51 12.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 75.03 110.887 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.719 ' HB3' HD21 ' A' ' 52' ' ' LEU . 26.3 m-85 -88.64 9.73 23.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.52 110.822 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.527 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 2.1 pp0? 31.69 49.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.908 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.418 ' NZ ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -155.46 -177.21 6.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 74.33 110.97 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 144.87 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 72.35 110.831 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 52' ' ' LEU . 93.8 t -76.57 123.63 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 73.34 111.089 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.2 p -134.48 20.78 3.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 74.22 111.149 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.805 ' HB2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -153.56 135.5 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 72.35 110.868 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.573 HG21 ' CD2' ' A' ' 98' ' ' LEU . 19.4 t -140.53 100.77 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 74.55 111.071 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.8 mt -79.42 121.02 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 65.44 111.171 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 91' ' ' ARG . 45.4 mm -105.72 130.47 57.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 70.11 111.079 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.0 p -90.91 -52.95 4.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 72.24 111.193 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -134.72 162.5 32.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 52.3 110.888 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.45 97.64 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.1 111.112 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.662 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.53 158.84 44.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 73.04 110.848 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.76 -30.32 63.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 71.5 111.118 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.29 9.99 21.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.899 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.401 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.9 mmp_? -121.86 -51.64 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 73.54 110.807 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.662 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -117.29 18.12 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 71.34 111.128 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.77 -28.45 23.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 72.43 112.495 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.05 21.31 27.38 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.698 -0.763 . . . . 60.44 112.552 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.421 HD11 ' C ' ' A' ' 122' ' ' GLU . 2.6 tt -48.7 -30.77 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 52.03 111.084 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -69.9 -44.05 70.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 70.41 110.842 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.0 m -67.02 -35.01 78.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 74.15 111.201 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.573 ' CD2' HG21 ' A' ' 82' ' ' VAL . 51.4 mt -62.61 -30.74 71.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 60.2 110.896 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.58 22.61 7.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.945 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -120.71 -31.29 4.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 73.14 110.86 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -103.48 12.08 35.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 64.42 110.861 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.14 18.62 68.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 65.25 112.539 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 98' ' ' LEU . 11.5 mt -83.64 157.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.819 0.343 . . . . 71.22 111.17 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.809 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -122.02 121.28 36.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 74.15 110.881 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.497 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -89.61 77.96 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.047 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.539 ' HA ' HD12 ' A' ' 124' ' ' LEU . 96.7 m-70 -53.83 146.34 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.848 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.15 168.25 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.31 110.858 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.657 HG22 ' HB3' ' A' ' 127' ' ' LEU . 81.0 p -83.7 176.4 9.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 70.21 111.173 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.07 -23.93 60.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 74.02 111.052 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 152' ' ' ASP . 10.2 tp -75.47 -51.2 13.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 64.45 110.923 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.665 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 91.7 m -52.65 -29.13 24.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 72.34 111.134 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.516 ' HB1' ' OE2' ' A' ' 122' ' ' GLU . . . -82.51 -30.41 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 70.32 111.074 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -58.93 -40.48 84.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 74.4 110.904 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.659 HD12 ' OD2' ' A' ' 152' ' ' ASP . 61.0 mt -85.09 -25.25 27.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 65.1 110.932 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.51 -68.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.34 111.099 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -56.35 -25.57 49.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 64.55 110.881 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -24.75 67.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 71.43 110.952 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -94.1 -37.25 11.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 75.23 110.896 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.14 -8.57 3.25 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.765 -0.731 . . . . 71.33 112.487 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -59.82 -172.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 74.21 110.967 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -101.21 0.24 37.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.148 -0.478 . . . . 62.34 110.903 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.516 ' OE2' ' HB1' ' A' ' 112' ' ' ALA . 1.5 mt-10 66.14 127.18 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 63.54 110.911 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -170.3 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.738 2.292 . . . . 71.25 112.294 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.809 HD11 ' HB2' ' A' ' 104' ' ' LYS . 69.8 mt -52.85 -41.42 64.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 71.54 110.958 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 55.16 58.56 13.18 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.771 -0.728 . . . . 72.04 112.502 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -148.97 54.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 61.41 110.916 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.657 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.3 OUTLIER -136.37 -169.7 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 73.2 110.909 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -150.75 -168.66 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 72.45 110.897 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.828 HG23 ' HB3' ' A' ' 144' ' ' TYR . 97.6 m -50.21 -41.1 49.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 70.42 111.149 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.76 140.78 25.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 64.41 111.146 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.6 m -149.55 102.47 3.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.106 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.33 95.44 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 70.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -86.48 159.18 19.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 63.13 110.924 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.46 107.23 2.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 73.14 110.902 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -99.59 -168.99 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 73.33 110.858 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -52.25 101.97 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.688 -0.767 . . . . 63.31 112.525 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.2 m120 51.76 49.4 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 63.31 110.876 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.45 ' HE3' HD22 ' A' ' 46' ' ' LEU . 3.1 tpp -148.68 155.13 40.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 71.43 110.935 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.62 130.05 45.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.889 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.577 HG13 HD23 ' A' ' 158' ' ' LEU . 4.3 t -142.92 159.54 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 72.51 111.203 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 140' ' ' VAL . 41.4 tt0 -160.44 118.12 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 74.12 110.925 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.46 HG22 ' CD1' ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.94 179.67 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 72.33 111.153 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -175.19 143.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 74.43 110.851 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.828 ' HB3' HG23 ' A' ' 129' ' ' THR . 66.2 t80 -120.78 94.98 49.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.673 0.749 . . . . 55.51 110.874 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 -48.59 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.649 2.233 . . . . 64.34 112.344 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.15 -161.55 34.71 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 75.42 112.426 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.47 125.46 38.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.891 0.377 . . . . 65.23 110.856 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -136.37 -97.38 0.49 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 42.32 112.498 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -69.72 -35.77 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 74.2 110.867 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.43 147.29 39.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 43.11 111.176 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.99 -40.72 61.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 74.55 110.927 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.659 ' OD2' HD12 ' A' ' 114' ' ' LEU . 11.1 p30 -106.46 53.01 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 64.15 110.912 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.97 134.8 42.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.886 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.46 ' CD1' HG22 ' A' ' 142' ' ' THR . 1.0 OUTLIER -136.62 160.73 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 60.41 111.091 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.0 m -109.46 155.43 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 65.21 111.115 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.0 t -111.31 142.28 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 54.15 111.118 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 158' ' ' LEU . 75.0 t-105 -127.7 151.48 48.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 73.2 110.904 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.577 HD23 HG13 ' A' ' 140' ' ' VAL . 13.3 mt -130.24 96.93 23.61 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.594 0.711 . . . . 53.4 110.935 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 72.64 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.668 2.245 . . . . 73.42 112.353 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 179.62 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 72.45 110.954 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.542 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.9 m-85 -118.04 -13.27 10.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 72.33 110.881 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.46 23.38 6.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 71.14 110.888 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.542 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.6 mp -93.97 118.92 40.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.11 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.453 HD11 HG13 ' A' ' 196' ' ' VAL . 0.4 OUTLIER -103.19 138.03 40.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 64.23 110.907 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.509 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.3 t -127.74 81.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 62.43 111.146 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.57 -67.94 1.68 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.8 -0.714 . . . . 73.04 112.528 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.87 89.35 2.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.707 -0.758 . . . . 63.33 112.457 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 63.6 m 61.48 16.85 7.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 73.31 110.873 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.643 HD12 ' NE1' ' A' ' 189' ' ' TRP . 21.7 tp -110.31 -45.48 3.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 51.24 110.901 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 218' ' ' LEU . 16.2 t -96.44 116.93 39.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.106 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.35 146.59 31.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.14 110.911 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.711 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.8 p -78.92 161.54 26.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 62.02 110.878 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.6 p -56.5 -48.47 77.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 63.51 111.088 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 53.7 p -56.36 -27.89 57.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 63.44 110.807 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 172' ' ' SER . . . -62.03 157.68 18.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 61.21 111.101 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -143.34 22.44 1.86 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 54.55 110.904 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.82 163.82 3.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.878 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.591 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 9.0 mt -81.19 -26.2 36.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 64.34 110.889 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.19 81.36 0.91 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.761 -0.733 . . . . 72.23 112.51 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.2 t30 64.15 155.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 71.34 110.906 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.3 m -150.44 24.81 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 71.31 111.048 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.48 91.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 62.22 111.124 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.77 43.3 2.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 64.14 110.834 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.2 164.53 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 71.15 111.064 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -112.87 90.08 3.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.893 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.414 HG13 HD23 ' A' ' 226' ' ' LEU . 21.6 t -67.56 -17.2 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 74.13 111.173 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -88.06 -20.08 26.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 65.21 110.938 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -104.63 -20.87 13.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 62.31 110.907 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.643 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -51.09 -55.77 16.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 75.03 110.912 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 60.4 p -51.88 -38.62 56.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 54.03 110.897 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -68.77 -36.09 77.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 71.15 111.141 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.0 m -65.31 -52.09 56.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.908 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.566 HG22 HD23 ' A' ' 197' ' ' LEU . 31.5 mm -57.56 -36.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 64.24 111.127 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.75 -15.45 61.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 65.11 110.887 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -97.84 -27.3 14.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 64.33 110.93 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.553 HG12 HD21 ' A' ' 219' ' ' LEU . 46.3 t -82.34 -30.36 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 62.23 111.108 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.566 HD23 HG22 ' A' ' 193' ' ' ILE . 2.8 pp -85.64 -24.26 27.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 65.54 110.916 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.26 -39.7 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 71.15 110.933 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -56.39 -49.03 75.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 71.11 110.844 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -119.34 127.72 53.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 74.23 110.927 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.75 26.03 8.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.093 -0.503 . . . . 72.22 110.848 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.49 22.13 2.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 71.31 110.844 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 203' ' ' ILE . 3.6 mp -52.11 147.42 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 64.12 111.198 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -106.85 -39.76 5.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 73.33 110.957 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.93 127.59 8.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.153 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.525 HG12 HD12 ' A' ' 218' ' ' LEU . 86.1 t -105.59 125.44 60.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 55.24 111.116 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.99 HG21 HD11 ' A' ' 44' ' ' LEU . 23.5 t -106.54 110.09 63.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.707 . . . . 53.43 111.142 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 54.43 112.341 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.89 -27.01 7.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 71.12 112.543 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -145.05 88.93 1.92 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.364 . . . . 75.15 110.871 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.17 -108.29 0.34 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.698 -0.763 . . . . 61.15 112.437 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -158.02 153.65 26.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.926 0.394 . . . . 52.23 110.894 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 21' ' ' LEU . 5.3 p -68.69 144.0 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 62.43 111.102 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.07 -104.51 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 61.31 112.498 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -157.3 -169.65 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.885 0.374 . . . . 63.4 110.873 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -56.96 -21.02 26.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.911 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.748 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -55.94 -33.85 60.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.772 -0.728 . . . . 71.4 112.446 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.711 HD22 ' HA ' ' A' ' 172' ' ' SER . 30.2 mt -50.63 -47.01 58.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.882 0.372 . . . . 73.41 110.913 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.553 HD21 HG12 ' A' ' 196' ' ' VAL . 7.1 mp -53.84 -42.7 68.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 74.01 110.98 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.748 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -67.37 -41.28 85.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.946 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -64.09 -39.31 93.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 72.45 110.794 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.3 m -51.59 -45.23 63.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 73.0 111.136 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.777 ' HA ' HD12 ' A' ' 226' ' ' LEU . 46.6 mt -61.26 -39.83 91.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 74.24 110.91 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.31 -26.76 61.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.843 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.3 mt -76.82 -24.05 52.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 71.05 110.865 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.5 mt -90.97 -39.38 12.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 63.21 110.899 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 71.44 110.878 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.72 ' HD2' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.792 0.329 . . . . 55.12 110.868 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -156.08 156.57 34.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 74.11 110.893 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.85 105.04 15.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.02 110.89 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -144.99 69.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 75.54 111.13 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -148.01 154.29 40.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.482 . . . . 62.03 110.817 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.25 160.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 72.34 110.943 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.457 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -148.4 -179.35 6.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 45.42 111.193 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 18' ' ' ILE . 95.1 t 61.26 100.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 54.54 111.16 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.581 HD11 ' HE3' ' A' ' 74' ' ' LYS . 2.6 mm -94.56 152.62 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.33 111.104 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -150.83 155.34 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 64.2 110.905 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.23 -168.95 2.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.923 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -76.89 -25.25 52.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 72.22 110.834 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 p -95.04 -35.21 12.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 73.21 111.138 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.66 -9.16 64.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.759 . . . . 64.01 112.446 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.77 HG23 HG13 ' A' ' 16' ' ' ILE . 1.7 t -50.12 -33.36 18.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.688 0.28 . . . . 71.02 111.128 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.77 HG13 HG23 ' A' ' 15' ' ' THR . 5.9 mt -124.21 160.32 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.433 . . . . 72.53 111.147 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 16' ' ' ILE . 1.8 p -178.42 166.75 1.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 63.31 110.858 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -129.24 -175.71 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 71.41 111.113 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.405 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.0 t -169.14 129.97 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.51 110.894 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.3 120.19 12.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 55.34 110.942 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.5 mm? -103.56 -74.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 63.23 110.906 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.98 -170.43 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 61.51 110.843 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' HG23 ' A' ' 25' ' ' VAL . 6.6 mmtt -52.62 109.48 0.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 70.22 110.876 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 58.6 23.86 11.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 75.53 110.832 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 23' ' ' LYS . 99.3 t -122.96 116.42 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 75.32 111.114 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.457 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.4 m95 -124.36 163.13 22.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 75.54 110.954 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.719 HG22 HD12 ' A' ' 44' ' ' LEU . 55.8 t -123.59 107.72 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 72.21 111.114 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.558 ' CE1' HD21 ' A' ' 67' ' ' LEU . 6.8 p80 -100.49 138.49 37.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 71.34 110.856 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.8 m -136.2 133.44 37.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.115 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.486 ' HB3' HG23 ' A' ' 16' ' ' ILE . 2.9 pm0 -124.59 173.98 8.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 44.13 110.91 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.496 ' O ' HD21 ' A' ' 63' ' ' LEU . 3.3 tp -124.15 136.23 54.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 52.32 110.914 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.37 141.69 8.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.733 -0.746 . . . . 73.43 112.447 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.04 139.91 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.961 0.41 . . . . 61.14 110.849 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -102.46 -31.98 10.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 75.13 110.945 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -169.78 30.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 64.33 110.907 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.56 7.5 6.82 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.741 . . . . 71.2 112.505 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -149.06 122.48 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.909 0.385 . . . . 65.15 110.851 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -68.3 128.5 36.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 74.41 111.074 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.468 HG11 ' HD1' ' A' ' 303' ' ' RTD . 32.4 t -124.95 132.17 24.26 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.619 0.723 . . . . 75.42 111.096 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 142.87 48.99 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.74 2.293 . . . . 71.44 112.344 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.92 102.06 5.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 74.51 110.927 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -67.48 153.44 43.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 75.1 110.861 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.71 -155.99 7.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 54.12 112.528 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.871 HD22 HG21 ' A' ' 165' ' ' VAL . 4.7 tp -161.36 142.01 11.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 74.41 110.903 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.631 HG22 HD13 ' A' ' 54' ' ' LEU . 46.4 t -125.06 132.17 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 53.32 111.13 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 mt -98.5 122.59 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 71.02 110.952 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -94.8 60.26 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 61.25 110.9 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.454 HG21 ' HB2' ' A' ' 135' ' ' PHE . 24.4 p -66.0 179.83 0.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 75.12 111.173 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.6 m -104.95 26.04 9.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 74.32 110.836 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.08 23.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 65.22 110.912 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.81 130.25 4.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.769 -0.729 . . . . 35.32 112.431 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.797 HD13 ' HB ' ' A' ' 71' ' ' VAL . 10.0 mt -60.33 158.96 10.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.825 0.345 . . . . 70.43 110.934 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.798 HG22 ' HB2' ' A' ' 81' ' ' ASP . 57.8 t -140.2 139.35 36.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 65.33 111.129 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.631 HD13 HG22 ' A' ' 45' ' ' VAL . 2.9 mm? -109.83 127.43 54.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.942 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 55' ' ' VAL . 18.0 t -79.8 -0.5 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 73.44 111.152 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.45 126.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 51.41 110.904 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -166.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 75.1 110.84 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -96.28 -174.46 3.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 70.32 110.874 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.771 ' HB2' HD13 ' A' ' 63' ' ' LEU . 92.9 m95 -67.68 -42.1 82.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 72.33 110.924 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.01 166.29 24.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 54.42 110.84 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.96 -36.18 80.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.861 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -71.21 -25.13 62.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.93 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -78.99 -49.68 12.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 64.21 110.819 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 t -58.84 -29.54 67.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.33 111.125 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -52.76 -44.3 66.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 70.55 110.893 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -80.94 -12.89 59.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 63.44 110.889 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 16' ' ' ILE . 38.9 tp -83.87 -50.29 8.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 72.3 110.904 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.4 mt -64.55 -18.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 52.33 111.193 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -80.91 -1.18 42.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 73.12 110.881 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.8 mtp -96.33 -57.56 2.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.843 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.797 ' HB ' HD13 ' A' ' 52' ' ' LEU . 20.5 m -58.29 -39.1 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 72.1 111.167 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.53 50.82 1.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 74.03 110.912 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -146.25 -40.95 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 72.4 110.879 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.581 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.19 -23.21 12.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 63.32 110.866 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.601 ' HB3' HD21 ' A' ' 52' ' ' LEU . 41.1 m-85 -90.03 11.57 20.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 73.43 110.851 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.515 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.78 46.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.43 110.927 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -152.05 -176.71 5.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.52 110.892 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.67 153.66 47.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 51.41 110.889 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 52' ' ' LEU . 87.2 t -89.25 117.19 32.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 64.2 111.123 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.54 HG23 ' HG2' ' A' ' 78' ' ' ARG . 42.8 p -130.76 36.53 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 75.12 111.155 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.798 ' HB2' HG22 ' A' ' 53' ' ' VAL . 6.1 m-20 -166.71 130.44 1.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 64.31 110.918 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.616 HG21 ' CD2' ' A' ' 98' ' ' LEU . 17.0 t -135.96 101.91 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 74.54 111.11 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.0 mt -80.22 119.79 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.14 111.074 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 91' ' ' ARG . 39.6 mm -107.33 134.59 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.117 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.1 p -91.9 -55.36 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 54.34 111.204 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -133.17 163.95 28.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 74.35 110.795 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -82.8 97.22 8.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 65.4 111.086 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.619 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.6 OUTLIER -151.05 158.8 44.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 64.54 110.851 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.27 -26.2 60.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.35 111.083 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.68 15.27 13.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 51.12 110.835 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.458 ' O ' HD12 ' A' ' 84' ' ' ILE . 3.1 mpt_? -129.66 -53.12 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 75.44 110.829 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -112.88 16.54 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 65.23 111.189 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.56 25.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.797 -0.716 . . . . 45.03 112.494 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.88 20.04 29.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.743 . . . . 73.2 112.496 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.483 HG21 ' H ' ' A' ' 121' ' ' GLU . 2.4 tt -48.23 -30.65 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.37 . . . . 73.32 111.127 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -70.13 -44.51 68.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 73.2 110.932 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.9 m -67.38 -32.59 73.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 53.43 111.142 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.616 ' CD2' HG21 ' A' ' 82' ' ' VAL . 58.3 mt -65.01 -30.53 71.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 71.3 110.944 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -96.69 21.6 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 63.2 110.925 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.44 -27.36 5.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.3 110.903 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.68 11.52 28.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 71.1 110.892 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.18 17.12 70.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 71.31 112.512 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 98' ' ' LEU . 11.9 mt -83.19 157.52 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.888 0.375 . . . . 75.32 111.126 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.774 ' HB2' HD11 ' A' ' 124' ' ' LEU . 10.9 ptpt -123.49 123.38 40.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.848 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . . . -91.24 80.85 5.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.33 111.066 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.504 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.4 m-70 -56.1 146.85 21.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.79 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.93 159.85 0.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 72.42 110.86 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.4 p -75.74 154.58 36.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 73.55 111.123 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.45 -32.41 26.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 73.42 111.043 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 152' ' ' ASP . 7.3 tp -73.64 -48.28 33.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.426 . . . . 74.31 110.878 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.73 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 99.8 m -52.02 -28.61 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 60.53 111.18 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -86.61 -31.6 21.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 63.13 111.127 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.03 -43.55 70.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 52.41 110.829 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.64 HD12 ' OD1' ' A' ' 152' ' ' ASP . 21.3 mt -79.87 -23.73 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 64.03 110.891 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.14 -69.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.42 111.061 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.42 -28.24 28.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 71.53 110.937 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -23.64 62.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 73.32 110.841 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -94.58 -38.78 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 74.33 110.827 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.72 -8.51 3.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 44.41 112.459 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.43 -172.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 71.43 110.936 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.483 ' H ' HG21 ' A' ' 95' ' ' ILE . 58.4 mm-40 -98.47 -1.23 41.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 74.42 110.849 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.478 ' C ' HD11 ' A' ' 95' ' ' ILE . 0.7 OUTLIER 66.34 129.92 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.656 0.741 . . . . 65.11 110.893 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.557 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.85 -169.65 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.608 2.205 . . . . 74.44 112.403 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 104' ' ' LYS . 86.4 mt -54.45 -37.75 65.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 73.41 110.872 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.06 57.71 12.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 72.04 112.527 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -153.29 49.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 72.12 110.829 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.19 -169.97 2.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 73.21 110.919 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -146.22 -169.08 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.925 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 144' ' ' TYR . 94.1 m -50.72 -62.74 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 64.24 111.169 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 143' ' ' PHE . 92.2 t -125.07 116.15 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.51 111.092 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.63 HG22 HD23 ' A' ' 133' ' ' LEU . 60.1 m -115.66 103.35 10.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 73.24 111.132 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -67.02 102.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 74.21 110.879 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.63 HD23 HG22 ' A' ' 131' ' ' THR . 1.8 mt -94.15 151.4 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 64.43 110.944 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.7 108.22 2.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 64.25 110.919 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.454 ' HB2' HG21 ' A' ' 48' ' ' THR . 17.8 m-85 -105.92 -167.87 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.909 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -51.06 102.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.726 -0.749 . . . . 45.01 112.499 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 51.59 56.47 7.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 75.41 110.862 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 43.7 tpp -153.36 149.11 27.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 61.14 110.825 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.51 124.65 36.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 62.22 110.91 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.693 HG13 HD23 ' A' ' 158' ' ' LEU . 8.5 t -143.32 157.45 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.426 . . . . 74.24 111.107 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.403 ' N ' HG12 ' A' ' 140' ' ' VAL . 83.8 tt0 -158.53 125.31 4.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 64.52 110.886 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.649 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -74.63 -178.74 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 62.13 111.175 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.759 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.5 t80 -175.18 137.66 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 63.12 110.895 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.816 ' HB3' HG23 ' A' ' 129' ' ' THR . 52.7 t80 -120.05 92.99 47.55 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.681 0.753 . . . . 63.41 110.881 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -48.81 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.744 2.296 . . . . 72.25 112.322 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.73 -166.34 39.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 63.32 112.458 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -85.35 126.94 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 74.3 110.875 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.49 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -135.75 -87.74 0.24 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 73.53 112.55 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -80.32 -23.67 40.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 55.45 110.842 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.52 158.3 43.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 74.15 111.215 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -63.1 -26.83 69.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 74.52 110.853 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.64 ' OD1' HD12 ' A' ' 114' ' ' LEU . 2.6 p30 -122.0 53.52 1.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 71.5 110.809 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.1 p30 -102.32 145.65 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 75.42 110.857 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.649 HD12 HG22 ' A' ' 142' ' ' THR . 6.4 pt -142.05 172.45 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 74.3 111.13 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.461 ' CG1' HD22 ' A' ' 169' ' ' LEU . 5.2 m -122.5 142.64 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.118 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.19 144.46 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 64.41 111.139 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -131.1 149.35 52.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 71.12 110.947 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.693 HD23 HG13 ' A' ' 140' ' ' VAL . 23.0 mt -126.52 95.93 37.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.568 0.699 . . . . 51.22 110.877 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 72.08 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.705 2.27 . . . . 63.34 112.326 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.5 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.912 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.544 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.3 m-85 -118.16 -13.21 9.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.833 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 m120 69.81 22.05 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 75.54 110.891 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.544 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.7 mp -92.79 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 72.44 111.072 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.41 136.57 39.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.968 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.871 HG21 HD22 ' A' ' 44' ' ' LEU . 23.2 t -123.24 65.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 45.11 111.158 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.87 -48.24 45.38 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.758 -0.734 . . . . 64.4 112.454 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.64 -130.9 10.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 74.3 112.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 96.5 m -69.58 -19.13 63.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 42.52 110.923 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.461 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.4 OUTLIER -67.65 -47.11 70.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 65.34 110.822 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.619 HG11 HG11 ' A' ' 206' ' ' VAL . 46.1 t -92.49 116.0 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 64.13 111.113 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.487 ' H ' HG23 ' A' ' 222' ' ' THR . 0.2 OUTLIER -89.95 147.74 23.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 53.43 110.864 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.741 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.6 t -87.19 157.24 19.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 71.04 110.84 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.1 p -54.53 -29.18 50.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 63.22 111.117 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.4 p -66.04 -27.05 67.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 54.42 110.83 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.64 -169.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.4 111.043 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.482 ' O ' HD22 ' A' ' 225' ' ' LEU . 2.1 tptt -152.39 -42.7 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 70.22 110.9 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -147.21 171.38 15.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 74.34 110.85 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.577 HD11 ' HG ' ' A' ' 226' ' ' LEU . 4.2 mt -91.35 -23.43 20.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 43.52 110.925 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 114.56 -142.91 17.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.798 -0.715 . . . . 60.54 112.507 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 181' ' ' VAL . 28.0 p30 -99.48 16.87 21.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 70.4 110.922 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.714 HG11 ' CG2' ' A' ' 186' ' ' VAL . 11.9 m 34.98 47.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.03 111.088 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -51.71 -58.03 7.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 64.3 111.077 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.7 27.12 9.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.847 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -104.86 168.94 8.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.03 111.122 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -130.87 88.59 2.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 75.11 110.939 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.714 ' CG2' HG11 ' A' ' 181' ' ' VAL . 61.0 t -62.46 -18.02 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.098 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -78.87 -22.13 46.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 53.42 110.896 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -108.91 -25.42 10.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 75.42 110.936 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.532 ' CH2' HD22 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -51.04 -57.97 7.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.95 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.3 p -51.85 -30.56 24.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 51.33 110.87 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.0 m -80.06 -34.3 38.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 75.51 111.142 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 44.5 m -66.99 -55.55 13.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 73.11 110.819 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.766 HG22 HD23 ' A' ' 197' ' ' LEU . 33.6 mm -56.17 -40.17 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 73.15 111.114 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.22 -16.46 60.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 65.22 110.831 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -97.93 -21.88 16.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.883 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.466 ' CG1' HD21 ' A' ' 219' ' ' LEU . 94.5 t -88.42 -24.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.094 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 193' ' ' ILE . 2.6 pp -98.84 1.53 45.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 73.23 110.94 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -117.25 -17.03 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 54.34 110.851 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -90.55 1.84 56.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 71.11 110.901 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -137.61 -72.46 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.32 110.9 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 61.16 25.3 15.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 54.44 110.87 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -147.29 21.06 1.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 75.4 110.856 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.45 144.93 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 65.32 111.174 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -103.87 -28.65 11.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 61.14 110.837 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.465 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -165.68 126.47 1.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 73.41 111.106 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.636 ' CG1' HD12 ' A' ' 218' ' ' LEU . 87.9 t -98.45 127.48 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 51.44 111.112 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.855 HG21 HD13 ' A' ' 44' ' ' LEU . 98.0 t -108.71 89.57 6.45 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.618 0.723 . . . . 74.2 111.133 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 167.96 22.92 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.632 2.221 . . . . 71.11 112.376 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.09 -15.94 63.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 73.14 112.46 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -146.83 111.09 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 60.22 110.904 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 137.69 -96.41 0.24 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.826 -0.702 . . . . 73.52 112.524 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -178.85 166.77 1.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 75.55 110.867 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.695 HG21 HG21 ' A' ' 27' ' ' VAL . 21.6 t -75.1 133.49 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 63.24 111.141 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.57 -106.62 0.73 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 53.12 112.497 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -155.64 -172.62 4.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.883 0.373 . . . . 73.11 110.856 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -22.04 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.42 110.901 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.75 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.4 -33.06 52.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.8 -0.714 . . . . 71.25 112.521 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 172' ' ' SER . 29.6 mt -50.38 -45.69 55.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 74.21 110.923 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.522 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -55.66 -44.54 77.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.912 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.75 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.5 mt -64.9 -41.36 95.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 63.13 110.921 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.47 ' NE2' HD21 ' A' ' 225' ' ' LEU . 64.7 t60 -61.67 -38.85 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 64.12 110.901 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.487 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.2 OUTLIER -51.6 -46.09 63.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 70.01 111.091 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 226' ' ' LEU . 79.2 mt -52.5 -38.95 60.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.5 110.928 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -46.4 90.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 72.03 110.823 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.482 HD22 ' O ' ' A' ' 176' ' ' LYS . 17.6 mt -56.54 -24.82 49.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.93 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.747 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.7 mt -87.32 -54.53 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 65.32 110.935 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.4 pttt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 72.42 110.955 179.802 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.468 ' HD1' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.857 0.36 . . . . 62.34 110.837 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.58 45.05 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 73.53 110.908 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.72 173.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 71.33 110.839 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.4 t -142.42 124.16 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 73.4 111.18 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -168.68 35.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 65.02 110.925 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -139.19 150.1 45.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.883 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -144.44 179.74 7.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 75.43 111.16 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.1 t 60.72 96.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.092 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.705 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.3 mm -89.03 154.86 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 71.22 111.082 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -150.84 172.96 14.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 64.35 110.854 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -104.61 -169.42 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 71.45 110.889 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -74.14 -26.18 60.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 72.03 110.882 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p -102.43 -35.48 8.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 75.31 111.135 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.16 -2.5 43.95 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 52.33 112.459 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.758 HG23 HG13 ' A' ' 16' ' ' ILE . 1.7 t -50.55 -33.26 21.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 53.14 111.195 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.758 HG13 HG23 ' A' ' 15' ' ' THR . 7.0 mt -127.89 158.77 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 71.34 111.095 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 p -176.21 166.61 2.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 70.3 110.838 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 19' ' ' SER . 0.2 OUTLIER -130.14 -172.7 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 63.32 111.12 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.409 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.9 t -171.75 130.67 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 53.32 110.796 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.83 121.72 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.053 -0.521 . . . . 71.54 110.869 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.8 mm? -105.26 -49.02 3.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 74.14 110.912 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -148.41 59.39 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 53.43 110.887 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.42 -81.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.52 110.929 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.604 ' OD1' HG23 ' A' ' 25' ' ' VAL . 14.7 p30 -82.93 -17.2 44.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.862 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.604 HG23 ' OD1' ' A' ' 24' ' ' ASN . 21.1 t -96.85 118.52 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 71.24 111.15 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.45 ' CH2' HG22 ' A' ' 7' ' ' THR . 16.7 m95 -126.14 160.11 31.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 72.24 110.918 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 213' ' ' VAL . 68.3 t -120.95 110.89 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 71.32 111.111 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.502 ' CE1' HD21 ' A' ' 67' ' ' LEU . 11.5 p80 -99.78 136.88 39.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 74.3 110.794 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.9 m -133.7 127.96 33.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.51 111.198 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.48 ' HB3' HG23 ' A' ' 16' ' ' ILE . 19.9 pm0 -120.91 -176.15 3.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 74.54 110.891 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 40' ' ' PRO . 3.6 tp -135.75 138.36 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 63.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.82 135.67 4.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 65.5 112.438 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.25 140.59 43.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.409 . . . . 70.42 110.797 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -105.74 -31.94 8.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 75.03 110.865 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -170.57 42.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 74.4 110.889 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.31 7.03 31.0 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.797 -0.715 . . . . 71.32 112.52 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -146.25 122.86 11.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.362 . . . . 73.44 110.908 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -70.55 129.36 39.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 51.23 111.107 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.617 HG11 ' HD1' ' A' ' 303' ' ' RTD . 97.0 t -120.44 125.07 27.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.601 0.715 . . . . 53.32 111.118 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.513 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.9 Cg_endo -69.75 142.96 49.37 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.66 2.24 . . . . 40.22 112.342 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 t -142.15 110.99 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.23 110.822 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -100.29 146.37 27.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 71.42 110.883 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.601 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -133.37 -114.34 1.51 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.708 -0.758 . . . . 51.33 112.468 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.784 HD13 HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -178.86 144.58 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.839 0.352 . . . . 72.23 110.989 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 71' ' ' VAL . 40.4 t -127.88 131.91 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 72.44 111.124 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.2 mt -101.24 124.85 47.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 73.21 110.924 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.56 55.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 65.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.52 HG21 ' HB2' ' A' ' 135' ' ' PHE . 16.3 p -63.21 176.74 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 63.4 111.16 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 t -99.22 16.74 21.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 64.33 110.895 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.54 33.24 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.917 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.94 134.65 7.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 42.54 112.493 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.558 HD13 ' HB ' ' A' ' 71' ' ' VAL . 7.4 mt -62.72 161.15 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.35 . . . . 71.44 110.918 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.756 HG22 ' HB2' ' A' ' 81' ' ' ASP . 64.6 t -139.91 143.38 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.33 111.168 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.609 HD13 HG22 ' A' ' 45' ' ' VAL . 3.2 mm? -116.2 129.73 56.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 73.52 110.857 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 55' ' ' VAL . 16.1 t -79.12 -1.87 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 62.42 111.222 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 179.44 130.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 73.23 110.844 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 p -67.79 -166.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 71.25 110.805 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.6 t -94.61 -174.07 3.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 63.42 110.894 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.675 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.4 m95 -70.21 -36.11 74.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 71.25 110.935 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.74 164.31 31.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 53.05 110.854 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -63.18 -28.46 70.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 53.12 110.865 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -78.43 -25.48 46.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.914 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 59' ' ' TRP . 1.2 mt -83.47 -46.43 12.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 60.24 110.994 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 t -55.41 -28.49 54.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 64.01 111.18 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -55.9 -43.09 76.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 44.41 110.877 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.21 0.28 41.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 55.31 110.898 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.502 HD21 ' CE1' ' A' ' 28' ' ' HIS . 51.6 tp -99.42 -50.68 4.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 73.33 110.9 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.664 HG23 HG21 ' A' ' 79' ' ' VAL . 37.1 mt -64.93 -35.29 74.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 73.24 111.164 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.99 -16.75 60.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 73.01 110.916 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 32.1 mtp -76.57 -59.19 2.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 75.11 110.923 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 45' ' ' VAL . 33.0 m -60.11 -33.3 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 74.13 111.158 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -87.76 49.72 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 74.11 110.896 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -147.65 -40.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 75.21 110.884 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.705 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -103.8 -26.63 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 62.31 110.838 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' CB ' HD21 ' A' ' 52' ' ' LEU . 38.8 m-85 -89.52 10.89 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 74.51 110.885 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.5 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.71 46.93 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 72.32 110.896 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -146.97 -178.8 6.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 75.31 110.905 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.28 142.71 50.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.888 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.664 HG21 HG23 ' A' ' 68' ' ' ILE . 21.4 t -75.48 130.81 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 61.31 111.09 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.5 p -142.86 24.74 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 51.1 111.11 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.756 ' HB2' HG22 ' A' ' 53' ' ' VAL . 4.9 m-20 -157.85 133.95 9.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 75.02 110.928 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 98' ' ' LEU . 15.4 t -140.24 101.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 63.24 111.134 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.8 mt -78.45 114.17 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 75.12 111.117 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 91' ' ' ARG . 45.5 mm -100.84 124.76 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 75.51 111.101 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.9 p -81.93 -59.02 2.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 61.51 111.141 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.43 ' C ' HG23 ' A' ' 111' ' ' THR . 37.9 p-80 -128.18 -175.11 3.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 64.13 110.895 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -102.97 100.2 10.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 53.22 111.127 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.676 ' O ' HD13 ' A' ' 92' ' ' ILE . 2.8 m170 -153.84 160.6 42.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 74.21 110.84 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.78 -28.9 62.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 75.41 111.071 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.8 12.45 19.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.4 110.875 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.493 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.3 mpt_? -124.36 -50.43 1.77 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.971 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -119.85 15.69 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 73.44 111.106 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.7 -37.07 33.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 74.24 112.53 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.0 19.39 43.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 72.03 112.473 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.55 HG21 ' H ' ' A' ' 121' ' ' GLU . 4.5 tt -45.83 -31.13 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 74.15 111.124 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.46 -55.46 17.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 62.41 110.962 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.9 m -57.57 -41.43 81.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 60.5 111.104 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 103' ' ' ILE . 28.6 mt -58.44 -28.52 65.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.03 110.881 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -100.94 23.4 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 73.02 110.864 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -116.7 -39.7 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 74.05 110.877 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -88.4 -22.9 23.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 71.43 110.862 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.48 18.51 4.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.751 . . . . 42.34 112.482 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.3 mt -84.84 155.71 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.915 0.388 . . . . 64.25 111.09 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.771 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.4 ptpm? -119.03 119.76 35.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 73.54 110.891 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.73 78.98 9.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 61.21 111.037 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.619 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.6 m-70 -53.8 144.94 17.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.886 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.33 160.97 0.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 45.4 110.914 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.4 p -76.66 -177.66 4.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 73.3 111.177 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.3 -31.62 60.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 72.4 111.116 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 152' ' ' ASP . 8.3 tp -74.68 -46.98 34.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.951 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 98.5 m -53.6 -27.7 28.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 44.22 111.098 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -89.89 -33.52 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 61.13 111.135 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.53 -39.58 67.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.855 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.632 HD12 ' OD2' ' A' ' 152' ' ' ASP . 38.3 mt -84.0 -23.65 30.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 74.25 110.958 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.62 -68.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.079 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -53.14 -28.57 26.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.933 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -23.63 51.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 73.41 110.828 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -95.1 -32.41 13.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 70.13 110.889 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.31 -7.25 5.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 55.15 112.557 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -59.5 -172.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 72.42 110.94 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.55 ' H ' HG21 ' A' ' 95' ' ' ILE . 7.7 mm-40 -97.93 -3.09 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 70.21 110.914 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.437 ' C ' HD11 ' A' ' 95' ' ' ILE . 0.9 OUTLIER 66.29 132.34 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.656 0.741 . . . . 62.2 110.914 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.73 -170.23 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.658 2.239 . . . . 62.25 112.342 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 104' ' ' LYS . 97.8 mt -53.53 -43.21 68.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 73.15 110.913 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 63.0 54.59 32.14 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 74.43 112.478 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -152.4 48.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.335 . . . . 74.52 110.844 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tp -131.7 167.54 19.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.253 -0.431 . . . . 73.1 110.924 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -126.18 -168.68 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 74.23 110.904 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.828 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.5 m -50.02 -56.44 10.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.427 . . . . 71.32 111.143 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.68 HG13 HG22 ' A' ' 129' ' ' THR . 17.8 m -131.65 145.62 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 71.13 111.156 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.2 m -152.97 113.23 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.13 111.122 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.28 87.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.426 . . . . 72.33 110.882 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.04 159.69 27.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.962 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.24 130.9 8.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 71.34 110.911 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.52 ' HB2' HG21 ' A' ' 48' ' ' THR . 4.8 m-85 -128.29 45.1 2.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 60.02 110.908 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.62 111.56 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 64.44 112.538 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 63.65 28.8 15.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 70.04 110.868 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.466 ' HB2' HG22 ' A' ' 48' ' ' THR . 59.7 tpp -155.36 125.38 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 74.1 110.873 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -114.26 122.25 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.05 110.846 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.631 HG13 HD23 ' A' ' 158' ' ' LEU . 4.3 t -130.75 159.28 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.105 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 35.6 tt0 -159.27 122.06 3.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 71.2 110.841 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.535 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.6 -178.28 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.08 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.665 ' HA ' HG12 ' A' ' 130' ' ' VAL . 72.5 t80 -174.86 135.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 65.41 110.891 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.828 ' HB3' HG23 ' A' ' 129' ' ' THR . 26.9 t80 -120.53 95.03 49.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.663 0.744 . . . . 50.14 110.919 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -48.71 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.686 2.257 . . . . 62.34 112.287 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.22 -155.44 24.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 73.44 112.451 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.03 123.59 37.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 72.11 110.858 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -135.69 -98.03 0.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.708 -0.758 . . . . 73.53 112.438 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -68.84 -27.64 66.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 72.25 110.878 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.62 154.02 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 75.41 111.131 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.57 -32.55 65.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.865 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.632 ' OD2' HD12 ' A' ' 114' ' ' LEU . 3.0 p30 -116.31 51.73 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 71.34 110.925 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.75 138.8 36.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 60.34 110.865 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.535 HD12 HG22 ' A' ' 142' ' ' THR . 6.8 pt -139.37 167.22 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 75.13 111.121 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 m -117.75 147.73 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 63.43 111.131 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.468 HG21 HG13 ' A' ' 55' ' ' VAL . 88.8 t -100.67 142.66 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 75.42 111.115 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -128.9 147.35 50.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 63.34 110.915 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.631 HD23 HG13 ' A' ' 140' ' ' VAL . 14.8 mt -125.11 95.91 40.8 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.62 0.724 . . . . 54.23 110.894 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 72.4 1.43 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.674 2.25 . . . . 73.11 112.343 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.5 -34.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 70.2 110.942 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.449 ' CB ' HD13 ' A' ' 163' ' ' ILE . 2.9 m-85 -116.97 -13.51 10.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 64.33 110.985 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.17 25.37 5.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 62.41 110.926 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.508 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -98.13 118.0 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 73.22 111.151 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.39 137.14 41.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 43.4 110.875 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.784 HG22 HD13 ' A' ' 44' ' ' LEU . 19.4 t -118.94 65.15 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 72.52 111.08 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.25 -52.77 34.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 53.42 112.444 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 103.5 -132.07 10.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.796 -0.716 . . . . 43.41 112.463 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 34.0 m -65.14 -23.66 67.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 61.24 110.886 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.664 HD12 ' NE1' ' A' ' 189' ' ' TRP . 24.5 tp -64.02 -52.1 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.51 110.871 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.751 HG11 HG11 ' A' ' 206' ' ' VAL . 21.3 t -88.44 109.06 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 74.22 111.107 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.527 ' H ' HG23 ' A' ' 222' ' ' THR . 0.4 OUTLIER -81.37 149.87 28.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 61.44 110.923 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.631 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.3 t -72.42 164.32 26.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 60.02 110.889 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.569 HG23 HD23 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -67.84 -29.1 68.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 72.52 111.115 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.73 -26.57 62.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 63.12 110.845 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.69 159.48 5.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 53.31 111.076 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.472 ' O ' HD22 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -117.88 -30.78 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 75.21 110.791 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -152.68 177.15 10.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 53.23 110.862 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.644 HD11 HD23 ' A' ' 226' ' ' LEU . 0.7 OUTLIER -79.8 -40.27 28.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 72.1 110.937 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 99.4 -152.9 19.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 33.53 112.523 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -53.02 133.94 38.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 75.41 110.9 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.497 HG11 ' CG2' ' A' ' 186' ' ' VAL . 15.9 m -129.63 31.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 74.12 111.162 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.29 -42.54 77.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 75.44 111.168 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.98 34.89 5.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.8 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.54 162.7 23.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 64.13 111.118 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -115.3 93.53 4.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 73.5 110.885 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.497 ' CG2' HG11 ' A' ' 181' ' ' VAL . 66.1 t -69.11 -21.29 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 63.22 111.154 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.39 -26.02 30.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 54.3 110.878 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -97.9 -21.08 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 70.13 110.87 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.664 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.4 t90 -51.15 -56.89 10.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 71.31 110.909 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 25.8 p -52.01 -36.91 51.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.856 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -70.82 -35.24 72.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 75.4 111.172 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 196' ' ' VAL . 50.7 m -66.47 -52.18 48.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 63.02 110.841 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.665 HG22 HD23 ' A' ' 197' ' ' LEU . 35.5 mm -56.47 -37.95 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 73.11 111.171 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -62.08 -24.15 66.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 72.04 110.879 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -89.35 -25.54 21.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 62.33 110.909 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.517 HG12 HD21 ' A' ' 219' ' ' LEU . 43.2 t -81.89 -33.59 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 71.43 111.194 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.665 HD23 HG22 ' A' ' 193' ' ' ILE . 4.6 pp -81.72 -25.53 35.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 72.31 110.904 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.452 ' N ' HD12 ' A' ' 197' ' ' LEU . 1.4 mttt -83.08 -44.4 15.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 74.31 110.928 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -56.21 -29.05 60.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 74.14 110.891 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -142.58 119.15 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 74.41 110.866 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.31 34.41 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 74.13 110.906 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.85 22.19 1.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 72.02 110.834 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.458 ' H ' HD12 ' A' ' 203' ' ' ILE . 3.5 mp -52.29 147.53 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.141 -0.481 . . . . 72.1 111.106 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -109.86 -25.77 10.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.109 -0.496 . . . . 72.4 110.909 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.508 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -163.58 132.54 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 65.53 111.124 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.751 HG11 HG11 ' A' ' 170' ' ' VAL . 89.0 t -115.12 122.15 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 75.21 111.097 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 213' ' ' VAL . 96.4 t -105.28 109.7 63.52 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.609 0.719 . . . . 64.41 111.141 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 52.8 Cg_endo -69.83 -167.99 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.711 2.274 . . . . 63.35 112.286 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.37 -32.23 6.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 62.51 112.522 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -138.49 101.16 4.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 74.55 110.887 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 150.99 -113.86 0.61 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 72.51 112.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.77 167.96 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 70.12 110.878 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 207' ' ' VAL . 21.7 t -71.31 150.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 62.04 111.123 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.75 -107.05 0.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 54.03 112.492 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -162.92 -170.15 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 73.44 110.836 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -20.33 37.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 75.21 110.942 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.754 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.89 -33.13 63.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.787 -0.72 . . . . 74.34 112.477 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.631 HD22 ' HA ' ' A' ' 172' ' ' SER . 31.5 mt -51.07 -45.35 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.874 0.369 . . . . 73.14 110.905 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.517 HD21 HG12 ' A' ' 196' ' ' VAL . 6.5 mp -55.93 -42.96 76.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.891 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.754 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -66.73 -41.41 87.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 70.4 110.963 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.652 ' NE2' HD21 ' A' ' 225' ' ' LEU . 85.8 t60 -61.58 -39.27 90.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 72.03 110.885 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.68 -42.85 62.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 73.32 111.15 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.801 ' HA ' HD12 ' A' ' 226' ' ' LEU . 26.4 mt -61.19 -40.43 93.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 75.5 110.962 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -39.62 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 63.12 110.858 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.652 HD21 ' NE2' ' A' ' 221' ' ' HIS . 12.6 mt -64.71 -26.28 68.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.93 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 223' ' ' LEU . 5.3 mt -85.6 -42.09 14.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 65.42 110.921 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.2 mttt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.891 179.786 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.617 ' HD1' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.806 0.336 . . . . 71.13 110.868 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.46 118.52 4.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 74.31 110.852 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.36 167.06 6.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 62.11 110.934 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.01 134.68 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 73.25 111.133 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.44 26.44 0.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 71.33 110.878 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 148.73 44.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 74.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.496 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -146.65 -179.99 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 54.44 111.167 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.9 t 60.42 95.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 64.44 111.123 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.548 HD11 ' HE3' ' A' ' 74' ' ' LYS . 4.1 mm -90.3 153.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 75.5 111.132 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.23 172.29 13.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 71.01 110.884 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -107.22 179.0 4.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.875 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -63.65 -28.05 69.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.869 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -102.27 -33.82 9.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.14 -0.482 . . . . 64.32 111.132 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.58 -5.92 48.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 73.13 112.452 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.735 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.78 -33.09 21.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.762 0.315 . . . . 71.53 111.125 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.735 HG13 HG23 ' A' ' 15' ' ' THR . 8.6 mt -126.36 150.86 32.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 75.14 111.106 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 p -171.16 163.76 7.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 54.35 110.851 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.654 HD12 ' NZ ' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -129.25 -175.8 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 63.22 111.112 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.414 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.1 t -167.15 135.54 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.44 110.792 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -71.5 117.87 13.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.112 -0.495 . . . . 62.43 110.919 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.403 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.8 mm? -99.75 -73.11 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 71.44 110.93 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -132.31 -170.37 2.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.939 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' O ' HG23 ' A' ' 25' ' ' VAL . 11.4 mtpt -52.67 109.97 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 72.12 110.913 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 58.47 24.26 11.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.842 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 23' ' ' LYS . 92.7 t -123.28 114.94 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 63.04 111.128 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.0 m95 -124.76 160.64 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 73.52 110.875 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 213' ' ' VAL . 69.8 t -122.98 108.69 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.071 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.585 ' HB3' HG23 ' A' ' 18' ' ' ILE . 7.3 p80 -102.3 138.24 39.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 74.42 110.873 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.477 HG23 ' C ' ' A' ' 41' ' ' SER . 41.0 m -138.77 117.5 12.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 63.23 111.135 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -101.39 -172.89 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 43.23 110.919 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.007 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -141.28 130.45 23.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 54.21 110.905 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.19 132.46 6.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.747 -0.74 . . . . 62.53 112.479 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.4 147.8 5.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 70.41 110.871 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.413 ' CD2' HG21 ' A' ' 39' ' ' VAL . 17.6 t80 -173.22 118.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 74.52 110.879 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.12 38.08 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 54.42 110.895 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.69 34.78 89.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.683 -0.77 . . . . 72.11 112.524 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -151.7 -172.79 4.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.8 0.333 . . . . 72.12 110.941 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.007 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -111.7 132.65 54.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 72.35 111.165 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.786 HG11 ' HD1' ' A' ' 303' ' ' RTD . 61.1 t -134.08 104.05 11.62 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.699 . . . . 63.13 111.07 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.9 Cg_endo -69.72 142.67 48.76 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 72.21 112.322 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.477 ' C ' HG23 ' A' ' 29' ' ' THR . 0.9 OUTLIER -122.63 114.53 20.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 64.23 110.84 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -60.81 169.94 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 72.3 110.863 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.629 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -172.28 -166.68 31.25 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.701 -0.762 . . . . 75.24 112.466 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.014 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -163.2 145.52 10.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 65.21 110.832 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 HD13 ' A' ' 54' ' ' LEU . 36.8 t -129.67 134.13 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 64.41 111.136 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.7 mt -102.71 126.72 49.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 72.4 110.901 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -97.32 59.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 63.34 110.878 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.516 HG21 ' HB2' ' A' ' 135' ' ' PHE . 28.1 p -68.04 171.6 6.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 74.33 111.091 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -97.13 30.2 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 72.21 110.875 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -156.54 35.52 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 74.33 110.935 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.74 126.03 5.54 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.787 -0.721 . . . . 50.44 112.506 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.735 HD21 ' HB3' ' A' ' 75' ' ' PHE . 30.9 mt -56.81 172.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 62.51 110.956 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 81' ' ' ASP . 98.0 t -150.08 143.42 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.233 -0.439 . . . . 63.44 111.094 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.563 HD13 HG22 ' A' ' 45' ' ' VAL . 3.3 mm? -114.9 128.37 56.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.43 . . . . 65.31 110.944 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.0 t -77.67 -3.77 5.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.446 . . . . 74.31 111.181 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.44 134.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.861 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -167.02 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 70.14 110.873 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.4 m -97.33 -175.84 3.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 61.42 110.928 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.699 ' HB2' HD13 ' A' ' 63' ' ' LEU . 93.6 m95 -64.45 -38.38 90.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 74.21 110.97 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -142.94 167.16 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 74.11 110.829 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.73 -35.77 80.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 75.24 110.789 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -69.39 -23.47 63.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.1 110.92 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -83.8 -50.78 7.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 73.51 110.945 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -60.33 -29.49 68.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 75.4 111.121 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -55.5 -40.65 72.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 73.21 110.872 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -88.15 3.17 50.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 71.11 110.888 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.562 HD21 ' CE1' ' A' ' 28' ' ' HIS . 12.7 tp -98.45 -41.75 7.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 73.11 110.942 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.2 mt -65.54 -34.44 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 73.12 111.074 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -69.29 -11.13 60.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.11 110.958 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.4 mtp -81.82 -50.85 8.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 64.24 110.87 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.544 ' HB ' HD13 ' A' ' 52' ' ' LEU . 29.1 m -67.42 -37.0 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 74.41 111.16 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -79.11 51.85 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 63.44 110.956 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -137.16 -42.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 71.01 110.901 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.654 ' NZ ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -106.15 -19.71 13.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.919 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.735 ' HB3' HD21 ' A' ' 52' ' ' LEU . 24.7 m-85 -91.83 6.2 47.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.04 110.893 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.501 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.19 48.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.849 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -150.87 -178.14 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.942 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.581 ' HD2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -130.53 138.91 50.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 72.42 110.859 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 52' ' ' LEU . 96.1 t -70.54 132.89 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 53.25 111.103 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.581 HG23 ' HD2' ' A' ' 78' ' ' ARG . 37.4 p -139.95 15.06 2.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 73.4 111.158 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.562 ' HB2' HG13 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -148.65 131.14 15.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 63.01 110.827 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 98' ' ' LEU . 20.5 t -134.04 99.34 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 65.14 111.077 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.4 mt -74.24 120.5 23.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 74.41 111.171 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 91' ' ' ARG . 45.1 mm -108.12 128.5 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.22 111.116 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.0 p -85.47 -58.01 2.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 71.14 111.127 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.582 ' HA ' HG23 ' A' ' 111' ' ' THR . 31.7 p-80 -128.97 -175.22 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.842 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -103.16 100.63 10.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 73.54 111.137 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.673 ' O ' HD13 ' A' ' 92' ' ' ILE . 3.6 m170 -154.4 160.96 41.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.02 110.908 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.84 -28.76 62.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 71.1 111.042 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.0 13.19 17.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 74.22 110.866 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.472 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.5 mpt_? -125.29 -50.78 1.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 70.2 110.877 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.673 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -119.54 15.44 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 72.24 111.133 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.88 -36.95 34.56 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.639 -0.791 . . . . 73.25 112.561 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.97 18.13 50.54 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.785 -0.721 . . . . 63.43 112.502 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.575 HG21 ' H ' ' A' ' 121' ' ' GLU . 5.0 tt -45.92 -31.13 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 73.52 111.127 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -55.09 18.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 73.34 110.948 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -57.54 -40.98 80.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 62.32 111.143 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.482 HD13 HG21 ' A' ' 82' ' ' VAL . 30.5 mt -58.31 -30.05 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 72.31 110.959 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -100.29 23.86 9.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 70.51 110.925 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -114.83 -30.39 6.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 70.23 110.87 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.0 mtp85 -100.26 -21.99 15.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 71.51 110.892 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.69 13.69 5.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 63.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.8 mt -81.85 155.8 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.94 0.4 . . . . 53.54 111.112 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.637 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -120.16 124.01 44.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 74.34 110.919 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.52 82.55 6.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 72.52 111.126 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.546 ' HA ' HD12 ' A' ' 124' ' ' LEU . 87.9 m-70 -51.73 143.45 12.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 75.13 110.849 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.73 151.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 73.14 110.832 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.646 HG22 ' HB3' ' A' ' 127' ' ' LEU . 60.9 p -74.87 175.02 8.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 75.22 111.148 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.26 83.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 51.43 111.03 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -65.93 -45.89 80.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 63.22 110.95 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.582 HG23 ' HA ' ' A' ' 86' ' ' HIS . 2.5 m -53.3 -40.68 64.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 44.04 111.179 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.561 ' HB1' ' OE2' ' A' ' 122' ' ' GLU . . . -73.41 -20.99 60.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 55.41 111.035 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -40.45 92.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.861 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.608 HD12 ' OD2' ' A' ' 152' ' ' ASP . 10.8 mt -87.97 -25.2 23.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 53.43 110.969 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.22 -65.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 63.11 111.118 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -23.83 63.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 61.4 110.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -23.03 67.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 73.54 110.89 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -95.67 -38.49 10.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 51.4 110.955 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.15 -5.64 3.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 75.14 112.543 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -59.5 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 70.22 110.91 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.575 ' H ' HG21 ' A' ' 95' ' ' ILE . 7.7 mm-40 -96.36 -2.88 44.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 71.35 110.908 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.561 ' OE2' ' HB1' ' A' ' 112' ' ' ALA . 1.6 mt-10 66.21 130.7 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.718 . . . . 71.32 110.884 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.71 2.273 . . . . 72.14 112.348 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' A' ' 104' ' ' LYS . 69.3 mt -53.51 -34.31 57.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.896 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.08 39.07 49.0 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 42.24 112.466 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -136.34 58.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 73.02 110.876 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.646 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -137.71 -169.86 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 53.54 110.894 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.36 -168.69 3.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.896 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.817 HG23 ' HB3' ' A' ' 144' ' ' TYR . 86.9 m -50.23 -65.32 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 70.31 111.05 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 143' ' ' PHE . 58.8 t -120.77 112.14 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 71.12 111.181 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.641 HG22 HD23 ' A' ' 133' ' ' LEU . 82.1 m -113.41 111.73 22.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 55.13 111.167 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -73.34 99.52 2.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 73.01 110.85 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.641 HD23 HG22 ' A' ' 131' ' ' THR . 2.9 mt -88.44 151.1 22.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 62.22 110.885 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.38 128.43 13.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 74.43 110.841 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.516 ' HB2' HG21 ' A' ' 48' ' ' THR . 12.5 m-85 -130.58 -166.24 1.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 72.14 110.82 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -52.11 98.23 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.683 -0.77 . . . . 75.01 112.501 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 52.72 55.6 8.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 75.43 110.922 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.1 tpt -151.75 151.29 31.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 72.51 110.862 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -134.49 117.39 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.9 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.695 HG13 HD23 ' A' ' 158' ' ' LEU . 10.9 t -130.5 156.13 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 75.11 111.108 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -153.21 123.78 7.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 61.23 110.852 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.691 ' O ' HG13 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -74.98 -178.03 3.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 74.41 111.151 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.754 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.4 t80 -175.45 137.49 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.24 110.819 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.817 ' HB3' HG23 ' A' ' 129' ' ' THR . 28.1 t80 -120.63 95.89 48.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.725 0.774 . . . . 74.42 110.884 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.2 Cg_endo -69.86 -48.74 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.653 2.235 . . . . 74.55 112.306 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.78 -155.94 24.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.771 -0.728 . . . . 53.22 112.512 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.0 124.68 39.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.741 0.305 . . . . 73.25 110.902 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.486 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.46 -94.51 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 71.42 112.453 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -69.83 -28.58 65.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 74.34 110.879 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.24 158.18 43.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 50.42 111.165 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -61.33 -25.42 67.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 70.32 110.949 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.673 ' HB3' HD12 ' A' ' 110' ' ' LEU . 1.3 p30 -121.42 49.57 1.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 74.12 110.901 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.0 OUTLIER -98.59 138.12 36.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 72.42 110.923 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.668 HD12 HG22 ' A' ' 142' ' ' THR . 7.4 pt -138.41 171.01 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 64.21 111.142 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.423 ' CG1' HD22 ' A' ' 169' ' ' LEU . 10.6 m -121.24 144.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 74.13 111.131 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.79 142.65 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 62.12 111.162 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -129.05 148.84 51.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 73.14 110.917 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.695 HD23 HG13 ' A' ' 140' ' ' VAL . 24.3 mt -125.65 94.74 41.83 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.618 0.723 . . . . 75.21 110.899 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 71.92 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.702 2.268 . . . . 63.32 112.347 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.59 -34.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 74.43 110.886 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.489 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.6 m-85 -117.7 -12.8 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 63.04 110.957 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.0 m120 69.18 25.29 5.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 45.11 110.898 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.518 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.6 mp -97.31 117.66 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.102 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.42 137.65 40.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 75.03 110.875 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 44' ' ' LEU . 20.7 t -121.35 63.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 63.35 111.103 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.93 -57.06 13.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 71.22 112.467 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.56 -135.57 12.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 72.3 112.485 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 34.7 m -61.49 -25.11 67.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 52.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.484 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.6 OUTLIER -63.3 -51.85 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 74.13 110.941 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 206' ' ' VAL . 39.8 t -89.91 103.55 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 72.4 111.15 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.517 ' H ' HG23 ' A' ' 222' ' ' THR . 1.1 tppt? -74.47 151.41 39.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 72.33 110.908 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.649 ' HA ' HD22 ' A' ' 218' ' ' LEU . 5.1 p -74.72 169.51 17.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.009 0.433 . . . . 50.41 110.804 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.507 HG23 HD23 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -70.92 -36.87 72.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.097 -0.501 . . . . 70.23 111.116 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -37.48 85.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 61.13 110.86 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.26 170.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 72.01 111.043 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -158.4 24.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.889 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -173.35 157.22 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 53.43 110.85 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.493 HD11 HD23 ' A' ' 226' ' ' LEU . 2.4 mt -87.13 -33.37 19.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 90.3 -166.94 32.35 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 65.04 112.529 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -52.16 112.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 72.23 110.892 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.7 m -108.4 33.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 74.32 111.165 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.38 -42.19 73.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 71.34 111.107 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -116.23 37.07 3.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 52.11 110.875 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.31 164.39 23.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 33.34 111.052 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -116.44 92.75 3.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 63.23 110.901 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.474 HG13 HD23 ' A' ' 226' ' ' LEU . 46.1 t -69.57 -22.62 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.32 111.091 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -80.65 -26.57 37.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 73.05 110.882 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -97.84 -22.76 16.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 75.51 110.964 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.5 -57.51 8.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 70.41 110.884 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.84 -35.93 46.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 62.02 110.801 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 94.0 m -72.74 -32.35 65.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 71.42 111.177 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.8 m -69.14 -52.67 25.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 63.23 110.88 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.681 HG22 HD23 ' A' ' 197' ' ' LEU . 34.0 mm -54.32 -41.8 54.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 75.22 111.086 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.71 -19.72 59.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.886 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -93.19 -23.87 18.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 65.33 110.919 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.432 HG12 HD21 ' A' ' 219' ' ' LEU . 33.3 t -85.65 -26.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.501 . . . . 73.04 111.159 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.681 HD23 HG22 ' A' ' 193' ' ' ILE . 4.6 pp -89.29 -25.29 21.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 65.3 110.912 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.477 ' N ' HD12 ' A' ' 197' ' ' LEU . 4.7 ptmm? -81.54 -31.37 32.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 70.43 110.922 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -72.67 -28.68 62.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 41.32 110.89 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -141.77 117.18 10.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 72.22 110.984 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -119.5 26.0 9.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 64.32 110.93 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.54 22.58 3.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 60.44 110.893 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.6 146.88 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 71.11 111.121 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -107.23 -25.7 11.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 72.15 110.871 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.482 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -164.07 133.39 3.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 43.55 111.163 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.747 ' CG1' HD12 ' A' ' 218' ' ' LEU . 97.9 t -114.16 124.0 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 50.43 111.133 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.014 HG21 HD11 ' A' ' 44' ' ' LEU . 52.1 t -107.35 104.87 54.18 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.629 0.728 . . . . 75.4 111.125 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.77 178.43 4.59 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.651 2.234 . . . . 50.31 112.307 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.05 -29.38 34.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 65.24 112.512 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -143.14 113.38 7.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 71.43 110.821 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 140.25 -112.61 0.82 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 75.55 112.478 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -155.05 166.55 33.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 74.1 110.888 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.763 HG22 HG22 ' A' ' 207' ' ' VAL . 21.8 t -72.41 150.03 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 51.15 111.168 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.35 -108.34 0.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.832 -0.699 . . . . 73.53 112.541 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -157.98 -173.33 4.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.931 0.396 . . . . 62.22 110.866 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -56.28 -21.53 24.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 72.32 110.869 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.749 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -55.41 -31.76 57.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 74.11 112.478 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.747 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.4 mt -50.91 -46.93 60.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.338 . . . . 75.44 110.869 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.446 ' O ' HG21 ' A' ' 193' ' ' ILE . 6.0 mp -55.06 -43.54 73.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 71.45 110.886 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.749 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -66.65 -41.55 88.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 64.21 110.875 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.696 ' NE2' HD21 ' A' ' 225' ' ' LEU . 85.1 t60 -61.46 -37.65 84.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 72.23 110.882 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.2 OUTLIER -51.76 -45.09 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 73.43 111.13 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.829 ' HA ' HD12 ' A' ' 226' ' ' LEU . 49.8 mt -58.16 -39.8 79.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.428 . . . . 74.2 110.872 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.47 -37.58 78.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.44 110.906 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.696 HD21 ' NE2' ' A' ' 221' ' ' HIS . 11.2 mt -68.67 -26.04 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 72.14 110.879 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.1 mt -86.68 -41.66 14.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 63.41 110.917 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 65.05 110.878 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.786 ' HD1' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.864 0.364 . . . . 75.15 110.84 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -143.82 129.99 19.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 63.11 110.894 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.15 175.15 10.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 64.44 110.906 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.6 p -169.91 146.06 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 65.43 111.171 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.21 167.28 4.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 74.41 110.838 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.42 160.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 71.14 110.874 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.462 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -149.8 -179.58 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 64.44 111.206 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 18' ' ' ILE . 92.8 t 60.85 99.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 53.12 111.153 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.688 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.7 mm -93.26 154.3 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 74.33 111.127 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -149.12 164.02 35.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 65.31 110.938 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -94.7 -169.32 2.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.913 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -23.08 55.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.23 110.902 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.5 p -103.54 -35.99 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 65.21 111.137 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.07 -4.28 45.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 54.41 112.478 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.768 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.7 -33.36 22.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.687 0.28 . . . . 74.2 111.184 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.768 HG13 HG23 ' A' ' 15' ' ' THR . 6.7 mt -127.83 159.46 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 72.22 111.126 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -175.82 167.18 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 65.53 110.807 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.551 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -130.25 -175.78 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 71.53 111.198 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.405 ' H ' HG22 ' A' ' 18' ' ' ILE . 1.9 t -168.98 129.73 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 75.44 110.797 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.51 120.48 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 64.14 110.895 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.7 mm? -103.53 -47.24 4.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.967 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -148.51 54.57 1.01 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 62.43 110.93 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.43 -77.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 62.4 110.852 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -83.63 -19.46 35.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 62.25 110.893 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.57 118.86 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 55.44 111.1 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.462 ' CH2' HG22 ' A' ' 7' ' ' THR . 16.5 m95 -125.25 158.91 32.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.158 -0.473 . . . . 64.25 110.894 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.404 HG23 ' HG ' ' A' ' 21' ' ' LEU . 73.0 t -121.86 109.52 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 72.12 111.113 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.551 ' HB3' HG23 ' A' ' 18' ' ' ILE . 7.2 p80 -103.23 138.51 39.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.805 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.7 m -135.39 133.55 38.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 61.33 111.171 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.562 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -124.39 174.61 7.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 73.53 110.881 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.667 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 4.7 tp -121.0 148.24 44.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 75.14 110.852 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.39 -121.86 2.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 74.4 112.493 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.34 150.37 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.877 0.37 . . . . 73.04 110.844 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -171.87 108.27 0.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 72.42 110.889 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.66 53.24 13.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 54.22 110.866 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.06 26.09 67.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.663 -0.779 . . . . 61.12 112.507 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -151.63 121.75 7.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 71.03 110.874 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.667 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -52.99 139.52 27.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.54 111.026 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.641 HG21 ' HD2' ' A' ' 303' ' ' RTD . 2.2 p -124.12 126.68 25.54 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.681 0.753 . . . . 63.24 111.05 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.535 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.5 Cg_endo -69.71 143.03 49.76 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.625 2.217 . . . . 72.44 112.352 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.0 t -129.96 95.23 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 52.32 110.825 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.96 162.47 0.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 70.42 110.846 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.646 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -164.09 -162.85 15.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 64.41 112.459 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -162.43 148.23 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 74.22 110.859 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 54' ' ' LEU . 62.0 t -131.43 138.1 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 75.52 111.043 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.483 HD22 ' HE3' ' A' ' 138' ' ' MET . 24.8 mt -105.39 136.89 44.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.48 . . . . 70.05 110.903 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -110.24 72.12 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 63.13 110.863 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 138' ' ' MET . 20.7 p -79.47 -173.22 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 62.12 111.162 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 t -107.61 28.05 8.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 74.41 110.87 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -154.32 25.01 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 70.51 110.916 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.45 137.35 5.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 73.13 112.494 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.8 HD13 ' HB ' ' A' ' 71' ' ' VAL . 9.2 mt -68.65 164.36 21.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 72.34 110.9 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' ' 81' ' ' ASP . 84.4 t -140.0 144.51 27.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 64.44 111.088 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.639 HD13 HG22 ' A' ' 45' ' ' VAL . 3.3 mm? -115.28 130.35 56.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.915 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG13 HG21 ' A' ' 156' ' ' VAL . 12.7 t -79.57 -1.72 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 71.14 111.179 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.5 130.58 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 75.13 110.895 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.426 ' OG ' HD11 ' A' ' 98' ' ' LEU . 7.7 m -67.19 -168.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.836 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.47 -172.31 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 74.11 110.848 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.567 ' CZ2' HG13 ' A' ' 39' ' ' VAL . 86.5 m95 -72.9 -44.92 60.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.495 . . . . 73.32 110.888 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -132.68 151.12 52.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.913 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -54.55 -30.81 55.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.448 . . . . 73.13 110.853 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -76.75 -26.84 55.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.862 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 -46.23 17.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 74.44 110.933 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 t -56.12 -25.38 45.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 63.52 111.111 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -55.28 -43.63 74.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.894 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -81.54 -4.5 56.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 65.5 110.877 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.562 HD22 ' OE2' ' A' ' 30' ' ' GLU . 16.4 tp -93.84 -45.62 7.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.219 -0.446 . . . . 70.01 110.927 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.0 mt -69.91 -33.42 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 62.32 111.096 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -67.61 -12.64 60.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 70.32 110.956 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.9 mmm -84.74 -59.47 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 54.03 110.944 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.8 ' HB ' HD13 ' A' ' 52' ' ' LEU . 28.0 m -55.04 -36.26 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 71.23 111.2 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HG3' HG23 ' A' ' 71' ' ' VAL . 55.6 mt-10 -88.13 48.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 74.11 110.869 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -142.92 -41.87 0.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 70.45 110.939 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.688 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -102.58 -24.54 13.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 63.34 110.878 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.657 ' HB3' HD21 ' A' ' 52' ' ' LEU . 37.4 m-85 -90.34 11.32 21.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 65.4 110.873 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.506 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 32.69 47.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 62.35 110.874 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -150.85 -178.43 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.881 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 149.16 50.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 75.23 110.87 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 52' ' ' LEU . 60.2 t -86.26 127.21 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 75.21 111.156 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 p -139.03 24.41 2.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 71.25 111.205 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.803 ' HB2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -153.74 133.51 13.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.889 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 82' ' ' VAL . 13.5 t -139.88 102.39 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 73.31 111.137 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.1 mt -79.11 115.68 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 62.4 111.134 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.483 HG23 ' HB3' ' A' ' 91' ' ' ARG . 46.4 mm -104.35 122.3 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 70.24 111.094 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.1 p -79.16 -58.25 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 74.13 111.148 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -127.36 -175.09 3.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 70.24 110.865 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -103.82 99.39 9.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 54.04 111.111 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.632 ' O ' HD13 ' A' ' 92' ' ' ILE . 4.5 m170 -152.88 159.66 43.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.834 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.69 -22.96 58.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 74.25 111.155 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.86 3.59 54.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 72.24 110.881 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HB3' HG23 ' A' ' 84' ' ' ILE . 25.5 mmt-85 -118.1 -52.17 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 71.54 110.867 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.632 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.78 19.31 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 72.2 111.133 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.84 -29.29 26.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 52.44 112.484 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.36 22.05 20.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 74.11 112.483 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 tt -45.38 -32.05 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 64.44 111.129 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -54.89 18.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 64.22 110.906 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 m -56.05 -40.02 72.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 63.0 111.207 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 103' ' ' ILE . 31.5 mt -59.22 -35.52 73.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 75.03 110.921 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.95 19.38 9.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 70.34 110.939 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.13 -25.95 6.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 52.54 110.92 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -106.48 7.52 30.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 73.23 110.801 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.99 14.69 66.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 61.42 112.49 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 98' ' ' LEU . 16.0 mt -80.79 154.19 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.877 0.37 . . . . 74.54 111.147 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.762 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.6 ptmt -117.41 119.56 35.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 71.21 110.863 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.05 81.3 6.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 54.31 111.052 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.606 ' HA ' HD12 ' A' ' 124' ' ' LEU . 93.8 m-70 -54.55 147.54 14.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 63.43 110.825 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.73 157.99 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 51.13 110.834 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 127' ' ' LEU . 20.3 p -82.35 157.68 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.42 111.146 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.34 -39.42 56.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.14 111.091 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -66.07 -40.98 91.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 65.31 110.926 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 96.8 m -56.29 -41.68 76.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.21 111.175 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.469 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -73.44 -22.58 60.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.4 111.064 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.66 -41.22 81.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 71.13 110.943 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.591 HD12 ' OD2' ' A' ' 152' ' ' ASP . 7.7 mt -84.05 -27.71 28.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 64.32 110.956 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.43 -69.49 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 40.22 111.144 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -55.19 -26.3 38.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 71.22 110.912 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -24.5 67.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 74.15 110.873 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -93.56 -39.08 11.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 64.22 110.91 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 137.24 -6.7 3.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 73.2 112.494 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -59.75 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.931 0.396 . . . . 64.32 110.906 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -97.55 -1.76 43.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.041 -0.527 . . . . 75.33 110.925 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.469 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.3 mt-10 66.38 129.93 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.601 0.715 . . . . 54.53 110.938 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.42 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.708 2.272 . . . . 70.35 112.338 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.762 HD11 ' HB2' ' A' ' 104' ' ' LYS . 91.4 mt -51.96 -46.53 64.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.888 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.86 57.75 14.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.798 -0.715 . . . . 51.34 112.509 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -152.09 51.07 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 72.35 110.869 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.655 ' HB3' HG22 ' A' ' 108' ' ' THR . 1.3 mp -129.91 -177.47 4.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.88 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.58 -168.38 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.22 110.906 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.755 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.0 m -49.73 -45.21 49.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.14 111.119 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 143' ' ' PHE . 3.6 m -141.31 142.6 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 73.44 111.157 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 HD23 ' A' ' 133' ' ' LEU . 63.6 m -149.56 110.89 4.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 72.43 111.139 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.02 98.93 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.834 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.637 HD23 HG22 ' A' ' 131' ' ' THR . 2.8 mt -89.19 150.22 22.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 72.45 110.887 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.18 109.6 4.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 73.31 110.933 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.694 ' HB2' HG21 ' A' ' 48' ' ' THR . 23.6 m-85 -112.5 113.03 24.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 52.44 110.782 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 54.78 -101.06 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.756 -0.735 . . . . 31.53 112.446 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.08 54.78 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.346 . . . . 65.43 110.899 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.782 ' HB2' HG22 ' A' ' 48' ' ' THR . 3.1 tpp -142.05 155.29 45.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 52.34 110.899 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.66 119.42 27.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 54.01 110.864 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.567 HG13 HD23 ' A' ' 158' ' ' LEU . 3.9 t -136.44 159.89 37.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 71.02 111.115 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 31.7 tt0 -163.12 123.67 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 74.34 110.915 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.0 178.3 4.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 74.44 111.156 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.428 ' HA ' HG12 ' A' ' 130' ' ' VAL . 75.2 t80 -172.72 135.03 0.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 72.24 110.836 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.755 ' HB3' HG23 ' A' ' 129' ' ' THR . 68.4 t80 -117.21 92.13 38.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.763 0.792 . . . . 70.11 110.964 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.6 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.642 2.228 . . . . 51.4 112.345 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.02 -170.46 43.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.806 -0.712 . . . . 72.14 112.537 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -83.78 125.14 31.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 61.11 110.924 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.48 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.73 -87.23 0.23 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 71.12 112.468 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -77.89 -28.57 49.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 72.21 110.761 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.16 159.39 43.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.2 111.136 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.05 -23.66 67.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.828 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.604 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -125.29 52.89 1.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 71.31 110.921 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.7 p30 -100.35 148.3 24.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.851 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.7 pt -147.04 162.5 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 63.35 111.128 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.502 HG11 HG21 ' A' ' 196' ' ' VAL . 8.0 m -109.73 139.01 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.13 111.202 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.514 HG21 HG13 ' A' ' 55' ' ' VAL . 74.5 t -93.35 129.18 44.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 65.12 111.07 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.437 ' O ' HD23 ' A' ' 158' ' ' LEU . 74.2 t-105 -117.06 150.6 38.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 71.24 110.946 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 163' ' ' ILE . 26.3 mt -127.05 97.64 31.84 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.619 0.723 . . . . 73.32 110.992 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 70.86 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.684 2.256 . . . . 74.45 112.339 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 179.35 -34.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 70.23 110.884 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.619 ' CB ' HD13 ' A' ' 163' ' ' ILE . 7.0 m-85 -118.34 -11.64 10.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 64.25 110.886 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.0 m120 67.34 21.97 9.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 74.11 110.892 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.619 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.5 mp -86.15 115.26 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 64.44 111.155 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.6 tm? -98.98 123.14 43.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 71.42 110.912 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.629 HG21 HD22 ' A' ' 44' ' ' LEU . 18.3 t -117.58 73.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 63.25 111.086 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.402 ' H ' HD13 ' A' ' 164' ' ' LEU . . . -64.06 -45.63 93.36 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.732 . . . . 52.41 112.521 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.42 -131.21 10.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 52.41 112.557 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.9 m -63.33 -22.45 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.818 0.342 . . . . 71.31 110.857 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.451 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.9 OUTLIER -64.9 -50.01 68.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.919 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.764 HG11 HG11 ' A' ' 206' ' ' VAL . 21.3 t -93.02 112.92 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 70.14 111.148 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.421 ' H ' HG23 ' A' ' 222' ' ' THR . 3.5 tppt? -83.0 154.45 24.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 62.12 110.882 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.617 ' HA ' HD22 ' A' ' 218' ' ' LEU . 15.8 p -78.13 162.11 26.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 74.01 110.889 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.591 HG23 HD23 ' A' ' 218' ' ' LEU . 1.5 p -66.06 -25.65 67.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 72.3 111.198 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 64.4 p -71.51 -31.44 67.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 52.11 110.912 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.08 170.86 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 74.45 111.114 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -152.18 22.59 0.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.931 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.37 168.74 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.873 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mt -93.91 -35.75 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 74.4 110.887 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.67 -167.08 24.21 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.743 . . . . 51.54 112.453 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -52.04 121.04 6.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 74.21 110.877 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.557 HG11 ' CG2' ' A' ' 186' ' ' VAL . 11.1 m -111.57 31.67 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 60.23 111.155 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.73 83.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 32.32 111.092 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -119.2 34.83 5.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.01 110.858 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -125.13 164.85 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.11 111.106 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -117.61 92.17 3.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.93 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.557 ' CG2' HG11 ' A' ' 181' ' ' VAL . 87.7 t -69.64 -23.88 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 73.25 111.108 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.28 -26.48 42.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.79 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.69 -24.07 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 72.51 110.879 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.55 -54.49 26.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 71.22 110.928 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -34.55 44.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 65.52 110.813 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 61.4 m -74.29 -35.71 63.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 62.13 111.15 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 196' ' ' VAL . 45.6 m -66.07 -55.55 16.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 54.35 110.905 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.792 HG22 HD23 ' A' ' 197' ' ' LEU . 34.3 mm -54.21 -46.99 68.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 64.35 111.122 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.38 -22.31 53.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.948 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -91.29 -25.03 19.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 42.32 110.917 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.502 HG21 HG11 ' A' ' 155' ' ' VAL . 91.8 t -84.05 -24.27 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 75.1 111.12 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.792 HD23 HG22 ' A' ' 193' ' ' ILE . 3.9 pp -95.85 -8.13 34.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 53.25 110.979 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.625 ' HG2' HD12 ' A' ' 197' ' ' LEU . 2.7 mmmt -113.15 -5.87 13.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 62.25 110.873 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -88.5 -23.83 23.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 72.14 110.838 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -118.41 -60.87 1.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.948 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.75 25.75 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 75.24 110.855 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.95 21.75 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.858 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.528 HG21 ' CG2' ' A' ' 206' ' ' VAL . 4.0 mp -55.33 145.0 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 63.34 111.134 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -106.86 -31.36 8.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.33 110.922 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.506 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -160.07 117.46 2.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 70.4 111.155 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.764 HG11 HG11 ' A' ' 170' ' ' VAL . 97.9 t -95.86 125.62 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 51.21 111.15 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 44' ' ' LEU . 58.4 t -107.46 109.07 62.47 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.581 0.705 . . . . 64.11 111.159 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -169.95 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.658 2.239 . . . . 73.11 112.35 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -106.49 -24.53 6.72 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.753 -0.736 . . . . 73.23 112.479 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -146.07 84.0 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 73.53 110.813 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 168.13 -102.0 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.759 . . . . 71.24 112.513 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.34 147.33 4.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.867 0.365 . . . . 72.01 110.876 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.62 143.89 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.132 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.56 -102.96 0.46 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 24.13 112.509 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -161.41 -169.83 2.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.801 0.334 . . . . 75.5 110.874 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -56.49 -21.77 28.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.865 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.753 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.82 -33.57 56.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.78 -0.724 . . . . 73.51 112.523 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.755 HD12 HG12 ' A' ' 206' ' ' VAL . 31.3 mt -50.86 -49.37 59.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 54.24 110.923 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.537 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -53.64 -42.25 67.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 71.22 110.89 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.753 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.7 mt -67.6 -41.39 84.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 52.31 110.93 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.4 -35.59 79.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.856 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -58.36 -45.17 88.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 75.45 111.191 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.713 ' HA ' HD12 ' A' ' 226' ' ' LEU . 82.4 mt -56.8 -37.86 71.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.963 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -42.81 97.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 72.55 110.946 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.25 -35.19 78.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 51.33 110.933 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.8 mt -78.57 -29.49 46.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 63.44 110.862 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.4 mttp . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 71.43 110.834 179.925 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 303' ' ' RTD . . . . . 0.641 ' HD2' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 18' ' ' ILE . 91.5 t . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.719 0.295 . . . . 72.4 111.137 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.73 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.1 mm -89.85 153.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 74.45 111.112 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -145.7 153.09 40.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 74.11 110.934 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -92.2 165.51 13.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.292 -0.413 . . . . 75.25 110.882 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.96 -35.13 45.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 60.45 110.844 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -88.06 -31.61 19.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.52 111.131 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.02 -12.9 67.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 73.11 112.523 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.727 HG23 HG13 ' A' ' 16' ' ' ILE . 2.2 t -51.05 -32.26 21.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 72.14 111.156 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.727 HG13 HG23 ' A' ' 15' ' ' THR . 16.5 mt -121.72 147.73 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 60.24 111.125 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -167.57 169.34 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 53.21 110.856 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.531 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -134.52 -176.04 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 64.33 111.117 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.3 t -166.97 133.79 2.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 65.43 110.859 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -70.17 118.12 12.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 75.41 110.875 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HG ' HG23 ' A' ' 27' ' ' VAL . 2.7 mm? -102.92 -42.36 5.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.924 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.62 -169.95 3.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 71.44 110.859 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -47.61 63.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 73.3 110.919 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -134.59 28.69 3.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.905 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.43 120.57 60.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.089 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -125.66 159.28 32.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.938 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 213' ' ' VAL . 73.5 t -121.74 108.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 65.21 111.122 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.531 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.0 p80 -101.17 138.26 38.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.33 110.832 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.1 m -137.01 124.39 21.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 60.12 111.156 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.589 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -110.68 177.46 4.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 51.4 110.888 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.431 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -132.78 135.76 45.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 74.21 110.929 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 70.32 112.499 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 98.1 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.646 0.736 . . . . 43.33 111.189 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.7 Cg_endo -69.67 142.7 49.03 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.641 2.227 . . . . 70.33 112.451 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -124.15 105.52 9.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 54.22 110.848 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -59.42 159.48 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 54.25 110.845 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.639 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -160.56 -160.22 10.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.74 . . . . 41.05 112.545 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.953 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -164.91 144.93 7.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 74.3 110.872 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 54' ' ' LEU . 54.1 t -128.62 134.76 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 73.32 111.078 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.49 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 19.2 mt -103.47 136.13 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 63.42 110.952 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -106.34 74.82 1.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.818 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.6 p -83.1 177.84 8.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 73.51 111.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.44 30.51 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 70.43 110.845 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -155.6 24.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 50.22 110.893 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.61 130.81 4.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 65.42 112.457 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.775 HD21 ' HB3' ' A' ' 75' ' ' PHE . 16.7 mt -59.98 166.76 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.845 0.355 . . . . 72.11 110.855 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 81' ' ' ASP . 60.1 t -141.17 144.59 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.11 111.168 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -116.77 128.23 55.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.932 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 55' ' ' VAL . 15.1 t -77.95 -3.04 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 70.11 111.136 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 179.23 132.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 72.53 110.87 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -71.34 -167.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 73.23 110.818 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.56 -173.28 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 71.32 110.825 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.798 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.4 m95 -67.55 -42.01 83.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 75.52 110.891 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.85 161.48 37.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 62.34 110.857 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.99 -38.07 69.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 64.42 110.86 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -71.45 -23.93 61.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 75.42 110.879 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -82.3 -45.1 15.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 71.44 110.93 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.0 t -67.02 -25.37 66.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 53.3 111.149 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -53.09 -39.2 63.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 64.23 110.901 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -85.54 -14.56 45.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 71.32 110.827 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.589 HD22 ' OE2' ' A' ' 30' ' ' GLU . 15.2 tp -77.76 -45.57 24.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.964 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.9 mt -71.73 -33.28 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.12 111.12 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.88 -17.15 62.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 72.51 110.846 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.2 mmm -85.43 -55.55 3.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.825 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.748 ' HB ' HD13 ' A' ' 52' ' ' LEU . 27.3 m -57.22 -37.2 55.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 71.23 111.068 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HG3' HG23 ' A' ' 71' ' ' VAL . 57.3 mt-10 -86.71 49.95 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 62.4 110.851 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tpmp? -145.43 -42.13 0.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.908 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.73 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.82 -23.43 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 73.43 110.843 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.775 ' HB3' HD21 ' A' ' 52' ' ' LEU . 34.6 m-85 -90.04 11.24 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 75.02 110.923 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.51 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.92 46.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 74.41 110.892 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -154.29 -178.59 7.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 62.35 110.863 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.42 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -127.09 149.49 49.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.2 110.825 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 52' ' ' LEU . 68.5 t -84.1 126.63 40.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 71.22 111.099 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.42 HG23 ' HD3' ' A' ' 78' ' ' ARG . 22.5 p -135.8 26.55 3.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 50.01 111.175 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.754 ' HB2' HG22 ' A' ' 53' ' ' VAL . 8.7 m-20 -158.33 135.27 9.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.865 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.643 HG21 ' CD2' ' A' ' 98' ' ' LEU . 20.5 t -140.55 99.87 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 71.41 111.079 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.9 mt -77.21 126.0 37.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 73.54 111.06 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.646 HG23 ' HB3' ' A' ' 91' ' ' ARG . 34.6 mm -112.99 123.27 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 71.22 111.165 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.1 p -81.0 -52.81 7.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 75.44 111.125 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -135.33 167.63 20.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.853 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -86.89 98.7 11.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 70.55 111.145 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.651 ' O ' HD13 ' A' ' 92' ' ' ILE . 1.4 m170 -153.0 160.38 43.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 74.42 110.863 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.31 -28.09 62.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 75.51 111.027 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.09 11.13 21.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.833 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.646 ' HB3' HG23 ' A' ' 84' ' ' ILE . 4.9 mmt180 -123.83 -52.62 1.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 72.11 110.924 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.79 16.92 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 70.55 111.165 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.42 -27.74 26.24 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.729 -0.748 . . . . 72.35 112.47 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.79 19.26 30.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.652 -0.785 . . . . 33.24 112.414 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.439 HG21 ' H ' ' A' ' 121' ' ' GLU . 4.2 tt -48.73 -30.64 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 63.25 111.214 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -68.45 -43.97 75.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 63.24 110.855 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -69.38 -33.48 73.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 64.14 111.163 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.643 ' CD2' HG21 ' A' ' 82' ' ' VAL . 58.8 mt -63.75 -27.3 69.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 72.41 110.973 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.71 19.07 16.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 74.02 110.933 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.75 -23.87 7.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.911 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -110.87 10.02 22.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 72.03 110.865 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.17 18.76 66.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 70.14 112.471 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.0 mt -83.18 157.59 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 70.25 111.105 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.67 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -121.3 119.78 33.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 64.3 110.895 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.527 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . . . -89.05 79.56 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 74.43 111.151 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.581 ' HA ' HD12 ' A' ' 124' ' ' LEU . 96.9 m-70 -54.36 146.98 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 74.21 110.909 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.5 163.86 0.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.923 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 127' ' ' LEU . 81.1 p -80.37 154.9 27.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 61.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.59 -29.88 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 44.13 111.104 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 152' ' ' ASP . 6.6 tp -74.87 -43.25 55.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.935 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.0 m -53.19 -27.44 21.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 63.25 111.17 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.3 -28.02 21.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.056 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -60.12 -25.17 65.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.413 . . . . 75.32 110.887 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.653 HD12 ' OD1' ' A' ' 152' ' ' ASP . 47.6 mt -99.07 -24.67 14.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 65.23 110.88 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.65 -63.14 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.11 111.106 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -55.62 -25.74 40.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 74.33 110.855 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -24.67 65.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 71.14 110.875 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -95.32 -28.33 15.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.1 110.863 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.07 -5.44 7.82 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 71.4 112.442 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -59.6 -173.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 73.15 110.926 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.439 ' H ' HG21 ' A' ' 95' ' ' ILE . 25.4 mm-40 -99.65 1.09 43.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.489 . . . . 53.14 110.911 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 65.69 122.84 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.719 0.771 . . . . 74.25 110.916 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.73 -170.52 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.647 2.231 . . . . 74.12 112.37 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 104' ' ' LYS . 60.1 mt -52.16 -40.49 61.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.44 110.877 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.03 59.59 8.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 62.01 112.547 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -152.75 51.23 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 73.21 110.889 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB3' HG22 ' A' ' 108' ' ' THR . 1.2 mp -130.1 -175.74 3.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 63.42 110.913 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.44 -167.93 2.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 60.1 110.952 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.794 HG23 ' HB3' ' A' ' 144' ' ' TYR . 96.3 m -49.15 -43.41 41.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 73.51 111.176 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 142' ' ' THR . 3.6 m -141.47 141.7 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 74.23 111.093 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 HD23 ' A' ' 133' ' ' LEU . 60.7 m -148.88 112.14 4.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.173 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.34 96.06 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 74.25 110.831 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.642 HD23 HG22 ' A' ' 131' ' ' THR . 3.7 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 51.31 110.889 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.73 ' HB2' HG22 ' A' ' 48' ' ' THR . 3.0 tpp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.876 0.37 . . . . 63.55 110.88 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 118.45 25.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.55 110.872 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.665 HG13 HD23 ' A' ' 158' ' ' LEU . 4.5 t -134.98 159.18 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 73.41 111.169 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.412 ' N ' HG12 ' A' ' 140' ' ' VAL . 32.3 tt0 -158.98 124.45 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 61.42 110.98 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.41 ' O ' HG12 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -75.16 178.5 5.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 55.4 111.096 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -171.98 136.76 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.842 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.794 ' HB3' HG23 ' A' ' 129' ' ' THR . 33.0 t80 -116.19 92.95 37.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.751 0.786 . . . . 74.34 110.896 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -48.72 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.615 2.21 . . . . 73.13 112.29 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.56 -170.38 42.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 72.11 112.479 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -84.26 123.61 30.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 75.13 110.938 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.492 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.18 -89.72 0.24 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.769 -0.729 . . . . 64.35 112.534 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -74.18 -28.27 61.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.367 . . . . 73.21 110.896 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.96 157.81 43.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 62.15 111.204 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -62.45 -25.14 67.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 43.5 110.891 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.653 ' OD1' HD12 ' A' ' 114' ' ' LEU . 16.0 p30 -123.28 52.06 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.901 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.523 ' OD1' HD13 ' A' ' 169' ' ' LEU . 2.0 p30 -99.94 142.71 31.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.968 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.8 pt -144.28 158.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 75.12 111.173 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 196' ' ' VAL . 18.4 m -105.11 150.5 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.44 111.113 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 96.0 t -102.56 139.05 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 72.05 111.116 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -126.99 150.71 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 74.42 110.904 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.665 HD23 HG13 ' A' ' 140' ' ' VAL . 20.7 mt -128.84 95.72 31.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.594 0.711 . . . . 75.41 110.853 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 72.18 1.51 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.699 2.266 . . . . 61.2 112.307 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.47 -34.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 65.14 110.908 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.535 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.6 m-85 -117.95 -13.21 10.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.976 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.8 m120 69.0 26.19 5.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 64.2 110.918 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.549 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.6 mp -96.83 117.61 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 51.41 111.107 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.13 138.04 41.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 71.24 110.946 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.499 HG21 HD22 ' A' ' 44' ' ' LEU . 21.7 t -121.52 68.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.31 111.143 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.37 -51.81 35.33 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.552 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.22 -135.44 12.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 52.43 112.501 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 31.4 m -62.22 -26.09 68.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 73.25 110.889 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.523 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.4 OUTLIER -66.14 -49.5 67.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 54.04 110.907 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 206' ' ' VAL . 57.7 t -92.24 96.18 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 71.34 111.099 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -69.06 153.13 44.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.35 110.955 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.698 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.7 p -74.87 167.06 22.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.857 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.447 HG23 HD23 ' A' ' 218' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 75.32 111.152 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 186' ' ' VAL . 17.1 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.808 0.337 . . . . 63.01 111.124 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.7 -46.85 83.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 74.44 111.111 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.56 40.99 2.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 55.51 110.792 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -134.02 165.64 24.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.11 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -116.9 92.25 3.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.889 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.469 ' CG2' HG11 ' A' ' 181' ' ' VAL . 90.3 t -69.59 -23.81 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 52.1 111.19 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -25.81 39.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 74.52 110.904 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -97.75 -23.55 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 70.4 110.937 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -51.29 -54.42 26.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.974 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.3 t -51.88 -33.77 38.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 71.34 110.893 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 82.3 m -76.33 -34.01 59.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 42.24 111.182 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.9 m -66.36 -53.22 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 70.25 110.87 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.784 HG22 HD23 ' A' ' 197' ' ' LEU . 34.6 mm -56.3 -43.15 76.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 73.33 111.163 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.76 -19.77 59.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 70.54 110.884 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.63 -31.09 15.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 50.1 110.858 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.503 ' CG1' HD21 ' A' ' 219' ' ' LEU . 94.2 t -75.5 -50.74 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.11 111.101 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.784 HD23 HG22 ' A' ' 193' ' ' ILE . 3.9 pp -65.08 -24.34 67.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 54.3 110.91 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.43 -43.78 15.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.92 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -52.95 -28.97 26.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.41 110.907 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -144.47 119.94 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.91 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.92 41.05 2.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 71.44 110.817 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.4 21.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.35 110.795 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -52.47 146.83 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 73.45 111.147 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.66 -28.87 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 74.43 110.902 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.447 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -159.61 139.28 11.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 74.11 111.069 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 170' ' ' VAL . 84.6 t -123.18 126.04 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 60.34 111.146 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.953 HG21 HD11 ' A' ' 44' ' ' LEU . 55.8 t -107.66 113.12 61.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 70.51 111.077 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -170.27 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.687 2.258 . . . . 73.34 112.33 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.57 -31.25 7.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.67 -0.776 . . . . 74.45 112.489 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -143.5 94.61 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.827 0.346 . . . . 75.03 110.883 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 160.38 -114.94 0.63 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 74.34 112.454 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -150.27 162.77 39.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.957 0.408 . . . . 71.53 110.864 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.793 HG22 HG22 ' A' ' 207' ' ' VAL . 22.0 t -67.95 150.23 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 72.32 111.095 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.45 -108.81 0.56 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.772 -0.728 . . . . 64.23 112.551 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -159.81 -169.83 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 75.44 110.834 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -58.25 -20.19 40.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 73.52 110.899 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -57.67 -32.27 65.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.778 -0.725 . . . . 51.22 112.485 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.698 HD22 ' HA ' ' A' ' 172' ' ' SER . 32.1 mt -51.03 -42.99 60.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.352 . . . . 65.33 110.892 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.503 HD21 ' CG1' ' A' ' 196' ' ' VAL . 1.0 OUTLIER -60.43 -45.25 94.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 54.22 110.829 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.752 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -64.27 -42.24 96.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 52.2 110.922 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.682 ' NE2' HD21 ' A' ' 225' ' ' LEU . 78.7 t60 -63.86 -39.67 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.963 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.5 m -51.75 -42.49 62.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 64.4 111.122 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' A' ' 226' ' ' LEU . 78.6 mt -59.95 -39.91 87.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.92 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -28.03 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.43 110.849 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.682 HD21 ' NE2' ' A' ' 221' ' ' HIS . 20.6 mt -72.27 -25.81 61.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 73.43 110.925 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.6 mt -87.42 -43.06 12.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 74.13 110.921 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 54.43 110.888 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.582 HG22 ' OG ' ' A' ' 19' ' ' SER . 88.4 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 55.13 111.071 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.88 155.78 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 71.15 111.156 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -145.58 146.62 31.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.913 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 173.72 9.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 73.35 110.94 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.82 -36.01 77.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 61.21 110.893 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.459 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.3 p -95.17 -24.9 16.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 71.41 111.086 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.94 -11.3 57.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.728 . . . . 41.45 112.425 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.808 HG23 HG13 ' A' ' 16' ' ' ILE . 3.7 t -51.09 -33.28 25.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 54.42 111.119 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.808 HG13 HG23 ' A' ' 15' ' ' THR . 18.8 mt -121.64 148.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.04 111.13 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 p -169.2 165.56 10.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 75.23 110.87 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.577 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -132.15 -172.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 70.12 111.134 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.582 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -173.45 134.64 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 75.14 110.876 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.96 119.93 14.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 54.14 110.872 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.406 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.4 mm? -100.96 -55.02 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.882 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -138.47 53.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 73.41 110.894 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mttt 68.0 -76.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 71.53 110.88 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -84.11 -19.52 34.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 63.3 110.916 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.21 121.28 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 64.34 111.164 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -125.45 160.23 29.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.947 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.406 HG23 ' HG ' ' A' ' 21' ' ' LEU . 72.8 t -122.4 112.44 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 62.34 111.081 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.577 ' HB3' HG23 ' A' ' 18' ' ' ILE . 8.7 p80 -105.47 137.6 43.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 65.14 110.93 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 m -133.34 127.72 34.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 51.14 111.137 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.646 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -118.11 164.98 14.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.914 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.493 HD12 ' CA ' ' A' ' 40' ' ' PRO . 5.3 tp -118.84 143.3 47.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.91 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 39' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 72.3 112.508 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.66 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.3 p . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 121.587 0.708 . . . . 63.2 111.172 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.493 ' CA ' HD12 ' A' ' 31' ' ' LEU . 53.8 Cg_endo -69.81 143.43 50.57 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.64 2.227 . . . . 50.21 112.349 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -130.92 95.87 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 74.44 110.857 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -51.94 155.21 1.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 62.21 110.843 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.621 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -155.97 -158.45 8.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.657 -0.782 . . . . 65.44 112.441 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.865 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -166.06 143.91 5.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 74.32 110.942 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.58 HG22 HD13 ' A' ' 54' ' ' LEU . 50.6 t -126.95 142.7 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 63.12 111.152 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.1 mt -111.92 127.5 55.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 53.3 110.908 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -93.33 48.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.871 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.6 p -56.52 166.18 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 60.34 111.127 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.5 t -95.99 34.17 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 72.4 110.843 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -157.65 28.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.43 110.9 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.6 124.1 4.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 75.32 112.516 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.772 HD13 ' HB ' ' A' ' 71' ' ' VAL . 20.1 mt -51.72 161.31 0.54 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.801 0.334 . . . . 74.12 110.88 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.774 HG22 ' HB2' ' A' ' 81' ' ' ASP . 59.8 t -139.74 144.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.114 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.58 HD13 HG22 ' A' ' 45' ' ' VAL . 3.5 mm? -116.63 129.93 56.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.003 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.5 t -80.36 -0.36 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 64.24 111.111 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -179.72 132.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.54 110.845 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 m -71.24 -169.04 0.35 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.216 -0.447 . . . . 75.54 110.851 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.79 -170.75 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 74.2 110.843 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.776 ' HB2' HD13 ' A' ' 63' ' ' LEU . 93.1 m95 -72.86 -40.46 65.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.891 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.77 162.31 35.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 63.21 110.933 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.43 -33.51 67.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 71.23 110.91 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -75.63 -25.46 56.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 71.1 110.958 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -81.75 -41.82 20.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.487 . . . . 72.4 110.939 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -68.03 -26.43 65.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.19 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.1 -43.69 70.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.936 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.05 -13.91 54.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.934 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.646 HD22 ' OE2' ' A' ' 30' ' ' GLU . 17.8 tp -77.35 -45.38 26.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.506 . . . . 75.42 110.926 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.22 -26.72 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 61.02 111.12 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.21 -10.15 59.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 74.34 110.891 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.0 mmm -90.82 -53.0 4.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 52.43 110.834 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.772 ' HB ' HD13 ' A' ' 52' ' ' LEU . 21.5 m -58.4 -39.85 76.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 72.33 111.155 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 71' ' ' VAL . 53.4 mt-10 -84.29 51.09 2.0 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 65.42 110.877 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.14 -41.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 71.13 110.953 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.5 -19.18 13.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 71.22 110.848 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.671 ' HB3' HD21 ' A' ' 52' ' ' LEU . 24.2 m-85 -88.15 9.52 22.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 75.43 110.924 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.96 46.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 71.03 110.862 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -154.32 -179.15 7.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 73.53 110.902 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.21 149.39 51.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 75.43 110.884 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 52' ' ' LEU . 69.9 t -82.22 128.43 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 75.15 111.13 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.5 p -138.94 23.04 2.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 75.4 111.15 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.774 ' HB2' HG22 ' A' ' 53' ' ' VAL . 3.7 m-20 -154.93 132.6 11.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.226 -0.443 . . . . 72.42 110.846 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.637 HG21 HD22 ' A' ' 98' ' ' LEU . 23.4 t -138.6 99.89 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 62.42 111.091 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.0 mt -79.3 124.84 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 73.41 111.129 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 91' ' ' ARG . 38.2 mm -111.51 132.88 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 75.35 111.171 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.5 p -89.05 -55.89 3.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 75.5 111.2 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -133.55 162.37 32.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.32 110.807 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -81.34 97.21 7.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 72.43 111.084 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.635 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.5 OUTLIER -150.91 158.54 44.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 74.53 110.859 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.44 -25.59 59.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.33 111.086 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.37 13.17 18.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 72.32 110.894 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.442 ' O ' HD12 ' A' ' 84' ' ' ILE . 3.3 mpt_? -128.12 -52.36 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 64.02 110.85 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.76 16.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 61.22 111.051 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.85 -27.52 21.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 44.43 112.512 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.11 20.83 23.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.723 . . . . 52.12 112.491 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' H ' ' A' ' 121' ' ' GLU . 4.5 tt -48.48 -30.92 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 63.02 111.166 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -69.16 -43.76 73.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 71.13 110.878 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.5 m -67.84 -34.98 77.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 74.25 111.169 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.637 HD22 HG21 ' A' ' 82' ' ' VAL . 51.4 mt -60.63 -34.73 74.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 74.1 110.874 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.05 22.34 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 74.04 110.954 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -117.42 -20.27 9.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 72.24 110.933 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -115.78 5.9 14.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 74.15 110.872 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.4 60.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 53.51 112.489 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 98' ' ' LEU . 15.4 mt -80.98 155.72 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.909 0.385 . . . . 75.23 111.106 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.785 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -120.48 122.94 41.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 73.51 110.914 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.537 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -90.98 81.61 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 61.42 111.055 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.438 ' ND1' HD12 ' A' ' 124' ' ' LEU . 96.9 m-70 -57.87 146.88 30.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 71.23 110.798 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.21 159.32 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 72.3 110.846 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.0 p -72.81 152.67 41.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 73.41 111.185 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.58 -29.72 18.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.289 -0.414 . . . . 74.04 111.073 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 152' ' ' ASP . 6.7 tp -74.6 -44.49 50.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.859 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 96.7 m -53.17 -27.63 22.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 53.13 111.168 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.422 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -88.66 -26.45 21.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 60.32 111.09 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -61.05 -26.88 67.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.202 -0.454 . . . . 73.33 110.979 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.538 HD13 ' OD2' ' A' ' 152' ' ' ASP . 8.9 mp -96.6 -25.08 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 74.43 110.878 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.3 -64.4 0.88 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 55.3 111.081 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -55.41 -26.04 39.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 75.43 110.884 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -24.37 66.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.11 110.945 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -95.71 -32.2 12.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 73.44 110.87 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.47 -6.64 5.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 72.41 112.475 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -59.53 -173.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 75.42 110.923 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.476 ' H ' HG21 ' A' ' 95' ' ' ILE . 40.2 mm-40 -99.46 -0.64 40.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 72.21 110.892 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.422 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.0 OUTLIER 66.07 125.15 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.606 0.717 . . . . 74.45 110.892 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -170.6 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.69 2.26 . . . . 52.34 112.334 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.785 HD11 ' HB2' ' A' ' 104' ' ' LYS . 61.5 mt -53.66 -35.25 60.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.985 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.35 43.74 65.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 71.33 112.497 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -138.72 57.7 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 71.05 110.814 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.75 -169.74 2.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.926 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.2 -169.15 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 74.43 110.961 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.825 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.2 m -50.97 -70.13 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.145 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.79 HG23 HG22 ' A' ' 129' ' ' THR . 62.4 t -120.45 109.27 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.094 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.1 m -112.72 103.69 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 71.03 111.146 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -66.14 96.18 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 62.02 110.861 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 72.45 110.818 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 tpt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.889 0.376 . . . . 72.23 110.862 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -130.42 127.62 39.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 72.44 110.917 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.563 HG13 HD23 ' A' ' 158' ' ' LEU . 5.9 t -139.76 157.5 26.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 75.42 111.084 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.423 ' HG2' HG13 ' A' ' 130' ' ' VAL . 74.6 tt0 -155.35 119.79 4.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 64.33 110.9 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.654 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.86 -178.17 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 75.03 111.169 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.712 ' HA ' HG22 ' A' ' 130' ' ' VAL . 74.0 t80 -175.49 137.93 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.5 110.943 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.825 ' HB3' HG23 ' A' ' 129' ' ' THR . 35.5 t80 -121.89 96.16 47.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.684 0.754 . . . . 74.1 110.923 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.59 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.634 2.223 . . . . 71.41 112.297 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.09 -157.64 28.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 60.34 112.532 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.33 124.84 36.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.351 . . . . 74.21 110.88 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.482 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.17 -98.64 0.51 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.794 -0.717 . . . . 73.31 112.489 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -66.59 -26.95 67.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 71.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.98 161.5 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 63.12 111.167 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -64.37 -26.27 68.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 75.22 110.86 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.538 ' OD2' HD13 ' A' ' 114' ' ' LEU . 11.6 p30 -120.83 50.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.843 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.18 136.99 38.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 64.2 110.879 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.654 HD12 HG22 ' A' ' 142' ' ' THR . 5.8 pt -137.59 172.22 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 72.2 111.138 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.442 ' CG1' HD22 ' A' ' 169' ' ' LEU . 9.4 m -123.11 149.17 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 75.32 111.166 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -103.39 144.28 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 74.34 111.125 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -130.29 145.94 51.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 73.13 110.91 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.563 HD23 HG13 ' A' ' 140' ' ' VAL . 13.4 mt -123.91 96.71 42.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.545 0.688 . . . . 63.23 110.944 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 72.89 1.42 Allowed 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.669 2.246 . . . . 72.35 112.345 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.31 -34.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 72.51 110.823 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.441 ' O ' HD12 ' A' ' 163' ' ' ILE . 7.1 m-85 -117.44 -13.55 10.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 74.31 110.947 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m120 69.07 24.91 6.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 73.54 110.849 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -97.73 116.64 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.12 111.101 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.81 136.51 39.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 75.53 110.919 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.526 HG21 HD22 ' A' ' 44' ' ' LEU . 19.4 t -120.53 62.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 72.44 111.158 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.36 -55.7 18.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.676 -0.774 . . . . 33.34 112.529 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.15 -137.11 14.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 73.22 112.503 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.06 -20.18 56.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 71.33 110.9 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.463 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.7 OUTLIER -65.86 -50.89 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.907 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.723 HG11 HG11 ' A' ' 206' ' ' VAL . 21.8 t -81.59 132.55 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.156 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.418 ' HB2' HG23 ' A' ' 222' ' ' THR . 0.6 OUTLIER -109.21 130.45 55.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 55.04 110.902 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.587 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.7 p -60.08 159.77 9.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 62.31 110.845 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 72.4 111.124 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.57 HG11 ' CG2' ' A' ' 186' ' ' VAL . 16.5 m . . . . . 0 C--O 1.23 0.034 0 CA-C-O 120.81 0.338 . . . . 53.14 111.097 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.46 -34.94 67.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 75.32 111.058 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -122.74 35.86 4.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 74.03 110.835 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -132.41 165.84 23.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 54.12 111.139 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -113.76 92.75 4.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 74.3 110.927 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.57 ' CG2' HG11 ' A' ' 181' ' ' VAL . 91.6 t -68.54 -23.12 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 73.44 111.158 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.1 -25.65 36.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 74.51 110.85 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.49 -23.44 16.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 64.12 110.862 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.54 -52.49 46.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 71.41 110.953 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.7 p -52.0 -36.19 49.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 64.21 110.921 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.4 m -73.8 -36.51 65.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 44.53 111.14 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 74.3 m -63.38 -54.32 38.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.846 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.605 HG22 HD23 ' A' ' 197' ' ' LEU . 30.1 mm -56.35 -37.13 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 72.34 111.15 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.76 -22.59 66.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.827 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.13 -33.39 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 72.11 110.904 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.404 HG21 HG11 ' A' ' 155' ' ' VAL . 92.6 t -74.53 -49.36 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.31 111.135 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.605 HD23 HG22 ' A' ' 193' ' ' ILE . 4.6 pp -64.7 -25.07 67.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 75.33 110.914 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -78.95 -45.55 20.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 61.52 110.947 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -60.09 -33.29 71.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 62.43 110.841 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -136.29 121.7 19.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.42 110.909 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -122.58 27.27 7.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 74.33 110.874 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.93 22.38 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 53.35 110.894 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.82 146.29 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.238 -0.437 . . . . 72.31 111.119 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -106.43 -25.69 11.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 74.32 110.878 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.507 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -163.59 128.6 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 71.34 111.128 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.732 ' CG1' HD12 ' A' ' 218' ' ' LEU . 75.9 t -107.15 118.88 55.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 61.41 111.17 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.865 HG21 HD11 ' A' ' 44' ' ' LEU . 47.1 t -105.8 98.05 16.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.699 . . . . 65.34 111.153 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.6 Cg_endo -69.77 -172.25 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.704 2.269 . . . . 72.51 112.383 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.74 -30.22 8.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.731 . . . . 64.21 112.475 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -142.56 106.23 4.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.872 0.368 . . . . 75.32 110.935 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 151.26 -96.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.81 -0.71 . . . . 70.35 112.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -178.96 153.99 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 62.23 110.838 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.534 HG22 HG22 ' A' ' 207' ' ' VAL . 22.4 t -63.79 147.83 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 72.34 111.114 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -152.38 -107.79 0.35 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.691 -0.766 . . . . 73.33 112.502 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -155.75 -173.57 4.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.926 0.393 . . . . 74.13 110.858 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -55.42 -22.83 21.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 61.31 110.843 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.751 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.03 -31.95 48.83 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 43.44 112.526 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.732 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.5 mt -50.99 -46.93 61.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 71.34 110.964 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.601 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -54.29 -43.3 70.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 75.44 110.92 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.751 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.6 mt -66.33 -41.54 89.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.994 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.489 ' NE2' HD21 ' A' ' 225' ' ' LEU . 78.9 t60 -61.82 -38.1 86.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 72.34 110.911 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -55.76 -46.11 77.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 73.34 111.116 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.789 ' HA ' HD12 ' A' ' 226' ' ' LEU . 2.5 mt -54.22 -39.99 67.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.14 110.917 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -46.13 91.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 52.32 110.85 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.489 HD21 ' NE2' ' A' ' 221' ' ' HIS . 17.5 mt -56.73 -26.39 56.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 72.41 110.889 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 223' ' ' LEU . 4.5 mt -85.53 -45.6 11.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 62.13 110.93 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 64.01 110.896 179.826 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.556 HG22 ' OG ' ' A' ' 19' ' ' SER . 94.8 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.801 0.334 . . . . 74.31 111.111 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.752 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.9 mm -89.34 157.54 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 74.11 111.144 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -146.53 179.18 7.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 74.14 110.901 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.05 168.47 9.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 70.11 110.918 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HG3' HG23 ' A' ' 13' ' ' THR . 8.4 pt-20 -53.13 -29.52 31.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.894 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.434 HG23 ' HG3' ' A' ' 12' ' ' GLU . 23.6 p -104.74 -35.5 7.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 74.52 111.111 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.69 -4.58 29.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.798 -0.715 . . . . 70.01 112.501 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.695 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -51.18 -33.78 28.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.825 0.345 . . . . 75.52 111.154 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.695 HG13 HG23 ' A' ' 15' ' ' THR . 11.4 mt -126.3 149.74 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 61.24 111.197 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.8 p -169.11 165.77 11.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 44.25 110.92 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.511 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -132.4 -171.79 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.081 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.556 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -174.49 133.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.881 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.57 120.66 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 72.13 110.93 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.4 mm? -101.61 -54.5 2.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 65.14 110.943 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -136.29 48.41 2.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 73.32 110.875 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt 70.68 -70.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 65.03 110.921 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -87.16 -22.18 25.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 71.51 110.924 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.45 123.78 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.12 111.121 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -125.43 159.94 30.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.904 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.824 HG21 HG21 ' A' ' 213' ' ' VAL . 75.8 t -120.23 110.1 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 72.23 111.097 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.511 ' HB3' HG23 ' A' ' 18' ' ' ILE . 3.4 p80 -104.59 139.25 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.833 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.3 m -137.07 132.27 33.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 75.15 111.17 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.42 166.75 14.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.844 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.496 HD12 ' CA ' ' A' ' 40' ' ' PRO . 5.3 tp -117.81 143.59 46.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 62.14 110.891 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 39' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 70.34 112.492 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.663 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.3 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.605 0.717 . . . . 63.15 111.123 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.496 ' CA ' HD12 ' A' ' 31' ' ' LEU . 54.1 Cg_endo -69.75 141.57 45.64 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.724 2.283 . . . . 65.11 112.34 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -129.75 93.96 3.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.04 110.847 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -53.69 164.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 75.01 110.878 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.33 -165.58 23.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 52.04 112.531 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.021 HD13 HG21 ' A' ' 207' ' ' VAL . 4.1 tp -157.32 142.04 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 61.52 110.919 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 54' ' ' LEU . 21.8 t -125.75 132.27 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 71.45 111.144 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.05 131.87 45.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.876 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -100.49 66.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 74.02 110.855 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.5 p -72.77 170.92 13.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 74.32 111.103 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.6 t -96.0 27.18 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 70.24 110.853 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -150.76 27.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 54.44 110.92 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.05 127.79 4.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.664 -0.779 . . . . 74.34 112.445 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.763 HD13 ' HB ' ' A' ' 71' ' ' VAL . 19.0 mt -55.51 161.04 2.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 63.11 110.962 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 81' ' ' ASP . 49.6 t -140.13 142.17 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 71.1 111.118 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.705 HD13 HG22 ' A' ' 45' ' ' VAL . 2.9 mm? -115.87 129.58 56.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.946 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 165' ' ' VAL . 14.2 t -80.73 0.36 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 72.5 111.148 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.12 129.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 72.32 110.804 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.53 -168.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.14 110.823 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.4 m -92.98 -174.54 3.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 63.21 110.833 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.697 ' HB2' HD13 ' A' ' 63' ' ' LEU . 95.9 m95 -67.41 -39.48 85.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 70.32 110.873 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.46 166.68 24.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 73.12 110.903 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -62.66 -28.29 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 71.11 110.828 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -75.94 -22.4 56.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 73.04 110.883 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.697 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -86.98 -46.45 9.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 52.45 110.943 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -58.36 -28.88 65.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.24 111.158 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -55.58 -43.29 75.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.44 . . . . 63.42 110.792 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -85.8 0.58 52.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.251 -0.431 . . . . 72.35 110.852 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.3 -47.19 6.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.31 110.907 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.5 mt -69.53 -32.7 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 64.13 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.05 -17.81 58.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.11 110.903 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 42.8 mtp -82.15 -58.73 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 72.21 110.905 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.763 ' HB ' HD13 ' A' ' 52' ' ' LEU . 33.4 m -57.12 -35.8 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 62.34 111.14 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -86.85 49.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 64.2 110.943 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.85 -40.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.888 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.752 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -105.56 -24.02 12.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 62.13 110.872 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.588 ' HB3' HD21 ' A' ' 52' ' ' LEU . 27.9 m-85 -88.89 10.23 21.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.41 . . . . 61.5 110.877 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.509 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.66 46.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.914 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -152.48 -179.23 7.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 75.03 110.906 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.63 143.82 51.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 64.04 110.895 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 52' ' ' LEU . 94.8 t -75.09 130.07 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 74.52 111.12 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.2 p -142.05 31.0 1.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 63.31 111.16 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.763 ' HB2' HG22 ' A' ' 53' ' ' VAL . 15.4 m-20 -164.35 126.67 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 64.42 110.89 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.705 HG23 HG21 ' A' ' 103' ' ' ILE . 17.3 t -133.69 101.85 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 73.05 111.096 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.7 mt -80.18 120.73 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 70.1 111.146 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 91' ' ' ARG . 36.2 mm -108.71 129.81 62.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 71.15 111.103 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.9 p -85.37 -53.73 5.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 72.14 111.124 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -134.71 166.54 22.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 74.33 110.855 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -84.35 96.18 8.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 53.14 111.118 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.617 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -149.33 159.22 44.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.837 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.31 62.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 62.42 111.09 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.84 11.51 20.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 64.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 84' ' ' ILE . 3.5 mpt_? -125.42 -54.67 1.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.882 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.617 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -111.3 16.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 65.31 111.106 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.21 -28.85 27.83 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.684 -0.77 . . . . 75.12 112.495 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.68 19.04 31.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 60.53 112.487 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.489 HD11 ' C ' ' A' ' 122' ' ' GLU . 3.9 tt -48.89 -30.18 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 74.12 111.14 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -72.22 -43.26 64.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 75.43 110.925 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.5 m -64.22 -40.75 96.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 74.52 111.161 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.617 HD12 ' HB2' ' A' ' 105' ' ' ALA . 32.5 mt -60.96 -35.46 76.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 52.51 110.913 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -81.61 -23.26 37.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 74.13 110.884 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -82.34 -35.03 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 75.45 110.947 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.539 ' HB2' HD12 ' A' ' 103' ' ' ILE . 3.1 mtt-85 -87.29 -45.77 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 61.31 110.873 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.12 -14.98 3.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.782 -0.723 . . . . 73.33 112.452 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.705 HG21 HG23 ' A' ' 82' ' ' VAL . 1.9 mp -60.72 150.39 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.918 0.39 . . . . 73.23 111.151 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.751 ' HB2' HD11 ' A' ' 124' ' ' LEU . 3.4 ptpt -111.46 126.65 55.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 75.32 110.932 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.617 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -89.29 83.02 6.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 61.25 111.043 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.435 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.3 m-70 -57.95 143.55 42.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 75.12 110.916 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.68 150.76 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 71.12 110.823 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.8 p -63.88 179.28 0.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 62.12 111.146 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.9 -33.22 63.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 43.23 111.05 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 152' ' ' ASP . 9.9 tp -72.88 -47.04 49.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 42.11 110.951 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.734 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 98.3 m -52.19 -28.9 20.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.54 111.153 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.92 -31.09 25.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.047 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -55.1 -48.38 73.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.892 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.678 HD12 ' OD2' ' A' ' 152' ' ' ASP . 39.9 mt -72.36 -25.0 61.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 71.21 110.901 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.73 -66.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 53.43 111.066 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -54.76 -26.57 35.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.42 110.91 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -23.83 67.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.02 110.89 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -93.74 -38.9 11.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 73.51 110.889 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 138.55 -7.76 3.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 54.22 112.508 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -59.55 -172.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.733 0.301 . . . . 70.15 110.987 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.46 ' H ' HG21 ' A' ' 95' ' ' ILE . 61.6 mm-40 -99.87 0.11 40.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 62.34 110.909 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.489 ' C ' HD11 ' A' ' 95' ' ' ILE . 0.9 OUTLIER 66.31 130.7 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.639 0.733 . . . . 73.22 110.867 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.85 -170.3 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.636 2.224 . . . . 74.44 112.292 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 104' ' ' LYS . 76.9 mt -53.81 -45.28 70.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 64.04 110.884 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.56 52.68 40.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.825 -0.703 . . . . 62.23 112.473 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -148.83 51.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 74.02 110.88 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 127' ' ' LEU . 17.6 mt -133.0 178.79 6.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.304 -0.407 . . . . 64.35 110.931 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -140.61 -168.63 2.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 75.03 110.995 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.844 HG23 ' HB3' ' A' ' 144' ' ' TYR . 92.3 m -50.29 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 73.24 111.146 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.769 HG23 HG22 ' A' ' 129' ' ' THR . 58.6 t -114.58 106.68 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.44 111.128 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.3 m -110.76 104.13 12.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 74.14 111.146 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -66.19 95.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 63.21 110.908 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.486 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 62.51 110.886 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.9 tpp . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.899 0.381 . . . . 72.14 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.86 128.75 39.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 62.45 110.922 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.644 HG13 HD23 ' A' ' 158' ' ' LEU . 5.9 t -141.06 157.39 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 74.23 111.142 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.441 ' HG2' HG13 ' A' ' 130' ' ' VAL . 41.8 tt0 -154.72 120.73 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 53.34 110.883 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.646 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -73.53 -179.1 3.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 71.43 111.184 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.711 ' HA ' HG22 ' A' ' 130' ' ' VAL . 76.8 t80 -175.61 139.89 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 65.21 110.897 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.844 ' HB3' HG23 ' A' ' 129' ' ' THR . 39.3 t80 -122.15 96.28 46.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.71 0.767 . . . . 71.03 110.882 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 -48.9 0.64 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.755 2.303 . . . . 73.33 112.327 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.39 -155.74 24.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 53.34 112.516 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.63 126.02 41.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 71.24 110.896 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.496 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -137.72 -94.0 0.33 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.721 -0.752 . . . . 34.35 112.472 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -71.97 -29.3 64.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.359 . . . . 65.52 110.859 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.31 151.88 34.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.153 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -54.71 -38.44 67.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 60.41 110.849 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.678 ' OD2' HD12 ' A' ' 114' ' ' LEU . 2.5 p30 -109.15 52.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 61.04 110.906 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.543 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.5 p30 -100.73 136.24 40.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.31 110.861 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.646 HD12 HG22 ' A' ' 142' ' ' THR . 4.5 pt -137.2 172.25 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 62.03 111.153 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.3 m -122.46 150.65 26.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.35 111.164 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.9 t -106.66 143.77 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.24 111.192 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -129.98 145.28 51.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 71.14 110.968 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.644 HD23 HG13 ' A' ' 140' ' ' VAL . 12.9 mt -122.91 96.83 44.6 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.643 0.735 . . . . 63.41 110.893 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 72.55 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.746 2.297 . . . . 70.54 112.315 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.54 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 75.42 110.848 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.449 ' O ' HD12 ' A' ' 163' ' ' ILE . 7.2 m-85 -117.05 -13.33 10.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 71.43 110.901 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m120 68.84 24.84 6.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 74.54 110.827 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.49 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.5 mp -98.19 116.62 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 55.22 111.154 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.1 136.92 38.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 73.24 110.904 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.633 ' CG2' HD22 ' A' ' 44' ' ' LEU . 19.5 t -121.47 62.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 71.53 111.089 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.4 -51.75 35.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 64.02 112.49 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.06 -139.23 15.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 53.35 112.535 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 81.4 m -62.94 -16.75 60.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 71.35 110.869 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.543 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.5 OUTLIER -66.25 -52.45 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 33.13 110.916 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.569 HG11 HG11 ' A' ' 206' ' ' VAL . 21.8 t -83.47 119.68 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 74.42 111.085 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.425 ' HB2' HG23 ' A' ' 222' ' ' THR . 0.3 OUTLIER -93.05 127.17 38.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 75.21 110.838 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.696 ' HA ' HD22 ' A' ' 218' ' ' LEU . 3.9 t -62.72 166.66 5.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 70.44 110.831 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.503 HG23 HD23 ' A' ' 218' ' ' LEU . 3.1 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 52.13 111.149 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.477 HG11 ' CG2' ' A' ' 186' ' ' VAL . 18.6 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.817 0.341 . . . . 74.2 111.1 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.31 75.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.093 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.19 38.96 3.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.791 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -140.92 165.91 26.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.23 111.123 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -113.89 92.73 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.962 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.477 ' CG2' HG11 ' A' ' 181' ' ' VAL . 62.1 t -69.5 -23.05 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.102 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -81.41 -24.6 36.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 61.33 110.908 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -98.63 -23.88 15.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 71.25 110.882 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -51.49 -54.23 29.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 72.43 110.927 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.5 t -51.91 -32.58 33.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 55.1 110.8 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.7 m -77.44 -34.78 54.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 74.41 111.15 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 m -65.94 -54.33 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.5 110.817 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.659 HG22 HD23 ' A' ' 197' ' ' LEU . 32.8 mm -56.29 -37.52 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 72.32 111.107 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -65.29 -23.52 67.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 63.22 110.91 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -87.16 -31.94 20.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.902 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.421 ' CG1' HD21 ' A' ' 219' ' ' LEU . 95.5 t -74.45 -51.57 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 73.45 111.142 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.659 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -63.59 -24.86 67.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 71.44 110.926 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -47.62 12.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.804 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -51.92 -34.1 40.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 72.13 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -137.76 118.36 13.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 72.01 110.948 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -116.64 32.87 5.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.98 21.28 2.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 74.3 110.882 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.16 146.42 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 72.22 111.135 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -107.24 -30.95 8.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 61.05 110.878 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -160.69 127.43 4.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 53.5 111.122 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.626 ' CG1' HD12 ' A' ' 218' ' ' LEU . 92.0 t -101.35 125.48 55.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 71.13 111.125 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.021 HG21 HD13 ' A' ' 44' ' ' LEU . 40.2 t -108.31 89.76 6.22 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.569 0.699 . . . . 73.24 111.197 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.78 171.76 13.89 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.691 2.26 . . . . 74.33 112.336 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.58 -26.2 47.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 63.42 112.475 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -143.35 119.37 10.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 73.32 110.813 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 135.76 -95.21 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.799 -0.715 . . . . 55.32 112.49 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -179.67 168.83 1.37 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 72.42 110.853 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.824 HG21 HG21 ' A' ' 27' ' ' VAL . 31.5 t -79.14 142.3 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 62.15 111.131 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.74 -107.13 0.4 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.729 . . . . 64.3 112.55 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -154.46 -172.95 4.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 73.44 110.918 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -23.12 14.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 61.41 110.893 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -53.57 -32.57 46.47 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.698 -0.763 . . . . 73.22 112.511 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.696 HD22 ' HA ' ' A' ' 172' ' ' SER . 30.5 mt -50.92 -44.45 60.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.866 0.365 . . . . 74.15 110.895 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.513 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -58.43 -44.75 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 53.14 110.871 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.752 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.6 mt -64.85 -41.97 95.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.44 110.895 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.489 ' NE2' HD21 ' A' ' 225' ' ' LEU . 77.2 t60 -62.37 -39.15 92.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 74.44 110.858 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.425 HG23 ' HB2' ' A' ' 171' ' ' LYS . 3.9 m -54.43 -41.58 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 73.43 111.137 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.806 ' HA ' HD12 ' A' ' 226' ' ' LEU . 95.9 mt -59.13 -41.41 88.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 75.35 110.965 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -32.28 69.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 71.35 110.826 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.489 HD21 ' NE2' ' A' ' 221' ' ' HIS . 16.0 mt -69.94 -25.79 63.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 72.31 110.938 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.806 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.5 mt -87.35 -44.97 10.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 71.54 110.885 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 72.42 110.892 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 18' ' ' ILE . 84.4 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.794 0.33 . . . . 70.33 111.103 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.69 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.0 mm -90.31 155.19 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 71.25 111.178 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -145.07 165.46 28.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.853 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.06 174.37 6.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 52.45 110.896 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -59.57 -28.57 67.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.855 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.485 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.7 p -101.92 -33.06 9.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 43.32 111.126 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.73 -8.66 47.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.63 -0.795 . . . . 72.2 112.484 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.777 HG23 HG13 ' A' ' 16' ' ' ILE . 3.2 t -50.99 -32.91 22.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.313 . . . . 73.23 111.167 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.777 HG13 HG23 ' A' ' 15' ' ' THR . 16.0 mt -124.23 147.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 73.43 111.093 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.6 p -166.75 171.42 11.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.954 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -137.78 -176.39 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.183 -0.462 . . . . 62.15 111.159 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 18' ' ' ILE . 6.7 t -166.44 133.67 2.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 61.34 110.878 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.46 118.33 12.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.511 . . . . 72.41 110.888 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.03 -41.64 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 74.02 110.973 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.56 -169.52 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 75.14 110.891 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -51.64 51.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 70.04 110.827 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -131.39 30.89 4.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 74.13 110.887 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.9 t -126.55 119.8 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 61.14 111.162 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -125.33 162.61 24.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 71.03 110.938 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 213' ' ' VAL . 75.9 t -122.49 108.13 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 71.43 111.147 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.475 ' HB3' HG23 ' A' ' 18' ' ' ILE . 5.3 p80 -102.02 139.45 37.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.885 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 41' ' ' SER . 25.2 m -137.77 125.24 22.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 71.51 111.138 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.521 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -114.17 -177.72 3.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 64.34 110.906 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.42 HD12 ' CA ' ' A' ' 40' ' ' PRO . 2.3 tp -134.38 134.8 42.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 73.3 110.952 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 61.55 112.485 179.881 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.621 0.724 . . . . 72.01 111.117 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' CA ' HD12 ' A' ' 31' ' ' LEU . 53.6 Cg_endo -69.8 140.03 41.51 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.631 2.22 . . . . 73.53 112.368 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 29' ' ' THR . 1.0 OUTLIER -128.62 122.22 30.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 54.32 110.841 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.59 HD21 ' N ' ' A' ' 212' ' ' GLU . 30.6 m-20 -67.46 168.6 10.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 70.44 110.915 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.41 170.12 43.25 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.672 -0.775 . . . . 71.23 112.45 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.011 HD13 HG21 ' A' ' 207' ' ' VAL . 3.9 tp -143.05 138.8 30.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.388 . . . . 74.01 110.897 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.71 HG22 HD13 ' A' ' 54' ' ' LEU . 38.3 t -122.05 130.23 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 70.12 111.138 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.574 HD22 ' HE3' ' A' ' 138' ' ' MET . 45.5 mt -96.9 125.54 41.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.837 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.02 45.37 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.1 110.874 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.632 HG22 ' HB2' ' A' ' 138' ' ' MET . 27.5 p -52.57 165.11 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 72.53 111.143 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.61 35.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 62.45 110.837 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -157.11 25.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.485 . . . . 64.33 110.924 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.68 124.6 3.77 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.66 -0.781 . . . . 52.44 112.442 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.721 HD21 ' HB3' ' A' ' 75' ' ' PHE . 35.2 mt -53.18 158.02 1.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 71.13 110.915 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.605 HG22 ' HB2' ' A' ' 81' ' ' ASP . 90.5 t -141.25 142.64 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 73.05 111.102 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.71 HD13 HG22 ' A' ' 45' ' ' VAL . 3.2 mm? -114.43 128.42 56.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 74.44 110.924 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 55' ' ' VAL . 13.1 t -80.4 -0.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 75.45 111.1 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -174.81 132.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 74.14 110.911 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -74.59 -166.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.05 110.844 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.42 -170.24 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 55.11 110.848 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.666 ' HB2' HD13 ' A' ' 63' ' ' LEU . 88.5 m95 -74.8 -34.9 62.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 74.53 110.884 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.16 174.5 11.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.427 . . . . 71.22 110.857 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.44 -30.43 68.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 65.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -76.04 -25.53 55.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 73.5 110.885 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -83.32 -48.34 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.85 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.1 t -60.54 -27.82 67.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 63.0 111.173 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -43.08 75.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.864 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.55 1.29 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.11 110.92 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.521 HD22 ' OE2' ' A' ' 30' ' ' GLU . 23.8 tp -95.46 -45.33 7.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 74.13 110.912 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -68.79 -40.03 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 62.12 111.157 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -60.39 -22.23 63.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.12 -0.491 . . . . 61.25 110.942 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.5 mmm -72.64 -60.81 2.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.914 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.514 ' HB ' HD13 ' A' ' 52' ' ' LEU . 19.7 m -59.39 -30.16 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 63.54 111.122 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -88.51 48.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 73.44 110.914 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 -41.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.02 110.958 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.69 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.05 -25.23 14.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.9 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.721 ' HB3' HD21 ' A' ' 52' ' ' LEU . 35.9 m-85 -89.31 9.84 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.882 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.499 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.68 47.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 73.3 110.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -147.92 -177.54 5.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.851 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.6 130.9 37.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.932 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 52' ' ' LEU . 61.4 t -67.86 130.12 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 72.32 111.112 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.4 p -136.82 18.62 3.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.481 . . . . 61.21 111.13 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.605 ' HB2' HG22 ' A' ' 53' ' ' VAL . 8.4 m-20 -153.99 130.59 10.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 75.14 110.878 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 98' ' ' LEU . 24.8 t -133.5 98.46 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.095 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.7 mt -73.71 125.73 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 73.43 111.128 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 91' ' ' ARG . 42.4 mm -113.08 142.47 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 65.44 111.131 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.0 p -97.51 -59.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 64.31 111.147 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -129.47 164.19 24.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 61.12 110.859 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.49 98.03 9.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.44 111.078 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.661 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -152.03 159.03 43.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 74.54 110.88 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -26.73 61.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 64.41 111.088 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -91.73 13.28 18.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 70.4 110.874 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HB3' HG23 ' A' ' 84' ' ' ILE . 2.0 mmp_? -126.68 -50.86 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.867 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -118.75 16.24 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 55.13 111.15 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.73 -33.26 34.34 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.714 -0.755 . . . . 63.45 112.525 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.27 15.92 53.74 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.749 -0.738 . . . . 61.4 112.487 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.517 HG21 ' H ' ' A' ' 121' ' ' GLU . 11.3 tt -46.16 -31.93 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 72.42 111.162 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -54.31 31.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.943 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.8 m -58.1 -41.07 82.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 72.2 111.16 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 82' ' ' VAL . 27.3 mt -59.61 -31.21 69.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 75.13 110.934 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -97.82 25.08 6.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.3 110.911 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -115.75 -24.79 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.902 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -107.83 -21.4 12.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 70.41 110.88 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.68 13.34 5.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 62.33 112.44 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 98' ' ' LEU . 16.0 mt -80.32 155.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 74.21 111.06 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.648 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -119.97 123.93 44.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 73.22 110.862 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.51 85.31 6.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 74.22 111.074 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.424 ' HB3' HD11 ' A' ' 127' ' ' LEU . 54.3 m-70 -55.87 148.07 17.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 71.15 110.873 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.93 164.88 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 64.04 110.813 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.8 p -81.98 155.77 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 44.15 111.199 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.72 -29.91 20.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 75.53 111.143 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 152' ' ' ASP . 7.1 tp -75.08 -47.58 28.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 73.02 110.904 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.706 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.7 m -53.93 -26.97 28.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 61.43 111.152 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.456 ' HB1' ' OE2' ' A' ' 122' ' ' GLU . . . -86.26 -27.1 24.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.24 111.05 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -64.13 -27.51 69.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 65.23 110.855 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.611 HD13 ' OD2' ' A' ' 152' ' ' ASP . 9.8 mp -92.96 -23.89 18.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 73.01 110.895 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.44 -62.98 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.51 111.137 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -25.42 42.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 51.42 110.873 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.0 -23.79 65.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.895 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -97.32 -26.36 14.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 72.33 110.876 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.89 -3.21 10.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.788 -0.72 . . . . 32.33 112.503 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -59.52 -173.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.887 0.375 . . . . 74.42 110.889 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.517 ' H ' HG21 ' A' ' 95' ' ' ILE . 8.6 mm-40 -97.75 -1.34 43.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.89 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.456 ' OE2' ' HB1' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 66.36 124.96 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.623 0.725 . . . . 74.41 110.865 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -170.46 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.629 2.219 . . . . 71.25 112.387 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 104' ' ' LYS . 65.7 mt -53.44 -39.76 64.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.884 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.12 59.03 9.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.768 -0.73 . . . . 73.02 112.461 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -155.33 47.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 64.22 110.854 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 106' ' ' HIS . 76.2 mt -127.07 -175.26 3.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 64.3 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -140.02 -168.66 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.858 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.831 HG23 ' HB3' ' A' ' 144' ' ' TYR . 78.7 m -50.21 -54.87 17.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 65.22 111.092 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.744 HG22 ' HA ' ' A' ' 143' ' ' PHE . 91.9 t -131.33 111.84 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 75.12 111.114 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.591 HG22 HD23 ' A' ' 133' ' ' LEU . 91.5 m -117.04 119.55 35.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 73.44 111.199 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -78.77 99.13 6.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 74.05 110.901 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.591 HD23 HG22 ' A' ' 131' ' ' THR . 3.6 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 64.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.632 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.7 tpp . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.851 0.357 . . . . 73.44 110.836 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.96 112.73 14.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 72.21 110.894 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.48 HG13 HD23 ' A' ' 158' ' ' LEU . 16.5 t -126.08 152.55 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 54.31 111.127 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -151.07 120.78 7.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 54.23 110.888 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.687 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.22 -179.08 2.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.45 111.149 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.744 ' HA ' HG22 ' A' ' 130' ' ' VAL . 78.4 t80 -175.29 136.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.879 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.831 ' HB3' HG23 ' A' ' 129' ' ' THR . 59.2 t80 -116.79 93.63 41.77 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.712 0.768 . . . . 73.23 110.838 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 -48.92 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 61.3 112.33 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.62 -170.35 42.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.664 -0.779 . . . . 34.53 112.454 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -84.52 126.55 33.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.884 0.373 . . . . 64.54 110.87 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.665 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -136.64 -88.3 0.23 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 71.32 112.498 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -78.27 -23.67 47.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 73.4 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.95 163.99 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.22 111.218 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -70.09 -24.48 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.916 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.611 ' OD2' HD13 ' A' ' 114' ' ' LEU . 10.6 p30 -123.59 52.63 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 62.42 110.87 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 2.1 p30 -100.77 146.35 27.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.925 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.687 HD12 HG22 ' A' ' 142' ' ' THR . 8.8 pt -145.14 173.28 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 74.25 111.161 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.1 m -123.03 138.8 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 64.32 111.156 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.454 ' O ' HD22 ' A' ' 164' ' ' LEU . 79.0 t -95.1 125.69 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 62.31 111.126 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -111.0 148.88 31.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 72.33 110.936 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 163' ' ' ILE . 47.5 mt -123.53 94.61 46.17 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.608 0.718 . . . . 71.44 110.888 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 70.98 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.716 2.278 . . . . 74.42 112.278 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.14 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.904 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.594 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.2 m-85 -118.74 -9.98 10.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 73.1 110.897 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 68.2 21.03 8.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 53.43 110.868 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.609 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.7 mp -87.1 115.67 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 71.14 111.129 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.478 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.5 tm? -101.37 122.93 44.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 70.11 110.923 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 44' ' ' LEU . 41.5 t -114.9 73.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 44.44 111.217 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.408 ' H ' HD13 ' A' ' 164' ' ' LEU . . . -64.12 -56.58 17.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 73.24 112.532 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 111.95 -139.0 15.36 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.749 -0.738 . . . . 72.25 112.412 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 46.6 m -58.03 -22.24 48.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 24.13 110.858 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.471 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.0 OUTLIER -62.88 -48.32 79.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.43 110.938 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.544 HG11 HG11 ' A' ' 206' ' ' VAL . 21.5 t -92.57 127.57 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 62.41 111.124 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.535 ' H ' HG23 ' A' ' 222' ' ' THR . 1.6 tppt? -95.49 134.94 37.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.925 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.641 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.2 p -70.23 157.03 38.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 74.12 110.829 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 75.2 111.164 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.869 0.366 . . . . 75.44 111.097 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.48 -46.06 77.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 62.14 111.084 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -112.38 44.09 1.51 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 73.35 110.921 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -134.87 173.92 11.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 31.34 111.114 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.61 88.48 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 75.23 110.918 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.419 HG13 HD23 ' A' ' 226' ' ' LEU . 23.5 t -68.11 -20.73 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 70.04 111.182 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -80.36 -28.41 38.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.868 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -22.59 16.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.04 110.918 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.07 -54.37 25.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.88 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -36.83 49.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 43.51 110.813 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 71.4 m -75.34 -39.01 59.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.53 111.139 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 44.6 m -58.81 -55.67 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.833 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.514 HG21 ' O ' ' A' ' 219' ' ' LEU . 33.1 mm -54.27 -37.5 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 73.2 111.145 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -23.08 65.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.881 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -90.6 -27.43 19.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 62.23 110.879 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.589 HG12 HD21 ' A' ' 219' ' ' LEU . 39.8 t -78.42 -31.98 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 72.22 111.156 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.7 -29.87 23.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 61.05 110.968 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -78.98 -50.06 11.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.1 110.865 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -51.92 -30.17 23.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 65.21 110.9 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -138.14 116.86 12.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 74.34 110.894 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -116.5 37.62 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 71.44 110.883 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.24 22.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 65.52 110.921 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.47 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.1 mp -51.63 142.74 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 64.13 111.093 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -103.53 -42.91 5.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 74.15 110.867 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.57 113.44 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 35.45 111.141 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.544 HG11 HG11 ' A' ' 170' ' ' VAL . 89.3 t -85.39 124.08 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.34 111.129 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.011 HG21 HD13 ' A' ' 44' ' ' LEU . 57.5 t -107.41 92.27 8.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.586 0.708 . . . . 72.41 111.129 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.3 Cg_endo -69.68 -174.7 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.269 . . . . 73.12 112.373 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.41 -17.44 33.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.804 -0.712 . . . . 60.02 112.515 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -147.19 125.97 12.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 75.31 110.906 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 123.0 -93.09 0.48 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.746 -0.74 . . . . 74.13 112.496 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.59 ' N ' HD21 ' A' ' 42' ' ' ASN . 0.6 OUTLIER -179.65 167.92 1.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 70.03 110.922 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 27' ' ' VAL . 42.6 t -79.85 135.53 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 72.14 111.145 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -137.36 -102.8 0.62 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.773 . . . . 54.34 112.46 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -158.96 -171.34 3.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.923 0.392 . . . . 61.4 110.827 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 -23.92 13.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 62.24 110.83 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -52.52 -35.52 45.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.769 -0.729 . . . . 34.11 112.488 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 172' ' ' SER . 23.9 mt -51.0 -46.35 61.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 75.52 110.86 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.589 HD21 HG12 ' A' ' 196' ' ' VAL . 7.1 mp -56.32 -42.95 78.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 54.32 110.882 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.755 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.1 mt -66.78 -41.46 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 73.24 110.893 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.45 ' NE2' HD21 ' A' ' 225' ' ' LEU . 85.2 t60 -61.31 -39.35 90.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 63.34 110.848 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.535 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.66 -46.22 63.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 75.25 111.103 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.81 ' HA ' HD12 ' A' ' 226' ' ' LEU . 51.5 mt -56.64 -44.22 81.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 74.42 110.939 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -31.51 60.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 60.42 110.872 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.45 HD21 ' NE2' ' A' ' 221' ' ' HIS . 6.8 mt -73.7 -27.92 61.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 73.13 110.887 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.5 mt -84.85 -30.87 24.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 73.0 110.899 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 75.25 110.894 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 18' ' ' ILE . 97.3 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.792 0.33 . . . . 73.24 111.072 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.467 HD11 ' HE3' ' A' ' 74' ' ' LYS . 3.4 mm -87.1 156.17 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 74.35 111.1 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -146.74 151.91 37.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 63.12 110.896 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.58 168.51 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 65.13 110.924 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.46 -32.55 62.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 71.13 110.92 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 p -93.04 -31.97 14.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 74.45 111.084 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.47 -12.51 58.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 53.04 112.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.714 HG23 HG13 ' A' ' 16' ' ' ILE . 2.4 t -51.73 -33.0 32.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 60.45 111.132 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.714 HG13 HG23 ' A' ' 15' ' ' THR . 28.2 mt -119.58 150.87 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 72.05 111.089 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -170.2 170.84 7.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.782 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -136.47 -174.7 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 74.41 111.215 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.442 ' OG ' HG22 ' A' ' 8' ' ' VAL . 1.2 t -170.8 129.95 0.81 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 63.35 110.882 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 122.12 15.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 53.31 110.944 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.436 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.5 mm? -104.45 -46.84 4.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 61.1 110.949 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -149.41 52.43 0.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.83 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.58 -76.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.931 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -83.63 -20.37 33.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.898 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.26 120.6 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 64.33 111.171 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -125.41 159.81 30.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 60.31 110.957 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.436 HG23 ' HG ' ' A' ' 21' ' ' LEU . 53.3 t -122.23 112.7 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 75.53 111.147 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.446 ' HB3' HG23 ' A' ' 18' ' ' ILE . 11.1 p80 -103.48 137.04 42.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 73.52 110.9 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.6 m -131.17 130.93 43.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 55.3 111.091 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.628 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -126.19 163.17 23.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 73.43 110.868 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.483 HD12 ' CA ' ' A' ' 40' ' ' PRO . 4.9 tp -110.14 145.7 36.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.924 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.736 -0.745 . . . . 72.22 112.465 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.533 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.2 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.572 0.701 . . . . 73.32 111.142 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.483 ' CA ' HD12 ' A' ' 31' ' ' LEU . 54.1 Cg_endo -69.75 142.93 49.31 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.65 2.234 . . . . 75.12 112.349 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -126.33 108.12 10.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.87 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -61.87 151.52 34.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 74.43 110.888 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.582 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -154.3 -163.37 11.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.7 -0.762 . . . . 54.24 112.478 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.998 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -162.36 145.3 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.903 0.382 . . . . 72.32 110.903 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 54' ' ' LEU . 43.8 t -129.49 130.12 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 62.22 111.097 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.471 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 46.7 mt -98.57 122.01 41.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.902 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -91.53 47.3 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 72.4 110.908 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 138' ' ' MET . 22.9 p -56.77 172.68 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 70.52 111.103 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.4 m -99.17 24.97 7.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 62.01 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.4 19.01 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.838 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.78 128.53 4.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 52.22 112.524 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.815 HD21 ' HB3' ' A' ' 75' ' ' PHE . 35.3 mt -52.63 157.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.817 0.341 . . . . 73.02 110.916 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.785 HG22 ' HB2' ' A' ' 81' ' ' ASP . 93.6 t -142.08 143.36 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 60.55 111.098 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 45' ' ' VAL . 3.5 mm? -112.24 129.58 56.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.831 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 55' ' ' VAL . 12.4 t -80.07 -1.26 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.044 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.32 130.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.24 -0.436 . . . . 75.42 110.89 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -67.82 -169.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.4 110.795 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.41 -175.94 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 70.2 110.826 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.699 ' HB2' HD13 ' A' ' 63' ' ' LEU . 92.1 m95 -67.35 -37.4 83.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 74.23 110.899 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -144.99 174.15 11.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 75.2 110.878 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.436 ' HA ' HG22 ' A' ' 64' ' ' THR . 1.0 OUTLIER -70.03 -28.46 65.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 71.13 110.84 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -77.63 -25.45 49.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.33 110.893 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 59' ' ' TRP . 1.3 mt -85.79 -40.98 15.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 75.33 110.863 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 61' ' ' ASP . 14.6 t -66.18 -29.74 70.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 42.45 111.197 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -51.62 -45.04 63.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 50.21 110.91 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -81.64 -14.9 56.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.881 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.628 HD22 ' OE2' ' A' ' 30' ' ' GLU . 40.0 tp -78.08 -48.45 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.888 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.9 mt -71.85 -18.63 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 45.21 111.097 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.06 2.35 39.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 71.24 110.894 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.2 mmm -101.62 -53.04 3.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 75.4 110.908 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.779 ' HB ' HD13 ' A' ' 52' ' ' LEU . 22.7 m -59.4 -39.53 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 64.5 111.125 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.483 ' HG3' HG23 ' A' ' 71' ' ' VAL . 33.5 mt-10 -84.86 50.98 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 75.2 110.889 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.74 -39.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.881 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.467 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -110.17 -20.19 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.931 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.815 ' HB3' HD21 ' A' ' 52' ' ' LEU . 25.1 m-85 -89.14 12.28 16.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.859 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.518 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.86 47.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 71.52 110.93 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -155.93 -178.72 7.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 70.43 110.891 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.41 157.45 39.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.02 110.848 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 52' ' ' LEU . 98.5 t -92.65 117.98 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 72.45 111.181 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.9 p -128.34 22.4 6.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.23 111.155 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.785 ' HB2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -153.45 133.9 13.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.831 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.567 HG11 HD11 ' A' ' 98' ' ' LEU . 24.1 t -138.64 99.47 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 54.12 111.128 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.0 mt -77.49 126.07 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.03 111.071 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.9 mm -112.46 130.26 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 75.33 111.091 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.0 p -87.76 -54.85 4.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 71.54 111.077 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -133.93 170.0 16.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.868 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -88.96 97.77 11.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.465 . . . . 54.44 111.075 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.65 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -150.33 158.65 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 73.1 110.826 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.03 63.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 51.34 111.104 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.9 9.26 25.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 72.15 110.831 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -121.43 -52.81 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 74.44 110.865 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.65 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.5 18.24 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 61.51 111.198 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.05 -26.72 20.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.636 -0.792 . . . . 54.11 112.534 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.64 22.01 20.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.737 -0.744 . . . . 71.3 112.523 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.427 HG21 ' H ' ' A' ' 121' ' ' GLU . 2.3 tt -48.55 -31.05 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.392 . . . . 74.02 111.137 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -70.65 -43.75 68.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.908 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.4 m -66.27 -35.49 80.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 61.3 111.119 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.567 HD11 HG11 ' A' ' 82' ' ' VAL . 48.4 mt -62.37 -32.51 73.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.933 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.29 20.92 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 64.45 110.88 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -117.35 -22.46 8.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 75.2 110.906 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.74 7.66 18.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 72.24 110.894 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.8 15.92 64.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.723 -0.751 . . . . 65.15 112.453 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 98' ' ' LEU . 16.9 mt -80.33 155.03 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 63.4 111.113 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.82 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -118.98 117.58 29.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 55.24 110.911 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.513 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -86.52 79.32 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 63.43 111.064 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.511 ' HA ' HD12 ' A' ' 124' ' ' LEU . 96.5 m-70 -55.16 147.66 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 70.05 110.896 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.463 ' C ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -179.86 166.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 73.44 110.916 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 127' ' ' LEU . 76.1 p -87.99 158.13 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 52.35 111.078 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.82 -43.09 62.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 72.04 111.129 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.625 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -61.81 -46.31 90.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 71.04 110.847 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.702 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.2 m -52.05 -42.58 63.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 63.04 111.08 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.464 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -73.3 -23.55 60.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 71.43 111.104 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -57.08 -40.49 77.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.856 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.63 HD12 ' OD1' ' A' ' 152' ' ' ASP . 8.4 mt -84.21 -28.43 27.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.927 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.71 -68.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 64.11 111.077 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.34 -24.94 47.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 73.21 110.879 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -24.17 66.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.885 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -95.71 -37.33 10.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 51.4 110.871 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.68 -5.3 4.07 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.718 . . . . 65.22 112.502 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -59.63 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.816 0.341 . . . . 63.4 110.935 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.427 ' H ' HG21 ' A' ' 95' ' ' ILE . 19.8 mm-40 -97.86 -1.0 44.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 72.4 110.891 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.464 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.0 OUTLIER 66.15 125.38 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.674 0.749 . . . . 65.44 110.886 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -170.37 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.238 . . . . 62.51 112.343 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 104' ' ' LYS . 70.8 mt -53.59 -41.2 66.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 71.23 110.942 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.28 59.72 8.6 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 74.32 112.482 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.75 54.63 0.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 75.4 110.896 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 107' ' ' SER . 67.1 mt -137.01 -173.21 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 61.51 110.902 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.0 -168.18 2.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.851 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.799 HG23 ' HB3' ' A' ' 144' ' ' TYR . 96.6 m -50.02 -41.66 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 61.3 111.197 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 m -140.51 141.82 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 72.42 111.141 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.647 HG22 HD23 ' A' ' 133' ' ' LEU . 60.0 m -149.04 110.88 4.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 63.34 111.154 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.89 98.01 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 64.53 110.865 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.647 HD23 HG22 ' A' ' 131' ' ' THR . 3.3 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 61.44 110.883 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.601 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.2 tpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.876 0.37 . . . . 72.23 110.823 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.44 118.14 21.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 63.23 110.958 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.645 HG13 HD23 ' A' ' 158' ' ' LEU . 4.6 t -135.14 159.19 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 63.31 111.15 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 140' ' ' VAL . 30.6 tt0 -160.52 126.7 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.24 110.907 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.9 178.32 6.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 62.33 111.133 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -172.84 138.23 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.906 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.799 ' HB3' HG23 ' A' ' 129' ' ' THR . 22.4 t80 -118.92 95.32 49.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.705 0.764 . . . . 73.21 110.864 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -48.75 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 45.31 112.365 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.42 -165.54 38.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 71.44 112.447 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -85.4 121.2 27.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.24 110.847 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.618 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -135.09 -94.28 0.46 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.738 -0.744 . . . . 75.14 112.443 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -70.58 -29.3 65.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.368 . . . . 74.33 110.814 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.32 154.71 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 65.24 111.129 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -58.35 -24.27 59.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 52.32 110.912 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.63 ' OD1' HD12 ' A' ' 114' ' ' LEU . 1.1 p30 -124.19 51.37 1.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 65.23 110.94 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.53 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.0 OUTLIER -100.79 136.36 40.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.976 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.467 HG22 ' CD1' ' A' ' 144' ' ' TYR . 10.3 pt -137.47 160.61 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.52 111.121 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 196' ' ' VAL . 15.4 m -106.34 157.73 6.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 45.35 111.065 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.29 141.1 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 74.12 111.16 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -128.24 150.2 50.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.888 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.645 HD23 HG13 ' A' ' 140' ' ' VAL . 15.1 mt -129.0 95.9 30.34 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.62 0.724 . . . . 74.45 110.917 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 72.49 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.687 2.258 . . . . 64.11 112.286 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.52 -34.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 64.13 110.924 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.523 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.8 m-85 -117.45 -13.56 10.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 71.41 110.975 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m120 69.38 25.82 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 55.43 110.835 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.545 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -97.09 119.12 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 63.44 111.099 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.479 HD11 HG13 ' A' ' 196' ' ' VAL . 0.5 OUTLIER -104.71 138.46 40.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 71.15 110.877 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.543 HG21 HD22 ' A' ' 44' ' ' LEU . 21.6 t -124.09 66.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 54.14 111.111 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.47 -45.11 53.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.744 -0.741 . . . . 53.42 112.46 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.74 -141.48 15.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.76 -0.733 . . . . 61.34 112.509 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 43.7 m -57.35 -23.91 51.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 62.42 110.92 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.53 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.5 OUTLIER -65.64 -49.35 69.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.927 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.562 HG11 HG11 ' A' ' 206' ' ' VAL . 46.3 t -90.41 105.37 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.14 111.166 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.92 151.31 37.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 64.11 110.903 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.671 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.3 p -75.26 169.47 17.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 71.55 110.841 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 63.15 111.114 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.486 HG11 ' CG2' ' A' ' 186' ' ' VAL . 35.3 m . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.881 0.372 . . . . 71.52 111.132 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.01 84.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.493 . . . . 73.21 111.125 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.0 39.94 2.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.23 110.817 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -139.72 170.84 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 72.11 111.056 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -119.9 90.16 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 73.34 110.917 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.486 ' CG2' HG11 ' A' ' 181' ' ' VAL . 61.5 t -69.55 -20.94 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 75.54 111.097 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.97 -26.32 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 60.44 110.938 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.23 -23.15 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 62.42 110.886 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -51.27 -55.81 16.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.878 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -36.16 49.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 62.42 110.83 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.6 m -75.48 -34.24 60.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 74.32 111.081 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 67.4 m -64.38 -51.55 62.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.51 110.89 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.739 HG22 HD23 ' A' ' 197' ' ' LEU . 32.9 mm -56.72 -38.91 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 74.53 111.09 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -62.68 -22.07 66.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 72.43 110.857 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -90.72 -30.3 17.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 53.33 110.885 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.485 ' CG1' HD21 ' A' ' 219' ' ' LEU . 99.5 t -77.49 -37.05 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 63.12 111.176 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.739 HD23 HG22 ' A' ' 193' ' ' ILE . 4.4 pp -78.93 -25.21 43.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.878 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -83.13 -42.48 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.14 110.939 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -55.24 -26.45 39.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.21 110.895 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -143.81 118.54 9.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 71.53 110.918 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.37 37.52 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 73.12 110.909 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.43 21.27 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 55.43 110.902 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.25 146.85 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 72.51 111.142 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.56 -31.51 8.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.892 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.545 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -156.48 140.17 16.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 54.14 111.09 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.742 ' CG1' HD12 ' A' ' 218' ' ' LEU . 92.7 t -120.72 125.64 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 61.33 111.144 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.998 HG21 HD11 ' A' ' 44' ' ' LEU . 97.1 t -107.71 105.74 56.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.604 0.716 . . . . 73.23 111.1 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.4 Cg_endo -69.76 -179.85 3.19 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.705 2.27 . . . . 74.4 112.314 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.79 -33.83 26.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.729 -0.748 . . . . 62.03 112.518 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -143.61 111.13 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.344 . . . . 74.23 110.847 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.46 -114.2 0.72 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.761 . . . . 53.34 112.422 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -151.84 166.86 30.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.85 0.357 . . . . 73.33 110.939 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.781 HG22 HG22 ' A' ' 207' ' ' VAL . 21.8 t -74.34 149.94 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 74.13 111.127 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -147.31 -108.54 0.53 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.76 -0.734 . . . . 74.42 112.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -157.73 -171.77 3.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 62.31 110.816 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 35.7 tttt -56.65 -21.51 27.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.889 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.759 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -55.29 -31.98 57.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 61.01 112.467 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.742 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.1 mt -51.06 -45.41 61.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 74.22 110.873 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.526 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -58.6 -44.58 89.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 72.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.759 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.7 mt -65.15 -42.01 94.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 73.03 110.95 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.657 ' NE2' HD21 ' A' ' 225' ' ' LEU . 77.5 t60 -66.24 -37.79 86.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.853 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.6 m -52.12 -43.01 63.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 73.45 111.08 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.753 ' HA ' HD12 ' A' ' 226' ' ' LEU . 61.5 mt -58.35 -42.29 86.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 75.11 110.863 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -26.86 66.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.841 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.657 HD21 ' NE2' ' A' ' 221' ' ' HIS . 22.4 mt -73.49 -25.88 60.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.45 110.925 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.753 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.1 mt -87.25 -42.2 13.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 35.15 110.88 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.31 110.922 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.562 HG22 ' OG ' ' A' ' 19' ' ' SER . 80.8 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.863 0.363 . . . . 54.24 111.08 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.697 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.3 mm -87.9 156.92 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.184 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -145.77 147.14 31.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 60.02 110.964 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.79 164.24 26.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 62.11 110.85 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -51.88 -38.2 55.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 73.4 110.958 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.473 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.5 p -92.43 -26.57 17.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 42.35 111.193 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.71 -11.69 56.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 53.45 112.501 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.796 HG23 HG13 ' A' ' 16' ' ' ILE . 4.2 t -51.48 -32.63 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 64.54 111.15 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.796 HG13 HG23 ' A' ' 15' ' ' THR . 29.3 mt -120.92 149.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 74.13 111.103 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 p -169.98 167.53 8.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 71.45 110.862 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -135.57 -173.22 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 73.25 111.175 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -172.83 132.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.86 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.03 120.38 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 74.13 110.816 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.11 -47.86 4.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 55.51 110.889 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -146.99 53.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 63.31 110.887 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.28 -76.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 74.03 110.937 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.76 -20.97 30.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.871 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 t -97.1 119.73 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 63.12 111.143 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -124.67 162.01 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.936 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.484 HG21 HG21 ' A' ' 213' ' ' VAL . 79.4 t -124.26 111.26 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 52.44 111.098 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.526 ' HB3' HG23 ' A' ' 18' ' ' ILE . 10.1 p80 -103.21 137.62 41.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.468 . . . . 72.44 110.829 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.2 m -133.05 120.51 21.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 71.03 111.185 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.618 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -111.33 170.44 8.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 62.43 110.878 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.84 133.49 51.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 63.4 110.879 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.779 -0.724 . . . . 72.41 112.484 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 60.5 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.601 0.715 . . . . 73.1 111.185 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.3 Cg_endo -69.78 141.01 44.0 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.707 2.271 . . . . 53.35 112.306 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -124.69 117.66 24.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 73.14 110.838 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -71.22 147.52 48.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 75.13 110.857 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.528 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -148.74 -160.41 9.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.758 -0.734 . . . . 73.25 112.404 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.974 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -161.74 143.7 11.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.384 . . . . 74.1 110.913 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 HD13 ' A' ' 54' ' ' LEU . 58.1 t -127.44 141.24 46.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 64.32 111.142 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.537 HD22 ' HE3' ' A' ' 138' ' ' MET . 13.3 mt -107.04 138.11 43.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 70.05 110.898 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -110.47 59.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.919 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.773 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.3 p -67.3 -172.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 71.41 111.16 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.26 26.38 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.992 0.425 . . . . 72.2 110.876 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -156.03 35.58 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 72.2 110.893 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.01 133.39 6.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.841 -0.695 . . . . 73.33 112.527 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.806 HD21 ' HB3' ' A' ' 75' ' ' PHE . 17.1 mt -64.19 172.84 2.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.874 0.369 . . . . 61.2 110.925 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 81' ' ' ASP . 61.0 t -148.18 143.42 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 75.53 111.103 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.563 HD13 HG22 ' A' ' 45' ' ' VAL . 3.3 mm? -115.84 130.01 56.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.119 -0.491 . . . . 74.1 110.876 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.5 t -80.36 -1.06 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 71.45 111.102 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -179.55 133.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 65.5 110.877 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -71.17 -168.64 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 55.32 110.864 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -173.18 3.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 74.33 110.906 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.718 ' HB2' HD13 ' A' ' 63' ' ' LEU . 89.9 m95 -69.54 -41.24 76.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 74.21 110.907 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.0 165.92 25.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.291 -0.413 . . . . 61.3 110.88 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -60.82 -34.69 74.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.916 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -73.94 -22.77 59.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 71.43 110.944 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.718 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -84.01 -43.44 15.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 75.15 110.893 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -66.99 -27.5 67.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 70.43 111.095 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.25 -43.52 71.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 73.12 110.89 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -82.91 -14.28 54.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 73.43 110.856 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.618 HD22 ' OE2' ' A' ' 30' ' ' GLU . 27.3 tp -76.63 -47.27 22.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 64.45 110.904 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.39 -33.4 53.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.43 111.12 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.8 -25.55 67.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 74.35 110.956 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 mmm -75.77 -59.83 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.499 . . . . 71.12 110.881 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.679 ' HB ' HD13 ' A' ' 52' ' ' LEU . 33.0 m -55.66 -31.91 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 72.41 111.102 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -89.69 48.29 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.875 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -143.65 -42.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.816 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.697 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -100.58 -25.9 14.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 75.4 110.869 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.806 ' HB3' HD21 ' A' ' 52' ' ' LEU . 35.5 m-85 -89.26 9.32 26.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 70.3 110.877 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.76 46.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.911 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -147.62 -177.76 5.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.05 110.896 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.95 130.04 39.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.824 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 52' ' ' LEU . 88.1 t -64.72 127.5 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.132 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.4 p -133.95 18.73 3.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 73.5 111.084 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.581 ' HB2' HG13 ' A' ' 53' ' ' VAL . 7.1 m-20 -153.63 136.13 15.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 53.24 110.846 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.453 HG11 ' CD1' ' A' ' 98' ' ' LEU . 25.2 t -139.75 97.82 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 63.24 111.086 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.1 mt -75.75 125.68 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 74.51 111.17 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 91' ' ' ARG . 41.1 mm -111.33 121.65 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 62.23 111.116 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.9 p -77.37 -53.7 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 72.55 111.074 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.499 ' HA ' HG23 ' A' ' 111' ' ' THR . 16.0 p-80 -135.8 171.12 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 75.04 110.886 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -91.02 101.09 13.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 70.44 111.025 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.643 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -155.23 159.85 40.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.46 . . . . 65.05 110.881 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.32 -25.31 48.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.052 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -94.0 20.15 8.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 73.22 110.879 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.5 mpt_? -135.17 -50.45 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 74.03 110.893 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -117.57 14.47 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.43 111.143 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.61 -35.55 30.11 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.735 -0.745 . . . . 73.4 112.449 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.18 19.04 41.26 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.705 -0.76 . . . . 64.43 112.421 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.593 HG21 ' H ' ' A' ' 121' ' ' GLU . 11.7 tt -45.97 -31.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 71.44 111.141 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -54.25 32.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 73.1 110.914 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.1 m -58.7 -41.15 85.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.416 . . . . 75.14 111.09 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.453 ' CD1' HG11 ' A' ' 82' ' ' VAL . 30.4 mt -57.49 -28.7 63.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 60.14 110.849 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -100.93 23.55 10.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 51.33 110.894 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -115.9 -26.57 7.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 44.4 110.861 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -103.34 -22.02 13.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 75.24 110.817 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.74 19.2 4.15 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.717 -0.754 . . . . 64.4 112.416 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.7 mt -87.23 154.67 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 74.24 111.117 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.499 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.5 ptpt -117.16 121.98 42.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.918 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.33 80.47 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 62.54 111.116 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.507 ' HA ' HD12 ' A' ' 124' ' ' LEU . 92.1 m-70 -54.32 144.11 21.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 64.44 110.869 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.8 153.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.15 110.88 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.618 HG22 ' HB3' ' A' ' 127' ' ' LEU . 19.4 p -74.75 158.4 33.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 51.42 111.159 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.83 -37.45 63.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 73.31 111.093 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -65.33 -46.0 82.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 65.32 110.892 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 2.0 m -52.89 -41.14 64.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 72.13 111.154 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.521 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -72.68 -22.33 60.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 55.31 111.114 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -38.78 82.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 72.44 110.839 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.679 HD12 ' OD2' ' A' ' 152' ' ' ASP . 12.2 mt -89.33 -26.27 21.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 74.04 110.906 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.4 -64.78 0.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 63.13 111.059 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -57.28 -23.96 51.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 71.11 110.912 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -23.77 66.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 72.12 110.914 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -94.47 -33.43 13.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 65.52 110.925 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 129.16 -5.15 6.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 65.04 112.464 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -59.81 -172.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 75.04 110.937 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.593 ' H ' HG21 ' A' ' 95' ' ' ILE . 29.4 mm-40 -96.11 -3.6 44.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 62.14 110.836 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.521 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.4 mt-10 66.38 125.52 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 75.12 110.886 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -172.52 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.646 2.231 . . . . 64.43 112.308 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 106' ' ' HIS . 37.7 mt -51.93 -39.36 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.898 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.0 53.99 27.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.79 -0.719 . . . . 72.32 112.447 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -146.62 54.81 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.819 0.343 . . . . 70.42 110.876 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.618 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.9 OUTLIER -132.31 -176.46 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 74.54 110.903 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -141.68 -168.4 2.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 51.02 110.883 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.741 HG23 ' HB3' ' A' ' 144' ' ' TYR . 87.3 m -49.93 -43.3 49.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 72.22 111.079 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 142' ' ' THR . 3.3 m -140.42 143.08 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 71.21 111.108 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 HD23 ' A' ' 133' ' ' LEU . 63.0 m -150.21 110.19 4.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 70.21 111.129 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -71.87 94.77 1.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 74.12 110.875 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 131' ' ' THR . 4.5 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 73.23 110.937 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.773 ' HB2' HG22 ' A' ' 48' ' ' THR . 15.7 tpp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.904 0.383 . . . . 73.22 110.867 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.28 120.29 26.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.32 110.899 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.699 HG13 HD23 ' A' ' 158' ' ' LEU . 5.3 t -137.42 158.68 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 75.34 111.167 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 30.7 tt0 -155.82 123.76 5.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 64.43 110.894 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -76.54 178.4 6.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 74.13 111.17 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -172.39 137.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 71.12 110.927 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.741 ' HB3' HG23 ' A' ' 129' ' ' THR . 27.7 t80 -118.09 92.52 42.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 73.45 110.862 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -48.72 0.67 Allowed 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.698 2.265 . . . . 73.31 112.371 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.62 -152.82 16.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.798 -0.715 . . . . 45.35 112.494 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.99 123.18 44.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 71.21 110.909 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.52 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -130.99 -89.43 0.5 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.741 -0.742 . . . . 65.33 112.481 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -77.32 -29.67 53.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.831 0.348 . . . . 74.02 110.85 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.68 155.4 40.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 73.45 111.145 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -60.25 -24.19 64.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 70.53 110.843 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.679 ' OD2' HD12 ' A' ' 114' ' ' LEU . 1.9 p30 -119.17 49.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.42 110.915 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.562 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.0 OUTLIER -100.11 137.78 38.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 61.21 110.897 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.453 HG22 ' HD1' ' A' ' 144' ' ' TYR . 5.0 pt -139.16 158.81 29.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 55.5 111.153 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.572 ' CG1' HD22 ' A' ' 169' ' ' LEU . 10.2 m -106.97 145.08 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 65.44 111.026 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.7 t -100.16 144.22 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 74.45 111.118 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -131.53 149.3 52.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.23 -0.441 . . . . 71.44 110.898 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.699 HD23 HG13 ' A' ' 140' ' ' VAL . 21.1 mt -127.52 95.71 34.89 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 61.43 110.91 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 72.47 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 62.25 112.336 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.35 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 72.11 110.839 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.54 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.1 m-85 -117.94 -13.05 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 72.34 110.954 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m120 69.51 23.15 6.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 61.3 110.923 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.54 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.7 mp -93.84 114.56 30.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 72.03 111.161 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.95 136.83 39.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.887 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.511 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.6 t -125.48 68.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.02 111.164 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.76 -41.42 43.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 42.2 112.541 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.39 -129.1 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 71.43 112.496 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 69.5 m -74.82 -6.9 51.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 63.43 110.864 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.572 HD22 ' CG1' ' A' ' 155' ' ' VAL . 2.1 tp -73.24 -53.5 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 72.14 110.876 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.03 128.37 43.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.091 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -91.21 163.9 14.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 71.14 110.896 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 p -89.61 159.25 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.01 110.88 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.435 HG23 ' CD2' ' A' ' 218' ' ' LEU . 20.9 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.02 111.159 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.716 HG11 ' CG2' ' A' ' 186' ' ' VAL . 11.6 m . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.87 0.367 . . . . 63.24 111.062 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -51.6 -58.62 5.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 73.03 111.077 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -117.34 28.16 8.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 71.1 110.869 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -104.66 174.88 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 75.31 111.063 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -137.28 85.18 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.918 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.716 ' CG2' HG11 ' A' ' 181' ' ' VAL . 86.2 t -58.83 -21.49 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 74.54 111.093 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -75.51 -21.72 57.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 71.3 110.947 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -107.83 -26.58 10.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 71.42 110.892 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -51.28 -57.12 9.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.893 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 90.0 p -52.03 -30.42 25.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 72.23 110.817 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.3 m -80.98 -32.44 34.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 75.4 111.204 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 196' ' ' VAL . 71.8 m -68.75 -56.66 7.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 70.13 110.912 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.8 mm -53.13 -42.03 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 64.14 111.157 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -63.43 -26.38 68.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 60.32 110.864 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -86.23 -31.23 21.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.53 110.858 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.531 HG21 HG11 ' A' ' 155' ' ' VAL . 99.1 t -73.22 -38.03 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 75.13 111.143 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.476 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -79.9 -25.62 40.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.879 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -42.6 33.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 73.04 110.913 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 33.4 tpt85 -60.73 -29.82 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 75.35 110.901 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -139.54 117.19 11.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 64.02 110.885 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 32.3 6.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 73.05 110.828 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.1 21.41 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 73.53 110.925 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -52.23 146.19 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 74.42 111.137 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -105.15 -34.82 7.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 64.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.404 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -156.88 133.56 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 74.34 111.087 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.735 ' CG1' HD12 ' A' ' 218' ' ' LEU . 88.5 t -109.72 128.3 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 71.13 111.09 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.974 HG21 HD11 ' A' ' 44' ' ' LEU . 89.5 t -111.29 102.46 53.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.612 0.72 . . . . 52.14 111.116 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.6 Cg_endo -69.69 -170.13 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 70.52 112.416 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.11 -29.29 7.26 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.853 -0.689 . . . . 75.43 112.559 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -143.46 101.01 3.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.824 0.345 . . . . 72.14 110.899 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.83 -101.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 72.55 112.527 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -168.42 165.18 12.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 70.31 110.856 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.66 HG22 HG22 ' A' ' 207' ' ' VAL . 22.4 t -74.74 149.63 7.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 73.01 111.159 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -151.35 -108.42 0.4 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.7 -0.762 . . . . 74.14 112.441 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -155.37 -172.77 4.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 73.32 110.884 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -55.56 -22.39 21.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 64.14 110.88 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.735 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.19 -31.57 49.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 63.32 112.503 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.735 HD12 ' CG1' ' A' ' 206' ' ' VAL . 35.7 mt -50.95 -46.89 61.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 73.24 110.92 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.498 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -53.55 -42.22 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 72.42 110.898 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.735 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.0 mt -68.08 -41.21 82.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 74.5 110.95 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -66.26 -36.48 83.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 72.04 110.872 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.0 m -51.66 -43.44 62.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 75.11 111.103 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.782 ' HA ' HD12 ' A' ' 226' ' ' LEU . 71.9 mt -56.85 -38.57 72.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 74.43 110.902 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -28.65 62.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.807 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.7 mt -76.13 -24.77 54.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.927 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.0 mt -89.06 -32.8 17.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.908 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.871 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 18' ' ' ILE . 81.1 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.864 0.364 . . . . 72.33 111.108 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.722 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.2 mm -90.48 154.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 74.42 111.08 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -146.01 146.06 30.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 75.22 110.868 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.34 163.34 21.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.871 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -51.67 -33.21 32.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 72.12 110.884 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -31.45 17.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 42.22 111.109 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.04 -12.45 65.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 61.03 112.425 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.698 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -51.21 -33.42 27.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.867 0.365 . . . . 73.04 111.144 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.698 HG13 HG23 ' A' ' 15' ' ' THR . 15.0 mt -121.92 148.54 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 73.23 111.108 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.8 p -166.17 170.18 13.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 43.43 110.859 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.56 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -135.51 -175.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 72.43 111.156 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.482 ' HA ' HG22 ' A' ' 8' ' ' VAL . 1.1 t -167.02 133.87 2.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 72.21 110.858 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.76 118.07 15.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.88 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.471 HD13 HG23 ' A' ' 27' ' ' VAL . 4.8 mp -103.16 -39.31 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 74.24 110.899 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -149.44 -170.98 3.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 75.53 110.84 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -49.86 -51.25 41.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 51.31 110.893 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -132.23 41.11 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 42.02 110.838 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.02 120.45 25.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 71.43 111.142 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -129.77 154.32 47.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.94 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.471 HG23 HD13 ' A' ' 21' ' ' LEU . 19.1 t -117.48 105.01 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 71.21 111.067 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.7 p80 -99.07 137.91 36.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.907 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.3 m -134.91 136.39 42.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 63.43 111.163 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -125.47 170.52 11.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 75.51 110.907 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 tp -120.76 137.04 54.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.895 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.793 -0.718 . . . . 62.21 112.548 179.868 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.2 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.598 0.713 . . . . 60.45 111.105 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 141.74 46.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.683 2.255 . . . . 72.33 112.332 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.08 114.61 17.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 50.34 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.38 145.11 56.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 74.1 110.918 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.41 -175.62 21.15 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 72.44 112.517 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.784 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -154.98 141.75 19.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 74.12 110.915 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.51 HG22 HD23 ' A' ' 54' ' ' LEU . 21.2 t -126.15 137.53 57.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 75.23 111.086 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.2 mt -105.12 134.74 47.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 53.54 110.919 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -103.89 71.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 71.22 110.927 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 p -80.83 -172.03 3.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 70.43 111.19 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.59 -9.07 21.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 51.4 110.886 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.5 42.68 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 72.05 110.917 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.79 138.58 9.51 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 73.0 112.485 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.728 HD21 ' HB3' ' A' ' 75' ' ' PHE . 25.1 mt -58.52 172.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 70.24 110.904 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 81' ' ' ASP . 85.1 t -150.22 144.18 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 73.44 111.102 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.758 HD12 HG11 ' A' ' 79' ' ' VAL . 1.9 mt -116.26 132.14 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.994 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 55' ' ' VAL . 12.3 t -82.17 0.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 63.23 111.164 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.86 132.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 63.21 110.892 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -73.14 -168.42 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.21 110.827 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.3 m -94.62 -172.59 2.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.05 110.829 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.485 ' HB2' HD13 ' A' ' 63' ' ' LEU . 95.1 m95 -68.3 -35.08 77.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 75.03 110.923 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.72 168.27 24.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 61.14 110.885 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.436 ' HA ' HG22 ' A' ' 64' ' ' THR . 1.0 OUTLIER -64.53 -25.82 68.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 63.12 110.886 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -76.28 -25.47 54.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 73.04 110.941 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -85.87 -48.07 9.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 71.13 110.866 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 61' ' ' ASP . 13.7 t -59.86 -29.73 68.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 55.24 111.144 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -53.56 -41.62 66.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 64.12 110.882 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -84.81 -11.89 54.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 60.34 110.897 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 16' ' ' ILE . 35.1 tp -80.44 -47.52 14.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.947 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.2 mt -64.94 -21.99 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 75.31 111.152 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -71.91 -21.69 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.863 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.4 mtp -81.24 -58.32 3.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 74.33 110.893 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.615 ' HB ' HD13 ' A' ' 52' ' ' LEU . 35.2 m -58.07 -35.66 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 63.22 111.2 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -88.75 48.79 1.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 64.53 110.88 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.47 -41.71 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 61.24 110.902 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.722 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -102.09 -26.34 13.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 70.14 110.881 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.728 ' HB3' HD21 ' A' ' 52' ' ' LEU . 37.8 m-85 -88.35 9.61 22.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.01 110.829 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.5 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.4 pp0? 32.38 48.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.15 110.867 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -151.22 180.0 7.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.4 110.919 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.25 133.16 46.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 75.31 110.833 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.758 HG11 HD12 ' A' ' 54' ' ' LEU . 61.7 t -69.79 130.52 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 74.45 111.102 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.7 p -137.47 17.79 2.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 63.24 111.121 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.567 ' HB2' HG13 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -149.87 133.59 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.51 110.865 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG11 HD11 ' A' ' 98' ' ' LEU . 17.0 t -137.36 101.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 64.22 111.069 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.9 mt -78.8 119.54 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 65.34 111.087 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 91' ' ' ARG . 44.6 mm -106.3 133.52 50.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 55.45 111.121 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.4 p -89.3 -56.08 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.12 111.156 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.445 ' C ' HG23 ' A' ' 111' ' ' THR . 19.6 p-80 -133.14 163.87 28.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 73.22 110.829 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.8 98.41 9.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 61.11 111.164 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.626 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -152.54 158.13 42.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 75.42 110.832 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.51 -25.32 51.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 41.43 111.069 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -93.31 19.07 8.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 64.51 110.924 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.427 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.5 mpt_? -134.0 -51.35 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 64.34 110.827 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.626 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.03 15.79 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 73.31 111.092 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.96 -29.25 27.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.674 -0.774 . . . . 50.41 112.516 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.49 18.78 32.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 42.24 112.483 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.519 HG21 ' H ' ' A' ' 121' ' ' GLU . 8.4 tt -49.24 -29.99 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 73.11 111.135 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -69.95 -43.03 72.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 62.23 110.811 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.3 m -69.32 -34.29 74.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 73.43 111.144 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.458 HD11 HG11 ' A' ' 82' ' ' VAL . 52.7 mt -64.36 -32.32 73.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 54.03 110.883 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -94.27 21.29 7.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 71.23 110.882 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.27 -19.89 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.868 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.73 1.82 14.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 75.2 110.895 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.31 14.68 53.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.685 -0.769 . . . . 73.54 112.478 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.9 mt -82.27 154.9 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.342 . . . . 75.11 111.101 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.638 ' HB2' HD11 ' A' ' 124' ' ' LEU . 10.1 ptpt -118.89 122.79 43.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.869 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.415 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -91.28 79.2 5.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 62.2 111.075 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.525 ' HA ' HD12 ' A' ' 124' ' ' LEU . 72.2 m-70 -51.82 145.95 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 64.24 110.887 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.23 154.77 0.87 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 53.41 110.851 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 127' ' ' LEU . 73.4 p -72.57 160.09 32.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 53.35 111.109 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.22 -22.18 50.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 64.35 111.099 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 152' ' ' ASP . 8.9 tp -76.83 -48.15 19.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.866 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 44.5 m -55.34 -27.27 46.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.34 111.094 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.59 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -83.45 -23.71 32.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.101 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.29 -33.71 75.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 55.44 110.877 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.695 HD13 ' OD2' ' A' ' 152' ' ' ASP . 6.8 mp -93.1 -25.46 17.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 73.4 110.932 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.78 -65.1 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 52.34 111.135 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -56.58 -24.94 50.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 70.44 110.914 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -24.45 65.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 72.41 110.896 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -93.3 -33.48 13.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 64.01 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.03 -7.06 5.44 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 42.34 112.463 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -59.72 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.38 . . . . 53.31 110.918 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.519 ' H ' HG21 ' A' ' 95' ' ' ILE . 23.8 mm-40 -98.01 -1.53 42.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 73.21 110.926 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.59 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 2.1 mt-10 66.15 125.22 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.624 0.726 . . . . 64.1 110.924 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -170.65 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.651 2.234 . . . . 73.42 112.379 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' A' ' 104' ' ' LYS . 56.9 mt -54.18 -40.41 67.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 75.14 110.866 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.16 57.65 12.66 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.728 -0.748 . . . . 63.45 112.453 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.685 ' O ' HD23 ' A' ' 127' ' ' LEU . 13.7 m-20 -148.37 54.98 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 63.25 110.903 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 126' ' ' ASP . 41.2 mt -136.0 -169.63 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.927 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.61 -168.06 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.41 110.906 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.782 HG23 ' HB3' ' A' ' 144' ' ' TYR . 97.8 m -49.25 -44.05 43.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 61.34 111.132 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.01 141.04 29.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 75.11 111.118 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.7 m -148.56 101.53 3.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 55.44 111.147 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -65.86 96.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 73.51 110.942 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 tpp . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.862 0.363 . . . . 72.42 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.59 128.13 48.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 75.52 110.904 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.557 HG13 HD23 ' A' ' 158' ' ' LEU . 3.9 t -140.92 160.02 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 73.23 111.112 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 33.3 tt0 -161.17 122.58 2.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.87 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.44 178.73 5.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 44.5 111.169 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -174.0 139.21 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 64.35 110.908 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.782 ' HB3' HG23 ' A' ' 129' ' ' THR . 69.3 t80 -118.89 94.82 48.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.634 0.73 . . . . 75.04 110.928 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.74 0.66 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.749 2.299 . . . . 33.33 112.287 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.83 -156.39 25.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.682 -0.77 . . . . 61.23 112.451 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.36 121.94 39.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.736 0.303 . . . . 63.04 110.9 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.621 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -130.89 -93.65 0.64 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.67 -0.776 . . . . 52.21 112.451 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -73.04 -27.83 61.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 74.41 110.846 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.36 164.75 34.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 72.14 111.154 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -70.15 -23.88 63.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.41 110.865 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.695 ' OD2' HD13 ' A' ' 114' ' ' LEU . 8.8 p30 -119.41 49.0 1.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.871 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.5 p30 -99.62 137.58 37.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 70.24 110.911 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.8 pt -139.88 160.07 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.04 111.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 196' ' ' VAL . 9.4 m -108.5 149.42 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 75.3 111.157 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -105.57 141.82 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 72.42 111.078 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -130.17 146.77 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.928 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.557 HD23 HG13 ' A' ' 140' ' ' VAL . 9.6 mt -124.39 97.13 40.31 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.636 0.731 . . . . 75.32 110.908 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 73.33 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.252 . . . . 73.23 112.353 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.79 -34.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 72.24 110.862 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.436 ' O ' HD12 ' A' ' 163' ' ' ILE . 6.5 m-85 -118.04 -12.38 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.897 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.6 m120 68.9 23.27 6.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.106 -0.497 . . . . 72.52 110.884 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.445 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.5 mp -96.18 115.8 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 72.22 111.111 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.406 HD11 HG13 ' A' ' 196' ' ' VAL . 0.7 OUTLIER -99.11 139.97 33.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 73.42 110.914 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.612 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.5 t -126.7 67.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 74.23 111.154 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.36 -54.13 25.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 52.24 112.478 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.38 -134.8 12.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.622 -0.799 . . . . 44.4 112.494 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 91.8 m -64.48 -15.6 61.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.401 . . . . 55.11 110.93 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.408 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.3 tp -69.92 -51.54 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 74.52 110.913 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 206' ' ' VAL . 22.2 t -80.95 133.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 62.33 111.07 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -109.26 138.22 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 74.43 110.925 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 3.3 p -57.06 154.68 9.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.2 110.872 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.786 HG23 HD23 ' A' ' 218' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 55.11 111.15 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.439 HG11 ' CG2' ' A' ' 186' ' ' VAL . 17.6 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.791 0.329 . . . . 75.31 111.114 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.85 78.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.52 111.131 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -119.21 40.99 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 62.22 110.935 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -132.85 172.78 12.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 73.11 111.055 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -119.79 89.78 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 71.51 110.868 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.439 ' CG2' HG11 ' A' ' 181' ' ' VAL . 58.0 t -68.5 -20.9 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 62.14 111.076 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -81.34 -27.24 35.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 53.31 110.91 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.83 -22.94 16.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 61.23 110.837 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.36 -55.05 20.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 73.42 110.865 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.3 p -51.88 -41.11 61.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 70.23 110.87 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 89.4 m -69.84 -40.21 75.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 70.12 111.175 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 70.6 m -58.31 -55.06 39.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 74.21 110.825 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.63 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.0 mm -54.36 -36.82 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 54.34 111.174 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -62.45 -23.39 66.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 71.33 110.914 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -90.41 -25.94 20.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 70.1 110.914 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.543 HG12 HD21 ' A' ' 219' ' ' LEU . 43.6 t -80.96 -32.7 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 73.31 111.08 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.452 HD23 HG22 ' A' ' 193' ' ' ILE . 2.9 pp -84.8 -25.04 28.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 71.54 110.895 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -82.3 -46.07 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 75.22 110.942 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -52.14 -38.41 57.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 70.12 110.781 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -131.88 117.57 18.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 75.14 110.937 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -115.34 41.65 2.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 73.24 110.861 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.01 21.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.89 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.431 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.3 mp -53.22 144.58 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.144 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.02 -33.2 8.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 70.43 110.916 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.445 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -157.54 127.26 6.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 75.51 111.085 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 170' ' ' VAL . 86.9 t -106.76 118.09 53.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 72.25 111.15 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.784 HG21 HD11 ' A' ' 44' ' ' LEU . 57.4 t -100.84 104.11 29.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.571 0.701 . . . . 75.31 111.235 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.72 -172.14 0.54 Allowed 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.705 2.27 . . . . 63.33 112.301 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -100.64 -25.11 8.81 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 71.44 112.541 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -146.34 104.94 3.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 72.23 110.875 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.97 -91.43 0.15 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.71 -0.757 . . . . 72.03 112.453 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -178.9 153.28 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.373 . . . . 73.32 110.902 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.48 143.88 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 41.33 111.18 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -143.22 -105.56 0.54 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.696 -0.764 . . . . 44.13 112.487 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -155.49 -170.14 3.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.802 0.334 . . . . 70.32 110.911 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -57.74 -20.49 35.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.888 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.766 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.6 -33.28 62.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.707 -0.758 . . . . 75.43 112.504 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.786 HD23 HG23 ' A' ' 173' ' ' THR . 31.9 mt -50.78 -47.69 59.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 75.12 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.63 ' O ' HG21 ' A' ' 193' ' ' ILE . 7.0 mp -56.93 -43.87 81.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.457 . . . . 44.35 110.836 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.766 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.3 mt -66.08 -41.66 90.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 75.44 110.951 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.679 ' NE2' HD21 ' A' ' 225' ' ' LEU . 84.4 t60 -60.34 -44.46 95.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.792 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -46.73 64.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 65.25 111.071 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.62 ' HA ' HD12 ' A' ' 226' ' ' LEU . 61.0 mt -51.78 -39.75 59.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.22 111.0 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -65.64 -44.62 85.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.886 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.679 HD21 ' NE2' ' A' ' 221' ' ' HIS . 20.7 mt -57.0 -25.84 59.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.908 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.0 mt -90.56 -40.21 12.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 72.15 110.875 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.0 mttt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 61.41 110.88 179.852 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.786 0.327 . . . . 74.32 111.155 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.694 HD11 ' HE3' ' A' ' 74' ' ' LYS . 2.8 mm -87.95 149.59 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 51.41 111.143 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -146.43 156.38 43.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 71.11 110.903 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.32 -177.52 4.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.878 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -67.14 -28.86 68.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.494 ' OG1' HG22 ' A' ' 15' ' ' THR . 5.6 p -93.06 -35.95 12.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.12 111.057 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.96 -15.16 58.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.664 -0.779 . . . . 65.14 112.425 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.707 HG23 HG13 ' A' ' 16' ' ' ILE . 2.0 t -51.72 -33.06 32.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.725 0.298 . . . . 53.02 111.151 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.707 HG13 HG23 ' A' ' 15' ' ' THR . 28.6 mt -117.11 150.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 45.51 111.027 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.9 p -170.66 173.24 5.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 71.15 110.827 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 19' ' ' SER . 0.3 OUTLIER -139.78 -177.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 62.24 111.13 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.444 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.2 t -167.72 135.77 2.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.473 . . . . 63.33 110.833 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -69.8 118.97 13.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 63.25 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.5 mm? -102.44 -56.8 2.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 65.03 110.946 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -152.69 -172.57 4.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.88 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.3 mttt -52.57 109.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 62.14 110.856 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 58.77 26.16 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 71.52 110.891 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 23' ' ' LYS . 69.5 t -128.44 110.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 75.42 111.124 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -123.39 163.75 20.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 75.44 110.94 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 213' ' ' VAL . 71.9 t -124.42 109.81 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 62.54 111.181 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -99.32 136.92 38.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 71.44 110.888 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.4 m -130.99 125.9 34.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 54.52 111.13 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.635 ' OE1' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -117.88 168.09 10.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.829 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.68 132.92 52.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 63.13 110.91 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.231 0 C-N-CA 120.687 -0.768 . . . . 74.52 112.437 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 69.9 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.668 0.747 . . . . 71.33 111.141 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.0 Cg_endo -69.67 139.51 40.73 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.782 2.321 . . . . 45.0 112.285 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.62 127.02 51.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 44.23 110.857 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -78.17 137.84 38.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 74.31 110.906 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.628 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -138.18 -160.47 8.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 62.21 112.529 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.049 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -165.15 143.63 6.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.84 0.352 . . . . 62.4 110.886 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.402 HG22 HD13 ' A' ' 54' ' ' LEU . 63.5 t -126.25 131.92 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 74.43 111.145 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.5 mt -101.85 119.1 38.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.438 . . . . 73.25 110.92 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -90.07 48.28 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 61.31 110.84 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.41 HG22 ' CB ' ' A' ' 138' ' ' MET . 19.5 p -58.48 176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 73.41 111.106 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.2 21.88 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 72.13 110.889 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.52 30.02 1.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.13 110.856 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.61 129.4 6.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 33.45 112.49 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.764 HD21 ' HB3' ' A' ' 75' ' ' PHE . 46.3 mt -51.62 165.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 52.43 110.97 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 81' ' ' ASP . 50.3 t -147.31 144.9 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 75.22 111.181 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 53' ' ' VAL . 3.5 mm? -115.7 126.66 54.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.11 110.921 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 55' ' ' VAL . 15.5 t -77.06 -3.85 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 75.11 111.181 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.8 129.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 74.31 110.846 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -166.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 70.23 110.857 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 t -94.66 -170.36 2.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 53.34 110.819 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.752 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.7 m95 -73.06 -38.8 66.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 72.25 110.878 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -140.0 161.73 36.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 71.13 110.87 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.22 -33.9 69.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 65.35 110.896 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -75.2 -25.75 58.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 70.21 110.903 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.752 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -81.16 -42.67 20.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 62.02 110.882 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -67.1 -27.05 67.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 65.4 111.168 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -53.42 -39.49 64.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.892 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -86.03 -13.96 45.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 65.54 110.912 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.635 HD22 ' OE1' ' A' ' 30' ' ' GLU . 11.7 tp -77.65 -43.14 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 72.34 110.911 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.24 -29.04 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 73.04 111.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.11 -11.7 61.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 73.15 110.889 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 mmm -89.38 -54.47 4.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.877 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.762 ' HB ' HD13 ' A' ' 52' ' ' LEU . 18.5 m -57.12 -39.87 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 60.3 111.051 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HG3' HG23 ' A' ' 71' ' ' VAL . 51.2 mt-10 -84.41 51.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 73.35 110.899 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -142.54 -41.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 75.13 110.878 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.694 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.62 -19.92 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 72.23 110.909 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.764 ' HB3' HD21 ' A' ' 52' ' ' LEU . 26.1 m-85 -89.22 10.81 20.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 65.31 110.883 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.518 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.64 47.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 61.43 110.902 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -155.3 -179.23 7.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 55.35 110.915 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.565 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -127.99 151.38 49.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 62.43 110.815 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 52' ' ' LEU . 57.7 t -86.11 128.66 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 70.15 111.116 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.565 HG23 ' HD3' ' A' ' 78' ' ' ARG . 65.4 p -137.25 20.76 2.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 72.11 111.173 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.582 ' HB2' HG13 ' A' ' 53' ' ' VAL . 5.8 m-20 -154.01 134.9 13.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 42.23 110.884 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.633 HG21 HD22 ' A' ' 98' ' ' LEU . 25.0 t -138.32 97.92 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 71.12 111.101 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.6 mt -75.02 129.69 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 71.21 111.131 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.5 mm -115.96 131.3 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 72.4 111.115 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.7 p -88.01 -57.93 2.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 64.34 111.157 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -132.86 157.6 44.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 53.24 110.865 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -76.25 96.98 4.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 63.11 111.151 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.639 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -150.65 157.94 43.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.871 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.83 -27.17 62.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 24.44 111.15 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.25 8.15 28.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 61.03 110.875 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -122.89 -53.6 1.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.903 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.639 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -113.4 18.36 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.128 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.61 -27.97 20.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.656 -0.783 . . . . 53.34 112.548 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.98 23.0 20.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.707 -0.759 . . . . 64.41 112.492 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.404 HG21 ' H ' ' A' ' 121' ' ' GLU . 3.9 tt -48.98 -30.36 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 62.22 111.111 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -71.06 -43.26 68.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.916 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 93.9 m -67.04 -36.03 81.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 70.44 111.118 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.633 HD22 HG21 ' A' ' 82' ' ' VAL . 48.6 mt -60.94 -33.48 73.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.33 110.926 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -94.3 21.84 6.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.911 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -117.24 -20.29 9.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.824 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -115.32 5.97 14.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.21 110.9 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.76 15.17 60.06 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 44.13 112.429 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 98' ' ' LEU . 14.3 mt -81.62 155.71 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 73.43 111.175 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.774 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -119.95 122.1 40.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 75.35 110.893 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -88.51 81.45 7.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 72.14 111.046 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.422 ' ND1' HD12 ' A' ' 124' ' ' LEU . 96.7 m-70 -56.58 147.71 21.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 70.41 110.889 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.64 166.43 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 71.14 110.799 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.1 p -86.08 157.05 20.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 61.01 111.145 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.41 -43.32 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.52 111.054 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.668 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -62.1 -46.04 90.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 52.12 110.986 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.679 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 98.2 m -52.04 -42.58 63.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 72.21 111.166 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.25 -24.79 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 63.32 111.117 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.87 -51.31 69.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 64.04 110.885 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.647 HD13 ' OD1' ' A' ' 152' ' ' ASP . 6.5 mp -76.26 -25.03 54.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.919 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.92 -69.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 74.42 111.155 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -54.72 -26.64 35.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 73.5 110.951 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -24.48 67.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 53.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -92.81 -38.97 11.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 74.53 110.873 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.86 -6.47 3.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 44.41 112.554 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -59.77 -172.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.832 0.348 . . . . 61.03 110.95 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.404 ' H ' HG21 ' A' ' 95' ' ' ILE . 56.0 mm-40 -98.63 -0.68 42.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 63.32 110.885 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 66.28 126.26 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.654 0.74 . . . . 72.21 110.85 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.677 2.251 . . . . 55.41 112.377 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 104' ' ' LYS . 62.9 mt -52.21 -40.55 61.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.903 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.1 55.97 18.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.531 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -148.98 52.93 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 71.31 110.912 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.8 mt -135.74 -177.67 4.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.883 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.83 -168.59 2.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.883 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.847 HG23 ' HB3' ' A' ' 144' ' ' TYR . 92.7 m -50.1 -54.26 21.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 70.23 111.158 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.699 HG22 ' HA ' ' A' ' 143' ' ' PHE . 90.8 t -131.34 130.98 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 64.02 111.106 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.565 HG22 HD23 ' A' ' 133' ' ' LEU . 99.1 m -135.6 123.67 22.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 75.11 111.167 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -81.41 103.97 11.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 75.1 110.85 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.565 HD23 HG22 ' A' ' 131' ' ' THR . 1.6 mt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 73.13 110.902 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.41 ' CB ' HG22 ' A' ' 48' ' ' THR . 58.5 tpp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.866 0.365 . . . . 75.41 110.838 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -117.17 115.24 24.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.926 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.6 t -123.01 153.55 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 61.31 111.144 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -153.15 122.38 6.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 70.21 110.938 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.538 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -73.24 -178.18 2.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 42.13 111.148 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.699 ' HA ' HG22 ' A' ' 130' ' ' VAL . 71.2 t80 -175.35 134.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.84 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.847 ' HB3' HG23 ' A' ' 129' ' ' THR . 29.1 t80 -121.09 96.06 48.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.702 0.763 . . . . 74.24 110.91 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.7 Cg_endo -69.79 -48.71 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.619 2.213 . . . . 64.25 112.336 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.61 -153.78 20.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.738 . . . . 63.15 112.451 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.7 124.62 39.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 71.33 110.905 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.48 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.42 -94.19 0.34 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 53.32 112.47 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -70.11 -26.86 64.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 62.4 110.895 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.41 159.62 42.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.468 . . . . 74.32 111.119 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.28 -23.09 66.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.873 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.668 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -124.02 50.07 1.69 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 75.52 110.868 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.19 139.87 34.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 73.12 110.904 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.538 HD12 HG22 ' A' ' 142' ' ' THR . 5.6 pt -140.12 172.85 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 61.44 111.149 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 196' ' ' VAL . 7.9 m -123.58 139.23 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 45.21 111.183 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.447 ' O ' HD22 ' A' ' 164' ' ' LEU . 77.6 t -94.04 128.68 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 70.34 111.139 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -114.84 150.32 35.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.905 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.674 HD12 ' HB ' ' A' ' 163' ' ' ILE . 53.7 mt -124.77 94.87 43.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.595 0.712 . . . . 73.15 110.926 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 69.65 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.687 2.258 . . . . 65.14 112.317 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.37 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 74.23 110.874 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.617 ' CB ' HD13 ' A' ' 163' ' ' ILE . 7.3 m-85 -117.49 -10.76 10.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 75.52 110.905 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.4 m120 68.18 21.01 8.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 73.35 110.88 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.674 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.5 mp -86.41 116.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 65.44 111.097 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.6 tm? -101.98 123.46 45.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 52.42 110.984 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.489 ' N ' HD22 ' A' ' 164' ' ' LEU . 26.0 t -117.37 72.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 65.12 111.078 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.416 ' H ' HD13 ' A' ' 164' ' ' LEU . . . -65.17 -51.71 47.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 71.43 112.482 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.94 -138.02 14.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 72.33 112.483 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.91 -25.72 31.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 52.23 110.854 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.483 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.6 OUTLIER -62.08 -49.63 75.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 63.43 110.95 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.741 HG11 HG11 ' A' ' 206' ' ' VAL . 21.4 t -89.56 131.37 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 61.53 111.111 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -101.6 148.64 24.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 73.01 110.887 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.632 ' HA ' HD22 ' A' ' 218' ' ' LEU . 2.2 t -73.56 158.86 34.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.827 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 72.03 111.197 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 186' ' ' VAL . 35.4 m . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.783 0.325 . . . . 61.4 111.069 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.3 80.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 71.55 111.039 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -114.03 42.23 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 74.3 110.927 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.24 164.65 28.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.43 111.072 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -115.61 92.61 3.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 72.45 110.931 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.53 ' CG2' HG11 ' A' ' 181' ' ' VAL . 61.7 t -67.07 -23.68 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.1 111.201 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -79.39 -31.52 42.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 25.31 110.886 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.51 -22.7 20.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 62.41 110.911 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -51.49 -53.21 39.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 64.15 110.884 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.6 p -51.88 -37.93 54.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 71.04 110.86 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 91.8 m -70.64 -37.77 73.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 60.22 111.128 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.2 m -63.38 -55.27 25.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 70.51 110.876 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.939 HG22 HD23 ' A' ' 197' ' ' LEU . 25.8 mm -56.54 -37.63 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 64.12 111.112 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.06 -17.49 62.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 75.12 110.842 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -96.55 -28.96 14.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 61.14 110.901 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.518 HG21 HG11 ' A' ' 155' ' ' VAL . 96.0 t -82.69 -26.02 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 71.42 111.099 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.939 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -90.51 -23.27 20.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 64.45 110.909 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -88.51 -47.38 8.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 72.4 110.88 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 32.9 tpt85 -55.31 -32.59 62.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.834 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -130.89 116.91 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 72.3 110.888 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -119.3 34.94 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 75.34 110.897 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.02 22.33 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 70.3 110.859 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.541 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.2 mp -51.51 143.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 74.44 111.146 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -103.0 -39.27 6.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 74.03 110.936 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.432 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -153.71 118.96 5.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 72.42 111.092 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.741 HG11 HG11 ' A' ' 170' ' ' VAL . 92.8 t -96.96 123.21 49.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 74.41 111.152 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.049 HG21 HD11 ' A' ' 44' ' ' LEU . 87.5 t -106.49 102.13 39.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 73.44 111.154 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.0 Cg_endo -69.69 -170.05 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.75 2.3 . . . . 50.23 112.347 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.87 -31.27 7.45 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.733 -0.746 . . . . 61.54 112.445 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -144.27 111.9 6.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 65.45 110.873 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 144.91 -94.17 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 74.44 112.447 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -176.06 164.09 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 72.55 110.917 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.694 HG22 HG22 ' A' ' 207' ' ' VAL . 21.3 t -72.59 150.57 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.41 111.07 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.77 -108.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.767 -0.73 . . . . 74.01 112.457 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -160.27 -169.85 2.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.876 0.369 . . . . 63.14 110.887 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -54.25 -24.76 19.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 72.41 110.87 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.73 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -52.16 -35.6 42.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 71.51 112.5 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.711 HD12 ' CG1' ' A' ' 206' ' ' VAL . 32.7 mt -50.96 -45.68 60.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.339 . . . . 64.31 110.918 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.716 HD12 HG23 ' A' ' 193' ' ' ILE . 4.3 mm? -54.14 -41.3 68.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 74.41 111.01 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.73 HD12 ' HA2' ' A' ' 217' ' ' GLY . 4.8 mt -69.36 -40.87 77.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.32 110.853 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -60.78 -42.14 96.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.762 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.25 -48.43 65.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 62.31 111.167 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.799 ' HA ' HD12 ' A' ' 226' ' ' LEU . 3.8 mt -56.28 -41.4 75.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 62.12 110.93 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.91 -42.07 79.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 73.22 110.904 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.5 mt -60.88 -37.4 82.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 75.03 110.894 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' A' ' 223' ' ' LEU . 4.7 mt -72.7 -40.53 66.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 65.22 110.944 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 71.32 110.909 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.575 HG22 ' OG ' ' A' ' 19' ' ' SER . 92.4 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.804 0.335 . . . . 60.2 111.154 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.6 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.1 mm -88.14 152.86 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 73.23 111.191 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -146.12 153.75 41.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 71.42 110.87 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.16 170.82 11.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 55.24 110.903 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -58.7 -27.17 64.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 73.42 110.885 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -100.13 -33.4 10.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 71.55 111.225 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.85 -9.76 51.8 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.737 -0.745 . . . . 50.42 112.446 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.704 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.94 -33.21 23.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.716 0.293 . . . . 72.51 111.123 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.704 HG13 HG23 ' A' ' 15' ' ' THR . 14.6 mt -124.81 149.18 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.15 111.084 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -168.34 169.75 10.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 72.31 110.845 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -135.05 -172.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.503 . . . . 75.02 111.143 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.575 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -173.76 132.86 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 60.51 110.908 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.21 120.72 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.104 -0.498 . . . . 74.5 110.923 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -103.8 -49.28 3.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.45 . . . . 54.22 110.932 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.33 51.87 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 69.03 -75.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.936 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.621 ' OD1' HG23 ' A' ' 25' ' ' VAL . 14.5 p30 -86.88 -19.91 28.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 71.45 110.897 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.621 HG23 ' OD1' ' A' ' 24' ' ' ASN . 99.6 t -97.45 118.52 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 65.34 111.123 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -122.35 161.56 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.939 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.5 HG21 HG21 ' A' ' 213' ' ' VAL . 70.4 t -122.35 106.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 64.55 111.108 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.456 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.1 p80 -95.83 137.37 34.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 74.24 110.876 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 41' ' ' SER . 37.3 m -132.46 128.76 38.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 62.14 111.156 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.651 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -120.29 -177.27 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.438 . . . . 73.0 110.865 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.507 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -136.79 133.16 35.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 73.23 110.865 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 75.53 112.484 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.421 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 59.4 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 121.643 0.735 . . . . 72.24 111.068 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.5 Cg_endo -69.69 141.04 44.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.649 2.233 . . . . 73.23 112.358 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.625 ' O ' HG23 ' A' ' 29' ' ' THR . 1.1 t -121.26 132.85 55.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 62.4 110.821 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -90.95 141.93 28.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 73.24 110.804 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.627 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -140.95 -155.87 6.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 52.04 112.53 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.919 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -164.93 144.13 6.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 71.44 110.903 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 54' ' ' LEU . 31.6 t -128.08 133.28 67.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 53.23 111.115 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.554 HD22 ' HE3' ' A' ' 138' ' ' MET . 39.6 mt -100.64 123.32 44.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.941 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -92.15 46.79 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 74.32 110.886 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.538 HG22 ' CB ' ' A' ' 138' ' ' MET . 24.5 p -55.35 171.26 0.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 63.44 111.125 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.3 t -99.24 28.45 4.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.83 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 22.8 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 70.33 110.941 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.8 129.98 4.4 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 65.13 112.503 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.799 HD13 ' HB ' ' A' ' 71' ' ' VAL . 26.0 mt -57.26 157.81 5.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 74.51 110.957 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' A' ' 81' ' ' ASP . 95.2 t -140.76 143.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 64.14 111.123 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.557 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -113.47 130.07 56.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 72.01 110.934 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.8 t -79.77 -1.78 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.096 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.78 134.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.88 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -166.7 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 71.41 110.821 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.17 -170.09 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 53.23 110.799 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.677 ' HB2' HD13 ' A' ' 63' ' ' LEU . 85.7 m95 -72.05 -40.22 68.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.094 -0.503 . . . . 71.21 110.931 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.79 175.54 9.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 32.31 110.958 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HA ' HG22 ' A' ' 64' ' ' THR . 4.1 p-10 -68.9 -30.61 69.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 75.12 110.823 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -74.54 -22.39 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 70.23 110.918 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.27 -52.41 5.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 64.44 110.89 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.495 HG21 ' HA3' ' A' ' 94' ' ' GLY . 10.2 t -57.4 -28.35 63.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 72.44 111.138 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -55.93 -40.82 73.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 53.24 110.874 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.96 -1.36 57.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.414 . . . . 74.53 110.866 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.651 HD22 ' OE2' ' A' ' 30' ' ' GLU . 15.5 tp -92.88 -45.15 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.902 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.8 mt -72.18 -14.65 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 73.42 111.072 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -87.11 5.9 35.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 63.15 110.848 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.1 mtp -106.54 -53.69 2.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 73.32 110.859 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.799 ' HB ' HD13 ' A' ' 52' ' ' LEU . 21.3 m -58.42 -37.77 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 71.32 111.083 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HG3' HG23 ' A' ' 71' ' ' VAL . 32.7 mt-10 -85.99 50.03 1.9 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.898 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.23 -42.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 72.02 110.837 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.6 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -103.9 -21.65 13.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.955 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.757 ' HB3' HD21 ' A' ' 52' ' ' LEU . 35.9 m-85 -91.23 12.94 18.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.883 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.511 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.72 46.91 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 71.13 110.923 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -155.57 -177.81 6.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 72.32 110.87 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.1 OUTLIER -125.85 159.13 33.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 71.13 110.875 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 52' ' ' LEU . 89.9 t -91.46 119.44 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 52.14 111.123 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.414 HG23 ' HG2' ' A' ' 78' ' ' ARG . 30.0 p -132.18 36.83 3.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.118 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.819 ' HB2' HG22 ' A' ' 53' ' ' VAL . 4.6 m-20 -169.76 134.29 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 73.12 110.794 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.677 HG23 HG21 ' A' ' 103' ' ' ILE . 22.4 t -140.66 100.27 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 71.22 111.09 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.7 mt -77.66 124.04 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 55.54 111.164 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.3 mm -109.24 142.43 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 74.24 111.132 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.8 p -98.69 -60.85 1.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 71.52 111.164 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -130.79 165.07 23.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 75.44 110.865 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.21 97.66 8.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.22 111.059 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.667 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.65 157.93 42.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 73.25 110.912 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.93 -29.57 63.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 73.33 111.087 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -89.66 10.7 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.873 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -121.94 -52.09 2.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 65.31 110.915 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -117.13 26.77 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.157 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.24 -28.19 18.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.707 -0.758 . . . . 60.04 112.479 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 64' ' ' THR . . . -116.02 30.61 6.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 65.32 112.543 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.514 HD11 ' C ' ' A' ' 122' ' ' GLU . 1.1 tt -48.56 -34.21 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 75.1 111.098 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -34.51 33.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 75.33 110.853 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.9 m -62.44 -34.18 76.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 72.44 111.063 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.967 HD12 ' HB2' ' A' ' 105' ' ' ALA . 27.6 mt -65.4 -43.24 91.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 63.32 110.878 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -26.26 59.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.866 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.25 -29.82 70.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 72.23 110.896 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -105.58 -48.29 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.35 110.858 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.62 -15.75 1.08 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.72 -0.753 . . . . 72.02 112.499 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.677 HG21 HG23 ' A' ' 82' ' ' VAL . 1.9 mp -54.56 151.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.13 111.123 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.787 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.6 ptpm? -113.66 127.84 56.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.923 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.967 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -90.12 82.03 6.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 40.42 111.043 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.456 ' ND1' HD12 ' A' ' 124' ' ' LEU . 93.7 m-70 -57.72 147.11 28.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.45 110.871 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.63 160.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 73.03 110.89 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.637 HG22 ' HB3' ' A' ' 127' ' ' LEU . 72.2 p -74.03 -175.61 2.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 41.14 111.111 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.12 -30.92 43.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 51.33 111.143 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.73 -44.68 40.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.958 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.7 m -55.41 -25.38 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 73.13 111.168 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.518 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -91.31 -34.34 14.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 64.23 111.159 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -53.69 -32.8 53.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 60.31 110.89 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.558 HD13 ' OD1' ' A' ' 152' ' ' ASP . 9.8 mp -91.79 -25.84 18.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 70.35 110.838 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . . . -53.65 -62.72 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.32 111.096 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -60.12 -26.09 65.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 71.3 110.898 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -25.18 68.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.893 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -92.16 -33.38 14.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 64.3 110.868 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.1 -10.78 4.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 32.34 112.494 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -59.59 -173.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.83 0.347 . . . . 72.41 110.871 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -98.71 0.32 44.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 54.44 110.886 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.514 ' C ' HD11 ' A' ' 95' ' ' ILE . 1.2 mt-10 66.42 132.59 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.656 0.741 . . . . 74.21 110.928 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.8 -169.63 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.653 2.235 . . . . 61.33 112.4 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.787 HD11 ' HB2' ' A' ' 104' ' ' LYS . 54.2 mt -54.83 -51.11 66.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 73.11 110.959 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.4 51.72 8.2 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.75 -0.738 . . . . 62.12 112.471 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.46 55.42 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 64.32 110.833 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.637 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.5 OUTLIER -137.61 -174.66 3.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 61.1 110.89 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.84 -168.16 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.764 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.1 m -49.66 -43.01 46.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 65.42 111.221 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.38 142.15 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 75.5 111.061 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.654 HG22 HD23 ' A' ' 133' ' ' LEU . 60.6 m -149.83 108.87 3.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.095 -0.502 . . . . 72.03 111.084 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -69.75 96.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 72.53 110.858 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.654 HD23 HG22 ' A' ' 131' ' ' THR . 3.3 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 54.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.554 ' HE3' HD22 ' A' ' 46' ' ' LEU . 2.2 tpt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.88 0.372 . . . . 65.33 110.832 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -120.51 127.72 52.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 62.34 110.848 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.702 HG13 HD23 ' A' ' 158' ' ' LEU . 5.0 t -141.51 158.96 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 43.35 111.145 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.417 ' N ' HG12 ' A' ' 140' ' ' VAL . 30.7 tt0 -159.01 124.58 4.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 52.11 110.891 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.412 HG22 ' CD1' ' A' ' 154' ' ' ILE . 0.0 OUTLIER -74.97 -178.27 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 72.33 111.13 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -175.36 140.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 71.5 110.895 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.764 ' HB3' HG23 ' A' ' 129' ' ' THR . 49.7 t80 -123.24 97.66 42.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.598 0.713 . . . . 74.02 110.927 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.478 ' HB3' HG23 ' A' ' 196' ' ' VAL . 54.0 Cg_endo -69.7 -48.98 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.699 2.266 . . . . 54.12 112.371 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.59 -153.95 22.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.786 -0.721 . . . . 55.22 112.467 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.51 122.44 39.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 74.23 110.934 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.507 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.04 -97.76 0.56 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 52.21 112.481 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -67.65 -28.41 67.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.818 0.342 . . . . 64.24 110.862 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.69 156.44 41.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 73.12 111.114 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -59.91 -29.26 68.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 72.01 110.844 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.558 ' OD1' HD13 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -117.9 52.12 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.89 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.507 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.4 p30 -100.72 135.0 42.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 75.43 110.884 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.415 HG22 ' HD1' ' A' ' 144' ' ' TYR . 1.1 pt -136.45 166.98 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 74.23 111.114 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.442 ' CG1' HD23 ' A' ' 169' ' ' LEU . 10.5 m -116.83 157.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 70.13 111.107 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.3 t -110.36 143.29 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.136 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -130.87 148.15 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 71.14 110.902 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.702 HD23 HG13 ' A' ' 140' ' ' VAL . 24.1 mt -125.53 95.37 40.8 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.57 0.7 . . . . 74.22 110.888 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 72.21 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.729 2.286 . . . . 52.12 112.317 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.08 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 70.33 110.934 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.89 -11.74 10.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.891 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 68.36 24.12 7.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 63.13 110.976 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.562 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.7 mp -96.24 117.24 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 64.33 111.172 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.23 142.65 33.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.952 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.507 HG21 HD22 ' A' ' 44' ' ' LEU . 21.6 t -127.9 67.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 75.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.62 -55.19 21.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.67 -0.776 . . . . 71.25 112.544 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.14 -137.12 13.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.668 -0.777 . . . . 34.01 112.468 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 59.3 m -64.24 -15.8 60.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 61.43 110.934 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.651 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.5 tp -70.11 -47.59 61.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.914 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 218' ' ' LEU . 21.8 t -95.91 115.92 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 53.43 111.148 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.615 ' H ' HG23 ' A' ' 222' ' ' THR . 0.1 OUTLIER -82.85 155.76 23.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 73.42 110.892 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.619 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.5 t -84.0 162.29 20.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 73.14 110.843 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 73.3 111.161 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.488 HG11 ' CG2' ' A' ' 186' ' ' VAL . 6.7 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.856 0.36 . . . . 63.14 111.115 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.27 -47.05 82.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 70.25 111.155 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -117.42 42.99 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.35 110.844 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -133.62 162.17 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 73.23 111.138 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -115.72 93.49 4.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.022 0.439 . . . . 75.45 110.902 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.488 ' CG2' HG11 ' A' ' 181' ' ' VAL . 49.1 t -69.36 -20.91 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 74.25 111.06 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -81.98 -26.84 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 70.34 110.943 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.54 -21.37 16.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.53 110.841 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.651 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -51.41 -56.18 14.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.9 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.3 p -51.96 -37.77 54.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.837 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.1 m -72.56 -37.84 68.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 72.15 111.127 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 75.7 m -61.92 -54.92 35.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.04 110.83 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.772 HG23 HD12 ' A' ' 219' ' ' LEU . 26.7 mm -55.83 -36.75 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 74.15 111.087 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.88 -17.31 64.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.3 110.828 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -93.93 -31.03 14.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 70.5 110.871 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 145' ' ' PRO . 87.3 t -77.26 -45.9 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 54.13 111.137 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.713 HD23 HG22 ' A' ' 193' ' ' ILE . 3.6 pp -69.77 -23.2 63.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.467 . . . . 63.12 110.878 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -86.23 -44.33 12.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 63.51 110.866 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -53.29 -28.5 28.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 73.02 110.874 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -142.52 121.24 12.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 64.53 110.96 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.42 35.69 4.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 73.41 110.879 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.25 21.8 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.914 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.449 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.6 mp -53.24 145.08 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.42 111.164 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -105.88 -33.76 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.91 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.562 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -155.92 128.37 7.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 44.23 111.111 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.498 HG12 HD12 ' A' ' 218' ' ' LEU . 94.8 t -109.85 117.42 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 44.41 111.126 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.919 HG21 HD11 ' A' ' 44' ' ' LEU . 75.3 t -100.04 104.3 28.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.594 0.711 . . . . 70.41 111.097 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.75 -173.7 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.707 2.271 . . . . 72.4 112.32 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.42 -28.85 10.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.737 . . . . 65.13 112.503 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -144.09 110.52 5.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 74.11 110.824 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 144.92 -98.41 0.2 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 44.23 112.508 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -174.62 154.75 2.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 72.12 110.928 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.816 HG22 HG22 ' A' ' 207' ' ' VAL . 22.9 t -57.32 149.59 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 62.33 111.157 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -148.72 -108.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.697 -0.763 . . . . 73.03 112.515 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -161.34 -169.85 2.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.893 0.378 . . . . 72.12 110.92 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -58.18 -20.56 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 44.32 110.949 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.63 -33.98 63.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.76 -0.734 . . . . 55.45 112.461 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 172' ' ' SER . 28.0 mt -50.59 -42.66 56.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.834 0.35 . . . . 72.14 110.896 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.772 HD12 HG23 ' A' ' 193' ' ' ILE . 4.6 mm? -55.43 -43.36 75.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.919 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.571 HD12 ' HA2' ' A' ' 217' ' ' GLY . 4.9 mt -68.54 -40.41 80.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 72.11 110.9 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -60.72 -38.91 86.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.52 110.879 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.615 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.78 -45.07 63.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 70.42 111.081 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.791 ' HA ' HD12 ' A' ' 226' ' ' LEU . 9.5 mt -59.4 -42.57 92.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.888 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -29.21 56.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.852 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.9 mt -75.21 -26.89 59.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 73.24 110.88 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.791 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.4 mt -86.09 -30.21 22.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.958 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 63.25 110.907 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 18' ' ' ILE . 95.4 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.808 0.337 . . . . 74.43 111.154 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.696 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.9 mm -93.76 156.88 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 70.23 111.155 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.42 170.08 19.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 75.12 110.933 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -99.89 -169.29 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 75.11 110.983 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.578 ' HG3' HG23 ' A' ' 13' ' ' THR . 18.5 pt-20 -75.28 -20.96 58.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.877 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 12' ' ' GLU . 26.3 p -107.66 -39.53 5.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 71.41 111.148 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.02 -2.65 30.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 54.11 112.473 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.733 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.57 -33.28 21.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 75.21 111.181 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.733 HG13 HG23 ' A' ' 15' ' ' THR . 8.1 mt -129.25 158.96 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.12 111.093 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 16' ' ' ILE . 35.9 p -175.8 164.23 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 64.02 110.823 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.572 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.88 -175.41 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.515 . . . . 62.14 111.163 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.443 ' HA ' HG22 ' A' ' 8' ' ' VAL . 1.7 t -167.54 131.07 1.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 53.52 110.845 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.12 118.48 11.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 71.44 110.922 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.57 -45.88 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.861 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -141.58 -169.63 2.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.3 110.916 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -51.07 -49.66 60.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.875 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -133.38 39.14 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 74.13 110.871 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.39 121.63 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 71.54 111.159 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -126.38 159.61 32.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 64.25 110.965 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.2 t -122.43 106.69 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 73.43 111.124 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.528 ' HB3' HG23 ' A' ' 18' ' ' ILE . 8.4 p80 -98.37 138.13 36.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 72.43 110.851 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 m -136.59 134.21 37.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 73.43 111.127 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' HB3' HG23 ' A' ' 16' ' ' ILE . 2.5 pm0 -125.93 175.74 7.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 64.21 110.907 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 40' ' ' PRO . 4.2 tp -119.76 150.05 41.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.13 110.975 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.775 -0.726 . . . . 55.33 112.526 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.622 0.725 . . . . 74.41 111.151 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.624 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.4 Cg_endo -69.73 151.97 69.34 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.693 2.262 . . . . 54.15 112.328 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 t -138.21 92.29 2.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 55.43 110.87 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -52.77 171.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 75.32 110.941 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -169.93 -156.43 11.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.729 -0.748 . . . . 74.11 112.5 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.912 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -166.68 144.39 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 75.13 110.934 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.632 HG11 HG11 ' A' ' 71' ' ' VAL . 41.5 t -128.94 138.51 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 62.0 111.144 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.61 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 45.8 mt -106.03 130.69 53.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 72.1 110.86 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.99 56.94 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 75.0 110.921 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 p -67.23 177.38 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 64.42 111.217 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.51 20.23 15.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 72.13 110.818 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.91 24.37 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.858 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.11 134.92 6.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 72.22 112.487 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.764 HD13 ' HB ' ' A' ' 71' ' ' VAL . 6.8 mt -60.93 157.54 15.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 72.25 110.908 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.809 HG22 ' HB2' ' A' ' 81' ' ' ASP . 84.5 t -136.94 142.8 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.03 111.121 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.587 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -113.86 128.85 56.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.14 110.92 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 55' ' ' VAL . 13.8 t -78.95 -1.76 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 55.34 111.154 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 179.93 127.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 63.04 110.872 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -66.57 -166.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.827 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -95.06 -171.38 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 70.32 110.842 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.782 ' HB2' HD13 ' A' ' 63' ' ' LEU . 88.6 m95 -72.61 -37.34 68.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.01 110.927 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -145.77 157.61 43.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 73.44 110.829 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -54.25 -34.61 61.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 54.11 110.869 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -74.91 -25.55 59.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 73.3 110.957 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.782 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -81.49 -44.76 16.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 71.53 110.908 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 t -60.26 -26.16 66.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 72.1 111.175 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -54.36 -42.4 70.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 52.14 110.82 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.33 -10.51 59.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 75.42 110.883 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 16' ' ' ILE . 55.2 tp -89.69 -52.38 5.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 74.22 110.909 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.1 mt -65.83 -15.3 18.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 52.12 111.117 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -87.3 7.09 30.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 63.32 110.866 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.1 mtp -103.26 -57.35 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 71.21 110.865 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.764 ' HB ' HD13 ' A' ' 52' ' ' LEU . 19.1 m -58.0 -39.22 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 71.5 111.117 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -84.07 50.79 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 72.35 110.846 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 -39.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 54.14 110.867 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.696 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -110.66 -21.62 12.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.897 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.516 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 29.0 m-85 -90.15 12.08 18.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 65.45 110.863 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.516 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.79 46.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 74.23 110.924 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.6 mttp -151.6 -177.04 5.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.252 -0.431 . . . . 72.14 110.977 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.535 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.41 158.4 38.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 70.43 110.863 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.452 ' CG1' HD23 ' A' ' 54' ' ' LEU . 26.1 t -89.53 117.13 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.42 111.096 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.535 HG23 ' HG2' ' A' ' 78' ' ' ARG . 42.9 p -133.03 38.19 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.4 111.247 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.809 ' HB2' HG22 ' A' ' 53' ' ' VAL . 2.4 m-20 -168.83 134.97 1.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 44.11 110.838 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 98' ' ' LEU . 16.1 t -143.01 102.19 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.43 111.162 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.8 mt -81.41 115.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 62.44 111.07 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.528 HG23 ' HB3' ' A' ' 91' ' ' ARG . 42.1 mm -101.33 129.86 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.11 111.097 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -87.68 -56.03 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.14 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -133.06 166.4 22.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 64.44 110.862 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -85.05 98.38 10.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.411 . . . . 43.34 111.149 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.645 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -152.23 159.65 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.9 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.09 -28.73 62.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 73.12 111.097 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.35 12.01 19.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 53.05 110.792 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.528 ' HB3' HG23 ' A' ' 84' ' ' ILE . 1.9 mmp_? -124.0 -52.26 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 74.1 110.866 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.32 17.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 61.04 111.157 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.9 -28.12 23.27 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.753 -0.736 . . . . 62.52 112.499 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.0 20.75 26.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 74.51 112.543 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.459 HG21 ' H ' ' A' ' 121' ' ' GLU . 1.6 tt -48.35 -31.03 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 74.24 111.134 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -69.49 -44.53 70.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 74.22 110.925 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 m -66.67 -34.36 77.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 63.51 111.14 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.561 ' CD2' HG21 ' A' ' 82' ' ' VAL . 50.1 mt -64.37 -26.87 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 71.51 110.912 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -99.77 21.01 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 64.32 110.914 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.07 -30.41 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 70.21 110.872 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -104.38 12.42 33.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 64.31 110.881 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.38 25.07 61.93 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.822 -0.704 . . . . 63.23 112.509 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 98' ' ' LEU . 11.4 mt -88.11 157.07 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 75.52 111.163 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.819 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -120.32 118.79 31.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 72.43 110.918 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.509 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . . . -90.17 78.31 6.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 64.51 111.009 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.504 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.3 m-70 -54.77 147.92 13.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 62.2 110.898 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.93 163.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 65.22 110.891 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 127' ' ' LEU . 68.7 p -85.13 158.17 20.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 51.32 111.182 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.7 61.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 72.54 111.103 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.692 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -62.71 -46.89 86.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 71.32 110.873 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.729 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 100.0 m -52.43 -41.98 63.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 73.34 111.168 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.49 -23.38 61.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 65.24 111.137 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.87 -43.08 85.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.473 HD13 ' OD2' ' A' ' 152' ' ' ASP . 7.3 mp -81.1 -28.03 35.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 54.51 110.936 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.425 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . . . -51.67 -70.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 65.25 111.03 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -26.0 36.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 72.15 110.962 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -23.65 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 75.23 110.869 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -96.07 -38.71 10.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 74.45 110.898 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.87 -6.39 3.76 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.698 -0.763 . . . . 71.22 112.483 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.62 -172.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 70.23 110.931 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.459 ' H ' HG21 ' A' ' 95' ' ' ILE . 26.4 mm-40 -97.8 -1.57 42.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 74.24 110.842 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.458 ' C ' HD11 ' A' ' 95' ' ' ILE . 1.1 mt-10 66.31 129.13 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.657 0.741 . . . . 52.41 110.84 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.648 2.232 . . . . 53.55 112.341 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 104' ' ' LYS . 79.6 mt -54.08 -35.96 62.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 51.32 110.955 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.12 49.04 51.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 70.21 112.457 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -142.8 56.28 1.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 71.5 110.857 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.519 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.7 OUTLIER -136.79 -169.8 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 75.11 110.91 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -148.84 -168.79 3.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 63.42 110.879 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.829 HG23 ' HB3' ' A' ' 144' ' ' TYR . 99.3 m -50.27 -56.99 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 72.32 111.156 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.701 HG23 HG22 ' A' ' 129' ' ' THR . 88.4 t -130.29 128.5 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 75.41 111.114 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.538 HG22 HD23 ' A' ' 133' ' ' LEU . 90.6 m -135.81 124.31 23.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 62.35 111.154 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -80.33 103.0 9.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.912 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.538 HD23 HG22 ' A' ' 131' ' ' THR . 2.6 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 55.21 110.926 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.61 ' HE3' ' HB3' ' A' ' 46' ' ' LEU . 32.0 tpp . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.882 0.372 . . . . 74.33 110.88 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.14 120.99 28.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 62.41 110.868 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.588 HG13 HD23 ' A' ' 158' ' ' LEU . 10.3 t -131.57 155.67 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.22 111.145 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -153.09 125.06 7.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.872 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.544 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -75.47 -177.95 3.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 64.32 111.18 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.678 ' HA ' HG22 ' A' ' 130' ' ' VAL . 73.4 t80 -175.18 137.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.887 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.829 ' HB3' HG23 ' A' ' 129' ' ' THR . 29.5 t80 -122.61 94.86 47.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.692 0.758 . . . . 74.22 110.974 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.9 Cg_endo -69.76 -48.74 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 73.03 112.292 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.45 -152.24 15.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 54.34 112.437 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.62 125.81 45.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.346 . . . . 75.35 110.903 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.653 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -136.5 -87.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.71 . . . . 42.24 112.495 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -76.33 -29.18 57.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 64.21 110.91 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.68 156.11 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.24 111.19 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.81 -24.88 62.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 74.12 110.789 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.692 ' HB3' HD12 ' A' ' 110' ' ' LEU . 14.4 p30 -119.98 47.36 1.76 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 73.35 110.827 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.495 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -97.27 134.55 40.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 62.41 110.848 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.577 HG22 ' CD1' ' A' ' 144' ' ' TYR . 2.6 pt -136.07 169.87 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 71.45 111.089 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.421 ' CG1' HD22 ' A' ' 169' ' ' LEU . 6.9 m -120.98 145.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 74.43 111.077 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.1 t -98.29 143.58 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 65.41 111.12 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -129.85 149.74 51.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 71.43 110.914 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.588 HD23 HG13 ' A' ' 140' ' ' VAL . 28.5 mt -126.96 95.71 36.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.604 0.716 . . . . 64.51 110.936 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 71.91 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.679 2.253 . . . . 74.14 112.35 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.928 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.552 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.2 m-85 -118.03 -13.18 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 71.11 110.908 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.6 m120 69.4 23.26 6.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 75.35 110.922 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.552 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.6 mp -93.51 114.38 30.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 70.41 111.113 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.14 136.61 39.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 74.35 110.898 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.596 HG21 HD22 ' A' ' 44' ' ' LEU . 31.7 t -122.11 67.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 73.01 111.16 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.34 -55.62 18.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.74 -0.743 . . . . 72.55 112.559 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.18 -122.83 6.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.746 -0.74 . . . . 72.4 112.467 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.7 m -80.82 -0.8 40.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 70.31 110.909 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.478 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.6 OUTLIER -85.31 -49.1 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 74.44 110.981 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 206' ' ' VAL . 45.2 t -94.32 105.77 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 74.14 111.125 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.532 ' H ' HG23 ' A' ' 222' ' ' THR . 0.1 OUTLIER -75.02 164.45 26.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.918 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.65 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.4 p -88.65 158.65 18.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.798 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.513 HG23 HD23 ' A' ' 218' ' ' LEU . 1.7 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 71.12 111.14 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 186' ' ' VAL . 26.0 m . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.827 0.346 . . . . 61.44 111.082 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.63 91.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 65.44 111.07 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.88 44.66 1.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.14 110.937 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -134.93 174.16 10.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 60.11 111.067 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -127.24 87.46 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 54.51 110.985 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' A' ' 181' ' ' VAL . 21.9 t -66.39 -22.22 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 71.14 111.181 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.7 -32.96 58.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 40.35 110.922 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -93.53 -22.8 18.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 73.35 110.877 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.48 -55.88 16.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 64.43 110.83 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.3 p -51.94 -37.05 51.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.88 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m -74.18 -35.62 63.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 63.55 111.111 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 196' ' ' VAL . 32.9 m -63.19 -52.38 62.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 74.53 110.838 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.975 HG22 HD23 ' A' ' 197' ' ' LEU . 27.7 mm -58.02 -39.15 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 74.22 111.092 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.22 -17.07 57.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 74.43 110.929 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -99.76 -23.83 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 73.52 110.843 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 192' ' ' SER . 48.6 t -88.34 -18.43 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 65.01 111.119 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.975 HD23 HG22 ' A' ' 193' ' ' ILE . 2.4 pp -105.52 1.27 27.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.939 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -117.81 -24.01 7.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 43.43 110.901 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -82.67 1.15 39.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 64.43 110.829 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -136.28 -72.3 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.215 -0.448 . . . . 63.52 110.972 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.78 21.97 9.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 63.41 110.866 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -144.51 21.95 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.4 110.889 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.27 145.86 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.52 111.184 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -102.56 -28.2 12.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 61.43 110.876 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -163.95 128.98 2.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 64.54 111.106 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.747 ' CG1' HD12 ' A' ' 218' ' ' LEU . 95.2 t -107.1 126.3 63.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 75.33 111.131 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.912 HG21 HD11 ' A' ' 44' ' ' LEU . 50.4 t -109.91 106.12 57.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.646 0.736 . . . . 73.13 111.102 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.75 -169.27 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.735 2.29 . . . . 63.35 112.304 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -111.14 -21.7 6.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 61.55 112.406 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -145.69 74.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 75.54 110.905 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.1 -101.75 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 73.52 112.5 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -171.66 140.26 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 74.32 110.83 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.45 143.78 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 61.3 111.142 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.6 -106.19 0.49 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.75 . . . . 63.32 112.489 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -156.22 -169.92 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.349 . . . . 63.13 110.9 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -56.36 -22.37 30.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.866 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.483 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.24 -32.8 51.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 75.33 112.484 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.747 HD12 ' CG1' ' A' ' 206' ' ' VAL . 31.3 mt -50.79 -41.55 57.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 53.02 110.98 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 193' ' ' ILE . 4.3 mm? -56.02 -44.77 79.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 73.22 110.962 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.483 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.1 mt -67.82 -40.48 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 72.23 110.956 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -58.66 -43.76 89.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.831 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.68 -48.36 63.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.22 111.16 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.75 ' HA ' HD12 ' A' ' 226' ' ' LEU . 44.1 mt -54.77 -41.28 70.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.925 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -32.73 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 64.11 110.863 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.21 -25.77 61.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 72.54 110.953 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.75 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.8 mt -87.37 -38.07 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.31 110.936 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 63.42 110.909 179.795 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 18' ' ' ILE . 97.0 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.789 0.328 . . . . 74.25 111.147 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.643 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.6 mm -94.64 153.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 64.31 111.167 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -148.84 156.29 42.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 72.34 110.846 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.45 -169.58 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.87 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 -23.49 52.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.874 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.9 p -101.79 -35.13 9.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.042 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.62 -5.13 51.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 52.31 112.478 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.78 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.49 -33.28 20.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 74.34 111.214 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.78 HG13 HG23 ' A' ' 15' ' ' THR . 6.3 mt -128.55 159.92 39.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 63.13 111.052 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -175.52 169.33 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.24 110.929 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -131.63 -174.13 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 64.02 111.137 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.467 ' HA ' HG22 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -169.38 131.7 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 65.04 110.894 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.52 119.09 14.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 70.02 110.916 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.56 HD21 HG21 ' A' ' 213' ' ' VAL . 4.1 mp -107.94 -33.9 7.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 72.41 110.918 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -149.22 -178.1 6.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 72.02 110.813 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -51.06 -41.01 59.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 65.42 110.861 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -139.93 38.6 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 73.11 110.882 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 22' ' ' ASN . 15.0 t -137.88 116.05 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 72.23 111.135 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -123.98 155.59 37.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 73.12 110.89 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.53 HG23 HD13 ' A' ' 21' ' ' LEU . 29.6 t -117.29 108.6 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 71.31 111.115 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.559 ' HB3' HG23 ' A' ' 18' ' ' ILE . 8.2 p80 -101.57 138.39 38.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 72.41 110.861 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.3 m -135.2 140.66 45.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 74.23 111.217 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HB3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -131.27 174.17 10.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 74.5 110.897 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 40' ' ' PRO . 5.2 tp -119.48 148.53 43.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.34 110.896 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 73.14 112.477 179.917 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.628 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.4 p . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.584 0.707 . . . . 71.41 111.153 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.5 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.1 Cg_endo -69.81 146.97 61.51 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.712 2.275 . . . . 74.14 112.317 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -134.55 98.19 4.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 51.23 110.904 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -51.99 168.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 61.13 110.887 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.635 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -167.68 -163.36 21.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 70.11 112.483 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.902 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -164.22 145.98 8.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.857 0.36 . . . . 63.41 110.917 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.636 HG22 HD13 ' A' ' 54' ' ' LEU . 59.3 t -131.05 140.77 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 74.02 111.14 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.472 HD13 ' HG2' ' A' ' 138' ' ' MET . 39.2 mt -108.0 128.17 54.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 62.41 110.909 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -97.26 55.25 1.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.908 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.525 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.8 p -60.36 -170.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 64.51 111.1 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.6 6.49 16.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 71.24 110.848 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -118.32 -18.75 9.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 70.44 110.925 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.76 130.54 1.31 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.823 -0.703 . . . . 41.14 112.543 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.746 HD13 ' HB ' ' A' ' 71' ' ' VAL . 14.1 mt -49.37 153.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.923 0.392 . . . . 65.45 110.877 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.576 HG13 ' HB2' ' A' ' 81' ' ' ASP . 93.8 t -136.96 143.23 35.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.158 -0.474 . . . . 73.15 111.11 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.636 HD13 HG22 ' A' ' 45' ' ' VAL . 3.5 mm? -114.88 128.44 56.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.2 110.816 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 55' ' ' VAL . 13.6 t -78.45 -2.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 64.13 111.147 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -179.47 131.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 54.25 110.89 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.55 -167.31 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 60.1 110.906 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -173.14 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 63.11 110.889 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.648 ' HB2' HD13 ' A' ' 63' ' ' LEU . 85.6 m95 -71.0 -38.51 72.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 75.41 110.93 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -141.72 161.64 37.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.802 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.51 -33.02 69.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.34 110.92 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -75.3 -25.58 58.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.869 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -81.7 -43.65 18.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 72.11 110.879 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.8 t -65.48 -23.35 66.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.174 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -53.81 -43.26 69.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 70.11 110.887 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.72 -15.73 55.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 74.41 110.941 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.461 HD22 ' OE2' ' A' ' 30' ' ' GLU . 21.6 tp -77.8 -50.17 12.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.491 . . . . 73.44 110.894 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.0 mt -71.93 -15.39 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 55.24 111.111 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -88.71 10.35 21.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 70.33 110.895 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.8 mmm -109.88 -55.56 2.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.913 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.746 ' HB ' HD13 ' A' ' 52' ' ' LEU . 17.0 m -57.55 -37.19 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 74.31 111.141 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.44 50.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 71.32 110.913 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.57 -39.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 74.52 110.865 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.643 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -110.9 -21.25 12.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.863 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.555 ' CB ' HD21 ' A' ' 52' ' ' LEU . 29.0 m-85 -90.62 12.67 18.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 63.31 110.89 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.522 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 2.1 pp0? 31.5 49.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.52 110.949 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.0 -176.54 5.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 75.03 110.962 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.629 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -133.98 152.26 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 63.44 110.863 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 52' ' ' LEU . 82.7 t -85.29 125.56 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 64.23 111.192 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.629 HG23 ' HD3' ' A' ' 78' ' ' ARG . 74.3 p -136.0 16.62 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 61.21 111.127 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.576 ' HB2' HG13 ' A' ' 53' ' ' VAL . 1.4 m-20 -150.02 134.92 17.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 74.51 110.898 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.623 HG21 ' CD2' ' A' ' 98' ' ' LEU . 24.6 t -139.3 99.01 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 74.35 111.034 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.8 mt -76.29 126.54 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 55.22 111.203 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 91' ' ' ARG . 40.8 mm -113.55 133.34 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 64.01 111.131 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -90.11 -54.89 3.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 72.41 111.134 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -134.38 165.78 24.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.848 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.692 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -84.79 98.32 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 40.33 111.133 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.654 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.75 159.44 43.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 71.12 110.848 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.23 -28.71 63.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 65.53 111.058 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.98 10.72 22.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 70.31 110.855 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HB3' HG23 ' A' ' 84' ' ' ILE . 1.9 mmp_? -122.67 -52.03 1.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 65.45 110.908 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -116.39 17.45 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 63.11 111.11 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.96 -26.53 27.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.701 -0.761 . . . . 63.23 112.442 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.93 18.46 31.42 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.77 -0.729 . . . . 63.52 112.5 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.435 HG21 ' H ' ' A' ' 121' ' ' GLU . 5.2 tt -48.93 -30.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.834 0.35 . . . . 72.2 111.077 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -67.96 -43.65 78.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 55.13 110.931 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.4 m -69.78 -34.09 73.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 74.52 111.072 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.623 ' CD2' HG21 ' A' ' 82' ' ' VAL . 55.8 mt -63.47 -28.2 69.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 70.33 110.895 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.95 19.49 14.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.922 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -117.33 -21.9 8.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 71.2 110.896 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -113.08 8.8 18.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 71.41 110.88 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.2 16.92 65.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 61.44 112.481 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 98' ' ' LEU . 13.9 mt -82.43 156.96 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 71.52 111.159 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.762 ' HB2' HD11 ' A' ' 124' ' ' LEU . 13.3 ptpt -120.65 122.86 41.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 55.22 110.891 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.483 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -90.58 78.42 6.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 71.11 111.061 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.617 ' HA ' HD12 ' A' ' 124' ' ' LEU . 88.6 m-70 -51.71 146.21 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 33.33 110.866 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.49 163.71 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 72.42 110.814 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -80.19 156.32 26.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 72.21 111.122 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.83 -27.03 27.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 53.0 111.091 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 152' ' ' ASP . 6.9 tp -74.95 -45.89 39.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 73.44 110.954 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.692 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 91.8 m -52.96 -28.1 22.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 60.13 111.142 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -84.08 -29.76 26.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 62.31 111.015 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -58.89 -31.12 68.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.409 . . . . 75.32 110.913 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.674 HD13 ' OD1' ' A' ' 152' ' ' ASP . 7.4 mp -93.55 -25.47 17.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.129 -0.487 . . . . 63.45 110.837 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.71 -65.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 65.34 111.135 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -56.59 -25.02 51.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 52.24 110.877 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -24.52 65.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 74.33 110.882 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -96.03 -28.22 14.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.881 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.23 -5.53 7.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 71.23 112.507 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -59.58 -173.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.826 0.346 . . . . 73.11 110.969 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.435 ' H ' HG21 ' A' ' 95' ' ' ILE . 40.7 mm-40 -99.75 1.17 43.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 71.31 110.888 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.523 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 0.9 OUTLIER 65.87 122.65 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 75.35 110.857 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -170.65 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.707 2.271 . . . . 61.44 112.39 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.762 HD11 ' HB2' ' A' ' 104' ' ' LYS . 58.5 mt -51.76 -39.25 58.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 71.52 110.922 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.0 37.3 44.79 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 64.45 112.45 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -132.89 48.44 2.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 64.11 110.836 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.52 -169.64 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.299 -0.409 . . . . 72.33 110.884 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -149.99 -169.05 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 72.12 110.919 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.8 HG23 ' HB3' ' A' ' 144' ' ' TYR . 94.6 m -50.63 -63.95 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 74.31 111.143 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.734 HG23 HG22 ' A' ' 129' ' ' THR . 86.1 t -124.26 112.03 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 54.13 111.108 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.0 m -121.35 111.34 17.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.05 111.111 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -67.25 90.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 74.02 110.884 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.451 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 64.25 110.884 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.525 ' HB2' HG22 ' A' ' 48' ' ' THR . 6.2 tpp . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.811 0.339 . . . . 71.53 110.977 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.72 116.25 18.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.302 -0.408 . . . . 71.43 110.946 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.63 151.55 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 70.35 111.204 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -148.81 117.45 6.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 61.11 110.839 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.732 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -70.47 -178.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 35.31 111.132 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.629 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.5 t80 -175.29 136.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 64.41 110.857 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.8 ' HB3' HG23 ' A' ' 129' ' ' THR . 31.6 t80 -118.24 92.66 43.39 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.715 0.769 . . . . 75.33 110.905 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -48.56 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.717 2.278 . . . . 73.2 112.407 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.04 -177.67 43.27 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 64.21 112.452 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -76.78 125.57 29.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.799 0.333 . . . . 73.31 110.926 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.518 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -136.28 -91.06 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 74.21 112.502 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -73.64 -30.73 63.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.367 . . . . 72.21 110.862 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.79 158.6 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 72.14 111.144 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -61.06 -27.66 68.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 72.14 110.893 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.674 ' OD1' HD13 ' A' ' 114' ' ' LEU . 11.7 p30 -119.6 50.07 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 75.41 110.851 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.8 OUTLIER -98.07 137.62 36.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 73.41 110.88 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.732 HD12 HG22 ' A' ' 142' ' ' THR . 12.5 pt -139.01 168.82 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 63.11 111.096 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.498 ' CG1' HD22 ' A' ' 169' ' ' LEU . 7.8 m -119.3 144.71 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 72.15 111.156 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.17 144.08 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 70.03 111.138 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -130.09 147.66 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.951 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.487 HD12 ' HB ' ' A' ' 163' ' ' ILE . 16.9 mt -124.78 96.62 40.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.616 0.722 . . . . 61.53 110.946 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 72.5 1.43 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.78 2.32 . . . . 73.42 112.273 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.12 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 74.13 110.943 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.482 ' CB ' HD13 ' A' ' 163' ' ' ILE . 4.4 m-85 -117.75 -13.91 10.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.952 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.5 m120 68.99 26.13 5.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.094 -0.503 . . . . 53.44 110.904 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.498 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -97.87 114.14 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 71.33 111.138 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.93 136.96 37.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.854 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.55 HG21 HD22 ' A' ' 44' ' ' LEU . 16.5 t -119.42 64.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 62.15 111.182 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.94 -54.5 25.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 54.12 112.477 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.26 -135.51 12.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.748 . . . . 74.22 112.467 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.5 m -60.89 -19.29 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 42.5 110.876 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.498 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.9 OUTLIER -66.93 -50.57 61.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.901 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.707 HG11 HG11 ' A' ' 206' ' ' VAL . 24.7 t -89.05 130.02 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 71.11 111.193 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.64 149.5 24.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 54.0 110.939 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.624 ' HA ' HD22 ' A' ' 218' ' ' LEU . 12.6 p -75.03 162.5 28.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 61.2 110.879 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.612 HG23 HD23 ' A' ' 218' ' ' LEU . 7.3 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 53.15 111.15 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.516 HG11 ' CG2' ' A' ' 186' ' ' VAL . 16.8 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.794 0.331 . . . . 74.53 111.087 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.61 -36.24 82.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 75.33 111.125 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -116.18 37.73 3.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.877 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -139.64 166.78 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 74.02 111.071 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -113.54 92.66 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 72.03 110.888 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.516 ' CG2' HG11 ' A' ' 181' ' ' VAL . 92.5 t -69.63 -23.21 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 72.25 111.155 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -25.3 38.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 62.23 110.886 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.34 -24.21 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 55.34 110.841 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -51.5 -53.9 32.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.463 . . . . 74.2 110.877 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 99.2 p -52.32 -35.44 50.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 54.13 110.856 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.2 m -73.58 -36.68 65.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 51.34 111.169 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.1 m -64.5 -54.12 37.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.812 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.753 HG22 HD23 ' A' ' 197' ' ' LEU . 31.6 mm -57.2 -41.26 77.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 75.02 111.126 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -60.85 -19.54 60.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 75.01 110.912 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -93.03 -29.61 15.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 54.21 110.914 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.403 ' CG1' HD21 ' A' ' 219' ' ' LEU . 59.4 t -81.42 -23.73 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 71.52 111.115 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.753 HD23 HG22 ' A' ' 193' ' ' ILE . 2.6 pp -97.25 -1.16 45.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 75.24 110.97 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -121.2 -6.67 9.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 61.5 110.879 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -89.77 -24.25 21.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.897 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -118.3 -67.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 71.21 110.925 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 63.41 27.46 15.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 72.44 110.873 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -151.47 23.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.836 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.41 HG21 HG22 ' A' ' 206' ' ' VAL . 3.4 mp -62.95 145.42 13.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 73.0 111.168 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -104.0 -26.45 12.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.31 110.902 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.498 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -161.24 128.73 4.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 53.01 111.1 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.707 HG11 HG11 ' A' ' 170' ' ' VAL . 71.9 t -108.86 124.51 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 71.31 111.058 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.902 HG21 HD11 ' A' ' 44' ' ' LEU . 48.6 t -108.99 104.38 54.77 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 121.558 0.694 . . . . 54.5 111.114 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.4 Cg_endo -69.76 -170.6 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.705 2.27 . . . . 65.43 112.369 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -103.27 -26.07 7.12 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.721 -0.752 . . . . 61.23 112.474 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -144.0 86.37 1.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 63.44 110.846 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 167.88 -102.76 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 40.24 112.457 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -169.62 158.94 7.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.885 0.374 . . . . 70.14 110.921 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.643 HG22 HG22 ' A' ' 207' ' ' VAL . 41.4 t -66.82 147.85 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 62.12 111.04 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -152.34 -107.12 0.32 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.774 -0.727 . . . . 71.32 112.526 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -159.13 -169.93 2.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 74.2 110.835 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -56.67 -21.79 30.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 65.35 110.892 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.749 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.98 -33.8 57.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.776 -0.726 . . . . 65.14 112.44 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 172' ' ' SER . 32.1 mt -50.79 -46.84 59.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.858 0.361 . . . . 71.12 110.912 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.552 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mp -54.12 -42.76 69.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 64.42 110.927 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.749 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.6 mt -67.07 -41.31 86.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 75.14 110.907 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.18 -36.54 82.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 75.3 110.849 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -45.64 83.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 43.55 111.07 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.803 ' HA ' HD12 ' A' ' 226' ' ' LEU . 2.5 mt -56.6 -40.21 74.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 73.03 110.994 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -41.05 77.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.55 110.825 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.09 -25.99 68.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 62.34 110.935 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.803 HD12 ' HA ' ' A' ' 223' ' ' LEU . 6.1 mt -85.52 -43.08 13.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 70.2 110.913 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.85 179.867 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 18' ' ' ILE . 89.6 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.762 0.315 . . . . 45.31 111.132 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.722 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.9 mm -91.23 153.97 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 53.44 111.105 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -145.81 146.09 31.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.893 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.4 164.33 21.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 71.45 110.894 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -51.94 -36.98 51.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.87 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.48 -27.87 22.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 40.12 111.091 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.05 -12.84 68.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.784 -0.722 . . . . 72.44 112.575 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.724 HG23 HG13 ' A' ' 16' ' ' ILE . 2.0 t -51.09 -32.6 22.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 74.14 111.191 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.724 HG13 HG23 ' A' ' 15' ' ' THR . 14.7 mt -121.42 147.86 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 64.13 111.094 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.7 p -166.19 169.61 14.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 64.42 110.873 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.518 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -136.52 -176.49 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 54.41 111.114 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 18' ' ' ILE . 6.1 t -166.09 135.33 3.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 61.42 110.867 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.48 117.79 13.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 73.03 110.858 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HG ' HG23 ' A' ' 27' ' ' VAL . 2.2 mm? -102.02 -45.59 5.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 63.32 110.942 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -142.27 -169.43 2.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.833 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -50.65 -51.08 52.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.855 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -132.34 37.99 3.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 75.14 110.816 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 t -133.91 122.06 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.31 111.19 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.76 159.06 35.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.866 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.983 HG21 HG21 ' A' ' 213' ' ' VAL . 69.5 t -119.42 107.9 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 64.34 111.173 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.518 ' HB3' HG23 ' A' ' 18' ' ' ILE . 4.0 p80 -102.32 142.02 34.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 72.31 110.828 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 m -140.06 130.73 25.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 74.14 111.159 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.93 171.36 8.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.862 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 40' ' ' PRO . 5.2 tp -117.17 147.27 42.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.894 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.688 -0.768 . . . . 71.31 112.432 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.476 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.2 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.595 0.712 . . . . 72.44 111.113 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.524 ' HA ' HD12 ' A' ' 31' ' ' LEU . 54.0 Cg_endo -69.78 148.41 64.89 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.691 2.261 . . . . 44.54 112.381 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -134.44 100.0 4.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 54.45 110.855 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.483 HD21 ' N ' ' A' ' 212' ' ' GLU . 24.0 m-20 -51.86 169.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 75.43 110.899 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.8 -173.19 39.12 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.705 -0.76 . . . . 74.25 112.449 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.047 HD13 HG21 ' A' ' 207' ' ' VAL . 3.9 tp -156.92 140.81 16.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.905 0.383 . . . . 73.23 110.907 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.719 HG22 HD13 ' A' ' 54' ' ' LEU . 21.4 t -125.51 132.01 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 72.32 111.178 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 41.5 mt -97.15 128.89 44.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 75.04 110.964 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.73 57.65 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 65.31 110.95 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 p -67.19 165.62 15.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 71.25 111.097 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.89 25.81 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.864 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -147.25 28.61 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 74.42 110.881 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.33 123.25 4.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 42.32 112.472 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' A' ' 75' ' ' PHE . 33.1 mt -51.28 159.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 74.13 110.903 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 81' ' ' ASP . 59.6 t -140.18 140.03 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.132 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.719 HD13 HG22 ' A' ' 45' ' ' VAL . 3.0 mm? -114.07 129.86 56.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.964 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.8 t -81.18 0.13 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.13 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -177.68 129.69 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.837 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -166.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.905 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.71 -169.9 2.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.247 -0.433 . . . . 73.03 110.884 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.779 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.4 m95 -74.81 -36.48 62.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 73.42 110.955 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -144.62 164.3 31.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 53.43 110.873 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.13 -34.57 72.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 54.22 110.888 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -74.88 -24.25 58.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 54.15 110.889 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -83.41 -41.14 18.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 73.11 110.927 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.3 t -70.13 -26.45 63.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 70.04 111.103 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -54.13 -42.64 69.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 74.55 110.891 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -83.49 -14.2 52.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 72.54 110.86 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.417 ' HB2' HD13 ' A' ' 16' ' ' ILE . 32.8 tp -77.03 -46.13 24.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 52.34 110.924 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.3 -31.93 40.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 74.04 111.135 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.78 -25.55 68.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 70.21 110.965 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.4 mmm -76.37 -58.84 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 61.22 110.873 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.705 ' HB ' HD13 ' A' ' 52' ' ' LEU . 33.9 m -56.23 -33.35 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 73.11 111.074 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -88.56 48.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 74.45 110.885 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -144.36 -41.82 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 53.14 110.895 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.722 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.64 -25.65 13.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 72.01 110.875 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.716 ' HB3' HD21 ' A' ' 52' ' ' LEU . 36.5 m-85 -88.94 9.22 25.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 74.53 110.851 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.5 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.86 46.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 75.0 110.896 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -147.15 -176.71 5.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 62.44 110.937 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.64 130.88 37.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 70.33 110.896 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.626 HG22 ' HB2' ' A' ' 52' ' ' LEU . 66.4 t -66.46 129.33 30.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 64.04 111.093 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.5 p -138.07 19.74 2.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 44.04 111.141 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.593 ' HB2' HG22 ' A' ' 53' ' ' VAL . 7.4 m-20 -154.18 129.35 9.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 43.43 110.829 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.426 HG11 ' CD1' ' A' ' 98' ' ' LEU . 24.9 t -133.84 98.15 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 63.33 111.169 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -74.64 124.9 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 71.03 111.198 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.613 HG23 ' HB3' ' A' ' 91' ' ' ARG . 38.7 mm -111.07 127.14 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 65.33 111.126 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.5 p -83.86 -53.47 5.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 74.0 111.075 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -135.6 168.39 19.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 73.25 110.895 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -87.82 100.41 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 63.35 111.087 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.669 ' O ' HD13 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -154.71 161.03 41.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 72.11 110.881 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.06 -27.72 61.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 71.14 111.04 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.23 13.8 16.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 33.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.613 ' HB3' HG23 ' A' ' 84' ' ' ILE . 1.1 mmt180 -127.11 -51.24 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 70.21 110.831 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.669 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -118.52 15.28 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 63.52 111.138 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.19 -33.84 31.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.736 -0.745 . . . . 44.22 112.439 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.93 17.68 44.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.757 -0.735 . . . . 62.45 112.461 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.565 HG21 ' H ' ' A' ' 121' ' ' GLU . 9.9 tt -46.03 -31.33 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 71.31 111.172 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -55.19 23.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.95 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.7 m -59.38 -41.73 90.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 64.41 111.14 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.464 ' HA ' HD12 ' A' ' 103' ' ' ILE . 31.7 mt -55.9 -30.0 60.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.912 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.49 24.27 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 64.1 110.856 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -116.93 -26.18 6.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 75.11 110.869 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -104.59 -22.2 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 61.11 110.832 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.67 14.28 4.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 52.01 112.501 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.7 mt -82.07 155.84 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.89 0.376 . . . . 52.32 111.159 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.554 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.8 OUTLIER -120.57 120.1 34.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 51.14 110.905 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.89 81.14 8.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 74.45 111.061 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.521 ' HA ' HD12 ' A' ' 124' ' ' LEU . 92.1 m-70 -55.04 147.28 16.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 50.13 110.853 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.44 161.78 0.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 44.14 110.851 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.557 HG22 ' HB3' ' A' ' 127' ' ' LEU . 19.9 p -85.64 161.07 19.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 75.23 111.135 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.35 -47.25 62.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 63.1 111.074 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.617 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -59.22 -44.45 92.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 62.44 110.984 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.671 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 80.4 m -53.03 -46.17 68.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 64.14 111.111 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.98 -21.99 61.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 74.34 111.103 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.12 -38.38 76.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 71.05 110.903 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.616 HD12 ' OD2' ' A' ' 152' ' ' ASP . 8.0 mt -87.52 -27.66 22.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 71.42 110.954 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.61 -65.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 72.44 111.141 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -26.09 38.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 75.03 110.875 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -23.07 66.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 73.1 110.927 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -96.88 -38.36 9.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 60.21 110.896 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.98 -1.64 5.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 53.24 112.501 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -59.75 -172.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 73.3 110.915 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.565 ' H ' HG21 ' A' ' 95' ' ' ILE . 23.9 mm-40 -94.8 -2.28 51.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 54.33 110.864 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 65.96 126.19 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.634 0.73 . . . . 74.21 110.897 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -170.91 0.42 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.71 2.273 . . . . 72.43 112.332 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 104' ' ' LYS . 51.5 mt -52.59 -38.43 60.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 72.4 110.915 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.98 43.81 55.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 75.44 112.584 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -139.17 57.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.768 0.318 . . . . 74.51 110.837 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.557 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -137.36 -171.63 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 62.01 110.93 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.43 -168.56 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 71.35 110.891 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.829 HG23 ' HB3' ' A' ' 144' ' ' TYR . 75.1 m -50.0 -64.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.23 111.11 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.765 HG22 ' HA ' ' A' ' 143' ' ' PHE . 58.4 t -122.49 111.1 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 64.13 111.124 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.631 HG22 HD23 ' A' ' 133' ' ' LEU . 68.5 m -111.61 114.15 27.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 70.51 111.176 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -75.14 101.02 4.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 53.42 110.881 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.631 HD23 HG22 ' A' ' 131' ' ' THR . 1.9 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 70.2 110.926 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.83 0.348 . . . . 63.44 110.872 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 121.61 28.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.423 . . . . 72.43 110.976 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.73 HG13 HD23 ' A' ' 158' ' ' LEU . 5.0 t -130.14 158.71 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 61.42 111.177 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 75.7 tt0 -154.38 117.4 4.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 53.12 110.895 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.699 ' O ' HG13 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -69.38 -177.86 1.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.15 111.139 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.765 ' HA ' HG22 ' A' ' 130' ' ' VAL . 82.4 t80 -175.65 136.53 0.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 63.33 110.857 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.829 ' HB3' HG23 ' A' ' 129' ' ' THR . 27.2 t80 -117.13 94.49 45.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 74.12 110.89 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -48.92 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.719 2.279 . . . . 63.51 112.384 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.69 -166.33 39.55 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.697 -0.763 . . . . 54.22 112.439 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -88.03 123.94 33.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.827 0.346 . . . . 65.33 110.879 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.668 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -134.06 -86.4 0.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 72.24 112.485 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -81.29 -26.02 36.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 75.15 110.897 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.52 157.02 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 73.1 111.14 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -64.17 -23.72 67.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 53.24 110.899 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.617 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -125.78 55.09 1.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 74.12 110.848 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.564 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.9 p30 -102.97 143.15 32.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 54.12 110.876 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.643 HD12 HG22 ' A' ' 142' ' ' THR . 11.2 pt -142.53 171.22 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 52.23 111.164 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.7 m -120.47 143.58 31.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.109 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.455 ' O ' HD22 ' A' ' 164' ' ' LEU . 68.6 t -100.11 129.07 51.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 61.43 111.144 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -115.76 145.41 42.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.261 -0.427 . . . . 71.23 110.926 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.73 HD23 HG13 ' A' ' 140' ' ' VAL . 23.6 mt -120.76 96.84 48.69 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.585 0.707 . . . . 70.1 110.967 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 70.16 1.54 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.689 2.259 . . . . 70.34 112.396 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.24 -33.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.992 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.56 ' CB ' HD13 ' A' ' 163' ' ' ILE . 10.2 m-85 -116.93 -12.41 10.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 73.53 110.876 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.05 19.74 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 61.24 110.896 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.624 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.7 mp -86.54 114.4 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 74.21 111.141 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.5 tm? -99.19 122.82 42.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.922 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.827 HG21 HD22 ' A' ' 44' ' ' LEU . 40.4 t -115.29 74.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 72.35 111.155 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.29 -50.28 51.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 63.51 112.553 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.08 -140.94 15.48 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 64.43 112.565 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 39.4 m -58.02 -21.99 47.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 70.24 110.863 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.564 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.0 OUTLIER -63.1 -48.63 77.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 72.03 110.912 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.642 HG11 HG11 ' A' ' 206' ' ' VAL . 22.8 t -90.77 126.58 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 73.11 111.149 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.51 144.7 25.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 64.13 110.887 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.693 ' HA ' HD22 ' A' ' 218' ' ' LEU . 6.8 p -72.4 163.99 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 62.43 110.825 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.548 HG23 HD23 ' A' ' 218' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.194 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 184' ' ' ALA . 33.4 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.86 0.362 . . . . 73.52 111.181 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.04 -40.44 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 71.53 111.097 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.65 40.65 3.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 75.02 110.92 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -129.9 173.45 10.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 73.4 111.098 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -121.11 89.01 3.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 74.41 110.971 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.601 ' CG2' HG21 ' A' ' 181' ' ' VAL . 21.7 t -69.28 -21.14 24.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.073 -0.512 . . . . 62.33 111.116 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.44 -26.81 46.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.52 110.895 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -100.39 -24.42 14.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 71.52 110.911 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.31 -53.79 32.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 65.53 110.902 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 34.3 p -52.0 -34.83 44.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 54.23 110.83 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 54.6 m -77.99 -37.98 46.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 71.25 111.134 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.1 m -59.96 -54.89 40.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.14 110.819 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.642 HG22 HD23 ' A' ' 197' ' ' LEU . 33.0 mm -56.98 -36.87 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 74.21 111.132 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.49 -21.97 66.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 73.44 110.878 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -90.92 -30.36 16.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 63.43 110.817 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.512 ' CG1' HD21 ' A' ' 219' ' ' LEU . 92.4 t -77.18 -40.09 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 74.45 111.034 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.642 HD23 HG22 ' A' ' 193' ' ' ILE . 3.8 pp -75.69 -25.78 57.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 54.11 110.913 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -84.46 -46.84 11.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 62.11 110.861 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -51.99 -30.16 23.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.857 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -138.52 116.9 11.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 70.41 110.868 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -115.26 39.11 3.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 71.31 110.884 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.75 22.03 0.79 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 63.34 110.811 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.465 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.2 mp -51.63 144.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 61.15 111.133 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -103.61 -44.56 5.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 72.22 110.884 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.47 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -151.23 113.4 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 41.32 111.097 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.645 ' CG1' HD12 ' A' ' 218' ' ' LEU . 82.8 t -85.51 125.93 40.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 75.52 111.148 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.047 HG21 HD13 ' A' ' 44' ' ' LEU . 63.0 t -106.9 93.78 9.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.663 0.744 . . . . 74.1 111.085 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.1 Cg_endo -69.75 -171.88 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.667 2.244 . . . . 65.33 112.387 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.66 -25.62 9.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 54.02 112.5 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -145.63 109.68 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.352 . . . . 65.25 110.879 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 145.18 -93.18 0.16 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.668 -0.777 . . . . 70.1 112.482 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.483 ' N ' HD21 ' A' ' 42' ' ' ASN . 14.4 pt-20 -179.69 169.55 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.878 0.371 . . . . 70.41 110.879 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.983 HG21 HG21 ' A' ' 27' ' ' VAL . 98.3 t -80.1 139.94 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 72.41 111.15 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -144.92 -105.94 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 54.33 112.443 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -157.69 -171.5 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.848 0.356 . . . . 74.04 110.848 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -53.37 -24.18 11.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 72.25 110.903 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -52.47 -34.37 42.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 73.22 112.402 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.693 HD22 ' HA ' ' A' ' 172' ' ' SER . 30.9 mt -50.85 -46.21 60.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 63.12 110.923 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.512 HD21 ' CG1' ' A' ' 196' ' ' VAL . 1.1 mt -57.78 -43.62 85.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 73.41 110.926 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.752 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.9 mt -66.36 -41.74 89.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 60.4 110.903 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -63.4 -35.98 82.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 62.54 110.811 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.0 m -58.76 -42.64 89.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 72.22 111.098 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.815 ' HA ' HD12 ' A' ' 226' ' ' LEU . 85.0 mt -60.14 -38.9 84.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 74.21 110.864 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -27.87 65.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 70.13 110.795 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 8.4 mt -77.53 -25.95 50.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 63.21 110.922 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 223' ' ' LEU . 1.9 mt -88.2 -27.43 21.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.904 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 64.42 110.883 179.815 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 18' ' ' ILE . 92.0 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.774 0.321 . . . . 64.04 111.11 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.727 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.0 mm -93.1 157.79 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 72.3 111.152 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.54 149.26 34.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 73.41 110.908 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.16 167.4 21.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 71.51 110.942 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 13' ' ' THR . 7.4 pt-20 -55.87 -32.47 63.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.921 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.464 ' OG1' HG22 ' A' ' 15' ' ' THR . 21.0 p -97.13 -29.93 13.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 50.04 111.171 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.2 -11.23 47.93 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 44.23 112.447 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.792 HG23 HG13 ' A' ' 16' ' ' ILE . 3.8 t -51.19 -32.6 24.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.701 0.286 . . . . 73.34 111.156 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.792 HG13 HG23 ' A' ' 15' ' ' THR . 23.3 mt -123.24 151.1 27.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.443 . . . . 73.43 111.105 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.6 p -169.48 163.44 10.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 75.54 110.894 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -130.24 -177.18 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 72.13 111.134 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.486 ' HA ' HG22 ' A' ' 8' ' ' VAL . 3.4 t -166.36 135.37 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 61.11 110.805 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.59 116.99 13.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.117 -0.492 . . . . 74.11 110.904 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.42 -42.21 6.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.914 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.85 -169.91 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.43 110.856 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -49.25 62.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 74.21 110.877 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -133.68 30.37 3.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.859 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.15 118.55 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 62.42 111.123 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -124.09 160.56 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 65.23 110.967 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.14 108.56 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 43.24 111.13 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.606 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.5 p80 -102.38 138.54 39.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 73.5 110.795 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 41' ' ' SER . 32.4 m -136.5 131.74 34.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 74.15 111.069 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.97 -175.68 2.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.2 110.847 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.7 131.56 39.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 75.01 110.978 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.768 -0.729 . . . . 71.51 112.525 179.868 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.593 0.711 . . . . 72.11 111.163 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 149.02 66.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.259 . . . . 70.23 112.321 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 29' ' ' THR . 0.8 OUTLIER -135.46 113.1 10.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 74.2 110.838 -179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.39 168.45 7.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 74.1 110.865 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.509 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -171.16 -169.55 34.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 71.54 112.462 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.996 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -158.94 146.62 17.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 72.54 110.919 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 54' ' ' LEU . 36.5 t -129.5 142.69 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 62.43 111.106 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -110.7 128.76 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 65.32 110.914 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -97.03 51.25 1.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 72.2 110.904 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.8 p -60.06 173.06 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.32 111.127 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 30.3 3.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 63.34 110.847 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -156.59 36.08 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 71.35 110.882 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.65 128.57 6.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 45.11 112.491 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.771 HD13 ' HB ' ' A' ' 71' ' ' VAL . 13.4 mt -58.4 160.62 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 50.32 110.959 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 81' ' ' ASP . 52.8 t -137.51 143.27 34.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.05 111.157 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.557 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -115.69 128.48 55.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 64.33 110.959 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.6 t -78.85 -2.08 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 62.25 111.093 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.45 128.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 75.51 110.851 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -166.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 62.53 110.798 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 m -96.73 -171.43 2.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 73.52 110.843 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.683 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.1 m95 -71.18 -34.82 71.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.959 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -148.64 165.32 31.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 71.41 110.883 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -63.03 -30.12 71.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 64.24 110.868 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -75.34 -22.86 57.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 72.44 110.916 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -84.78 -49.98 7.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 62.34 110.858 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 t -61.27 -25.2 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 63.22 111.178 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -52.86 -39.67 62.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 72.33 110.914 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -85.55 -14.34 46.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 63.34 110.903 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' A' ' 16' ' ' ILE . 13.5 tp -82.49 -45.62 14.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 63.24 110.937 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.8 mt -70.58 -19.36 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 75.14 111.106 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -83.01 -3.39 57.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 73.33 110.921 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.2 mmm -98.9 -51.58 3.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 73.24 110.824 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.771 ' HB ' HD13 ' A' ' 52' ' ' LEU . 29.2 m -58.58 -38.06 68.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.22 111.099 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' HG3' HG23 ' A' ' 71' ' ' VAL . 36.4 mt-10 -88.19 48.06 1.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 64.41 110.848 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 -39.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.872 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.727 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -109.01 -21.86 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 54.02 110.929 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.56 ' HB3' HD21 ' A' ' 52' ' ' LEU . 25.5 m-85 -89.23 11.08 19.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 72.14 110.887 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.515 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.5 pp0? 32.51 47.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 65.35 110.944 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -153.28 -179.83 8.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 71.13 110.904 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 150.92 49.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.11 110.827 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 52' ' ' LEU . 98.0 t -83.18 129.74 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.21 111.1 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.3 p -144.25 31.67 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 65.23 111.085 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.755 ' HB2' HG22 ' A' ' 53' ' ' VAL . 15.5 m-20 -163.62 125.88 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 53.01 110.835 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 103' ' ' ILE . 24.3 t -133.89 98.91 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.5 111.125 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.5 mt -76.87 118.06 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 65.45 111.035 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 91' ' ' ARG . 44.3 mm -104.96 133.18 49.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 72.5 111.108 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.8 p -88.79 -55.93 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.33 111.197 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -133.4 161.74 33.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.894 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -80.71 97.52 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 62.24 111.079 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.631 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -150.73 157.64 43.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 70.1 110.859 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.17 -26.59 60.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 74.22 111.07 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -90.91 13.43 16.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 64.11 110.899 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.424 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.4 mpt_? -127.56 -52.43 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.813 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.631 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.56 16.97 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 71.21 111.129 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.39 -29.39 30.57 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.691 -0.766 . . . . 32.44 112.484 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -107.4 17.34 37.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 42.11 112.451 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.497 HG21 ' H ' ' A' ' 121' ' ' GLU . 8.3 tt -47.0 -31.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 64.5 111.115 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.7 -54.76 23.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 71.3 110.906 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.1 m -56.95 -41.18 77.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 63.45 111.171 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.435 ' CD1' HG21 ' A' ' 82' ' ' VAL . 24.8 mt -60.84 -37.79 83.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 62.04 110.928 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -81.52 -19.23 42.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.22 -0.446 . . . . 73.02 110.943 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -84.73 -39.53 18.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 75.33 110.857 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.53 ' HB2' HD12 ' A' ' 103' ' ' ILE . 2.3 mtp85 -81.4 -40.1 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 72.11 110.829 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.4 -16.28 4.11 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.699 -0.762 . . . . 63.44 112.435 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 82' ' ' VAL . 2.1 mp -57.83 149.17 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.873 0.368 . . . . 74.45 111.111 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.74 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.2 ptpt -109.19 124.56 51.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.45 . . . . 74.55 110.918 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.45 83.23 6.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 74.1 111.127 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.437 ' ND1' HD12 ' A' ' 124' ' ' LEU . 96.3 m-70 -56.95 147.63 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.92 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.85 160.11 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.014 0.435 . . . . 74.13 110.852 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.638 HG22 ' HB3' ' A' ' 127' ' ' LEU . 19.9 p -78.72 159.56 27.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 65.34 111.174 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.58 -36.78 46.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 55.21 111.038 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 152' ' ' ASP . 8.6 tp -71.57 -48.75 46.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 74.23 110.912 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.76 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 77.8 m -51.79 -29.09 17.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 74.02 111.128 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.586 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -87.82 -31.8 19.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 72.43 111.085 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -56.17 -44.43 79.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.932 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.641 HD12 ' OD2' ' A' ' 152' ' ' ASP . 44.6 mt -76.82 -23.03 52.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.41 110.934 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.27 -65.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 64.53 111.101 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -27.62 33.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.856 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -24.38 66.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 72.11 110.946 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -95.69 -37.48 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 52.52 110.877 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.68 -3.28 4.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 65.41 112.477 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -59.45 -173.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.312 . . . . 72.4 110.945 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.497 ' H ' HG21 ' A' ' 95' ' ' ILE . 16.4 mm-40 -97.03 -0.82 46.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 75.31 110.947 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 65.95 126.0 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.677 0.751 . . . . 72.05 110.887 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.586 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.1 Cg_endo -69.69 -170.05 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.657 2.238 . . . . 73.05 112.379 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' A' ' 104' ' ' LYS . 56.6 mt -55.33 -35.58 65.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 73.41 110.879 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.96 54.26 29.61 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 54.12 112.434 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -147.39 54.32 1.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.886 0.374 . . . . 72.43 110.931 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.638 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.2 OUTLIER -132.28 -172.19 2.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 72.05 110.86 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.2 -167.9 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.917 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.756 HG23 ' HB3' ' A' ' 144' ' ' TYR . 97.8 m -49.3 -41.77 39.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 75.53 111.126 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 m -144.31 137.43 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.092 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 HD23 ' A' ' 133' ' ' LEU . 39.2 m -142.66 107.39 4.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 70.42 111.132 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -71.56 99.41 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 64.24 110.91 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.637 HD23 HG22 ' A' ' 131' ' ' THR . 2.6 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.963 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.502 ' HB2' HG22 ' A' ' 48' ' ' THR . 54.6 tpp . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.809 0.338 . . . . 71.04 110.875 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.1 mmpm? -121.91 126.72 49.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 74.33 110.86 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.616 HG13 HD23 ' A' ' 158' ' ' LEU . 4.1 t -141.75 159.67 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 75.31 111.195 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.415 ' N ' HG12 ' A' ' 140' ' ' VAL . 25.6 tt0 -161.09 123.72 3.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.049 0.452 . . . . 71.52 110.839 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.92 179.92 4.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.507 . . . . 62.33 111.095 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -173.71 137.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.895 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.756 ' HB3' HG23 ' A' ' 129' ' ' THR . 65.3 t80 -116.24 94.94 43.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.687 0.756 . . . . 65.41 110.898 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -48.66 0.66 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.741 2.294 . . . . 60.13 112.239 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.73 -164.67 38.25 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.742 -0.742 . . . . 75.53 112.514 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -86.52 118.71 26.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.785 0.326 . . . . 72.33 110.899 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.517 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -129.97 -98.4 0.84 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.679 -0.772 . . . . 73.51 112.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -69.86 -26.74 64.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 52.14 110.867 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.61 159.42 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 60.31 111.163 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -66.09 -23.97 66.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.949 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.641 ' OD2' HD12 ' A' ' 114' ' ' LEU . 9.3 p30 -123.17 53.09 1.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.904 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.548 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.7 p30 -102.41 149.32 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 31.22 110.9 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.4 pt -150.03 161.88 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.23 111.172 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 196' ' ' VAL . 14.1 m -108.46 150.5 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 72.35 111.131 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.47 ' O ' HD22 ' A' ' 164' ' ' LEU . 67.1 t -104.23 125.44 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 54.13 111.201 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.461 ' O ' HD23 ' A' ' 158' ' ' LEU . 73.0 t-105 -111.7 150.63 29.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.12 110.92 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.616 HD23 HG13 ' A' ' 140' ' ' VAL . 35.2 mt -126.53 96.15 36.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.718 . . . . 64.32 110.878 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 71.23 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 75.25 112.329 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.12 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.885 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.609 ' CB ' HD13 ' A' ' 163' ' ' ILE . 5.9 m-85 -118.85 -11.73 9.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 63.21 110.928 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 m120 67.88 22.79 8.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 63.41 110.843 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.609 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.5 mp -88.41 115.06 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 71.2 111.187 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.8 tm? -98.12 126.24 43.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 52.12 110.978 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.598 HG21 HD22 ' A' ' 44' ' ' LEU . 16.5 t -120.71 75.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 61.4 111.138 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.27 -54.79 27.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.762 -0.732 . . . . 72.55 112.503 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 109.39 -134.93 12.53 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.721 -0.752 . . . . 74.5 112.392 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 67.0 m -60.62 -19.07 56.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 72.35 110.861 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.548 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.6 OUTLIER -69.41 -49.19 57.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 72.42 110.907 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.621 HG11 HG11 ' A' ' 206' ' ' VAL . 28.8 t -92.63 127.47 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 71.35 111.201 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.49 152.82 19.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.916 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.568 ' HA ' HD22 ' A' ' 218' ' ' LEU . 4.4 t -73.04 164.59 26.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 72.24 110.896 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.592 HG23 HD23 ' A' ' 218' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.31 111.136 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 184' ' ' ALA . 35.9 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.777 0.322 . . . . 42.2 111.084 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -52.34 -46.9 66.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 55.35 111.134 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -118.66 41.63 2.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.32 110.871 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . . . -126.23 166.13 17.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.115 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -117.86 91.71 3.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 75.05 110.946 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.5 t -67.65 -21.8 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 73.43 111.174 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -82.36 -26.38 32.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 71.24 110.933 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -96.95 -21.76 17.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 71.14 110.861 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -51.1 -51.86 49.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 64.23 110.975 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.5 p -51.95 -35.67 46.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 70.01 110.878 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.7 m -74.1 -38.3 63.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 75.23 111.139 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 34.0 m -61.86 -56.24 21.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.809 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.587 HG21 ' O ' ' A' ' 219' ' ' LEU . 28.8 mm -55.22 -38.67 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.457 . . . . 71.11 111.109 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.406 ' HA ' HD21 ' A' ' 197' ' ' LEU . 7.6 mt-10 -63.82 -25.15 68.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 62.11 110.873 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -85.79 -31.88 22.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 62.13 110.973 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.429 HG21 HG11 ' A' ' 155' ' ' VAL . 99.7 t -73.28 -40.29 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.04 111.138 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.586 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -76.68 -25.33 53.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 71.2 110.931 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.95 -44.23 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 73.15 110.967 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.83 -26.24 67.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 73.34 110.861 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -141.03 117.08 10.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 70.35 110.97 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.96 37.35 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 74.23 110.897 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.15 22.03 1.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 71.53 110.891 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.523 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.4 mp -51.57 145.67 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 71.4 111.113 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -107.67 -29.32 9.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 62.45 110.881 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.43 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -162.71 121.33 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 75.44 111.13 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.621 HG11 HG11 ' A' ' 170' ' ' VAL . 97.6 t -101.88 118.91 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 62.15 111.099 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.996 HG21 HD11 ' A' ' 44' ' ' LEU . 69.8 t -102.9 106.88 52.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.661 0.743 . . . . 72.21 111.07 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.4 Cg_endo -69.78 -170.36 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.657 2.238 . . . . 75.44 112.372 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.85 -26.95 6.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 51.53 112.441 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -143.84 98.14 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 70.45 110.878 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.54 -95.07 0.15 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 61.31 112.491 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -174.34 152.41 1.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.828 0.347 . . . . 33.32 110.922 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.466 ' HB ' HG22 ' A' ' 207' ' ' VAL . 5.9 p -67.38 144.12 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 63.14 111.143 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.67 -105.51 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.716 -0.754 . . . . 72.51 112.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -156.84 -169.61 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.891 0.377 . . . . 65.01 110.861 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -20.43 35.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.212 -0.449 . . . . 63.43 110.88 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.741 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.66 -33.1 62.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.715 -0.755 . . . . 63.25 112.5 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.592 HD23 HG23 ' A' ' 173' ' ' THR . 30.2 mt -50.63 -48.91 57.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 75.54 110.984 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.587 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -54.16 -42.41 69.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 53.1 110.954 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.741 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.0 mt -68.12 -41.26 82.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 62.51 110.862 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.55 ' NE2' HD21 ' A' ' 225' ' ' LEU . 86.0 t60 -66.11 -36.91 84.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 52.32 110.839 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.2 m -54.1 -45.25 71.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.164 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.772 ' HA ' HD12 ' A' ' 226' ' ' LEU . 70.5 mt -57.24 -38.91 74.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.893 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -33.74 74.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 75.5 110.871 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.55 HD21 ' NE2' ' A' ' 221' ' ' HIS . 16.9 mt -67.73 -25.81 65.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 61.51 110.89 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 223' ' ' LEU . 4.4 mt -84.92 -48.99 8.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 71.22 110.92 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.7 mttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 61.4 110.885 179.852 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 18' ' ' ILE . 95.9 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.807 0.337 . . . . 75.31 111.081 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.482 HD11 ' HE3' ' A' ' 74' ' ' LYS . 3.0 mm -89.96 154.23 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 52.51 111.103 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -150.96 163.71 38.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.885 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -91.43 -169.14 2.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 54.41 110.888 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.592 ' HG3' HG23 ' A' ' 13' ' ' THR . 7.0 pt-20 -76.75 -18.46 58.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 62.01 110.846 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 12' ' ' GLU . 22.3 p -108.73 -39.83 5.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 54.4 111.149 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.52 -2.94 29.3 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.692 -0.766 . . . . 34.03 112.432 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.716 HG23 HG13 ' A' ' 16' ' ' ILE . 1.7 t -50.62 -33.53 22.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 63.31 111.127 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.716 HG13 HG23 ' A' ' 15' ' ' THR . 7.6 mt -130.04 159.71 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 64.4 111.096 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.403 ' N ' HG22 ' A' ' 16' ' ' ILE . 74.8 p -175.52 167.55 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 65.1 110.836 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -130.7 -174.77 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 73.12 111.154 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -169.46 129.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 75.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 121.47 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.919 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.8 mm? -105.06 -42.42 5.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.4 110.916 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -146.1 -168.34 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 64.25 110.91 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -51.55 48.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 63.55 110.886 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -132.21 34.24 3.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.917 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.66 122.48 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 73.52 111.145 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -126.91 160.08 32.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.129 -0.487 . . . . 71.44 110.906 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.423 HG23 ' HG ' ' A' ' 21' ' ' LEU . 61.0 t -122.56 111.81 31.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 64.23 111.134 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -100.88 135.97 41.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 64.21 110.855 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 m -130.56 137.65 49.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.51 111.165 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HB3' HG23 ' A' ' 16' ' ' ILE . 2.5 pm0 -133.85 170.09 16.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 65.24 110.925 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.622 HD12 ' HA ' ' A' ' 40' ' ' PRO . 3.8 tp -116.98 148.17 41.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 62.42 110.924 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.764 -0.731 . . . . 75.44 112.494 179.885 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.23 0.049 0 CA-C-O 121.655 0.741 . . . . 64.11 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.622 ' HA ' HD12 ' A' ' 31' ' ' LEU . 52.9 Cg_endo -69.87 157.35 60.46 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.62 2.213 . . . . 75.3 112.34 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.26 112.79 7.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 70.23 110.857 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -76.39 147.49 37.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 70.51 110.909 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.593 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -146.29 -153.81 6.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 63.24 112.526 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.895 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -166.22 142.61 4.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 61.4 110.912 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG22 HD13 ' A' ' 54' ' ' LEU . 47.4 t -127.47 138.85 53.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 65.33 111.124 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.7 mt -102.12 135.11 44.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.957 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -111.75 61.48 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.917 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 138' ' ' MET . 18.1 p -77.95 176.15 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 71.53 111.137 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.14 26.87 3.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 61.34 110.855 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -145.74 24.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 71.04 110.889 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.52 142.08 8.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 72.51 112.455 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.809 HD13 ' HB ' ' A' ' 71' ' ' VAL . 8.8 mt -70.96 162.3 29.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 53.03 110.852 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 81' ' ' ASP . 61.1 t -141.81 144.49 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.33 111.088 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.568 HD13 HG22 ' A' ' 45' ' ' VAL . 3.1 mm? -115.45 128.27 55.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 64.42 110.877 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.6 t -78.62 -2.47 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 63.12 111.104 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p30 179.98 130.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 74.34 110.859 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.06 -167.41 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.895 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.85 -169.69 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 75.12 110.869 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.726 ' HB2' HD13 ' A' ' 63' ' ' LEU . 88.0 m95 -74.36 -37.47 63.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 65.23 110.923 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -142.19 165.68 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 64.42 110.831 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.48 -33.89 74.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 74.45 110.889 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -74.17 -24.76 59.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.957 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.726 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -80.88 -48.36 12.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 61.24 110.939 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -57.57 -26.71 61.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 70.23 111.161 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -42.72 75.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.25 110.933 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -86.92 1.7 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 73.24 110.892 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.516 HD13 HG21 ' A' ' 16' ' ' ILE . 16.7 tp -96.9 -47.7 5.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 64.24 110.899 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.4 mt -70.81 -24.76 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.22 111.104 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -72.74 -12.83 61.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 60.4 110.834 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 30.5 mtp -82.28 -50.41 8.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 61.55 110.855 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.809 ' HB ' HD13 ' A' ' 52' ' ' LEU . 29.1 m -65.94 -40.57 87.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.53 111.142 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG3' HG23 ' A' ' 71' ' ' VAL . 47.4 mt-10 -83.95 51.63 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.913 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 -38.14 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.902 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -111.81 -22.93 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.926 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.63 ' HB3' HD21 ' A' ' 52' ' ' LEU . 24.9 m-85 -87.85 10.86 17.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 65.4 110.888 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.511 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.97 46.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 73.23 110.941 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -151.9 -178.46 6.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 72.12 110.916 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.444 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -129.23 150.87 50.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 54.42 110.838 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 52' ' ' LEU . 98.0 t -86.84 127.57 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 64.44 111.099 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.444 HG23 ' HD3' ' A' ' 78' ' ' ARG . 22.4 p -138.22 25.84 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.116 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.734 ' HB2' HG22 ' A' ' 53' ' ' VAL . 24.3 m-20 -156.89 133.06 9.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.926 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.586 HG21 ' CD2' ' A' ' 98' ' ' LEU . 21.5 t -138.98 99.89 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 62.44 111.128 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.4 mt -76.93 123.23 33.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 64.41 111.141 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 91' ' ' ARG . 43.9 mm -111.65 131.74 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 54.15 111.106 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.487 HG22 HG13 ' A' ' 154' ' ' ILE . 19.5 p -86.96 -58.12 2.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 75.3 111.185 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.629 ' C ' HG23 ' A' ' 111' ' ' THR . 31.4 p-80 -129.92 175.32 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.897 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -93.58 98.09 10.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 74.41 111.103 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.637 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.55 158.54 43.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.885 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.39 -26.72 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 63.12 111.102 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.88 11.48 22.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 72.02 110.827 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.434 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.4 mpt_? -124.88 -52.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 75.1 110.917 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.61 17.35 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.51 111.117 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.36 -27.33 24.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.779 -0.725 . . . . 54.34 112.477 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.8 19.43 28.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 53.25 112.42 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' H ' ' A' ' 121' ' ' GLU . 3.3 tt -48.92 -30.38 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 71.44 111.147 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -69.52 -43.96 71.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 72.44 110.878 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.1 m -68.04 -34.1 75.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 34.34 111.207 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.586 ' CD2' HG21 ' A' ' 82' ' ' VAL . 52.5 mt -63.01 -29.33 70.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.935 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.78 19.67 13.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.02 110.885 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -117.92 -22.73 7.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 62.2 110.825 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -111.69 8.5 20.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 75.32 110.835 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.11 15.56 66.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 64.11 112.455 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 98' ' ' LEU . 14.1 mt -81.58 156.59 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.399 . . . . 65.44 111.143 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.781 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.3 ptpm? -121.86 121.0 36.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.52 110.91 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -87.93 79.98 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 63.13 111.097 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.488 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.8 m-70 -54.67 145.63 18.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 71.32 110.824 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.69 160.71 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 72.1 110.812 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -73.86 -176.64 2.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.511 . . . . 73.22 111.069 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.65 -27.24 45.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 75.31 111.115 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 152' ' ' ASP . 5.5 tp -76.31 -47.88 22.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 71.43 110.933 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.749 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.5 m -54.38 -26.27 29.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 72.34 111.081 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -88.62 -29.29 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 64.51 111.11 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -61.54 -31.29 71.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 72.44 110.855 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.43 HD22 ' OD2' ' A' ' 152' ' ' ASP . 10.2 mp -89.38 -25.4 21.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.34 110.974 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.46 -67.48 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 72.01 111.116 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -26.4 37.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 64.33 110.842 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -24.59 67.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 71.33 110.884 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -94.75 -37.53 11.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.443 . . . . 73.54 110.871 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 138.95 -7.96 3.26 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.753 -0.737 . . . . 72.01 112.476 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.76 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 64.12 110.852 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.476 ' H ' HG21 ' A' ' 95' ' ' ILE . 36.7 mm-40 -99.73 -1.14 38.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 65.21 110.894 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.469 ' C ' HD11 ' A' ' 95' ' ' ILE . 1.6 mt-10 66.41 129.33 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.719 . . . . 60.12 110.859 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.405 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.3 Cg_endo -69.83 -169.66 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.721 2.281 . . . . 63.41 112.3 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 104' ' ' LYS . 76.2 mt -53.45 -43.89 68.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 75.31 110.876 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.44 57.13 19.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.716 . . . . 64.22 112.479 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -152.13 36.51 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 51.41 110.825 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.82 -169.67 1.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 75.24 110.906 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -153.82 -169.06 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 53.32 110.943 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.84 HG23 ' HB3' ' A' ' 144' ' ' TYR . 99.5 m -50.81 -57.8 7.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.146 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.695 HG23 HG22 ' A' ' 129' ' ' THR . 93.7 t -129.54 123.09 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 73.12 111.214 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.556 HG22 HD23 ' A' ' 133' ' ' LEU . 93.6 m -131.54 124.97 31.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.083 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -80.82 103.04 10.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 65.03 110.948 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.556 HD23 HG22 ' A' ' 131' ' ' THR . 2.3 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 73.32 110.934 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.45 ' HB2' HG22 ' A' ' 48' ' ' THR . 30.5 tpp . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.854 0.359 . . . . 70.43 110.873 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -128.52 121.27 28.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 75.42 110.844 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.593 HG13 HD23 ' A' ' 158' ' ' LEU . 12.1 t -131.66 154.55 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.179 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -152.19 125.85 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.849 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.5 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -76.17 -178.19 4.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.482 . . . . 62.11 111.15 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.625 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.0 t80 -175.28 140.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 73.53 110.854 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.84 ' HB3' HG23 ' A' ' 129' ' ' THR . 39.6 t80 -125.22 96.21 39.89 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.639 0.733 . . . . 72.44 110.897 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 54.9 Cg_endo -69.7 -49.02 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.225 . . . . 53.05 112.426 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.73 -155.64 21.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 74.45 112.491 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.48 127.5 42.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 72.4 110.934 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.591 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -138.94 -93.51 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 72.03 112.496 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -69.67 -30.12 67.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.929 0.395 . . . . 61.42 110.879 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.57 160.33 43.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 53.55 111.147 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.82 -23.99 67.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 71.42 110.888 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.455 ' HB3' HD23 ' A' ' 110' ' ' LEU . 6.9 p30 -120.63 45.2 2.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 73.22 110.908 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -94.11 134.34 36.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 50.55 110.893 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.562 HG22 ' CD1' ' A' ' 144' ' ' TYR . 2.0 pt -136.19 171.3 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.116 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.466 ' CG1' HD22 ' A' ' 169' ' ' LEU . 5.9 m -121.85 150.11 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 74.51 111.131 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -103.07 143.48 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 73.1 111.082 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -129.52 150.09 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.928 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.593 HD23 HG13 ' A' ' 140' ' ' VAL . 36.6 mt -127.12 95.04 37.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.67 0.747 . . . . 72.44 110.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 71.96 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.685 2.257 . . . . 33.5 112.367 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.4 110.96 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.532 ' CB ' HD13 ' A' ' 163' ' ' ILE . 5.8 m-85 -118.15 -13.08 9.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 65.24 110.898 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.8 m120 69.26 25.33 5.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 72.22 110.908 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.541 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.6 mp -96.16 116.52 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 55.44 111.185 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.94 138.48 38.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 64.51 110.885 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.557 HG21 HD22 ' A' ' 44' ' ' LEU . 24.9 t -123.22 66.55 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 52.05 111.152 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.6 -54.28 25.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 30.03 112.5 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.48 -135.1 12.41 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.727 -0.749 . . . . 64.41 112.469 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 33.7 m -62.58 -17.04 59.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.85 0.357 . . . . 72.33 110.874 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.485 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.8 OUTLIER -69.87 -51.36 33.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.895 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.617 HG11 HG11 ' A' ' 206' ' ' VAL . 38.8 t -87.48 129.18 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 53.33 111.108 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.02 145.27 29.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 75.45 110.905 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.63 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.6 p -70.3 157.78 37.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 55.15 110.851 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.554 HG23 HD23 ' A' ' 218' ' ' LEU . 6.9 p . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 65.34 111.119 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.853 0.358 . . . . 72.21 111.075 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.27 84.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 65.33 111.148 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.42 39.65 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 62.21 110.856 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -135.53 168.62 18.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 63.13 111.109 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -115.35 91.89 3.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 63.22 110.916 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.413 HG13 HD23 ' A' ' 226' ' ' LEU . 94.3 t -68.71 -23.65 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.04 -0.527 . . . . 75.53 111.098 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -80.38 -25.63 39.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 64.44 110.875 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -97.57 -23.82 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 75.04 110.936 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.43 -56.88 10.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 75.54 110.949 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.7 t -51.89 -35.18 44.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 64.43 110.852 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.2 m -72.94 -33.8 66.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 54.42 111.055 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 57.1 m -68.01 -52.41 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 62.31 110.848 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.88 HG22 HD23 ' A' ' 197' ' ' LEU . 30.4 mm -58.56 -38.26 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 54.22 111.118 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.21 -16.53 60.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 73.1 110.919 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -99.29 -20.5 16.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 62.11 110.905 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.434 ' CG1' HD21 ' A' ' 219' ' ' LEU . 79.1 t -88.85 -25.42 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.13 111.166 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.88 HD23 HG22 ' A' ' 193' ' ' ILE . 2.6 pp -99.24 2.38 45.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 73.33 110.919 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -117.68 -14.59 10.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 70.44 110.89 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -93.28 2.11 56.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 73.03 110.911 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -137.89 -72.39 0.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 74.3 110.914 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 60.56 25.94 15.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 75.24 110.901 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -149.14 23.44 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 64.02 110.853 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -63.53 145.64 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 72.23 111.2 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -102.47 -28.1 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 65.43 110.915 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.408 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -161.3 131.26 4.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 63.23 111.075 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.743 ' CG1' HD12 ' A' ' 218' ' ' LEU . 89.5 t -110.84 123.67 66.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 74.13 111.149 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 44' ' ' LEU . 49.1 t -110.3 103.84 54.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.672 0.749 . . . . 75.44 111.129 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.0 Cg_endo -69.81 -170.78 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.762 2.308 . . . . 70.15 112.314 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -105.48 -22.26 8.26 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 72.44 112.503 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -146.03 86.79 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 71.35 110.892 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 165.25 -99.33 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.705 -0.759 . . . . 62.34 112.47 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -171.75 161.38 5.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 62.53 110.872 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 207' ' ' VAL . 21.4 t -70.5 150.5 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 60.31 111.133 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.12 -107.63 0.28 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 52.41 112.45 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -159.16 -170.04 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 75.4 110.897 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -23.23 26.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 64.05 110.878 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.769 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -53.59 -33.44 48.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.684 -0.77 . . . . 34.33 112.553 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.743 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.8 mt -51.16 -46.56 62.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 74.33 110.913 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.601 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -57.79 -43.7 85.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.949 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.769 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.9 mt -66.46 -41.77 88.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 72.35 110.924 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.682 ' NE2' HD21 ' A' ' 225' ' ' LEU . 84.5 t60 -66.13 -38.79 89.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 74.03 110.847 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.9 m -52.57 -46.46 66.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 71.32 111.178 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.69 ' HA ' HD12 ' A' ' 226' ' ' LEU . 63.8 mt -53.59 -40.49 65.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 73.01 110.911 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -35.25 80.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 61.42 110.858 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.682 HD21 ' NE2' ' A' ' 221' ' ' HIS . 31.5 mt -62.68 -25.91 68.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 74.4 110.882 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 223' ' ' LEU . 1.2 mt -90.12 -42.56 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 43.14 110.899 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 70.42 110.902 179.785 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.574 HG22 ' OG ' ' A' ' 19' ' ' SER . 91.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.756 0.312 . . . . 74.44 111.132 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.727 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.0 mm -88.89 155.92 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 62.43 111.096 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -146.78 156.76 43.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 71.43 110.854 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.35 171.69 10.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.12 110.941 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -58.71 -30.29 67.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 75.53 110.928 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.459 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.6 p -99.46 -32.13 11.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.159 -0.473 . . . . 62.31 111.136 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.06 -8.42 42.08 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 71.21 112.481 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.769 HG23 HG13 ' A' ' 16' ' ' ILE . 2.8 t -51.27 -33.14 27.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 71.12 111.146 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.769 HG13 HG23 ' A' ' 15' ' ' THR . 18.9 mt -124.15 152.6 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 64.31 111.165 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 p -171.93 165.32 6.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 72.23 110.834 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -130.68 -172.49 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 53.5 111.153 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.574 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -173.96 132.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 45.33 110.874 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -67.81 120.71 14.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 64.22 110.9 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.65 -45.47 5.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 75.23 110.967 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -146.09 48.75 1.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.0 110.879 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.502 ' H ' ' NE2' ' A' ' 20' ' ' GLN . 7.3 ttmm 70.59 -70.89 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.832 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -88.31 -23.25 23.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.929 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.82 120.21 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 54.24 111.139 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -123.89 161.01 26.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 70.04 110.852 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.508 HG21 HG21 ' A' ' 213' ' ' VAL . 84.9 t -123.15 107.98 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.13 111.127 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.614 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.8 p80 -101.59 137.68 39.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.44 110.861 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 m -133.12 136.27 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.108 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' OE1' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -128.15 165.16 20.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.411 . . . . 74.1 110.899 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.64 136.49 53.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 63.44 110.931 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.728 -0.749 . . . . 75.43 112.478 179.913 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 60.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.673 0.749 . . . . 43.43 111.178 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.3 Cg_endo -69.7 140.17 42.23 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.706 2.27 . . . . 74.54 112.438 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -122.76 108.58 13.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 71.12 110.848 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -67.88 143.02 55.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 52.33 110.858 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.643 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -141.49 -153.58 5.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 42.52 112.458 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -165.85 145.18 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 62.11 110.904 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.602 HG22 HD13 ' A' ' 54' ' ' LEU . 78.8 t -128.6 137.08 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.24 111.098 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.7 mt -105.11 130.3 53.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.109 -0.496 . . . . 75.1 110.949 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.422 ' HA ' HD23 ' A' ' 52' ' ' LEU . 82.3 m-20 -99.66 56.43 0.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.862 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.2 p -65.69 169.74 5.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 71.53 111.061 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.99 27.26 3.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 20.33 110.869 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -150.04 28.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 74.31 110.876 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.42 127.34 5.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 41.13 112.508 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.695 HD13 ' HB ' ' A' ' 71' ' ' VAL . 9.1 mt -54.78 168.03 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 65.25 110.97 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 81' ' ' ASP . 60.2 t -146.68 143.49 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 61.43 111.138 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.602 HD13 HG22 ' A' ' 45' ' ' VAL . 3.6 mm? -114.52 127.92 56.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 71.14 110.993 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG11 HG11 ' A' ' 165' ' ' VAL . 14.7 t -78.06 -2.91 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 43.01 111.122 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.21 132.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 61.5 110.848 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.57 -166.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.866 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.6 m -94.06 -175.04 3.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.841 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.739 ' HB2' HD13 ' A' ' 63' ' ' LEU . 90.1 m95 -68.38 -41.21 80.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 75.51 110.892 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.39 166.72 23.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.419 . . . . 44.25 110.859 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.44 -35.94 80.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 74.42 110.865 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -70.39 -23.48 62.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 64.13 110.927 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -81.81 -50.6 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 75.23 110.985 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -57.7 -31.07 66.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 72.34 111.129 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -54.58 -38.55 66.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 54.34 110.856 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.55 -11.31 54.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 74.24 110.828 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.541 HD13 HG21 ' A' ' 16' ' ' ILE . 36.8 tp -85.03 -47.36 10.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 60.23 110.923 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 68' ' ' ILE . 37.3 mt -68.65 -11.98 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.21 111.106 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -92.17 16.45 11.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 70.31 110.889 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.5 mtp -115.83 -51.55 2.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 63.12 110.892 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.695 ' HB ' HD13 ' A' ' 52' ' ' LEU . 28.1 m -64.21 -36.08 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 73.3 111.128 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -85.72 50.56 1.99 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 70.41 110.885 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -142.84 -40.15 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 75.42 110.915 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.727 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.28 -23.81 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 75.52 110.889 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.548 ' CB ' HD21 ' A' ' 52' ' ' LEU . 30.4 m-85 -89.52 11.23 20.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 74.34 110.864 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.81 46.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 74.5 110.956 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -150.42 -176.57 5.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 72.21 110.857 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -134.01 152.09 51.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.817 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.559 HG22 ' HB2' ' A' ' 52' ' ' LEU . 85.0 t -87.19 118.18 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 55.35 111.178 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.487 HG23 ' HG2' ' A' ' 78' ' ' ARG . 74.1 p -127.37 21.3 6.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 73.02 111.142 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 53' ' ' VAL . 5.6 m-20 -154.0 134.1 13.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 73.11 110.912 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.564 HG21 HD13 ' A' ' 98' ' ' LEU . 21.2 t -136.65 99.6 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 75.44 111.126 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.9 mt -74.89 126.11 35.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 72.41 111.094 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.497 HG23 ' HB3' ' A' ' 91' ' ' ARG . 29.4 mm -113.88 129.5 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 63.44 111.116 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.0 p -88.34 -54.11 4.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.163 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -133.68 162.81 30.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 73.43 110.884 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -84.24 98.5 10.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 62.12 111.041 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.627 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.8 OUTLIER -151.74 158.76 43.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.0 110.897 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.36 -24.38 54.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 45.13 111.098 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.87 16.36 12.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 74.44 110.94 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HB3' HG23 ' A' ' 84' ' ' ILE . 53.3 mmt-85 -132.19 -52.53 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 73.43 110.889 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.15 15.24 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.44 111.109 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.91 -34.45 30.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 45.24 112.503 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.09 18.15 43.21 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.72 -0.752 . . . . 72.35 112.451 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.561 HG21 ' H ' ' A' ' 121' ' ' GLU . 8.0 tt -46.16 -31.69 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 40.2 111.118 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -54.67 26.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 70.14 110.878 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.8 m -58.54 -39.82 81.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.19 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.564 HD13 HG21 ' A' ' 82' ' ' VAL . 28.9 mt -60.4 -29.52 69.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 71.42 110.888 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -99.31 24.11 8.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.898 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -114.1 -34.69 5.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 54.13 110.878 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -96.17 -21.94 17.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 63.23 110.856 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.59 16.82 4.48 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.772 -0.727 . . . . 40.52 112.503 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.2 mt -83.06 156.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 64.22 111.167 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.616 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -119.26 125.01 48.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.44 . . . . 73.33 110.853 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.04 82.4 5.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 55.33 111.092 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.518 ' HA ' HD12 ' A' ' 124' ' ' LEU . 59.1 m-70 -51.91 142.59 15.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 73.42 110.855 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.67 151.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.03 110.899 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.64 HG22 ' HB3' ' A' ' 127' ' ' LEU . 71.1 p -70.63 157.45 37.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 74.2 111.137 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.62 -24.07 45.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 34.34 111.134 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' A' ' 152' ' ' ASP . 10.8 tp -77.0 -46.96 22.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 73.24 110.915 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 33.5 m -55.62 -27.93 52.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.224 -0.444 . . . . 61.1 111.184 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.645 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -80.49 -23.46 40.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.24 111.127 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.88 -38.25 90.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 71.14 110.839 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.4 mt -85.24 -24.52 27.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 73.14 110.878 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.8 -65.78 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 72.41 111.066 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -55.24 -26.2 38.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 63.33 110.949 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -24.17 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.877 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -95.09 -31.46 13.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.924 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.82 -4.84 6.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.731 . . . . 51.23 112.49 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -59.72 -172.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.883 0.373 . . . . 73.12 110.907 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.561 ' H ' HG21 ' A' ' 95' ' ' ILE . 9.5 mm-40 -98.19 -1.32 42.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 74.41 110.9 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.645 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 66.16 126.97 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.71 0.767 . . . . 73.15 110.86 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -170.64 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.612 2.208 . . . . 65.31 112.39 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' A' ' 104' ' ' LYS . 64.7 mt -51.89 -36.38 48.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 55.13 110.907 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.98 53.93 28.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 75.1 112.48 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -152.02 48.46 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 72.11 110.833 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.64 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.2 OUTLIER -123.65 -169.64 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.904 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -151.96 -168.74 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 74.2 110.936 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.817 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.3 m -50.24 -64.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 54.05 111.134 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.764 HG23 HG22 ' A' ' 129' ' ' THR . 68.6 t -124.63 110.62 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 43.3 111.133 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.632 HG22 HD23 ' A' ' 133' ' ' LEU . 90.7 m -113.33 105.32 13.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.151 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.57 100.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 64.45 110.872 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.632 HD23 HG22 ' A' ' 131' ' ' THR . 2.9 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.908 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.3 tpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.8 0.333 . . . . 45.3 110.913 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -124.24 125.34 44.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 65.13 110.897 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.749 HG13 HD23 ' A' ' 158' ' ' LEU . 6.5 t -138.0 157.69 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 62.42 111.147 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 140' ' ' VAL . 64.8 tt0 -155.66 125.22 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 61.1 110.842 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.693 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -74.99 -177.06 3.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.138 -0.483 . . . . 65.11 111.124 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.744 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.0 t80 -175.33 136.19 0.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.817 ' HB3' HG23 ' A' ' 129' ' ' THR . 28.4 t80 -119.47 93.77 47.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.624 0.726 . . . . 75.11 110.978 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 -48.55 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 72.31 112.355 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.88 -155.29 22.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 34.11 112.462 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.15 123.97 41.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.371 . . . . 73.15 110.826 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.638 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -134.66 -94.3 0.48 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.483 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -71.46 -29.58 65.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 73.14 110.899 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.8 153.13 34.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.117 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.52 -37.9 65.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 72.12 110.916 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.5 ' HB3' HD23 ' A' ' 110' ' ' LEU . 1.4 p30 -108.74 51.13 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.887 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.567 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.9 OUTLIER -100.49 136.35 40.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 70.05 110.889 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.693 HD12 HG22 ' A' ' 142' ' ' THR . 18.5 pt -137.48 169.01 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.22 111.122 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.43 ' CG1' HD22 ' A' ' 169' ' ' LEU . 10.6 m -119.37 140.93 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 61.01 111.177 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 84.4 t -95.85 144.24 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.11 111.145 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -131.16 146.94 52.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 75.31 110.896 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.749 HD23 HG13 ' A' ' 140' ' ' VAL . 15.7 mt -123.43 97.47 42.39 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.599 0.714 . . . . 50.12 110.887 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 72.22 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 53.11 112.388 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.17 -34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.888 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -117.42 -13.28 10.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 54.54 110.904 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 m120 68.62 23.28 7.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 73.23 110.909 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.437 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.7 mp -95.58 116.26 36.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 41.11 111.16 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.7 137.0 37.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 75.33 110.97 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.517 HG21 HD22 ' A' ' 44' ' ' LEU . 21.5 t -121.27 66.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 73.13 111.109 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.77 -55.33 21.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 73.13 112.452 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.21 -119.76 5.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 63.35 112.492 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 90.3 m -87.2 7.23 29.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 62.23 110.951 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.567 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.0 OUTLIER -88.72 -50.17 6.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.157 -0.474 . . . . 75.13 110.922 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.469 HG11 HG11 ' A' ' 206' ' ' VAL . 21.7 t -91.1 120.86 40.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 61.43 111.098 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.03 154.78 19.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 62.53 110.963 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.608 ' HA ' HD22 ' A' ' 218' ' ' LEU . 5.8 p -77.65 161.43 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 52.44 110.861 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.592 HG23 HD23 ' A' ' 218' ' ' LEU . 1.4 p . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 73.02 111.115 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 186' ' ' VAL . 21.8 m . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.768 0.318 . . . . 54.34 111.118 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.67 85.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 64.4 111.116 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.06 44.82 2.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 61.45 110.867 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -138.52 171.34 14.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.064 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -117.37 90.57 3.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 70.25 110.952 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.484 HG13 ' CD2' ' A' ' 226' ' ' LEU . 91.1 t -69.91 -22.05 24.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 73.13 111.15 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -78.35 -24.88 46.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 62.3 110.957 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -101.76 -24.9 14.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 73.14 110.91 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -51.46 -56.72 11.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 64.33 110.945 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.2 p -52.17 -32.03 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 71.4 110.848 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.4 m -78.22 -31.47 49.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.01 111.164 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 196' ' ' VAL . 40.2 m -69.45 -52.14 29.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 62.22 110.892 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.796 HG22 HD23 ' A' ' 197' ' ' LEU . 35.6 mm -56.08 -42.26 71.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 63.2 111.145 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.72 -19.81 59.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 72.23 110.864 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -95.84 -25.59 15.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 70.32 110.944 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.404 ' CG1' HD21 ' A' ' 219' ' ' LEU . 60.6 t -85.36 -20.79 8.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 63.24 111.159 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.796 HD23 HG22 ' A' ' 193' ' ' ILE . 2.5 pp -101.17 -2.33 31.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 71.25 110.933 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -116.4 -22.92 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.885 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -71.1 -23.73 62.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 75.15 110.841 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -118.09 -66.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 74.41 110.922 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.64 25.81 14.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 74.23 110.918 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -149.35 22.59 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 61.45 110.839 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.5 mp -60.19 144.62 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 55.25 111.175 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -103.07 -26.05 13.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.878 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -166.07 130.82 2.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 53.53 111.097 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.482 ' CG1' HD12 ' A' ' 218' ' ' LEU . 89.9 t -107.53 128.09 62.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 72.12 111.106 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.936 HG21 HD11 ' A' ' 44' ' ' LEU . 39.7 t -110.82 103.28 54.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.588 0.709 . . . . 70.21 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.7 -169.76 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.707 2.271 . . . . 60.44 112.336 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -108.86 -22.33 7.01 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 70.15 112.44 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -144.6 88.73 1.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 71.44 110.896 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 161.25 -93.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.783 -0.722 . . . . 50.41 112.523 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -178.91 156.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.925 0.393 . . . . 70.4 110.886 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 207' ' ' VAL . 39.1 t -67.2 147.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 72.33 111.135 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -150.04 -107.97 0.42 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.684 -0.77 . . . . 54.24 112.405 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -154.52 -170.47 3.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 42.32 110.87 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -58.01 -20.2 36.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 75.45 110.878 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.742 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.93 -32.43 62.36 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.685 -0.769 . . . . 62.31 112.452 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 172' ' ' SER . 29.8 mt -50.74 -43.2 58.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 53.11 110.908 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.529 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -59.97 -45.05 93.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.965 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.742 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.2 mt -64.58 -42.04 95.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 70.41 110.866 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -65.5 -36.6 84.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 73.21 110.869 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 33.0 m -51.7 -44.29 63.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 53.11 111.162 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.755 ' HA ' HD12 ' A' ' 226' ' ' LEU . 76.4 mt -56.32 -38.96 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.86 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -27.77 65.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 73.41 110.856 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.9 -25.47 56.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 62.33 110.866 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.755 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.6 mt -89.22 -38.63 14.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 63.23 110.923 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.6 mttp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 75.22 110.914 179.836 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.593 HG22 ' OG ' ' A' ' 19' ' ' SER . 91.4 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.846 0.355 . . . . 72.34 111.09 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.52 154.52 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 52.24 111.19 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.403 ' N ' ' HE3' ' A' ' 70' ' ' MET . 21.6 mtmt -145.37 146.58 31.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.892 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.32 165.49 21.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 64.32 110.815 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -52.03 -43.35 63.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 63.14 110.878 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.52 -24.01 31.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 70.23 111.157 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.68 -14.0 66.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 70.52 112.484 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.715 HG23 HG13 ' A' ' 16' ' ' ILE . 1.9 t -50.81 -32.77 21.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 64.51 111.165 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.715 HG13 HG23 ' A' ' 15' ' ' THR . 20.1 mt -118.79 148.08 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 55.34 111.072 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 p -170.59 166.97 8.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 73.54 110.851 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -133.27 -172.91 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 72.32 111.109 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.593 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -173.74 133.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.89 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.98 119.12 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.41 110.879 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.401 HD11 HG11 ' A' ' 213' ' ' VAL . 1.4 mm? -101.5 -57.8 2.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 64.0 110.887 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -148.3 -170.08 3.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 72.15 110.861 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.532 ' O ' HG23 ' A' ' 25' ' ' VAL . 16.3 mttt -52.34 108.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.922 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 57.96 23.21 9.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.426 . . . . 73.24 110.831 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 23' ' ' LYS . 99.1 t -122.44 110.76 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 64.31 111.18 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -121.91 163.83 18.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.887 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.5 t -126.02 109.95 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 43.03 111.151 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.552 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.2 p80 -101.61 137.0 40.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.852 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 m -132.39 113.06 12.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 73.12 111.19 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.569 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -100.27 162.49 12.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 74.3 110.874 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.419 HD22 ' CA ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -113.33 126.14 55.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 74.03 110.907 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 63.11 112.46 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.1 p . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.608 0.718 . . . . 63.4 111.109 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.419 ' CA ' HD22 ' A' ' 31' ' ' LEU . 53.5 Cg_endo -69.75 166.22 28.34 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.667 2.245 . . . . 74.13 112.352 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -149.06 99.41 2.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 73.13 110.938 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -51.76 168.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 72.52 110.852 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.583 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -170.24 -160.3 18.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 73.43 112.478 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.99 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -165.81 141.49 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 64.02 110.932 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 54' ' ' LEU . 21.8 t -125.84 135.58 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 74.23 111.141 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.45 HD22 ' HE3' ' A' ' 138' ' ' MET . 18.5 mt -103.16 133.4 48.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 65.12 110.916 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -99.65 57.95 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 71.23 110.939 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 p -60.38 -169.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 41.51 111.182 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.5 m -114.43 2.89 14.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 71.45 110.83 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -118.53 -17.4 9.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.878 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.19 131.17 1.3 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.658 -0.782 . . . . 74.24 112.432 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 75' ' ' PHE . 16.5 mt -48.98 159.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 70.13 110.932 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 81' ' ' ASP . 96.5 t -140.12 144.07 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 74.13 111.153 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.459 HD13 HG22 ' A' ' 45' ' ' VAL . 3.6 mm? -115.72 128.83 56.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 61.42 110.901 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.4 t -78.84 -2.34 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 63.41 111.061 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 179.57 125.36 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.28 -0.418 . . . . 72.12 110.897 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -167.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 54.2 110.892 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 p -94.61 -169.75 2.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 72.05 110.842 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.425 ' HB2' HD13 ' A' ' 63' ' ' LEU . 84.2 m95 -73.45 -38.45 65.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.953 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -143.66 154.98 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.52 110.87 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HA ' HG22 ' A' ' 64' ' ' THR . 5.4 p-10 -55.88 -28.35 56.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 73.13 110.862 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -78.1 -23.77 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 71.35 110.945 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -87.24 -40.19 14.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.03 110.929 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 61' ' ' ASP . 14.1 t -66.53 -23.61 66.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.52 111.167 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -43.04 72.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 52.32 110.884 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -82.76 -14.6 54.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 64.32 110.886 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.569 HD22 ' OE2' ' A' ' 30' ' ' GLU . 15.3 tp -76.51 -44.49 34.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 72.25 110.949 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.9 mt -74.6 -30.06 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.04 111.185 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.52 -13.2 61.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 63.12 110.888 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.403 ' HE3' ' N ' ' A' ' 10' ' ' LYS . 2.7 mmm -88.7 -54.76 4.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 73.2 110.87 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 52' ' ' LEU . 19.2 m -57.5 -39.61 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 72.33 111.124 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.449 ' HG3' HG23 ' A' ' 71' ' ' VAL . 63.5 mt-10 -83.97 50.86 1.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 52.34 110.871 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.19 -41.02 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 64.22 110.897 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.83 -19.51 12.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 75.03 110.887 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.719 ' HB3' HD21 ' A' ' 52' ' ' LEU . 26.3 m-85 -88.64 9.73 23.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.52 110.822 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.527 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 2.1 pp0? 31.69 49.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.908 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.418 ' NZ ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -155.46 -177.21 6.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 74.33 110.97 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 144.87 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 72.35 110.831 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 52' ' ' LEU . 93.8 t -76.57 123.63 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 73.34 111.089 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.2 p -134.48 20.78 3.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 74.22 111.149 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.805 ' HB2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -153.56 135.5 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 72.35 110.868 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.573 HG21 ' CD2' ' A' ' 98' ' ' LEU . 19.4 t -140.53 100.77 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 74.55 111.071 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.8 mt -79.42 121.02 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 65.44 111.171 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 91' ' ' ARG . 45.4 mm -105.72 130.47 57.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 70.11 111.079 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.0 p -90.91 -52.95 4.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 72.24 111.193 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -134.72 162.5 32.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 52.3 110.888 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.45 97.64 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.1 111.112 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.662 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.53 158.84 44.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 73.04 110.848 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.76 -30.32 63.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 71.5 111.118 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.29 9.99 21.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.899 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.401 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.9 mmp_? -121.86 -51.64 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 73.54 110.807 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.662 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -117.29 18.12 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 71.34 111.128 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.77 -28.45 23.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 72.43 112.495 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.05 21.31 27.38 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.698 -0.763 . . . . 60.44 112.552 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.421 HD11 ' C ' ' A' ' 122' ' ' GLU . 2.6 tt -48.7 -30.77 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 52.03 111.084 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -69.9 -44.05 70.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 70.41 110.842 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.0 m -67.02 -35.01 78.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 74.15 111.201 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.573 ' CD2' HG21 ' A' ' 82' ' ' VAL . 51.4 mt -62.61 -30.74 71.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 60.2 110.896 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.58 22.61 7.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.945 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -120.71 -31.29 4.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 73.14 110.86 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -103.48 12.08 35.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 64.42 110.861 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.14 18.62 68.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 65.25 112.539 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 98' ' ' LEU . 11.5 mt -83.64 157.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.819 0.343 . . . . 71.22 111.17 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.809 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -122.02 121.28 36.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 74.15 110.881 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.497 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -89.61 77.96 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.047 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.539 ' HA ' HD12 ' A' ' 124' ' ' LEU . 96.7 m-70 -53.83 146.34 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.848 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.15 168.25 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.31 110.858 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.657 HG22 ' HB3' ' A' ' 127' ' ' LEU . 81.0 p -83.7 176.4 9.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 70.21 111.173 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.07 -23.93 60.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 74.02 111.052 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 152' ' ' ASP . 10.2 tp -75.47 -51.2 13.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 64.45 110.923 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.665 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 91.7 m -52.65 -29.13 24.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 72.34 111.134 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.516 ' HB1' ' OE2' ' A' ' 122' ' ' GLU . . . -82.51 -30.41 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 70.32 111.074 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -58.93 -40.48 84.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 74.4 110.904 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.659 HD12 ' OD2' ' A' ' 152' ' ' ASP . 61.0 mt -85.09 -25.25 27.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 65.1 110.932 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.51 -68.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.34 111.099 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -56.35 -25.57 49.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 64.55 110.881 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -24.75 67.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 71.43 110.952 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -94.1 -37.25 11.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 75.23 110.896 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.14 -8.57 3.25 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.765 -0.731 . . . . 71.33 112.487 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -59.82 -172.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 74.21 110.967 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -101.21 0.24 37.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.148 -0.478 . . . . 62.34 110.903 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.516 ' OE2' ' HB1' ' A' ' 112' ' ' ALA . 1.5 mt-10 66.14 127.18 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 63.54 110.911 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -170.3 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.738 2.292 . . . . 71.25 112.294 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.809 HD11 ' HB2' ' A' ' 104' ' ' LYS . 69.8 mt -52.85 -41.42 64.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 71.54 110.958 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 55.16 58.56 13.18 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.771 -0.728 . . . . 72.04 112.502 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -148.97 54.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 61.41 110.916 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.657 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.3 OUTLIER -136.37 -169.7 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 73.2 110.909 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -150.75 -168.66 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 72.45 110.897 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.828 HG23 ' HB3' ' A' ' 144' ' ' TYR . 97.6 m -50.21 -41.1 49.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 70.42 111.149 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.76 140.78 25.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 64.41 111.146 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.6 m -149.55 102.47 3.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.106 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.33 95.44 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 70.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 63.13 110.924 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.45 ' HE3' HD22 ' A' ' 46' ' ' LEU . 3.1 tpp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.838 0.352 . . . . 71.43 110.935 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.62 130.05 45.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.889 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.577 HG13 HD23 ' A' ' 158' ' ' LEU . 4.3 t -142.92 159.54 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 72.51 111.203 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 140' ' ' VAL . 41.4 tt0 -160.44 118.12 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 74.12 110.925 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.46 HG22 ' CD1' ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.94 179.67 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 72.33 111.153 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -175.19 143.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 74.43 110.851 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.828 ' HB3' HG23 ' A' ' 129' ' ' THR . 66.2 t80 -120.78 94.98 49.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.673 0.749 . . . . 55.51 110.874 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 -48.59 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.649 2.233 . . . . 64.34 112.344 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.15 -161.55 34.71 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 75.42 112.426 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.47 125.46 38.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.891 0.377 . . . . 65.23 110.856 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.489 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -136.37 -97.38 0.49 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 42.32 112.498 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -69.72 -35.77 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 74.2 110.867 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.43 147.29 39.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 43.11 111.176 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.99 -40.72 61.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 74.55 110.927 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.659 ' OD2' HD12 ' A' ' 114' ' ' LEU . 11.1 p30 -106.46 53.01 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 64.15 110.912 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 2.1 p30 -99.97 134.8 42.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.886 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.46 ' CD1' HG22 ' A' ' 142' ' ' THR . 1.0 OUTLIER -136.62 160.73 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 60.41 111.091 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.0 m -109.46 155.43 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 65.21 111.115 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.0 t -111.31 142.28 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 54.15 111.118 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 158' ' ' LEU . 75.0 t-105 -127.7 151.48 48.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 73.2 110.904 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.577 HD23 HG13 ' A' ' 140' ' ' VAL . 13.3 mt -130.24 96.93 23.61 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.594 0.711 . . . . 53.4 110.935 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 72.64 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.668 2.245 . . . . 73.42 112.353 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.62 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 72.45 110.954 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.542 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.9 m-85 -118.04 -13.27 10.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 72.33 110.881 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.46 23.38 6.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 71.14 110.888 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.542 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.6 mp -93.97 118.92 40.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.11 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.453 HD11 HG13 ' A' ' 196' ' ' VAL . 0.4 OUTLIER -103.19 138.03 40.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 64.23 110.907 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.509 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.3 t -127.74 81.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 62.43 111.146 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.57 -67.94 1.68 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.8 -0.714 . . . . 73.04 112.528 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.87 89.35 2.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.707 -0.758 . . . . 63.33 112.457 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 63.6 m 61.48 16.85 7.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 73.31 110.873 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.643 HD12 ' NE1' ' A' ' 189' ' ' TRP . 21.7 tp -110.31 -45.48 3.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 51.24 110.901 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 218' ' ' LEU . 16.2 t -96.44 116.93 39.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.106 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.35 146.59 31.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.14 110.911 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.711 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.8 p -78.92 161.54 26.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 62.02 110.878 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 63.51 111.088 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.723 0.297 . . . . 71.31 111.048 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.48 91.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 62.22 111.124 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.77 43.3 2.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 64.14 110.834 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.2 164.53 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 71.15 111.064 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -112.87 90.08 3.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.893 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.414 HG13 HD23 ' A' ' 226' ' ' LEU . 21.6 t -67.56 -17.2 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 74.13 111.173 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -88.06 -20.08 26.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 65.21 110.938 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -104.63 -20.87 13.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 62.31 110.907 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.643 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -51.09 -55.77 16.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 75.03 110.912 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 60.4 p -51.88 -38.62 56.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 54.03 110.897 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -68.77 -36.09 77.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 71.15 111.141 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.0 m -65.31 -52.09 56.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.908 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.566 HG22 HD23 ' A' ' 197' ' ' LEU . 31.5 mm -57.56 -36.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 64.24 111.127 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.75 -15.45 61.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 65.11 110.887 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -97.84 -27.3 14.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 64.33 110.93 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.553 HG12 HD21 ' A' ' 219' ' ' LEU . 46.3 t -82.34 -30.36 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 62.23 111.108 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.566 HD23 HG22 ' A' ' 193' ' ' ILE . 2.8 pp -85.64 -24.26 27.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 65.54 110.916 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.26 -39.7 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 71.15 110.933 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -56.39 -49.03 75.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 71.11 110.844 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -119.34 127.72 53.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 74.23 110.927 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.75 26.03 8.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.093 -0.503 . . . . 72.22 110.848 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.49 22.13 2.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 71.31 110.844 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 203' ' ' ILE . 3.6 mp -52.11 147.42 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 64.12 111.198 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -106.85 -39.76 5.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 73.33 110.957 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.93 127.59 8.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.153 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.525 HG12 HD12 ' A' ' 218' ' ' LEU . 86.1 t -105.59 125.44 60.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 55.24 111.116 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.99 HG21 HD11 ' A' ' 44' ' ' LEU . 23.5 t -106.54 110.09 63.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.707 . . . . 53.43 111.142 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 54.43 112.341 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.89 -27.01 7.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 71.12 112.543 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -145.05 88.93 1.92 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.364 . . . . 75.15 110.871 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.17 -108.29 0.34 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.698 -0.763 . . . . 61.15 112.437 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -158.02 153.65 26.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.926 0.394 . . . . 52.23 110.894 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 21' ' ' LEU . 5.3 p -68.69 144.0 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 62.43 111.102 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.07 -104.51 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 61.31 112.498 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -157.3 -169.65 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.885 0.374 . . . . 63.4 110.873 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -56.96 -21.02 26.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.911 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.748 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -55.94 -33.85 60.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.772 -0.728 . . . . 71.4 112.446 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.711 HD22 ' HA ' ' A' ' 172' ' ' SER . 30.2 mt -50.63 -47.01 58.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.882 0.372 . . . . 73.41 110.913 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.553 HD21 HG12 ' A' ' 196' ' ' VAL . 7.1 mp -53.84 -42.7 68.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 74.01 110.98 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.748 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -67.37 -41.28 85.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.946 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -64.09 -39.31 93.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 72.45 110.794 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.3 m -51.59 -45.23 63.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 73.0 111.136 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.777 ' HA ' HD12 ' A' ' 226' ' ' LEU . 46.6 mt -61.26 -39.83 91.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 74.24 110.91 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.31 -26.76 61.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.843 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.3 mt -76.82 -24.05 52.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 71.05 110.865 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.5 mt -90.97 -39.38 12.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 63.21 110.899 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 71.44 110.878 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 18' ' ' ILE . 95.1 t . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.827 0.346 . . . . 54.54 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.581 HD11 ' HE3' ' A' ' 74' ' ' LYS . 2.6 mm -94.56 152.62 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.33 111.104 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -150.83 155.34 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 64.2 110.905 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.23 -168.95 2.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.923 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -76.89 -25.25 52.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 72.22 110.834 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 p -95.04 -35.21 12.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 73.21 111.138 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.66 -9.16 64.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.759 . . . . 64.01 112.446 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.77 HG23 HG13 ' A' ' 16' ' ' ILE . 1.7 t -50.12 -33.36 18.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.688 0.28 . . . . 71.02 111.128 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.77 HG13 HG23 ' A' ' 15' ' ' THR . 5.9 mt -124.21 160.32 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.433 . . . . 72.53 111.147 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 16' ' ' ILE . 1.8 p -178.42 166.75 1.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 63.31 110.858 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -129.24 -175.71 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 71.41 111.113 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.405 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.0 t -169.14 129.97 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.51 110.894 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.3 120.19 12.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 55.34 110.942 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.5 mm? -103.56 -74.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 63.23 110.906 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.98 -170.43 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 61.51 110.843 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' HG23 ' A' ' 25' ' ' VAL . 6.6 mmtt -52.62 109.48 0.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 70.22 110.876 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 58.6 23.86 11.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 75.53 110.832 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 23' ' ' LYS . 99.3 t -122.96 116.42 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 75.32 111.114 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -124.36 163.13 22.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 75.54 110.954 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.719 HG22 HD12 ' A' ' 44' ' ' LEU . 55.8 t -123.59 107.72 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 72.21 111.114 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.558 ' CE1' HD21 ' A' ' 67' ' ' LEU . 6.8 p80 -100.49 138.49 37.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 71.34 110.856 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.8 m -136.2 133.44 37.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.115 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.486 ' HB3' HG23 ' A' ' 16' ' ' ILE . 2.9 pm0 -124.59 173.98 8.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 44.13 110.91 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.496 ' O ' HD21 ' A' ' 63' ' ' LEU . 3.3 tp -124.15 136.23 54.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 52.32 110.914 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.733 -0.746 . . . . 73.43 112.447 179.926 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.619 0.723 . . . . 75.42 111.096 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 142.87 48.99 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.74 2.293 . . . . 71.44 112.344 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.92 102.06 5.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 74.51 110.927 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -67.48 153.44 43.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 75.1 110.861 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.71 -155.99 7.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 54.12 112.528 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.871 HD22 HG21 ' A' ' 165' ' ' VAL . 4.7 tp -161.36 142.01 11.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 74.41 110.903 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.631 HG22 HD13 ' A' ' 54' ' ' LEU . 46.4 t -125.06 132.17 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 53.32 111.13 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 mt -98.5 122.59 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 71.02 110.952 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -94.8 60.26 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 61.25 110.9 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.4 p -66.0 179.83 0.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 75.12 111.173 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.6 m -104.95 26.04 9.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 74.32 110.836 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.08 23.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 65.22 110.912 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.81 130.25 4.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.769 -0.729 . . . . 35.32 112.431 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.797 HD13 ' HB ' ' A' ' 71' ' ' VAL . 10.0 mt -60.33 158.96 10.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.825 0.345 . . . . 70.43 110.934 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.798 HG22 ' HB2' ' A' ' 81' ' ' ASP . 57.8 t -140.2 139.35 36.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 65.33 111.129 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.631 HD13 HG22 ' A' ' 45' ' ' VAL . 2.9 mm? -109.83 127.43 54.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.942 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 55' ' ' VAL . 18.0 t -79.8 -0.5 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 73.44 111.152 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.45 126.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 51.41 110.904 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -166.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 75.1 110.84 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -96.28 -174.46 3.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 70.32 110.874 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.771 ' HB2' HD13 ' A' ' 63' ' ' LEU . 92.9 m95 -67.68 -42.1 82.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 72.33 110.924 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.01 166.29 24.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 54.42 110.84 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.96 -36.18 80.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.861 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -71.21 -25.13 62.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.93 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -78.99 -49.68 12.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 64.21 110.819 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 t -58.84 -29.54 67.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.33 111.125 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -52.76 -44.3 66.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 70.55 110.893 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -80.94 -12.89 59.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 63.44 110.889 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 16' ' ' ILE . 38.9 tp -83.87 -50.29 8.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 72.3 110.904 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.4 mt -64.55 -18.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 52.33 111.193 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -80.91 -1.18 42.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 73.12 110.881 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.8 mtp -96.33 -57.56 2.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.843 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.797 ' HB ' HD13 ' A' ' 52' ' ' LEU . 20.5 m -58.29 -39.1 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 72.1 111.167 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.53 50.82 1.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 74.03 110.912 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -146.25 -40.95 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 72.4 110.879 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.581 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.19 -23.21 12.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 63.32 110.866 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.601 ' HB3' HD21 ' A' ' 52' ' ' LEU . 41.1 m-85 -90.03 11.57 20.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 73.43 110.851 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.515 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.78 46.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.43 110.927 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -152.05 -176.71 5.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.52 110.892 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.67 153.66 47.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 51.41 110.889 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 52' ' ' LEU . 87.2 t -89.25 117.19 32.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 64.2 111.123 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.54 HG23 ' HG2' ' A' ' 78' ' ' ARG . 42.8 p -130.76 36.53 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 75.12 111.155 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.798 ' HB2' HG22 ' A' ' 53' ' ' VAL . 6.1 m-20 -166.71 130.44 1.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 64.31 110.918 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.616 HG21 ' CD2' ' A' ' 98' ' ' LEU . 17.0 t -135.96 101.91 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 74.54 111.11 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.0 mt -80.22 119.79 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.14 111.074 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 91' ' ' ARG . 39.6 mm -107.33 134.59 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.117 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.1 p -91.9 -55.36 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 54.34 111.204 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -133.17 163.95 28.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 74.35 110.795 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -82.8 97.22 8.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 65.4 111.086 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.619 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.6 OUTLIER -151.05 158.8 44.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 64.54 110.851 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.27 -26.2 60.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.35 111.083 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.68 15.27 13.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 51.12 110.835 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.458 ' O ' HD12 ' A' ' 84' ' ' ILE . 3.1 mpt_? -129.66 -53.12 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 75.44 110.829 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -112.88 16.54 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 65.23 111.189 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.56 25.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.797 -0.716 . . . . 45.03 112.494 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.88 20.04 29.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.743 . . . . 73.2 112.496 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.483 HG21 ' H ' ' A' ' 121' ' ' GLU . 2.4 tt -48.23 -30.65 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.37 . . . . 73.32 111.127 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -70.13 -44.51 68.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 73.2 110.932 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.9 m -67.38 -32.59 73.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 53.43 111.142 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.616 ' CD2' HG21 ' A' ' 82' ' ' VAL . 58.3 mt -65.01 -30.53 71.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 71.3 110.944 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -96.69 21.6 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 63.2 110.925 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.44 -27.36 5.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.3 110.903 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.68 11.52 28.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 71.1 110.892 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.18 17.12 70.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 71.31 112.512 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 98' ' ' LEU . 11.9 mt -83.19 157.52 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.888 0.375 . . . . 75.32 111.126 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.774 ' HB2' HD11 ' A' ' 124' ' ' LEU . 10.9 ptpt -123.49 123.38 40.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.848 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . . . -91.24 80.85 5.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.33 111.066 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.504 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.4 m-70 -56.1 146.85 21.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.79 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.93 159.85 0.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 72.42 110.86 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.4 p -75.74 154.58 36.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 73.55 111.123 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.45 -32.41 26.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 73.42 111.043 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 152' ' ' ASP . 7.3 tp -73.64 -48.28 33.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.426 . . . . 74.31 110.878 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.73 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 99.8 m -52.02 -28.61 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 60.53 111.18 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -86.61 -31.6 21.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 63.13 111.127 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.03 -43.55 70.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 52.41 110.829 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.64 HD12 ' OD1' ' A' ' 152' ' ' ASP . 21.3 mt -79.87 -23.73 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 64.03 110.891 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.14 -69.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.42 111.061 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.42 -28.24 28.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 71.53 110.937 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -23.64 62.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 73.32 110.841 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -94.58 -38.78 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 74.33 110.827 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.72 -8.51 3.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 44.41 112.459 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.43 -172.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 71.43 110.936 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.483 ' H ' HG21 ' A' ' 95' ' ' ILE . 58.4 mm-40 -98.47 -1.23 41.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 74.42 110.849 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.478 ' C ' HD11 ' A' ' 95' ' ' ILE . 0.7 OUTLIER 66.34 129.92 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.656 0.741 . . . . 65.11 110.893 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.557 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.85 -169.65 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.608 2.205 . . . . 74.44 112.403 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 104' ' ' LYS . 86.4 mt -54.45 -37.75 65.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 73.41 110.872 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.06 57.71 12.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 72.04 112.527 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -153.29 49.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 72.12 110.829 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.19 -169.97 2.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 73.21 110.919 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -146.22 -169.08 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.925 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 144' ' ' TYR . 94.1 m -50.72 -62.74 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 64.24 111.169 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 143' ' ' PHE . 92.2 t -125.07 116.15 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.51 111.092 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.63 HG22 HD23 ' A' ' 133' ' ' LEU . 60.1 m -115.66 103.35 10.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 73.24 111.132 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -67.02 102.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 74.21 110.879 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.63 HD23 HG22 ' A' ' 131' ' ' THR . 1.8 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 64.43 110.944 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 43.7 tpp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.9 0.381 . . . . 61.14 110.825 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.51 124.65 36.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 62.22 110.91 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.693 HG13 HD23 ' A' ' 158' ' ' LEU . 8.5 t -143.32 157.45 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.426 . . . . 74.24 111.107 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.403 ' N ' HG12 ' A' ' 140' ' ' VAL . 83.8 tt0 -158.53 125.31 4.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 64.52 110.886 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.649 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -74.63 -178.74 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 62.13 111.175 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.759 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.5 t80 -175.18 137.66 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 63.12 110.895 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.816 ' HB3' HG23 ' A' ' 129' ' ' THR . 52.7 t80 -120.05 92.99 47.55 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.681 0.753 . . . . 63.41 110.881 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -48.81 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.744 2.296 . . . . 72.25 112.322 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.73 -166.34 39.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 63.32 112.458 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -85.35 126.94 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 74.3 110.875 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.49 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -135.75 -87.74 0.24 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 73.53 112.55 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -80.32 -23.67 40.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 55.45 110.842 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.52 158.3 43.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 74.15 111.215 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -63.1 -26.83 69.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 74.52 110.853 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.64 ' OD1' HD12 ' A' ' 114' ' ' LEU . 2.6 p30 -122.0 53.52 1.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 71.5 110.809 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.1 p30 -102.32 145.65 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 75.42 110.857 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.649 HD12 HG22 ' A' ' 142' ' ' THR . 6.4 pt -142.05 172.45 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 74.3 111.13 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.461 ' CG1' HD22 ' A' ' 169' ' ' LEU . 5.2 m -122.5 142.64 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.118 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.19 144.46 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 64.41 111.139 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -131.1 149.35 52.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 71.12 110.947 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.693 HD23 HG13 ' A' ' 140' ' ' VAL . 23.0 mt -126.52 95.93 37.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.568 0.699 . . . . 51.22 110.877 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 72.08 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.705 2.27 . . . . 63.34 112.326 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.5 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.912 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.544 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.3 m-85 -118.16 -13.21 9.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.833 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 m120 69.81 22.05 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 75.54 110.891 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.544 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.7 mp -92.79 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 72.44 111.072 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.41 136.57 39.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.968 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.871 HG21 HD22 ' A' ' 44' ' ' LEU . 23.2 t -123.24 65.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 45.11 111.158 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.87 -48.24 45.38 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.758 -0.734 . . . . 64.4 112.454 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.64 -130.9 10.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 74.3 112.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 96.5 m -69.58 -19.13 63.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 42.52 110.923 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.461 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.4 OUTLIER -67.65 -47.11 70.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 65.34 110.822 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.619 HG11 HG11 ' A' ' 206' ' ' VAL . 46.1 t -92.49 116.0 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 64.13 111.113 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.487 ' H ' HG23 ' A' ' 222' ' ' THR . 0.2 OUTLIER -89.95 147.74 23.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 53.43 110.864 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.741 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.6 t -87.19 157.24 19.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 71.04 110.84 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.1 p . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 63.22 111.117 -179.914 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.714 HG11 ' CG2' ' A' ' 186' ' ' VAL . 11.9 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.805 0.336 . . . . 74.03 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -51.71 -58.03 7.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 64.3 111.077 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.7 27.12 9.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.847 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -104.86 168.94 8.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.03 111.122 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -130.87 88.59 2.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 75.11 110.939 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.714 ' CG2' HG11 ' A' ' 181' ' ' VAL . 61.0 t -62.46 -18.02 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.098 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -78.87 -22.13 46.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 53.42 110.896 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -108.91 -25.42 10.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 75.42 110.936 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -51.04 -57.97 7.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.95 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.3 p -51.85 -30.56 24.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 51.33 110.87 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.0 m -80.06 -34.3 38.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 75.51 111.142 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 44.5 m -66.99 -55.55 13.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 73.11 110.819 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.766 HG22 HD23 ' A' ' 197' ' ' LEU . 33.6 mm -56.17 -40.17 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 73.15 111.114 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.22 -16.46 60.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 65.22 110.831 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -97.93 -21.88 16.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.883 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.466 ' CG1' HD21 ' A' ' 219' ' ' LEU . 94.5 t -88.42 -24.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.094 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 193' ' ' ILE . 2.6 pp -98.84 1.53 45.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 73.23 110.94 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -117.25 -17.03 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 54.34 110.851 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -90.55 1.84 56.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 71.11 110.901 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -137.61 -72.46 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.32 110.9 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 61.16 25.3 15.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 54.44 110.87 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -147.29 21.06 1.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 75.4 110.856 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.45 144.93 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 65.32 111.174 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -103.87 -28.65 11.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 61.14 110.837 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.465 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -165.68 126.47 1.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 73.41 111.106 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.636 ' CG1' HD12 ' A' ' 218' ' ' LEU . 87.9 t -98.45 127.48 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 51.44 111.112 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.855 HG21 HD13 ' A' ' 44' ' ' LEU . 98.0 t -108.71 89.57 6.45 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.618 0.723 . . . . 74.2 111.133 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 167.96 22.92 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.632 2.221 . . . . 71.11 112.376 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.09 -15.94 63.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 73.14 112.46 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -146.83 111.09 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 60.22 110.904 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 137.69 -96.41 0.24 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.826 -0.702 . . . . 73.52 112.524 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -178.85 166.77 1.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 75.55 110.867 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.695 HG21 HG21 ' A' ' 27' ' ' VAL . 21.6 t -75.1 133.49 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 63.24 111.141 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.57 -106.62 0.73 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 53.12 112.497 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -155.64 -172.62 4.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.883 0.373 . . . . 73.11 110.856 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -22.04 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.42 110.901 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.75 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.4 -33.06 52.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.8 -0.714 . . . . 71.25 112.521 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 172' ' ' SER . 29.6 mt -50.38 -45.69 55.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 74.21 110.923 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.522 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -55.66 -44.54 77.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.912 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.75 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.5 mt -64.9 -41.36 95.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 63.13 110.921 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.47 ' NE2' HD21 ' A' ' 225' ' ' LEU . 64.7 t60 -61.67 -38.85 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 64.12 110.901 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.487 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.2 OUTLIER -51.6 -46.09 63.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 70.01 111.091 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 226' ' ' LEU . 79.2 mt -52.5 -38.95 60.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.5 110.928 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -46.4 90.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 72.03 110.823 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.47 HD21 ' NE2' ' A' ' 221' ' ' HIS . 17.6 mt -56.54 -24.82 49.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.93 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.747 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.7 mt -87.32 -54.53 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 65.32 110.935 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.4 pttt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 72.42 110.955 179.802 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.1 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 74.31 111.092 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.705 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.3 mm -89.03 154.86 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 71.22 111.082 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -150.84 172.96 14.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 64.35 110.854 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -104.61 -169.42 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 71.45 110.889 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -74.14 -26.18 60.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 72.03 110.882 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p -102.43 -35.48 8.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 75.31 111.135 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.16 -2.5 43.95 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 52.33 112.459 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.758 HG23 HG13 ' A' ' 16' ' ' ILE . 1.7 t -50.55 -33.26 21.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 53.14 111.195 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.758 HG13 HG23 ' A' ' 15' ' ' THR . 7.0 mt -127.89 158.77 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 71.34 111.095 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 p -176.21 166.61 2.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 70.3 110.838 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 19' ' ' SER . 0.2 OUTLIER -130.14 -172.7 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 63.32 111.12 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.409 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.9 t -171.75 130.67 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 53.32 110.796 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 121.72 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.053 -0.521 . . . . 71.54 110.869 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.8 mm? -105.26 -49.02 3.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 74.14 110.912 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -148.41 59.39 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 53.43 110.887 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.42 -81.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.52 110.929 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.604 ' OD1' HG23 ' A' ' 25' ' ' VAL . 14.7 p30 -82.93 -17.2 44.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.862 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.604 HG23 ' OD1' ' A' ' 24' ' ' ASN . 21.1 t -96.85 118.52 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 71.24 111.15 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -126.14 160.11 31.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 72.24 110.918 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 213' ' ' VAL . 68.3 t -120.95 110.89 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 71.32 111.111 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.502 ' CE1' HD21 ' A' ' 67' ' ' LEU . 11.5 p80 -99.78 136.88 39.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 74.3 110.794 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.9 m -133.7 127.96 33.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.51 111.198 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.48 ' HB3' HG23 ' A' ' 16' ' ' ILE . 19.9 pm0 -120.91 -176.15 3.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 74.54 110.891 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 40' ' ' PRO . 3.6 tp -135.75 138.36 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 63.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 65.5 112.438 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 121.601 0.715 . . . . 53.32 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.513 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.9 Cg_endo -69.75 142.96 49.37 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.66 2.24 . . . . 40.22 112.342 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 t -142.15 110.99 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.23 110.822 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -100.29 146.37 27.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 71.42 110.883 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.601 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -133.37 -114.34 1.51 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.708 -0.758 . . . . 51.33 112.468 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.784 HD13 HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -178.86 144.58 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.839 0.352 . . . . 72.23 110.989 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 71' ' ' VAL . 40.4 t -127.88 131.91 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 72.44 111.124 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.2 mt -101.24 124.85 47.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 73.21 110.924 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.56 55.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 65.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 138' ' ' MET . 16.3 p -63.21 176.74 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 63.4 111.16 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 t -99.22 16.74 21.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 64.33 110.895 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.54 33.24 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.917 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.94 134.65 7.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 42.54 112.493 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.558 HD13 ' HB ' ' A' ' 71' ' ' VAL . 7.4 mt -62.72 161.15 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.35 . . . . 71.44 110.918 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.756 HG22 ' HB2' ' A' ' 81' ' ' ASP . 64.6 t -139.91 143.38 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.33 111.168 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.609 HD13 HG22 ' A' ' 45' ' ' VAL . 3.2 mm? -116.2 129.73 56.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 73.52 110.857 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 55' ' ' VAL . 16.1 t -79.12 -1.87 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 62.42 111.222 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 179.44 130.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 73.23 110.844 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 p -67.79 -166.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 71.25 110.805 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.6 t -94.61 -174.07 3.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 63.42 110.894 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.675 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.4 m95 -70.21 -36.11 74.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 71.25 110.935 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.74 164.31 31.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 53.05 110.854 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -63.18 -28.46 70.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 53.12 110.865 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -78.43 -25.48 46.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.914 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 59' ' ' TRP . 1.2 mt -83.47 -46.43 12.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 60.24 110.994 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 t -55.41 -28.49 54.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 64.01 111.18 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -55.9 -43.09 76.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 44.41 110.877 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.21 0.28 41.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 55.31 110.898 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.502 HD21 ' CE1' ' A' ' 28' ' ' HIS . 51.6 tp -99.42 -50.68 4.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 73.33 110.9 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.664 HG23 HG21 ' A' ' 79' ' ' VAL . 37.1 mt -64.93 -35.29 74.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 73.24 111.164 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.99 -16.75 60.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 73.01 110.916 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 32.1 mtp -76.57 -59.19 2.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 75.11 110.923 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 45' ' ' VAL . 33.0 m -60.11 -33.3 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 74.13 111.158 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -87.76 49.72 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 74.11 110.896 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -147.65 -40.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 75.21 110.884 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.705 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -103.8 -26.63 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 62.31 110.838 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' CB ' HD21 ' A' ' 52' ' ' LEU . 38.8 m-85 -89.52 10.89 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 74.51 110.885 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.5 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.71 46.93 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 72.32 110.896 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -146.97 -178.8 6.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 75.31 110.905 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.28 142.71 50.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.888 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.664 HG21 HG23 ' A' ' 68' ' ' ILE . 21.4 t -75.48 130.81 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 61.31 111.09 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.5 p -142.86 24.74 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 51.1 111.11 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.756 ' HB2' HG22 ' A' ' 53' ' ' VAL . 4.9 m-20 -157.85 133.95 9.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 75.02 110.928 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 98' ' ' LEU . 15.4 t -140.24 101.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 63.24 111.134 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.8 mt -78.45 114.17 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 75.12 111.117 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 91' ' ' ARG . 45.5 mm -100.84 124.76 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 75.51 111.101 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.9 p -81.93 -59.02 2.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 61.51 111.141 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.43 ' C ' HG23 ' A' ' 111' ' ' THR . 37.9 p-80 -128.18 -175.11 3.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 64.13 110.895 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -102.97 100.2 10.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 53.22 111.127 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.676 ' O ' HD13 ' A' ' 92' ' ' ILE . 2.8 m170 -153.84 160.6 42.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 74.21 110.84 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.78 -28.9 62.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 75.41 111.071 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.8 12.45 19.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.4 110.875 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.493 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.3 mpt_? -124.36 -50.43 1.77 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.971 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -119.85 15.69 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 73.44 111.106 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.7 -37.07 33.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 74.24 112.53 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.0 19.39 43.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 72.03 112.473 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.55 HG21 ' H ' ' A' ' 121' ' ' GLU . 4.5 tt -45.83 -31.13 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 74.15 111.124 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.46 -55.46 17.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 62.41 110.962 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.9 m -57.57 -41.43 81.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 60.5 111.104 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 103' ' ' ILE . 28.6 mt -58.44 -28.52 65.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.03 110.881 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -100.94 23.4 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 73.02 110.864 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -116.7 -39.7 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 74.05 110.877 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -88.4 -22.9 23.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 71.43 110.862 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.48 18.51 4.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.751 . . . . 42.34 112.482 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.3 mt -84.84 155.71 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.915 0.388 . . . . 64.25 111.09 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.771 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.4 ptpm? -119.03 119.76 35.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 73.54 110.891 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.73 78.98 9.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 61.21 111.037 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.619 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.6 m-70 -53.8 144.94 17.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.886 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.33 160.97 0.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 45.4 110.914 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.4 p -76.66 -177.66 4.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 73.3 111.177 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.3 -31.62 60.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 72.4 111.116 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 152' ' ' ASP . 8.3 tp -74.68 -46.98 34.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.951 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 98.5 m -53.6 -27.7 28.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 44.22 111.098 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -89.89 -33.52 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 61.13 111.135 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.53 -39.58 67.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.855 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.632 HD12 ' OD2' ' A' ' 152' ' ' ASP . 38.3 mt -84.0 -23.65 30.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 74.25 110.958 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.62 -68.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.079 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -53.14 -28.57 26.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.933 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -23.63 51.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 73.41 110.828 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -95.1 -32.41 13.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 70.13 110.889 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.31 -7.25 5.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 55.15 112.557 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -59.5 -172.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 72.42 110.94 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.55 ' H ' HG21 ' A' ' 95' ' ' ILE . 7.7 mm-40 -97.93 -3.09 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 70.21 110.914 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.437 ' C ' HD11 ' A' ' 95' ' ' ILE . 0.9 OUTLIER 66.29 132.34 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.656 0.741 . . . . 62.2 110.914 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.73 -170.23 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.658 2.239 . . . . 62.25 112.342 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 104' ' ' LYS . 97.8 mt -53.53 -43.21 68.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 73.15 110.913 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 63.0 54.59 32.14 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 74.43 112.478 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -152.4 48.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.335 . . . . 74.52 110.844 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tp -131.7 167.54 19.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.253 -0.431 . . . . 73.1 110.924 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -126.18 -168.68 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 74.23 110.904 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.828 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.5 m -50.02 -56.44 10.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.427 . . . . 71.32 111.143 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.68 HG13 HG22 ' A' ' 129' ' ' THR . 17.8 m -131.65 145.62 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 71.13 111.156 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.2 m -152.97 113.23 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.13 111.122 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.28 87.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.426 . . . . 72.33 110.882 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.962 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.466 ' HB2' HG22 ' A' ' 48' ' ' THR . 59.7 tpp . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.916 0.389 . . . . 74.1 110.873 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -114.26 122.25 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.05 110.846 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.631 HG13 HD23 ' A' ' 158' ' ' LEU . 4.3 t -130.75 159.28 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.105 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 35.6 tt0 -159.27 122.06 3.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 71.2 110.841 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.535 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.6 -178.28 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.08 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.665 ' HA ' HG12 ' A' ' 130' ' ' VAL . 72.5 t80 -174.86 135.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 65.41 110.891 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.828 ' HB3' HG23 ' A' ' 129' ' ' THR . 26.9 t80 -120.53 95.03 49.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.663 0.744 . . . . 50.14 110.919 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -48.71 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.686 2.257 . . . . 62.34 112.287 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.22 -155.44 24.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 73.44 112.451 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.03 123.59 37.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 72.11 110.858 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.486 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.69 -98.03 0.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.708 -0.758 . . . . 73.53 112.438 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -68.84 -27.64 66.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 72.25 110.878 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.62 154.02 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 75.41 111.131 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.57 -32.55 65.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.865 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.632 ' OD2' HD12 ' A' ' 114' ' ' LEU . 3.0 p30 -116.31 51.73 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 71.34 110.925 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.75 138.8 36.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 60.34 110.865 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.535 HD12 HG22 ' A' ' 142' ' ' THR . 6.8 pt -139.37 167.22 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 75.13 111.121 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 m -117.75 147.73 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 63.43 111.131 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.468 HG21 HG13 ' A' ' 55' ' ' VAL . 88.8 t -100.67 142.66 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 75.42 111.115 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -128.9 147.35 50.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 63.34 110.915 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.631 HD23 HG13 ' A' ' 140' ' ' VAL . 14.8 mt -125.11 95.91 40.8 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.62 0.724 . . . . 54.23 110.894 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 72.4 1.43 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.674 2.25 . . . . 73.11 112.343 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.5 -34.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 70.2 110.942 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.449 ' CB ' HD13 ' A' ' 163' ' ' ILE . 2.9 m-85 -116.97 -13.51 10.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 64.33 110.985 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.17 25.37 5.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 62.41 110.926 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.508 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -98.13 118.0 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 73.22 111.151 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.39 137.14 41.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 43.4 110.875 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.784 HG22 HD13 ' A' ' 44' ' ' LEU . 19.4 t -118.94 65.15 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 72.52 111.08 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.25 -52.77 34.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 53.42 112.444 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 103.5 -132.07 10.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.796 -0.716 . . . . 43.41 112.463 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 34.0 m -65.14 -23.66 67.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 61.24 110.886 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.664 HD12 ' NE1' ' A' ' 189' ' ' TRP . 24.5 tp -64.02 -52.1 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.51 110.871 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.751 HG11 HG11 ' A' ' 206' ' ' VAL . 21.3 t -88.44 109.06 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 74.22 111.107 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.527 ' H ' HG23 ' A' ' 222' ' ' THR . 0.4 OUTLIER -81.37 149.87 28.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 61.44 110.923 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.631 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.3 t -72.42 164.32 26.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 60.02 110.889 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.569 HG23 HD23 ' A' ' 218' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 72.52 111.115 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.497 HG11 ' CG2' ' A' ' 186' ' ' VAL . 15.9 m . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.881 0.372 . . . . 74.12 111.162 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.29 -42.54 77.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 75.44 111.168 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.98 34.89 5.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.8 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.54 162.7 23.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 64.13 111.118 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -115.3 93.53 4.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 73.5 110.885 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.497 ' CG2' HG11 ' A' ' 181' ' ' VAL . 66.1 t -69.11 -21.29 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 63.22 111.154 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.39 -26.02 30.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 54.3 110.878 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -97.9 -21.08 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 70.13 110.87 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.664 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.4 t90 -51.15 -56.89 10.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 71.31 110.909 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 25.8 p -52.01 -36.91 51.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.856 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -70.82 -35.24 72.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 75.4 111.172 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 196' ' ' VAL . 50.7 m -66.47 -52.18 48.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 63.02 110.841 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.665 HG22 HD23 ' A' ' 197' ' ' LEU . 35.5 mm -56.47 -37.95 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 73.11 111.171 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -62.08 -24.15 66.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 72.04 110.879 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -89.35 -25.54 21.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 62.33 110.909 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.517 HG12 HD21 ' A' ' 219' ' ' LEU . 43.2 t -81.89 -33.59 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 71.43 111.194 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.665 HD23 HG22 ' A' ' 193' ' ' ILE . 4.6 pp -81.72 -25.53 35.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 72.31 110.904 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.452 ' N ' HD12 ' A' ' 197' ' ' LEU . 1.4 mttt -83.08 -44.4 15.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 74.31 110.928 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -56.21 -29.05 60.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 74.14 110.891 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -142.58 119.15 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 74.41 110.866 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.31 34.41 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 74.13 110.906 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.85 22.19 1.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 72.02 110.834 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.458 ' H ' HD12 ' A' ' 203' ' ' ILE . 3.5 mp -52.29 147.53 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.141 -0.481 . . . . 72.1 111.106 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -109.86 -25.77 10.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.109 -0.496 . . . . 72.4 110.909 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.508 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -163.58 132.54 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 65.53 111.124 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.751 HG11 HG11 ' A' ' 170' ' ' VAL . 89.0 t -115.12 122.15 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 75.21 111.097 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 213' ' ' VAL . 96.4 t -105.28 109.7 63.52 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.609 0.719 . . . . 64.41 111.141 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 52.8 Cg_endo -69.83 -167.99 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.711 2.274 . . . . 63.35 112.286 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.37 -32.23 6.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 62.51 112.522 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -138.49 101.16 4.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 74.55 110.887 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 150.99 -113.86 0.61 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 72.51 112.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.77 167.96 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 70.12 110.878 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 207' ' ' VAL . 21.7 t -71.31 150.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 62.04 111.123 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.75 -107.05 0.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 54.03 112.492 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -162.92 -170.15 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 73.44 110.836 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -20.33 37.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 75.21 110.942 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.754 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.89 -33.13 63.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.787 -0.72 . . . . 74.34 112.477 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.631 HD22 ' HA ' ' A' ' 172' ' ' SER . 31.5 mt -51.07 -45.35 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.874 0.369 . . . . 73.14 110.905 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.517 HD21 HG12 ' A' ' 196' ' ' VAL . 6.5 mp -55.93 -42.96 76.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.891 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.754 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -66.73 -41.41 87.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 70.4 110.963 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.652 ' NE2' HD21 ' A' ' 225' ' ' LEU . 85.8 t60 -61.58 -39.27 90.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 72.03 110.885 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.68 -42.85 62.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 73.32 111.15 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.801 ' HA ' HD12 ' A' ' 226' ' ' LEU . 26.4 mt -61.19 -40.43 93.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 75.5 110.962 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -39.62 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 63.12 110.858 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.652 HD21 ' NE2' ' A' ' 221' ' ' HIS . 12.6 mt -64.71 -26.28 68.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.93 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 223' ' ' LEU . 5.3 mt -85.6 -42.09 14.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 65.42 110.921 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.2 mttt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.891 179.786 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.878 0.37 . . . . 64.44 111.123 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.548 HD11 ' HE3' ' A' ' 74' ' ' LYS . 4.1 mm -90.3 153.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 75.5 111.132 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.23 172.29 13.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 71.01 110.884 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -107.22 179.0 4.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.875 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -63.65 -28.05 69.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.869 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -102.27 -33.82 9.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.14 -0.482 . . . . 64.32 111.132 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.58 -5.92 48.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 73.13 112.452 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.735 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.78 -33.09 21.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.762 0.315 . . . . 71.53 111.125 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.735 HG13 HG23 ' A' ' 15' ' ' THR . 8.6 mt -126.36 150.86 32.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 75.14 111.106 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 p -171.16 163.76 7.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 54.35 110.851 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.654 HD12 ' NZ ' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -129.25 -175.8 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 63.22 111.112 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.414 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.1 t -167.15 135.54 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.44 110.792 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -71.5 117.87 13.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.112 -0.495 . . . . 62.43 110.919 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.403 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.8 mm? -99.75 -73.11 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 71.44 110.93 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -132.31 -170.37 2.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.939 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' O ' HG23 ' A' ' 25' ' ' VAL . 11.4 mtpt -52.67 109.97 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 72.12 110.913 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 58.47 24.26 11.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.842 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 23' ' ' LYS . 92.7 t -123.28 114.94 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 63.04 111.128 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -124.76 160.64 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 73.52 110.875 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 213' ' ' VAL . 69.8 t -122.98 108.69 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.071 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.585 ' HB3' HG23 ' A' ' 18' ' ' ILE . 7.3 p80 -102.3 138.24 39.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 74.42 110.873 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.477 HG23 ' C ' ' A' ' 41' ' ' SER . 41.0 m -138.77 117.5 12.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 63.23 111.135 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -101.39 -172.89 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 43.23 110.919 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.503 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -141.28 130.45 23.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 54.21 110.905 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.747 -0.74 . . . . 62.53 112.479 179.914 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 61.1 t . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.567 0.699 . . . . 63.13 111.07 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.9 Cg_endo -69.72 142.67 48.76 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 72.21 112.322 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.477 ' C ' HG23 ' A' ' 29' ' ' THR . 0.9 OUTLIER -122.63 114.53 20.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 64.23 110.84 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -60.81 169.94 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 72.3 110.863 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.629 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -172.28 -166.68 31.25 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.701 -0.762 . . . . 75.24 112.466 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.014 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -163.2 145.52 10.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 65.21 110.832 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 HD13 ' A' ' 54' ' ' LEU . 36.8 t -129.67 134.13 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 64.41 111.136 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.7 mt -102.71 126.72 49.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 72.4 110.901 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -97.32 59.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 63.34 110.878 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.1 p -68.04 171.6 6.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 74.33 111.091 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -97.13 30.2 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 72.21 110.875 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -156.54 35.52 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 74.33 110.935 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.74 126.03 5.54 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.787 -0.721 . . . . 50.44 112.506 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.735 HD21 ' HB3' ' A' ' 75' ' ' PHE . 30.9 mt -56.81 172.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 62.51 110.956 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 81' ' ' ASP . 98.0 t -150.08 143.42 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.233 -0.439 . . . . 63.44 111.094 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.563 HD13 HG22 ' A' ' 45' ' ' VAL . 3.3 mm? -114.9 128.37 56.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.43 . . . . 65.31 110.944 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.0 t -77.67 -3.77 5.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.446 . . . . 74.31 111.181 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.44 134.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.861 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -167.02 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 70.14 110.873 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.4 m -97.33 -175.84 3.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 61.42 110.928 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.699 ' HB2' HD13 ' A' ' 63' ' ' LEU . 93.6 m95 -64.45 -38.38 90.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 74.21 110.97 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -142.94 167.16 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 74.11 110.829 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.73 -35.77 80.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 75.24 110.789 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -69.39 -23.47 63.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.1 110.92 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -83.8 -50.78 7.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 73.51 110.945 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -60.33 -29.49 68.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 75.4 111.121 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -55.5 -40.65 72.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 73.21 110.872 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -88.15 3.17 50.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 71.11 110.888 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.562 HD21 ' CE1' ' A' ' 28' ' ' HIS . 12.7 tp -98.45 -41.75 7.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 73.11 110.942 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.2 mt -65.54 -34.44 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 73.12 111.074 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -69.29 -11.13 60.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.11 110.958 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.4 mtp -81.82 -50.85 8.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 64.24 110.87 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.544 ' HB ' HD13 ' A' ' 52' ' ' LEU . 29.1 m -67.42 -37.0 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 74.41 111.16 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -79.11 51.85 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 63.44 110.956 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -137.16 -42.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 71.01 110.901 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.654 ' NZ ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -106.15 -19.71 13.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.919 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.735 ' HB3' HD21 ' A' ' 52' ' ' LEU . 24.7 m-85 -91.83 6.2 47.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.04 110.893 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.501 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.3 pp0? 32.19 48.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.849 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -150.87 -178.14 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.942 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.581 ' HD2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -130.53 138.91 50.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 72.42 110.859 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 52' ' ' LEU . 96.1 t -70.54 132.89 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 53.25 111.103 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.581 HG23 ' HD2' ' A' ' 78' ' ' ARG . 37.4 p -139.95 15.06 2.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 73.4 111.158 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.562 ' HB2' HG13 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -148.65 131.14 15.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 63.01 110.827 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 98' ' ' LEU . 20.5 t -134.04 99.34 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 65.14 111.077 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.4 mt -74.24 120.5 23.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 74.41 111.171 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 91' ' ' ARG . 45.1 mm -108.12 128.5 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.22 111.116 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.0 p -85.47 -58.01 2.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 71.14 111.127 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.582 ' HA ' HG23 ' A' ' 111' ' ' THR . 31.7 p-80 -128.97 -175.22 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.842 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -103.16 100.63 10.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 73.54 111.137 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.673 ' O ' HD13 ' A' ' 92' ' ' ILE . 3.6 m170 -154.4 160.96 41.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.02 110.908 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.84 -28.76 62.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 71.1 111.042 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.0 13.19 17.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 74.22 110.866 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.472 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.5 mpt_? -125.29 -50.78 1.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 70.2 110.877 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.673 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -119.54 15.44 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 72.24 111.133 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.88 -36.95 34.56 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.639 -0.791 . . . . 73.25 112.561 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.97 18.13 50.54 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.785 -0.721 . . . . 63.43 112.502 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.575 HG21 ' H ' ' A' ' 121' ' ' GLU . 5.0 tt -45.92 -31.13 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 73.52 111.127 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -55.09 18.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 73.34 110.948 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -57.54 -40.98 80.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 62.32 111.143 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.482 HD13 HG21 ' A' ' 82' ' ' VAL . 30.5 mt -58.31 -30.05 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 72.31 110.959 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -100.29 23.86 9.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 70.51 110.925 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -114.83 -30.39 6.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 70.23 110.87 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.0 mtp85 -100.26 -21.99 15.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 71.51 110.892 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.69 13.69 5.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 63.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.8 mt -81.85 155.8 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.94 0.4 . . . . 53.54 111.112 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.637 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -120.16 124.01 44.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 74.34 110.919 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.52 82.55 6.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 72.52 111.126 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.546 ' HA ' HD12 ' A' ' 124' ' ' LEU . 87.9 m-70 -51.73 143.45 12.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 75.13 110.849 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.73 151.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 73.14 110.832 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.646 HG22 ' HB3' ' A' ' 127' ' ' LEU . 60.9 p -74.87 175.02 8.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 75.22 111.148 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.26 83.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 51.43 111.03 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -65.93 -45.89 80.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 63.22 110.95 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.582 HG23 ' HA ' ' A' ' 86' ' ' HIS . 2.5 m -53.3 -40.68 64.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 44.04 111.179 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.561 ' HB1' ' OE2' ' A' ' 122' ' ' GLU . . . -73.41 -20.99 60.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 55.41 111.035 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -40.45 92.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.861 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.608 HD12 ' OD2' ' A' ' 152' ' ' ASP . 10.8 mt -87.97 -25.2 23.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 53.43 110.969 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.22 -65.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 63.11 111.118 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -23.83 63.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 61.4 110.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -23.03 67.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 73.54 110.89 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -95.67 -38.49 10.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 51.4 110.955 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.15 -5.64 3.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 75.14 112.543 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -59.5 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 70.22 110.91 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.575 ' H ' HG21 ' A' ' 95' ' ' ILE . 7.7 mm-40 -96.36 -2.88 44.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 71.35 110.908 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.561 ' OE2' ' HB1' ' A' ' 112' ' ' ALA . 1.6 mt-10 66.21 130.7 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.718 . . . . 71.32 110.884 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.71 2.273 . . . . 72.14 112.348 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' A' ' 104' ' ' LYS . 69.3 mt -53.51 -34.31 57.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.896 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.08 39.07 49.0 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 42.24 112.466 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -136.34 58.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 73.02 110.876 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.646 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -137.71 -169.86 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 53.54 110.894 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.36 -168.69 3.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.896 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.817 HG23 ' HB3' ' A' ' 144' ' ' TYR . 86.9 m -50.23 -65.32 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 70.31 111.05 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 143' ' ' PHE . 58.8 t -120.77 112.14 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 71.12 111.181 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.641 HG22 HD23 ' A' ' 133' ' ' LEU . 82.1 m -113.41 111.73 22.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 55.13 111.167 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -73.34 99.52 2.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 73.01 110.85 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.641 HD23 HG22 ' A' ' 131' ' ' THR . 2.9 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 62.22 110.885 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.1 tpt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.877 0.37 . . . . 72.51 110.862 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -134.49 117.39 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.9 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.695 HG13 HD23 ' A' ' 158' ' ' LEU . 10.9 t -130.5 156.13 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 75.11 111.108 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -153.21 123.78 7.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 61.23 110.852 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.691 ' O ' HG13 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -74.98 -178.03 3.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 74.41 111.151 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.754 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.4 t80 -175.45 137.49 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.24 110.819 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.817 ' HB3' HG23 ' A' ' 129' ' ' THR . 28.1 t80 -120.63 95.89 48.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.725 0.774 . . . . 74.42 110.884 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.2 Cg_endo -69.86 -48.74 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.653 2.235 . . . . 74.55 112.306 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.78 -155.94 24.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.771 -0.728 . . . . 53.22 112.512 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.0 124.68 39.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.741 0.305 . . . . 73.25 110.902 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.486 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.46 -94.51 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 71.42 112.453 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -69.83 -28.58 65.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 74.34 110.879 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.24 158.18 43.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 50.42 111.165 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -61.33 -25.42 67.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 70.32 110.949 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.673 ' HB3' HD12 ' A' ' 110' ' ' LEU . 1.3 p30 -121.42 49.57 1.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 74.12 110.901 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.0 OUTLIER -98.59 138.12 36.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 72.42 110.923 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.668 HD12 HG22 ' A' ' 142' ' ' THR . 7.4 pt -138.41 171.01 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 64.21 111.142 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.423 ' CG1' HD22 ' A' ' 169' ' ' LEU . 10.6 m -121.24 144.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 74.13 111.131 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.79 142.65 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 62.12 111.162 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -129.05 148.84 51.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 73.14 110.917 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.695 HD23 HG13 ' A' ' 140' ' ' VAL . 24.3 mt -125.65 94.74 41.83 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.618 0.723 . . . . 75.21 110.899 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 71.92 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.702 2.268 . . . . 63.32 112.347 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.59 -34.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 74.43 110.886 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.489 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.6 m-85 -117.7 -12.8 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 63.04 110.957 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.0 m120 69.18 25.29 5.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 45.11 110.898 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.518 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.6 mp -97.31 117.66 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.102 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.42 137.65 40.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 75.03 110.875 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 44' ' ' LEU . 20.7 t -121.35 63.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 63.35 111.103 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.93 -57.06 13.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 71.22 112.467 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.56 -135.57 12.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 72.3 112.485 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 34.7 m -61.49 -25.11 67.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 52.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.484 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.6 OUTLIER -63.3 -51.85 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 74.13 110.941 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 206' ' ' VAL . 39.8 t -89.91 103.55 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 72.4 111.15 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.517 ' H ' HG23 ' A' ' 222' ' ' THR . 1.1 tppt? -74.47 151.41 39.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 72.33 110.908 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.649 ' HA ' HD22 ' A' ' 218' ' ' LEU . 5.1 p -74.72 169.51 17.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.009 0.433 . . . . 50.41 110.804 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.507 HG23 HD23 ' A' ' 218' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.097 -0.501 . . . . 70.23 111.116 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.7 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.87 0.367 . . . . 74.32 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.38 -42.19 73.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 71.34 111.107 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -116.23 37.07 3.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 52.11 110.875 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.31 164.39 23.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 33.34 111.052 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -116.44 92.75 3.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 63.23 110.901 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.474 HG13 HD23 ' A' ' 226' ' ' LEU . 46.1 t -69.57 -22.62 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.32 111.091 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -80.65 -26.57 37.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 73.05 110.882 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -97.84 -22.76 16.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 75.51 110.964 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.5 -57.51 8.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 70.41 110.884 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.84 -35.93 46.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 62.02 110.801 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 94.0 m -72.74 -32.35 65.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 71.42 111.177 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.8 m -69.14 -52.67 25.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 63.23 110.88 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.681 HG22 HD23 ' A' ' 197' ' ' LEU . 34.0 mm -54.32 -41.8 54.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 75.22 111.086 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.71 -19.72 59.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.886 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -93.19 -23.87 18.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 65.33 110.919 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.432 HG12 HD21 ' A' ' 219' ' ' LEU . 33.3 t -85.65 -26.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.501 . . . . 73.04 111.159 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.681 HD23 HG22 ' A' ' 193' ' ' ILE . 4.6 pp -89.29 -25.29 21.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 65.3 110.912 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.477 ' N ' HD12 ' A' ' 197' ' ' LEU . 4.7 ptmm? -81.54 -31.37 32.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 70.43 110.922 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -72.67 -28.68 62.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 41.32 110.89 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -141.77 117.18 10.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 72.22 110.984 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -119.5 26.0 9.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 64.32 110.93 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.54 22.58 3.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 60.44 110.893 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.6 146.88 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 71.11 111.121 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -107.23 -25.7 11.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 72.15 110.871 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.482 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -164.07 133.39 3.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 43.55 111.163 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.747 ' CG1' HD12 ' A' ' 218' ' ' LEU . 97.9 t -114.16 124.0 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 50.43 111.133 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.014 HG21 HD11 ' A' ' 44' ' ' LEU . 52.1 t -107.35 104.87 54.18 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.629 0.728 . . . . 75.4 111.125 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.77 178.43 4.59 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.651 2.234 . . . . 50.31 112.307 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.05 -29.38 34.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 65.24 112.512 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -143.14 113.38 7.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 71.43 110.821 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 140.25 -112.61 0.82 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 75.55 112.478 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -155.05 166.55 33.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 74.1 110.888 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.763 HG22 HG22 ' A' ' 207' ' ' VAL . 21.8 t -72.41 150.03 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 51.15 111.168 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.35 -108.34 0.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.832 -0.699 . . . . 73.53 112.541 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -157.98 -173.33 4.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.931 0.396 . . . . 62.22 110.866 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -56.28 -21.53 24.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 72.32 110.869 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.749 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -55.41 -31.76 57.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 74.11 112.478 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.747 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.4 mt -50.91 -46.93 60.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.338 . . . . 75.44 110.869 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.446 ' O ' HG21 ' A' ' 193' ' ' ILE . 6.0 mp -55.06 -43.54 73.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 71.45 110.886 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.749 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -66.65 -41.55 88.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 64.21 110.875 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.696 ' NE2' HD21 ' A' ' 225' ' ' LEU . 85.1 t60 -61.46 -37.65 84.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 72.23 110.882 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.2 OUTLIER -51.76 -45.09 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 73.43 111.13 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.829 ' HA ' HD12 ' A' ' 226' ' ' LEU . 49.8 mt -58.16 -39.8 79.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.428 . . . . 74.2 110.872 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.47 -37.58 78.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.44 110.906 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.696 HD21 ' NE2' ' A' ' 221' ' ' HIS . 11.2 mt -68.67 -26.04 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 72.14 110.879 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.1 mt -86.68 -41.66 14.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 63.41 110.917 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 65.05 110.878 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 18' ' ' ILE . 92.8 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.773 0.32 . . . . 53.12 111.153 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.688 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.7 mm -93.26 154.3 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 74.33 111.127 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -149.12 164.02 35.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 65.31 110.938 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -94.7 -169.32 2.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.913 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -23.08 55.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.23 110.902 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.5 p -103.54 -35.99 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 65.21 111.137 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.07 -4.28 45.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 54.41 112.478 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.768 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.7 -33.36 22.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.687 0.28 . . . . 74.2 111.184 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.768 HG13 HG23 ' A' ' 15' ' ' THR . 6.7 mt -127.83 159.46 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 72.22 111.126 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -175.82 167.18 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 65.53 110.807 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.551 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -130.25 -175.78 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 71.53 111.198 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.405 ' H ' HG22 ' A' ' 18' ' ' ILE . 1.9 t -168.98 129.73 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 75.44 110.797 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.51 120.48 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 64.14 110.895 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.7 mm? -103.53 -47.24 4.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.967 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -148.51 54.57 1.01 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 62.43 110.93 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.43 -77.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 62.4 110.852 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -83.63 -19.46 35.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 62.25 110.893 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.57 118.86 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 55.44 111.1 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -125.25 158.91 32.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.158 -0.473 . . . . 64.25 110.894 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.404 HG23 ' HG ' ' A' ' 21' ' ' LEU . 73.0 t -121.86 109.52 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 72.12 111.113 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.551 ' HB3' HG23 ' A' ' 18' ' ' ILE . 7.2 p80 -103.23 138.51 39.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.805 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.7 m -135.39 133.55 38.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 61.33 111.171 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.562 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -124.39 174.61 7.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 73.53 110.881 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 40' ' ' PRO . 4.7 tp -121.0 148.24 44.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 75.14 110.852 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 74.4 112.493 179.933 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.567 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.2 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.681 0.753 . . . . 63.24 111.05 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.535 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.5 Cg_endo -69.71 143.03 49.76 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.625 2.217 . . . . 72.44 112.352 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.0 t -129.96 95.23 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 52.32 110.825 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.96 162.47 0.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 70.42 110.846 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.646 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -164.09 -162.85 15.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 64.41 112.459 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -162.43 148.23 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 74.22 110.859 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 54' ' ' LEU . 62.0 t -131.43 138.1 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 75.52 111.043 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.483 HD22 ' HE3' ' A' ' 138' ' ' MET . 24.8 mt -105.39 136.89 44.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.48 . . . . 70.05 110.903 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -110.24 72.12 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 63.13 110.863 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 138' ' ' MET . 20.7 p -79.47 -173.22 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 62.12 111.162 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 t -107.61 28.05 8.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 74.41 110.87 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -154.32 25.01 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 70.51 110.916 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.45 137.35 5.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 73.13 112.494 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.8 HD13 ' HB ' ' A' ' 71' ' ' VAL . 9.2 mt -68.65 164.36 21.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 72.34 110.9 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' ' 81' ' ' ASP . 84.4 t -140.0 144.51 27.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 64.44 111.088 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.639 HD13 HG22 ' A' ' 45' ' ' VAL . 3.3 mm? -115.28 130.35 56.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.915 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.514 HG13 HG21 ' A' ' 156' ' ' VAL . 12.7 t -79.57 -1.72 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 71.14 111.179 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.5 130.58 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 75.13 110.895 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.426 ' OG ' HD11 ' A' ' 98' ' ' LEU . 7.7 m -67.19 -168.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.836 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.47 -172.31 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 74.11 110.848 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.567 ' CZ2' HG13 ' A' ' 39' ' ' VAL . 86.5 m95 -72.9 -44.92 60.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.495 . . . . 73.32 110.888 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -132.68 151.12 52.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.913 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -54.55 -30.81 55.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.448 . . . . 73.13 110.853 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -76.75 -26.84 55.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.862 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 -46.23 17.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 74.44 110.933 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 t -56.12 -25.38 45.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 63.52 111.111 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -55.28 -43.63 74.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.894 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -81.54 -4.5 56.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 65.5 110.877 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.562 HD22 ' OE2' ' A' ' 30' ' ' GLU . 16.4 tp -93.84 -45.62 7.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.219 -0.446 . . . . 70.01 110.927 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.0 mt -69.91 -33.42 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 62.32 111.096 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -67.61 -12.64 60.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 70.32 110.956 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.9 mmm -84.74 -59.47 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 54.03 110.944 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.8 ' HB ' HD13 ' A' ' 52' ' ' LEU . 28.0 m -55.04 -36.26 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 71.23 111.2 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HG3' HG23 ' A' ' 71' ' ' VAL . 55.6 mt-10 -88.13 48.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 74.11 110.869 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -142.92 -41.87 0.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 70.45 110.939 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.688 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -102.58 -24.54 13.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 63.34 110.878 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.657 ' HB3' HD21 ' A' ' 52' ' ' LEU . 37.4 m-85 -90.34 11.32 21.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 65.4 110.873 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.506 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.5 pp0? 32.69 47.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 62.35 110.874 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -150.85 -178.43 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.881 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 149.16 50.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 75.23 110.87 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 52' ' ' LEU . 60.2 t -86.26 127.21 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 75.21 111.156 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 p -139.03 24.41 2.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 71.25 111.205 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.803 ' HB2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -153.74 133.51 13.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.889 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 82' ' ' VAL . 13.5 t -139.88 102.39 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 73.31 111.137 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.1 mt -79.11 115.68 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 62.4 111.134 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.483 HG23 ' HB3' ' A' ' 91' ' ' ARG . 46.4 mm -104.35 122.3 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 70.24 111.094 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.1 p -79.16 -58.25 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 74.13 111.148 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -127.36 -175.09 3.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 70.24 110.865 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -103.82 99.39 9.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 54.04 111.111 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.632 ' O ' HD13 ' A' ' 92' ' ' ILE . 4.5 m170 -152.88 159.66 43.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.834 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.69 -22.96 58.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 74.25 111.155 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.86 3.59 54.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 72.24 110.881 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HB3' HG23 ' A' ' 84' ' ' ILE . 25.5 mmt-85 -118.1 -52.17 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 71.54 110.867 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.632 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.78 19.31 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 72.2 111.133 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.84 -29.29 26.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 52.44 112.484 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.36 22.05 20.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 74.11 112.483 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 tt -45.38 -32.05 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 64.44 111.129 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -54.89 18.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 64.22 110.906 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 m -56.05 -40.02 72.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 63.0 111.207 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 103' ' ' ILE . 31.5 mt -59.22 -35.52 73.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 75.03 110.921 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.95 19.38 9.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 70.34 110.939 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.13 -25.95 6.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 52.54 110.92 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -106.48 7.52 30.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 73.23 110.801 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.99 14.69 66.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 61.42 112.49 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 98' ' ' LEU . 16.0 mt -80.79 154.19 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.877 0.37 . . . . 74.54 111.147 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.762 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.6 ptmt -117.41 119.56 35.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 71.21 110.863 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.05 81.3 6.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 54.31 111.052 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.606 ' HA ' HD12 ' A' ' 124' ' ' LEU . 93.8 m-70 -54.55 147.54 14.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 63.43 110.825 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.73 157.99 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 51.13 110.834 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 127' ' ' LEU . 20.3 p -82.35 157.68 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.42 111.146 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.34 -39.42 56.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.14 111.091 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -66.07 -40.98 91.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 65.31 110.926 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 96.8 m -56.29 -41.68 76.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.21 111.175 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.469 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -73.44 -22.58 60.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.4 111.064 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.66 -41.22 81.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 71.13 110.943 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.591 HD12 ' OD2' ' A' ' 152' ' ' ASP . 7.7 mt -84.05 -27.71 28.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 64.32 110.956 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.43 -69.49 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 40.22 111.144 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -55.19 -26.3 38.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 71.22 110.912 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -24.5 67.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 74.15 110.873 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -93.56 -39.08 11.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 64.22 110.91 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 137.24 -6.7 3.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 73.2 112.494 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -59.75 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.931 0.396 . . . . 64.32 110.906 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -97.55 -1.76 43.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.041 -0.527 . . . . 75.33 110.925 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.469 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.3 mt-10 66.38 129.93 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.601 0.715 . . . . 54.53 110.938 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.42 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.708 2.272 . . . . 70.35 112.338 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.762 HD11 ' HB2' ' A' ' 104' ' ' LYS . 91.4 mt -51.96 -46.53 64.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.888 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.86 57.75 14.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.798 -0.715 . . . . 51.34 112.509 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -152.09 51.07 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 72.35 110.869 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.655 ' HB3' HG22 ' A' ' 108' ' ' THR . 1.3 mp -129.91 -177.47 4.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.88 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.58 -168.38 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.22 110.906 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.755 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.0 m -49.73 -45.21 49.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.14 111.119 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 143' ' ' PHE . 3.6 m -141.31 142.6 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 73.44 111.157 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 HD23 ' A' ' 133' ' ' LEU . 63.6 m -149.56 110.89 4.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 72.43 111.139 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.02 98.93 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.834 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.637 HD23 HG22 ' A' ' 131' ' ' THR . 2.8 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 72.45 110.887 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.782 ' HB2' HG22 ' A' ' 48' ' ' THR . 3.1 tpp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.775 0.321 . . . . 52.34 110.899 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.66 119.42 27.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 54.01 110.864 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.567 HG13 HD23 ' A' ' 158' ' ' LEU . 3.9 t -136.44 159.89 37.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 71.02 111.115 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 31.7 tt0 -163.12 123.67 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 74.34 110.915 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.0 178.3 4.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 74.44 111.156 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.428 ' HA ' HG12 ' A' ' 130' ' ' VAL . 75.2 t80 -172.72 135.03 0.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 72.24 110.836 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.755 ' HB3' HG23 ' A' ' 129' ' ' THR . 68.4 t80 -117.21 92.13 38.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.763 0.792 . . . . 70.11 110.964 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.6 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.642 2.228 . . . . 51.4 112.345 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.02 -170.46 43.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.806 -0.712 . . . . 72.14 112.537 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -83.78 125.14 31.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 61.11 110.924 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.48 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.73 -87.23 0.23 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 71.12 112.468 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -77.89 -28.57 49.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 72.21 110.761 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.16 159.39 43.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.2 111.136 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.05 -23.66 67.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.828 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.604 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -125.29 52.89 1.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 71.31 110.921 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.7 p30 -100.35 148.3 24.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.851 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.7 pt -147.04 162.5 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 63.35 111.128 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.502 HG11 HG21 ' A' ' 196' ' ' VAL . 8.0 m -109.73 139.01 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.13 111.202 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.514 HG21 HG13 ' A' ' 55' ' ' VAL . 74.5 t -93.35 129.18 44.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 65.12 111.07 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.437 ' O ' HD23 ' A' ' 158' ' ' LEU . 74.2 t-105 -117.06 150.6 38.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 71.24 110.946 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 163' ' ' ILE . 26.3 mt -127.05 97.64 31.84 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.619 0.723 . . . . 73.32 110.992 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 70.86 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.684 2.256 . . . . 74.45 112.339 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.35 -34.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 70.23 110.884 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.619 ' CB ' HD13 ' A' ' 163' ' ' ILE . 7.0 m-85 -118.34 -11.64 10.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 64.25 110.886 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.0 m120 67.34 21.97 9.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 74.11 110.892 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.619 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.5 mp -86.15 115.26 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 64.44 111.155 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.6 tm? -98.98 123.14 43.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 71.42 110.912 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.629 HG21 HD22 ' A' ' 44' ' ' LEU . 18.3 t -117.58 73.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 63.25 111.086 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.402 ' H ' HD13 ' A' ' 164' ' ' LEU . . . -64.06 -45.63 93.36 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.732 . . . . 52.41 112.521 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.42 -131.21 10.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 52.41 112.557 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.9 m -63.33 -22.45 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.818 0.342 . . . . 71.31 110.857 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.451 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.9 OUTLIER -64.9 -50.01 68.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.919 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.764 HG11 HG11 ' A' ' 206' ' ' VAL . 21.3 t -93.02 112.92 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 70.14 111.148 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.421 ' H ' HG23 ' A' ' 222' ' ' THR . 3.5 tppt? -83.0 154.45 24.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 62.12 110.882 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.617 ' HA ' HD22 ' A' ' 218' ' ' LEU . 15.8 p -78.13 162.11 26.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 74.01 110.889 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.591 HG23 HD23 ' A' ' 218' ' ' LEU . 1.5 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 72.3 111.198 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.557 HG11 ' CG2' ' A' ' 186' ' ' VAL . 11.1 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.785 0.326 . . . . 60.23 111.155 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.73 83.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 32.32 111.092 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -119.2 34.83 5.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.01 110.858 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -125.13 164.85 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.11 111.106 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -117.61 92.17 3.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.93 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.557 ' CG2' HG11 ' A' ' 181' ' ' VAL . 87.7 t -69.64 -23.88 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 73.25 111.108 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.28 -26.48 42.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.79 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.69 -24.07 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 72.51 110.879 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.55 -54.49 26.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 71.22 110.928 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -34.55 44.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 65.52 110.813 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 61.4 m -74.29 -35.71 63.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 62.13 111.15 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 196' ' ' VAL . 45.6 m -66.07 -55.55 16.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 54.35 110.905 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.792 HG22 HD23 ' A' ' 197' ' ' LEU . 34.3 mm -54.21 -46.99 68.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 64.35 111.122 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.38 -22.31 53.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.948 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -91.29 -25.03 19.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 42.32 110.917 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.502 HG21 HG11 ' A' ' 155' ' ' VAL . 91.8 t -84.05 -24.27 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 75.1 111.12 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.792 HD23 HG22 ' A' ' 193' ' ' ILE . 3.9 pp -95.85 -8.13 34.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 53.25 110.979 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.625 ' HG2' HD12 ' A' ' 197' ' ' LEU . 2.7 mmmt -113.15 -5.87 13.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 62.25 110.873 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -88.5 -23.83 23.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 72.14 110.838 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -118.41 -60.87 1.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.948 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.75 25.75 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 75.24 110.855 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.95 21.75 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.858 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.528 HG21 ' CG2' ' A' ' 206' ' ' VAL . 4.0 mp -55.33 145.0 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 63.34 111.134 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -106.86 -31.36 8.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.33 110.922 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.506 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -160.07 117.46 2.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 70.4 111.155 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.764 HG11 HG11 ' A' ' 170' ' ' VAL . 97.9 t -95.86 125.62 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 51.21 111.15 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 44' ' ' LEU . 58.4 t -107.46 109.07 62.47 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.581 0.705 . . . . 64.11 111.159 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -169.95 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.658 2.239 . . . . 73.11 112.35 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -106.49 -24.53 6.72 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.753 -0.736 . . . . 73.23 112.479 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -146.07 84.0 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 73.53 110.813 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 168.13 -102.0 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.759 . . . . 71.24 112.513 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.34 147.33 4.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.867 0.365 . . . . 72.01 110.876 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.62 143.89 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.132 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.56 -102.96 0.46 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 24.13 112.509 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -161.41 -169.83 2.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.801 0.334 . . . . 75.5 110.874 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -56.49 -21.77 28.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.865 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.753 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.82 -33.57 56.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.78 -0.724 . . . . 73.51 112.523 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.755 HD12 HG12 ' A' ' 206' ' ' VAL . 31.3 mt -50.86 -49.37 59.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 54.24 110.923 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.537 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -53.64 -42.25 67.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 71.22 110.89 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.753 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.7 mt -67.6 -41.39 84.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 52.31 110.93 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.4 -35.59 79.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.856 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -58.36 -45.17 88.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 75.45 111.191 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.713 ' HA ' HD12 ' A' ' 226' ' ' LEU . 82.4 mt -56.8 -37.86 71.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.963 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -42.81 97.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 72.55 110.946 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.25 -35.19 78.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 51.33 110.933 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.8 mt -78.57 -29.49 46.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 63.44 110.862 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.4 mttp . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 71.43 110.834 179.925 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.3 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.863 0.364 . . . . 72.24 110.838 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -172.63 162.65 5.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 71.04 110.933 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.6 mptt 55.96 84.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 63.21 110.909 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -145.17 147.85 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.34 111.216 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -106.1 57.91 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 72.33 110.878 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -121.25 150.69 40.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 72.21 110.962 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -147.89 -179.81 7.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 64.45 111.162 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 18' ' ' ILE . 91.5 t 61.08 97.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 72.4 111.137 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.73 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.1 mm -89.85 153.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 74.45 111.112 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -145.7 153.09 40.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 74.11 110.934 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -92.2 165.51 13.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.292 -0.413 . . . . 75.25 110.882 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.96 -35.13 45.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 60.45 110.844 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -88.06 -31.61 19.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.52 111.131 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.02 -12.9 67.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 73.11 112.523 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.727 HG23 HG13 ' A' ' 16' ' ' ILE . 2.2 t -51.05 -32.26 21.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 72.14 111.156 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.727 HG13 HG23 ' A' ' 15' ' ' THR . 16.5 mt -121.72 147.73 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 60.24 111.125 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -167.57 169.34 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 53.21 110.856 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.531 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -134.52 -176.04 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 64.33 111.117 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.3 t -166.97 133.79 2.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 65.43 110.859 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -70.17 118.12 12.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 75.41 110.875 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HG ' HG23 ' A' ' 27' ' ' VAL . 2.7 mm? -102.92 -42.36 5.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.924 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.62 -169.95 3.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 71.44 110.859 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 -47.61 63.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 73.3 110.919 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -134.59 28.69 3.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.905 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.43 120.57 60.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.089 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.46 ' CH2' HG22 ' A' ' 7' ' ' THR . 16.0 m95 -125.66 159.28 32.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.938 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 213' ' ' VAL . 73.5 t -121.74 108.62 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 65.21 111.122 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.531 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.0 p80 -101.17 138.26 38.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.33 110.832 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.1 m -137.01 124.39 21.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 60.12 111.156 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.589 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -110.68 177.46 4.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 51.4 110.888 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.775 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.3 OUTLIER -132.78 135.76 45.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 74.21 110.929 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -138.53 127.49 3.8 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.724 -0.751 . . . . 70.32 112.499 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.22 146.63 6.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.391 . . . . 62.55 110.834 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -172.19 122.41 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 73.41 110.889 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 62.07 35.01 16.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 62.14 110.855 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.33 29.32 74.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.754 -0.736 . . . . 62.21 112.49 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -151.14 179.79 7.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 70.03 110.875 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.775 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -104.08 138.99 39.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 74.55 111.059 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.773 HG11 ' HD2' ' A' ' 303' ' ' RTD . 98.1 t -137.01 104.11 8.89 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.646 0.736 . . . . 43.33 111.189 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.7 Cg_endo -69.67 142.7 49.03 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.641 2.227 . . . . 70.33 112.451 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -124.15 105.52 9.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 54.22 110.848 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -59.42 159.48 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 54.25 110.845 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.639 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -160.56 -160.22 10.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.74 . . . . 41.05 112.545 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.953 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -164.91 144.93 7.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 74.3 110.872 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 54' ' ' LEU . 54.1 t -128.62 134.76 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 73.32 111.078 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.49 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 19.2 mt -103.47 136.13 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 63.42 110.952 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -106.34 74.82 1.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.818 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.6 p -83.1 177.84 8.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 73.51 111.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.44 30.51 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 70.43 110.845 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -155.6 24.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 50.22 110.893 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.61 130.81 4.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 65.42 112.457 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.775 HD21 ' HB3' ' A' ' 75' ' ' PHE . 16.7 mt -59.98 166.76 2.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.845 0.355 . . . . 72.11 110.855 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 81' ' ' ASP . 60.1 t -141.17 144.59 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.11 111.168 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -116.77 128.23 55.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.932 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 55' ' ' VAL . 15.1 t -77.95 -3.04 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 70.11 111.136 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 179.23 132.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 72.53 110.87 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -71.34 -167.08 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 73.23 110.818 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.56 -173.28 2.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 71.32 110.825 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.798 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.4 m95 -67.55 -42.01 83.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 75.52 110.891 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.85 161.48 37.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 62.34 110.857 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.99 -38.07 69.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 64.42 110.86 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -71.45 -23.93 61.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 75.42 110.879 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -82.3 -45.1 15.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 71.44 110.93 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.0 t -67.02 -25.37 66.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 53.3 111.149 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -53.09 -39.2 63.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 64.23 110.901 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -85.54 -14.56 45.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 71.32 110.827 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.589 HD22 ' OE2' ' A' ' 30' ' ' GLU . 15.2 tp -77.76 -45.57 24.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.964 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.9 mt -71.73 -33.28 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.12 111.12 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.88 -17.15 62.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 72.51 110.846 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.2 mmm -85.43 -55.55 3.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.825 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.748 ' HB ' HD13 ' A' ' 52' ' ' LEU . 27.3 m -57.22 -37.2 55.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 71.23 111.068 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HG3' HG23 ' A' ' 71' ' ' VAL . 57.3 mt-10 -86.71 49.95 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 62.4 110.851 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tpmp? -145.43 -42.13 0.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.908 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.73 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.82 -23.43 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 73.43 110.843 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.775 ' HB3' HD21 ' A' ' 52' ' ' LEU . 34.6 m-85 -90.04 11.24 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 75.02 110.923 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.51 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.92 46.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 74.41 110.892 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -154.29 -178.59 7.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 62.35 110.863 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.42 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -127.09 149.49 49.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.2 110.825 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 52' ' ' LEU . 68.5 t -84.1 126.63 40.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 71.22 111.099 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.42 HG23 ' HD3' ' A' ' 78' ' ' ARG . 22.5 p -135.8 26.55 3.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 50.01 111.175 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.754 ' HB2' HG22 ' A' ' 53' ' ' VAL . 8.7 m-20 -158.33 135.27 9.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.865 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.643 HG21 ' CD2' ' A' ' 98' ' ' LEU . 20.5 t -140.55 99.87 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 71.41 111.079 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.9 mt -77.21 126.0 37.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 73.54 111.06 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.646 HG23 ' HB3' ' A' ' 91' ' ' ARG . 34.6 mm -112.99 123.27 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 71.22 111.165 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.1 p -81.0 -52.81 7.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 75.44 111.125 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -135.33 167.63 20.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.853 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -86.89 98.7 11.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 70.55 111.145 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.651 ' O ' HD13 ' A' ' 92' ' ' ILE . 1.4 m170 -153.0 160.38 43.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 74.42 110.863 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.31 -28.09 62.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 75.51 111.027 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.09 11.13 21.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.833 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.646 ' HB3' HG23 ' A' ' 84' ' ' ILE . 4.9 mmt180 -123.83 -52.62 1.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 72.11 110.924 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.79 16.92 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 70.55 111.165 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.42 -27.74 26.24 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.729 -0.748 . . . . 72.35 112.47 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.79 19.26 30.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.652 -0.785 . . . . 33.24 112.414 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.439 HG21 ' H ' ' A' ' 121' ' ' GLU . 4.2 tt -48.73 -30.64 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 63.25 111.214 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -68.45 -43.97 75.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 63.24 110.855 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -69.38 -33.48 73.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 64.14 111.163 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.643 ' CD2' HG21 ' A' ' 82' ' ' VAL . 58.8 mt -63.75 -27.3 69.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 72.41 110.973 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.71 19.07 16.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 74.02 110.933 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.75 -23.87 7.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.911 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -110.87 10.02 22.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 72.03 110.865 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.17 18.76 66.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 70.14 112.471 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.0 mt -83.18 157.59 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 70.25 111.105 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.67 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -121.3 119.78 33.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 64.3 110.895 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.527 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . . . -89.05 79.56 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 74.43 111.151 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.581 ' HA ' HD12 ' A' ' 124' ' ' LEU . 96.9 m-70 -54.36 146.98 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 74.21 110.909 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.5 163.86 0.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.923 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 127' ' ' LEU . 81.1 p -80.37 154.9 27.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 61.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.59 -29.88 19.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 44.13 111.104 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 152' ' ' ASP . 6.6 tp -74.87 -43.25 55.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.935 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.699 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.0 m -53.19 -27.44 21.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.474 . . . . 63.25 111.17 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.3 -28.02 21.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.056 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -60.12 -25.17 65.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.413 . . . . 75.32 110.887 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.653 HD12 ' OD1' ' A' ' 152' ' ' ASP . 47.6 mt -99.07 -24.67 14.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.486 . . . . 65.23 110.88 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.65 -63.14 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.11 111.106 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -55.62 -25.74 40.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 74.33 110.855 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -24.67 65.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 71.14 110.875 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -95.32 -28.33 15.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 73.1 110.863 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.07 -5.44 7.82 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 71.4 112.442 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -59.6 -173.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 73.15 110.926 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.439 ' H ' HG21 ' A' ' 95' ' ' ILE . 25.4 mm-40 -99.65 1.09 43.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.489 . . . . 53.14 110.911 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 65.69 122.84 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.719 0.771 . . . . 74.25 110.916 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.73 -170.52 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.647 2.231 . . . . 74.12 112.37 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 104' ' ' LYS . 60.1 mt -52.16 -40.49 61.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.44 110.877 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.03 59.59 8.61 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 62.01 112.547 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -152.75 51.23 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 73.21 110.889 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB3' HG22 ' A' ' 108' ' ' THR . 1.2 mp -130.1 -175.74 3.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 63.42 110.913 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.44 -167.93 2.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 60.1 110.952 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.794 HG23 ' HB3' ' A' ' 144' ' ' TYR . 96.3 m -49.15 -43.41 41.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 73.51 111.176 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 142' ' ' THR . 3.6 m -141.47 141.7 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 74.23 111.093 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 HD23 ' A' ' 133' ' ' LEU . 60.7 m -148.88 112.14 4.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.173 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -73.34 96.06 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 74.25 110.831 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.642 HD23 HG22 ' A' ' 131' ' ' THR . 3.7 mt -85.17 149.51 25.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 51.31 110.889 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.77 107.09 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.11 110.904 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.55 ' HB2' HG21 ' A' ' 48' ' ' THR . 23.6 m-85 -110.61 111.14 22.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 65.4 110.888 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 55.79 -100.55 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 24.11 112.47 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -120.02 59.55 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 74.31 110.86 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.73 ' HB2' HG22 ' A' ' 48' ' ' THR . 3.0 tpp -147.99 155.01 41.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 63.55 110.88 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 118.45 25.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.55 110.872 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.665 HG13 HD23 ' A' ' 158' ' ' LEU . 4.5 t -134.98 159.18 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 73.41 111.169 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.412 ' N ' HG12 ' A' ' 140' ' ' VAL . 32.3 tt0 -158.98 124.45 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 61.42 110.98 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.41 ' O ' HG12 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -75.16 178.5 5.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 55.4 111.096 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -171.98 136.76 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.842 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.794 ' HB3' HG23 ' A' ' 129' ' ' THR . 33.0 t80 -116.19 92.95 37.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.751 0.786 . . . . 74.34 110.896 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -48.72 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.615 2.21 . . . . 73.13 112.29 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.56 -170.38 42.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 72.11 112.479 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -84.26 123.61 30.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 75.13 110.938 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.492 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.18 -89.72 0.24 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.769 -0.729 . . . . 64.35 112.534 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -74.18 -28.27 61.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.367 . . . . 73.21 110.896 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.96 157.81 43.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 62.15 111.204 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -62.45 -25.14 67.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 43.5 110.891 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.653 ' OD1' HD12 ' A' ' 114' ' ' LEU . 16.0 p30 -123.28 52.06 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.901 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.523 ' OD1' HD13 ' A' ' 169' ' ' LEU . 2.0 p30 -99.94 142.71 31.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.968 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.8 pt -144.28 158.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 75.12 111.173 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 196' ' ' VAL . 18.4 m -105.11 150.5 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.44 111.113 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 96.0 t -102.56 139.05 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 72.05 111.116 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -126.99 150.71 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 74.42 110.904 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.665 HD23 HG13 ' A' ' 140' ' ' VAL . 20.7 mt -128.84 95.72 31.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.594 0.711 . . . . 75.41 110.853 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 72.18 1.51 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.699 2.266 . . . . 61.2 112.307 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.47 -34.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 65.14 110.908 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.535 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.6 m-85 -117.95 -13.21 10.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.976 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.8 m120 69.0 26.19 5.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 64.2 110.918 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.549 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.6 mp -96.83 117.61 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 51.41 111.107 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.13 138.04 41.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 71.24 110.946 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.499 HG21 HD22 ' A' ' 44' ' ' LEU . 21.7 t -121.52 68.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.31 111.143 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.37 -51.81 35.33 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.552 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 98.22 -135.44 12.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 52.43 112.501 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 31.4 m -62.22 -26.09 68.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 73.25 110.889 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.523 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.4 OUTLIER -66.14 -49.5 67.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 54.04 110.907 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 206' ' ' VAL . 57.7 t -92.24 96.18 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 71.34 111.099 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -69.06 153.13 44.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.35 110.955 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.698 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.7 p -74.87 167.06 22.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.857 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.447 HG23 HD23 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -68.85 -42.11 77.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 75.32 111.152 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.41 -29.27 65.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.238 -0.437 . . . . 74.43 110.833 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.36 160.28 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 73.32 111.079 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -117.88 -32.4 4.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.907 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.27 -177.08 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.828 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.538 HD22 ' CE3' ' A' ' 189' ' ' TRP . 0.6 OUTLIER -87.23 -36.93 17.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.948 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.46 -154.29 21.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.672 -0.775 . . . . 64.41 112.5 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -52.08 126.75 19.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 72.11 110.878 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 186' ' ' VAL . 17.1 m -123.56 29.96 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 63.01 111.124 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.7 -46.85 83.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 74.44 111.111 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.56 40.99 2.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 55.51 110.792 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -134.02 165.64 24.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.11 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -116.9 92.25 3.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.889 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.469 ' CG2' HG11 ' A' ' 181' ' ' VAL . 90.3 t -69.59 -23.81 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 52.1 111.19 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -25.81 39.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.131 -0.486 . . . . 74.52 110.904 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -97.75 -23.55 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 70.4 110.937 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.538 ' CE3' HD22 ' A' ' 178' ' ' LEU . 1.2 t90 -51.29 -54.42 26.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.974 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.3 t -51.88 -33.77 38.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 71.34 110.893 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 82.3 m -76.33 -34.01 59.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 42.24 111.182 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.9 m -66.36 -53.22 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 70.25 110.87 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.784 HG22 HD23 ' A' ' 197' ' ' LEU . 34.6 mm -56.3 -43.15 76.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 73.33 111.163 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.76 -19.77 59.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 70.54 110.884 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -91.63 -31.09 15.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 50.1 110.858 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.503 ' CG1' HD21 ' A' ' 219' ' ' LEU . 94.2 t -75.5 -50.74 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.11 111.101 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.784 HD23 HG22 ' A' ' 193' ' ' ILE . 3.9 pp -65.08 -24.34 67.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 54.3 110.91 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.43 -43.78 15.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.92 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -52.95 -28.97 26.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.41 110.907 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -144.47 119.94 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.91 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.92 41.05 2.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 71.44 110.817 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.4 21.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.35 110.795 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -52.47 146.83 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 73.45 111.147 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.66 -28.87 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 74.43 110.902 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.447 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -159.61 139.28 11.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 74.11 111.069 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 170' ' ' VAL . 84.6 t -123.18 126.04 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 60.34 111.146 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.953 HG21 HD11 ' A' ' 44' ' ' LEU . 55.8 t -107.66 113.12 61.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 70.51 111.077 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -170.27 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.687 2.258 . . . . 73.34 112.33 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.57 -31.25 7.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.67 -0.776 . . . . 74.45 112.489 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -143.5 94.61 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.827 0.346 . . . . 75.03 110.883 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 160.38 -114.94 0.63 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 74.34 112.454 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -150.27 162.77 39.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.957 0.408 . . . . 71.53 110.864 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.793 HG22 HG22 ' A' ' 207' ' ' VAL . 22.0 t -67.95 150.23 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 72.32 111.095 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.45 -108.81 0.56 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.772 -0.728 . . . . 64.23 112.551 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -159.81 -169.83 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 75.44 110.834 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -58.25 -20.19 40.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 73.52 110.899 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -57.67 -32.27 65.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.778 -0.725 . . . . 51.22 112.485 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.698 HD22 ' HA ' ' A' ' 172' ' ' SER . 32.1 mt -51.03 -42.99 60.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.352 . . . . 65.33 110.892 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.503 HD21 ' CG1' ' A' ' 196' ' ' VAL . 1.0 OUTLIER -60.43 -45.25 94.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 54.22 110.829 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.752 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -64.27 -42.24 96.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 52.2 110.922 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.682 ' NE2' HD21 ' A' ' 225' ' ' LEU . 78.7 t60 -63.86 -39.67 94.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.963 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.5 m -51.75 -42.49 62.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 64.4 111.122 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' A' ' 226' ' ' LEU . 78.6 mt -59.95 -39.91 87.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.92 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -28.03 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.43 110.849 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.682 HD21 ' NE2' ' A' ' 221' ' ' HIS . 20.6 mt -72.27 -25.81 61.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 73.43 110.925 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.6 mt -87.42 -43.06 12.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 74.13 110.921 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 54.43 110.888 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.773 ' HD2' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.8 m . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.866 0.365 . . . . 64.31 110.895 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -124.36 132.94 53.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 60.55 110.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.14 136.95 3.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 74.11 110.912 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.1 p -176.22 145.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 75.34 111.109 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -137.79 66.13 1.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 61.02 110.892 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -148.83 155.02 40.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 71.2 110.929 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.586 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -146.56 178.38 8.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 71.4 111.089 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.582 HG22 ' OG ' ' A' ' 19' ' ' SER . 88.4 t 60.54 94.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 55.13 111.071 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.88 155.78 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 71.15 111.156 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -145.58 146.62 31.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.913 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 173.72 9.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 73.35 110.94 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.82 -36.01 77.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 61.21 110.893 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.459 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.3 p -95.17 -24.9 16.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 71.41 111.086 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.94 -11.3 57.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.728 . . . . 41.45 112.425 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.808 HG23 HG13 ' A' ' 16' ' ' ILE . 3.7 t -51.09 -33.28 25.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 54.42 111.119 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.808 HG13 HG23 ' A' ' 15' ' ' THR . 18.8 mt -121.64 148.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.04 111.13 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 p -169.2 165.56 10.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 75.23 110.87 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.577 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -132.15 -172.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 70.12 111.134 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.582 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -173.45 134.64 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 75.14 110.876 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.96 119.93 14.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 54.14 110.872 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.406 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.4 mm? -100.96 -55.02 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.882 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -138.47 53.99 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 73.41 110.894 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mttt 68.0 -76.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 71.53 110.88 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -84.11 -19.52 34.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 63.3 110.916 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.21 121.28 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 64.34 111.164 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.586 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.0 m95 -125.45 160.23 29.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.947 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.406 HG23 ' HG ' ' A' ' 21' ' ' LEU . 72.8 t -122.4 112.44 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 62.34 111.081 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.577 ' HB3' HG23 ' A' ' 18' ' ' ILE . 8.7 p80 -105.47 137.6 43.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 65.14 110.93 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 m -133.34 127.72 34.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 51.14 111.137 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.646 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -118.11 164.98 14.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.914 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.637 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 5.3 tp -118.84 143.3 47.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.91 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 39' ' ' VAL . . . -158.42 137.01 5.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 72.3 112.508 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.3 137.41 50.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.953 0.406 . . . . 33.45 110.888 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -103.45 -32.55 9.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 72.33 110.914 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -171.31 34.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 51.24 110.916 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.05 6.89 8.83 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.707 -0.759 . . . . 44.45 112.495 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -152.83 127.28 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 70.41 110.937 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.637 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -67.2 133.88 50.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 61.22 111.08 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.66 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.3 p -126.11 126.72 24.77 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.587 0.708 . . . . 63.2 111.172 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.493 ' CA ' HD12 ' A' ' 31' ' ' LEU . 53.8 Cg_endo -69.81 143.43 50.57 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.64 2.227 . . . . 50.21 112.349 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -130.92 95.87 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 74.44 110.857 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -51.94 155.21 1.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 62.21 110.843 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.621 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -155.97 -158.45 8.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.657 -0.782 . . . . 65.44 112.441 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.865 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -166.06 143.91 5.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 74.32 110.942 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.58 HG22 HD13 ' A' ' 54' ' ' LEU . 50.6 t -126.95 142.7 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 63.12 111.152 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.1 mt -111.92 127.5 55.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 53.3 110.908 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -93.33 48.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.871 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.6 p -56.52 166.18 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 60.34 111.127 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.5 t -95.99 34.17 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 72.4 110.843 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -157.65 28.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.43 110.9 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.6 124.1 4.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 75.32 112.516 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.772 HD13 ' HB ' ' A' ' 71' ' ' VAL . 20.1 mt -51.72 161.31 0.54 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.801 0.334 . . . . 74.12 110.88 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.774 HG22 ' HB2' ' A' ' 81' ' ' ASP . 59.8 t -139.74 144.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.114 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.58 HD13 HG22 ' A' ' 45' ' ' VAL . 3.5 mm? -116.63 129.93 56.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.003 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.5 t -80.36 -0.36 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 64.24 111.111 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -179.72 132.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.54 110.845 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 m -71.24 -169.04 0.35 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.216 -0.447 . . . . 75.54 110.851 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.79 -170.75 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 74.2 110.843 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.776 ' HB2' HD13 ' A' ' 63' ' ' LEU . 93.1 m95 -72.86 -40.46 65.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.891 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.77 162.31 35.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 63.21 110.933 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.43 -33.51 67.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 71.23 110.91 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -75.63 -25.46 56.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 71.1 110.958 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -81.75 -41.82 20.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.487 . . . . 72.4 110.939 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -68.03 -26.43 65.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.19 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.1 -43.69 70.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.936 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.05 -13.91 54.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.934 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.646 HD22 ' OE2' ' A' ' 30' ' ' GLU . 17.8 tp -77.35 -45.38 26.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.506 . . . . 75.42 110.926 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.22 -26.72 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 61.02 111.12 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.21 -10.15 59.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 74.34 110.891 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.0 mmm -90.82 -53.0 4.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 52.43 110.834 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.772 ' HB ' HD13 ' A' ' 52' ' ' LEU . 21.5 m -58.4 -39.85 76.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 72.33 111.155 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 71' ' ' VAL . 53.4 mt-10 -84.29 51.09 2.0 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 65.42 110.877 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.14 -41.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 71.13 110.953 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.5 -19.18 13.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 71.22 110.848 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.671 ' HB3' HD21 ' A' ' 52' ' ' LEU . 24.2 m-85 -88.15 9.52 22.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 75.43 110.924 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.96 46.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 71.03 110.862 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -154.32 -179.15 7.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 73.53 110.902 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.21 149.39 51.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 75.43 110.884 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 52' ' ' LEU . 69.9 t -82.22 128.43 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 75.15 111.13 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.5 p -138.94 23.04 2.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 75.4 111.15 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.774 ' HB2' HG22 ' A' ' 53' ' ' VAL . 3.7 m-20 -154.93 132.6 11.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.226 -0.443 . . . . 72.42 110.846 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.637 HG21 HD22 ' A' ' 98' ' ' LEU . 23.4 t -138.6 99.89 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 62.42 111.091 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.0 mt -79.3 124.84 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 73.41 111.129 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 91' ' ' ARG . 38.2 mm -111.51 132.88 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 75.35 111.171 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.5 p -89.05 -55.89 3.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 75.5 111.2 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -133.55 162.37 32.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.32 110.807 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -81.34 97.21 7.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 72.43 111.084 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.635 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.5 OUTLIER -150.91 158.54 44.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 74.53 110.859 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.44 -25.59 59.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.33 111.086 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.37 13.17 18.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 72.32 110.894 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.442 ' O ' HD12 ' A' ' 84' ' ' ILE . 3.3 mpt_? -128.12 -52.36 1.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 64.02 110.85 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.76 16.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 61.22 111.051 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.85 -27.52 21.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 44.43 112.512 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.11 20.83 23.33 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.723 . . . . 52.12 112.491 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' H ' ' A' ' 121' ' ' GLU . 4.5 tt -48.48 -30.92 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 63.02 111.166 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -69.16 -43.76 73.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 71.13 110.878 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.5 m -67.84 -34.98 77.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 74.25 111.169 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.637 HD22 HG21 ' A' ' 82' ' ' VAL . 51.4 mt -60.63 -34.73 74.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 74.1 110.874 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.05 22.34 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 74.04 110.954 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -117.42 -20.27 9.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 72.24 110.933 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -115.78 5.9 14.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 74.15 110.872 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.4 60.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 53.51 112.489 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 98' ' ' LEU . 15.4 mt -80.98 155.72 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.909 0.385 . . . . 75.23 111.106 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.785 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -120.48 122.94 41.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 73.51 110.914 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.537 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -90.98 81.61 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 61.42 111.055 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.438 ' ND1' HD12 ' A' ' 124' ' ' LEU . 96.9 m-70 -57.87 146.88 30.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 71.23 110.798 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.21 159.32 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 72.3 110.846 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.0 p -72.81 152.67 41.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 73.41 111.185 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.58 -29.72 18.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.289 -0.414 . . . . 74.04 111.073 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 152' ' ' ASP . 6.7 tp -74.6 -44.49 50.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.859 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.724 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 96.7 m -53.17 -27.63 22.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 53.13 111.168 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.422 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -88.66 -26.45 21.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 60.32 111.09 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -61.05 -26.88 67.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.202 -0.454 . . . . 73.33 110.979 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.538 HD13 ' OD2' ' A' ' 152' ' ' ASP . 8.9 mp -96.6 -25.08 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 74.43 110.878 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.3 -64.4 0.88 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 55.3 111.081 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -55.41 -26.04 39.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 75.43 110.884 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -24.37 66.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.11 110.945 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -95.71 -32.2 12.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 73.44 110.87 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.47 -6.64 5.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 72.41 112.475 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -59.53 -173.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 75.42 110.923 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.476 ' H ' HG21 ' A' ' 95' ' ' ILE . 40.2 mm-40 -99.46 -0.64 40.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 72.21 110.892 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.422 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.0 OUTLIER 66.07 125.15 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.606 0.717 . . . . 74.45 110.892 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -170.6 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.69 2.26 . . . . 52.34 112.334 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.785 HD11 ' HB2' ' A' ' 104' ' ' LYS . 61.5 mt -53.66 -35.25 60.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.985 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.35 43.74 65.44 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.743 -0.741 . . . . 71.33 112.497 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -138.72 57.7 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.362 . . . . 71.05 110.814 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.75 -169.74 2.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.926 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.2 -169.15 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 74.43 110.961 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.825 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.2 m -50.97 -70.13 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.145 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.79 HG23 HG22 ' A' ' 129' ' ' THR . 62.4 t -120.45 109.27 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.094 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.1 m -112.72 103.69 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 71.03 111.146 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -66.14 96.18 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 62.02 110.861 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.484 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -88.59 159.71 17.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 72.45 110.818 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -156.7 106.51 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.954 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.08 -169.32 1.8 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 72.5 110.837 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -55.58 99.92 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 65.21 112.543 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 m120 58.22 49.77 10.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 52.23 110.9 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 tpt -151.77 153.13 33.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.862 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -130.42 127.62 39.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 72.44 110.917 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.563 HG13 HD23 ' A' ' 158' ' ' LEU . 5.9 t -139.76 157.5 26.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 75.42 111.084 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.423 ' HG2' HG13 ' A' ' 130' ' ' VAL . 74.6 tt0 -155.35 119.79 4.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.215 -0.448 . . . . 64.33 110.9 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.654 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.86 -178.17 2.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.138 -0.483 . . . . 75.03 111.169 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.712 ' HA ' HG22 ' A' ' 130' ' ' VAL . 74.0 t80 -175.49 137.93 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 75.5 110.943 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.825 ' HB3' HG23 ' A' ' 129' ' ' THR . 35.5 t80 -121.89 96.16 47.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.684 0.754 . . . . 74.1 110.923 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -48.59 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.634 2.223 . . . . 71.41 112.297 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.09 -157.64 28.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 60.34 112.532 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.33 124.84 36.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.351 . . . . 74.21 110.88 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.482 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.17 -98.64 0.51 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.794 -0.717 . . . . 73.31 112.489 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -66.59 -26.95 67.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 71.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.98 161.5 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 63.12 111.167 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -64.37 -26.27 68.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 75.22 110.86 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.538 ' OD2' HD13 ' A' ' 114' ' ' LEU . 11.6 p30 -120.83 50.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.843 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.18 136.99 38.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 64.2 110.879 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.654 HD12 HG22 ' A' ' 142' ' ' THR . 5.8 pt -137.59 172.22 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 72.2 111.138 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.442 ' CG1' HD22 ' A' ' 169' ' ' LEU . 9.4 m -123.11 149.17 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 75.32 111.166 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -103.39 144.28 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 74.34 111.125 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -130.29 145.94 51.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 73.13 110.91 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.563 HD23 HG13 ' A' ' 140' ' ' VAL . 13.4 mt -123.91 96.71 42.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.545 0.688 . . . . 63.23 110.944 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 72.89 1.42 Allowed 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.669 2.246 . . . . 72.35 112.345 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.31 -34.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 72.51 110.823 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.441 ' O ' HD12 ' A' ' 163' ' ' ILE . 7.1 m-85 -117.44 -13.55 10.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 74.31 110.947 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m120 69.07 24.91 6.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 73.54 110.849 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -97.73 116.64 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.12 111.101 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.81 136.51 39.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 75.53 110.919 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.526 HG21 HD22 ' A' ' 44' ' ' LEU . 19.4 t -120.53 62.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 72.44 111.158 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.36 -55.7 18.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.676 -0.774 . . . . 33.34 112.529 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.15 -137.11 14.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.773 -0.727 . . . . 73.22 112.503 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.06 -20.18 56.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 71.33 110.9 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.463 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.7 OUTLIER -65.86 -50.89 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.907 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.723 HG11 HG11 ' A' ' 206' ' ' VAL . 21.8 t -81.59 132.55 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.156 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.418 ' HB2' HG23 ' A' ' 222' ' ' THR . 0.6 OUTLIER -109.21 130.45 55.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 55.04 110.902 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.587 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.7 p -60.08 159.77 9.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 62.31 110.845 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.3 -48.03 83.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 72.4 111.124 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.9 t -53.48 -28.71 32.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 63.31 110.843 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 172' ' ' SER . . . -52.66 158.23 1.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 71.14 111.086 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.28 -30.58 5.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 71.34 110.852 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.78 175.7 12.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.301 -0.409 . . . . 71.34 110.788 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.565 HD11 HD23 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -80.08 -37.02 34.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 55.04 110.89 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 103.45 -167.19 16.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.681 -0.771 . . . . 54.5 112.472 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -51.94 118.62 3.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.916 0.389 . . . . 54.43 110.877 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.57 HG11 ' CG2' ' A' ' 186' ' ' VAL . 16.5 m -112.82 30.26 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 53.14 111.097 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.46 -34.94 67.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 75.32 111.058 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -122.74 35.86 4.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 74.03 110.835 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -132.41 165.84 23.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 54.12 111.139 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -113.76 92.75 4.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 74.3 110.927 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.57 ' CG2' HG11 ' A' ' 181' ' ' VAL . 91.6 t -68.54 -23.12 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 73.44 111.158 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.1 -25.65 36.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 74.51 110.85 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.49 -23.44 16.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 64.12 110.862 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.477 ' CE3' HD22 ' A' ' 178' ' ' LEU . 1.4 t90 -51.54 -52.49 46.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 71.41 110.953 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.7 p -52.0 -36.19 49.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 64.21 110.921 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.4 m -73.8 -36.51 65.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 44.53 111.14 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 74.3 m -63.38 -54.32 38.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.846 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.605 HG22 HD23 ' A' ' 197' ' ' LEU . 30.1 mm -56.35 -37.13 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 72.34 111.15 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -66.76 -22.59 66.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.827 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -85.13 -33.39 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 72.11 110.904 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.404 HG21 HG11 ' A' ' 155' ' ' VAL . 92.6 t -74.53 -49.36 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.31 111.135 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.605 HD23 HG22 ' A' ' 193' ' ' ILE . 4.6 pp -64.7 -25.07 67.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 75.33 110.914 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -78.95 -45.55 20.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 61.52 110.947 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -60.09 -33.29 71.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 62.43 110.841 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -136.29 121.7 19.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.42 110.909 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -122.58 27.27 7.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 74.33 110.874 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.93 22.38 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 53.35 110.894 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.82 146.29 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.238 -0.437 . . . . 72.31 111.119 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -106.43 -25.69 11.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 74.32 110.878 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.507 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -163.59 128.6 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 71.34 111.128 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.732 ' CG1' HD12 ' A' ' 218' ' ' LEU . 75.9 t -107.15 118.88 55.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 61.41 111.17 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.865 HG21 HD11 ' A' ' 44' ' ' LEU . 47.1 t -105.8 98.05 16.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.699 . . . . 65.34 111.153 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.6 Cg_endo -69.77 -172.25 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.704 2.269 . . . . 72.51 112.383 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.74 -30.22 8.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.731 . . . . 64.21 112.475 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -142.56 106.23 4.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.872 0.368 . . . . 75.32 110.935 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 151.26 -96.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.81 -0.71 . . . . 70.35 112.492 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -178.96 153.99 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 62.23 110.838 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.534 HG22 HG22 ' A' ' 207' ' ' VAL . 22.4 t -63.79 147.83 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 72.34 111.114 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -152.38 -107.79 0.35 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.691 -0.766 . . . . 73.33 112.502 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -155.75 -173.57 4.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.926 0.393 . . . . 74.13 110.858 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -55.42 -22.83 21.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 61.31 110.843 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.751 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.03 -31.95 48.83 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 43.44 112.526 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.732 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.5 mt -50.99 -46.93 61.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 71.34 110.964 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.601 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -54.29 -43.3 70.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 75.44 110.92 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.751 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.6 mt -66.33 -41.54 89.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.994 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.489 ' NE2' HD21 ' A' ' 225' ' ' LEU . 78.9 t60 -61.82 -38.1 86.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 72.34 110.911 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -55.76 -46.11 77.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 73.34 111.116 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.789 ' HA ' HD12 ' A' ' 226' ' ' LEU . 2.5 mt -54.22 -39.99 67.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.14 110.917 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -46.13 91.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 52.32 110.85 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.489 HD21 ' NE2' ' A' ' 221' ' ' HIS . 17.5 mt -56.73 -26.39 56.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 72.41 110.889 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 223' ' ' LEU . 4.5 mt -85.53 -45.6 11.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 62.13 110.93 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 64.01 110.896 179.826 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.622 ' HD1' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.816 0.341 . . . . 72.54 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.44 -32.33 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 72.5 110.95 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -162.15 149.87 14.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.928 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.7 p -175.26 143.02 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 61.4 111.139 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.42 60.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 71.43 110.936 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -142.56 154.07 44.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.53 110.941 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.58 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -145.86 179.92 7.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 60.33 111.132 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.556 HG22 ' OG ' ' A' ' 19' ' ' SER . 94.8 t 60.79 94.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.111 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.752 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.9 mm -89.34 157.54 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 74.11 111.144 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -146.53 179.18 7.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 74.14 110.901 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.05 168.47 9.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 70.11 110.918 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HG3' HG23 ' A' ' 13' ' ' THR . 8.4 pt-20 -53.13 -29.52 31.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.894 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.434 HG23 ' HG3' ' A' ' 12' ' ' GLU . 23.6 p -104.74 -35.5 7.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 74.52 111.111 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.69 -4.58 29.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.798 -0.715 . . . . 70.01 112.501 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.695 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -51.18 -33.78 28.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.825 0.345 . . . . 75.52 111.154 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.695 HG13 HG23 ' A' ' 15' ' ' THR . 11.4 mt -126.3 149.74 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 61.24 111.197 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.8 p -169.11 165.77 11.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 44.25 110.92 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.511 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -132.4 -171.79 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 75.11 111.081 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.556 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -174.49 133.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.881 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.57 120.66 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 72.13 110.93 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.4 mm? -101.61 -54.5 2.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 65.14 110.943 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -136.29 48.41 2.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 73.32 110.875 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt 70.68 -70.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 65.03 110.921 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -87.16 -22.18 25.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 71.51 110.924 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.45 123.78 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.12 111.121 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.58 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.3 m95 -125.43 159.94 30.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.904 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.824 HG21 HG21 ' A' ' 213' ' ' VAL . 75.8 t -120.23 110.1 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 72.23 111.097 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.511 ' HB3' HG23 ' A' ' 18' ' ' ILE . 3.4 p80 -104.59 139.25 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 74.21 110.833 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.3 m -137.07 132.27 33.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 75.15 111.17 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.42 166.75 14.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.844 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.618 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 5.3 tp -117.81 143.59 46.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 62.14 110.891 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 39' ' ' VAL . . . -158.39 137.18 5.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 70.34 112.492 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.78 135.74 48.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.344 . . . . 63.01 110.967 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -102.6 -32.33 9.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 72.5 110.811 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -172.3 38.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 73.15 110.892 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.64 7.13 16.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.729 -0.748 . . . . 71.33 112.529 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -152.77 127.68 9.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 71.32 110.869 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.618 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -68.25 134.14 49.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 54.52 111.121 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.663 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.3 p -126.75 126.82 24.52 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.605 0.717 . . . . 63.15 111.123 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.496 ' CA ' HD12 ' A' ' 31' ' ' LEU . 54.1 Cg_endo -69.75 141.57 45.64 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.724 2.283 . . . . 65.11 112.34 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -129.75 93.96 3.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.04 110.847 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -53.69 164.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 75.01 110.878 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.33 -165.58 23.93 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 52.04 112.531 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.021 HD13 HG21 ' A' ' 207' ' ' VAL . 4.1 tp -157.32 142.04 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 61.52 110.919 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 54' ' ' LEU . 21.8 t -125.75 132.27 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 71.45 111.144 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.05 131.87 45.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.876 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -100.49 66.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 74.02 110.855 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.418 HG21 ' HB2' ' A' ' 135' ' ' PHE . 18.5 p -72.77 170.92 13.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 74.32 111.103 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.6 t -96.0 27.18 3.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 70.24 110.853 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -150.76 27.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 54.44 110.92 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.05 127.79 4.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.664 -0.779 . . . . 74.34 112.445 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.763 HD13 ' HB ' ' A' ' 71' ' ' VAL . 19.0 mt -55.51 161.04 2.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 63.11 110.962 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 81' ' ' ASP . 49.6 t -140.13 142.17 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 71.1 111.118 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.705 HD13 HG22 ' A' ' 45' ' ' VAL . 2.9 mm? -115.87 129.58 56.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.946 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 165' ' ' VAL . 14.2 t -80.73 0.36 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 72.5 111.148 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.12 129.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 72.32 110.804 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.53 -168.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.14 110.823 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.4 m -92.98 -174.54 3.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 63.21 110.833 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.697 ' HB2' HD13 ' A' ' 63' ' ' LEU . 95.9 m95 -67.41 -39.48 85.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 70.32 110.873 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.46 166.68 24.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 73.12 110.903 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -62.66 -28.29 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 71.11 110.828 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -75.94 -22.4 56.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 73.04 110.883 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.697 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -86.98 -46.45 9.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 52.45 110.943 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -58.36 -28.88 65.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.24 111.158 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -55.58 -43.29 75.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.44 . . . . 63.42 110.792 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -85.8 0.58 52.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.251 -0.431 . . . . 72.35 110.852 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.3 -47.19 6.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.31 110.907 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.5 mt -69.53 -32.7 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 64.13 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.05 -17.81 58.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.11 110.903 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 42.8 mtp -82.15 -58.73 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 72.21 110.905 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.763 ' HB ' HD13 ' A' ' 52' ' ' LEU . 33.4 m -57.12 -35.8 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 62.34 111.14 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -86.85 49.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 64.2 110.943 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.85 -40.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.888 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.752 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -105.56 -24.02 12.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 62.13 110.872 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.588 ' HB3' HD21 ' A' ' 52' ' ' LEU . 27.9 m-85 -88.89 10.23 21.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.41 . . . . 61.5 110.877 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.509 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.66 46.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.914 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -152.48 -179.23 7.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 75.03 110.906 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.63 143.82 51.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 64.04 110.895 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 52' ' ' LEU . 94.8 t -75.09 130.07 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 74.52 111.12 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.2 p -142.05 31.0 1.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 63.31 111.16 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.763 ' HB2' HG22 ' A' ' 53' ' ' VAL . 15.4 m-20 -164.35 126.67 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 64.42 110.89 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.705 HG23 HG21 ' A' ' 103' ' ' ILE . 17.3 t -133.69 101.85 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 73.05 111.096 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.7 mt -80.18 120.73 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 70.1 111.146 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 91' ' ' ARG . 36.2 mm -108.71 129.81 62.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 71.15 111.103 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 74.9 p -85.37 -53.73 5.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 72.14 111.124 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -134.71 166.54 22.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 74.33 110.855 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -84.35 96.18 8.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 53.14 111.118 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.617 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -149.33 159.22 44.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.837 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.31 62.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 62.42 111.09 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.84 11.51 20.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 64.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 84' ' ' ILE . 3.5 mpt_? -125.42 -54.67 1.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.882 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.617 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -111.3 16.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 65.31 111.106 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.21 -28.85 27.83 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.684 -0.77 . . . . 75.12 112.495 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.68 19.04 31.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 60.53 112.487 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.489 HD11 ' C ' ' A' ' 122' ' ' GLU . 3.9 tt -48.89 -30.18 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 74.12 111.14 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -72.22 -43.26 64.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 75.43 110.925 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.5 m -64.22 -40.75 96.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 74.52 111.161 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.617 HD12 ' HB2' ' A' ' 105' ' ' ALA . 32.5 mt -60.96 -35.46 76.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 52.51 110.913 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -81.61 -23.26 37.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 74.13 110.884 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -82.34 -35.03 28.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 75.45 110.947 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.539 ' HB2' HD12 ' A' ' 103' ' ' ILE . 3.1 mtt-85 -87.29 -45.77 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 61.31 110.873 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.12 -14.98 3.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.782 -0.723 . . . . 73.33 112.452 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.705 HG21 HG23 ' A' ' 82' ' ' VAL . 1.9 mp -60.72 150.39 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.918 0.39 . . . . 73.23 111.151 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.751 ' HB2' HD11 ' A' ' 124' ' ' LEU . 3.4 ptpt -111.46 126.65 55.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 75.32 110.932 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.617 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -89.29 83.02 6.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 61.25 111.043 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.435 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.3 m-70 -57.95 143.55 42.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 75.12 110.916 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.68 150.76 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 71.12 110.823 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.8 p -63.88 179.28 0.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 62.12 111.146 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.9 -33.22 63.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 43.23 111.05 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 152' ' ' ASP . 9.9 tp -72.88 -47.04 49.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 42.11 110.951 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.734 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 98.3 m -52.19 -28.9 20.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.54 111.153 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.92 -31.09 25.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.047 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -55.1 -48.38 73.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.892 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.678 HD12 ' OD2' ' A' ' 152' ' ' ASP . 39.9 mt -72.36 -25.0 61.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 71.21 110.901 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.73 -66.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 53.43 111.066 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -54.76 -26.57 35.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 74.42 110.91 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -23.83 67.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.02 110.89 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -93.74 -38.9 11.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 73.51 110.889 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 138.55 -7.76 3.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 54.22 112.508 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -59.55 -172.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.733 0.301 . . . . 70.15 110.987 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.46 ' H ' HG21 ' A' ' 95' ' ' ILE . 61.6 mm-40 -99.87 0.11 40.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 62.34 110.909 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.489 ' C ' HD11 ' A' ' 95' ' ' ILE . 0.9 OUTLIER 66.31 130.7 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.639 0.733 . . . . 73.22 110.867 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.85 -170.3 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.636 2.224 . . . . 74.44 112.292 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 104' ' ' LYS . 76.9 mt -53.81 -45.28 70.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 64.04 110.884 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.56 52.68 40.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.825 -0.703 . . . . 62.23 112.473 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -148.83 51.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 74.02 110.88 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 127' ' ' LEU . 17.6 mt -133.0 178.79 6.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.304 -0.407 . . . . 64.35 110.931 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -140.61 -168.63 2.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 75.03 110.995 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.844 HG23 ' HB3' ' A' ' 144' ' ' TYR . 92.3 m -50.29 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 73.24 111.146 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.769 HG23 HG22 ' A' ' 129' ' ' THR . 58.6 t -114.58 106.68 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.44 111.128 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.3 m -110.76 104.13 12.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 74.14 111.146 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -66.19 95.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 63.21 110.908 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.486 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -87.72 159.74 18.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 62.51 110.886 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.31 106.87 2.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.465 . . . . 64.13 110.918 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.418 ' HB2' HG21 ' A' ' 48' ' ' THR . 20.6 m-85 -98.46 -169.15 1.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 74.15 110.887 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.39 100.96 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 43.21 112.458 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.0 46.72 21.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 72.41 110.901 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.9 tpp -147.01 154.83 41.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 72.14 110.899 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.86 128.75 39.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 62.45 110.922 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.644 HG13 HD23 ' A' ' 158' ' ' LEU . 5.9 t -141.06 157.39 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 74.23 111.142 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.441 ' HG2' HG13 ' A' ' 130' ' ' VAL . 41.8 tt0 -154.72 120.73 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 53.34 110.883 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.646 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -73.53 -179.1 3.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 71.43 111.184 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.711 ' HA ' HG22 ' A' ' 130' ' ' VAL . 76.8 t80 -175.61 139.89 0.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 65.21 110.897 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.844 ' HB3' HG23 ' A' ' 129' ' ' THR . 39.3 t80 -122.15 96.28 46.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.71 0.767 . . . . 71.03 110.882 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 -48.9 0.64 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.755 2.303 . . . . 73.33 112.327 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.39 -155.74 24.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 53.34 112.516 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.63 126.02 41.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 71.24 110.896 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.496 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -137.72 -94.0 0.33 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.721 -0.752 . . . . 34.35 112.472 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -71.97 -29.3 64.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.359 . . . . 65.52 110.859 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.31 151.88 34.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.153 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -54.71 -38.44 67.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 60.41 110.849 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.678 ' OD2' HD12 ' A' ' 114' ' ' LEU . 2.5 p30 -109.15 52.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 61.04 110.906 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.543 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.5 p30 -100.73 136.24 40.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.31 110.861 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.646 HD12 HG22 ' A' ' 142' ' ' THR . 4.5 pt -137.2 172.25 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 62.03 111.153 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.3 m -122.46 150.65 26.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.35 111.164 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.9 t -106.66 143.77 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.24 111.192 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -129.98 145.28 51.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 71.14 110.968 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.644 HD23 HG13 ' A' ' 140' ' ' VAL . 12.9 mt -122.91 96.83 44.6 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.643 0.735 . . . . 63.41 110.893 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 72.55 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.746 2.297 . . . . 70.54 112.315 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.54 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 75.42 110.848 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.449 ' O ' HD12 ' A' ' 163' ' ' ILE . 7.2 m-85 -117.05 -13.33 10.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 71.43 110.901 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m120 68.84 24.84 6.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 74.54 110.827 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.49 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.5 mp -98.19 116.62 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 55.22 111.154 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.1 136.92 38.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 73.24 110.904 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.633 ' CG2' HD22 ' A' ' 44' ' ' LEU . 19.5 t -121.47 62.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 71.53 111.089 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.4 -51.75 35.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 64.02 112.49 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.06 -139.23 15.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 53.35 112.535 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 81.4 m -62.94 -16.75 60.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 71.35 110.869 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.543 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.5 OUTLIER -66.25 -52.45 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 33.13 110.916 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.569 HG11 HG11 ' A' ' 206' ' ' VAL . 21.8 t -83.47 119.68 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 74.42 111.085 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.425 ' HB2' HG23 ' A' ' 222' ' ' THR . 0.3 OUTLIER -93.05 127.17 38.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 75.21 110.838 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.696 ' HA ' HD22 ' A' ' 218' ' ' LEU . 3.9 t -62.72 166.66 5.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 70.44 110.831 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.503 HG23 HD23 ' A' ' 218' ' ' LEU . 3.1 p -63.96 -43.48 95.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 52.13 111.149 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.11 -30.78 27.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 70.4 110.846 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.83 163.92 24.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 60.44 111.095 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -154.03 24.23 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 71.22 110.842 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.85 154.01 1.82 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 61.12 110.811 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.47 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 1.8 mt -85.79 -33.89 21.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 65.21 110.902 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.422 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 92.96 -164.85 27.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 72.45 112.513 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.01 105.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 64.45 110.971 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.477 HG11 ' CG2' ' A' ' 186' ' ' VAL . 18.6 m -97.14 26.13 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 74.2 111.1 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.31 75.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 63.23 111.093 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.19 38.96 3.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.791 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -140.92 165.91 26.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 72.23 111.123 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -113.89 92.73 4.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.962 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.477 ' CG2' HG11 ' A' ' 181' ' ' VAL . 62.1 t -69.5 -23.05 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.102 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -81.41 -24.6 36.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 61.33 110.908 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -98.63 -23.88 15.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 71.25 110.882 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.47 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.2 t90 -51.49 -54.23 29.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 72.43 110.927 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.5 t -51.91 -32.58 33.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 55.1 110.8 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.7 m -77.44 -34.78 54.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 74.41 111.15 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 m -65.94 -54.33 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.5 110.817 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.659 HG22 HD23 ' A' ' 197' ' ' LEU . 32.8 mm -56.29 -37.52 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 72.32 111.107 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -65.29 -23.52 67.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 63.22 110.91 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -87.16 -31.94 20.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.902 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.421 ' CG1' HD21 ' A' ' 219' ' ' LEU . 95.5 t -74.45 -51.57 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 73.45 111.142 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.659 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -63.59 -24.86 67.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 71.44 110.926 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -47.62 12.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.804 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -51.92 -34.1 40.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 72.13 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -137.76 118.36 13.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 72.01 110.948 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -116.64 32.87 5.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.98 21.28 2.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 74.3 110.882 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.16 146.42 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 72.22 111.135 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -107.24 -30.95 8.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 61.05 110.878 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -160.69 127.43 4.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 53.5 111.122 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.626 ' CG1' HD12 ' A' ' 218' ' ' LEU . 92.0 t -101.35 125.48 55.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 71.13 111.125 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.021 HG21 HD13 ' A' ' 44' ' ' LEU . 40.2 t -108.31 89.76 6.22 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.569 0.699 . . . . 73.24 111.197 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.78 171.76 13.89 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.691 2.26 . . . . 74.33 112.336 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.58 -26.2 47.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 63.42 112.475 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -143.35 119.37 10.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 73.32 110.813 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 135.76 -95.21 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.799 -0.715 . . . . 55.32 112.49 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -179.67 168.83 1.37 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 72.42 110.853 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.824 HG21 HG21 ' A' ' 27' ' ' VAL . 31.5 t -79.14 142.3 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 62.15 111.131 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.74 -107.13 0.4 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.729 . . . . 64.3 112.55 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -154.46 -172.95 4.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 73.44 110.918 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -23.12 14.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 61.41 110.893 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -53.57 -32.57 46.47 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.698 -0.763 . . . . 73.22 112.511 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.696 HD22 ' HA ' ' A' ' 172' ' ' SER . 30.5 mt -50.92 -44.45 60.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.866 0.365 . . . . 74.15 110.895 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.513 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -58.43 -44.75 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 53.14 110.871 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.752 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.6 mt -64.85 -41.97 95.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.44 110.895 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.489 ' NE2' HD21 ' A' ' 225' ' ' LEU . 77.2 t60 -62.37 -39.15 92.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 74.44 110.858 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.425 HG23 ' HB2' ' A' ' 171' ' ' LYS . 3.9 m -54.43 -41.58 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 73.43 111.137 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.806 ' HA ' HD12 ' A' ' 226' ' ' LEU . 95.9 mt -59.13 -41.41 88.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 75.35 110.965 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -32.28 69.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 71.35 110.826 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.489 HD21 ' NE2' ' A' ' 221' ' ' HIS . 16.0 mt -69.94 -25.79 63.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 72.31 110.938 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.806 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.5 mt -87.35 -44.97 10.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 71.54 110.885 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 72.42 110.892 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.643 ' HD1' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.828 0.347 . . . . 51.0 110.834 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.28 172.84 13.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 64.34 110.889 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 105.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 73.03 110.847 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.22 176.18 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 54.23 111.165 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -108.48 80.79 1.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 73.1 110.918 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -127.3 149.42 50.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 62.32 110.964 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.466 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -147.88 179.66 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 63.25 111.13 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 18' ' ' ILE . 84.4 t 60.71 97.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.434 . . . . 70.33 111.103 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.69 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.0 mm -90.31 155.19 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 71.25 111.178 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -145.07 165.46 28.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.853 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.06 174.37 6.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 52.45 110.896 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -59.57 -28.57 67.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.855 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.485 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.7 p -101.92 -33.06 9.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 43.32 111.126 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.73 -8.66 47.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.63 -0.795 . . . . 72.2 112.484 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.777 HG23 HG13 ' A' ' 16' ' ' ILE . 3.2 t -50.99 -32.91 22.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.313 . . . . 73.23 111.167 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.777 HG13 HG23 ' A' ' 15' ' ' THR . 16.0 mt -124.23 147.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 73.43 111.093 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.6 p -166.75 171.42 11.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.954 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -137.78 -176.39 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.183 -0.462 . . . . 62.15 111.159 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 18' ' ' ILE . 6.7 t -166.44 133.67 2.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 61.34 110.878 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.46 118.33 12.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.511 . . . . 72.41 110.888 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.03 -41.64 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 74.02 110.973 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.56 -169.52 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 75.14 110.891 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -51.64 51.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 70.04 110.827 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -131.39 30.89 4.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 74.13 110.887 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.9 t -126.55 119.8 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 61.14 111.162 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.466 ' CH2' HG22 ' A' ' 7' ' ' THR . 14.3 m95 -125.33 162.61 24.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 71.03 110.938 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 213' ' ' VAL . 75.9 t -122.49 108.13 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 71.43 111.147 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.475 ' HB3' HG23 ' A' ' 18' ' ' ILE . 5.3 p80 -102.02 139.45 37.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.885 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 41' ' ' SER . 25.2 m -137.77 125.24 22.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 71.51 111.138 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.521 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -114.17 -177.72 3.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 64.34 110.906 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.543 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 2.3 tp -134.38 134.8 42.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 73.3 110.952 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.77 144.35 11.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 61.55 112.485 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.23 142.16 36.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.893 0.378 . . . . 60.3 110.89 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -103.14 -32.45 9.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 53.14 110.858 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -164.82 32.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 70.44 110.958 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.13 13.88 8.81 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.791 -0.719 . . . . 55.34 112.513 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -149.66 119.27 6.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.835 0.35 . . . . 75.1 110.907 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -59.87 137.76 57.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 62.31 111.096 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.705 HG11 ' HD2' ' A' ' 303' ' ' RTD . 96.7 t -136.71 124.91 14.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.621 0.724 . . . . 72.01 111.117 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' CA ' HD12 ' A' ' 31' ' ' LEU . 53.6 Cg_endo -69.8 140.03 41.51 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.631 2.22 . . . . 73.53 112.368 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 29' ' ' THR . 1.0 OUTLIER -128.62 122.22 30.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 54.32 110.841 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.59 HD21 ' N ' ' A' ' 212' ' ' GLU . 30.6 m-20 -67.46 168.6 10.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 70.44 110.915 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.41 170.12 43.25 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.672 -0.775 . . . . 71.23 112.45 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.011 HD13 HG21 ' A' ' 207' ' ' VAL . 3.9 tp -143.05 138.8 30.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.388 . . . . 74.01 110.897 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.71 HG22 HD13 ' A' ' 54' ' ' LEU . 38.3 t -122.05 130.23 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 70.12 111.138 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.574 HD22 ' HE3' ' A' ' 138' ' ' MET . 45.5 mt -96.9 125.54 41.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.837 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.02 45.37 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.1 110.874 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.632 HG22 ' HB2' ' A' ' 138' ' ' MET . 27.5 p -52.57 165.11 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 72.53 111.143 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.61 35.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 62.45 110.837 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -157.11 25.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.485 . . . . 64.33 110.924 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.68 124.6 3.77 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.66 -0.781 . . . . 52.44 112.442 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.721 HD21 ' HB3' ' A' ' 75' ' ' PHE . 35.2 mt -53.18 158.02 1.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 71.13 110.915 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.605 HG22 ' HB2' ' A' ' 81' ' ' ASP . 90.5 t -141.25 142.64 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 73.05 111.102 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.71 HD13 HG22 ' A' ' 45' ' ' VAL . 3.2 mm? -114.43 128.42 56.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 74.44 110.924 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 55' ' ' VAL . 13.1 t -80.4 -0.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 75.45 111.1 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -174.81 132.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 74.14 110.911 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -74.59 -166.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.05 110.844 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.42 -170.24 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 55.11 110.848 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.666 ' HB2' HD13 ' A' ' 63' ' ' LEU . 88.5 m95 -74.8 -34.9 62.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 74.53 110.884 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.16 174.5 11.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.427 . . . . 71.22 110.857 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.44 -30.43 68.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 65.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -76.04 -25.53 55.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 73.5 110.885 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -83.32 -48.34 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.85 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.1 t -60.54 -27.82 67.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 63.0 111.173 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -43.08 75.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.864 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.55 1.29 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.11 110.92 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.521 HD22 ' OE2' ' A' ' 30' ' ' GLU . 23.8 tp -95.46 -45.33 7.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 74.13 110.912 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -68.79 -40.03 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 62.12 111.157 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -60.39 -22.23 63.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.12 -0.491 . . . . 61.25 110.942 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.5 mmm -72.64 -60.81 2.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.914 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.514 ' HB ' HD13 ' A' ' 52' ' ' LEU . 19.7 m -59.39 -30.16 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 63.54 111.122 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -88.51 48.57 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 73.44 110.914 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 -41.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.02 110.958 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.69 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.05 -25.23 14.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.9 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.721 ' HB3' HD21 ' A' ' 52' ' ' LEU . 35.9 m-85 -89.31 9.84 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.882 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.499 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.68 47.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 73.3 110.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -147.92 -177.54 5.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.851 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.6 130.9 37.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.932 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 52' ' ' LEU . 61.4 t -67.86 130.12 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 72.32 111.112 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 48.4 p -136.82 18.62 3.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.481 . . . . 61.21 111.13 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.605 ' HB2' HG22 ' A' ' 53' ' ' VAL . 8.4 m-20 -153.99 130.59 10.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 75.14 110.878 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 98' ' ' LEU . 24.8 t -133.5 98.46 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.095 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.7 mt -73.71 125.73 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 73.43 111.128 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 91' ' ' ARG . 42.4 mm -113.08 142.47 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 65.44 111.131 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.0 p -97.51 -59.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 64.31 111.147 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -129.47 164.19 24.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 61.12 110.859 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.49 98.03 9.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.44 111.078 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.661 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -152.03 159.03 43.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.457 . . . . 74.54 110.88 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -26.73 61.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 64.41 111.088 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -91.73 13.28 18.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 70.4 110.874 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HB3' HG23 ' A' ' 84' ' ' ILE . 2.0 mmp_? -126.68 -50.86 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.867 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -118.75 16.24 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 55.13 111.15 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.73 -33.26 34.34 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.714 -0.755 . . . . 63.45 112.525 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.27 15.92 53.74 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.749 -0.738 . . . . 61.4 112.487 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.517 HG21 ' H ' ' A' ' 121' ' ' GLU . 11.3 tt -46.16 -31.93 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.882 0.373 . . . . 72.42 111.162 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -54.31 31.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.943 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.8 m -58.1 -41.07 82.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 72.2 111.16 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 82' ' ' VAL . 27.3 mt -59.61 -31.21 69.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 75.13 110.934 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -97.82 25.08 6.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.3 110.911 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -115.75 -24.79 8.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.902 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -107.83 -21.4 12.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 70.41 110.88 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.68 13.34 5.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 62.33 112.44 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 98' ' ' LEU . 16.0 mt -80.32 155.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 74.21 111.06 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.648 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -119.97 123.93 44.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 73.22 110.862 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.51 85.31 6.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 74.22 111.074 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.424 ' HB3' HD11 ' A' ' 127' ' ' LEU . 54.3 m-70 -55.87 148.07 17.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 71.15 110.873 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.93 164.88 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 64.04 110.813 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 71.8 p -81.98 155.77 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 44.15 111.199 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.72 -29.91 20.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 75.53 111.143 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 152' ' ' ASP . 7.1 tp -75.08 -47.58 28.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 73.02 110.904 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.706 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.7 m -53.93 -26.97 28.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 61.43 111.152 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.456 ' HB1' ' OE2' ' A' ' 122' ' ' GLU . . . -86.26 -27.1 24.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 74.24 111.05 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -64.13 -27.51 69.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 65.23 110.855 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.611 HD13 ' OD2' ' A' ' 152' ' ' ASP . 9.8 mp -92.96 -23.89 18.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 73.01 110.895 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.44 -62.98 1.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.51 111.137 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -25.42 42.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 51.42 110.873 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.0 -23.79 65.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.895 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -97.32 -26.36 14.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 72.33 110.876 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.89 -3.21 10.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.788 -0.72 . . . . 32.33 112.503 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -59.52 -173.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.887 0.375 . . . . 74.42 110.889 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.517 ' H ' HG21 ' A' ' 95' ' ' ILE . 8.6 mm-40 -97.75 -1.34 43.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.89 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.456 ' OE2' ' HB1' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 66.36 124.96 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.623 0.725 . . . . 74.41 110.865 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -170.46 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.629 2.219 . . . . 71.25 112.387 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 104' ' ' LYS . 65.7 mt -53.44 -39.76 64.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.884 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.12 59.03 9.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.768 -0.73 . . . . 73.02 112.461 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -155.33 47.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 64.22 110.854 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 106' ' ' HIS . 76.2 mt -127.07 -175.26 3.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 64.3 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -140.02 -168.66 2.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.858 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.831 HG23 ' HB3' ' A' ' 144' ' ' TYR . 78.7 m -50.21 -54.87 17.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 65.22 111.092 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.744 HG22 ' HA ' ' A' ' 143' ' ' PHE . 91.9 t -131.33 111.84 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 75.12 111.114 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.591 HG22 HD23 ' A' ' 133' ' ' LEU . 91.5 m -117.04 119.55 35.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 73.44 111.199 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -78.77 99.13 6.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 74.05 110.901 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.591 HD23 HG22 ' A' ' 131' ' ' THR . 3.6 mt -85.76 149.44 25.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 64.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 106.96 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 74.43 110.905 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.434 ' HB2' HG21 ' A' ' 48' ' ' THR . 13.1 m-85 -106.06 57.9 0.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.893 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.11 -117.02 5.65 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.641 -0.79 . . . . 61.43 112.413 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -91.14 48.62 1.53 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.735 0.302 . . . . 65.41 110.825 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.632 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.7 tpp -143.17 151.6 40.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 73.44 110.836 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.96 112.73 14.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 72.21 110.894 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.48 HG13 HD23 ' A' ' 158' ' ' LEU . 16.5 t -126.08 152.55 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 54.31 111.127 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -151.07 120.78 7.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 54.23 110.888 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.687 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.22 -179.08 2.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.45 111.149 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.744 ' HA ' HG22 ' A' ' 130' ' ' VAL . 78.4 t80 -175.29 136.46 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.879 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.831 ' HB3' HG23 ' A' ' 129' ' ' THR . 59.2 t80 -116.79 93.63 41.77 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.712 0.768 . . . . 73.23 110.838 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 -48.92 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 61.3 112.33 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.62 -170.35 42.64 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.664 -0.779 . . . . 34.53 112.454 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -84.52 126.55 33.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.884 0.373 . . . . 64.54 110.87 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.665 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -136.64 -88.3 0.23 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 71.32 112.498 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -78.27 -23.67 47.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 73.4 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.95 163.99 36.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.22 111.218 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -70.09 -24.48 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.916 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.611 ' OD2' HD13 ' A' ' 114' ' ' LEU . 10.6 p30 -123.59 52.63 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 62.42 110.87 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 2.1 p30 -100.77 146.35 27.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.925 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.687 HD12 HG22 ' A' ' 142' ' ' THR . 8.8 pt -145.14 173.28 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 74.25 111.161 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.1 m -123.03 138.8 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 64.32 111.156 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.454 ' O ' HD22 ' A' ' 164' ' ' LEU . 79.0 t -95.1 125.69 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 62.31 111.126 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -111.0 148.88 31.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 72.33 110.936 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 163' ' ' ILE . 47.5 mt -123.53 94.61 46.17 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.608 0.718 . . . . 71.44 110.888 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 70.98 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.716 2.278 . . . . 74.42 112.278 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.14 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.904 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.594 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.2 m-85 -118.74 -9.98 10.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 73.1 110.897 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 68.2 21.03 8.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 53.43 110.868 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.609 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.7 mp -87.1 115.67 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 71.14 111.129 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.478 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.5 tm? -101.37 122.93 44.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 70.11 110.923 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 44' ' ' LEU . 41.5 t -114.9 73.53 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 44.44 111.217 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.408 ' H ' HD13 ' A' ' 164' ' ' LEU . . . -64.12 -56.58 17.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 73.24 112.532 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 111.95 -139.0 15.36 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.749 -0.738 . . . . 72.25 112.412 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 46.6 m -58.03 -22.24 48.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 24.13 110.858 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.471 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.0 OUTLIER -62.88 -48.32 79.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.43 110.938 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.544 HG11 HG11 ' A' ' 206' ' ' VAL . 21.5 t -92.57 127.57 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 62.41 111.124 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.535 ' H ' HG23 ' A' ' 222' ' ' THR . 1.6 tppt? -95.49 134.94 37.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.925 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.641 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.2 p -70.23 157.03 38.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 74.12 110.829 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.1 p -59.52 -30.57 68.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 75.2 111.164 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.68 -31.16 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 71.31 110.86 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.5 -171.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.068 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.615 ' O ' HD22 ' A' ' 225' ' ' LEU . 1.2 tptt -145.77 -42.38 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 75.55 110.948 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -143.63 178.22 7.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 55.44 110.846 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.664 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 1.8 mt -78.61 -49.18 13.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 74.31 110.915 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 98.74 -140.13 14.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 50.33 112.476 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -67.85 133.14 48.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.859 0.362 . . . . 73.52 110.906 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.83 44.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 75.44 111.097 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.48 -46.06 77.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 62.14 111.084 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -112.38 44.09 1.51 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 73.35 110.921 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -134.87 173.92 11.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 31.34 111.114 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -123.61 88.48 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 75.23 110.918 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.419 HG13 HD23 ' A' ' 226' ' ' LEU . 23.5 t -68.11 -20.73 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 70.04 111.182 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -80.36 -28.41 38.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.868 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -22.59 16.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.04 110.918 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.664 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.3 t90 -51.07 -54.37 25.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.88 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.79 -36.83 49.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 43.51 110.813 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 71.4 m -75.34 -39.01 59.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.53 111.139 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 44.6 m -58.81 -55.67 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.833 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.514 HG21 ' O ' ' A' ' 219' ' ' LEU . 33.1 mm -54.27 -37.5 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 73.2 111.145 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.62 -23.08 65.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.881 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -90.6 -27.43 19.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 62.23 110.879 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.589 HG12 HD21 ' A' ' 219' ' ' LEU . 39.8 t -78.42 -31.98 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 72.22 111.156 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.7 -29.87 23.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 61.05 110.968 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -78.98 -50.06 11.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.1 110.865 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -51.92 -30.17 23.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 65.21 110.9 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -138.14 116.86 12.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 74.34 110.894 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.6 mpp_? -116.5 37.62 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 71.44 110.883 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.24 22.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 65.52 110.921 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.47 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.1 mp -51.63 142.74 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 64.13 111.093 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -103.53 -42.91 5.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.482 . . . . 74.15 110.867 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.57 113.44 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 35.45 111.141 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.544 HG11 HG11 ' A' ' 170' ' ' VAL . 89.3 t -85.39 124.08 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.34 111.129 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.011 HG21 HD13 ' A' ' 44' ' ' LEU . 57.5 t -107.41 92.27 8.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.586 0.708 . . . . 72.41 111.129 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.3 Cg_endo -69.68 -174.7 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.269 . . . . 73.12 112.373 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.41 -17.44 33.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.804 -0.712 . . . . 60.02 112.515 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -147.19 125.97 12.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 75.31 110.906 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 123.0 -93.09 0.48 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.746 -0.74 . . . . 74.13 112.496 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.59 ' N ' HD21 ' A' ' 42' ' ' ASN . 0.6 OUTLIER -179.65 167.92 1.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 70.03 110.922 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.906 HG21 HG21 ' A' ' 27' ' ' VAL . 42.6 t -79.85 135.53 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 72.14 111.145 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -137.36 -102.8 0.62 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.773 . . . . 54.34 112.46 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -158.96 -171.34 3.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.923 0.392 . . . . 61.4 110.827 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 -23.92 13.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 62.24 110.83 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -52.52 -35.52 45.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.769 -0.729 . . . . 34.11 112.488 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 172' ' ' SER . 23.9 mt -51.0 -46.35 61.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 75.52 110.86 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.589 HD21 HG12 ' A' ' 196' ' ' VAL . 7.1 mp -56.32 -42.95 78.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 54.32 110.882 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.755 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.1 mt -66.78 -41.46 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 73.24 110.893 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.45 ' NE2' HD21 ' A' ' 225' ' ' LEU . 85.2 t60 -61.31 -39.35 90.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 63.34 110.848 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.535 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.66 -46.22 63.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 75.25 111.103 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.81 ' HA ' HD12 ' A' ' 226' ' ' LEU . 51.5 mt -56.64 -44.22 81.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 74.42 110.939 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -31.51 60.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 60.42 110.872 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.615 HD22 ' O ' ' A' ' 176' ' ' LYS . 6.8 mt -73.7 -27.92 61.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 73.13 110.887 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.5 mt -84.85 -30.87 24.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 73.0 110.899 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 75.25 110.894 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.705 ' HD2' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.9 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.853 0.358 . . . . 71.34 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -159.26 -177.37 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 62.41 110.859 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.19 142.1 37.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 74.2 110.905 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.72 172.37 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 64.12 111.086 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -137.97 55.79 1.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 71.04 110.885 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -146.46 151.91 38.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 63.44 110.893 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.461 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -145.53 179.78 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 71.42 111.164 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 18' ' ' ILE . 97.3 t 60.92 94.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 73.24 111.072 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.467 HD11 ' HE3' ' A' ' 74' ' ' LYS . 3.4 mm -87.1 156.17 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 74.35 111.1 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -146.74 151.91 37.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 63.12 110.896 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.58 168.51 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 65.13 110.924 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.46 -32.55 62.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 71.13 110.92 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 p -93.04 -31.97 14.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 74.45 111.084 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.47 -12.51 58.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 53.04 112.491 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.714 HG23 HG13 ' A' ' 16' ' ' ILE . 2.4 t -51.73 -33.0 32.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 60.45 111.132 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.714 HG13 HG23 ' A' ' 15' ' ' THR . 28.2 mt -119.58 150.87 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 72.05 111.089 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -170.2 170.84 7.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.202 -0.454 . . . . 73.31 110.782 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -136.47 -174.7 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 74.41 111.215 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.442 ' OG ' HG22 ' A' ' 8' ' ' VAL . 1.2 t -170.8 129.95 0.81 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 63.35 110.882 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 122.12 15.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 53.31 110.944 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.436 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.5 mm? -104.45 -46.84 4.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 61.1 110.949 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -149.41 52.43 0.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.83 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.58 -76.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.931 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -83.63 -20.37 33.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.898 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.26 120.6 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 64.33 111.171 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.461 ' CH2' HG22 ' A' ' 7' ' ' THR . 18.2 m95 -125.41 159.81 30.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 60.31 110.957 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.436 HG23 ' HG ' ' A' ' 21' ' ' LEU . 53.3 t -122.23 112.7 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 75.53 111.147 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.446 ' HB3' HG23 ' A' ' 18' ' ' ILE . 11.1 p80 -103.48 137.04 42.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 73.52 110.9 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.6 m -131.17 130.93 43.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 55.3 111.091 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.628 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -126.19 163.17 23.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 73.43 110.868 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.604 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 4.9 tp -110.14 145.7 36.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 73.25 110.924 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.09 -122.58 2.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.736 -0.745 . . . . 72.22 112.465 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.2 155.26 46.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.93 0.395 . . . . 74.31 110.832 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -173.44 102.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 73.32 110.848 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 51.45 56.23 8.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 75.3 110.921 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.91 26.37 67.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.802 -0.713 . . . . 54.12 112.49 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -151.57 119.46 6.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 62.43 110.873 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.604 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -54.45 144.19 21.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 63.41 111.098 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.694 HG21 ' HD1' ' A' ' 303' ' ' RTD . 2.2 p -132.07 126.68 20.71 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 73.32 111.142 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.483 ' CA ' HD12 ' A' ' 31' ' ' LEU . 54.1 Cg_endo -69.75 142.93 49.31 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.65 2.234 . . . . 75.12 112.349 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -126.33 108.12 10.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.87 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -61.87 151.52 34.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 74.43 110.888 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.582 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -154.3 -163.37 11.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.7 -0.762 . . . . 54.24 112.478 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.998 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -162.36 145.3 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.903 0.382 . . . . 72.32 110.903 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 54' ' ' LEU . 43.8 t -129.49 130.12 67.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 62.22 111.097 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.471 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 46.7 mt -98.57 122.01 41.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.902 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -91.53 47.3 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 72.4 110.908 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 138' ' ' MET . 22.9 p -56.77 172.68 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 70.52 111.103 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.4 m -99.17 24.97 7.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 62.01 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.4 19.01 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.838 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.78 128.53 4.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 52.22 112.524 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.815 HD21 ' HB3' ' A' ' 75' ' ' PHE . 35.3 mt -52.63 157.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.817 0.341 . . . . 73.02 110.916 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.785 HG22 ' HB2' ' A' ' 81' ' ' ASP . 93.6 t -142.08 143.36 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 60.55 111.098 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 45' ' ' VAL . 3.5 mm? -112.24 129.58 56.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.831 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 55' ' ' VAL . 12.4 t -80.07 -1.26 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.044 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.32 130.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.24 -0.436 . . . . 75.42 110.89 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -67.82 -169.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.4 110.795 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.41 -175.94 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 70.2 110.826 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.699 ' HB2' HD13 ' A' ' 63' ' ' LEU . 92.1 m95 -67.35 -37.4 83.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 74.23 110.899 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -144.99 174.15 11.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 75.2 110.878 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.436 ' HA ' HG22 ' A' ' 64' ' ' THR . 1.0 OUTLIER -70.03 -28.46 65.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 71.13 110.84 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -77.63 -25.45 49.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.33 110.893 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 59' ' ' TRP . 1.3 mt -85.79 -40.98 15.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 75.33 110.863 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 61' ' ' ASP . 14.6 t -66.18 -29.74 70.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 42.45 111.197 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -51.62 -45.04 63.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 50.21 110.91 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -81.64 -14.9 56.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.881 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.628 HD22 ' OE2' ' A' ' 30' ' ' GLU . 40.0 tp -78.08 -48.45 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.888 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.9 mt -71.85 -18.63 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 45.21 111.097 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.06 2.35 39.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 71.24 110.894 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.2 mmm -101.62 -53.04 3.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 75.4 110.908 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.779 ' HB ' HD13 ' A' ' 52' ' ' LEU . 22.7 m -59.4 -39.53 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 64.5 111.125 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.483 ' HG3' HG23 ' A' ' 71' ' ' VAL . 33.5 mt-10 -84.86 50.98 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 75.2 110.889 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.74 -39.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.881 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -110.17 -20.19 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.931 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.815 ' HB3' HD21 ' A' ' 52' ' ' LEU . 25.1 m-85 -89.14 12.28 16.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.859 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.518 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.86 47.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 71.52 110.93 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -155.93 -178.72 7.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 70.43 110.891 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.41 157.45 39.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.02 110.848 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 52' ' ' LEU . 98.5 t -92.65 117.98 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 72.45 111.181 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.9 p -128.34 22.4 6.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.23 111.155 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.785 ' HB2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -153.45 133.9 13.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.831 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.567 HG11 HD11 ' A' ' 98' ' ' LEU . 24.1 t -138.64 99.47 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 54.12 111.128 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.0 mt -77.49 126.07 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.03 111.071 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.9 mm -112.46 130.26 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 75.33 111.091 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.0 p -87.76 -54.85 4.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 71.54 111.077 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -133.93 170.0 16.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.868 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -88.96 97.77 11.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.465 . . . . 54.44 111.075 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.65 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -150.33 158.65 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 73.1 110.826 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.03 63.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 51.34 111.104 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.9 9.26 25.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 72.15 110.831 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -121.43 -52.81 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 74.44 110.865 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.65 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.5 18.24 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 61.51 111.198 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.05 -26.72 20.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.636 -0.792 . . . . 54.11 112.534 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.64 22.01 20.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.737 -0.744 . . . . 71.3 112.523 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.427 HG21 ' H ' ' A' ' 121' ' ' GLU . 2.3 tt -48.55 -31.05 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.392 . . . . 74.02 111.137 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -70.65 -43.75 68.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.908 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.4 m -66.27 -35.49 80.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 61.3 111.119 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.567 HD11 HG11 ' A' ' 82' ' ' VAL . 48.4 mt -62.37 -32.51 73.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.933 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.29 20.92 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 64.45 110.88 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -117.35 -22.46 8.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 75.2 110.906 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.74 7.66 18.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 72.24 110.894 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.8 15.92 64.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.723 -0.751 . . . . 65.15 112.453 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 98' ' ' LEU . 16.9 mt -80.33 155.03 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 63.4 111.113 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.82 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -118.98 117.58 29.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 55.24 110.911 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.513 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -86.52 79.32 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 63.43 111.064 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.511 ' HA ' HD12 ' A' ' 124' ' ' LEU . 96.5 m-70 -55.16 147.66 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 70.05 110.896 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.463 ' C ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -179.86 166.42 1.3 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 73.44 110.916 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 127' ' ' LEU . 76.1 p -87.99 158.13 18.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 52.35 111.078 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.82 -43.09 62.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 72.04 111.129 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.625 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -61.81 -46.31 90.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 71.04 110.847 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.702 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.2 m -52.05 -42.58 63.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 63.04 111.08 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.464 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -73.3 -23.55 60.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 71.43 111.104 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -57.08 -40.49 77.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.856 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.63 HD12 ' OD1' ' A' ' 152' ' ' ASP . 8.4 mt -84.21 -28.43 27.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.927 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.71 -68.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 64.11 111.077 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.34 -24.94 47.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 73.21 110.879 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -24.17 66.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.885 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -95.71 -37.33 10.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 51.4 110.871 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.68 -5.3 4.07 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.718 . . . . 65.22 112.502 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -59.63 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.816 0.341 . . . . 63.4 110.935 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.427 ' H ' HG21 ' A' ' 95' ' ' ILE . 19.8 mm-40 -97.86 -1.0 44.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 72.4 110.891 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.464 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.0 OUTLIER 66.15 125.38 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.674 0.749 . . . . 65.44 110.886 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -170.37 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.238 . . . . 62.51 112.343 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 104' ' ' LYS . 70.8 mt -53.59 -41.2 66.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 71.23 110.942 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.28 59.72 8.6 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 74.32 112.482 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.75 54.63 0.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 75.4 110.896 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 107' ' ' SER . 67.1 mt -137.01 -173.21 3.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 61.51 110.902 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.0 -168.18 2.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.851 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.799 HG23 ' HB3' ' A' ' 144' ' ' TYR . 96.6 m -50.02 -41.66 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 61.3 111.197 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 m -140.51 141.82 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 72.42 111.141 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.647 HG22 HD23 ' A' ' 133' ' ' LEU . 60.0 m -149.04 110.88 4.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 63.34 111.154 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.89 98.01 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 64.53 110.865 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.647 HD23 HG22 ' A' ' 131' ' ' THR . 3.3 mt -87.62 149.77 24.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 61.44 110.883 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.31 131.29 17.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.889 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.401 ' HB2' HG21 ' A' ' 48' ' ' THR . 16.6 m-85 -134.35 99.17 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 73.32 110.863 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 61.51 -96.76 0.12 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.713 -0.756 . . . . 63.21 112.479 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -118.86 49.6 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 64.14 110.869 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.601 ' HB2' HG22 ' A' ' 48' ' ' THR . 2.2 tpt -138.1 152.97 49.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 72.23 110.823 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.44 118.14 21.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 63.23 110.958 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.645 HG13 HD23 ' A' ' 158' ' ' LEU . 4.6 t -135.14 159.19 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 63.31 111.15 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 140' ' ' VAL . 30.6 tt0 -160.52 126.7 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.24 110.907 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.9 178.32 6.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 62.33 111.133 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -172.84 138.23 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.906 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.799 ' HB3' HG23 ' A' ' 129' ' ' THR . 22.4 t80 -118.92 95.32 49.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.705 0.764 . . . . 73.21 110.864 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -48.75 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 45.31 112.365 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.42 -165.54 38.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 71.44 112.447 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -85.4 121.2 27.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 75.24 110.847 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.618 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -135.09 -94.28 0.46 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.738 -0.744 . . . . 75.14 112.443 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -70.58 -29.3 65.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.368 . . . . 74.33 110.814 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.32 154.71 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 65.24 111.129 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -58.35 -24.27 59.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 52.32 110.912 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.63 ' OD1' HD12 ' A' ' 114' ' ' LEU . 1.1 p30 -124.19 51.37 1.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 65.23 110.94 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.53 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.0 OUTLIER -100.79 136.36 40.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.976 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.467 HG22 ' CD1' ' A' ' 144' ' ' TYR . 10.3 pt -137.47 160.61 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.52 111.121 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 196' ' ' VAL . 15.4 m -106.34 157.73 6.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 45.35 111.065 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.29 141.1 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 74.12 111.16 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -128.24 150.2 50.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.888 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.645 HD23 HG13 ' A' ' 140' ' ' VAL . 15.1 mt -129.0 95.9 30.34 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.62 0.724 . . . . 74.45 110.917 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 72.49 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.687 2.258 . . . . 64.11 112.286 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.52 -34.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 64.13 110.924 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.523 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.8 m-85 -117.45 -13.56 10.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 71.41 110.975 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m120 69.38 25.82 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 55.43 110.835 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.545 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -97.09 119.12 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 63.44 111.099 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.479 HD11 HG13 ' A' ' 196' ' ' VAL . 0.5 OUTLIER -104.71 138.46 40.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 71.15 110.877 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.543 HG21 HD22 ' A' ' 44' ' ' LEU . 21.6 t -124.09 66.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 54.14 111.111 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.47 -45.11 53.73 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.744 -0.741 . . . . 53.42 112.46 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.74 -141.48 15.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.76 -0.733 . . . . 61.34 112.509 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 43.7 m -57.35 -23.91 51.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 62.42 110.92 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.53 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.5 OUTLIER -65.64 -49.35 69.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.927 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.562 HG11 HG11 ' A' ' 206' ' ' VAL . 46.3 t -90.41 105.37 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.14 111.166 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.92 151.31 37.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 64.11 110.903 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.671 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.3 p -75.26 169.47 17.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 71.55 110.841 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -38.61 86.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 63.15 111.114 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.57 -26.89 68.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.281 -0.418 . . . . 64.11 110.844 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.96 151.69 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 45.42 111.032 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.34 -30.79 5.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 64.53 110.859 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.19 173.55 15.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 64.52 110.809 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.554 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 0.5 OUTLIER -85.45 -37.07 20.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 73.32 110.943 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 97.18 -163.47 22.09 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.755 -0.736 . . . . 75.44 112.409 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -52.07 112.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 70.32 110.895 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 179' ' ' GLY . 35.3 m -105.95 34.82 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.144 -0.48 . . . . 71.52 111.132 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.01 84.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.493 . . . . 73.21 111.125 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.0 39.94 2.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.23 110.817 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -139.72 170.84 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 72.11 111.056 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -119.9 90.16 3.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 73.34 110.917 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.486 ' CG2' HG11 ' A' ' 181' ' ' VAL . 61.5 t -69.55 -20.94 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 75.54 111.097 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.97 -26.32 43.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 60.44 110.938 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.23 -23.15 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 62.42 110.886 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.554 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.6 t90 -51.27 -55.81 16.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.878 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -36.16 49.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 62.42 110.83 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.6 m -75.48 -34.24 60.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 74.32 111.081 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 67.4 m -64.38 -51.55 62.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.51 110.89 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.739 HG22 HD23 ' A' ' 197' ' ' LEU . 32.9 mm -56.72 -38.91 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 74.53 111.09 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -62.68 -22.07 66.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 72.43 110.857 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -90.72 -30.3 17.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 53.33 110.885 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.485 ' CG1' HD21 ' A' ' 219' ' ' LEU . 99.5 t -77.49 -37.05 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 63.12 111.176 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.739 HD23 HG22 ' A' ' 193' ' ' ILE . 4.4 pp -78.93 -25.21 43.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.878 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -83.13 -42.48 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.14 110.939 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -55.24 -26.45 39.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.21 110.895 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -143.81 118.54 9.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 71.53 110.918 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.37 37.52 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 73.12 110.909 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.43 21.27 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 55.43 110.902 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -52.25 146.85 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 72.51 111.142 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.56 -31.51 8.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.892 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.545 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -156.48 140.17 16.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 54.14 111.09 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.742 ' CG1' HD12 ' A' ' 218' ' ' LEU . 92.7 t -120.72 125.64 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 61.33 111.144 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.998 HG21 HD11 ' A' ' 44' ' ' LEU . 97.1 t -107.71 105.74 56.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.604 0.716 . . . . 73.23 111.1 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.4 Cg_endo -69.76 -179.85 3.19 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.705 2.27 . . . . 74.4 112.314 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.79 -33.83 26.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.729 -0.748 . . . . 62.03 112.518 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -143.61 111.13 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.344 . . . . 74.23 110.847 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.46 -114.2 0.72 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.701 -0.761 . . . . 53.34 112.422 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -151.84 166.86 30.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.85 0.357 . . . . 73.33 110.939 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.781 HG22 HG22 ' A' ' 207' ' ' VAL . 21.8 t -74.34 149.94 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 74.13 111.127 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -147.31 -108.54 0.53 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.76 -0.734 . . . . 74.42 112.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -157.73 -171.77 3.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 62.31 110.816 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 35.7 tttt -56.65 -21.51 27.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.889 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.759 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -55.29 -31.98 57.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 61.01 112.467 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.742 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.1 mt -51.06 -45.41 61.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 74.22 110.873 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.526 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -58.6 -44.58 89.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 72.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.759 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.7 mt -65.15 -42.01 94.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 73.03 110.95 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.657 ' NE2' HD21 ' A' ' 225' ' ' LEU . 77.5 t60 -66.24 -37.79 86.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.853 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.6 m -52.12 -43.01 63.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 73.45 111.08 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.753 ' HA ' HD12 ' A' ' 226' ' ' LEU . 61.5 mt -58.35 -42.29 86.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 75.11 110.863 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -26.86 66.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.841 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.657 HD21 ' NE2' ' A' ' 221' ' ' HIS . 22.4 mt -73.49 -25.88 60.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.45 110.925 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.753 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.1 mt -87.25 -42.2 13.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 35.15 110.88 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.31 110.922 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.694 ' HD1' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.77 0.319 . . . . 54.33 110.835 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -127.82 153.64 46.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 74.23 110.957 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -147.91 128.29 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.92 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 m -134.29 -176.32 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 75.53 111.142 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.35 115.64 30.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.874 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -155.96 154.7 31.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 70.34 110.875 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.553 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -147.5 178.46 8.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 74.34 111.072 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.562 HG22 ' OG ' ' A' ' 19' ' ' SER . 80.8 t 60.37 94.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 54.24 111.08 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.697 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.3 mm -87.9 156.92 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.184 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -145.77 147.14 31.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 60.02 110.964 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.79 164.24 26.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 62.11 110.85 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -51.88 -38.2 55.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 73.4 110.958 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.473 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.5 p -92.43 -26.57 17.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 42.35 111.193 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.71 -11.69 56.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 53.45 112.501 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.796 HG23 HG13 ' A' ' 16' ' ' ILE . 4.2 t -51.48 -32.63 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 64.54 111.15 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.796 HG13 HG23 ' A' ' 15' ' ' THR . 29.3 mt -120.92 149.88 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 74.13 111.103 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 p -169.98 167.53 8.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 71.45 110.862 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -135.57 -173.22 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 73.25 111.175 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.7 OUTLIER -172.83 132.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.86 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.03 120.38 13.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 74.13 110.816 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.11 -47.86 4.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 55.51 110.889 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -146.99 53.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 63.31 110.887 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.28 -76.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 74.03 110.937 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.76 -20.97 30.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.871 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 t -97.1 119.73 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 63.12 111.143 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.553 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.7 m95 -124.67 162.01 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.936 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.484 HG21 HG21 ' A' ' 213' ' ' VAL . 79.4 t -124.26 111.26 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.422 . . . . 52.44 111.098 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.526 ' HB3' HG23 ' A' ' 18' ' ' ILE . 10.1 p80 -103.21 137.62 41.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.468 . . . . 72.44 110.829 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.2 m -133.05 120.51 21.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 71.03 111.185 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.618 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -111.33 170.44 8.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 62.43 110.878 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.955 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -125.84 133.49 51.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 63.4 110.879 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -127.52 113.72 1.76 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.779 -0.724 . . . . 72.41 112.484 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.67 111.36 0.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.962 0.411 . . . . 74.41 110.777 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.69 105.54 15.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 73.45 110.885 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.8 t30 53.07 29.24 7.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 74.2 110.897 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.25 18.89 44.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.711 -0.756 . . . . 60.02 112.525 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -131.57 119.57 21.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.819 0.343 . . . . 72.13 110.88 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.955 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -65.84 132.68 49.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 35.33 111.096 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.727 HG11 ' HD1' ' A' ' 303' ' ' RTD . 60.5 t -139.84 102.65 6.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.601 0.715 . . . . 73.1 111.185 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.3 Cg_endo -69.78 141.01 44.0 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.707 2.271 . . . . 53.35 112.306 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -124.69 117.66 24.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 73.14 110.838 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -71.22 147.52 48.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 75.13 110.857 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.528 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -148.74 -160.41 9.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.758 -0.734 . . . . 73.25 112.404 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.974 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -161.74 143.7 11.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.384 . . . . 74.1 110.913 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 HD13 ' A' ' 54' ' ' LEU . 58.1 t -127.44 141.24 46.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 64.32 111.142 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.537 HD22 ' HE3' ' A' ' 138' ' ' MET . 13.3 mt -107.04 138.11 43.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 70.05 110.898 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -110.47 59.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.919 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.773 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.3 p -67.3 -172.76 0.24 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 71.41 111.16 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.26 26.38 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.992 0.425 . . . . 72.2 110.876 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -156.03 35.58 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 72.2 110.893 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.01 133.39 6.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.841 -0.695 . . . . 73.33 112.527 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.806 HD21 ' HB3' ' A' ' 75' ' ' PHE . 17.1 mt -64.19 172.84 2.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.874 0.369 . . . . 61.2 110.925 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 81' ' ' ASP . 61.0 t -148.18 143.42 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 75.53 111.103 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.563 HD13 HG22 ' A' ' 45' ' ' VAL . 3.3 mm? -115.84 130.01 56.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.119 -0.491 . . . . 74.1 110.876 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.5 t -80.36 -1.06 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 71.45 111.102 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -179.55 133.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 65.5 110.877 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -71.17 -168.64 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 55.32 110.864 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -173.18 3.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 74.33 110.906 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.718 ' HB2' HD13 ' A' ' 63' ' ' LEU . 89.9 m95 -69.54 -41.24 76.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 74.21 110.907 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.0 165.92 25.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.291 -0.413 . . . . 61.3 110.88 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -60.82 -34.69 74.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.916 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -73.94 -22.77 59.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 71.43 110.944 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.718 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -84.01 -43.44 15.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 75.15 110.893 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.6 t -66.99 -27.5 67.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 70.43 111.095 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.25 -43.52 71.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 73.12 110.89 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -82.91 -14.28 54.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 73.43 110.856 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.618 HD22 ' OE2' ' A' ' 30' ' ' GLU . 27.3 tp -76.63 -47.27 22.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 64.45 110.904 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -70.39 -33.4 53.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.43 111.12 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.8 -25.55 67.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 74.35 110.956 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 mmm -75.77 -59.83 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.499 . . . . 71.12 110.881 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.679 ' HB ' HD13 ' A' ' 52' ' ' LEU . 33.0 m -55.66 -31.91 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 72.41 111.102 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -89.69 48.29 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.875 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -143.65 -42.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.816 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.697 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -100.58 -25.9 14.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 75.4 110.869 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.806 ' HB3' HD21 ' A' ' 52' ' ' LEU . 35.5 m-85 -89.26 9.32 26.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 70.3 110.877 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.76 46.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.911 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -147.62 -177.76 5.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.05 110.896 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.95 130.04 39.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.824 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 52' ' ' LEU . 88.1 t -64.72 127.5 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.132 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.4 p -133.95 18.73 3.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 73.5 111.084 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.581 ' HB2' HG13 ' A' ' 53' ' ' VAL . 7.1 m-20 -153.63 136.13 15.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 53.24 110.846 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.453 HG11 ' CD1' ' A' ' 98' ' ' LEU . 25.2 t -139.75 97.82 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 63.24 111.086 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.1 mt -75.75 125.68 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 74.51 111.17 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 91' ' ' ARG . 41.1 mm -111.33 121.65 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 62.23 111.116 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.9 p -77.37 -53.7 7.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 72.55 111.074 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.499 ' HA ' HG23 ' A' ' 111' ' ' THR . 16.0 p-80 -135.8 171.12 14.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 75.04 110.886 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -91.02 101.09 13.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 70.44 111.025 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.643 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -155.23 159.85 40.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.46 . . . . 65.05 110.881 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.32 -25.31 48.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.052 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -94.0 20.15 8.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 73.22 110.879 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.439 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.5 mpt_? -135.17 -50.45 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 74.03 110.893 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -117.57 14.47 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 72.43 111.143 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.61 -35.55 30.11 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.735 -0.745 . . . . 73.4 112.449 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.18 19.04 41.26 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.705 -0.76 . . . . 64.43 112.421 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.593 HG21 ' H ' ' A' ' 121' ' ' GLU . 11.7 tt -45.97 -31.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 71.44 111.141 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.18 -54.25 32.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 73.1 110.914 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 87.1 m -58.7 -41.15 85.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.416 . . . . 75.14 111.09 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.453 ' CD1' HG11 ' A' ' 82' ' ' VAL . 30.4 mt -57.49 -28.7 63.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.446 . . . . 60.14 110.849 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -100.93 23.55 10.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 51.33 110.894 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -115.9 -26.57 7.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 44.4 110.861 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -103.34 -22.02 13.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 75.24 110.817 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.74 19.2 4.15 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.717 -0.754 . . . . 64.4 112.416 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.7 mt -87.23 154.67 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 74.24 111.117 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.499 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.5 ptpt -117.16 121.98 42.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.918 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.33 80.47 6.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 62.54 111.116 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.507 ' HA ' HD12 ' A' ' 124' ' ' LEU . 92.1 m-70 -54.32 144.11 21.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 64.44 110.869 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.8 153.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 72.15 110.88 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.618 HG22 ' HB3' ' A' ' 127' ' ' LEU . 19.4 p -74.75 158.4 33.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 51.42 111.159 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.83 -37.45 63.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 73.31 111.093 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -65.33 -46.0 82.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 65.32 110.892 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 2.0 m -52.89 -41.14 64.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 72.13 111.154 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.521 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -72.68 -22.33 60.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 55.31 111.114 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -38.78 82.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 72.44 110.839 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.679 HD12 ' OD2' ' A' ' 152' ' ' ASP . 12.2 mt -89.33 -26.27 21.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 74.04 110.906 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.4 -64.78 0.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 63.13 111.059 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -57.28 -23.96 51.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 71.11 110.912 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -23.77 66.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 72.12 110.914 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -94.47 -33.43 13.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 65.52 110.925 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 129.16 -5.15 6.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 65.04 112.464 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -59.81 -172.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 75.04 110.937 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.593 ' H ' HG21 ' A' ' 95' ' ' ILE . 29.4 mm-40 -96.11 -3.6 44.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 62.14 110.836 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.521 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.4 mt-10 66.38 125.52 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 75.12 110.886 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -172.52 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.646 2.231 . . . . 64.43 112.308 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 106' ' ' HIS . 37.7 mt -51.93 -39.36 59.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.898 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.0 53.99 27.85 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.79 -0.719 . . . . 72.32 112.447 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -146.62 54.81 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.819 0.343 . . . . 70.42 110.876 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.618 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.9 OUTLIER -132.31 -176.46 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 74.54 110.903 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -141.68 -168.4 2.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 51.02 110.883 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.741 HG23 ' HB3' ' A' ' 144' ' ' TYR . 87.3 m -49.93 -43.3 49.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 72.22 111.079 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 142' ' ' THR . 3.3 m -140.42 143.08 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 71.21 111.108 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 HD23 ' A' ' 133' ' ' LEU . 63.0 m -150.21 110.19 4.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 70.21 111.129 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -71.87 94.77 1.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 74.12 110.875 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 131' ' ' THR . 4.5 mt -82.7 149.18 27.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 73.23 110.937 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.28 109.56 4.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 64.32 110.895 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.641 ' HB2' HG21 ' A' ' 48' ' ' THR . 18.6 m-85 -109.94 98.13 7.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 73.02 110.889 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 58.09 -98.74 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.714 -0.755 . . . . 75.14 112.477 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -112.57 58.5 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 61.23 110.887 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.773 ' HB2' HG22 ' A' ' 48' ' ' THR . 15.7 tpp -151.2 151.66 32.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 73.22 110.867 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.28 120.29 26.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.32 110.899 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.699 HG13 HD23 ' A' ' 158' ' ' LEU . 5.3 t -137.42 158.68 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 75.34 111.167 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 30.7 tt0 -155.82 123.76 5.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 64.43 110.894 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.447 ' O ' HG12 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -76.54 178.4 6.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 74.13 111.17 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -172.39 137.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 71.12 110.927 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.741 ' HB3' HG23 ' A' ' 129' ' ' THR . 27.7 t80 -118.09 92.52 42.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.647 0.737 . . . . 73.45 110.862 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -48.72 0.67 Allowed 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.698 2.265 . . . . 73.31 112.371 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.62 -152.82 16.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.798 -0.715 . . . . 45.35 112.494 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.99 123.18 44.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 71.21 110.909 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.52 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -130.99 -89.43 0.5 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.741 -0.742 . . . . 65.33 112.481 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.3 t60 -77.32 -29.67 53.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.831 0.348 . . . . 74.02 110.85 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.68 155.4 40.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 73.45 111.145 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -60.25 -24.19 64.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 70.53 110.843 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.679 ' OD2' HD12 ' A' ' 114' ' ' LEU . 1.9 p30 -119.17 49.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.42 110.915 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.562 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.0 OUTLIER -100.11 137.78 38.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 61.21 110.897 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.453 HG22 ' HD1' ' A' ' 144' ' ' TYR . 5.0 pt -139.16 158.81 29.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 55.5 111.153 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.572 ' CG1' HD22 ' A' ' 169' ' ' LEU . 10.2 m -106.97 145.08 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 65.44 111.026 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.7 t -100.16 144.22 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 74.45 111.118 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -131.53 149.3 52.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.23 -0.441 . . . . 71.44 110.898 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.699 HD23 HG13 ' A' ' 140' ' ' VAL . 21.1 mt -127.52 95.71 34.89 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 61.43 110.91 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 72.47 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 62.25 112.336 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.35 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 72.11 110.839 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.54 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.1 m-85 -117.94 -13.05 10.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 72.34 110.954 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m120 69.51 23.15 6.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 61.3 110.923 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.54 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.7 mp -93.84 114.56 30.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 72.03 111.161 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.95 136.83 39.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.887 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.511 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.6 t -125.48 68.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.02 111.164 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.76 -41.42 43.45 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.721 -0.752 . . . . 42.2 112.541 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.39 -129.1 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 71.43 112.496 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 69.5 m -74.82 -6.9 51.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 63.43 110.864 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.572 HD22 ' CG1' ' A' ' 155' ' ' VAL . 2.1 tp -73.24 -53.5 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 72.14 110.876 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.03 128.37 43.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.091 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.733 ' HE2' HD23 ' A' ' 178' ' ' LEU . 1.2 tppt? -91.21 163.9 14.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 71.14 110.896 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 p -89.61 159.25 17.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.01 110.88 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.435 HG23 ' CD2' ' A' ' 218' ' ' LEU . 20.9 p -55.29 -28.49 53.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 73.02 111.159 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.46 -25.77 57.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 62.22 110.815 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.8 170.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 72.31 111.155 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.06 -41.67 0.58 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 64.15 110.779 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -148.98 179.6 7.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 74.25 110.801 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.784 HD22 ' CH2' ' A' ' 189' ' ' TRP . 3.0 mt -100.03 -27.2 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 71.3 110.9 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 120.56 -142.31 15.73 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 75.44 112.52 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 181' ' ' VAL . 37.1 t30 -99.03 16.45 22.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.897 0.38 . . . . 74.34 110.927 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.716 HG11 ' CG2' ' A' ' 186' ' ' VAL . 11.6 m 34.86 48.67 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 63.24 111.062 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -51.6 -58.62 5.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 73.03 111.077 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -117.34 28.16 8.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 71.1 110.869 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -104.66 174.88 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 75.31 111.063 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -137.28 85.18 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.918 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.716 ' CG2' HG11 ' A' ' 181' ' ' VAL . 86.2 t -58.83 -21.49 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 74.54 111.093 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -75.51 -21.72 57.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 71.3 110.947 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -107.83 -26.58 10.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 71.42 110.892 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.784 ' CH2' HD22 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -51.28 -57.12 9.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.893 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 90.0 p -52.03 -30.42 25.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 72.23 110.817 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.3 m -80.98 -32.44 34.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 75.4 111.204 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 196' ' ' VAL . 71.8 m -68.75 -56.66 7.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 70.13 110.912 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.8 mm -53.13 -42.03 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 64.14 111.157 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -63.43 -26.38 68.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 60.32 110.864 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -86.23 -31.23 21.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.53 110.858 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.531 HG21 HG11 ' A' ' 155' ' ' VAL . 99.1 t -73.22 -38.03 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 75.13 111.143 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.476 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -79.9 -25.62 40.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.879 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -42.6 33.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 73.04 110.913 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 33.4 tpt85 -60.73 -29.82 69.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 75.35 110.901 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -139.54 117.19 11.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 64.02 110.885 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 32.3 6.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 73.05 110.828 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.1 21.41 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 73.53 110.925 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -52.23 146.19 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 74.42 111.137 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -105.15 -34.82 7.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 64.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.404 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -156.88 133.56 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 74.34 111.087 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.735 ' CG1' HD12 ' A' ' 218' ' ' LEU . 88.5 t -109.72 128.3 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 71.13 111.09 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.974 HG21 HD11 ' A' ' 44' ' ' LEU . 89.5 t -111.29 102.46 53.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.612 0.72 . . . . 52.14 111.116 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.6 Cg_endo -69.69 -170.13 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 70.52 112.416 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.11 -29.29 7.26 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.853 -0.689 . . . . 75.43 112.559 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -143.46 101.01 3.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.824 0.345 . . . . 72.14 110.899 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.83 -101.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 72.55 112.527 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -168.42 165.18 12.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 70.31 110.856 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.66 HG22 HG22 ' A' ' 207' ' ' VAL . 22.4 t -74.74 149.63 7.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 73.01 111.159 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -151.35 -108.42 0.4 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.7 -0.762 . . . . 74.14 112.441 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -155.37 -172.77 4.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.867 0.365 . . . . 73.32 110.884 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -55.56 -22.39 21.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 64.14 110.88 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.735 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.19 -31.57 49.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 63.32 112.503 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.735 HD12 ' CG1' ' A' ' 206' ' ' VAL . 35.7 mt -50.95 -46.89 61.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 73.24 110.92 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.498 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -53.55 -42.22 67.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 72.42 110.898 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.735 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.0 mt -68.08 -41.21 82.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 74.5 110.95 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -66.26 -36.48 83.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 72.04 110.872 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.0 m -51.66 -43.44 62.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 75.11 111.103 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.782 ' HA ' HD12 ' A' ' 226' ' ' LEU . 71.9 mt -56.85 -38.57 72.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 74.43 110.902 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -28.65 62.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.807 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.7 mt -76.13 -24.77 54.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.927 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.0 mt -89.06 -32.8 17.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.908 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.871 179.883 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.727 ' HD1' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.848 0.356 . . . . 74.3 110.839 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.52 177.9 3.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 63.43 110.867 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.71 128.29 10.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 75.34 110.922 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 m -142.71 176.79 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 44.52 111.134 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.88 41.01 3.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.465 . . . . 71.42 110.888 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -134.76 151.25 50.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 70.22 110.902 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.436 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -146.14 -179.65 6.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.21 111.16 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 18' ' ' ILE . 81.1 t 60.8 98.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 72.33 111.108 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.722 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.2 mm -90.48 154.18 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 74.42 111.08 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -146.01 146.06 30.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 75.22 110.868 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.34 163.34 21.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.871 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -51.67 -33.21 32.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 72.12 110.884 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -31.45 17.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 42.22 111.109 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.04 -12.45 65.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 61.03 112.425 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.698 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -51.21 -33.42 27.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.867 0.365 . . . . 73.04 111.144 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.698 HG13 HG23 ' A' ' 15' ' ' THR . 15.0 mt -121.92 148.54 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 73.23 111.108 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.8 p -166.17 170.18 13.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 43.43 110.859 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.56 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -135.51 -175.65 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 72.43 111.156 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.482 ' HA ' HG22 ' A' ' 8' ' ' VAL . 1.1 t -167.02 133.87 2.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 72.21 110.858 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.76 118.07 15.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.88 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.471 HD13 HG23 ' A' ' 27' ' ' VAL . 4.8 mp -103.16 -39.31 6.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 74.24 110.899 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -149.44 -170.98 3.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 75.53 110.84 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -49.86 -51.25 41.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 51.31 110.893 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -132.23 41.11 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 42.02 110.838 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 t -136.02 120.45 25.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 71.43 111.142 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.436 ' CH2' HG22 ' A' ' 7' ' ' THR . 16.8 m95 -129.77 154.32 47.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.94 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.471 HG23 HD13 ' A' ' 21' ' ' LEU . 19.1 t -117.48 105.01 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 71.21 111.067 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.7 p80 -99.07 137.91 36.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.907 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.3 m -134.91 136.39 42.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 63.43 111.163 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -125.47 170.52 11.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 75.51 110.907 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 2.2 tp -120.76 137.04 54.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.895 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.83 138.74 6.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.793 -0.718 . . . . 62.21 112.548 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.93 141.32 44.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.93 0.395 . . . . 73.01 110.816 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -101.74 -32.55 10.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 74.14 110.869 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -166.36 34.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.918 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 114.6 13.63 9.43 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 64.21 112.522 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -151.41 119.74 6.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.829 0.347 . . . . 72.14 110.877 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -58.27 146.32 34.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 70.05 111.083 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.758 HG11 ' HD1' ' A' ' 303' ' ' RTD . 78.2 t -146.89 125.25 6.17 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.598 0.713 . . . . 60.45 111.105 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 141.74 46.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.683 2.255 . . . . 72.33 112.332 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.08 114.61 17.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 50.34 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.38 145.11 56.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 74.1 110.918 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -148.41 -175.62 21.15 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 72.44 112.517 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.784 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -154.98 141.75 19.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 74.12 110.915 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.51 HG22 HD23 ' A' ' 54' ' ' LEU . 21.2 t -126.15 137.53 57.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 75.23 111.086 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.2 mt -105.12 134.74 47.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 53.54 110.919 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -103.89 71.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 71.22 110.927 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 p -80.83 -172.03 3.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 70.43 111.19 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.59 -9.07 21.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 51.4 110.886 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.5 42.68 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 72.05 110.917 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.79 138.58 9.51 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 73.0 112.485 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.728 HD21 ' HB3' ' A' ' 75' ' ' PHE . 25.1 mt -58.52 172.93 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 70.24 110.904 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 81' ' ' ASP . 85.1 t -150.22 144.18 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 73.44 111.102 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.758 HD12 HG11 ' A' ' 79' ' ' VAL . 1.9 mt -116.26 132.14 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.994 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 55' ' ' VAL . 12.3 t -82.17 0.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 63.23 111.164 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.86 132.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 63.21 110.892 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -73.14 -168.42 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.21 110.827 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.3 m -94.62 -172.59 2.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.05 110.829 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.485 ' HB2' HD13 ' A' ' 63' ' ' LEU . 95.1 m95 -68.3 -35.08 77.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 75.03 110.923 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.72 168.27 24.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 61.14 110.885 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.436 ' HA ' HG22 ' A' ' 64' ' ' THR . 1.0 OUTLIER -64.53 -25.82 68.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 63.12 110.886 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -76.28 -25.47 54.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 73.04 110.941 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -85.87 -48.07 9.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 71.13 110.866 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 61' ' ' ASP . 13.7 t -59.86 -29.73 68.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 55.24 111.144 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -53.56 -41.62 66.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 64.12 110.882 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -84.81 -11.89 54.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 60.34 110.897 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 16' ' ' ILE . 35.1 tp -80.44 -47.52 14.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.23 110.947 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.2 mt -64.94 -21.99 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 75.31 111.152 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -71.91 -21.69 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.863 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.4 mtp -81.24 -58.32 3.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 74.33 110.893 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.615 ' HB ' HD13 ' A' ' 52' ' ' LEU . 35.2 m -58.07 -35.66 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 63.22 111.2 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -88.75 48.79 1.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 64.53 110.88 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.47 -41.71 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 61.24 110.902 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.722 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -102.09 -26.34 13.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 70.14 110.881 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.728 ' HB3' HD21 ' A' ' 52' ' ' LEU . 37.8 m-85 -88.35 9.61 22.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.01 110.829 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.5 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.4 pp0? 32.38 48.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.15 110.867 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -151.22 180.0 7.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.4 110.919 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.25 133.16 46.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 75.31 110.833 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.758 HG11 HD12 ' A' ' 54' ' ' LEU . 61.7 t -69.79 130.52 34.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 74.45 111.102 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.7 p -137.47 17.79 2.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 63.24 111.121 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.567 ' HB2' HG13 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -149.87 133.59 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.51 110.865 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG11 HD11 ' A' ' 98' ' ' LEU . 17.0 t -137.36 101.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 64.22 111.069 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.9 mt -78.8 119.54 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 65.34 111.087 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 91' ' ' ARG . 44.6 mm -106.3 133.52 50.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 55.45 111.121 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.4 p -89.3 -56.08 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.12 111.156 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.445 ' C ' HG23 ' A' ' 111' ' ' THR . 19.6 p-80 -133.14 163.87 28.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 73.22 110.829 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.8 98.41 9.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 61.11 111.164 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.626 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -152.54 158.13 42.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 75.42 110.832 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.51 -25.32 51.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 41.43 111.069 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -93.31 19.07 8.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 64.51 110.924 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.427 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.5 mpt_? -134.0 -51.35 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 64.34 110.827 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.626 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.03 15.79 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 73.31 111.092 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.96 -29.25 27.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.674 -0.774 . . . . 50.41 112.516 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.49 18.78 32.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 42.24 112.483 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.519 HG21 ' H ' ' A' ' 121' ' ' GLU . 8.4 tt -49.24 -29.99 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 73.11 111.135 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -69.95 -43.03 72.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 62.23 110.811 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.3 m -69.32 -34.29 74.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 73.43 111.144 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.458 HD11 HG11 ' A' ' 82' ' ' VAL . 52.7 mt -64.36 -32.32 73.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 54.03 110.883 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -94.27 21.29 7.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 71.23 110.882 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.27 -19.89 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.868 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.73 1.82 14.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 75.2 110.895 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.31 14.68 53.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.685 -0.769 . . . . 73.54 112.478 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.9 mt -82.27 154.9 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.342 . . . . 75.11 111.101 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.638 ' HB2' HD11 ' A' ' 124' ' ' LEU . 10.1 ptpt -118.89 122.79 43.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.869 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.415 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -91.28 79.2 5.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 62.2 111.075 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.525 ' HA ' HD12 ' A' ' 124' ' ' LEU . 72.2 m-70 -51.82 145.95 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 64.24 110.887 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.23 154.77 0.87 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 53.41 110.851 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 127' ' ' LEU . 73.4 p -72.57 160.09 32.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 53.35 111.109 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.22 -22.18 50.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 64.35 111.099 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 152' ' ' ASP . 8.9 tp -76.83 -48.15 19.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.866 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 44.5 m -55.34 -27.27 46.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.34 111.094 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.59 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -83.45 -23.71 32.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.101 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.29 -33.71 75.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 55.44 110.877 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.695 HD13 ' OD2' ' A' ' 152' ' ' ASP . 6.8 mp -93.1 -25.46 17.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 73.4 110.932 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.78 -65.1 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 52.34 111.135 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -56.58 -24.94 50.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 70.44 110.914 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -24.45 65.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 72.41 110.896 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -93.3 -33.48 13.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 64.01 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.03 -7.06 5.44 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 42.34 112.463 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -59.72 -172.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.38 . . . . 53.31 110.918 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.519 ' H ' HG21 ' A' ' 95' ' ' ILE . 23.8 mm-40 -98.01 -1.53 42.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 73.21 110.926 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.59 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 2.1 mt-10 66.15 125.22 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.624 0.726 . . . . 64.1 110.924 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -170.65 0.41 Allowed 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.651 2.234 . . . . 73.42 112.379 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' A' ' 104' ' ' LYS . 56.9 mt -54.18 -40.41 67.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 75.14 110.866 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.16 57.65 12.66 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.728 -0.748 . . . . 63.45 112.453 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.685 ' O ' HD23 ' A' ' 127' ' ' LEU . 13.7 m-20 -148.37 54.98 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 63.25 110.903 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 126' ' ' ASP . 41.2 mt -136.0 -169.63 2.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.927 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.61 -168.06 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.41 110.906 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.782 HG23 ' HB3' ' A' ' 144' ' ' TYR . 97.8 m -49.25 -44.05 43.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 61.34 111.132 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.01 141.04 29.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 75.11 111.118 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 93.7 m -148.56 101.53 3.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 55.44 111.147 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -65.86 96.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -88.94 159.21 17.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 73.51 110.942 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.33 107.1 3.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.3 110.914 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -98.89 -167.63 1.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 54.33 110.91 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -51.57 100.77 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.727 . . . . 62.34 112.513 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 50.77 42.25 27.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.376 . . . . 75.33 110.86 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 tpp -139.42 151.71 46.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 72.42 110.867 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.59 128.13 48.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 75.52 110.904 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.557 HG13 HD23 ' A' ' 158' ' ' LEU . 3.9 t -140.92 160.02 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 73.23 111.112 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 33.3 tt0 -161.17 122.58 2.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.87 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.44 178.73 5.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 44.5 111.169 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -174.0 139.21 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 64.35 110.908 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.782 ' HB3' HG23 ' A' ' 129' ' ' THR . 69.3 t80 -118.89 94.82 48.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.634 0.73 . . . . 75.04 110.928 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -48.74 0.66 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.749 2.299 . . . . 33.33 112.287 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.83 -156.39 25.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.682 -0.77 . . . . 61.23 112.451 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.36 121.94 39.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.736 0.303 . . . . 63.04 110.9 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.621 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -130.89 -93.65 0.64 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.67 -0.776 . . . . 52.21 112.451 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -73.04 -27.83 61.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 74.41 110.846 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.36 164.75 34.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 72.14 111.154 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -70.15 -23.88 63.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.41 110.865 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.695 ' OD2' HD13 ' A' ' 114' ' ' LEU . 8.8 p30 -119.41 49.0 1.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.871 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.5 p30 -99.62 137.58 37.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 70.24 110.911 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.8 pt -139.88 160.07 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.04 111.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 196' ' ' VAL . 9.4 m -108.5 149.42 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 75.3 111.157 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -105.57 141.82 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 72.42 111.078 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -130.17 146.77 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.928 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.557 HD23 HG13 ' A' ' 140' ' ' VAL . 9.6 mt -124.39 97.13 40.31 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.636 0.731 . . . . 75.32 110.908 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 73.33 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.677 2.252 . . . . 73.23 112.353 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.79 -34.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 72.24 110.862 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.436 ' O ' HD12 ' A' ' 163' ' ' ILE . 6.5 m-85 -118.04 -12.38 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.897 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.6 m120 68.9 23.27 6.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.106 -0.497 . . . . 72.52 110.884 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.445 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.5 mp -96.18 115.8 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 72.22 111.111 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.406 HD11 HG13 ' A' ' 196' ' ' VAL . 0.7 OUTLIER -99.11 139.97 33.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 73.42 110.914 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.612 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.5 t -126.7 67.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 74.23 111.154 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.36 -54.13 25.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 52.24 112.478 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.38 -134.8 12.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.622 -0.799 . . . . 44.4 112.494 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 91.8 m -64.48 -15.6 61.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.401 . . . . 55.11 110.93 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.408 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.3 tp -69.92 -51.54 32.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 74.52 110.913 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 206' ' ' VAL . 22.2 t -80.95 133.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 62.33 111.07 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -109.26 138.22 45.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 74.43 110.925 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 175' ' ' ALA . 3.3 p -57.06 154.68 9.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.2 110.872 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.786 HG23 HD23 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -60.23 -49.95 75.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 55.11 111.15 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.22 -28.85 29.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 54.45 110.829 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 172' ' ' SER . . . -54.72 158.34 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 72.15 111.08 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -144.72 22.44 1.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 75.14 110.908 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.59 150.26 1.35 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 72.12 110.89 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.413 HD11 HD23 ' A' ' 226' ' ' LEU . 1.2 mt -80.64 -34.77 34.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.871 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.45 -169.21 20.3 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.763 -0.732 . . . . 65.22 112.456 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -54.62 115.48 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 74.55 110.933 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.439 HG11 ' CG2' ' A' ' 186' ' ' VAL . 17.6 m -110.29 32.16 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 75.31 111.114 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.85 78.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 75.52 111.131 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -119.21 40.99 3.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 62.22 110.935 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -132.85 172.78 12.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 73.11 111.055 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -119.79 89.78 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 71.51 110.868 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.439 ' CG2' HG11 ' A' ' 181' ' ' VAL . 58.0 t -68.5 -20.9 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 62.14 111.076 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -81.34 -27.24 35.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 53.31 110.91 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.83 -22.94 16.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 61.23 110.837 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.36 -55.05 20.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 73.42 110.865 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.3 p -51.88 -41.11 61.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 70.23 110.87 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 89.4 m -69.84 -40.21 75.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 70.12 111.175 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 70.6 m -58.31 -55.06 39.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 74.21 110.825 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.63 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.0 mm -54.36 -36.82 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 54.34 111.174 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -62.45 -23.39 66.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 71.33 110.914 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -90.41 -25.94 20.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 70.1 110.914 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.543 HG12 HD21 ' A' ' 219' ' ' LEU . 43.6 t -80.96 -32.7 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 73.31 111.08 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.452 HD23 HG22 ' A' ' 193' ' ' ILE . 2.9 pp -84.8 -25.04 28.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 71.54 110.895 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -82.3 -46.07 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 75.22 110.942 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -52.14 -38.41 57.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 70.12 110.781 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -131.88 117.57 18.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 75.14 110.937 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -115.34 41.65 2.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 73.24 110.861 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.01 21.74 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.89 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.431 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.3 mp -53.22 144.58 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.144 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.02 -33.2 8.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 70.43 110.916 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.445 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -157.54 127.26 6.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 75.51 111.085 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 170' ' ' VAL . 86.9 t -106.76 118.09 53.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 72.25 111.15 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.784 HG21 HD11 ' A' ' 44' ' ' LEU . 57.4 t -100.84 104.11 29.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.571 0.701 . . . . 75.31 111.235 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.72 -172.14 0.54 Allowed 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.705 2.27 . . . . 63.33 112.301 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -100.64 -25.11 8.81 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 71.44 112.541 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -146.34 104.94 3.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 72.23 110.875 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 146.97 -91.43 0.15 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.71 -0.757 . . . . 72.03 112.453 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -178.9 153.28 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.373 . . . . 73.32 110.902 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.48 143.88 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 41.33 111.18 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -143.22 -105.56 0.54 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.696 -0.764 . . . . 44.13 112.487 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -155.49 -170.14 3.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.802 0.334 . . . . 70.32 110.911 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -57.74 -20.49 35.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.888 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.766 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.6 -33.28 62.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.707 -0.758 . . . . 75.43 112.504 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.786 HD23 HG23 ' A' ' 173' ' ' THR . 31.9 mt -50.78 -47.69 59.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 75.12 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.63 ' O ' HG21 ' A' ' 193' ' ' ILE . 7.0 mp -56.93 -43.87 81.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.457 . . . . 44.35 110.836 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.766 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.3 mt -66.08 -41.66 90.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 75.44 110.951 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.679 ' NE2' HD21 ' A' ' 225' ' ' LEU . 84.4 t60 -60.34 -44.46 95.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.792 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -46.73 64.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 65.25 111.071 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.62 ' HA ' HD12 ' A' ' 226' ' ' LEU . 61.0 mt -51.78 -39.75 59.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.22 111.0 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -65.64 -44.62 85.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.886 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.679 HD21 ' NE2' ' A' ' 221' ' ' HIS . 20.7 mt -57.0 -25.84 59.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.908 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.0 mt -90.56 -40.21 12.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 72.15 110.875 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.0 mttt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 61.41 110.88 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.758 ' HD1' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.791 0.329 . . . . 54.42 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.36 111.28 5.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.491 . . . . 63.11 110.928 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -138.46 169.64 17.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.931 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t 63.56 98.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 73.14 111.12 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -125.13 122.34 36.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 63.42 110.91 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mttp 60.37 170.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 64.42 110.909 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -113.4 90.49 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 73.4 111.171 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 7' ' ' THR . 3.0 t -157.85 114.04 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 74.32 111.155 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.694 HD11 ' HE3' ' A' ' 74' ' ' LYS . 2.8 mm -87.95 149.59 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 51.41 111.143 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -146.43 156.38 43.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 71.11 110.903 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.32 -177.52 4.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.878 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -67.14 -28.86 68.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.494 ' OG1' HG22 ' A' ' 15' ' ' THR . 5.6 p -93.06 -35.95 12.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.12 111.057 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.96 -15.16 58.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.664 -0.779 . . . . 65.14 112.425 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.707 HG23 HG13 ' A' ' 16' ' ' ILE . 2.0 t -51.72 -33.06 32.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.725 0.298 . . . . 53.02 111.151 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.707 HG13 HG23 ' A' ' 15' ' ' THR . 28.6 mt -117.11 150.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 45.51 111.027 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.9 p -170.66 173.24 5.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 71.15 110.827 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 19' ' ' SER . 0.3 OUTLIER -139.78 -177.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 62.24 111.13 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.444 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.2 t -167.72 135.77 2.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.473 . . . . 63.33 110.833 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -69.8 118.97 13.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 63.25 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.5 mm? -102.44 -56.8 2.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 65.03 110.946 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -152.69 -172.57 4.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.88 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.3 mttt -52.57 109.72 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 62.14 110.856 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 58.77 26.16 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 71.52 110.891 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 23' ' ' LYS . 69.5 t -128.44 110.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 75.42 111.124 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.494 ' HH2' HG22 ' A' ' 7' ' ' THR . 16.7 m95 -123.39 163.75 20.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 75.44 110.94 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 213' ' ' VAL . 71.9 t -124.42 109.81 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 62.54 111.181 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -99.32 136.92 38.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 71.44 110.888 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.4 m -130.99 125.9 34.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 54.52 111.13 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.635 ' OE1' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -117.88 168.09 10.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.829 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -125.68 132.92 52.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 63.13 110.91 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.29 114.94 1.54 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.687 -0.768 . . . . 74.52 112.437 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.91 129.81 27.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 63.22 110.838 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.77 102.18 7.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 74.44 110.916 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 55.44 26.08 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 72.33 110.899 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.05 23.88 18.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 42.34 112.448 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -141.39 119.71 12.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 73.44 110.919 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -65.5 141.68 58.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 72.55 111.087 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.734 HG11 ' HD2' ' A' ' 303' ' ' RTD . 69.9 t -146.55 103.08 3.97 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.668 0.747 . . . . 71.33 111.141 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.0 Cg_endo -69.67 139.51 40.73 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.782 2.321 . . . . 45.0 112.285 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.62 127.02 51.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 44.23 110.857 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -78.17 137.84 38.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 74.31 110.906 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.628 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -138.18 -160.47 8.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 62.21 112.529 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.049 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -165.15 143.63 6.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.84 0.352 . . . . 62.4 110.886 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.402 HG22 HD13 ' A' ' 54' ' ' LEU . 63.5 t -126.25 131.92 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 74.43 111.145 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.5 mt -101.85 119.1 38.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.438 . . . . 73.25 110.92 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -90.07 48.28 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 61.31 110.84 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 135' ' ' PHE . 19.5 p -58.48 176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 73.41 111.106 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.2 21.88 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 72.13 110.889 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.52 30.02 1.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.13 110.856 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.61 129.4 6.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 33.45 112.49 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.764 HD21 ' HB3' ' A' ' 75' ' ' PHE . 46.3 mt -51.62 165.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 52.43 110.97 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 81' ' ' ASP . 50.3 t -147.31 144.9 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 75.22 111.181 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 53' ' ' VAL . 3.5 mm? -115.7 126.66 54.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.11 110.921 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 55' ' ' VAL . 15.5 t -77.06 -3.85 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 75.11 111.181 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.8 129.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 74.31 110.846 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -166.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 70.23 110.857 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 t -94.66 -170.36 2.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 53.34 110.819 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.752 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.7 m95 -73.06 -38.8 66.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 72.25 110.878 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -140.0 161.73 36.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 71.13 110.87 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.22 -33.9 69.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 65.35 110.896 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -75.2 -25.75 58.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 70.21 110.903 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.752 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -81.16 -42.67 20.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 62.02 110.882 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -67.1 -27.05 67.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 65.4 111.168 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -53.42 -39.49 64.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.892 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -86.03 -13.96 45.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 65.54 110.912 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.635 HD22 ' OE1' ' A' ' 30' ' ' GLU . 11.7 tp -77.65 -43.14 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 72.34 110.911 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.24 -29.04 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 73.04 111.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -69.11 -11.7 61.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 73.15 110.889 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.7 mmm -89.38 -54.47 4.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.877 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.762 ' HB ' HD13 ' A' ' 52' ' ' LEU . 18.5 m -57.12 -39.87 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 60.3 111.051 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HG3' HG23 ' A' ' 71' ' ' VAL . 51.2 mt-10 -84.41 51.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 73.35 110.899 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -142.54 -41.23 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 75.13 110.878 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.694 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.62 -19.92 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 72.23 110.909 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.764 ' HB3' HD21 ' A' ' 52' ' ' LEU . 26.1 m-85 -89.22 10.81 20.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 65.31 110.883 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.518 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.64 47.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 61.43 110.902 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -155.3 -179.23 7.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 55.35 110.915 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.565 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -127.99 151.38 49.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 62.43 110.815 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 52' ' ' LEU . 57.7 t -86.11 128.66 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 70.15 111.116 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.565 HG23 ' HD3' ' A' ' 78' ' ' ARG . 65.4 p -137.25 20.76 2.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 72.11 111.173 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.582 ' HB2' HG13 ' A' ' 53' ' ' VAL . 5.8 m-20 -154.01 134.9 13.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 42.23 110.884 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.633 HG21 HD22 ' A' ' 98' ' ' LEU . 25.0 t -138.32 97.92 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 71.12 111.101 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.6 mt -75.02 129.69 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 71.21 111.131 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.5 mm -115.96 131.3 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 72.4 111.115 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.7 p -88.01 -57.93 2.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 64.34 111.157 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -132.86 157.6 44.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 53.24 110.865 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -76.25 96.98 4.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 63.11 111.151 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.639 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -150.65 157.94 43.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.871 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.83 -27.17 62.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 24.44 111.15 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.25 8.15 28.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 61.03 110.875 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -122.89 -53.6 1.85 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.903 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.639 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -113.4 18.36 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.128 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.61 -27.97 20.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.656 -0.783 . . . . 53.34 112.548 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.98 23.0 20.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.707 -0.759 . . . . 64.41 112.492 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.404 HG21 ' H ' ' A' ' 121' ' ' GLU . 3.9 tt -48.98 -30.36 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 62.22 111.111 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -71.06 -43.26 68.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.916 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 93.9 m -67.04 -36.03 81.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 70.44 111.118 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.633 HD22 HG21 ' A' ' 82' ' ' VAL . 48.6 mt -60.94 -33.48 73.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 75.33 110.926 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -94.3 21.84 6.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.911 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -117.24 -20.29 9.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.824 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -115.32 5.97 14.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.21 110.9 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.76 15.17 60.06 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 44.13 112.429 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 98' ' ' LEU . 14.3 mt -81.62 155.71 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 73.43 111.175 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.774 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -119.95 122.1 40.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 75.35 110.893 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -88.51 81.45 7.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 72.14 111.046 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.422 ' ND1' HD12 ' A' ' 124' ' ' LEU . 96.7 m-70 -56.58 147.71 21.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 70.41 110.889 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.64 166.43 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 71.14 110.799 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.1 p -86.08 157.05 20.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 61.01 111.145 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.41 -43.32 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.52 111.054 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.668 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -62.1 -46.04 90.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 52.12 110.986 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.679 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 98.2 m -52.04 -42.58 63.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 72.21 111.166 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.25 -24.79 61.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 63.32 111.117 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.87 -51.31 69.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 64.04 110.885 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.647 HD13 ' OD1' ' A' ' 152' ' ' ASP . 6.5 mp -76.26 -25.03 54.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.919 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.92 -69.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 74.42 111.155 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -54.72 -26.64 35.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 73.5 110.951 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -24.48 67.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 53.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -92.81 -38.97 11.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 74.53 110.873 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.86 -6.47 3.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 44.41 112.554 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -59.77 -172.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.832 0.348 . . . . 61.03 110.95 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.404 ' H ' HG21 ' A' ' 95' ' ' ILE . 56.0 mm-40 -98.63 -0.68 42.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 63.32 110.885 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 66.28 126.26 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.654 0.74 . . . . 72.21 110.85 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.677 2.251 . . . . 55.41 112.377 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 104' ' ' LYS . 62.9 mt -52.21 -40.55 61.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.903 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.1 55.97 18.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 71.41 112.531 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -148.98 52.93 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 71.31 110.912 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.8 mt -135.74 -177.67 4.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.883 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.83 -168.59 2.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.883 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.847 HG23 ' HB3' ' A' ' 144' ' ' TYR . 92.7 m -50.1 -54.26 21.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 70.23 111.158 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.699 HG22 ' HA ' ' A' ' 143' ' ' PHE . 90.8 t -131.34 130.98 63.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 64.02 111.106 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.565 HG22 HD23 ' A' ' 133' ' ' LEU . 99.1 m -135.6 123.67 22.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 75.11 111.167 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -81.41 103.97 11.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 75.1 110.85 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.565 HD23 HG22 ' A' ' 131' ' ' THR . 1.6 mt -91.97 150.43 21.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 73.13 110.902 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 130.42 16.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 74.22 110.898 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.489 ' HB2' HG21 ' A' ' 48' ' ' THR . 7.3 m-85 -133.42 37.6 3.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 54.14 110.873 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.76 111.67 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 72.33 112.496 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.73 28.29 14.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.352 . . . . 74.44 110.858 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.41 ' CB ' HG22 ' A' ' 48' ' ' THR . 58.5 tpp -152.73 126.02 8.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 75.41 110.838 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -117.17 115.24 24.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.926 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.6 t -123.01 153.55 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 61.31 111.144 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -153.15 122.38 6.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 70.21 110.938 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.538 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -73.24 -178.18 2.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 42.13 111.148 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.699 ' HA ' HG22 ' A' ' 130' ' ' VAL . 71.2 t80 -175.35 134.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.84 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.847 ' HB3' HG23 ' A' ' 129' ' ' THR . 29.1 t80 -121.09 96.06 48.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.702 0.763 . . . . 74.24 110.91 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.7 Cg_endo -69.79 -48.71 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.619 2.213 . . . . 64.25 112.336 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.61 -153.78 20.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.738 . . . . 63.15 112.451 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.7 124.62 39.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 71.33 110.905 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.48 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.42 -94.19 0.34 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.74 -0.743 . . . . 53.32 112.47 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -70.11 -26.86 64.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.919 0.39 . . . . 62.4 110.895 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.41 159.62 42.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.468 . . . . 74.32 111.119 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.28 -23.09 66.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.873 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.668 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.5 OUTLIER -124.02 50.07 1.69 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 75.52 110.868 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.19 139.87 34.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 73.12 110.904 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.538 HD12 HG22 ' A' ' 142' ' ' THR . 5.6 pt -140.12 172.85 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 61.44 111.149 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 196' ' ' VAL . 7.9 m -123.58 139.23 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 45.21 111.183 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.447 ' O ' HD22 ' A' ' 164' ' ' LEU . 77.6 t -94.04 128.68 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 70.34 111.139 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -114.84 150.32 35.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.905 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.674 HD12 ' HB ' ' A' ' 163' ' ' ILE . 53.7 mt -124.77 94.87 43.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.595 0.712 . . . . 73.15 110.926 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 69.65 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.687 2.258 . . . . 65.14 112.317 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.37 -34.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 74.23 110.874 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.617 ' CB ' HD13 ' A' ' 163' ' ' ILE . 7.3 m-85 -117.49 -10.76 10.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 75.52 110.905 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.4 m120 68.18 21.01 8.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 73.35 110.88 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.674 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.5 mp -86.41 116.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 65.44 111.097 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.6 tm? -101.98 123.46 45.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 52.42 110.984 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.489 ' N ' HD22 ' A' ' 164' ' ' LEU . 26.0 t -117.37 72.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 65.12 111.078 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.416 ' H ' HD13 ' A' ' 164' ' ' LEU . . . -65.17 -51.71 47.59 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 71.43 112.482 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.94 -138.02 14.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 72.33 112.483 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.91 -25.72 31.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 52.23 110.854 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.483 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.6 OUTLIER -62.08 -49.63 75.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 63.43 110.95 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.741 HG11 HG11 ' A' ' 206' ' ' VAL . 21.4 t -89.56 131.37 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 61.53 111.111 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -101.6 148.64 24.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 73.01 110.887 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.632 ' HA ' HD22 ' A' ' 218' ' ' LEU . 2.2 t -73.56 158.86 34.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.827 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.74 -24.95 66.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 72.03 111.197 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.8 p -77.9 -26.28 49.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 54.05 110.872 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.79 173.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 73.02 111.071 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.546 ' O ' HD22 ' A' ' 225' ' ' LEU . 0.1 OUTLIER -123.48 -39.69 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 72.24 110.901 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.549 ' HA ' HD22 ' A' ' 225' ' ' LEU . 0.3 OUTLIER -155.04 178.39 10.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 53.15 110.865 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.473 HD22 ' CE3' ' A' ' 189' ' ' TRP . 0.6 OUTLIER -77.07 -41.42 42.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.902 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 95.31 -158.35 22.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 73.14 112.484 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -52.09 137.13 28.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 72.41 110.93 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 186' ' ' VAL . 35.4 m -133.41 38.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 61.4 111.069 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.48 -46.3 80.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 71.55 111.039 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -114.03 42.23 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.268 -0.423 . . . . 74.3 110.927 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.24 164.65 28.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.43 111.072 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -115.61 92.61 3.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 72.45 110.931 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.53 ' CG2' HG11 ' A' ' 181' ' ' VAL . 61.7 t -67.07 -23.68 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.1 111.201 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -79.39 -31.52 42.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 25.31 110.886 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.51 -22.7 20.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 62.41 110.911 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.473 ' CE3' HD22 ' A' ' 178' ' ' LEU . 1.5 t90 -51.49 -53.21 39.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 64.15 110.884 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.6 p -51.88 -37.93 54.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 71.04 110.86 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 91.8 m -70.64 -37.77 73.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 60.22 111.128 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.2 m -63.38 -55.27 25.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 70.51 110.876 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.939 HG22 HD23 ' A' ' 197' ' ' LEU . 25.8 mm -56.54 -37.63 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 64.12 111.112 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.06 -17.49 62.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 75.12 110.842 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -96.55 -28.96 14.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 61.14 110.901 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.518 HG21 HG11 ' A' ' 155' ' ' VAL . 96.0 t -82.69 -26.02 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 71.42 111.099 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.939 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -90.51 -23.27 20.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 64.45 110.909 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -88.51 -47.38 8.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 72.4 110.88 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 32.9 tpt85 -55.31 -32.59 62.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.834 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -130.89 116.91 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 72.3 110.888 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -119.3 34.94 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 75.34 110.897 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.02 22.33 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 70.3 110.859 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.541 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.2 mp -51.51 143.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 74.44 111.146 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -103.0 -39.27 6.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 74.03 110.936 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.432 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -153.71 118.96 5.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 72.42 111.092 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.741 HG11 HG11 ' A' ' 170' ' ' VAL . 92.8 t -96.96 123.21 49.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 74.41 111.152 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.049 HG21 HD11 ' A' ' 44' ' ' LEU . 87.5 t -106.49 102.13 39.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 73.44 111.154 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.0 Cg_endo -69.69 -170.05 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.75 2.3 . . . . 50.23 112.347 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.87 -31.27 7.45 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.733 -0.746 . . . . 61.54 112.445 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -144.27 111.9 6.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 65.45 110.873 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 144.91 -94.17 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 74.44 112.447 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -176.06 164.09 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 72.55 110.917 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.694 HG22 HG22 ' A' ' 207' ' ' VAL . 21.3 t -72.59 150.57 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.41 111.07 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -149.77 -108.0 0.43 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.767 -0.73 . . . . 74.01 112.457 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -160.27 -169.85 2.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.876 0.369 . . . . 63.14 110.887 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -54.25 -24.76 19.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 72.41 110.87 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.73 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -52.16 -35.6 42.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.79 -0.719 . . . . 71.51 112.5 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.711 HD12 ' CG1' ' A' ' 206' ' ' VAL . 32.7 mt -50.96 -45.68 60.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.339 . . . . 64.31 110.918 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.716 HD12 HG23 ' A' ' 193' ' ' ILE . 4.3 mm? -54.14 -41.3 68.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 74.41 111.01 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.73 HD12 ' HA2' ' A' ' 217' ' ' GLY . 4.8 mt -69.36 -40.87 77.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.32 110.853 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -60.78 -42.14 96.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.762 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.25 -48.43 65.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 62.31 111.167 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.799 ' HA ' HD12 ' A' ' 226' ' ' LEU . 3.8 mt -56.28 -41.4 75.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 62.12 110.93 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.91 -42.07 79.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 73.22 110.904 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 177' ' ' ASP . 17.5 mt -60.88 -37.4 82.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 75.03 110.894 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' A' ' 223' ' ' LEU . 4.7 mt -72.7 -40.53 66.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 65.22 110.944 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 71.32 110.909 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.734 ' HD2' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.773 0.32 . . . . 75.3 110.886 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.29 159.31 42.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 72.23 110.91 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -135.86 155.45 50.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 63.24 110.908 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -172.14 133.94 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 70.52 111.048 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 59.57 78.57 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 64.43 110.826 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.46 152.92 10.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.447 . . . . 53.15 110.929 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.529 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -146.09 -179.34 6.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 60.14 111.11 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.575 HG22 ' OG ' ' A' ' 19' ' ' SER . 92.4 t 60.96 95.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 60.2 111.154 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.6 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.1 mm -88.14 152.86 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 73.23 111.191 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -146.12 153.75 41.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 71.42 110.87 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.16 170.82 11.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 55.24 110.903 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -58.7 -27.17 64.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 73.42 110.885 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -100.13 -33.4 10.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 71.55 111.225 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.85 -9.76 51.8 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.737 -0.745 . . . . 50.42 112.446 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.704 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.94 -33.21 23.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.716 0.293 . . . . 72.51 111.123 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.704 HG13 HG23 ' A' ' 15' ' ' THR . 14.6 mt -124.81 149.18 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.15 111.084 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -168.34 169.75 10.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 72.31 110.845 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -135.05 -172.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.503 . . . . 75.02 111.143 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.575 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -173.76 132.86 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 60.51 110.908 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.21 120.72 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.104 -0.498 . . . . 74.5 110.923 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -103.8 -49.28 3.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.45 . . . . 54.22 110.932 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.33 51.87 1.57 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 69.03 -75.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.936 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.621 ' OD1' HG23 ' A' ' 25' ' ' VAL . 14.5 p30 -86.88 -19.91 28.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 71.45 110.897 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.621 HG23 ' OD1' ' A' ' 24' ' ' ASN . 99.6 t -97.45 118.52 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 65.34 111.123 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.529 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.4 m95 -122.35 161.56 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.939 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.5 HG21 HG21 ' A' ' 213' ' ' VAL . 70.4 t -122.35 106.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 64.55 111.108 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.456 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.1 p80 -95.83 137.37 34.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 74.24 110.876 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 41' ' ' SER . 37.3 m -132.46 128.76 38.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 62.14 111.156 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.651 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -120.29 -177.27 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.438 . . . . 73.0 110.865 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.09 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.3 OUTLIER -136.79 133.16 35.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 73.23 110.865 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.83 111.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 75.53 112.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.94 137.93 44.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 71.23 110.868 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -99.81 -22.3 15.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.918 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -172.63 31.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 75.31 110.863 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.91 17.17 10.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.683 -0.77 . . . . 35.21 112.447 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -125.07 -169.5 2.0 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.924 0.392 . . . . 72.23 110.868 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.09 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -128.31 101.77 6.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 60.21 111.108 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.743 HG11 ' HD1' ' A' ' 303' ' ' RTD . 59.4 t -113.07 103.4 55.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.643 0.735 . . . . 72.24 111.068 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.5 Cg_endo -69.69 141.04 44.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.649 2.233 . . . . 73.23 112.358 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.625 ' O ' HG23 ' A' ' 29' ' ' THR . 1.1 t -121.26 132.85 55.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 62.4 110.821 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -90.95 141.93 28.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 73.24 110.804 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.627 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -140.95 -155.87 6.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 52.04 112.53 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.919 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -164.93 144.13 6.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.931 0.396 . . . . 71.44 110.903 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 54' ' ' LEU . 31.6 t -128.08 133.28 67.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 53.23 111.115 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.554 HD22 ' HE3' ' A' ' 138' ' ' MET . 39.6 mt -100.64 123.32 44.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.941 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -92.15 46.79 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 74.32 110.886 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.538 HG22 ' CB ' ' A' ' 138' ' ' MET . 24.5 p -55.35 171.26 0.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 63.44 111.125 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.3 t -99.24 28.45 4.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.83 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.55 22.8 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 70.33 110.941 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.8 129.98 4.4 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 65.13 112.503 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.799 HD13 ' HB ' ' A' ' 71' ' ' VAL . 26.0 mt -57.26 157.81 5.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 74.51 110.957 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' A' ' 81' ' ' ASP . 95.2 t -140.76 143.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 64.14 111.123 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.557 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -113.47 130.07 56.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 72.01 110.934 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.8 t -79.77 -1.78 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 73.43 111.096 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.78 134.2 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.88 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -166.7 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 71.41 110.821 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.17 -170.09 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 53.23 110.799 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.677 ' HB2' HD13 ' A' ' 63' ' ' LEU . 85.7 m95 -72.05 -40.22 68.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.094 -0.503 . . . . 71.21 110.931 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.79 175.54 9.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 32.31 110.958 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HA ' HG22 ' A' ' 64' ' ' THR . 4.1 p-10 -68.9 -30.61 69.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 75.12 110.823 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -74.54 -22.39 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 70.23 110.918 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -88.27 -52.41 5.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 64.44 110.89 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.495 HG21 ' HA3' ' A' ' 94' ' ' GLY . 10.2 t -57.4 -28.35 63.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 72.44 111.138 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -55.93 -40.82 73.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 53.24 110.874 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.96 -1.36 57.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.414 . . . . 74.53 110.866 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.651 HD22 ' OE2' ' A' ' 30' ' ' GLU . 15.5 tp -92.88 -45.15 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.902 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.8 mt -72.18 -14.65 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 73.42 111.072 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -87.11 5.9 35.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 63.15 110.848 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.1 mtp -106.54 -53.69 2.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 73.32 110.859 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.799 ' HB ' HD13 ' A' ' 52' ' ' LEU . 21.3 m -58.42 -37.77 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 71.32 111.083 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HG3' HG23 ' A' ' 71' ' ' VAL . 32.7 mt-10 -85.99 50.03 1.9 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.898 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.23 -42.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 72.02 110.837 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.6 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -103.9 -21.65 13.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.955 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.757 ' HB3' HD21 ' A' ' 52' ' ' LEU . 35.9 m-85 -91.23 12.94 18.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.883 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.511 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.72 46.91 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.484 . . . . 71.13 110.923 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -155.57 -177.81 6.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 72.32 110.87 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.1 OUTLIER -125.85 159.13 33.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 71.13 110.875 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 52' ' ' LEU . 89.9 t -91.46 119.44 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 52.14 111.123 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.414 HG23 ' HG2' ' A' ' 78' ' ' ARG . 30.0 p -132.18 36.83 3.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.118 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.819 ' HB2' HG22 ' A' ' 53' ' ' VAL . 4.6 m-20 -169.76 134.29 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 73.12 110.794 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.677 HG23 HG21 ' A' ' 103' ' ' ILE . 22.4 t -140.66 100.27 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 71.22 111.09 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.7 mt -77.66 124.04 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 55.54 111.164 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.3 mm -109.24 142.43 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 74.24 111.132 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.8 p -98.69 -60.85 1.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.439 . . . . 71.52 111.164 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -130.79 165.07 23.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 75.44 110.865 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.21 97.66 8.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.22 111.059 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.667 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.65 157.93 42.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 73.25 110.912 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.93 -29.57 63.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 73.33 111.087 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -89.66 10.7 22.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.873 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -121.94 -52.09 2.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 65.31 110.915 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -117.13 26.77 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.157 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.24 -28.19 18.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.707 -0.758 . . . . 60.04 112.479 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' A' ' 64' ' ' THR . . . -116.02 30.61 6.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 65.32 112.543 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.514 HD11 ' C ' ' A' ' 122' ' ' GLU . 1.1 tt -48.56 -34.21 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 75.1 111.098 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -34.51 33.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 75.33 110.853 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.9 m -62.44 -34.18 76.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 72.44 111.063 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.967 HD12 ' HB2' ' A' ' 105' ' ' ALA . 27.6 mt -65.4 -43.24 91.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 63.32 110.878 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -26.26 59.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.866 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.25 -29.82 70.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 72.23 110.896 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -105.58 -48.29 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.35 110.858 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.62 -15.75 1.08 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.72 -0.753 . . . . 72.02 112.499 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.677 HG21 HG23 ' A' ' 82' ' ' VAL . 1.9 mp -54.56 151.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.13 111.123 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.787 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.6 ptpm? -113.66 127.84 56.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.923 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.967 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -90.12 82.03 6.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 40.42 111.043 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.456 ' ND1' HD12 ' A' ' 124' ' ' LEU . 93.7 m-70 -57.72 147.11 28.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.45 110.871 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.63 160.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 73.03 110.89 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.637 HG22 ' HB3' ' A' ' 127' ' ' LEU . 72.2 p -74.03 -175.61 2.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 41.14 111.111 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.12 -30.92 43.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 51.33 111.143 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.73 -44.68 40.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.958 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.7 m -55.41 -25.38 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 73.13 111.168 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.518 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -91.31 -34.34 14.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 64.23 111.159 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -53.69 -32.8 53.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 60.31 110.89 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.558 HD13 ' OD1' ' A' ' 152' ' ' ASP . 9.8 mp -91.79 -25.84 18.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 70.35 110.838 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . . . -53.65 -62.72 1.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.32 111.096 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -60.12 -26.09 65.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 71.3 110.898 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -25.18 68.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.893 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -92.16 -33.38 14.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 64.3 110.868 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.1 -10.78 4.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 32.34 112.494 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -59.59 -173.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.83 0.347 . . . . 72.41 110.871 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -98.71 0.32 44.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 54.44 110.886 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.514 ' C ' HD11 ' A' ' 95' ' ' ILE . 1.2 mt-10 66.42 132.59 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.656 0.741 . . . . 74.21 110.928 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.8 -169.63 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.653 2.235 . . . . 61.33 112.4 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.787 HD11 ' HB2' ' A' ' 104' ' ' LYS . 54.2 mt -54.83 -51.11 66.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 73.11 110.959 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.4 51.72 8.2 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.75 -0.738 . . . . 62.12 112.471 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.46 55.42 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.864 0.364 . . . . 64.32 110.833 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.637 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.5 OUTLIER -137.61 -174.66 3.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 61.1 110.89 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.84 -168.16 2.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.764 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.1 m -49.66 -43.01 46.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 65.42 111.221 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.38 142.15 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 75.5 111.061 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.654 HG22 HD23 ' A' ' 133' ' ' LEU . 60.6 m -149.83 108.87 3.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.095 -0.502 . . . . 72.03 111.084 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -69.75 96.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 72.53 110.858 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.654 HD23 HG22 ' A' ' 131' ' ' THR . 3.3 mt -86.82 150.64 23.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 54.0 110.94 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 130.21 12.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 45.23 110.928 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.474 ' HB2' HG21 ' A' ' 48' ' ' THR . 6.7 m-85 -132.54 99.42 4.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 74.0 110.881 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 58.69 -97.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 72.12 112.514 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -115.12 57.81 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 52.41 110.877 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.554 ' HE3' HD22 ' A' ' 46' ' ' LEU . 2.2 tpt -153.72 142.68 21.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 65.33 110.832 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -120.51 127.72 52.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 62.34 110.848 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.702 HG13 HD23 ' A' ' 158' ' ' LEU . 5.0 t -141.51 158.96 21.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 43.35 111.145 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.417 ' N ' HG12 ' A' ' 140' ' ' VAL . 30.7 tt0 -159.01 124.58 4.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 52.11 110.891 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.412 HG22 ' CD1' ' A' ' 154' ' ' ILE . 0.0 OUTLIER -74.97 -178.27 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 72.33 111.13 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -175.36 140.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 71.5 110.895 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.764 ' HB3' HG23 ' A' ' 129' ' ' THR . 49.7 t80 -123.24 97.66 42.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.598 0.713 . . . . 74.02 110.927 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.478 ' HB3' HG23 ' A' ' 196' ' ' VAL . 54.0 Cg_endo -69.7 -48.98 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.699 2.266 . . . . 54.12 112.371 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.59 -153.95 22.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.786 -0.721 . . . . 55.22 112.467 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.51 122.44 39.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 74.23 110.934 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.507 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.04 -97.76 0.56 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 52.21 112.481 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -67.65 -28.41 67.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.818 0.342 . . . . 64.24 110.862 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.69 156.44 41.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 73.12 111.114 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -59.91 -29.26 68.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 72.01 110.844 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.558 ' OD1' HD13 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -117.9 52.12 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.89 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.507 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.4 p30 -100.72 135.0 42.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 75.43 110.884 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.415 HG22 ' HD1' ' A' ' 144' ' ' TYR . 1.1 pt -136.45 166.98 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 74.23 111.114 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.442 ' CG1' HD23 ' A' ' 169' ' ' LEU . 10.5 m -116.83 157.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 70.13 111.107 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.3 t -110.36 143.29 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.136 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -130.87 148.15 52.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 71.14 110.902 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.702 HD23 HG13 ' A' ' 140' ' ' VAL . 24.1 mt -125.53 95.37 40.8 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.57 0.7 . . . . 74.22 110.888 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 72.21 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.729 2.286 . . . . 52.12 112.317 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.08 -33.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 70.33 110.934 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.89 -11.74 10.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.891 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 68.36 24.12 7.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 63.13 110.976 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.562 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.7 mp -96.24 117.24 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 64.33 111.172 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.23 142.65 33.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.21 110.952 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.507 HG21 HD22 ' A' ' 44' ' ' LEU . 21.6 t -127.9 67.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 75.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.62 -55.19 21.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.67 -0.776 . . . . 71.25 112.544 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.14 -137.12 13.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.668 -0.777 . . . . 34.01 112.468 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 59.3 m -64.24 -15.8 60.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 61.43 110.934 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.651 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.5 tp -70.11 -47.59 61.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.914 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.505 HG12 ' HB3' ' A' ' 218' ' ' LEU . 21.8 t -95.91 115.92 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 53.43 111.148 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.615 ' H ' HG23 ' A' ' 222' ' ' THR . 0.1 OUTLIER -82.85 155.76 23.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 73.42 110.892 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.619 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.5 t -84.0 162.29 20.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 73.14 110.843 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.1 p -59.15 -31.41 68.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 73.3 111.161 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.38 -28.57 64.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.143 -0.481 . . . . 61.13 110.832 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.4 162.4 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 52.22 111.084 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -122.32 -37.02 2.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.884 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -154.91 171.92 18.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 41.11 110.918 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.601 HD11 HD23 ' A' ' 226' ' ' LEU . 2.1 mt -72.66 -43.38 63.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.958 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 99.29 -154.47 19.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.686 -0.769 . . . . 73.42 112.523 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -52.03 126.85 19.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 72.15 110.906 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.488 HG11 ' CG2' ' A' ' 186' ' ' VAL . 6.7 m -117.7 31.68 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 63.14 111.115 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.27 -47.05 82.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 70.25 111.155 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -117.42 42.99 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.35 110.844 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -133.62 162.17 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 73.23 111.138 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -115.72 93.49 4.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.022 0.439 . . . . 75.45 110.902 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.488 ' CG2' HG11 ' A' ' 181' ' ' VAL . 49.1 t -69.36 -20.91 24.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 74.25 111.06 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -81.98 -26.84 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 70.34 110.943 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.54 -21.37 16.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.53 110.841 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.651 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -51.41 -56.18 14.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.9 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.3 p -51.96 -37.77 54.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.837 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.1 m -72.56 -37.84 68.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 72.15 111.127 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 75.7 m -61.92 -54.92 35.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.04 110.83 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.772 HG23 HD12 ' A' ' 219' ' ' LEU . 26.7 mm -55.83 -36.75 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 74.15 111.087 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.88 -17.31 64.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.3 110.828 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -93.93 -31.03 14.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 70.5 110.871 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 145' ' ' PRO . 87.3 t -77.26 -45.9 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 54.13 111.137 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.713 HD23 HG22 ' A' ' 193' ' ' ILE . 3.6 pp -69.77 -23.2 63.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.467 . . . . 63.12 110.878 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -86.23 -44.33 12.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 63.51 110.866 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -53.29 -28.5 28.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 73.02 110.874 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -142.52 121.24 12.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 64.53 110.96 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.42 35.69 4.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 73.41 110.879 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.25 21.8 1.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.914 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.449 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.6 mp -53.24 145.08 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 72.42 111.164 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -105.88 -33.76 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.91 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.562 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -155.92 128.37 7.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 44.23 111.111 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.498 HG12 HD12 ' A' ' 218' ' ' LEU . 94.8 t -109.85 117.42 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 44.41 111.126 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.919 HG21 HD11 ' A' ' 44' ' ' LEU . 75.3 t -100.04 104.3 28.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.594 0.711 . . . . 70.41 111.097 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.75 -173.7 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.707 2.271 . . . . 72.4 112.32 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -93.42 -28.85 10.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.737 . . . . 65.13 112.503 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -144.09 110.52 5.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 74.11 110.824 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 144.92 -98.41 0.2 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.747 . . . . 44.23 112.508 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -174.62 154.75 2.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 72.12 110.928 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.816 HG22 HG22 ' A' ' 207' ' ' VAL . 22.9 t -57.32 149.59 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 62.33 111.157 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -148.72 -108.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.697 -0.763 . . . . 73.03 112.515 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -161.34 -169.85 2.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.893 0.378 . . . . 72.12 110.92 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -58.18 -20.56 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 44.32 110.949 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.571 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.63 -33.98 63.59 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.76 -0.734 . . . . 55.45 112.461 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 172' ' ' SER . 28.0 mt -50.59 -42.66 56.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.834 0.35 . . . . 72.14 110.896 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.772 HD12 HG23 ' A' ' 193' ' ' ILE . 4.6 mm? -55.43 -43.36 75.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.919 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.571 HD12 ' HA2' ' A' ' 217' ' ' GLY . 4.9 mt -68.54 -40.41 80.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 72.11 110.9 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -60.72 -38.91 86.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.52 110.879 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.615 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.78 -45.07 63.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 70.42 111.081 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.791 ' HA ' HD12 ' A' ' 226' ' ' LEU . 9.5 mt -59.4 -42.57 92.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.888 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -29.21 56.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.852 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.9 mt -75.21 -26.89 59.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 73.24 110.88 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.791 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.4 mt -86.09 -30.21 22.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.958 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 63.25 110.907 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.743 ' HD1' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.894 0.378 . . . . 73.51 110.899 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -134.96 133.85 39.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.057 -0.52 . . . . 64.04 110.859 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -133.44 162.45 31.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 71.41 110.924 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.5 m -149.81 164.38 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 72.5 111.207 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -99.89 43.78 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 64.21 110.865 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -108.05 150.85 26.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 51.43 110.941 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -145.74 -179.99 7.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 74.41 111.15 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 18' ' ' ILE . 95.4 t 61.29 100.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 74.43 111.154 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.696 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.9 mm -93.76 156.88 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 70.23 111.155 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.42 170.08 19.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 75.12 110.933 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -99.89 -169.29 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 75.11 110.983 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.578 ' HG3' HG23 ' A' ' 13' ' ' THR . 18.5 pt-20 -75.28 -20.96 58.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.877 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 12' ' ' GLU . 26.3 p -107.66 -39.53 5.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 71.41 111.148 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.02 -2.65 30.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 54.11 112.473 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.733 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.57 -33.28 21.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 75.21 111.181 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.733 HG13 HG23 ' A' ' 15' ' ' THR . 8.1 mt -129.25 158.96 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.12 111.093 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 16' ' ' ILE . 35.9 p -175.8 164.23 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 64.02 110.823 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.572 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.88 -175.41 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.515 . . . . 62.14 111.163 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.443 ' HA ' HG22 ' A' ' 8' ' ' VAL . 1.7 t -167.54 131.07 1.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 53.52 110.845 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.12 118.48 11.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 71.44 110.922 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.57 -45.88 5.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.861 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -141.58 -169.63 2.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 74.3 110.916 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -51.07 -49.66 60.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.875 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -133.38 39.14 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 74.13 110.871 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.39 121.63 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 71.54 111.159 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.45 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.1 m95 -126.38 159.61 32.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 64.25 110.965 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.2 t -122.43 106.69 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 73.43 111.124 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.528 ' HB3' HG23 ' A' ' 18' ' ' ILE . 8.4 p80 -98.37 138.13 36.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 72.43 110.851 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 m -136.59 134.21 37.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 73.43 111.127 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' HB3' HG23 ' A' ' 16' ' ' ILE . 2.5 pm0 -125.93 175.74 7.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 64.21 110.907 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 40' ' ' PRO . 4.2 tp -119.76 150.05 41.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.13 110.975 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.72 -135.78 3.44 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.775 -0.726 . . . . 55.33 112.526 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.01 159.46 34.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.89 0.376 . . . . 64.0 110.825 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -177.91 91.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.93 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.94 61.7 2.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 63.11 110.822 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.03 30.71 60.8 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.744 -0.741 . . . . 34.53 112.437 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -149.28 128.68 12.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.865 0.364 . . . . 71.24 110.889 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.491 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -68.06 129.79 40.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 74.42 111.054 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.66 HG21 ' HD2' ' A' ' 303' ' ' RTD . 2.3 p -119.51 124.33 28.13 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.622 0.725 . . . . 74.41 111.151 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.624 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.4 Cg_endo -69.73 151.97 69.34 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.693 2.262 . . . . 54.15 112.328 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 t -138.21 92.29 2.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 55.43 110.87 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -52.77 171.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 75.32 110.941 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.644 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -169.93 -156.43 11.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.729 -0.748 . . . . 74.11 112.5 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.912 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -166.68 144.39 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 75.13 110.934 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.632 HG11 HG11 ' A' ' 71' ' ' VAL . 41.5 t -128.94 138.51 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 62.0 111.144 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.61 ' HB3' ' HE3' ' A' ' 138' ' ' MET . 45.8 mt -106.03 130.69 53.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 72.1 110.86 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.99 56.94 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 75.0 110.921 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 135' ' ' PHE . 17.9 p -67.23 177.38 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 64.42 111.217 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.51 20.23 15.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 72.13 110.818 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.91 24.37 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.858 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.11 134.92 6.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 72.22 112.487 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.764 HD13 ' HB ' ' A' ' 71' ' ' VAL . 6.8 mt -60.93 157.54 15.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 72.25 110.908 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.809 HG22 ' HB2' ' A' ' 81' ' ' ASP . 84.5 t -136.94 142.8 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.03 111.121 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.587 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -113.86 128.85 56.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 75.14 110.92 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 55' ' ' VAL . 13.8 t -78.95 -1.76 4.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 55.34 111.154 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 179.93 127.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 63.04 110.872 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 p -66.57 -166.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.827 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -95.06 -171.38 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 70.32 110.842 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.782 ' HB2' HD13 ' A' ' 63' ' ' LEU . 88.6 m95 -72.61 -37.34 68.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.01 110.927 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -145.77 157.61 43.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 73.44 110.829 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -54.25 -34.61 61.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 54.11 110.869 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -74.91 -25.55 59.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 73.3 110.957 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.782 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -81.49 -44.76 16.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 71.53 110.908 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 t -60.26 -26.16 66.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 72.1 111.175 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -54.36 -42.4 70.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 52.14 110.82 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.33 -10.51 59.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 75.42 110.883 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 16' ' ' ILE . 55.2 tp -89.69 -52.38 5.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 74.22 110.909 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.1 mt -65.83 -15.3 18.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 52.12 111.117 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -87.3 7.09 30.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 63.32 110.866 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 31.1 mtp -103.26 -57.35 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 71.21 110.865 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.764 ' HB ' HD13 ' A' ' 52' ' ' LEU . 19.1 m -58.0 -39.22 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 71.5 111.117 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -84.07 50.79 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 72.35 110.846 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 -39.79 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 54.14 110.867 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.696 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -110.66 -21.62 12.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.897 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.516 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 29.0 m-85 -90.15 12.08 18.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 65.45 110.863 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.516 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.79 46.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 74.23 110.924 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.6 mttp -151.6 -177.04 5.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.252 -0.431 . . . . 72.14 110.977 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.535 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.41 158.4 38.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 70.43 110.863 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.452 ' CG1' HD23 ' A' ' 54' ' ' LEU . 26.1 t -89.53 117.13 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.42 111.096 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.535 HG23 ' HG2' ' A' ' 78' ' ' ARG . 42.9 p -133.03 38.19 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.4 111.247 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.809 ' HB2' HG22 ' A' ' 53' ' ' VAL . 2.4 m-20 -168.83 134.97 1.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 44.11 110.838 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 98' ' ' LEU . 16.1 t -143.01 102.19 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.43 111.162 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.8 mt -81.41 115.65 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 62.44 111.07 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.528 HG23 ' HB3' ' A' ' 91' ' ' ARG . 42.1 mm -101.33 129.86 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.11 111.097 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -87.68 -56.03 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.14 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -133.06 166.4 22.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 64.44 110.862 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -85.05 98.38 10.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.411 . . . . 43.34 111.149 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.645 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -152.23 159.65 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.9 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.09 -28.73 62.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 73.12 111.097 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.35 12.01 19.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 53.05 110.792 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.528 ' HB3' HG23 ' A' ' 84' ' ' ILE . 1.9 mmp_? -124.0 -52.26 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 74.1 110.866 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -115.32 17.03 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 61.04 111.157 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.9 -28.12 23.27 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.753 -0.736 . . . . 62.52 112.499 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.0 20.75 26.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 74.51 112.543 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.459 HG21 ' H ' ' A' ' 121' ' ' GLU . 1.6 tt -48.35 -31.03 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 74.24 111.134 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -69.49 -44.53 70.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 74.22 110.925 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 m -66.67 -34.36 77.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 63.51 111.14 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.561 ' CD2' HG21 ' A' ' 82' ' ' VAL . 50.1 mt -64.37 -26.87 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 71.51 110.912 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -99.77 21.01 13.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 64.32 110.914 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.07 -30.41 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 70.21 110.872 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -104.38 12.42 33.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 64.31 110.881 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.38 25.07 61.93 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.822 -0.704 . . . . 63.23 112.509 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 98' ' ' LEU . 11.4 mt -88.11 157.07 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 75.52 111.163 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.819 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -120.32 118.79 31.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 72.43 110.918 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.509 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . . . -90.17 78.31 6.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 64.51 111.009 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.504 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.3 m-70 -54.77 147.92 13.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 62.2 110.898 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.93 163.43 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 65.22 110.891 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 127' ' ' LEU . 68.7 p -85.13 158.17 20.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 51.32 111.182 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.7 61.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 72.54 111.103 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.692 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -62.71 -46.89 86.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 71.32 110.873 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.729 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 100.0 m -52.43 -41.98 63.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 73.34 111.168 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.49 -23.38 61.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 65.24 111.137 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.87 -43.08 85.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.88 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.473 HD13 ' OD2' ' A' ' 152' ' ' ASP . 7.3 mp -81.1 -28.03 35.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 54.51 110.936 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.425 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . . . -51.67 -70.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 65.25 111.03 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -26.0 36.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 72.15 110.962 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -23.65 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 75.23 110.869 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -96.07 -38.71 10.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 74.45 110.898 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.87 -6.39 3.76 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.698 -0.763 . . . . 71.22 112.483 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.62 -172.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 70.23 110.931 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.459 ' H ' HG21 ' A' ' 95' ' ' ILE . 26.4 mm-40 -97.8 -1.57 42.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 74.24 110.842 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.458 ' C ' HD11 ' A' ' 95' ' ' ILE . 1.1 mt-10 66.31 129.13 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.657 0.741 . . . . 52.41 110.84 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -170.03 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.648 2.232 . . . . 53.55 112.341 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 104' ' ' LYS . 79.6 mt -54.08 -35.96 62.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 51.32 110.955 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.12 49.04 51.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 70.21 112.457 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -142.8 56.28 1.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.331 . . . . 71.5 110.857 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.519 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.7 OUTLIER -136.79 -169.8 2.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 75.11 110.91 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -148.84 -168.79 3.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 63.42 110.879 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.829 HG23 ' HB3' ' A' ' 144' ' ' TYR . 99.3 m -50.27 -56.99 8.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 72.32 111.156 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.701 HG23 HG22 ' A' ' 129' ' ' THR . 88.4 t -130.29 128.5 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 75.41 111.114 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.538 HG22 HD23 ' A' ' 133' ' ' LEU . 90.6 m -135.81 124.31 23.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 62.35 111.154 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -80.33 103.0 9.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.912 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.538 HD23 HG22 ' A' ' 131' ' ' THR . 2.6 mt -90.01 150.38 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 55.21 110.926 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.48 122.64 9.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 62.0 110.893 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.635 ' HB2' HG21 ' A' ' 48' ' ' THR . 11.0 m-85 -123.37 42.82 3.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 54.3 110.955 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.53 113.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 72.33 112.503 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.0 m120 62.45 27.17 16.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 74.31 110.85 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.61 ' HE3' ' HB3' ' A' ' 46' ' ' LEU . 32.0 tpp -149.76 139.66 21.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.88 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.14 120.99 28.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 62.41 110.868 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.588 HG13 HD23 ' A' ' 158' ' ' LEU . 10.3 t -131.57 155.67 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 73.22 111.145 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -153.09 125.06 7.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.872 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.544 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -75.47 -177.95 3.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 64.32 111.18 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.678 ' HA ' HG22 ' A' ' 130' ' ' VAL . 73.4 t80 -175.18 137.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.887 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.829 ' HB3' HG23 ' A' ' 129' ' ' THR . 29.5 t80 -122.61 94.86 47.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.692 0.758 . . . . 74.22 110.974 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.9 Cg_endo -69.76 -48.74 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.701 2.267 . . . . 73.03 112.292 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.45 -152.24 15.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 54.34 112.437 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.62 125.81 45.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.346 . . . . 75.35 110.903 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.653 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -136.5 -87.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.71 . . . . 42.24 112.495 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -76.33 -29.18 57.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 64.21 110.91 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.68 156.11 39.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.24 111.19 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.81 -24.88 62.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 74.12 110.789 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.692 ' HB3' HD12 ' A' ' 110' ' ' LEU . 14.4 p30 -119.98 47.36 1.76 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 73.35 110.827 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.495 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -97.27 134.55 40.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 62.41 110.848 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.577 HG22 ' CD1' ' A' ' 144' ' ' TYR . 2.6 pt -136.07 169.87 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 71.45 111.089 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.421 ' CG1' HD22 ' A' ' 169' ' ' LEU . 6.9 m -120.98 145.17 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 74.43 111.077 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.1 t -98.29 143.58 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 65.41 111.12 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -129.85 149.74 51.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 71.43 110.914 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.588 HD23 HG13 ' A' ' 140' ' ' VAL . 28.5 mt -126.96 95.71 36.39 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.604 0.716 . . . . 64.51 110.936 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 71.91 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.679 2.253 . . . . 74.14 112.35 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.3 -34.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.928 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.552 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.2 m-85 -118.03 -13.18 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 71.11 110.908 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.6 m120 69.4 23.26 6.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 75.35 110.922 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.552 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.6 mp -93.51 114.38 30.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 70.41 111.113 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.14 136.61 39.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 74.35 110.898 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.596 HG21 HD22 ' A' ' 44' ' ' LEU . 31.7 t -122.11 67.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 73.01 111.16 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.34 -55.62 18.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.74 -0.743 . . . . 72.55 112.559 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.18 -122.83 6.45 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.746 -0.74 . . . . 72.4 112.467 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.7 m -80.82 -0.8 40.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 70.31 110.909 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.478 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.6 OUTLIER -85.31 -49.1 8.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 74.44 110.981 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.633 HG11 HG11 ' A' ' 206' ' ' VAL . 45.2 t -94.32 105.77 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 74.14 111.125 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.532 ' H ' HG23 ' A' ' 222' ' ' THR . 0.1 OUTLIER -75.02 164.45 26.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.918 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.65 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.4 p -88.65 158.65 18.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.798 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.513 HG23 HD23 ' A' ' 218' ' ' LEU . 1.7 p -58.88 -27.21 64.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 71.12 111.14 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.9 t -74.09 -29.0 61.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.421 . . . . 65.41 110.873 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.62 158.49 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 43.1 111.09 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.65 -27.39 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 70.51 110.918 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -164.57 -180.0 6.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 70.14 110.822 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.513 HD11 HD23 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -82.61 -37.51 24.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 54.41 110.877 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.49 -157.53 22.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.793 -0.718 . . . . 72.21 112.453 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -52.24 129.67 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 74.53 110.898 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.458 HG11 ' CG2' ' A' ' 186' ' ' VAL . 26.0 m -122.59 39.7 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 61.44 111.082 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.63 91.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 65.44 111.07 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.88 44.66 1.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.14 110.937 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -134.93 174.16 10.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 60.11 111.067 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -127.24 87.46 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 54.51 110.985 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' A' ' 181' ' ' VAL . 21.9 t -66.39 -22.22 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 71.14 111.181 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.7 -32.96 58.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 40.35 110.922 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -93.53 -22.8 18.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 73.35 110.877 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.495 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.4 t90 -51.48 -55.88 16.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 64.43 110.83 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 79.3 p -51.94 -37.05 51.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.88 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m -74.18 -35.62 63.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 63.55 111.111 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 196' ' ' VAL . 32.9 m -63.19 -52.38 62.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 74.53 110.838 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.975 HG22 HD23 ' A' ' 197' ' ' LEU . 27.7 mm -58.02 -39.15 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 74.22 111.092 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.22 -17.07 57.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 74.43 110.929 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -99.76 -23.83 14.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 73.52 110.843 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 192' ' ' SER . 48.6 t -88.34 -18.43 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 65.01 111.119 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.975 HD23 HG22 ' A' ' 193' ' ' ILE . 2.4 pp -105.52 1.27 27.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.939 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -117.81 -24.01 7.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 43.43 110.901 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -82.67 1.15 39.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 64.43 110.829 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -136.28 -72.3 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.215 -0.448 . . . . 63.52 110.972 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.78 21.97 9.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 63.41 110.866 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -144.51 21.95 1.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 73.4 110.889 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.27 145.86 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.52 111.184 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -102.56 -28.2 12.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 61.43 110.876 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -163.95 128.98 2.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 64.54 111.106 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.747 ' CG1' HD12 ' A' ' 218' ' ' LEU . 95.2 t -107.1 126.3 63.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 75.33 111.131 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.912 HG21 HD11 ' A' ' 44' ' ' LEU . 50.4 t -109.91 106.12 57.91 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.646 0.736 . . . . 73.13 111.102 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.75 -169.27 0.32 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.735 2.29 . . . . 63.35 112.304 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -111.14 -21.7 6.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 61.55 112.406 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -145.69 74.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 75.54 110.905 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.1 -101.75 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 73.52 112.5 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -171.66 140.26 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 74.32 110.83 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.45 143.78 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 61.3 111.142 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.6 -106.19 0.49 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.75 . . . . 63.32 112.489 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -156.22 -169.92 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.349 . . . . 63.13 110.9 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -56.36 -22.37 30.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.866 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.483 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.24 -32.8 51.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 75.33 112.484 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.747 HD12 ' CG1' ' A' ' 206' ' ' VAL . 31.3 mt -50.79 -41.55 57.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 53.02 110.98 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 193' ' ' ILE . 4.3 mm? -56.02 -44.77 79.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 73.22 110.962 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.483 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.1 mt -67.82 -40.48 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 72.23 110.956 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -58.66 -43.76 89.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.831 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.532 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.68 -48.36 63.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.22 111.16 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.75 ' HA ' HD12 ' A' ' 226' ' ' LEU . 44.1 mt -54.77 -41.28 70.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.925 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -32.73 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 64.11 110.863 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.21 -25.77 61.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 72.54 110.953 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.75 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.8 mt -87.37 -38.07 16.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.31 110.936 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 63.42 110.909 179.795 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.66 ' HD2' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.894 0.378 . . . . 44.52 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.94 178.76 4.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 73.42 110.837 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.77 137.74 51.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 63.43 110.89 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 p -173.21 142.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 64.33 111.14 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -82.24 91.14 6.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.888 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -132.25 151.83 51.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 64.42 110.878 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.436 HG22 ' CH2' ' A' ' 26' ' ' TRP . 1.1 p -144.24 -179.06 6.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 72.04 111.144 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 18' ' ' ILE . 97.0 t 61.29 101.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 74.25 111.147 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.643 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.6 mm -94.64 153.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 64.31 111.167 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -148.84 156.29 42.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 72.34 110.846 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.45 -169.58 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.87 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 -23.49 52.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.874 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.9 p -101.79 -35.13 9.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.042 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.62 -5.13 51.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 52.31 112.478 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.78 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.49 -33.28 20.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 74.34 111.214 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.78 HG13 HG23 ' A' ' 15' ' ' THR . 6.3 mt -128.55 159.92 39.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 63.13 111.052 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -175.52 169.33 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.24 110.929 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -131.63 -174.13 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 64.02 111.137 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.467 ' HA ' HG22 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -169.38 131.7 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 65.04 110.894 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.52 119.09 14.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 70.02 110.916 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.56 HD21 HG21 ' A' ' 213' ' ' VAL . 4.1 mp -107.94 -33.9 7.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 72.41 110.918 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -149.22 -178.1 6.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 72.02 110.813 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -51.06 -41.01 59.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 65.42 110.861 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -139.93 38.6 1.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 73.11 110.882 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 22' ' ' ASN . 15.0 t -137.88 116.05 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 72.23 111.135 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.436 ' CH2' HG22 ' A' ' 7' ' ' THR . 14.0 m95 -123.98 155.59 37.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 73.12 110.89 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.53 HG23 HD13 ' A' ' 21' ' ' LEU . 29.6 t -117.29 108.6 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 71.31 111.115 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.559 ' HB3' HG23 ' A' ' 18' ' ' ILE . 8.2 p80 -101.57 138.39 38.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 72.41 110.861 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.3 m -135.2 140.66 45.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 74.23 111.217 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HB3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -131.27 174.17 10.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 74.5 110.897 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.66 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 5.2 tp -119.48 148.53 43.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.34 110.896 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.2 -120.01 1.98 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 73.14 112.477 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.53 148.97 35.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 61.32 110.876 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -170.26 109.05 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.881 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 51.48 53.16 13.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 52.01 110.876 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.23 25.83 67.01 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.776 -0.726 . . . . 55.41 112.477 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -151.73 120.69 6.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 70.41 110.886 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -51.49 138.54 21.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 55.11 111.142 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.628 HG13 ' CZ2' ' A' ' 59' ' ' TRP . 2.4 p -123.6 129.95 24.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.584 0.707 . . . . 71.41 111.153 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.5 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.1 Cg_endo -69.81 146.97 61.51 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.712 2.275 . . . . 74.14 112.317 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -134.55 98.19 4.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 51.23 110.904 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -51.99 168.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 61.13 110.887 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.635 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -167.68 -163.36 21.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 70.11 112.483 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.902 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -164.22 145.98 8.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.857 0.36 . . . . 63.41 110.917 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.636 HG22 HD13 ' A' ' 54' ' ' LEU . 59.3 t -131.05 140.77 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 74.02 111.14 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.472 HD13 ' HG2' ' A' ' 138' ' ' MET . 39.2 mt -108.0 128.17 54.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 62.41 110.909 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -97.26 55.25 1.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.908 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.827 HG21 ' HB2' ' A' ' 135' ' ' PHE . 19.8 p -60.36 -170.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 64.51 111.1 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.6 6.49 16.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 71.24 110.848 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -118.32 -18.75 9.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 70.44 110.925 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.76 130.54 1.31 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.823 -0.703 . . . . 41.14 112.543 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.746 HD13 ' HB ' ' A' ' 71' ' ' VAL . 14.1 mt -49.37 153.55 1.04 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.923 0.392 . . . . 65.45 110.877 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.707 HG21 ' CG ' ' A' ' 135' ' ' PHE . 93.8 t -136.96 143.23 35.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.158 -0.474 . . . . 73.15 111.11 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.636 HD13 HG22 ' A' ' 45' ' ' VAL . 3.5 mm? -114.88 128.44 56.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.2 110.816 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 55' ' ' VAL . 13.6 t -78.45 -2.78 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 64.13 111.147 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -179.47 131.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 54.25 110.89 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.55 -167.31 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 60.1 110.906 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -173.14 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 63.11 110.889 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.648 ' HB2' HD13 ' A' ' 63' ' ' LEU . 85.6 m95 -71.0 -38.51 72.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 75.41 110.93 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -141.72 161.64 37.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 74.01 110.802 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.51 -33.02 69.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.34 110.92 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -75.3 -25.58 58.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.869 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -81.7 -43.65 18.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 72.11 110.879 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.8 t -65.48 -23.35 66.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.174 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -53.81 -43.26 69.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 70.11 110.887 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.72 -15.73 55.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 74.41 110.941 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.461 HD22 ' OE2' ' A' ' 30' ' ' GLU . 21.6 tp -77.8 -50.17 12.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.491 . . . . 73.44 110.894 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.0 mt -71.93 -15.39 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 55.24 111.111 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -88.71 10.35 21.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 70.33 110.895 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.8 mmm -109.88 -55.56 2.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.913 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.746 ' HB ' HD13 ' A' ' 52' ' ' LEU . 17.0 m -57.55 -37.19 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 74.31 111.141 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -85.44 50.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 71.32 110.913 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.57 -39.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 74.52 110.865 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.643 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -110.9 -21.25 12.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.863 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.555 ' CB ' HD21 ' A' ' 52' ' ' LEU . 29.0 m-85 -90.62 12.67 18.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 63.31 110.89 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.522 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 2.1 pp0? 31.5 49.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.52 110.949 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.0 -176.54 5.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 75.03 110.962 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.629 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -133.98 152.26 51.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 63.44 110.863 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 52' ' ' LEU . 82.7 t -85.29 125.56 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 64.23 111.192 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.629 HG23 ' HD3' ' A' ' 78' ' ' ARG . 74.3 p -136.0 16.62 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 61.21 111.127 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.576 ' HB2' HG13 ' A' ' 53' ' ' VAL . 1.4 m-20 -150.02 134.92 17.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 74.51 110.898 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.623 HG21 ' CD2' ' A' ' 98' ' ' LEU . 24.6 t -139.3 99.01 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 74.35 111.034 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.8 mt -76.29 126.54 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 55.22 111.203 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 91' ' ' ARG . 40.8 mm -113.55 133.34 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 64.01 111.131 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -90.11 -54.89 3.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 72.41 111.134 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -134.38 165.78 24.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.848 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.692 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -84.79 98.32 10.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 40.33 111.133 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.654 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.75 159.44 43.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 71.12 110.848 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.23 -28.71 63.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 65.53 111.058 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.98 10.72 22.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 70.31 110.855 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HB3' HG23 ' A' ' 84' ' ' ILE . 1.9 mmp_? -122.67 -52.03 1.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 65.45 110.908 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -116.39 17.45 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 63.11 111.11 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.96 -26.53 27.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.701 -0.761 . . . . 63.23 112.442 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.93 18.46 31.42 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.77 -0.729 . . . . 63.52 112.5 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.435 HG21 ' H ' ' A' ' 121' ' ' GLU . 5.2 tt -48.93 -30.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.834 0.35 . . . . 72.2 111.077 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -67.96 -43.65 78.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 55.13 110.931 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.4 m -69.78 -34.09 73.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 74.52 111.072 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.623 ' CD2' HG21 ' A' ' 82' ' ' VAL . 55.8 mt -63.47 -28.2 69.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 70.33 110.895 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.95 19.49 14.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.922 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -117.33 -21.9 8.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 71.2 110.896 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -113.08 8.8 18.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 71.41 110.88 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.2 16.92 65.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 61.44 112.481 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 98' ' ' LEU . 13.9 mt -82.43 156.96 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 71.52 111.159 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.762 ' HB2' HD11 ' A' ' 124' ' ' LEU . 13.3 ptpt -120.65 122.86 41.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 55.22 110.891 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.483 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -90.58 78.42 6.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 71.11 111.061 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.617 ' HA ' HD12 ' A' ' 124' ' ' LEU . 88.6 m-70 -51.71 146.21 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 33.33 110.866 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.49 163.71 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.453 . . . . 72.42 110.814 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -80.19 156.32 26.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 72.21 111.122 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.83 -27.03 27.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 53.0 111.091 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 152' ' ' ASP . 6.9 tp -74.95 -45.89 39.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 73.44 110.954 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.692 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 91.8 m -52.96 -28.1 22.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 60.13 111.142 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -84.08 -29.76 26.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 62.31 111.015 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -58.89 -31.12 68.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.409 . . . . 75.32 110.913 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.674 HD13 ' OD1' ' A' ' 152' ' ' ASP . 7.4 mp -93.55 -25.47 17.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.129 -0.487 . . . . 63.45 110.837 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.71 -65.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 65.34 111.135 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -56.59 -25.02 51.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 52.24 110.877 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -24.52 65.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 74.33 110.882 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -96.03 -28.22 14.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.881 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.23 -5.53 7.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 71.23 112.507 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -59.58 -173.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.826 0.346 . . . . 73.11 110.969 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.435 ' H ' HG21 ' A' ' 95' ' ' ILE . 40.7 mm-40 -99.75 1.17 43.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 71.31 110.888 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.523 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 0.9 OUTLIER 65.87 122.65 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 75.35 110.857 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -170.65 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.707 2.271 . . . . 61.44 112.39 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.762 HD11 ' HB2' ' A' ' 104' ' ' LYS . 58.5 mt -51.76 -39.25 58.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 71.52 110.922 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.0 37.3 44.79 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 64.45 112.45 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -132.89 48.44 2.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 64.11 110.836 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.52 -169.64 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.299 -0.409 . . . . 72.33 110.884 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -149.99 -169.05 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 72.12 110.919 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.8 HG23 ' HB3' ' A' ' 144' ' ' TYR . 94.6 m -50.63 -63.95 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 74.31 111.143 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.734 HG23 HG22 ' A' ' 129' ' ' THR . 86.1 t -124.26 112.03 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 54.13 111.108 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 96.0 m -121.35 111.34 17.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.05 111.111 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -67.25 90.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 74.02 110.884 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.451 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -81.78 159.39 23.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 64.25 110.884 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.41 117.46 4.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.84 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.827 ' HB2' HG21 ' A' ' 48' ' ' THR . 19.0 m-85 -109.17 49.57 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 75.2 110.889 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.64 -108.08 3.54 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 61.2 112.466 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -93.69 47.22 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 63.3 110.907 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.525 ' HB2' HG22 ' A' ' 48' ' ' THR . 6.2 tpp -149.19 154.09 38.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 71.53 110.977 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.72 116.25 18.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.302 -0.408 . . . . 71.43 110.946 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.63 151.55 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.4 . . . . 70.35 111.204 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -148.81 117.45 6.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 61.11 110.839 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.732 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -70.47 -178.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 35.31 111.132 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.629 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.5 t80 -175.29 136.67 0.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 64.41 110.857 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.8 ' HB3' HG23 ' A' ' 129' ' ' THR . 31.6 t80 -118.24 92.66 43.39 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.715 0.769 . . . . 75.33 110.905 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -48.56 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.717 2.278 . . . . 73.2 112.407 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.04 -177.67 43.27 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 64.21 112.452 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -76.78 125.57 29.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.799 0.333 . . . . 73.31 110.926 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.518 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -136.28 -91.06 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 74.21 112.502 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -73.64 -30.73 63.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.367 . . . . 72.21 110.862 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.79 158.6 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 72.14 111.144 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -61.06 -27.66 68.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 72.14 110.893 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.674 ' OD1' HD13 ' A' ' 114' ' ' LEU . 11.7 p30 -119.6 50.07 1.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 75.41 110.851 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.8 OUTLIER -98.07 137.62 36.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 73.41 110.88 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.732 HD12 HG22 ' A' ' 142' ' ' THR . 12.5 pt -139.01 168.82 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 63.11 111.096 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.498 ' CG1' HD22 ' A' ' 169' ' ' LEU . 7.8 m -119.3 144.71 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 72.15 111.156 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.17 144.08 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 70.03 111.138 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -130.09 147.66 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.951 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.487 HD12 ' HB ' ' A' ' 163' ' ' ILE . 16.9 mt -124.78 96.62 40.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.616 0.722 . . . . 61.53 110.946 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 72.5 1.43 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.78 2.32 . . . . 73.42 112.273 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.12 -34.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 74.13 110.943 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.482 ' CB ' HD13 ' A' ' 163' ' ' ILE . 4.4 m-85 -117.75 -13.91 10.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.952 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.5 m120 68.99 26.13 5.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.094 -0.503 . . . . 53.44 110.904 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.498 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -97.87 114.14 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 71.33 111.138 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.93 136.96 37.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.854 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.55 HG21 HD22 ' A' ' 44' ' ' LEU . 16.5 t -119.42 64.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 62.15 111.182 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.94 -54.5 25.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 54.12 112.477 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.26 -135.51 12.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.748 . . . . 74.22 112.467 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.5 m -60.89 -19.29 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 42.5 110.876 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.498 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.9 OUTLIER -66.93 -50.57 61.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.901 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.707 HG11 HG11 ' A' ' 206' ' ' VAL . 24.7 t -89.05 130.02 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 71.11 111.193 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.64 149.5 24.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 54.0 110.939 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.624 ' HA ' HD22 ' A' ' 218' ' ' LEU . 12.6 p -75.03 162.5 28.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 61.2 110.879 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.612 HG23 HD23 ' A' ' 218' ' ' LEU . 7.3 p -69.05 -25.66 64.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 53.15 111.15 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.15 -26.25 60.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 63.52 110.835 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.84 177.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 54.12 111.066 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.6 ' O ' HD22 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -128.24 -39.93 1.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 71.2 110.916 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -153.64 -177.41 6.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.453 . . . . 62.13 110.862 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.531 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 0.7 OUTLIER -82.05 -39.15 23.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.132 -0.486 . . . . 72.41 110.901 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 95.42 -155.39 21.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.716 -0.754 . . . . 73.2 112.455 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.77 118.22 3.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 74.22 110.874 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.516 HG11 ' CG2' ' A' ' 186' ' ' VAL . 16.8 m -116.15 30.76 2.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 74.53 111.087 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.61 -36.24 82.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 75.33 111.125 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -116.18 37.73 3.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.877 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -139.64 166.78 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 74.02 111.071 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -113.54 92.66 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 72.03 110.888 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.516 ' CG2' HG11 ' A' ' 181' ' ' VAL . 92.5 t -69.63 -23.21 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 72.25 111.155 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.67 -25.3 38.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 62.23 110.886 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.34 -24.21 15.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 55.34 110.841 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.531 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.5 t90 -51.5 -53.9 32.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.463 . . . . 74.2 110.877 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 99.2 p -52.32 -35.44 50.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 54.13 110.856 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.2 m -73.58 -36.68 65.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 51.34 111.169 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.1 m -64.5 -54.12 37.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.812 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.753 HG22 HD23 ' A' ' 197' ' ' LEU . 31.6 mm -57.2 -41.26 77.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 75.02 111.126 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -60.85 -19.54 60.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 75.01 110.912 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -93.03 -29.61 15.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 54.21 110.914 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.403 ' CG1' HD21 ' A' ' 219' ' ' LEU . 59.4 t -81.42 -23.73 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 71.52 111.115 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.753 HD23 HG22 ' A' ' 193' ' ' ILE . 2.6 pp -97.25 -1.16 45.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 75.24 110.97 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -121.2 -6.67 9.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 61.5 110.879 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -89.77 -24.25 21.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.897 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -118.3 -67.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 71.21 110.925 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 63.41 27.46 15.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 72.44 110.873 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -151.47 23.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 73.23 110.836 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.41 HG21 HG22 ' A' ' 206' ' ' VAL . 3.4 mp -62.95 145.42 13.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 73.0 111.168 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -104.0 -26.45 12.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.31 110.902 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.498 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -161.24 128.73 4.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 53.01 111.1 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.707 HG11 HG11 ' A' ' 170' ' ' VAL . 71.9 t -108.86 124.51 65.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 71.31 111.058 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.902 HG21 HD11 ' A' ' 44' ' ' LEU . 48.6 t -108.99 104.38 54.77 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 121.558 0.694 . . . . 54.5 111.114 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.4 Cg_endo -69.76 -170.6 0.4 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.705 2.27 . . . . 65.43 112.369 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -103.27 -26.07 7.12 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.721 -0.752 . . . . 61.23 112.474 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -144.0 86.37 1.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 63.44 110.846 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 167.88 -102.76 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 40.24 112.457 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -169.62 158.94 7.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.885 0.374 . . . . 70.14 110.921 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.643 HG22 HG22 ' A' ' 207' ' ' VAL . 41.4 t -66.82 147.85 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 62.12 111.04 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -152.34 -107.12 0.32 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.774 -0.727 . . . . 71.32 112.526 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -159.13 -169.93 2.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 74.2 110.835 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -56.67 -21.79 30.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 65.35 110.892 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.749 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.98 -33.8 57.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.776 -0.726 . . . . 65.14 112.44 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 172' ' ' SER . 32.1 mt -50.79 -46.84 59.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.858 0.361 . . . . 71.12 110.912 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.552 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mp -54.12 -42.76 69.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 64.42 110.927 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.749 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.6 mt -67.07 -41.31 86.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 75.14 110.907 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.18 -36.54 82.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 75.3 110.849 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -45.64 83.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 43.55 111.07 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.803 ' HA ' HD12 ' A' ' 226' ' ' LEU . 2.5 mt -56.6 -40.21 74.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 73.03 110.994 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -41.05 77.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.55 110.825 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.6 HD22 ' O ' ' A' ' 176' ' ' LYS . 12.2 mt -65.09 -25.99 68.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 62.34 110.935 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.803 HD12 ' HA ' ' A' ' 223' ' ' LEU . 6.1 mt -85.52 -43.08 13.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 70.2 110.913 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 73.32 110.85 179.867 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.831 0.348 . . . . 64.54 110.847 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -130.94 178.61 6.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.94 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -117.95 161.3 20.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 63.5 110.862 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.0 p -143.8 139.31 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 75.25 111.18 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -98.39 79.4 2.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 61.52 110.908 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -137.83 151.96 48.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 75.12 110.875 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.454 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -147.17 -179.17 6.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 61.34 111.135 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 18' ' ' ILE . 89.6 t 61.21 98.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 45.31 111.132 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.722 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.9 mm -91.23 153.97 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 53.44 111.105 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -145.81 146.09 31.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.893 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.4 164.33 21.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 71.45 110.894 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -51.94 -36.98 51.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.87 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.48 -27.87 22.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 40.12 111.091 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.05 -12.84 68.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.784 -0.722 . . . . 72.44 112.575 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.724 HG23 HG13 ' A' ' 16' ' ' ILE . 2.0 t -51.09 -32.6 22.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 74.14 111.191 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.724 HG13 HG23 ' A' ' 15' ' ' THR . 14.7 mt -121.42 147.86 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 64.13 111.094 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.7 p -166.19 169.61 14.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 64.42 110.873 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.518 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -136.52 -176.49 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 54.41 111.114 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 18' ' ' ILE . 6.1 t -166.09 135.33 3.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 61.42 110.867 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.48 117.79 13.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 73.03 110.858 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HG ' HG23 ' A' ' 27' ' ' VAL . 2.2 mm? -102.02 -45.59 5.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 63.32 110.942 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -142.27 -169.43 2.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.833 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -50.65 -51.08 52.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.855 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -132.34 37.99 3.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.316 -0.402 . . . . 75.14 110.816 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 t -133.91 122.06 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.31 111.19 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.454 ' CH2' HG22 ' A' ' 7' ' ' THR . 14.9 m95 -127.76 159.06 35.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.866 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.983 HG21 HG21 ' A' ' 213' ' ' VAL . 69.5 t -119.42 107.9 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 64.34 111.173 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.518 ' HB3' HG23 ' A' ' 18' ' ' ILE . 4.0 p80 -102.32 142.02 34.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 72.31 110.828 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 m -140.06 130.73 25.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 74.14 111.159 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.93 171.36 8.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.862 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.624 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 5.2 tp -117.17 147.27 42.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.894 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -133.02 -123.18 2.39 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.688 -0.768 . . . . 71.31 112.432 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.02 152.4 43.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.9 0.381 . . . . 52.44 110.853 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -172.06 104.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 63.44 110.91 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 t30 51.35 57.05 7.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 74.13 110.929 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.06 27.0 64.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.692 -0.766 . . . . 73.24 112.462 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -151.63 119.77 6.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 55.25 110.88 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.624 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -54.31 138.07 40.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 64.32 111.062 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.681 HG21 ' HD2' ' A' ' 303' ' ' RTD . 2.2 p -123.52 126.55 25.79 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.595 0.712 . . . . 72.44 111.113 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.524 ' HA ' HD12 ' A' ' 31' ' ' LEU . 54.0 Cg_endo -69.78 148.41 64.89 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.691 2.261 . . . . 44.54 112.381 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -134.44 100.0 4.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 54.45 110.855 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.483 HD21 ' N ' ' A' ' 212' ' ' GLU . 24.0 m-20 -51.86 169.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 75.43 110.899 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.8 -173.19 39.12 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.705 -0.76 . . . . 74.25 112.449 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.047 HD13 HG21 ' A' ' 207' ' ' VAL . 3.9 tp -156.92 140.81 16.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.905 0.383 . . . . 73.23 110.907 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.719 HG22 HD13 ' A' ' 54' ' ' LEU . 21.4 t -125.51 132.01 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 72.32 111.178 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 41.5 mt -97.15 128.89 44.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 75.04 110.964 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.73 57.65 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.278 -0.419 . . . . 65.31 110.95 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 p -67.19 165.62 15.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 71.25 111.097 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.89 25.81 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.864 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -147.25 28.61 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 74.42 110.881 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.33 123.25 4.35 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 42.32 112.472 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' A' ' 75' ' ' PHE . 33.1 mt -51.28 159.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 74.13 110.903 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 81' ' ' ASP . 59.6 t -140.18 140.03 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.132 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.719 HD13 HG22 ' A' ' 45' ' ' VAL . 3.0 mm? -114.07 129.86 56.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.964 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.8 t -81.18 0.13 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.13 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -177.68 129.69 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.837 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -166.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.905 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.71 -169.9 2.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.247 -0.433 . . . . 73.03 110.884 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.779 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.4 m95 -74.81 -36.48 62.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.165 -0.47 . . . . 73.42 110.955 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -144.62 164.3 31.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 53.43 110.873 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.13 -34.57 72.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 54.22 110.888 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -74.88 -24.25 58.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 54.15 110.889 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -83.41 -41.14 18.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 73.11 110.927 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.3 t -70.13 -26.45 63.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 70.04 111.103 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -54.13 -42.64 69.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 74.55 110.891 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -83.49 -14.2 52.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 72.54 110.86 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.417 ' HB2' HD13 ' A' ' 16' ' ' ILE . 32.8 tp -77.03 -46.13 24.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 52.34 110.924 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.3 -31.93 40.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 74.04 111.135 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.78 -25.55 68.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 70.21 110.965 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.4 mmm -76.37 -58.84 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 61.22 110.873 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.705 ' HB ' HD13 ' A' ' 52' ' ' LEU . 33.9 m -56.23 -33.35 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 73.11 111.074 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -88.56 48.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.277 -0.419 . . . . 74.45 110.885 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -144.36 -41.82 0.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 53.14 110.895 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.722 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.64 -25.65 13.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 72.01 110.875 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.716 ' HB3' HD21 ' A' ' 52' ' ' LEU . 36.5 m-85 -88.94 9.22 25.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 74.53 110.851 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.5 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.86 46.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 75.0 110.896 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -147.15 -176.71 5.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 62.44 110.937 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.64 130.88 37.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 70.33 110.896 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.626 HG22 ' HB2' ' A' ' 52' ' ' LEU . 66.4 t -66.46 129.33 30.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 64.04 111.093 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.5 p -138.07 19.74 2.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 44.04 111.141 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.593 ' HB2' HG22 ' A' ' 53' ' ' VAL . 7.4 m-20 -154.18 129.35 9.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 43.43 110.829 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.426 HG11 ' CD1' ' A' ' 98' ' ' LEU . 24.9 t -133.84 98.15 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 63.33 111.169 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -74.64 124.9 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 71.03 111.198 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.613 HG23 ' HB3' ' A' ' 91' ' ' ARG . 38.7 mm -111.07 127.14 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 65.33 111.126 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.5 p -83.86 -53.47 5.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 74.0 111.075 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -135.6 168.39 19.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 73.25 110.895 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -87.82 100.41 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 63.35 111.087 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.669 ' O ' HD13 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -154.71 161.03 41.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 72.11 110.881 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.06 -27.72 61.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 71.14 111.04 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.23 13.8 16.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 33.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.613 ' HB3' HG23 ' A' ' 84' ' ' ILE . 1.1 mmt180 -127.11 -51.24 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 70.21 110.831 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.669 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -118.52 15.28 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 63.52 111.138 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.19 -33.84 31.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.736 -0.745 . . . . 44.22 112.439 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.93 17.68 44.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.757 -0.735 . . . . 62.45 112.461 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.565 HG21 ' H ' ' A' ' 121' ' ' GLU . 9.9 tt -46.03 -31.33 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 71.31 111.172 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -55.19 23.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.95 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 61.7 m -59.38 -41.73 90.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 64.41 111.14 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.464 ' HA ' HD12 ' A' ' 103' ' ' ILE . 31.7 mt -55.9 -30.0 60.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.912 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.49 24.27 9.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 64.1 110.856 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -116.93 -26.18 6.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 75.11 110.869 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -104.59 -22.2 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 61.11 110.832 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.67 14.28 4.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 52.01 112.501 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.7 mt -82.07 155.84 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.89 0.376 . . . . 52.32 111.159 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.554 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.8 OUTLIER -120.57 120.1 34.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 51.14 110.905 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.89 81.14 8.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 74.45 111.061 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.521 ' HA ' HD12 ' A' ' 124' ' ' LEU . 92.1 m-70 -55.04 147.28 16.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 50.13 110.853 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.44 161.78 0.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 44.14 110.851 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.557 HG22 ' HB3' ' A' ' 127' ' ' LEU . 19.9 p -85.64 161.07 19.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 75.23 111.135 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.35 -47.25 62.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 63.1 111.074 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.617 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -59.22 -44.45 92.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 62.44 110.984 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.671 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 80.4 m -53.03 -46.17 68.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 64.14 111.111 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.98 -21.99 61.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 74.34 111.103 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.12 -38.38 76.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 71.05 110.903 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.616 HD12 ' OD2' ' A' ' 152' ' ' ASP . 8.0 mt -87.52 -27.66 22.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 71.42 110.954 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.61 -65.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 72.44 111.141 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -26.09 38.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 75.03 110.875 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -23.07 66.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 73.1 110.927 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -96.88 -38.36 9.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.462 . . . . 60.21 110.896 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.98 -1.64 5.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 53.24 112.501 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -59.75 -172.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 73.3 110.915 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.565 ' H ' HG21 ' A' ' 95' ' ' ILE . 23.9 mm-40 -94.8 -2.28 51.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 54.33 110.864 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 65.96 126.19 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.634 0.73 . . . . 74.21 110.897 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -170.91 0.42 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.71 2.273 . . . . 72.43 112.332 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 104' ' ' LYS . 51.5 mt -52.59 -38.43 60.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 72.4 110.915 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.98 43.81 55.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 75.44 112.584 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -139.17 57.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.768 0.318 . . . . 74.51 110.837 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.557 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -137.36 -171.63 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 62.01 110.93 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.43 -168.56 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 71.35 110.891 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.829 HG23 ' HB3' ' A' ' 144' ' ' TYR . 75.1 m -50.0 -64.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.23 111.11 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.765 HG22 ' HA ' ' A' ' 143' ' ' PHE . 58.4 t -122.49 111.1 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 64.13 111.124 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.631 HG22 HD23 ' A' ' 133' ' ' LEU . 68.5 m -111.61 114.15 27.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 70.51 111.176 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -75.14 101.02 4.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 53.42 110.881 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.631 HD23 HG22 ' A' ' 131' ' ' THR . 1.9 mt -91.95 152.07 20.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 70.2 110.926 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.42 108.48 3.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 60.41 110.881 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -106.84 -167.77 1.32 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 74.32 110.86 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -50.9 101.73 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 72.34 112.489 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 51.03 56.94 7.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.826 0.346 . . . . 52.14 110.922 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.2 tpt -158.27 147.54 19.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 63.44 110.872 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 121.61 28.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.423 . . . . 72.43 110.976 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.73 HG13 HD23 ' A' ' 158' ' ' LEU . 5.0 t -130.14 158.71 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 61.42 111.177 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 75.7 tt0 -154.38 117.4 4.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 53.12 110.895 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.699 ' O ' HG13 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -69.38 -177.86 1.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.15 111.139 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.765 ' HA ' HG22 ' A' ' 130' ' ' VAL . 82.4 t80 -175.65 136.53 0.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 63.33 110.857 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.829 ' HB3' HG23 ' A' ' 129' ' ' THR . 27.2 t80 -117.13 94.49 45.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 74.12 110.89 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -48.92 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.719 2.279 . . . . 63.51 112.384 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.69 -166.33 39.55 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.697 -0.763 . . . . 54.22 112.439 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -88.03 123.94 33.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.827 0.346 . . . . 65.33 110.879 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.668 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -134.06 -86.4 0.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 72.24 112.485 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -81.29 -26.02 36.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 75.15 110.897 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.52 157.02 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 73.1 111.14 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -64.17 -23.72 67.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 53.24 110.899 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.617 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -125.78 55.09 1.46 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 74.12 110.848 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.564 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.9 p30 -102.97 143.15 32.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 54.12 110.876 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.643 HD12 HG22 ' A' ' 142' ' ' THR . 11.2 pt -142.53 171.22 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 52.23 111.164 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.7 m -120.47 143.58 31.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.109 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.455 ' O ' HD22 ' A' ' 164' ' ' LEU . 68.6 t -100.11 129.07 51.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 61.43 111.144 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -115.76 145.41 42.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.261 -0.427 . . . . 71.23 110.926 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.73 HD23 HG13 ' A' ' 140' ' ' VAL . 23.6 mt -120.76 96.84 48.69 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.585 0.707 . . . . 70.1 110.967 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 70.16 1.54 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.689 2.259 . . . . 70.34 112.396 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.24 -33.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.992 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.56 ' CB ' HD13 ' A' ' 163' ' ' ILE . 10.2 m-85 -116.93 -12.41 10.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 73.53 110.876 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.05 19.74 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 61.24 110.896 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.624 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.7 mp -86.54 114.4 25.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 74.21 111.141 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.5 tm? -99.19 122.82 42.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.922 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.827 HG21 HD22 ' A' ' 44' ' ' LEU . 40.4 t -115.29 74.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 72.35 111.155 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.29 -50.28 51.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 63.51 112.553 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.08 -140.94 15.48 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.746 -0.74 . . . . 64.43 112.565 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 39.4 m -58.02 -21.99 47.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 70.24 110.863 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.564 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.0 OUTLIER -63.1 -48.63 77.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 72.03 110.912 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.642 HG11 HG11 ' A' ' 206' ' ' VAL . 22.8 t -90.77 126.58 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 73.11 111.149 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.8 ' HE3' HD23 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -93.51 144.7 25.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 64.13 110.887 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.693 ' HA ' HD22 ' A' ' 218' ' ' LEU . 6.8 p -72.4 163.99 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 62.43 110.825 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.548 HG23 HD23 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -66.71 -35.32 79.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.194 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -26.95 63.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 73.51 110.842 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.77 167.8 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 71.11 111.099 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.631 ' O ' HD22 ' A' ' 225' ' ' LEU . 0.1 OUTLIER -130.64 -41.42 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 73.45 110.904 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -136.72 166.52 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.895 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.8 HD23 ' HE3' ' A' ' 171' ' ' LYS . 5.3 mt -72.85 -26.31 61.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 42.43 110.922 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.86 65.24 1.5 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.75 . . . . 52.34 112.401 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 63.3 160.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.324 . . . . 74.43 110.919 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 184' ' ' ALA . 33.4 m -150.35 40.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 73.52 111.181 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -54.04 -40.44 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 71.53 111.097 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.65 40.65 3.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 75.02 110.92 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -129.9 173.45 10.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 73.4 111.098 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -121.11 89.01 3.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 74.41 110.971 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.601 ' CG2' HG21 ' A' ' 181' ' ' VAL . 21.7 t -69.28 -21.14 24.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.073 -0.512 . . . . 62.33 111.116 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.44 -26.81 46.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.52 110.895 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -100.39 -24.42 14.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 71.52 110.911 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.31 -53.79 32.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 65.53 110.902 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 34.3 p -52.0 -34.83 44.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 54.23 110.83 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 54.6 m -77.99 -37.98 46.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 71.25 111.134 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.1 m -59.96 -54.89 40.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.14 110.819 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.642 HG22 HD23 ' A' ' 197' ' ' LEU . 33.0 mm -56.98 -36.87 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 74.21 111.132 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.49 -21.97 66.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 73.44 110.878 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -90.92 -30.36 16.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 63.43 110.817 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.512 ' CG1' HD21 ' A' ' 219' ' ' LEU . 92.4 t -77.18 -40.09 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 74.45 111.034 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.642 HD23 HG22 ' A' ' 193' ' ' ILE . 3.8 pp -75.69 -25.78 57.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 54.11 110.913 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -84.46 -46.84 11.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 62.11 110.861 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 17.5 tpt85 -51.99 -30.16 23.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.857 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -138.52 116.9 11.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 70.41 110.868 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -115.26 39.11 3.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 71.31 110.884 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.75 22.03 0.79 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 63.34 110.811 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.465 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.2 mp -51.63 144.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 61.15 111.133 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -103.61 -44.56 5.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 72.22 110.884 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.47 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -151.23 113.4 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 41.32 111.097 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.645 ' CG1' HD12 ' A' ' 218' ' ' LEU . 82.8 t -85.51 125.93 40.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 75.52 111.148 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.047 HG21 HD13 ' A' ' 44' ' ' LEU . 63.0 t -106.9 93.78 9.51 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.663 0.744 . . . . 74.1 111.085 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.1 Cg_endo -69.75 -171.88 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.667 2.244 . . . . 65.33 112.387 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.66 -25.62 9.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 54.02 112.5 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -145.63 109.68 4.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.352 . . . . 65.25 110.879 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 145.18 -93.18 0.16 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.668 -0.777 . . . . 70.1 112.482 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.483 ' N ' HD21 ' A' ' 42' ' ' ASN . 14.4 pt-20 -179.69 169.55 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.878 0.371 . . . . 70.41 110.879 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.983 HG21 HG21 ' A' ' 27' ' ' VAL . 98.3 t -80.1 139.94 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 72.41 111.15 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -144.92 -105.94 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 54.33 112.443 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -157.69 -171.5 3.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.848 0.356 . . . . 74.04 110.848 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -53.37 -24.18 11.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 72.25 110.903 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -52.47 -34.37 42.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 73.22 112.402 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.693 HD22 ' HA ' ' A' ' 172' ' ' SER . 30.9 mt -50.85 -46.21 60.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 63.12 110.923 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.512 HD21 ' CG1' ' A' ' 196' ' ' VAL . 1.1 mt -57.78 -43.62 85.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 73.41 110.926 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.752 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.9 mt -66.36 -41.74 89.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 60.4 110.903 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -63.4 -35.98 82.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 62.54 110.811 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.0 m -58.76 -42.64 89.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 72.22 111.098 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.815 ' HA ' HD12 ' A' ' 226' ' ' LEU . 85.0 mt -60.14 -38.9 84.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 74.21 110.864 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.58 -27.87 65.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 70.13 110.795 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.631 HD22 ' O ' ' A' ' 176' ' ' LYS . 8.4 mt -77.53 -25.95 50.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 63.21 110.922 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.815 HD12 ' HA ' ' A' ' 223' ' ' LEU . 1.9 mt -88.2 -27.43 21.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.904 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 64.42 110.883 179.815 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.681 ' HD2' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.9 p . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.847 0.356 . . . . 75.02 110.822 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.57 153.97 51.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 73.34 110.88 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -111.29 170.88 7.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 60.12 110.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.2 p -172.52 148.93 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 74.51 111.11 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 56.13 82.59 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 71.43 110.889 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.34 153.19 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 43.54 110.905 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.487 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -146.82 178.25 8.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.088 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 18' ' ' ILE . 92.0 t 60.64 99.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.04 111.11 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.727 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.0 mm -93.1 157.79 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 72.3 111.152 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.54 149.26 34.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 73.41 110.908 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.16 167.4 21.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 71.51 110.942 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 13' ' ' THR . 7.4 pt-20 -55.87 -32.47 63.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.921 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.464 ' OG1' HG22 ' A' ' 15' ' ' THR . 21.0 p -97.13 -29.93 13.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 50.04 111.171 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.2 -11.23 47.93 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 44.23 112.447 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.792 HG23 HG13 ' A' ' 16' ' ' ILE . 3.8 t -51.19 -32.6 24.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.701 0.286 . . . . 73.34 111.156 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.792 HG13 HG23 ' A' ' 15' ' ' THR . 23.3 mt -123.24 151.1 27.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.443 . . . . 73.43 111.105 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.6 p -169.48 163.44 10.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 75.54 110.894 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -130.24 -177.18 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 72.13 111.134 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.486 ' HA ' HG22 ' A' ' 8' ' ' VAL . 3.4 t -166.36 135.37 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 61.11 110.805 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.59 116.99 13.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.117 -0.492 . . . . 74.11 110.904 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.42 -42.21 6.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.914 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.85 -169.91 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.43 110.856 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -49.25 62.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 74.21 110.877 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -133.68 30.37 3.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.859 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.15 118.55 51.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 62.42 111.123 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CH2' HG22 ' A' ' 7' ' ' THR . 13.8 m95 -124.09 160.56 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 65.23 110.967 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.14 108.56 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 43.24 111.13 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.606 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.5 p80 -102.38 138.54 39.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 73.5 110.795 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 41' ' ' SER . 32.4 m -136.5 131.74 34.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 74.15 111.069 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.97 -175.68 2.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.2 110.847 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.856 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -133.7 131.56 39.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.135 -0.484 . . . . 75.01 110.978 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.51 -174.65 13.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.768 -0.729 . . . . 71.51 112.525 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.36 133.51 54.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 73.41 110.849 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -104.54 -18.35 14.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 75.14 110.877 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -176.53 45.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 71.2 110.919 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.81 14.84 57.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.709 -0.758 . . . . 45.51 112.464 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -124.58 -168.98 1.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 60.31 110.874 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.856 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -122.37 124.1 42.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 61.14 111.111 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.545 HG21 ' HD2' ' A' ' 303' ' ' RTD . 2.5 p -131.93 118.64 16.56 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.593 0.711 . . . . 72.11 111.163 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 149.02 66.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.259 . . . . 70.23 112.321 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 29' ' ' THR . 0.8 OUTLIER -135.46 113.1 10.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 74.2 110.838 -179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.39 168.45 7.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 74.1 110.865 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.509 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -171.16 -169.55 34.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.739 -0.743 . . . . 71.54 112.462 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.996 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -158.94 146.62 17.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 72.54 110.919 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.557 HG22 HD13 ' A' ' 54' ' ' LEU . 36.5 t -129.5 142.69 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 62.43 111.106 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -110.7 128.76 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 65.32 110.914 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -97.03 51.25 1.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 72.2 110.904 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 138' ' ' MET . 19.8 p -60.06 173.06 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.32 111.127 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 30.3 3.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 63.34 110.847 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -156.59 36.08 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 71.35 110.882 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.65 128.57 6.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 45.11 112.491 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.771 HD13 ' HB ' ' A' ' 71' ' ' VAL . 13.4 mt -58.4 160.62 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 50.32 110.959 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 81' ' ' ASP . 52.8 t -137.51 143.27 34.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.05 111.157 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.557 HD13 HG22 ' A' ' 45' ' ' VAL . 3.4 mm? -115.69 128.48 55.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 64.33 110.959 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 55' ' ' VAL . 11.6 t -78.85 -2.08 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 62.25 111.093 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.45 128.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 75.51 110.851 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -166.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 62.53 110.798 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 m -96.73 -171.43 2.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 73.52 110.843 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.683 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.1 m95 -71.18 -34.82 71.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.959 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -148.64 165.32 31.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 71.41 110.883 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -63.03 -30.12 71.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 64.24 110.868 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -75.34 -22.86 57.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 72.44 110.916 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -84.78 -49.98 7.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 62.34 110.858 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 t -61.27 -25.2 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 63.22 111.178 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -52.86 -39.67 62.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 72.33 110.914 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -85.55 -14.34 46.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 63.34 110.903 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' A' ' 16' ' ' ILE . 13.5 tp -82.49 -45.62 14.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 63.24 110.937 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 45.8 mt -70.58 -19.36 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 75.14 111.106 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -83.01 -3.39 57.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 73.33 110.921 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.2 mmm -98.9 -51.58 3.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 73.24 110.824 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.771 ' HB ' HD13 ' A' ' 52' ' ' LEU . 29.2 m -58.58 -38.06 68.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.22 111.099 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' HG3' HG23 ' A' ' 71' ' ' VAL . 36.4 mt-10 -88.19 48.06 1.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 64.41 110.848 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 -39.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.872 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.727 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -109.01 -21.86 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 54.02 110.929 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.56 ' HB3' HD21 ' A' ' 52' ' ' LEU . 25.5 m-85 -89.23 11.08 19.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 72.14 110.887 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.515 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.5 pp0? 32.51 47.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 65.35 110.944 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -153.28 -179.83 8.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 71.13 110.904 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 150.92 49.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 75.11 110.827 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 52' ' ' LEU . 98.0 t -83.18 129.74 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.21 111.1 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.3 p -144.25 31.67 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 65.23 111.085 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.755 ' HB2' HG22 ' A' ' 53' ' ' VAL . 15.5 m-20 -163.62 125.88 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 53.01 110.835 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 103' ' ' ILE . 24.3 t -133.89 98.91 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.5 111.125 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.5 mt -76.87 118.06 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 65.45 111.035 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 91' ' ' ARG . 44.3 mm -104.96 133.18 49.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 72.5 111.108 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.8 p -88.79 -55.93 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.33 111.197 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -133.4 161.74 33.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.894 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -80.71 97.52 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 62.24 111.079 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.631 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -150.73 157.64 43.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 70.1 110.859 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.17 -26.59 60.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 74.22 111.07 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -90.91 13.43 16.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 64.11 110.899 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.424 ' O ' HD12 ' A' ' 84' ' ' ILE . 2.4 mpt_? -127.56 -52.43 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.813 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.631 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.56 16.97 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 71.21 111.129 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.39 -29.39 30.57 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.691 -0.766 . . . . 32.44 112.484 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -107.4 17.34 37.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 42.11 112.451 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.497 HG21 ' H ' ' A' ' 121' ' ' GLU . 8.3 tt -47.0 -31.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 64.5 111.115 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.7 -54.76 23.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 71.3 110.906 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.1 m -56.95 -41.18 77.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.27 -0.423 . . . . 63.45 111.171 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.435 ' CD1' HG21 ' A' ' 82' ' ' VAL . 24.8 mt -60.84 -37.79 83.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 62.04 110.928 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -81.52 -19.23 42.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.22 -0.446 . . . . 73.02 110.943 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -84.73 -39.53 18.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 75.33 110.857 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.53 ' HB2' HD12 ' A' ' 103' ' ' ILE . 2.3 mtp85 -81.4 -40.1 23.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 72.11 110.829 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.4 -16.28 4.11 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.699 -0.762 . . . . 63.44 112.435 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 82' ' ' VAL . 2.1 mp -57.83 149.17 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.873 0.368 . . . . 74.45 111.111 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.74 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.2 ptpt -109.19 124.56 51.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.45 . . . . 74.55 110.918 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.45 83.23 6.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 74.1 111.127 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.437 ' ND1' HD12 ' A' ' 124' ' ' LEU . 96.3 m-70 -56.95 147.63 23.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.92 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.85 160.11 0.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.014 0.435 . . . . 74.13 110.852 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.638 HG22 ' HB3' ' A' ' 127' ' ' LEU . 19.9 p -78.72 159.56 27.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 65.34 111.174 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.58 -36.78 46.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 55.21 111.038 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 152' ' ' ASP . 8.6 tp -71.57 -48.75 46.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 74.23 110.912 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.76 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 77.8 m -51.79 -29.09 17.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 74.02 111.128 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.586 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -87.82 -31.8 19.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 72.43 111.085 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -56.17 -44.43 79.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.932 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.641 HD12 ' OD2' ' A' ' 152' ' ' ASP . 44.6 mt -76.82 -23.03 52.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.41 110.934 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.27 -65.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 64.53 111.101 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -27.62 33.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.856 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -24.38 66.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 72.11 110.946 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -95.69 -37.48 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 52.52 110.877 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.68 -3.28 4.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 65.41 112.477 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -59.45 -173.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.312 . . . . 72.4 110.945 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.497 ' H ' HG21 ' A' ' 95' ' ' ILE . 16.4 mm-40 -97.03 -0.82 46.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 75.31 110.947 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 65.95 126.0 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.677 0.751 . . . . 72.05 110.887 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.586 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.1 Cg_endo -69.69 -170.05 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.657 2.238 . . . . 73.05 112.379 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' A' ' 104' ' ' LYS . 56.6 mt -55.33 -35.58 65.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 73.41 110.879 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.96 54.26 29.61 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 54.12 112.434 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -147.39 54.32 1.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.886 0.374 . . . . 72.43 110.931 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.638 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.2 OUTLIER -132.28 -172.19 2.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 72.05 110.86 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.2 -167.9 2.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.917 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.756 HG23 ' HB3' ' A' ' 144' ' ' TYR . 97.8 m -49.3 -41.77 39.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 75.53 111.126 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 m -144.31 137.43 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.092 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 HD23 ' A' ' 133' ' ' LEU . 39.2 m -142.66 107.39 4.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 70.42 111.132 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -71.56 99.41 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 64.24 110.91 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.637 HD23 HG22 ' A' ' 131' ' ' THR . 2.6 mt -90.19 151.07 21.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.963 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.14 127.99 11.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.896 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -129.31 -166.25 1.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 71.31 110.873 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -51.9 98.28 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 52.34 112.465 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 51.91 52.26 14.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 62.41 110.933 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.502 ' HB2' HG22 ' A' ' 48' ' ' THR . 54.6 tpp -150.53 140.64 22.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 71.04 110.875 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.1 mmpm? -121.91 126.72 49.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 74.33 110.86 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.616 HG13 HD23 ' A' ' 158' ' ' LEU . 4.1 t -141.75 159.67 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 75.31 111.195 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.415 ' N ' HG12 ' A' ' 140' ' ' VAL . 25.6 tt0 -161.09 123.72 3.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.049 0.452 . . . . 71.52 110.839 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.92 179.92 4.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.507 . . . . 62.33 111.095 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -173.71 137.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.895 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.756 ' HB3' HG23 ' A' ' 129' ' ' THR . 65.3 t80 -116.24 94.94 43.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.687 0.756 . . . . 65.41 110.898 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -48.66 0.66 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.741 2.294 . . . . 60.13 112.239 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.73 -164.67 38.25 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.742 -0.742 . . . . 75.53 112.514 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -86.52 118.71 26.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.785 0.326 . . . . 72.33 110.899 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.517 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -129.97 -98.4 0.84 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.679 -0.772 . . . . 73.51 112.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -69.86 -26.74 64.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 52.14 110.867 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.61 159.42 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 60.31 111.163 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -66.09 -23.97 66.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.949 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.641 ' OD2' HD12 ' A' ' 114' ' ' LEU . 9.3 p30 -123.17 53.09 1.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.904 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.548 ' OD1' HD13 ' A' ' 169' ' ' LEU . 1.7 p30 -102.41 149.32 24.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 31.22 110.9 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.4 pt -150.03 161.88 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.23 111.172 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 196' ' ' VAL . 14.1 m -108.46 150.5 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 72.35 111.131 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.47 ' O ' HD22 ' A' ' 164' ' ' LEU . 67.1 t -104.23 125.44 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 54.13 111.201 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.461 ' O ' HD23 ' A' ' 158' ' ' LEU . 73.0 t-105 -111.7 150.63 29.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 75.12 110.92 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.616 HD23 HG13 ' A' ' 140' ' ' VAL . 35.2 mt -126.53 96.15 36.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.718 . . . . 64.32 110.878 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 71.23 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 75.25 112.329 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.12 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.885 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.609 ' CB ' HD13 ' A' ' 163' ' ' ILE . 5.9 m-85 -118.85 -11.73 9.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 63.21 110.928 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 m120 67.88 22.79 8.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 63.41 110.843 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.609 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.5 mp -88.41 115.06 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 71.2 111.187 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.8 tm? -98.12 126.24 43.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 52.12 110.978 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.598 HG21 HD22 ' A' ' 44' ' ' LEU . 16.5 t -120.71 75.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 61.4 111.138 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.27 -54.79 27.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.762 -0.732 . . . . 72.55 112.503 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 109.39 -134.93 12.53 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.721 -0.752 . . . . 74.5 112.392 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 67.0 m -60.62 -19.07 56.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 72.35 110.861 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.548 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.6 OUTLIER -69.41 -49.19 57.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 72.42 110.907 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.621 HG11 HG11 ' A' ' 206' ' ' VAL . 28.8 t -92.63 127.47 44.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 71.35 111.201 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.49 152.82 19.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.916 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.568 ' HA ' HD22 ' A' ' 218' ' ' LEU . 4.4 t -73.04 164.59 26.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 72.24 110.896 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.592 HG23 HD23 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -67.56 -38.91 84.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.31 111.136 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.84 -27.4 68.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 71.01 110.866 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.28 158.87 3.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 62.32 111.071 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.43 ' O ' HD22 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -115.08 -30.94 6.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.45 110.973 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -151.25 -179.85 7.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 64.24 110.878 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.686 HD11 HD23 ' A' ' 226' ' ' LEU . 1.0 OUTLIER -81.93 -42.97 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.31 110.923 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.44 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 103.64 -161.79 15.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.728 . . . . 62.14 112.504 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -52.01 137.32 27.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 75.44 110.88 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 184' ' ' ALA . 35.9 m -136.22 41.64 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 42.2 111.084 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -52.34 -46.9 66.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 55.35 111.134 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -118.66 41.63 2.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 75.32 110.871 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . . . -126.23 166.13 17.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.115 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -117.86 91.71 3.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 75.05 110.946 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 65.5 t -67.65 -21.8 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 73.43 111.174 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -82.36 -26.38 32.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 71.24 110.933 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -96.95 -21.76 17.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 71.14 110.861 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.589 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.2 t90 -51.1 -51.86 49.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 64.23 110.975 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.5 p -51.95 -35.67 46.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 70.01 110.878 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.7 m -74.1 -38.3 63.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 75.23 111.139 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 34.0 m -61.86 -56.24 21.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.809 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.587 HG21 ' O ' ' A' ' 219' ' ' LEU . 28.8 mm -55.22 -38.67 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.457 . . . . 71.11 111.109 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.406 ' HA ' HD21 ' A' ' 197' ' ' LEU . 7.6 mt-10 -63.82 -25.15 68.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 62.11 110.873 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -85.79 -31.88 22.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 62.13 110.973 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.429 HG21 HG11 ' A' ' 155' ' ' VAL . 99.7 t -73.28 -40.29 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.04 111.138 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.586 HD23 HG22 ' A' ' 193' ' ' ILE . 4.3 pp -76.68 -25.33 53.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 71.2 110.931 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.95 -44.23 18.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 73.15 110.967 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.83 -26.24 67.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 73.34 110.861 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -141.03 117.08 10.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 70.35 110.97 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.96 37.35 4.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 74.23 110.897 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.15 22.03 1.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 71.53 110.891 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.523 HG21 ' CG2' ' A' ' 206' ' ' VAL . 3.4 mp -51.57 145.67 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 71.4 111.113 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -107.67 -29.32 9.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 62.45 110.881 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.43 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -162.71 121.33 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 75.44 111.13 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.621 HG11 HG11 ' A' ' 170' ' ' VAL . 97.6 t -101.88 118.91 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 62.15 111.099 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.996 HG21 HD11 ' A' ' 44' ' ' LEU . 69.8 t -102.9 106.88 52.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.661 0.743 . . . . 72.21 111.07 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.4 Cg_endo -69.78 -170.36 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.657 2.238 . . . . 75.44 112.372 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.85 -26.95 6.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 51.53 112.441 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -143.84 98.14 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 70.45 110.878 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.54 -95.07 0.15 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.735 -0.745 . . . . 61.31 112.491 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -174.34 152.41 1.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.828 0.347 . . . . 33.32 110.922 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.466 ' HB ' HG22 ' A' ' 207' ' ' VAL . 5.9 p -67.38 144.12 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 63.14 111.143 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.67 -105.51 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.716 -0.754 . . . . 72.51 112.495 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -156.84 -169.61 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.891 0.377 . . . . 65.01 110.861 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -20.43 35.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.212 -0.449 . . . . 63.43 110.88 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.741 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.66 -33.1 62.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.715 -0.755 . . . . 63.25 112.5 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.592 HD23 HG23 ' A' ' 173' ' ' THR . 30.2 mt -50.63 -48.91 57.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 75.54 110.984 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.587 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -54.16 -42.41 69.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 53.1 110.954 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.741 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.0 mt -68.12 -41.26 82.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 62.51 110.862 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.55 ' NE2' HD21 ' A' ' 225' ' ' LEU . 86.0 t60 -66.11 -36.91 84.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 52.32 110.839 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.2 m -54.1 -45.25 71.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.164 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.772 ' HA ' HD12 ' A' ' 226' ' ' LEU . 70.5 mt -57.24 -38.91 74.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.893 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -33.74 74.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 75.5 110.871 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.55 HD21 ' NE2' ' A' ' 221' ' ' HIS . 16.9 mt -67.73 -25.81 65.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 61.51 110.89 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 223' ' ' LEU . 4.4 mt -84.92 -48.99 8.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 71.22 110.92 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.7 mttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 61.4 110.885 179.852 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.545 ' HD2' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.851 0.358 . . . . 53.0 110.841 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -149.84 108.16 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 73.12 110.878 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -151.05 -175.27 5.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 73.31 110.858 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.1 t 62.55 99.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 65.04 111.116 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -106.33 144.32 33.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 73.3 110.92 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -156.25 151.93 27.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 73.52 110.891 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -143.42 -179.2 6.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 72.12 111.134 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 18' ' ' ILE . 95.9 t 61.0 96.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 75.31 111.081 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.482 HD11 ' HE3' ' A' ' 74' ' ' LYS . 3.0 mm -89.96 154.23 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 52.51 111.103 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -150.96 163.71 38.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.885 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -91.43 -169.14 2.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 54.41 110.888 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.592 ' HG3' HG23 ' A' ' 13' ' ' THR . 7.0 pt-20 -76.75 -18.46 58.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 62.01 110.846 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 12' ' ' GLU . 22.3 p -108.73 -39.83 5.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 54.4 111.149 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.52 -2.94 29.3 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.692 -0.766 . . . . 34.03 112.432 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.716 HG23 HG13 ' A' ' 16' ' ' ILE . 1.7 t -50.62 -33.53 22.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 63.31 111.127 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.716 HG13 HG23 ' A' ' 15' ' ' THR . 7.6 mt -130.04 159.71 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 64.4 111.096 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.403 ' N ' HG22 ' A' ' 16' ' ' ILE . 74.8 p -175.52 167.55 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 65.1 110.836 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -130.7 -174.77 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 73.12 111.154 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -169.46 129.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 75.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 121.47 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.919 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.8 mm? -105.06 -42.42 5.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 73.4 110.916 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -146.1 -168.34 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 64.25 110.91 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -51.55 48.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 63.55 110.886 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -132.21 34.24 3.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.917 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.66 122.48 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 73.52 111.145 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -126.91 160.08 32.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.129 -0.487 . . . . 71.44 110.906 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.423 HG23 ' HG ' ' A' ' 21' ' ' LEU . 61.0 t -122.56 111.81 31.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 64.23 111.134 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -100.88 135.97 41.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 64.21 110.855 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 m -130.56 137.65 49.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.51 111.165 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HB3' HG23 ' A' ' 16' ' ' ILE . 2.5 pm0 -133.85 170.09 16.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 65.24 110.925 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.622 HD12 ' HA ' ' A' ' 40' ' ' PRO . 3.8 tp -116.98 148.17 41.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 62.42 110.924 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.03 -141.27 4.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.764 -0.731 . . . . 75.44 112.494 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.68 161.66 22.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.901 0.382 . . . . 64.42 110.827 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -178.57 88.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 74.23 110.877 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 m120 55.08 58.51 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 72.51 110.914 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.54 28.26 67.33 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.764 -0.731 . . . . 72.43 112.496 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -144.52 133.62 22.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 72.51 110.899 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.555 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -72.16 127.4 32.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 73.2 111.17 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.701 HG21 ' HD2' ' A' ' 303' ' ' RTD . 2.5 p -120.36 119.97 30.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.655 0.741 . . . . 64.11 111.091 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.622 ' HA ' HD12 ' A' ' 31' ' ' LEU . 52.9 Cg_endo -69.87 157.35 60.46 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.62 2.213 . . . . 75.3 112.34 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.26 112.79 7.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 70.23 110.857 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -76.39 147.49 37.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 70.51 110.909 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.593 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -146.29 -153.81 6.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 63.24 112.526 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.895 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -166.22 142.61 4.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 61.4 110.912 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG22 HD13 ' A' ' 54' ' ' LEU . 47.4 t -127.47 138.85 53.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 65.33 111.124 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.7 mt -102.12 135.11 44.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.957 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -111.75 61.48 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.917 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.501 HG21 ' HB2' ' A' ' 135' ' ' PHE . 18.1 p -77.95 176.15 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 71.53 111.137 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.14 26.87 3.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 61.34 110.855 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -145.74 24.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 71.04 110.889 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.52 142.08 8.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 72.51 112.455 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.809 HD13 ' HB ' ' A' ' 71' ' ' VAL . 8.8 mt -70.96 162.3 29.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 53.03 110.852 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 81' ' ' ASP . 61.1 t -141.81 144.49 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 74.33 111.088 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.568 HD13 HG22 ' A' ' 45' ' ' VAL . 3.1 mm? -115.45 128.27 55.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 64.42 110.877 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.6 t -78.62 -2.47 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 63.12 111.104 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p30 179.98 130.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 74.34 110.859 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.06 -167.41 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.895 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.85 -169.69 2.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 75.12 110.869 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.726 ' HB2' HD13 ' A' ' 63' ' ' LEU . 88.0 m95 -74.36 -37.47 63.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 65.23 110.923 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -142.19 165.68 26.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 64.42 110.831 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.48 -33.89 74.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 74.45 110.889 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -74.17 -24.76 59.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.957 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.726 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -80.88 -48.36 12.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 61.24 110.939 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -57.57 -26.71 61.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 70.23 111.161 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -42.72 75.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 72.25 110.933 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -86.92 1.7 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 73.24 110.892 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.516 HD13 HG21 ' A' ' 16' ' ' ILE . 16.7 tp -96.9 -47.7 5.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 64.24 110.899 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.4 mt -70.81 -24.76 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.22 111.104 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -72.74 -12.83 61.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 60.4 110.834 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 30.5 mtp -82.28 -50.41 8.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 61.55 110.855 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.809 ' HB ' HD13 ' A' ' 52' ' ' LEU . 29.1 m -65.94 -40.57 87.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.53 111.142 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG3' HG23 ' A' ' 71' ' ' VAL . 47.4 mt-10 -83.95 51.63 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.913 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 -38.14 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.902 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -111.81 -22.93 10.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.926 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.63 ' HB3' HD21 ' A' ' 52' ' ' LEU . 24.9 m-85 -87.85 10.86 17.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 65.4 110.888 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.511 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.97 46.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 73.23 110.941 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -151.9 -178.46 6.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 72.12 110.916 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.444 ' HD3' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -129.23 150.87 50.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 54.42 110.838 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 52' ' ' LEU . 98.0 t -86.84 127.57 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 64.44 111.099 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.444 HG23 ' HD3' ' A' ' 78' ' ' ARG . 22.4 p -138.22 25.84 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 74.23 111.116 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.734 ' HB2' HG22 ' A' ' 53' ' ' VAL . 24.3 m-20 -156.89 133.06 9.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.926 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.586 HG21 ' CD2' ' A' ' 98' ' ' LEU . 21.5 t -138.98 99.89 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 62.44 111.128 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.4 mt -76.93 123.23 33.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 64.41 111.141 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 91' ' ' ARG . 43.9 mm -111.65 131.74 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 54.15 111.106 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.487 HG22 HG13 ' A' ' 154' ' ' ILE . 19.5 p -86.96 -58.12 2.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 75.3 111.185 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.629 ' C ' HG23 ' A' ' 111' ' ' THR . 31.4 p-80 -129.92 175.32 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.897 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -93.58 98.09 10.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 74.41 111.103 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.637 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.55 158.54 43.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.885 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.39 -26.72 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 63.12 111.102 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.88 11.48 22.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 72.02 110.827 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.434 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.4 mpt_? -124.88 -52.55 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 75.1 110.917 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.61 17.35 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.51 111.117 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -52.36 -27.33 24.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.779 -0.725 . . . . 54.34 112.477 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.8 19.43 28.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 53.25 112.42 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.476 HG21 ' H ' ' A' ' 121' ' ' GLU . 3.3 tt -48.92 -30.38 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 71.44 111.147 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -69.52 -43.96 71.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 72.44 110.878 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.1 m -68.04 -34.1 75.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 34.34 111.207 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.586 ' CD2' HG21 ' A' ' 82' ' ' VAL . 52.5 mt -63.01 -29.33 70.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.935 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.78 19.67 13.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.02 110.885 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -117.92 -22.73 7.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 62.2 110.825 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -111.69 8.5 20.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 75.32 110.835 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.11 15.56 66.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 64.11 112.455 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 98' ' ' LEU . 14.1 mt -81.58 156.59 4.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.937 0.399 . . . . 65.44 111.143 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.781 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.3 ptpm? -121.86 121.0 36.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 73.52 110.91 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -87.93 79.98 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 63.13 111.097 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.488 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.8 m-70 -54.67 145.63 18.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 71.32 110.824 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.69 160.71 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 72.1 110.812 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -73.86 -176.64 2.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.511 . . . . 73.22 111.069 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.65 -27.24 45.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 75.31 111.115 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 152' ' ' ASP . 5.5 tp -76.31 -47.88 22.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 71.43 110.933 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.749 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 97.5 m -54.38 -26.27 29.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 72.34 111.081 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -88.62 -29.29 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 64.51 111.11 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -61.54 -31.29 71.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 72.44 110.855 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.43 HD22 ' OD2' ' A' ' 152' ' ' ASP . 10.2 mp -89.38 -25.4 21.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.34 110.974 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.46 -67.48 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 72.01 111.116 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -26.4 37.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 64.33 110.842 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -24.59 67.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 71.33 110.884 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -94.75 -37.53 11.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.443 . . . . 73.54 110.871 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 138.95 -7.96 3.26 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.753 -0.737 . . . . 72.01 112.476 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.76 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 64.12 110.852 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.476 ' H ' HG21 ' A' ' 95' ' ' ILE . 36.7 mm-40 -99.73 -1.14 38.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 65.21 110.894 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.469 ' C ' HD11 ' A' ' 95' ' ' ILE . 1.6 mt-10 66.41 129.33 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.719 . . . . 60.12 110.859 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.405 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.3 Cg_endo -69.83 -169.66 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.721 2.281 . . . . 63.41 112.3 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 104' ' ' LYS . 76.2 mt -53.45 -43.89 68.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 75.31 110.876 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.44 57.13 19.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.716 . . . . 64.22 112.479 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -152.13 36.51 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.798 0.332 . . . . 51.41 110.825 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.82 -169.67 1.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.45 . . . . 75.24 110.906 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -153.82 -169.06 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 53.32 110.943 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.84 HG23 ' HB3' ' A' ' 144' ' ' TYR . 99.5 m -50.81 -57.8 7.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.146 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.695 HG23 HG22 ' A' ' 129' ' ' THR . 93.7 t -129.54 123.09 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 73.12 111.214 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.556 HG22 HD23 ' A' ' 133' ' ' LEU . 93.6 m -131.54 124.97 31.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.083 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -80.82 103.04 10.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 65.03 110.948 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.556 HD23 HG22 ' A' ' 131' ' ' THR . 2.3 mt -91.16 150.75 21.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 73.32 110.934 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 124.34 12.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 70.22 110.917 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.501 ' HB2' HG21 ' A' ' 48' ' ' THR . 14.1 m-85 -126.32 47.76 2.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.926 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.97 117.76 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.678 -0.772 . . . . 41.12 112.531 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.0 t30 52.46 29.53 7.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.789 0.328 . . . . 70.31 110.864 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.45 ' HB2' HG22 ' A' ' 48' ' ' THR . 30.5 tpp -145.81 140.57 27.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 70.43 110.873 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -128.52 121.27 28.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 75.42 110.844 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.593 HG13 HD23 ' A' ' 158' ' ' LEU . 12.1 t -131.66 154.55 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.179 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -152.19 125.85 8.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.849 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.5 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -76.17 -178.19 4.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.482 . . . . 62.11 111.15 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.625 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.0 t80 -175.28 140.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 73.53 110.854 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.84 ' HB3' HG23 ' A' ' 129' ' ' THR . 39.6 t80 -125.22 96.21 39.89 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.639 0.733 . . . . 72.44 110.897 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 54.9 Cg_endo -69.7 -49.02 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.637 2.225 . . . . 53.05 112.426 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.73 -155.64 21.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 74.45 112.491 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.48 127.5 42.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 72.4 110.934 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.591 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -138.94 -93.51 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 72.03 112.496 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -69.67 -30.12 67.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.929 0.395 . . . . 61.42 110.879 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.57 160.33 43.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 53.55 111.147 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.82 -23.99 67.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 71.42 110.888 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.455 ' HB3' HD23 ' A' ' 110' ' ' LEU . 6.9 p30 -120.63 45.2 2.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 73.22 110.908 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -94.11 134.34 36.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 50.55 110.893 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.562 HG22 ' CD1' ' A' ' 144' ' ' TYR . 2.0 pt -136.19 171.3 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.116 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.466 ' CG1' HD22 ' A' ' 169' ' ' LEU . 5.9 m -121.85 150.11 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 74.51 111.131 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -103.07 143.48 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 73.1 111.082 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -129.52 150.09 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.928 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.593 HD23 HG13 ' A' ' 140' ' ' VAL . 36.6 mt -127.12 95.04 37.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.67 0.747 . . . . 72.44 110.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 71.96 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.685 2.257 . . . . 33.5 112.367 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -34.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.4 110.96 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.532 ' CB ' HD13 ' A' ' 163' ' ' ILE . 5.8 m-85 -118.15 -13.08 9.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 65.24 110.898 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.8 m120 69.26 25.33 5.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 72.22 110.908 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.541 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.6 mp -96.16 116.52 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 55.44 111.185 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.94 138.48 38.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 64.51 110.885 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.557 HG21 HD22 ' A' ' 44' ' ' LEU . 24.9 t -123.22 66.55 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 52.05 111.152 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.6 -54.28 25.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 30.03 112.5 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.48 -135.1 12.41 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.727 -0.749 . . . . 64.41 112.469 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 33.7 m -62.58 -17.04 59.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.85 0.357 . . . . 72.33 110.874 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.485 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.8 OUTLIER -69.87 -51.36 33.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.895 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.617 HG11 HG11 ' A' ' 206' ' ' VAL . 38.8 t -87.48 129.18 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 53.33 111.108 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.02 145.27 29.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 75.45 110.905 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.63 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.6 p -70.3 157.78 37.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 55.15 110.851 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.554 HG23 HD23 ' A' ' 218' ' ' LEU . 6.9 p -56.73 -47.86 79.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 65.34 111.119 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.39 -28.71 30.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 74.11 110.865 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 172' ' ' SER . . . -58.1 150.68 20.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 70.33 111.068 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -116.39 -26.49 7.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 73.13 110.851 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -148.77 179.35 7.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 74.42 110.887 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.58 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 0.6 OUTLIER -91.07 -36.83 13.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 55.21 110.916 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 104.08 -156.44 17.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 73.15 112.539 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -57.15 117.47 4.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 64.45 110.902 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 15.4 m -116.35 38.03 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.075 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.27 84.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 65.33 111.148 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.42 39.65 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 62.21 110.856 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -135.53 168.62 18.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 63.13 111.109 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -115.35 91.89 3.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 63.22 110.916 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.413 HG13 HD23 ' A' ' 226' ' ' LEU . 94.3 t -68.71 -23.65 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.04 -0.527 . . . . 75.53 111.098 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -80.38 -25.63 39.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 64.44 110.875 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -97.57 -23.82 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 75.04 110.936 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.58 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.4 t90 -51.43 -56.88 10.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 75.54 110.949 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.7 t -51.89 -35.18 44.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 64.43 110.852 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.2 m -72.94 -33.8 66.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 54.42 111.055 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 57.1 m -68.01 -52.41 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 62.31 110.848 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.88 HG22 HD23 ' A' ' 197' ' ' LEU . 30.4 mm -58.56 -38.26 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 54.22 111.118 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.21 -16.53 60.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 73.1 110.919 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -99.29 -20.5 16.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 62.11 110.905 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.434 ' CG1' HD21 ' A' ' 219' ' ' LEU . 79.1 t -88.85 -25.42 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.13 111.166 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.88 HD23 HG22 ' A' ' 193' ' ' ILE . 2.6 pp -99.24 2.38 45.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 73.33 110.919 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -117.68 -14.59 10.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 70.44 110.89 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -93.28 2.11 56.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 73.03 110.911 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -137.89 -72.39 0.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 74.3 110.914 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 60.56 25.94 15.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 75.24 110.901 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -149.14 23.44 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 64.02 110.853 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -63.53 145.64 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 72.23 111.2 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -102.47 -28.1 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 65.43 110.915 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.408 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -161.3 131.26 4.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 63.23 111.075 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.743 ' CG1' HD12 ' A' ' 218' ' ' LEU . 89.5 t -110.84 123.67 66.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 74.13 111.149 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.895 HG21 HD11 ' A' ' 44' ' ' LEU . 49.1 t -110.3 103.84 54.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.672 0.749 . . . . 75.44 111.129 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.0 Cg_endo -69.81 -170.78 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.762 2.308 . . . . 70.15 112.314 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -105.48 -22.26 8.26 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 72.44 112.503 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -146.03 86.79 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 71.35 110.892 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 165.25 -99.33 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.705 -0.759 . . . . 62.34 112.47 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -171.75 161.38 5.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.929 0.395 . . . . 62.53 110.872 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 207' ' ' VAL . 21.4 t -70.5 150.5 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 60.31 111.133 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.12 -107.63 0.28 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 52.41 112.45 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -159.16 -170.04 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 75.4 110.897 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -23.23 26.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 64.05 110.878 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.769 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -53.59 -33.44 48.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.684 -0.77 . . . . 34.33 112.553 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.743 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.8 mt -51.16 -46.56 62.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 74.33 110.913 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.601 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -57.79 -43.7 85.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.949 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.769 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.9 mt -66.46 -41.77 88.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 72.35 110.924 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.682 ' NE2' HD21 ' A' ' 225' ' ' LEU . 84.5 t60 -66.13 -38.79 89.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 74.03 110.847 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.9 m -52.57 -46.46 66.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 71.32 111.178 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.69 ' HA ' HD12 ' A' ' 226' ' ' LEU . 63.8 mt -53.59 -40.49 65.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 73.01 110.911 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -35.25 80.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 61.42 110.858 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.682 HD21 ' NE2' ' A' ' 221' ' ' HIS . 31.5 mt -62.68 -25.91 68.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 74.4 110.882 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 223' ' ' LEU . 1.2 mt -90.12 -42.56 11.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 43.14 110.899 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 70.42 110.902 179.785 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.701 ' HD2' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.905 0.383 . . . . 60.24 110.855 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -150.19 126.7 10.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 73.23 110.883 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.33 148.56 41.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 74.24 110.937 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.3 t -138.68 141.4 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 74.33 111.16 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.85 147.75 2.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 45.24 110.936 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 mttp 62.5 163.41 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.807 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.539 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -147.08 179.72 7.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 71.14 111.119 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.574 HG22 ' OG ' ' A' ' 19' ' ' SER . 91.9 t 60.83 94.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 74.44 111.132 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.727 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.0 mm -88.89 155.92 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 62.43 111.096 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -146.78 156.76 43.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 71.43 110.854 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.35 171.69 10.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.12 110.941 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -58.71 -30.29 67.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 75.53 110.928 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.459 ' OG1' HG22 ' A' ' 15' ' ' THR . 20.6 p -99.46 -32.13 11.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.159 -0.473 . . . . 62.31 111.136 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.06 -8.42 42.08 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 71.21 112.481 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.769 HG23 HG13 ' A' ' 16' ' ' ILE . 2.8 t -51.27 -33.14 27.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 71.12 111.146 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.769 HG13 HG23 ' A' ' 15' ' ' THR . 18.9 mt -124.15 152.6 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 64.31 111.165 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 p -171.93 165.32 6.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 72.23 110.834 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -130.68 -172.49 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 53.5 111.153 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.574 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -173.96 132.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 45.33 110.874 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -67.81 120.71 14.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.082 -0.508 . . . . 64.22 110.9 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.65 -45.47 5.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 75.23 110.967 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -146.09 48.75 1.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.0 110.879 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.502 ' H ' ' NE2' ' A' ' 20' ' ' GLN . 7.3 ttmm 70.59 -70.89 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.832 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -88.31 -23.25 23.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.929 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.82 120.21 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 54.24 111.139 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.539 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.1 m95 -123.89 161.01 26.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 70.04 110.852 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.508 HG21 HG21 ' A' ' 213' ' ' VAL . 84.9 t -123.15 107.98 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.13 111.127 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.614 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.8 p80 -101.59 137.68 39.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.44 110.861 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 m -133.12 136.27 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.108 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' OE1' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -128.15 165.16 20.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.411 . . . . 74.1 110.899 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.897 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -117.64 136.49 53.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.474 . . . . 63.44 110.931 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.51 109.48 0.85 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.728 -0.749 . . . . 75.43 112.478 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.95 120.1 4.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 51.32 110.887 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.92 96.26 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 72.11 110.914 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.1 t30 57.07 26.15 11.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 74.1 110.934 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.39 30.48 7.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.705 -0.76 . . . . 51.04 112.449 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -144.54 120.06 10.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 73.32 110.841 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.897 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -68.31 132.65 47.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 64.12 111.076 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.72 HG11 ' HD2' ' A' ' 303' ' ' RTD . 60.4 t -142.31 103.12 5.56 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.673 0.749 . . . . 43.43 111.178 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 54.3 Cg_endo -69.7 140.17 42.23 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.706 2.27 . . . . 74.54 112.438 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -122.76 108.58 13.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 71.12 110.848 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -67.88 143.02 55.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 52.33 110.858 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.643 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -141.49 -153.58 5.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 42.52 112.458 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -165.85 145.18 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 62.11 110.904 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.602 HG22 HD13 ' A' ' 54' ' ' LEU . 78.8 t -128.6 137.08 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.24 111.098 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.7 mt -105.11 130.3 53.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.109 -0.496 . . . . 75.1 110.949 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.422 ' HA ' HD23 ' A' ' 52' ' ' LEU . 82.3 m-20 -99.66 56.43 0.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.862 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.411 HG21 ' HB2' ' A' ' 135' ' ' PHE . 22.2 p -65.69 169.74 5.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 71.53 111.061 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.99 27.26 3.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 20.33 110.869 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -150.04 28.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 74.31 110.876 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.42 127.34 5.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 41.13 112.508 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.695 HD13 ' HB ' ' A' ' 71' ' ' VAL . 9.1 mt -54.78 168.03 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 65.25 110.97 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 81' ' ' ASP . 60.2 t -146.68 143.49 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 61.43 111.138 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.602 HD13 HG22 ' A' ' 45' ' ' VAL . 3.6 mm? -114.52 127.92 56.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 71.14 110.993 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG11 HG11 ' A' ' 165' ' ' VAL . 14.7 t -78.06 -2.91 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 43.01 111.122 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.21 132.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 61.5 110.848 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.57 -166.71 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.866 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.6 m -94.06 -175.04 3.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.841 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.739 ' HB2' HD13 ' A' ' 63' ' ' LEU . 90.1 m95 -68.38 -41.21 80.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 75.51 110.892 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -137.39 166.72 23.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.419 . . . . 44.25 110.859 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.44 -35.94 80.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 74.42 110.865 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -70.39 -23.48 62.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 64.13 110.927 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -81.81 -50.6 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 75.23 110.985 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -57.7 -31.07 66.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 72.34 111.129 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -54.58 -38.55 66.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 54.34 110.856 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.55 -11.31 54.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 74.24 110.828 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.541 HD13 HG21 ' A' ' 16' ' ' ILE . 36.8 tp -85.03 -47.36 10.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 60.23 110.923 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 68' ' ' ILE . 37.3 mt -68.65 -11.98 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.21 111.106 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -92.17 16.45 11.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 70.31 110.889 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.5 mtp -115.83 -51.55 2.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 63.12 110.892 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.695 ' HB ' HD13 ' A' ' 52' ' ' LEU . 28.1 m -64.21 -36.08 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 73.3 111.128 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -85.72 50.56 1.99 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 70.41 110.885 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -142.84 -40.15 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 75.42 110.915 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.727 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.28 -23.81 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 75.52 110.889 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.548 ' CB ' HD21 ' A' ' 52' ' ' LEU . 30.4 m-85 -89.52 11.23 20.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 74.34 110.864 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.7 pp0? 32.81 46.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 74.5 110.956 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -150.42 -176.57 5.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 72.21 110.857 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -134.01 152.09 51.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.817 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.559 HG22 ' HB2' ' A' ' 52' ' ' LEU . 85.0 t -87.19 118.18 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 55.35 111.178 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.487 HG23 ' HG2' ' A' ' 78' ' ' ARG . 74.1 p -127.37 21.3 6.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 73.02 111.142 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 53' ' ' VAL . 5.6 m-20 -154.0 134.1 13.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 73.11 110.912 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.564 HG21 HD13 ' A' ' 98' ' ' LEU . 21.2 t -136.65 99.6 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 75.44 111.126 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.9 mt -74.89 126.11 35.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 72.41 111.094 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.497 HG23 ' HB3' ' A' ' 91' ' ' ARG . 29.4 mm -113.88 129.5 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 63.44 111.116 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.0 p -88.34 -54.11 4.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.163 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -133.68 162.81 30.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 73.43 110.884 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -84.24 98.5 10.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 62.12 111.041 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.627 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.8 OUTLIER -151.74 158.76 43.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.0 110.897 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.36 -24.38 54.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 45.13 111.098 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.87 16.36 12.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 74.44 110.94 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HB3' HG23 ' A' ' 84' ' ' ILE . 53.3 mmt-85 -132.19 -52.53 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 73.43 110.889 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.15 15.24 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.44 111.109 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.91 -34.45 30.25 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 45.24 112.503 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.09 18.15 43.21 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.72 -0.752 . . . . 72.35 112.451 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.561 HG21 ' H ' ' A' ' 121' ' ' GLU . 8.0 tt -46.16 -31.69 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 40.2 111.118 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -54.67 26.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 70.14 110.878 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.8 m -58.54 -39.82 81.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.19 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.564 HD13 HG21 ' A' ' 82' ' ' VAL . 28.9 mt -60.4 -29.52 69.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 71.42 110.888 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -99.31 24.11 8.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 74.44 110.898 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -114.1 -34.69 5.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 54.13 110.878 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -96.17 -21.94 17.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 63.23 110.856 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.59 16.82 4.48 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.772 -0.727 . . . . 40.52 112.503 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.2 mt -83.06 156.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 64.22 111.167 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.616 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -119.26 125.01 48.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.44 . . . . 73.33 110.853 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.04 82.4 5.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 55.33 111.092 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.518 ' HA ' HD12 ' A' ' 124' ' ' LEU . 59.1 m-70 -51.91 142.59 15.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 73.42 110.855 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.67 151.43 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.03 110.899 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.64 HG22 ' HB3' ' A' ' 127' ' ' LEU . 71.1 p -70.63 157.45 37.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 74.2 111.137 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.62 -24.07 45.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 34.34 111.134 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' A' ' 152' ' ' ASP . 10.8 tp -77.0 -46.96 22.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 73.24 110.915 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 33.5 m -55.62 -27.93 52.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.224 -0.444 . . . . 61.1 111.184 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.645 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -80.49 -23.46 40.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.24 111.127 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.88 -38.25 90.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 71.14 110.839 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.4 mt -85.24 -24.52 27.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 73.14 110.878 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.8 -65.78 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 72.41 111.066 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -55.24 -26.2 38.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 63.33 110.949 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.64 -24.17 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.877 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -95.09 -31.46 13.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.924 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.82 -4.84 6.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.731 . . . . 51.23 112.49 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -59.72 -172.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.883 0.373 . . . . 73.12 110.907 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.561 ' H ' HG21 ' A' ' 95' ' ' ILE . 9.5 mm-40 -98.19 -1.32 42.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 74.41 110.9 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.645 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 0.7 OUTLIER 66.16 126.97 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.71 0.767 . . . . 73.15 110.86 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -170.64 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.612 2.208 . . . . 65.31 112.39 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' A' ' 104' ' ' LYS . 64.7 mt -51.89 -36.38 48.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 55.13 110.907 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.98 53.93 28.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 75.1 112.48 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -152.02 48.46 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 72.11 110.833 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.64 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.2 OUTLIER -123.65 -169.64 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.904 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -151.96 -168.74 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 74.2 110.936 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.817 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.3 m -50.24 -64.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 54.05 111.134 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.764 HG23 HG22 ' A' ' 129' ' ' THR . 68.6 t -124.63 110.62 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 43.3 111.133 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.632 HG22 HD23 ' A' ' 133' ' ' LEU . 90.7 m -113.33 105.32 13.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.151 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -66.57 100.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 64.45 110.872 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.632 HD23 HG22 ' A' ' 131' ' ' THR . 2.9 mt -89.92 153.69 20.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.908 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -151.94 128.14 10.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 74.41 110.873 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.411 ' HB2' HG21 ' A' ' 48' ' ' THR . 10.3 m-85 -129.51 -165.97 1.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 70.32 110.857 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -51.63 98.95 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.753 . . . . 71.22 112.517 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 51.37 52.42 14.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.331 . . . . 71.54 110.906 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.3 tpt -150.85 142.2 23.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 45.3 110.913 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -124.24 125.34 44.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 65.13 110.897 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.749 HG13 HD23 ' A' ' 158' ' ' LEU . 6.5 t -138.0 157.69 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 62.42 111.147 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 140' ' ' VAL . 64.8 tt0 -155.66 125.22 6.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 61.1 110.842 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.693 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -74.99 -177.06 3.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.138 -0.483 . . . . 65.11 111.124 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.744 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.0 t80 -175.33 136.19 0.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.817 ' HB3' HG23 ' A' ' 129' ' ' THR . 28.4 t80 -119.47 93.77 47.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.624 0.726 . . . . 75.11 110.978 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 -48.55 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.69 2.26 . . . . 72.31 112.355 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.88 -155.29 22.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 34.11 112.462 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.15 123.97 41.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.371 . . . . 73.15 110.826 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.638 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -134.66 -94.3 0.48 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.741 -0.742 . . . . 74.33 112.483 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -71.46 -29.58 65.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.389 . . . . 73.14 110.899 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.8 153.13 34.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 72.11 111.117 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.52 -37.9 65.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 72.12 110.916 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.5 ' HB3' HD23 ' A' ' 110' ' ' LEU . 1.4 p30 -108.74 51.13 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.887 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.567 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.9 OUTLIER -100.49 136.35 40.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 70.05 110.889 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.693 HD12 HG22 ' A' ' 142' ' ' THR . 18.5 pt -137.48 169.01 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.22 111.122 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.43 ' CG1' HD22 ' A' ' 169' ' ' LEU . 10.6 m -119.37 140.93 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 61.01 111.177 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 84.4 t -95.85 144.24 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.11 111.145 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -131.16 146.94 52.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 75.31 110.896 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.749 HD23 HG13 ' A' ' 140' ' ' VAL . 15.7 mt -123.43 97.47 42.39 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.599 0.714 . . . . 50.12 110.887 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 72.22 1.44 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 53.11 112.388 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.17 -34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.888 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -117.42 -13.28 10.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 54.54 110.904 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 m120 68.62 23.28 7.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 73.23 110.909 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.437 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.7 mp -95.58 116.26 36.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 41.11 111.16 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.7 137.0 37.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 75.33 110.97 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.517 HG21 HD22 ' A' ' 44' ' ' LEU . 21.5 t -121.27 66.95 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 73.13 111.109 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.77 -55.33 21.12 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 73.13 112.452 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.21 -119.76 5.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 63.35 112.492 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 90.3 m -87.2 7.23 29.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 62.23 110.951 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.567 HD13 ' OD1' ' A' ' 153' ' ' ASN . 1.0 OUTLIER -88.72 -50.17 6.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.157 -0.474 . . . . 75.13 110.922 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.469 HG11 HG11 ' A' ' 206' ' ' VAL . 21.7 t -91.1 120.86 40.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 61.43 111.098 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.03 154.78 19.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 62.53 110.963 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.608 ' HA ' HD22 ' A' ' 218' ' ' LEU . 5.8 p -77.65 161.43 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 52.44 110.861 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.592 HG23 HD23 ' A' ' 218' ' ' LEU . 1.4 p -61.79 -34.61 76.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 73.02 111.115 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -26.68 65.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 53.15 110.864 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.53 154.39 11.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 32.21 111.111 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.95 -32.63 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 73.24 110.851 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.41 -179.83 5.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 73.43 110.854 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.624 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 3.8 mt -78.18 -48.29 16.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 62.02 110.871 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 112.3 68.22 0.53 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.764 -0.731 . . . . 73.43 112.468 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.1 t30 62.73 104.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 54.53 110.823 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 186' ' ' VAL . 21.8 m -100.11 35.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 54.34 111.118 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.67 85.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 64.4 111.116 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.06 44.82 2.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 61.45 110.867 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -138.52 171.34 14.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.064 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -117.37 90.57 3.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 70.25 110.952 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.484 HG13 ' CD2' ' A' ' 226' ' ' LEU . 91.1 t -69.91 -22.05 24.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.078 -0.51 . . . . 73.13 111.15 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -78.35 -24.88 46.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 62.3 110.957 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -101.76 -24.9 14.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 73.14 110.91 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.624 ' CZ3' HD22 ' A' ' 178' ' ' LEU . 1.5 t90 -51.46 -56.72 11.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 64.33 110.945 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.2 p -52.17 -32.03 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 71.4 110.848 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.4 m -78.22 -31.47 49.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.01 111.164 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 196' ' ' VAL . 40.2 m -69.45 -52.14 29.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 62.22 110.892 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.796 HG22 HD23 ' A' ' 197' ' ' LEU . 35.6 mm -56.08 -42.26 71.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 63.2 111.145 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.72 -19.81 59.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 72.23 110.864 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -95.84 -25.59 15.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 70.32 110.944 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.404 ' CG1' HD21 ' A' ' 219' ' ' LEU . 60.6 t -85.36 -20.79 8.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 63.24 111.159 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.796 HD23 HG22 ' A' ' 193' ' ' ILE . 2.5 pp -101.17 -2.33 31.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 71.25 110.933 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -116.4 -22.92 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.885 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -71.1 -23.73 62.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 75.15 110.841 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -118.09 -66.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 74.41 110.922 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.64 25.81 14.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 74.23 110.918 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -149.35 22.59 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 61.45 110.839 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.5 mp -60.19 144.62 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 55.25 111.175 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -103.07 -26.05 13.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.878 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -166.07 130.82 2.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 53.53 111.097 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.482 ' CG1' HD12 ' A' ' 218' ' ' LEU . 89.9 t -107.53 128.09 62.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 72.12 111.106 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.936 HG21 HD11 ' A' ' 44' ' ' LEU . 39.7 t -110.82 103.28 54.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.588 0.709 . . . . 70.21 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.7 -169.76 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.707 2.271 . . . . 60.44 112.336 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -108.86 -22.33 7.01 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 70.15 112.44 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -144.6 88.73 1.94 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 71.44 110.896 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 161.25 -93.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.783 -0.722 . . . . 50.41 112.523 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -178.91 156.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.925 0.393 . . . . 70.4 110.886 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 207' ' ' VAL . 39.1 t -67.2 147.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 72.33 111.135 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -150.04 -107.97 0.42 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.684 -0.77 . . . . 54.24 112.405 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -154.52 -170.47 3.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 42.32 110.87 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -58.01 -20.2 36.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 75.45 110.878 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.742 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.93 -32.43 62.36 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.685 -0.769 . . . . 62.31 112.452 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 172' ' ' SER . 29.8 mt -50.74 -43.2 58.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 53.11 110.908 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.529 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -59.97 -45.05 93.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.965 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.742 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.2 mt -64.58 -42.04 95.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 70.41 110.866 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -65.5 -36.6 84.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 73.21 110.869 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 33.0 m -51.7 -44.29 63.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 53.11 111.162 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.755 ' HA ' HD12 ' A' ' 226' ' ' LEU . 76.4 mt -56.32 -38.96 72.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.86 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -27.77 65.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 73.41 110.856 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.9 -25.47 56.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 62.33 110.866 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.755 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.6 mt -89.22 -38.63 14.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 63.23 110.923 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.6 mttp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 75.22 110.914 179.836 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.72 ' HD2' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.853 0.358 . . . . 75.41 110.926 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -159.06 150.86 20.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 72.35 110.887 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.52 97.84 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 61.15 110.896 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 p -166.89 146.63 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 54.54 111.164 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.31 107.29 18.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 63.33 110.938 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -148.4 153.12 38.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 60.52 110.947 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.577 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -146.54 179.0 7.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 70.11 111.102 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.593 HG22 ' OG ' ' A' ' 19' ' ' SER . 91.4 t 60.56 93.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.462 . . . . 72.34 111.09 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mm -88.52 154.52 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 52.24 111.19 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' N ' ' HE3' ' A' ' 70' ' ' MET . 21.6 mtmt -145.37 146.58 31.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.892 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.32 165.49 21.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 64.32 110.815 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -52.03 -43.35 63.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 63.14 110.878 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.52 -24.01 31.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 70.23 111.157 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.68 -14.0 66.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 70.52 112.484 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.715 HG23 HG13 ' A' ' 16' ' ' ILE . 1.9 t -50.81 -32.77 21.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 64.51 111.165 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.715 HG13 HG23 ' A' ' 15' ' ' THR . 20.1 mt -118.79 148.08 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 55.34 111.072 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 p -170.59 166.97 8.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 73.54 110.851 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -133.27 -172.91 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 72.32 111.109 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.593 ' OG ' HG22 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -173.74 133.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.89 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.98 119.12 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.41 110.879 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.401 HD11 HG11 ' A' ' 213' ' ' VAL . 1.4 mm? -101.5 -57.8 2.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 64.0 110.887 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -148.3 -170.08 3.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.441 . . . . 72.15 110.861 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.532 ' O ' HG23 ' A' ' 25' ' ' VAL . 16.3 mttt -52.34 108.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.922 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 57.96 23.21 9.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.426 . . . . 73.24 110.831 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 23' ' ' LYS . 99.1 t -122.44 110.76 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 64.31 111.18 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.577 ' CH2' HG22 ' A' ' 7' ' ' THR . 14.9 m95 -121.91 163.83 18.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.887 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.5 t -126.02 109.95 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 43.03 111.151 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.552 ' HB3' HG23 ' A' ' 18' ' ' ILE . 9.2 p80 -101.61 137.0 40.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.852 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 m -132.39 113.06 12.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 73.12 111.19 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.569 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -100.27 162.49 12.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 74.3 110.874 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.655 ' CD1' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -113.33 126.14 55.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 74.03 110.907 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.0 -173.0 17.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 63.11 112.46 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.3 163.8 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 72.34 110.835 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -178.37 112.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.917 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 51.9 40.71 28.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.839 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.59 27.67 72.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 75.43 112.492 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -134.43 -171.17 2.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 53.1 110.853 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.655 ' HB1' ' CD1' ' A' ' 31' ' ' LEU . . . -116.13 127.77 55.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 60.11 111.067 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.72 HG21 ' HD2' ' A' ' 303' ' ' RTD . 4.1 p -131.26 116.61 16.59 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 121.608 0.718 . . . . 63.4 111.109 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.419 ' CA ' HD22 ' A' ' 31' ' ' LEU . 53.5 Cg_endo -69.75 166.22 28.34 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.667 2.245 . . . . 74.13 112.352 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -149.06 99.41 2.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 73.13 110.938 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -51.76 168.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 72.52 110.852 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.583 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -170.24 -160.3 18.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 73.43 112.478 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.99 HD11 HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -165.81 141.49 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.374 . . . . 64.02 110.932 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 54' ' ' LEU . 21.8 t -125.84 135.58 63.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 74.23 111.141 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.45 HD22 ' HE3' ' A' ' 138' ' ' MET . 18.5 mt -103.16 133.4 48.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 65.12 110.916 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -99.65 57.95 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 71.23 110.939 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.7 p -60.38 -169.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 41.51 111.182 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.5 m -114.43 2.89 14.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 71.45 110.83 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -118.53 -17.4 9.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.878 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.19 131.17 1.3 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.658 -0.782 . . . . 74.24 112.432 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 75' ' ' PHE . 16.5 mt -48.98 159.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 70.13 110.932 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 81' ' ' ASP . 96.5 t -140.12 144.07 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 74.13 111.153 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.459 HD13 HG22 ' A' ' 45' ' ' VAL . 3.6 mm? -115.72 128.83 56.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 61.42 110.901 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.4 t -78.84 -2.34 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 63.41 111.061 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 179.57 125.36 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.28 -0.418 . . . . 72.12 110.897 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -167.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 54.2 110.892 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 p -94.61 -169.75 2.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 72.05 110.842 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.425 ' HB2' HD13 ' A' ' 63' ' ' LEU . 84.2 m95 -73.45 -38.45 65.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.953 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -143.66 154.98 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.52 110.87 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' HA ' HG22 ' A' ' 64' ' ' THR . 5.4 p-10 -55.88 -28.35 56.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 73.13 110.862 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -78.1 -23.77 47.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 71.35 110.945 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -87.24 -40.19 14.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.03 110.929 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 61' ' ' ASP . 14.1 t -66.53 -23.61 66.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.52 111.167 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.82 -43.04 72.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 52.32 110.884 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -82.76 -14.6 54.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 64.32 110.886 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.569 HD22 ' OE2' ' A' ' 30' ' ' GLU . 15.3 tp -76.51 -44.49 34.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 72.25 110.949 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.9 mt -74.6 -30.06 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.04 111.185 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.52 -13.2 61.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 63.12 110.888 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.403 ' HE3' ' N ' ' A' ' 10' ' ' LYS . 2.7 mmm -88.7 -54.76 4.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 73.2 110.87 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 52' ' ' LEU . 19.2 m -57.5 -39.61 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 72.33 111.124 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.449 ' HG3' HG23 ' A' ' 71' ' ' VAL . 63.5 mt-10 -83.97 50.86 1.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 52.34 110.871 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.19 -41.02 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 64.22 110.897 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.83 -19.51 12.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 75.03 110.887 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.719 ' HB3' HD21 ' A' ' 52' ' ' LEU . 26.3 m-85 -88.64 9.73 23.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 72.52 110.822 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.527 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 2.1 pp0? 31.69 49.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.908 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.418 ' NZ ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -155.46 -177.21 6.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 74.33 110.97 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 144.87 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 72.35 110.831 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 52' ' ' LEU . 93.8 t -76.57 123.63 33.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 73.34 111.089 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.2 p -134.48 20.78 3.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 74.22 111.149 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.805 ' HB2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -153.56 135.5 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 72.35 110.868 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.573 HG21 ' CD2' ' A' ' 98' ' ' LEU . 19.4 t -140.53 100.77 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 74.55 111.071 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.8 mt -79.42 121.02 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 65.44 111.171 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 91' ' ' ARG . 45.4 mm -105.72 130.47 57.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 70.11 111.079 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.0 p -90.91 -52.95 4.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 72.24 111.193 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -134.72 162.5 32.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 52.3 110.888 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -83.45 97.64 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.1 111.112 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.662 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -151.53 158.84 44.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.447 . . . . 73.04 110.848 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.76 -30.32 63.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 71.5 111.118 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.29 9.99 21.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.899 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.401 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.9 mmp_? -121.86 -51.64 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 73.54 110.807 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.662 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -117.29 18.12 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 71.34 111.128 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.77 -28.45 23.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 72.43 112.495 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.05 21.31 27.38 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.698 -0.763 . . . . 60.44 112.552 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.421 HD11 ' C ' ' A' ' 122' ' ' GLU . 2.6 tt -48.7 -30.77 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 52.03 111.084 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -69.9 -44.05 70.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 70.41 110.842 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.0 m -67.02 -35.01 78.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 74.15 111.201 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.573 ' CD2' HG21 ' A' ' 82' ' ' VAL . 51.4 mt -62.61 -30.74 71.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 60.2 110.896 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.58 22.61 7.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.945 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -120.71 -31.29 4.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 73.14 110.86 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -103.48 12.08 35.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 64.42 110.861 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.14 18.62 68.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 65.25 112.539 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 98' ' ' LEU . 11.5 mt -83.64 157.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.819 0.343 . . . . 71.22 111.17 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.809 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -122.02 121.28 36.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 74.15 110.881 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.497 ' HB2' HD12 ' A' ' 98' ' ' LEU . . . -89.61 77.96 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.047 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.539 ' HA ' HD12 ' A' ' 124' ' ' LEU . 96.7 m-70 -53.83 146.34 14.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.848 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.15 168.25 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.31 110.858 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.657 HG22 ' HB3' ' A' ' 127' ' ' LEU . 81.0 p -83.7 176.4 9.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 70.21 111.173 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.07 -23.93 60.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 74.02 111.052 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 152' ' ' ASP . 10.2 tp -75.47 -51.2 13.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.411 . . . . 64.45 110.923 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.665 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 91.7 m -52.65 -29.13 24.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 72.34 111.134 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.516 ' HB1' ' OE2' ' A' ' 122' ' ' GLU . . . -82.51 -30.41 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 70.32 111.074 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -58.93 -40.48 84.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 74.4 110.904 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.659 HD12 ' OD2' ' A' ' 152' ' ' ASP . 61.0 mt -85.09 -25.25 27.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 65.1 110.932 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.51 -68.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.34 111.099 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -56.35 -25.57 49.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 64.55 110.881 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -24.75 67.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 71.43 110.952 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -94.1 -37.25 11.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 75.23 110.896 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.14 -8.57 3.25 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.765 -0.731 . . . . 71.33 112.487 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -59.82 -172.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 74.21 110.967 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -101.21 0.24 37.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.148 -0.478 . . . . 62.34 110.903 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.516 ' OE2' ' HB1' ' A' ' 112' ' ' ALA . 1.5 mt-10 66.14 127.18 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 63.54 110.911 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -170.3 0.39 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.738 2.292 . . . . 71.25 112.294 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.809 HD11 ' HB2' ' A' ' 104' ' ' LYS . 69.8 mt -52.85 -41.42 64.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 71.54 110.958 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 55.16 58.56 13.18 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.771 -0.728 . . . . 72.04 112.502 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -148.97 54.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 61.41 110.916 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.657 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.3 OUTLIER -136.37 -169.7 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 73.2 110.909 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -150.75 -168.66 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 72.45 110.897 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.828 HG23 ' HB3' ' A' ' 144' ' ' TYR . 97.6 m -50.21 -41.1 49.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 70.42 111.149 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -143.76 140.78 25.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 64.41 111.146 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 95.6 m -149.55 102.47 3.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.106 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -66.33 95.44 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 70.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -86.48 159.18 19.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 63.13 110.924 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.46 107.23 2.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 73.14 110.902 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -99.59 -168.99 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 73.33 110.858 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -52.25 101.97 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.688 -0.767 . . . . 63.31 112.525 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.2 m120 51.76 49.4 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 63.31 110.876 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.45 ' HE3' HD22 ' A' ' 46' ' ' LEU . 3.1 tpp -148.68 155.13 40.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 71.43 110.935 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.62 130.05 45.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.889 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.577 HG13 HD23 ' A' ' 158' ' ' LEU . 4.3 t -142.92 159.54 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 72.51 111.203 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 140' ' ' VAL . 41.4 tt0 -160.44 118.12 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 74.12 110.925 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.46 HG22 ' CD1' ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.94 179.67 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 72.33 111.153 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -175.19 143.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 74.43 110.851 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.828 ' HB3' HG23 ' A' ' 129' ' ' THR . 66.2 t80 -120.78 94.98 49.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.673 0.749 . . . . 55.51 110.874 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 -48.59 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.649 2.233 . . . . 64.34 112.344 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.15 -161.55 34.71 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 75.42 112.426 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.47 125.46 38.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.891 0.377 . . . . 65.23 110.856 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.489 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -136.37 -97.38 0.49 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 42.32 112.498 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -69.72 -35.77 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 74.2 110.867 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.43 147.29 39.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 43.11 111.176 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.99 -40.72 61.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 74.55 110.927 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.659 ' OD2' HD12 ' A' ' 114' ' ' LEU . 11.1 p30 -106.46 53.01 0.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 64.15 110.912 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 2.1 p30 -99.97 134.8 42.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.886 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.46 ' CD1' HG22 ' A' ' 142' ' ' THR . 1.0 OUTLIER -136.62 160.73 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 60.41 111.091 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.0 m -109.46 155.43 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 65.21 111.115 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.0 t -111.31 142.28 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 54.15 111.118 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 158' ' ' LEU . 75.0 t-105 -127.7 151.48 48.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 73.2 110.904 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.577 HD23 HG13 ' A' ' 140' ' ' VAL . 13.3 mt -130.24 96.93 23.61 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.594 0.711 . . . . 53.4 110.935 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 72.64 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.668 2.245 . . . . 73.42 112.353 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.62 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 72.45 110.954 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.542 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.9 m-85 -118.04 -13.27 10.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 72.33 110.881 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.46 23.38 6.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 71.14 110.888 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.542 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.6 mp -93.97 118.92 40.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 71.42 111.11 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.453 HD11 HG13 ' A' ' 196' ' ' VAL . 0.4 OUTLIER -103.19 138.03 40.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 64.23 110.907 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.509 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.3 t -127.74 81.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 62.43 111.146 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.57 -67.94 1.68 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.8 -0.714 . . . . 73.04 112.528 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.87 89.35 2.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.707 -0.758 . . . . 63.33 112.457 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 63.6 m 61.48 16.85 7.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 73.31 110.873 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.643 HD12 ' NE1' ' A' ' 189' ' ' TRP . 21.7 tp -110.31 -45.48 3.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 51.24 110.901 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 218' ' ' LEU . 16.2 t -96.44 116.93 39.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.23 111.106 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.35 146.59 31.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.14 110.911 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.711 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.8 p -78.92 161.54 26.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 62.02 110.878 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.6 p -56.5 -48.47 77.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 63.51 111.088 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 53.7 p -56.36 -27.89 57.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 63.44 110.807 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 172' ' ' SER . . . -62.03 157.68 18.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 61.21 111.101 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -143.34 22.44 1.86 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 54.55 110.904 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.82 163.82 3.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.878 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.591 HD22 ' CZ3' ' A' ' 189' ' ' TRP . 9.0 mt -81.19 -26.2 36.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 64.34 110.889 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.19 81.36 0.91 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.761 -0.733 . . . . 72.23 112.51 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.2 t30 64.15 155.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 71.34 110.906 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.3 m -150.44 24.81 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 71.31 111.048 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.51 -40.48 91.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 62.22 111.124 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.77 43.3 2.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 64.14 110.834 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.2 164.53 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 71.15 111.064 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -112.87 90.08 3.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.893 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.414 HG13 HD23 ' A' ' 226' ' ' LEU . 21.6 t -67.56 -17.2 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 74.13 111.173 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -88.06 -20.08 26.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 65.21 110.938 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -104.63 -20.87 13.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 62.31 110.907 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.643 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -51.09 -55.77 16.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 75.03 110.912 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 60.4 p -51.88 -38.62 56.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 54.03 110.897 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -68.77 -36.09 77.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 71.15 111.141 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.0 m -65.31 -52.09 56.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.908 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.566 HG22 HD23 ' A' ' 197' ' ' LEU . 31.5 mm -57.56 -36.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 64.24 111.127 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.75 -15.45 61.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 65.11 110.887 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -97.84 -27.3 14.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 64.33 110.93 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.553 HG12 HD21 ' A' ' 219' ' ' LEU . 46.3 t -82.34 -30.36 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 62.23 111.108 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.566 HD23 HG22 ' A' ' 193' ' ' ILE . 2.8 pp -85.64 -24.26 27.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 65.54 110.916 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.26 -39.7 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 71.15 110.933 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -56.39 -49.03 75.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 71.11 110.844 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -119.34 127.72 53.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 74.23 110.927 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.75 26.03 8.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.093 -0.503 . . . . 72.22 110.848 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.49 22.13 2.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 71.31 110.844 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 203' ' ' ILE . 3.6 mp -52.11 147.42 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 64.12 111.198 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -106.85 -39.76 5.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 73.33 110.957 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -153.93 127.59 8.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.153 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.525 HG12 HD12 ' A' ' 218' ' ' LEU . 86.1 t -105.59 125.44 60.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 55.24 111.116 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.99 HG21 HD11 ' A' ' 44' ' ' LEU . 23.5 t -106.54 110.09 63.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.707 . . . . 53.43 111.142 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 54.43 112.341 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -101.89 -27.01 7.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 71.12 112.543 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -145.05 88.93 1.92 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.364 . . . . 75.15 110.871 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 163.17 -108.29 0.34 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.698 -0.763 . . . . 61.15 112.437 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -158.02 153.65 26.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.926 0.394 . . . . 52.23 110.894 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 21' ' ' LEU . 5.3 p -68.69 144.0 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 62.43 111.102 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.07 -104.51 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 61.31 112.498 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -157.3 -169.65 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.885 0.374 . . . . 63.4 110.873 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -56.96 -21.02 26.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.911 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.748 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -55.94 -33.85 60.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.772 -0.728 . . . . 71.4 112.446 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.711 HD22 ' HA ' ' A' ' 172' ' ' SER . 30.2 mt -50.63 -47.01 58.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.882 0.372 . . . . 73.41 110.913 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.553 HD21 HG12 ' A' ' 196' ' ' VAL . 7.1 mp -53.84 -42.7 68.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 74.01 110.98 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.748 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -67.37 -41.28 85.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.946 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -64.09 -39.31 93.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 72.45 110.794 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.3 m -51.59 -45.23 63.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 73.0 111.136 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.777 ' HA ' HD12 ' A' ' 226' ' ' LEU . 46.6 mt -61.26 -39.83 91.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 74.24 110.91 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.31 -26.76 61.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.843 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.3 mt -76.82 -24.05 52.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 71.05 110.865 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.5 mt -90.97 -39.38 12.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 63.21 110.899 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 71.44 110.878 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.72 ' HD2' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.792 0.329 . . . . 55.12 110.868 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -156.08 156.57 34.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 74.11 110.893 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.85 105.04 15.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.02 110.89 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m -144.99 69.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 75.54 111.13 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -148.01 154.29 40.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.482 . . . . 62.03 110.817 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.25 160.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 72.34 110.943 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.457 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -148.4 -179.35 6.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 45.42 111.193 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 18' ' ' ILE . 95.1 t 61.26 100.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 54.54 111.16 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.581 HD11 ' HE3' ' A' ' 74' ' ' LYS . 2.6 mm -94.56 152.62 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.33 111.104 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -150.83 155.34 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 64.2 110.905 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.23 -168.95 2.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.923 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -76.89 -25.25 52.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 72.22 110.834 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 p -95.04 -35.21 12.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 73.21 111.138 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.66 -9.16 64.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.759 . . . . 64.01 112.446 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.77 HG23 HG13 ' A' ' 16' ' ' ILE . 1.7 t -50.12 -33.36 18.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.688 0.28 . . . . 71.02 111.128 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.77 HG13 HG23 ' A' ' 15' ' ' THR . 5.9 mt -124.21 160.32 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.433 . . . . 72.53 111.147 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 16' ' ' ILE . 1.8 p -178.42 166.75 1.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 63.31 110.858 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -129.24 -175.71 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 71.41 111.113 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.405 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.0 t -169.14 129.97 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.51 110.894 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.3 120.19 12.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 55.34 110.942 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.5 mm? -103.56 -74.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 63.23 110.906 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.98 -170.43 2.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 61.51 110.843 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' HG23 ' A' ' 25' ' ' VAL . 6.6 mmtt -52.62 109.48 0.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 70.22 110.876 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 58.6 23.86 11.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 75.53 110.832 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 23' ' ' LYS . 99.3 t -122.96 116.42 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 75.32 111.114 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.457 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.4 m95 -124.36 163.13 22.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 75.54 110.954 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.719 HG22 HD12 ' A' ' 44' ' ' LEU . 55.8 t -123.59 107.72 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 72.21 111.114 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.558 ' CE1' HD21 ' A' ' 67' ' ' LEU . 6.8 p80 -100.49 138.49 37.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 71.34 110.856 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.8 m -136.2 133.44 37.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.115 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.486 ' HB3' HG23 ' A' ' 16' ' ' ILE . 2.9 pm0 -124.59 173.98 8.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 44.13 110.91 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.496 ' O ' HD21 ' A' ' 63' ' ' LEU . 3.3 tp -124.15 136.23 54.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 52.32 110.914 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.37 141.69 8.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.733 -0.746 . . . . 73.43 112.447 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.04 139.91 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.961 0.41 . . . . 61.14 110.849 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -102.46 -31.98 10.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 75.13 110.945 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -169.78 30.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 64.33 110.907 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.56 7.5 6.82 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.741 . . . . 71.2 112.505 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -149.06 122.48 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.909 0.385 . . . . 65.15 110.851 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -68.3 128.5 36.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 74.41 111.074 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.468 HG11 ' HD1' ' A' ' 303' ' ' RTD . 32.4 t -124.95 132.17 24.26 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.619 0.723 . . . . 75.42 111.096 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 142.87 48.99 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.74 2.293 . . . . 71.44 112.344 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.92 102.06 5.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 74.51 110.927 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -67.48 153.44 43.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.063 -0.517 . . . . 75.1 110.861 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.71 -155.99 7.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 54.12 112.528 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.871 HD22 HG21 ' A' ' 165' ' ' VAL . 4.7 tp -161.36 142.01 11.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 74.41 110.903 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.631 HG22 HD13 ' A' ' 54' ' ' LEU . 46.4 t -125.06 132.17 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 53.32 111.13 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 mt -98.5 122.59 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 71.02 110.952 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -94.8 60.26 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 61.25 110.9 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.454 HG21 ' HB2' ' A' ' 135' ' ' PHE . 24.4 p -66.0 179.83 0.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 75.12 111.173 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.6 m -104.95 26.04 9.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 74.32 110.836 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.08 23.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 65.22 110.912 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.81 130.25 4.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.769 -0.729 . . . . 35.32 112.431 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.797 HD13 ' HB ' ' A' ' 71' ' ' VAL . 10.0 mt -60.33 158.96 10.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.825 0.345 . . . . 70.43 110.934 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.798 HG22 ' HB2' ' A' ' 81' ' ' ASP . 57.8 t -140.2 139.35 36.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 65.33 111.129 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.631 HD13 HG22 ' A' ' 45' ' ' VAL . 2.9 mm? -109.83 127.43 54.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.942 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 55' ' ' VAL . 18.0 t -79.8 -0.5 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 73.44 111.152 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.45 126.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 51.41 110.904 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -166.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 75.1 110.84 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -96.28 -174.46 3.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 70.32 110.874 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.771 ' HB2' HD13 ' A' ' 63' ' ' LEU . 92.9 m95 -67.68 -42.1 82.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 72.33 110.924 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.01 166.29 24.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 54.42 110.84 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.96 -36.18 80.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.861 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -71.21 -25.13 62.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.93 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -78.99 -49.68 12.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 64.21 110.819 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 t -58.84 -29.54 67.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.33 111.125 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -52.76 -44.3 66.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 70.55 110.893 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -80.94 -12.89 59.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 63.44 110.889 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 16' ' ' ILE . 38.9 tp -83.87 -50.29 8.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 72.3 110.904 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.4 mt -64.55 -18.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 52.33 111.193 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -80.91 -1.18 42.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 73.12 110.881 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.8 mtp -96.33 -57.56 2.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.843 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.797 ' HB ' HD13 ' A' ' 52' ' ' LEU . 20.5 m -58.29 -39.1 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 72.1 111.167 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.53 50.82 1.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 74.03 110.912 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -146.25 -40.95 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 72.4 110.879 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.581 ' HE3' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.19 -23.21 12.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 63.32 110.866 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.601 ' HB3' HD21 ' A' ' 52' ' ' LEU . 41.1 m-85 -90.03 11.57 20.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 73.43 110.851 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.515 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.78 46.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.43 110.927 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -152.05 -176.71 5.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.52 110.892 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HG2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.67 153.66 47.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 51.41 110.889 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 52' ' ' LEU . 87.2 t -89.25 117.19 32.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 64.2 111.123 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.54 HG23 ' HG2' ' A' ' 78' ' ' ARG . 42.8 p -130.76 36.53 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 75.12 111.155 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.798 ' HB2' HG22 ' A' ' 53' ' ' VAL . 6.1 m-20 -166.71 130.44 1.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 64.31 110.918 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.616 HG21 ' CD2' ' A' ' 98' ' ' LEU . 17.0 t -135.96 101.91 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 74.54 111.11 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.0 mt -80.22 119.79 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.14 111.074 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 91' ' ' ARG . 39.6 mm -107.33 134.59 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.117 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.1 p -91.9 -55.36 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 54.34 111.204 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -133.17 163.95 28.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 74.35 110.795 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -82.8 97.22 8.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 65.4 111.086 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.619 ' O ' HD13 ' A' ' 92' ' ' ILE . 0.6 OUTLIER -151.05 158.8 44.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 64.54 110.851 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.27 -26.2 60.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.35 111.083 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.68 15.27 13.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 51.12 110.835 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.458 ' O ' HD12 ' A' ' 84' ' ' ILE . 3.1 mpt_? -129.66 -53.12 1.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 75.44 110.829 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.619 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -112.88 16.54 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 65.23 111.189 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.56 25.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.797 -0.716 . . . . 45.03 112.494 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.88 20.04 29.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.739 -0.743 . . . . 73.2 112.496 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.483 HG21 ' H ' ' A' ' 121' ' ' GLU . 2.4 tt -48.23 -30.65 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.37 . . . . 73.32 111.127 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -70.13 -44.51 68.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 73.2 110.932 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.9 m -67.38 -32.59 73.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 53.43 111.142 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.616 ' CD2' HG21 ' A' ' 82' ' ' VAL . 58.3 mt -65.01 -30.53 71.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 71.3 110.944 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -96.69 21.6 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 63.2 110.925 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.44 -27.36 5.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.3 110.903 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.68 11.52 28.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 71.1 110.892 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.18 17.12 70.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 71.31 112.512 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 98' ' ' LEU . 11.9 mt -83.19 157.52 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.888 0.375 . . . . 75.32 111.126 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.774 ' HB2' HD11 ' A' ' 124' ' ' LEU . 10.9 ptpt -123.49 123.38 40.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.848 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.514 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . . . -91.24 80.85 5.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.33 111.066 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.504 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.4 m-70 -56.1 146.85 21.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.79 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.93 159.85 0.62 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 72.42 110.86 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.4 p -75.74 154.58 36.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 73.55 111.123 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.45 -32.41 26.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 73.42 111.043 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 152' ' ' ASP . 7.3 tp -73.64 -48.28 33.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.426 . . . . 74.31 110.878 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.73 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 99.8 m -52.02 -28.61 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 60.53 111.18 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -86.61 -31.6 21.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 63.13 111.127 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.03 -43.55 70.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 52.41 110.829 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.64 HD12 ' OD1' ' A' ' 152' ' ' ASP . 21.3 mt -79.87 -23.73 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 64.03 110.891 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.14 -69.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.42 111.061 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.42 -28.24 28.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 71.53 110.937 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -23.64 62.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 73.32 110.841 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -94.58 -38.78 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 74.33 110.827 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.72 -8.51 3.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 44.41 112.459 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -59.43 -172.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 71.43 110.936 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.483 ' H ' HG21 ' A' ' 95' ' ' ILE . 58.4 mm-40 -98.47 -1.23 41.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 74.42 110.849 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.478 ' C ' HD11 ' A' ' 95' ' ' ILE . 0.7 OUTLIER 66.34 129.92 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.656 0.741 . . . . 65.11 110.893 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.557 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.85 -169.65 0.35 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.608 2.205 . . . . 74.44 112.403 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 104' ' ' LYS . 86.4 mt -54.45 -37.75 65.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 73.41 110.872 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.06 57.71 12.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 72.04 112.527 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -153.29 49.13 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 72.12 110.829 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.19 -169.97 2.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 73.21 110.919 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -146.22 -169.08 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.925 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 144' ' ' TYR . 94.1 m -50.72 -62.74 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 64.24 111.169 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 143' ' ' PHE . 92.2 t -125.07 116.15 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.51 111.092 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.63 HG22 HD23 ' A' ' 133' ' ' LEU . 60.1 m -115.66 103.35 10.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 73.24 111.132 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -67.02 102.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 74.21 110.879 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.63 HD23 HG22 ' A' ' 131' ' ' THR . 1.8 mt -94.15 151.4 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 64.43 110.944 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.7 108.22 2.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 64.25 110.919 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.454 ' HB2' HG21 ' A' ' 48' ' ' THR . 17.8 m-85 -105.92 -167.87 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.909 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -51.06 102.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.726 -0.749 . . . . 45.01 112.499 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 51.59 56.47 7.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 75.41 110.862 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 43.7 tpp -153.36 149.11 27.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 61.14 110.825 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.51 124.65 36.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 62.22 110.91 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.693 HG13 HD23 ' A' ' 158' ' ' LEU . 8.5 t -143.32 157.45 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.426 . . . . 74.24 111.107 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.403 ' N ' HG12 ' A' ' 140' ' ' VAL . 83.8 tt0 -158.53 125.31 4.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 64.52 110.886 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.649 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -74.63 -178.74 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 62.13 111.175 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.759 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.5 t80 -175.18 137.66 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 63.12 110.895 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.816 ' HB3' HG23 ' A' ' 129' ' ' THR . 52.7 t80 -120.05 92.99 47.55 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.681 0.753 . . . . 63.41 110.881 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -48.81 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.744 2.296 . . . . 72.25 112.322 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.73 -166.34 39.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 63.32 112.458 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -85.35 126.94 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 74.3 110.875 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.49 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -135.75 -87.74 0.24 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 73.53 112.55 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -80.32 -23.67 40.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 55.45 110.842 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.52 158.3 43.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 74.15 111.215 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -63.1 -26.83 69.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 74.52 110.853 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.64 ' OD1' HD12 ' A' ' 114' ' ' LEU . 2.6 p30 -122.0 53.52 1.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 71.5 110.809 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.1 p30 -102.32 145.65 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 75.42 110.857 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.649 HD12 HG22 ' A' ' 142' ' ' THR . 6.4 pt -142.05 172.45 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 74.3 111.13 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.461 ' CG1' HD22 ' A' ' 169' ' ' LEU . 5.2 m -122.5 142.64 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.118 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.19 144.46 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 64.41 111.139 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -131.1 149.35 52.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 71.12 110.947 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.693 HD23 HG13 ' A' ' 140' ' ' VAL . 23.0 mt -126.52 95.93 37.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.568 0.699 . . . . 51.22 110.877 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 72.08 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.705 2.27 . . . . 63.34 112.326 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.5 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.912 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.544 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.3 m-85 -118.16 -13.21 9.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.833 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 m120 69.81 22.05 6.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 75.54 110.891 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.544 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.7 mp -92.79 114.18 29.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 72.44 111.072 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.41 136.57 39.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.968 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.871 HG21 HD22 ' A' ' 44' ' ' LEU . 23.2 t -123.24 65.61 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 45.11 111.158 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.87 -48.24 45.38 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.758 -0.734 . . . . 64.4 112.454 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.64 -130.9 10.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 74.3 112.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 96.5 m -69.58 -19.13 63.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 42.52 110.923 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.461 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.4 OUTLIER -67.65 -47.11 70.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 65.34 110.822 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.619 HG11 HG11 ' A' ' 206' ' ' VAL . 46.1 t -92.49 116.0 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 64.13 111.113 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.487 ' H ' HG23 ' A' ' 222' ' ' THR . 0.2 OUTLIER -89.95 147.74 23.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 53.43 110.864 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.741 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.6 t -87.19 157.24 19.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 71.04 110.84 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.1 p -54.53 -29.18 50.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 63.22 111.117 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.4 p -66.04 -27.05 67.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 54.42 110.83 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.64 -169.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.4 111.043 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.482 ' O ' HD22 ' A' ' 225' ' ' LEU . 2.1 tptt -152.39 -42.7 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 70.22 110.9 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -147.21 171.38 15.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 74.34 110.85 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.577 HD11 ' HG ' ' A' ' 226' ' ' LEU . 4.2 mt -91.35 -23.43 20.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 43.52 110.925 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 114.56 -142.91 17.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.798 -0.715 . . . . 60.54 112.507 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 181' ' ' VAL . 28.0 p30 -99.48 16.87 21.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 70.4 110.922 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.714 HG11 ' CG2' ' A' ' 186' ' ' VAL . 11.9 m 34.98 47.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.03 111.088 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -51.71 -58.03 7.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 64.3 111.077 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.7 27.12 9.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.847 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -104.86 168.94 8.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.03 111.122 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -130.87 88.59 2.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 75.11 110.939 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.714 ' CG2' HG11 ' A' ' 181' ' ' VAL . 61.0 t -62.46 -18.02 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.098 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -78.87 -22.13 46.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 53.42 110.896 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -108.91 -25.42 10.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 75.42 110.936 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.532 ' CH2' HD22 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -51.04 -57.97 7.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.95 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 30.3 p -51.85 -30.56 24.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 51.33 110.87 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 31.0 m -80.06 -34.3 38.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 75.51 111.142 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 44.5 m -66.99 -55.55 13.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 73.11 110.819 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.766 HG22 HD23 ' A' ' 197' ' ' LEU . 33.6 mm -56.17 -40.17 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 73.15 111.114 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.22 -16.46 60.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.448 . . . . 65.22 110.831 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -97.93 -21.88 16.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.883 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.466 ' CG1' HD21 ' A' ' 219' ' ' LEU . 94.5 t -88.42 -24.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.094 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 193' ' ' ILE . 2.6 pp -98.84 1.53 45.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 73.23 110.94 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -117.25 -17.03 10.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 54.34 110.851 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -90.55 1.84 56.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 71.11 110.901 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -137.61 -72.46 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.32 110.9 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.6 mmm-85 61.16 25.3 15.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 54.44 110.87 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -147.29 21.06 1.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 75.4 110.856 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.45 144.93 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 65.32 111.174 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -103.87 -28.65 11.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 61.14 110.837 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.465 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -165.68 126.47 1.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 73.41 111.106 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.636 ' CG1' HD12 ' A' ' 218' ' ' LEU . 87.9 t -98.45 127.48 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 51.44 111.112 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.855 HG21 HD13 ' A' ' 44' ' ' LEU . 98.0 t -108.71 89.57 6.45 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.618 0.723 . . . . 74.2 111.133 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 167.96 22.92 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.632 2.221 . . . . 71.11 112.376 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.09 -15.94 63.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 73.14 112.46 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -146.83 111.09 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 60.22 110.904 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 137.69 -96.41 0.24 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.826 -0.702 . . . . 73.52 112.524 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -178.85 166.77 1.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 75.55 110.867 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.695 HG21 HG21 ' A' ' 27' ' ' VAL . 21.6 t -75.1 133.49 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 63.24 111.141 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -138.57 -106.62 0.73 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 53.12 112.497 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -155.64 -172.62 4.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.883 0.373 . . . . 73.11 110.856 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -22.04 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.42 110.901 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.75 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.4 -33.06 52.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.8 -0.714 . . . . 71.25 112.521 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 172' ' ' SER . 29.6 mt -50.38 -45.69 55.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 74.21 110.923 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.522 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.0 OUTLIER -55.66 -44.54 77.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.912 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.75 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.5 mt -64.9 -41.36 95.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 63.13 110.921 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.47 ' NE2' HD21 ' A' ' 225' ' ' LEU . 64.7 t60 -61.67 -38.85 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 64.12 110.901 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.487 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.2 OUTLIER -51.6 -46.09 63.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 70.01 111.091 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 226' ' ' LEU . 79.2 mt -52.5 -38.95 60.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.5 110.928 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -46.4 90.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 72.03 110.823 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.482 HD22 ' O ' ' A' ' 176' ' ' LYS . 17.6 mt -56.54 -24.82 49.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.93 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.747 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.7 mt -87.32 -54.53 4.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 65.32 110.935 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.4 pttt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 72.42 110.955 179.802 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.468 ' HD1' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.857 0.36 . . . . 62.34 110.837 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.58 45.05 1.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 73.53 110.908 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.72 173.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 71.33 110.839 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.4 t -142.42 124.16 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 73.4 111.18 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -168.68 35.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 65.02 110.925 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -139.19 150.1 45.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.883 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -144.44 179.74 7.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 75.43 111.16 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.1 t 60.72 96.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.092 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.705 HD11 ' CE ' ' A' ' 74' ' ' LYS . 3.3 mm -89.03 154.86 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 71.22 111.082 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -150.84 172.96 14.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 64.35 110.854 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -104.61 -169.42 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 71.45 110.889 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -74.14 -26.18 60.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 72.03 110.882 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p -102.43 -35.48 8.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 75.31 111.135 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.16 -2.5 43.95 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.739 -0.743 . . . . 52.33 112.459 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.758 HG23 HG13 ' A' ' 16' ' ' ILE . 1.7 t -50.55 -33.26 21.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 53.14 111.195 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.758 HG13 HG23 ' A' ' 15' ' ' THR . 7.0 mt -127.89 158.77 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 71.34 111.095 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 p -176.21 166.61 2.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 70.3 110.838 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 19' ' ' SER . 0.2 OUTLIER -130.14 -172.7 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 63.32 111.12 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.409 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.9 t -171.75 130.67 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 53.32 110.796 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 121.72 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.053 -0.521 . . . . 71.54 110.869 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.8 mm? -105.26 -49.02 3.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 74.14 110.912 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -148.41 59.39 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 53.43 110.887 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.42 -81.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.52 110.929 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.604 ' OD1' HG23 ' A' ' 25' ' ' VAL . 14.7 p30 -82.93 -17.2 44.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.862 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.604 HG23 ' OD1' ' A' ' 24' ' ' ASN . 21.1 t -96.85 118.52 43.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 71.24 111.15 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.45 ' CH2' HG22 ' A' ' 7' ' ' THR . 16.7 m95 -126.14 160.11 31.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 72.24 110.918 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 213' ' ' VAL . 68.3 t -120.95 110.89 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 71.32 111.111 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.502 ' CE1' HD21 ' A' ' 67' ' ' LEU . 11.5 p80 -99.78 136.88 39.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 74.3 110.794 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.9 m -133.7 127.96 33.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.51 111.198 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.48 ' HB3' HG23 ' A' ' 16' ' ' ILE . 19.9 pm0 -120.91 -176.15 3.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 74.54 110.891 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 40' ' ' PRO . 3.6 tp -135.75 138.36 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 63.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.82 135.67 4.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 65.5 112.438 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.25 140.59 43.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.409 . . . . 70.42 110.797 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -105.74 -31.94 8.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 75.03 110.865 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -170.57 42.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 74.4 110.889 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.31 7.03 31.0 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.797 -0.715 . . . . 71.32 112.52 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -146.25 122.86 11.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.362 . . . . 73.44 110.908 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -70.55 129.36 39.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 51.23 111.107 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.617 HG11 ' HD1' ' A' ' 303' ' ' RTD . 97.0 t -120.44 125.07 27.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.601 0.715 . . . . 53.32 111.118 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.513 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.9 Cg_endo -69.75 142.96 49.37 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.66 2.24 . . . . 40.22 112.342 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 t -142.15 110.99 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.23 110.822 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -100.29 146.37 27.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 71.42 110.883 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.601 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -133.37 -114.34 1.51 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.708 -0.758 . . . . 51.33 112.468 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.784 HD13 HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -178.86 144.58 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.839 0.352 . . . . 72.23 110.989 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 71' ' ' VAL . 40.4 t -127.88 131.91 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 72.44 111.124 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.2 mt -101.24 124.85 47.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 73.21 110.924 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.56 55.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 65.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.52 HG21 ' HB2' ' A' ' 135' ' ' PHE . 16.3 p -63.21 176.74 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 63.4 111.16 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 t -99.22 16.74 21.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 64.33 110.895 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.54 33.24 2.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.917 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.94 134.65 7.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 42.54 112.493 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.558 HD13 ' HB ' ' A' ' 71' ' ' VAL . 7.4 mt -62.72 161.15 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.35 . . . . 71.44 110.918 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.756 HG22 ' HB2' ' A' ' 81' ' ' ASP . 64.6 t -139.91 143.38 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.33 111.168 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.609 HD13 HG22 ' A' ' 45' ' ' VAL . 3.2 mm? -116.2 129.73 56.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 73.52 110.857 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 55' ' ' VAL . 16.1 t -79.12 -1.87 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 62.42 111.222 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 179.44 130.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 73.23 110.844 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 p -67.79 -166.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 71.25 110.805 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.6 t -94.61 -174.07 3.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 63.42 110.894 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.675 ' HB2' HD13 ' A' ' 63' ' ' LEU . 91.4 m95 -70.21 -36.11 74.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 71.25 110.935 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.74 164.31 31.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 53.05 110.854 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -63.18 -28.46 70.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 53.12 110.865 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -78.43 -25.48 46.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.914 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 59' ' ' TRP . 1.2 mt -83.47 -46.43 12.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 60.24 110.994 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 t -55.41 -28.49 54.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 64.01 111.18 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -55.9 -43.09 76.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 44.41 110.877 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.21 0.28 41.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 55.31 110.898 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.502 HD21 ' CE1' ' A' ' 28' ' ' HIS . 51.6 tp -99.42 -50.68 4.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 73.33 110.9 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.664 HG23 HG21 ' A' ' 79' ' ' VAL . 37.1 mt -64.93 -35.29 74.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 73.24 111.164 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.99 -16.75 60.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 73.01 110.916 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 32.1 mtp -76.57 -59.19 2.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 75.11 110.923 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 45' ' ' VAL . 33.0 m -60.11 -33.3 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 74.13 111.158 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -87.76 49.72 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 74.11 110.896 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -147.65 -40.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 75.21 110.884 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.705 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -103.8 -26.63 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 62.31 110.838 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' CB ' HD21 ' A' ' 52' ' ' LEU . 38.8 m-85 -89.52 10.89 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 74.51 110.885 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.5 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.6 pp0? 32.71 46.93 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 72.32 110.896 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -146.97 -178.8 6.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 75.31 110.905 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.28 142.71 50.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 73.53 110.888 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.664 HG21 HG23 ' A' ' 68' ' ' ILE . 21.4 t -75.48 130.81 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 61.31 111.09 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.5 p -142.86 24.74 1.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 51.1 111.11 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.756 ' HB2' HG22 ' A' ' 53' ' ' VAL . 4.9 m-20 -157.85 133.95 9.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 75.02 110.928 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 98' ' ' LEU . 15.4 t -140.24 101.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 63.24 111.134 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.8 mt -78.45 114.17 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 75.12 111.117 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 91' ' ' ARG . 45.5 mm -100.84 124.76 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 75.51 111.101 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.9 p -81.93 -59.02 2.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 61.51 111.141 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.43 ' C ' HG23 ' A' ' 111' ' ' THR . 37.9 p-80 -128.18 -175.11 3.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 64.13 110.895 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -102.97 100.2 10.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 53.22 111.127 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.676 ' O ' HD13 ' A' ' 92' ' ' ILE . 2.8 m170 -153.84 160.6 42.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 74.21 110.84 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.78 -28.9 62.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 75.41 111.071 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.8 12.45 19.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.4 110.875 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.493 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.3 mpt_? -124.36 -50.43 1.77 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.971 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -119.85 15.69 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 73.44 111.106 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.7 -37.07 33.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 74.24 112.53 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.0 19.39 43.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 72.03 112.473 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.55 HG21 ' H ' ' A' ' 121' ' ' GLU . 4.5 tt -45.83 -31.13 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 74.15 111.124 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.46 -55.46 17.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 62.41 110.962 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.9 m -57.57 -41.43 81.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 60.5 111.104 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 103' ' ' ILE . 28.6 mt -58.44 -28.52 65.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.03 110.881 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -100.94 23.4 10.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 73.02 110.864 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -116.7 -39.7 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 74.05 110.877 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -88.4 -22.9 23.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 71.43 110.862 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.48 18.51 4.05 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.751 . . . . 42.34 112.482 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 98' ' ' LEU . 12.3 mt -84.84 155.71 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.915 0.388 . . . . 64.25 111.09 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.771 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.4 ptpm? -119.03 119.76 35.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 73.54 110.891 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.73 78.98 9.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 61.21 111.037 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.619 ' HA ' HD12 ' A' ' 124' ' ' LEU . 97.6 m-70 -53.8 144.94 17.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.886 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.33 160.97 0.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 45.4 110.914 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.4 p -76.66 -177.66 4.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 73.3 111.177 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.3 -31.62 60.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 72.4 111.116 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 152' ' ' ASP . 8.3 tp -74.68 -46.98 34.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.951 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 98.5 m -53.6 -27.7 28.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 44.22 111.098 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -89.89 -33.52 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 61.13 111.135 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.53 -39.58 67.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.855 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.632 HD12 ' OD2' ' A' ' 152' ' ' ASP . 38.3 mt -84.0 -23.65 30.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 74.25 110.958 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.62 -68.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.079 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -53.14 -28.57 26.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.933 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -23.63 51.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 73.41 110.828 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -95.1 -32.41 13.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 70.13 110.889 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.31 -7.25 5.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 55.15 112.557 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -59.5 -172.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 72.42 110.94 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.55 ' H ' HG21 ' A' ' 95' ' ' ILE . 7.7 mm-40 -97.93 -3.09 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 70.21 110.914 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.437 ' C ' HD11 ' A' ' 95' ' ' ILE . 0.9 OUTLIER 66.29 132.34 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.656 0.741 . . . . 62.2 110.914 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.73 -170.23 0.38 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.658 2.239 . . . . 62.25 112.342 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 104' ' ' LYS . 97.8 mt -53.53 -43.21 68.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 73.15 110.913 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 63.0 54.59 32.14 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 74.43 112.478 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -152.4 48.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.335 . . . . 74.52 110.844 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tp -131.7 167.54 19.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.253 -0.431 . . . . 73.1 110.924 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -126.18 -168.68 1.89 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 74.23 110.904 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.828 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.5 m -50.02 -56.44 10.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.427 . . . . 71.32 111.143 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.68 HG13 HG22 ' A' ' 129' ' ' THR . 17.8 m -131.65 145.62 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 71.13 111.156 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 92.2 m -152.97 113.23 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.13 111.122 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.28 87.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.426 . . . . 72.33 110.882 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.04 159.69 27.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.962 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.24 130.9 8.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.263 -0.426 . . . . 71.34 110.911 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.52 ' HB2' HG21 ' A' ' 48' ' ' THR . 4.8 m-85 -128.29 45.1 2.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 60.02 110.908 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.62 111.56 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 64.44 112.538 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 63.65 28.8 15.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 70.04 110.868 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.466 ' HB2' HG22 ' A' ' 48' ' ' THR . 59.7 tpp -155.36 125.38 6.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 74.1 110.873 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -114.26 122.25 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.05 110.846 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.631 HG13 HD23 ' A' ' 158' ' ' LEU . 4.3 t -130.75 159.28 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.105 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 35.6 tt0 -159.27 122.06 3.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 71.2 110.841 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.535 HG22 HD12 ' A' ' 154' ' ' ILE . 0.0 OUTLIER -71.6 -178.28 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.08 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.665 ' HA ' HG12 ' A' ' 130' ' ' VAL . 72.5 t80 -174.86 135.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 65.41 110.891 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.828 ' HB3' HG23 ' A' ' 129' ' ' THR . 26.9 t80 -120.53 95.03 49.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.663 0.744 . . . . 50.14 110.919 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -48.71 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.686 2.257 . . . . 62.34 112.287 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.22 -155.44 24.46 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 73.44 112.451 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.03 123.59 37.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 72.11 110.858 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.486 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.69 -98.03 0.54 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.708 -0.758 . . . . 73.53 112.438 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -68.84 -27.64 66.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 72.25 110.878 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.62 154.02 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 75.41 111.131 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.57 -32.55 65.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.865 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.632 ' OD2' HD12 ' A' ' 114' ' ' LEU . 3.0 p30 -116.31 51.73 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 71.34 110.925 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 0.9 OUTLIER -99.75 138.8 36.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 60.34 110.865 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.535 HD12 HG22 ' A' ' 142' ' ' THR . 6.8 pt -139.37 167.22 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 75.13 111.121 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 m -117.75 147.73 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 63.43 111.131 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.468 HG21 HG13 ' A' ' 55' ' ' VAL . 88.8 t -100.67 142.66 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 75.42 111.115 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -128.9 147.35 50.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 63.34 110.915 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.631 HD23 HG13 ' A' ' 140' ' ' VAL . 14.8 mt -125.11 95.91 40.8 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.62 0.724 . . . . 54.23 110.894 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 72.4 1.43 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.674 2.25 . . . . 73.11 112.343 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.5 -34.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 70.2 110.942 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.449 ' CB ' HD13 ' A' ' 163' ' ' ILE . 2.9 m-85 -116.97 -13.51 10.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 64.33 110.985 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.17 25.37 5.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 62.41 110.926 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.508 HG13 ' HB3' ' A' ' 205' ' ' ALA . 1.6 mp -98.13 118.0 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 73.22 111.151 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.39 137.14 41.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 43.4 110.875 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.784 HG22 HD13 ' A' ' 44' ' ' LEU . 19.4 t -118.94 65.15 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 72.52 111.08 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.25 -52.77 34.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 53.42 112.444 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 103.5 -132.07 10.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.796 -0.716 . . . . 43.41 112.463 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 34.0 m -65.14 -23.66 67.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 61.24 110.886 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.664 HD12 ' NE1' ' A' ' 189' ' ' TRP . 24.5 tp -64.02 -52.1 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.51 110.871 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.751 HG11 HG11 ' A' ' 206' ' ' VAL . 21.3 t -88.44 109.06 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 74.22 111.107 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.527 ' H ' HG23 ' A' ' 222' ' ' THR . 0.4 OUTLIER -81.37 149.87 28.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 61.44 110.923 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.631 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.3 t -72.42 164.32 26.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 60.02 110.889 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.569 HG23 HD23 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -67.84 -29.1 68.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 72.52 111.115 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.73 -26.57 62.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 63.12 110.845 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.69 159.48 5.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 53.31 111.076 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.472 ' O ' HD22 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -117.88 -30.78 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 75.21 110.791 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -152.68 177.15 10.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 53.23 110.862 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.644 HD11 HD23 ' A' ' 226' ' ' LEU . 0.7 OUTLIER -79.8 -40.27 28.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 72.1 110.937 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 99.4 -152.9 19.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 33.53 112.523 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -53.02 133.94 38.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 75.41 110.9 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.497 HG11 ' CG2' ' A' ' 186' ' ' VAL . 15.9 m -129.63 31.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 74.12 111.162 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.29 -42.54 77.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 75.44 111.168 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.98 34.89 5.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.8 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.54 162.7 23.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 64.13 111.118 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -115.3 93.53 4.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 73.5 110.885 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.497 ' CG2' HG11 ' A' ' 181' ' ' VAL . 66.1 t -69.11 -21.29 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 63.22 111.154 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.39 -26.02 30.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 54.3 110.878 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -97.9 -21.08 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 70.13 110.87 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.664 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.4 t90 -51.15 -56.89 10.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 71.31 110.909 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 25.8 p -52.01 -36.91 51.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.856 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 96.0 m -70.82 -35.24 72.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 75.4 111.172 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 196' ' ' VAL . 50.7 m -66.47 -52.18 48.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 63.02 110.841 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.665 HG22 HD23 ' A' ' 197' ' ' LEU . 35.5 mm -56.47 -37.95 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 73.11 111.171 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -62.08 -24.15 66.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 72.04 110.879 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -89.35 -25.54 21.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 62.33 110.909 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.517 HG12 HD21 ' A' ' 219' ' ' LEU . 43.2 t -81.89 -33.59 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 71.43 111.194 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.665 HD23 HG22 ' A' ' 193' ' ' ILE . 4.6 pp -81.72 -25.53 35.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 72.31 110.904 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.452 ' N ' HD12 ' A' ' 197' ' ' LEU . 1.4 mttt -83.08 -44.4 15.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 74.31 110.928 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -56.21 -29.05 60.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 74.14 110.891 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -142.58 119.15 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 74.41 110.866 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.31 34.41 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 74.13 110.906 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -144.85 22.19 1.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 72.02 110.834 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.458 ' H ' HD12 ' A' ' 203' ' ' ILE . 3.5 mp -52.29 147.53 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.141 -0.481 . . . . 72.1 111.106 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -109.86 -25.77 10.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.109 -0.496 . . . . 72.4 110.909 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.508 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -163.58 132.54 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 65.53 111.124 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.751 HG11 HG11 ' A' ' 170' ' ' VAL . 89.0 t -115.12 122.15 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 75.21 111.097 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 213' ' ' VAL . 96.4 t -105.28 109.7 63.52 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.609 0.719 . . . . 64.41 111.141 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 52.8 Cg_endo -69.83 -167.99 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.711 2.274 . . . . 63.35 112.286 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.37 -32.23 6.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 62.51 112.522 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -138.49 101.16 4.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.854 0.359 . . . . 74.55 110.887 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 150.99 -113.86 0.61 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 72.51 112.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.77 167.96 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 70.12 110.878 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.857 HG22 HG22 ' A' ' 207' ' ' VAL . 21.7 t -71.31 150.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 62.04 111.123 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.75 -107.05 0.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 54.03 112.492 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -162.92 -170.15 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 73.44 110.836 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -20.33 37.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 75.21 110.942 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.754 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -56.89 -33.13 63.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.787 -0.72 . . . . 74.34 112.477 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.631 HD22 ' HA ' ' A' ' 172' ' ' SER . 31.5 mt -51.07 -45.35 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.874 0.369 . . . . 73.14 110.905 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.517 HD21 HG12 ' A' ' 196' ' ' VAL . 6.5 mp -55.93 -42.96 76.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.891 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.754 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -66.73 -41.41 87.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 70.4 110.963 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.652 ' NE2' HD21 ' A' ' 225' ' ' LEU . 85.8 t60 -61.58 -39.27 90.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 72.03 110.885 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.1 OUTLIER -51.68 -42.85 62.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 73.32 111.15 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.801 ' HA ' HD12 ' A' ' 226' ' ' LEU . 26.4 mt -61.19 -40.43 93.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 75.5 110.962 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -39.62 78.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 63.12 110.858 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.652 HD21 ' NE2' ' A' ' 221' ' ' HIS . 12.6 mt -64.71 -26.28 68.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.93 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 223' ' ' LEU . 5.3 mt -85.6 -42.09 14.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 65.42 110.921 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.2 mttt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.31 110.891 179.786 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.617 ' HD1' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.806 0.336 . . . . 71.13 110.868 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.46 118.52 4.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 74.31 110.852 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.36 167.06 6.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 62.11 110.934 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.01 134.68 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 73.25 111.133 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.44 26.44 0.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 71.33 110.878 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 148.73 44.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 74.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.496 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -146.65 -179.99 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 54.44 111.167 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.9 t 60.42 95.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 64.44 111.123 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.548 HD11 ' HE3' ' A' ' 74' ' ' LYS . 4.1 mm -90.3 153.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 75.5 111.132 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.23 172.29 13.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 71.01 110.884 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -107.22 179.0 4.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.875 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -63.65 -28.05 69.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.869 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -102.27 -33.82 9.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.14 -0.482 . . . . 64.32 111.132 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.58 -5.92 48.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 73.13 112.452 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.735 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.78 -33.09 21.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.762 0.315 . . . . 71.53 111.125 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.735 HG13 HG23 ' A' ' 15' ' ' THR . 8.6 mt -126.36 150.86 32.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 75.14 111.106 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 p -171.16 163.76 7.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 54.35 110.851 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.654 HD12 ' NZ ' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -129.25 -175.8 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 63.22 111.112 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.414 ' H ' HG22 ' A' ' 18' ' ' ILE . 3.1 t -167.15 135.54 2.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.44 110.792 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -71.5 117.87 13.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.112 -0.495 . . . . 62.43 110.919 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.403 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.8 mm? -99.75 -73.11 0.64 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 71.44 110.93 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -132.31 -170.37 2.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.939 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' O ' HG23 ' A' ' 25' ' ' VAL . 11.4 mtpt -52.67 109.97 0.46 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 72.12 110.913 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 58.47 24.26 11.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.842 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 23' ' ' LYS . 92.7 t -123.28 114.94 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 63.04 111.128 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CH2' HG22 ' A' ' 7' ' ' THR . 15.0 m95 -124.76 160.64 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 73.52 110.875 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 213' ' ' VAL . 69.8 t -122.98 108.69 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.071 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.585 ' HB3' HG23 ' A' ' 18' ' ' ILE . 7.3 p80 -102.3 138.24 39.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 74.42 110.873 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.477 HG23 ' C ' ' A' ' 41' ' ' SER . 41.0 m -138.77 117.5 12.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 63.23 111.135 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -101.39 -172.89 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 43.23 110.919 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.007 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -141.28 130.45 23.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 54.21 110.905 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.19 132.46 6.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.747 -0.74 . . . . 62.53 112.479 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.4 147.8 5.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 70.41 110.871 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.413 ' CD2' HG21 ' A' ' 39' ' ' VAL . 17.6 t80 -173.22 118.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 74.52 110.879 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.12 38.08 10.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 54.42 110.895 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.69 34.78 89.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.683 -0.77 . . . . 72.11 112.524 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -151.7 -172.79 4.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.8 0.333 . . . . 72.12 110.941 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.007 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -111.7 132.65 54.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 72.35 111.165 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.786 HG11 ' HD1' ' A' ' 303' ' ' RTD . 61.1 t -134.08 104.05 11.62 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.699 . . . . 63.13 111.07 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.9 Cg_endo -69.72 142.67 48.76 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 72.21 112.322 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.477 ' C ' HG23 ' A' ' 29' ' ' THR . 0.9 OUTLIER -122.63 114.53 20.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 64.23 110.84 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -60.81 169.94 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 72.3 110.863 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.629 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -172.28 -166.68 31.25 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.701 -0.762 . . . . 75.24 112.466 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.014 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -163.2 145.52 10.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 65.21 110.832 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 HD13 ' A' ' 54' ' ' LEU . 36.8 t -129.67 134.13 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 64.41 111.136 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.7 mt -102.71 126.72 49.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 72.4 110.901 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -97.32 59.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 63.34 110.878 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.516 HG21 ' HB2' ' A' ' 135' ' ' PHE . 28.1 p -68.04 171.6 6.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 74.33 111.091 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -97.13 30.2 2.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 72.21 110.875 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -156.54 35.52 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 74.33 110.935 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.74 126.03 5.54 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.787 -0.721 . . . . 50.44 112.506 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.735 HD21 ' HB3' ' A' ' 75' ' ' PHE . 30.9 mt -56.81 172.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 62.51 110.956 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 81' ' ' ASP . 98.0 t -150.08 143.42 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.233 -0.439 . . . . 63.44 111.094 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.563 HD13 HG22 ' A' ' 45' ' ' VAL . 3.3 mm? -114.9 128.37 56.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.43 . . . . 65.31 110.944 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 55' ' ' VAL . 14.0 t -77.67 -3.77 5.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.22 -0.446 . . . . 74.31 111.181 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.44 134.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.861 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -167.02 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 70.14 110.873 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.4 m -97.33 -175.84 3.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 61.42 110.928 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.699 ' HB2' HD13 ' A' ' 63' ' ' LEU . 93.6 m95 -64.45 -38.38 90.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 74.21 110.97 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -142.94 167.16 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 74.11 110.829 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.73 -35.77 80.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 75.24 110.789 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -69.39 -23.47 63.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.1 110.92 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -83.8 -50.78 7.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 73.51 110.945 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -60.33 -29.49 68.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 75.4 111.121 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -55.5 -40.65 72.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 73.21 110.872 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -88.15 3.17 50.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 71.11 110.888 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.562 HD21 ' CE1' ' A' ' 28' ' ' HIS . 12.7 tp -98.45 -41.75 7.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 73.11 110.942 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.2 mt -65.54 -34.44 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 73.12 111.074 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -69.29 -11.13 60.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.11 110.958 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 39.4 mtp -81.82 -50.85 8.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 64.24 110.87 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.544 ' HB ' HD13 ' A' ' 52' ' ' LEU . 29.1 m -67.42 -37.0 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 74.41 111.16 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -79.11 51.85 1.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 63.44 110.956 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -137.16 -42.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 71.01 110.901 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.654 ' NZ ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -106.15 -19.71 13.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.919 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.735 ' HB3' HD21 ' A' ' 52' ' ' LEU . 24.7 m-85 -91.83 6.2 47.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.04 110.893 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.501 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.3 pp0? 32.19 48.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.849 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -150.87 -178.14 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.942 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.581 ' HD2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER -130.53 138.91 50.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.272 -0.422 . . . . 72.42 110.859 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 52' ' ' LEU . 96.1 t -70.54 132.89 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 53.25 111.103 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.581 HG23 ' HD2' ' A' ' 78' ' ' ARG . 37.4 p -139.95 15.06 2.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 73.4 111.158 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.562 ' HB2' HG13 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -148.65 131.14 15.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 63.01 110.827 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 98' ' ' LEU . 20.5 t -134.04 99.34 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 65.14 111.077 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.4 mt -74.24 120.5 23.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 74.41 111.171 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 91' ' ' ARG . 45.1 mm -108.12 128.5 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.22 111.116 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.0 p -85.47 -58.01 2.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 71.14 111.127 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.582 ' HA ' HG23 ' A' ' 111' ' ' THR . 31.7 p-80 -128.97 -175.22 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.842 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -103.16 100.63 10.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 73.54 111.137 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.673 ' O ' HD13 ' A' ' 92' ' ' ILE . 3.6 m170 -154.4 160.96 41.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.02 110.908 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.84 -28.76 62.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 71.1 111.042 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.0 13.19 17.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 74.22 110.866 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.472 ' O ' HD12 ' A' ' 84' ' ' ILE . 1.5 mpt_? -125.29 -50.78 1.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 70.2 110.877 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.673 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -119.54 15.44 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 72.24 111.133 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.88 -36.95 34.56 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.639 -0.791 . . . . 73.25 112.561 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.97 18.13 50.54 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.785 -0.721 . . . . 63.43 112.502 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.575 HG21 ' H ' ' A' ' 121' ' ' GLU . 5.0 tt -45.92 -31.13 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 73.52 111.127 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -55.09 18.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 73.34 110.948 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -57.54 -40.98 80.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 62.32 111.143 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.482 HD13 HG21 ' A' ' 82' ' ' VAL . 30.5 mt -58.31 -30.05 66.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 72.31 110.959 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -100.29 23.86 9.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 70.51 110.925 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -114.83 -30.39 6.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 70.23 110.87 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.0 mtp85 -100.26 -21.99 15.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 71.51 110.892 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.69 13.69 5.03 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 63.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 13.8 mt -81.85 155.8 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.94 0.4 . . . . 53.54 111.112 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.637 ' HB2' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -120.16 124.01 44.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 74.34 110.919 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.52 82.55 6.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 72.52 111.126 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.546 ' HA ' HD12 ' A' ' 124' ' ' LEU . 87.9 m-70 -51.73 143.45 12.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 75.13 110.849 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.73 151.63 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 73.14 110.832 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.646 HG22 ' HB3' ' A' ' 127' ' ' LEU . 60.9 p -74.87 175.02 8.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 75.22 111.148 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.26 83.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 51.43 111.03 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -65.93 -45.89 80.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 63.22 110.95 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.582 HG23 ' HA ' ' A' ' 86' ' ' HIS . 2.5 m -53.3 -40.68 64.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 44.04 111.179 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.561 ' HB1' ' OE2' ' A' ' 122' ' ' GLU . . . -73.41 -20.99 60.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 55.41 111.035 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -40.45 92.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.861 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.608 HD12 ' OD2' ' A' ' 152' ' ' ASP . 10.8 mt -87.97 -25.2 23.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 53.43 110.969 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.22 -65.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 63.11 111.118 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -23.83 63.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 61.4 110.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -23.03 67.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 73.54 110.89 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -95.67 -38.49 10.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 51.4 110.955 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.15 -5.64 3.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 75.14 112.543 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -59.5 -172.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 70.22 110.91 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.575 ' H ' HG21 ' A' ' 95' ' ' ILE . 7.7 mm-40 -96.36 -2.88 44.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 71.35 110.908 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.561 ' OE2' ' HB1' ' A' ' 112' ' ' ALA . 1.6 mt-10 66.21 130.7 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.609 0.718 . . . . 71.32 110.884 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.71 2.273 . . . . 72.14 112.348 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' A' ' 104' ' ' LYS . 69.3 mt -53.51 -34.31 57.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.896 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.08 39.07 49.0 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 42.24 112.466 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -136.34 58.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 73.02 110.876 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.646 ' HB3' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -137.71 -169.86 2.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 53.54 110.894 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.36 -168.69 3.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.896 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.817 HG23 ' HB3' ' A' ' 144' ' ' TYR . 86.9 m -50.23 -65.32 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 70.31 111.05 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 143' ' ' PHE . 58.8 t -120.77 112.14 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 71.12 111.181 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.641 HG22 HD23 ' A' ' 133' ' ' LEU . 82.1 m -113.41 111.73 22.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 55.13 111.167 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -73.34 99.52 2.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 73.01 110.85 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.641 HD23 HG22 ' A' ' 131' ' ' THR . 2.9 mt -88.44 151.1 22.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 62.22 110.885 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.38 128.43 13.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 74.43 110.841 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.516 ' HB2' HG21 ' A' ' 48' ' ' THR . 12.5 m-85 -130.58 -166.24 1.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 72.14 110.82 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -52.11 98.23 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.683 -0.77 . . . . 75.01 112.501 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 52.72 55.6 8.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 75.43 110.922 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.1 tpt -151.75 151.29 31.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 72.51 110.862 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -134.49 117.39 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.9 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.695 HG13 HD23 ' A' ' 158' ' ' LEU . 10.9 t -130.5 156.13 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 75.11 111.108 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -153.21 123.78 7.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 61.23 110.852 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.691 ' O ' HG13 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -74.98 -178.03 3.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 74.41 111.151 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.754 ' HA ' HG22 ' A' ' 130' ' ' VAL . 75.4 t80 -175.45 137.49 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.24 110.819 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.817 ' HB3' HG23 ' A' ' 129' ' ' THR . 28.1 t80 -120.63 95.89 48.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.725 0.774 . . . . 74.42 110.884 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.2 Cg_endo -69.86 -48.74 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.653 2.235 . . . . 74.55 112.306 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.78 -155.94 24.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.771 -0.728 . . . . 53.22 112.512 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.0 124.68 39.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.741 0.305 . . . . 73.25 110.902 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.486 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -137.46 -94.51 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 71.42 112.453 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -69.83 -28.58 65.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 74.34 110.879 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.24 158.18 43.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 50.42 111.165 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -61.33 -25.42 67.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 70.32 110.949 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.673 ' HB3' HD12 ' A' ' 110' ' ' LEU . 1.3 p30 -121.42 49.57 1.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.497 . . . . 74.12 110.901 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.0 OUTLIER -98.59 138.12 36.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 72.42 110.923 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.668 HD12 HG22 ' A' ' 142' ' ' THR . 7.4 pt -138.41 171.01 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 64.21 111.142 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.423 ' CG1' HD22 ' A' ' 169' ' ' LEU . 10.6 m -121.24 144.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 74.13 111.131 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.79 142.65 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 62.12 111.162 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -129.05 148.84 51.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.482 . . . . 73.14 110.917 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.695 HD23 HG13 ' A' ' 140' ' ' VAL . 24.3 mt -125.65 94.74 41.83 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.618 0.723 . . . . 75.21 110.899 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 71.92 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.702 2.268 . . . . 63.32 112.347 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.59 -34.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 74.43 110.886 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.489 ' CB ' HD13 ' A' ' 163' ' ' ILE . 6.6 m-85 -117.7 -12.8 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 63.04 110.957 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.0 m120 69.18 25.29 5.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 45.11 110.898 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.518 ' HB ' HD12 ' A' ' 158' ' ' LEU . 1.6 mp -97.31 117.66 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.102 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.42 137.65 40.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 75.03 110.875 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 44' ' ' LEU . 20.7 t -121.35 63.07 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 63.35 111.103 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.93 -57.06 13.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.755 -0.736 . . . . 71.22 112.467 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.56 -135.57 12.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 72.3 112.485 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 34.7 m -61.49 -25.11 67.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 52.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.484 HD13 ' OD1' ' A' ' 153' ' ' ASN . 0.6 OUTLIER -63.3 -51.85 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 74.13 110.941 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 206' ' ' VAL . 39.8 t -89.91 103.55 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 72.4 111.15 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.517 ' H ' HG23 ' A' ' 222' ' ' THR . 1.1 tppt? -74.47 151.41 39.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 72.33 110.908 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.649 ' HA ' HD22 ' A' ' 218' ' ' LEU . 5.1 p -74.72 169.51 17.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.009 0.433 . . . . 50.41 110.804 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.507 HG23 HD23 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -70.92 -36.87 72.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.097 -0.501 . . . . 70.23 111.116 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -37.48 85.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 61.13 110.86 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.26 170.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 72.01 111.043 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -158.4 24.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.889 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -173.35 157.22 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 53.43 110.85 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.493 HD11 HD23 ' A' ' 226' ' ' LEU . 2.4 mt -87.13 -33.37 19.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 90.3 -166.94 32.35 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 65.04 112.529 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -52.16 112.91 0.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 72.23 110.892 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.7 m -108.4 33.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 74.32 111.165 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -55.38 -42.19 73.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 71.34 111.107 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -116.23 37.07 3.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 52.11 110.875 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.31 164.39 23.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 33.34 111.052 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -116.44 92.75 3.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 63.23 110.901 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.474 HG13 HD23 ' A' ' 226' ' ' LEU . 46.1 t -69.57 -22.62 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.32 111.091 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -80.65 -26.57 37.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 73.05 110.882 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -97.84 -22.76 16.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 75.51 110.964 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.5 -57.51 8.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 70.41 110.884 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.84 -35.93 46.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 62.02 110.801 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 94.0 m -72.74 -32.35 65.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 71.42 111.177 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 71.8 m -69.14 -52.67 25.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 63.23 110.88 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.681 HG22 HD23 ' A' ' 197' ' ' LEU . 34.0 mm -54.32 -41.8 54.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 75.22 111.086 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.71 -19.72 59.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.886 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -93.19 -23.87 18.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 65.33 110.919 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.432 HG12 HD21 ' A' ' 219' ' ' LEU . 33.3 t -85.65 -26.39 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.501 . . . . 73.04 111.159 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.681 HD23 HG22 ' A' ' 193' ' ' ILE . 4.6 pp -89.29 -25.29 21.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 65.3 110.912 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.477 ' N ' HD12 ' A' ' 197' ' ' LEU . 4.7 ptmm? -81.54 -31.37 32.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 70.43 110.922 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -72.67 -28.68 62.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 41.32 110.89 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -141.77 117.18 10.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 72.22 110.984 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -119.5 26.0 9.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 64.32 110.93 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.54 22.58 3.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 60.44 110.893 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.1 mp -51.6 146.88 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 71.11 111.121 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -107.23 -25.7 11.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 72.15 110.871 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.482 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -164.07 133.39 3.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 43.55 111.163 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.747 ' CG1' HD12 ' A' ' 218' ' ' LEU . 97.9 t -114.16 124.0 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.273 -0.421 . . . . 50.43 111.133 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.014 HG21 HD11 ' A' ' 44' ' ' LEU . 52.1 t -107.35 104.87 54.18 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.629 0.728 . . . . 75.4 111.125 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.5 Cg_endo -69.77 178.43 4.59 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.651 2.234 . . . . 50.31 112.307 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.05 -29.38 34.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 65.24 112.512 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -143.14 113.38 7.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 71.43 110.821 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 140.25 -112.61 0.82 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 75.55 112.478 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -155.05 166.55 33.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 74.1 110.888 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.763 HG22 HG22 ' A' ' 207' ' ' VAL . 21.8 t -72.41 150.03 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 51.15 111.168 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.35 -108.34 0.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.832 -0.699 . . . . 73.53 112.541 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -157.98 -173.33 4.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.931 0.396 . . . . 62.22 110.866 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -56.28 -21.53 24.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 72.32 110.869 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.749 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -55.41 -31.76 57.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 74.11 112.478 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.747 HD12 ' CG1' ' A' ' 206' ' ' VAL . 37.4 mt -50.91 -46.93 60.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.338 . . . . 75.44 110.869 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.446 ' O ' HG21 ' A' ' 193' ' ' ILE . 6.0 mp -55.06 -43.54 73.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 71.45 110.886 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.749 HD12 ' HA2' ' A' ' 217' ' ' GLY . 5.4 mt -66.65 -41.55 88.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 64.21 110.875 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.696 ' NE2' HD21 ' A' ' 225' ' ' LEU . 85.1 t60 -61.46 -37.65 84.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 72.23 110.882 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.2 OUTLIER -51.76 -45.09 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 73.43 111.13 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.829 ' HA ' HD12 ' A' ' 226' ' ' LEU . 49.8 mt -58.16 -39.8 79.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.428 . . . . 74.2 110.872 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.47 -37.58 78.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 64.44 110.906 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.696 HD21 ' NE2' ' A' ' 221' ' ' HIS . 11.2 mt -68.67 -26.04 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 72.14 110.879 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 223' ' ' LEU . 3.1 mt -86.68 -41.66 14.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 63.41 110.917 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 65.05 110.878 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.786 ' HD1' HG11 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.864 0.364 . . . . 75.15 110.84 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.82 129.99 19.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 63.11 110.894 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.15 175.15 10.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 64.44 110.906 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.6 p -169.91 146.06 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 65.43 111.171 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.21 167.28 4.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 74.41 110.838 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 63.42 160.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 71.14 110.874 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.462 HG22 ' CH2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -149.8 -179.58 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 64.44 111.206 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 18' ' ' ILE . 92.8 t 60.85 99.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 53.12 111.153 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.688 HD11 ' CE ' ' A' ' 74' ' ' LYS . 2.7 mm -93.26 154.3 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 74.33 111.127 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -149.12 164.02 35.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 65.31 110.938 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -94.7 -169.32 2.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.913 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -23.08 55.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.23 110.902 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.5 p -103.54 -35.99 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 65.21 111.137 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.07 -4.28 45.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 54.41 112.478 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.768 HG23 HG13 ' A' ' 16' ' ' ILE . 1.8 t -50.7 -33.36 22.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.687 0.28 . . . . 74.2 111.184 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.768 HG13 HG23 ' A' ' 15' ' ' THR . 6.7 mt -127.83 159.46 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 72.22 111.126 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -175.82 167.18 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 65.53 110.807 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.551 HG23 ' HB3' ' A' ' 28' ' ' HIS . 0.3 OUTLIER -130.25 -175.78 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 71.53 111.198 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.405 ' H ' HG22 ' A' ' 18' ' ' ILE . 1.9 t -168.98 129.73 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 75.44 110.797 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.51 120.48 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 64.14 110.895 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HG ' HG23 ' A' ' 27' ' ' VAL . 1.7 mm? -103.53 -47.24 4.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.967 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -148.51 54.57 1.01 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 62.43 110.93 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.43 -77.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 62.4 110.852 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -83.63 -19.46 35.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 62.25 110.893 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.57 118.86 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 55.44 111.1 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.462 ' CH2' HG22 ' A' ' 7' ' ' THR . 16.5 m95 -125.25 158.91 32.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.158 -0.473 . . . . 64.25 110.894 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.404 HG23 ' HG ' ' A' ' 21' ' ' LEU . 73.0 t -121.86 109.52 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 72.12 111.113 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.551 ' HB3' HG23 ' A' ' 18' ' ' ILE . 7.2 p80 -103.23 138.51 39.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.805 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.7 m -135.39 133.55 38.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 61.33 111.171 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.562 ' OE2' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -124.39 174.61 7.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 73.53 110.881 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.667 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 4.7 tp -121.0 148.24 44.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 75.14 110.852 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.39 -121.86 2.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 74.4 112.493 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.34 150.37 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.877 0.37 . . . . 73.04 110.844 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -171.87 108.27 0.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 72.42 110.889 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.7 t30 51.66 53.24 13.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 54.22 110.866 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.06 26.09 67.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.663 -0.779 . . . . 61.12 112.507 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -151.63 121.75 7.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 71.03 110.874 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.667 ' HB1' ' HG ' ' A' ' 31' ' ' LEU . . . -52.99 139.52 27.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.54 111.026 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.641 HG21 ' HD2' ' A' ' 303' ' ' RTD . 2.2 p -124.12 126.68 25.54 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.681 0.753 . . . . 63.24 111.05 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.535 ' HA ' HD12 ' A' ' 31' ' ' LEU . 53.5 Cg_endo -69.71 143.03 49.76 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.625 2.217 . . . . 72.44 112.352 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.0 t -129.96 95.23 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 52.32 110.825 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.96 162.47 0.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 70.42 110.846 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.646 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -164.09 -162.85 15.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 64.41 112.459 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -162.43 148.23 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 74.22 110.859 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 54' ' ' LEU . 62.0 t -131.43 138.1 53.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 75.52 111.043 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.483 HD22 ' HE3' ' A' ' 138' ' ' MET . 24.8 mt -105.39 136.89 44.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.48 . . . . 70.05 110.903 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -110.24 72.12 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 63.13 110.863 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 138' ' ' MET . 20.7 p -79.47 -173.22 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 62.12 111.162 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 t -107.61 28.05 8.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 74.41 110.87 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -154.32 25.01 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 70.51 110.916 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.45 137.35 5.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 73.13 112.494 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.8 HD13 ' HB ' ' A' ' 71' ' ' VAL . 9.2 mt -68.65 164.36 21.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 72.34 110.9 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' ' 81' ' ' ASP . 84.4 t -140.0 144.51 27.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 64.44 111.088 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.639 HD13 HG22 ' A' ' 45' ' ' VAL . 3.3 mm? -115.28 130.35 56.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.915 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG13 HG21 ' A' ' 156' ' ' VAL . 12.7 t -79.57 -1.72 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 71.14 111.179 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.5 130.58 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 75.13 110.895 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.426 ' OG ' HD11 ' A' ' 98' ' ' LEU . 7.7 m -67.19 -168.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.836 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.47 -172.31 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 74.11 110.848 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.567 ' CZ2' HG13 ' A' ' 39' ' ' VAL . 86.5 m95 -72.9 -44.92 60.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.112 -0.495 . . . . 73.32 110.888 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -132.68 151.12 52.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.913 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -54.55 -30.81 55.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.448 . . . . 73.13 110.853 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.0 tttt -76.75 -26.84 55.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.862 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 -46.23 17.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 74.44 110.933 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 t -56.12 -25.38 45.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 63.52 111.111 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -55.28 -43.63 74.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.894 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -81.54 -4.5 56.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 65.5 110.877 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.562 HD22 ' OE2' ' A' ' 30' ' ' GLU . 16.4 tp -93.84 -45.62 7.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.219 -0.446 . . . . 70.01 110.927 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.0 mt -69.91 -33.42 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 62.32 111.096 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -67.61 -12.64 60.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 70.32 110.956 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.9 mmm -84.74 -59.47 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 54.03 110.944 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.8 ' HB ' HD13 ' A' ' 52' ' ' LEU . 28.0 m -55.04 -36.26 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 71.23 111.2 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HG3' HG23 ' A' ' 71' ' ' VAL . 55.6 mt-10 -88.13 48.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 74.11 110.869 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -142.92 -41.87 0.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 70.45 110.939 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.688 ' CE ' HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -102.58 -24.54 13.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 63.34 110.878 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.657 ' HB3' HD21 ' A' ' 52' ' ' LEU . 37.4 m-85 -90.34 11.32 21.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 65.4 110.873 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.506 ' HG3' ' C ' ' A' ' 75' ' ' PHE . 3.5 pp0? 32.69 47.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 62.35 110.874 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -150.85 -178.43 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.881 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 149.16 50.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 75.23 110.87 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 52' ' ' LEU . 60.2 t -86.26 127.21 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 75.21 111.156 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 p -139.03 24.41 2.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 71.25 111.205 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.803 ' HB2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -153.74 133.51 13.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.889 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 82' ' ' VAL . 13.5 t -139.88 102.39 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 73.31 111.137 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.1 mt -79.11 115.68 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 62.4 111.134 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.483 HG23 ' HB3' ' A' ' 91' ' ' ARG . 46.4 mm -104.35 122.3 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 70.24 111.094 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.1 p -79.16 -58.25 3.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 74.13 111.148 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -127.36 -175.09 3.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 70.24 110.865 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 111' ' ' THR . . . -103.82 99.39 9.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 54.04 111.111 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.632 ' O ' HD13 ' A' ' 92' ' ' ILE . 4.5 m170 -152.88 159.66 43.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.834 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.69 -22.96 58.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 74.25 111.155 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.86 3.59 54.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 72.24 110.881 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HB3' HG23 ' A' ' 84' ' ' ILE . 25.5 mmt-85 -118.1 -52.17 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 71.54 110.867 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.632 HD13 ' O ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER -114.78 19.31 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 72.2 111.133 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.84 -29.29 26.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 52.44 112.484 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.36 22.05 20.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 74.11 112.483 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 tt -45.38 -32.05 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 64.44 111.129 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -54.89 18.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 64.22 110.906 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 m -56.05 -40.02 72.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 63.0 111.207 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 103' ' ' ILE . 31.5 mt -59.22 -35.52 73.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 75.03 110.921 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.95 19.38 9.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 70.34 110.939 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.13 -25.95 6.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.442 . . . . 52.54 110.92 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -106.48 7.52 30.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 73.23 110.801 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.99 14.69 66.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.749 -0.739 . . . . 61.42 112.49 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 98' ' ' LEU . 16.0 mt -80.79 154.19 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.877 0.37 . . . . 74.54 111.147 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.762 ' HB2' HD11 ' A' ' 124' ' ' LEU . 1.6 ptmt -117.41 119.56 35.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 71.21 110.863 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.05 81.3 6.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 54.31 111.052 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.606 ' HA ' HD12 ' A' ' 124' ' ' LEU . 93.8 m-70 -54.55 147.54 14.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 63.43 110.825 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.73 157.99 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 51.13 110.834 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 127' ' ' LEU . 20.3 p -82.35 157.68 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.42 111.146 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.34 -39.42 56.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.14 111.091 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -66.07 -40.98 91.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 65.31 110.926 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 96.8 m -56.29 -41.68 76.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 71.21 111.175 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.469 ' HB1' ' OE1' ' A' ' 122' ' ' GLU . . . -73.44 -22.58 60.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 75.4 111.064 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.66 -41.22 81.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 71.13 110.943 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.591 HD12 ' OD2' ' A' ' 152' ' ' ASP . 7.7 mt -84.05 -27.71 28.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 64.32 110.956 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.43 -69.49 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 40.22 111.144 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -55.19 -26.3 38.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 71.22 110.912 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -24.5 67.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 74.15 110.873 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -93.56 -39.08 11.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 64.22 110.91 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 137.24 -6.7 3.68 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 73.2 112.494 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -59.75 -172.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.931 0.396 . . . . 64.32 110.906 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -97.55 -1.76 43.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.041 -0.527 . . . . 75.33 110.925 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.469 ' OE1' ' HB1' ' A' ' 112' ' ' ALA . 1.3 mt-10 66.38 129.93 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.601 0.715 . . . . 54.53 110.938 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -169.42 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.708 2.272 . . . . 70.35 112.338 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.762 HD11 ' HB2' ' A' ' 104' ' ' LYS . 91.4 mt -51.96 -46.53 64.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.888 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.86 57.75 14.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.798 -0.715 . . . . 51.34 112.509 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -152.09 51.07 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 72.35 110.869 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.655 ' HB3' HG22 ' A' ' 108' ' ' THR . 1.3 mp -129.91 -177.47 4.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.88 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.58 -168.38 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.22 110.906 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.755 HG23 ' HB3' ' A' ' 144' ' ' TYR . 98.0 m -49.73 -45.21 49.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.14 111.119 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 143' ' ' PHE . 3.6 m -141.31 142.6 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 73.44 111.157 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.637 HG22 HD23 ' A' ' 133' ' ' LEU . 63.6 m -149.56 110.89 4.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 72.43 111.139 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.02 98.93 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.834 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.637 HD23 HG22 ' A' ' 131' ' ' THR . 2.8 mt -89.19 150.22 22.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 72.45 110.887 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.18 109.6 4.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 73.31 110.933 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.694 ' HB2' HG21 ' A' ' 48' ' ' THR . 23.6 m-85 -112.5 113.03 24.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 52.44 110.782 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 54.78 -101.06 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.756 -0.735 . . . . 31.53 112.446 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -120.08 54.78 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.346 . . . . 65.43 110.899 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.782 ' HB2' HG22 ' A' ' 48' ' ' THR . 3.1 tpp -142.05 155.29 45.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 52.34 110.899 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.66 119.42 27.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 54.01 110.864 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.567 HG13 HD23 ' A' ' 158' ' ' LEU . 3.9 t -136.44 159.89 37.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 71.02 111.115 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 140' ' ' VAL . 31.7 tt0 -163.12 123.67 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 74.34 110.915 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.0 178.3 4.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 74.44 111.156 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.428 ' HA ' HG12 ' A' ' 130' ' ' VAL . 75.2 t80 -172.72 135.03 0.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 72.24 110.836 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.755 ' HB3' HG23 ' A' ' 129' ' ' THR . 68.4 t80 -117.21 92.13 38.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.763 0.792 . . . . 70.11 110.964 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -48.6 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.642 2.228 . . . . 51.4 112.345 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.02 -170.46 43.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.806 -0.712 . . . . 72.14 112.537 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -83.78 125.14 31.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.797 0.332 . . . . 61.11 110.924 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.48 ' H ' ' ND2' ' A' ' 153' ' ' ASN . . . -135.73 -87.23 0.23 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 71.12 112.468 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -77.89 -28.57 49.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 72.21 110.761 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.16 159.39 43.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 75.2 111.136 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.05 -23.66 67.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.828 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.604 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -125.29 52.89 1.57 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 71.31 110.921 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 148' ' ' GLY . 1.7 p30 -100.35 148.3 24.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.851 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.7 pt -147.04 162.5 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 63.35 111.128 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.502 HG11 HG21 ' A' ' 196' ' ' VAL . 8.0 m -109.73 139.01 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.13 111.202 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.514 HG21 HG13 ' A' ' 55' ' ' VAL . 74.5 t -93.35 129.18 44.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 65.12 111.07 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.437 ' O ' HD23 ' A' ' 158' ' ' LEU . 74.2 t-105 -117.06 150.6 38.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 71.24 110.946 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.609 HD12 ' HB ' ' A' ' 163' ' ' ILE . 26.3 mt -127.05 97.64 31.84 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.619 0.723 . . . . 73.32 110.992 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 70.86 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.684 2.256 . . . . 74.45 112.339 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.35 -34.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 70.23 110.884 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.619 ' CB ' HD13 ' A' ' 163' ' ' ILE . 7.0 m-85 -118.34 -11.64 10.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 64.25 110.886 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.0 m120 67.34 21.97 9.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 74.11 110.892 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.619 HD13 ' CB ' ' A' ' 161' ' ' TYR . 1.5 mp -86.15 115.26 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 64.44 111.155 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 165' ' ' VAL . 2.6 tm? -98.98 123.14 43.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 71.42 110.912 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.629 HG21 HD22 ' A' ' 44' ' ' LEU . 18.3 t -117.58 73.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 63.25 111.086 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.402 ' H ' HD13 ' A' ' 164' ' ' LEU . . . -64.06 -45.63 93.36 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.732 . . . . 52.41 112.521 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.42 -131.21 10.5 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 52.41 112.557 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.9 m -63.33 -22.45 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.818 0.342 . . . . 71.31 110.857 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.451 HD22 ' CG1' ' A' ' 155' ' ' VAL . 0.9 OUTLIER -64.9 -50.01 68.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.919 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.764 HG11 HG11 ' A' ' 206' ' ' VAL . 21.3 t -93.02 112.92 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 70.14 111.148 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.421 ' H ' HG23 ' A' ' 222' ' ' THR . 3.5 tppt? -83.0 154.45 24.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 62.12 110.882 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.617 ' HA ' HD22 ' A' ' 218' ' ' LEU . 15.8 p -78.13 162.11 26.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 74.01 110.889 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.591 HG23 HD23 ' A' ' 218' ' ' LEU . 1.5 p -66.06 -25.65 67.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 72.3 111.198 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 64.4 p -71.51 -31.44 67.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 52.11 110.912 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.08 170.86 2.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.494 . . . . 74.45 111.114 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -152.18 22.59 0.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.931 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.37 168.74 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.873 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 mt -93.91 -35.75 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 74.4 110.887 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.67 -167.08 24.21 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.743 . . . . 51.54 112.453 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -52.04 121.04 6.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 74.21 110.877 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.557 HG11 ' CG2' ' A' ' 186' ' ' VAL . 11.1 m -111.57 31.67 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 60.23 111.155 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.73 83.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 32.32 111.092 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -119.2 34.83 5.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 63.01 110.858 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -125.13 164.85 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 73.11 111.106 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -117.61 92.17 3.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.93 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.557 ' CG2' HG11 ' A' ' 181' ' ' VAL . 87.7 t -69.64 -23.88 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 73.25 111.108 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.28 -26.48 42.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.79 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.69 -24.07 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 72.51 110.879 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -51.55 -54.49 26.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 71.22 110.928 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -34.55 44.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 65.52 110.813 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 61.4 m -74.29 -35.71 63.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 62.13 111.15 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 196' ' ' VAL . 45.6 m -66.07 -55.55 16.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 54.35 110.905 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.792 HG22 HD23 ' A' ' 197' ' ' LEU . 34.3 mm -54.21 -46.99 68.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 64.35 111.122 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -58.38 -22.31 53.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.948 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -91.29 -25.03 19.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 42.32 110.917 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.502 HG21 HG11 ' A' ' 155' ' ' VAL . 91.8 t -84.05 -24.27 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 75.1 111.12 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.792 HD23 HG22 ' A' ' 193' ' ' ILE . 3.9 pp -95.85 -8.13 34.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 53.25 110.979 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.625 ' HG2' HD12 ' A' ' 197' ' ' LEU . 2.7 mmmt -113.15 -5.87 13.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 62.25 110.873 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -88.5 -23.83 23.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 72.14 110.838 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -118.41 -60.87 1.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.948 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.75 25.75 15.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 75.24 110.855 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.95 21.75 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.858 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.528 HG21 ' CG2' ' A' ' 206' ' ' VAL . 4.0 mp -55.33 145.0 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 63.34 111.134 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -106.86 -31.36 8.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.33 110.922 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.506 ' HB3' HG13 ' A' ' 163' ' ' ILE . . . -160.07 117.46 2.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 70.4 111.155 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.764 HG11 HG11 ' A' ' 170' ' ' VAL . 97.9 t -95.86 125.62 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 51.21 111.15 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 44' ' ' LEU . 58.4 t -107.46 109.07 62.47 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.581 0.705 . . . . 64.11 111.159 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -169.95 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.658 2.239 . . . . 73.11 112.35 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -106.49 -24.53 6.72 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.753 -0.736 . . . . 73.23 112.479 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -146.07 84.0 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 73.53 110.813 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 168.13 -102.0 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.759 . . . . 71.24 112.513 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.34 147.33 4.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.867 0.365 . . . . 72.01 110.876 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.62 143.89 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.132 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.56 -102.96 0.46 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 24.13 112.509 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -161.41 -169.83 2.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.801 0.334 . . . . 75.5 110.874 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -56.49 -21.77 28.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.865 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.753 ' HA2' HD12 ' A' ' 220' ' ' LEU . . . -54.82 -33.57 56.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.78 -0.724 . . . . 73.51 112.523 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.755 HD12 HG12 ' A' ' 206' ' ' VAL . 31.3 mt -50.86 -49.37 59.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 54.24 110.923 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.537 ' O ' HG21 ' A' ' 193' ' ' ILE . 1.1 mt -53.64 -42.25 67.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 71.22 110.89 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.753 HD12 ' HA2' ' A' ' 217' ' ' GLY . 6.7 mt -67.6 -41.39 84.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 52.31 110.93 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.4 -35.59 79.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.856 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -58.36 -45.17 88.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 75.45 111.191 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.713 ' HA ' HD12 ' A' ' 226' ' ' LEU . 82.4 mt -56.8 -37.86 71.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.963 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -42.81 97.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 72.55 110.946 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.25 -35.19 78.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 51.33 110.933 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 223' ' ' LEU . 2.8 mt -78.57 -29.49 46.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 63.44 110.862 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.4 mttp . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 71.43 110.834 179.925 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' RTD . . . . . 0.641 ' HD2' HG21 ' A' ' 39' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_